Psyllid ID: psy5690
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 434 | 2.2.26 [Sep-21-2011] | |||||||
| Q16832 | 855 | Discoidin domain-containi | yes | N/A | 0.511 | 0.259 | 0.451 | 1e-62 | |
| Q62371 | 854 | Discoidin domain-containi | yes | N/A | 0.506 | 0.257 | 0.456 | 1e-62 | |
| Q08345 | 913 | Epithelial discoidin doma | no | N/A | 0.513 | 0.244 | 0.405 | 4e-59 | |
| Q7YR43 | 909 | Epithelial discoidin doma | no | N/A | 0.513 | 0.245 | 0.405 | 5e-59 | |
| Q03146 | 911 | Epithelial discoidin doma | no | N/A | 0.513 | 0.244 | 0.405 | 7e-58 | |
| Q63474 | 910 | Epithelial discoidin doma | no | N/A | 0.513 | 0.245 | 0.402 | 3e-57 | |
| Q03351 | 864 | NT-3 growth factor recept | no | N/A | 0.562 | 0.282 | 0.345 | 8e-39 | |
| P10447 | 439 | Tyrosine-protein kinase t | N/A | N/A | 0.463 | 0.457 | 0.359 | 2e-38 | |
| P00521 | 746 | Tyrosine-protein kinase t | no | N/A | 0.495 | 0.288 | 0.329 | 3e-37 | |
| P00519 | 1130 | Tyrosine-protein kinase A | no | N/A | 0.463 | 0.177 | 0.347 | 8e-37 |
| >sp|Q16832|DDR2_HUMAN Discoidin domain-containing receptor 2 OS=Homo sapiens GN=DDR2 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 240 bits (613), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 120/266 (45%), Positives = 157/266 (59%), Gaps = 44/266 (16%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH---NCNSQENPAISYGCLI 57
M LKDPN++ ++ VC T+DP+ I EY E GDL+ FL H N +S + +SY L
Sbjct: 629 MSRLKDPNIIHLLAVCITDDPLCMITEYMENGDLNQFLSRHEPPNSSSSDVRTVSYTNLK 688
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
FMATQIASGMKYL S + VHRDLA RN
Sbjct: 689 FMATQIASGMKYLSSLNFVHRDLATRN--------------------------------- 715
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
C+VGKNYTIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT
Sbjct: 716 --------CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 767
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SDVW+F VTLWE C ++PY++L++EQVIEN ++++ +Q YLP+PA C ++ L
Sbjct: 768 SDVWAFGVTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQTYLPQPAICPDSVYKL 827
Query: 238 MLECWKTNETDRPRFSEIHLFLQRKN 263
ML CW+ + +RP F EIHL L ++
Sbjct: 828 MLSCWRRDTKNRPSFQEIHLLLLQQG 853
|
Tyrosine kinase that functions as cell surface receptor for fibrillar collagen and regulates cell differentiation, remodeling of the extracellular matrix, cell migration and cell proliferation. Required for normal bone development. Regulates osteoblast differentiation and chondrocyte maturation via a signaling pathway that involves MAP kinases and leads to the activation of the transcription factor RUNX2. Regulates remodeling of the extracellular matrix by up-regulation of the collagenases MMP1, MMP2 and MMP13, and thereby facilitates cell migration and tumor cell invasion. Promotes fibroblast migration and proliferation, and thereby contributes to cutaneous wound healing. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1 |
| >sp|Q62371|DDR2_MOUSE Discoidin domain-containing receptor 2 OS=Mus musculus GN=Ddr2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 240 bits (613), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 122/267 (45%), Positives = 157/267 (58%), Gaps = 47/267 (17%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH----NCNSQENPAISYGCL 56
M LKDPN++R++ VC TEDP+ I EY E GDL+ FL H +C+S + +SY L
Sbjct: 629 MSRLKDPNIIRLLAVCITEDPLCMITEYMENGDLNQFLSRHEPLSSCSS--DATVSYANL 686
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
FMATQIASGMKYL S + VHRDLA RN
Sbjct: 687 KFMATQIASGMKYLSSLNFVHRDLATRN-------------------------------- 714
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
C+VGKNYTIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT
Sbjct: 715 ---------CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT 765
Query: 177 KSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236
SDVW+F VTLWE C ++PY++L++EQVIEN ++++ +Q YLP+PA C ++
Sbjct: 766 ASDVWAFGVTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQIYLPQPALCPDSVYK 825
Query: 237 LMLECWKTNETDRPRFSEIHLFLQRKN 263
LML CW+ RP F EIHL L ++
Sbjct: 826 LMLSCWRRETKHRPSFQEIHLLLLQQG 852
|
Tyrosine kinase that functions as cell surface receptor for fibrillar collagen and regulates cell differentiation, remodeling of the extracellular matrix, cell migration and cell proliferation. Required for normal bone development. Regulates osteoblast differentiation and chondrocyte maturation via a signaling pathway that involves MAP kinases and leads to the activation of the transcription factor RUNX2. Regulates remodeling of the extracellular matrix by up-regulation of the collagenases MMP1, MMP2 and MMP13, and thereby facilitates cell migration and tumor cell invasion. Promotes fibroblast migration and proliferation, and thereby contributes to cutaneous wound healing. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q08345|DDR1_HUMAN Epithelial discoidin domain-containing receptor 1 OS=Homo sapiens GN=DDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 229 bits (583), Expect = 4e-59, Method: Compositional matrix adjust.
Identities = 112/276 (40%), Positives = 154/276 (55%), Gaps = 53/276 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH------------NCNSQEN 48
M LKDPN++R++GVC +DP+ I +Y E GDL+ FL H + + +
Sbjct: 676 MSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQG 735
Query: 49 PAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESD 108
P ISY L+ +A QIASGM+YL + + VHRDLA RN
Sbjct: 736 PTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRN------------------------ 771
Query: 109 YYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWES 168
C+VG+N+TIKI+D M + Y DYY +A LPIRWMAWE
Sbjct: 772 -----------------CLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWEC 814
Query: 169 LLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA 228
+L+GK TT SDVW+F VTLWE+L+ C +P+ +LT+EQVIEN ++++ +Q YL RP
Sbjct: 815 ILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPP 874
Query: 229 TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264
C + +++LML CW RP FS++H FL L
Sbjct: 875 ACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDAL 910
|
Tyrosine kinase that functions as cell surface receptor for fibrillar collagen and regulates cell attachment to the extracellular matrix, remodeling of the extracellular matrix, cell migration, differentiation, survival and cell proliferation. Collagen binding triggers a signaling pathway that involves SRC and leads to the activation of MAP kinases. Regulates remodeling of the extracellular matrix by up-regulation of the matrix metalloproteinases MMP2, MMP7 and MMP9, and thereby facilitates cell migration and wound healing. Required for normal blastocyst implantation during pregnancy, for normal mammary gland differentiation and normal lactation. Required for normal ear morphology and normal hearing (By similarity). Promotes smooth muscle cell migration, and thereby contributes to arterial wound healing. Also plays a role in tumor cell invasion. Phosphorylates PTPN11. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q7YR43|DDR1_PANTR Epithelial discoidin domain-containing receptor 1 OS=Pan troglodytes GN=DDR1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 229 bits (583), Expect = 5e-59, Method: Compositional matrix adjust.
Identities = 112/276 (40%), Positives = 154/276 (55%), Gaps = 53/276 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH------------NCNSQEN 48
M LKDPN++R++GVC +DP+ I +Y E GDL+ FL H + + +
Sbjct: 672 MSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDGQAAQG 731
Query: 49 PAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESD 108
P ISY L+ +A QIASGM+YL + + VHRDLA RN
Sbjct: 732 PTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRN------------------------ 767
Query: 109 YYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWES 168
C+VG+N+TIKI+D M + Y DYY +A LPIRWMAWE
Sbjct: 768 -----------------CLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWEC 810
Query: 169 LLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA 228
+L+GK TT SDVW+F VTLWE+L+ C +P+ +LT+EQVIEN ++++ +Q YL RP
Sbjct: 811 ILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPP 870
Query: 229 TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264
C + +++LML CW RP FS++H FL L
Sbjct: 871 ACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDAL 906
|
Tyrosine kinase that functions as cell surface receptor for fibrillar collagen and regulates cell attachment to the extracellular matrix, remodeling of the extracellular matrix, cell migration, differentiation, survival and cell proliferation. Collagen binding triggers a signaling pathway that involves SRC and leads to the activation of MAP kinases. Regulates remodeling of the extracellular matrix by up-regulation of the matrix metalloproteinases MMP2, MMP7 and MMP9, and thereby facilitates cell migration and wound healing. Promotes smooth muscle cell migration, and thereby contributes to arterial wound healing. Also plays a role in tumor cell invasion. Phosphorylates PTPN11. Required for normal blastocyst implantation during pregnancy, for normal mammary gland differentiation and normal lactation. Required for normal ear morphology and normal hearing. Pan troglodytes (taxid: 9598) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q03146|DDR1_MOUSE Epithelial discoidin domain-containing receptor 1 OS=Mus musculus GN=Ddr1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 224 bits (572), Expect = 7e-58, Method: Compositional matrix adjust.
Identities = 112/276 (40%), Positives = 154/276 (55%), Gaps = 53/276 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFL---QIHN---------CNSQEN 48
M LKDPN++R++GVC +DP+ I +Y E GDL+ FL Q+ N S +
Sbjct: 674 MSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSARQLENKATQGLSGDTESDQG 733
Query: 49 PAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESD 108
P ISY L+ + QIASGM+YL + + VHRDLA RN
Sbjct: 734 PTISYPMLLHVGAQIASGMRYLATLNFVHRDLATRN------------------------ 769
Query: 109 YYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWES 168
C+VG+N+TIKI+D M + Y DYY +A LPIRWMAWE
Sbjct: 770 -----------------CLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWEC 812
Query: 169 LLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA 228
+L+GK TT SDVW+F VTLWE+L+ C +P+ +LT+EQVIEN ++++ +Q YL RP
Sbjct: 813 ILMGKFTTASDVWAFGVTLWEVLMLCRSQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPP 872
Query: 229 TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264
C + +++LML CW RP F+++H FL L
Sbjct: 873 ACPQTLYELMLRCWSREPEQRPPFAQLHRFLADDAL 908
|
Tyrosine kinase that functions as cell surface receptor for fibrillar collagen and regulates cell attachment to the extracellular matrix, remodeling of the extracellular matrix, cell migration, differentiation, survival and cell proliferation. Collagen binding triggers a signaling pathway that involves SRC and leads to the activation of MAP kinases. Regulates remodeling of the extracellular matrix by up-regulation of the matrix metalloproteinases MMP2, MMP7 and MMP9, and thereby facilitates cell migration and wound healing, but also tumor cell invasion. Promotes smooth muscle cell migration, and thereby contributes to arterial wound healing. Phosphorylates PTPN11 (By similarity). Required for normal blastocyst implantation during pregnancy, for normal mammary gland differentiation and normal lactation. Required for normal ear morphology and normal hearing. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q63474|DDR1_RAT Epithelial discoidin domain-containing receptor 1 OS=Rattus norvegicus GN=Ddr1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 111/276 (40%), Positives = 151/276 (54%), Gaps = 53/276 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN------------SQEN 48
M LKD N++R++GVC +DP+ I +Y E GDL+ FL H S +
Sbjct: 673 MSRLKDLNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLENKVTQGLPGDRESDQG 732
Query: 49 PAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESD 108
P ISY L+ + QIASGM+YL + + VHRDLA RN
Sbjct: 733 PTISYPMLLHVGAQIASGMRYLATLNFVHRDLATRN------------------------ 768
Query: 109 YYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWES 168
C+VG+N+TIKI+D M + Y DYY +A LPIRWMAWE
Sbjct: 769 -----------------CLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWEC 811
Query: 169 LLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA 228
+L+GK TT SDVW+F VTLWE+L+ C +P+ +LT+EQVIEN ++++ +Q YL RP
Sbjct: 812 ILMGKFTTASDVWAFGVTLWEVLMLCRSQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPP 871
Query: 229 TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264
C + +++LML CW RP FS++H FL L
Sbjct: 872 ACPQTLYELMLRCWSREPEQRPPFSQLHRFLADDAL 907
|
Tyrosine kinase that functions as cell surface receptor for fibrillar collagen and regulates cell attachment to the extracellular matrix, remodeling of the extracellular matrix, cell migration, differentiation, survival and cell proliferation. Collagen binding triggers a signaling pathway that involves SRC and leads to the activation of MAP kinases. Regulates remodeling of the extracellular matrix by up-regulation of the matrix metalloproteinases MMP2, MMP7 and MMP9, and thereby facilitates cell migration and wound healing. Promotes smooth muscle cell migration, and thereby contributes to arterial wound healing. Also plays a role in tumor cell invasion. Phosphorylates PTPN11. Required for normal blastocyst implantation during pregnancy, for normal mammary gland differentiation and normal lactation. Required for normal ear morphology and normal hearing. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q03351|NTRK3_RAT NT-3 growth factor receptor OS=Rattus norvegicus GN=Ntrk3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 8e-39, Method: Compositional matrix adjust.
Identities = 95/275 (34%), Positives = 140/275 (50%), Gaps = 31/275 (11%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAI 51
+ +L+ ++V+ GVC DP+ + EY + GDL+ FL+ H ++ Q +
Sbjct: 592 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 651
Query: 52 SYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYL 111
++ +A+QIASGM YL S+ VHRDLA RNC+VG N +KI D M Y +DYY
Sbjct: 652 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 711
Query: 112 SDTKARLP--IRW----MANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 165
+ P + W +A + +D ++C LPIRWM
Sbjct: 712 EGPYQKGPFSVSWQQQRLAASAASTLFNPSGNDFCIWCE--------VGGHTMLPIRWMP 763
Query: 166 WESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLP 225
ES++ K TT+SDVWSF V LWEI + Q P+ +L+N +VIE ++ + L
Sbjct: 764 PESIMYRKFTTESDVWSFGVILWEIFTYGKQ-PWFQLSNTEVIECI-------TQGRVLE 815
Query: 226 RPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQ 260
RP C KE++D+ML CW+ R EI+ L
Sbjct: 816 RPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 850
|
Receptor for neurotrophin-3 (NTF3). This is a tyrosine-protein kinase receptor. Known substrates for the TRK receptors are SHC1, PI-3 kinase, and PLCG1. TrkC isoforms containing insertions within the kinase domain can autophosphorylate in response to NT-3, but cannot mediate downstream phenotypic responses. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|P10447|ABL_FSVHY Tyrosine-protein kinase transforming protein Abl OS=Feline sarcoma virus (strain Hardy-Zuckerman 2) GN=ABL PE=2 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (405), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 92/256 (35%), Positives = 135/256 (52%), Gaps = 55/256 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +K PNLV+++GVC+ E P I E+ +G+L +L+ CN QE A+ L++MA
Sbjct: 239 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAV---VLLYMA 293
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
TQI+S M+YLE ++ +HRDLAARNC+VG+N+ +K++D + +RL
Sbjct: 294 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL---------------SRL-- 336
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
M G YT + + PI+W A ESL K + KSDV
Sbjct: 337 ------MTGDTYT-------------------AHAGTKFPIKWTAPESLAYNKFSIKSDV 371
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F V LWEI + PY + QV Y+ K + RP C +++++LM
Sbjct: 372 WAFGVLLWEIATY-GMSPYPGIDLSQV-------YELLEKDYRMERPEGCPEKVYELMRA 423
Query: 241 CWKTNETDRPRFSEIH 256
CW+ N +DRP F+EIH
Sbjct: 424 CWQWNPSDRPAFAEIH 439
|
Felidae (taxid: 9681) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P00521|ABL_MLVAB Tyrosine-protein kinase transforming protein Abl OS=Abelson murine leukemia virus GN=ABL PE=3 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (395), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 93/282 (32%), Positives = 138/282 (48%), Gaps = 67/282 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +K PNLV+++GVC+ E P I E+ +G+L +L+ CN QE A+ L++MA
Sbjct: 176 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAV---VLLYMA 230
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
TQI+S M+YLE ++ +HRDLAARNC+VG+N+ +K++D + D Y + A+ PI
Sbjct: 231 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPI 289
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+W A ESL K + KSDV
Sbjct: 290 KWTAP-----------------------------------------ESLAYNKFSIKSDV 308
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F V LWEI + PY + QV E Y+ + RP C +++++LM
Sbjct: 309 WAFGVLLWEIATY-GMSPYPGIDLSQVYELLEKDYR-------MERPEGCPEKVYELMRA 360
Query: 241 CWKTNETDRPRFSEIHLFLQ------------RKNLGARASK 270
CW+ N +DRP F+EIH + K LG R ++
Sbjct: 361 CWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGTR 402
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P00519|ABL1_HUMAN Tyrosine-protein kinase ABL1 OS=Homo sapiens GN=ABL1 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 155 bits (391), Expect = 8e-37, Method: Compositional matrix adjust.
Identities = 89/256 (34%), Positives = 131/256 (51%), Gaps = 55/256 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +K PNLV+++GVC+ E P I E+ +G+L +L+ CN QE A+ L++MA
Sbjct: 290 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAV---VLLYMA 344
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
TQI+S M+YLE ++ +HRDLAARNC+VG+N+ +K++D + D Y + A+ PI
Sbjct: 345 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPI 403
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+W A ESL K + KSDV
Sbjct: 404 KWTAP-----------------------------------------ESLAYNKFSIKSDV 422
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F V LWEI + PY + QV E Y+ + RP C +++++LM
Sbjct: 423 WAFGVLLWEIATY-GMSPYPGIDLSQVYELLEKDYR-------MERPEGCPEKVYELMRA 474
Query: 241 CWKTNETDRPRFSEIH 256
CW+ N +DRP F+EIH
Sbjct: 475 CWQWNPSDRPSFAEIH 490
|
Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine-phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 434 | ||||||
| 189234894 | 1099 | PREDICTED: similar to Discoidin domain r | 0.516 | 0.203 | 0.585 | 5e-90 | |
| 242020730 | 792 | discoidin domain receptor, putative [Ped | 0.516 | 0.282 | 0.569 | 3e-86 | |
| 328718365 | 1310 | PREDICTED: hypothetical protein LOC10016 | 0.511 | 0.169 | 0.556 | 1e-85 | |
| 270001437 | 220 | hypothetical protein TcasGA2_TC000266 [T | 0.440 | 0.868 | 0.612 | 7e-77 | |
| 405970308 | 953 | Discoidin domain-containing receptor 2 [ | 0.516 | 0.235 | 0.514 | 2e-71 | |
| 443692802 | 905 | hypothetical protein CAPTEDRAFT_150374 [ | 0.516 | 0.247 | 0.479 | 3e-67 | |
| 242022568 | 953 | Discoidin domain-containing receptor 2 p | 0.516 | 0.235 | 0.492 | 2e-65 | |
| 443715384 | 917 | hypothetical protein CAPTEDRAFT_155564 [ | 0.516 | 0.244 | 0.474 | 3e-65 | |
| 270003120 | 932 | hypothetical protein TcasGA2_TC001551 [T | 0.516 | 0.240 | 0.470 | 1e-63 | |
| 296489874 | 855 | TPA: discoidin domain-containing recepto | 0.509 | 0.258 | 0.464 | 1e-62 |
| >gi|189234894|ref|XP_966707.2| PREDICTED: similar to Discoidin domain receptor CG33531-PA [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 337 bits (865), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 157/268 (58%), Positives = 190/268 (70%), Gaps = 44/268 (16%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQ---IHNCNSQENPAISYGCLI 57
+ L+DPNL RV+G+CS ++P+ + E+ + GDL FL + +Q P ISYGCLI
Sbjct: 865 LAGLRDPNLARVVGLCSQDEPMCALLEHSDPGDLPRFLAQRAVSEDGNQVGPTISYGCLI 924
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
+MATQIASGMKYLES D+VHRDLAARN
Sbjct: 925 YMATQIASGMKYLESLDLVHRDLAARN--------------------------------- 951
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
C++ K +T+KISDHAMYC YESDYY+SDTKARLPIRWM+WESLLLG+ TTK
Sbjct: 952 --------CVIDKTFTVKISDHAMYCDRYESDYYISDTKARLPIRWMSWESLLLGRQTTK 1003
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SDVW+FAVTLWE+L+ C Q+PYAELT+EQV+ENC+HWYQN+ Q+YLPRPA C +EI+DL
Sbjct: 1004 SDVWAFAVTLWEVLMLCTQQPYAELTSEQVVENCNHWYQNDGCQRYLPRPAACPREIYDL 1063
Query: 238 MLECWKTNETDRPRFSEIHLFLQRKNLG 265
M ECWK N TDRPRF+EIHLFLQRKNLG
Sbjct: 1064 MGECWKRNATDRPRFAEIHLFLQRKNLG 1091
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242020730|ref|XP_002430804.1| discoidin domain receptor, putative [Pediculus humanus corporis] gi|212516007|gb|EEB18066.1| discoidin domain receptor, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 325 bits (833), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 152/267 (56%), Positives = 187/267 (70%), Gaps = 43/267 (16%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQE--NPAISYGCLIF 58
+ SLKD NL R++G+CS E+P IQEY + GDL+ FL++ N + + A+SYGCLI+
Sbjct: 561 LASLKDVNLCRIVGICSLEEPFYVIQEYTDLGDLTQFLRLENSTEENGNDDAVSYGCLIY 620
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
MATQIASGMKYLES ++ HRDL+ARN
Sbjct: 621 MATQIASGMKYLESLELTHRDLSARN---------------------------------- 646
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
C+VGK+Y+IKISDHA+Y S Y +DYY DTKARLP+RWMAWE LLLGK ++KS
Sbjct: 647 -------CLVGKHYSIKISDHAIYASKYNNDYYQVDTKARLPVRWMAWECLLLGKQSSKS 699
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
DVWSFAVTLWEIL+HC+++P+AELTNEQV+ENC+H YQNN +YLPRP+ C +EI+DLM
Sbjct: 700 DVWSFAVTLWEILMHCDEQPFAELTNEQVVENCNHLYQNNGLVRYLPRPSLCPREIYDLM 759
Query: 239 LECWKTNETDRPRFSEIHLFLQRKNLG 265
ECWK DRP FSEIHLFLQRKNLG
Sbjct: 760 CECWKRQAADRPLFSEIHLFLQRKNLG 786
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328718365|ref|XP_001945267.2| PREDICTED: hypothetical protein LOC100165486, partial [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 323 bits (827), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 147/264 (55%), Positives = 189/264 (71%), Gaps = 42/264 (15%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQE-NPAISYGCLIFMAT 61
+++DPNL R++GVCS ++P+ IQEYCE+GDL +FL++ S E +P I+YGCL++ AT
Sbjct: 1083 TVRDPNLARIVGVCSPDEPLCIIQEYCEYGDLPSFLKVQTTESTEAHPTINYGCLLYFAT 1142
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 121
QIASGMK+LE + IVHRDLAARN
Sbjct: 1143 QIASGMKHLEGKGIVHRDLAARN------------------------------------- 1165
Query: 122 WMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVW 181
C+VGKNY++KISDHA+YCS Y+SDYY+SDTK+RLPIRWM+WESLLLGK T+KSDVW
Sbjct: 1166 ----CLVGKNYSLKISDHALYCSQYDSDYYVSDTKSRLPIRWMSWESLLLGKYTSKSDVW 1221
Query: 182 SFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241
SFAVTLWEIL+ C+ +P AELTNEQV+EN +H Y N K +Y P +C +E++++M EC
Sbjct: 1222 SFAVTLWEILMFCSHQPLAELTNEQVVENANHMYLANGKHRYAEPPPSCPREMYEIMAEC 1281
Query: 242 WKTNETDRPRFSEIHLFLQRKNLG 265
WK ++DRP+FSEIHLFLQRKNLG
Sbjct: 1282 WKRGDSDRPKFSEIHLFLQRKNLG 1305
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270001437|gb|EEZ97884.1| hypothetical protein TcasGA2_TC000266 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 294 bits (752), Expect = 7e-77, Method: Compositional matrix adjust.
Identities = 142/232 (61%), Positives = 164/232 (70%), Gaps = 41/232 (17%)
Query: 34 LSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTI 93
L F HN S + SYGCLI+MATQIASGMKYLES D+VHRDLAARN
Sbjct: 22 LGKFNIEHNNESGDFSRQSYGCLIYMATQIASGMKYLESLDLVHRDLAARN--------- 72
Query: 94 KISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153
C++ K +T+KISDHAMYC YESDYY+S
Sbjct: 73 --------------------------------CVIDKTFTVKISDHAMYCDRYESDYYIS 100
Query: 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSH 213
DTKARLPIRWM+WESLLLG+ TTKSDVW+FAVTLWE+L+ C Q+PYAELT+EQV+ENC+H
Sbjct: 101 DTKARLPIRWMSWESLLLGRQTTKSDVWAFAVTLWEVLMLCTQQPYAELTSEQVVENCNH 160
Query: 214 WYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNLG 265
WYQN+ Q+YLPRPA C +EI+DLM ECWK N TDRPRF+EIHLFLQRKNLG
Sbjct: 161 WYQNDGCQRYLPRPAACPREIYDLMGECWKRNATDRPRFAEIHLFLQRKNLG 212
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|405970308|gb|EKC35223.1| Discoidin domain-containing receptor 2 [Crassostrea gigas] | Back alignment and taxonomy information |
|---|
Score = 276 bits (705), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 139/270 (51%), Positives = 171/270 (63%), Gaps = 46/270 (17%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-----QENPAISYGC 55
M LKDPN+VRV+GVC+ E+P+ I EY ++GDL+ FL H S +SYGC
Sbjct: 709 MSQLKDPNIVRVLGVCTREEPLCMIVEYMKYGDLNQFLLDHVPESPVAMATNAKTLSYGC 768
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L++MA+QIASGMKYLES ++VHRDLA RN
Sbjct: 769 LVYMASQIASGMKYLESLNMVHRDLATRN------------------------------- 797
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
C+VG NYTIKISD M S Y +DYY + +A LPIRWMAWES+LLGK T
Sbjct: 798 ----------CLVGTNYTIKISDFGMSRSLYSADYYRIEGRAVLPIRWMAWESILLGKFT 847
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
TKSDVWSFAVTLWEIL +P+ LT+EQVIEN H+Y+N++K+ YL P C KEI+
Sbjct: 848 TKSDVWSFAVTLWEILTFAKDQPFDTLTDEQVIENAGHYYRNDNKEVYLSLPPNCPKEIY 907
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQRKNLG 265
DLM+ECW NE RP F E+H+FLQRKN+G
Sbjct: 908 DLMVECWNRNEACRPTFREVHMFLQRKNMG 937
|
Source: Crassostrea gigas Species: Crassostrea gigas Genus: Crassostrea Family: Ostreidae Order: Ostreoida Class: Bivalvia Phylum: Mollusca Superkingdom: Eukaryota |
| >gi|443692802|gb|ELT94315.1| hypothetical protein CAPTEDRAFT_150374 [Capitella teleta] | Back alignment and taxonomy information |
|---|
Score = 261 bits (668), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 130/271 (47%), Positives = 167/271 (61%), Gaps = 47/271 (17%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPA------ISYG 54
M L+DPN+VRV+GVC+ ++P++ + EY +FGDL+ FLQ H A +SYG
Sbjct: 658 MSQLRDPNIVRVLGVCTRDEPLAVVVEYMKFGDLNQFLQQHVPEGSTLAARPGQHTLSYG 717
Query: 55 CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDT 114
CLIFMATQI SGMKYLE+ ++VHRDLA RN
Sbjct: 718 CLIFMATQITSGMKYLETLNMVHRDLATRN------------------------------ 747
Query: 115 KARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN 174
C+VG TIKISD M S Y DYY + KA LPIRWMAWES+LLGK
Sbjct: 748 -----------CLVGPQATIKISDFGMSRSLYNVDYYRIEGKAVLPIRWMAWESVLLGKF 796
Query: 175 TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234
+ KSDVWS AVTLWE+L ++P+ L +EQVIENC H+Y+++ ++ LP+P+ C KEI
Sbjct: 797 SCKSDVWSMAVTLWEVLTFAREQPFDALNDEQVIENCGHYYRSDGQELCLPQPSNCPKEI 856
Query: 235 FDLMLECWKTNETDRPRFSEIHLFLQRKNLG 265
+DLM ECW +E RP F E+H+FL RKN+G
Sbjct: 857 YDLMCECWNRDELQRPSFREMHMFLSRKNMG 887
|
Source: Capitella teleta Species: Capitella teleta Genus: Capitella Family: Capitellidae Order: Capitellida Class: Polychaeta Phylum: Annelida Superkingdom: Eukaryota |
| >gi|242022568|ref|XP_002431712.1| Discoidin domain-containing receptor 2 precursor, putative [Pediculus humanus corporis] gi|212517020|gb|EEB18974.1| Discoidin domain-containing receptor 2 precursor, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 256 bits (653), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 133/270 (49%), Positives = 160/270 (59%), Gaps = 46/270 (17%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQ-----ENPAISYGC 55
+ +KD N+VRV+G DPI + EY ++GDL FLQ H ++ +SYGC
Sbjct: 721 LSKIKDSNIVRVLGASLDHDPIFVVIEYMDYGDLYQFLQDHVADTTSPLPTNAKTLSYGC 780
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
LI+MATQIASGMKYLES + VHRDLAARN
Sbjct: 781 LIYMATQIASGMKYLESLNFVHRDLAARN------------------------------- 809
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
C+VG Y IKI+D M S Y DYY D LPIRWM+WES+LL K T
Sbjct: 810 ----------CLVGTGYKIKITDIGMSRSLYSGDYYQIDGDLMLPIRWMSWESILLEKFT 859
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
TKSDVWSFAVTLWEIL ++PY E+ +E+VIEN YQ++ K L +P C KEI+
Sbjct: 860 TKSDVWSFAVTLWEILTFAREQPYEEMCDEKVIENVGLLYQDSGKNVLLHQPKNCPKEIY 919
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQRKNLG 265
DLM ECW+ NE+DRP F EIHLFLQRKNLG
Sbjct: 920 DLMKECWQRNESDRPNFREIHLFLQRKNLG 949
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|443715384|gb|ELU07385.1| hypothetical protein CAPTEDRAFT_155564 [Capitella teleta] | Back alignment and taxonomy information |
|---|
Score = 255 bits (651), Expect = 3e-65, Method: Compositional matrix adjust.
Identities = 130/274 (47%), Positives = 166/274 (60%), Gaps = 50/274 (18%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN--------SQENPA-I 51
M LKDPN+V+V+GV + E+P+S + EY E GDL FL+ + + S++N I
Sbjct: 673 MSRLKDPNIVQVLGVMTQEEPLSVVVEYMEGGDLHQFLRQRSLDCGNGTMTRSRKNAKLI 732
Query: 52 SYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYL 111
S+GCL+++ATQIASGMKYLE ++VHRDLA RN
Sbjct: 733 SHGCLVYVATQIASGMKYLEGLNMVHRDLATRN--------------------------- 765
Query: 112 SDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL 171
C+VG NY IKI+D M S Y +DYY + LPIRWMAWESLLL
Sbjct: 766 --------------CLVGHNYAIKIADFGMSRSLYSTDYYKIEGNTVLPIRWMAWESLLL 811
Query: 172 GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231
GK +TKSDVWSF VTLWE+L + PY L+++QVI NC+ Y N LP+PATC
Sbjct: 812 GKFSTKSDVWSFGVTLWEVLTLAKEHPYEGLSDDQVIANCNQCYLGNGLDIVLPQPATCP 871
Query: 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRKNLG 265
+EI+DLM+ECW +E RP F EIH+FLQRKN+G
Sbjct: 872 REIYDLMVECWNRDEVARPSFREIHMFLQRKNMG 905
|
Source: Capitella teleta Species: Capitella teleta Genus: Capitella Family: Capitellidae Order: Capitellida Class: Polychaeta Phylum: Annelida Superkingdom: Eukaryota |
| >gi|270003120|gb|EEZ99567.1| hypothetical protein TcasGA2_TC001551 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 250 bits (638), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 127/270 (47%), Positives = 159/270 (58%), Gaps = 46/270 (17%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPA-----ISYGC 55
+ L DPN+ R++G C +PI ++EY GDL FLQ H + A +SYGC
Sbjct: 698 LARLNDPNIARLLGACLDTEPICAVREYAPMGDLCQFLQDHVAETATPLATTAKTLSYGC 757
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L++MATQIASGMKYLES VH+DLAARN
Sbjct: 758 LVYMATQIASGMKYLESLRYVHKDLAARN------------------------------- 786
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
C+VG+ Y IK+SD Y Y SDY LP+RWMAWES+LLGK +
Sbjct: 787 ----------CLVGRRYEIKVSDLGSYRRMYSSDYCQIGESRPLPLRWMAWESVLLGKFS 836
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
KSDVWSFAV LWEI+ ++P+ EL++++VIEN +H+YQ++ K L P C KEIF
Sbjct: 837 GKSDVWSFAVLLWEIMTFAREQPFEELSDDKVIENVTHFYQDDGKHVLLSPPINCPKEIF 896
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQRKNLG 265
DLM ECW+ NE+DRP F EIHLFLQRKNLG
Sbjct: 897 DLMCECWQRNESDRPNFREIHLFLQRKNLG 926
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|296489874|tpg|DAA31987.1| TPA: discoidin domain-containing receptor 2 [Bos taurus] | Back alignment and taxonomy information |
|---|
Score = 247 bits (630), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 123/265 (46%), Positives = 157/265 (59%), Gaps = 44/265 (16%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH---NCNSQENPAISYGCLI 57
M LKDPN++R++ VC TEDP+ I EY E GDL+ FL H N +S P +SY L
Sbjct: 629 MSRLKDPNIIRLLAVCITEDPLCMITEYMENGDLNQFLSRHEPPNSSSASVPTVSYANLK 688
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
FMATQIASGMKYL S + VHRDLA RN
Sbjct: 689 FMATQIASGMKYLSSLNFVHRDLATRN--------------------------------- 715
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
C+VGKNYTIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT
Sbjct: 716 --------CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 767
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SDVW+F VTLWE C ++PY++L++EQVIEN ++++ +Q YLP+PA C ++ L
Sbjct: 768 SDVWAFGVTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQTYLPQPAICPDSVYKL 827
Query: 238 MLECWKTNETDRPRFSEIHLFLQRK 262
ML CW+ + RP F EIHL L ++
Sbjct: 828 MLSCWRRDTKHRPSFQEIHLLLLQQ 852
|
Source: Bos taurus Species: Bos taurus Genus: Bos Family: Bovidae Order: Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 434 | ||||||
| UNIPROTKB|F1S212 | 872 | DDR2 "Uncharacterized protein" | 0.322 | 0.160 | 0.531 | 3.7e-39 | |
| UNIPROTKB|Q16832 | 855 | DDR2 "Discoidin domain-contain | 0.311 | 0.157 | 0.540 | 5.7e-39 | |
| UNIPROTKB|F1MIE0 | 855 | DDR2 "Uncharacterized protein" | 0.311 | 0.157 | 0.540 | 9.3e-39 | |
| MGI|MGI:1345277 | 854 | Ddr2 "discoidin domain recepto | 0.311 | 0.158 | 0.540 | 2e-38 | |
| UNIPROTKB|E2RNZ4 | 866 | DDR2 "Uncharacterized protein" | 0.311 | 0.155 | 0.533 | 4.3e-38 | |
| UNIPROTKB|J3KQG8 | 378 | DDR1 "Epithelial discoidin dom | 0.311 | 0.357 | 0.511 | 8.9e-38 | |
| UNIPROTKB|F1NG66 | 862 | DDR2 "Uncharacterized protein" | 0.313 | 0.157 | 0.522 | 8.9e-38 | |
| ZFIN|ZDB-GENE-090316-2 | 868 | ddr2a "discoidin domain recept | 0.304 | 0.152 | 0.537 | 9.1e-38 | |
| UNIPROTKB|F1MCM5 | 466 | DDR1 "Tyrosine-protein kinase | 0.311 | 0.289 | 0.511 | 1.5e-37 | |
| UNIPROTKB|D4A0H8 | 873 | Ddr1 "Epithelial discoidin dom | 0.311 | 0.154 | 0.511 | 6.8e-37 |
| UNIPROTKB|F1S212 DDR2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 427 (155.4 bits), Expect = 3.7e-39, P = 3.7e-39
Identities = 76/143 (53%), Positives = 101/143 (70%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VGKNYTIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT SDVW+F
Sbjct: 730 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 789
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE+ C ++PY++L++EQVIEN ++++ +Q YLP+PA C ++ LML CW+
Sbjct: 790 VTLWEMFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQTYLPQPAICPDSVYKLMLSCWRR 849
Query: 245 NETDRPRFSEIHLFLQ---RKNL 264
+ RP F EIHL L +KNL
Sbjct: 850 DTKHRPSFQEIHLLLLQQGKKNL 872
|
|
| UNIPROTKB|Q16832 DDR2 "Discoidin domain-containing receptor 2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 425 (154.7 bits), Expect = 5.7e-39, P = 5.7e-39
Identities = 73/135 (54%), Positives = 97/135 (71%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VGKNYTIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT SDVW+F
Sbjct: 715 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 774
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE C ++PY++L++EQVIEN ++++ +Q YLP+PA C ++ LML CW+
Sbjct: 775 VTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQTYLPQPAICPDSVYKLMLSCWRR 834
Query: 245 NETDRPRFSEIHLFL 259
+ +RP F EIHL L
Sbjct: 835 DTKNRPSFQEIHLLL 849
|
|
| UNIPROTKB|F1MIE0 DDR2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 423 (154.0 bits), Expect = 9.3e-39, P = 9.3e-39
Identities = 73/135 (54%), Positives = 96/135 (71%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VGKNYTIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT SDVW+F
Sbjct: 715 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 774
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE C ++PY++L++EQVIEN ++++ +Q YLP+PA C ++ LML CW+
Sbjct: 775 VTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQTYLPQPAICPDSVYKLMLSCWRR 834
Query: 245 NETDRPRFSEIHLFL 259
+ RP F EIHL L
Sbjct: 835 DTKHRPSFQEIHLLL 849
|
|
| MGI|MGI:1345277 Ddr2 "discoidin domain receptor family, member 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 2.0e-38, P = 2.0e-38
Identities = 73/135 (54%), Positives = 95/135 (70%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VGKNYTIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT SDVW+F
Sbjct: 714 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 773
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE C ++PY++L++EQVIEN ++++ +Q YLP+PA C ++ LML CW+
Sbjct: 774 VTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQIYLPQPALCPDSVYKLMLSCWRR 833
Query: 245 NETDRPRFSEIHLFL 259
RP F EIHL L
Sbjct: 834 ETKHRPSFQEIHLLL 848
|
|
| UNIPROTKB|E2RNZ4 DDR2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 4.3e-38, P = 4.3e-38
Identities = 72/135 (53%), Positives = 95/135 (70%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VGKNYTIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT SDVW+F
Sbjct: 726 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 785
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE C ++PY++L++EQVIEN ++++ +Q YLP+P C ++ LML CW+
Sbjct: 786 VTLWETFTFCQEQPYSQLSDEQVIENTGEFFRDQGRQIYLPQPVICPDSVYKLMLSCWRR 845
Query: 245 NETDRPRFSEIHLFL 259
+ RP F EIHL L
Sbjct: 846 DTKHRPSFQEIHLLL 860
|
|
| UNIPROTKB|J3KQG8 DDR1 "Epithelial discoidin domain-containing receptor 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 405 (147.6 bits), Expect = 8.9e-38, P = 8.9e-38
Identities = 69/135 (51%), Positives = 95/135 (70%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VG+N+TIKI+D M + Y DYY +A LPIRWMAWE +L+GK TT SDVW+F
Sbjct: 236 NCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFG 295
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE+L+ C +P+ +LT+EQVIEN ++++ +Q YL RP C + +++LML CW
Sbjct: 296 VTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSR 355
Query: 245 NETDRPRFSEIHLFL 259
RP FS++H FL
Sbjct: 356 ESEQRPPFSQLHRFL 370
|
|
| UNIPROTKB|F1NG66 DDR2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 8.9e-38, P = 8.9e-38
Identities = 71/136 (52%), Positives = 96/136 (70%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VGK YTIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT SDVW+F
Sbjct: 721 NCLVGKRYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 780
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE C ++PY++L++EQVIEN ++++ +Q YLP+PA C ++ LML CW+
Sbjct: 781 VTLWETFTLCREQPYSQLSDEQVIENTGEFFRDQGRQTYLPKPALCPDSVYKLMLSCWRR 840
Query: 245 NETDRPRFSEIHLFLQ 260
+ DRP F ++H LQ
Sbjct: 841 DTKDRPSFQDLHRQLQ 856
|
|
| ZFIN|ZDB-GENE-090316-2 ddr2a "discoidin domain receptor tyrosine kinase 2a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 9.1e-38, P = 9.1e-38
Identities = 71/132 (53%), Positives = 95/132 (71%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VGKN+TIKI+D M + Y DYY +A LPIRWM+WES+LLGK TT SDVW+F
Sbjct: 729 NCLVGKNFTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTSSDVWAFG 788
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE+L C ++PY++L++EQVIEN ++++ +Q YLP+P C ++ LML CW
Sbjct: 789 VTLWEMLTFCKEQPYSQLSDEQVIENTGEFFRDQRRQIYLPQPPMCPDPVYKLMLSCWHR 848
Query: 245 NETDRPRFSEIH 256
N +RP F EIH
Sbjct: 849 NTKERPSFQEIH 860
|
|
| UNIPROTKB|F1MCM5 DDR1 "Tyrosine-protein kinase receptor" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 403 (146.9 bits), Expect = 1.5e-37, P = 1.5e-37
Identities = 69/135 (51%), Positives = 94/135 (69%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VG+N+TIKI+D M + Y DYY +A LPIRWMAWE +L+GK TT SDVW+F
Sbjct: 324 NCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFG 383
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE+L+ C +P+ +LT+EQVIEN ++++ +Q YL RP C +++LML CW
Sbjct: 384 VTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPLSLYELMLRCWSR 443
Query: 245 NETDRPRFSEIHLFL 259
RP FS++H FL
Sbjct: 444 EPEQRPPFSQLHRFL 458
|
|
| UNIPROTKB|D4A0H8 Ddr1 "Epithelial discoidin domain-containing receptor 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 6.8e-37, P = 6.8e-37
Identities = 69/135 (51%), Positives = 95/135 (70%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
NC+VG+N+TIKI+D M + Y DYY +A LPIRWMAWE +L+GK TT SDVW+F
Sbjct: 731 NCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFG 790
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
VTLWE+L+ C +P+ +LT+EQVIEN ++++ +Q YL RP C + +++LML CW
Sbjct: 791 VTLWEVLMLCRSQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQTLYELMLRCWSR 850
Query: 245 NETDRPRFSEIHLFL 259
RP FS++H FL
Sbjct: 851 EPEQRPPFSQLHRFL 865
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.10 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 434 | |||
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-109 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-88 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-80 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-79 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-78 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-78 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-78 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-77 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-60 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-56 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-56 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-54 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-53 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-53 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-49 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-49 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-49 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-48 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-46 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-45 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-45 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-45 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-44 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-44 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-44 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-43 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-43 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-42 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-42 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-41 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-41 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-41 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-41 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-40 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-40 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-40 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-40 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-39 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-39 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-38 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-38 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-38 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-38 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-37 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-37 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-36 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-36 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-35 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-35 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-35 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-34 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-34 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-34 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-34 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-34 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-33 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-33 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-33 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-32 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-31 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-31 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-31 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-30 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-30 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-30 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-29 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-29 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-28 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-28 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-28 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-27 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-27 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-25 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-24 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-24 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-24 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-24 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-23 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-22 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-22 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-21 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-18 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-18 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-18 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-11 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-08 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-08 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-05 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-05 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-04 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-04 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-04 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 0.001 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.001 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.001 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.001 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.002 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 0.002 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.002 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.002 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 0.004 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.004 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 323 bits (829), Expect = e-109
Identities = 132/268 (49%), Positives = 169/268 (63%), Gaps = 51/268 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH-------NCNSQENPAISY 53
+ L DPN+ R++GVC+ + P+ I EY E GDL+ FLQ H CNS ++S+
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS---KSLSF 129
Query: 54 GCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSD 113
L++MATQIASGM+YLES + VHRDLA RNC+VGKNYTIKI+D M + Y SDYY
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY--- 186
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
++ A LPIRWMAWES+LLGK
Sbjct: 187 ---------------------RVQGRAP-----------------LPIRWMAWESVLLGK 208
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233
TTKSDVW+F VTLWEIL C ++PY LT++QVIEN H+++++ +Q YLPRP C K+
Sbjct: 209 FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD 268
Query: 234 IFDLMLECWKTNETDRPRFSEIHLFLQR 261
I++LMLECW+ +E DRP F EIHLFLQR
Sbjct: 269 IYELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 3e-88
Identities = 124/264 (46%), Positives = 155/264 (58%), Gaps = 45/264 (17%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQ----ENPAISYGCL 56
M LKDPN++R++ VC T DP+ I EY E GDL+ FL H + ISY L
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
IFMATQIASGMKYL S + VHRDLA RNC+VGKNYTIKI+D M
Sbjct: 133 IFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM---------------- 176
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
+N Y DYY +A LPIRWM+WES+LLGK TT
Sbjct: 177 ------------SRNL-------------YSGDYYRIQGRAVLPIRWMSWESILLGKFTT 211
Query: 177 KSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236
SDVW+F VTLWEIL C ++PY++L++EQVIEN ++++ +Q YLP+PA C ++
Sbjct: 212 ASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYK 271
Query: 237 LMLECWKTNETDRPRFSEIHLFLQ 260
LML CW+ N +RP F EIH L
Sbjct: 272 LMLSCWRRNAKERPSFQEIHATLL 295
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 247 bits (632), Expect = 9e-80
Identities = 101/262 (38%), Positives = 137/262 (52%), Gaps = 51/262 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNC--NSQENPAISYGCLIF 58
M L PN+VR++GVC+ E+P+ + EY E GDL +L+ S E +S L+
Sbjct: 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
A QIA GM+YL S+ VHRDLAARNC+VG++ +KISD + +R
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGL---------------SRD 154
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
Y+ DYY T +LPIRWMA ESL G T+KS
Sbjct: 155 --------------------------VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKS 188
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
DVWSF V LWEI PY L+NE+V+E + + + LP+P C E+++LM
Sbjct: 189 DVWSFGVLLWEIFTLG-ATPYPGLSNEEVLE----YLRKGYR---LPKPEYCPDELYELM 240
Query: 239 LECWKTNETDRPRFSEIHLFLQ 260
L CW+ + DRP FSE+ L+
Sbjct: 241 LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 248 bits (634), Expect = 1e-79
Identities = 121/271 (44%), Positives = 159/271 (58%), Gaps = 53/271 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQEN------------ 48
+ LKDPN++R++GVC EDP+ I EY E GDL+ FL H+ + +E
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 49 PAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESD 108
PAISY L+ +A QIASGMKYL S + VHRDLA RNC+VG+N TIKI+D M
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM-------- 184
Query: 109 YYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWES 168
+N Y DYY +A LPIRWMAWE
Sbjct: 185 --------------------SRNL-------------YAGDYYRIQGRAVLPIRWMAWEC 211
Query: 169 LLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA 228
+L+GK TT SDVW+F VTLWEIL+ C ++PY ELT+EQVIEN ++++ +Q YL RP
Sbjct: 212 ILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPP 271
Query: 229 TCQKEIFDLMLECWKTNETDRPRFSEIHLFL 259
C + +++LML+CW + +RP FS+IH FL
Sbjct: 272 PCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 1e-78
Identities = 96/259 (37%), Positives = 131/259 (50%), Gaps = 55/259 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L PN+V+++GVC+ E+P+ + EY GDL +L+ + +S L+ A
Sbjct: 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-----RPKELSLSDLLSFA 109
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM+YLES++ +HRDLAARNC+VG+N +KISD + Y+ DYY
Sbjct: 110 LQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG----- 164
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+LPIRWMA ESL GK T+KSDV
Sbjct: 165 -------------------------------------KLPIRWMAPESLKEGKFTSKSDV 187
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V LWEI + PY ++N +V+E Y LP+P C E++ LML+
Sbjct: 188 WSFGVLLWEIFTLG-EEPYPGMSNAEVLEYLKKGY-------RLPKPPNCPPELYKLMLQ 239
Query: 241 CWKTNETDRPRFSEIHLFL 259
CW + DRP FSE+ L
Sbjct: 240 CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 2e-78
Identities = 100/259 (38%), Positives = 138/259 (53%), Gaps = 56/259 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L PN+V+++GVC+ E+P+ + EY E GDL ++L+ + P +S L+ A
Sbjct: 55 MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR------PKLSLSDLLSFA 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM+YLES++ +HRDLAARNC+VG+N +KISD + Y+ DYY
Sbjct: 109 LQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG----- 163
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+LPIRWMA ESL GK T+KSDV
Sbjct: 164 -------------------------------------KLPIRWMAPESLKEGKFTSKSDV 186
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V LWEI ++PY ++NE+V+E + Y LP+P C E++DLML+
Sbjct: 187 WSFGVLLWEIFTLG-EQPYPGMSNEEVLEYLKNGY-------RLPQPPNCPPELYDLMLQ 238
Query: 241 CWKTNETDRPRFSEIHLFL 259
CW + DRP FSE+ L
Sbjct: 239 CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 3e-78
Identities = 102/259 (39%), Positives = 135/259 (52%), Gaps = 55/259 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L PN+VR++GVC+ +P+ + EY GDL FL+ H ++ L+ MA
Sbjct: 55 MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG------EKLTLKDLLQMA 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM+YLES++ VHRDLAARNC+V +N +KISD + +R
Sbjct: 109 LQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGL---------------SRD-- 151
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
YE DYY +LPI+WMA ESL GK T+KSDV
Sbjct: 152 ------------------------IYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDV 187
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V LWEI Q PY ++NE+V+E Y+ LPRP C E+++LML+
Sbjct: 188 WSFGVLLWEIFTLGEQ-PYPGMSNEEVLELLEDGYR-------LPRPENCPDELYELMLQ 239
Query: 241 CWKTNETDRPRFSEIHLFL 259
CW + DRP FSE+ L
Sbjct: 240 CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 2e-77
Identities = 115/264 (43%), Positives = 155/264 (58%), Gaps = 46/264 (17%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFL---QIHNCNSQEN--PAISYGC 55
M LK+PN++R++GVC ++DP+ I EY E GDL+ FL +I + + N P++S
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L++MA QIASGMKYL S + VHRDLA RNC+VG +YTIKI+D M
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGM--------------- 175
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
+N Y DYY +A LPIRWMAWES+LLGK T
Sbjct: 176 -------------SRNL-------------YSGDYYRIQGRAVLPIRWMAWESILLGKFT 209
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
T SDVW+F VTLWE+ C ++PY+ L++EQVIEN +++N +Q YL + C +F
Sbjct: 210 TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVF 269
Query: 236 DLMLECWKTNETDRPRFSEIHLFL 259
LM+ CW + DRP F++IH FL
Sbjct: 270 KLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 1e-60
Identities = 92/264 (34%), Positives = 122/264 (46%), Gaps = 52/264 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENP---AISYGCLI 57
M ++VR++GV ST P + E GDL ++L+ ++ NP + I
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
MA +IA GM YL ++ VHRDLAARNCMV ++ T+KI D M R
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM---------------TR 167
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
YE+DYY K LP+RWMA ESL G TTK
Sbjct: 168 DI--------------------------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTK 201
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SDVWSF V LWE+ Q PY L+NE+V++ +L P C ++ +L
Sbjct: 202 SDVWSFGVVLWEMATLAEQ-PYQGLSNEEVLKFV-------IDGGHLDLPENCPDKLLEL 253
Query: 238 MLECWKTNETDRPRFSEIHLFLQR 261
M CW+ N RP F EI L+
Sbjct: 254 MRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 5e-56
Identities = 94/265 (35%), Positives = 131/265 (49%), Gaps = 58/265 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAI 51
M L+ PN+V ++GVC+ E P + EY GDL FL ++ +S ++
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 52 SYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYL 111
+ +A QIA+GM+YL S VHRDLAARNC+VG+ T+KISD + Y +DYY
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY- 180
Query: 112 SDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL 171
R+ +K+ LP+RWM E++L
Sbjct: 181 -----RVQ-----------------------------------SKSLLPVRWMPPEAILY 200
Query: 172 GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231
GK TT+SD+WSF V LWEI + Q PY +N++VIE +Q LP P C
Sbjct: 201 GKFTTESDIWSFGVVLWEIFSYGLQ-PYYGFSNQEVIEMI-------RSRQLLPCPEDCP 252
Query: 232 KEIFDLMLECWKTNETDRPRFSEIH 256
++ LM+ECW RPRF +IH
Sbjct: 253 ARVYALMIECWNEIPARRPRFKDIH 277
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 7e-56
Identities = 96/267 (35%), Positives = 128/267 (47%), Gaps = 56/267 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHN-------CNSQENPAISY 53
+ + + N+V+ GVC+ DP + EY E GDL+ FL+ H ++
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 54 GCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSD 113
L+ +A QIASGM YL S+ VHRDLA RNC+VG + +KI D M Y +DYY
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY--- 178
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
++ H M LPIRWM ES++ K
Sbjct: 179 ---------------------RVGGHTM-----------------LPIRWMPPESIMYRK 200
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233
TT+SDVWSF V LWEI + Q P+ L+NE+VIE Q Q RP TC E
Sbjct: 201 FTTESDVWSFGVVLWEIFTYGKQ-PWYGLSNEEVIE---CITQGRLLQ----RPRTCPSE 252
Query: 234 IFDLMLECWKTNETDRPRFSEIHLFLQ 260
++D+ML CWK + R +IH LQ
Sbjct: 253 VYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 3e-54
Identities = 92/260 (35%), Positives = 128/260 (49%), Gaps = 55/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ LV++ VCS E+PI + EY G L FL+ S E + L+ MA
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK-----SGEGKKLRLPQLVDMA 109
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM YLESR+ +HRDLAARN +VG+N KI+D + ARL
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGL---------------ARL-- 152
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E D Y + A+ PI+W A E+ G+ T KSDV
Sbjct: 153 -------------------------IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L EI+ + + PY +TN +V+E Y+ +PRP C +E++DLML+
Sbjct: 188 WSFGILLTEIVTY-GRVPYPGMTNREVLEQVERGYR-------MPRPPNCPEELYDLMLQ 239
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CW + +RP F + FL+
Sbjct: 240 CWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 94/257 (36%), Positives = 136/257 (52%), Gaps = 57/257 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +K PNLV+++GVC+ E P I E+ +G+L +L+ CN QE A+ L++MA
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVV---LLYMA 110
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
TQI+S M+YLE ++ +HRDLAARNC+VG+N+ +K++D + +RL
Sbjct: 111 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL---------------SRL-- 153
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
M G YT HA A+ PI+W A ESL K + KSDV
Sbjct: 154 ------MTGDTYTA----HA---------------GAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 181 WSFAVTLWEILIH-CNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
W+F V LWEI + + P +L S Y+ K + RP C ++++LM
Sbjct: 189 WAFGVLLWEIATYGMSPYPGIDL---------SQVYELLEKGYRMERPEGCPPKVYELMR 239
Query: 240 ECWKTNETDRPRFSEIH 256
CW+ N +DRP F+EIH
Sbjct: 240 ACWQWNPSDRPSFAEIH 256
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 88/261 (33%), Positives = 122/261 (46%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P +VR+IGVC +P+ + E G L +L+ + I L +A
Sbjct: 50 MAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLLKYLK-------KRREIPVSDLKELA 101
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+A GM YLES+ VHRDLAARN ++ + KISD M ++A
Sbjct: 102 HQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM-------------SRA---- 144
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+G SDYY + T R P++W A E + GK ++KSDV
Sbjct: 145 -------LGAG----------------SDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VTLWE + +PY E+ +VI + LPRP C +EI+ +ML
Sbjct: 182 WSYGVTLWEAFSY-GAKPYGEMKGAEVIAMLESGER-------LPRPEECPQEIYSIMLS 233
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CWK DRP FSE+ +R
Sbjct: 234 CWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-49
Identities = 82/252 (32%), Positives = 126/252 (50%), Gaps = 55/252 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ P L+++ VC+ E+PI + E ++G L +LQ A+ LI MA
Sbjct: 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ-----GGAGRALKLPQLIDMA 109
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ASGM YLE+++ +HRDLAARN +VG+N K++D + AR+
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGL---------------ARV-- 152
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ D Y + A+ PI+W A E+ L + + KSDV
Sbjct: 153 -------------------------IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L EI+ + + PY +TN +V++ Y+ +P P C KE++D+ML+
Sbjct: 188 WSFGILLTEIVTY-GRMPYPGMTNAEVLQQVDQGYR-------MPCPPGCPKELYDIMLD 239
Query: 241 CWKTNETDRPRF 252
CWK + DRP F
Sbjct: 240 CWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-49
Identities = 74/256 (28%), Positives = 112/256 (43%), Gaps = 58/256 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAI-SYGCLIFM 59
M L PNLV++ GVC+ + PI + EY G L +L+ E L+ M
Sbjct: 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR-------ERKGKLGTEWLLDM 105
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
+ + M+YLES +HRDLAARNC+VG++ +K+SD + + Y L D
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGL------ARYVLDDQ----- 154
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
Y S + P++W E + ++KSD
Sbjct: 155 -------------------------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF V +WE+ + PY +N +V+E+ S Y+ L RP E++ +M
Sbjct: 184 VWSFGVLMWEVF-SEGKMPYERFSNSEVVESVSAGYR-------LYRPKLAPTEVYTIMY 235
Query: 240 ECWKTNETDRPRFSEI 255
CW DRP F ++
Sbjct: 236 SCWHEKPEDRPAFKKL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 2e-49
Identities = 87/277 (31%), Positives = 128/277 (46%), Gaps = 66/277 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNC----------------N 44
M PN+V+++GVC+ P+ + EY +GDL+ FL+ H
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR-HRSPRAQCSLSHSTSSARKC 120
Query: 45 SQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSH 104
+S + +A Q+A+GM YL R VHRDLA RNC+VG+N +KI+D + +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 105 YESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164
Y +DYY + E+D +PIRWM
Sbjct: 181 YSADYYKAS---------------------------------ENDA--------IPIRWM 199
Query: 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYL 224
ES+ + TT+SDVW++ V LWEI + Q PY + +E+VI + N L
Sbjct: 200 PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ-PYYGMAHEEVI---YYVRDGN----VL 251
Query: 225 PRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
P C E+++LM CW +DRP F+ I+ LQR
Sbjct: 252 SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 88/260 (33%), Positives = 122/260 (46%), Gaps = 44/260 (16%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M + PN+V+++GVC +P I E E GDL ++L+ P ++ L+ +
Sbjct: 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+A G YLE +HRDLAARNC+V E Y R
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVS-----------------EKGY----DADR--- 148
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+KI D + Y+SDYY + + LP+RWMA ESLL GK TT+SDV
Sbjct: 149 ------------VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDV 196
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V +WEIL Q PY L N++V+ + L +P C +I+ LM
Sbjct: 197 WSFGVLMWEILTLGQQ-PYPALNNQEVL----QHVTAGGR---LQKPENCPDKIYQLMTN 248
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CW + ++RP F I LQ
Sbjct: 249 CWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 7e-46
Identities = 84/256 (32%), Positives = 121/256 (47%), Gaps = 56/256 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L+ +L+ + VCS +P+ I E E G L FL S E + LI MA
Sbjct: 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL-----RSPEGQVLPVASLIDMA 110
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+A GM YLE ++ +HRDLAARN +VG++ K++D + ARL
Sbjct: 111 CQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGL---------------ARL-- 153
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
IK D YLS K ++P +W A E+ G +TKSDV
Sbjct: 154 -------------IK------------EDVYLSSDK-KIPYKWTAPEAASHGTFSTKSDV 187
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L+E+ + Q PY + N +V + + Y+ +P PA C +EI+ +MLE
Sbjct: 188 WSFGILLYEMFTY-GQVPYPGMNNHEVYDQITAGYR-------MPCPAKCPQEIYKIMLE 239
Query: 241 CWKTNETDRPRFSEIH 256
CW DRP F +
Sbjct: 240 CWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-45
Identities = 93/268 (34%), Positives = 133/268 (49%), Gaps = 58/268 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAI 51
+ +L+ ++V+ GVC DP+ + EY + GDL+ FL+ H ++ Q +
Sbjct: 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 120
Query: 52 SYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYL 111
++ +A+QIASGM YL S+ VHRDLA RNC+VG N +KI D M Y +DYY
Sbjct: 121 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY- 179
Query: 112 SDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL 171
++ H M LPIRWM ES++
Sbjct: 180 -----------------------RVGGHTM-----------------LPIRWMPPESIMY 199
Query: 172 GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231
K TT+SDVWSF V LWEI + Q P+ +L+N +VIE C ++ + L RP C
Sbjct: 200 RKFTTESDVWSFGVILWEIFTYGKQ-PWFQLSNTEVIE-CI------TQGRVLERPRVCP 251
Query: 232 KEIFDLMLECWKTNETDRPRFSEIHLFL 259
KE++D+ML CW+ R EI+ L
Sbjct: 252 KEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 4e-45
Identities = 86/254 (33%), Positives = 127/254 (50%), Gaps = 55/254 (21%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
PN+V++IGVC + PI + E G L TFL+ ++ ++ L+ M+ A+G
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLR------KKKNRLTVKKLLQMSLDAAAG 105
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
M+YLES++ +HRDLAARNC+VG+N +KISD M S E
Sbjct: 106 MEYLESKNCIHRDLAARNCLVGENNVLKISDFGM--SREEEG------------------ 145
Query: 127 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVT 186
Y +SD ++PI+W A E+L G+ T++SDVWS+ +
Sbjct: 146 ---------------------GIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGIL 184
Query: 187 LWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNE 246
LWE PY ++N+Q E Y+ +P P C +EI+ LML+CW +
Sbjct: 185 LWETFSL-GDTPYPGMSNQQTRERIESGYR-------MPAPQLCPEEIYRLMLQCWAYDP 236
Query: 247 TDRPRFSEIHLFLQ 260
+RP FSEI+ LQ
Sbjct: 237 ENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-45
Identities = 80/254 (31%), Positives = 118/254 (46%), Gaps = 51/254 (20%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQEN--PAISYGCLIFMAT 61
L N+VR++G+C +P I EY + GDL FL+ ++ P +S + + T
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 121
QIA GM +L + VHRDLAARNC+V +K+S LS +K
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS-------------LLSLSKDV---- 167
Query: 122 WMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVW 181
Y S+YY A +P+RW+A E++ +TKSDVW
Sbjct: 168 ------------------------YNSEYYKL-RNALIPLRWLAPEAVQEDDFSTKSDVW 202
Query: 182 SFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241
SF V +WE+ P+ L++E+V+ + + + LP P C ++ LM C
Sbjct: 203 SFGVLMWEVFTQGEL-PFYGLSDEEVLN------RLQAGKLELPVPEGCPSRLYKLMTRC 255
Query: 242 WKTNETDRPRFSEI 255
W N DRP FSE+
Sbjct: 256 WAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 1e-44
Identities = 76/259 (29%), Positives = 115/259 (44%), Gaps = 53/259 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M SL NL+R+ GV T P+ + E G L + L A
Sbjct: 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSL-----LDRLRKDALGHFLISTLCDYA 103
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA+GM+YLES+ +HRDLAARN ++ + +KI D + L LP
Sbjct: 104 VQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGD-----------FGLM---RALPQ 149
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
D+Y+ + ++P W A ESL + SDV
Sbjct: 150 --------------------------NEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDV 183
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W F VTLWE+ + + P+A L+ Q+++ + + + L RP C ++I+++ML+
Sbjct: 184 WMFGVTLWEMFTYG-EEPWAGLSGSQILKKI------DKEGERLERPEACPQDIYNVMLQ 236
Query: 241 CWKTNETDRPRFSEIHLFL 259
CW N DRP F+ + FL
Sbjct: 237 CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 2e-44
Identities = 99/277 (35%), Positives = 142/277 (51%), Gaps = 58/277 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS----QENPA--ISYG 54
+ +L+ ++V+ GVC DP+ + EY + GDL+ FL+ H ++ + N ++
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 55 CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDT 114
++ +A QIA+GM YL S+ VHRDLA RNC+VG+N +KI D M Y +DYY
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY---- 176
Query: 115 KARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN 174
++ H M LPIRWM ES++ K
Sbjct: 177 --------------------RVGGHTM-----------------LPIRWMPPESIMYRKF 199
Query: 175 TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234
TT+SDVWS V LWEI + Q P+ +L+N +VIE ++ + L RP TC KE+
Sbjct: 200 TTESDVWSLGVVLWEIFTYGKQ-PWYQLSNNEVIECI-------TQGRVLQRPRTCPKEV 251
Query: 235 FDLMLECWKTNETDRPRFSEIHLFLQRKNLGARASKI 271
+DLML CW+ R EIH LQ NL A+AS +
Sbjct: 252 YDLMLGCWQREPHMRLNIKEIHSLLQ--NL-AKASPV 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-44
Identities = 91/266 (34%), Positives = 129/266 (48%), Gaps = 57/266 (21%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN------SQENP--AISYGC 55
L+ ++VR GVC+ P+ + EY GDL+ FL+ H + ++ ++ G
Sbjct: 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
++ +A+QIASGM YL S VHRDLA RNC+VG+ +KI D M Y +DYY
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----- 178
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
R+ R M LPIRWM ES+L K T
Sbjct: 179 -RVGGRTM-----------------------------------LPIRWMPPESILYRKFT 202
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
T+SD+WSF V LWEI + Q P+ +L+N + IE C ++ + L RP TC E++
Sbjct: 203 TESDIWSFGVVLWEIFTYGKQ-PWYQLSNTEAIE-CI------TQGRELERPRTCPPEVY 254
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQR 261
+M CW+ R +IH LQ
Sbjct: 255 AIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 154 bits (389), Expect = 1e-43
Identities = 92/270 (34%), Positives = 134/270 (49%), Gaps = 59/270 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHN------CNSQEN----PA 50
M L PN+V ++GV + E P+ + EY GDL FL + + C+S E+ +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY 110
+ +G + +A QIA+GM+YL S VH+DLAARN ++G+ +KISD
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISD------------- 167
Query: 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL 170
+G + I Y +DYY K+ LPIRWM E+++
Sbjct: 168 -----------------LGLSREI-----------YSADYYRVQPKSLLPIRWMPPEAIM 199
Query: 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230
GK ++ SD+WSF V LWEI Q PY +N++VIE K+Q LP C
Sbjct: 200 YGKFSSDSDIWSFGVVLWEIFSFGLQ-PYYGFSNQEVIEMV-------RKRQLLPCSEDC 251
Query: 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQ 260
++ LM ECW+ + RPRF +IH L+
Sbjct: 252 PPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-43
Identities = 92/251 (36%), Positives = 120/251 (47%), Gaps = 52/251 (20%)
Query: 8 NLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQEN---PAISYGCLIFMATQIA 64
++VR++GV S P + E GDL ++L+ ++ N P + +I MA +IA
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 65 SGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 124
GM YL ++ VHRDLAARNCMV ++T+KI D M
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM------------------------ 165
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
T I YE+DYY K LP+RWMA ESL G TT SD+WSF
Sbjct: 166 --------TRDI---------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG 208
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
V LWEI Q PY L+NEQV++ YL +P C + + DLM CW+
Sbjct: 209 VVLWEITSLAEQ-PYQGLSNEQVLKFV-------MDGGYLDQPDNCPERVTDLMRMCWQF 260
Query: 245 NETDRPRFSEI 255
N RP F EI
Sbjct: 261 NPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 81/271 (29%), Positives = 117/271 (43%), Gaps = 58/271 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDP----ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
+ +L N+V+ GVC E P + I EY G L +LQ H I+ L
Sbjct: 60 LRTLDHENIVKYKGVC--EKPGGRSLRLIMEYLPSGSLRDYLQRHR------DQINLKRL 111
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
+ ++QI GM YL S+ +HRDLAARN +V +KISD + A
Sbjct: 112 LLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGL---------------A 156
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
++ + DYY PI W A E L K ++
Sbjct: 157 KVL-------------------------PEDKDYYYVKEPGESPIFWYAPECLRTSKFSS 191
Query: 177 KSDVWSFAVTLWEILIHC--NQRPYAELT----NEQVIENCSHWYQNNSKQQYLPRPATC 230
SDVWSF VTL+E+ + +Q P AE Q + + + + LPRP +C
Sbjct: 192 ASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSC 251
Query: 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++DLM CW+ DRP F+++ L + R
Sbjct: 252 PDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 75/267 (28%), Positives = 119/267 (44%), Gaps = 58/267 (21%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQEN---------PAISYGC 55
K N++ ++GVC+ E P+ + EY G+L FL+ + ++
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L+ A Q+A GM++L S+ +HRDLAARN +V +++ +KI+D +
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGL--------------- 178
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
AR + DYY T RLP++WMA E+L T
Sbjct: 179 AR--------------------------DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT 212
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
+SDVWSF V LWEI PY + E++ + Y+ + +P C +E++
Sbjct: 213 HQSDVWSFGVLLWEIFT-LGGSPYPGIPVEELFKLLKEGYR-------MEKPQNCTQELY 264
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQRK 262
LM +CW + RP F ++ L R
Sbjct: 265 HLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 2e-41
Identities = 85/254 (33%), Positives = 120/254 (47%), Gaps = 55/254 (21%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
PN+VR+IGVC+ + PI + E + GD TFL+ E P + LI M A+G
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR------TEGPRLKVKELIQMVENAAAG 106
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
M+YLES+ +HRDLAARNC+V + +KISD M S E D
Sbjct: 107 MEYLESKHCIHRDLAARNCLVTEKNVLKISDFGM--SREEED------------------ 146
Query: 127 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVT 186
+Y S + ++P++W A E+L G+ +++SDVWSF +
Sbjct: 147 -------------GVYAS--------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGIL 185
Query: 187 LWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNE 246
LWE PYA L+N+Q E + LP P C ++ LM CW+ +
Sbjct: 186 LWEAF-SLGAVPYANLSNQQTREAI-------EQGVRLPCPELCPDAVYRLMERCWEYDP 237
Query: 247 TDRPRFSEIHLFLQ 260
RP FS +H LQ
Sbjct: 238 GQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-41
Identities = 83/255 (32%), Positives = 124/255 (48%), Gaps = 55/255 (21%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
PN++R+ GV + P+ I EY E G L FL+ ++ + G L+ M IASG
Sbjct: 65 PNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASG 118
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
MKYL + VHRDLAARN +V N K+SD + L D++A
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL-------SRRLEDSEA---------- 161
Query: 127 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVT 186
YT K ++PIRW A E++ K T+ SDVWSF +
Sbjct: 162 ----TYTTK--------------------GGKIPIRWTAPEAIAYRKFTSASDVWSFGIV 197
Query: 187 LWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNE 246
+WE++ + +RPY +++N+ VI+ Y+ LP P C ++ LML+CW+ +
Sbjct: 198 MWEVMSY-GERPYWDMSNQDVIKAVEDGYR-------LPPPMDCPSALYQLMLDCWQKDR 249
Query: 247 TDRPRFSEIHLFLQR 261
+RP FS+I L +
Sbjct: 250 NERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 6e-41
Identities = 81/256 (31%), Positives = 112/256 (43%), Gaps = 48/256 (18%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPA-ISYGCLIFM 59
M N+VR+IGV P + E GDL +FL+ N E P+ ++ L+F
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFC 121
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
A +A G KYLE +HRD+AARNC+ L+
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCL------------------------LTCK----- 152
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
G KI+D M Y + YY +A LPI+WM E+ L G T+K+D
Sbjct: 153 ---------GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTD 203
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF V LWEI PY TN++V+E + L P C ++ +M
Sbjct: 204 VWSFGVLLWEIF-SLGYMPYPGRTNQEVMEFV-------TGGGRLDPPKGCPGPVYRIMT 255
Query: 240 ECWKTNETDRPRFSEI 255
+CW+ DRP F+ I
Sbjct: 256 DCWQHTPEDRPNFATI 271
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 8e-41
Identities = 92/251 (36%), Positives = 118/251 (47%), Gaps = 52/251 (20%)
Query: 8 NLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL---IFMATQIA 64
++VR++GV S P I E GDL ++L+ + NP + L I MA +IA
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 65 SGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 124
GM YL + VHRDLAARNCMV +++T+KI D M
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM------------------------ 165
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
T I YE+DYY K LP+RWM+ ESL G TT SDVWSF
Sbjct: 166 --------TRDI---------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 208
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
V LWEI Q PY ++NEQV+ + L +P C +F+LM CW+
Sbjct: 209 VVLWEIATLAEQ-PYQGMSNEQVLRFV-------MEGGLLDKPDNCPDMLFELMRMCWQY 260
Query: 245 NETDRPRFSEI 255
N RP F EI
Sbjct: 261 NPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 76/258 (29%), Positives = 121/258 (46%), Gaps = 63/258 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M P++V++IGV TE+P+ + E G+L ++LQ ++ LI +
Sbjct: 61 MRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQ------VNKYSLDLASLILYS 113
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+++ + YLES+ VHRD+AARN +V +K+ D+ LS
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKL-----------GDFGLS-------- 154
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
R++ + YY + +K +LPI+WMA ES+ + T+ SDV
Sbjct: 155 RYLE----------------------DESYYKA-SKGKLPIKWMAPESINFRRFTSASDV 191
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVI---ENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
W F V +WEIL+ +P+ + N VI EN LP P C ++ L
Sbjct: 192 WMFGVCMWEILML-GVKPFQGVKNNDVIGRIENGER----------LPMPPNCPPTLYSL 240
Query: 238 MLECWKTNETDRPRFSEI 255
M +CW + + RPRF+E+
Sbjct: 241 MTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 84/262 (32%), Positives = 125/262 (47%), Gaps = 58/262 (22%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQE---------NPAISYG 54
L+ PN+V ++GV + E P+S I YC DL FL + + +S +
Sbjct: 65 LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 55 CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDT 114
+ + TQIA+GM++L S +VH+DLA RN +V +KISD ++ Y +DYY
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---- 180
Query: 115 KARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN 174
+ M N + LPIRWM+ E+++ GK
Sbjct: 181 ------KLMGNSL-------------------------------LPIRWMSPEAIMYGKF 203
Query: 175 TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234
+ SD+WS+ V LWE+ + Q PY +N+ VIE + +Q LP P C +
Sbjct: 204 SIDSDIWSYGVVLWEVFSYGLQ-PYCGYSNQDVIEMIRN-------RQVLPCPDDCPAWV 255
Query: 235 FDLMLECWKTNETDRPRFSEIH 256
+ LMLECW + RPRF +IH
Sbjct: 256 YTLMLECWNEFPSRRPRFKDIH 277
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 6e-40
Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 59/261 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +L+ PNLV+++GV +P+ + EY G L +L+ S+ I+ + A
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR-----SRGRAVITLAQQLGFA 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ GM+YLE ++ VHRDLAARN +V ++ K+S D+ L+
Sbjct: 109 LDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVS-----------DFGLA-------- 149
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ +LP++W A E+L K +TKSDV
Sbjct: 150 ---------------------------KEASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + LWEI + PY + + V+ + Y+ + P C E++ +M +
Sbjct: 183 WSFGILLWEIYSF-GRVPYPRIPLKDVVPHVEKGYRMEA-------PEGCPPEVYKVMKD 234
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ + RP F ++ L
Sbjct: 235 CWELDPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 7e-40
Identities = 80/267 (29%), Positives = 119/267 (44%), Gaps = 56/267 (20%)
Query: 1 MCSLKDPNLVRVIGVC----STEDPIS--TIQEYCEFGDLSTFLQIHNCNSQENPAISYG 54
M PN++++IGVC S + I + + GDL +FL
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 55 CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDT 114
L FM IA GM+YL +R+ +HRDLAARNCM+ ++ T+ ++D
Sbjct: 115 LLKFMV-DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVAD----------------- 156
Query: 115 KARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN 174
G + I Y DYY A++P++W+A ESL
Sbjct: 157 -------------FGLSKKI-----------YSGDYYRQGRIAKMPVKWIAIESLADRVY 192
Query: 175 TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234
T+KSDVW+F VT+WEI Q PY + N ++ Y L +P C E+
Sbjct: 193 TSKSDVWAFGVTMWEIATR-GQTPYPGVENHEI-------YDYLRHGNRLKQPEDCLDEL 244
Query: 235 FDLMLECWKTNETDRPRFSEIHLFLQR 261
+DLM CW+ + DRP F+++ L+
Sbjct: 245 YDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 72/260 (27%), Positives = 119/260 (45%), Gaps = 66/260 (25%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH--NCNSQENPAISYGCLIF 58
M S+ P++VR++G+C + + I + G L +++ H N SQ L+
Sbjct: 63 MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQY--------LLN 113
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
QIA GM YLE + +VHRDLAARN +V +KI+D + A+L
Sbjct: 114 WCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL---------------AKL 158
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
+ Y ++ ++PI+WMA ES+L T KS
Sbjct: 159 LDV-------------------------DEKEYHAE-GGKVPIKWMALESILHRIYTHKS 192
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQV---IENCSHWYQNNSKQQYLPRPATCQKEIF 235
DVWS+ VT+WE++ +PY + ++ +E K + LP+P C +++
Sbjct: 193 DVWSYGVTVWELMTF-GAKPYEGIPAVEIPDLLE----------KGERLPQPPICTIDVY 241
Query: 236 DLMLECWKTNETDRPRFSEI 255
++++CW + RP F E+
Sbjct: 242 MVLVKCWMIDAESRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 9e-39
Identities = 78/256 (30%), Positives = 123/256 (48%), Gaps = 54/256 (21%)
Query: 1 MCSLKDPNLVRVIGVC-STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
M PN++ ++G+C +E + Y + GDL F++ + NP + LI
Sbjct: 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIR----SETHNPTVKD--LIGF 103
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
Q+A GM+YL S+ VHRDLAARNCM+ +++T+K++D + Y+ +YY
Sbjct: 104 GLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--------- 154
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
+ +H T A+LP++WMA ESL K TTKSD
Sbjct: 155 ---------------SVHNH---------------TGAKLPVKWMALESLQTQKFTTKSD 184
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF V LWE++ PY ++ + + + + + L +P C ++++ML
Sbjct: 185 VWSFGVLLWELMTR-GAPPYPDVDSFDI----TVYLLQGRR---LLQPEYCPDPLYEVML 236
Query: 240 ECWKTNETDRPRFSEI 255
CW RP FSE+
Sbjct: 237 SCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 79/252 (31%), Positives = 118/252 (46%), Gaps = 60/252 (23%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
PN+V++IGVC+ PI + E GD +FL+ ++ + L+ A A+G
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLR------KKKDELKTKQLVKFALDAAAG 105
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
M YLES++ +HRDLAARNC+VG+N +KISD M S E D
Sbjct: 106 MAYLESKNCIHRDLAARNCLVGENNVLKISDFGM--SRQEDD------------------ 145
Query: 127 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVT 186
Y S ++PI+W A E+L G+ +++SDVWS+ +
Sbjct: 146 ----------------------GIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGIL 183
Query: 187 LWEI--LIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
LWE L C PY +TN+Q E Y+ + P C +++ +M CW
Sbjct: 184 LWETFSLGVC---PYPGMTNQQAREQVEKGYR-------MSCPQKCPDDVYKVMQRCWDY 233
Query: 245 NETDRPRFSEIH 256
+RP+FSE+
Sbjct: 234 KPENRPKFSELQ 245
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-38
Identities = 79/262 (30%), Positives = 123/262 (46%), Gaps = 51/262 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTE-DPISTIQEYCEFGDLSTFLQIHNCNSQENP-AISYGCLIF 58
+ L N++ ++ VC + +P + Y +G+L FLQ NP A+S L+
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
MA QIA GM YL R ++H+D+AARNC++ + +KI+D+A+ + DY
Sbjct: 122 MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY--------- 172
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
+C L D + R P++WMA ESL+ + ++ S
Sbjct: 173 ------HC-------------------------LGDNENR-PVKWMALESLVNKEYSSAS 200
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
DVWSF V LWE L+ Q PY E+ ++ Y+ L +P C E+F +M
Sbjct: 201 DVWSFGVLLWE-LMTLGQTPYVEIDPFEMAAYLKDGYR-------LAQPINCPDELFAVM 252
Query: 239 LECWKTNETDRPRFSEIHLFLQ 260
CW + +RP FS++ L
Sbjct: 253 ACCWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 8e-38
Identities = 83/252 (32%), Positives = 120/252 (47%), Gaps = 56/252 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ P LVR+ V T++PI I EY E G L FL+ + E ++ LI MA
Sbjct: 55 MKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMA 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM ++E ++ +HRDL A N +V + KI+D + ARL
Sbjct: 109 AQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGL---------------ARL-- 151
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E++ G T KSDV
Sbjct: 152 -------------------------IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L EI+ + + PY +TN +VI+N Y+ +PRP C +E+++LM
Sbjct: 187 WSFGILLTEIVTY-GRIPYPGMTNPEVIQNLERGYR-------MPRPDNCPEELYELMRL 238
Query: 241 CWKTNETDRPRF 252
CWK +RP F
Sbjct: 239 CWKEKPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 9e-38
Identities = 78/261 (29%), Positives = 119/261 (45%), Gaps = 54/261 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M PN++ + GV + P+ + EY E G L FL+ H+ + L+ M
Sbjct: 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ------FTVIQLVGML 112
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
IASGMKYL VHRDLAARN +V N K+SD
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSD----------------------- 149
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
G + ++ A Y + ++PIRW A E++ K T+ SDV
Sbjct: 150 -------FGLSRVLEDDPEAAYTT----------RGGKIPIRWTAPEAIAYRKFTSASDV 192
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ + +WE++ + +RPY E++N+ VI+ Y+ LP P C + LML+
Sbjct: 193 WSYGIVMWEVMSY-GERPYWEMSNQDVIKAIEEGYR-------LPAPMDCPAALHQLMLD 244
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ + +RP+F +I L +
Sbjct: 245 CWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 77/253 (30%), Positives = 116/253 (45%), Gaps = 56/253 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P LV++ GVC+ PI + E+ E G LS +L+ + S L+ M
Sbjct: 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR------AQRGKFSQETLLGMC 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ GM YLES +++HRDLAARNC+VG+N +K+SD M + + L D
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGM------TRFVLDDQ------ 154
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
Y S T + P++W + E K ++KSDV
Sbjct: 155 ------------------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V +WE+ + PY +N +V+E + ++ L +P + +++LM
Sbjct: 185 WSFGVLMWEVFSE-GKTPYENRSNSEVVETINAGFR-------LYKPRLASQSVYELMQH 236
Query: 241 CWKTNETDRPRFS 253
CWK DRP FS
Sbjct: 237 CWKERPEDRPSFS 249
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 85/266 (31%), Positives = 125/266 (46%), Gaps = 66/266 (24%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQI--------------HNCNSQENP--- 49
P+++++ G CS + P+ I EY ++G L +FL+ N + +NP
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 50 AISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDY 109
A++ G LI A QI+ GM+YL +VHRDLAARN +V + +KISD + D
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGL-----SRDV 177
Query: 110 YLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESL 169
YE D Y+ +K R+P++WMA ESL
Sbjct: 178 ------------------------------------YEEDSYVKRSKGRIPVKWMAIESL 201
Query: 170 LLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229
TT+SDVWSF V LWEI + PY + E++ Y+ + RP
Sbjct: 202 FDHIYTTQSDVWSFGVLLWEI-VTLGGNPYPGIAPERLFNLLKTGYR-------MERPEN 253
Query: 230 CQKEIFDLMLECWKTNETDRPRFSEI 255
C +E+++LML CWK RP F++I
Sbjct: 254 CSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 82/256 (32%), Positives = 121/256 (47%), Gaps = 54/256 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M PN++ + GV + P+ I E+ E G L +FL+ N + I L+ M
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQ---LVGML 112
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
IA+GMKYL + VHRDLAARN +V N K+SD + S + DT
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL------SRFLEDDT------ 160
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
SD Y S ++PIRW A E++ K T+ SDV
Sbjct: 161 ----------------SDPT----------YTSSLGGKIPIRWTAPEAIAYRKFTSASDV 194
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY-LPRPATCQKEIFDLML 239
WS+ + +WE++ + +RPY +++N+ VI N +Q Y LP P C + LML
Sbjct: 195 WSYGIVMWEVMSY-GERPYWDMSNQDVI--------NAIEQDYRLPPPMDCPTALHQLML 245
Query: 240 ECWKTNETDRPRFSEI 255
+CW+ + RP+F +I
Sbjct: 246 DCWQKDRNARPKFGQI 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-36
Identities = 73/255 (28%), Positives = 109/255 (42%), Gaps = 56/255 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L LV++ GVC+ + PI + EY G L +L+ H + S L+ M
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH----GKRFQPSQ--LLEMC 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ GM YLES+ +HRDLAARNC+V +K+SD + S Y L D
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGL------SRYVLDDE------ 154
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
Y S ++ P+RW E LL K ++KSDV
Sbjct: 155 ------------------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F V +WE+ + PY N + +E S + L RP ++++ +M
Sbjct: 185 WAFGVLMWEVY-SLGKMPYERFNNSETVEKVSQGLR-------LYRPHLASEKVYAIMYS 236
Query: 241 CWKTNETDRPRFSEI 255
CW +RP F ++
Sbjct: 237 CWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 2e-35
Identities = 77/260 (29%), Positives = 118/260 (45%), Gaps = 56/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +L+ LV++ V T++PI I E+ G L FL+ + Q P LI +
Sbjct: 55 MKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK-----LIDFS 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM ++E R+ +HRDL A N +V + KI+D + AR+
Sbjct: 109 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL---------------ARV-- 151
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E++ G T KSDV
Sbjct: 152 -------------------------IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L EI+ + + PY ++N +VI Y+ +PRP C +E++++M+
Sbjct: 187 WSFGILLMEIVTY-GRIPYPGMSNPEVIRALERGYR-------MPRPENCPEELYNIMMR 238
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CWK +RP F I L
Sbjct: 239 CWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 85/268 (31%), Positives = 122/268 (45%), Gaps = 58/268 (21%)
Query: 1 MCSLKDPNLVRVIGVC--STED-----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISY 53
M PN++R+IGVC + E P+ I + + GDL +FL +
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPV-VILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112
Query: 54 GCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSD 113
+ FM T IASGM+YL S+ +HRDLAARNCM+ +N + ++D +
Sbjct: 113 MLVKFM-TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL------------- 158
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
+ KI Y DYY A++P++W+A ESL
Sbjct: 159 -------------------SKKI---------YNGDYYRQGRIAKMPVKWIAIESLADRV 190
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233
TTKSDVWSF VT+WEI Q PY + N ++ + + Q N +Q P C
Sbjct: 191 YTTKSDVWSFGVTMWEIATR-GQTPYPGVENSEIYD---YLRQGNRLKQ----PPDCLDG 242
Query: 234 IFDLMLECWKTNETDRPRFSEIHLFLQR 261
++ LM CW N DRP F + L++
Sbjct: 243 LYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 81/272 (29%), Positives = 124/272 (45%), Gaps = 64/272 (23%)
Query: 1 MCSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPA--------- 50
+C L PN++ ++G C + EY +G+L FL+ + +PA
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRV-LETDPAFAKEHGTAS 114
Query: 51 -ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDY 109
++ L+ A+ +A+GM+YL + +HRDLAARN +VG+N KI+D +
Sbjct: 115 TLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGL--------- 165
Query: 110 YLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESL 169
S E + Y+ T RLP+RWMA ESL
Sbjct: 166 ----------------------------------SRGE-EVYVKKTMGRLPVRWMAIESL 190
Query: 170 LLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229
TTKSDVWSF V LWEI + PY +T C+ Y+ + + +P
Sbjct: 191 NYSVYTTKSDVWSFGVLLWEI-VSLGGTPYCGMT-------CAELYEKLPQGYRMEKPRN 242
Query: 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
C E+++LM +CW+ +RP F++I + L R
Sbjct: 243 CDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 84/271 (30%), Positives = 124/271 (45%), Gaps = 60/271 (22%)
Query: 1 MCSLKDPNLVRVIGVC-----STEDPIS-TIQEYCEFGDLSTFLQIHNCNSQENP-AISY 53
M PN++++IGV PI I + + GDL TFL + E P +
Sbjct: 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG--EEPFTLPL 112
Query: 54 GCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSD 113
L+ IASGM+YL S++ +HRDLAARNCM+ +N T+ ++D +
Sbjct: 113 QTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL------------- 159
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
+ KI Y DYY ++LP++W+A ESL
Sbjct: 160 -------------------SKKI---------YSGDYYRQGCASKLPVKWLALESLADNV 191
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233
TT SDVW+F VT+WEI+ Q PYA + N ++ Y K L +P C ++
Sbjct: 192 YTTHSDVWAFGVTMWEIMTR-GQTPYAGVENSEI-------YNYLIKGNRLKQPPDCLED 243
Query: 234 IFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264
+++LM +CW RP F HL Q + +
Sbjct: 244 VYELMCQCWSPEPKCRPSFQ--HLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-34
Identities = 77/248 (31%), Positives = 117/248 (47%), Gaps = 54/248 (21%)
Query: 8 NLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGM 67
N++R+ GV + P I EY E G L +L+ H+ S L+ M IA+GM
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE------FSSYQLVGMLRGIAAGM 120
Query: 68 KYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCM 127
KYL + VHRDLAARN +V N K+SD + LS P
Sbjct: 121 KYLSDMNYVHRDLAARNILVNSNLECKVSD-----------FGLSRVLEDDP-------- 161
Query: 128 VGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTL 187
E Y + + ++PIRW A E++ K T+ SDVWSF + +
Sbjct: 162 -------------------EGTY--TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 200
Query: 188 WEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNET 247
WE++ +RPY +++N +V++ + ++ LP P C ++ LML+CW+ +
Sbjct: 201 WEVMSF-GERPYWDMSNHEVMKAINDGFR-------LPAPMDCPSAVYQLMLQCWQQDRA 252
Query: 248 DRPRFSEI 255
RPRF +I
Sbjct: 253 RRPRFVDI 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 82/272 (30%), Positives = 120/272 (44%), Gaps = 64/272 (23%)
Query: 1 MCSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPA--------- 50
+C L PN++ ++G C + EY G+L FL+ + +PA
Sbjct: 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV-LETDPAFAIANSTAS 107
Query: 51 -ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDY 109
+S L+ A +A GM YL + +HRDLAARN +VG+NY KI+D +
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL--------- 158
Query: 110 YLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESL 169
S + + Y+ T RLP+RWMA ESL
Sbjct: 159 ----------------------------------SRGQ-EVYVKKTMGRLPVRWMAIESL 183
Query: 170 LLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229
TT SDVWS+ V LWEI + PY +T C+ Y+ + L +P
Sbjct: 184 NYSVYTTNSDVWSYGVLLWEI-VSLGGTPYCGMT-------CAELYEKLPQGYRLEKPLN 235
Query: 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
C E++DLM +CW+ +RP F++I + L R
Sbjct: 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 72/255 (28%), Positives = 112/255 (43%), Gaps = 56/255 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P LV++ GVC+ + P+ + E+ E G L +L+ Q +S L+ M
Sbjct: 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR------QRQGKLSKDMLLSMC 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ GM+YLE +HRDLAARNC+V +K+SD M + Y L D
Sbjct: 107 QDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGM------TRYVLDDE------ 154
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
Y S + A+ P++W E K ++KSDV
Sbjct: 155 ------------------------------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V +WE+ + P+ + +N +V+E S ++ L RP ++++M
Sbjct: 185 WSFGVLMWEVFTE-GKMPFEKKSNYEVVEMISRGFR-------LYRPKLASMTVYEVMYS 236
Query: 241 CWKTNETDRPRFSEI 255
CW RP F+E+
Sbjct: 237 CWHEKPEGRPTFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 73/259 (28%), Positives = 115/259 (44%), Gaps = 46/259 (17%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
L PN+++ +G C P + E+C GDL +L+ + L MA ++
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLR--SNRGMVAQMAQKDVLQRMACEV 109
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 123
ASG+ +L D +H DLA RNC + + ++KI D+ + Y DYY++ +P+RW+
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169
Query: 124 ANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSF 183
A +V I+ D LL T KS++WS
Sbjct: 170 APELV----EIRGQD------------------------------LLPKDQTKKSNIWSL 195
Query: 184 AVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK---EIFDLMLE 240
VT+WE L +PY +L++EQV++ + LP+P K +++M
Sbjct: 196 GVTMWE-LFTAADQPYPDLSDEQVLK-----QVVREQDIKLPKPQLDLKYSDRWYEVMQF 249
Query: 241 CWKTNETDRPRFSEIHLFL 259
CW ET RP E+H L
Sbjct: 250 CWLDPET-RPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 77/259 (29%), Positives = 116/259 (44%), Gaps = 55/259 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +L+ LVR+ V + E+PI I EY G L FL+ S E + LI +
Sbjct: 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLK-----SDEGGKVLLPKLIDFS 109
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM Y+E ++ +HRDL A N +V ++ KI+D + AR+
Sbjct: 110 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGL---------------ARV-- 152
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E++ G T KSDV
Sbjct: 153 -------------------------IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L+EI+ + + PY ++N V+ Y+ +PR C E++D+M
Sbjct: 188 WSFGILLYEIVTY-GKIPYPGMSNSDVMSALQRGYR-------MPRMENCPDELYDIMKT 239
Query: 241 CWKTNETDRPRFSEIHLFL 259
CWK +RP F + L
Sbjct: 240 CWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 72/254 (28%), Positives = 113/254 (44%), Gaps = 55/254 (21%)
Query: 8 NLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGM 67
N+V ++G C+ PI I EYC +GDL FL+ + ++ L+ + Q+A GM
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLR-----RKRESFLTLEDLLSFSYQVAKGM 154
Query: 68 KYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCM 127
+L S++ +HRDLAARN ++ +KI D + AR + M
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFGL---------------AR-------DIM 192
Query: 128 VGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTL 187
NY +K + ARLP++WMA ES+ T +SDVWS+ + L
Sbjct: 193 NDSNYVVKGN-------------------ARLPVKWMAPESIFNCVYTFESDVWSYGILL 233
Query: 188 WEILIHCNQRPYAEL-TNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNE 246
WEI PY + + + + Y+ + +P EI+D+M CW +
Sbjct: 234 WEIF-SLGSNPYPGMPVDSKFYKLIKEGYR-------MAQPEHAPAEIYDIMKTCWDADP 285
Query: 247 TDRPRFSEIHLFLQ 260
RP F +I +
Sbjct: 286 LKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-33
Identities = 81/272 (29%), Positives = 118/272 (43%), Gaps = 64/272 (23%)
Query: 1 MCSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPA--------- 50
+C L PN++ ++G C + EY G+L FL+ + +PA
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV-LETDPAFAIANSTAS 119
Query: 51 -ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDY 109
+S L+ A +A GM YL + +HRDLAARN +VG+NY KI+D +
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL--------- 170
Query: 110 YLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESL 169
+ Y+ T RLP+RWMA ESL
Sbjct: 171 -----------------------------------SRGQEVYVKKTMGRLPVRWMAIESL 195
Query: 170 LLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229
TT SDVWS+ V LWEI + PY +T C+ Y+ + L +P
Sbjct: 196 NYSVYTTNSDVWSYGVLLWEI-VSLGGTPYCGMT-------CAELYEKLPQGYRLEKPLN 247
Query: 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
C E++DLM +CW+ +RP F++I + L R
Sbjct: 248 CDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 80/260 (30%), Positives = 118/260 (45%), Gaps = 56/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ LV++ V S E+PI + EY G L FL+ E A+ L+ MA
Sbjct: 55 MKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK-----DGEGRALKLPNLVDMA 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+A+GM Y+E + +HRDL + N +VG KI+D + ARL
Sbjct: 109 AQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGL---------------ARL-- 151
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E+ L G+ T KSDV
Sbjct: 152 -------------------------IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L E L+ + PY + N +V+E Y+ +P P C + +LML+
Sbjct: 187 WSFGILLTE-LVTKGRVPYPGMNNREVLEQVERGYR-------MPCPQDCPISLHELMLQ 238
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CWK + +RP F + FL+
Sbjct: 239 CWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 77/261 (29%), Positives = 119/261 (45%), Gaps = 60/261 (22%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHN----------CNSQENPAISYG 54
K N++ ++GVC+ E P+ I EY G+L FL+ E +S+
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ-LSFK 134
Query: 55 CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDT 114
L+ A Q+A GM+YLESR +HRDLAARN +V ++ +KI+D +
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL-------------- 180
Query: 115 KARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN 174
AR ++ DYY + RLP++WMA E+L
Sbjct: 181 -AR--------------------------GVHDIDYYKKTSNGRLPVKWMAPEALFDRVY 213
Query: 175 TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234
T +SDVWSF + +WEI PY + E++ + ++ + +P+ C E+
Sbjct: 214 THQSDVWSFGILMWEIFT-LGGSPYPGIPVEELFKLLREGHR-------MDKPSNCTHEL 265
Query: 235 FDLMLECWKTNETDRPRFSEI 255
+ LM ECW T RP F ++
Sbjct: 266 YMLMRECWHAVPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 79/260 (30%), Positives = 117/260 (45%), Gaps = 56/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ LV++ V S E+PI + EY G L FL+ + + L+ MA
Sbjct: 55 MKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK-----GEMGKYLRLPQLVDMA 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIASGM Y+E + VHRDL A N +VG+N K++D + ARL
Sbjct: 109 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL---------------ARL-- 151
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E+ L G+ T KSDV
Sbjct: 152 -------------------------IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L E+ + PY + N +V++ Y+ +P P C + + DLM +
Sbjct: 187 WSFGILLTELTTK-GRVPYPGMVNREVLDQVERGYR-------MPCPPECPESLHDLMCQ 238
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CW+ +RP F + FL+
Sbjct: 239 CWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 75/260 (28%), Positives = 123/260 (47%), Gaps = 46/260 (17%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
SL+ NL++ +G C+ P + E+C GDL +L+ +C E L MA +
Sbjct: 51 SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR--SCRKAELMTPDPTTLQRMACE 108
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 122
IA G+ +L + +H DLA RNC++ + T+KI D+ + + Y+ DYY++ + +P+RW
Sbjct: 109 IALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 123 MANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWS 182
+A +V + + +LL+ T +S+VWS
Sbjct: 169 IAPELVDEVHG----------------------------------NLLVVDQTKESNVWS 194
Query: 183 FAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRP---ATCQKEIFDLML 239
VT+WE+ +Q PY L++EQV+ Y +Q LP+P +++M
Sbjct: 195 LGVTIWELFELGSQ-PYRHLSDEQVLT-----YTVREQQLKLPKPRLKLPLSDRWYEVMQ 248
Query: 240 ECWKTNETDRPRFSEIHLFL 259
CW E RP E+HL L
Sbjct: 249 FCWLQPE-QRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 75/260 (28%), Positives = 116/260 (44%), Gaps = 56/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +P +VR+IG+C E + + E E G L+ FLQ +N ++ + +
Sbjct: 50 MQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQ-------KNKHVTEKNITELV 101
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q++ GMKYLE + VHRDLAARN ++ + KISD + S +D
Sbjct: 102 HQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL------SKALGAD------- 148
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+YY + T + P++W A E + K ++KSDV
Sbjct: 149 ---------------------------ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDV 181
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V +WE + Q+PY + +V Q + + P C E++DLM
Sbjct: 182 WSFGVLMWEAFSY-GQKPYKGMKGNEVT-------QMIESGERMECPQRCPPEMYDLMKL 233
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CW +RP F+ + L L+
Sbjct: 234 CWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 72/255 (28%), Positives = 121/255 (47%), Gaps = 55/255 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +P +VR+IGVC E + + E G L+ FL S + I+ ++ +
Sbjct: 49 MHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFL------SGKKDEITVSNVVELM 101
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q++ GMKYLE ++ VHRDLAARN ++ + KISD + +KA
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGL-------------SKA---- 144
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+G + YY + + + P++W A E + K +++SDV
Sbjct: 145 -------LGA----------------DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDV 181
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ +T+WE + Q+PY ++ +V+ + + + L PA C E++ LM +
Sbjct: 182 WSYGITMWEAFSY-GQKPYKKMKGPEVMS----FIEQGKR---LDCPAECPPEMYALMKD 233
Query: 241 CWKTNETDRPRFSEI 255
CW DRP F+++
Sbjct: 234 CWIYKWEDRPNFAKV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 72/262 (27%), Positives = 117/262 (44%), Gaps = 62/262 (23%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH-----------NCNSQENPAISY 53
K N++ ++G C+ + P+ I EY G+L +L+ +E +S+
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ--LSF 139
Query: 54 GCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSD 113
L+ A Q+A GM+YL S+ +HRDLAARN +V ++ +KI+D +
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL------------- 186
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
AR + DYY T RLP++WMA E+L
Sbjct: 187 --AR--------------------------DIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233
T +SDVWSF V LWEI PY + E++ + ++ + +P+ C E
Sbjct: 219 YTHQSDVWSFGVLLWEIFT-LGGSPYPGVPVEELFKLLKEGHR-------MDKPSNCTNE 270
Query: 234 IFDLMLECWKTNETDRPRFSEI 255
++ +M +CW + RP F ++
Sbjct: 271 LYMMMRDCWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 81/260 (31%), Positives = 116/260 (44%), Gaps = 56/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ LV + V S E+PI + E+ G L FL+ + + P L+ MA
Sbjct: 55 MKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ-----LVDMA 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM Y+E + +HRDL A N +VG N KI+D + ARL
Sbjct: 109 AQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGL---------------ARL-- 151
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E+ L G+ T KSDV
Sbjct: 152 -------------------------IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L E L+ + PY + N +V+E Y+ +P P C + + +LM
Sbjct: 187 WSFGILLTE-LVTKGRVPYPGMVNREVLEQVERGYR-------MPCPQGCPESLHELMKL 238
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CWK + +RP F I FL+
Sbjct: 239 CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 56/254 (22%)
Query: 8 NLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGM 67
N+VR+ GV + + + + EY G L +FL+ H + G L+ M +ASGM
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ------LVAGQLMGMLPGLASGM 120
Query: 68 KYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCM 127
KYL VH+ LAA +V + KIS RL
Sbjct: 121 KYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-----------------RLQEDKS---- 159
Query: 128 VGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTL 187
A+Y + + P+ W A E++ ++ SDVWSF + +
Sbjct: 160 -----------EAIY----------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVM 198
Query: 188 WEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNET 247
WE++ + +RPY +++ + VI+ ++ LP P C + LML+CW+
Sbjct: 199 WEVMSY-GERPYWDMSGQDVIKAVEDGFR-------LPAPRNCPNLLHQLMLDCWQKERG 250
Query: 248 DRPRFSEIHLFLQR 261
+RPRFS+IH L +
Sbjct: 251 ERPRFSQIHSILSK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 72/255 (28%), Positives = 118/255 (46%), Gaps = 56/255 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M SL +VR++G+C P +++Q + L + L Q ++ L+
Sbjct: 63 MGSLDHAYIVRLLGIC----PGASLQLVTQLSPLGSLLDHVR---QHRDSLDPQRLLNWC 115
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM YLE +VHR+LAARN ++ + ++I+D + +D D K
Sbjct: 116 VQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGV------ADLLYPDDK----- 164
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
Y+ S+ K PI+WMA ES+L G+ T +SDV
Sbjct: 165 ----------------------------KYFYSEHKT--PIKWMALESILFGRYTHQSDV 194
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VT+WE++ + PYA + +V + K + L +P C +++ +M++
Sbjct: 195 WSYGVTVWEMMSY-GAEPYAGMRPHEVPDLL-------EKGERLAQPQICTIDVYMVMVK 246
Query: 241 CWKTNETDRPRFSEI 255
CW +E RP F E+
Sbjct: 247 CWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 79/304 (25%), Positives = 136/304 (44%), Gaps = 71/304 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M S+ +P++ R++G+C T + I + FG L +++ H ++N Y L+
Sbjct: 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH----KDNIGSQY--LLNWC 115
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM YLE R +VHRDLAARN +V +KI+D + + +D K
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL------AKLLGADEKE---- 165
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
Y ++ ++PI+WMA ES+L T +SDV
Sbjct: 166 -------------------------YHAE------GGKVPIKWMALESILHRIYTHQSDV 194
Query: 181 WSFAVTLWEILIHCNQRPY-----AELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
WS+ VT+WE++ +PY +E+++ ++E K + LP+P C +++
Sbjct: 195 WSYGVTVWELMTF-GSKPYDGIPASEISS--ILE----------KGERLPQPPICTIDVY 241
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQRKNLGARASKITPVMKRLPLHVFSTV---KIFFSM 292
+M++CW + RP+F E L ++ + + + +H+ S M
Sbjct: 242 MIMVKCWMIDADSRPKFRE--LIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALM 299
Query: 293 DGSS 296
D
Sbjct: 300 DEED 303
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 71/260 (27%), Positives = 116/260 (44%), Gaps = 58/260 (22%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQE---------NPAISYGC 55
K N++ ++G C+ + P+ + EY G+L +L+ + +++
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L+ A Q+A GM+YL S+ +HRDLAARN +V ++ +KI+D +
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGL--------------- 180
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
AR + DYY T RLP++WMA E+L T
Sbjct: 181 AR--------------------------DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT 214
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
+SDVWSF V LWEI PY + E++ + ++ + +PA C E++
Sbjct: 215 HQSDVWSFGVLLWEIFT-LGGSPYPGIPVEELFKLLKEGHR-------MDKPANCTHELY 266
Query: 236 DLMLECWKTNETDRPRFSEI 255
+M ECW + RP F ++
Sbjct: 267 MIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 58/260 (22%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQI---------HNCNSQENPAISYGC 55
K N++ ++G C+ + P+ I EY G+L +L+ ++ + +++
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L+ Q+A GM+YL S+ +HRDLAARN +V +N +KI+D +
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL--------------- 183
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
R + N DYY T RLP++WMA E+L T
Sbjct: 184 ----ARDVNNI----------------------DYYKKTTNGRLPVKWMAPEALFDRVYT 217
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
+SDVWSF V +WEI PY + E++ + ++ + +PA C E++
Sbjct: 218 HQSDVWSFGVLMWEIFT-LGGSPYPGIPVEELFKLLKEGHR-------MDKPANCTNELY 269
Query: 236 DLMLECWKTNETDRPRFSEI 255
+M +CW + RP F ++
Sbjct: 270 MMMRDCWHAIPSHRPTFKQL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 60/262 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L NLVR++GV + + + E G+L FL+ ++ +S L+ +
Sbjct: 53 MTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFS 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+A GM+YLES+ +VHRDLAARN +V ++ K+SD + AR+
Sbjct: 107 LDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGL---------------ARVGS 151
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ N ++LP++W A E+L K ++KSDV
Sbjct: 152 MGVDN-------------------------------SKLPVKWTAPEALKHKKFSSKSDV 180
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ V LWE+ + PY +++ ++V E Y+ + P C +++ LM
Sbjct: 181 WSYGVLLWEVFSYGRA-PYPKMSLKEVKECVEKGYR-------MEPPEGCPADVYVLMTS 232
Query: 241 CWKTNETDRPRFSEIHLFLQRK 262
CW+T RP F ++ L+++
Sbjct: 233 CWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 78/262 (29%), Positives = 110/262 (41%), Gaps = 55/262 (20%)
Query: 3 SLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
SL+ N+V+ GVC + + + EY +G L +LQ H + + L+ A
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYA 114
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+QI GM+YL S+ VHRDLA RN +V +KI D + TK LP
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL-------------TKV-LPQ 160
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ +YY PI W A ESL K + SDV
Sbjct: 161 --------------------------DKEYYKVREPGESPIFWYAPESLTESKFSVASDV 194
Query: 181 WSFAVTLWEILIHC--NQRPYAEL-----TNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233
WSF V L+E+ + + P AE ++Q H + LP P C E
Sbjct: 195 WSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAE 254
Query: 234 IFDLMLECWKTNETDRPRFSEI 255
I+ +M ECW + + RP FSE+
Sbjct: 255 IYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 7e-27
Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 56/255 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M S+ P+LVR++GVC + I + + G L ++ H N I L+
Sbjct: 63 MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN------IGSQLLLNWC 115
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM YLE R +VHRDLAARN +V +KI+D + ARL
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGL---------------ARL-- 158
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ G Y +D ++PI+WMA E + K T +SDV
Sbjct: 159 ------LEGDE------------KEYNAD------GGKMPIKWMALECIHYRKFTHQSDV 194
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VT+WE++ +PY + ++ + K + LP+P C +++ +M++
Sbjct: 195 WSYGVTIWELMTF-GGKPYDGIPTREIPDLL-------EKGERLPQPPICTIDVYMVMVK 246
Query: 241 CWKTNETDRPRFSEI 255
CW + RP+F E+
Sbjct: 247 CWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 9e-27
Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 49/260 (18%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLI-FMATQ 62
L+ PN+++ +G C P + EYCE GDL ++L Q + S L+ MA +
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRMACE 107
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 122
IA+G+ ++ + +H DLA RNC + + T+K+ D+ + S Y+ DY ++ +P+RW
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 123 MANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWS 182
+A +VG+ + L+ + T S+VW+
Sbjct: 168 LAPELVGEFH----------------------------------GGLITAEQTKPSNVWA 193
Query: 183 FAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ---KEIFDLML 239
VTLWE L +PY+ L++ +V+ + +Q L +P + ++++
Sbjct: 194 LGVTLWE-LFENAAQPYSHLSDREVLNHVI-----KDQQVKLFKPQLELPYSERWYEVLQ 247
Query: 240 ECWKTNETDRPRFSEIHLFL 259
CW + E R E+H L
Sbjct: 248 FCWLSPE-KRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 77/259 (29%), Positives = 120/259 (46%), Gaps = 64/259 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNC---NSQENPA-ISYGCL 56
M + P + R++G+C T ST+Q L T L + C +EN I L
Sbjct: 63 MAGVGSPYVCRLLGICLT----STVQ-------LVTQLMPYGCLLDYVRENKDRIGSQDL 111
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
+ QIA GM YLE +VHRDLAARN +V +KI+D + A
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL---------------A 156
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
RL + I + + Y +D ++PI+WMA ES+L + T
Sbjct: 157 RL---------------LDIDE-----TEYHAD------GGKVPIKWMALESILHRRFTH 190
Query: 177 KSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236
+SDVWS+ VT+WE++ +PY + ++ + K + LP+P C +++
Sbjct: 191 QSDVWSYGVTVWELMTF-GAKPYDGIPAREIPDLL-------EKGERLPQPPICTIDVYM 242
Query: 237 LMLECWKTNETDRPRFSEI 255
+M++CW + RPRF E+
Sbjct: 243 IMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 75/263 (28%), Positives = 107/263 (40%), Gaps = 60/263 (22%)
Query: 3 SLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+L N+V+ G CS + I EY G L +L H ++ L+ A
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--------LNLAQLLLFA 113
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QI GM YL S+ +HRDLAARN ++ + +KI D + KA +P
Sbjct: 114 QQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGL-------------AKA-VP- 158
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
H +YY P+ W A E L K + SDV
Sbjct: 159 ----------------EGH---------EYYRVREDGDSPVFWYAVECLKENKFSYASDV 193
Query: 181 WSFAVTLWEILIHCN--QRPYAELTNEQVIE------NCSHWYQNNSKQQYLPRPATCQK 232
WSF VTL+E+L HC+ Q P + E++I + + LP P C +
Sbjct: 194 WSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQ 251
Query: 233 EIFDLMLECWKTNETDRPRFSEI 255
E++ LM CW+T RP F +
Sbjct: 252 EVYILMKNCWETEAKFRPTFRSL 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 74/258 (28%), Positives = 109/258 (42%), Gaps = 58/258 (22%)
Query: 8 NLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIAS 65
N+V+ G+C+ + + I I E+ G L +L N N I+ + A QI
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNK-----INLKQQLKYAVQICK 120
Query: 66 GMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAN 125
GM YL SR VHRDLAARN +V + +KI D + TKA
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL-------------TKA--------- 158
Query: 126 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAV 185
I + +YY P+ W A E L+ K SDVWSF V
Sbjct: 159 ----------IET--------DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGV 200
Query: 186 TLWEILIHCNQR--PYAEL------TNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
TL+E+L +C+ P T+ Q+ + + + + LPRP C +E++ L
Sbjct: 201 TLYELLTYCDSESSPMTLFLKMIGPTHGQM--TVTRLVRVLEEGKRLPRPPNCPEEVYQL 258
Query: 238 MLECWKTNETDRPRFSEI 255
M +CW+ + R F +
Sbjct: 259 MRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 70/261 (26%), Positives = 113/261 (43%), Gaps = 60/261 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
M L+ NLV+++GV E + + EY G L +L+ S+ + CL+
Sbjct: 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKF 107
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
+ + M+YLE+ + VHRDLAARN +V ++ K+SD + TK
Sbjct: 108 SLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGL-------------TKEASS 154
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
+ DT +LP++W A E+L K +TKSD
Sbjct: 155 TQ--------------------------------DT-GKLPVKWTAPEALREKKFSTKSD 181
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF + LWEI + PY + + V+ Y+ ++ P C ++D+M
Sbjct: 182 VWSFGILLWEIY-SFGRVPYPRIPLKDVVPRVEKGYKMDA-------PDGCPPVVYDVMK 233
Query: 240 ECWKTNETDRPRFSEIHLFLQ 260
+CW + RP F ++ L+
Sbjct: 234 QCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 52/217 (23%)
Query: 47 ENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYE 106
E+PA+SY L+ + Q+A+GM++L S++ VHRDLAARN ++ + +KI D +
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGL------ 285
Query: 107 SDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAW 166
AR + M NY +S LP++WMA
Sbjct: 286 ---------AR-------DIMRDSNY-------------------ISKGSTFLPLKWMAP 310
Query: 167 ESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAEL-TNEQVIENCSHWYQNNSKQQY-L 224
ES+ TT SDVWSF + LWEI PY EL NEQ + N K+ Y +
Sbjct: 311 ESIFNNLYTTLSDVWSFGILLWEIFT-LGGTPYPELPMNEQ--------FYNAIKRGYRM 361
Query: 225 PRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
+PA EI+++M +CW+ RP FS++ +
Sbjct: 362 AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 64/201 (31%), Positives = 90/201 (44%), Gaps = 50/201 (24%)
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
LI + Q+A GM++L SR +HRDLAARN ++ +N +KI D +
Sbjct: 175 LISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL--------------- 219
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
AR Y+ Y+ ARLP++WMA ES+ T
Sbjct: 220 AR--------------------------DIYKDPDYVRKGDARLPLKWMAPESIFDKVYT 253
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELT-NEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234
T+SDVWSF V LWEI PY + +E+ + + + P EI
Sbjct: 254 TQSDVWSFGVLLWEIF-SLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATP-------EI 305
Query: 235 FDLMLECWKTNETDRPRFSEI 255
+ +ML+CW N DRP FSE+
Sbjct: 306 YSIMLDCWHNNPEDRPTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 59/257 (22%), Positives = 92/257 (35%), Gaps = 61/257 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ LK PN+VR+ V ED + + EYCE GDL L+ + +S F
Sbjct: 51 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK-------KRGRLSEDEARFYL 103
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QI S ++YL S+ IVHRDL N ++ ++ +K++D + + L+
Sbjct: 104 RQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGL-ARQLDPGEKLTT------- 155
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
VG T Y MA E LL D+
Sbjct: 156 ------FVG---TP---------------EY------------MAPEVLLGKGYGKAVDI 179
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN--NSKQQYLPRPATCQKEIFDLM 238
WS V L+E+L + P+ + ++ K + P E DL+
Sbjct: 180 WSLGVILYELL--TGKPPFPGDDQLLEL------FKKIGKPKPPFPPPEWDISPEAKDLI 231
Query: 239 LECWKTNETDRPRFSEI 255
+ + R E
Sbjct: 232 RKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 61/263 (23%), Positives = 96/263 (36%), Gaps = 62/263 (23%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
L PN+VR+I +D + + EYCE GDL +L +S +A Q
Sbjct: 54 RLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP-------LSEDEAKKIALQ 106
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 122
I G++YL S I+HRDL N ++ +N +KI+D + +S
Sbjct: 107 ILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-------------- 152
Query: 123 MANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSDVW 181
T + +MA E LL G K DVW
Sbjct: 153 ------SSLTTFVGT-----------------------PWYMAPEVLLGGNGYGPKVDVW 183
Query: 182 SFAVTLWEILIHCNQRPYAELTNE---QVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
S V L+E+L + P++ Q+I + ++ + DL+
Sbjct: 184 SLGVILYELL--TGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK----DLI 237
Query: 239 LECWKTNETDRPRFSEI--HLFL 259
+C + + RP EI H +
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 55/256 (21%), Positives = 86/256 (33%), Gaps = 90/256 (35%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L PN+V++ GV E+ + + EYCE G L L+ + E+ +
Sbjct: 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRI------L 98
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QI G++YL S I+HRDL N ++ +
Sbjct: 99 LQILEGLEYLHSNGIIHRDLKPENILLDSD------------------------------ 128
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL-LGKNTTKSD 179
N +K++D + SD L T +MA E LL G + KSD
Sbjct: 129 ----------NGKVKLADFGL-SKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKSD 176
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
+WS V L+E+ E+ DL+
Sbjct: 177 IWSLGVILYEL-----------------------------------------PELKDLIR 195
Query: 240 ECWKTNETDRPRFSEI 255
+ + + RP EI
Sbjct: 196 KMLQKDPEKRPSAKEI 211
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 62/200 (31%), Positives = 91/200 (45%), Gaps = 48/200 (24%)
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
LI + Q+A GM++L SR +HRDLAARN ++ +N +KI D +
Sbjct: 176 LICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL--------------- 220
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
AR Y+ Y+ ARLP++WMA ES+ T
Sbjct: 221 AR--------------------------DIYKDPDYVRKGSARLPLKWMAPESIFDKVYT 254
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
T+SDVWSF V LWEI PY + Q+ E ++ ++ + P EI+
Sbjct: 255 TQSDVWSFGVLLWEIF-SLGASPYPGV---QINEEFCQRLKDGTRMR---APENATPEIY 307
Query: 236 DLMLECWKTNETDRPRFSEI 255
+ML CW+ + +RP FS +
Sbjct: 308 RIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 50/207 (24%)
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L+ ++Q+A GM +L S++ +HRD+AARN ++ KI D +
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGL--------------- 258
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
AR + M NY +K ARLP++WMA ES+ T
Sbjct: 259 AR-------DIMNDSNYVVK-------------------GNARLPVKWMAPESIFDCVYT 292
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAE-LTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234
+SDVWS+ + LWEI + PY L N + + YQ + RP EI
Sbjct: 293 VQSDVWSYGILLWEIF-SLGKSPYPGILVNSKFYKMVKRGYQ-------MSRPDFAPPEI 344
Query: 235 FDLMLECWKTNETDRPRFSEIHLFLQR 261
+ +M CW T+RP FS+I +QR
Sbjct: 345 YSIMKMCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 60/200 (30%), Positives = 87/200 (43%), Gaps = 48/200 (24%)
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
LI + Q+A GM++L SR +HRDLAARN ++ +N +KI D +
Sbjct: 181 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL--------------- 225
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
AR Y+ Y+ ARLP++WMA E++ T
Sbjct: 226 AR--------------------------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 259
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
+SDVWSF V LWEI PY + ++ E C + + P E++
Sbjct: 260 IQSDVWSFGVLLWEIF-SLGASPYPGVKIDE--EFCRRLKEGTRMRA----PDYTTPEMY 312
Query: 236 DLMLECWKTNETDRPRFSEI 255
ML+CW + RP FSE+
Sbjct: 313 QTMLDCWHGEPSQRPTFSEL 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-18
Identities = 62/257 (24%), Positives = 106/257 (41%), Gaps = 59/257 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +LV++ GVC D ++EY +FG L FL ++N +S + +A
Sbjct: 55 MSQLSHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLH-----REKNN-VSLHWKLDVA 107
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+AS + YLE + +VH ++ +N +V + + +P
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVAR---------------------YGLNEGYVPF 146
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN--TTKS 178
IK+SD + + + + I W+A E + G+ T +
Sbjct: 147 -------------IKLSDPGIPITVLSREERVE------RIPWIAPECIRNGQASLTIAA 187
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
D WSF TL EI + + ++E+ +YQ+ + LP P E+ +L+
Sbjct: 188 DKWSFGTTLLEICSNGEEPLSTLSSSEKE-----RFYQDQHR---LPMPD--CAELANLI 237
Query: 239 LECWKTNETDRPRFSEI 255
+CW + T RP F I
Sbjct: 238 NQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 50/198 (25%)
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L+ Q+A GM++L S++ VHRDLAARN ++ + +KI D +
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGL--------------- 283
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
AR + M NY K S LP++WMA ES+ T
Sbjct: 284 AR-------DIMHDSNYVSKGSTF-------------------LPVKWMAPESIFDNLYT 317
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY-LPRPATCQKEI 234
T SDVWS+ + LWEI PY + + + N K Y + +P +E+
Sbjct: 318 TLSDVWSYGILLWEIF-SLGGTPYPGMIVDST-------FYNKIKSGYRMAKPDHATQEV 369
Query: 235 FDLMLECWKTNETDRPRF 252
+D+M++CW + RP F
Sbjct: 370 YDIMVKCWNSEPEKRPSF 387
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 6e-18
Identities = 43/206 (20%), Positives = 74/206 (35%), Gaps = 52/206 (25%)
Query: 1 MCSLKDPNLVRVIGVCSTEDP--ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ SL+ PN+VR G E+ ++ EY G LS+ L+ + + +
Sbjct: 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-------KFGKLPEPVIRK 105
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
QI G+ YL S IVHRD+ N +V + +K++ D+ + +
Sbjct: 106 YTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLA-----------DFGCAKRLGDI 154
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
+ G WMA E + + +
Sbjct: 155 ETGEGTGSVRGT------------------------------PYWMAPEVIRGEEYGRAA 184
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTN 204
D+WS T+ E+ + P++EL N
Sbjct: 185 DIWSLGCTVIEMA--TGKPPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 58/200 (29%), Positives = 87/200 (43%), Gaps = 48/200 (24%)
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L+ + Q+A GM +L S++ +HRDLAARN ++ KI D +
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGL--------------- 260
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
AR IR +N +V N ARLP++WMA ES+ T
Sbjct: 261 AR-DIRNDSNYVVKGN-------------------------ARLPVKWMAPESIFNCVYT 294
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
+SDVWS+ + LWEI PY + + S +Y+ + + P E++
Sbjct: 295 FESDVWSYGILLWEIF-SLGSSPYPGMPVD------SKFYKMIKEGYRMLSPECAPSEMY 347
Query: 236 DLMLECWKTNETDRPRFSEI 255
D+M CW + RP F +I
Sbjct: 348 DIMKSCWDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 9e-17
Identities = 56/251 (22%), Positives = 100/251 (39%), Gaps = 67/251 (26%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
LK PN+V+ IG T D + I EY E G L ++ E+ Y Q+
Sbjct: 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP-FPESLVAVY------VYQV 108
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 123
G+ YL + ++HRD+ A N + K+ +K++ D+ ++ TK
Sbjct: 109 LQGLAYLHEQGVIHRDIKAANILTTKDGVVKLA-----------DFGVA-TKLN------ 150
Query: 124 ANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSF 183
+ D ++ + Y WMA E + + +T SD+WS
Sbjct: 151 ---------DVSKDDASVVGTPY----------------WMAPEVIEMSGASTASDIWSL 185
Query: 184 AVTLWEILIHCNQRPYAELTNE----QVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
T+ E L+ N PY +L +++++ + P P E+ D ++
Sbjct: 186 GCTVIE-LLTGNP-PYYDLNPMAALFRIVQD-----------DHPPLPEGISPELKDFLM 232
Query: 240 ECWKTNETDRP 250
+C++ + RP
Sbjct: 233 QCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (172), Expect = 2e-13
Identities = 60/258 (23%), Positives = 95/258 (36%), Gaps = 65/258 (25%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
L PN+++ + + + EY + GDLS +I +E ++ Q
Sbjct: 55 KLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQ--KIKKQK-KEGKPFPEEQILDWFVQ 111
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD----HAMYCSHYESDYYLSDTKARL 118
+ +KYL SR I+HRD+ +N + N +K+ D LS T
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-----------LSSTVD-- 158
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTK 177
+A +VG T YYLS P E L K K
Sbjct: 159 ----LAKTVVG---TP---------------YYLS------P------E-LCQNKPYNYK 183
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SD+WS L+E+ C + E N + K QY P P+ E+ +L
Sbjct: 184 SDIWSLGCVLYEL---CTLKHPFEGENLLEL------ALKILKGQYPPIPSQYSSELRNL 234
Query: 238 MLECWKTNETDRPRFSEI 255
+ + + +RP ++I
Sbjct: 235 VSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 61/265 (23%), Positives = 98/265 (36%), Gaps = 74/265 (27%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL----IFM 59
L+ PN+V+ +G ED + E G L+ L+ YG I +
Sbjct: 59 LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK------------KYGSFPEPVIRL 106
Query: 60 AT-QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
T QI G++YL R+ VHRD+ N +V N +K++D M K +
Sbjct: 107 YTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGM-------------AKQVV 153
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL-LGKNTTK 177
A G Y WMA E + G
Sbjct: 154 EFS-FAKSFKGSPY------------------------------WMAPEVIAQQGGYGLA 182
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPR-PATCQKEIFD 236
+D+WS T+ E+ + P+++L + + SK+ LP P E D
Sbjct: 183 ADIWSLGCTVLEMAT--GKPPWSQLEGVAAV-----FKIGRSKE--LPPIPDHLSDEAKD 233
Query: 237 LMLECWKTNETDRPRFSEI--HLFL 259
+L+C + + + RP +E+ H F+
Sbjct: 234 FILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 4e-11
Identities = 27/94 (28%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
LK PN+V+++ V TE + + EYC+ DL +L +P + + + Q+
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNL----IKSIMYQL 107
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
G+ Y S I+HRDL +N ++ ++ +K++D
Sbjct: 108 LRGLAYCHSHRILHRDLKPQNILINRDGVLKLAD 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 61/249 (24%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
K PN+V+ G +D + + E+C G L L+ N E+ I+Y C ++
Sbjct: 54 CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES-QIAYVCK-----EL 107
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 123
G++YL S I+HRD+ A N ++ + +K+ D + + LSDTKAR
Sbjct: 108 LKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGL-SAQ------LSDTKAR------ 154
Query: 124 ANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSF 183
N MVG Y WMA E + K+D+WS
Sbjct: 155 -NTMVGTPY------------------------------WMAPEVINGKPYDYKADIWSL 183
Query: 184 AVTLWEILIHCNQR-PYAELTNEQVIENCSHWYQNNSKQQY-LPRPATCQKEIFDLMLEC 241
+T E+ + PY+EL + + ++ + L P E D + +C
Sbjct: 184 GITAIELA---EGKPPYSELPPMKAL------FKIATNGPPGLRNPEKWSDEFKDFLKKC 234
Query: 242 WKTNETDRP 250
+ N RP
Sbjct: 235 LQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 38/141 (26%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L N+V+ +G +TE+ +S EY G + + L+ + E + F
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVR-----FFT 114
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY--LSDTKARL 118
Q+ G+ YL S+ I+HRDL A N +V + KISD + S D Y + +
Sbjct: 115 EQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGI--SKKSDDIYDNDQNMSMQG 172
Query: 119 PIRWMANCMV---GKNYTIKI 136
+ WMA ++ + Y+ K+
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKV 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 4e-10
Identities = 25/98 (25%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
+ L P ++++ E+ + + EY G+L +++ + + C F
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-------LDEKCTRFY 107
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
A +I ++YL S+ I+HRDL N ++ K+ IKI+D
Sbjct: 108 AAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITD 145
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 60.5 bits (145), Expect = 5e-10
Identities = 57/346 (16%), Positives = 110/346 (31%), Gaps = 48/346 (13%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
PN+V++ E + + EY + G L L+ +S +F+ QI S
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK----KIGRKGPLSESEALFILAQILSA 113
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYT-IKISDHAMYCSHYESDYYLSDTKARLPIRWMAN 125
++YL S+ I+HRD+ N ++ ++ +K+ D + L D + I + +
Sbjct: 114 LEYLHSKGIIHRDIKPENILLDRDGRVVKLID-------FGLAKLLPDPGSTSSIPALPS 166
Query: 126 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAV 185
VG Y + L L ++ SD+WS +
Sbjct: 167 TSVGTPG---------YMAPEV------------------LLGLSLAYASSSSDIWSLGI 199
Query: 186 TLWEILIHCN--QRPYAELTNEQVIENCSHWYQNNSKQQYLPR-PATCQKEIFDLMLECW 242
TL+E+L + Q ++ + P P K DL+ +
Sbjct: 200 TLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLL 259
Query: 243 KTNETDRPRFSEI--HLFLQRKNL----GARASKITPVMKRLPLHVFSTVKIFFSMDGSS 296
+ +R S H L L + K S + S++ +
Sbjct: 260 AKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLA 319
Query: 297 FQSNMSPIKESPNPEFFPKNRTAFNVVVGLKNRVSRFIKVQLYFKA 342
+ + +S + N + + +S +
Sbjct: 320 ISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKRSSLPK 365
|
Length = 384 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 57/256 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M + +L V GVC ++E+ E G L L+ +E + I +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR------KEKGRVPVAWKITVA 123
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+AS + YLE +++VH ++ A+N ++ + L++
Sbjct: 124 QQLASALSYLEDKNLVHGNVCAKNILLARL-------------------GLAE------- 157
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSD 179
G + IK+SD + S LS + I W+A E + G + +T +D
Sbjct: 158 --------GTSPFIKLSDPGV------SFTALSREERVERIPWIAPECVPGGNSLSTAAD 203
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
WSF TL EI + P E T + +Y+ K+ LP P +C KE+ L+
Sbjct: 204 KWSFGTTLLEICFD-GEVPLKERTPSEK----ERFYE---KKHRLPEP-SC-KELATLIS 253
Query: 240 ECWKTNETDRPRFSEI 255
+C T RP F I
Sbjct: 254 QCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
LK N+VR+ V ++ ++ + EYC+ DL + +CN +P I FM Q
Sbjct: 55 ELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFD--SCNGDIDPEI---VKSFM-FQ 107
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ G+ + S +++HRDL +N ++ KN +K++D
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLAD 142
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 49/205 (23%), Positives = 79/205 (38%), Gaps = 46/205 (22%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
L+ N+V+ +G D ++ EY G ++ L N + E + QI
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NYGAFEETLVRN-----FVRQI 115
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 123
G+ YL +R I+HRD+ N +V IKISD + +K +
Sbjct: 116 LKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGI-------------SK-----KLE 157
Query: 124 ANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSF 183
AN + K + S + S + WMA E + T K+D+WS
Sbjct: 158 ANSLSTKTNGARPS---LQGSVF----------------WMAPEVVKQTSYTRKADIWSL 198
Query: 184 AVTLWEILIHCNQRPYAELTNEQVI 208
+ E+L + P+ + T Q I
Sbjct: 199 GCLVVEMLT--GKHPFPDCTQLQAI 221
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 58/256 (22%), Positives = 90/256 (35%), Gaps = 57/256 (22%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
LK PNLV+ GV + + EYC G L L+ H E+ + Q+
Sbjct: 56 LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE-HGRILDEH------VIRVYTLQL 108
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 123
G+ YL S IVHRD+ N + N IK+ D + L + +
Sbjct: 109 LEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGD-------FGCAVKLKNNT--TTMGEE 159
Query: 124 ANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK---SDV 180
+ G Y MA E + GK +D+
Sbjct: 160 VQSLAGT---------PAY---------------------MAPEVITGGKGKGHGRAADI 189
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ-YLPRPATCQKEIFDLML 239
WS + E+ +RP++EL NE I + + + +P E D +
Sbjct: 190 WSLGCVVLEMAT--GKRPWSELDNEFQI-----MFHVGAGHKPPIPDSLQLSPEGKDFLD 242
Query: 240 ECWKTNETDRPRFSEI 255
C +++ RP SE+
Sbjct: 243 RCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 30/102 (29%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 1 MCSLKDPNLVRVIGVC-----STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGC 55
+ S + PN+VR++ VC E ++ + E+ + DL+T+L C P +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLS--KCPK---PGLPPET 108
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ + Q+ G+ +L S IVHRDL +N +V + +KI+D
Sbjct: 109 IKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIAD 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 52/252 (20%), Positives = 83/252 (32%), Gaps = 60/252 (23%)
Query: 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMAT 61
S + P +V+ G E IS + EY + G L+ L+ I L ++A
Sbjct: 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-------GKIPEPVLAYIAR 106
Query: 62 QIASGMKYLES-RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QI G+ YL + R I+HRD+ N ++ +KI+D + L +T
Sbjct: 107 QILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGI-SKV------LENTLD---- 155
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSD 179
N VG Y S P R + G++ + +D
Sbjct: 156 --QCNTFVGT---------VTYMS---------------PER-------IQGESYSYAAD 182
Query: 180 VWSFAVTLWEILI-HCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
+WS +TL E + P+ E E D +
Sbjct: 183 IWSLGLTLLECALGKF---PFLPPGQPSFFELM---QAICDGPPPSLPAEEFSPEFRDFI 236
Query: 239 LECWKTNETDRP 250
C + + RP
Sbjct: 237 SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 53/193 (27%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M K PN+V D + + EY + G L T + N P I+Y C
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCR---- 123
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL-P 119
++ G++YL S++++HRD+ + N ++ K+ ++K++D + A+L
Sbjct: 124 -EVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFG-FA-------------AQLTK 168
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKS 178
+ N +VG Y WMA E ++ K+ K
Sbjct: 169 EKSKRNSVVGTPY------------------------------WMAPE-VIKRKDYGPKV 197
Query: 179 DVWSFAVTLWEIL 191
D+WS + E+
Sbjct: 198 DIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 56/256 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +LV GVC D +QEY +FG L T+L+ + I+ + +A
Sbjct: 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK------KNKNLINISWKLEVA 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+A + +LE + + H ++ A+N ++ + E D P
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIR----------------EED----RKTGNPPF 146
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSD 179
IK+SD + + + L R+P W+ E + +N + +D
Sbjct: 147 -------------IKLSDPGISITVLPKEILLE----RIP--WVPPECIENPQNLSLAAD 187
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
WSF TLWEI ++ P + L +++ ++ +Y+ + Q LP P E+ +L+
Sbjct: 188 KWSFGTTLWEIFSGGDK-PLSALDSQKKLQ----FYE--DRHQ-LPAPK--WTELANLIN 237
Query: 240 ECWKTNETDRPRFSEI 255
+C RP F I
Sbjct: 238 QCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 60/264 (22%), Positives = 97/264 (36%), Gaps = 63/264 (23%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM--- 59
SLK N+V+ +G C ++ IS E+ G +S+ L +G L
Sbjct: 58 SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN------------RFGPLPEPVFC 105
Query: 60 --ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
QI G+ YL + +VHRD+ N M+ N IK+ D C+ R
Sbjct: 106 KYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFG--CAR------------R 151
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
L VG + T +M+ + Y WMA E + K
Sbjct: 152 L-------AWVGLHGTHSNMLKSMHGTPY----------------WMAPEVINESGYGRK 188
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SD+WS T++E+ + P A + + +Y + P + D
Sbjct: 189 SDIWSIGCTVFEMAT--GKPPLASMDRLAAM-----FYIGAHRGLMPRLPDSFSAAAIDF 241
Query: 238 MLECWKTNETDRPRFSEI--HLFL 259
+ C ++ +RP ++ H FL
Sbjct: 242 VTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 7e-07
Identities = 59/256 (23%), Positives = 105/256 (41%), Gaps = 57/256 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M + ++V + GVC + ++E+ EFG L F+ +++ ++ +A
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH------RKSDVLTTPWKFKVA 111
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+AS + YLE +D+VH ++ +N ++ + + +
Sbjct: 112 KQLASALSYLEDKDLVHGNVCTKNILLARE-------------GIDGEC----------- 147
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSD 179
IK+SD + + LS + I W+A E + KN + +D
Sbjct: 148 ----------GPFIKLSDPGIPIT------VLSRQECVERIPWIAPECVEDSKNLSIAAD 191
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
WSF TLWEI + + P L ++ + E +Y+ Q + +C KE+ DLM
Sbjct: 192 KWSFGTTLWEICYN-GEIP---LKDKTLAEK-ERFYEG----QCMLVTPSC-KELADLMT 241
Query: 240 ECWKTNETDRPRFSEI 255
C + RP F I
Sbjct: 242 HCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 33/97 (34%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISY-GCLIFMATQ 62
LK N+V+ +G S E G LS L+ S+ P +IF Q
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLR-----SKWGPLKDNEQTIIFYTKQ 116
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYT--IKISD 97
I G+KYL IVHRD+ N +V Y+ +KISD
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLV-NTYSGVVKISD 152
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 9/97 (9%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFMATQI 63
K P L ++ T+D + + EY GDL I E A F A +I
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRAR------FYAAEI 105
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
G+++L R I++RDL N ++ IKI+D M
Sbjct: 106 VLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 53/204 (25%), Positives = 82/204 (40%), Gaps = 52/204 (25%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
P L + T++ + + EY GDL I +C+ + P + F A +I G
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRAT-----FYAAEIICG 108
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
+++L S+ IV+RDL N ++ + IKI+D M C
Sbjct: 109 LQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGM-CKE---------------------N 146
Query: 127 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVT 186
M+G T +C DY +A E LL K T D WSF V
Sbjct: 147 MLGDAKT------CTFCG--TPDY-------------IAPEILLGQKYNTSVDWWSFGVL 185
Query: 187 LWEILIHCNQRPYAELTNEQVIEN 210
L+E+LI Q P+ E++ ++
Sbjct: 186 LYEMLI--GQSPFHGHDEEELFQS 207
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 24/99 (24%), Positives = 50/99 (50%), Gaps = 13/99 (13%)
Query: 3 SLKDPNLVRVIGVCSTEDPIST--IQEYCEFGDLSTFLQIHNCNSQENPAISYGC--LIF 58
L+ PN+VR+ + +++ S + EY + DL+ L ++P + + +
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL--------DSPEVKFTESQIKC 104
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G++YL S I+HRD+ N ++ + +K++D
Sbjct: 105 YMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLAD 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 26/103 (25%), Positives = 49/103 (47%), Gaps = 15/103 (14%)
Query: 3 SLKDPNLVRVIGVCSTE--------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYG 54
LK N+V +I +C T+ + E+CE DL+ L S +N +
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL------SNKNVKFTLS 119
Query: 55 CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ + + +G+ Y+ I+HRD+ A N ++ K+ +K++D
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 28/103 (27%), Positives = 52/103 (50%), Gaps = 11/103 (10%)
Query: 3 SLKDPNLVRVIGVCST-----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLI 57
+ + PN+VR+ VC+ E ++ + E+ + DL+T+L P + +
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLD-----KVPEPGVPTETIK 113
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
M Q+ G+ +L S +VHRDL +N +V + IK++D +
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 6e-06
Identities = 67/270 (24%), Positives = 99/270 (36%), Gaps = 79/270 (29%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQEN--PAISYGCLIFMAT 61
+K PN + G E + EYC G S L++H QE AI++G L
Sbjct: 82 IKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGAL----- 135
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 121
G+ YL S +++HRD+ A N ++ + +K++D + S S
Sbjct: 136 ---QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLAD-------FGSASIASP-------- 177
Query: 122 WMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL---GKNTTKS 178
AN VG Y WMA E +L G+ K
Sbjct: 178 --ANSFVGTPY------------------------------WMAPEVILAMDEGQYDGKV 205
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD-- 236
DVWS +T E+ ++P L N + H QN S P E D
Sbjct: 206 DVWSLGITCIEL---AERKP--PLFNMNAMSALYHIAQNES-------PTLQSNEWSDYF 253
Query: 237 --LMLECWKTNETDRPRFSEI--HLFLQRK 262
+ C + DRP E+ H+F+ R+
Sbjct: 254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 57/221 (25%), Positives = 85/221 (38%), Gaps = 66/221 (29%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQEN--PAISYGCLIFMAT 61
LK PN + G E + EYC G S L++H QE AI++G L
Sbjct: 78 LKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGAL----- 131
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 121
G+ YL S +++HRD+ A N ++ + +K++D + S +K+
Sbjct: 132 ---QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLAD------------FGSASKSS---- 172
Query: 122 WMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL---GKNTTKS 178
AN VG Y WMA E +L G+ K
Sbjct: 173 -PANSFVGTPY------------------------------WMAPEVILAMDEGQYDGKV 201
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS 219
DVWS +T E+ ++P L N + H QN+S
Sbjct: 202 DVWSLGITCIEL---AERKP--PLFNMNAMSALYHIAQNDS 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 42/188 (22%), Positives = 70/188 (37%), Gaps = 53/188 (28%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHN--CNSQENPAISYGCLIFMATQ 62
P +V+ G + + EYC G +S ++I N +E AI Y L
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTL------ 109
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 122
G++YL S +HRD+ A N ++ + K++D + L+DT A+
Sbjct: 110 --KGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGV-------SGQLTDTMAK----- 155
Query: 123 MANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWS 182
N ++G + WMA E + K+D+WS
Sbjct: 156 -RNTVIGTPF------------------------------WMAPEVIQEIGYNNKADIWS 184
Query: 183 FAVTLWEI 190
+T E+
Sbjct: 185 LGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 30/96 (31%), Positives = 44/96 (45%), Gaps = 7/96 (7%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIA 64
K P L ++ T D + + EY GDL I + P +F A +IA
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHA-----VFYAAEIA 111
Query: 65 SGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
G+ +L S+ I++RDL N M+ IKI+D M
Sbjct: 112 IGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 25/87 (28%), Positives = 42/87 (48%), Gaps = 5/87 (5%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
+K PN+V + + EYC+ GDL + N Q S ++ QI
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDL-----MKRINRQRGVLFSEDQILSWFVQI 110
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKN 90
+ G+K++ R I+HRD+ ++N + KN
Sbjct: 111 SLGLKHIHDRKILHRDIKSQNIFLSKN 137
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 25/97 (25%), Positives = 46/97 (47%), Gaps = 11/97 (11%)
Query: 3 SLKDPNLVRVIGVCS--TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ P +V++ + TE+ + + EY G+L + L S+E F A
Sbjct: 49 RINHPFIVKLH--YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-------RARFYA 99
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+I ++YL S I++RDL N ++ + IK++D
Sbjct: 100 AEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTD 136
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 51/264 (19%), Positives = 96/264 (36%), Gaps = 75/264 (28%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ +K PN+V + + + EYC+ GDL + Q ++
Sbjct: 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL-----MQKIKLQRGKLFPEDTILQWF 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ G++++ + ++HRD+ ++N + +N +K+ D ARL
Sbjct: 107 VQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFG---------------SARL-- 149
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ + A C++ + YY+ WE++ KSD+
Sbjct: 150 --LTSPG------------AYACTYVGTPYYVPPE---------IWENM---PYNNKSDI 183
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS---------KQQYLPRPATCQ 231
WS L+E+ C + H +Q NS + Y P P+
Sbjct: 184 WSLGCILYEL---CTLK---------------HPFQANSWKNLILKVCQGSYKPLPSHYS 225
Query: 232 KEIFDLMLECWKTNETDRPRFSEI 255
E+ L+ + +K N RP + I
Sbjct: 226 YELRSLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 7/96 (7%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIA 64
K P L ++ T D + + EY GDL QI + P +F A +IA
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHA-----VFYAAEIA 111
Query: 65 SGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
G+ +L S+ I++RDL N M+ IKI+D M
Sbjct: 112 IGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 43/194 (22%), Positives = 68/194 (35%), Gaps = 50/194 (25%)
Query: 3 SLKDPNLVRVIGVCSTEDP--ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
S K P +V+ G E I EYCE G L + I+ + I L +A
Sbjct: 55 SCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEKVLGKIA 111
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ G+ YL SR I+HRD+ N ++ + +K+ D + S
Sbjct: 112 ESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS------------- 158
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+A G ++ +MA E + + SDV
Sbjct: 159 --LAGTFTGTSF------------------------------YMAPERIQGKPYSITSDV 186
Query: 181 WSFAVTLWEILIHC 194
WS +TL E+ +
Sbjct: 187 WSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 44/195 (22%), Positives = 65/195 (33%), Gaps = 54/195 (27%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
P +V G IS EY + G L L + I L +A + G
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKG 112
Query: 67 MKYL-ESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAN 125
+ YL E I+HRD+ N +V IK+ D + L ++ +A
Sbjct: 113 LTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGV-------SGQLVNS--------LAK 157
Query: 126 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAV 185
VG S Y MA E + + KSD+WS +
Sbjct: 158 TFVG-------------TSSY-----------------MAPERIQGNDYSVKSDIWSLGL 187
Query: 186 TLWEILIHCNQRPYA 200
+L E+ + PY
Sbjct: 188 SLIELAT--GRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 30/135 (22%), Positives = 53/135 (39%), Gaps = 11/135 (8%)
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
+ +V +NY +KI H + + + + + + + + T K D++S
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKML---NDIFSEYTIKDDIYSLG 209
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
V LWEI P+ LT +++ + N + L P C EI ++ C
Sbjct: 210 VVLWEIFTGK--IPFENLTTKEIYDLII----NKNNSLKL--PLDCPLEIKCIVEACTSH 261
Query: 245 NETDRPRFSEIHLFL 259
+ RP EI L
Sbjct: 262 DSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 62/266 (23%), Positives = 94/266 (35%), Gaps = 71/266 (26%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQEN--PAISYGCLIFMAT 61
L+ PN ++ G E + EYC G S L++H QE A+++G L
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGAL----- 125
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 121
G+ YL S +++HRD+ A N ++ + +K+ D I
Sbjct: 126 ---QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDF-----------------GSASIM 165
Query: 122 WMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL---GKNTTKS 178
AN VG Y WMA E +L G+ K
Sbjct: 166 APANXFVGTPY------------------------------WMAPEVILAMDEGQYDGKV 195
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
DVWS +T E+ ++P L N + H QN S + + D
Sbjct: 196 DVWSLGITCIEL---AERKP--PLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD-- 248
Query: 239 LECWKTNETDRPRFSEI--HLFLQRK 262
C + DRP + H F+ R+
Sbjct: 249 -SCLQKIPQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 26/97 (26%), Positives = 46/97 (47%), Gaps = 5/97 (5%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M LK N+VR+ V TE+ + + EY + DL ++ H +P F
Sbjct: 52 MKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKS---FT- 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G+ + ++HRDL +N ++ K +K++D
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLAD 143
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 3 SLKDPNLVRVIGVCSTEDP--ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
S++ P LV + G S +D + + EY G+L + L+ P F A
Sbjct: 57 SIRHPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPVAR-----FYA 107
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ ++YL S DIV+RDL N ++ + IKI+D
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITD 144
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 45/193 (23%), Positives = 69/193 (35%), Gaps = 53/193 (27%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQ---ENPAISYGCLI 57
+ L P +V+ D I EYCE DL L+ + EN +
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI-- 113
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
Q+ G+ Y+ R I+HRDL A+N + KN +KI D +
Sbjct: 114 ----QLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSR--------------- 153
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
M +C + +T + YY+S E+L +K
Sbjct: 154 ---LLMGSCDLATTFT-------------GTPYYMSP------------EALKHQGYDSK 185
Query: 178 SDVWSFAVTLWEI 190
SD+WS L+E+
Sbjct: 186 SDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 3/97 (3%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ S+ PN++ + + + EY FGDLS + + I + +
Sbjct: 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAIS--KRKKKRKL-IPEQEIWRIF 109
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G++ L + I+HRDL + N ++ N +KI D
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGD 146
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 52/195 (26%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIA 64
++P L + T++ + + E+ GDL +Q + F A +I
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ-------DKGRFDLYRATFYAAEIV 106
Query: 65 SGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 124
G+++L S+ I++RDL N M+ ++ IKI+D M C + D +A
Sbjct: 107 CGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGM-C----KENVFGDNRA-------- 153
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
+ +C DY +A E L K T D WSF
Sbjct: 154 ---------------STFCG--TPDY-------------IAPEILQGLKYTFSVDWWSFG 183
Query: 185 VTLWEILIHCNQRPY 199
V L+E+LI Q P+
Sbjct: 184 VLLYEMLI--GQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 7/83 (8%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77
T D + + EY G+L L ++E F +I S ++YL SRD+V+
Sbjct: 66 THDRLCFVMEYANGGELFFHLSRERVFTEERAR-------FYGAEIVSALEYLHSRDVVY 118
Query: 78 RDLAARNCMVGKNYTIKISDHAM 100
RD+ N M+ K+ IKI+D +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 38/148 (25%), Positives = 60/148 (40%), Gaps = 7/148 (4%)
Query: 1 MCSLKDPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
+ LK PN+V ED + + +CE GDL H Q+ + ++
Sbjct: 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL-----YHKLKEQKGKLLPENQVVEW 107
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
QIA ++YL + I+HRDL +N + + IK+ D + E+ ++ T P
Sbjct: 108 FVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGI-ARVLENQCDMASTLIGTP 166
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYE 147
K Y K A+ C YE
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 23/66 (34%), Positives = 36/66 (54%), Gaps = 3/66 (4%)
Query: 32 GDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNY 91
GDL I+N + +ENP F QI SG+++L R I++RDL N ++ +
Sbjct: 78 GDLR--YHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG 134
Query: 92 TIKISD 97
++ISD
Sbjct: 135 NVRISD 140
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 21/78 (26%), Positives = 35/78 (44%), Gaps = 17/78 (21%)
Query: 25 IQEYCEFGDLSTFLQIHNCNSQENPAISYGCL-----IFMATQIASGMKYLESRDIVHRD 79
+ EY GDL++ L+ + G L +I ++YL S I+HRD
Sbjct: 71 VMEYLPGGDLASLLE------------NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 80 LAARNCMVGKNYTIKISD 97
L N ++ N +K++D
Sbjct: 119 LKPDNILIDSNGHLKLTD 136
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 46/196 (23%), Positives = 70/196 (35%), Gaps = 54/196 (27%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFMATQI 63
+ P L + T++ + + EY GDL I + E A Y +I
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAA------EI 105
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 123
G+++L + I++RDL N ++ K+ IKI+D M K +
Sbjct: 106 ICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGM-------------CKENMNGEGK 152
Query: 124 ANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSF 183
A+ G DY +A E L K D WSF
Sbjct: 153 ASTFCGT-----------------PDY-------------IAPEILKGQKYNESVDWWSF 182
Query: 184 AVTLWEILIHCNQRPY 199
V L+E+LI Q P+
Sbjct: 183 GVLLYEMLI--GQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 41/201 (20%), Positives = 73/201 (36%), Gaps = 62/201 (30%)
Query: 7 PNLVRVIGVCSTEDP-ISTIQEYCEFGDLSTFLQIHNCNSQENPAIS--YGCLIFMATQI 63
PN+ + G + P + I EY E G + T + + I+ Y +I +
Sbjct: 62 PNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLM--------KAGPIAEKYISVIIREVLV 112
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 123
A +KY+ ++HRD+ A N +V +K+ D + ++ R
Sbjct: 113 A--LKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAAL------LNQNSSKR------ 158
Query: 124 ANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSDVWS 182
+ VG Y WMA E + GK TK+D+WS
Sbjct: 159 -STFVGTPY------------------------------WMAPEVITEGKYYDTKADIWS 187
Query: 183 FAVTLWEILI----HCNQRPY 199
+T++E+ + + +
Sbjct: 188 LGITIYEMATGNPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 27/97 (27%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ ++K PN+V+ + + +YCE GDL + +I N+Q ++
Sbjct: 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL--YKKI---NAQRGVLFPEDQILDWF 107
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI +K++ R I+HRD+ ++N + K+ TIK+ D
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGD 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 9e-05
Identities = 17/36 (47%), Positives = 23/36 (63%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI G+KYL S +++HRDL N +V N +KI D
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICD 146
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 37/163 (22%), Positives = 68/163 (41%), Gaps = 30/163 (18%)
Query: 7 PNLVRVIGVCST-----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMAT 61
PN+VR++ VC+T E ++ + E+ + DL T+L P + + +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLD-----KVPPPGLPAETIKDLMR 115
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM---YCSH-----------YES 107
Q G+ +L + IVHRDL N +V +K++D + Y Y +
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 108 DYYLSDTKARLPIR-WMANCMVGKNYTIKISDHAMYCSHYESD 149
L + P+ W C+ + + K ++C + E+D
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGNSEAD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 28/124 (22%), Positives = 56/124 (45%), Gaps = 10/124 (8%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M LK+PN+V + D + + EY G L+ + + + A+ CL
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---- 125
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+++L + ++HRD+ + N ++G + ++K++D +C+ + T P
Sbjct: 126 ----QALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFG-FCAQITPEQSKRSTMVGTPY 180
Query: 121 RWMA 124
WMA
Sbjct: 181 -WMA 183
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 67/268 (25%), Positives = 97/268 (36%), Gaps = 75/268 (27%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQEN--PAISYGCLIFMAT 61
L+ PN + G E + EYC G S L++H QE AI +G L
Sbjct: 72 LRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGAL----- 125
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD--HAMYCSHYESDYYLSDTKARLP 119
G+ YL S + +HRD+ A N ++ + T+K++D A S P
Sbjct: 126 ---QGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS---------------P 167
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL---GKNTT 176
AN VG Y WMA E +L G+
Sbjct: 168 ----ANSFVGTPY------------------------------WMAPEVILAMDEGQYDG 193
Query: 177 KSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236
K DVWS +T E+ ++P L N + H QN+S L +
Sbjct: 194 KVDVWSLGITCIEL---AERKP--PLFNMNAMSALYHIAQNDSPT--LS-SNDWSDYFRN 245
Query: 237 LMLECWKTNETDRPRFSEI--HLFLQRK 262
+ C + DRP E+ H F+ R+
Sbjct: 246 FVDSCLQKIPQDRPSSEELLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 26/96 (27%), Positives = 43/96 (44%), Gaps = 9/96 (9%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAI--SYGCLIFMAT 61
L+ PN+V + V E + I E+ DL +L + + SY
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSY------LY 108
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI G+ + SR ++HRDL +N ++ IK++D
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLAD 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 19/94 (20%), Positives = 42/94 (44%), Gaps = 7/94 (7%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
L PN+++++ V + + + E+ + DL ++ I ++ Q+
Sbjct: 55 LNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIK-DRQRGLPESLIKS----YL-YQL 107
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
G+ + S I+HRDL N ++ +K++D
Sbjct: 108 LQGLAFCHSHGILHRDLKPENLLINTEGVLKLAD 141
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 7/96 (7%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIA 64
K P L ++ T D + + EY GDL I + P +F A +I+
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQA-----VFYAAEIS 111
Query: 65 SGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
G+ +L R I++RDL N M+ IKI+D M
Sbjct: 112 VGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 24/99 (24%), Positives = 47/99 (47%), Gaps = 17/99 (17%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYG-----CLIF 58
LK PN++ ++ V + I+ + E+ E DL + ++ +I +
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI--------KDKSIVLTPADIKSYML 109
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
M + G++YL S I+HRDL N ++ + +K++D
Sbjct: 110 MTLR---GLEYLHSNWILHRDLKPNNLLIASDGVLKLAD 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 14/39 (35%), Positives = 25/39 (64%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
Q+ G+KY+ S +++HRDL N +V ++ ++I D M
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGM 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 6/93 (6%)
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
IF A QI G+++L R IV+RDL N ++ + ++ISD + K
Sbjct: 98 IFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG----KKIKG 153
Query: 117 RLPIR-WMA-NCMVGKNYTIKISDHAMYCSHYE 147
R +MA + G+ Y + A+ C+ YE
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYE 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/97 (27%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 3 SLKDPNLVRVIGVCSTEDP--ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ P ++R+ + D + + EY G+L ++L+ NS S +F A
Sbjct: 57 EVSHPFIIRLF--WTEHDQRFLYMLMEYVPGGELFSYLR----NSGR---FSNSTGLFYA 107
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
++I ++YL S++IV+RDL N ++ K IK++D
Sbjct: 108 SEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTD 144
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 9/81 (11%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFMATQIASGMKYLESRDIV 76
T D + + EY G+L F + E+ A YG +I S + YL S D+V
Sbjct: 66 THDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYG------AEIVSALGYLHSCDVV 117
Query: 77 HRDLAARNCMVGKNYTIKISD 97
+RDL N M+ K+ IKI+D
Sbjct: 118 YRDLKLENLMLDKDGHIKITD 138
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 43/195 (22%), Positives = 77/195 (39%), Gaps = 35/195 (17%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQ-IHNCNSQENP---AISYGCLIFM 59
L P +V V +CS DP+ Y E L + L+ + S S G + +
Sbjct: 59 LIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD--HAMYCSHYESDYYLSDTKAR 117
+I + ++Y+ S+ ++HRDL N ++G + I D A++ E D L D
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED--LLDIDVD 176
Query: 118 LPIRWMANCMV-GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
++ + GK + T +MA E LL +
Sbjct: 177 ERNICYSSMTIPGK---------------------IVGT-----PDYMAPERLLGVPASE 210
Query: 177 KSDVWSFAVTLWEIL 191
+D+++ V L+++L
Sbjct: 211 STDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 23/67 (34%), Positives = 35/67 (52%), Gaps = 1/67 (1%)
Query: 32 GDLSTFLQIHNCNSQENPAISY-GCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKN 90
G++ L+ + S E I+ L +A QI SG+ YL R IVHRD+ N ++
Sbjct: 145 GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA 204
Query: 91 YTIKISD 97
+KI+D
Sbjct: 205 KNVKIAD 211
|
Length = 353 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
+LK N+V + + TE ++ + EY + DL +L NC N + IFM Q
Sbjct: 59 NLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLD--NCG---NLMSMHNVKIFM-FQ 111
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
+ G+ Y R I+HRDL +N ++ + +K++D +
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGL 149
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 4e-04
Identities = 56/263 (21%), Positives = 98/263 (37%), Gaps = 57/263 (21%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
K PN+V + E+ + + E+C+ G L + + E P I Y C Q
Sbjct: 58 ECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTE-PQIRYVC-----RQ 111
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 122
+ + +L S ++HRDL A N ++ + +K++D + + + DT P W
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-RDTFIGTP-YW 169
Query: 123 MANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWS 182
MA + C ++ + Y K+D+WS
Sbjct: 170 MA-------------PEVVACETFKDNPYDY-----------------------KADIWS 193
Query: 183 FAVTLWEILIHCNQR--PYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
+TL E+ Q P+ EL +V+ S+ L +P+ D +
Sbjct: 194 LGITLIELA----QMEPPHHELNPMRVLLKIL-----KSEPPTLDQPSKWSSSFNDFLKS 244
Query: 241 CWKTNETDRPRFSEI--HLFLQR 261
C + DRP +E+ H F+
Sbjct: 245 CLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 27/120 (22%), Positives = 53/120 (44%), Gaps = 10/120 (8%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIA 64
K+PN+V + D + + EY G L+ + + + A+ CL
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------- 125
Query: 65 SGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 124
+ +L S ++HRD+ + N ++G + ++K++D +C+ + T P WMA
Sbjct: 126 QALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG-FCAQITPEQSKRSTMVGTPY-WMA 183
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77
T D +S I + GDL L H S+ + F A +I G++++ +R +V+
Sbjct: 68 TPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGLEHMHNRFVVY 120
Query: 78 RDLAARNCMVGKNYTIKISDHAMYC 102
RDL N ++ ++ ++ISD + C
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLAC 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 23/99 (23%), Positives = 44/99 (44%), Gaps = 10/99 (10%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
M L P+++R++G + + E+ G +S L + +E I+Y
Sbjct: 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL--SKYGAFKEAVIINY------ 108
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV-GKNYTIKISD 97
Q+ G+ YL I+HRD+ N ++ ++I+D
Sbjct: 109 TEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIAD 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 7/83 (8%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77
T+D + + EY G+L L S++ F +I S + YL S IV+
Sbjct: 66 TKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR-------FYGAEIVSALDYLHSGKIVY 118
Query: 78 RDLAARNCMVGKNYTIKISDHAM 100
RDL N M+ K+ IKI+D +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 9e-04
Identities = 17/40 (42%), Positives = 24/40 (60%)
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
F+ QI G+KY+ S I+HRDL N V ++ +KI D
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILD 161
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 30/97 (30%), Positives = 47/97 (48%), Gaps = 9/97 (9%)
Query: 3 SLKDPNLVRVIGVC--STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+L+ PN+V + V D I + EYCE DL++ L E + CL+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSE-SQVK--CLM--- 114
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G++YL I+HRDL N ++ +KI+D
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIAD 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 21/95 (22%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
L+ N+V + + + + EY E T L++ + P + I+ Q
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSYIW---Q 108
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ + Y S +I+HRD+ N +V ++ +K+ D
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCD 143
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 16/40 (40%), Positives = 24/40 (60%)
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ QI G+KY+ S +VHRDL N ++ +N +KI D
Sbjct: 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICD 151
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 18/43 (41%), Positives = 26/43 (60%)
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
F+ QI G+KY+ S DI+HRDL N V ++ +KI D +
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 22/95 (23%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
L PN+VR++ V +E+ + + E+ + DL ++ + + +P + ++ Q
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMD-SSPLTGLDPPLIKS---YL-YQ 107
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ G+ Y S ++HRDL +N ++ + +K++D
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLAD 142
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 17/36 (47%), Positives = 22/36 (61%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI G+KYL S I+HRD+ N +V N +KI D
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 18/79 (22%), Positives = 41/79 (51%), Gaps = 5/79 (6%)
Query: 19 EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78
+D + + E+C G ++ ++ N+ + I+Y C +I G+ +L ++HR
Sbjct: 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC-----REILRGLSHLHQHKVIHR 135
Query: 79 DLAARNCMVGKNYTIKISD 97
D+ +N ++ +N +K+ D
Sbjct: 136 DIKGQNVLLTENAEVKLVD 154
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.001
Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 9/100 (9%)
Query: 3 SLKDPNLVRV--IGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
L+ PN+V V + V S D I + EY E DL + ++ + +
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMK------QPFLQSEVKCLM 112
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
Q+ SG+ +L I+HRDL N ++ +KI D +
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL 152
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 8/95 (8%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAI-SYGCLIFMATQ 62
L PN+V+++ V TE+ + + E+ DL F+ + P I SY +F Q
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSY---LF---Q 108
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ G+ + S ++HRDL +N ++ IK++D
Sbjct: 109 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLAD 143
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 8/84 (9%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIV 76
T D + + EY G+L L S++ F +I S + YL S +++V
Sbjct: 66 THDRLCFVMEYANGGELFFHLSRERVFSEDRAR-------FYGAEIVSALDYLHSEKNVV 118
Query: 77 HRDLAARNCMVGKNYTIKISDHAM 100
+RDL N M+ K+ IKI+D +
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 55/257 (21%), Positives = 98/257 (38%), Gaps = 54/257 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L PN+++ + + ++ + E + GDLS I + Q+ I +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRM--IKHFKKQKRL-IPERTIWKYF 112
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ S ++++ S+ I+HRD+ N + +K+ D + ++ S T A
Sbjct: 113 VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTA---- 162
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
A+ +VG + YY+S + E+ G N KSD+
Sbjct: 163 ---AHSLVG------------------TPYYMSPERIH--------EN---GYN-FKSDI 189
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT-CQKEIFDLML 239
WS L+E+ Q P+ N + K Y P PA +E+ DL+
Sbjct: 190 WSLGCLLYEMA--ALQSPF-----YGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242
Query: 240 ECWKTNETDRPRFSEIH 256
C + RP S +
Sbjct: 243 RCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 27/120 (22%), Positives = 54/120 (45%), Gaps = 10/120 (8%)
Query: 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIA 64
K+PN+V + D + + EY G L+ + + + A+ CL
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------- 126
Query: 65 SGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 124
+++L S ++HRD+ + N ++G + ++K++D +C+ + T P WMA
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG-FCAQITPEQSKRSTMVGTPY-WMA 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 8/91 (8%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
P LV + TED + + EY GDL + IH E A+ Y + + G
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVL------G 113
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
++YL IV+RDL N ++ +KI+D
Sbjct: 114 LQYLHENKIVYRDLKLDNLLLDTEGFVKIAD 144
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 24/85 (28%), Positives = 44/85 (51%), Gaps = 7/85 (8%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77
T D + I + GDL L H S++ + F AT+I G++++ +R +V+
Sbjct: 68 TPDKLCFILDLMNGGDLHYHLSQHGVFSEKE-------MRFYATEIILGLEHMHNRFVVY 120
Query: 78 RDLAARNCMVGKNYTIKISDHAMYC 102
RDL N ++ ++ ++ISD + C
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLAC 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 16/45 (35%), Positives = 25/45 (55%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYE 106
QI G+KY+ S +++HRDL N +V + +KI D + E
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 18/79 (22%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 19 EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78
+D + + E+C G ++ ++ N+ + I+Y C +I G+ +L + ++HR
Sbjct: 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC-----REILRGLAHLHAHKVIHR 145
Query: 79 DLAARNCMVGKNYTIKISD 97
D+ +N ++ +N +K+ D
Sbjct: 146 DIKGQNVLLTENAEVKLVD 164
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 23/89 (25%), Positives = 44/89 (49%)
Query: 12 VIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE 71
VIG+ P ++I+ + E ++ + N + +S + F+ Q+ G+KY+
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 72 SRDIVHRDLAARNCMVGKNYTIKISDHAM 100
S I+HRDL N V ++ ++I D +
Sbjct: 136 SAGIIHRDLKPSNVAVNEDCELRILDFGL 164
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 24/97 (24%), Positives = 42/97 (43%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ +L+ +V+ G ++ +S EY G + L+ + + E Y
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALT-ETVTRKY------T 110
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI G++YL S IVHRD+ N + +K+ D
Sbjct: 111 RQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGD 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 7/94 (7%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
P LV + TE + + EY GDL +Q +E+ F + +I+
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR-------FYSAEISLA 108
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
+ YL R I++RDL N ++ IK++D+ M
Sbjct: 109 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 25/95 (26%), Positives = 43/95 (45%), Gaps = 7/95 (7%)
Query: 6 DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIAS 65
+P LV + T + + EY GDL +Q +E+ F A +I
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHAR-------FYAAEICI 107
Query: 66 GMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100
+ +L R I++RDL N ++ + IK++D+ M
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
+ P V + G E + + E+ G+ TFL+ ++ P GC F A QI
Sbjct: 88 INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR----RNKRFPN-DVGC--FYAAQI 140
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+YL+S +IV+RDL N ++ K+ IK++D
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTD 174
|
Length = 340 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 434 | |||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0589|consensus | 426 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0600|consensus | 560 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG4279|consensus | 1226 | 100.0 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0200|consensus | 609 | 100.0 | ||
| KOG0584|consensus | 632 | 100.0 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0696|consensus | 683 | 99.98 | ||
| KOG0608|consensus | 1034 | 99.98 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG1025|consensus | 1177 | 99.98 | ||
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| KOG1024|consensus | 563 | 99.97 | ||
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0666|consensus | 438 | 99.97 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0695|consensus | 593 | 99.97 | ||
| KOG4236|consensus | 888 | 99.97 | ||
| KOG1006|consensus | 361 | 99.97 | ||
| KOG0669|consensus | 376 | 99.97 | ||
| KOG1151|consensus | 775 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0587|consensus | 953 | 99.96 | ||
| KOG0671|consensus | 415 | 99.96 | ||
| KOG1027|consensus | 903 | 99.96 | ||
| KOG4250|consensus | 732 | 99.96 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG3653|consensus | 534 | 99.96 | ||
| KOG0662|consensus | 292 | 99.96 | ||
| KOG0665|consensus | 369 | 99.96 | ||
| KOG0984|consensus | 282 | 99.95 | ||
| KOG2052|consensus | 513 | 99.95 | ||
| KOG1035|consensus | 1351 | 99.95 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0664|consensus | 449 | 99.94 | ||
| KOG0576|consensus | 829 | 99.93 | ||
| KOG0670|consensus | 752 | 99.93 | ||
| KOG1152|consensus | 772 | 99.93 | ||
| KOG1345|consensus | 378 | 99.92 | ||
| KOG0668|consensus | 338 | 99.92 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG1167|consensus | 418 | 99.91 | ||
| KOG0590|consensus | 601 | 99.9 | ||
| KOG0195|consensus | 448 | 99.89 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| KOG1290|consensus | 590 | 99.88 | ||
| KOG1023|consensus | 484 | 99.88 | ||
| KOG4158|consensus | 598 | 99.87 | ||
| KOG0603|consensus | 612 | 99.83 | ||
| KOG1240|consensus | 1431 | 99.81 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1164|consensus | 322 | 99.81 | ||
| KOG1165|consensus | 449 | 99.8 | ||
| KOG1033|consensus | 516 | 99.79 | ||
| KOG1163|consensus | 341 | 99.78 | ||
| KOG0606|consensus | 1205 | 99.75 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.65 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.65 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.6 | |
| KOG0590|consensus | 601 | 99.59 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.58 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.57 | |
| KOG1166|consensus | 974 | 99.5 | ||
| KOG0606|consensus | 1205 | 99.48 | ||
| KOG1094|consensus | 807 | 99.47 | ||
| KOG1266|consensus | 458 | 99.45 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.41 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.39 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.38 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.36 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.33 | |
| KOG1243|consensus | 690 | 99.3 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.27 | |
| KOG0601|consensus | 524 | 99.23 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.07 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.04 | |
| KOG0601|consensus | 524 | 98.93 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.92 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| KOG2137|consensus | 700 | 98.85 | ||
| KOG3741|consensus | 655 | 98.8 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.8 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| KOG3087|consensus | 229 | 98.69 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.62 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.16 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.96 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| KOG1035|consensus | 1351 | 97.89 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.73 | |
| KOG0576|consensus | 829 | 97.67 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.16 | |
| KOG1093|consensus | 725 | 96.96 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.93 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.93 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.92 | |
| KOG1826|consensus | 2724 | 96.92 | ||
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.58 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.13 | |
| KOG1235|consensus | 538 | 96.08 | ||
| KOG2268|consensus | 465 | 95.67 | ||
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.44 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.35 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.72 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.54 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 93.54 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 93.37 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.35 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 92.73 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 92.44 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 92.3 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.07 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.55 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.47 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 90.57 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 90.34 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 90.17 | |
| PLN02236 | 344 | choline kinase | 89.53 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 89.36 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 89.1 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 89.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 86.49 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 86.38 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 85.82 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 85.59 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 83.51 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 83.23 | |
| COG1862 | 97 | YajC Preprotein translocase subunit YajC [Intracel | 83.16 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 82.1 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 81.6 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 81.08 | |
| PF02009 | 299 | Rifin_STEVOR: Rifin/stevor family; InterPro: IPR00 | 80.92 |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=348.25 Aligned_cols=208 Identities=39% Similarity=0.720 Sum_probs=187.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|+|||+++|+|..++++||||||++.|+|.+||+.. .+..+...+.+.++.|||+|++||+++++|||||
T Consensus 255 Mk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~-----~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDL 329 (468)
T KOG0197|consen 255 MKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTR-----EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDL 329 (468)
T ss_pred HHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhc-----CCCccchHHHHHHHHHHHHHHHHHHhCCccchhh
Confidence 68999999999999999989999999999999999999842 4578899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
.++|||++++..+||+|||+||...+ ++|....+..-+
T Consensus 330 AARNiLV~~~~~vKIsDFGLAr~~~d------------------------------------------~~Y~~~~~~kfP 367 (468)
T KOG0197|consen 330 AARNILVDEDLVVKISDFGLARLIGD------------------------------------------DEYTASEGGKFP 367 (468)
T ss_pred hhhheeeccCceEEEcccccccccCC------------------------------------------CceeecCCCCCC
Confidence 99999999999999999999985322 223344555667
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|.|||.+..+.++.|||||||||+||||+| .|+.||.+.++.+..+.+. .+.+++.|..||+++.++|..
T Consensus 368 IkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT-~G~~py~~msn~ev~~~le-------~GyRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 368 IKWTAPEALNYGKFSSKSDVWSFGVLLWELFT-YGRVPYPGMSNEEVLELLE-------RGYRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred ceecCHHHHhhCCcccccceeehhhhHHHHhc-cCCCCCCCCCHHHHHHHHh-------ccCcCCCCCCCCHHHHHHHHH
Confidence 88999999999999999999999999999998 6999999999999988775 567899999999999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
||+.+|++|||++.+...+++..
T Consensus 440 CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 440 CWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HhhCCcccCCCHHHHHHHHHHhh
Confidence 99999999999999988887753
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=334.40 Aligned_cols=201 Identities=23% Similarity=0.338 Sum_probs=174.0
Q ss_pred CCCCCCCeeeEEEEEecCCc-eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDP-ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrD 79 (434)
++.+|||||.+||.|..++. .+|+||||++|||++++. ..+.+++...-+++.++++||.|||+ ++|||||
T Consensus 132 ~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k-------~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRD 204 (364)
T KOG0581|consen 132 RSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILK-------RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRD 204 (364)
T ss_pred hhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeecc
Confidence 56799999999999999985 999999999999999997 44679999999999999999999995 9999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++..|.+||||||.++....+ ...+..|
T Consensus 205 IKPsNlLvNskGeVKicDFGVS~~lvnS---------------------------------------------~a~tfvG 239 (364)
T KOG0581|consen 205 IKPSNLLVNSKGEVKICDFGVSGILVNS---------------------------------------------IANTFVG 239 (364)
T ss_pred CCHHHeeeccCCCEEeccccccHHhhhh---------------------------------------------hcccccc
Confidence 9999999999999999999997652111 2356789
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCC-----ChHHHHHhhhhhhhcCCcccCCCCCCc-cHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAEL-----TNEQVIENCSHWYQNNSKQQYLPRPAT-CQKE 233 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (434)
|..|||||.+.+..|+.++||||||++++|+. .|+.||... ...+++..|. ....+..|.. ++++
T Consensus 240 T~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a--~GrfP~~~~~~~~~~~~~Ll~~Iv-------~~ppP~lP~~~fS~e 310 (364)
T KOG0581|consen 240 TSAYMSPERISGESYSVKSDIWSLGLSLLELA--IGRFPYPPPNPPYLDIFELLCAIV-------DEPPPRLPEGEFSPE 310 (364)
T ss_pred cccccChhhhcCCcCCcccceecccHHHHHHh--hCCCCCCCcCCCCCCHHHHHHHHh-------cCCCCCCCcccCCHH
Confidence 99999999999999999999999999999999 899999874 3444444443 2333444554 9999
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+++|+..||++||.+||+++|+ |+|+++..
T Consensus 311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 9999999999999999999999 99998754
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=347.74 Aligned_cols=200 Identities=24% Similarity=0.394 Sum_probs=180.3
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++|+|||||+++++|++.+++|||.|+|+.|+|..+++ ....+++.+++.++.||+.||.|||+++|+|||||
T Consensus 73 r~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-------rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLK 145 (592)
T KOG0575|consen 73 RSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-------RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLK 145 (592)
T ss_pred HhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-------hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccc
Confidence 57999999999999999999999999999999999998 44689999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
..|++++++.++||+|||+|.....+. ....+.+||+
T Consensus 146 LGNlfL~~~~~VKIgDFGLAt~le~~~-------------------------------------------Erk~TlCGTP 182 (592)
T KOG0575|consen 146 LGNLFLNENMNVKIGDFGLATQLEYDG-------------------------------------------ERKKTLCGTP 182 (592)
T ss_pred hhheeecCcCcEEecccceeeeecCcc-------------------------------------------cccceecCCC
Confidence 999999999999999999986532211 1336679999
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
+|.|||++.....+..+||||+||++|.|+ .|++||...+..+.+..++. .....|..++.+.++||.++
T Consensus 183 NYIAPEVl~k~gHsfEvDiWSlGcvmYtLL--~G~PPFetk~vkety~~Ik~--------~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 183 NYIAPEVLNKSGHSFEVDIWSLGCVMYTLL--VGRPPFETKTVKETYNKIKL--------NEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cccChhHhccCCCCCchhhhhhhhHHHhhh--hCCCCcccchHHHHHHHHHh--------cCcccccccCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999999998888887753 23344678999999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHh
Q psy5690 242 WKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~ 261 (434)
|+.||.+|||+++| |+||++
T Consensus 253 L~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred hcCCcccCCCHHHHhcCHhhhC
Confidence 99999999999999 899954
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=336.17 Aligned_cols=206 Identities=22% Similarity=0.273 Sum_probs=176.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||+++++|+..+..|+||||++||+|.+++- .+..+.+..-+.+++|++.|+.|||++||+||||
T Consensus 230 LkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv-------~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDi 302 (475)
T KOG0615|consen 230 LKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVV-------ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDI 302 (475)
T ss_pred HHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHH-------hccccccchhHHHHHHHHHHHHHHHHcCcccccC
Confidence 678999999999999999999999999999999999997 4567888888999999999999999999999999
Q ss_pred CCCCeeeecC---CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVGKN---YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||+..+ ..+||+|||+|+..++.. -..+.
T Consensus 303 KPeNILl~~~~e~~llKItDFGlAK~~g~~s--------------------------------------------fm~Tl 338 (475)
T KOG0615|consen 303 KPENILLSNDAEDCLLKITDFGLAKVSGEGS--------------------------------------------FMKTL 338 (475)
T ss_pred CcceEEeccCCcceEEEecccchhhccccce--------------------------------------------ehhhh
Confidence 9999999765 679999999998743221 22667
Q ss_pred CCCccccchhhhhcCCC---CCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 158 RLPIRWMAWESLLLGKN---TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~---s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
+||+.|.|||++.+..+ ..++||||+||++|-++ +|.+||.+..... ..+++... .....++....++++
T Consensus 339 CGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcL--sG~pPFS~~~~~~sl~eQI~~G----~y~f~p~~w~~Isee 412 (475)
T KOG0615|consen 339 CGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCL--SGYPPFSEEYTDPSLKEQILKG----RYAFGPLQWDRISEE 412 (475)
T ss_pred cCCccccChhheecCCeecccchheeeeccceEEEEe--ccCCCcccccCCccHHHHHhcC----cccccChhhhhhhHH
Confidence 99999999999987654 45789999999999999 8999999877666 55655432 222334556788999
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
..+||.+||..||++|||++|+ |+||+...
T Consensus 413 a~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 413 ALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 9999999999999999999999 89999754
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=335.65 Aligned_cols=207 Identities=33% Similarity=0.527 Sum_probs=179.4
Q ss_pred CCCCCCCCeeeEEEEEecCC-ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-cccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD-IVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-iiHr 78 (434)
|++|+|||||+++|+|.++. ..++||||+++|+|.+++.++ ....+++..++.|+.||+.||+|||+++ ||||
T Consensus 93 l~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-----~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHr 167 (362)
T KOG0192|consen 93 LSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-----RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHR 167 (362)
T ss_pred HHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeec
Confidence 46799999999999998887 799999999999999999842 3568999999999999999999999999 9999
Q ss_pred CCCCCCeeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 79 DLAARNCMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 79 Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||||+|||++.++ ++||+|||+++...... ...+..
T Consensus 168 DLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-------------------------------------------~~~~~~ 204 (362)
T KOG0192|consen 168 DLKSDNILVDLKGKTLKIADFGLSREKVISK-------------------------------------------TSMTSV 204 (362)
T ss_pred ccChhhEEEcCCCCEEEECCCccceeecccc-------------------------------------------ccccCC
Confidence 9999999999998 99999999987622110 122447
Q ss_pred CCCccccchhhhh--cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 158 RLPIRWMAWESLL--LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 158 ~gt~~y~aPE~~~--~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
.||+.|||||++. ...|+.|+||||||+++|||+ +|..||.+....+....+. ....+++.+..+++.+.
T Consensus 205 ~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~--t~~~Pf~~~~~~~~~~~v~------~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 205 AGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL--TGEIPFEDLAPVQVASAVV------VGGLRPPIPKECPPHLS 276 (362)
T ss_pred CCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH--HCCCCCCCCCHHHHHHHHH------hcCCCCCCCccCCHHHH
Confidence 8899999999999 568999999999999999999 8999999998866654443 24556666777999999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 236 DLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+|.+||+.||+.||++.+++..|+...
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 9999999999999999999988887653
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.40 Aligned_cols=228 Identities=20% Similarity=0.295 Sum_probs=193.1
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
.+| .||.|++|+-.|.++..+|+|+||+++|+|.++|++ -+.+++..++.++.||+.||+|||++|||||||
T Consensus 128 ~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K-------~Gsfde~caR~YAAeIldAleylH~~GIIHRDl 200 (604)
T KOG0592|consen 128 TQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKK-------YGSFDETCARFYAAEILDALEYLHSNGIIHRDL 200 (604)
T ss_pred HHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHH-------hCcchHHHHHHHHHHHHHHHHHHHhcCceeccC
Confidence 456 899999999999999999999999999999999984 458999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||||+++++||+|||-|+.+........... ..........+.+||
T Consensus 201 KPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~------------------------------~~~~a~s~~~SFVGT 250 (604)
T KOG0592|consen 201 KPENILLDKDGHIKITDFGSAKILSPSQKSQENPV------------------------------DPNQASSRRSSFVGT 250 (604)
T ss_pred ChhheeEcCCCcEEEeeccccccCChhhccccCcc------------------------------CcccccCcccceeee
Confidence 99999999999999999999988665443211000 000001113668999
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|.+||++..+..++.+|||+|||++|+|+ .|.+||.+.++..+++.|... ..+.+..+++.+.+|+++
T Consensus 251 AeYVSPElL~~~~~~~~sDiWAlGCilyQml--aG~PPFra~NeyliFqkI~~l--------~y~fp~~fp~~a~dLv~K 320 (604)
T KOG0592|consen 251 AEYVSPELLNDSPAGPSSDLWALGCILYQML--AGQPPFRAANEYLIFQKIQAL--------DYEFPEGFPEDARDLIKK 320 (604)
T ss_pred ecccCHHHhcCCCCCcccchHHHHHHHHHHh--cCCCCCccccHHHHHHHHHHh--------cccCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999 999999999999998887652 345578888999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcccCCCccccccccc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKNLGARASKITPVMK 276 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~~~~~~~~~~~~~~ 276 (434)
.|..||.+|+++++| |+||+..++.-.-...+|.+.
T Consensus 321 LLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~ 358 (604)
T KOG0592|consen 321 LLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQ 358 (604)
T ss_pred HHccCccccccHHHHhhCcccccCChhhhhhcCCCccc
Confidence 999999999999999 899999877654444444443
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=320.91 Aligned_cols=207 Identities=23% Similarity=0.311 Sum_probs=182.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|.+++||.||+++..|++++.+|+|+||+.||.|..+|+ .+..+++..++.++.+|+.||.|||++|||||||
T Consensus 79 L~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~-------~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDl 151 (357)
T KOG0598|consen 79 LSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQ-------REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDL 151 (357)
T ss_pred HHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHH-------hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 457899999999999999999999999999999999998 5668999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||+|.+|+++|+|||+|+..-.. .....+.+||
T Consensus 152 KPENILLd~~GHi~LtDFgL~k~~~~~-------------------------------------------~~~t~tfcGT 188 (357)
T KOG0598|consen 152 KPENILLDEQGHIKLTDFGLCKEDLKD-------------------------------------------GDATRTFCGT 188 (357)
T ss_pred CHHHeeecCCCcEEEeccccchhcccC-------------------------------------------CCccccccCC
Confidence 999999999999999999998752111 1123457999
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.+..|+..+|+||||+++|||+ +|.+||.+.+..+..+.+.. ......+..++.+.++++.+
T Consensus 189 ~eYmAPEil~~~gy~~~vDWWsLGillYeML--~G~pPF~~~~~~~~~~~I~~-------~k~~~~p~~ls~~ardll~~ 259 (357)
T KOG0598|consen 189 PEYMAPEILLGKGYDKAVDWWSLGILLYEML--TGKPPFYAEDVKKMYDKILK-------GKLPLPPGYLSEEARDLLKK 259 (357)
T ss_pred ccccChHHHhcCCCCcccchHhHHHHHHHHh--hCCCCCcCccHHHHHHHHhc-------CcCCCCCccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999999998888877753 22233355588999999999
Q ss_pred hccCCCCCCC----CHHHH--HHHHHhcccCC
Q psy5690 241 CWKTNETDRP----RFSEI--HLFLQRKNLGA 266 (434)
Q Consensus 241 cl~~dP~~Rp----s~~el--~~~L~~~~~~~ 266 (434)
+|..||++|. ++++| |+|++..+++.
T Consensus 260 LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~ 291 (357)
T KOG0598|consen 260 LLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK 291 (357)
T ss_pred HhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence 9999999995 68888 99999887654
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.25 Aligned_cols=215 Identities=47% Similarity=0.846 Sum_probs=190.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCC------C-CCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQ------E-NPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~------~-~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
|+.|+|||||+|+|+|.+++++|+|+||+..|||.++|+.+..... . ...++..+.+.|+.|||.|++||-++
T Consensus 543 la~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~ 622 (774)
T KOG1026|consen 543 LAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH 622 (774)
T ss_pred HHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4679999999999999999999999999999999999987653211 1 34488999999999999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
.+|||||..+|+|++++..|||+|||++|..... ++|..
T Consensus 623 ~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYss-----------------------------------------DYYk~ 661 (774)
T KOG1026|consen 623 HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSS-----------------------------------------DYYKV 661 (774)
T ss_pred cccccchhhhhceeccceEEEecccccchhhhhh-----------------------------------------hhhcc
Confidence 9999999999999999999999999999874444 44444
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
......+++|||||.+..++|+.+||||||||++||+++ .|..||.+.+++++++.+. .+...+.|..||.+
T Consensus 662 ~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFs-yG~QPy~glSn~EVIe~i~-------~g~lL~~Pe~CP~~ 733 (774)
T KOG1026|consen 662 RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFS-YGKQPYYGLSNQEVIECIR-------AGQLLSCPENCPTE 733 (774)
T ss_pred cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhc-cccCcccccchHHHHHHHH-------cCCcccCCCCCCHH
Confidence 455566788999999999999999999999999999998 6999999999999998775 34458889999999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
+++||..||+.+|++||++.||+..|+....
T Consensus 734 vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 734 VYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 9999999999999999999999999988643
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=308.95 Aligned_cols=202 Identities=19% Similarity=0.286 Sum_probs=173.3
Q ss_pred CCCCCCCCeeeEEE-EEecCCc-eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh--CC--
Q psy5690 1 MCSLKDPNLVRVIG-VCSTEDP-ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES--RD-- 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~-~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~--~~-- 74 (434)
|++|+|||||++++ .|.+++. ++||||||.+|+|.+.++..+ +.+..++++.+|+++.|++.||..+|+ ..
T Consensus 72 LkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K---~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~ 148 (375)
T KOG0591|consen 72 LKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFK---KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGT 148 (375)
T ss_pred HHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHH---hccccCchHHHHHHHHHHHHHHHHHhccccccc
Confidence 57899999999999 5555555 899999999999999998654 356789999999999999999999998 44
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||.||+++.+|.+||+|||+++.+.... ...
T Consensus 149 VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~-------------------------------------------tfA 185 (375)
T KOG0591|consen 149 VMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKT-------------------------------------------TFA 185 (375)
T ss_pred eeeccCcchheEEcCCCceeeccchhHhHhcchh-------------------------------------------HHH
Confidence 9999999999999999999999999988743322 122
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCC-CccHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRP-ATCQKE 233 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 233 (434)
.+.+||+.||+||.+...+|+.||||||+||++|||+ .-+.||.+.+-.++..+|. .+..++.| ..+|.+
T Consensus 186 ~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMc--aL~~PF~g~n~~~L~~KI~-------qgd~~~~p~~~YS~~ 256 (375)
T KOG0591|consen 186 HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMC--ALQSPFYGDNLLSLCKKIE-------QGDYPPLPDEHYSTD 256 (375)
T ss_pred HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHH--hcCCCcccccHHHHHHHHH-------cCCCCCCcHHHhhhH
Confidence 5568899999999999999999999999999999999 7899999998888777664 34555666 678999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHL 257 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~ 257 (434)
+.+|+..|+..||+.||+...++.
T Consensus 257 l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 257 LRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred HHHHHHHHccCCcccCCCcchHHH
Confidence 999999999999999998644433
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=314.42 Aligned_cols=204 Identities=24% Similarity=0.409 Sum_probs=174.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.|+|||||++++++..++.+|+|||||.||||.+|+++ .+.+++..++.++.||+.||++||+++||||||
T Consensus 63 Lkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~-------~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDL 135 (429)
T KOG0595|consen 63 LKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR-------RGRLPEATARHFMQQLASALQFLHENNIIHRDL 135 (429)
T ss_pred HHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccC
Confidence 5789999999999999999999999999999999999984 458999999999999999999999999999999
Q ss_pred CCCCeeeecC------CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 81 AARNCMVGKN------YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 81 kp~NILl~~~------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
||+|||++.. -.+||+|||+|+...... ..
T Consensus 136 KPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~--------------------------------------------~a 171 (429)
T KOG0595|consen 136 KPQNILLSTTARNDTSPVLKIADFGFARFLQPGS--------------------------------------------MA 171 (429)
T ss_pred CcceEEeccCCCCCCCceEEecccchhhhCCchh--------------------------------------------HH
Confidence 9999999764 458999999998743221 12
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
.+.+|++-|||||++...+|+.|+|+||+|+++|+++ +|+.||...+..++...+. ......+..+..++...
T Consensus 172 ~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l--~g~~Pf~a~t~~eL~~~~~-----k~~~~~~~~~~~~s~~~ 244 (429)
T KOG0595|consen 172 ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCL--TGKPPFDAETPKELLLYIK-----KGNEIVPVLPAELSNPL 244 (429)
T ss_pred HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHH--hCCCCccccCHHHHHHHHh-----ccccccCchhhhccCch
Confidence 4567888899999999999999999999999999999 8999999999888876433 22333444456677788
Q ss_pred HHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 235 FDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+++...++++|.+|.++.+- ++++...
T Consensus 245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 245 RELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred hhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 899999999999999988776 6677654
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=321.25 Aligned_cols=255 Identities=18% Similarity=0.251 Sum_probs=197.9
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
...++|+||++|-.|.+.+.+||||||++|||+..+|. ....+++..++.++.+++.|++.+|+.|+||||||
T Consensus 196 ~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~-------~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIK 268 (550)
T KOG0605|consen 196 AEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLM-------RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIK 268 (550)
T ss_pred hhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHH-------hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCC
Confidence 34678999999999999999999999999999999998 55689999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCccccccccccccccc-ccccchhhhhhcccCcccceeecCccc------------cccccCC
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDT-KARLPIRWMANCMVGKNYTIKISDHAM------------YCSHYES 148 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~------------~~~~~~~ 148 (434)
|+|+|||..|++||+|||+|............. ....... .. ...-.++.. -...+..
T Consensus 269 PdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~-----~~----~~~~~~~~~~~~~~~~~~~~~~~~~w~~ 339 (550)
T KOG0605|consen 269 PDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQIN-----LS----EAKPSDFPKFNTPRSTMSRREQLQTWKR 339 (550)
T ss_pred hhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhh-----hc----cCCCccccccccccchhhHHHHHHHHHh
Confidence 999999999999999999986544332211000 0000000 00 000000100 0001111
Q ss_pred cccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCC
Q psy5690 149 DYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA 228 (434)
Q Consensus 149 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (434)
.......+.+||+.|||||++.+..|+..+|+||||||+|||+ .|.+||.+.+..+...++..|.... ..|...
T Consensus 340 nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmL--vGyPPF~s~tp~~T~rkI~nwr~~l----~fP~~~ 413 (550)
T KOG0605|consen 340 NRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEML--VGYPPFCSETPQETYRKIVNWRETL----KFPEEV 413 (550)
T ss_pred hhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhhhc----cCCCcC
Confidence 2222334578999999999999999999999999999999999 8999999999999999988765333 334445
Q ss_pred ccHHHHHHHHHHhccCCCCCCC---CHHHH--HHHHHhcccCCCccccccccccCC
Q psy5690 229 TCQKEIFDLMLECWKTNETDRP---RFSEI--HLFLQRKNLGARASKITPVMKRLP 279 (434)
Q Consensus 229 ~~~~~l~~li~~cl~~dP~~Rp---s~~el--~~~L~~~~~~~~~~~~~~~~~~~~ 279 (434)
.++++++|||.+|+. ||++|. +++|| |+||+..+++......+|+.+...
T Consensus 414 ~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~ 468 (550)
T KOG0605|consen 414 DLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVN 468 (550)
T ss_pred cccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCC
Confidence 677999999999999 999998 48899 999999999887777777665543
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=326.49 Aligned_cols=204 Identities=23% Similarity=0.386 Sum_probs=179.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+..+|+|||++++.|..++.+|+||||++||+|.+.+. ...+++.++..|++++++||+|||.+||+||||
T Consensus 324 m~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt--------~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDI 395 (550)
T KOG0578|consen 324 MRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT--------KTRMTEGQIAAICREILQGLKFLHARGIIHRDI 395 (550)
T ss_pred HHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh--------cccccHHHHHHHHHHHHHHHHHHHhcceeeecc
Confidence 678899999999999999999999999999999999995 446999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|.+|||++.+|.+||+|||+|..+.... ....+..||
T Consensus 396 KSDnILL~~~g~vKltDFGFcaqi~~~~-------------------------------------------~KR~TmVGT 432 (550)
T KOG0578|consen 396 KSDNILLTMDGSVKLTDFGFCAQISEEQ-------------------------------------------SKRSTMVGT 432 (550)
T ss_pred ccceeEeccCCcEEEeeeeeeecccccc-------------------------------------------CccccccCC
Confidence 9999999999999999999975532221 133567899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++....|++|.||||||++++||+ .|++||...+.......+. .........+..+++++++|+.+
T Consensus 433 PYWMAPEVvtrk~YG~KVDIWSLGIMaIEMv--eGEPPYlnE~PlrAlyLIa-----~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 433 PYWMAPEVVTRKPYGPKVDIWSLGIMAIEMV--EGEPPYLNENPLRALYLIA-----TNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred CCccchhhhhhcccCccccchhhhhHHHHHh--cCCCCccCCChHHHHHHHh-----hcCCCCcCCccccCHHHHHHHHH
Confidence 9999999999999999999999999999999 9999999877766665443 34555666688999999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.|+++|+++.|+ |+||+..
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhhc
Confidence 999999999999999 8999553
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.23 Aligned_cols=203 Identities=22% Similarity=0.311 Sum_probs=182.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.+.||.++++++.|.+.+.+++||||.+||.|..+++ ..+++++..++.++.||+.||+|||+.+|++|||
T Consensus 98 L~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lr-------k~~rF~e~~arFYAAeivlAleylH~~~iiYRDL 170 (355)
T KOG0616|consen 98 LKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLR-------KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDL 170 (355)
T ss_pred HhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHH-------hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccC
Confidence 467899999999999999999999999999999999998 4458999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||+|.+|.+||+|||+|+...+. ..+.+||
T Consensus 171 KPENiLlD~~G~iKitDFGFAK~v~~r----------------------------------------------T~TlCGT 204 (355)
T KOG0616|consen 171 KPENLLLDQNGHIKITDFGFAKRVSGR----------------------------------------------TWTLCGT 204 (355)
T ss_pred ChHHeeeccCCcEEEEeccceEEecCc----------------------------------------------EEEecCC
Confidence 999999999999999999998763222 2457899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||+++...|..++|.|||||++|||+ .|.+||...+..+++++|.. .....|..++.++++|+.+
T Consensus 205 PeYLAPEii~sk~ynkavDWWalGVLIYEMl--aG~pPF~~~~~~~iY~KI~~--------~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 205 PEYLAPEIIQSKGYNKAVDWWALGVLIYEML--AGYPPFYDDNPIQIYEKILE--------GKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred ccccChHHhhcCCCCcchhHHHHHHHHHHHH--cCCCCCcCCChHHHHHHHHh--------CcccCCcccCHHHHHHHHH
Confidence 9999999999999999999999999999999 99999999999888888754 2345578899999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhcccCC
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKNLGA 266 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~~~~ 266 (434)
.|+.|-.+|. ...+| |+|++...+..
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 9999999993 45677 99998876543
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=324.81 Aligned_cols=202 Identities=23% Similarity=0.304 Sum_probs=181.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+-|.||||+++|+++++..++|+|.||++||.|.+++- .++.+++.++.+++.||+.|+.|+|..+|+||||
T Consensus 66 MkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv-------~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDL 138 (786)
T KOG0588|consen 66 MKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLV-------RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDL 138 (786)
T ss_pred HHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHH-------hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Confidence 677899999999999999999999999999999999998 4568999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|+|||..+++||+|||+|....+. ....+.||.
T Consensus 139 KpENlLLd~~~nIKIADFGMAsLe~~g--------------------------------------------klLeTSCGS 174 (786)
T KOG0588|consen 139 KPENLLLDVKNNIKIADFGMASLEVPG--------------------------------------------KLLETSCGS 174 (786)
T ss_pred CchhhhhhcccCEeeeccceeecccCC--------------------------------------------ccccccCCC
Confidence 999999999999999999997542111 123567899
Q ss_pred ccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+.+| +.++||||+|||||.|+ +|+.||++.+-..++.++.+ .....|..++.++++|+.
T Consensus 175 PHYA~PEIV~G~pYdG~~sDVWSCGVILfALL--tG~LPFdDdNir~LLlKV~~--------G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 175 PHYAAPEIVSGRPYDGRPSDVWSCGVILFALL--TGKLPFDDDNIRVLLLKVQR--------GVFEMPSNISSEAQDLLR 244 (786)
T ss_pred cccCCchhhcCCCCCCCccccchhHHHHHHHH--hCCCCCCCccHHHHHHHHHc--------CcccCCCcCCHHHHHHHH
Confidence 99999999999998 78999999999999999 89999999988888877754 234457899999999999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+|+..||+.|.|.+|| |+|+.+..
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999 89998753
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=306.62 Aligned_cols=263 Identities=19% Similarity=0.237 Sum_probs=201.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||.++.||+.|+.+...|+|||||+||+|..+.++. .+..+++..++.++.+++.||+|||-.|||+|||
T Consensus 131 L~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQ-----p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDL 205 (459)
T KOG0610|consen 131 LSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQ-----PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDL 205 (459)
T ss_pred HHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhC-----CCCccchhhHHHHHHHHHHHHHHHHhhceeeccC
Confidence 46799999999999999999999999999999999999843 5678999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCccccccccc-ccccccccc-------c--chhhhhhc-ccCcccceeecCccc---ccccc
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESD-YYLSDTKAR-------L--PIRWMANC-MVGKNYTIKISDHAM---YCSHY 146 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~~~~-------~--~~~~~~~~-~~~~~~~~~~~d~~~---~~~~~ 146 (434)
||+|||+.++|++.|+||.++....... ......... . ....+... .......-+ .+... .....
T Consensus 206 KPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k-~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 206 KPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKK-KDESASRSLPELV 284 (459)
T ss_pred CcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccc-ccccccccchhhh
Confidence 9999999999999999999987753211 111100000 0 00000000 001000000 01000 00011
Q ss_pred CCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCC
Q psy5690 147 ESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPR 226 (434)
Q Consensus 147 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (434)
.........+.+||-.|+|||++.+...+.++|+|+|||++|||+ .|..||.+.+..+.+.++.. +....+.
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmL--yG~TPFKG~~~~~Tl~NIv~------~~l~Fp~ 356 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEML--YGTTPFKGSNNKETLRNIVG------QPLKFPE 356 (459)
T ss_pred cCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHH--hCCCCcCCCCchhhHHHHhc------CCCcCCC
Confidence 122223456789999999999999999999999999999999999 99999999999999887753 3333343
Q ss_pred CCccHHHHHHHHHHhccCCCCCCCC----HHHH--HHHHHhcccCCCcccccccccc
Q psy5690 227 PATCQKEIFDLMLECWKTNETDRPR----FSEI--HLFLQRKNLGARASKITPVMKR 277 (434)
Q Consensus 227 ~~~~~~~l~~li~~cl~~dP~~Rps----~~el--~~~L~~~~~~~~~~~~~~~~~~ 277 (434)
....+.+++|||++.|.+||.+|.. +.|| |+||+..++.......+|.++.
T Consensus 357 ~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~ 413 (459)
T KOG0610|consen 357 EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPK 413 (459)
T ss_pred CCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCC
Confidence 4477899999999999999999997 9999 9999999999877777776554
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=320.90 Aligned_cols=202 Identities=24% Similarity=0.335 Sum_probs=176.4
Q ss_pred CCCCC-CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLK-DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++ ||||+++++++.....+++|||||.||+|.+++. ...++.+..+..++.|+++|++|||++||+|||
T Consensus 73 ~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~-------~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRD 145 (370)
T KOG0583|consen 73 LRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV-------NKGRLKEDEARKYFRQLISAVAYCHSRGIVHRD 145 (370)
T ss_pred HHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH-------HcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCC
Confidence 35677 9999999999999999999999999999999998 346889999999999999999999999999999
Q ss_pred CCCCCeeeecC-CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 80 LAARNCMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 80 lkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|||+|||++.+ +++||+|||++.... .......+.+
T Consensus 146 LK~ENilld~~~~~~Kl~DFG~s~~~~-------------------------------------------~~~~~l~t~c 182 (370)
T KOG0583|consen 146 LKPENILLDGNEGNLKLSDFGLSAISP-------------------------------------------GEDGLLKTFC 182 (370)
T ss_pred CCHHHEEecCCCCCEEEeccccccccC-------------------------------------------CCCCcccCCC
Confidence 99999999999 999999999976521 1112336788
Q ss_pred CCccccchhhhhcCC-C-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc-HHHHH
Q psy5690 159 LPIRWMAWESLLLGK-N-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC-QKEIF 235 (434)
Q Consensus 159 gt~~y~aPE~~~~~~-~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~ 235 (434)
|++.|+|||++.+.. | +.++||||+||+||.|+ +|..||...+...+...+. ......|..+ ++++.
T Consensus 183 Gsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml--~G~~PF~d~~~~~l~~ki~--------~~~~~~p~~~~S~~~~ 252 (370)
T KOG0583|consen 183 GSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL--CGRLPFDDSNVPNLYRKIR--------KGEFKIPSYLLSPEAR 252 (370)
T ss_pred CCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH--hCCCCCCCccHHHHHHHHh--------cCCccCCCCcCCHHHH
Confidence 999999999999977 7 58999999999999999 9999999987777766543 2334446666 99999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+|+.+||..||.+|+++.+| |+||+..
T Consensus 253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 253 SLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred HHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 99999999999999999999 8999974
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=311.13 Aligned_cols=209 Identities=24% Similarity=0.393 Sum_probs=168.3
Q ss_pred CCCCCCCCeeeEEEEEecCC--ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED--PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++|+|||||+++|...... .++++|||+++|+|.+++.+.+ ..+++..+..+.+||++||+|||++||+||
T Consensus 68 L~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~ 141 (313)
T KOG0198|consen 68 LSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSKGIVHC 141 (313)
T ss_pred HHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence 46789999999999854444 6999999999999999998442 269999999999999999999999999999
Q ss_pred CCCCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 79 DLAARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 79 Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||||+|||++. ++.+||+|||+++..... ..........
T Consensus 142 DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~----------------------------------------~~~~~~~~~~ 181 (313)
T KOG0198|consen 142 DIKPANILLDPSNGDVKLADFGLAKKLESK----------------------------------------GTKSDSELSV 181 (313)
T ss_pred CcccceEEEeCCCCeEEeccCccccccccc----------------------------------------cccccccccc
Confidence 99999999999 799999999997653210 0111123457
Q ss_pred CCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCC-ChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 158 RLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAEL-TNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
.||+.|||||++..+ ....++|||||||++.||+ +|..||... ...+..-.+ ......+..|..++++.+
T Consensus 182 ~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~--Tg~~PW~~~~~~~~~~~~i------g~~~~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 182 QGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEML--TGKPPWSEFFEEAEALLLI------GREDSLPEIPDSLSDEAK 253 (313)
T ss_pred cCCccccCchhhcCCCcCCccchhhhcCCEEEecc--CCCCcchhhcchHHHHHHH------hccCCCCCCCcccCHHHH
Confidence 889999999999963 3346999999999999999 899999874 222222111 112234466788999999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+++.+|+.+||++||||+++ |+|+++..
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 99999999999999999999 78887643
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=316.93 Aligned_cols=200 Identities=32% Similarity=0.568 Sum_probs=175.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+||||+.|.|+|.....+|||||||..|-|..+|+ ....++......|..+|+.|+.|||.+.||||||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk-------a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDL 238 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK-------AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDL 238 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh-------ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhcc
Confidence 578999999999999999999999999999999999998 6678899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|.-||||+.+..+||+|||-++...+- ...-..+||
T Consensus 239 KSPNiLIs~~d~VKIsDFGTS~e~~~~--------------------------------------------STkMSFaGT 274 (904)
T KOG4721|consen 239 KSPNILISYDDVVKISDFGTSKELSDK--------------------------------------------STKMSFAGT 274 (904)
T ss_pred CCCceEeeccceEEeccccchHhhhhh--------------------------------------------hhhhhhhhh
Confidence 999999999999999999987652211 122457899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|||||++...+.+.|+|||||||+||||+ ||..||.+.+...++- .-......++.|..|++.++-||++
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmL--T~EiPYkdVdssAIIw------GVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEML--TGEIPYKDVDSSAIIW------GVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHH--hcCCCccccchheeEE------eccCCcccccCcccCchHHHHHHHH
Confidence 9999999999999999999999999999999 8999999877655432 2233455678899999999999999
Q ss_pred hccCCCCCCCCHHHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L 259 (434)
||+..|..||++.+|+..|
T Consensus 347 cw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHhcCCCCCccHHHHHHHH
Confidence 9999999999999995433
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=338.01 Aligned_cols=213 Identities=39% Similarity=0.683 Sum_probs=189.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++|||||+++|+|.+.+..+|++|||++|||..||++.++.......++..+.+.++.|||+|++||+++++|||||
T Consensus 749 m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDL 828 (1025)
T KOG1095|consen 749 MSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDL 828 (1025)
T ss_pred HhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcch
Confidence 68899999999999999999999999999999999999987766666778999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
..+|+||+....+||+|||+||.+. ..++|........+
T Consensus 829 AaRNCLL~~~r~VKIaDFGlArDiy-----------------------------------------~~~yyr~~~~a~lP 867 (1025)
T KOG1095|consen 829 AARNCLLDERRVVKIADFGLARDIY-----------------------------------------DKDYYRKHGEAMLP 867 (1025)
T ss_pred hhhheeecccCcEEEcccchhHhhh-----------------------------------------hchheeccCccccc
Confidence 9999999999999999999998633 33344444445667
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.+|||||.+..+.++.|+|||||||++||++| .|..||.+.++.++...+. .+.+++.|..|++.++++|..
T Consensus 868 vkWm~PEsl~d~iFtskSDvWsFGVllWEifs-lG~~PY~~~~n~~v~~~~~-------~ggRL~~P~~CP~~ly~lM~~ 939 (1025)
T KOG1095|consen 868 VKWMPPESLKDGIFTSKSDVWSFGVLLWEIFS-LGATPYPSRSNFEVLLDVL-------EGGRLDPPSYCPEKLYQLMLQ 939 (1025)
T ss_pred eecCCHHHHhhcccccccchhhhHHHHHHHHh-CCCCCCCCcchHHHHHHHH-------hCCccCCCCCCChHHHHHHHH
Confidence 88999999999999999999999999999998 5999999999998876443 233888899999999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.+|++||++..|++.+.+.
T Consensus 940 CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 940 CWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred HccCChhhCccHHHHHhhhhhh
Confidence 9999999999999998766554
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=303.15 Aligned_cols=220 Identities=54% Similarity=1.015 Sum_probs=176.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS------------QENPAISYGCLIFMATQIASGMK 68 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~------------~~~~~l~~~~~~~i~~qi~~gL~ 68 (434)
|++++||||+++++++.+.+..++||||+++|+|.+++....... .....+++..+..++.||+.||.
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 467899999999999999999999999999999999996532110 11235788899999999999999
Q ss_pred HhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCC
Q psy5690 69 YLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYES 148 (434)
Q Consensus 69 yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 148 (434)
|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 153 ~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~---------------------------------------- 192 (304)
T cd05096 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD---------------------------------------- 192 (304)
T ss_pred HHHHCCccccCcchhheEEcCCccEEECCCccceecccCc----------------------------------------
Confidence 9999999999999999999999999999999976421111
Q ss_pred cccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCC
Q psy5690 149 DYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA 228 (434)
Q Consensus 149 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (434)
.........++..|+|||++.++.++.++|||||||++|||+++++..||......+....+...............+.
T Consensus 193 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (304)
T cd05096 193 -YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPP 271 (304)
T ss_pred -eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCC
Confidence 0111123345678999999999999999999999999999997668899998877776665544333322233333456
Q ss_pred ccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 229 TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 229 ~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
.+++.+.+++.+||+.||++|||+++|+++|++
T Consensus 272 ~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 272 PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=297.61 Aligned_cols=212 Identities=20% Similarity=0.346 Sum_probs=172.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||++++..|..++.+|+||.|+.+||+.++++..- ...+.+..+..|++++++||.|||.+|.|||||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~-----~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdv 152 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY-----PDGLEEASIATILREVLKALDYLHQNGHIHRDV 152 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc-----cccccHHHHHHHHHHHHHHHHHHHhcCceeccc
Confidence 677899999999999999999999999999999999998542 345999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC-CCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD-TKARL 159 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~-~~~~g 159 (434)
|+.|||++++|.+||+|||.+-.+..+. ...... ....|
T Consensus 153 KAgnILi~~dG~VkLadFgvsa~l~~~G----------------------------------------~R~~~rf~tfvg 192 (516)
T KOG0582|consen 153 KAGNILIDSDGTVKLADFGVSASLFDSG----------------------------------------DRQVTRFNTFVG 192 (516)
T ss_pred ccccEEEcCCCcEEEcCceeeeeecccC----------------------------------------ceeeEeeccccC
Confidence 9999999999999999999854322211 011111 56789
Q ss_pred Cccccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc-----ccCCCCCCccHH
Q psy5690 160 PIRWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK-----QQYLPRPATCQK 232 (434)
Q Consensus 160 t~~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 232 (434)
|+.|||||++.. ..|+.|+||||||++..||. +|..||......++.-.-. +.... .........++.
T Consensus 193 tp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA--~G~aPf~k~pPmkvLl~tL---qn~pp~~~t~~~~~d~~k~~~k 267 (516)
T KOG0582|consen 193 TPCWMAPEVLMQQLHGYDFKADIWSFGITACELA--HGHAPFSKYPPMKVLLLTL---QNDPPTLLTSGLDKDEDKKFSK 267 (516)
T ss_pred cccccChHHhhhcccCccchhhhhhhhHHHHHHh--cCCCCcccCChHHHHHHHh---cCCCCCcccccCChHHhhhhcH
Confidence 999999999654 57899999999999999999 9999999998877653211 11000 001111234567
Q ss_pred HHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+++++..||++||.+|||++++ |.||++.
T Consensus 268 sf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 268 SFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 89999999999999999999999 8899865
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=309.23 Aligned_cols=216 Identities=50% Similarity=0.968 Sum_probs=194.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|.+|+|||||+++|+|..++++|+|+||+++|+|.+++.++.. ..+.-.....|+.||+.||+||.+.++|||||
T Consensus 589 LsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahea-----pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~ 663 (807)
T KOG1094|consen 589 LSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHEL-----PTAETAPGVSICTQIASGMAYLESLNFVHRDL 663 (807)
T ss_pred HhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccC-----cccccchhHHHHHHHHHHHHHHHhhchhhccc
Confidence 5789999999999999999999999999999999999985531 12344556679999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
.++|+|++.++++||+|||++|. ....+++........+
T Consensus 664 a~rNcLv~~e~~iKiadfgmsR~-----------------------------------------lysg~yy~vqgr~vlp 702 (807)
T KOG1094|consen 664 ATRNCLVDGEFTIKIADFGMSRN-----------------------------------------LYSGDYYRVQGRAVLP 702 (807)
T ss_pred cccceeecCcccEEecCcccccc-----------------------------------------cccCCceeeecceeee
Confidence 99999999999999999999875 3344555666677888
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
++|||+|.+..++++.++|+|+||+++||+++.+...||....+++..++...++........+..|.-|+..++++|.+
T Consensus 703 iRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~ 782 (807)
T KOG1094|consen 703 IRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLR 782 (807)
T ss_pred eeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHH
Confidence 99999999999999999999999999999998899999999999999999888887777888888999999999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||.+|-++||+++++|.+|++.
T Consensus 783 Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 783 CWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HhchhhhcCCCHHHHHHHHHHh
Confidence 9999999999999999999874
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=300.99 Aligned_cols=212 Identities=22% Similarity=0.352 Sum_probs=172.6
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++|||||+|+++..+. +.+|||+|||..|.+...=. ....+++.++++++++++.||+|||.+|||||
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~-------d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHR 234 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP-------DKPELSEQQARKYLRDVVLGLEYLHYQGIIHR 234 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-------CcccccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 6899999999999998654 67999999999988765321 22339999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+|+|++++|++||+|||.+....... ....+. ......
T Consensus 235 DIKPsNLLl~~~g~VKIsDFGVs~~~~~~~------------------------------------~~~~d~--~L~~tv 276 (576)
T KOG0585|consen 235 DIKPSNLLLSSDGTVKISDFGVSNEFPQGS------------------------------------DEGSDD--QLSRTV 276 (576)
T ss_pred ccchhheEEcCCCcEEeeccceeeecccCC------------------------------------ccccHH--HHhhcC
Confidence 999999999999999999999976532210 001111 113378
Q ss_pred CCccccchhhhhcCC----CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 159 LPIRWMAWESLLLGK----NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 159 gt~~y~aPE~~~~~~----~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
||+.|+|||.+.++. .+.+.||||+||+||.|+ .|+.||.+....+++.+|.+ .....|....+.+++
T Consensus 277 GTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll--fG~~PF~~~~~~~l~~KIvn------~pL~fP~~pe~~e~~ 348 (576)
T KOG0585|consen 277 GTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL--FGQLPFFDDFELELFDKIVN------DPLEFPENPEINEDL 348 (576)
T ss_pred CCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh--hccCCcccchHHHHHHHHhc------CcccCCCcccccHHH
Confidence 999999999998743 277899999999999999 89999999999998887764 233333344578999
Q ss_pred HHHHHHhccCCCCCCCCHHHH--HHHHHhcccC
Q psy5690 235 FDLMLECWKTNETDRPRFSEI--HLFLQRKNLG 265 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el--~~~L~~~~~~ 265 (434)
++||++||.+||++|.+..+| |+|..+....
T Consensus 349 kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 349 KDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred HHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 999999999999999999999 9999876443
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=275.83 Aligned_cols=206 Identities=19% Similarity=0.203 Sum_probs=176.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.|+|||||++.+.+.+.+..|+|+|+++||+|-.-+-. ...+++..+-.+++||++||.|+|.+||||||+|
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~-------R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvk 137 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-------REFYSEADASHCIQQILEALAYCHSNGIVHRDLK 137 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCC
Confidence 468999999999999999999999999999999876652 2568889999999999999999999999999999
Q ss_pred CCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|+|+.. ..-+||+|||+|...+.. ..-.+..
T Consensus 138 P~nllLASK~~~A~vKL~~FGvAi~l~~g--------------------------------------------~~~~G~~ 173 (355)
T KOG0033|consen 138 PENLLLASKAKGAAVKLADFGLAIEVNDG--------------------------------------------EAWHGFA 173 (355)
T ss_pred hhheeeeeccCCCceeecccceEEEeCCc--------------------------------------------ccccccc
Confidence 99999954 346899999998663311 1225678
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|||||++....|+..+|||+.||++|-|+ .|.+||.+.+...+++++...... ...+..+.++++.++|+
T Consensus 174 GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL--~G~~PF~~~~~~rlye~I~~g~yd----~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 174 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL--VGYPPFWDEDQHRLYEQIKAGAYD----YPSPEWDTVTPEAKSLI 247 (355)
T ss_pred CCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH--hCCCCCCCccHHHHHHHHhccccC----CCCcccCcCCHHHHHHH
Confidence 999999999999999999999999999999999 899999999999999888653322 22334677889999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
.+||..||.+|.|+.|. |+|+.+...
T Consensus 248 rrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred HHHhccChhhhccHHHHhCCchhcchHH
Confidence 99999999999999998 899977543
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=281.10 Aligned_cols=202 Identities=21% Similarity=0.295 Sum_probs=176.8
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
..||||+++.++|+.+..+++|+|.|+.|.|.+++. +.-.++++...+|++|+.+|++|||.++||||||||+
T Consensus 80 ~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLt-------s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpE 152 (411)
T KOG0599|consen 80 MGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLT-------SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPE 152 (411)
T ss_pred cCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhh-------hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChh
Confidence 369999999999999999999999999999999997 6678999999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
|||++++.++||+|||+++...... .....+||++|
T Consensus 153 NILlddn~~i~isDFGFa~~l~~Ge--------------------------------------------kLrelCGTPgY 188 (411)
T KOG0599|consen 153 NILLDDNMNIKISDFGFACQLEPGE--------------------------------------------KLRELCGTPGY 188 (411)
T ss_pred heeeccccceEEeccceeeccCCch--------------------------------------------hHHHhcCCCcc
Confidence 9999999999999999987632221 12456899999
Q ss_pred cchhhhhcC------CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 164 MAWESLLLG------KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 164 ~aPE~~~~~------~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+|||.+.+. .|+..+|+||+||++|.|+ .|.+||....+.-+...+.+. ......+...+++...++|
T Consensus 189 LAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL--aGcpPFwHRkQmlMLR~ImeG----kyqF~speWadis~~~KdL 262 (411)
T KOG0599|consen 189 LAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL--AGCPPFWHRKQMLMLRMIMEG----KYQFRSPEWADISATVKDL 262 (411)
T ss_pred cChhheeeecccCCCCccchhhHHHHHHHHHHHH--cCCCchhHHHHHHHHHHHHhc----ccccCCcchhhccccHHHH
Confidence 999998753 5788999999999999999 899999887777666666543 2334556678889999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
|.+||+.||.+|.|++|. |+|+.+.
T Consensus 263 IsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 263 ISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred HHHHHeeCchhcccHHHHhcChHHHHH
Confidence 999999999999999998 8999775
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=295.26 Aligned_cols=201 Identities=24% Similarity=0.372 Sum_probs=168.3
Q ss_pred CCCCCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-Cc
Q psy5690 1 MCSLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~i 75 (434)
|++++|||||+++|++.+ ....++||||+++|+|.+++. ....+++.....++.|++.||.|||+. ++
T Consensus 72 l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 144 (283)
T PHA02988 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD-------KEKDLSFKTKLDMAIDCCKGLYNLYKYTNK 144 (283)
T ss_pred HHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh-------hCCCCChhHHHHHHHHHHHHHHHHHhcCCC
Confidence 468999999999999876 356899999999999999997 345688999999999999999999984 99
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+||+|||+++..... ..
T Consensus 145 ~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----------------------------------------------~~ 178 (283)
T PHA02988 145 PYKNLTSVSFLVTENYKLKIICHGLEKILSSP----------------------------------------------PF 178 (283)
T ss_pred CCCcCChhhEEECCCCcEEEcccchHhhhccc----------------------------------------------cc
Confidence 99999999999999999999999986542110 12
Q ss_pred CCCCCccccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 156 KARLPIRWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
...++..|+|||++.+ ..++.++|||||||++|||+ +|..||...+..+....+.. .....+.+..++++
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~--~g~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~ 250 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF--TGKIPFENLTTKEIYDLIIN------KNNSLKLPLDCPLE 250 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHh------cCCCCCCCCcCcHH
Confidence 2356778999999976 67899999999999999999 89999998877666554421 12233445568899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+++.+||+.||++|||++|++..|+..
T Consensus 251 l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 251 IKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 99999999999999999999998888764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=306.12 Aligned_cols=204 Identities=25% Similarity=0.318 Sum_probs=172.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..|+||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDl 121 (323)
T cd05571 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-------RERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121 (323)
T ss_pred HHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCC
Confidence 357899999999999999999999999999999999997 3457899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......||
T Consensus 122 kp~NIll~~~~~~kl~DfG~a~~~~~~~-------------------------------------------~~~~~~~gt 158 (323)
T cd05571 122 KLENLMLDKDGHIKITDFGLCKEGISDG-------------------------------------------ATMKTFCGT 158 (323)
T ss_pred CHHHEEECCCCCEEEeeCCCCcccccCC-------------------------------------------CcccceecC
Confidence 9999999999999999999875411000 011234688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||...+.......+.. .....+..+++++.+++.+
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell--tg~~Pf~~~~~~~~~~~~~~--------~~~~~p~~~~~~~~~li~~ 228 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM--CGRLPFYNQDHEKLFELILM--------EEIRFPRTLSPEAKSLLAG 228 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhh--cCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999988777665544321 1223456788999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
||+.||++|| ++.++ |+|++..++
T Consensus 229 ~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 229 LLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred HccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999999 79999 788877543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=312.56 Aligned_cols=201 Identities=22% Similarity=0.319 Sum_probs=177.9
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||.+++++..|...+++|+||||+.||++..+. ....+++..+..++..|+.||+|||++||||||||.+|
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~--------~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdN 498 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI--------HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDN 498 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEE--------ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhh
Confidence 7999999999999999999999999999955544 34679999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||||.+|++||+|||+++.... ......+.+||+.||
T Consensus 499 iLLD~eGh~kiADFGlcKe~m~-------------------------------------------~g~~TsTfCGTpey~ 535 (694)
T KOG0694|consen 499 LLLDTEGHVKIADFGLCKEGMG-------------------------------------------QGDRTSTFCGTPEFL 535 (694)
T ss_pred eEEcccCcEEecccccccccCC-------------------------------------------CCCccccccCChhhc
Confidence 9999999999999999876211 112346789999999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 244 (434)
|||++.+..|+.++|.|||||++|||+ .|+.||.+.+.+++++.|.. .....|..++.+..++|+++|.+
T Consensus 536 aPEil~e~~Yt~aVDWW~lGVLlyeML--~Gq~PF~gddEee~FdsI~~--------d~~~yP~~ls~ea~~il~~ll~k 605 (694)
T KOG0694|consen 536 APEVLTEQSYTRAVDWWGLGVLLYEML--VGESPFPGDDEEEVFDSIVN--------DEVRYPRFLSKEAIAIMRRLLRK 605 (694)
T ss_pred ChhhhccCcccchhhHHHHHHHHHHHH--cCCCCCCCCCHHHHHHHHhc--------CCCCCCCcccHHHHHHHHHHhcc
Confidence 999999999999999999999999999 99999999999999988753 34455788999999999999999
Q ss_pred CCCCCCC-----HHHH--HHHHHhcccCC
Q psy5690 245 NETDRPR-----FSEI--HLFLQRKNLGA 266 (434)
Q Consensus 245 dP~~Rps-----~~el--~~~L~~~~~~~ 266 (434)
+|++|.. +++| |+|++..++..
T Consensus 606 ~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 606 NPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred CcccccCCCCCCchhhhhCCccccCCHHH
Confidence 9999984 5666 89999886654
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=308.41 Aligned_cols=209 Identities=34% Similarity=0.608 Sum_probs=180.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++||++..+.++++|||+|.||+|.++|++. ...++..+...++.+.+.||+|||+++++||||
T Consensus 215 Mr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~------~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDI 288 (474)
T KOG0194|consen 215 MRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN------KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDI 288 (474)
T ss_pred HHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhH
Confidence 67899999999999999999999999999999999999843 236999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
..+|+|++.++.+||+|||+++... .+.........+
T Consensus 289 AARNcL~~~~~~vKISDFGLs~~~~-------------------------------------------~~~~~~~~~klP 325 (474)
T KOG0194|consen 289 AARNCLYSKKGVVKISDFGLSRAGS-------------------------------------------QYVMKKFLKKLP 325 (474)
T ss_pred hHHHheecCCCeEEeCccccccCCc-------------------------------------------ceeeccccccCc
Confidence 9999999999999999999976511 111122233567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+..+.|+.++|||||||++||+++ .|..||.+....+....+.. .+.+.+.+...+.++..++.+
T Consensus 326 irWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~-~g~~Py~g~~~~~v~~kI~~------~~~r~~~~~~~p~~~~~~~~~ 398 (474)
T KOG0194|consen 326 IRWLAPETLNTGIFSFKTDVWSFGVLLWEIFE-NGAEPYPGMKNYEVKAKIVK------NGYRMPIPSKTPKELAKVMKQ 398 (474)
T ss_pred ceecChhhhccCccccccchhheeeeEEeeec-cCCCCCCCCCHHHHHHHHHh------cCccCCCCCCCHHHHHHHHHH
Confidence 88999999999999999999999999999996 47889999999988877632 344566677889999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhcccC
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKNLG 265 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~~~ 265 (434)
||..||++||++.++.++++.....
T Consensus 399 c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 399 CWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred hccCChhhccCHHHHHHHHHHHHhc
Confidence 9999999999999999999876543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=299.74 Aligned_cols=209 Identities=20% Similarity=0.257 Sum_probs=171.0
Q ss_pred CCCCC-CCCeeeEEEEEecCC-ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLK-DPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~-HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++|+ |||||++.+++.+.+ .+++|||||+. +|+++++.+ +..+++..+..|+.||++||+|+|.+|+.||
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R------~r~fse~~irnim~QilqGL~hiHk~GfFHR 134 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDR------NRLFSESDIRNIMYQILQGLAHIHKHGFFHR 134 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhc------CCcCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 46888 999999999998887 89999999976 999999843 4789999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+||+|||+..+..+||+|||+||......- -+..+
T Consensus 135 DlKPENiLi~~~~~iKiaDFGLARev~SkpP--------------------------------------------YTeYV 170 (538)
T KOG0661|consen 135 DLKPENILISGNDVIKIADFGLAREVRSKPP--------------------------------------------YTEYV 170 (538)
T ss_pred cCChhheEecccceeEecccccccccccCCC--------------------------------------------cchhh
Confidence 9999999999999999999999987433221 14456
Q ss_pred CCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCccc-------------CC
Q psy5690 159 LPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ-------------YL 224 (434)
Q Consensus 159 gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~ 224 (434)
.|..|.|||++.. +-|+.+.|+||+||+++|+. +-++-|.+.++.+.+.++.+.+....... ..
T Consensus 171 STRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~--sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~ 248 (538)
T KOG0661|consen 171 STRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELY--SLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRF 248 (538)
T ss_pred hcccccchHHhhhccccCCchHHHHHHHHHHHHH--HhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCC
Confidence 6788999999875 56799999999999999999 67888988887766655543322111100 00
Q ss_pred C---------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 225 P---------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 225 ~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
| ....++.++.++|.+|+++||++||||+|. |+|++..
T Consensus 249 P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 249 PQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred CcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 0 123478899999999999999999999999 7788754
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=304.83 Aligned_cols=201 Identities=23% Similarity=0.346 Sum_probs=178.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++|+|||||.++++|+...++|+|+|||.| +|..++. .+..++++.+..++.|++.||.|||+.+|+|||+
T Consensus 55 ~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~-------~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~ 126 (808)
T KOG0597|consen 55 LRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILE-------QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDM 126 (808)
T ss_pred HHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccC
Confidence 4689999999999999999999999999976 9999998 6778999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++..+.+|+||||+|+.+.... ...+...||
T Consensus 127 kPqniLl~~~~~~KlcdFg~Ar~m~~~t-------------------------------------------~vltsikGt 163 (808)
T KOG0597|consen 127 KPQNILLEKGGTLKLCDFGLARAMSTNT-------------------------------------------SVLTSIKGT 163 (808)
T ss_pred CcceeeecCCCceeechhhhhhhcccCc-------------------------------------------eeeeeccCc
Confidence 9999999999999999999988743321 233567899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+-|||||.+.+..|+..+|.||+||++||++ .|++||...+-.++...|.. .....|...+..+..++..
T Consensus 164 PlYmAPElv~e~pyd~~sDlWslGcilYE~~--~G~PPF~a~si~~Lv~~I~~--------d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 164 PLYMAPELVEEQPYDHTSDLWSLGCILYELY--VGQPPFYARSITQLVKSILK--------DPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred ccccCHHHHcCCCccchhhHHHHHHHHHHHh--cCCCCchHHHHHHHHHHHhc--------CCCCCcccccHHHHHHHHH
Confidence 9999999999999999999999999999999 89999998887777766542 2233356888999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.|.+||.+|.+..++ |+|.++.
T Consensus 234 LL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 234 LLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HhhcChhhcccHHHHhcChHHhhh
Confidence 999999999999999 8888764
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.74 Aligned_cols=199 Identities=22% Similarity=0.332 Sum_probs=178.2
Q ss_pred CCCCCCCCeeeEEEEEecCCc-eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDP-ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
+++++|||||.+.+.|+.++. .+|||+||+||+|.+.+.+. .+..++++.++.|+.|++.|+.|||+++|+|||
T Consensus 57 is~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~-----k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRD 131 (426)
T KOG0589|consen 57 LSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ-----KGVLFPEERILKWFVQILLAVNYLHENRVLHRD 131 (426)
T ss_pred HHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHH-----hhccccHHHHHHHHHHHHHHHHHHHhhhhhccc
Confidence 367999999999999999888 99999999999999999854 346799999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
||+.||+++.++.+||+|||+|+...... ....+..|
T Consensus 132 lK~~Nifltk~~~VkLgDfGlaK~l~~~~-------------------------------------------~~a~tvvG 168 (426)
T KOG0589|consen 132 LKCANIFLTKDKKVKLGDFGLAKILNPED-------------------------------------------SLASTVVG 168 (426)
T ss_pred chhhhhhccccCceeecchhhhhhcCCch-------------------------------------------hhhheecC
Confidence 99999999999999999999998743332 12356788
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|+.||+||.+.+.+|+.|+|||||||++|||+ +-+.+|.+.+...+...+.. ....|.+..++.+++.+++
T Consensus 169 Tp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~--~lk~aF~a~~m~~Li~ki~~-------~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 169 TPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC--TLKPAFKASNMSELILKINR-------GLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred CCcccCHHHhCCCCCCccCcchhhcchHHHHH--hcccccCccchHHHHHHHhh-------ccCCCCCccccHHHHHHHH
Confidence 99999999999999999999999999999999 88999999998888776643 3356778899999999999
Q ss_pred HhccCCCCCCCCHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIH 256 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~ 256 (434)
.|+..+|..||++.+++
T Consensus 240 ~~l~~~P~~RPsa~~LL 256 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELL 256 (426)
T ss_pred HHhhcCCccCCCHHHHh
Confidence 99999999999999993
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=304.52 Aligned_cols=201 Identities=20% Similarity=0.295 Sum_probs=171.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+.+|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 72 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dl 144 (329)
T PTZ00263 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR-------KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDL 144 (329)
T ss_pred HHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 457899999999999999999999999999999999997 3456889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++..... .....||
T Consensus 145 kp~NIll~~~~~~kl~Dfg~~~~~~~~----------------------------------------------~~~~~gt 178 (329)
T PTZ00263 145 KPENLLLDNKGHVKVTDFGFAKKVPDR----------------------------------------------TFTLCGT 178 (329)
T ss_pred CHHHEEECCCCCEEEeeccCceEcCCC----------------------------------------------cceecCC
Confidence 999999999999999999987542110 1224578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||.+....+..+.+.. .....+..++..+.+++.+
T Consensus 179 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell--tg~~pf~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI--AGYPPFFDDTPFRIYEKILA--------GRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred hhhcCHHHHcCCCCCCcceeechHHHHHHHH--cCCCCCCCCCHHHHHHHHhc--------CCcCCCCCCCHHHHHHHHH
Confidence 8899999999999999999999999999999 89999988877666554432 1233456678899999999
Q ss_pred hccCCCCCCCC-----HHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRPR-----FSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rps-----~~el--~~~L~~~~~ 264 (434)
||+.||.+|++ ++++ |+|+++..+
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 99999999996 6888 789876543
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.84 Aligned_cols=206 Identities=39% Similarity=0.727 Sum_probs=183.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++|||+|+++|+|..+..+|||+|||.+|+|.+||++++ ...++.-..+.++.||.+|++||..+++|||||
T Consensus 317 MKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn-----r~ev~avvLlyMAtQIsSaMeYLEkknFIHRDL 391 (1157)
T KOG4278|consen 317 MKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECN-----RSEVPAVVLLYMATQISSAMEYLEKKNFIHRDL 391 (1157)
T ss_pred HHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhc-----hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 678999999999999999999999999999999999999763 345677788899999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
..+|+|+.++..+|++|||+++.+.... |....+...+
T Consensus 392 AARNCLVgEnhiVKvADFGLsRlMtgDT------------------------------------------YTAHAGAKFP 429 (1157)
T KOG4278|consen 392 AARNCLVGENHIVKVADFGLSRLMTGDT------------------------------------------YTAHAGAKFP 429 (1157)
T ss_pred hhhhccccccceEEeeccchhhhhcCCc------------------------------------------eecccCccCc
Confidence 9999999999999999999988743332 3344555667
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|.|||.+..+.++.|+|||+|||+|||+.| .|..||.+.+..+++..+. .+.++..|..|++.+++||..
T Consensus 430 IKWTAPEsLAyNtFSiKSDVWAFGVLLWEIAT-YGMsPYPGidlSqVY~LLE-------kgyRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 430 IKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT-YGMSPYPGIDLSQVYGLLE-------KGYRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred ccccCcccccccccccchhhHHHHHHHHHHHh-cCCCCCCCccHHHHHHHHh-------ccccccCCCCCCHHHHHHHHH
Confidence 88999999999999999999999999999998 6999999998888776543 556778899999999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||+++|.+||+++|+|+.|+.
T Consensus 502 CW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred HhcCCcccCccHHHHHHHHHH
Confidence 999999999999999988864
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=283.03 Aligned_cols=209 Identities=18% Similarity=0.276 Sum_probs=169.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||+|.++++|.....+++|+|||+. ++.+-+++ ....++...+.+++.|++.|+.|+|++++|||||
T Consensus 55 LKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~------~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDI 127 (396)
T KOG0593|consen 55 LKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELER------YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDI 127 (396)
T ss_pred HHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHh------ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccC
Confidence 5789999999999999999999999999988 66666653 2356889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.+|.+||||||+|+....+.. .-+..+.|
T Consensus 128 KPENILit~~gvvKLCDFGFAR~L~~pgd-------------------------------------------~YTDYVAT 164 (396)
T KOG0593|consen 128 KPENILITQNGVVKLCDFGFARTLSAPGD-------------------------------------------NYTDYVAT 164 (396)
T ss_pred ChhheEEecCCcEEeccchhhHhhcCCcc-------------------------------------------hhhhhhhh
Confidence 99999999999999999999987432211 01445667
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc-------------CCcccCCCC
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN-------------NSKQQYLPR 226 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~ 226 (434)
..|.|||.+.+ .+|+..+||||+||++.||+ +|.+-|.+.++.+....|...+.. ...+...|.
T Consensus 165 RWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~--~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~ 242 (396)
T KOG0593|consen 165 RWYRAPELLVGDTQYGKPVDIWAIGCVFAELL--TGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPE 242 (396)
T ss_pred hhccChhhhcccCcCCCcccchhhhHHHHHHh--cCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCC
Confidence 88999999997 78999999999999999999 899999998877665554432211 011222222
Q ss_pred C----------CccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 227 P----------ATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 227 ~----------~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+ +..+.-+.+++++||..||++|++.+++ |++|+.
T Consensus 243 ~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 243 PEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred CCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 2 2345678899999999999999999999 777754
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.75 Aligned_cols=213 Identities=34% Similarity=0.625 Sum_probs=165.9
Q ss_pred CCC-CCCCeeeEEEEEecC-CceEEEEecCCCCCHHHHHhhccCCC----------------------------------
Q psy5690 2 CSL-KDPNLVRVIGVCSTE-DPISTIQEYCEFGDLSTFLQIHNCNS---------------------------------- 45 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~---------------------------------- 45 (434)
+++ +||||++++++|... +.+++||||+++|+|.+++.......
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (338)
T cd05102 65 IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASV 144 (338)
T ss_pred HHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCc
Confidence 345 899999999998764 46899999999999999997532100
Q ss_pred ---------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCccccc
Q psy5690 46 ---------------------QENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSH 104 (434)
Q Consensus 46 ---------------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 104 (434)
.....+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~ 224 (338)
T cd05102 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224 (338)
T ss_pred cccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence 00235788899999999999999999999999999999999999999999999997652
Q ss_pred ccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHH
Q psy5690 105 YESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184 (434)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlG 184 (434)
.... .........++..|+|||++.+..++.++||||||
T Consensus 225 ~~~~-----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG 263 (338)
T cd05102 225 YKDP-----------------------------------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFG 263 (338)
T ss_pred ccCc-----------------------------------------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHH
Confidence 1110 00111233456789999999999999999999999
Q ss_pred HHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 185 vil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
|++|||++ .|..||......+...... ........+..+++++.+++.+||+.||++||++.|+++.|++.
T Consensus 264 ~il~el~~-~g~~pf~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 264 VLLWEIFS-LGASPYPGVQINEEFCQRL------KDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHh-CCCCCCCCCCccHHHHHHH------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999994 3899998765433222111 11222334567789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=297.70 Aligned_cols=201 Identities=19% Similarity=0.293 Sum_probs=171.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+||||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 127 (291)
T cd05612 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR-------NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDL 127 (291)
T ss_pred HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 467899999999999999999999999999999999997 3356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++.... ......|+
T Consensus 128 kp~NIli~~~~~~kl~Dfg~~~~~~~----------------------------------------------~~~~~~gt 161 (291)
T cd05612 128 KPENILLDKEGHIKLTDFGFAKKLRD----------------------------------------------RTWTLCGT 161 (291)
T ss_pred CHHHeEECCCCCEEEEecCcchhccC----------------------------------------------CcccccCC
Confidence 99999999999999999998654211 01223577
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|+|+ +|..||......+..+.+.. .....+..+++.+.+++.+
T Consensus 162 ~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~--~g~~pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~ 231 (291)
T cd05612 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEML--VGYPPFFDDNPFGIYEKILA--------GKLEFPRHLDLYAKDLIKK 231 (291)
T ss_pred hhhcCHHHHcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHh--------CCcCCCccCCHHHHHHHHH
Confidence 8899999999999999999999999999999 89999998877666655432 1223455678899999999
Q ss_pred hccCCCCCCCC-----HHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRPR-----FSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rps-----~~el--~~~L~~~~~ 264 (434)
||+.||.+||+ ++++ |+|++....
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 262 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKSVDW 262 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence 99999999995 8998 889876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=301.66 Aligned_cols=201 Identities=21% Similarity=0.253 Sum_probs=171.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+||||
T Consensus 85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDL 157 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-------RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDL 157 (340)
T ss_pred HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCC
Confidence 357899999999999999999999999999999999997 3456899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++.... ......||
T Consensus 158 kp~NILl~~~~~ikL~DFG~a~~~~~----------------------------------------------~~~~~~gt 191 (340)
T PTZ00426 158 KPENLLLDKDGFIKMTDFGFAKVVDT----------------------------------------------RTYTLCGT 191 (340)
T ss_pred CHHHEEECCCCCEEEecCCCCeecCC----------------------------------------------CcceecCC
Confidence 99999999999999999998754210 01234578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||...+.......+.. .....+..+++.+.+++.+
T Consensus 192 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell--~G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~li~~ 261 (340)
T PTZ00426 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEIL--VGCPPFYANEPLLIYQKILE--------GIIYFPKFLDNNCKHLMKK 261 (340)
T ss_pred hhhcCHHHHhCCCCCccccccchhhHHHHHh--cCCCCCCCCCHHHHHHHHhc--------CCCCCCCCCCHHHHHHHHH
Confidence 8999999999988999999999999999999 89999998877665554432 1122356678899999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
||+.||++|+ +++++ |+|+++.++
T Consensus 262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred HcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 9999999995 89999 888877543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=300.38 Aligned_cols=209 Identities=21% Similarity=0.290 Sum_probs=173.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..|+||||+++|+|.+++. ....+++..+..++.||+.||.|||++||+||||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-------~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 127 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-------NLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 356789999999999999999999999999999999997 3456899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++.... ......||
T Consensus 128 kp~Nil~~~~~~~kL~Dfg~a~~~~~----------------------------------------------~~~~~~gt 161 (333)
T cd05600 128 KPENFLIDASGHIKLTDFGLSKGIVT----------------------------------------------YANSVVGS 161 (333)
T ss_pred CHHHEEECCCCCEEEEeCcCCccccc----------------------------------------------ccCCcccC
Confidence 99999999999999999998754111 11345678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+..+...............+++++.+++.+
T Consensus 162 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 239 (333)
T cd05600 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL--CGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239 (333)
T ss_pred ccccChhHhcCCCCCCccceecchHHHhhhh--hCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHH
Confidence 8999999999999999999999999999999 89999998887776665544322111111111112568899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
||..+|.+||+++++ |+|+.+...
T Consensus 240 ~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 240 LINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred HhhChhhhcCCHHHHHhCcccCCCCH
Confidence 999999999999999 788887543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.46 Aligned_cols=203 Identities=24% Similarity=0.330 Sum_probs=170.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..|+||||+++|+|..++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dl 121 (323)
T cd05595 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-------RERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121 (323)
T ss_pred HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence 457899999999999999999999999999999999986 3456899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......||
T Consensus 122 kp~NIll~~~~~~kL~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt 158 (323)
T cd05595 122 KLENLMLDKDGHIKITDFGLCKEGISDG-------------------------------------------ATMKTFCGT 158 (323)
T ss_pred CHHHEEEcCCCCEEecccHHhccccCCC-------------------------------------------CccccccCC
Confidence 9999999999999999999865311100 011234578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||...+.......+.. .....+..+++++.+++.+
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell--~g~~Pf~~~~~~~~~~~~~~--------~~~~~p~~~~~~~~~li~~ 228 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM--CGRLPFYNQDHERLFELILM--------EEIRFPRTLSPEAKSLLAG 228 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHH--hCCCCCCCCCHHHHHHHHhc--------CCCCCCCCCCHHHHHHHHH
Confidence 8999999999999999999999999999999 89999988776665544321 1123356788999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~ 263 (434)
||+.||++|+ ++.++ |+|+.+..
T Consensus 229 ~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 229 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 9999999998 89998 77886643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=287.00 Aligned_cols=197 Identities=21% Similarity=0.312 Sum_probs=171.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.|+||||+++|++|+..+.+.|||||..+|.|++|+. ....+++.++..+++||++|+.|+|.++++||||
T Consensus 107 MSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiS-------er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDL 179 (668)
T KOG0611|consen 107 MSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYIS-------ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDL 179 (668)
T ss_pred HhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHH-------HhccccHHHHHHHHHHHHHHHHHHhhccceeccc
Confidence 688999999999999999999999999999999999998 4458999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|.+|||+|.++++||+|||++..+.... -..+.+|.
T Consensus 180 KLENILLD~N~NiKIADFGLSNly~~~k--------------------------------------------fLqTFCGS 215 (668)
T KOG0611|consen 180 KLENILLDQNNNIKIADFGLSNLYADKK--------------------------------------------FLQTFCGS 215 (668)
T ss_pred chhheeecCCCCeeeeccchhhhhcccc--------------------------------------------HHHHhcCC
Confidence 9999999999999999999975532222 12567888
Q ss_pred ccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+-|.+||++.+.+| ++.+|.|||||+||.|+ .|.+||++.+...+..++.... +. .+.-+.+..-||+
T Consensus 216 PLYASPEIvNG~PY~GPEVDsWsLGvLLYtLV--yGtMPFDG~Dhk~lvrQIs~Ga-------Yr--EP~~PSdA~gLIR 284 (668)
T KOG0611|consen 216 PLYASPEIVNGTPYKGPEVDSWSLGVLLYTLV--YGTMPFDGRDHKRLVRQISRGA-------YR--EPETPSDASGLIR 284 (668)
T ss_pred cccCCccccCCCCCCCCccchhhHHHHHHHHh--hcccccCCchHHHHHHHhhccc-------cc--CCCCCchHHHHHH
Confidence 99999999999998 78999999999999999 8999999999888887775422 11 1223456789999
Q ss_pred HhccCCCCCCCCHHHH--HHHH
Q psy5690 240 ECWKTNETDRPRFSEI--HLFL 259 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L 259 (434)
.||..||++|.|+++| |-|+
T Consensus 285 wmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred HHHhcCcccchhHHHHhhhhee
Confidence 9999999999999999 5555
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.16 Aligned_cols=202 Identities=18% Similarity=0.262 Sum_probs=170.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 47 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDl 119 (312)
T cd05585 47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ-------REGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119 (312)
T ss_pred HHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCC
Confidence 357899999999999999999999999999999999997 3356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......||
T Consensus 120 kp~Nili~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt 156 (312)
T cd05585 120 KPENILLDYQGHIALCDFGLCKLNMKDD-------------------------------------------DKTNTFCGT 156 (312)
T ss_pred CHHHeEECCCCcEEEEECcccccCccCC-------------------------------------------CccccccCC
Confidence 9999999999999999999875411100 011334678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+.. .....+..+++++.+++.+
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~--tg~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~ 226 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEML--TGLPPFYDENVNEMYRKILQ--------EPLRFPDGFDRDAKDLLIG 226 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHH--hCCCCcCCCCHHHHHHHHHc--------CCCCCCCcCCHHHHHHHHH
Confidence 8999999999999999999999999999999 89999998877666554421 1233456788999999999
Q ss_pred hccCCCCCCCC---HHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPR---FSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps---~~el--~~~L~~~ 262 (434)
||+.||++||+ +.|+ |+|+.+.
T Consensus 227 ~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 227 LLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 99999999985 6777 6787764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=266.55 Aligned_cols=201 Identities=20% Similarity=0.285 Sum_probs=178.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.|+||||+++|++|.+....|+++||...|+|...++.. ....+++..+..++.|++.||.|+|.++|+|||||
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~-----~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiK 151 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEG-----RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIK 151 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhc-----ccccccccchhHHHHHHHHHHHHhccCCcccCCCC
Confidence 4689999999999999999999999999999999999833 34578999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|+|++..+..|++|||-+.... .....+.+||.
T Consensus 152 penlLlg~~~~lkiAdfGwsV~~p---------------------------------------------~~kR~tlcgt~ 186 (281)
T KOG0580|consen 152 PENLLLGSAGELKIADFGWSVHAP---------------------------------------------SNKRKTLCGTL 186 (281)
T ss_pred HHHhccCCCCCeeccCCCceeecC---------------------------------------------CCCceeeeccc
Confidence 999999999999999999854311 12335678999
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|.+||+..+..++..+|+|++|++.||++ .|.+||......+.+..+.. .....|..++.++.++|.+|
T Consensus 187 dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl--vg~ppFes~~~~etYkrI~k--------~~~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 187 DYLPPEMVEGRGHDKFVDLWSLGVLCYEFL--VGLPPFESQSHSETYKRIRK--------VDLKFPSTISGGAADLISRL 256 (281)
T ss_pred ccCCHhhcCCCCccchhhHHHHHHHHHHHH--hcCCchhhhhhHHHHHHHHH--------ccccCCcccChhHHHHHHHH
Confidence 999999999999999999999999999999 89999999998888877754 23344688999999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHhc
Q psy5690 242 WKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~~ 262 (434)
+..+|.+|....|+ |+|+.+.
T Consensus 257 l~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred hccCccccccHHHHhhhHHHHhc
Confidence 99999999999999 8898753
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=309.32 Aligned_cols=207 Identities=21% Similarity=0.272 Sum_probs=171.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++|||||+++++|..++..|+||||+++|+|.+++.... .....+++..+..++.||+.||+|||++||+||||
T Consensus 119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDl 195 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRL---KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDL 195 (478)
T ss_pred HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCc
Confidence 467899999999999999999999999999999999886432 13456889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .........||
T Consensus 196 kp~NIll~~~~~~kL~DFgla~~~~~~~-----------------------------------------~~~~~~~~~gt 234 (478)
T PTZ00267 196 KSANIFLMPTGIIKLGDFGFSKQYSDSV-----------------------------------------SLDVASSFCGT 234 (478)
T ss_pred CHHhEEECCCCcEEEEeCcCceecCCcc-----------------------------------------ccccccccCCC
Confidence 9999999999999999999976532110 00112345688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+.. ....+.+..++.++.++|.+
T Consensus 235 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~--tg~~Pf~~~~~~~~~~~~~~-------~~~~~~~~~~s~~~~~li~~ 305 (478)
T PTZ00267 235 PYYLAPELWERKRYSKKADMWSLGVILYELL--TLHRPFKGPSQREIMQQVLY-------GKYDPFPCPVSSGMKALLDP 305 (478)
T ss_pred ccccCHhHhCCCCCCcHHhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHh-------CCCCCCCccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999988877666554431 22234456788999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHH
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQ 260 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~ 260 (434)
||+.||++||+++++ ++|++
T Consensus 306 ~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 306 LLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred HhccChhhCcCHHHHHhCHHHH
Confidence 999999999999998 45554
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=296.90 Aligned_cols=201 Identities=22% Similarity=0.271 Sum_probs=168.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++.+++..++||||+++|+|..++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 51 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dik 123 (323)
T cd05575 51 KNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ-------RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLK 123 (323)
T ss_pred hhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence 56899999999999999999999999999999999997 34578999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++..... ........||+
T Consensus 124 p~NIll~~~~~~kl~Dfg~~~~~~~~-------------------------------------------~~~~~~~~gt~ 160 (323)
T cd05575 124 PENILLDSQGHVVLTDFGLCKEGIEH-------------------------------------------SKTTSTFCGTP 160 (323)
T ss_pred HHHeEECCCCcEEEeccCCCcccccC-------------------------------------------CCccccccCCh
Confidence 99999999999999999986531100 00113346788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+.. .....+...++++.+++.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell--~g~~pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~ 230 (323)
T cd05575 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEML--YGLPPFYSRDTAEMYDNILN--------KPLRLKPNISVSARHLLEGL 230 (323)
T ss_pred hhcChhhhcCCCCCccccccccchhhhhhh--cCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999998877766655432 11223455689999999999
Q ss_pred ccCCCCCCCCH----HHH--HHHHHhc
Q psy5690 242 WKTNETDRPRF----SEI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~----~el--~~~L~~~ 262 (434)
|+.||++||++ .++ |+|+...
T Consensus 231 l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 231 LQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred hhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 99999999987 465 5666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=297.35 Aligned_cols=202 Identities=23% Similarity=0.304 Sum_probs=170.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDi 121 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS-------RERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121 (328)
T ss_pred HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccc
Confidence 467899999999999999999999999999999999986 3457899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......||
T Consensus 122 kp~NIll~~~~~~kL~DfG~~~~~~~~~-------------------------------------------~~~~~~~gt 158 (328)
T cd05593 122 KLENLMLDKDGHIKITDFGLCKEGITDA-------------------------------------------ATMKTFCGT 158 (328)
T ss_pred CHHHeEECCCCcEEEecCcCCccCCCcc-------------------------------------------cccccccCC
Confidence 9999999999999999999865411000 011234678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|+|+ +|..||...+..+....+.. .....+..+++++.+++.+
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell--tG~~Pf~~~~~~~~~~~~~~--------~~~~~p~~~~~~~~~li~~ 228 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM--CGRLPFYNQDHEKLFELILM--------EDIKFPRTLSADAKSLLSG 228 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHh--hCCCCCCCCCHHHHHHHhcc--------CCccCCCCCCHHHHHHHHH
Confidence 8999999999999999999999999999999 89999988776665543321 1223456788999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~ 262 (434)
||+.||++|+ ++.++ |+|+...
T Consensus 229 ~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 229 LLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999997 89999 6777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=294.59 Aligned_cols=200 Identities=23% Similarity=0.320 Sum_probs=167.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..|+||||+++|+|..++. ...+++..+..++.||+.||+|||++||+|||||
T Consensus 57 ~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~--------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlk 128 (324)
T cd05589 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLK 128 (324)
T ss_pred cccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCC
Confidence 56789999999999999999999999999999998885 2468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++..... ........|++
T Consensus 129 p~Nill~~~~~~kL~Dfg~~~~~~~~-------------------------------------------~~~~~~~~g~~ 165 (324)
T cd05589 129 LDNLLLDTEGFVKIADFGLCKEGMGF-------------------------------------------GDRTSTFCGTP 165 (324)
T ss_pred HHHeEECCCCcEEeCcccCCccCCCC-------------------------------------------CCcccccccCc
Confidence 99999999999999999986531100 00113356788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.. .....+..+++++.+++.+|
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslG~il~el~--~G~~pf~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~li~~~ 235 (324)
T cd05589 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEML--VGESPFPGDDEEEVFDSIVN--------DEVRYPRFLSREAISIMRRL 235 (324)
T ss_pred cccCHhHhcCCCCCcccchhhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHh--------CCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999998877666554432 12234566789999999999
Q ss_pred ccCCCCCCC-----CHHHH--HHHHHhc
Q psy5690 242 WKTNETDRP-----RFSEI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rp-----s~~el--~~~L~~~ 262 (434)
|+.||++|| ++.++ |+|+++.
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999999 57777 6677654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=297.48 Aligned_cols=203 Identities=35% Similarity=0.714 Sum_probs=179.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|+|.+ .+.|||||.++.|.|..|++. .+..++......++.||+.||.|||+.++|||||
T Consensus 445 MrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~------nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDI 517 (974)
T KOG4257|consen 445 MRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQ------NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDI 517 (974)
T ss_pred HHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHh------ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhh
Confidence 789999999999999965 589999999999999999984 4467899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
..+|||+.....+||+|||++|...+..++ .......+
T Consensus 518 AaRNiLVsSp~CVKLaDFGLSR~~ed~~yY------------------------------------------kaS~~kLP 555 (974)
T KOG4257|consen 518 AARNILVSSPQCVKLADFGLSRYLEDDAYY------------------------------------------KASRGKLP 555 (974)
T ss_pred hhhheeecCcceeeecccchhhhccccchh------------------------------------------hccccccc
Confidence 999999999999999999998875444332 23355667
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||.+....++.++|||-|||++||++. .|..||.+..+.+++. ..+.+.++|.|+.|++.++.|+.+
T Consensus 556 IKWmaPESINfRrFTtASDVWMFgVCmWEIl~-lGvkPfqgvkNsDVI~-------~iEnGeRlP~P~nCPp~LYslmsk 627 (974)
T KOG4257|consen 556 IKWMAPESINFRRFTTASDVWMFGVCMWEILS-LGVKPFQGVKNSDVIG-------HIENGERLPCPPNCPPALYSLMSK 627 (974)
T ss_pred eeecCccccchhcccchhhHHHHHHHHHHHHH-hcCCccccccccceEE-------EecCCCCCCCCCCCChHHHHHHHH
Confidence 88999999999999999999999999999997 6999999988877653 345778999999999999999999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~ 260 (434)
||++||.+||.+.||...|.
T Consensus 628 cWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 628 CWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred HhccCcccCCcHHHHHHHHH
Confidence 99999999999999955443
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=295.35 Aligned_cols=202 Identities=21% Similarity=0.312 Sum_probs=170.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..|+||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 54 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 126 (323)
T cd05584 54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE-------REGIFMEDTACFYLSEISLALEHLHQQGIIYRDL 126 (323)
T ss_pred HHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 467899999999999999999999999999999999997 3346888999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......||
T Consensus 127 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt 163 (323)
T cd05584 127 KPENILLDAQGHVKLTDFGLCKESIHEG-------------------------------------------TVTHTFCGT 163 (323)
T ss_pred CHHHeEECCCCCEEEeeCcCCeecccCC-------------------------------------------CcccccCCC
Confidence 9999999999999999999865311100 011234678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+.. .....+..+++++.+++.+
T Consensus 164 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~G~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDML--TGAPPFTAENRKKTIDKILK--------GKLNLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccChhhccCCCCCCcceecccHHHHHHHh--cCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHH
Confidence 8999999999988999999999999999999 89999998877665554432 1233456778999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~ 262 (434)
||+.||++|| +++++ |+|+...
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999 88988 7787654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=285.75 Aligned_cols=212 Identities=44% Similarity=0.824 Sum_probs=173.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
|++++||||+++++++...+..+++|||+++|+|.+++....... .....+++..+..++.|++.||+|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999997543110 01246888999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++|++||||||+||++++++.++|+|||+++...... .+
T Consensus 142 ~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~-----------------------------------------~~ 180 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD-----------------------------------------YY 180 (283)
T ss_pred hCCeeccccccceEEEcCCCcEEECCCcceeeccccc-----------------------------------------cc
Confidence 9999999999999999999999999999975421111 01
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
.......++..|+|||.+.+..++.++|||||||++|||++ .|..||.+....+....+.. ....+.+..++
T Consensus 181 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~-~g~~p~~~~~~~~~~~~i~~-------~~~~~~~~~~~ 252 (283)
T cd05048 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS-YGLQPYYGFSNQEVIEMIRS-------RQLLPCPEDCP 252 (283)
T ss_pred cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHc-------CCcCCCcccCC
Confidence 11223345678999999998899999999999999999993 28999998877766554432 22334467789
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+++.+++.+||+.||++||++.||.+.|++
T Consensus 253 ~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 253 ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=286.83 Aligned_cols=220 Identities=59% Similarity=1.096 Sum_probs=177.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS----QENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~----~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
|++++||||+++++++..++..+++|||+++++|.+++....... .....+++..++.++.|++.||+|||++|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~ 152 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV 152 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 467899999999999999999999999999999999997543110 1123689999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+||+++.++.++|+|||+++...... .......
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-----------------------------------------~~~~~~~ 191 (296)
T cd05051 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSD-----------------------------------------YYRVQGR 191 (296)
T ss_pred ccccchhceeecCCCceEEccccceeecccCc-----------------------------------------ceeecCc
Confidence 99999999999999999999999875422111 0011123
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..++..|+|||.+.+..++.++|||||||++|||+++.+..||......+........+.........+.+..+++++.+
T Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 271 (296)
T cd05051 192 APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYE 271 (296)
T ss_pred CCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHH
Confidence 34567899999999888999999999999999999655888998887777666655443333333334445667899999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 237 LMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
++.+||+.||++||++.||+++|++
T Consensus 272 li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 272 LMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHhccChhcCCCHHHHHHHhcC
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=288.95 Aligned_cols=209 Identities=19% Similarity=0.249 Sum_probs=169.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++.+++..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++||+||||
T Consensus 54 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~di 128 (285)
T cd05631 54 LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-----GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDL 128 (285)
T ss_pred HHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCC
Confidence 35789999999999999999999999999999999888632 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||+++++.++|+|||++....... ......||
T Consensus 129 kp~Nill~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------~~~~~~g~ 164 (285)
T cd05631 129 KPENILLDDRGHIRISDLGLAVQIPEGE--------------------------------------------TVRGRVGT 164 (285)
T ss_pred CHHHEEECCCCCEEEeeCCCcEEcCCCC--------------------------------------------eecCCCCC
Confidence 9999999999999999999875421100 01234578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|||||||++|||+ +|..||...........+.... .......+..+++++.+|+.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~--~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 165 VGYMAPEVINNEKYTFSPDWWGLGCLIYEMI--QGQSPFRKRKERVKREEVDRRV----KEDQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCccCHhhhcCCCCCcccCchhHHHHHHHHH--hCCCCCCCCCcchhHHHHHHHh----hcccccCCccCCHHHHHHHHH
Confidence 8999999999999999999999999999999 8999998765433222221111 112223455678999999999
Q ss_pred hccCCCCCCCC-----HHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRPR-----FSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rps-----~~el--~~~L~~~~~ 264 (434)
||+.||++||+ ++++ |+|++..+.
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 99999999997 8888 789987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=292.92 Aligned_cols=200 Identities=21% Similarity=0.299 Sum_probs=169.0
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.+||||+++++++...+..|+||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+||||||+
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~-------~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~ 125 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ-------KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHH
Confidence 479999999999999999999999999999999997 3356899999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
|||++.++.+||+|||+++...... .......||+.|
T Consensus 126 NIli~~~~~~kL~DfG~~~~~~~~~-------------------------------------------~~~~~~~gt~~y 162 (320)
T cd05590 126 NVLLDHEGHCKLADFGMCKEGIFNG-------------------------------------------KTTSTFCGTPDY 162 (320)
T ss_pred HeEECCCCcEEEeeCCCCeecCcCC-------------------------------------------CcccccccCccc
Confidence 9999999999999999865311000 011234678899
Q ss_pred cchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhcc
Q psy5690 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWK 243 (434)
Q Consensus 164 ~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 243 (434)
+|||++.+..++.++|||||||++|||+ +|..||...+..+....+.. .....+..+++++.+++.+||+
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~--~g~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 163 IAPEILQEMLYGPSVDWWAMGVLLYEML--CGHAPFEAENEDDLFEAILN--------DEVVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred cCHHHHcCCCCCCccchhhhHHHHHHHh--hCCCCCCCCCHHHHHHHHhc--------CCCCCCCCCCHHHHHHHHHHcc
Confidence 9999999999999999999999999999 89999998887776655432 1223355678999999999999
Q ss_pred CCCCCCCCH------HHH--HHHHHhcc
Q psy5690 244 TNETDRPRF------SEI--HLFLQRKN 263 (434)
Q Consensus 244 ~dP~~Rps~------~el--~~~L~~~~ 263 (434)
.||++||++ +++ |+|++...
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 999999998 677 78887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=293.17 Aligned_cols=203 Identities=21% Similarity=0.319 Sum_probs=173.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|.+++|+||.++||.+..+..+|++||||.||++.+.++ ....+.+..+.-++++++.||.|||.++.+||||
T Consensus 65 Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~-------~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDI 137 (467)
T KOG0201|consen 65 LSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK-------SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDI 137 (467)
T ss_pred HHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc-------cCCCCccceeeeehHHHHHHhhhhhhcceecccc
Confidence 357889999999999999999999999999999999997 4445588888889999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|+.|||+..+|.+|++|||.+..... ......+..||
T Consensus 138 Kaanil~s~~g~vkl~DfgVa~ql~~-------------------------------------------~~~rr~tfvGT 174 (467)
T KOG0201|consen 138 KAANILLSESGDVKLADFGVAGQLTN-------------------------------------------TVKRRKTFVGT 174 (467)
T ss_pred cccceeEeccCcEEEEecceeeeeec-------------------------------------------hhhcccccccc
Confidence 99999999999999999998644211 11123677899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.+..|+.|+||||||++.+||. +|.+|+......... ........+.....+++.+++|+..
T Consensus 175 PfwMAPEVI~~~~Y~~KADIWSLGITaiEla--~GePP~s~~hPmrvl-------flIpk~~PP~L~~~~S~~~kEFV~~ 245 (467)
T KOG0201|consen 175 PFWMAPEVIKQSGYDTKADIWSLGITAIELA--KGEPPHSKLHPMRVL-------FLIPKSAPPRLDGDFSPPFKEFVEA 245 (467)
T ss_pred ccccchhhhccccccchhhhhhhhHHHHHHh--cCCCCCcccCcceEE-------EeccCCCCCccccccCHHHHHHHHH
Confidence 9999999999999999999999999999999 999999988774332 2222333344455889999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||.+||+.||+|.++ |+|+++.
T Consensus 246 CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred HhhcCcccCcCHHHHhhhHHHHhc
Confidence 999999999999999 8899873
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=291.83 Aligned_cols=201 Identities=24% Similarity=0.345 Sum_probs=168.9
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
..+||||+++++++..++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||||
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~-------~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp 124 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ-------SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKL 124 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 3589999999999999999999999999999999997 334689999999999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+|||++.++.+||+|||+++...... .......||..
T Consensus 125 ~Nill~~~~~~kL~Dfg~a~~~~~~~-------------------------------------------~~~~~~~gt~~ 161 (316)
T cd05592 125 DNVLLDKDGHIKIADFGMCKENMNGE-------------------------------------------GKASTFCGTPD 161 (316)
T ss_pred HHeEECCCCCEEEccCcCCeECCCCC-------------------------------------------CccccccCCcc
Confidence 99999999999999999875411100 01133467889
Q ss_pred ccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhc
Q psy5690 163 WMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECW 242 (434)
Q Consensus 163 y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 242 (434)
|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.. .....+..++.++.+++.+||
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~ell--~G~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 162 YIAPEILKGQKYNESVDWWSFGVLLYEML--IGQSPFHGEDEDELFDSILN--------DRPHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred ccCHHHHcCCCCCCcccchhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHHHc
Confidence 99999999999999999999999999999 89999998887766654432 223345668899999999999
Q ss_pred cCCCCCCCCHH-HH--HHHHHhcc
Q psy5690 243 KTNETDRPRFS-EI--HLFLQRKN 263 (434)
Q Consensus 243 ~~dP~~Rps~~-el--~~~L~~~~ 263 (434)
+.||++||++. ++ |+|+....
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCC
Confidence 99999999864 66 67776643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=281.55 Aligned_cols=205 Identities=32% Similarity=0.619 Sum_probs=170.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||++++|++..++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|++||||
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~di 133 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH------EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGL 133 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 45789999999999999999999999999999999999732 246899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++++|||.+....... ........++
T Consensus 134 kp~nili~~~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 171 (266)
T cd05064 134 AAHKVLVNSDLVCKISGFRRLQEDKSEA------------------------------------------IYTTMSGKSP 171 (266)
T ss_pred cHhhEEEcCCCcEEECCCcccccccccc------------------------------------------hhcccCCCCc
Confidence 9999999999999999999754311000 0011123345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|||||||++||+++ +|..||......+..+.+.+ ....+.+..++..+.+++.+
T Consensus 172 ~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~ 243 (266)
T cd05064 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS-YGERPYWDMSGQDVIKAVED-------GFRLPAPRNCPNLLHQLMLD 243 (266)
T ss_pred eeecCHHHHhhCCccchhHHHHHHHHHHHHhc-CCCCCcCcCCHHHHHHHHHC-------CCCCCCCCCCCHHHHHHHHH
Confidence 67999999999999999999999999999873 48999998877766554432 22344567788999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||+.+|++||++++|.+.|.+
T Consensus 244 c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 244 CWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred HcCCCchhCCCHHHHHHHHHh
Confidence 999999999999999888865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=292.26 Aligned_cols=201 Identities=26% Similarity=0.345 Sum_probs=168.9
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
.++||||+++++++.+++..|+||||+.+|+|..++. ....+++..+..++.|++.||+|||++||+||||||
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp 124 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ-------DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKL 124 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH
Confidence 3589999999999999999999999999999999997 335688999999999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+|||++.++.+||+|||+++...... .......||..
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~~ 161 (316)
T cd05620 125 DNVMLDRDGHIKIADFGMCKENVFGD-------------------------------------------NRASTFCGTPD 161 (316)
T ss_pred HHeEECCCCCEEeCccCCCeecccCC-------------------------------------------CceeccCCCcC
Confidence 99999999999999999865310000 01133467889
Q ss_pred ccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhc
Q psy5690 163 WMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECW 242 (434)
Q Consensus 163 y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 242 (434)
|+|||++.+..++.++|||||||++|||+ +|..||...+..+..+.+.. .....+..++.++.+++.+||
T Consensus 162 y~aPE~~~~~~~~~~~DiwslGvil~el~--~g~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 162 YIAPEILQGLKYTFSVDWWSFGVLLYEML--IGQSPFHGDDEDELFESIRV--------DTPHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCHHHHcCCCCCcccchhhhHHHHHHHH--hCCCCCCCCCHHHHHHHHHh--------CCCCCCCCCCHHHHHHHHHHc
Confidence 99999999999999999999999999999 89999998877766654432 122334567899999999999
Q ss_pred cCCCCCCCCH-HHH--HHHHHhcc
Q psy5690 243 KTNETDRPRF-SEI--HLFLQRKN 263 (434)
Q Consensus 243 ~~dP~~Rps~-~el--~~~L~~~~ 263 (434)
+.||++||++ +++ |+|++...
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCC
Confidence 9999999997 567 78887654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=286.89 Aligned_cols=210 Identities=20% Similarity=0.275 Sum_probs=172.3
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++|+||||+++.+...+. +.+|+|+|||++ ||.-++. ...-.|++.++..+++||+.||+|||++||+||
T Consensus 170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~------~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHR 242 (560)
T KOG0600|consen 170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLS------SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHR 242 (560)
T ss_pred HHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhc------CCCcccChHHHHHHHHHHHHHHHHHhhcCeeec
Confidence 5789999999999998766 689999999988 9999986 245689999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|||.+|||||.+|.+||+|||+|+.+.... ...-+..+
T Consensus 243 DIK~SNiLidn~G~LKiaDFGLAr~y~~~~------------------------------------------~~~~T~rV 280 (560)
T KOG0600|consen 243 DIKGSNILIDNNGVLKIADFGLARFYTPSG------------------------------------------SAPYTSRV 280 (560)
T ss_pred cccccceEEcCCCCEEeccccceeeccCCC------------------------------------------Ccccccce
Confidence 999999999999999999999998643322 11136677
Q ss_pred CCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCccc----CCC--------
Q psy5690 159 LPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ----YLP-------- 225 (434)
Q Consensus 159 gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~-------- 225 (434)
.|..|.|||.+.+. .|+.++|+||.|||+.||+ .|++.|.+.+..+....|-+.+....... .+|
T Consensus 281 vTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~--~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~ 358 (560)
T KOG0600|consen 281 VTLWYRPPELLLGATSYGTAVDLWSVGCILAELF--LGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQ 358 (560)
T ss_pred EEeeccChHHhcCCcccccceeehhhhHHHHHHH--cCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCC
Confidence 89999999999974 6899999999999999999 89999999888777666543322111100 000
Q ss_pred ---------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 226 ---------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 226 ---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
....+++...+|+..+|..||.+|.|+.++ ++||..
T Consensus 359 ~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 359 QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 013456788999999999999999999998 678843
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=295.85 Aligned_cols=201 Identities=22% Similarity=0.307 Sum_probs=167.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..|+||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 124 (318)
T cd05582 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS-------KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDL 124 (318)
T ss_pred HHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence 467899999999999999999999999999999999996 3456899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .......|+
T Consensus 125 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~-------------------------------------------~~~~~~~g~ 161 (318)
T cd05582 125 KPENILLDEEGHIKLTDFGLSKESIDHE-------------------------------------------KKAYSFCGT 161 (318)
T ss_pred CHHHeEECCCCcEEEeeccCCcccCCCC-------------------------------------------CceecccCC
Confidence 9999999999999999999865421100 011234678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|||||||++|||+ +|..||......+....+.. .....+..+++++.+++.+
T Consensus 162 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~--tg~~p~~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~li~~ 231 (318)
T cd05582 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEML--TGSLPFQGKDRKETMTMILK--------AKLGMPQFLSPEAQSLLRA 231 (318)
T ss_pred hhhcCHHHHcCCCCCCccceeccceEeeeec--cCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHH
Confidence 8999999999988999999999999999999 89999998877666554421 1223456678999999999
Q ss_pred hccCCCCCCCCH-----HHH--HHHHHh
Q psy5690 241 CWKTNETDRPRF-----SEI--HLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~-----~el--~~~L~~ 261 (434)
||+.||++||++ +++ |+|++.
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 999999999995 445 455554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=294.87 Aligned_cols=202 Identities=24% Similarity=0.321 Sum_probs=169.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrD 79 (434)
|++++||||+++++++..++..|+||||+++|+|..++. ....+++..+..++.||+.||+|||+ +||+|||
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~-------~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrD 121 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-------RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecC
Confidence 356899999999999999999999999999999999986 34578999999999999999999997 7999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++...... .......|
T Consensus 122 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~-------------------------------------------~~~~~~~g 158 (325)
T cd05594 122 LKLENLMLDKDGHIKITDFGLCKEGIKDG-------------------------------------------ATMKTFCG 158 (325)
T ss_pred CCCCeEEECCCCCEEEecCCCCeecCCCC-------------------------------------------cccccccC
Confidence 99999999999999999999865311100 01123457
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|..|+|||++.+..++.++|||||||++|||+ +|..||......+....+.. .....+..+++++.+++.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~--tG~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~li~ 228 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM--CGRLPFYNQDHEKLFELILM--------EEIRFPRTLSPEAKSLLS 228 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeec--cCCCCCCCCCHHHHHHHHhc--------CCCCCCCCCCHHHHHHHH
Confidence 88999999999999999999999999999999 89999988777665544321 122335667899999999
Q ss_pred HhccCCCCCCC-----CHHHH--HHHHHhc
Q psy5690 240 ECWKTNETDRP-----RFSEI--HLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rp-----s~~el--~~~L~~~ 262 (434)
+||+.||++|+ ++.++ |+|+.+.
T Consensus 229 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 229 GLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 99999999997 89999 7787654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=272.32 Aligned_cols=209 Identities=22% Similarity=0.276 Sum_probs=170.2
Q ss_pred CCCCeeeEEEEEecC----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 5 KDPNLVRVIGVCSTE----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
.|||||+++++|++. ..+.+|||.++||.|.+.++.+ ....+++.++-.|+.||+.|+.|||+.+|.||||
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~-----g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDl 187 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDR-----GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDL 187 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHc-----ccccchHHHHHHHHHHHHHHHHHHHhcchhhccC
Confidence 599999999998643 4588999999999999999855 4567999999999999999999999999999999
Q ss_pred CCCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|+|.+. +-.+||+|||+|+.... .....+.
T Consensus 188 KpENLLyt~t~~na~lKLtDfGFAK~t~~--------------------------------------------~~~L~TP 223 (400)
T KOG0604|consen 188 KPENLLYTTTSPNAPLKLTDFGFAKETQE--------------------------------------------PGDLMTP 223 (400)
T ss_pred ChhheeeecCCCCcceEecccccccccCC--------------------------------------------CccccCC
Confidence 999999965 45689999999876221 1123556
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+-|+.|.|||++...+|+..+|+||+||++|-|+ +|.+||.......+....+..+.........+....+|++.+++
T Consensus 224 c~TPyYvaPevlg~eKydkscdmwSlgVimYIlL--CGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdl 301 (400)
T KOG0604|consen 224 CFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL--CGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDL 301 (400)
T ss_pred cccccccCHHHhCchhcCCCCCccchhHHHHHhh--cCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHH
Confidence 7789999999999999999999999999999999 99999987654332222222122222223334456788999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
|+.+|..+|.+|.|+.++ |+|+.+...
T Consensus 302 IR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 302 IRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred HHHHhcCCchhheeHHHhhcCchhccccc
Confidence 999999999999999999 899987644
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=289.31 Aligned_cols=208 Identities=20% Similarity=0.285 Sum_probs=166.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrD 79 (434)
|++++||||+++++++..++..++||||+++|+|.+++. ....+++..+..++.|++.||.|||++ +|+|||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~d 129 (331)
T cd06649 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-------EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRD 129 (331)
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCC
Confidence 467899999999999999999999999999999999997 334689999999999999999999986 699999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++..... ......|
T Consensus 130 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~---------------------------------------------~~~~~~g 164 (331)
T cd06649 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS---------------------------------------------MANSFVG 164 (331)
T ss_pred CChhhEEEcCCCcEEEccCccccccccc---------------------------------------------ccccCCC
Confidence 9999999999999999999986542110 0123457
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc----------------------
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN---------------------- 217 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~---------------------- 217 (434)
+..|+|||++.+..++.++|||||||++|||+ +|+.||......+....+..-...
T Consensus 165 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd06649 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELA--IGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 242 (331)
T ss_pred CcCcCCHhHhcCCCCCchHhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence 78899999999999999999999999999999 899999776554433221100000
Q ss_pred -----------------CCcccCCCC-CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 218 -----------------NSKQQYLPR-PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 218 -----------------~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
......... ...+++++.+|+.+||+.||++|||++|+ |+|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000000111 12467899999999999999999999999 8999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=284.59 Aligned_cols=203 Identities=35% Similarity=0.651 Sum_probs=163.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||++++|++...+..++|+||+++|+|.+++... ....+++..+..|+.||++||+|||+++++|+||+
T Consensus 56 ~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~-----~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~ 130 (259)
T PF07714_consen 56 RKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK-----NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLS 130 (259)
T ss_dssp HTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT-----CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cccccccccccccccccccccccccccccccccccccccc-----ccccccccccccccccccccccccccccccccccc
Confidence 5679999999999999888899999999999999999843 24678999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
++||+++.++.+||+|||++....... ..........+.
T Consensus 131 ~~nill~~~~~~Kl~~f~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~ 169 (259)
T PF07714_consen 131 PSNILLDSNGQVKLSDFGLSRPISEKS-----------------------------------------KYKNDSSQQLPL 169 (259)
T ss_dssp GGGEEEETTTEEEEESTTTGEETTTSS-----------------------------------------SEEESTTSESGG
T ss_pred ccccccccccccccccccccccccccc-----------------------------------------cccccccccccc
Confidence 999999999999999999976531111 111223334567
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||.+.+..++.++||||||+++||++ + |..||.+....+....+. .....+.+..++..+.+++.+
T Consensus 170 ~~~aPE~~~~~~~~~ksDVysfG~~l~ei~--~~~~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 240 (259)
T PF07714_consen 170 RYLAPEVLKDGEYTKKSDVYSFGMLLYEIL--TLGKFPFSDYDNEEIIEKLK-------QGQRLPIPDNCPKDIYSLIQQ 240 (259)
T ss_dssp GGS-HHHHHHSEESHHHHHHHHHHHHHHHH--TTSSGTTTTSCHHHHHHHHH-------TTEETTSBTTSBHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccc--cccccccccccccccccccc-------ccccceeccchhHHHHHHHHH
Confidence 899999999999999999999999999999 6 789999888777666553 223344566789999999999
Q ss_pred hccCCCCCCCCHHHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L 259 (434)
||+.||++||++.+|++.|
T Consensus 241 C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 241 CWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HT-SSGGGS--HHHHHHHH
T ss_pred HcCCChhhCcCHHHHHhcC
Confidence 9999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=290.45 Aligned_cols=200 Identities=21% Similarity=0.277 Sum_probs=169.3
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.+||||+++++++.+++..|+||||+++|+|..++. ....+++..+..++.||+.||+|||++||+||||||+
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~ 125 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ-------RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLD 125 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 489999999999999999999999999999999997 3356899999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
|||++.++.+||+|||+++...... .......||..|
T Consensus 126 Nill~~~~~~kL~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~~y 162 (321)
T cd05591 126 NILLDAEGHCKLADFGMCKEGILNG-------------------------------------------VTTTTFCGTPDY 162 (321)
T ss_pred HeEECCCCCEEEeecccceecccCC-------------------------------------------ccccccccCccc
Confidence 9999999999999999865311100 011234578899
Q ss_pred cchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhcc
Q psy5690 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWK 243 (434)
Q Consensus 164 ~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 243 (434)
+|||++.+..++.++|||||||++|||+ +|..||...+..+..+.+.. .....+..+++++.+++.+||+
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~el~--tg~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 163 IAPEILQELEYGPSVDWWALGVLMYEMM--AGQPPFEADNEDDLFESILH--------DDVLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred cCHHHHcCCCCCCccceechhHHHHHHh--cCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999999999999999999999999 89999998887777665432 1122345678999999999999
Q ss_pred CCCCCCC-------CHHHH--HHHHHhcc
Q psy5690 244 TNETDRP-------RFSEI--HLFLQRKN 263 (434)
Q Consensus 244 ~dP~~Rp-------s~~el--~~~L~~~~ 263 (434)
.||++|+ +++++ |+|++...
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 9999999 88888 78886643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=295.21 Aligned_cols=209 Identities=17% Similarity=0.293 Sum_probs=170.9
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++.+++..++||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++||+|||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlk 129 (330)
T cd05601 56 SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY------EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIK 129 (330)
T ss_pred HhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCc
Confidence 5679999999999999999999999999999999999733 2468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||++....... ........||+
T Consensus 130 p~NIll~~~~~~kL~Dfg~a~~~~~~~------------------------------------------~~~~~~~~gt~ 167 (330)
T cd05601 130 PENVLIDRTGHIKLADFGSAARLTANK------------------------------------------MVNSKLPVGTP 167 (330)
T ss_pred hHheEECCCCCEEeccCCCCeECCCCC------------------------------------------ceeeecccCCc
Confidence 999999999999999999975421111 00112346788
Q ss_pred cccchhhhh------cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 162 RWMAWESLL------LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 162 ~y~aPE~~~------~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
.|+|||++. ...++.++|||||||++|||+ +|..||......+....+... ......+....+++++.
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~--~g~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~~ 241 (330)
T cd05601 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI--YGRSPFHEGTSAKTYNNIMNF----QRFLKFPEDPKVSSDFL 241 (330)
T ss_pred cccCHHHhccccccccCCCCCcceeecccceeeeec--cCCCCCCCCCHHHHHHHHHcC----CCccCCCCCCCCCHHHH
Confidence 999999987 456789999999999999999 899999888776666554332 11112233345789999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhcccC
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRKNLG 265 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~~~~ 265 (434)
+++.+||. +|++||+++++ |+|+++.+..
T Consensus 242 ~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 242 DLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred HHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 99999998 99999999999 7899876544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=282.28 Aligned_cols=220 Identities=56% Similarity=1.022 Sum_probs=175.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN----SQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
|++++|+||+++++++..++..++||||+++|+|.+++...... ......+++..+..++.|++.||+|||++|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~ 152 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV 152 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45789999999999999999999999999999999999754311 11123578889999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+||+++.++.++|+|||+++...... .......
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-----------------------------------------~~~~~~~ 191 (296)
T cd05095 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGD-----------------------------------------YYRIQGR 191 (296)
T ss_pred cccCChheEEEcCCCCEEeccCcccccccCCc-----------------------------------------ceeccCc
Confidence 99999999999999999999999976421110 0001122
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..++..|+|||...++.++.++|||||||++|||+++.|..||...+..+.......++.........+.+..+++.+.+
T Consensus 192 ~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (296)
T cd05095 192 AVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYK 271 (296)
T ss_pred CcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHH
Confidence 33457799999998889999999999999999999655889998877766655544333333333344556678899999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 237 LMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
++.+||+.||++||++.+|++.|++
T Consensus 272 li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 272 LMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHcCCCcccCCCHHHHHHHHhC
Confidence 9999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=294.74 Aligned_cols=213 Identities=32% Similarity=0.644 Sum_probs=167.2
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC------------------------------------
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN------------------------------------ 44 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------ 44 (434)
+.+ +|+|||+++++|..++..++|||||++|+|.++++.....
T Consensus 96 ~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (374)
T cd05106 96 SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSS 175 (374)
T ss_pred HhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccc
Confidence 456 8999999999999999999999999999999999653210
Q ss_pred ---------------------------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEcc
Q psy5690 45 ---------------------------SQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97 (434)
Q Consensus 45 ---------------------------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~D 97 (434)
......+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~D 255 (374)
T cd05106 176 QGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICD 255 (374)
T ss_pred cccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEee
Confidence 01123578889999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCc
Q psy5690 98 HAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177 (434)
Q Consensus 98 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~ 177 (434)
||+++...... .........++..|+|||++.+..++.+
T Consensus 256 fGla~~~~~~~-----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 294 (374)
T cd05106 256 FGLARDIMNDS-----------------------------------------NYVVKGNARLPVKWMAPESIFDCVYTVQ 294 (374)
T ss_pred ceeeeeccCCc-----------------------------------------ceeeccCCCCccceeCHHHhcCCCCCcc
Confidence 99976421110 0001122334567999999998899999
Q ss_pred CChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHH
Q psy5690 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHL 257 (434)
Q Consensus 178 sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 257 (434)
+|||||||++|||++ .|..||.............. .......+...++++.+++.+||+.||++||++.+|.+
T Consensus 295 ~DvwSlGvil~ellt-~G~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 295 SDVWSYGILLWEIFS-LGKSPYPGILVNSKFYKMVK------RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ccHHHHHHHHHHHHh-CCCCCCccccccHHHHHHHH------cccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999993 28999987654433222211 11223334556799999999999999999999999999
Q ss_pred HHHhc
Q psy5690 258 FLQRK 262 (434)
Q Consensus 258 ~L~~~ 262 (434)
.|++.
T Consensus 368 ~l~~~ 372 (374)
T cd05106 368 LIQRQ 372 (374)
T ss_pred HHHHH
Confidence 98863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=283.75 Aligned_cols=220 Identities=51% Similarity=0.981 Sum_probs=174.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN-----SQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|++++||||+++++++..++..++||||+++++|.+++...... ......+++..+..++.|++.||+|||++|+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 150 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF 150 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCe
Confidence 46789999999999999999999999999999999999643200 0111247888999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+||+++.++.+||+|||+++...... ......
T Consensus 151 ~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----------------------------------------~~~~~~ 189 (295)
T cd05097 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD-----------------------------------------YYRIQG 189 (295)
T ss_pred eccccChhhEEEcCCCcEEecccccccccccCc-----------------------------------------ceeccC
Confidence 999999999999999999999999875421110 001112
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
...++..|+|||++.++.++.++|||||||++|+|+++.+..||......+....+...............+..+++.+.
T Consensus 190 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 269 (295)
T cd05097 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVF 269 (295)
T ss_pred cCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHH
Confidence 33456789999999988899999999999999999965688899888777766555443333223333344556789999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 236 DLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+++.+||+.||++||++++|+++|++
T Consensus 270 ~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 270 KLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 99999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=281.66 Aligned_cols=213 Identities=42% Similarity=0.777 Sum_probs=173.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
+++++||||+++++++..++..++||||+++|+|.+++..++.. ......+++..++.++.||+.||+|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999754321 112345899999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++|++||||||+||+++.++.++|+|||+++...... ..
T Consensus 141 ~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~-----------------------------------------~~ 179 (291)
T cd05094 141 SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----------------------------------------YY 179 (291)
T ss_pred hCCeeecccCcceEEEccCCcEEECCCCcccccCCCc-----------------------------------------ee
Confidence 9999999999999999999999999999976422111 00
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (434)
.......++..|+|||.+.+..++.++|||||||++|||+ + |..||......+..+.+.. ......+..+
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~ 250 (291)
T cd05094 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF--TYGKQPWFQLSNTEVIECITQ-------GRVLERPRVC 250 (291)
T ss_pred ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHhC-------CCCCCCCccC
Confidence 1112334567899999999999999999999999999999 6 8999988777665544321 2222334567
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+..+.+++.+||+.||++||++.+|.+.|++..
T Consensus 251 ~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 251 PKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 889999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=281.22 Aligned_cols=213 Identities=42% Similarity=0.782 Sum_probs=173.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN------SQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++||||+++++++..++..++||||+++|+|.+++...+.. ......+++..+..++.|++.||+|||++|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45789999999999999999999999999999999999754311 012235899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
++||||||+||++++++.++|+|||+++...... .....
T Consensus 141 i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-----------------------------------------~~~~~ 179 (288)
T cd05093 141 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-----------------------------------------YYRVG 179 (288)
T ss_pred eeecccCcceEEEccCCcEEeccCCccccccCCc-----------------------------------------eeecC
Confidence 9999999999999999999999999876421111 00111
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
....++..|+|||++.+..++.++|||||||++|+|+ + |..||......+....+.. ......+..++.+
T Consensus 180 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~--t~g~~p~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~ 250 (288)
T cd05093 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF--TYGKQPWYQLSNNEVIECITQ-------GRVLQRPRTCPKE 250 (288)
T ss_pred CCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCcCCCCCCCCHH
Confidence 2233567899999999888999999999999999999 6 8999988777665554432 1222334567889
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+.+++.+||+.||.+||++.+++..|++..
T Consensus 251 l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 251 VYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=283.61 Aligned_cols=212 Identities=17% Similarity=0.222 Sum_probs=169.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|..++.... .....+++..+..++.||+.||+|||++||+||||
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 123 (280)
T cd05608 47 LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVD---EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDL 123 (280)
T ss_pred HHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 457899999999999999999999999999999998885322 13456899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......||
T Consensus 124 kp~Nili~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~g~ 160 (280)
T cd05608 124 KPENVLLDNDGNVRISDLGLAVELKDGQ-------------------------------------------SKTKGYAGT 160 (280)
T ss_pred CHHHEEECCCCCEEEeeCccceecCCCC-------------------------------------------ccccccCCC
Confidence 9999999999999999999875421110 011234578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|||||||++|||+ +|..||...........+.... .......+..+++++.+++.+
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~--~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~ 234 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMI--AARGPFRARGEKVENKELKQRI----LNDSVTYPDKFSPASKSFCEA 234 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHH--hCCCCCCCCCcchhHHHHHHhh----cccCCCCcccCCHHHHHHHHH
Confidence 8999999999999999999999999999999 8999997654322211111100 111223355688999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
||+.||++|| +++++ |+|++...+
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 235 LLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred HhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 9999999999 77888 889987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=302.63 Aligned_cols=208 Identities=36% Similarity=0.676 Sum_probs=185.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|-+++||||++|.|+.....++.||+|||++|+|+.+|+. .++.++..++..+++.|+.|++||-+.|+|||||
T Consensus 684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~------~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDL 757 (996)
T KOG0196|consen 684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ------NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDL 757 (996)
T ss_pred cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh------cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhh
Confidence 6689999999999999999999999999999999999984 3456999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
..+|||++.+..+|++|||++|...+. .+.+....+..-+
T Consensus 758 AARNILVNsnLvCKVsDFGLSRvledd----------------------------------------~~~~ytt~GGKIP 797 (996)
T KOG0196|consen 758 AARNILVNSNLVCKVSDFGLSRVLEDD----------------------------------------PEAAYTTLGGKIP 797 (996)
T ss_pred hhhheeeccceEEEeccccceeecccC----------------------------------------CCccccccCCccc
Confidence 999999999999999999998863221 1222333445567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
++|.|||.+...+++.++||||+|+++||.++ .|..||-++++.+.+..+. .+.++|.|-+|+..+..||..
T Consensus 798 iRWTAPEAIa~RKFTsASDVWSyGIVmWEVmS-yGERPYWdmSNQdVIkaIe-------~gyRLPpPmDCP~aL~qLMld 869 (996)
T KOG0196|consen 798 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-YGERPYWDMSNQDVIKAIE-------QGYRLPPPMDCPAALYQLMLD 869 (996)
T ss_pred eeecChhHhhhcccCchhhccccceEEEEecc-cCCCcccccchHHHHHHHH-------hccCCCCCCCCcHHHHHHHHH
Confidence 89999999999999999999999999999998 7999999999999988775 456788899999999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||++|-.+||.+.+|+..|.+.
T Consensus 870 CWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 870 CWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHHHHhhcCCCHHHHHHHHHHH
Confidence 9999999999999999888874
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=297.44 Aligned_cols=207 Identities=26% Similarity=0.390 Sum_probs=174.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++|+|.|||+++|.+.+++.+-|.||-++||+|.++++.+.+. -.-.+...-.+.+||++||.|||++.|||||||
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGP----lKDNEstm~fYtkQILeGLkYLHen~IVHRDIK 702 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGP----LKDNESTMNFYTKQILEGLKYLHENKIVHRDIK 702 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCC----CccchhHHHHHHHHHHHHhhhhhhcceeecccc
Confidence 4689999999999999999999999999999999999865422 122677888999999999999999999999999
Q ss_pred CCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 82 ARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 82 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
.+|||++. .|.+||+|||-++....- .....+..||
T Consensus 703 GDNVLvNTySGvlKISDFGTsKRLAgi-------------------------------------------nP~TETFTGT 739 (1226)
T KOG4279|consen 703 GDNVLVNTYSGVLKISDFGTSKRLAGI-------------------------------------------NPCTETFTGT 739 (1226)
T ss_pred CCcEEEeeccceEEecccccchhhccC-------------------------------------------Cccccccccc
Confidence 99999975 789999999987652111 1123567899
Q ss_pred ccccchhhhhcC--CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 161 IRWMAWESLLLG--KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 161 ~~y~aPE~~~~~--~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
..|||||++..+ .|+.++|||||||++.||. ||++||......+... ++-......++.|..++.+.+.+|
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMA--TGrPPF~ElgspqAAM-----FkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMA--TGRPPFVELGSPQAAM-----FKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeec--cCCCCeeecCChhHhh-----hhhcceecCCCCcHHHHHHHHHHH
Confidence 999999999875 5799999999999999999 9999999877665543 223344556788999999999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+|+..||.+||++.++ -+||+..
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccC
Confidence 99999999999999999 4677765
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.93 Aligned_cols=200 Identities=23% Similarity=0.307 Sum_probs=166.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++.+.+..++||||+++|+|..++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 51 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlk 123 (321)
T cd05603 51 KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ-------RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLK 123 (321)
T ss_pred HhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence 56899999999999999999999999999999999886 34568899999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... .......||+
T Consensus 124 p~NIll~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~ 160 (321)
T cd05603 124 PENILLDSQGHVVLTDFGLCKEGVEPE-------------------------------------------ETTSTFCGTP 160 (321)
T ss_pred HHHeEECCCCCEEEccCCCCccCCCCC-------------------------------------------CccccccCCc
Confidence 999999999999999999865311100 0112345788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+.. .....+...+.++.+++.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~ 230 (321)
T cd05603 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEML--YGLPPFYSRDVSQMYDNILH--------KPLQLPGGKTVAACDLLVGL 230 (321)
T ss_pred ccCCHHHhcCCCCCCcCcccccchhhhhhh--cCCCCCCCCCHHHHHHHHhc--------CCCCCCCCCCHHHHHHHHHH
Confidence 999999999989999999999999999999 89999998876666554432 12334556788999999999
Q ss_pred ccCCCCCCCCHH----HH--HHHHHh
Q psy5690 242 WKTNETDRPRFS----EI--HLFLQR 261 (434)
Q Consensus 242 l~~dP~~Rps~~----el--~~~L~~ 261 (434)
|+.||.+|+++. ++ |.|+..
T Consensus 231 l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 231 LHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred ccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 999999999753 55 455543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=290.26 Aligned_cols=211 Identities=24% Similarity=0.389 Sum_probs=161.0
Q ss_pred CCCCCCCCeeeEEEEEecCC-ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---Ccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR---DIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---~ii 76 (434)
|.+++|||+|+++|||.+++ ..++|+||+++|+|.+++.... .. .++|..+++|+.++|+||+|||+. .||
T Consensus 125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~----~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~ii 199 (361)
T KOG1187|consen 125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKK----GE-PLDWETRLKIALGAARGLAYLHEGCPPPII 199 (361)
T ss_pred HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCC----CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEe
Confidence 46899999999999999988 4999999999999999997432 11 889999999999999999999985 399
Q ss_pred ccCCCCCCeeeecCCceEEccCCccccccc-ccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYE-SDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
|||||++|||||+++++||+|||+|+.... .. ...
T Consensus 200 HrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~--------------------------------------------~~~ 235 (361)
T KOG1187|consen 200 HRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT--------------------------------------------SVS 235 (361)
T ss_pred cCCCCHHHeeECCCCCEEccCccCcccCCcccc--------------------------------------------cee
Confidence 999999999999999999999999865211 00 001
Q ss_pred CC-CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC---hHHHHHhhhhhhhcCC-----cccC--C
Q psy5690 156 KA-RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT---NEQVIENCSHWYQNNS-----KQQY--L 224 (434)
Q Consensus 156 ~~-~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~---~~~~~~~~~~~~~~~~-----~~~~--~ 224 (434)
.. .||.+|+|||+...+..+.|+|||||||++.|++ +|+.+.+... ................ .... .
T Consensus 236 ~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli--tgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 236 TTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI--TGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eecCCCCccCChhhhccCCcCcccccccchHHHHHHH--hCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 11 7889999999999999999999999999999999 7887776432 1112221111111110 0000 1
Q ss_pred CCCC-ccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 225 PRPA-TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 225 ~~~~-~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
..+. ..-..+..+..+|++.+|.+||++.||.+.|+..
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 1111 2234577888999999999999999998888553
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=262.27 Aligned_cols=209 Identities=19% Similarity=0.233 Sum_probs=168.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++|+||+.++++|...+.+.+|+||++. +|+..++. ....++..++..++.++++||+|||++.|+||||
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd------~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDl 127 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKD------KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDL 127 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcc------cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccC
Confidence 4678999999999999999999999999987 99999973 4567899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||.|+|++.+|.+||+|||+|+.+..+.. ..+..+.|
T Consensus 128 KPnNLLis~~g~lKiADFGLAr~f~~p~~-------------------------------------------~~~~~V~T 164 (318)
T KOG0659|consen 128 KPNNLLISSDGQLKIADFGLARFFGSPNR-------------------------------------------IQTHQVVT 164 (318)
T ss_pred CccceEEcCCCcEEeecccchhccCCCCc-------------------------------------------ccccceee
Confidence 99999999999999999999988544331 11223667
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc-------------------
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK------------------- 220 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------- 220 (434)
..|.|||.+.+ ..|+..+|+||.||++.||+ .+.+-|.+.++-+....+-..+.....
T Consensus 165 RWYRAPELLfGsr~Yg~~VDmWavGCI~AELl--lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P 242 (318)
T KOG0659|consen 165 RWYRAPELLFGSRQYGTGVDMWAVGCIFAELL--LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFP 242 (318)
T ss_pred eeccChHHhccchhcCCcchhhhHHHHHHHHH--ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCC
Confidence 88999999986 56899999999999999999 777777777766555443321111000
Q ss_pred -ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 221 -QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 221 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
......-..++.++.+|+.+||.+||.+|+++.|. |++|+.
T Consensus 243 ~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 243 KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 00000123456788999999999999999999999 788886
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=289.12 Aligned_cols=202 Identities=25% Similarity=0.352 Sum_probs=168.7
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
.++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+||||||
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~-------~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp 124 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ-------SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKL 124 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCH
Confidence 3589999999999999999999999999999999997 334688999999999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+|||++.++.+||+|||+++...... .......||..
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~~ 161 (316)
T cd05619 125 DNILLDTDGHIKIADFGMCKENMLGD-------------------------------------------AKTCTFCGTPD 161 (316)
T ss_pred HHEEECCCCCEEEccCCcceECCCCC-------------------------------------------CceeeecCCcc
Confidence 99999999999999999865311000 01123457889
Q ss_pred ccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhc
Q psy5690 163 WMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECW 242 (434)
Q Consensus 163 y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 242 (434)
|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+.. .....+..++.++.+++.+||
T Consensus 162 y~aPE~~~~~~~~~~~DvwslG~il~el~--~G~~pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 162 YIAPEILLGQKYNTSVDWWSFGVLLYEML--IGQSPFHGHDEEELFQSIRM--------DNPCYPRWLTREAKDILVKLF 231 (316)
T ss_pred ccCHHHHcCCCCCchhhhhhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHh--------CCCCCCccCCHHHHHHHHHHh
Confidence 99999999999999999999999999999 89999998877766654431 112234567889999999999
Q ss_pred cCCCCCCCCHH-HH--HHHHHhccc
Q psy5690 243 KTNETDRPRFS-EI--HLFLQRKNL 264 (434)
Q Consensus 243 ~~dP~~Rps~~-el--~~~L~~~~~ 264 (434)
+.||++||++. ++ |+|++...+
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCH
Confidence 99999999986 77 678876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=292.49 Aligned_cols=212 Identities=31% Similarity=0.602 Sum_probs=166.4
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC-----------------------------------
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS----------------------------------- 45 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~----------------------------------- 45 (434)
+.+ +||||++++++|.+++..++|||||++|+|.++++..+...
T Consensus 93 ~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 172 (375)
T cd05104 93 SYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMK 172 (375)
T ss_pred HHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcC
Confidence 346 89999999999999999999999999999999997532100
Q ss_pred ---------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCc
Q psy5690 46 ---------------------------------QENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYT 92 (434)
Q Consensus 46 ---------------------------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~ 92 (434)
.....+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~ 252 (375)
T cd05104 173 PGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI 252 (375)
T ss_pred CCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc
Confidence 01235788899999999999999999999999999999999999999
Q ss_pred eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcC
Q psy5690 93 IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLG 172 (434)
Q Consensus 93 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 172 (434)
+||+|||+++...... .........++..|+|||++.+.
T Consensus 253 ~kl~DfG~a~~~~~~~-----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~ 291 (375)
T cd05104 253 TKICDFGLARDIRNDS-----------------------------------------NYVVKGNARLPVKWMAPESIFNC 291 (375)
T ss_pred EEEecCccceeccCcc-----------------------------------------cccccCCCCCCcceeChhHhcCC
Confidence 9999999976421110 00011223456679999999999
Q ss_pred CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCH
Q psy5690 173 KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRF 252 (434)
Q Consensus 173 ~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 252 (434)
.++.++|||||||++|||++ .|..||.............. .......+...+.++.+++.+||+.||++||++
T Consensus 292 ~~~~~sDi~slG~~l~ellt-~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 292 VYTFESDVWSYGILLWEIFS-LGSSPYPGMPVDSKFYKMIK------EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred CCCCCCCHHHHHHHHHHHHh-cCCCCCCCCCchHHHHHHHH------hCccCCCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 99999999999999999994 28899987654433222111 111223345567899999999999999999999
Q ss_pred HHHHHHHHh
Q psy5690 253 SEIHLFLQR 261 (434)
Q Consensus 253 ~el~~~L~~ 261 (434)
.||++.|++
T Consensus 365 ~eil~~l~~ 373 (375)
T cd05104 365 KQIVQLIEQ 373 (375)
T ss_pred HHHHHHHHh
Confidence 999998875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=295.80 Aligned_cols=246 Identities=17% Similarity=0.209 Sum_probs=175.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++.+++..|+||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~-------~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl 127 (364)
T cd05599 55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM-------KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127 (364)
T ss_pred HHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccC
Confidence 356899999999999999999999999999999999997 3346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.++|+|||+++............................+. .....................||
T Consensus 128 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~gt 202 (364)
T cd05599 128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM-----SSKRKAETWKRNRRALAYSTVGT 202 (364)
T ss_pred CHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccc-----cccccccchhhcccccccccccC
Confidence 9999999999999999999987543221100000000000000000000000 00000000000000111245789
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+..+. .....+....+++++.+++.+
T Consensus 203 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~--~G~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~ 276 (364)
T cd05599 203 PDYIAPEVFLQTGYNKECDWWSLGVIMYEML--VGYPPFCSDNPQETYRKIINWK----ETLQFPDEVPLSPEAKDLIKR 276 (364)
T ss_pred ccccCHHHHcCCCCCCeeeeecchhHHHHhh--cCCCCCCCCCHHHHHHHHHcCC----CccCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999 8999999888776665544321 111222233568899999999
Q ss_pred hccCCCCCCCC---HHHH--HHHHHhcccC
Q psy5690 241 CWKTNETDRPR---FSEI--HLFLQRKNLG 265 (434)
Q Consensus 241 cl~~dP~~Rps---~~el--~~~L~~~~~~ 265 (434)
|+. +|.+|++ ++|+ |+|++.....
T Consensus 277 ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 277 LCC-EAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred Hcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 997 9999998 9999 7898776443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=279.68 Aligned_cols=211 Identities=44% Similarity=0.788 Sum_probs=172.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN-------SQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
|++++||||+++++++..++..++||||+++|+|.+++...+.. ......+++..+..++.|++.||.|||++
T Consensus 62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 35789999999999999999999999999999999999865321 12235688999999999999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|++||||||+||+++.++.+||+|||+++...... ....
T Consensus 142 ~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~-----------------------------------------~~~~ 180 (280)
T cd05049 142 HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD-----------------------------------------YYRV 180 (280)
T ss_pred CeeccccccceEEEcCCCeEEECCcccceecccCc-----------------------------------------ceec
Confidence 99999999999999999999999999875421111 0011
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
.....+++.|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ......+..++.
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 251 (280)
T cd05049 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIF--TYGKQPWYGLSNEEVIECITQ-------GRLLQRPRTCPS 251 (280)
T ss_pred CCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHH--hcCCCCCCCCCHHHHHHHHHc-------CCcCCCCCCCCH
Confidence 12334567899999999999999999999999999999 6 8999988777666554431 222233456789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
.+.+++.+||+.||++||++.|+++.|++
T Consensus 252 ~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 252 EVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 99999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=292.37 Aligned_cols=207 Identities=20% Similarity=0.248 Sum_probs=164.0
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++ +||||+++++++..++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDl 131 (332)
T cd05614 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-------QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDI 131 (332)
T ss_pred HhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Confidence 345 59999999999999999999999999999999997 3356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........||
T Consensus 132 kp~Nili~~~~~~kl~DfG~~~~~~~~~------------------------------------------~~~~~~~~gt 169 (332)
T cd05614 132 KLENILLDSEGHVVLTDFGLSKEFLSEE------------------------------------------KERTYSFCGT 169 (332)
T ss_pred CHHHeEECCCCCEEEeeCcCCccccccC------------------------------------------CCccccccCC
Confidence 9999999999999999999975421100 0011234678
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+. .++.++|||||||++|||+ +|..||...........+.... .....+.+..+++.+.+++.
T Consensus 170 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--tg~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~ 243 (332)
T cd05614 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELL--TGASPFTLEGERNTQSEVSRRI----LKCDPPFPSFIGPEAQDLLH 243 (332)
T ss_pred ccccCHHHhcCCCCCCCccccccchhhhhhhh--cCCCCCCCCCCCCCHHHHHHHH----hcCCCCCCCCCCHHHHHHHH
Confidence 999999999865 4788999999999999999 8999997543221111111111 11223445678899999999
Q ss_pred HhccCCCCCCC-----CHHHH--HHHHHhcc
Q psy5690 240 ECWKTNETDRP-----RFSEI--HLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rp-----s~~el--~~~L~~~~ 263 (434)
+||+.||++|| +++++ |+|+++..
T Consensus 244 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 244 KLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999999999 77788 78887643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=294.99 Aligned_cols=248 Identities=18% Similarity=0.251 Sum_probs=172.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..|+||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+||||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-------~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDl 127 (377)
T cd05629 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-------KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127 (377)
T ss_pred HHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 357899999999999999999999999999999999997 3456889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccc------cccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYL------SDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
||+|||++.++.+||+|||+++......... .......+.. ...............+.... ...........
T Consensus 128 kp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 205 (377)
T cd05629 128 KPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID-NRNSVAVDSINLTMSSKDQI-ATWKKNRRLMA 205 (377)
T ss_pred CHHHEEECCCCCEEEeecccccccccccccccccccccccccccccc-cccccccccccccccchhhh-hhhhhcccccc
Confidence 9999999999999999999986432211000 0000000000 00000000000000000000 00000000011
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
....||+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+..+. .....+....++.++
T Consensus 206 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell--tG~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~~~~s~~~ 279 (377)
T cd05629 206 YSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL--IGWPPFCSENSHETYRKIINWR----ETLYFPDDIHLSVEA 279 (377)
T ss_pred cccCCCccccCHHHHccCCCCCceeeEecchhhhhhh--cCCCCCCCCCHHHHHHHHHccC----CccCCCCCCCCCHHH
Confidence 2357899999999999999999999999999999999 8999998877766655443321 112222233578899
Q ss_pred HHHHHHhccCCCCCC---CCHHHH--HHHHHhccc
Q psy5690 235 FDLMLECWKTNETDR---PRFSEI--HLFLQRKNL 264 (434)
Q Consensus 235 ~~li~~cl~~dP~~R---ps~~el--~~~L~~~~~ 264 (434)
.+++.+||. +|.+| +++.|+ |+||+..+.
T Consensus 280 ~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 280 EDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred HHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 999999997 77765 599999 889876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=277.93 Aligned_cols=211 Identities=36% Similarity=0.642 Sum_probs=169.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|+||+++++++.+.+..++||||+++|+|.+++...+........+++..+..++.||+.||+|||+++++||||
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 142 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDI 142 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 35789999999999999999999999999999999999765432223346899999999999999999999999999999
Q ss_pred CCCCeeeecCC---ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVGKNY---TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+||+++.++ .+||+|||+++....... .......
T Consensus 143 kp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------~~~~~~~ 181 (277)
T cd05036 143 AARNCLLTCKGPGRVAKIADFGMARDIYRASY-----------------------------------------YRKGGRA 181 (277)
T ss_pred chheEEEeccCCCcceEeccCccccccCCccc-----------------------------------------eecCCCC
Confidence 99999998754 589999999765311110 0011122
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..+..|+|||++.+..++.++|||||||++|||++ .|..||......+....+.. ......+..++..+.++
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 253 (277)
T cd05036 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS-LGYMPYPGRTNQEVMEFVTG-------GGRLDPPKGCPGPVYRI 253 (277)
T ss_pred CccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHc-------CCcCCCCCCCCHHHHHH
Confidence 33467999999999999999999999999999993 28999988776665443321 12233456778999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHH
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~ 260 (434)
+.+||+.+|++||++.+|++.|+
T Consensus 254 i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 254 MTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHcCCCcccCcCHHHHHHHhh
Confidence 99999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=283.99 Aligned_cols=208 Identities=24% Similarity=0.331 Sum_probs=180.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+-++|||||++|++......+|+|+|+-++|+|.+|+-++ ...+.+..+.+++.||+.|+.|+|+..+|||||
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKH------e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDL 144 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH------EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDL 144 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhh------hccccHHHHHHHHHHHHHHHHHHhhhhhhcccC
Confidence 56689999999999999999999999999999999999743 467999999999999999999999999999999
Q ss_pred CCCCeeee-cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 81 AARNCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 81 kp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
||+||.+- +-|-+||.|||++..+... ...++.+|
T Consensus 145 KPENVVFFEKlGlVKLTDFGFSNkf~PG--------------------------------------------~kL~TsCG 180 (864)
T KOG4717|consen 145 KPENVVFFEKLGLVKLTDFGFSNKFQPG--------------------------------------------KKLTTSCG 180 (864)
T ss_pred CcceeEEeeecCceEeeeccccccCCCc--------------------------------------------chhhcccc
Confidence 99998874 5789999999996542221 12366789
Q ss_pred CccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
...|.|||++.+..| -+++|||||||+||-|+ +|+.||...++.+....|.. .....|..++.++++||
T Consensus 181 SLAYSAPEILLGDsYDAPAVDiWSLGVILyMLV--CGq~PFqeANDSETLTmImD--------CKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 181 SLAYSAPEILLGDSYDAPAVDIWSLGVILYMLV--CGQPPFQEANDSETLTMIMD--------CKYTVPSHVSKECRDLI 250 (864)
T ss_pred hhhccCchhhhcCccCCcchhhhHHHHHHHHHH--hCCCccccccchhhhhhhhc--------ccccCchhhhHHHHHHH
Confidence 999999999999998 57899999999999999 99999999998888766543 23345788999999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhcccCCCc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKNLGARA 268 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~~~~~~ 268 (434)
..||.+||++|.+.+|| +.||+....+...
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCCCccc
Confidence 99999999999999999 8999987655433
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=275.13 Aligned_cols=204 Identities=35% Similarity=0.651 Sum_probs=167.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++. ++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++|++||||
T Consensus 50 l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl 121 (257)
T cd05116 50 MQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQ-------KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121 (257)
T ss_pred HHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 35789999999999985 456799999999999999997 3346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++....... .........++
T Consensus 122 kp~nill~~~~~~kl~Dfg~~~~~~~~~~----------------------------------------~~~~~~~~~~~ 161 (257)
T cd05116 122 AARNVLLVTQHYAKISDFGLSKALGADEN----------------------------------------YYKAKTHGKWP 161 (257)
T ss_pred chhhEEEcCCCeEEECCCccccccCCCCC----------------------------------------eeeecCCCCCC
Confidence 99999999999999999999765321110 00011222345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+....++.++|||||||++|||+ + |..||......+....+. .....+.+..+++++.++|.
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~--t~g~~p~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAF--SYGQKPYKGMKGNEVTQMIE-------SGERMECPQRCPPEMYDLMK 232 (257)
T ss_pred ccccCHhHhccCCcCchhHHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHH-------CCCCCCCCCCCCHHHHHHHH
Confidence 7899999998888899999999999999999 5 899998877666555443 22234456678899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.||++||++++|.+.|++
T Consensus 233 ~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 233 LCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHhccCchhCcCHHHHHHHHhc
Confidence 9999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.58 Aligned_cols=201 Identities=21% Similarity=0.261 Sum_probs=167.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++..++..++||||+++|+|..++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 51 ~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlk 123 (325)
T cd05604 51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ-------RERSFPEPRARFYAAEIASALGYLHSINIVYRDLK 123 (325)
T ss_pred HhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 56899999999999999999999999999999999987 34578999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++..... ........||.
T Consensus 124 p~NIll~~~~~~kL~DfG~~~~~~~~-------------------------------------------~~~~~~~~gt~ 160 (325)
T cd05604 124 PENILLDSQGHVVLTDFGLCKEGIAQ-------------------------------------------SDTTTTFCGTP 160 (325)
T ss_pred HHHeEECCCCCEEEeecCCcccCCCC-------------------------------------------CCCcccccCCh
Confidence 99999999999999999986531000 00113346788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+.. .....+...+..+.+++.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~--~G~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ll~~l 230 (325)
T cd05604 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEML--YGLPPFYCRDVAEMYDNILH--------KPLVLRPGASLTAWSILEEL 230 (325)
T ss_pred hhCCHHHHcCCCCCCcCccccccceehhhh--cCCCCCCCCCHHHHHHHHHc--------CCccCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999998877766655432 11222345778999999999
Q ss_pred ccCCCCCCCCHH----HH--HHHHHhc
Q psy5690 242 WKTNETDRPRFS----EI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~~----el--~~~L~~~ 262 (434)
|+.||.+||++. ++ |+|++..
T Consensus 231 l~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 231 LEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred hccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 999999999874 55 6666653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=287.86 Aligned_cols=199 Identities=23% Similarity=0.329 Sum_probs=167.8
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+.+..|+||||+++|+|..++. ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~N 126 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-------RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDN 126 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHH
Confidence 79999999999999999999999999999999987 34478999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
|+++.++.+||+|||+++...... .......|+..|+
T Consensus 127 ill~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~g~~~y~ 163 (318)
T cd05570 127 VLLDSEGHIKIADFGMCKEGILGG-------------------------------------------VTTSTFCGTPDYI 163 (318)
T ss_pred eEECCCCcEEecccCCCeecCcCC-------------------------------------------CcccceecCcccc
Confidence 999999999999999865310000 0112345788899
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 244 (434)
|||++.+..++.++|||||||++|+|+ +|..||...+..+....+.. .....+..+++++.+++.+||+.
T Consensus 164 aPE~~~~~~~~~~~DiwslGvil~~l~--~G~~pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 164 APEILSYQPYGPAVDWWALGVLLYEML--AGQSPFEGDDEDELFQSILE--------DEVRYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred CHHHhcCCCCCcchhhhhHHHHHHHHh--hCCCCCCCCCHHHHHHHHHc--------CCCCCCCcCCHHHHHHHHHHccC
Confidence 999999999999999999999999999 89999988877666554432 12233556789999999999999
Q ss_pred CCCCCCCH-----HHH--HHHHHhcc
Q psy5690 245 NETDRPRF-----SEI--HLFLQRKN 263 (434)
Q Consensus 245 dP~~Rps~-----~el--~~~L~~~~ 263 (434)
||++||++ .++ |+|++...
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999 888 67886653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=288.14 Aligned_cols=193 Identities=22% Similarity=0.259 Sum_probs=163.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++..++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 51 ~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlk 123 (325)
T cd05602 51 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-------RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 123 (325)
T ss_pred HhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 56899999999999999999999999999999999997 34568888999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .......||+
T Consensus 124 p~Nili~~~~~~kl~DfG~a~~~~~~~-------------------------------------------~~~~~~~gt~ 160 (325)
T cd05602 124 PENILLDSQGHIVLTDFGLCKENIEHN-------------------------------------------GTTSTFCGTP 160 (325)
T ss_pred HHHeEECCCCCEEEccCCCCcccccCC-------------------------------------------CCcccccCCc
Confidence 999999999999999999875411100 0113346888
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+.. .....+..+++.+.+++.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~ 230 (325)
T cd05602 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEML--YGLPPFYSRNTAEMYDNILN--------KPLQLKPNITNSARHLLEGL 230 (325)
T ss_pred cccCHHHHcCCCCCCccccccccHHHHHHh--cCCCCCCCCCHHHHHHHHHh--------CCcCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999998877766555432 11223456789999999999
Q ss_pred ccCCCCCCCCHHH
Q psy5690 242 WKTNETDRPRFSE 254 (434)
Q Consensus 242 l~~dP~~Rps~~e 254 (434)
|+.||.+|+++.+
T Consensus 231 l~~~p~~R~~~~~ 243 (325)
T cd05602 231 LQKDRTKRLGAKD 243 (325)
T ss_pred cccCHHHCCCCCC
Confidence 9999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=275.11 Aligned_cols=205 Identities=40% Similarity=0.754 Sum_probs=169.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..+++|||+++|+|.+++... ....+++..++.++.|+++||+|||++|++||||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 130 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-----NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 35789999999999999999999999999999999999732 2346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||++++++.+||+|||+++...... ........++
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~------------------------------------------~~~~~~~~~~ 168 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDT------------------------------------------YTAHAGAKFP 168 (263)
T ss_pred CcceEEEcCCCcEEeCCCccccccccce------------------------------------------eeccCCCCCc
Confidence 9999999999999999999975522111 0011122335
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.+..++.++|||||||++|||+ + |..||.+....+....+.. ....+.+..++.++.+++.
T Consensus 169 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIA--TYGMSPYPGIDLSQVYELLEK-------GYRMERPEGCPPKVYELMR 239 (263)
T ss_pred cccCCHHHhccCCCCchhHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHC-------CCCCCCCCCCCHHHHHHHH
Confidence 6799999999999999999999999999999 5 8899988776665544432 1233446678899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.||++||++.++.+.|+.
T Consensus 240 ~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred HHccCCcccCCCHHHHHHHHHh
Confidence 9999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=277.22 Aligned_cols=211 Identities=42% Similarity=0.678 Sum_probs=171.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---CCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---QENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
|++++||||+++++++..++..++||||+++|+|.+++....... .....+++..+..++.|++.||.|||+++++|
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 142 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH 142 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 357899999999999999999999999999999999997543111 12235788999999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+||+++.++.+||+|||+++...... ........
T Consensus 143 ~di~p~nill~~~~~~kl~dfg~~~~~~~~~-----------------------------------------~~~~~~~~ 181 (277)
T cd05032 143 RDLAARNCMVAEDLTVKIGDFGMTRDIYETD-----------------------------------------YYRKGGKG 181 (277)
T ss_pred cccChheEEEcCCCCEEECCcccchhhccCc-----------------------------------------ccccCCCC
Confidence 9999999999999999999999876532211 01111233
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
.++..|+|||.+.+..++.++|||||||++||++ + |..||...+..+....+. .......+..++.++.+
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~--t~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~ 252 (277)
T cd05032 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA--TLAEQPYQGLSNEEVLKFVI-------DGGHLDLPENCPDKLLE 252 (277)
T ss_pred CccccccCHHHHhcCCCCcccchHHHHHHHHHhh--ccCCCCCccCCHHHHHHHHh-------cCCCCCCCCCCCHHHHH
Confidence 4567899999999888999999999999999999 6 889998877766654432 22233446677899999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 237 LMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
++.+||+.+|++|||+.+++..|++
T Consensus 253 li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 253 LMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHHHcCCChhhCCCHHHHHHHhcC
Confidence 9999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=277.17 Aligned_cols=210 Identities=42% Similarity=0.689 Sum_probs=168.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQ---ENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
++.++||||+++++++.+++..++||||+++|+|.+++.+.+.... ....+++..+..++.|++.||+|||+.|++|
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH 142 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVH 142 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 3568999999999999999999999999999999999975331111 1234678889999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+||++++++.++|+|||+++....... .......
T Consensus 143 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~-----------------------------------------~~~~~~~ 181 (277)
T cd05062 143 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDY-----------------------------------------YRKGGKG 181 (277)
T ss_pred CCcchheEEEcCCCCEEECCCCCccccCCcce-----------------------------------------eecCCCC
Confidence 99999999999999999999998754221110 0111223
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
.++..|+|||.+.+..++.++|||||||++|||+ + |..||.+....+....+.. ....+.+..++..+.+
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~--~~~~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 252 (277)
T cd05062 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--TLAEQPYQGMSNEQVLRFVME-------GGLLDKPDNCPDMLFE 252 (277)
T ss_pred ccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHc-------CCcCCCCCCCCHHHHH
Confidence 4567899999999888999999999999999999 5 6889988776665543321 1122345667889999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHH
Q psy5690 237 LMLECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el~~~L~ 260 (434)
++.+||+.||++||++.|++..|+
T Consensus 253 li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 253 LMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCChhhCcCHHHHHHHhh
Confidence 999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=274.25 Aligned_cols=202 Identities=34% Similarity=0.674 Sum_probs=167.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++|++||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 126 (256)
T cd05114 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126 (256)
T ss_pred HHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 46789999999999999999999999999999999999732 235889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||.++...... ........++
T Consensus 127 ~p~ni~i~~~~~~kl~d~g~~~~~~~~~------------------------------------------~~~~~~~~~~ 164 (256)
T cd05114 127 AARNCLVSSTGVVKVSDFGMTRYVLDDE------------------------------------------YTSSSGAKFP 164 (256)
T ss_pred CcceEEEcCCCeEEECCCCCccccCCCc------------------------------------------eeccCCCCCc
Confidence 9999999999999999999865421110 0011223345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+..++.++||||||+++|||+ + |+.||...+..+....+.. ......+...+.++.+++.
T Consensus 165 ~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~--~~g~~p~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVF--TEGKMPFEKKSNYEVVEMISR-------GFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred hhhCChhhcccCccchhhhhHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHC-------CCCCCCCCCCCHHHHHHHH
Confidence 6799999999888999999999999999999 6 8999988877766655532 1223334556789999999
Q ss_pred HhccCCCCCCCCHHHHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L 259 (434)
+||+.+|++||++++++..|
T Consensus 236 ~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 236 SCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHccCCcccCcCHHHHHHhh
Confidence 99999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=273.55 Aligned_cols=207 Identities=33% Similarity=0.639 Sum_probs=168.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++. .+..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++|++||||
T Consensus 49 l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 121 (257)
T cd05115 49 MHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSG------KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121 (257)
T ss_pred HHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccc
Confidence 46789999999999985 4578999999999999999963 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ..........++
T Consensus 122 kp~nil~~~~~~~kl~dfg~~~~~~~~~----------------------------------------~~~~~~~~~~~~ 161 (257)
T cd05115 122 AARNVLLVNQHYAKISDFGLSKALGADD----------------------------------------SYYKARSAGKWP 161 (257)
T ss_pred chheEEEcCCCcEEeccCCccccccCCc----------------------------------------cceeccCCCCCC
Confidence 9999999999999999999875421111 000111222345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++....++.++|||||||++||+++ +|..||......+....+. .....+.+..+++++.+++.+
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05115 162 LKWYAPECINFRKFSSRSDVWSYGITMWEAFS-YGQKPYKKMKGPEVMSFIE-------QGKRLDCPAECPPEMYALMKD 233 (257)
T ss_pred cccCCHHHHccCCCCchhhHHHHHHHHHHHhc-CCCCCcCcCCHHHHHHHHH-------CCCCCCCCCCCCHHHHHHHHH
Confidence 67999999998889999999999999999993 2899998887766554332 122344566788999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||..||++||++.+|.+.|+..
T Consensus 234 c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 234 CWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=293.39 Aligned_cols=249 Identities=16% Similarity=0.195 Sum_probs=172.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-------~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDl 127 (381)
T cd05626 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-------RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDI 127 (381)
T ss_pred HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Confidence 357899999999999999999999999999999999997 3346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccc-cccccchhhhhhcccCcccceeecCccccc-----cccCCcccccC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSD-TKARLPIRWMANCMVGKNYTIKISDHAMYC-----SHYESDYYLSD 154 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-----~~~~~~~~~~~ 154 (434)
||+|||++.++.+||+|||+++........... ................. ....+..+... ...........
T Consensus 128 Kp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (381)
T cd05626 128 KPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD--DVSNCRCGDRLKTLEQRATKQHQRCLA 205 (381)
T ss_pred cHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccc--cccccccccccchhhcccccccccccc
Confidence 999999999999999999997653221100000 00000000000000000 00000000000 00000001112
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
....||..|+|||++.+..++.++|||||||++|||+ +|..||......+....+..+ ......+....+++++
T Consensus 206 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~ell--tG~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~ 279 (381)
T cd05626 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML--VGQPPFLAPTPTETQLKVINW----ENTLHIPPQVKLSPEA 279 (381)
T ss_pred ccccCCccccCHHHHcCCCCCCccceeehhhHHHHHH--hCCCCCcCCCHHHHHHHHHcc----ccccCCCCCCCCCHHH
Confidence 3457899999999999999999999999999999999 899999887765554443221 1122233344678999
Q ss_pred HHHHHHh--ccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 235 FDLMLEC--WKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 235 ~~li~~c--l~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
.+++.+| +..++..|++++++ |+|+++...
T Consensus 280 ~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 280 VDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 9999984 45666679999999 889987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=287.60 Aligned_cols=214 Identities=18% Similarity=0.249 Sum_probs=162.1
Q ss_pred CCCCCCCCeeeEEEEEecCC-----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED-----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|++++||||+++++++...+ ..|+||||+. ++|.+++. ....+++..+..++.||++||+|||++||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 124 (338)
T cd07859 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK-------ANDDLTPEHHQFFLYQLLRALKYIHTANV 124 (338)
T ss_pred HHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHH-------hcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45789999999999985432 4899999995 69999987 34468999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+||+|||+++...... .......
T Consensus 125 vH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----------------------------------------~~~~~~~ 164 (338)
T cd07859 125 FHRDLKPKNILANADCKLKICDFGLARVAFNDT----------------------------------------PTAIFWT 164 (338)
T ss_pred ecCCCCHHHeEECCCCcEEEccCcccccccccc----------------------------------------Ccccccc
Confidence 999999999999999999999999976421110 0000113
Q ss_pred CCCCCccccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhh-------------------
Q psy5690 156 KARLPIRWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHW------------------- 214 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~------------------- 214 (434)
...+|..|+|||++.+ ..++.++|||||||++|||+ +|+.||.+.+.......+...
T Consensus 165 ~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~--tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 242 (338)
T cd07859 165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL--TGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARR 242 (338)
T ss_pred CCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHH--cCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence 3567889999999876 67899999999999999999 899999876543322211110
Q ss_pred -hhcCCcccCC---CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 215 -YQNNSKQQYL---PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 215 -~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
.......... .....+++++.+++.+||+.||++||+++|+ |+||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 243 YLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000000000 0112456789999999999999999999999 899987543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=273.09 Aligned_cols=205 Identities=40% Similarity=0.722 Sum_probs=166.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl 120 (252)
T cd05084 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT------EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120 (252)
T ss_pred HHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Confidence 4678999999999999999999999999999999999963 2345889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||++........ .........+
T Consensus 121 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------~~~~~~~~~~ 159 (252)
T cd05084 121 AARNCLVTEKNVLKISDFGMSREEEDGVY-----------------------------------------ASTGGMKQIP 159 (252)
T ss_pred chheEEEcCCCcEEECccccCcccccccc-----------------------------------------cccCCCCCCc
Confidence 99999999999999999998654211000 0000111234
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.++.++.++|||||||++|||++ .|..||...........+.. ....+.+..++..+.+++.+
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~-~~~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~ 231 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFS-LGAVPYANLSNQQTREAIEQ-------GVRLPCPELCPDAVYRLMER 231 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHh-CCCCCccccCHHHHHHHHHc-------CCCCCCcccCCHHHHHHHHH
Confidence 56999999999889999999999999999993 28889987766554443321 12234456778999999999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~ 260 (434)
||+.||++||++.++.+.|+
T Consensus 232 ~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCChhhCcCHHHHHHHHh
Confidence 99999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=282.80 Aligned_cols=206 Identities=18% Similarity=0.280 Sum_probs=160.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++ +|.+++... ...+++..+..++.||+.||+|||++||+||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dl 129 (288)
T cd07871 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC------GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129 (288)
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 3578999999999999999999999999975 999998632 245788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......++
T Consensus 130 kp~Nil~~~~~~~kl~DfG~~~~~~~~~-------------------------------------------~~~~~~~~~ 166 (288)
T cd07871 130 KPQNLLINEKGELKLADFGLARAKSVPT-------------------------------------------KTYSNEVVT 166 (288)
T ss_pred CHHHEEECCCCCEEECcCcceeeccCCC-------------------------------------------ccccCceec
Confidence 9999999999999999999875421100 011234567
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC--------------------
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS-------------------- 219 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------- 219 (434)
..|+|||++.+ ..++.++||||+||++|+|+ +|..||.+.+..+....+........
T Consensus 167 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
T cd07871 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA--TGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQ 244 (288)
T ss_pred ccccChHHhcCCcccCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCc
Confidence 88999999875 56799999999999999999 89999988776555443322111000
Q ss_pred --cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHH
Q psy5690 220 --KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLF 258 (434)
Q Consensus 220 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~ 258 (434)
..........++++..+++.+||+.||.+|||++|+ |+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 245 YRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred cCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 000000123457889999999999999999999999 444
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=291.28 Aligned_cols=204 Identities=18% Similarity=0.266 Sum_probs=163.1
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+++..|+||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~-------~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N 126 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ-------RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDN 126 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence 79999999999999999999999999999999986 33579999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.++.+||+|||+++...... .......||..|+
T Consensus 127 ili~~~~~~kL~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~~y~ 163 (329)
T cd05588 127 VLLDAEGHIKLTDYGMCKEGIRPG-------------------------------------------DTTSTFCGTPNYI 163 (329)
T ss_pred eEECCCCCEEECcCccccccccCC-------------------------------------------CccccccCCcccc
Confidence 999999999999999865311000 0112346788999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-----HHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-----VIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|||++.+..++.++|||||||++|+|+ +|..||....... ......+ .........+..++.++.+++.
T Consensus 164 aPE~~~~~~~~~~~DiwslG~~l~el~--~g~~Pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 164 APEILRGEDYGFSVDWWALGVLMFEMM--AGRSPFDIVGMSDNPDQNTEDYLFQ----VILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CHHHHcCCCCCCccceechHHHHHHHH--HCCCCcccccccccccccchHHHHH----HHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999999999999999999999 8999996322111 0000000 0011223345678899999999
Q ss_pred HhccCCCCCCCC------HHHH--HHHHHhccc
Q psy5690 240 ECWKTNETDRPR------FSEI--HLFLQRKNL 264 (434)
Q Consensus 240 ~cl~~dP~~Rps------~~el--~~~L~~~~~ 264 (434)
+||+.||.+|++ ++++ |+|+....+
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 999999999997 6788 788876433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=281.05 Aligned_cols=203 Identities=22% Similarity=0.304 Sum_probs=159.9
Q ss_pred CCCCCCCeeeEEEEEe-----cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCS-----TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++++||||++++++|. .....++||||+. |+|.+++... ....+++..+..++.|++.||+|||++||+
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~lH~~~ii 132 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV-----PEPGVPTETIKDMMFQLLRGLDFLHSHRVV 132 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 4568999999999985 2456899999996 5999999732 234589999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+|||++.++.+||+|||+++..... .....
T Consensus 133 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~ 168 (290)
T cd07862 133 HRDLKPQNILVTSSGQIKLADFGLARIYSFQ--------------------------------------------MALTS 168 (290)
T ss_pred eCCCCHHHEEEcCCCCEEEccccceEeccCC--------------------------------------------ccccc
Confidence 9999999999999999999999987542110 01133
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCccc--------------
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ-------------- 222 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------- 222 (434)
..|+..|+|||++.+..++.++|||||||++|||+ +|..||.+....+....+...........
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~--~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (290)
T cd07862 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHS 246 (290)
T ss_pred ccccccccChHHHhCCCCCCccchHHHHHHHHHHH--cCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccC
Confidence 45788899999999989999999999999999999 89999998877665554432211000000
Q ss_pred CC-----CCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 223 YL-----PRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 223 ~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
.. .....+++.+.+++.+||+.||++|||+.|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 247 KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 00 01134677889999999999999999999994
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=290.95 Aligned_cols=241 Identities=15% Similarity=0.235 Sum_probs=173.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++.+.+++..|+||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+||||
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-------~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDl 127 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-------KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDI 127 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCC
Confidence 356899999999999999999999999999999999997 3457899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccc--cccccccchhhhhhcccCcccceeecCccccc--cccCCcccccCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYL--SDTKARLPIRWMANCMVGKNYTIKISDHAMYC--SHYESDYYLSDTK 156 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~~~~ 156 (434)
||+|||++.++.+||+|||+++......... .......+.. .......... .............
T Consensus 128 Kp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (363)
T cd05628 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD------------FTFQNMNSKRKAETWKRNRRQLAFS 195 (363)
T ss_pred CHHHeEECCCCCEEEeeccCccccccccccccccccccccccc------------ccccccccccccchhhhcccccccc
Confidence 9999999999999999999987643211000 0000000000 0000000000 0000000111234
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..||+.|+|||++.+..++.++|||||||++|||+ +|..||.+....+....+..+. .....+....+++++.+
T Consensus 196 ~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell--~G~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~~~~s~~~~~ 269 (363)
T cd05628 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML--IGYPPFCSETPQETYKKVMNWK----ETLIFPPEVPISEKAKD 269 (363)
T ss_pred ccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH--hCCCCCCCCCHHHHHHHHHcCc----CcccCCCcCCCCHHHHH
Confidence 57999999999999999999999999999999999 8999999888777666554321 11112222346789999
Q ss_pred HHHHhcc--CCCCCCCCHHHH--HHHHHhcccCC
Q psy5690 237 LMLECWK--TNETDRPRFSEI--HLFLQRKNLGA 266 (434)
Q Consensus 237 li~~cl~--~dP~~Rps~~el--~~~L~~~~~~~ 266 (434)
++.+++. .++..||+++|| |+|++..++..
T Consensus 270 li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 270 LILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred HHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 9998664 233356899999 88998765443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=277.92 Aligned_cols=212 Identities=38% Similarity=0.736 Sum_probs=172.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC-----------------CCCCCCCCHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN-----------------SQENPAISYGCLIFMATQI 63 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~qi 63 (434)
|++++||||+++++.+..++..++++||+.+|+|.+++...... ......+++..++.++.|+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 46789999999999999999999999999999999998753211 0122458899999999999
Q ss_pred HHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccc
Q psy5690 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYC 143 (434)
Q Consensus 64 ~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 143 (434)
+.||+|||+++++||||||+||++++++.+||+|||+++......
T Consensus 137 ~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~----------------------------------- 181 (290)
T cd05045 137 SRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED----------------------------------- 181 (290)
T ss_pred HHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCcc-----------------------------------
Confidence 999999999999999999999999999999999999976421111
Q ss_pred cccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCccc
Q psy5690 144 SHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQ 222 (434)
Q Consensus 144 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 222 (434)
.+.......++..|+|||.+.+..++.++||||||+++|||+ + |..||.+....+..+.+.. ..
T Consensus 182 ------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~--t~g~~p~~~~~~~~~~~~~~~-------~~ 246 (290)
T cd05045 182 ------SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV--TLGGNPYPGIAPERLFNLLKT-------GY 246 (290)
T ss_pred ------chhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHH--hcCCCCCCCCCHHHHHHHHhC-------CC
Confidence 001112234456799999998888999999999999999999 6 8899988776665544322 12
Q ss_pred CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 223 YLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 223 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
..+.+..++.++.+++.+||+.+|++||+++|+...|++.
T Consensus 247 ~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 247 RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 3344567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=276.35 Aligned_cols=211 Identities=41% Similarity=0.777 Sum_probs=170.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC----------CCCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN----------SQENPAISYGCLIFMATQIASGMKYL 70 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~~l~~~~~~~i~~qi~~gL~yL 70 (434)
|++++||||+++++++..++..|+||||+++|+|.+++...... ......+++..+..++.|++.||+||
T Consensus 61 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred HhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999999999999999999643210 01123578899999999999999999
Q ss_pred hhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 71 ESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 71 H~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
|++|++||||||+|||++.++.+||+|||+++.......
T Consensus 141 H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----------------------------------------- 179 (283)
T cd05090 141 SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADY----------------------------------------- 179 (283)
T ss_pred HhcCeehhccccceEEEcCCCcEEeccccccccccCCcc-----------------------------------------
Confidence 999999999999999999999999999999765321110
Q ss_pred cccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCc
Q psy5690 151 YLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (434)
........++..|+|||++.+..++.++|||||||++|||+ + |..||.+.......+.+. .....+.+..
T Consensus 180 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~--~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~ 250 (283)
T cd05090 180 YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF--SFGLQPYYGFSNQEVIEMVR-------KRQLLPCSED 250 (283)
T ss_pred eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH-------cCCcCCCCCC
Confidence 01112233457799999999888999999999999999999 5 889998876655544432 1223345667
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+++++.+++.+||+.||++||++.+|.+.|+.
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 251 CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 88999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=292.87 Aligned_cols=237 Identities=18% Similarity=0.255 Sum_probs=177.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dl 127 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI-------RKDVFPEETARFYIAELVLALDSVHKLGFIHRDI 127 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 356889999999999999999999999999999999997 3357899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++................... ..+....................||
T Consensus 128 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~gt 193 (350)
T cd05573 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL--------------FRDNVLVRRRDHKQRRVRANSTVGT 193 (350)
T ss_pred CHHHeEECCCCCEEeecCCCCccCcccCccccccccccccc--------------ccccccccccccccccccccccccC
Confidence 99999999999999999999876433221000000000000 0000000000111111223445689
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+..+. .....+....+++++.+++.+
T Consensus 194 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell--~g~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~~~~~~~~~~li~~ 267 (350)
T cd05573 194 PDYIAPEVLRGTPYGLECDWWSLGVILYEML--YGFPPFYSDTLQETYNKIINWK----ESLRFPPDPPVSPEAIDLICR 267 (350)
T ss_pred ccccCHHHHcCCCCCCceeeEecchhhhhhc--cCCCCCCCCCHHHHHHHHhccC----CcccCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999 8999999888766655554321 222233334478999999999
Q ss_pred hccCCCCCCCC-HHHH--HHHHHhcccC
Q psy5690 241 CWKTNETDRPR-FSEI--HLFLQRKNLG 265 (434)
Q Consensus 241 cl~~dP~~Rps-~~el--~~~L~~~~~~ 265 (434)
||. ||.+||+ ++++ |+|+++....
T Consensus 268 ll~-dp~~R~~s~~~ll~hp~~~~~~~~ 294 (350)
T cd05573 268 LLC-DPEDRLGSFEEIKSHPFFKGIDWE 294 (350)
T ss_pred Hcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence 997 9999999 9999 7888876443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=283.31 Aligned_cols=204 Identities=20% Similarity=0.195 Sum_probs=159.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||++++.+..+.. ....+++..+..++.|++.||+|||+.||+||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl 126 (287)
T cd07848 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE-------MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126 (287)
T ss_pred HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 467899999999999999999999999999877766543 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ........++
T Consensus 127 kp~Nill~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 164 (287)
T cd07848 127 KPENLLISHNDVLKLCDFGFARNLSEGS------------------------------------------NANYTEYVAT 164 (287)
T ss_pred CHHHEEEcCCCcEEEeeccCcccccccc------------------------------------------cccccccccc
Confidence 9999999999999999999976421110 0011234577
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc-----------C-C-cccCCC--
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN-----------N-S-KQQYLP-- 225 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~-----------~-~-~~~~~~-- 225 (434)
..|+|||++.+..++.++|||||||++|||+ +|+.||...+..+....+...... . . .....+
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07848 165 RWYRSPELLLGAPYGKAVDMWSVGCILGELS--DGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242 (287)
T ss_pred cccCCcHHHcCCCCCCchhHHhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcc
Confidence 8899999999988999999999999999999 899999887654433322211100 0 0 000000
Q ss_pred ---------CCCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 226 ---------RPATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 226 ---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
....++.++.+++.+||+.||++|||++|+
T Consensus 243 ~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~ 281 (287)
T cd07848 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281 (287)
T ss_pred cCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 012367889999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=276.22 Aligned_cols=211 Identities=38% Similarity=0.746 Sum_probs=170.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
++++||||+++++++...+..++++||+.+++|.+++...... ......+++..+..++.|++.||+|||+
T Consensus 63 ~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~ 142 (283)
T cd05091 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS 142 (283)
T ss_pred hcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 5789999999999999999999999999999999998632110 0112458888999999999999999999
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
+||+||||||+||++++++.+||+|||+++....... ..
T Consensus 143 ~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------~~ 181 (283)
T cd05091 143 HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY-----------------------------------------YK 181 (283)
T ss_pred cCccccccchhheEecCCCceEecccccccccccchh-----------------------------------------ee
Confidence 9999999999999999999999999999765321110 00
Q ss_pred cCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 153 SDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
......+++.|+|||.+.++.++.++|||||||++|||++ .|..||.+....+..+.+.. ....+.+..++.
T Consensus 182 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~-~g~~p~~~~~~~~~~~~i~~-------~~~~~~~~~~~~ 253 (283)
T cd05091 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS-YGLQPYCGYSNQDVIEMIRN-------RQVLPCPDDCPA 253 (283)
T ss_pred eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCHHHHHHHHHc-------CCcCCCCCCCCH
Confidence 1122345678999999998889999999999999999993 27889988777666554432 223344677889
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
.+.+++.+||+.+|++||++++|+..|+.
T Consensus 254 ~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 254 WVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 99999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=293.75 Aligned_cols=246 Identities=18% Similarity=0.250 Sum_probs=173.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++.+.+++..|+|||||++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDl 127 (376)
T cd05598 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-------RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDI 127 (376)
T ss_pred HHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 457899999999999999999999999999999999997 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCccccccccc---ccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESD---YYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||++.++.+||+|||++..+.... ....................... ....... ................
T Consensus 128 kp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~ 204 (376)
T cd05598 128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID-RCRLKPL--ERRRKRQHQRCLAHSL 204 (376)
T ss_pred CHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccc-cccccch--hhhhhhhccccccccc
Confidence 9999999999999999999975432111 00000000000000000000000 0000000 0000000001112345
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+..+ ......+....+++++.++
T Consensus 205 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell--~G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~l 278 (376)
T cd05598 205 VGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML--VGQPPFLADTPAETQLKVINW----ETTLHIPSQAKLSREASDL 278 (376)
T ss_pred CCCccccCHHHHcCCCCCcceeeeeccceeeehh--hCCCCCCCCCHHHHHHHHhcc----CccccCCCCCCCCHHHHHH
Confidence 7899999999999999999999999999999999 899999988766655444322 1122223344678899999
Q ss_pred HHHhccCCCCCCC---CHHHH--HHHHHhcc
Q psy5690 238 MLECWKTNETDRP---RFSEI--HLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~Rp---s~~el--~~~L~~~~ 263 (434)
+.+|+ .+|.+|+ ++.++ |+|++...
T Consensus 279 i~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 279 ILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred HHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99987 5999999 89999 88887653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=272.09 Aligned_cols=205 Identities=41% Similarity=0.751 Sum_probs=168.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++. .+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+++++||||
T Consensus 50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di 121 (257)
T cd05060 50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLK-------KRREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121 (257)
T ss_pred HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHH-------hCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCc
Confidence 46789999999999876 456899999999999999997 3346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ..........++
T Consensus 122 ~p~nili~~~~~~kl~df~~~~~~~~~~----------------------------------------~~~~~~~~~~~~ 161 (257)
T cd05060 122 AARNVLLVNRHQAKISDFGMSRALGAGS----------------------------------------DYYRATTAGRWP 161 (257)
T ss_pred ccceEEEcCCCcEEeccccccceeecCC----------------------------------------cccccccCcccc
Confidence 9999999999999999999876532111 001111222345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.+..++.++|||||||++|+++ + |..||......+....+.. ....+.+..++..+++++.
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAF--SYGAKPYGEMKGAEVIAMLES-------GERLPRPEECPQEIYSIML 232 (257)
T ss_pred ccccCHHHhcCCCCCccchHHHHHHHHHHHH--cCCCCCcccCCHHHHHHHHHc-------CCcCCCCCCCCHHHHHHHH
Confidence 6799999999889999999999999999999 6 8999988776665544432 2233456678899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||..+|++||++.++++.|++.
T Consensus 233 ~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 233 SCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHhcCChhhCcCHHHHHHHHHhc
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=273.25 Aligned_cols=210 Identities=40% Similarity=0.760 Sum_probs=169.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++...+..++||||+++|+|.+++............+++..+..++.|++.||+|||+++++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl 132 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDL 132 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 46789999999999999999999999999999999999754322213345788999999999999999999999999999
Q ss_pred CCCCeeeecCC-----ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 81 AARNCMVGKNY-----TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 81 kp~NILl~~~~-----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
||+||+++.++ .++++|||+++....... .....
T Consensus 133 ~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~-----------------------------------------~~~~~ 171 (269)
T cd05044 133 AARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-----------------------------------------YRKEG 171 (269)
T ss_pred ChheEEEecCCCCCCcceEECCcccccccccccc-----------------------------------------cccCc
Confidence 99999999877 899999998764321110 00111
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
...++..|+|||.+.++.++.++|||||||++|||+ + |..||......+....+. .......+..++..+
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell--t~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~ 242 (269)
T cd05044 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL--TLGQQPYPALNNQEVLQHVT-------AGGRLQKPENCPDKI 242 (269)
T ss_pred ccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH--HcCCCCCcccCHHHHHHHHh-------cCCccCCcccchHHH
Confidence 223456799999999999999999999999999999 5 889998777666554332 122333456678999
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHH
Q psy5690 235 FDLMLECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el~~~L~ 260 (434)
.+++.+||+.+|.+||+++++.+.|+
T Consensus 243 ~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 243 YQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99999999999999999999988876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=272.95 Aligned_cols=205 Identities=35% Similarity=0.646 Sum_probs=170.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|+||+++++++.+++..+++|||+++|+|.+++.+. ....+++..+..++.|++.||+|||+.+++||||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl 129 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-----EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 129 (261)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 35789999999999999999999999999999999999742 2346888899999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... ........++
T Consensus 130 ~p~nili~~~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 167 (261)
T cd05072 130 RAANVLVSESLMCKIADFGLARVIEDNE------------------------------------------YTAREGAKFP 167 (261)
T ss_pred chhhEEecCCCcEEECCCccceecCCCc------------------------------------------eeccCCCccc
Confidence 9999999999999999999976521110 0011223356
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+....++.++|||||||++|+|+ + |..||......+....+.. ....+....++.++.+++.
T Consensus 168 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIV--TYGKIPYPGMSNSDVMSALQR-------GYRMPRMENCPDELYDIMK 238 (261)
T ss_pred eecCCHHHhccCCCChhhhhhhhHHHHHHHH--ccCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHH
Confidence 6799999999888999999999999999999 6 8999988776665554432 1223344567889999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.+|++||+++++.++|++
T Consensus 239 ~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 239 TCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=291.72 Aligned_cols=207 Identities=18% Similarity=0.243 Sum_probs=169.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++.+++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||
T Consensus 97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDL 168 (370)
T cd05596 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDV 168 (370)
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 3578999999999999999999999999999999999862 24788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........||
T Consensus 169 kp~NILl~~~~~~kL~DfG~~~~~~~~~------------------------------------------~~~~~~~~gt 206 (370)
T cd05596 169 KPDNMLLDKSGHLKLADFGTCMKMDANG------------------------------------------MVRCDTAVGT 206 (370)
T ss_pred CHHHEEEcCCCCEEEEeccceeeccCCC------------------------------------------cccCCCCCCC
Confidence 9999999999999999999875421110 0011335688
Q ss_pred ccccchhhhhcC----CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 161 IRWMAWESLLLG----KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 161 ~~y~aPE~~~~~----~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
+.|+|||++.+. .++.++|||||||++|||+ +|..||...+.......+... ......+....++.++.+
T Consensus 207 ~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell--tG~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~ 280 (370)
T cd05596 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML--VGDTPFYADSLVGTYSKIMDH----KNSLTFPDDIEISKQAKD 280 (370)
T ss_pred cCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH--hCCCCcCCCCHHHHHHHHHcC----CCcCCCCCcCCCCHHHHH
Confidence 999999998753 3788999999999999999 899999988776665554321 111222333457899999
Q ss_pred HHHHhccCCCCC--CCCHHHH--HHHHHhcc
Q psy5690 237 LMLECWKTNETD--RPRFSEI--HLFLQRKN 263 (434)
Q Consensus 237 li~~cl~~dP~~--Rps~~el--~~~L~~~~ 263 (434)
++.+||+.+|++ |++++|+ |+|++...
T Consensus 281 li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 281 LICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred HHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 999999999987 9999999 88997643
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=276.30 Aligned_cols=211 Identities=41% Similarity=0.753 Sum_probs=169.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN--------SQENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
+++++|+||+++++++.+++..+++|||+++|+|.+++...+.. ......+++..+..++.|++.||+|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999754311 0112358899999999999999999999
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
+|++||||||+||++++++.+||+|||+++...... .+.
T Consensus 141 ~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~-----------------------------------------~~~ 179 (280)
T cd05092 141 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-----------------------------------------YYR 179 (280)
T ss_pred CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCc-----------------------------------------eee
Confidence 999999999999999999999999999875421110 001
Q ss_pred cCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 153 SDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
......+++.|+|||.+.+..++.++|||||||++|||++ .|..||......+....+.. ......+..+++
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 251 (280)
T cd05092 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT-YGKQPWYQLSNTEAIECITQ-------GRELERPRTCPP 251 (280)
T ss_pred cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHc-CCCCCCccCCHHHHHHHHHc-------CccCCCCCCCCH
Confidence 1122334678999999999999999999999999999993 28999988776655543321 122334567889
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L~ 260 (434)
.+.+++.+||+.||.+||+++||...|+
T Consensus 252 ~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 252 EVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 9999999999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=274.23 Aligned_cols=205 Identities=33% Similarity=0.636 Sum_probs=166.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++. +...++++||+++|+|.+++..+ ...+++..+..++.||+.||+|||++|++||||
T Consensus 63 l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dl 135 (279)
T cd05111 63 MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQH------RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNL 135 (279)
T ss_pred HhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHCCEecccc
Confidence 35789999999999975 45678999999999999999732 346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .........++
T Consensus 136 kp~nili~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 174 (279)
T cd05111 136 AARNILLKSDSIVQIADFGVADLLYPDD-----------------------------------------KKYFYSEHKTP 174 (279)
T ss_pred CcceEEEcCCCcEEEcCCccceeccCCC-----------------------------------------cccccCCCCCc
Confidence 9999999999999999999976421110 00011234466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.++.++.++|||||||++||++ + |..||.+.......+.+. .....+.+..++.++.+++.
T Consensus 175 ~~y~~pE~~~~~~~~~~~Dv~slG~il~el~--t~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~ 245 (279)
T cd05111 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMM--SYGAEPYAGMRPHEVPDLLE-------KGERLAQPQICTIDVYMVMV 245 (279)
T ss_pred ccccCHHHhccCCcCchhhHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHH-------CCCcCCCCCCCCHHHHHHHH
Confidence 7899999999889999999999999999999 5 899998876655443322 22233345567788999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||..||++||++.|+.+.|...
T Consensus 246 ~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 246 KCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred HHcCCCcccCcCHHHHHHHHHHH
Confidence 99999999999999998888764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=277.37 Aligned_cols=212 Identities=34% Similarity=0.652 Sum_probs=171.6
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
+++ +|+||+++++++..++..+++|||+++|+|.++++.+... ......+++..++.++.|++.||+|||
T Consensus 70 ~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH 149 (293)
T cd05053 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA 149 (293)
T ss_pred HhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 356 7999999999999999999999999999999999754210 023456899999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++||+||||||+||+++.++.+||+|||+++....... .
T Consensus 150 ~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-----------------------------------------~ 188 (293)
T cd05053 150 SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY-----------------------------------------Y 188 (293)
T ss_pred HCCccccccceeeEEEcCCCeEEeCccccccccccccc-----------------------------------------e
Confidence 99999999999999999999999999999765322110 0
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
.......++..|+|||.+.+..++.++|||||||++||+++ .|..||......+....+.. ......+..++
T Consensus 189 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 260 (293)
T cd05053 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-LGGSPYPGIPVEELFKLLKE-------GYRMEKPQNCT 260 (293)
T ss_pred eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhc-CCCCCCCCCCHHHHHHHHHc-------CCcCCCCCCCC
Confidence 01122234567999999998899999999999999999993 28899988777666554332 22334456778
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.++.+++.+||..||++|||+.|++..|++.
T Consensus 261 ~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 261 QELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 8999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=271.37 Aligned_cols=202 Identities=34% Similarity=0.683 Sum_probs=166.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++...+..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++|++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 126 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH------GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDL 126 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 46789999999999999999999999999999999999732 236899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||.++...... ........++
T Consensus 127 ~p~nili~~~~~~kl~d~g~~~~~~~~~------------------------------------------~~~~~~~~~~ 164 (256)
T cd05113 127 AARNCLVDDQGCVKVSDFGLSRYVLDDE------------------------------------------YTSSVGSKFP 164 (256)
T ss_pred CcceEEEcCCCCEEECCCccceecCCCc------------------------------------------eeecCCCccC
Confidence 9999999999999999999865421110 0011223456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.+..++.++|||||||++|+|+ + |..||......+....+.. ......+...+..+.+++.
T Consensus 165 ~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVY--SLGKMPYERFNNSETVEKVSQ-------GLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred hhhCCHHHHhcCcccchhHHHHHHHHHHHHh--cCCCCCcCcCCHHHHHHHHhc-------CCCCCCCCCCCHHHHHHHH
Confidence 7799999999888999999999999999999 6 8999988776665554432 1222334556789999999
Q ss_pred HhccCCCCCCCCHHHHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L 259 (434)
+||+.||++||++.+|+..+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred HHcCCCcccCCCHHHHHHhh
Confidence 99999999999999997655
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=284.67 Aligned_cols=208 Identities=20% Similarity=0.283 Sum_probs=163.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrD 79 (434)
|++++||||++++++|.+++..++||||+++|+|.+++. ....+++..+..++.|++.||.|||++ +|+|||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~d 129 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-------KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 129 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecC
Confidence 357899999999999999999999999999999999997 334688999999999999999999975 799999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||++...... ......+
T Consensus 130 lkp~Nili~~~~~~kL~Dfg~~~~~~~~---------------------------------------------~~~~~~~ 164 (333)
T cd06650 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS---------------------------------------------MANSFVG 164 (333)
T ss_pred CChhhEEEcCCCCEEEeeCCcchhhhhh---------------------------------------------ccccCCC
Confidence 9999999999999999999986542110 0123357
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhh------------------------
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWY------------------------ 215 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~------------------------ 215 (434)
+..|+|||++.+..++.++|||||||++|+|+ +|..||......+....+....
T Consensus 165 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (333)
T cd06650 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA--IGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242 (333)
T ss_pred CccccCHHHhcCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence 78899999999888999999999999999999 8899997655433321110000
Q ss_pred -------------hcCCcccCCCC-CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 216 -------------QNNSKQQYLPR-PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 216 -------------~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
........... ....+.++.+|+.+||+.||++||+++|+ |+||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00000000001 11356789999999999999999999999 8999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=271.48 Aligned_cols=202 Identities=35% Similarity=0.695 Sum_probs=167.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++...+..++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 126 (256)
T cd05059 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER------KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126 (256)
T ss_pred HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 35789999999999999999999999999999999999732 236899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ........++
T Consensus 127 ~p~ni~i~~~~~~kl~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 164 (256)
T cd05059 127 AARNCLVGEDNVVKVSDFGLARYVLDDQ------------------------------------------YTSSQGTKFP 164 (256)
T ss_pred cHhhEEECCCCcEEECCcccceeccccc------------------------------------------ccccCCCCCC
Confidence 9999999999999999999875421110 0011122334
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.+..++.++||||||+++|+++ + |..||......+....+.. ......+..++.++.+++.
T Consensus 165 ~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVF--SEGKMPYERFSNSEVVESVSA-------GYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccccCHHHhccCCCCchhhHHHHHHHHHHHh--ccCCCCCCCCCHHHHHHHHHc-------CCcCCCCCCCCHHHHHHHH
Confidence 6799999999999999999999999999999 6 7999988776665544432 1223345567899999999
Q ss_pred HhccCCCCCCCCHHHHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L 259 (434)
+||..+|++||++.|++..|
T Consensus 236 ~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 236 SCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHh
Confidence 99999999999999998776
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=285.70 Aligned_cols=201 Identities=23% Similarity=0.332 Sum_probs=166.7
Q ss_pred CCCC-CCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 3 SLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 3 ~L~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
.++| ++|+++++++.+.+..|+||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlk 128 (324)
T cd05587 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK 128 (324)
T ss_pred hcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 4555 568899999999999999999999999999997 33568899999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .......||.
T Consensus 129 p~Nill~~~~~~kL~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~ 165 (324)
T cd05587 129 LDNVMLDAEGHIKIADFGMCKENIFGG-------------------------------------------KTTRTFCGTP 165 (324)
T ss_pred HHHeEEcCCCCEEEeecCcceecCCCC-------------------------------------------CceeeecCCc
Confidence 999999999999999999865311000 0112345788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++||||+||++|||+ +|..||.+....+....+.. .....+..+++++.+++.+|
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslGvil~ell--tG~~pf~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~li~~~ 235 (324)
T cd05587 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEML--AGQPPFDGEDEDELFQSIME--------HNVSYPKSLSKEAVSICKGL 235 (324)
T ss_pred cccChhhhcCCCCCcccchhhhHHHHHHHH--hCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999998887766655432 12334567889999999999
Q ss_pred ccCCCCCCCCH-----HHH--HHHHHhcc
Q psy5690 242 WKTNETDRPRF-----SEI--HLFLQRKN 263 (434)
Q Consensus 242 l~~dP~~Rps~-----~el--~~~L~~~~ 263 (434)
|+.||.+|++. +++ |+|+++.+
T Consensus 236 l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 236 LTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999976 677 67776653
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=285.42 Aligned_cols=199 Identities=24% Similarity=0.338 Sum_probs=167.2
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+|++|+++++++.+.+..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 131 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-------QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 131 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHH
Confidence 68999999999999999999999999999999997 33468899999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.++.+||+|||+++...... .......||+.|+
T Consensus 132 ill~~~~~~kL~DfG~~~~~~~~~-------------------------------------------~~~~~~~gt~~y~ 168 (323)
T cd05616 132 VMLDSEGHIKIADFGMCKENMWDG-------------------------------------------VTTKTFCGTPDYI 168 (323)
T ss_pred eEECCCCcEEEccCCCceecCCCC-------------------------------------------CccccCCCChhhc
Confidence 999999999999999875311100 0113346788999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 244 (434)
|||++.+..++.++|||||||++|||+ +|..||...+..+....+.. .....+..+++++.+++.+||+.
T Consensus 169 aPE~~~~~~~~~~~DiwSlGvil~ell--tg~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 169 APEIIAYQPYGKSVDWWAFGVLLYEML--AGQAPFEGEDEDELFQSIME--------HNVAYPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred CHHHhcCCCCCCccchhchhHHHHHHH--hCCCCCCCCCHHHHHHHHHh--------CCCCCCCcCCHHHHHHHHHHccc
Confidence 999999999999999999999999999 89999998887776655432 12234567889999999999999
Q ss_pred CCCCCCCH-----HHH--HHHHHhcc
Q psy5690 245 NETDRPRF-----SEI--HLFLQRKN 263 (434)
Q Consensus 245 dP~~Rps~-----~el--~~~L~~~~ 263 (434)
||++|++. .++ |+|++...
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred CHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999974 666 66776543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=280.74 Aligned_cols=207 Identities=33% Similarity=0.658 Sum_probs=167.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||++++|+|..+ ..++++||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dl 135 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH------KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDL 135 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhc------cccCCHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence 4678999999999999764 578999999999999999732 346888999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++....... ........++
T Consensus 136 kp~Nill~~~~~~kl~DfG~a~~~~~~~~-----------------------------------------~~~~~~~~~~ 174 (316)
T cd05108 136 AARNVLVKTPQHVKITDFGLAKLLGADEK-----------------------------------------EYHAEGGKVP 174 (316)
T ss_pred chhheEecCCCcEEEccccccccccCCCc-----------------------------------------ceeccCCccc
Confidence 99999999999999999999765321110 0011223345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|||||||++|||++ .|..||.+....+....+. .....+.+..++.++.+++.+
T Consensus 175 ~~y~apE~~~~~~~~~~~Di~slGv~l~el~t-~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 246 (316)
T cd05108 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT-FGSKPYDGIPASEISSILE-------KGERLPQPPICTIDVYMIMVK 246 (316)
T ss_pred eeecChHHhccCCCCchhhhHHHHHHHHHHHc-CCCCCCCCCCHHHHHHHHh-------CCCCCCCCCCCCHHHHHHHHH
Confidence 67999999999999999999999999999983 2899998876655433221 223344466778899999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
||..||++||++.++...+.+..
T Consensus 247 cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 247 CWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999988887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=271.86 Aligned_cols=206 Identities=38% Similarity=0.710 Sum_probs=170.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di 132 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN------DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDL 132 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 36789999999999999999999999999999999999732 246899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++...... .........++
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 171 (266)
T cd05033 133 AARNILVNSNLVCKVSDFGLSRRLEDSE-----------------------------------------ATYTTKGGKIP 171 (266)
T ss_pred CcceEEEcCCCCEEECccchhhcccccc-----------------------------------------cceeccCCCCC
Confidence 9999999999999999999976532100 00011123345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++||||||+++|+|++ .|..||......+....+.. ....+.+..+++.+.+++.+
T Consensus 172 ~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~ 243 (266)
T cd05033 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS-YGERPYWDMSNQDVIKAVED-------GYRLPPPMDCPSALYQLMLD 243 (266)
T ss_pred ccccChhhhccCCCccccchHHHHHHHHHHHc-cCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHHH
Confidence 77999999999899999999999999999993 28999988777666554432 12333456778999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||+.+|++||+++||.+.|++
T Consensus 244 cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 244 CWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred HcCCCcccCcCHHHHHHHHHh
Confidence 999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=277.85 Aligned_cols=208 Identities=17% Similarity=0.203 Sum_probs=163.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.++...++||||+++|+|.+++... ....+++..+..++.|++.||+|||++||+||||
T Consensus 47 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~di 121 (277)
T cd05607 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV-----GERGLEMERVIHYSAQITCGILHLHSMDIVYRDM 121 (277)
T ss_pred HHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-----cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccC
Confidence 45789999999999999999999999999999999988632 2345888999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... ......++
T Consensus 122 kp~Nili~~~~~~~l~Dfg~~~~~~~~~--------------------------------------------~~~~~~~~ 157 (277)
T cd05607 122 KPENVLLDDQGNCRLSDLGLAVELKDGK--------------------------------------------TITQRAGT 157 (277)
T ss_pred ChHhEEEcCCCCEEEeeceeeeecCCCc--------------------------------------------eeeccCCC
Confidence 9999999999999999999865421100 01223577
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++||||+||++|||+ +|..||...........+.... ...........+++++.+++.+
T Consensus 158 ~~y~aPE~~~~~~~~~~~DvwslGv~l~el~--~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~ 232 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMV--AGRTPFKDHKEKVAKEELKRRT---LEDEVKFEHQNFTEESKDICRL 232 (277)
T ss_pred CCccCHHHHccCCCCCchhHHHHHHHHHHHH--hCCCCCCCCcchhhHHHHHHHh---hccccccccccCCHHHHHHHHH
Confidence 8899999999988999999999999999999 8999997654322111111100 0111111224578899999999
Q ss_pred hccCCCCCCCCHHH----H--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSE----I--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~e----l--~~~L~~~ 262 (434)
||+.||++||++.| + |+|++..
T Consensus 233 ~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 233 FLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HhccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999954 3 7788664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.61 Aligned_cols=204 Identities=19% Similarity=0.285 Sum_probs=162.9
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.+||||+++++++..++..++||||+++|+|..++. ....+++..+..++.||+.||+|||++||+||||||+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-------~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~ 125 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-------RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 125 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH
Confidence 489999999999999999999999999999999886 3457899999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
||+++.++.+||+|||+++...... .......||..|
T Consensus 126 Nili~~~~~~kL~DfG~~~~~~~~~-------------------------------------------~~~~~~~gt~~y 162 (329)
T cd05618 126 NVLLDSEGHIKLTDYGMCKEGLRPG-------------------------------------------DTTSTFCGTPNY 162 (329)
T ss_pred HEEECCCCCEEEeeCCccccccCCC-------------------------------------------CccccccCCccc
Confidence 9999999999999999865311100 011234678899
Q ss_pred cchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-----HHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-----QVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 164 ~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
+|||++.+..++.++|||||||++|||+ +|..||...... .....+.. .........+..++.++.+++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~--~g~~Pf~~~~~~~~~~~~~~~~~~~----~i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 163 IAPEILRGEDYGFSVDWWALGVLMFEMM--AGRSPFDIVGSSDNPDQNTEDYLFQ----VILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred cCHHHHcCCCCCCccceecccHHHHHHh--hCCCCCccCCCcCCcccccHHHHHH----HHhcCCCCCCCCCCHHHHHHH
Confidence 9999999999999999999999999999 899999532111 00000000 001122334667889999999
Q ss_pred HHhccCCCCCCCC------HHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRPR------FSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps------~~el--~~~L~~~~ 263 (434)
.+||+.||++||+ ++++ |+|++..+
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 9999999999998 4677 78886653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=277.99 Aligned_cols=213 Identities=35% Similarity=0.660 Sum_probs=170.9
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
+++ +||||+++++++..++..++||||+++|+|.+++...... ......+++..+..++.|++.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 151 (314)
T cd05099 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE 151 (314)
T ss_pred HhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 345 6999999999999999999999999999999999754311 112346889999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++|++||||||+||+++.++.+||+|||+++....... .
T Consensus 152 ~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~-----------------------------------------~ 190 (314)
T cd05099 152 SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDY-----------------------------------------Y 190 (314)
T ss_pred HCCeeeccccceeEEEcCCCcEEEcccccccccccccc-----------------------------------------c
Confidence 99999999999999999999999999999765321110 0
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
.......++..|+|||.+.+..++.++|||||||++|||++ .|..||......+....+.. ......+..++
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 262 (314)
T cd05099 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT-LGGSPYPGIPVEELFKLLRE-------GHRMDKPSNCT 262 (314)
T ss_pred cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCC
Confidence 00111223457999999998889999999999999999993 28899988777666554432 12233456778
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.++.+++.+||+.||++||++.+++..|++..
T Consensus 263 ~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 263 HELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 89999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=287.25 Aligned_cols=199 Identities=21% Similarity=0.271 Sum_probs=164.4
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-------~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~N 126 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ-------KEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPEN 126 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHH
Confidence 79999999999999999999999999999999997 34578999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.++.+||+|||+++...... .......||..|+
T Consensus 127 ili~~~~~~kl~Dfg~a~~~~~~~-------------------------------------------~~~~~~~gt~~y~ 163 (330)
T cd05586 127 ILLDATGHIALCDFGLSKANLTDN-------------------------------------------KTTNTFCGTTEYL 163 (330)
T ss_pred eEECCCCCEEEecCCcCcCCCCCC-------------------------------------------CCccCccCCcccc
Confidence 999999999999999865411100 0113456888999
Q ss_pred chhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhcc
Q psy5690 165 AWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWK 243 (434)
Q Consensus 165 aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 243 (434)
|||++.+. .++.++|||||||++|+|+ +|..||......+....+... ....+ ...+++++.+++.+||+
T Consensus 164 aPE~~~~~~~~~~~~DvwslGvil~ell--tG~~Pf~~~~~~~~~~~i~~~------~~~~~-~~~~~~~~~~li~~~L~ 234 (330)
T cd05586 164 APEVLLDEKGYTKHVDFWSLGVLVFEMC--CGWSPFYAEDTQQMYRNIAFG------KVRFP-KNVLSDEGRQFVKGLLN 234 (330)
T ss_pred CHHHHcCCCCCCCccceeccccEEEEec--cCCCCCCCCCHHHHHHHHHcC------CCCCC-CccCCHHHHHHHHHHcC
Confidence 99999764 4799999999999999999 899999888776665544321 11111 23467899999999999
Q ss_pred CCCCCCC----CHHHH--HHHHHhc
Q psy5690 244 TNETDRP----RFSEI--HLFLQRK 262 (434)
Q Consensus 244 ~dP~~Rp----s~~el--~~~L~~~ 262 (434)
.||++|| +++++ |+|+...
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccccCC
Confidence 9999998 67787 7788654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=271.03 Aligned_cols=204 Identities=36% Similarity=0.662 Sum_probs=171.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+.+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||++|++|+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl 130 (261)
T cd05148 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-----EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDL 130 (261)
T ss_pred HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 46889999999999999999999999999999999999732 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||.+....... .......++
T Consensus 131 ~~~nilv~~~~~~kl~d~g~~~~~~~~~-------------------------------------------~~~~~~~~~ 167 (261)
T cd05148 131 AARNILVGEDLVCKVADFGLARLIKEDV-------------------------------------------YLSSDKKIP 167 (261)
T ss_pred CcceEEEcCCceEEEccccchhhcCCcc-------------------------------------------ccccCCCCc
Confidence 9999999999999999999875421110 011133356
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+....++.++||||||+++|+|+ + |..||......+....+.. ....+.+..+++++.+++.
T Consensus 168 ~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMF--TYGQVPYPGMNNHEVYDQITA-------GYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred eEecCHHHHccCCCCchhhHHHHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHh-------CCcCCCCCCCCHHHHHHHH
Confidence 7799999999888999999999999999999 5 8999988776666554431 2233446678899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.||.+|||++++.+.|+.
T Consensus 239 ~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 239 ECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHcCCCchhCcCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=279.96 Aligned_cols=208 Identities=19% Similarity=0.243 Sum_probs=169.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++.+..++..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.|++||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 128 (285)
T cd05605 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM-----GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDL 128 (285)
T ss_pred HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc-----CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCC
Confidence 35789999999999999999999999999999999988632 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||++++++.++|+|||++....... ......|+
T Consensus 129 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~--------------------------------------------~~~~~~~~ 164 (285)
T cd05605 129 KPENILLDDYGHIRISDLGLAVEIPEGE--------------------------------------------TIRGRVGT 164 (285)
T ss_pred CHHHEEECCCCCEEEeeCCCceecCCCC--------------------------------------------ccccccCC
Confidence 9999999999999999999865421000 01234578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++||||+||++|||+ +|..||.+.......+.+.... .......+..+++.+.+++.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~Diws~G~~l~el~--~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 165 VGYMAPEVVKNERYTFSPDWWGLGCLIYEMI--EGKSPFRQRKEKVKREEVERRV----KEDQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred CCccCcHHhcCCCCCccccchhHHHHHHHHH--HCCCCCCCCchhhHHHHHHHHh----hhcccccCcccCHHHHHHHHH
Confidence 8999999999888999999999999999999 8999998766544333332211 111223345678899999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~ 263 (434)
||+.||++|| +++++ |+||.+.+
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 9999999999 88899 78887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=289.71 Aligned_cols=210 Identities=17% Similarity=0.231 Sum_probs=160.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||++++++..++..++|+|++. ++|..++. ....+++..++.++.||+.||+|||++||+||||
T Consensus 137 l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~-------~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDi 208 (391)
T PHA03212 137 LRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLA-------AKRNIAICDILAIERSVLRAIQYLHENRIIHRDI 208 (391)
T ss_pred HHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 467999999999999999999999999995 69999886 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........||
T Consensus 209 KP~NIll~~~~~vkL~DFG~a~~~~~~~------------------------------------------~~~~~~~~gt 246 (391)
T PHA03212 209 KAENIFINHPGDVCLGDFGAACFPVDIN------------------------------------------ANKYYGWAGT 246 (391)
T ss_pred ChHhEEEcCCCCEEEEeCCccccccccc------------------------------------------ccccccccCc
Confidence 9999999999999999999975411100 0011235688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-------HHHHHhhhhh-------------------
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-------EQVIENCSHW------------------- 214 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-------~~~~~~~~~~------------------- 214 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||..... ......+...
T Consensus 247 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell--tg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~ 324 (391)
T PHA03212 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMA--TCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEI 324 (391)
T ss_pred cCCCChhhhcCCCCCcHHHHHHHHHHHHHHH--HCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHH
Confidence 9999999999999999999999999999999 77877653211 1111111000
Q ss_pred h----hcCCcc-cCCC---CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 215 Y----QNNSKQ-QYLP---RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 215 ~----~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+ ...... ...+ .....+.++.+|+.+||+.||++|||++|+ |+||+..
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 325 YIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0 000000 0000 011346789999999999999999999999 8999764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=287.77 Aligned_cols=206 Identities=18% Similarity=0.260 Sum_probs=166.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++.+++..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+|||||
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLK 169 (370)
T cd05621 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVK 169 (370)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 568999999999999999999999999999999999962 247889999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ........||+
T Consensus 170 p~NILl~~~~~~kL~DFG~a~~~~~~~------------------------------------------~~~~~~~~gt~ 207 (370)
T cd05621 170 PDNMLLDKHGHLKLADFGTCMKMDETG------------------------------------------MVRCDTAVGTP 207 (370)
T ss_pred HHHEEECCCCCEEEEecccceecccCC------------------------------------------ceecccCCCCc
Confidence 999999999999999999976521110 00113456889
Q ss_pred cccchhhhhcCC----CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 162 RWMAWESLLLGK----NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 162 ~y~aPE~~~~~~----~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.|+|||++.+.. ++.++||||+||++|||+ +|..||...+.......+... ......+....++..+.++
T Consensus 208 ~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell--~G~~Pf~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~~l 281 (370)
T cd05621 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML--VGDTPFYADSLVGTYSKIMDH----KNSLNFPEDVEISKHAKNL 281 (370)
T ss_pred ccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH--hCCCCCCCCCHHHHHHHHHhC----CcccCCCCcccCCHHHHHH
Confidence 999999997643 688999999999999999 899999988776665554321 1112223334568899999
Q ss_pred HHHhccCCCCC--CCCHHHH--HHHHHhcc
Q psy5690 238 MLECWKTNETD--RPRFSEI--HLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~--Rps~~el--~~~L~~~~ 263 (434)
+.+||..++.+ |++++|+ |+|++...
T Consensus 282 i~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 282 ICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred HHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 99999865543 8899999 88997643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=271.61 Aligned_cols=210 Identities=36% Similarity=0.719 Sum_probs=169.3
Q ss_pred CCCCCCCCeeeEEEEEecCCc------eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDP------ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|+.++||||+++++++...+. .++++||+++|+|..++...... .....+++..+..++.|++.||+|||+++
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~~ 133 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNRN 133 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 357899999999999866554 79999999999999998643211 12346899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
++||||||+||++++++.+||+|||+++....... +...
T Consensus 134 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------~~~~ 172 (273)
T cd05035 134 FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY-----------------------------------------YRQG 172 (273)
T ss_pred eeccccchheEEECCCCeEEECCccceeecccccc-----------------------------------------cccc
Confidence 99999999999999999999999999765322110 0111
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
....++..|+|||.+.+..++.++|||||||++|||+ + |..||.+....+..+.+.. ......+..++++
T Consensus 173 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 243 (273)
T cd05035 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA--TRGQTPYPGVENHEIYDYLRH-------GNRLKQPEDCLDE 243 (273)
T ss_pred ccccCCccccCHhhcccCCCCcccchHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCcCCCHH
Confidence 1223456799999998888999999999999999999 5 8899988777666544432 2233445678899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+.+++.+||+.||++||++.|+...|++
T Consensus 244 ~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 244 LYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 9999999999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=272.36 Aligned_cols=212 Identities=30% Similarity=0.607 Sum_probs=161.9
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++.+...+..++||||+++|+|.+++...... .....++..+..++.||+.||+|||++||+|||||
T Consensus 50 ~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 127 (269)
T cd05042 50 RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGM--VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLA 127 (269)
T ss_pred HhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhcccc--ccccccHHHHHHHHHHHHHHHHHHHhcCEeccccc
Confidence 5689999999999999999999999999999999999754311 12345678889999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++..... ..........++.
T Consensus 128 p~Nill~~~~~~kl~dfg~~~~~~~~-----------------------------------------~~~~~~~~~~~~~ 166 (269)
T cd05042 128 LRNCQLTADLSVKIGDYGLALEQYPE-----------------------------------------DYYITKDCHAVPL 166 (269)
T ss_pred HhheEecCCCcEEEeccccccccccc-----------------------------------------hheeccCCCCCcc
Confidence 99999999999999999986541111 0011112334567
Q ss_pred cccchhhhhc-------CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 162 RWMAWESLLL-------GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 162 ~y~aPE~~~~-------~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
.|+|||++.. ..++.++|||||||++|||++ .|..||......+........ ..........+..+++.+
T Consensus 167 ~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 243 (269)
T cd05042 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-AADQPYPDLSDEQVLKQVVRE--QDIKLPKPQLDLKYSDRW 243 (269)
T ss_pred cccCHHHHhhccccccccccchhhHHHHHHHHHHHHHh-CCCCCCCcCCHHHHHHHHhhc--cCccCCCCcccccCCHHH
Confidence 7999999753 345789999999999999994 278899887665544433211 111111122344678899
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHH
Q psy5690 235 FDLMLECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el~~~L~ 260 (434)
.+++..|| .||++||++++|.+.|.
T Consensus 244 ~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 244 YEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHHHh-cCcccccCHHHHHHHhc
Confidence 99999999 59999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=282.88 Aligned_cols=210 Identities=18% Similarity=0.260 Sum_probs=165.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++|+||+++++++.+++..|+||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++||+|||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 129 (331)
T cd05597 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK 129 (331)
T ss_pred HhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCC
Confidence 4579999999999999999999999999999999999732 3468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||++....... ........||+
T Consensus 130 p~Nill~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~gt~ 167 (331)
T cd05597 130 PDNVLLDKNGHIRLADFGSCLRLLADG------------------------------------------TVQSNVAVGTP 167 (331)
T ss_pred HHHEEECCCCCEEEEECCceeecCCCC------------------------------------------Cccccceeccc
Confidence 999999999999999999865421110 00112245788
Q ss_pred cccchhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 162 RWMAWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 162 ~y~aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
.|+|||++.. ..++.++|||||||++|||+ +|..||...+..+....+... .......+....+++++++
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~--~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd05597 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML--YGETPFYAESLVETYGKIMNH---KEHFQFPPDVTDVSEEAKD 242 (331)
T ss_pred cccCHHHHhhccccccCCCCcceeehhhhHHHHHh--hCCCCCCCCCHHHHHHHHHcC---CCcccCCCccCCCCHHHHH
Confidence 9999999973 45688999999999999999 899999887766655544321 1111122223457899999
Q ss_pred HHHHhccCCCCC--CCCHHHH--HHHHHhccc
Q psy5690 237 LMLECWKTNETD--RPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 237 li~~cl~~dP~~--Rps~~el--~~~L~~~~~ 264 (434)
++.+|+..+++. |++++++ |+|+....+
T Consensus 243 li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 243 LIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred HHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 999988654433 7899999 889876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=287.16 Aligned_cols=213 Identities=31% Similarity=0.608 Sum_probs=167.9
Q ss_pred CCCC-CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC-----------------------------------
Q psy5690 2 CSLK-DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS----------------------------------- 45 (434)
Q Consensus 2 ~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~----------------------------------- 45 (434)
++++ |||||+++++|.+.+..|+|||||++|+|.+++.......
T Consensus 95 ~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (400)
T cd05105 95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENK 174 (400)
T ss_pred HhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccc
Confidence 4575 9999999999999999999999999999999987532100
Q ss_pred ------------------------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 46 ------------------------------------------------------QENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 46 ------------------------------------------------------~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
.....+++..+..++.|++.||+|||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 254 (400)
T cd05105 175 GDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA 254 (400)
T ss_pred ccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 01134788889999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
+++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 255 ~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~-----------------------------------------~~ 293 (400)
T cd05105 255 SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDS-----------------------------------------NY 293 (400)
T ss_pred hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccc-----------------------------------------cc
Confidence 9999999999999999999999999999976421110 00
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
.......++..|+|||.+.+..++.++|||||||++|||++ .|..||............. ......+.+..++
T Consensus 294 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-~g~~P~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 366 (400)
T cd05105 294 VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS-LGGTPYPGMIVDSTFYNKI------KSGYRMAKPDHAT 366 (400)
T ss_pred cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH-CCCCCCcccchhHHHHHHH------hcCCCCCCCccCC
Confidence 11123345678999999999899999999999999999994 2888988765433322111 1122334456788
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 367 ~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 367 QEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=292.04 Aligned_cols=249 Identities=19% Similarity=0.254 Sum_probs=172.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++.+.+++..++|||||++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-------~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDl 127 (382)
T cd05625 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-------RMGIFPEDLARFYIAELTCAVESVHKMGFIHRDI 127 (382)
T ss_pred HHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 357899999999999999999999999999999999997 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccc---cccccccccchhhhhhcccCcccceeecCccccc--cccCCcccccCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDY---YLSDTKARLPIRWMANCMVGKNYTIKISDHAMYC--SHYESDYYLSDT 155 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~~~ 155 (434)
||+|||++.++.+||+|||+++....... ................ ..+.+......+..... ............
T Consensus 128 Kp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (382)
T cd05625 128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN-EWGDPANCRCGDRLKPLERRAARQHQRCLAH 206 (382)
T ss_pred CHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccc-cccccccccccccccchhhhhcccccccccc
Confidence 99999999999999999999764321110 0000000000000000 00000000000000000 000000001123
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
...||+.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+..+ ......+....+++++.
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ell--tG~~Pf~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~ 280 (382)
T cd05625 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML--VGQPPFLAQTPLETQMKVINW----QTSLHIPPQAKLSPEAS 280 (382)
T ss_pred ccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHH--hCCCCCCCCCHHHHHHHHHcc----CCCcCCCCcccCCHHHH
Confidence 457899999999999999999999999999999999 899999987766655444322 12222333456788999
Q ss_pred HHHHHhccCCCCCCCC---HHHH--HHHHHhccc
Q psy5690 236 DLMLECWKTNETDRPR---FSEI--HLFLQRKNL 264 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps---~~el--~~~L~~~~~ 264 (434)
+++.+|+ .+|++|++ ++++ |+|++....
T Consensus 281 ~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 281 DLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 9999876 59999997 8998 788876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=277.30 Aligned_cols=210 Identities=37% Similarity=0.712 Sum_probs=168.7
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
.++ +||||+++++++..++..++||||+++|+|.+++.+.+... .....+++..++.++.|++.||+|||
T Consensus 62 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 141 (303)
T cd05088 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 141 (303)
T ss_pred HHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH
Confidence 456 89999999999999999999999999999999997543211 12246889999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++|++||||||+|||++.++.+||+|||+++.... .
T Consensus 142 ~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--------------------------------------------~ 177 (303)
T cd05088 142 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------------------------------------------Y 177 (303)
T ss_pred hCCccccccchheEEecCCCcEEeCccccCcccch--------------------------------------------h
Confidence 99999999999999999999999999998642100 0
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (434)
.......++..|+|||.+.+..++.++|||||||++|||+ + |..||......+....+.. ......+..+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~ 248 (303)
T cd05088 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV--SLGGTPYCGMTCAELYEKLPQ-------GYRLEKPLNC 248 (303)
T ss_pred hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHH--hcCCCCcccCChHHHHHHHhc-------CCcCCCCCCC
Confidence 0111223356799999998888899999999999999999 5 8999987776665543321 1222334557
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
++++.+++.+||+.+|++||++++++..+++...
T Consensus 249 ~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 249 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 7899999999999999999999999888776533
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=275.95 Aligned_cols=212 Identities=33% Similarity=0.647 Sum_probs=171.2
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
+.+ +||||+++++++...+..++||||+++|+|.+++....... .....+++..+..++.||++||.|||
T Consensus 75 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 154 (304)
T cd05101 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA 154 (304)
T ss_pred HhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH
Confidence 456 79999999999999999999999999999999997543210 11245788899999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++|++||||||+||+++.++.+||+|||+++....... .
T Consensus 155 ~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~-----------------------------------------~ 193 (304)
T cd05101 155 SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDY-----------------------------------------Y 193 (304)
T ss_pred HCCeeecccccceEEEcCCCcEEECCCccceecccccc-----------------------------------------c
Confidence 99999999999999999999999999999765321110 0
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
.......++..|+|||++.+..++.++||||||+++|++++ .|..||...+..+....+.. ......+..++
T Consensus 194 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 265 (304)
T cd05101 194 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-LGGSPYPGIPVEELFKLLKE-------GHRMDKPANCT 265 (304)
T ss_pred ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHc-CCCCCcccCCHHHHHHHHHc-------CCcCCCCCCCC
Confidence 01122345567999999998889999999999999999993 27889988877766654432 12233456788
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.++.+++.+||+.+|++||++.|+++.|++.
T Consensus 266 ~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 266 NELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 9999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=273.53 Aligned_cols=213 Identities=42% Similarity=0.717 Sum_probs=169.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQ---ENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~---~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
|++++||||+++++++.+.+..++||||+++|+|.+++...+.... .....+...+..++.|++.||.|||+++|+|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 142 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVH 142 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 4578999999999999999999999999999999999975431111 1234567788999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+||+++.++.++|+|||+++...... ........
T Consensus 143 ~dikp~nili~~~~~~~L~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~ 181 (288)
T cd05061 143 RDLAARNCMVAHDFTVKIGDFGMTRDIYETD-----------------------------------------YYRKGGKG 181 (288)
T ss_pred CCCChheEEEcCCCcEEECcCCccccccccc-----------------------------------------cccccCCC
Confidence 9999999999999999999999876522111 00111223
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.++..|+|||.+.++.++.++|||||||++|||++ .|..||.+....+....+. .....+.+..+++.+.++
T Consensus 182 ~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~-~~~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l 253 (288)
T cd05061 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-LAEQPYQGLSNEQVLKFVM-------DGGYLDQPDNCPERVTDL 253 (288)
T ss_pred cccccccCHHHhccCCCChHhHHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHH-------cCCCCCCCCCCCHHHHHH
Confidence 34567999999998889999999999999999993 2788998877666544332 122233355677899999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+||+.||++||++.++.+.|++.
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 254 MRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHcCCChhHCcCHHHHHHHHHhh
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=267.48 Aligned_cols=212 Identities=18% Similarity=0.226 Sum_probs=167.5
Q ss_pred CCCCCCCCeeeEEEEEec-----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCST-----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|+.++|+||+.+.+++.. -+.+|+|+|+++. +|.+.++ .+..++...+..+++||+.||.|+|+.+|
T Consensus 75 Lr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMet-DL~~iik-------~~~~L~d~H~q~f~YQiLrgLKyiHSAnV 146 (359)
T KOG0660|consen 75 LRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQIIK-------SQQDLTDDHAQYFLYQILRGLKYIHSANV 146 (359)
T ss_pred HHHhcCCCcceEEeecccccccccceeEEehhHHhh-HHHHHHH-------cCccccHHHHHHHHHHHHHhcchhhcccc
Confidence 467899999999999865 2469999999955 9999997 55569999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||.|+|++.+..+||+|||+||..... .....-+
T Consensus 147 iHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-----------------------------------------~~~~~mT 185 (359)
T KOG0660|consen 147 IHRDLKPSNLLLNADCDLKICDFGLARYLDKF-----------------------------------------FEDGFMT 185 (359)
T ss_pred cccccchhheeeccCCCEEeccccceeecccc-----------------------------------------Ccccchh
Confidence 99999999999999999999999999874321 0001124
Q ss_pred CCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhh--------------------h
Q psy5690 156 KARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSH--------------------W 214 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~--------------------~ 214 (434)
....|..|.|||++.. ..|+.+.||||+||++.||+ +|++-|.+.+..+....+.. +
T Consensus 186 eYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL--~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~y 263 (359)
T KOG0660|consen 186 EYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML--TGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPY 263 (359)
T ss_pred cceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH--cCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHH
Confidence 5567888999999874 67899999999999999999 88888887654443332221 1
Q ss_pred hhcCCcccCCC---CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 215 YQNNSKQQYLP---RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 215 ~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
..........+ .-+..++...+|+.+||..||.+|+|++|. |++|...-
T Consensus 264 i~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 264 IKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 11111111111 124677899999999999999999999999 89998754
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=285.26 Aligned_cols=209 Identities=25% Similarity=0.466 Sum_probs=168.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++-+|.||+-|.|+|..++. .||+.+|+|.+|+.+++. .+..|.....+.|++||++|+.|||.++||||||
T Consensus 442 lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv------~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDL 514 (678)
T KOG0193|consen 442 LKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV------QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDL 514 (678)
T ss_pred HhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc------hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhc
Confidence 467799999999999988766 999999999999999973 4467889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|..||++.+++.|||+|||++..-.. + ..........|.
T Consensus 515 KSnNIFl~~~~kVkIgDFGLatvk~~---------------------------------------w--~g~~q~~qp~gs 553 (678)
T KOG0193|consen 515 KSNNIFLHEDLKVKIGDFGLATVKTR---------------------------------------W--SGEQQLEQPHGS 553 (678)
T ss_pred cccceEEccCCcEEEecccceeeeee---------------------------------------e--ccccccCCCccc
Confidence 99999999999999999999643100 0 001122345677
Q ss_pred ccccchhhhhc---CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLLL---GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~---~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|||||++.. .+|++.+||||||+++|||+ +|..||.....++++-.+..++ ...........+++++++|
T Consensus 554 ilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl--tg~lPysi~~~dqIifmVGrG~---l~pd~s~~~s~~pk~mk~L 628 (678)
T KOG0193|consen 554 LLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL--TGELPYSIQNRDQIIFMVGRGY---LMPDLSKIRSNCPKAMKRL 628 (678)
T ss_pred hhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH--hCcCCcCCCChhheEEEecccc---cCccchhhhccCHHHHHHH
Confidence 88999999974 56899999999999999999 8999999666665543222111 0112222346788999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+..||.+++++||.+.+|+..|+..
T Consensus 629 l~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 629 LSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred HHHHHhcCcccCccHHHHHHHHHHh
Confidence 9999999999999999998877764
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=268.91 Aligned_cols=210 Identities=47% Similarity=0.820 Sum_probs=172.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN--SQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
+.++|+||+++++++..++..++||||+++|+|.+++...... ......+++..++.++.|++.||+|||++|++|||
T Consensus 51 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~d 130 (262)
T cd00192 51 KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130 (262)
T ss_pred hhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCc
Confidence 5688999999999999999999999999999999999743100 00136789999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||+++.++.++|+|||.+........ ........+
T Consensus 131 i~p~nili~~~~~~~l~dfg~~~~~~~~~~-----------------------------------------~~~~~~~~~ 169 (262)
T cd00192 131 LAARNCLVGEDLVVKISDFGLSRDVYDDDY-----------------------------------------YRKKTGGKL 169 (262)
T ss_pred cCcceEEECCCCcEEEcccccccccccccc-----------------------------------------cccccCCCc
Confidence 999999999999999999998765322110 112234456
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+..|+|||.+....++.++||||+||++|+|++ .|..||......+..+.+.. ......+..++.++.+++.
T Consensus 170 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 241 (262)
T cd00192 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT-LGATPYPGLSNEEVLEYLRK-------GYRLPKPEYCPDELYELML 241 (262)
T ss_pred CccccCHHHhccCCcchhhccHHHHHHHHHHHh-cCCCCCCCCCHHHHHHHHHc-------CCCCCCCccCChHHHHHHH
Confidence 778999999998889999999999999999993 26999998877766655432 2344456677899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~ 260 (434)
+||..||++||++.|+...|+
T Consensus 242 ~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 242 SCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHccCCcccCcCHHHHHHhhC
Confidence 999999999999999987763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.14 Aligned_cols=212 Identities=28% Similarity=0.549 Sum_probs=162.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++.++||||+++++.|.+....++||||+++|+|.+++.+... .....++..+..++.||+.||+|||+++++||||
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~di 125 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQW---HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDL 125 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhc---ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 3578999999999999999999999999999999999974321 1234677788899999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.++|+|||++....... .........++
T Consensus 126 kp~nil~~~~~~~~l~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 164 (268)
T cd05086 126 ALRNCFLTSDLTVKVGDYGIGPSRYKED-----------------------------------------YIETEDDKCVP 164 (268)
T ss_pred ccceEEEcCCccEEecccccccccCcch-----------------------------------------hhhcccCCcCc
Confidence 9999999999999999999864311100 00111234567
Q ss_pred ccccchhhhhc-------CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 161 IRWMAWESLLL-------GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 161 ~~y~aPE~~~~-------~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
..|+|||++.. ..++.++|||||||++|||++ .+..||......+....+.. ...........+..+++.
T Consensus 165 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-~~~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05086 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE-NAAQPYSHLSDREVLNHVIK--DQQVKLFKPQLELPYSER 241 (268)
T ss_pred ccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHHh--hcccccCCCccCCCCcHH
Confidence 88999998853 234789999999999999995 36778887776655544321 111111122234457889
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~ 260 (434)
+.+++..|| .+|++||++++|++.|.
T Consensus 242 ~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 242 WYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 999999999 67999999999988774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=275.15 Aligned_cols=209 Identities=36% Similarity=0.719 Sum_probs=168.2
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
+++ +||||+++++++...+..++|+||+++|+|.+++.+..... .....+++..+..++.|++.||+|||
T Consensus 57 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH 136 (297)
T cd05089 57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS 136 (297)
T ss_pred HhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 356 79999999999999999999999999999999997533111 11235889999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++||+||||||+|||++.++.+||+|||++..... .
T Consensus 137 ~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~--------------------------------------------~ 172 (297)
T cd05089 137 EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV--------------------------------------------Y 172 (297)
T ss_pred HCCcccCcCCcceEEECCCCeEEECCcCCCccccc--------------------------------------------e
Confidence 99999999999999999999999999998642100 0
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (434)
........+..|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ....+.+..+
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~--t~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~~~ 243 (297)
T cd05089 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV--SLGGTPYCGMTCAELYEKLPQ-------GYRMEKPRNC 243 (297)
T ss_pred eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHhc-------CCCCCCCCCC
Confidence 0011122345699999999888999999999999999999 5 8999988877666554321 2223345668
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+.++.+++.+||+.+|.+||+++++...|++..
T Consensus 244 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 244 DDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 899999999999999999999999977776653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=273.70 Aligned_cols=212 Identities=39% Similarity=0.770 Sum_probs=169.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---------------CCCCCCCHHHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------------QENPAISYGCLIFMATQIAS 65 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------------~~~~~l~~~~~~~i~~qi~~ 65 (434)
|++++||||+++++++.+++..++|+||+++|+|.+++....... .....+++..++.++.|++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999997543210 11235788999999999999
Q ss_pred HHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccc
Q psy5690 66 GMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSH 145 (434)
Q Consensus 66 gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 145 (434)
||+|||+++++||||||+||+++.++.++|+|||+++......
T Consensus 142 aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~------------------------------------- 184 (288)
T cd05050 142 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD------------------------------------- 184 (288)
T ss_pred HHHHHHhCCeecccccHhheEecCCCceEECccccceecccCc-------------------------------------
Confidence 9999999999999999999999999999999999865421111
Q ss_pred cCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCC
Q psy5690 146 YESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLP 225 (434)
Q Consensus 146 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (434)
..........+..|+|||.+.+..++.++|||||||++|||++ .|..||.+....+....+.. ....+
T Consensus 185 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~-~~~~p~~~~~~~~~~~~~~~-------~~~~~ 252 (288)
T cd05050 185 ----YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS-YGMQPYYGMAHEEVIYYVRD-------GNVLS 252 (288)
T ss_pred ----cccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhc-------CCCCC
Confidence 0001112233567999999998999999999999999999993 27789987776665544321 22233
Q ss_pred CCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 226 RPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 226 ~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
.+..++.++.+++.+||+.||++||++.|++..|++
T Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 253 CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 455678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=269.75 Aligned_cols=213 Identities=31% Similarity=0.574 Sum_probs=161.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+....++||||+++|+|.+++...... .....++..+..++.|++.||+|||+++++||||
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl 126 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDL 126 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHCCEecccc
Confidence 35789999999999999999999999999999999999754311 2234567788899999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .+.......++
T Consensus 127 kp~nil~~~~~~~kL~dfg~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 165 (269)
T cd05087 127 ALRNCLLTADLTVKIGDYGLSHNKYKED-----------------------------------------YYVTPDQLWVP 165 (269)
T ss_pred CcceEEEcCCCcEEECCccccccccCcc-----------------------------------------eeecCCCcCCc
Confidence 9999999999999999999865421110 01111234456
Q ss_pred ccccchhhhhcC-------CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 161 IRWMAWESLLLG-------KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 161 ~~y~aPE~~~~~-------~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
..|+|||++.+. .++.++|||||||++|||++ .|..||......+....... ...............++.
T Consensus 166 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~-~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 242 (269)
T cd05087 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFE-LGSQPYRHLSDEQVLTYTVR--EQQLKLPKPRLKLPLSDR 242 (269)
T ss_pred ccccCHhHhccccccccccCCCccchhHHHHHHHHHHHh-CCCCCCCCCChHHHHHHHhh--cccCCCCCCccCCCCChH
Confidence 789999998642 35789999999999999993 28899987766554332111 001111111222346788
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~ 260 (434)
+.+++.+|| .+|++|||++||+..|+
T Consensus 243 ~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 243 WYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 999999999 68999999999988764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=286.72 Aligned_cols=202 Identities=36% Similarity=0.641 Sum_probs=178.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|-+|+|||+++|||+..+ ....+|||+++.|+|.+.|++. ....|.......++.||+.||.||.++++|||||
T Consensus 165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka-----~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDL 238 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKA-----KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDL 238 (1039)
T ss_pred HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhc-----cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhh
Confidence 568999999999999877 7899999999999999999851 3456888899999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
..+|+|+.....+||+|||+.|.....+ +.|........+
T Consensus 239 AARNlllasprtVKI~DFGLmRaLg~ne----------------------------------------d~Yvm~p~rkvP 278 (1039)
T KOG0199|consen 239 AARNLLLASPRTVKICDFGLMRALGENE----------------------------------------DMYVMAPQRKVP 278 (1039)
T ss_pred hhhhheecccceeeeecccceeccCCCC----------------------------------------cceEecCCCcCc
Confidence 9999999999999999999988754332 333334455667
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||.+....++.++|||+|||++|||++ .|..||.+....++++++. .+.+++.|..|+++++++++.
T Consensus 279 fAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt-yGEePW~G~~g~qIL~~iD-------~~erLpRPk~csedIY~imk~ 350 (1039)
T KOG0199|consen 279 FAWCAPESLRHRKFSHASDVWMYGVTIWEMFT-YGEEPWVGCRGIQILKNID-------AGERLPRPKYCSEDIYQIMKN 350 (1039)
T ss_pred ccccCHhHhccccccccchhhhhhhhHHhhhc-cCCCCCCCCCHHHHHHhcc-------ccccCCCCCCChHHHHHHHHH
Confidence 88999999999999999999999999999998 6999999999998877653 567888899999999999999
Q ss_pred hccCCCCCCCCHHHHH
Q psy5690 241 CWKTNETDRPRFSEIH 256 (434)
Q Consensus 241 cl~~dP~~Rps~~el~ 256 (434)
||..+|++||++..|.
T Consensus 351 cWah~paDRptFsair 366 (1039)
T KOG0199|consen 351 CWAHNPADRPTFSAIR 366 (1039)
T ss_pred hccCCccccccHHHHH
Confidence 9999999999999995
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=286.32 Aligned_cols=202 Identities=22% Similarity=0.300 Sum_probs=158.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++..++..++||||+++|+|.+.. ...+..+..++.||+.||+|||++||+||||
T Consensus 126 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 194 (353)
T PLN00034 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----------IADEQFLADVARQILSGIAYLHRRHIVHRDI 194 (353)
T ss_pred HHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-----------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCC
Confidence 46789999999999999999999999999999986532 3567788899999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......||
T Consensus 195 kp~NIll~~~~~~kL~DfG~~~~~~~~~-------------------------------------------~~~~~~~gt 231 (353)
T PLN00034 195 KPSNLLINSAKNVKIADFGVSRILAQTM-------------------------------------------DPCNSSVGT 231 (353)
T ss_pred CHHHEEEcCCCCEEEcccccceeccccc-------------------------------------------ccccccccC
Confidence 9999999999999999999976421110 011234678
Q ss_pred ccccchhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 161 IRWMAWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 161 ~~y~aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
..|+|||++.. ...+.++|||||||++|||+ +|+.||......+....... .........+..++.++.
T Consensus 232 ~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~--~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~ 305 (353)
T PLN00034 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY--LGRFPFGVGRQGDWASLMCA----ICMSQPPEAPATASREFR 305 (353)
T ss_pred ccccCccccccccccCcCCCcchhHHHHHHHHHHHH--hCCCCCCCCCCccHHHHHHH----HhccCCCCCCCccCHHHH
Confidence 89999998753 22356899999999999999 89999974433222111111 111222334567789999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+||.+||+.||++||+++|+ |+||.+.
T Consensus 306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 306 HFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 99999999999999999999 7888774
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=270.13 Aligned_cols=210 Identities=37% Similarity=0.695 Sum_probs=166.4
Q ss_pred CCCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|+.++||||+++++++... ...+++|||+++|+|.+++...+. ......+++..+..++.|++.||+|||++|
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 132 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRL-GDCPQYLPTQMLVKFMTDIASGMEYLSSKS 132 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcc-cCCcccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3578999999999987432 247899999999999998853321 112345899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 133 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------~~~~ 171 (272)
T cd05075 133 FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY-----------------------------------------YRQG 171 (272)
T ss_pred eeccccchhheEEcCCCCEEECCCCcccccCcccc-----------------------------------------eecC
Confidence 99999999999999999999999999765321110 0011
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
....++..|+|||...+..++.++|||||||++|||+ + |..||......+....+.. ....+.+..+++.
T Consensus 172 ~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 242 (272)
T cd05075 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIA--TRGQTPYPGVENSEIYDYLRQ-------GNRLKQPPDCLDG 242 (272)
T ss_pred CcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHH
Confidence 2234556799999999999999999999999999999 5 7899988766655544321 1223345577889
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+.+++.+||+.||++|||+++|.+.|++
T Consensus 243 ~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 243 LYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 9999999999999999999999888875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=269.43 Aligned_cols=205 Identities=39% Similarity=0.712 Sum_probs=169.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++++|.+++... ....+++..+..++.|++.||.|||++|++||||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 129 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG-----AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDL 129 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 35789999999999999999999999999999999999732 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++...... .........+
T Consensus 130 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 167 (261)
T cd05068 130 AARNVLVGENNICKVADFGLARVIKEDI------------------------------------------YEAREGAKFP 167 (261)
T ss_pred CcceEEEcCCCCEEECCcceEEEccCCc------------------------------------------ccccCCCcCc
Confidence 9999999999999999999976532110 0011122234
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.+..++.++||||||+++|||+ + |..||.+....+....+.. ....+.+..++..+.+++.
T Consensus 168 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 238 (261)
T cd05068 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIV--TYGRMPYPGMTNAEVLQQVDQ-------GYRMPCPPGCPKELYDIML 238 (261)
T ss_pred eeccCccccccCCCCchhhHHHHHHHHHHHH--hcCCCCCCCCCHHHHHHHHHc-------CCCCCCCCcCCHHHHHHHH
Confidence 6799999999888999999999999999999 6 8999988777666554432 1123345667899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.+|++||+++++...|+.
T Consensus 239 ~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 239 DCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHhhcCcccCCCHHHHHHHHhc
Confidence 9999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=268.80 Aligned_cols=207 Identities=36% Similarity=0.657 Sum_probs=169.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++...+..++||||+++|+|.+++..+ ...+++..+..++.|++.||+|||+.|++||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl 133 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH------DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDL 133 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 46789999999999999999999999999999999999732 346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||++....... ...........+
T Consensus 134 kp~Nili~~~~~~kl~dfg~~~~~~~~~----------------------------------------~~~~~~~~~~~~ 173 (268)
T cd05063 134 AARNILVNSNLECKVSDFGLSRVLEDDP----------------------------------------EGTYTTSGGKIP 173 (268)
T ss_pred chhhEEEcCCCcEEECCCccceeccccc----------------------------------------ccceeccCCCcC
Confidence 9999999999999999999865421110 000011122234
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|||||||++||+++ .|..||......+....+.. ....+.+..++.++.+++.+
T Consensus 174 ~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~-~g~~p~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~~~~li~~ 245 (268)
T cd05063 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS-FGERPYWDMSNHEVMKAIND-------GFRLPAPMDCPSAVYQLMLQ 245 (268)
T ss_pred ceecCHHHhhcCCcChHhHHHHHHHHHHHHHh-CCCCCCCcCCHHHHHHHHhc-------CCCCCCCCCCCHHHHHHHHH
Confidence 67999999998889999999999999999983 28999988776665554432 22334455678899999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||+.+|++||++.+|...|++
T Consensus 246 c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 246 CWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred HcCCCcccCcCHHHHHHHHHh
Confidence 999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.55 Aligned_cols=209 Identities=37% Similarity=0.720 Sum_probs=167.5
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
+++ +||||+++++++...+..++||||+++|+|.+++...... ......+++..+..++.|++.||+|||
T Consensus 50 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH 129 (270)
T cd05047 50 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS 129 (270)
T ss_pred HhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456 7999999999999999999999999999999999754311 012235889999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++|++||||||+||++++++.+||+|||+++.... .
T Consensus 130 ~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~--------------------------------------------~ 165 (270)
T cd05047 130 QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------------------------------------------Y 165 (270)
T ss_pred HCCEeecccccceEEEcCCCeEEECCCCCccccch--------------------------------------------h
Confidence 99999999999999999999999999998642100 0
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
........+..|+|||++....++.++|||||||++|||++ .|..||...+..+....+.. ....+.+..++
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~-~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~~~~ 237 (270)
T cd05047 166 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-LGGTPYCGMTCAELYEKLPQ-------GYRLEKPLNCD 237 (270)
T ss_pred hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHc-CCCCCccccCHHHHHHHHhC-------CCCCCCCCcCC
Confidence 00111233567999999988889999999999999999993 28999988776665544321 12233455677
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.++.+++.+||+.||.+||++++++..|++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 238 DEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 8999999999999999999999998888753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=278.66 Aligned_cols=210 Identities=16% Similarity=0.249 Sum_probs=159.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+. ++|.+++.. ....+++..+..++.||+.||+|||++||+||||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dl 129 (303)
T cd07869 57 LKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK------HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDL 129 (303)
T ss_pred HhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 467899999999999999999999999995 588888863 2346888999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......++
T Consensus 130 kp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 166 (303)
T cd07869 130 KPQNLLISDTGELKLADFGLARAKSVPS-------------------------------------------HTYSNEVVT 166 (303)
T ss_pred CHHHEEECCCCCEEECCCCcceeccCCC-------------------------------------------ccCCCCccc
Confidence 9999999999999999999865311100 011234567
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhhcCCc---------------ccC
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSK---------------QQY 223 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~~~~~---------------~~~ 223 (434)
+.|+|||++.+ ..++.++||||+||++|||+ +|..||.+.... +....+......... ...
T Consensus 167 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T cd07869 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI--QGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFT 244 (303)
T ss_pred CCCCChHHHcCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccccc
Confidence 88999999875 45788999999999999999 899999875432 222211110000000 000
Q ss_pred CCC---------CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 224 LPR---------PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 224 ~~~---------~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
... ....++++.+++.+||+.||++|||+.|+ |+||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 245 LYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 000 01234678999999999999999999999 8899764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=267.16 Aligned_cols=206 Identities=36% Similarity=0.668 Sum_probs=169.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.. ...++|+||+++|+|.+++.... ...+++..++.++.|++.||+|||++|++|+||
T Consensus 50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di 123 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDA-----LGHFLISTLCDYAVQIANGMRYLESKRFIHRDL 123 (257)
T ss_pred HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcc-----cccCcHHHHHHHHHHHHHHHHHHHhCCcccccc
Confidence 467899999999999988 88999999999999999997431 146899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ..+.......++
T Consensus 124 ~p~nil~~~~~~~kl~dfg~~~~~~~~~----------------------------------------~~~~~~~~~~~~ 163 (257)
T cd05040 124 AARNILLASDDKVKIGDFGLMRALPQNE----------------------------------------DHYVMEEHLKVP 163 (257)
T ss_pred CcccEEEecCCEEEeccccccccccccc----------------------------------------cceecccCCCCC
Confidence 9999999999999999999876532111 001111234456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. .....+.+..++..+.+++.
T Consensus 164 ~~y~~pE~~~~~~~~~~~Di~slG~~l~el~--t~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMF--TYGEEPWAGLSGSQILKKIDK------EGERLERPEACPQDIYNVML 235 (257)
T ss_pred ceecCHHHhcccCcCchhhhHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHh------cCCcCCCCccCCHHHHHHHH
Confidence 7899999999889999999999999999999 6 8999988777666554432 12223345567889999999
Q ss_pred HhccCCCCCCCCHHHHHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~ 260 (434)
+||+.+|++||++.++...|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=284.26 Aligned_cols=200 Identities=20% Similarity=0.298 Sum_probs=162.9
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+.+..|+||||+++|+|..++. ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~N 126 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-------RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDN 126 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 69999999999999999999999999999999987 33569999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.++.+||+|||+++...... .......||+.|+
T Consensus 127 ili~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~~y~ 163 (327)
T cd05617 127 VLLDADGHIKLTDYGMCKEGLGPG-------------------------------------------DTTSTFCGTPNYI 163 (327)
T ss_pred EEEeCCCCEEEeccccceeccCCC-------------------------------------------CceecccCCcccC
Confidence 999999999999999865311000 0112346788999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh------HH-HHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN------EQ-VIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
|||++.+..++.++|||||||++|||+ +|..||..... .+ ....+ .......+..++..+.++
T Consensus 164 aPE~~~~~~~~~~~DiwslGvil~ell--~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~p~~~~~~~~~l 233 (327)
T cd05617 164 APEILRGEEYGFSVDWWALGVLMFEMM--AGRSPFDIITDNPDMNTEDYLFQVI--------LEKPIRIPRFLSVKASHV 233 (327)
T ss_pred CHHHHCCCCCCchheeehhHHHHHHHH--hCCCCCCccCCCcccccHHHHHHHH--------HhCCCCCCCCCCHHHHHH
Confidence 999999999999999999999999999 89999964321 11 11111 112233456778999999
Q ss_pred HHHhccCCCCCCCCH------HHH--HHHHHhccc
Q psy5690 238 MLECWKTNETDRPRF------SEI--HLFLQRKNL 264 (434)
Q Consensus 238 i~~cl~~dP~~Rps~------~el--~~~L~~~~~ 264 (434)
+.+||+.||++|+++ +++ |+|++...+
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~ 268 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDW 268 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCH
Confidence 999999999999984 577 778876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=281.03 Aligned_cols=210 Identities=17% Similarity=0.244 Sum_probs=167.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++|+||+++++++.+++..++||||+++|+|.+++.+. ...+++..+..++.||+.||+|||++||+|||||
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~------~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlk 129 (332)
T cd05623 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIK 129 (332)
T ss_pred hhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 4679999999999999999999999999999999999732 3468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ........||+
T Consensus 130 p~Nili~~~~~~kL~DfG~a~~~~~~~------------------------------------------~~~~~~~~gt~ 167 (332)
T cd05623 130 PDNILMDMNGHIRLADFGSCLKLMEDG------------------------------------------TVQSSVAVGTP 167 (332)
T ss_pred HHHEEECCCCCEEEeecchheecccCC------------------------------------------cceecccccCc
Confidence 999999999999999999875421110 00112346889
Q ss_pred cccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 162 RWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 162 ~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
.|+|||++. ...++.++|||||||++|||+ +|..||...+..+....+... ......+.....+++++.+
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell--~g~~Pf~~~~~~~~~~~i~~~---~~~~~~p~~~~~~s~~~~~ 242 (332)
T cd05623 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML--YGETPFYAESLVETYGKIMNH---KERFQFPAQVTDVSEDAKD 242 (332)
T ss_pred cccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh--cCCCCCCCCCHHHHHHHHhCC---CccccCCCccccCCHHHHH
Confidence 999999986 345789999999999999999 899999988777666554321 1111122233467899999
Q ss_pred HHHHhccCCCCC--CCCHHHH--HHHHHhccc
Q psy5690 237 LMLECWKTNETD--RPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 237 li~~cl~~dP~~--Rps~~el--~~~L~~~~~ 264 (434)
++.+|+..+++. |++++|+ |+|+....+
T Consensus 243 li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 243 LIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred HHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 999999665444 6899999 888876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=287.37 Aligned_cols=240 Identities=15% Similarity=0.232 Sum_probs=173.9
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
.+++||||+++++.+.+++..|+||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+|||||
T Consensus 56 ~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~-------~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLk 128 (360)
T cd05627 56 VEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM-------KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128 (360)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCC
Confidence 56899999999999999999999999999999999997 34568999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccc-cccccchhhhhhcccCcccceeecCccccc--cccCCcccccCCCCC
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSD-TKARLPIRWMANCMVGKNYTIKISDHAMYC--SHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~~~~~~ 158 (434)
|+|||++.++.+||+|||+++........... ..... .+....+....... ...............
T Consensus 129 p~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (360)
T cd05627 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN-----------PPSDFSFQNMNSKRKAETWKKNRRQLAYSTV 197 (360)
T ss_pred HHHEEECCCCCEEEeeccCCcccccccccccccccccC-----------CcccccccccccccccccccccccccccccC
Confidence 99999999999999999998754321100000 00000 00000000000000 000000011123457
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+..+. .....+....+++++.+++
T Consensus 198 gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~--tG~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~~~~s~~~~~li 271 (360)
T cd05627 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML--IGYPPFCSETPQETYRKVMNWK----ETLVFPPEVPISEKAKDLI 271 (360)
T ss_pred CCccccCHHHHcCCCCCCcceeccccceeeecc--cCCCCCCCCCHHHHHHHHHcCC----CceecCCCCCCCHHHHHHH
Confidence 899999999999999999999999999999999 8999999888777665554321 1111222234678999999
Q ss_pred HHhccCCCCCCCC---HHHH--HHHHHhcccCC
Q psy5690 239 LECWKTNETDRPR---FSEI--HLFLQRKNLGA 266 (434)
Q Consensus 239 ~~cl~~dP~~Rps---~~el--~~~L~~~~~~~ 266 (434)
.+|+. ||.+|++ ++|+ |+|++..++..
T Consensus 272 ~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 272 LRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred HHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 99874 9999984 7888 88998765543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=266.21 Aligned_cols=213 Identities=16% Similarity=0.242 Sum_probs=167.8
Q ss_pred CCCCCCCC-eeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 1 MCSLKDPN-LVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 1 l~~L~Hpn-Iv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
|++|+|+| ||++++++...+ .+++|+||++. +|.+++...... ...++...++.++.||+.||+|||++
T Consensus 64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~---~~g~~~~~ik~~m~Qll~gl~~~H~~ 139 (323)
T KOG0594|consen 64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKK---PQGLPPRLIKSFMRQLLRGLAFLHSH 139 (323)
T ss_pred HHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhcccc---ccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999 999999998877 79999999976 999999854321 14577789999999999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
+|+||||||+|||++.+|.+||+|||+|+...-+. ..
T Consensus 140 ~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~-------------------------------------------~~ 176 (323)
T KOG0594|consen 140 GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPM-------------------------------------------RT 176 (323)
T ss_pred CeecccCCcceEEECCCCcEeeeccchHHHhcCCc-------------------------------------------cc
Confidence 99999999999999999999999999987532211 01
Q ss_pred CCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc-----------
Q psy5690 154 DTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ----------- 221 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------- 221 (434)
-+...+|..|.|||++.+. .|+...||||+||++.||+ +++.-|.+.++.+....+-+........
T Consensus 177 yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~--~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~ 254 (323)
T KOG0594|consen 177 YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMF--TRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDY 254 (323)
T ss_pred ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHH--hCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccc
Confidence 2456778889999999986 7899999999999999999 7889999888766554443221111000
Q ss_pred ----cCCC-------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 222 ----QYLP-------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 222 ----~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.... .....+++..+++.+||+++|.+|.|++.+ |++|...
T Consensus 255 k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 255 KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 0000 011223578999999999999999999998 7888775
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=265.71 Aligned_cols=203 Identities=36% Similarity=0.703 Sum_probs=166.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++...+..++||||+++|+|.+++... ...+++..+..++.|++.||.|||++|++||||
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl 119 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK------KDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence 35789999999999999999999999999999999998632 245789999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||++....... ........++
T Consensus 120 ~p~nili~~~~~~~l~d~g~~~~~~~~~------------------------------------------~~~~~~~~~~ 157 (250)
T cd05085 120 AARNCLVGENNVLKISDFGMSRQEDDGI------------------------------------------YSSSGLKQIP 157 (250)
T ss_pred ChheEEEcCCCeEEECCCccceeccccc------------------------------------------cccCCCCCCc
Confidence 9999999999999999999865311100 0011122335
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+..++.++||||||+++|+++ + |..||...........+.. ......+..++.++.+++.
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 228 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETF--SLGVCPYPGMTNQQAREQVEK-------GYRMSCPQKCPDDVYKVMQ 228 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHH
Confidence 6799999999888999999999999999999 6 8999988776655544322 1223345567899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~ 260 (434)
+||+.+|++||++.|+.+.|.
T Consensus 229 ~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 229 RCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHcccCcccCCCHHHHHHHhc
Confidence 999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=274.97 Aligned_cols=211 Identities=34% Similarity=0.653 Sum_probs=169.6
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
.+ +||||+++++++..++..++||||+++|+|.+++..++... .....+++..+..++.|++.||+|||+
T Consensus 79 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~ 158 (307)
T cd05098 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS 158 (307)
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 45 79999999999999999999999999999999997543210 123458899999999999999999999
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
+|++||||||+||+++.++.+||+|||+++....... ..
T Consensus 159 ~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~-----------------------------------------~~ 197 (307)
T cd05098 159 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY-----------------------------------------YK 197 (307)
T ss_pred CCcccccccHHheEEcCCCcEEECCCcccccccccch-----------------------------------------hh
Confidence 9999999999999999999999999998754211100 00
Q ss_pred cCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 153 SDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
......++..|+|||++.+..++.++|||||||++|||++ .|..||...+..+....+.. ....+.+..++.
T Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 269 (307)
T cd05098 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-LGGSPYPGVPVEELFKLLKE-------GHRMDKPSNCTN 269 (307)
T ss_pred ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHc-CCCCCCCcCCHHHHHHHHHc-------CCCCCCCCcCCH
Confidence 0112233467999999998889999999999999999993 28889987776665544321 223344567789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++.+++.+||..+|++||++.+++..|++.
T Consensus 270 ~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 270 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999998888774
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=288.90 Aligned_cols=211 Identities=14% Similarity=0.181 Sum_probs=163.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||++++++...+..|+|||++. ++|.+++. ....+++..++.++.||+.||+|||++||+||||
T Consensus 140 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-------~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDl 211 (392)
T PHA03207 140 LKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD-------RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDV 211 (392)
T ss_pred HHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 467899999999999999999999999995 68999885 3457899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.++|+|||+++...... .........||
T Consensus 212 kp~Nill~~~~~~~l~DfG~a~~~~~~~-----------------------------------------~~~~~~~~~gt 250 (392)
T PHA03207 212 KTENIFLDEPENAVLGDFGAACKLDAHP-----------------------------------------DTPQCYGWSGT 250 (392)
T ss_pred CHHHEEEcCCCCEEEccCccccccCccc-----------------------------------------ccccccccccc
Confidence 9999999999999999999976422110 00111245688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH---HHHhhhhhhh-------------------cC
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ---VIENCSHWYQ-------------------NN 218 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~---~~~~~~~~~~-------------------~~ 218 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||.+..... ....+..... ..
T Consensus 251 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~--~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (392)
T PHA03207 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMS--VKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQY 328 (392)
T ss_pred cCccCHhHhcCCCCCchhhHHHHHHHHHHHH--HCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhh
Confidence 9999999999999999999999999999999 8899997654221 1111111000 00
Q ss_pred CcccCC--CC-----CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 SKQQYL--PR-----PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 ~~~~~~--~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
....+. .. ...++.++.++|.+||..||++||++.|+ |+||++.
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 329 AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 000000 00 12346788999999999999999999998 8999764
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=268.96 Aligned_cols=207 Identities=36% Similarity=0.678 Sum_probs=169.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||++|++||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dl 132 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH------DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDL 132 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhh
Confidence 35789999999999999999999999999999999999732 246899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++...... ..........++
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~~----------------------------------------~~~~~~~~~~~~ 172 (267)
T cd05066 133 AARNILVNSNLVCKVSDFGLSRVLEDDP----------------------------------------EAAYTTRGGKIP 172 (267)
T ss_pred chhcEEECCCCeEEeCCCCccccccccc----------------------------------------ceeeecCCCccc
Confidence 9999999999999999999876532110 000011122334
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+|||||++||+++ .|..||......+....+.+ ....+.+..+++.+.+++.+
T Consensus 173 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~ 244 (267)
T cd05066 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-YGERPYWEMSNQDVIKAIEE-------GYRLPAPMDCPAALHQLMLD 244 (267)
T ss_pred eeecCHhHhccCccCchhhhHHHHHHHHHHhc-CCCCCcccCCHHHHHHHHhC-------CCcCCCCCCCCHHHHHHHHH
Confidence 67999999998889999999999999999883 38999988776655544432 12234456678899999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||+.+|.+||++.++++.|++
T Consensus 245 ~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 245 CWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred HcccCchhCCCHHHHHHHHHh
Confidence 999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=284.72 Aligned_cols=206 Identities=21% Similarity=0.378 Sum_probs=176.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+..+||+||++++.|..++.+||+.|||.||-.+..+-. -+..+++.++.-+++|++.||.|||+++||||||
T Consensus 83 La~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE------L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDL 156 (1187)
T KOG0579|consen 83 LAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE------LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDL 156 (1187)
T ss_pred hhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH------hccccchHHHHHHHHHHHHHHHHHhhcchhhhhc
Confidence 4567899999999999999999999999999999999863 4468999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|..|||++.+|.++|+|||.+-.. ........+..||
T Consensus 157 KAGNiL~TldGdirLADFGVSAKn-------------------------------------------~~t~qkRDsFIGT 193 (1187)
T KOG0579|consen 157 KAGNILLTLDGDIRLADFGVSAKN-------------------------------------------KSTRQKRDSFIGT 193 (1187)
T ss_pred cccceEEEecCcEeeecccccccc-------------------------------------------hhHHhhhccccCC
Confidence 999999999999999999985321 0111123456789
Q ss_pred ccccchhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 161 IRWMAWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 161 ~~y~aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
+.|||||+..+ .+|++++||||||++|.||. .+.+|-...+...++-.+. ......+..|..++..+.
T Consensus 194 PYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMA--qiEPPHhelnpMRVllKia-----KSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 194 PYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMA--QIEPPHHELNPMRVLLKIA-----KSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred cccccchheeeccccCCCchhhhhHHhhhhHHHHHh--ccCCCccccchHHHHHHHh-----hcCCCcccCcchhhhHHH
Confidence 99999998864 57899999999999999999 8999999988887765543 234455556889999999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+++.+||..||..||+++++ |+|++..
T Consensus 267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 99999999999999999999 8888754
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=271.24 Aligned_cols=201 Identities=21% Similarity=0.275 Sum_probs=164.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++|+||+++++|.+++. ....+++..+..++.|++.||.|||+.|++||||
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl 130 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK-------AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDI 130 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH-------HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 357899999999999999999999999999999999997 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||+++....... .........++
T Consensus 131 ~p~nilv~~~~~~~l~dfg~~~~~~~~~~----------------------------------------~~~~~~~~~~~ 170 (263)
T cd06625 131 KGANILRDSAGNVKLGDFGASKRLQTICS----------------------------------------SGTGMKSVTGT 170 (263)
T ss_pred CHHHEEEcCCCCEEEeecccceecccccc----------------------------------------ccccccCCCcC
Confidence 99999999999999999998754211100 00000223456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++||||||+++|||+ +|+.||.............. .......+..++..+.+++.+
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~ 242 (263)
T cd06625 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEML--TEKPPWAEFEAMAAIFKIAT------QPTNPQLPSHVSPDARNFLRR 242 (263)
T ss_pred ccccCcceeccCCCCchhhhHHHHHHHHHHH--hCCCCccccchHHHHHHHhc------cCCCCCCCccCCHHHHHHHHH
Confidence 7899999999988999999999999999999 88999987655544332221 122334456788999999999
Q ss_pred hccCCCCCCCCHHHHH
Q psy5690 241 CWKTNETDRPRFSEIH 256 (434)
Q Consensus 241 cl~~dP~~Rps~~el~ 256 (434)
||..+|++||++.+++
T Consensus 243 ~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 243 TFVENAKKRPSAEELL 258 (263)
T ss_pred HhhcCcccCCCHHHHh
Confidence 9999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=266.75 Aligned_cols=202 Identities=31% Similarity=0.622 Sum_probs=165.4
Q ss_pred CCCCCCCCeeeEEEEE-ecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVC-STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
+++++|+|++++++++ ..++..++|+||+++|+|.++++.. ....+++..+..++.|++.||+|||++|++|||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 127 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-----GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127 (256)
T ss_pred HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccc
Confidence 4678999999999976 4556799999999999999999743 223588999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||++++++.+||+|||+++..... .....+
T Consensus 128 lkp~nil~~~~~~~kl~dfg~~~~~~~~----------------------------------------------~~~~~~ 161 (256)
T cd05082 128 LAARNVLVSEDNVAKVSDFGLTKEASST----------------------------------------------QDTGKL 161 (256)
T ss_pred cchheEEEcCCCcEEecCCccceecccc----------------------------------------------CCCCcc
Confidence 9999999999999999999986541110 011223
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+..|+|||++....++.++|||||||++|||++ .|..||......+....+.. ......+..+++.+.+++.
T Consensus 162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS-FGRVPYPRIPLKDVVPRVEK-------GYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred ceeecCHHHHccCCCCchhhhHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhc-------CCCCCCCCCCCHHHHHHHH
Confidence 457999999998889999999999999999993 28999987776665544432 1222345677899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.+|++|||+.++.+.|++
T Consensus 234 ~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 234 QCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHhcCChhhCcCHHHHHHHHhc
Confidence 9999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=284.43 Aligned_cols=205 Identities=19% Similarity=0.263 Sum_probs=165.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++.+++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+|||||
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk 169 (371)
T cd05622 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169 (371)
T ss_pred HhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 567999999999999999999999999999999999862 247888999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ........||+
T Consensus 170 p~NIll~~~~~ikL~DfG~a~~~~~~~------------------------------------------~~~~~~~~gt~ 207 (371)
T cd05622 170 PDNMLLDKSGHLKLADFGTCMKMNKEG------------------------------------------MVRCDTAVGTP 207 (371)
T ss_pred HHHEEECCCCCEEEEeCCceeEcCcCC------------------------------------------cccccCcccCc
Confidence 999999999999999999976421110 01113456889
Q ss_pred cccchhhhhcCC----CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 162 RWMAWESLLLGK----NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 162 ~y~aPE~~~~~~----~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.|+|||++.+.. ++.++|||||||++|||+ +|..||...+.......+... ......+....++.++.++
T Consensus 208 ~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell--~G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~l 281 (371)
T cd05622 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML--VGDTPFYADSLVGTYSKIMNH----KNSLTFPDDNDISKEAKNL 281 (371)
T ss_pred cccCHHHHhccCCCccCCCccceeehhHHHHHHH--hCCCCCCCCCHHHHHHHHHcC----CCcccCCCcCCCCHHHHHH
Confidence 999999997543 788999999999999999 899999988776665554321 1112233345688999999
Q ss_pred HHHhccCCCCC--CCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETD--RPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~--Rps~~el--~~~L~~~ 262 (434)
+.+||..++.+ |++++|+ |+|+++.
T Consensus 282 i~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 282 ICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999844433 7799999 7788764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=266.66 Aligned_cols=204 Identities=36% Similarity=0.663 Sum_probs=167.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+|++++++++. .+..+++|||+++|+|.+++... ....+++..+..++.|++.||+|||++|++||||
T Consensus 55 l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di 128 (260)
T cd05070 55 MKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDG-----EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDL 128 (260)
T ss_pred HHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 46789999999999885 45689999999999999999732 2345899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||++++++.++|+|||++....... ........++
T Consensus 129 ~p~Nili~~~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 166 (260)
T cd05070 129 RSANILVGDGLVCKIADFGLARLIEDNE------------------------------------------YTARQGAKFP 166 (260)
T ss_pred ccceEEEeCCceEEeCCceeeeeccCcc------------------------------------------cccccCCCCC
Confidence 9999999999999999999875421110 0011122345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.+..++.++||||||+++|+|+ + |..||.+....+....+.. ....+.+...+..+.+++.
T Consensus 167 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05070 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELV--TKGRVPYPGMNNREVLEQVER-------GYRMPCPQDCPISLHELML 237 (260)
T ss_pred ccccChHHHhcCCCcchhhhHHHHHHHHHHH--hcCCCCCCCCCHHHHHHHHHc-------CCCCCCCCcCCHHHHHHHH
Confidence 6799999998888999999999999999999 5 8899988776665554321 2233445677899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||..||++|||++++.++|++
T Consensus 238 ~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 238 QCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=273.86 Aligned_cols=206 Identities=33% Similarity=0.655 Sum_probs=166.4
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++ +||||+++++++...+..++||||+.+|+|.++++.. ....+++.++..++.|++.||+|||+++++|+||
T Consensus 93 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 167 (302)
T cd05055 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-----RESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167 (302)
T ss_pred HhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 467 7999999999999999999999999999999999732 2234899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++++|||+++...... .........++
T Consensus 168 kp~Nil~~~~~~~~l~dfg~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 206 (302)
T cd05055 168 AARNVLLTHGKIVKICDFGLARDIMNDS-----------------------------------------NYVVKGNARLP 206 (302)
T ss_pred ccceEEEcCCCeEEECCCcccccccCCC-----------------------------------------ceeecCCCCcc
Confidence 9999999999999999999875421110 00011223456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.+..++.++||||+||++|||+ + |..||......+....... .......+...++++.+++.
T Consensus 207 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~--t~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~ 278 (302)
T cd05055 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIF--SLGSNPYPGMPVDSKFYKLIK------EGYRMAQPEHAPAEIYDIMK 278 (302)
T ss_pred cccCCHhhhccCCCCcHhHHHHHHHHHHHHH--hCCCCCcCCCCchHHHHHHHH------cCCcCCCCCCCCHHHHHHHH
Confidence 7899999999999999999999999999999 6 8899987665544322211 11122334556789999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.+|++||++.|+++.|++
T Consensus 279 ~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 279 TCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred HHcCCCchhCcCHHHHHHHHHh
Confidence 9999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=280.27 Aligned_cols=199 Identities=24% Similarity=0.362 Sum_probs=165.7
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+|++|+++++++.+++..|+||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~-------~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~N 131 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-------QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDN 131 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 56888899999999999999999999999999997 34569999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.++.+||+|||+++...... .......||..|+
T Consensus 132 ill~~~~~ikL~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~~y~ 168 (323)
T cd05615 132 VMLDSEGHIKIADFGMCKEHMVDG-------------------------------------------VTTRTFCGTPDYI 168 (323)
T ss_pred eEECCCCCEEEeccccccccCCCC-------------------------------------------ccccCccCCcccc
Confidence 999999999999999865311100 0112345788999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 244 (434)
|||++.+..++.++||||+||++|||+ +|..||......+....+.. .....+..++.++.+++.+||+.
T Consensus 169 aPE~~~~~~~~~~~DiwslGvil~ell--tG~~pf~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 169 APEIIAYQPYGKSVDWWAYGVLLYEML--AGQPPFDGEDEDELFQSIME--------HNVSYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred CHHHHcCCCCCCccchhhhHHHHHHHH--hCCCCCCCCCHHHHHHHHHh--------CCCCCCccCCHHHHHHHHHHccc
Confidence 999999999999999999999999999 89999998877766655432 11233556788999999999999
Q ss_pred CCCCCCCH-----HHH--HHHHHhcc
Q psy5690 245 NETDRPRF-----SEI--HLFLQRKN 263 (434)
Q Consensus 245 dP~~Rps~-----~el--~~~L~~~~ 263 (434)
||.+|++. +++ |+|++..+
T Consensus 239 ~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 239 HPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred CHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 99999974 455 67776543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=266.82 Aligned_cols=204 Identities=36% Similarity=0.641 Sum_probs=166.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|||++++++++. .+..++||||+.+|+|.+++... ....+++..+..++.|++.||.|||+.|++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl 128 (260)
T cd05069 55 MKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG-----DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128 (260)
T ss_pred HHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 35789999999999885 45689999999999999999732 2345789999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||++++++.++|+|||+++...... ........++
T Consensus 129 ~~~Nill~~~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 166 (260)
T cd05069 129 RAANILVGDNLVCKIADFGLARLIEDNE------------------------------------------YTARQGAKFP 166 (260)
T ss_pred CcceEEEcCCCeEEECCCccceEccCCc------------------------------------------ccccCCCccc
Confidence 9999999999999999999875421110 0011223345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||...+..++.++||||||+++|||+ + |..||.+....+....+.. ....+.+...+..+.+++.
T Consensus 167 ~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05069 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELV--TKGRVPYPGMVNREVLEQVER-------GYRMPCPQGCPESLHELMK 237 (260)
T ss_pred hhhCCHHHhccCCcChHHHHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCcccCHHHHHHHH
Confidence 7799999999888999999999999999999 6 8999988776665544322 1223345567899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.||++||++++|.++|++
T Consensus 238 ~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 238 LCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHccCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=278.20 Aligned_cols=218 Identities=15% Similarity=0.234 Sum_probs=162.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||++++++|..++..++||||+++|+|.+++..+ ....+++..+..++.|++.||+|||++||+|||||
T Consensus 54 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlk 128 (327)
T cd08227 54 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH-----FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVK 128 (327)
T ss_pred HhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence 5689999999999999999999999999999999999643 12358899999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.++++||+.+........ ..... ........++.
T Consensus 129 p~Nil~~~~~~~~l~~~~~~~~~~~~~~--------------------------------~~~~~----~~~~~~~~~~~ 172 (327)
T cd08227 129 ASHILISVDGKVYLSGLRSNLSMINHGQ--------------------------------RLRVV----HDFPKYSVKVL 172 (327)
T ss_pred hhhEEEecCCcEEEcccchhhccccccc--------------------------------ccccc----cccccccccee
Confidence 9999999999999999986432111000 00000 00011234567
Q ss_pred cccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc-C--------------------
Q psy5690 162 RWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN-N-------------------- 218 (434)
Q Consensus 162 ~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~-~-------------------- 218 (434)
.|+|||++.+ ..++.++|||||||++|||+ +|..||......+........... .
T Consensus 173 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T cd08227 173 PWLSPEVLQQNLQGYDAKSDIYSVGITACELA--NGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGA 250 (327)
T ss_pred cccChHHhhcccCCCCchhhHHHHHHHHHHHH--HCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCC
Confidence 7999999976 45889999999999999999 899999876544332211100000 0
Q ss_pred -----------------CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 -----------------SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 -----------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
......+....+++++.+++.+||+.||++|||++|+ |+|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 251 NSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0000001122456789999999999999999999999 7899764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.61 Aligned_cols=207 Identities=18% Similarity=0.222 Sum_probs=168.0
Q ss_pred CCCCCCCeeeEEEEEecCC--------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 2 CSLKDPNLVRVIGVCSTED--------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
..++|+||+++++.+...+ .+++||||+++|+|.+++..+. .....+++..+..++.|++.||+|||++
T Consensus 86 ~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~---~~~~~l~e~~~~~i~~qll~aL~~lH~~ 162 (496)
T PTZ00283 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRA---KTNRTFREHEAGLLFIQVLLAVHHVHSK 162 (496)
T ss_pred hcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678999999998875432 2689999999999999997432 1345789999999999999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
||+||||||+|||++.++.+||+|||+++...... ....
T Consensus 163 ~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~-----------------------------------------~~~~ 201 (496)
T PTZ00283 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV-----------------------------------------SDDV 201 (496)
T ss_pred CEecCCCCHHHEEEeCCCCEEEEecccCeeccccc-----------------------------------------cccc
Confidence 99999999999999999999999999976522110 0001
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
.....||+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+. .....+.+..++++
T Consensus 202 ~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLl--tG~~Pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 272 (496)
T PTZ00283 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL--TLKRPFDGENMEEVMHKTL-------AGRYDPLPPSISPE 272 (496)
T ss_pred cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHh-------cCCCCCCCCCCCHH
Confidence 23456889999999999999999999999999999999 8999998877766554432 12233456778899
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+.+++.+||+.||++||++.++ |++++.
T Consensus 273 l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 273 MQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999 455443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=266.62 Aligned_cols=199 Identities=19% Similarity=0.291 Sum_probs=165.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl 127 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ-----RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDI 127 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 36789999999999999999999999999999999999743 2356889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++...... .......++
T Consensus 128 ~~~nili~~~~~~~l~df~~~~~~~~~~-------------------------------------------~~~~~~~~~ 164 (256)
T cd08529 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNT-------------------------------------------NFANTIVGT 164 (256)
T ss_pred CcceEEEeCCCCEEEcccccceeccCcc-------------------------------------------chhhccccC
Confidence 9999999999999999999865422110 011223466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|+|||||++|+|+ +|..||...+..+....+. .....+.+..++.++.+++.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECC--TGKHPFDANNQGALILKII-------RGVFPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred ccccCHHHhcCCCCCCccchHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHH-------cCCCCCCccccCHHHHHHHHH
Confidence 7899999999998999999999999999999 8999998887655544332 122333344678899999999
Q ss_pred hccCCCCCCCCHHHHH
Q psy5690 241 CWKTNETDRPRFSEIH 256 (434)
Q Consensus 241 cl~~dP~~Rps~~el~ 256 (434)
||+.+|++||++.+++
T Consensus 236 ~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 236 CLTKDYRQRPDTFQLL 251 (256)
T ss_pred HccCCcccCcCHHHHh
Confidence 9999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=279.76 Aligned_cols=205 Identities=20% Similarity=0.179 Sum_probs=176.3
Q ss_pred CCCCC-CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLK-DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++|. |||||+++++|++...+++|||+|.||.|.+.+.+. .+++..+..++.|++.|+.|||+.||+|||
T Consensus 89 l~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~gvvHrD 160 (382)
T KOG0032|consen 89 LQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSLGVVHRD 160 (382)
T ss_pred HHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhCCceecc
Confidence 46777 999999999999999999999999999999999732 399999999999999999999999999999
Q ss_pred CCCCCeeeecC----CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 80 LAARNCMVGKN----YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 80 lkp~NILl~~~----~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
|||+|+|+... +.+|++|||++..... .....
T Consensus 161 lKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--------------------------------------------~~~~~ 196 (382)
T KOG0032|consen 161 LKPENLLLASKDEGSGRIKLIDFGLAKFIKP--------------------------------------------GERLH 196 (382)
T ss_pred CCHHHeeeccccCCCCcEEEeeCCCceEccC--------------------------------------------CceEe
Confidence 99999999643 4799999999866322 11235
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
..+||+.|+|||++....|+..+||||+||++|.|+ +|..||.+.+.......+...- .....+....++..+.
T Consensus 197 ~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL--~G~~PF~~~~~~~~~~~i~~~~----~~f~~~~w~~is~~ak 270 (382)
T KOG0032|consen 197 TIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILL--SGVPPFWGETEFEIFLAILRGD----FDFTSEPWDDISESAK 270 (382)
T ss_pred eecCCccccCchhhcCCCCCcccchhHHHHHHHHHh--hCCCCCcCCChhHHHHHHHcCC----CCCCCCCccccCHHHH
Confidence 678999999999999999999999999999999999 9999999999888777654321 1223344567789999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+++.+|+..||.+|+++.++ |+|++...
T Consensus 271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 271 DFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred HHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 99999999999999999999 88988753
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=268.01 Aligned_cols=196 Identities=27% Similarity=0.418 Sum_probs=155.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++..+...++||||+++|+|..++.. ....+++..+..++.||++||+|||++||+||||
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 131 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR------KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNV 131 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCC
Confidence 3578999999999999999999999999999999999863 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCc-------eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 81 AARNCMVGKNYT-------IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 81 kp~NILl~~~~~-------~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
||+|||++.++. ++++|||++.... .
T Consensus 132 kp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~-----------------------------------------------~ 164 (262)
T cd05077 132 CTKNILLAREGIDGECGPFIKLSDPGIPITVL-----------------------------------------------S 164 (262)
T ss_pred CcccEEEecCCccCCCCceeEeCCCCCCcccc-----------------------------------------------C
Confidence 999999987654 8999999854310 0
Q ss_pred CCCCCCCccccchhhhh-cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 154 DTKARLPIRWMAWESLL-LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~-~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
.....++..|+|||.+. +..++.++|||||||++|||++ .|..||......+...... . ........++
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~-~~~~p~~~~~~~~~~~~~~-------~--~~~~~~~~~~ 234 (262)
T cd05077 165 RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY-NGEIPLKDKTLAEKERFYE-------G--QCMLVTPSCK 234 (262)
T ss_pred cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHh-CCCCCCCCcchhHHHHHHh-------c--CccCCCCChH
Confidence 12234567799999987 4668999999999999999974 4788887665443322110 0 1111233467
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L 259 (434)
++.+++.+||+.||.+||++.+|+..+
T Consensus 235 ~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 235 ELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 899999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.20 Aligned_cols=212 Identities=20% Similarity=0.232 Sum_probs=165.6
Q ss_pred CCCCCCCCeeeEEEEEecCC-----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED-----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|+.++|||||++.-+|.... ...+||||++. +|.++++... ..+..++...++-+..||.+||.|||+.||
T Consensus 71 m~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~---~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~I 146 (364)
T KOG0658|consen 71 MRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYT---RANQRMPLLEIKLYTYQLFRGLAYLHSHGI 146 (364)
T ss_pred HHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHh---hcCCCCceeeeHHHHHHHHHHHHHHHhcCc
Confidence 56899999999998885432 35689999987 9999997421 235678888999999999999999999999
Q ss_pred cccCCCCCCeeeecC-CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 76 VHRDLAARNCMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 76 iHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
+||||||+|+|+|.+ |.+||||||.|+...... ..
T Consensus 147 cHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e--------------------------------------------pn 182 (364)
T KOG0658|consen 147 CHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE--------------------------------------------PN 182 (364)
T ss_pred ccCCCChheEEEcCCCCeEEeccCCcceeeccCC--------------------------------------------Cc
Confidence 999999999999976 899999999987743221 11
Q ss_pred CCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC--------c-----
Q psy5690 155 TKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS--------K----- 220 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~----- 220 (434)
.+...+.-|.|||.+.+ ..|+.+.||||.||++.||+ .|++-|.+.+..+....+.+.+.... .
T Consensus 183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl--~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~ 260 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELL--KGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF 260 (364)
T ss_pred eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHh--cCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence 23344567999999987 46899999999999999999 89999999876655544432211100 0
Q ss_pred --ccC------CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 221 --QQY------LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 221 --~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
... .-.....+++..+|+.++|.++|.+|.++.|+ |+++...
T Consensus 261 ~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 261 KFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred cCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 000 01234567899999999999999999999999 8888775
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=265.86 Aligned_cols=208 Identities=36% Similarity=0.702 Sum_probs=164.4
Q ss_pred CCCCCCCCeeeEEEEEe-cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCS-TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|+.++||||+++++++. .++..++||||+.+|+|.+++.+. ....++..+..++.|+++||+|||+.+++|||
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 123 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE------THNPTVKDLIGFGLQVAKGMEYLASKKFVHRD 123 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 46789999999999875 456689999999999999999732 23467778899999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++........ .........+
T Consensus 124 lk~~nili~~~~~~kl~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~ 164 (262)
T cd05058 124 LAARNCMLDESFTVKVADFGLARDIYDKEYY---------------------------------------SVHNHTGAKL 164 (262)
T ss_pred cCcceEEEcCCCcEEECCccccccccCCcce---------------------------------------eecccccCcC
Confidence 9999999999999999999987642211100 0001123345
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
+..|+|||.+.+..++.++|||||||++|||+ + |..||......+....+. .....+.+..+++.+.+++
T Consensus 165 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~--~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li 235 (262)
T cd05058 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELM--TRGAPPYPDVDSFDITVYLL-------QGRRLLQPEYCPDPLYEVM 235 (262)
T ss_pred CccccChhHhccCccchHHHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHh-------cCCCCCCCCcCCHHHHHHH
Confidence 66799999999889999999999999999999 5 567777666555443332 1223333456778999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.+||+.+|++||++.++...|++.
T Consensus 236 ~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 236 LSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred HHHcCCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=268.92 Aligned_cols=206 Identities=31% Similarity=0.610 Sum_probs=166.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++.. ...++++||+++|+|.+++... ...+++..+..++.|++.||+|||++||+|||||
T Consensus 64 ~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlk 136 (279)
T cd05109 64 AGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVREN------KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLA 136 (279)
T ss_pred HhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 56899999999999865 4578999999999999999732 3468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||+++++.+||+|||+++....... ........++.
T Consensus 137 p~Nil~~~~~~~kL~dfG~~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 175 (279)
T cd05109 137 ARNVLVKSPNHVKITDFGLARLLDIDET-----------------------------------------EYHADGGKVPI 175 (279)
T ss_pred cceEEEcCCCcEEECCCCceeecccccc-----------------------------------------eeecCCCccch
Confidence 9999999999999999999765321110 00011223456
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||.+.+..++.++|||||||++|||++ .|..||...........+. .....+.+..++.++.+++.+|
T Consensus 176 ~y~~PE~~~~~~~~~~~Di~slG~~l~el~t-~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~ 247 (279)
T cd05109 176 KWMALESILHRRFTHQSDVWSYGVTVWELMT-FGAKPYDGIPAREIPDLLE-------KGERLPQPPICTIDVYMIMVKC 247 (279)
T ss_pred hhCCHHHhccCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCHHHHHHHHH-------CCCcCCCCccCCHHHHHHHHHH
Confidence 7999999998899999999999999999993 2889998776655544332 1223334566789999999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhcc
Q psy5690 242 WKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 242 l~~dP~~Rps~~el~~~L~~~~ 263 (434)
|+.||++||++.+++..|++..
T Consensus 248 l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 248 WMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred cCCChhhCcCHHHHHHHHHHhh
Confidence 9999999999999988887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=269.21 Aligned_cols=196 Identities=29% Similarity=0.399 Sum_probs=156.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+++..++||||+++|+|..++.+ ....+++..+..++.||+.||+|||++||+||||
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dl 143 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK------EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNV 143 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCC
Confidence 4678999999999999999999999999999999999863 2356889999999999999999999999999999
Q ss_pred CCCCeeeecCC-------ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 81 AARNCMVGKNY-------TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 81 kp~NILl~~~~-------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
||+|||++..+ .+|++|||++.... .
T Consensus 144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~-----------------------------------------------~ 176 (274)
T cd05076 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTAL-----------------------------------------------S 176 (274)
T ss_pred CcccEEEeccCcccCccceeeecCCccccccc-----------------------------------------------c
Confidence 99999997643 37999999753310 0
Q ss_pred CCCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 154 DTKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
.....++..|+|||.+.+ ..++.++|||||||++||+++ +|..||......+...... . ....+....+
T Consensus 177 ~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~-~g~~p~~~~~~~~~~~~~~-------~--~~~~~~~~~~ 246 (274)
T cd05076 177 REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF-DGEVPLKERTPSEKERFYE-------K--KHRLPEPSCK 246 (274)
T ss_pred ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHh-CCCCCccccChHHHHHHHH-------h--ccCCCCCCCh
Confidence 012235567999998875 567999999999999999953 6889998766554332111 0 1112233457
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L 259 (434)
++.+++.+||+.+|++||++.+|+..|
T Consensus 247 ~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 247 ELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 899999999999999999999997765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=290.64 Aligned_cols=213 Identities=17% Similarity=0.205 Sum_probs=161.9
Q ss_pred CCCCCCCCeeeEEEEEecC--------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
|++++|||||++++++... ..+++||||+++ +|.+++.... .....+++..++.++.||+.||+|||+
T Consensus 113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~gL~yLH~ 188 (440)
T PTZ00036 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYA---RNNHALPLFLVKLYSYQLCRALAYIHS 188 (440)
T ss_pred HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999987432 236799999975 7887775321 134578999999999999999999999
Q ss_pred CCccccCCCCCCeeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 73 RDIVHRDLAARNCMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
+||+||||||+|||++.++ .+||+|||+++......
T Consensus 189 ~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~------------------------------------------- 225 (440)
T PTZ00036 189 KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ------------------------------------------- 225 (440)
T ss_pred CCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC-------------------------------------------
Confidence 9999999999999998665 69999999976421100
Q ss_pred ccCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC-----------
Q psy5690 152 LSDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS----------- 219 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 219 (434)
......+|+.|+|||++.+. .++.++|||||||++|||+ +|..||.+....+....+........
T Consensus 226 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell--tG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~ 302 (440)
T PTZ00036 226 -RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI--LGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY 302 (440)
T ss_pred -CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence 11234567889999998764 6899999999999999999 89999988776554443322110000
Q ss_pred ----------cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 220 ----------KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 220 ----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.......+...++++.+|+.+||++||.+|||+.|+ |+||+...
T Consensus 303 ~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 303 ADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000011234567899999999999999999999999 89998753
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=261.56 Aligned_cols=209 Identities=21% Similarity=0.257 Sum_probs=169.1
Q ss_pred CCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
.+.+|||||.+-++.... +.+|+|||||+. ||..++.. -..++...++..++.|+++|++|||.+.|+|||
T Consensus 130 l~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~------m~q~F~~~evK~L~~QlL~glk~lH~~wilHRD 202 (419)
T KOG0663|consen 130 LKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET------MKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRD 202 (419)
T ss_pred HhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh------ccCCCchHHHHHHHHHHHHHHHHHhhceeEecc
Confidence 467899999999987543 569999999988 99999973 336899999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
||++|+|++..|.+||+|||+||.++.+.. .-+..+.
T Consensus 203 LK~SNLLm~~~G~lKiaDFGLAR~ygsp~k-------------------------------------------~~T~lVV 239 (419)
T KOG0663|consen 203 LKTSNLLLSHKGILKIADFGLAREYGSPLK-------------------------------------------PYTPLVV 239 (419)
T ss_pred cchhheeeccCCcEEecccchhhhhcCCcc-------------------------------------------cCcceEE
Confidence 999999999999999999999988654421 1255677
Q ss_pred CccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc--------------c--
Q psy5690 160 PIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ--------------Q-- 222 (434)
Q Consensus 160 t~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~-- 222 (434)
|..|.|||.+.+. .|+.+.|+||+|||+.||+ .+++-|.+.+..+....|-..+...... .
T Consensus 240 TLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l--~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~ 317 (419)
T KOG0663|consen 240 TLWYRAPELLLGAKTYSTAVDMWSVGCIFAELL--TQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFS 317 (419)
T ss_pred EeeecCHHHhcCCcccCcchhhhhHHHHHHHHH--hcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccC
Confidence 8999999999975 5899999999999999999 8899999888776665554322110000 0
Q ss_pred -------CCCCCC-ccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 223 -------YLPRPA-TCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 223 -------~~~~~~-~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+...+. ..++.-.+|+..+|.+||.+|.|++|. |.|+.+.
T Consensus 318 ~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 318 EHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred CCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 000111 156888999999999999999999998 8899874
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=269.18 Aligned_cols=213 Identities=33% Similarity=0.653 Sum_probs=170.2
Q ss_pred CCCCCCCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCN-SQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++.. +...++++||+++|+|.+++...... ......+++..++.++.|++.||+|||+++++||
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 141 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK 141 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 457899999999998765 57789999999999999999754311 1112568999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||++++++.+||+|||+++....... ........
T Consensus 142 di~p~nil~~~~~~~kl~d~g~~~~~~~~~~-----------------------------------------~~~~~~~~ 180 (280)
T cd05043 142 DIAARNCVIDEELQVKITDNALSRDLFPMDY-----------------------------------------HCLGDNEN 180 (280)
T ss_pred ccCHhhEEEcCCCcEEECCCCCcccccCCce-----------------------------------------EEeCCCCC
Confidence 9999999999999999999999765322110 00011223
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
++..|+|||++.+..++.++|||||||++||++ + |..||......+....+.. ......+..+++++.++
T Consensus 181 ~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l 251 (280)
T cd05043 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELM--TLGQTPYVEIDPFEMAAYLKD-------GYRLAQPINCPDELFAV 251 (280)
T ss_pred cchhccCHHHHhcCCCCchhhHHHhHHHHHHHh--cCCCCCcCcCCHHHHHHHHHc-------CCCCCCCCcCCHHHHHH
Confidence 456799999999888999999999999999999 6 8999988776655443321 12233345678899999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+.+||..||++||++.++...|++..
T Consensus 252 i~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 252 MACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 99999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=279.58 Aligned_cols=211 Identities=17% Similarity=0.236 Sum_probs=166.8
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++|+||+++++++.+++..|+||||+++|+|.+++.+. ...+++..+..++.|++.||+|||++||+|||||
T Consensus 56 ~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlk 129 (331)
T cd05624 56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF------EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK 129 (331)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCc
Confidence 4578999999999999999999999999999999999732 3468899999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ........||+
T Consensus 130 p~Nill~~~~~~kl~DfG~a~~~~~~~------------------------------------------~~~~~~~~gt~ 167 (331)
T cd05624 130 PDNVLLDMNGHIRLADFGSCLKMNQDG------------------------------------------TVQSSVAVGTP 167 (331)
T ss_pred hHHEEEcCCCCEEEEeccceeeccCCC------------------------------------------ceeeccccCCc
Confidence 999999999999999999975421110 00112345889
Q ss_pred cccchhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 162 RWMAWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 162 ~y~aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
.|+|||++.+ +.++.++|||||||++|||+ +|..||...+..+....+... ......+.....+++++.+
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell--~g~~Pf~~~~~~~~~~~i~~~---~~~~~~p~~~~~~~~~~~~ 242 (331)
T cd05624 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML--YGETPFYAESLVETYGKIMNH---EERFQFPSHITDVSEEAKD 242 (331)
T ss_pred ccCCHHHHhccccCCCCCCCcccEEeeehhhhhhh--hCCCCccCCCHHHHHHHHHcC---CCcccCCCccccCCHHHHH
Confidence 9999999876 46788999999999999999 899999887766655544321 1111122223456889999
Q ss_pred HHHHhccCCCCC--CCCHHHH--HHHHHhcccC
Q psy5690 237 LMLECWKTNETD--RPRFSEI--HLFLQRKNLG 265 (434)
Q Consensus 237 li~~cl~~dP~~--Rps~~el--~~~L~~~~~~ 265 (434)
++.+|+..++.+ |++++++ |+|++...+.
T Consensus 243 li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 243 LIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred HHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 999999876544 4688998 7888765443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=265.70 Aligned_cols=202 Identities=33% Similarity=0.646 Sum_probs=168.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++.+++..++||||+++++|.++++.. ....+++..+..++.|++.||.|||++|++||||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di 128 (256)
T cd05039 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-----GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDL 128 (256)
T ss_pred HHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhc
Confidence 35789999999999999999999999999999999999732 2236899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||.++..... ......+
T Consensus 129 ~p~Nili~~~~~~~l~d~g~~~~~~~~----------------------------------------------~~~~~~~ 162 (256)
T cd05039 129 AARNVLVSEDLVAKVSDFGLAKEASQG----------------------------------------------QDSGKLP 162 (256)
T ss_pred ccceEEEeCCCCEEEcccccccccccc----------------------------------------------cccCCCc
Confidence 999999999999999999987552110 0112234
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+..+.++.++||||||+++||+++ .|..||......+....+.. ......+..+++++.+++.+
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYS-FGRVPYPRIPLKDVVPHVEK-------GYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHh-cCCCCCCCCCHHHHHHHHhc-------CCCCCCccCCCHHHHHHHHH
Confidence 57999999998889999999999999999993 28999988877666544432 11223345678999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||..+|++||+++|+++.|++
T Consensus 235 ~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 235 CWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HhccChhhCcCHHHHHHHHhc
Confidence 999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=269.17 Aligned_cols=203 Identities=24% Similarity=0.373 Sum_probs=165.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+.+..++||||+++++|.+++. ....+++..+..++.|++.||+|||+.|++||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di 132 (267)
T cd06628 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-------NYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDI 132 (267)
T ss_pred HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHH-------hccCccHHHHHHHHHHHHHHHHHHHhcCcccccC
Confidence 357899999999999999999999999999999999997 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||++++++.++|+|||.++....... ............++
T Consensus 133 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~ 175 (267)
T cd06628 133 KGANILVDNKGGIKISDFGISKKLEANSL-------------------------------------STKTNGARPSLQGS 175 (267)
T ss_pred CHHHEEEcCCCCEEecccCCCcccccccc-------------------------------------cCCccccccccCCC
Confidence 99999999999999999998765321110 00000011234467
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+|||||++|+|+ +|..||...........+.. ......+..++.++.+++.+
T Consensus 176 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~ 246 (267)
T cd06628 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEML--TGKHPFPDCTQLQAIFKIGE-------NASPEIPSNISSEAIDFLEK 246 (267)
T ss_pred cCccChhHhccCCCCchhhhHHHHHHHHHHh--hCCCCCCCccHHHHHHHHhc-------cCCCcCCcccCHHHHHHHHH
Confidence 8899999999888999999999999999999 89999987765544333221 22333456678999999999
Q ss_pred hccCCCCCCCCHHHHH
Q psy5690 241 CWKTNETDRPRFSEIH 256 (434)
Q Consensus 241 cl~~dP~~Rps~~el~ 256 (434)
||+.||++||++.|++
T Consensus 247 ~l~~~p~~Rp~~~~il 262 (267)
T cd06628 247 TFEIDHNKRPTAAELL 262 (267)
T ss_pred HccCCchhCcCHHHHh
Confidence 9999999999999994
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=276.84 Aligned_cols=213 Identities=36% Similarity=0.645 Sum_probs=164.6
Q ss_pred CCC-CCCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCCC----------------------------------
Q psy5690 2 CSL-KDPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCNS---------------------------------- 45 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~---------------------------------- 45 (434)
+++ +|+||++++++|.. +..+++++||+++|+|.+++.......
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (337)
T cd05054 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS 144 (337)
T ss_pred HhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence 355 79999999998864 467899999999999999996432100
Q ss_pred --------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccc
Q psy5690 46 --------------------QENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHY 105 (434)
Q Consensus 46 --------------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~ 105 (434)
.....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~ 224 (337)
T cd05054 145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224 (337)
T ss_pred cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcc
Confidence 001368899999999999999999999999999999999999999999999999976531
Q ss_pred cccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHH
Q psy5690 106 ESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAV 185 (434)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGv 185 (434)
... .........++..|+|||++.+..++.++|||||||
T Consensus 225 ~~~-----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv 263 (337)
T cd05054 225 KDP-----------------------------------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGV 263 (337)
T ss_pred cCc-----------------------------------------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHH
Confidence 110 001112334567799999999999999999999999
Q ss_pred HHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 186 TLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 186 il~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++|||++ .|..||......+...... ........+..+++++.+++.+||+.+|++||+++|+.+.|++.
T Consensus 264 ~l~el~t-~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 264 LLWEIFS-LGASPYPGVQIDEEFCRRL------KEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHH-cCCCCCCCCCccHHHHHHH------hccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999993 2889997654333222111 11122233456778999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=265.10 Aligned_cols=204 Identities=36% Similarity=0.638 Sum_probs=166.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++. ++..++||||+++|+|.+++.+. ....+++..+..++.|++.||+|||+.+++|||||
T Consensus 56 ~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 129 (262)
T cd05071 56 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE-----MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129 (262)
T ss_pred HhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhc-----cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence 5689999999999874 45689999999999999999732 22457899999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||.++...... ........++.
T Consensus 130 p~Nill~~~~~~~L~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~~ 167 (262)
T cd05071 130 AANILVGENLVCKVADFGLARLIEDNE------------------------------------------YTARQGAKFPI 167 (262)
T ss_pred cccEEEcCCCcEEeccCCceeeccccc------------------------------------------cccccCCcccc
Confidence 999999999999999999875422111 00112234567
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||+..+..++.++|||||||++|||+ + |..||.+....+....+.. ....+.+..++..+.+++.+
T Consensus 168 ~y~~PE~~~~~~~~~~~DvwslG~~l~ell--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 168 KWTAPEAALYGRFTIKSDVWSFGILLTELT--TKGRVPYPGMVNREVLDQVER-------GYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred eecCHhHhccCCCCchhhHHHHHHHHHHHH--cCCCCCCCCCChHHHHHHHhc-------CCCCCCccccCHHHHHHHHH
Confidence 799999999888999999999999999999 6 7889988776665544321 11223345678899999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++||++++++.+|+..
T Consensus 239 ~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 239 CWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HccCCcccCCCHHHHHHHHHHh
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=275.32 Aligned_cols=213 Identities=33% Similarity=0.640 Sum_probs=171.6
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
+++ +||||++++++|..++..++++||+++|+|.+++.+.... ......+++..+..++.|++.||+|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 151 (334)
T cd05100 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA 151 (334)
T ss_pred HhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence 456 7999999999999999999999999999999999754311 112345888999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++|++||||||+||+++.++.+||+|||+++...... ..
T Consensus 152 ~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-----------------------------------------~~ 190 (334)
T cd05100 152 SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID-----------------------------------------YY 190 (334)
T ss_pred HCCeeccccccceEEEcCCCcEEECCcccceeccccc-----------------------------------------cc
Confidence 9999999999999999999999999999876522111 00
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
.......++..|+|||++.+..++.++|||||||++|||++ .|..||...+..+....+.. ....+.+..++
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 262 (334)
T cd05100 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-LGGSPYPGIPVEELFKLLKE-------GHRMDKPANCT 262 (334)
T ss_pred ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh-cCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCC
Confidence 01122334567999999999999999999999999999993 27899988877666554431 22334456778
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.++.+++.+||+.+|++||++.|++..|++..
T Consensus 263 ~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 263 HELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 89999999999999999999999998888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=269.87 Aligned_cols=212 Identities=32% Similarity=0.553 Sum_probs=162.4
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++... ...++||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~ 131 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQICEGMAYLHSQHYIHR 131 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 4678999999999998654 458999999999999999962 248999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.++|+|||+++...... ..........
T Consensus 132 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~----------------------------------------~~~~~~~~~~ 171 (283)
T cd05080 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGH----------------------------------------EYYRVREDGD 171 (283)
T ss_pred ccChheEEEcCCCcEEEeecccccccCCcc----------------------------------------hhhccCCCCC
Confidence 999999999999999999999876422110 0000112223
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH--HHHHhh------hhhhhcCCcccCCCCCCcc
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE--QVIENC------SHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~--~~~~~~------~~~~~~~~~~~~~~~~~~~ 230 (434)
++..|+|||.+.+..++.++||||||+++|||+ +|..||...... +..... .............+.+..+
T Consensus 172 ~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T cd05080 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELL--THCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNC 249 (283)
T ss_pred CCceeeCHhHhcccCCCcccccHHHHHHHHHHH--hCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCC
Confidence 456699999999888999999999999999999 788888654321 000000 0000001112233445677
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.++.+++.+||+.||++||+++++...|++.
T Consensus 250 ~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 250 PQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 89999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=265.93 Aligned_cols=200 Identities=20% Similarity=0.329 Sum_probs=165.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++.+.+++..++||||+++|+|.+++... ....+++..+..++.|++.||.|||++|++|+||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl 126 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ-----RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCC
Confidence 35789999999999999999999999999999999998632 2345789999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||++++++.++++|||.+....... .......++
T Consensus 127 ~p~nili~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 163 (255)
T cd08219 127 KSKNIFLTQNGKVKLGDFGSARLLTSPG-------------------------------------------AYACTYVGT 163 (255)
T ss_pred CcceEEECCCCcEEEcccCcceeecccc-------------------------------------------cccccccCC
Confidence 9999999999999999999865421110 001223567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|+||||+++|+|+ +|..||...+.......+. .....+.+..++..+.+++.+
T Consensus 164 ~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~--~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELC--TLKHPFQANSWKNLILKVC-------QGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred ccccCHHHHccCCcCchhhhhhhchhheehh--hccCCCCCCCHHHHHHHHh-------cCCCCCCCcccCHHHHHHHHH
Confidence 7899999999888999999999999999999 8999998876655544332 122333456678899999999
Q ss_pred hccCCCCCCCCHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHL 257 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~ 257 (434)
||+.||++||++.+++.
T Consensus 235 ~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 235 MFKRNPRSRPSATTILS 251 (255)
T ss_pred HHhCCcccCCCHHHHhh
Confidence 99999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=291.16 Aligned_cols=211 Identities=17% Similarity=0.250 Sum_probs=162.6
Q ss_pred CCCCC-CCCeeeEEEEE-ec---C---CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 1 MCSLK-DPNLVRVIGVC-ST---E---DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 1 l~~L~-HpnIv~l~~~~-~~---~---~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
|++|+ |+|||.++|.. .. + -.++|.||||.||.|-+++..+. ...|++.++++|+.|+++|+.+||.
T Consensus 88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl-----q~~lte~eVLkIf~dv~~AVa~mH~ 162 (738)
T KOG1989|consen 88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL-----QTRLTEDEVLKIFYDVCEAVAAMHY 162 (738)
T ss_pred HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHH-----hccCChHHHHHHHHHHHHHHHHHhc
Confidence 56776 99999999943 21 1 24789999999999999998553 3459999999999999999999998
Q ss_pred CC--ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 73 RD--IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 73 ~~--iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
.+ |||||||-|||||+.+++.||||||.+........ . ..+-..
T Consensus 163 ~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~----~------------------------------~~e~~~ 208 (738)
T KOG1989|consen 163 LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPT----S------------------------------AQEVNY 208 (738)
T ss_pred CCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCc----c------------------------------HHHHHH
Confidence 87 99999999999999999999999998754211110 0 000000
Q ss_pred cccCCCCCCCccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCC
Q psy5690 151 YLSDTKARLPIRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRP 227 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (434)
....-....|+.|+|||++. +...+.|+|||+|||+||-|+ ....||.......+. ......|..
T Consensus 209 ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC--y~t~PFe~sg~laIl----------ng~Y~~P~~ 276 (738)
T KOG1989|consen 209 VEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC--YFTTPFEESGKLAIL----------NGNYSFPPF 276 (738)
T ss_pred HHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH--HhCCCcCcCcceeEE----------eccccCCCC
Confidence 01112234578899999986 556799999999999999999 788999876443322 122334445
Q ss_pred CccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 228 ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 228 ~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.++..+.+||..||+.||++||++.++...+.+.
T Consensus 277 p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 277 PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 68899999999999999999999999997666544
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=265.94 Aligned_cols=209 Identities=35% Similarity=0.659 Sum_probs=168.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++|++|+||
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl 132 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN------DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDL 132 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhC------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 35789999999999999999999999999999999999732 346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++....... ............+
T Consensus 133 ~p~nili~~~~~~kl~dfg~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~ 174 (269)
T cd05065 133 AARNILVNSNLVCKVSDFGLSRFLEDDTS--------------------------------------DPTYTSSLGGKIP 174 (269)
T ss_pred ChheEEEcCCCcEEECCCccccccccCcc--------------------------------------ccccccccCCCcc
Confidence 99999999999999999998654221110 0000011111224
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|||||||++||+++ .|..||......+....+.. ....+.+..++..+.+++.+
T Consensus 175 ~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~-~g~~p~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~~~~li~~ 246 (269)
T cd05065 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS-YGERPYWDMSNQDVINAIEQ-------DYRLPPPMDCPTALHQLMLD 246 (269)
T ss_pred eeecCHhHhccCcccchhhhhhhHHHHHHHhc-CCCCCCCCCCHHHHHHHHHc-------CCcCCCcccCCHHHHHHHHH
Confidence 57999999999999999999999999999883 38999988776665544421 22334456778899999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||+.+|.+||++++|...|++
T Consensus 247 ~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 247 CWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred HcCCChhhCcCHHHHHHHHHh
Confidence 999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=271.60 Aligned_cols=202 Identities=20% Similarity=0.276 Sum_probs=157.2
Q ss_pred CCCCCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++++||||+++++++... ...++||||+.+ +|.+++... ....+++..+..++.|++.||+|||++||+
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 130 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV-----PPPGLPAETIKDLMRQFLRGLDFLHANCIV 130 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 346899999999998642 458999999975 899988632 234589999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+||+++.++.+||+|||+++..... .....
T Consensus 131 H~dikp~Nili~~~~~~kl~dfg~~~~~~~~--------------------------------------------~~~~~ 166 (288)
T cd07863 131 HRDLKPENILVTSGGQVKLADFGLARIYSCQ--------------------------------------------MALTP 166 (288)
T ss_pred cCCCCHHHEEECCCCCEEECccCccccccCc--------------------------------------------ccCCC
Confidence 9999999999999999999999987542110 01123
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc-----------c---
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ-----------Q--- 222 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~--- 222 (434)
..+|..|+|||++.+..++.++||||+||++|+|+ +|..||......+....+.......... .
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~--~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
T cd07863 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSP 244 (288)
T ss_pred ccccccccCchHhhCCCCCCcchhhhHHHHHHHHH--hCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCC
Confidence 45678899999999999999999999999999999 8899998776655544433211100000 0
Q ss_pred -----CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 223 -----YLPRPATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 223 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
.......+++++.+++.+||+.||++|||+.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 282 (288)
T cd07863 245 RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282 (288)
T ss_pred CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence 000123467789999999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=270.50 Aligned_cols=205 Identities=23% Similarity=0.355 Sum_probs=165.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++..++..++|+||+++|+|..++.+ ....+++..+..++.|+++||.|||+.|++||||
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~------~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dl 129 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE------LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 3568999999999999999999999999999999998862 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||++....... .......++
T Consensus 130 kp~nili~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 166 (282)
T cd06643 130 KAGNILFTLDGDIKLADFGVSAKNTRTI-------------------------------------------QRRDSFIGT 166 (282)
T ss_pred CcccEEEccCCCEEEccccccccccccc-------------------------------------------ccccccccc
Confidence 9999999999999999999865421100 011223567
Q ss_pred ccccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 161 IRWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 161 ~~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
..|+|||++. +..++.++|||||||++|||+ +|..||...+..+....+.. ........+..++.++.
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA--QIEPPHHELNPMRVLLKIAK-----SEPPTLAQPSRWSSEFK 239 (282)
T ss_pred ccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc--cCCCCccccCHHHHHHHHhh-----cCCCCCCCccccCHHHH
Confidence 8899999984 345678999999999999999 88999988766554433321 11122334556788999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+++.+||+.||.+||+++++ |+|+..
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 99999999999999999999 677664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=271.74 Aligned_cols=204 Identities=20% Similarity=0.333 Sum_probs=165.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++.+..++..++||||+++|+|.+++.. ..+++.++..++.|++.||+|||++||+||||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dL 142 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 3568999999999999999999999999999999999852 34788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 143 kp~Nill~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 179 (296)
T cd06654 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ-------------------------------------------SKRSTMVGT 179 (296)
T ss_pred CHHHEEEcCCCCEEECccccchhccccc-------------------------------------------cccCcccCC
Confidence 9999999999999999999865421100 011223567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|||||||++|+|+ +|..||............. .........+..+++.+.+++.+
T Consensus 180 ~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~--~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI--EGEPPYLNENPLRALYLIA-----TNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred ccccCHHHHcCCCCCccchHHHHHHHHHHHH--hCCCCCCCCCHHHhHHHHh-----cCCCCCCCCccccCHHHHHHHHH
Confidence 7899999999888899999999999999999 8999998766543322111 11111223345677899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||..||++||+++++ ++|+...
T Consensus 253 ~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 253 CLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999 6788764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=278.84 Aligned_cols=206 Identities=17% Similarity=0.238 Sum_probs=157.5
Q ss_pred CCCCCCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|+.++||||+++++++...+ ..|+||||+++ +|.+.+. ..+++..+..++.|++.||+|||++|
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~ 143 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH---------MELDHERMSYLLYQMLCGIKHLHSAG 143 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh---------ccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999986543 47999999975 6777664 24788899999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 144 ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------~~~ 179 (359)
T cd07876 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--------------------------------------------FMM 179 (359)
T ss_pred cccCCCCHHHEEECCCCCEEEecCCCccccccC--------------------------------------------ccC
Confidence 999999999999999999999999987541110 011
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhh-------------------hh
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSH-------------------WY 215 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~-------------------~~ 215 (434)
....+|..|+|||++.+..++.++|||||||++|+|+ +|..||.+.+.......+.. +.
T Consensus 180 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~--tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (359)
T cd07876 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV--KGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV 257 (359)
T ss_pred CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 3345778899999999999999999999999999999 89999987654332221110 00
Q ss_pred hcCCcc---------------cCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 216 QNNSKQ---------------QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 216 ~~~~~~---------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
...... .........++++++|+.+||+.||++|||++|+ |+|+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 258 ENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred hhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 000000 0001112345789999999999999999999999 7898753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=279.47 Aligned_cols=213 Identities=36% Similarity=0.659 Sum_probs=167.9
Q ss_pred CCCC-CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC-----------------------------------
Q psy5690 2 CSLK-DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS----------------------------------- 45 (434)
Q Consensus 2 ~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~----------------------------------- 45 (434)
.++. |||||+++++|..++..++||||+++|+|.+++++.+...
T Consensus 95 ~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (401)
T cd05107 95 SHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSES 174 (401)
T ss_pred HhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhcc
Confidence 4566 9999999999999999999999999999999997543100
Q ss_pred --------------------------------------------------------CCCCCCCHHHHHHHHHHHHHHHHH
Q psy5690 46 --------------------------------------------------------QENPAISYGCLIFMATQIASGMKY 69 (434)
Q Consensus 46 --------------------------------------------------------~~~~~l~~~~~~~i~~qi~~gL~y 69 (434)
.....+++..+..++.||+.||+|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 254 (401)
T cd05107 175 DGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEF 254 (401)
T ss_pred CccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 011346778889999999999999
Q ss_pred hhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCc
Q psy5690 70 LESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESD 149 (434)
Q Consensus 70 LH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 149 (434)
||+.+++||||||+|||+++++.+||+|||+++......
T Consensus 255 LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~----------------------------------------- 293 (401)
T cd05107 255 LASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS----------------------------------------- 293 (401)
T ss_pred HhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccc-----------------------------------------
Confidence 999999999999999999999999999999976421110
Q ss_pred ccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCc
Q psy5690 150 YYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 150 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (434)
.........++..|+|||.+.+..++.++|||||||++|||++ .|..||......+....... .....+.+..
T Consensus 294 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~-~g~~P~~~~~~~~~~~~~~~------~~~~~~~p~~ 366 (401)
T cd05107 294 NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT-LGGTPYPELPMNEQFYNAIK------RGYRMAKPAH 366 (401)
T ss_pred ccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHH-cCCCCCCCCCchHHHHHHHH------cCCCCCCCCC
Confidence 0001122345678999999998889999999999999999993 27889987655444322211 1223344567
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++.++.+++.+||..+|.+||+++||+..|++.
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 789999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=265.93 Aligned_cols=205 Identities=32% Similarity=0.637 Sum_probs=169.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.. ...++||||+++|+|.+++... ...+++..+..++.|++.||+|||++|++||||
T Consensus 63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di 135 (279)
T cd05057 63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNH------KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDL 135 (279)
T ss_pred HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeccc
Confidence 457899999999999987 7899999999999999999732 345899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++....... ........++
T Consensus 136 ~p~nil~~~~~~~kL~dfg~~~~~~~~~~-----------------------------------------~~~~~~~~~~ 174 (279)
T cd05057 136 AARNVLVKTPQHVKITDFGLAKLLDVDEK-----------------------------------------EYHAEGGKVP 174 (279)
T ss_pred CcceEEEcCCCeEEECCCcccccccCccc-----------------------------------------ceecCCCccc
Confidence 99999999999999999999765321110 0001112235
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+....++.++|+|||||++||++ + |..||......+....+. .....+.+..++.++.+++.
T Consensus 175 ~~y~~PE~~~~~~~~~~~Di~slG~~l~el~--~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 245 (279)
T cd05057 175 IKWMALESILHRIYTHKSDVWSYGVTVWELM--TFGAKPYEGIPAVEIPDLLE-------KGERLPQPPICTIDVYMVLV 245 (279)
T ss_pred ccccCHHHhhcCCcCchhhHHHHHHHHHHHh--cCCCCCCCCCCHHHHHHHHh-------CCCCCCCCCCCCHHHHHHHH
Confidence 6799999998888999999999999999999 6 899998887766554432 22234445667889999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||..||++||++.++...|++.
T Consensus 246 ~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 246 KCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred HHcCCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=261.82 Aligned_cols=205 Identities=40% Similarity=0.726 Sum_probs=166.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|+||+++++++.+.+..++||||+.+++|.+++... ...+++..+..++.|++.||+|||+++++||||
T Consensus 46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di 119 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK------KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119 (251)
T ss_pred HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhc
Confidence 35789999999999999999999999999999999999632 246788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++....... .........+
T Consensus 120 ~p~nili~~~~~~~l~d~g~~~~~~~~~~-----------------------------------------~~~~~~~~~~ 158 (251)
T cd05041 120 AARNCLVGENNVLKISDFGMSREEEGGIY-----------------------------------------TVSDGLKQIP 158 (251)
T ss_pred CcceEEEcCCCcEEEeeccccccccCCcc-----------------------------------------eeccccCcce
Confidence 99999999999999999998754211000 0001112335
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.++.++.++|+|||||++|||+++ |..||...........+.. ....+.+..++.++.+++.+
T Consensus 159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~-~~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~ 230 (251)
T cd05041 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSL-GDTPYPGMSNQQTRERIES-------GYRMPAPQLCPEEIYRLMLQ 230 (251)
T ss_pred eccCChHhhccCCCCcchhHHHHHHHHHHHHhc-cCCCCccCCHHHHHHHHhc-------CCCCCCCccCCHHHHHHHHH
Confidence 679999999988899999999999999999931 7889988776555444321 12233456778999999999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~ 260 (434)
||..+|++||+++|+++.|+
T Consensus 231 ~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 231 CWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HhccChhhCcCHHHHHHHhh
Confidence 99999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=271.47 Aligned_cols=207 Identities=18% Similarity=0.239 Sum_probs=166.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++.+.+++..++||||+++|+|.+++... ....+++..+..++.|++.||.|||++||+||||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~di 128 (285)
T cd05630 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-----GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDL 128 (285)
T ss_pred HHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCC
Confidence 35789999999999999999999999999999999998632 2245889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... ......|+
T Consensus 129 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~--------------------------------------------~~~~~~g~ 164 (285)
T cd05630 129 KPENILLDDHGHIRISDLGLAVHVPEGQ--------------------------------------------TIKGRVGT 164 (285)
T ss_pred CHHHEEECCCCCEEEeeccceeecCCCc--------------------------------------------cccCCCCC
Confidence 9999999999999999999864311000 01233578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++||||+||++|+|+ +|..||................. ......+..+++++.+++.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~--~g~~Pf~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 165 VGYMAPEVVKNERYTFSPDWWALGCLLYEMI--AGQSPFQQRKKKIKREEVERLVK----EVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred ccccChHHHcCCCCCCccccHHHHHHHHHHH--hCCCCCCCCCccchHHHHHhhhh----hhhhhcCccCCHHHHHHHHH
Confidence 8999999999999999999999999999999 89999987543221111111111 11112345678899999999
Q ss_pred hccCCCCCCCC-----HHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPR-----FSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps-----~~el--~~~L~~~ 262 (434)
||+.||++||| ++|+ |+|+++.
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 99999999999 8899 7899764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=263.29 Aligned_cols=204 Identities=38% Similarity=0.676 Sum_probs=167.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++. .+..+++|||+++|+|.+++... ....+++..+..++.|++.||+|||+.|++||||
T Consensus 55 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl 128 (260)
T cd05067 55 MKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-----EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128 (260)
T ss_pred HHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccc
Confidence 46789999999999874 56789999999999999998632 2346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... ........++
T Consensus 129 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 166 (260)
T cd05067 129 RAANILVSETLCCKIADFGLARLIEDNE------------------------------------------YTAREGAKFP 166 (260)
T ss_pred cHHhEEEcCCCCEEEccCcceeecCCCC------------------------------------------cccccCCccc
Confidence 9999999999999999999865421110 0011223456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++....++.++||||||+++||++ + |..||.+.+..+....+.. ....+.+..++.++.+++.
T Consensus 167 ~~y~~pe~~~~~~~~~~~Di~slG~~l~el~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 237 (260)
T cd05067 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV--TYGRIPYPGMTNPEVIQNLER-------GYRMPRPDNCPEELYELMR 237 (260)
T ss_pred ccccCHHHhccCCcCcccchHHHHHHHHHHH--hCCCCCCCCCChHHHHHHHHc-------CCCCCCCCCCCHHHHHHHH
Confidence 7899999999888999999999999999999 6 8999988776665544321 2233445667889999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.+|++||+++++..+|+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 238 LCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHccCChhhCCCHHHHHHHhhc
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=265.19 Aligned_cols=195 Identities=27% Similarity=0.447 Sum_probs=155.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++..++..++||||+++|+|.++++.. ...+++..+..++.||+.||+|||++||+||||
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dl 126 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN------KNLINISWKLEVAKQLAWALHFLEDKGLTHGNV 126 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 35789999999999999999999999999999999999732 236889999999999999999999999999999
Q ss_pred CCCCeeeecCCc--------eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 81 AARNCMVGKNYT--------IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 81 kp~NILl~~~~~--------~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
||+||+++.++. ++++|||++....
T Consensus 127 kp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~----------------------------------------------- 159 (258)
T cd05078 127 CAKNVLLIREEDRKTGNPPFIKLSDPGISITVL----------------------------------------------- 159 (258)
T ss_pred ccceEEEecccccccCCCceEEecccccccccC-----------------------------------------------
Confidence 999999987765 5888888753310
Q ss_pred cCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcC-CCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc
Q psy5690 153 SDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCN-QRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (434)
......++..|+|||++.+. .++.++|||||||++|||+ +| ..||............. .....+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~--~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~ 228 (258)
T cd05078 160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF--SGGDKPLSALDSQKKLQFYE---------DRHQLPAPK 228 (258)
T ss_pred CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHH--cCCCCChhhccHHHHHHHHH---------ccccCCCCC
Confidence 01123456779999999874 4789999999999999999 66 56766655443322111 112234456
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L 259 (434)
+.++.+++.+||+.||++|||++++++.|
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 68899999999999999999999997765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=272.84 Aligned_cols=241 Identities=19% Similarity=0.269 Sum_probs=176.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++.+.+++..++||||+.+++|.+++... ....+++..+..++.|++.||+|||+.|++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 129 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQ-----PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDL 129 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhC-----CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 35789999999999999999999999999999999998732 2356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++.................. . ... .... .................|+
T Consensus 130 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~-~------~~~-----~~~~--~~~~~~~~~~~~~~~~~g~ 195 (316)
T cd05574 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS-R------RSS-----VNSI--PSETFSEEPSFRSNSFVGT 195 (316)
T ss_pred ChHHeEEcCCCCEEEeecchhhccccccccccccccccc-c------ccc-----cccc--chhhhcccccCCCCCCcCc
Confidence 999999999999999999997654322110000000000 0 000 0000 0000000111122345678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++||||||+++|+|+ +|..||.+.+.......+.. .....+.....++++.+++.+
T Consensus 196 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~--~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~ 267 (316)
T cd05574 196 EEYIAPEVISGDGHGSAVDWWTLGILLYEML--YGTTPFKGSNRDETFSNILK------KEVTFPGSPPVSSSARDLIRK 267 (316)
T ss_pred cCCcCHHHHcCCCCCchHHHHHHHHHHHHHh--hCCCCCCCCchHHHHHHHhc------CCccCCCccccCHHHHHHHHH
Confidence 8999999999988999999999999999999 89999988776655543321 111222233368999999999
Q ss_pred hccCCCCCCCC----HHHH--HHHHHhcccCCCc
Q psy5690 241 CWKTNETDRPR----FSEI--HLFLQRKNLGARA 268 (434)
Q Consensus 241 cl~~dP~~Rps----~~el--~~~L~~~~~~~~~ 268 (434)
||+.||++||+ ++|+ |+|++........
T Consensus 268 ~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 268 LLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred HccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence 99999999999 9998 7899876544433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=273.58 Aligned_cols=210 Identities=17% Similarity=0.303 Sum_probs=163.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++ +|.+++... ...+++..+..++.||+.||+|||++||+||||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dl 130 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC------GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL 130 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 3578999999999999999999999999975 898888632 345788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .......++
T Consensus 131 kp~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 167 (309)
T cd07872 131 KPQNLLINERGELKLADFGLARAKSVPT-------------------------------------------KTYSNEVVT 167 (309)
T ss_pred CHHHEEECCCCCEEECccccceecCCCc-------------------------------------------ccccccccc
Confidence 9999999999999999999875421110 011223467
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc-----------------CCccc
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN-----------------NSKQQ 222 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~-----------------~~~~~ 222 (434)
..|+|||++.+ ..++.++|||||||++|+|+ +|..||...+..+....+...... .....
T Consensus 168 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07872 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA--SGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPK 245 (309)
T ss_pred ccccCCHHHhCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCc
Confidence 88999999875 45789999999999999999 899999887665444333211100 00000
Q ss_pred C-----CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 223 Y-----LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 223 ~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
. ......+++++.+++.+||+.||.+|||++|+ |+|++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 246 YKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred cCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 0 01123467889999999999999999999999 8899874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=269.64 Aligned_cols=204 Identities=19% Similarity=0.333 Sum_probs=168.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++.++||||+++++++..++..++|+||+++|+|..++.. ..+++.++..++.|++.||+|||++|++||||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL 141 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHANQVIHRDI 141 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 3578999999999999999999999999999999999852 35889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 142 ~p~Nili~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 178 (296)
T cd06655 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQ-------------------------------------------SKRSTMVGT 178 (296)
T ss_pred CHHHEEECCCCCEEEccCccchhccccc-------------------------------------------ccCCCcCCC
Confidence 9999999999999999999865421100 011223567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|||||||++|+++ +|..||...........+.. ........+..+++.+.+++.+
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGvil~~ll--tg~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV--EGEPPYLNENPLRALYLIAT-----NGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred ccccCcchhcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHh-----cCCcccCCcccCCHHHHHHHHH
Confidence 7899999999888999999999999999999 89999988766544332211 1112223356678899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||..||++||++.++ |+|++..
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999 8999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=265.27 Aligned_cols=207 Identities=18% Similarity=0.303 Sum_probs=165.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+.+..++|+||+++|+|.+++.... .....+++..+..++.|++.||+|||++|++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl 132 (267)
T cd08228 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFK---KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDI 132 (267)
T ss_pred HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhh---hccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCC
Confidence 467899999999999999999999999999999999886432 12345889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 133 ~~~nil~~~~~~~~l~d~g~~~~~~~~~-------------------------------------------~~~~~~~~~ 169 (267)
T cd08228 133 KPANVFITATGVVKLGDLGLGRFFSSKT-------------------------------------------TAAHSLVGT 169 (267)
T ss_pred CHHHEEEcCCCCEEECccccceeccchh-------------------------------------------HHHhcCCCC
Confidence 9999999999999999999865421110 011223466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh--HHHHHhhhhhhhcCCcccCCCC-CCccHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN--EQVIENCSHWYQNNSKQQYLPR-PATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l 237 (434)
..|+|||.+.+..++.++|+||||+++|||+ +|..||..... .+....+. .....+. ...++..+.++
T Consensus 170 ~~~~aPE~~~~~~~~~~~Di~slG~~l~el~--~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMA--ALQSPFYGDKMNLFSLCQKIE-------QCDYPPLPTEHYSEKLREL 240 (267)
T ss_pred ccccChhhhccCCCCchhhHHHHHHHHHHHh--cCCCCCccccccHHHHHHHHh-------cCCCCCCChhhcCHHHHHH
Confidence 7899999999888999999999999999999 88999865432 22222221 1112222 23567889999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+||+.+|++||++.++++.+++.
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHCCCCcccCcCHHHHHHHHHHh
Confidence 9999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=264.93 Aligned_cols=205 Identities=34% Similarity=0.699 Sum_probs=167.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+ +..++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+.|++||||
T Consensus 61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl 133 (270)
T cd05056 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVN------KYSLDLASLILYSYQLSTALAYLESKRFVHRDI 133 (270)
T ss_pred HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 357899999999999865 5678999999999999999732 235899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++....... .......++
T Consensus 134 ~p~nili~~~~~~~l~d~g~~~~~~~~~~------------------------------------------~~~~~~~~~ 171 (270)
T cd05056 134 AARNVLVSSPDCVKLGDFGLSRYLEDESY------------------------------------------YKASKGKLP 171 (270)
T ss_pred ChheEEEecCCCeEEccCceeeecccccc------------------------------------------eecCCCCcc
Confidence 99999999999999999998754221110 011222345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+....++.++||||||+++||+++ .|..||......+....+. .....+.+..++.++.+++.+
T Consensus 172 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~-~g~~pf~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 243 (270)
T cd05056 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILM-LGVKPFQGVKNNDVIGRIE-------NGERLPMPPNCPPTLYSLMTK 243 (270)
T ss_pred ccccChhhhccCCCCchhhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHH-------cCCcCCCCCCCCHHHHHHHHH
Confidence 67999999988889999999999999999984 4899998887666554432 222334567788999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||..+|++||++.++...|++.
T Consensus 244 ~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 244 CWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred HcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999998888774
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=267.77 Aligned_cols=206 Identities=22% Similarity=0.390 Sum_probs=167.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|.+++.+. ...+++..+..++.|++.||.|||++||+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl 129 (280)
T cd06611 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL------ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129 (280)
T ss_pred HHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 36789999999999999999999999999999999999732 246899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++...... ........++
T Consensus 130 ~p~nili~~~~~~~l~d~g~~~~~~~~-------------------------------------------~~~~~~~~~~ 166 (280)
T cd06611 130 KAGNILLTLDGDVKLADFGVSAKNKST-------------------------------------------LQKRDTFIGT 166 (280)
T ss_pred ChhhEEECCCCCEEEccCccchhhccc-------------------------------------------ccccceeecc
Confidence 999999999999999999986431110 0011233567
Q ss_pred ccccchhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 161 IRWMAWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 161 ~~y~aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
..|+|||.+.. ..++.++|+|||||++|+|+ +|..||......+....+.. ........+..++.++.
T Consensus 167 ~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA--QMEPPHHELNPMRVLLKILK-----SEPPTLDQPSKWSSSFN 239 (280)
T ss_pred hhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH--hCCCCcccCCHHHHHHHHhc-----CCCCCcCCcccCCHHHH
Confidence 78999999853 34678999999999999999 89999988766554443321 11122233556788999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+++.+||+.+|.+||+++++ |+|+.+.
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999 7888765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=262.76 Aligned_cols=205 Identities=41% Similarity=0.738 Sum_probs=169.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|+||+++++++..+...++||||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-----~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di 129 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-----EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDL 129 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 36789999999999999989999999999999999999732 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... ........++
T Consensus 130 ~p~nili~~~~~~~l~d~g~~~~~~~~~------------------------------------------~~~~~~~~~~ 167 (261)
T cd05034 130 AARNILVGENLVCKIADFGLARLIEDDE------------------------------------------YTAREGAKFP 167 (261)
T ss_pred chheEEEcCCCCEEECccccceeccchh------------------------------------------hhhhhccCCC
Confidence 9999999999999999999875422110 0011122234
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.+..++.++|+||||+++|+++ + |..||.+.........+.. ....+.+..++.++.+++.
T Consensus 168 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05034 168 IKWTAPEAANYGRFTIKSDVWSFGILLTEIV--TYGRVPYPGMTNREVLEQVER-------GYRMPRPPNCPEELYDLML 238 (261)
T ss_pred ccccCHHHhccCCcCchhHHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHH
Confidence 6799999999888999999999999999999 5 8999988776665554432 1233445566889999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.+|++||+++++..+|+.
T Consensus 239 ~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 239 QCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcccCcccCCCHHHHHHHHhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=271.16 Aligned_cols=208 Identities=22% Similarity=0.313 Sum_probs=163.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrD 79 (434)
|++++||||++++++|.+++..++||||+++|+|.++++ ....+++..+..++.|+++||.|||+ .+++|||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~d 125 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-------KAGRIPENILGKISIAVLRGLTYLREKHKIMHRD 125 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECC
Confidence 357899999999999999999999999999999999997 33568999999999999999999997 5999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||+++.++.+||+|||++...... ......+
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~---------------------------------------------~~~~~~~ 160 (308)
T cd06615 126 VKPSNILVNSRGEIKLCDFGVSGQLIDS---------------------------------------------MANSFVG 160 (308)
T ss_pred CChHHEEEecCCcEEEccCCCccccccc---------------------------------------------ccccCCC
Confidence 9999999999999999999986431100 0123456
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC--------------------
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS-------------------- 219 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------- 219 (434)
+..|+|||.+.+..++.++|+|||||++|+|+ +|..||...........+........
T Consensus 161 ~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06615 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA--IGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238 (308)
T ss_pred CcCccChhHhcCCCCCccchHHHHHHHHHHHH--hCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence 78899999998888999999999999999999 88999876554333221111000000
Q ss_pred ---------cccCCCC-CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 220 ---------KQQYLPR-PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 220 ---------~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
....+.. ...++.++.+++.+||..||++||+++++ ++|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0000000 12367789999999999999999999999 8899763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=268.41 Aligned_cols=208 Identities=20% Similarity=0.234 Sum_probs=169.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++.+..++..++||||+++|+|.+++... ....+++..+..++.|++.||.|||++||+||||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~di 128 (285)
T cd05632 54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-----GNPGFEEERALFYAAEILCGLEDLHRENTVYRDL 128 (285)
T ss_pred HHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Confidence 45789999999999999999999999999999999988632 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++...... .......|+
T Consensus 129 kp~Nili~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~~~g~ 164 (285)
T cd05632 129 KPENILLDDYGHIRISDLGLAVKIPEG--------------------------------------------ESIRGRVGT 164 (285)
T ss_pred CHHHEEECCCCCEEEecCCcceecCCC--------------------------------------------CcccCCCCC
Confidence 999999999999999999986431100 001234578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|+|||||++|+|+ +|..||.........+.+..... ......+..+++++.+|+.+
T Consensus 165 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~--~g~~P~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05632 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI--EGQSPFRGRKEKVKREEVDRRVL----ETEEVYSAKFSEEAKSICKM 238 (285)
T ss_pred cCccChHHhcCCCCCcccchHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhhh----ccccccCccCCHHHHHHHHH
Confidence 8999999999889999999999999999999 89999988765544333322111 11122345678899999999
Q ss_pred hccCCCCCCCC-----HHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPR-----FSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps-----~~el--~~~L~~~~ 263 (434)
||+.||++||+ ++++ |+||....
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 99999999999 7788 78887753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=265.57 Aligned_cols=211 Identities=36% Similarity=0.671 Sum_probs=168.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS--QENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++|+||+++++++.+.+..++||||+++|+|.+++....... .....+++..+..++.|++.||+|||+.+|+||
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~ 141 (275)
T cd05046 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHR 141 (275)
T ss_pred HHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccC
Confidence 357899999999999999999999999999999999997432110 012268999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.++++|||+++...... ........
T Consensus 142 dlkp~Nili~~~~~~~l~~~~~~~~~~~~~------------------------------------------~~~~~~~~ 179 (275)
T cd05046 142 DLAARNCLVSSQREVKVSLLSLSKDVYNSE------------------------------------------YYKLRNAL 179 (275)
T ss_pred cCccceEEEeCCCcEEEcccccccccCccc------------------------------------------ccccCCce
Confidence 999999999999999999999865321100 01112334
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
++..|+|||.+.+..++.++||||||+++|++++ .|..||...........+.. .....+.+..++..+.+++
T Consensus 180 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~~i 252 (275)
T cd05046 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDEEVLNRLQA------GKLELPVPEGCPSRLYKLM 252 (275)
T ss_pred eEEeecChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCccccchHHHHHHHHc------CCcCCCCCCCCCHHHHHHH
Confidence 5677999999998888999999999999999994 27889987766655544321 1112233556789999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHH
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~ 260 (434)
.+||+.||++||++.|++..|+
T Consensus 253 ~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 253 TRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHcCCCcccCCCHHHHHHHhc
Confidence 9999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=263.56 Aligned_cols=206 Identities=25% Similarity=0.329 Sum_probs=180.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.-+||.+..+--.|+..+++|+||||+.||.|.-++. ....+++.....+..+|+.||.|||+++||.|||
T Consensus 222 L~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs-------rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDl 294 (516)
T KOG0690|consen 222 LQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS-------RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDL 294 (516)
T ss_pred HHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehh-------hhhcccchhhhhhhHHHHHHhhhhhhCCeeeeec
Confidence 345689999999999999999999999999999999997 4568999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|.+|+|+|.+|++||+|||+++... .+.....+.+||
T Consensus 295 KLENLlLDkDGHIKitDFGLCKE~I-------------------------------------------~~g~t~kTFCGT 331 (516)
T KOG0690|consen 295 KLENLLLDKDGHIKITDFGLCKEEI-------------------------------------------KYGDTTKTFCGT 331 (516)
T ss_pred hhhhheeccCCceEeeecccchhcc-------------------------------------------cccceeccccCC
Confidence 9999999999999999999987521 111233678999
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++....|+.++|.|.+||++|||+ +|+.||.+.+...+++.+.- .....|..++++.+.|+..
T Consensus 332 PEYLAPEVleDnDYgraVDWWG~GVVMYEMm--CGRLPFyn~dh~kLFeLIl~--------ed~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 332 PEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM--CGRLPFYNKDHEKLFELILM--------EDLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred hhhcCchhhccccccceeehhhhhHHHHHHH--hccCcccccchhHHHHHHHh--------hhccCCccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 99999999998888776542 2344578899999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhcccCC
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKNLGA 266 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~~~~ 266 (434)
.|.+||++|. .+.|| |+|+...++..
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 9999999996 47777 88998876654
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=261.45 Aligned_cols=201 Identities=33% Similarity=0.602 Sum_probs=164.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..+ ..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.|++||||
T Consensus 53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl 126 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR-----GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126 (254)
T ss_pred HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc-----CcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 3578999999999998654 479999999999999999743 2345789999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||++...... ......+
T Consensus 127 ~p~nili~~~~~~kl~Dfg~~~~~~~~----------------------------------------------~~~~~~~ 160 (254)
T cd05083 127 AARNILVSEDGVAKVSDFGLARVGSMG----------------------------------------------VDNSKLP 160 (254)
T ss_pred CcceEEEcCCCcEEECCCccceecccc----------------------------------------------CCCCCCC
Confidence 999999999999999999986531100 0112234
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+|||||++|||++ .|..||......+....+.. ....+.+..+++++.+++.+
T Consensus 161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~ 232 (254)
T cd05083 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS-YGRAPYPKMSLKEVKECVEK-------GYRMEPPEGCPADVYVLMTS 232 (254)
T ss_pred ceecCHHHhccCCcCchhhHHHHHHHHHHHHh-CCCCCCccCCHHHHHHHHhC-------CCCCCCCCcCCHHHHHHHHH
Confidence 56999999998889999999999999999993 28999988776665544321 12233355678999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||+.+|++||+++++...|++
T Consensus 233 ~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 233 CWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=278.62 Aligned_cols=205 Identities=19% Similarity=0.225 Sum_probs=158.3
Q ss_pred CCCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|+.++||||+++++++... ...|+||||+++ +|.+++. ..+++..+..++.|++.||+|||++|
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~ 146 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG 146 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH---------hcCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 3578999999999988543 357999999965 7888775 24788899999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 147 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~--------------------------------------------~~ 182 (364)
T cd07875 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--------------------------------------------MM 182 (364)
T ss_pred eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC--------------------------------------------cc
Confidence 9999999999999999999999999975421100 11
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhh------------------
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQ------------------ 216 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~------------------ 216 (434)
....+|..|+|||++.+..++.++|||||||++|+|+ +|..||.+.+..+....+.....
T Consensus 183 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (364)
T cd07875 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI--KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260 (364)
T ss_pred cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHH
Confidence 2345778899999999999999999999999999999 89999988765544433321100
Q ss_pred -cCCc---------------ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 217 -NNSK---------------QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 217 -~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
.... ..........+.++++++.+||+.||++|||++|+ |+|++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0000 00000011234678999999999999999999999 788864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=280.25 Aligned_cols=210 Identities=20% Similarity=0.285 Sum_probs=164.2
Q ss_pred CCCCCCCCeeeEEEEEecCC-----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED-----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|+.++||||+++++++...+ ..|+|+||+. ++|.+++. ....+++..+..++.||+.||+|||++||
T Consensus 53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~~i 124 (372)
T cd07853 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIV-------SPQPLSSDHVKVFLYQILRGLKYLHSAGI 124 (372)
T ss_pred HHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 35789999999999998776 7899999996 58988886 44578999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+||+|||+++...... .....
T Consensus 125 vH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~------------------------------------------~~~~~ 162 (372)
T cd07853 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE------------------------------------------SKHMT 162 (372)
T ss_pred eCCCCChHHEEECCCCCEEeccccceeecccCc------------------------------------------cccCC
Confidence 999999999999999999999999876421100 00112
Q ss_pred CCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC----------------
Q psy5690 156 KARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN---------------- 218 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 218 (434)
...++..|+|||.+.+. .++.++||||+||++|||+ +|+.||.+.+..+....+.......
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 240 (372)
T cd07853 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL--GRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240 (372)
T ss_pred CCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHH--cCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHH
Confidence 33567889999999874 4789999999999999999 8999998877655444332211000
Q ss_pred -CcccC-------CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 -SKQQY-------LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 -~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
..... .......++++.+++.+||+.||++|||++|+ |+|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00000 01223457889999999999999999999999 7899874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=270.12 Aligned_cols=203 Identities=21% Similarity=0.323 Sum_probs=160.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|..+. .+++..+..++.|++.||+|||+.||+|+||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 121 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCC
Confidence 35789999999999999999999999999999997653 3678889999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++...... ......++
T Consensus 122 kp~Nill~~~~~~~l~dfg~~~~~~~~---------------------------------------------~~~~~~~~ 156 (279)
T cd06619 122 KPSNMLVNTRGQVKLCDFGVSTQLVNS---------------------------------------------IAKTYVGT 156 (279)
T ss_pred CHHHEEECCCCCEEEeeCCcceecccc---------------------------------------------cccCCCCC
Confidence 999999999999999999986542110 11234677
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHH---HhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVI---ENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||++.+..++.++|+|||||++|+|+ +|..||......+.. ......... ..... ......++++.++
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~l 232 (279)
T cd06619 157 NAYMAPERISGEQYGIHSDVWSLGISFMELA--LGRFPYPQIQKNQGSLMPLQLLQCIVD-EDPPV-LPVGQFSEKFVHF 232 (279)
T ss_pred hhhcCceeecCCCCCCcchHHHHHHHHHHHH--hCCCCchhhcccccccchHHHHHHHhc-cCCCC-CCCCcCCHHHHHH
Confidence 8899999999989999999999999999999 899999754322110 000000000 01111 1123467899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+.+||+.||++||+++|+ |+|+...+
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCccccccc
Confidence 999999999999999999 78887653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=261.29 Aligned_cols=204 Identities=37% Similarity=0.705 Sum_probs=166.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|||++++++++......++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl 126 (256)
T cd05112 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ------RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126 (256)
T ss_pred HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhC------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 35789999999999999999999999999999999999732 245789999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... ........++
T Consensus 127 ~p~ni~i~~~~~~~l~d~g~~~~~~~~~------------------------------------------~~~~~~~~~~ 164 (256)
T cd05112 127 AARNCLVGENQVVKVSDFGMTRFVLDDQ------------------------------------------YTSSTGTKFP 164 (256)
T ss_pred ccceEEEcCCCeEEECCCcceeecccCc------------------------------------------ccccCCCccc
Confidence 9999999999999999999865421110 0011223345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.++.++.++||||||+++|||++ .|..||......+..+.+.. ......+...++++.+++.+
T Consensus 165 ~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS-EGKTPYENRSNSEVVETINA-------GFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred hhhcCHhHhccCCcChHHHHHHHHHHHHHHHc-CCCCCCCcCCHHHHHHHHhC-------CCCCCCCCCCCHHHHHHHHH
Confidence 67999999998889999999999999999993 28999988776666554432 11222345567899999999
Q ss_pred hccCCCCCCCCHHHHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~ 260 (434)
||+.+|++||+++++++.|+
T Consensus 237 ~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HcccChhhCCCHHHHHHhhC
Confidence 99999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=269.67 Aligned_cols=208 Identities=21% Similarity=0.361 Sum_probs=165.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++..++..++||||+++++|..++.+ ....+++..+..++.|++.||+|||++|++||||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 136 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCC
Confidence 3578999999999999999999999999999999988863 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++...... ........++
T Consensus 137 kp~Nili~~~~~~kl~dfg~~~~~~~~-------------------------------------------~~~~~~~~~~ 173 (292)
T cd06644 137 KAGNVLLTLDGDIKLADFGVSAKNVKT-------------------------------------------LQRRDSFIGT 173 (292)
T ss_pred CcceEEEcCCCCEEEccCccceecccc-------------------------------------------ccccceecCC
Confidence 999999999999999999986431110 0011223456
Q ss_pred ccccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 161 IRWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 161 ~~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
..|+|||.+. ...++.++|||||||++|||+ +|..||......+....+.. ........+..++.++.
T Consensus 174 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA--QIEPPHHELNPMRVLLKIAK-----SEPPTLSQPSKWSMEFR 246 (292)
T ss_pred ccccCceeeccccccCCCCCchhhhHhHHHHHHHHh--cCCCCCccccHHHHHHHHhc-----CCCccCCCCcccCHHHH
Confidence 7899999985 344688999999999999999 89999987665444333211 11122233556788999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
+++.+||..||++||+++++ |+|+.....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 99999999999999999999 778876543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=265.19 Aligned_cols=204 Identities=23% Similarity=0.319 Sum_probs=164.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++.+++..++|+||+++|+|.+++. ....+++..+..++.|++.||+|||+.+++|+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 128 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILN-------RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDI 128 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 357899999999999999999999999999999999997 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||+++........ ...........++
T Consensus 129 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~ 171 (265)
T cd06631 129 KGNNVMLMPNGIIKLIDFGCARRLAWVGLH-------------------------------------GTHSNMLKSMHGT 171 (265)
T ss_pred CHHhEEECCCCeEEeccchhhHhhhhcccc-------------------------------------ccccccccccCCC
Confidence 999999999999999999987542111100 0000011234577
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+|||||++|+|+ +|..||...+.......+.. ........+..++.++.+++.+
T Consensus 172 ~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~ 244 (265)
T cd06631 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMA--TGKPPLASMDRLAAMFYIGA-----HRGLMPRLPDSFSAAAIDFVTS 244 (265)
T ss_pred ccccChhhhcCCCCcchhhHHHHHHHHHHHH--hCCCccccCChHHHHHHhhh-----ccCCCCCCCCCCCHHHHHHHHH
Confidence 8899999999888999999999999999999 89999987655443322211 1122333456788999999999
Q ss_pred hccCCCCCCCCHHHH
Q psy5690 241 CWKTNETDRPRFSEI 255 (434)
Q Consensus 241 cl~~dP~~Rps~~el 255 (434)
||+.+|++||++.++
T Consensus 245 ~l~~~p~~Rp~~~~~ 259 (265)
T cd06631 245 CLTRDQHERPSALQL 259 (265)
T ss_pred HhcCCcccCCCHHHH
Confidence 999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=284.42 Aligned_cols=211 Identities=17% Similarity=0.200 Sum_probs=157.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|+|||++++++..++..++|||++. |+|.+++... ...+++..++.++.||+.||.|||++||+||||
T Consensus 214 L~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDL 286 (461)
T PHA03211 214 LRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGAR------LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDI 286 (461)
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcC
Confidence 467999999999999999999999999995 6999988632 246899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .........||
T Consensus 287 KP~NILl~~~~~vkL~DFGla~~~~~~~-----------------------------------------~~~~~~~~~GT 325 (461)
T PHA03211 287 KTENVLVNGPEDICLGDFGAACFARGSW-----------------------------------------STPFHYGIAGT 325 (461)
T ss_pred CHHHEEECCCCCEEEcccCCceeccccc-----------------------------------------ccccccccCCC
Confidence 9999999999999999999976521110 00011234688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC--------hHHHHHhhhhhhhcCC-------------
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT--------NEQVIENCSHWYQNNS------------- 219 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~--------~~~~~~~~~~~~~~~~------------- 219 (434)
..|+|||++.+..++.++|||||||++|||+ +|..++.... ..+....+........
T Consensus 326 ~~Y~APE~~~~~~~~~~sDvwSlGviL~El~--~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~ 403 (461)
T PHA03211 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA--VHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ 403 (461)
T ss_pred cCCcCHHHHcCCCCCchHHHHHHHHHHHHHH--HcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence 9999999999999999999999999999999 5554432211 1222221111000000
Q ss_pred ------cccCCC-------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 220 ------KQQYLP-------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 220 ------~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
...... .....+.++.+|+.+||+.||.+|||+.|+ |+||+.
T Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000 011345689999999999999999999999 777764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=265.44 Aligned_cols=201 Identities=19% Similarity=0.283 Sum_probs=158.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++.++||||+++++++..++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++|++|+||
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 132 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH-------VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 356899999999999999999999999999999999997 3356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++...... ........|+
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~-------------------------------------------~~~~~~~~~~ 169 (267)
T cd06645 133 KGANILLTDNGHVKLADFGVSAQITAT-------------------------------------------IAKRKSFIGT 169 (267)
T ss_pred CHHHEEECCCCCEEECcceeeeEccCc-------------------------------------------ccccccccCc
Confidence 999999999999999999986542110 0011234577
Q ss_pred ccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||++. ...++.++|+|||||++|+|+ +|..||.............. .............++..+.++
T Consensus 170 ~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~--~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06645 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA--ELQPPMFDLHPMRALFLMTK---SNFQPPKLKDKMKWSNSFHHF 244 (267)
T ss_pred ccccChhhhccccCCCCCchhhhHHHHHHHHHHh--cCCCCcccccchhhHHhhhc---cCCCCCcccccCCCCHHHHHH
Confidence 8899999985 455788999999999999999 88899876554332221110 000111111123467889999
Q ss_pred HHHhccCCCCCCCCHHHHH
Q psy5690 238 MLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~ 256 (434)
+.+||+.+|++||++++|+
T Consensus 245 i~~~l~~~P~~R~~~~~ll 263 (267)
T cd06645 245 VKMALTKNPKKRPTAEKLL 263 (267)
T ss_pred HHHHccCCchhCcCHHHHh
Confidence 9999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=279.38 Aligned_cols=199 Identities=23% Similarity=0.382 Sum_probs=170.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||++.+-|+|..+...|+|||||- ||-.+++.-++ .++.+..+..|+.+.+.||+|||+++.|||||
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhk------KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDi 152 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHNRIHRDI 152 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHh------ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhc
Confidence 468999999999999999999999999995 59999887543 57889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|..|||+++.|.|||+|||.|... ....+.+||
T Consensus 153 KAGNILLse~g~VKLaDFGSAsi~-----------------------------------------------~PAnsFvGT 185 (948)
T KOG0577|consen 153 KAGNILLSEPGLVKLADFGSASIM-----------------------------------------------APANSFVGT 185 (948)
T ss_pred cccceEecCCCeeeeccccchhhc-----------------------------------------------CchhcccCC
Confidence 999999999999999999986431 123667899
Q ss_pred ccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+.|||||++. .+.|+-++||||||++..||. ..++|+.+++.......|.. + ..+.. ....++..++.|
T Consensus 186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELA--ERkPPlFnMNAMSALYHIAQ---N--esPtL-qs~eWS~~F~~F 257 (948)
T KOG0577|consen 186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA--ERKPPLFNMNAMSALYHIAQ---N--ESPTL-QSNEWSDYFRNF 257 (948)
T ss_pred ccccchhHheeccccccCCccceeeccchhhhhh--hcCCCccCchHHHHHHHHHh---c--CCCCC-CCchhHHHHHHH
Confidence 9999999986 578999999999999999999 88999999988877765532 1 11122 256789999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+..||++-|.+|||.+++ |.|+.+
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhcc
Confidence 999999999999999998 666643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=277.27 Aligned_cols=206 Identities=18% Similarity=0.225 Sum_probs=157.6
Q ss_pred CCCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|+.++||||+++++++... ...++||||+++ +|.+.+. ..+++..+..++.|+++||+|||++|
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~g 139 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG 139 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3568999999999998644 347999999965 7777775 24788899999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 140 ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------~~ 175 (355)
T cd07874 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--------------------------------------------MM 175 (355)
T ss_pred cccCCCChHHEEECCCCCEEEeeCcccccCCCcc--------------------------------------------cc
Confidence 9999999999999999999999999975421110 11
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhh-------------------hh
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSH-------------------WY 215 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~-------------------~~ 215 (434)
....+|..|+|||++.+..++.++|||||||++|+|+ +|..||.+....+....+.. +.
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (355)
T cd07874 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253 (355)
T ss_pred CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHH
Confidence 2345778899999999999999999999999999999 89999987664433222111 00
Q ss_pred hcCCccc---------------CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 216 QNNSKQQ---------------YLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 216 ~~~~~~~---------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
....... ........+.++.+++.+||+.||++|||++|+ |+|+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred hcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0000000 000112235678999999999999999999999 7888754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=268.94 Aligned_cols=206 Identities=18% Similarity=0.205 Sum_probs=158.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||++ |+|.+++.... ....+++..+..++.||+.||+|||++|++||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl 127 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP----KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDL 127 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC----CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Confidence 357899999999999999999999999997 58999886432 2356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 128 ~p~nil~~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 164 (285)
T cd07861 128 KPQNLLIDNKGVIKLADFGLARAFGIPV-------------------------------------------RVYTHEVVT 164 (285)
T ss_pred CHHHEEEcCCCcEEECcccceeecCCCc-------------------------------------------ccccCCccc
Confidence 9999999999999999999865421100 011223456
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhh---------------------cC
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQ---------------------NN 218 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~---------------------~~ 218 (434)
..|+|||++.+. .++.++|||||||++|+|+ +|..||.+............... ..
T Consensus 165 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~--tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd07861 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA--TKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKW 242 (285)
T ss_pred ccccChHHhcCCCCcCcHHHHHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcccc
Confidence 789999998754 4688999999999999999 88999987654432221111000 00
Q ss_pred CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 219 SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 219 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
...........+++++.++|.+||+.||++|||+.+|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 243 KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 00011111234678999999999999999999999993
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=268.69 Aligned_cols=199 Identities=22% Similarity=0.306 Sum_probs=168.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.|++.||.|||++|++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-------~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl 127 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR-------KSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDL 127 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence 467899999999999999999999999999999999997 3357899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.+||+|||+++..... .....++
T Consensus 128 ~p~nili~~~~~~kl~dfg~~~~~~~~----------------------------------------------~~~~~~~ 161 (290)
T cd05580 128 KPENLLLDSDGYIKITDFGFAKRVKGR----------------------------------------------TYTLCGT 161 (290)
T ss_pred CHHHEEECCCCCEEEeeCCCccccCCC----------------------------------------------CCCCCCC
Confidence 999999999999999999986542110 1233467
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||.+.+...+.++||||||+++|+|+ +|..||......+..+.+.. ...+.+...+..+++++.+
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~ 231 (290)
T cd05580 162 PEYLAPEIILSKGYGKAVDWWALGILIYEML--AGYPPFFDDNPIQIYEKILE--------GKVRFPSFFSPDAKDLIRN 231 (290)
T ss_pred ccccChhhhcCCCCCccccHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHhc--------CCccCCccCCHHHHHHHHH
Confidence 8899999998888899999999999999999 89999988775555444321 1233456678999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~ 262 (434)
||+.||.+|+ +++|+ |+|++..
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccccC
Confidence 9999999999 88888 6777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=265.41 Aligned_cols=202 Identities=19% Similarity=0.261 Sum_probs=159.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++..++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+||||
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 132 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDI 132 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 357899999999999999999999999999999999986 3346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 133 ~p~nill~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 169 (267)
T cd06646 133 KGANILLTDNGDVKLADFGVAAKITATI-------------------------------------------AKRKSFIGT 169 (267)
T ss_pred CHHHEEECCCCCEEECcCccceeecccc-------------------------------------------cccCccccC
Confidence 9999999999999999999875421100 011233567
Q ss_pred ccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||.+. ...++.++|+|||||++|||+ +|..||......+....+.. .............++.++.++
T Consensus 170 ~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~--~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 244 (267)
T cd06646 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA--ELQPPMFDLHPMRALFLMSK---SNFQPPKLKDKTKWSSTFHNF 244 (267)
T ss_pred ccccCHhHcccccCCCCcchhhHHHHHHHHHHHH--hCCCCccccchhhhheeeec---CCCCCCCCccccccCHHHHHH
Confidence 7899999985 344688999999999999999 88999876554332221110 001111112234567899999
Q ss_pred HHHhccCCCCCCCCHHHHHH
Q psy5690 238 MLECWKTNETDRPRFSEIHL 257 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~ 257 (434)
+.+||+.||++||++++++.
T Consensus 245 i~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 245 VKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred HHHHhhCChhhCcCHHHHhc
Confidence 99999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=261.71 Aligned_cols=205 Identities=20% Similarity=0.333 Sum_probs=173.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|.+.+.|+||++||.|.....+|+|||||..|+..+.++. .+..++++++..+++.-++||+|||...-+||||
T Consensus 82 MQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~------R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDI 155 (502)
T KOG0574|consen 82 MQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA------RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDI 155 (502)
T ss_pred HHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH------hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhc
Confidence 4677899999999999999999999999999999999984 3468999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|..|||++.+|.+||+|||.|... .+.....++..||
T Consensus 156 KAGNILLNT~G~AKLADFGVAGQL-------------------------------------------TDTMAKRNTVIGT 192 (502)
T KOG0574|consen 156 KAGNILLNTDGIAKLADFGVAGQL-------------------------------------------TDTMAKRNTVIGT 192 (502)
T ss_pred ccccEEEcccchhhhhhccccchh-------------------------------------------hhhHHhhCccccC
Confidence 999999999999999999986442 1111233667899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+-|||||++..-.|..++||||||++..||. .|++||.+.......- ............|..++.++.+++++
T Consensus 193 PFWMAPEVI~EIGY~~~ADIWSLGITaIEMA--EG~PPYsDIHPMRAIF-----MIPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 193 PFWMAPEVIEEIGYDTKADIWSLGITAIEMA--EGRPPYSDIHPMRAIF-----MIPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred cccccHHHHHHhccchhhhHhhhcchhhhhh--cCCCCcccccccceeE-----eccCCCCCCCCChHhhhhHHHHHHHH
Confidence 9999999999999999999999999999999 9999998876543321 11112223333467889999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHh
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~ 261 (434)
||.++|++|-++-++ |.|+++
T Consensus 266 CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhcC
Confidence 999999999999998 777754
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=267.98 Aligned_cols=206 Identities=33% Similarity=0.653 Sum_probs=165.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||++++|++... ..++++||+++|+|.+++..+ ...+++..+..++.|++.||+|||++||+||||
T Consensus 63 ~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~di 135 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEH------KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDL 135 (303)
T ss_pred HHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHhhcCeecccc
Confidence 3578999999999998654 577999999999999999732 245889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .........++
T Consensus 136 kp~Nill~~~~~~kL~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 174 (303)
T cd05110 136 AARNVLVKSPNHVKITDFGLARLLEGDE-----------------------------------------KEYNADGGKMP 174 (303)
T ss_pred ccceeeecCCCceEEccccccccccCcc-----------------------------------------cccccCCCccc
Confidence 9999999999999999999976522110 00011223346
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|||||||++||+++ .|..||.+....+....+. .....+.+..++..+.+++.+
T Consensus 175 ~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t-~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 246 (303)
T cd05110 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT-FGGKPYDGIPTREIPDLLE-------KGERLPQPPICTIDVYMVMVK 246 (303)
T ss_pred cccCCHHHhccCCCChHHHHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHH-------CCCCCCCCCCCCHHHHHHHHH
Confidence 67999999998899999999999999999984 3889998776555443322 122333455677899999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||..+|++||+++++...|++.
T Consensus 247 c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 247 CWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999998888764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=262.10 Aligned_cols=201 Identities=20% Similarity=0.291 Sum_probs=165.7
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
..+|+|++++++++..++..++|+||+++|+|.++++ ....+++..+..++.|++.||.|||+.+++||||+|
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p 125 (260)
T cd05611 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK-------TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKP 125 (260)
T ss_pred cCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 4689999999999999999999999999999999997 334689999999999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+||+++.++.++|+|||+++.... .....++..
T Consensus 126 ~nil~~~~~~~~l~dfg~~~~~~~-----------------------------------------------~~~~~~~~~ 158 (260)
T cd05611 126 ENLLIDQTGHLKLTDFGLSRNGLE-----------------------------------------------NKKFVGTPD 158 (260)
T ss_pred HHeEECCCCcEEEeecccceeccc-----------------------------------------------cccCCCCcC
Confidence 999999999999999998643110 122345677
Q ss_pred ccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhc
Q psy5690 163 WMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECW 242 (434)
Q Consensus 163 y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 242 (434)
|+|||.+.+..++.++||||||+++|+|+ +|..||...+..+....+... ...........+++++.+++.+||
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFL--FGYPPFHAETPDAVFDNILSR----RINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHhc----ccCCCCcccccCCHHHHHHHHHHc
Confidence 99999999888899999999999999999 899999887776655443221 111111223457899999999999
Q ss_pred cCCCCCCCCH---HHH--HHHHHhcc
Q psy5690 243 KTNETDRPRF---SEI--HLFLQRKN 263 (434)
Q Consensus 243 ~~dP~~Rps~---~el--~~~L~~~~ 263 (434)
+.||++||++ +|+ |+|+++.+
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcCC
Confidence 9999999965 576 78887654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=262.84 Aligned_cols=203 Identities=21% Similarity=0.289 Sum_probs=167.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++|+||+++|+|.+++. ....+++..+..++.||+.||+|||++|++|+||+
T Consensus 48 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~ 120 (262)
T cd05572 48 EECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILR-------DRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120 (262)
T ss_pred HhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence 57899999999999999999999999999999999997 33458999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||++....... ......++.
T Consensus 121 ~~nilv~~~~~~~l~df~~~~~~~~~~--------------------------------------------~~~~~~~~~ 156 (262)
T cd05572 121 PENLLLDSNGYVKLVDFGFAKKLKSGQ--------------------------------------------KTWTFCGTP 156 (262)
T ss_pred HHHEEEcCCCCEEEeeCCcccccCccc--------------------------------------------ccccccCCc
Confidence 999999999999999999865421110 112234567
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC--hHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT--NEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
.|+|||.+....++.++|+||+|+++|+|+ +|..||.... ..+....+.. .......+...++++.+++.
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~i~ 228 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELL--TGRPPFGEDDEDPMEIYNDILK------GNGKLEFPNYIDKAAKDLIK 228 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHH--hCCCCcCCCCCCHHHHHHHHhc------cCCCCCCCcccCHHHHHHHH
Confidence 799999998888999999999999999999 8999998776 3333332221 12233445556889999999
Q ss_pred HhccCCCCCCCC-----HHHH--HHHHHhcc
Q psy5690 240 ECWKTNETDRPR-----FSEI--HLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps-----~~el--~~~L~~~~ 263 (434)
+||+.||++||+ ++|+ |+|+++..
T Consensus 229 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 229 QLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred HHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 999999999999 8999 78998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=265.63 Aligned_cols=202 Identities=21% Similarity=0.321 Sum_probs=165.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++..++..++||||+++|+|.+++. ...+++..+..++.|+++|+.|||++|++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl 127 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--------PGPLEETYIATILREILKGLDYLHSERKIHRDI 127 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCC
Confidence 367899999999999999999999999999999999985 235889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||++....... .......++
T Consensus 128 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 164 (277)
T cd06642 128 KAANVLLSEQGDVKLADFGVAGQLTDTQ-------------------------------------------IKRNTFVGT 164 (277)
T ss_pred ChheEEEeCCCCEEEccccccccccCcc-------------------------------------------hhhhcccCc
Confidence 9999999999999999999865421110 011223466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|+|||||++|||+ +|..||...........+. ..........++.++.+++.+
T Consensus 165 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~--tg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELA--KGEPPNSDLHPMRVLFLIP-------KNSPPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred ccccCHHHhCcCCCchhhhHHHHHHHHHHHH--hCCCCCcccchhhHHhhhh-------cCCCCCCCcccCHHHHHHHHH
Confidence 7899999999988999999999999999999 8999997665544332221 111222344577899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.+|++||++.++ |+|+.+.
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 236 CLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HccCCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999 7788764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=259.72 Aligned_cols=204 Identities=35% Similarity=0.646 Sum_probs=167.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++.+ ...+++|||+++|+|.+++.+. ....+++..+..++.|++.||.|||+.|++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl 128 (260)
T cd05073 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-----EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128 (260)
T ss_pred HHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC-----CccccCHHHHHHHHHHHHHHHHHHHhCCcccccc
Confidence 467899999999999877 7889999999999999999742 2346788899999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||.+....... ........++
T Consensus 129 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~------------------------------------------~~~~~~~~~~ 166 (260)
T cd05073 129 RAANILVSASLVCKIADFGLARVIEDNE------------------------------------------YTAREGAKFP 166 (260)
T ss_pred CcceEEEcCCCcEEECCCcceeeccCCC------------------------------------------cccccCCccc
Confidence 9999999999999999999865421110 0011223345
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++....++.++|+|||||++|+++ + |..||...+.......+.. ....+.+...+.++.+++.
T Consensus 167 ~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIV--TYGRIPYPGMSNPEVIRALER-------GYRMPRPENCPEELYNIMM 237 (260)
T ss_pred ccccCHhHhccCCcCccccchHHHHHHHHHH--hcCCCCCCCCCHHHHHHHHhC-------CCCCCCcccCCHHHHHHHH
Confidence 6799999999888999999999999999999 6 8999988776665544322 1223345567889999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.+|++||++.+++..|+.
T Consensus 238 ~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 238 RCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHcccCcccCcCHHHHHHHHhc
Confidence 9999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=261.85 Aligned_cols=200 Identities=21% Similarity=0.352 Sum_probs=163.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+++..|+++||+.+++|.+++.. ....+++..+..++.|++.||.|||+.+++||||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~------~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl 125 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI------TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh------CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 3578999999999999999999999999999999999963 2356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||++....... .......++
T Consensus 126 ~~~ni~~~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 162 (256)
T cd06612 126 KAGNILLNEEGQAKLADFGVSGQLTDTM-------------------------------------------AKRNTVIGT 162 (256)
T ss_pred CcceEEECCCCcEEEcccccchhcccCc-------------------------------------------cccccccCC
Confidence 9999999999999999999865421110 011223356
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++||||||+++|+|+ +|..||......+....+.. ........+..++.++.+++.+
T Consensus 163 ~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMA--EGKPPYSDIHPMRAIFMIPN-----KPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccccCHHHHhcCCCCchhhHHHHHHHHHHHH--hCCCCCCCcchhhhhhhhcc-----CCCCCCCchhhcCHHHHHHHHH
Confidence 7899999999989999999999999999999 88999987665544332211 1112222344567899999999
Q ss_pred hccCCCCCCCCHHHHH
Q psy5690 241 CWKTNETDRPRFSEIH 256 (434)
Q Consensus 241 cl~~dP~~Rps~~el~ 256 (434)
||+.||++||++.|++
T Consensus 236 ~l~~~P~~Rps~~~il 251 (256)
T cd06612 236 CLVKDPEERPSAIQLL 251 (256)
T ss_pred HHhcChhhCcCHHHHh
Confidence 9999999999999993
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=267.02 Aligned_cols=202 Identities=21% Similarity=0.281 Sum_probs=162.2
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
..+||||+++++++..++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||+++|+||||||
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~-------~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp 125 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS-------QHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKP 125 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCH
Confidence 3579999999999999999999999999999999987 334699999999999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+||+++.++.++|+|||++...... ......++..
T Consensus 126 ~Nil~~~~~~~~l~dfg~~~~~~~~---------------------------------------------~~~~~~~~~~ 160 (279)
T cd05633 126 ANILLDEHGHVRISDLGLACDFSKK---------------------------------------------KPHASVGTHG 160 (279)
T ss_pred HHEEECCCCCEEEccCCcceecccc---------------------------------------------CccCcCCCcC
Confidence 9999999999999999986431100 0122357788
Q ss_pred ccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 163 WMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 163 y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
|+|||.+.. ..++.++||||+||++|+|+ +|..||.......... +... ........+..+++++.+++.+|
T Consensus 161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~--~g~~pf~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLL--RGHSPFRQHKTKDKHE-IDRM----TLTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred ccCHHHhcCCCCCCchhhhHHHHHHHHHHH--hCCCCcCCCCCcCHHH-HHHH----hhcCCcCCccccCHHHHHHHHHH
Confidence 999999874 55789999999999999999 8899997643221111 1110 01112234566889999999999
Q ss_pred ccCCCCCCC-----CHHHH--HHHHHhcc
Q psy5690 242 WKTNETDRP-----RFSEI--HLFLQRKN 263 (434)
Q Consensus 242 l~~dP~~Rp-----s~~el--~~~L~~~~ 263 (434)
|..||++|| ++.|+ |+|++..+
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 999999999 59999 77887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.78 Aligned_cols=201 Identities=25% Similarity=0.311 Sum_probs=168.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
..|+|||+|++||+-.+++..+|.||||++|+|.+.++ .+...++.....+..|++.|+.|||++||||||||
T Consensus 1289 E~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~-------~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK 1361 (1509)
T KOG4645|consen 1289 EGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE-------HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIK 1361 (1509)
T ss_pred HhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH-------hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCC
Confidence 46899999999999999999999999999999999997 44567777788899999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.+|.+|++|||.|..+..+.. ..........||+
T Consensus 1362 ~aNI~Ld~~g~iK~~DFGsa~ki~~~~~---------------------------------------~~~~el~~~~GT~ 1402 (1509)
T KOG4645|consen 1362 PANILLDFNGLIKYGDFGSAVKIKNNAQ---------------------------------------TMPGELQSMMGTP 1402 (1509)
T ss_pred ccceeeecCCcEEeecccceeEecCchh---------------------------------------cCCHHHHhhcCCc
Confidence 9999999999999999999876433210 0001234678999
Q ss_pred cccchhhhhcCC---CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 162 RWMAWESLLLGK---NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 162 ~y~aPE~~~~~~---~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
.|||||++.+.. ...++||||+||++.||+ +|+.||...+.+=.+. .....+..++.|..++.+-++++
T Consensus 1403 ~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~--tGkrPW~~~dne~aIM------y~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1403 MYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA--TGKRPWAELDNEWAIM------YHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred hhcCchhhcccccCCCCcchhhhcccceEEEee--cCCCchhhccchhHHH------hHHhccCCCCCchhhhHhHHHHH
Confidence 999999998644 467899999999999999 9999999876553321 22335566777888999999999
Q ss_pred HHhccCCCCCCCCHHHHH
Q psy5690 239 LECWKTNETDRPRFSEIH 256 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~ 256 (434)
..||+.||+.|.++.|++
T Consensus 1475 e~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred HHHHhcCchhhhHHHHHH
Confidence 999999999999998883
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=259.13 Aligned_cols=200 Identities=19% Similarity=0.261 Sum_probs=166.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++.+.+..+++|||+++|+|.+++.+. ....+++..+..++.|++.||.|||+.|++|+||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl 127 (256)
T cd08221 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ-----KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127 (256)
T ss_pred HHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc-----cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 46789999999999999999999999999999999999732 2356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.+||+|||++....... .......++
T Consensus 128 ~p~ni~~~~~~~~kl~d~~~~~~~~~~~-------------------------------------------~~~~~~~~~ 164 (256)
T cd08221 128 KTLNIFLTKAGLIKLGDFGISKILGSEY-------------------------------------------SMAETVVGT 164 (256)
T ss_pred ChHhEEEeCCCCEEECcCcceEEccccc-------------------------------------------ccccccCCC
Confidence 9999999999999999999875421111 011234567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+||||+++|||+ +|..||......+....+.. ....+.+..++.++.+++.+
T Consensus 165 ~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~--~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELL--TLKRTFDATNPLNLVVKIVQ-------GNYTPVVSVYSSELISLVHS 235 (256)
T ss_pred ccccCHhhcCCCCCCCcchhHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHc-------CCCCCCccccCHHHHHHHHH
Confidence 8899999999888899999999999999999 88999988776665544321 22233346678899999999
Q ss_pred hccCCCCCCCCHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHL 257 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~ 257 (434)
||..+|++||+++++++
T Consensus 236 ~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 236 LLQQDPEKRPTADEVLD 252 (256)
T ss_pred HcccCcccCCCHHHHhh
Confidence 99999999999999954
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=262.80 Aligned_cols=202 Identities=20% Similarity=0.321 Sum_probs=162.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..+++|||+++++|.+++... ...+++..+..++.|++.||+|||++|++|+||
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl 127 (262)
T cd06613 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT------RGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127 (262)
T ss_pred HHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Confidence 46789999999999999999999999999999999999732 256899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 128 ~p~ni~i~~~~~~~l~d~g~~~~~~~~~-------------------------------------------~~~~~~~~~ 164 (262)
T cd06613 128 KGANILLTEDGDVKLADFGVSAQLTATI-------------------------------------------AKRKSFIGT 164 (262)
T ss_pred ChhhEEECCCCCEEECccccchhhhhhh-------------------------------------------hccccccCC
Confidence 9999999999999999999865421100 011233566
Q ss_pred ccccchhhhhcC---CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLLLG---KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~~---~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||.+.+. .++.++|+|||||++|+|+ +|..||......+....+.. .............++.++.++
T Consensus 165 ~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~--tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l 239 (262)
T cd06613 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELA--ELQPPMFDLHPMRALFLISK---SNFPPPKLKDKEKWSPVFHDF 239 (262)
T ss_pred ccccCchhhcccccCCcCchhhhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHh---ccCCCccccchhhhhHHHHHH
Confidence 789999999876 7889999999999999999 89999988765554332221 100111122234567889999
Q ss_pred HHHhccCCCCCCCCHHHHH
Q psy5690 238 MLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~ 256 (434)
+.+||..||.+||++.+|+
T Consensus 240 i~~~l~~~p~~Rpt~~~il 258 (262)
T cd06613 240 IKKCLTKDPKKRPTATKLL 258 (262)
T ss_pred HHHHcCCChhhCCCHHHHh
Confidence 9999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=269.32 Aligned_cols=205 Identities=17% Similarity=0.248 Sum_probs=166.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++.+..++..++||||+++++|.+++. ...+++..+..++.||+.||+|||++||+||||
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 144 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT--------HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 144 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCC
Confidence 356899999999999999999999999999999999885 235889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 145 kp~Nill~~~~~~kL~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 181 (292)
T cd06658 145 KSDSILLTSDGRIKLSDFGFCAQVSKEV-------------------------------------------PKRKSLVGT 181 (292)
T ss_pred CHHHEEEcCCCCEEEccCcchhhccccc-------------------------------------------ccCceeecC
Confidence 9999999999999999999865321100 011223467
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++||||||+++|||+ +|..||......+....+... .....+.....+..+.+++.+
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~--~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMI--DGEPPYFNEPPLQAMRRIRDN-----LPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhc-----CCCccccccccCHHHHHHHHH
Confidence 8899999999888999999999999999999 889999877665544433211 111122233567889999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||..||++|||++++ ++|++...
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccC
Confidence 999999999999999 67887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=261.26 Aligned_cols=199 Identities=20% Similarity=0.288 Sum_probs=161.6
Q ss_pred CCCCCCCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
+++++|+|++++++.+.. ++..+++|||+++++|.+++... ....+++.++..++.|++.||+|||++|++|||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-----~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~d 127 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ-----KGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 357899999999998864 44689999999999999999732 234689999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||+++.++.++|+|||++....... .......+
T Consensus 128 i~p~nil~~~~~~~~l~df~~~~~~~~~~-------------------------------------------~~~~~~~~ 164 (257)
T cd08223 128 LKTQNVFLTRTNIIKVGDLGIARVLENQC-------------------------------------------DMASTLIG 164 (257)
T ss_pred CCchhEEEecCCcEEEecccceEEecccC-------------------------------------------CccccccC
Confidence 99999999999999999999865421100 01123446
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+..|+|||++.+..++.++|+|||||++|+++ +|..||...+.......+.. ....+.+...++++.+++.
T Consensus 165 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~--~g~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMA--TLKHAFNAKDMNSLVYRIIE-------GKLPPMPKDYSPELGELIA 235 (257)
T ss_pred CcCccChhHhcCCCCCchhhhHHHHHHHHHHH--cCCCCCCCCCHHHHHHHHHh-------cCCCCCccccCHHHHHHHH
Confidence 77899999999999999999999999999999 88999987765554433221 1122335567899999999
Q ss_pred HhccCCCCCCCCHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIH 256 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~ 256 (434)
+||+.||++||++.+++
T Consensus 236 ~~l~~~p~~Rp~~~~~l 252 (257)
T cd08223 236 TMLSKRPEKRPSVKSIL 252 (257)
T ss_pred HHhccCcccCCCHHHHh
Confidence 99999999999999993
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=263.43 Aligned_cols=203 Identities=20% Similarity=0.314 Sum_probs=167.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+++..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl 127 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCC
Confidence 3578999999999999999999999999999999999862 35788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++++|||++....... .......++
T Consensus 128 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 164 (277)
T cd06640 128 KAANVLLSEQGDVKLADFGVAGQLTDTQ-------------------------------------------IKRNTFVGT 164 (277)
T ss_pred ChhhEEEcCCCCEEEcccccceeccCCc-------------------------------------------cccccccCc
Confidence 9999999999999999999865421100 011223466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+|||||++|||+ +|..||...........+. .......+..++..+.+++.+
T Consensus 165 ~~y~apE~~~~~~~~~~~Dv~slG~il~el~--tg~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELA--KGEPPNSDMHPMRVLFLIP-------KNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred ccccCHhHhccCCCccHHHHHHHHHHHHHHH--HCCCCCCCcChHhHhhhhh-------cCCCCCCchhhhHHHHHHHHH
Confidence 7799999999888999999999999999999 8999998776555443221 112233345678899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||+.+|++||+++++ |+|+.+..
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 236 CLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HcccCcccCcCHHHHHhChHhhhcc
Confidence 999999999999999 78887653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=277.19 Aligned_cols=190 Identities=22% Similarity=0.329 Sum_probs=161.7
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
-+||||+++.+.+.++.+.|+|||++.||-+.+.+.. ...+. .++..|+.+|+.|+.|||++||+||||||+
T Consensus 373 ~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~-------~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~ 444 (612)
T KOG0603|consen 373 RDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS-------KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPG 444 (612)
T ss_pred cCCCcceeecceecCCceeeeeehhccccHHHHHHHh-------cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChh
Confidence 4799999999999999999999999999988888862 22333 778889999999999999999999999999
Q ss_pred Ceee-ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 84 NCMV-GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 84 NILl-~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
|||+ +..++++|+|||.++..... ..+.+-|..
T Consensus 445 NIL~~~~~g~lrltyFG~a~~~~~~----------------------------------------------~~tp~~t~~ 478 (612)
T KOG0603|consen 445 NILLDGSAGHLRLTYFGFWSELERS----------------------------------------------CDTPALTLQ 478 (612)
T ss_pred heeecCCCCcEEEEEechhhhCchh----------------------------------------------hcccchhhc
Confidence 9999 68999999999997652111 123456778
Q ss_pred ccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 163 WMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 163 y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
|.|||++....|+.++||||||++||+|+ +|+.||...+.. ++...+. ..+....+|++.++|+.+|
T Consensus 479 y~APEvl~~~~yt~acD~WSLGvlLy~ML--~G~tp~~~~P~~~ei~~~i~----------~~~~s~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 479 YVAPEVLAIQEYTEACDWWSLGVLLYEML--TGRTLFAAHPAGIEIHTRIQ----------MPKFSECVSDEAKDLLQQL 546 (612)
T ss_pred ccChhhhccCCCCcchhhHHHHHHHHHHH--hCCCccccCCchHHHHHhhc----------CCccccccCHHHHHHHHHh
Confidence 99999999999999999999999999999 999999888776 3333221 2222377899999999999
Q ss_pred ccCCCCCCCCHHHH--HHHH
Q psy5690 242 WKTNETDRPRFSEI--HLFL 259 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L 259 (434)
|+.||.+|++++++ |+|+
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 99999999999999 8999
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.37 Aligned_cols=197 Identities=17% Similarity=0.320 Sum_probs=156.1
Q ss_pred CC-CCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 3 SL-KDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
++ +||||+++++++... ...++||||+.+|+|.+++... ....+++..+..++.|++.||+|||+++|
T Consensus 58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-----~~~~l~~~~~~~~~~qi~~~l~~LH~~~i 132 (272)
T cd06637 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-----KGNTLKEEWIAYICREILRGLSHLHQHKV 132 (272)
T ss_pred HhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 45 799999999998653 4589999999999999999732 23468899999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+|+||||+||+++.++.++|+|||+++..... .....
T Consensus 133 vh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~-------------------------------------------~~~~~ 169 (272)
T cd06637 133 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-------------------------------------------VGRRN 169 (272)
T ss_pred ccCCCCHHHEEECCCCCEEEccCCCceecccc-------------------------------------------cccCC
Confidence 99999999999999999999999996542110 00113
Q ss_pred CCCCCccccchhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc
Q psy5690 156 KARLPIRWMAWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (434)
...|+..|+|||++.+ ..++.++|||||||++|||+ +|..||............. ...........+
T Consensus 170 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~--~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~ 241 (272)
T cd06637 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA--EGAPPLCDMHPMRALFLIP------RNPAPRLKSKKW 241 (272)
T ss_pred cccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHH--hCCCCccccCHHHHHHHHh------cCCCCCCCCCCc
Confidence 3457788999999863 35788999999999999999 8899997665444332221 111122223457
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
+.++.+++.+||..||.+||+++++
T Consensus 242 ~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 242 SKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHH
Confidence 7899999999999999999999999
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=259.68 Aligned_cols=203 Identities=48% Similarity=0.877 Sum_probs=166.8
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++|+||+++++++.+.+..+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.|++|+|||
T Consensus 56 ~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~ 130 (258)
T smart00219 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR-----PKELSLSDLLSFALQIARGMEYLESKNFIHRDLA 130 (258)
T ss_pred HhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh-----hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccc
Confidence 56899999999999999999999999999999999997321 1128999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||+++....... + ......++.
T Consensus 131 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-----------------------------------------~-~~~~~~~~~ 168 (258)
T smart00219 131 ARNCLVGENLVVKISDFGLSRDLYDDDY-----------------------------------------Y-KKKGGKLPI 168 (258)
T ss_pred cceEEEccCCeEEEcccCCceecccccc-----------------------------------------c-ccccCCCcc
Confidence 9999999999999999998765322110 0 001223667
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||.+.+..++.++||||+|+++|+|++ .|..||......+..+.+.. ....+.+..++.++.+++.+|
T Consensus 169 ~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~-~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~ 240 (258)
T smart00219 169 RWMAPESLKDGKFTSKSDVWSFGVLLWEIFT-LGESPYPGMSNEEVLEYLKK-------GYRLPKPENCPPEIYKLMLQC 240 (258)
T ss_pred cccChHHhccCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCCHHHHHHHHhc-------CCCCCCCCcCCHHHHHHHHHH
Confidence 8999999988889999999999999999993 27889988777666655432 223344556889999999999
Q ss_pred ccCCCCCCCCHHHHHHHH
Q psy5690 242 WKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 242 l~~dP~~Rps~~el~~~L 259 (434)
|..||++|||+.|+..+|
T Consensus 241 l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 241 WAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CcCChhhCcCHHHHHhhC
Confidence 999999999999997654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=268.60 Aligned_cols=205 Identities=20% Similarity=0.330 Sum_probs=166.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++..++..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL 141 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDI 141 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 3568999999999999999999999999999999999852 35788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 142 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 178 (297)
T cd06656 142 KSDNILLGMDGSVKLTDFGFCAQITPEQ-------------------------------------------SKRSTMVGT 178 (297)
T ss_pred CHHHEEECCCCCEEECcCccceEccCCc-------------------------------------------cCcCcccCC
Confidence 9999999999999999999865421110 011233567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+|||||++|+++ +|..||...........+. .........+..+++.+.+++.+
T Consensus 179 ~~y~aPE~~~~~~~~~~~Di~slGvil~~l~--tg~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV--EGEPPYLNENPLRALYLIA-----TNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred ccccCHHHHcCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCcchheeeec-----cCCCCCCCCccccCHHHHHHHHH
Confidence 7899999999988999999999999999999 8999997765433221110 11112222355677889999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||+.||++||+++++ |+|++...
T Consensus 252 ~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 252 CLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HccCChhhCcCHHHHhcCchhcccc
Confidence 999999999999999 78998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=277.77 Aligned_cols=209 Identities=17% Similarity=0.222 Sum_probs=156.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++|+||+. |+|.+++.. ....+++..+..++.||+.||.|||++||+||||
T Consensus 111 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 183 (357)
T PHA03209 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK------RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDV 183 (357)
T ss_pred HHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 467899999999999999999999999995 589998863 3356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++..... .......||
T Consensus 184 kp~Nill~~~~~~kl~DfG~a~~~~~~--------------------------------------------~~~~~~~gt 219 (357)
T PHA03209 184 KTENIFINDVDQVCIGDLGAAQFPVVA--------------------------------------------PAFLGLAGT 219 (357)
T ss_pred CHHHEEECCCCCEEEecCccccccccC--------------------------------------------ccccccccc
Confidence 999999999999999999986531100 011234578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH--H-------HHHhhhhhhhcC-------------
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE--Q-------VIENCSHWYQNN------------- 218 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~--~-------~~~~~~~~~~~~------------- 218 (434)
..|+|||++.+..++.++|||||||++|||++ .+..+|...... . ....+.......
T Consensus 220 ~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~-~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 298 (357)
T PHA03209 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLA-YPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLV 298 (357)
T ss_pred ccccCCeecCCCCCCchhhHHHHHHHHHHHHH-cCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHH
Confidence 89999999999999999999999999999994 244444432211 0 000000000000
Q ss_pred ------CcccCCC-------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 219 ------SKQQYLP-------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 219 ------~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
......+ ....++.++.++|.+||+.||++|||+.|+ |+||++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 299 RGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0000000 011345677889999999999999999999 888875
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=267.97 Aligned_cols=215 Identities=19% Similarity=0.201 Sum_probs=163.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++.++||||+++++.+..++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++|++||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 127 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK-------NIGALPVDMARMYFAETVLALEYLHNYGIVHRDL 127 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 356899999999999999999999999999999999997 3346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++.......... .+.. ..............++
T Consensus 128 ~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~------------------------~~~~----~~~~~~~~~~~~~~~~ 179 (305)
T cd05609 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL------------------------YEGH----IEKDTREFLDKQVCGT 179 (305)
T ss_pred chHHEEECCCCCEEEeeCCCccccCcCccccc------------------------cccc----cccchhhccccCCccC
Confidence 99999999999999999998764211100000 0000 0000001112234567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+|||||++||++ +|..||.+....+........ ....+.....+++++.+++.+
T Consensus 180 ~~y~aPE~~~~~~~~~~~Di~slG~vl~el~--~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~ 252 (305)
T cd05609 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFL--VGCVPFFGDTPEELFGQVISD-----DIEWPEGDEALPADAQDLISR 252 (305)
T ss_pred ccccCchhccCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhc-----ccCCCCccccCCHHHHHHHHH
Confidence 8899999999888999999999999999999 899999887766655543221 111122223578899999999
Q ss_pred hccCCCCCCCCHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHL 257 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~ 257 (434)
||+.||++||++.++.+
T Consensus 253 ~l~~~P~~R~~~~~~~~ 269 (305)
T cd05609 253 LLRQNPLERLGTGGAFE 269 (305)
T ss_pred HhccChhhccCccCHHH
Confidence 99999999998544433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=263.57 Aligned_cols=202 Identities=20% Similarity=0.341 Sum_probs=167.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++|+||+++++++.++...++|+||+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||+
T Consensus 54 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~ 125 (274)
T cd06609 54 SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIK 125 (274)
T ss_pred HHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 568999999999999999999999999999999999962 268999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||+++...... .......++.
T Consensus 126 p~ni~i~~~~~~~l~d~g~~~~~~~~~-------------------------------------------~~~~~~~~~~ 162 (274)
T cd06609 126 AANILLSEEGDVKLADFGVSGQLTSTM-------------------------------------------SKRNTFVGTP 162 (274)
T ss_pred HHHEEECCCCCEEEcccccceeecccc-------------------------------------------cccccccCCc
Confidence 999999999999999999876532110 0112334667
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCc-cHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT-CQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~ 240 (434)
.|+|||.+.+..++.++|||||||++|+|+ +|..||...........+.. ......+.. +++++.+++.+
T Consensus 163 ~y~~PE~~~~~~~~~~sDv~slG~il~~l~--tg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~ 233 (274)
T cd06609 163 FWMAPEVIKQSGYDEKADIWSLGITAIELA--KGEPPLSDLHPMRVLFLIPK-------NNPPSLEGNKFSKPFKDFVSL 233 (274)
T ss_pred cccChhhhccCCCCchhhHHHHHHHHHHHH--hCCCCcccCchHHHHHHhhh-------cCCCCCcccccCHHHHHHHHH
Confidence 899999999888999999999999999999 89999987665544333221 111111222 78899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||..||++||+++++ |+|+++..
T Consensus 234 ~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 234 CLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HhhCChhhCcCHHHHhhChhhcCCC
Confidence 999999999999999 88997753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=260.85 Aligned_cols=207 Identities=20% Similarity=0.321 Sum_probs=166.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++..++..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+.|++||||
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl 132 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFK---KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDI 132 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhc---ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCc
Confidence 357899999999999999999999999999999999986432 13456899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++...... .......++
T Consensus 133 ~p~nil~~~~~~~~l~d~~~~~~~~~~~-------------------------------------------~~~~~~~~~ 169 (267)
T cd08224 133 KPANVFITATGVVKLGDLGLGRFFSSKT-------------------------------------------TAAHSLVGT 169 (267)
T ss_pred ChhhEEECCCCcEEEeccceeeeccCCC-------------------------------------------cccceecCC
Confidence 9999999999999999999865421100 011223466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh--HHHHHhhhhhhhcCCcccCCCCCC-ccHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN--EQVIENCSHWYQNNSKQQYLPRPA-TCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l 237 (434)
..|+|||.+.+..++.++|+|||||++|+|+ +|..||..... .+..+.+. .....+.+. .++.++.++
T Consensus 170 ~~y~apE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMA--ALQSPFYGDKMNLYSLCKKIE-------KCDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccccCHHHhccCCCCchhcHHHHHHHHHHHH--HCCCCcccCCccHHHHHhhhh-------cCCCCCCChhhcCHHHHHH
Confidence 7799999999888999999999999999999 78999865432 12222211 122223333 677899999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+||..+|++||++.+|.+.|++.
T Consensus 241 i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHcCCCcccCCCHHHHHHHHHHh
Confidence 9999999999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=264.26 Aligned_cols=205 Identities=17% Similarity=0.276 Sum_probs=167.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++..++..++++||+++++|.+++. . ..+++..+..++.|++.||+|||++|++||||
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-------~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 141 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT-------H-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDI 141 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHH-------h-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 356899999999999999999999999999999999996 2 45889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||++...... ........++
T Consensus 142 ~p~Nil~~~~~~~~l~d~g~~~~~~~~-------------------------------------------~~~~~~~~~~ 178 (285)
T cd06648 142 KSDSILLTSDGRVKLSDFGFCAQVSKE-------------------------------------------VPRRKSLVGT 178 (285)
T ss_pred ChhhEEEcCCCcEEEcccccchhhccC-------------------------------------------CcccccccCC
Confidence 999999999999999999985431110 0011223467
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|||||||++|+|+ +|..||...+..+....+... .......+..++..+.+++.+
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell--~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMV--DGEPPYFNEPPLQAMKRIRDN-----LPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHH--hCCCCCcCCCHHHHHHHHHhc-----CCCCCcccccCCHHHHHHHHH
Confidence 7899999999888999999999999999999 889999877665554443321 111222233477899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||+.+|++||++.++ |+|+++..
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HcccChhhCcCHHHHccCcccccCC
Confidence 999999999999999 68887743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=264.19 Aligned_cols=210 Identities=31% Similarity=0.517 Sum_probs=160.7
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++... ...++||||+++++|.+++.+. ...+++..+..++.|++.||+|||++|++||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~ 133 (284)
T cd05079 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN------KNKINLKQQLKYAVQICKGMDYLGSRQYVHR 133 (284)
T ss_pred HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 3678999999999999775 5689999999999999999632 2358999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.++|+|||+++....... .........
T Consensus 134 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~----------------------------------------~~~~~~~~~ 173 (284)
T cd05079 134 DLAARNVLVESEHQVKIGDFGLTKAIETDKE----------------------------------------YYTVKDDLD 173 (284)
T ss_pred ccchheEEEcCCCCEEECCCccccccccCcc----------------------------------------ceeecCCCC
Confidence 9999999999999999999998765321110 000112334
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-----------HHHHhhhhhhhcCCcccCCCCC
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-----------QVIENCSHWYQNNSKQQYLPRP 227 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 227 (434)
++..|+|||++.+..++.++|||||||++|||+ ++..|+...... ........ ........+.+
T Consensus 174 ~~~~y~apE~~~~~~~~~~~Di~slG~il~ell--t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 248 (284)
T cd05079 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELL--TYCDSESSPMTLFLKMIGPTHGQMTVTRLVR---VLEEGKRLPRP 248 (284)
T ss_pred CCccccCHHHhccCCCCccccchhhhhhhhhhh--cCCCCCccccchhhhhcccccccccHHHHHH---HHHcCccCCCC
Confidence 566799999999888999999999999999999 555543221100 00000000 01112233445
Q ss_pred CccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 228 ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 228 ~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
..++.++.+++.+||+.||++||+++++...|++
T Consensus 249 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 249 PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 6788999999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=261.79 Aligned_cols=206 Identities=18% Similarity=0.295 Sum_probs=165.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++..++..+++|||+++++|.+++.... .....+++..++.++.||+.||.|||++|++|+|||
T Consensus 57 ~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~ 133 (267)
T cd08229 57 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK---KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIK 133 (267)
T ss_pred HHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhh---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 56899999999999999999999999999999999986432 134568999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||++....... .......++.
T Consensus 134 p~nili~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~~ 170 (267)
T cd08229 134 PANVFITATGVVKLGDLGLGRFFSSKT-------------------------------------------TAAHSLVGTP 170 (267)
T ss_pred HHHEEEcCCCCEEECcchhhhccccCC-------------------------------------------cccccccCCc
Confidence 999999999999999999865421110 0012234677
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH--HHHHhhhhhhhcCCcccCCC-CCCccHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE--QVIENCSHWYQNNSKQQYLP-RPATCQKEIFDLM 238 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li 238 (434)
.|+|||.+.+..++.++|+||||+++|+|+ +|..||...... +....+. .....+ .+..+++++.+++
T Consensus 171 ~~~ape~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08229 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMA--ALQSPFYGDKMNLYSLCKKIE-------QCDYPPLPSDHYSEELRQLV 241 (267)
T ss_pred CccCHHHhcCCCccchhhHHHHHHHHHHHH--hCCCCcccccchHHHHhhhhh-------cCCCCCCCcccccHHHHHHH
Confidence 899999999888999999999999999999 889999755432 2211111 111111 1345778999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.+||+.||++|||+.+|.+.+++.
T Consensus 242 ~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 242 NMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHhcCCCcccCCCHHHHHHHHhhh
Confidence 999999999999999998888763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=263.69 Aligned_cols=212 Identities=33% Similarity=0.581 Sum_probs=159.5
Q ss_pred CCCCCCCCeeeEEEEEec--CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++.. ....++|+||+++|+|.+++.+. ...+++..+..++.|++.||+|||++|++||
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~ 132 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH------RERLDHRKLLLYASQICKGMEYLGSKRYVHR 132 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhc------CcCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 357899999999998754 34689999999999999999632 2458999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.+||+|||+++...... ..........
T Consensus 133 dlkp~nili~~~~~~~l~dfg~~~~~~~~~----------------------------------------~~~~~~~~~~ 172 (284)
T cd05081 133 DLATRNILVESENRVKIGDFGLTKVLPQDK----------------------------------------EYYKVREPGE 172 (284)
T ss_pred cCCHhhEEECCCCeEEECCCcccccccCCC----------------------------------------cceeecCCCC
Confidence 999999999999999999999976532111 0000111122
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhh----------hhhcCCcccCCCCCC
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSH----------WYQNNSKQQYLPRPA 228 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~ 228 (434)
++..|+|||++.+..++.++|||||||++|||+ ++..++....... ...... ...........+.+.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~--~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (284)
T cd05081 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELF--TYSDKSCSPPAEF-MRMMGNDKQGQMIVYHLIELLKNNGRLPAPP 249 (284)
T ss_pred CceEeeCHHHhccCCcChHHHHHHHHHHHHHHh--hcCCcCCCcchhh-hhhcccccccccchHHHHHHHhcCCcCCCCC
Confidence 345699999999888999999999999999999 6555544332111 000000 000011122334456
Q ss_pred ccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 229 TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 229 ~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
.++.++.+++.+||+.+|++|||+.||...|++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 250 GCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 788999999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=287.92 Aligned_cols=210 Identities=42% Similarity=0.767 Sum_probs=176.1
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhcc-CC--CCC----C--CCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHN-CN--SQE----N--PAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~--~~~----~--~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
+|+||+.++|+|..++..++|+|||..|+|.++++.++ .. ... . ..++..+.+.++.||+.|++||+++++
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~ 439 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC 439 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 69999999999999999999999999999999998766 10 001 1 248999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||..+|||++.+..+||+|||+|+.......+.. ...
T Consensus 440 vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~----------------------------------------~~~ 479 (609)
T KOG0200|consen 440 VHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT----------------------------------------KSS 479 (609)
T ss_pred cchhhhhhhEEecCCCEEEEccccceeccCCCCceEe----------------------------------------cCC
Confidence 9999999999999999999999999886333322210 111
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC-hHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT-NEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
....+..|||||.+....|+.++||||||+++||+++ -|..||.+.. ..+..+.+ ..+.++..|..|++++
T Consensus 480 ~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eifs-LG~~PYp~~~~~~~l~~~l-------~~G~r~~~P~~c~~ei 551 (609)
T KOG0200|consen 480 AGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFT-LGGTPYPGIPPTEELLEFL-------KEGNRMEQPEHCSDEI 551 (609)
T ss_pred CCccceeecCHHHhccCcccccchhhHHHHHHHHHhh-CCCCCCCCCCcHHHHHHHH-------hcCCCCCCCCCCCHHH
Confidence 1125677999999999999999999999999999998 5999999865 44444333 3566788899999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 235 FDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+++|+.||+.+|++||++.++.++|+..
T Consensus 552 Y~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 552 YDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 9999999999999999999999999873
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=275.09 Aligned_cols=199 Identities=25% Similarity=0.354 Sum_probs=165.5
Q ss_pred CCCCCCCCeeeEEEEEecCCc--eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC--Ccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDP--ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR--DIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~--~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--~ii 76 (434)
|+.|+|||||++|+++.+... .-+|+|.+..|+|..|++++ ...+.+.++.|++||++||.|||++ .||
T Consensus 95 LKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~-------~~vn~kaik~W~RQILkGL~yLHs~~PPII 167 (632)
T KOG0584|consen 95 LKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH-------RRVNIKAIKSWCRQILKGLVYLHSQDPPII 167 (632)
T ss_pred HccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh-------ccCCHHHHHHHHHHHHHHhhhhhcCCCCcc
Confidence 578999999999999987765 78899999999999999855 4788899999999999999999988 599
Q ss_pred ccCCCCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 77 HRDLAARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 77 HrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
|||||.+||+++. .|.|||+|.|+|.....+. ..
T Consensus 168 HRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~---------------------------------------------ak 202 (632)
T KOG0584|consen 168 HRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH---------------------------------------------AK 202 (632)
T ss_pred ccccccceEEEcCCcCceeecchhHHHHhhccc---------------------------------------------cc
Confidence 9999999999986 5899999999986632222 14
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhhhhhhcCCcccCCCC-CCccHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQYLPR-PATCQKE 233 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (434)
...||+.|||||+.. ..|+..+||||||++++||+ |+..||....+ .+++.++..+. .+.. ..--.++
T Consensus 203 svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv--T~eYPYsEC~n~AQIYKKV~SGi-------KP~sl~kV~dPe 272 (632)
T KOG0584|consen 203 SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV--TSEYPYSECTNPAQIYKKVTSGI-------KPAALSKVKDPE 272 (632)
T ss_pred eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHH--hccCChhhhCCHHHHHHHHHcCC-------CHHHhhccCCHH
Confidence 468999999999987 78999999999999999999 89999987654 45555554321 1111 1112479
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+++||.+|+.. .++|+|+.|+ ++||...
T Consensus 273 vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 273 VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 99999999999 9999999999 7888875
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=262.51 Aligned_cols=204 Identities=23% Similarity=0.301 Sum_probs=160.9
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++.+. +..++++||+++++|.+++. ....+++...+.++.|++.||+|||+.+++||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~ 130 (266)
T cd06651 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK-------AYGALTESVTRKYTRQILEGMSYLHSNMIVHR 130 (266)
T ss_pred HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence 3578999999999998653 56889999999999999997 33458899999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.++|+|||+++....... .........
T Consensus 131 ~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~----------------------------------------~~~~~~~~~ 170 (266)
T cd06651 131 DIKGANILRDSAGNVKLGDFGASKRLQTICM----------------------------------------SGTGIRSVT 170 (266)
T ss_pred CCCHHHEEECCCCCEEEccCCCccccccccc----------------------------------------cCCccccCC
Confidence 9999999999999999999998754211100 000012234
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
++..|+|||.+.+..++.++|||||||++|||+ +|..||......+...... ........+..+++.+.+++
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~--~g~~pf~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li 242 (266)
T cd06651 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEML--TEKPPWAEYEAMAAIFKIA------TQPTNPQLPSHISEHARDFL 242 (266)
T ss_pred ccccccCHHHhCCCCCCchhhhHHHHHHHHHHH--HCCCCccccchHHHHHHHh------cCCCCCCCchhcCHHHHHHH
Confidence 678899999999888999999999999999999 8899998765544332221 11122333456678899998
Q ss_pred HHhccCCCCCCCCHHHH--HHHHH
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQ 260 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~ 260 (434)
+||..+|++||+++|| |+|++
T Consensus 243 -~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 243 -GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -HHhcCChhhCcCHHHHhcCcccc
Confidence 6888999999999999 66764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=262.18 Aligned_cols=195 Identities=21% Similarity=0.296 Sum_probs=160.6
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++..++..++||||+++|+|.+++. ....+++..+..++.|+++||.|||+.|++||||||+|
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~n 139 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-------KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLEN 139 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 79999999999999999999999999999999997 33478999999999999999999999999999999999
Q ss_pred eeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 85 CMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 85 ILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
|+++.++ .++|+|||+++.... .....++..|
T Consensus 140 il~~~~~~~~~l~dfg~~~~~~~-----------------------------------------------~~~~~~~~~y 172 (267)
T PHA03390 140 VLYDRAKDRIYLCDYGLCKIIGT-----------------------------------------------PSCYDGTLDY 172 (267)
T ss_pred EEEeCCCCeEEEecCccceecCC-----------------------------------------------CccCCCCCcc
Confidence 9999988 999999998654210 0123467789
Q ss_pred cchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHH-HhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhc
Q psy5690 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVI-ENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECW 242 (434)
Q Consensus 164 ~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 242 (434)
+|||++.+..++.++||||+|+++|+|+ +|..||......... ..+. ... ....+.+..+++.+.+++.+||
T Consensus 173 ~aPE~~~~~~~~~~~DvwslG~il~~l~--~g~~p~~~~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~~li~~~l 245 (267)
T PHA03390 173 FSPEKIKGHNYDVSFDWWAVGVLTYELL--TGKHPFKEDEDEELDLESLL---KRQ--QKKLPFIKNVSKNANDFVQSML 245 (267)
T ss_pred cChhhhcCCCCCchhhHHHHHHHHHHHH--HCCCCCCCCCcchhhHHHHH---Hhh--cccCCcccccCHHHHHHHHHHh
Confidence 9999999989999999999999999999 889999865433221 1111 111 1222334568899999999999
Q ss_pred cCCCCCCCC-HHHH--HHHHH
Q psy5690 243 KTNETDRPR-FSEI--HLFLQ 260 (434)
Q Consensus 243 ~~dP~~Rps-~~el--~~~L~ 260 (434)
+.||.+||+ ++++ |+|++
T Consensus 246 ~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 246 KYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ccChhhCCchHHHHhcCCccc
Confidence 999999995 6998 67765
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=268.17 Aligned_cols=200 Identities=20% Similarity=0.304 Sum_probs=155.1
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
.|.+||++++|-..++.+|+||||=+. +|..+|+++. ...+.-.++.+..|++.|+.++|++||||.||||.|
T Consensus 418 g~~~IIqL~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~------~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPAN 490 (677)
T KOG0596|consen 418 GHDKIIQLYDYEVTDGYLYMVMECGDI-DLNKILKKKK------SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPAN 490 (677)
T ss_pred CCceEEEEeeeeccCceEEEEeecccc-cHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCccc
Confidence 489999999999999999999998754 9999998443 223323788999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
+|+ ..|.+||+|||+|..+.... ........+||+.||
T Consensus 491 FLl-VkG~LKLIDFGIA~aI~~DT-----------------------------------------TsI~kdsQvGT~NYM 528 (677)
T KOG0596|consen 491 FLL-VKGRLKLIDFGIANAIQPDT-----------------------------------------TSIVKDSQVGTVNYM 528 (677)
T ss_pred EEE-EeeeEEeeeechhcccCccc-----------------------------------------cceeeccccCccccc
Confidence 998 56899999999987643322 222346678999999
Q ss_pred chhhhhcCC-----------CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhhhcCCcccCCCCCCccH-
Q psy5690 165 AWESLLLGK-----------NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWYQNNSKQQYLPRPATCQ- 231 (434)
Q Consensus 165 aPE~~~~~~-----------~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (434)
+||.+.... .+.++|||||||+||+|+ .|+.||....+.. -+..+ .......+.+..-+
T Consensus 529 sPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv--YgktPf~~~~n~~aKl~aI------~~P~~~Iefp~~~~~ 600 (677)
T KOG0596|consen 529 SPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV--YGKTPFGQIINQIAKLHAI------TDPNHEIEFPDIPEN 600 (677)
T ss_pred CHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH--hcCCchHHHHHHHHHHHhh------cCCCccccccCCCCc
Confidence 999997543 357899999999999999 9999998765322 11112 11222222222222
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
.++.++|+.||++||++||++.|+ |+|++-
T Consensus 601 ~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 601 DELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 339999999999999999999999 677764
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=259.42 Aligned_cols=195 Identities=31% Similarity=0.515 Sum_probs=155.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.. +..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||
T Consensus 55 l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl 127 (259)
T cd05037 55 MSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE------KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNV 127 (259)
T ss_pred HHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccC
Confidence 467899999999999988 7889999999999999999732 226889999999999999999999999999999
Q ss_pred CCCCeeeecCC-------ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 81 AARNCMVGKNY-------TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 81 kp~NILl~~~~-------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
||+||+++.++ .+||+|||++.....
T Consensus 128 kp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----------------------------------------------- 160 (259)
T cd05037 128 CGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----------------------------------------------- 160 (259)
T ss_pred ccceEEEecCccccCCceeEEeCCCCccccccc-----------------------------------------------
Confidence 99999999887 799999998654211
Q ss_pred CCCCCCCccccchhhhhcC--CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 154 DTKARLPIRWMAWESLLLG--KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~--~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
.....++..|+|||++.+. .++.++|||||||++|||+++ |..||......+...... .....+.+ ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~-~~~p~~~~~~~~~~~~~~-------~~~~~~~~--~~ 230 (259)
T cd05037 161 REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN-GEEPLSTLSSSEKERFYQ-------DQHRLPMP--DC 230 (259)
T ss_pred ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhC-CCCCcccCCchhHHHHHh-------cCCCCCCC--Cc
Confidence 1122344679999999876 789999999999999999942 688887765433322111 11112222 23
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L 259 (434)
..+.+++.+||..+|.+||++.++++.|
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 231 AELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 7899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=264.34 Aligned_cols=203 Identities=21% Similarity=0.273 Sum_probs=163.6
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
..+||||+++++++..++..++||||+.||+|.+++. ....+++..+..++.|++.||+|||+++|+||||||
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~-------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p 125 (278)
T cd05606 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-------QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKP 125 (278)
T ss_pred hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCH
Confidence 4579999999999999999999999999999999986 335699999999999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+||+++.++.++|+|||+++..... ......|+..
T Consensus 126 ~nili~~~~~~kl~dfg~~~~~~~~---------------------------------------------~~~~~~~~~~ 160 (278)
T cd05606 126 ANILLDEHGHVRISDLGLACDFSKK---------------------------------------------KPHASVGTHG 160 (278)
T ss_pred HHEEECCCCCEEEccCcCccccCcc---------------------------------------------CCcCcCCCcC
Confidence 9999999999999999986532110 0112357788
Q ss_pred ccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 163 WMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 163 y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
|+|||.+.++ .++.++||||+||++|||+ +|..||............ . .........+..+++++.+++.+|
T Consensus 161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~--~g~~p~~~~~~~~~~~~~-~----~~~~~~~~~~~~~s~~~~~li~~~ 233 (278)
T cd05606 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLL--RGHSPFRQHKTKDKHEID-R----MTLTMAVELPDSFSPELRSLLEGL 233 (278)
T ss_pred CcCcHHhcCCCCCCcccchHhHHHHHHHHH--hCCCCCCCCCccchHHHH-H----HhhccCCCCCCcCCHHHHHHHHHH
Confidence 9999999754 5789999999999999999 899999876322111100 0 011122334556789999999999
Q ss_pred ccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 242 WKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 242 l~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
|..+|.+|| ++.++ |+|+++...
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 999999999 99999 678877543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=260.15 Aligned_cols=199 Identities=20% Similarity=0.314 Sum_probs=165.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++...+..++|+||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l 127 (256)
T cd08218 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-----RGVLFPEDQILDWFVQICLALKHVHDRKILHRDI 127 (256)
T ss_pred HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 46789999999999999999999999999999999999732 2235789999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++++|||++........ ......++
T Consensus 128 ~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------------------------------------------~~~~~~~~ 164 (256)
T cd08218 128 KSQNIFLTKDGTIKLGDFGIARVLNSTVE-------------------------------------------LARTCIGT 164 (256)
T ss_pred CHHHEEEcCCCCEEEeeccceeecCcchh-------------------------------------------hhhhccCC
Confidence 99999999999999999998654211100 01123456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|+|||||++|+|+ +|..||......+....+. .+...+.+..++.++.+++.+
T Consensus 165 ~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~--~g~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMC--TLKHAFEAGNMKNLVLKII-------RGSYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred ccccCHHHhCCCCCCCccchhHHHHHHHHHH--cCCCCccCCCHHHHHHHHh-------cCCCCCCcccCCHHHHHHHHH
Confidence 7899999999888999999999999999999 8999998776665554332 122334456778999999999
Q ss_pred hccCCCCCCCCHHHHH
Q psy5690 241 CWKTNETDRPRFSEIH 256 (434)
Q Consensus 241 cl~~dP~~Rps~~el~ 256 (434)
||+.+|++||++.+|+
T Consensus 236 ~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 236 LFKRNPRDRPSVNSIL 251 (256)
T ss_pred HhhCChhhCcCHHHHh
Confidence 9999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=267.75 Aligned_cols=211 Identities=17% Similarity=0.285 Sum_probs=163.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++..++..++||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+|+||
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dl 130 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC------GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 357899999999999999999999999997 5999988632 345889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 131 kp~Nil~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 167 (301)
T cd07873 131 KPQNLLINERGELKLADFGLARAKSIPT-------------------------------------------KTYSNEVVT 167 (301)
T ss_pred CHHHEEECCCCcEEECcCcchhccCCCC-------------------------------------------Cccccccee
Confidence 9999999999999999999865421100 001223456
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC--------------cccCC-
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS--------------KQQYL- 224 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~~~~- 224 (434)
..|+|||++.+. .++.++|||||||++|||+ +|..||...+..+....+........ .....
T Consensus 168 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~--tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (301)
T cd07873 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS--TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPK 245 (301)
T ss_pred ecccCcHHHhCCCCCccHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCc
Confidence 789999998764 4788999999999999999 89999988776554433222110000 00000
Q ss_pred -------CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 225 -------PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 225 -------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.....+++.+.++|.+||+.||.+|||++|+ |+|++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 246 YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0123467889999999999999999999999 77997653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=274.40 Aligned_cols=205 Identities=19% Similarity=0.250 Sum_probs=158.7
Q ss_pred CCCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++||||+++++++... ...++++|++ +++|.++++ ...+++..+..++.||+.||+|||++|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ 138 (343)
T cd07878 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK--------CQKLSDEHVQFLIYQLLRGLKYIHSAG 138 (343)
T ss_pred HHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4678999999999988543 3478999998 779998875 235899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 139 ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----------------------------------------------~~ 172 (343)
T cd07878 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADD----------------------------------------------EM 172 (343)
T ss_pred eecccCChhhEEECCCCCEEEcCCccceecCC----------------------------------------------Cc
Confidence 99999999999999999999999999754211 01
Q ss_pred CCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC--------------
Q psy5690 155 TKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS-------------- 219 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 219 (434)
....+|..|+|||++.+ ..++.++|||||||++|+|+ +|..||......+....+........
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07878 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL--KGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250 (343)
T ss_pred CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH--HCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence 23456788999999977 56789999999999999999 88999987665444333221110000
Q ss_pred ---cccCCC------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 220 ---KQQYLP------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 220 ---~~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.....+ .....++.+.+|+.+||+.||++|||+.|+ |+|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 000000 012345678999999999999999999999 7899764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=267.42 Aligned_cols=204 Identities=17% Similarity=0.266 Sum_probs=166.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++..++..++|+||+++++|.+++. ...+++..+..++.|++.||+|||++|++||||
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~--------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl 143 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--------QTRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh--------hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 356899999999999999999999999999999999875 235889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 144 ~p~Nill~~~~~~kL~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 180 (297)
T cd06659 144 KSDSILLTLDGRVKLSDFGFCAQISKDV-------------------------------------------PKRKSLVGT 180 (297)
T ss_pred CHHHeEEccCCcEEEeechhHhhccccc-------------------------------------------ccccceecC
Confidence 9999999999999999999865321100 011234567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|||||||++|||+ +|..||......+....+... ..........+++.+.+++.+
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~--~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMV--DGEPPYFSDSPVQAMKRLRDS-----PPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHhcc-----CCCCccccCCCCHHHHHHHHH
Confidence 8899999999888999999999999999999 899999877665554433211 111122234567889999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.+|++||+++++ |+|+.+.
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccC
Confidence 999999999999999 6777754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=265.62 Aligned_cols=207 Identities=22% Similarity=0.342 Sum_probs=165.9
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDl 80 (434)
++++||||+++++.+..++..++||||+++++|..++.... ....+++..+..++.|++.||.|||+ .|++||||
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl 129 (286)
T cd06622 54 HKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV----ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDV 129 (286)
T ss_pred HhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCC
Confidence 56899999999999999999999999999999999987321 23478999999999999999999997 59999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++...... ......++
T Consensus 130 ~p~nil~~~~~~~~l~dfg~~~~~~~~---------------------------------------------~~~~~~~~ 164 (286)
T cd06622 130 KPTNVLVNGNGQVKLCDFGVSGNLVAS---------------------------------------------LAKTNIGC 164 (286)
T ss_pred CHHHEEECCCCCEEEeecCCcccccCC---------------------------------------------ccccCCCc
Confidence 999999999999999999986542110 01223466
Q ss_pred ccccchhhhhcCC------CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 161 IRWMAWESLLLGK------NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 161 ~~y~aPE~~~~~~------~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
..|+|||.+.+.. ++.++|||||||++|+|+ +|..||...........+... ........+..+++++
T Consensus 165 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 238 (286)
T cd06622 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA--LGRYPYPPETYANIFAQLSAI----VDGDPPTLPSGYSDDA 238 (286)
T ss_pred cCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH--hCCCCCCCcchhhHHHHHHHH----hhcCCCCCCcccCHHH
Confidence 7899999986543 478999999999999999 899999776554443332211 1222333455688999
Q ss_pred HHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 235 FDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+++.+||+.+|++||+++++ ++|+.+..
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999 78887653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=266.22 Aligned_cols=209 Identities=21% Similarity=0.243 Sum_probs=174.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
.+++.+.||.+--.|+..+.+|+|+..|.||+|.-+|... .+..++++.+..++.+|+.||++||..+||+||+|
T Consensus 240 ~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~-----g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLK 314 (591)
T KOG0986|consen 240 EKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNH-----GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLK 314 (591)
T ss_pred HHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeecc-----CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCC
Confidence 4678899999999999999999999999999999998744 34689999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||+|+.|+++|+|.|+|..+.+.. ...+.+||.
T Consensus 315 PeNILLDd~GhvRISDLGLAvei~~g~--------------------------------------------~~~~rvGT~ 350 (591)
T KOG0986|consen 315 PENILLDDHGHVRISDLGLAVEIPEGK--------------------------------------------PIRGRVGTV 350 (591)
T ss_pred hhheeeccCCCeEeeccceEEecCCCC--------------------------------------------ccccccCcc
Confidence 999999999999999999987643322 224558999
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
+|||||++.+..|+...|.|||||++|||+ .|+.||.......-.+.+.+. ........+..++++++++....
T Consensus 351 GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi--~G~sPFr~~KeKvk~eEvdrr----~~~~~~ey~~kFS~eakslc~~L 424 (591)
T KOG0986|consen 351 GYMAPEVLQNEVYDFSPDWFSLGCLLYEMI--AGHSPFRQRKEKVKREEVDRR----TLEDPEEYSDKFSEEAKSLCEGL 424 (591)
T ss_pred cccCHHHHcCCcccCCccHHHHHhHHHHHH--cccCchhhhhhhhhHHHHHHH----HhcchhhcccccCHHHHHHHHHH
Confidence 999999999999999999999999999999 999999876543333222221 12223334678899999999999
Q ss_pred ccCCCCCCCC-----HHHH--HHHHHhcccC
Q psy5690 242 WKTNETDRPR-----FSEI--HLFLQRKNLG 265 (434)
Q Consensus 242 l~~dP~~Rps-----~~el--~~~L~~~~~~ 265 (434)
|++||++|.. +++| |++|+..++.
T Consensus 425 L~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 425 LTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred HccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 9999999974 5577 8899887653
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=266.99 Aligned_cols=219 Identities=16% Similarity=0.278 Sum_probs=164.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..+++|||+++|+|.+++... ....+++..+..++.|+++||+|||+++|+||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dl 127 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH-----FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 35789999999999999999999999999999999999743 2245889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||.+.......... ...........++
T Consensus 128 k~~Nili~~~~~~kl~d~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~ 171 (314)
T cd08216 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQ------------------------------------RVVHDFPKSSVKN 171 (314)
T ss_pred CcceEEEecCCceEEecCccceeeccccccc------------------------------------ccccccccccccc
Confidence 9999999999999999999875432111000 0000011233456
Q ss_pred ccccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHH-Hhhhhhhhc----C---------------
Q psy5690 161 IRWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVI-ENCSHWYQN----N--------------- 218 (434)
Q Consensus 161 ~~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~-~~~~~~~~~----~--------------- 218 (434)
..|+|||++.+ ..++.++|+|||||++|||+ +|..||......... +.+...... .
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELA--NGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccc
Confidence 78999999976 35788999999999999999 899999876544322 111100000 0
Q ss_pred ------CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 ------SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 ------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
...........++.++.+++.+||+.||++|||++++ |+|++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0000111122345789999999999999999999999 8899864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=269.74 Aligned_cols=212 Identities=18% Similarity=0.260 Sum_probs=151.0
Q ss_pred CCCCCCCCeeeEEEEEec--CCceEEEEecCCCCCHHHHHhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNS--QENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
|++++||||+++++++.. +...+++|||+. ++|.+++....... .....+++..+..++.||+.||+|||++||+
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv 130 (317)
T cd07868 52 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 457899999999999854 456899999995 58998886432111 1223589999999999999999999999999
Q ss_pred ccCCCCCCeee----ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 77 HRDLAARNCMV----GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 77 HrDlkp~NILl----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 131 HrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~----------------------------------------~~~ 170 (317)
T cd07868 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK----------------------------------------PLA 170 (317)
T ss_pred cCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCc----------------------------------------ccc
Confidence 99999999999 4567899999999765321110 001
Q ss_pred cCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH---------HHHHhhhhhhh------
Q psy5690 153 SDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE---------QVIENCSHWYQ------ 216 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~---------~~~~~~~~~~~------ 216 (434)
......+|+.|+|||++.+. .++.++||||+||++|||+ +|..||...... .....+.....
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T cd07868 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL--TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 248 (317)
T ss_pred ccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHH--hCCCCccCCcccccccccccHHHHHHHHHhcCCCChHH
Confidence 11345678899999999874 5799999999999999999 889999653321 11111100000
Q ss_pred ---------------cCCcccC---------CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 217 ---------------NNSKQQY---------LPRPATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 217 ---------------~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
....... .......+.++.+++.+||+.||++|||++|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~ 311 (317)
T cd07868 249 WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 311 (317)
T ss_pred hHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHH
Confidence 0000000 00011224568899999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=262.28 Aligned_cols=209 Identities=20% Similarity=0.240 Sum_probs=167.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++...+..|+||||+++++|.+++.+.. ...+++..+..++.|++.||.|||++|++||||
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di 121 (277)
T cd05577 47 LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG-----EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDL 121 (277)
T ss_pred HHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcC-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 467899999999999999999999999999999999997432 236899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||++...... .......++
T Consensus 122 ~p~Nil~~~~~~~~l~dfg~~~~~~~~--------------------------------------------~~~~~~~~~ 157 (277)
T cd05577 122 KPENVLLDDHGNVRISDLGLAVELKGG--------------------------------------------KKIKGRAGT 157 (277)
T ss_pred CHHHEEECCCCCEEEccCcchhhhccC--------------------------------------------CccccccCC
Confidence 999999999999999999986542110 011223456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++|||||||++|+|+ +|..||...........+.. .........+..+++++.+++.+
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~ 231 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMI--AGRSPFRQRKEKVEKEELKR----RTLEMAVEYPDKFSPEAKDLCEA 231 (277)
T ss_pred CCcCCHHHhcCCCCCchhhhHHHHHHHHHHh--hCCCCCCCCcccccHHHHHh----ccccccccCCccCCHHHHHHHHH
Confidence 7899999999888999999999999999999 89999977654221111111 11112233455678999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
||+.||++|| ++.++ |+|+.+.++
T Consensus 232 ~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 232 LLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred HccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 9999999999 77778 788876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=262.49 Aligned_cols=203 Identities=18% Similarity=0.246 Sum_probs=158.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++..++..++||||+++++|..++. ....+++..+..++.|++.||+|||+.|++||||
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl 126 (286)
T cd07847 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK-------NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126 (286)
T ss_pred HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Confidence 357899999999999999999999999999988888775 3346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++........ ......++
T Consensus 127 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------~~~~~~~~ 163 (286)
T cd07847 127 KPENILITKQGQIKLCDFGFARILTGPGD-------------------------------------------DYTDYVAT 163 (286)
T ss_pred ChhhEEEcCCCcEEECccccceecCCCcc-------------------------------------------cccCcccc
Confidence 99999999999999999998654211100 01123456
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC-------------cccCCCC
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS-------------KQQYLPR 226 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~ 226 (434)
..|+|||.+.+ ..++.++||||||+++|+|+ +|..||.+....+....+........ .....+.
T Consensus 164 ~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd07847 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELL--TGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPE 241 (286)
T ss_pred cccCCHHHHhCCCCcCchhhhHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCC
Confidence 77999999876 45788999999999999999 88999987765544333221110000 0000000
Q ss_pred ----------CCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 227 ----------PATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 227 ----------~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
....+..+.+++.+||+.||++||++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 280 (286)
T cd07847 242 PETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280 (286)
T ss_pred cccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence 12456789999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=262.78 Aligned_cols=206 Identities=22% Similarity=0.310 Sum_probs=161.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDl 80 (434)
+.++||||+++++++...+..++||||+++|+|.+++. ....+++..+..++.|++.||.|||+ .+++||||
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl 130 (284)
T cd06620 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-------KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130 (284)
T ss_pred HHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCC
Confidence 56899999999999999999999999999999999987 33468999999999999999999997 68999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++...... ......++
T Consensus 131 ~p~nil~~~~~~~~l~d~gl~~~~~~~---------------------------------------------~~~~~~~~ 165 (284)
T cd06620 131 KPSNILVNSRGQIKLCDFGVSGELINS---------------------------------------------IADTFVGT 165 (284)
T ss_pred CHHHEEECCCCcEEEccCCcccchhhh---------------------------------------------ccCccccC
Confidence 999999999999999999986431000 01234577
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH----HHHhhhhhhhcCCcccCCCCC-CccHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ----VIENCSHWYQNNSKQQYLPRP-ATCQKEIF 235 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~ 235 (434)
..|+|||++.+..++.++|||||||++|+++ +|..||......+ ....+...............+ ..++.++.
T Consensus 166 ~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd06620 166 STYMSPERIQGGKYTVKSDVWSLGISIIELA--LGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243 (284)
T ss_pred cccCCHHHHccCCCCccchHHHHHHHHHHHH--hCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHH
Confidence 8899999998888999999999999999999 8999998655421 111111111111111111112 23678899
Q ss_pred HHHHHhccCCCCCCCCHHHHH--HHHHh
Q psy5690 236 DLMLECWKTNETDRPRFSEIH--LFLQR 261 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el~--~~L~~ 261 (434)
+++.+||+.||++||+++|+. +|+.+
T Consensus 244 ~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 244 DFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999994 45544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=259.67 Aligned_cols=204 Identities=23% Similarity=0.351 Sum_probs=160.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++...+..++||||+++|+|.++++ ....+++..+..++.||+.||.|||+++++||||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 134 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR-------TYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDL 134 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHh-------hccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCC
Confidence 467899999999999999999999999999999999997 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||+++...... .........++
T Consensus 135 ~~~nil~~~~~~~~l~d~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~ 173 (272)
T cd06629 135 KADNLLVDADGICKISDFGISKKSDDIY-----------------------------------------DNDQNMSMQGS 173 (272)
T ss_pred ChhhEEEcCCCeEEEeeccccccccccc-----------------------------------------cccccccccCC
Confidence 9999999999999999999865421100 00011334567
Q ss_pred ccccchhhhhcCC--CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 161 IRWMAWESLLLGK--NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 161 ~~y~aPE~~~~~~--~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
..|+|||.+.... ++.++|+||||+++|+++ +|..||......+....+.. ..............++.++.+++
T Consensus 174 ~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li 249 (272)
T cd06629 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF--AGRRPWSDEEAIAAMFKLGN--KRSAPPIPPDVSMNLSPVALDFL 249 (272)
T ss_pred ccccCHHHhccccCCCCccchhHHHHHHHHHHH--hCCCCCcCcchHHHHHHhhc--cccCCcCCccccccCCHHHHHHH
Confidence 8899999988655 789999999999999999 88999976555433322111 00000001111234678999999
Q ss_pred HHhccCCCCCCCCHHHHH
Q psy5690 239 LECWKTNETDRPRFSEIH 256 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~ 256 (434)
.+||..+|++||++++++
T Consensus 250 ~~~l~~~p~~Rps~~~il 267 (272)
T cd06629 250 NACFTINPDNRPTARELL 267 (272)
T ss_pred HHHhcCChhhCCCHHHHh
Confidence 999999999999999983
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=260.88 Aligned_cols=199 Identities=24% Similarity=0.335 Sum_probs=156.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAI--SYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l--~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
++++|+||+++++++..++..++|+||+++++|.+++.... ..+ ++..+..++.||+.||+|||++||+|||
T Consensus 60 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~d 133 (268)
T cd06624 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133 (268)
T ss_pred HhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecC
Confidence 57899999999999999999999999999999999997421 234 7888899999999999999999999999
Q ss_pred CCCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 80 LAARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 80 lkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|||+||+++. ++.++|+|||++....... .......
T Consensus 134 l~p~nil~~~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~ 170 (268)
T cd06624 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGIN-------------------------------------------PCTETFT 170 (268)
T ss_pred CCHHHEEEcCCCCeEEEecchhheecccCC-------------------------------------------CccccCC
Confidence 9999999976 6789999999865421100 0112234
Q ss_pred CCccccchhhhhcCC--CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 159 LPIRWMAWESLLLGK--NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 159 gt~~y~aPE~~~~~~--~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
++..|+|||++.... ++.++|+||||+++|+|+ +|..||............ ..........+..+++++.+
T Consensus 171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~--~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA--TGKPPFIELGEPQAAMFK-----VGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CCccccChhhhccccccCCchhhhHHHHHHHHHHH--hCCCCCccccChhhhHhh-----hhhhccCCCCCcccCHHHHH
Confidence 677899999987644 788999999999999999 889999765432221110 01111223345667899999
Q ss_pred HHHHhccCCCCCCCCHHHHH
Q psy5690 237 LMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el~ 256 (434)
++.+||+.+|++||++.|++
T Consensus 244 li~~~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLL 263 (268)
T ss_pred HHHHHcCCCchhCCCHHHHH
Confidence 99999999999999999993
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=289.44 Aligned_cols=218 Identities=20% Similarity=0.265 Sum_probs=183.4
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+.+.|++++-.|.+++++|+||||++||+|-.++. ....++++.++.++..|+.||+-||+.|+|||||||+|
T Consensus 133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlS-------k~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDN 205 (1317)
T KOG0612|consen 133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLS-------KFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDN 205 (1317)
T ss_pred CcHHHHHHHHHhcCccceEEEEecccCchHHHHHh-------hcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcce
Confidence 45678999999999999999999999999999997 33379999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||+|.+|++||+|||.|-.+. .+........+|||.|.
T Consensus 206 vLld~~GHikLADFGsClkm~------------------------------------------~dG~V~s~~aVGTPDYI 243 (1317)
T KOG0612|consen 206 VLLDKSGHIKLADFGSCLKMD------------------------------------------ADGTVRSSVAVGTPDYI 243 (1317)
T ss_pred eEecccCcEeeccchhHHhcC------------------------------------------CCCcEEeccccCCCCcc
Confidence 999999999999999754322 12223346678999999
Q ss_pred chhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 165 AWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 165 aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+||++.. +.|+..+|.||+||++|||+ .|..||...+..+.+.+|.+... ....|....+|++.++||.
T Consensus 244 SPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMl--yG~TPFYadslveTY~KIm~hk~----~l~FP~~~~VSeeakdLI~ 317 (1317)
T KOG0612|consen 244 SPEVLQSQGDGKGEYGRECDWWSLGVFMYEML--YGETPFYADSLVETYGKIMNHKE----SLSFPDETDVSEEAKDLIE 317 (1317)
T ss_pred CHHHHHhhcCCccccCCccchhhhHHHHHHHH--cCCCcchHHHHHHHHHHHhchhh----hcCCCcccccCHHHHHHHH
Confidence 9999972 56899999999999999999 99999999998888887765321 1122233568999999999
Q ss_pred HhccCCCCCCCC---HHHH--HHHHHhcccCCCccccccccccC
Q psy5690 240 ECWKTNETDRPR---FSEI--HLFLQRKNLGARASKITPVMKRL 278 (434)
Q Consensus 240 ~cl~~dP~~Rps---~~el--~~~L~~~~~~~~~~~~~~~~~~~ 278 (434)
+.+. +|+.|.. ++++ |+||....++......+|..+..
T Consensus 318 ~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 318 ALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred HHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 9886 6889987 9999 99999999987777777766654
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=257.96 Aligned_cols=198 Identities=18% Similarity=0.303 Sum_probs=162.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++.+..++..++||||+++++|.+++... ....+++..+..++.|++.||+|||++|++|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl 127 (256)
T cd08220 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-----CNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127 (256)
T ss_pred HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 46789999999999999999999999999999999999743 2345899999999999999999999999999999
Q ss_pred CCCCeeeecC-CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 81 AARNCMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 81 kp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
||+||+++.+ +.++|+|||++....... ......+
T Consensus 128 ~~~nil~~~~~~~~~l~d~~~~~~~~~~~--------------------------------------------~~~~~~~ 163 (256)
T cd08220 128 KTQNILLDKHKMVVKIGDFGISKILSSKS--------------------------------------------KAYTVVG 163 (256)
T ss_pred CHHHEEEcCCCCEEEEccCCCceecCCCc--------------------------------------------ccccccc
Confidence 9999999865 467999999865421110 1122346
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+..|+|||.+.+..++.++||||||+++|+|+ +|..||...+.......+. .....+.+..++.++.+++.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~--~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~ 234 (256)
T cd08220 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELA--SLKRAFEAANLPALVLKIM-------SGTFAPISDRYSPDLRQLIL 234 (256)
T ss_pred CCcccCchhccCCCCCcccchHHHHHHHHHHH--hCCCCcccCchHHHHHHHH-------hcCCCCCCCCcCHHHHHHHH
Confidence 67899999999888899999999999999999 8899998876655544332 12223345567899999999
Q ss_pred HhccCCCCCCCCHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIH 256 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~ 256 (434)
+||+.||++||+++|++
T Consensus 235 ~~l~~~p~~Rpt~~~ll 251 (256)
T cd08220 235 SMLNLDPSKRPQLSQIM 251 (256)
T ss_pred HHccCChhhCCCHHHHh
Confidence 99999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=261.90 Aligned_cols=211 Identities=36% Similarity=0.634 Sum_probs=164.7
Q ss_pred CCCCCCCCeeeEEEEEec--CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
+++++||||+++++++.. +...++||||+++|+|.+++... ...+++..+..++.|++.||+|||++|++|+
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~ 133 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH------RDQINLKRLLLFSSQICKGMDYLGSQRYIHR 133 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhC------ccccCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 357899999999999977 55799999999999999999732 2368999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.++|+|||.+....... ..+.......
T Consensus 134 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----------------------------------------~~~~~~~~~~ 173 (284)
T cd05038 134 DLAARNILVESEDLVKISDFGLAKVLPEDK----------------------------------------DYYYVKEPGE 173 (284)
T ss_pred CCCHHhEEEcCCCCEEEcccccccccccCC----------------------------------------cceeccCCCC
Confidence 999999999999999999999876532111 0001111223
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHH-----------HHhhhhhhhcCCcccCCCCC
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQV-----------IENCSHWYQNNSKQQYLPRP 227 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~ 227 (434)
++..|+|||.+.+..++.++||||||+++|||+ +|..|+........ ...+..... .....+.+
T Consensus 174 ~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 248 (284)
T cd05038 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELF--TYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK---EGERLPRP 248 (284)
T ss_pred CcccccCcHHHccCCCCcccchHHHhhhhheee--ccCCCcccccchhccccccccccccHHHHHHHHH---cCCcCCCC
Confidence 445699999999888999999999999999999 78888765432211 111111111 22233445
Q ss_pred CccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 228 ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 228 ~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
..++.++.+++.+||+.+|++||++.||.+.|++.
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 249 PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 66788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=266.41 Aligned_cols=220 Identities=17% Similarity=0.257 Sum_probs=163.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||++++++|..++..++|+||+.+|+|.+++.... ...+++..+..++.|++.||+|||++|++|||||
T Consensus 54 ~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlk 128 (328)
T cd08226 54 HFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF-----PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIK 128 (328)
T ss_pred HhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 45899999999999999999999999999999999997432 2358899999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++++||+.+........ .............++.
T Consensus 129 p~Nill~~~~~~~~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~ 172 (328)
T cd08226 129 ASHILISGDGLVSLSGLSHLYSLVRNGQ------------------------------------KAKVVYDFPQFSTSVL 172 (328)
T ss_pred HHHEEEeCCCcEEEechHHHhhhhccCc------------------------------------cccccccccccccCcc
Confidence 9999999999999999986432110000 0000000011123456
Q ss_pred cccchhhhhcC--CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhh-----------------------
Q psy5690 162 RWMAWESLLLG--KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQ----------------------- 216 (434)
Q Consensus 162 ~y~aPE~~~~~--~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~----------------------- 216 (434)
.|+|||++.+. .++.++|||||||++|||+ +|..||......+..........
T Consensus 173 ~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (328)
T cd08226 173 PWLSPELLRQDLYGYNVKSDIYSVGITACELA--TGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGV 250 (328)
T ss_pred CccChhhhcCCCCCCCchhhHHHHHHHHHHHH--hCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhh
Confidence 79999999764 4689999999999999999 89999987665443322111000
Q ss_pred ----------------cCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 217 ----------------NNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 217 ----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
........+....+++.+.+|+.+||+.||++|||++|+ |+|++....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 251 DSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000001112234467889999999999999999999999 899987543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=267.77 Aligned_cols=213 Identities=33% Similarity=0.623 Sum_probs=162.4
Q ss_pred CCC-CCCCeeeEEEEEecC-CceEEEEecCCCCCHHHHHhhccCCC----------------------------------
Q psy5690 2 CSL-KDPNLVRVIGVCSTE-DPISTIQEYCEFGDLSTFLQIHNCNS---------------------------------- 45 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~---------------------------------- 45 (434)
.++ +||||+++++++... ...++|||||++|+|.+++.......
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (343)
T cd05103 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS 144 (343)
T ss_pred HhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence 456 689999999988654 56899999999999999997532100
Q ss_pred --------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCC
Q psy5690 46 --------------------------QENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHA 99 (434)
Q Consensus 46 --------------------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFG 99 (434)
.....+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg 224 (343)
T cd05103 145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224 (343)
T ss_pred cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecc
Confidence 001246888899999999999999999999999999999999999999999999
Q ss_pred cccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCC
Q psy5690 100 MYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179 (434)
Q Consensus 100 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sD 179 (434)
+++...... .........++..|+|||.+.+..++.++|
T Consensus 225 ~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 263 (343)
T cd05103 225 LARDIYKDP-----------------------------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSD 263 (343)
T ss_pred cccccccCc-----------------------------------------chhhcCCCCCCcceECcHHhcCCCCCchhh
Confidence 875421110 001112233556799999999889999999
Q ss_pred hHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy5690 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 180 IwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 259 (434)
|||||+++|+|++ .|..||......+...... ......+.+...++++.+++.+||+.||++||++.||+..|
T Consensus 264 i~slG~~l~el~~-~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 264 VWSFGVLLWEIFS-LGASPYPGVKIDEEFCRRL------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred HHHHHHHHHHHHH-CCCCCCCCccccHHHHHHH------hccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999999999994 3888987654332221111 11122333455678999999999999999999999998888
Q ss_pred Hhc
Q psy5690 260 QRK 262 (434)
Q Consensus 260 ~~~ 262 (434)
+..
T Consensus 337 ~~~ 339 (343)
T cd05103 337 GNL 339 (343)
T ss_pred HHH
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=280.25 Aligned_cols=203 Identities=15% Similarity=0.170 Sum_probs=155.5
Q ss_pred CCCCCeeeEEEEEecC-CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCC
Q psy5690 4 LKDPNLVRVIGVCSTE-DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDLA 81 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlk 81 (434)
.+|.+++++++++..+ +..|+|||++ +++|.+++. ....+++..+..++.||+.||+|||+ .||+|||||
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlK 259 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM-------KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 3567799999998765 5789999998 779999987 33468999999999999999999998 599999999
Q ss_pred CCCeeeecCC----------------ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccc
Q psy5690 82 ARNCMVGKNY----------------TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSH 145 (434)
Q Consensus 82 p~NILl~~~~----------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 145 (434)
|+|||++.++ .+||+|||.++...
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---------------------------------------- 299 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---------------------------------------- 299 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccCc----------------------------------------
Confidence 9999998765 48999999753210
Q ss_pred cCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC-------
Q psy5690 146 YESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN------- 218 (434)
Q Consensus 146 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~------- 218 (434)
.......||..|+|||++.+..++.++|||||||++|||+ +|+.||...+..+....+.......
T Consensus 300 ------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell--tG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~ 371 (467)
T PTZ00284 300 ------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY--TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGR 371 (467)
T ss_pred ------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHcCCCCHHHHhh
Confidence 0123456889999999999999999999999999999999 8999998877654433322111000
Q ss_pred ------------CcccCCC---------------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 ------------SKQQYLP---------------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 ------------~~~~~~~---------------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
....... ......+.+.+||.+||++||++|||++|+ |+||.+.
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 372 CGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred ccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 0000000 000123567899999999999999999999 8899874
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=289.40 Aligned_cols=206 Identities=20% Similarity=0.284 Sum_probs=159.8
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-----
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR----- 73 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----- 73 (434)
|++|+|||||+++++|.+. ..+|+||||+++|+|.+++.... .....+++..++.|+.||+.||+|||+.
T Consensus 66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~---~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~ 142 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCY---KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPN 142 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhcccccc
Confidence 3578999999999988543 56899999999999999997432 1235699999999999999999999984
Q ss_pred --CccccCCCCCCeeeec-----------------CCceEEccCCcccccccccccccccccccchhhhhhcccCcccce
Q psy5690 74 --DIVHRDLAARNCMVGK-----------------NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTI 134 (434)
Q Consensus 74 --~iiHrDlkp~NILl~~-----------------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (434)
+|+||||||+|||++. .+.+||+|||++.......
T Consensus 143 ~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-------------------------- 196 (1021)
T PTZ00266 143 GERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-------------------------- 196 (1021)
T ss_pred cCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc--------------------------
Confidence 5999999999999964 2348999999875421100
Q ss_pred eecCccccccccCCcccccCCCCCCCccccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHH-Hhh
Q psy5690 135 KISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVI-ENC 211 (434)
Q Consensus 135 ~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~-~~~ 211 (434)
......||+.|+|||++.+ ..++.++|||||||++|||+ +|..||......... ..+
T Consensus 197 ------------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL--TGk~PF~~~~~~~qli~~l 256 (1021)
T PTZ00266 197 ------------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC--SGKTPFHKANNFSQLISEL 256 (1021)
T ss_pred ------------------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH--HCCCCCCcCCcHHHHHHHH
Confidence 1123467889999999964 45789999999999999999 899999866543322 211
Q ss_pred hhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 212 SHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
. .....+ ....+.++.+||..||+.+|.+||++.|+ ++|++...
T Consensus 257 k-------~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 257 K-------RGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred h-------cCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 1 111111 23467899999999999999999999999 58887653
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=262.11 Aligned_cols=204 Identities=18% Similarity=0.319 Sum_probs=159.1
Q ss_pred CC-CCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 3 SL-KDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++ +|||++++++++... +..++||||+++|+|.++++... .....+++..++.++.|++.||+|||++|++
T Consensus 74 ~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 150 (291)
T cd06639 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLL---ICGQRLDEAMISYILYGALLGLQHLHNNRII 150 (291)
T ss_pred HhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 45 799999999998653 35899999999999999986322 1335689999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+||+++.++.+||+|||++....... .....
T Consensus 151 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~ 187 (291)
T cd06639 151 HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-------------------------------------------LRRNT 187 (291)
T ss_pred ccCCCHHHEEEcCCCCEEEeecccchhccccc-------------------------------------------ccccC
Confidence 99999999999999999999999865421110 00122
Q ss_pred CCCCccccchhhhhcCC-----CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 157 ARLPIRWMAWESLLLGK-----NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~-----~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
..++..|+|||.+.... ++.++|||||||++|||+ +|..||......+....+.. ........+..++
T Consensus 188 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 260 (291)
T cd06639 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG--DGDPPLFDMHPVKTLFKIPR-----NPPPTLLHPEKWC 260 (291)
T ss_pred ccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh--hCCCCCCCCcHHHHHHHHhc-----CCCCCCCcccccC
Confidence 34677899999986543 588999999999999999 89999988765544433221 1111122244566
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHH--HHHH
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEI--HLFL 259 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el--~~~L 259 (434)
..+.+++.+||+.+|++||++.|+ |+||
T Consensus 261 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 261 RSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred HHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 789999999999999999999999 5555
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=263.23 Aligned_cols=205 Identities=20% Similarity=0.329 Sum_probs=166.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++..++..++|+||+++|+|.+++.+ ..+++..+..++.|++.||.|||++|++|+||
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL 141 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 141 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccC
Confidence 4678999999999999999999999999999999999962 34788899999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 142 ~p~Nili~~~~~~kL~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 178 (293)
T cd06647 142 KSDNILLGMDGSVKLTDFGFCAQITPEQ-------------------------------------------SKRSTMVGT 178 (293)
T ss_pred CHHHEEEcCCCCEEEccCcceecccccc-------------------------------------------cccccccCC
Confidence 9999999999999999999864321110 011223567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+....++.++|+|||||++|+++ +|..||...+.......+. .........+...+..+.+++.+
T Consensus 179 ~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll--~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV--EGEPPYLNENPLRALYLIA-----TNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred hhhcCchhhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCChhhheeehh-----cCCCCCCCCccccCHHHHHHHHH
Confidence 7899999998888999999999999999999 8999998765543322111 01111222244567889999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||+.+|++||+++++ |+|++...
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999 89998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=260.90 Aligned_cols=208 Identities=21% Similarity=0.314 Sum_probs=163.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++.+++..++|+||+++++|.+++. ....+++..+..++.|++.||.|||++|++|+||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i 129 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-------KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDV 129 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHH-------HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 357899999999999999999999999999999999997 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 81 AARNCMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 81 kp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
||+||+++.++ .++|+|||.+........ ..........+
T Consensus 130 ~~~nil~~~~~~~~~l~dfg~~~~~~~~~~---------------------------------------~~~~~~~~~~~ 170 (268)
T cd06630 130 KGANLLIDSTGQRLRIADFGAAARLAAKGT---------------------------------------GAGEFQGQLLG 170 (268)
T ss_pred CHHHEEEcCCCCEEEEcccccccccccccc---------------------------------------cCCcccccccc
Confidence 99999998776 589999998655321100 00001122356
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+..|+|||.+.+..++.++|+||+|+++|+|+ +|..||...........+.. ..........+...++++.+++.
T Consensus 171 ~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~ 245 (268)
T cd06630 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA--TAKPPWNAEKHSNHLALIFK---IASATTAPSIPEHLSPGLRDVTL 245 (268)
T ss_pred ccceeCHhHhccCCCCcccchHHHHHHHHHHH--hCCCCCCCCCCcchHHHHHH---HhccCCCCCCchhhCHHHHHHHH
Confidence 78899999998888899999999999999999 88999975543222222111 11112223445567889999999
Q ss_pred HhccCCCCCCCCHHHH--HHHH
Q psy5690 240 ECWKTNETDRPRFSEI--HLFL 259 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L 259 (434)
+||..+|++||++.++ |+|+
T Consensus 246 ~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 246 RCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred HHcCCCcccCcCHHHHhcCccc
Confidence 9999999999999999 5554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=287.02 Aligned_cols=230 Identities=18% Similarity=0.215 Sum_probs=165.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN----SQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~----~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
+++++||||+++++++.+++..++||||++||+|.+++...... .......++..+..++.||++||+|||++||+
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GII 135 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVL 135 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 35789999999999999999999999999999999999743211 01123456778899999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+||+++.++.++|+|||+++.............. ... ............
T Consensus 136 HRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~--------------------~~~-----~s~~s~~t~~g~ 190 (932)
T PRK13184 136 HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV--------------------DER-----NICYSSMTIPGK 190 (932)
T ss_pred ccCCchheEEEcCCCCEEEEecCcceeccccccccccccc--------------------ccc-----cccccccccCCC
Confidence 9999999999999999999999998764211100000000 000 000000111234
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..||+.|+|||++.+..++.++|||||||++|||+ +|..||............ .............+++.+.+
T Consensus 191 ~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELL--TG~~PF~~~~~~ki~~~~-----~i~~P~~~~p~~~iP~~L~~ 263 (932)
T PRK13184 191 IVGTPDYMAPERLLGVPASESTDIYALGVILYQML--TLSFPYRRKKGRKISYRD-----VILSPIEVAPYREIPPFLSQ 263 (932)
T ss_pred CCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHH--HCCCCCCCcchhhhhhhh-----hccChhhccccccCCHHHHH
Confidence 56899999999999999999999999999999999 899999875543332110 00111111112467789999
Q ss_pred HHHHhccCCCCCCCC-HHHHHHHHHhc
Q psy5690 237 LMLECWKTNETDRPR-FSEIHLFLQRK 262 (434)
Q Consensus 237 li~~cl~~dP~~Rps-~~el~~~L~~~ 262 (434)
++.+||+.||++|++ ++++...|+..
T Consensus 264 LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 264 IAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999975 66665555443
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=262.27 Aligned_cols=196 Identities=17% Similarity=0.321 Sum_probs=154.4
Q ss_pred CCCCeeeEEEEEec------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 5 KDPNLVRVIGVCST------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 5 ~HpnIv~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
+||||+++++++.. ++..+++|||+++|+|.+++... ....+++..+..++.||+.||+|||++|++|+
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~ 145 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-----KGNALKEDWIAYICREILRGLAHLHAHKVIHR 145 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 79999999999853 45689999999999999999743 23457888899999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.++|+|||++....... .......
T Consensus 146 dl~~~nili~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~ 182 (282)
T cd06636 146 DIKGQNVLLTENAEVKLVDFGVSAQLDRTV-------------------------------------------GRRNTFI 182 (282)
T ss_pred CCCHHHEEECCCCCEEEeeCcchhhhhccc-------------------------------------------cCCCccc
Confidence 999999999999999999999865421100 0112345
Q ss_pred CCccccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 159 LPIRWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 159 gt~~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
++..|+|||.+. ...++.++|||||||++|||+ +|..||...........+.. ..........++.+
T Consensus 183 ~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 254 (282)
T cd06636 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA--EGAPPLCDMHPMRALFLIPR------NPPPKLKSKKWSKK 254 (282)
T ss_pred ccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH--hCCCCccccCHHhhhhhHhh------CCCCCCcccccCHH
Confidence 678899999986 345788999999999999999 88999977654433322111 11111223457889
Q ss_pred HHHHHHHhccCCCCCCCCHHHHH
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~ 256 (434)
+.++|.+||+.||.+||++.||+
T Consensus 255 ~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 255 FIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred HHHHHHHHhCCChhhCcCHHHHh
Confidence 99999999999999999999993
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=273.43 Aligned_cols=200 Identities=24% Similarity=0.280 Sum_probs=171.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.|+|||||+++.+.+....+|+||||+.+|.+.+|+.+ .....+..+..++.|+++|++|||+++||||||
T Consensus 109 mk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~-------~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdL 181 (596)
T KOG0586|consen 109 MKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK-------HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDL 181 (596)
T ss_pred HHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh-------cccchhhhhhhhhHHHHHHHHHHhhcceecccc
Confidence 6789999999999999999999999999999999999984 456777889999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|++||||+.+.++||+|||++..+... ....+.+|+
T Consensus 182 k~eNilL~~~mnikIaDfgfS~~~~~~--------------------------------------------~~lqt~cgs 217 (596)
T KOG0586|consen 182 KAENILLDENMNIKIADFGFSTFFDYG--------------------------------------------LMLQTFCGS 217 (596)
T ss_pred chhhcccccccceeeeccccceeeccc--------------------------------------------ccccccCCC
Confidence 999999999999999999997553221 123567889
Q ss_pred ccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|.|||++.+.+| ++.+|+||+|+++|.|+ .|..||++.+-.+....+.. .....+-.++.++.++|+
T Consensus 218 ppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV--~GsLPFDG~~lk~Lr~rvl~--------gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 218 PPYAAPELFNGKKYDGPEVDIWSLGVVLYALV--EGSLPFDGQNLKELRPRVLR--------GKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred CCccChHhhcCcccCCcceehhhhhhhheeee--ecccccCCcccccccchhee--------eeecccceeechhHHHHH
Confidence 99999999999887 78999999999999999 99999998877666544432 122335567789999999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHh
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
++|..+|.+|++.+++ +.|+..
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred HhhccCccccCCHHHhhhhcccch
Confidence 9999999999999999 566643
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=257.54 Aligned_cols=207 Identities=20% Similarity=0.303 Sum_probs=164.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++|+||+++++.+..++..++|+|++++++|.++++... ....+++..+..++.|++.||+|||+.|++||||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l 128 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY----PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDI 128 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhc----ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 357899999999999999999999999999999999997432 1246899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||++++++.++|+|||++......... .........++
T Consensus 129 ~p~ni~~~~~~~~~l~df~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~ 169 (267)
T cd06610 129 KAGNILLGEDGSVKIADFGVSASLADGGDR---------------------------------------TRKVRKTFVGT 169 (267)
T ss_pred CHHhEEEcCCCCEEEcccchHHHhccCccc---------------------------------------cccccccccCC
Confidence 999999999999999999987553221100 00112334567
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCC--CCCccHHHHHHH
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLP--RPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l 237 (434)
..|+|||++... .++.++|+|||||++|+|+ +|..||...+..+....... . ....... ....+++++.++
T Consensus 170 ~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~--~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~l 243 (267)
T cd06610 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELA--TGAAPYSKYPPMKVLMLTLQ---N-DPPSLETGADYKKYSKSFRKM 243 (267)
T ss_pred hhhcChHHHccccCcCcccchHhHhHHHHHHH--hCCCCccccChhhhHHHHhc---C-CCCCcCCccccccccHHHHHH
Confidence 889999999877 7899999999999999999 89999987766554433321 1 1111111 123677899999
Q ss_pred HHHhccCCCCCCCCHHHHH
Q psy5690 238 MLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~ 256 (434)
+.+||+.||++||++++++
T Consensus 244 i~~~l~~~p~~Rp~~~~ll 262 (267)
T cd06610 244 ISLCLQKDPSKRPTAEELL 262 (267)
T ss_pred HHHHcCCChhhCcCHHHHh
Confidence 9999999999999999983
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=245.13 Aligned_cols=217 Identities=16% Similarity=0.258 Sum_probs=163.0
Q ss_pred CCCCCCCeeeEEEEEecCC-----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--
Q psy5690 2 CSLKDPNLVRVIGVCSTED-----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD-- 74 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-- 74 (434)
++++||||++++++...+. ..|++++|...|+|.+.++... .++..+++.+++.|+.+|++||++||+..
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k---~kg~~~sE~~iL~if~gic~gL~~lH~~~~~ 149 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLK---IKGNFVSEAQILWIFLGICRGLEALHEKEPP 149 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHh---hcCCccCHHHHHHHHHHHHHHHHHHhccCCc
Confidence 5789999999999875443 4999999999999999998654 24457999999999999999999999998
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
+.||||||.|||+++++.++|.|||.++...-.-. ...... .-...
T Consensus 150 yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~---~~~~a~-------------------------------~lQe~ 195 (302)
T KOG2345|consen 150 YAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE---GSRQAL-------------------------------RLQEW 195 (302)
T ss_pred ccccCCCcceeEecCCCceEEEeccCccccceEee---chHHHH-------------------------------HHHHH
Confidence 99999999999999999999999998765211100 000000 00011
Q ss_pred CCCCCCccccchhhhhcCC---CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 155 TKARLPIRWMAWESLLLGK---NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~---~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
.....|..|.|||.+.... .+.++|||||||++|+|+ .|..||......-. .+ -+.........|....++
T Consensus 196 a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m--f~~sPfe~~~~~Gg--Sl--aLAv~n~q~s~P~~~~ys 269 (302)
T KOG2345|consen 196 AEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM--FGESPFERIYQQGG--SL--ALAVQNAQISIPNSSRYS 269 (302)
T ss_pred HHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH--HcCCcchHHhhcCC--eE--EEeeeccccccCCCCCcc
Confidence 2335678899999997544 488999999999999999 88999864322100 00 011112233344455689
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+.+.++++.|++.||.+||++.+++..+++
T Consensus 270 e~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 270 EALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 999999999999999999999999777664
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=256.63 Aligned_cols=197 Identities=24% Similarity=0.408 Sum_probs=162.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++.+++..++++||+++++|.+++. ....+++..+..++.|++.||+|||+.|++|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 128 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK-------KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDI 128 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 357899999999999999999999999999999999997 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.+||+|||++....... ......++
T Consensus 129 ~~~ni~~~~~~~~kl~d~~~~~~~~~~~--------------------------------------------~~~~~~~~ 164 (258)
T cd06632 129 KGANILVDTNGVVKLADFGMAKQVVEFS--------------------------------------------FAKSFKGS 164 (258)
T ss_pred CHHHEEECCCCCEEEccCccceeccccc--------------------------------------------cccccCCC
Confidence 9999999999999999999865421100 11234567
Q ss_pred ccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.... ++.++|+|||||++|+|+ +|..||......+....+.. .......+..+++++.+++.
T Consensus 165 ~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~--~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA--TGKPPWSQLEGVAAVFKIGR------SKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred cceeCHHHhcCCCCCCchhhhHHHHHHHHHHH--hCCCCcccCcHHHHHHHHHh------cccCCCcCCCcCHHHHHHHH
Confidence 7899999998776 899999999999999999 89999987764444332211 11223345667899999999
Q ss_pred HhccCCCCCCCCHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIH 256 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~ 256 (434)
+||+.+|++||++++++
T Consensus 237 ~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 237 KCLQRDPSLRPTAAELL 253 (258)
T ss_pred HHhhcCcccCcCHHHHh
Confidence 99999999999999983
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=261.53 Aligned_cols=210 Identities=17% Similarity=0.220 Sum_probs=162.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|+||+++++++.+++..++||||+ +|+|.+++... ...+++..+..++.||++||.|||++|++|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~------~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl 128 (298)
T cd07841 56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK------SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDL 128 (298)
T ss_pred HhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Confidence 46789999999999999999999999999 88999999721 136899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++...... .......++
T Consensus 129 ~p~nill~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 165 (298)
T cd07841 129 KPNNLLIASDGVLKLADFGLARSFGSPN-------------------------------------------RKMTHQVVT 165 (298)
T ss_pred ChhhEEEcCCCCEEEccceeeeeccCCC-------------------------------------------ccccccccc
Confidence 9999999999999999999875421110 001122346
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC---------------cccCC
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS---------------KQQYL 224 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~~ 224 (434)
..|+|||.+.+ ..++.++|||||||++|||+ +|..+|......+....+........ .....
T Consensus 166 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T cd07841 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELL--LRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFP 243 (298)
T ss_pred eeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHH--cCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccC
Confidence 77999999865 45688999999999999999 78788876665444333321110000 00000
Q ss_pred -----CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 225 -----PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 225 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
......+.++.+++.+||+.||++||+++|+ |+||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 244 PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred CcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0123456789999999999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=259.61 Aligned_cols=207 Identities=21% Similarity=0.359 Sum_probs=168.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++..++..++|+||+++++|.+++..+. ..+++..+..++.|++.||.|||+.|++|+||
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl 142 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCC
Confidence 357899999999999999999999999999999999997431 37899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||++....... .......++
T Consensus 143 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~-------------------------------------------~~~~~~~~~ 179 (286)
T cd06614 143 KSDNILLSKDGSVKLADFGFAAQLTKEK-------------------------------------------SKRNSVVGT 179 (286)
T ss_pred ChhhEEEcCCCCEEECccchhhhhccch-------------------------------------------hhhccccCC
Confidence 9999999999999999999854311100 001223356
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+|||||++|+|+ +|..||...........+.. ........+..++.++.+++.+
T Consensus 180 ~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~ 252 (286)
T cd06614 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA--EGEPPYLREPPLRALFLITT-----KGIPPLKNPEKWSPEFKDFLNK 252 (286)
T ss_pred cccCCHhHhcCCCCCCccccHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHh-----cCCCCCcchhhCCHHHHHHHHH
Confidence 7899999999888999999999999999999 88999987766554433221 1111122233477899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||+.+|.+||++.++ ++|+++..
T Consensus 253 ~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 253 CLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HhccChhhCcCHHHHhhChHhhccC
Confidence 999999999999999 78998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=260.77 Aligned_cols=201 Identities=19% Similarity=0.349 Sum_probs=156.8
Q ss_pred CC-CCCCeeeEEEEEe-----cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 3 SL-KDPNLVRVIGVCS-----TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++ +||||+++++++. .++..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+++++
T Consensus 70 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 146 (286)
T cd06638 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL---KRGERMEEPIIAYILHEALMGLQHLHVNKTI 146 (286)
T ss_pred HHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhh---ccCccccHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 45 6999999999884 3456899999999999999886332 1335688999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+||+++.++.++|+|||+++...... .....
T Consensus 147 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~ 183 (286)
T cd06638 147 HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-------------------------------------------LRRNT 183 (286)
T ss_pred ccCCCHHhEEECCCCCEEEccCCceeecccCC-------------------------------------------Ccccc
Confidence 99999999999999999999999865421100 01123
Q ss_pred CCCCccccchhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 157 ARLPIRWMAWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
..|+..|+|||++.. ..++.++||||+||++|||+ +|..||.............. ........+..++
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 256 (286)
T cd06638 184 SVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG--DGDPPLADLHPMRALFKIPR-----NPPPTLHQPELWS 256 (286)
T ss_pred ccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh--cCCCCCCCCchhHHHhhccc-----cCCCcccCCCCcC
Confidence 357788999999853 44788999999999999999 89999987655443322111 1111222344567
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
.++.+++.+||+.||++||++.|++
T Consensus 257 ~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 257 NEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHh
Confidence 8899999999999999999999994
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=257.42 Aligned_cols=199 Identities=21% Similarity=0.235 Sum_probs=158.1
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++.+. ..++++|||+++|+|.+++.+ ...+++..+..++.|++.||+|||+++++|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~ 130 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS-------YGALTENVTRKYTRQILEGVSYLHSNMIVHR 130 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 3578999999999998764 468899999999999999973 2457889999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.++|+|||+++....... .........
T Consensus 131 dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~----------------------------------------~~~~~~~~~ 170 (265)
T cd06652 131 DIKGANILRDSVGNVKLGDFGASKRLQTICL----------------------------------------SGTGMKSVT 170 (265)
T ss_pred CCCHHHEEecCCCCEEECcCccccccccccc----------------------------------------cccccccCC
Confidence 9999999999999999999998654211000 000112234
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
++..|+|||.+.+..++.++|||||||++|||+ +|..||............. ........+...+..+.+++
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~--~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~i 242 (265)
T cd06652 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEML--TEKPPWAEFEAMAAIFKIA------TQPTNPVLPPHVSDHCRDFL 242 (265)
T ss_pred CCccccChhhhcCCCCCcchhHHHHHHHHHHHh--hCCCCCCccchHHHHHHHh------cCCCCCCCchhhCHHHHHHH
Confidence 678899999999888999999999999999999 8999998765444433221 11122334556778899999
Q ss_pred HHhccCCCCCCCCHHHH
Q psy5690 239 LECWKTNETDRPRFSEI 255 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el 255 (434)
.+||. +|++||+++||
T Consensus 243 ~~~l~-~p~~Rp~~~~i 258 (265)
T cd06652 243 KRIFV-EAKLRPSADEL 258 (265)
T ss_pred HHHhc-ChhhCCCHHHH
Confidence 99995 89999999999
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=259.09 Aligned_cols=211 Identities=24% Similarity=0.344 Sum_probs=161.4
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||++++++|.+. +..++||||+++++|.+++.... .....+++..+..++.||+.||+|||+.|++|+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~ 129 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVK---KRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHR 129 (287)
T ss_pred HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 4678999999999998654 46899999999999999876432 134568899999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||+|+||+++.++.++|+|||++...... ......
T Consensus 130 dl~~~nil~~~~~~~~l~dfg~~~~~~~~---------------------------------------------~~~~~~ 164 (287)
T cd06621 130 DIKPSNILLTRKGQVKLCDFGVSGELVNS---------------------------------------------LAGTFT 164 (287)
T ss_pred CCCHHHEEEecCCeEEEeecccccccccc---------------------------------------------cccccc
Confidence 99999999999999999999986542110 001223
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-----HHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-----EQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
++..|+|||.+.+..++.++|||||||++|+|+ +|..||..... .+....+... ..............++++
T Consensus 165 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (287)
T cd06621 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA--QNRFPFPPEGEPPLGPIELLSYIVNM-PNPELKDEPGNGIKWSEE 241 (287)
T ss_pred CCccccCHHHhcCCCCCchhhHHHHHHHHHHHH--hCCCCCCcccCCCCChHHHHHHHhcC-CchhhccCCCCCCchHHH
Confidence 566799999999999999999999999999999 88999976522 2222211110 000000111111345789
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+++.+||+.||++|||+.|+ |+|+++.
T Consensus 242 ~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 242 FKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 9999999999999999999999 6798654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=257.37 Aligned_cols=202 Identities=21% Similarity=0.328 Sum_probs=166.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++..++..++||||+++|+|.+++. ...+++..+..++.|++.|+.|||++|++|+||
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl 127 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--------PGPLDETQIATILREILKGLDYLHSEKKIHRDI 127 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCC
Confidence 357899999999999999999999999999999999985 235889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 128 ~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 164 (277)
T cd06641 128 KAANVLLSEHGEVKLADFGVAGQLTDTQ-------------------------------------------IKRNTFVGT 164 (277)
T ss_pred CHHhEEECCCCCEEEeecccceecccch-------------------------------------------hhhccccCC
Confidence 9999999999999999999865421100 001223456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+|||||++|+|+ +|..||...........+. .......+..++.++.+++.+
T Consensus 165 ~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELA--KGEPPHSELHPMKVLFLIP-------KNNPPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred ccccChhhhccCCCCchhhHHHHHHHHHHHH--cCCCCCCccchHHHHHHHh-------cCCCCCCCcccCHHHHHHHHH
Confidence 7799999998888899999999999999999 8999998766554443321 112223345678899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.+|++||++.++ |+|+.+.
T Consensus 236 ~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 236 CLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HccCChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999 6788764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=263.96 Aligned_cols=204 Identities=20% Similarity=0.279 Sum_probs=154.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+.+..++|+||+. ++|.+++.. ....+++..+..++.||++||.|||++|++||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl 125 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDS------CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDL 125 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence 357899999999999999999999999997 588888763 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .......++
T Consensus 126 ~~~nil~~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 162 (284)
T cd07839 126 KPQNLLINKNGELKLADFGLARAFGIPV-------------------------------------------RCYSAEVVT 162 (284)
T ss_pred CHHHEEEcCCCcEEECccchhhccCCCC-------------------------------------------CCcCCCccc
Confidence 9999999999999999999875421100 001223456
Q ss_pred ccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCC-CCCChHHHHHhhhhhhhc------------CCcccC---
Q psy5690 161 IRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPY-AELTNEQVIENCSHWYQN------------NSKQQY--- 223 (434)
Q Consensus 161 ~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf-~~~~~~~~~~~~~~~~~~------------~~~~~~--- 223 (434)
..|+|||++.+.. ++.++|||||||++|+|+ +|..|+ .+.+..+....+...... ......
T Consensus 163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07839 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA--NAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240 (284)
T ss_pred cCCcChHHHhCCcccCcHHHHHHHHHHHHHHH--hcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence 7899999987654 689999999999999999 677775 443333332222111000 000000
Q ss_pred ------CCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 224 ------LPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 224 ------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
......+++++.+++.+||+.||.+|||+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il 279 (284)
T cd07839 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279 (284)
T ss_pred CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence 011234678999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=254.55 Aligned_cols=211 Identities=36% Similarity=0.684 Sum_probs=164.6
Q ss_pred CCCCCCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++||||+++++++.... ..++++||+.+|+|.+++...... .....+++..+..++.|++.||+|||++|
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 133 (273)
T cd05074 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFMIDIASGMEYLSSKN 133 (273)
T ss_pred HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46889999999999986532 247899999999999987532211 12235788999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+||+++.++.+||+|||+++...... .+...
T Consensus 134 i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~-----------------------------------------~~~~~ 172 (273)
T cd05074 134 FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD-----------------------------------------YYRQG 172 (273)
T ss_pred EeecccchhhEEEcCCCCEEECcccccccccCCc-----------------------------------------ceecC
Confidence 9999999999999999999999999876521111 00111
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
....++..|++||.+....++.++|||||||++|||+ + |..||......+....+.. ......+..++..
T Consensus 173 ~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 243 (273)
T cd05074 173 CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM--TRGQTPYAGVENSEIYNYLIK-------GNRLKQPPDCLED 243 (273)
T ss_pred CCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHh--hCCCCCCCCCCHHHHHHHHHc-------CCcCCCCCCCCHH
Confidence 2233456799999999888999999999999999999 5 8899987776555443321 1122234567789
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+++.+||+.+|++||++.++...|++.
T Consensus 244 ~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 244 VYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=266.69 Aligned_cols=213 Identities=17% Similarity=0.236 Sum_probs=151.1
Q ss_pred CCCCCCCCeeeEEEEEec--CCceEEEEecCCCCCHHHHHhhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCN--SQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
|++++||||+++++++.. +...++|+||+.+ +|.+++...... ......+++..+..++.||+.||+|||++||+
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv 130 (317)
T cd07867 52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 457899999999999853 4678999999965 888888643211 11234588999999999999999999999999
Q ss_pred ccCCCCCCeee----ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 77 HRDLAARNCMV----GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 77 HrDlkp~NILl----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 131 H~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~----------------------------------------~~~ 170 (317)
T cd07867 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK----------------------------------------PLA 170 (317)
T ss_pred cCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcc----------------------------------------ccc
Confidence 99999999999 4567899999999865322110 000
Q ss_pred cCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH---------HHHhhhhhhh------
Q psy5690 153 SDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ---------VIENCSHWYQ------ 216 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~---------~~~~~~~~~~------ 216 (434)
......+|..|+|||++.+. .++.++|||||||++|||+ +|..||....... ....+.....
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~--tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T cd07867 171 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL--TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKD 248 (317)
T ss_pred ccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHH--hCCCCcccccccccccccccHHHHHHHHHhcCCCChhh
Confidence 11234577889999999764 5789999999999999999 8899997543211 0000000000
Q ss_pred --c---C------C---ccc----------CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 217 --N---N------S---KQQ----------YLPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 217 --~---~------~---~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
. . . ... ........+..+.+++.+||+.||.+|||++|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l 312 (317)
T cd07867 249 WEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL 312 (317)
T ss_pred hhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence 0 0 0 000 0000112345788999999999999999999993
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=259.15 Aligned_cols=202 Identities=19% Similarity=0.348 Sum_probs=157.4
Q ss_pred CCC-CCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 2 CSL-KDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
+++ +|+||+++++++.... ..++||||+++++|.+++.... ..+..+++..+..++.|++.||+|||++|
T Consensus 57 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~ql~~al~~lH~~~ 133 (275)
T cd06608 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR---KKGKRLKEEWIAYILRETLRGLAYLHENK 133 (275)
T ss_pred HHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 345 7999999999997654 4899999999999999987432 12457899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 134 i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------------------------------------------~~~ 170 (275)
T cd06608 134 VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL-------------------------------------------GRR 170 (275)
T ss_pred cccCCCCHHHEEEccCCeEEECCCccceecccch-------------------------------------------hhh
Confidence 9999999999999999999999999865421100 011
Q ss_pred CCCCCCccccchhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCc
Q psy5690 155 TKARLPIRWMAWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (434)
....++..|+|||.+.. ..++.++|||||||++|+|+ +|..||...........+.. ........+..
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 243 (275)
T cd06608 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA--DGKPPLCDMHPMRALFKIPR-----NPPPTLKSPEN 243 (275)
T ss_pred cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH--hCCCCccccchHHHHHHhhc-----cCCCCCCchhh
Confidence 23456788999999864 34578999999999999999 89999986654444333221 11112222344
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
+++++.+++.+||..||++|||+++++
T Consensus 244 ~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 244 WSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred cCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 778999999999999999999999993
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=255.03 Aligned_cols=203 Identities=18% Similarity=0.290 Sum_probs=164.9
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDLA 81 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlk 81 (434)
.++||||+++++++..++..+++|||+++++|.+++.... .....+++..++.++.|++.||.|||+ .+++|+||+
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~ 141 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK---EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLT 141 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCC
Confidence 5799999999999999999999999999999999986422 133568999999999999999999996 789999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||.+....... ......++.
T Consensus 142 ~~nil~~~~~~~~l~dfg~~~~~~~~~--------------------------------------------~~~~~~~~~ 177 (269)
T cd08528 142 PNNIMLGEDDKVTITDFGLAKQKQPES--------------------------------------------KLTSVVGTI 177 (269)
T ss_pred HHHEEECCCCcEEEecccceeeccccc--------------------------------------------ccccccCcc
Confidence 999999999999999999865421110 112345677
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||.+.+..++.++|+||||+++|+|+ +|..||...........+... .........+++++.+++.+|
T Consensus 178 ~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~--~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~c 249 (269)
T cd08528 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMC--TLQPPFYSTNMLSLATKIVEA------VYEPLPEGMYSEDVTDVITSC 249 (269)
T ss_pred cCcChhhhcCCCCchHHHHHHHHHHHHHHH--hCCCcccccCHHHHHHHHhhc------cCCcCCcccCCHHHHHHHHHH
Confidence 899999999888999999999999999999 889999877665554433221 111111235678999999999
Q ss_pred ccCCCCCCCCHHHHHHHHH
Q psy5690 242 WKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 242 l~~dP~~Rps~~el~~~L~ 260 (434)
|+.||++||++.|+...++
T Consensus 250 l~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 250 LTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCCCCccCCCHHHHHHHhc
Confidence 9999999999999977664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=262.44 Aligned_cols=204 Identities=26% Similarity=0.405 Sum_probs=161.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+.+..++||||+++++|.+++. ....+++..+..++.|+++||++||++|++|+|||
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dik 125 (260)
T PF00069_consen 53 RRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-------KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIK 125 (260)
T ss_dssp HHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-------HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBS
T ss_pred cccccccccccccccccccccccccccccccccccccc-------ccccccccccccccccccccccccccccccccccc
Confidence 35689999999999999999999999999999999997 33578999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||.+.... ..........++.
T Consensus 126 p~NIl~~~~~~~~l~Dfg~~~~~~-------------------------------------------~~~~~~~~~~~~~ 162 (260)
T PF00069_consen 126 PENILLDENGEVKLIDFGSSVKLS-------------------------------------------ENNENFNPFVGTP 162 (260)
T ss_dssp GGGEEESTTSEEEESSGTTTEEST-------------------------------------------STTSEBSSSSSSG
T ss_pred cccccccccccccccccccccccc-------------------------------------------ccccccccccccc
Confidence 999999999999999999865420 0011223456678
Q ss_pred cccchhhhh-cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLL-LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~-~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++. +..++.++||||+|+++|+|+ +|..||......+....+....... ...........++++.+++.+
T Consensus 163 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 239 (260)
T PF00069_consen 163 EYMAPEVLQQGKKYTRKSDIWSLGIILYELL--TGKLPFEESNSDDQLEIIEKILKRP-LPSSSQQSREKSEELRDLIKK 239 (260)
T ss_dssp GGSCHHHHTTTSSBSTHHHHHHHHHHHHHHH--HSSSSSTTSSHHHHHHHHHHHHHTH-HHHHTTSHTTSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccc--ccccccccccchhhhhhhhhccccc-ccccccccchhHHHHHHHHHH
Confidence 899999998 788899999999999999999 8899999874333322222111100 000111112234899999999
Q ss_pred hccCCCCCCCCHHHH--HHH
Q psy5690 241 CWKTNETDRPRFSEI--HLF 258 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~ 258 (434)
||+.||++||++.++ |+|
T Consensus 240 ~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 240 MLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp HSSSSGGGSTTHHHHHTSGG
T ss_pred HccCChhHCcCHHHHhcCCC
Confidence 999999999999999 454
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=247.68 Aligned_cols=202 Identities=22% Similarity=0.350 Sum_probs=164.4
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDLAA 82 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp 82 (434)
-+.|+||+.+|+|..+..+++.||.+.. .++.++++ ....+++..+-++...+++||.||.+ +||+|||+||
T Consensus 148 ~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkr------ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKP 220 (391)
T KOG0983|consen 148 HDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKR------IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 220 (391)
T ss_pred cCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHH------hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCc
Confidence 3579999999999999999999999854 67777763 34679999999999999999999986 5899999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+|||+|+.|++||||||++...-++. ..+...|-+.
T Consensus 221 SNILlDe~GniKlCDFGIsGrlvdSk--------------------------------------------AhtrsAGC~~ 256 (391)
T KOG0983|consen 221 SNILLDERGNIKLCDFGISGRLVDSK--------------------------------------------AHTRSAGCAA 256 (391)
T ss_pred cceEEccCCCEEeecccccceeeccc--------------------------------------------ccccccCCcc
Confidence 99999999999999999975532222 3355567788
Q ss_pred ccchhhhhc---CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 163 WMAWESLLL---GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 163 y~aPE~~~~---~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
|||||-+.- ..|+.++||||||++++||. ||+.||.+.+. .+....+.+ ......+....+++.+.+++
T Consensus 257 YMaPERidp~~~~kYDiRaDVWSlGITlveLa--Tg~yPy~~c~tdFe~ltkvln-----~ePP~L~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 257 YMAPERIDPPDKPKYDIRADVWSLGITLVELA--TGQYPYKGCKTDFEVLTKVLN-----EEPPLLPGHMGFSPDFQSFV 329 (391)
T ss_pred ccCccccCCCCCCccchhhhhhhhccchhhhh--cccCCCCCCCccHHHHHHHHh-----cCCCCCCcccCcCHHHHHHH
Confidence 999999863 46889999999999999999 89999988543 344444322 23344554556899999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
..||++|+.+||...++ |+|+...+
T Consensus 330 ~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 330 KDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHhhcCcccCcchHHHhcCcceeecc
Confidence 99999999999999998 67776543
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=260.30 Aligned_cols=204 Identities=23% Similarity=0.346 Sum_probs=163.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDl 80 (434)
++++||||+++++++..++..++++||+++++|.+++... ...+++..+..++.|++.||+|||+ .|++|+||
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl 127 (265)
T cd06605 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV------QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDV 127 (265)
T ss_pred HHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc------cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCC
Confidence 5678999999999999999999999999999999999732 1578899999999999999999999 99999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||.+....... .....++
T Consensus 128 ~~~ni~~~~~~~~~l~d~g~~~~~~~~~---------------------------------------------~~~~~~~ 162 (265)
T cd06605 128 KPSNILVNSRGQIKLCDFGVSGQLVNSL---------------------------------------------AKTFVGT 162 (265)
T ss_pred CHHHEEECCCCCEEEeecccchhhHHHH---------------------------------------------hhcccCC
Confidence 9999999999999999999864421100 0114466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh--HHHHHhhhhhhhcCCcccCCCCCCc-cHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN--EQVIENCSHWYQNNSKQQYLPRPAT-CQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 237 (434)
..|+|||.+.+..++.++||||||+++|+|+ +|..||..... .......... ........+.. ++.++.++
T Consensus 163 ~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELA--TGRFPYPPENDPPDGIFELLQYI----VNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred hhccCHHHHcCCCCCchhhHHHHHHHHHHHH--hCCCCCCccccccccHHHHHHHH----hcCCCCCCChhhcCHHHHHH
Confidence 7899999999999999999999999999999 88999976521 1111111111 11112222233 78899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
|.+||..||++||++.++ ++||++.
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999 7888764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=279.79 Aligned_cols=215 Identities=13% Similarity=0.127 Sum_probs=155.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++..++..++|+|++. ++|..++..... ..........+..++.||+.||+|||++||+||||
T Consensus 217 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDL 293 (501)
T PHA03210 217 LGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAF--DWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293 (501)
T ss_pred HHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccc--cccccccHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 457899999999999999999999999995 588888753221 11223446678889999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........||
T Consensus 294 KP~NILl~~~~~vkL~DFGla~~~~~~~------------------------------------------~~~~~~~~gt 331 (501)
T PHA03210 294 KLENIFLNCDGKIVLGDFGTAMPFEKER------------------------------------------EAFDYGWVGT 331 (501)
T ss_pred CHHHEEECCCCCEEEEeCCCceecCccc------------------------------------------ccccccccCC
Confidence 9999999999999999999976532110 0011235688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCC-CCCCCCCh--HHHHHhhhhhhh------------------cCC
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQ-RPYAELTN--EQVIENCSHWYQ------------------NNS 219 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~-~pf~~~~~--~~~~~~~~~~~~------------------~~~ 219 (434)
..|+|||++.+..++.++|||||||++|||+ +|. .||..... ......+..... ...
T Consensus 332 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell--~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~ 409 (501)
T PHA03210 332 VATNSPEILAGDGYCEITDIWSCGLILLDML--SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAE 409 (501)
T ss_pred cCCCCchhhcCCCCCcHHHHHHHHHHHHHHH--HCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhh
Confidence 9999999999999999999999999999999 555 45543221 111111111000 000
Q ss_pred cccCC-C-----CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 220 KQQYL-P-----RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 220 ~~~~~-~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
..... . ....++.++.+++.+||+.||++|||+.|+ |+||...
T Consensus 410 ~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 410 IDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred cccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 00000 0 011245678889999999999999999999 7898764
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=254.29 Aligned_cols=202 Identities=24% Similarity=0.377 Sum_probs=166.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDl 80 (434)
++++|+||+++++++..++..++|+||+++++|.+++. ....+++..+..++.|+++||+|||+ .|++||||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l 126 (264)
T cd06623 54 RSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK-------KVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDI 126 (264)
T ss_pred HhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCC
Confidence 46789999999999999999999999999999999997 33578999999999999999999999 99999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||.+........ ......++
T Consensus 127 ~~~ni~~~~~~~~~l~df~~~~~~~~~~~-------------------------------------------~~~~~~~~ 163 (264)
T cd06623 127 KPSNLLINSKGEVKIADFGISKVLENTLD-------------------------------------------QCNTFVGT 163 (264)
T ss_pred CHHHEEECCCCCEEEccCccceecccCCC-------------------------------------------cccceeec
Confidence 99999999999999999998654211110 00223456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC---hHHHHHhhhhhhhcCCcccCCCCCCc-cHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT---NEQVIENCSHWYQNNSKQQYLPRPAT-CQKEIFD 236 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ 236 (434)
..|+|||.+....++.++|+||||+++|+|+ +|..||.... ..+....+. .......+.. ++..+.+
T Consensus 164 ~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~--tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 164 VTYMSPERIQGESYSYAADIWSLGLTLLECA--LGKFPFLPPGQPSFFELMQAIC-------DGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred ccccCHhhhCCCCCCchhhHHHHHHHHHHHH--hCCCCCccccccCHHHHHHHHh-------cCCCCCCCcccCCHHHHH
Confidence 7899999999988999999999999999999 8999998774 223332221 1222233444 7889999
Q ss_pred HHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 237 LMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
++.+||..+|++||++.++ ++|++..
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999 7888764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=259.30 Aligned_cols=205 Identities=15% Similarity=0.236 Sum_probs=167.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++..++..++||||+++++|.+++. ...+++..+..++.|++.||+|||++|++||||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl 142 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--------HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 356899999999999999999999999999999999874 235789999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||++....... .......++
T Consensus 143 ~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 179 (292)
T cd06657 143 KSDSILLTHDGRVKLSDFGFCAQVSKEV-------------------------------------------PRRKSLVGT 179 (292)
T ss_pred CHHHEEECCCCCEEEcccccceeccccc-------------------------------------------ccccccccC
Confidence 9999999999999999999854311100 011223467
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+||+|+++|+|+ +|..||......+....+... ..........+++.+.+++.+
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~--tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~ 252 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMV--DGEPPYFNEPPLKAMKMIRDN-----LPPKLKNLHKVSPSLKGFLDR 252 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhh-----CCcccCCcccCCHHHHHHHHH
Confidence 7899999998888899999999999999999 889999877665544433211 111222234567889999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||+.||.+||++.++ |+||.+..
T Consensus 253 ~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 253 LLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHhCCcccCcCHHHHhcChHHhccC
Confidence 999999999999999 88998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=255.89 Aligned_cols=201 Identities=21% Similarity=0.302 Sum_probs=164.3
Q ss_pred CCCCCCCCeeeEEEEEec--CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----hC
Q psy5690 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE-----SR 73 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-----~~ 73 (434)
|++++||||+++++++.. +...+++|||+++++|.+++.... .....+++..++.++.||+.||+||| +.
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~ 129 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK---KERKYIEEEFIWRILTQLLLALYECHNRSDPGN 129 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHhcCccccC
Confidence 457899999999998754 356899999999999999997542 13457899999999999999999999 89
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
+++|+||||+||+++.++.+||+|||++....... ..
T Consensus 130 ~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-------------------------------------------~~ 166 (265)
T cd08217 130 TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-------------------------------------------SF 166 (265)
T ss_pred cceecCCCHHHEEEecCCCEEEecccccccccCCc-------------------------------------------cc
Confidence 99999999999999999999999999865421110 00
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
.....++..|+|||.+....++.++|+||||+++|+|+ +|..||......+..+.+.. ......+..++.+
T Consensus 167 ~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 237 (265)
T cd08217 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC--ALSPPFTARNQLQLASKIKE-------GKFRRIPYRYSSE 237 (265)
T ss_pred ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHH--HCCCcccCcCHHHHHHHHhc-------CCCCCCccccCHH
Confidence 12234677899999999888999999999999999999 88999988776555444322 2223445677899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHH
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~ 256 (434)
+.+++.+||+.+|++||++++|+
T Consensus 238 ~~~l~~~~l~~~p~~Rp~~~~il 260 (265)
T cd08217 238 LNEVIKSMLNVDPDKRPSTEELL 260 (265)
T ss_pred HHHHHHHHccCCcccCCCHHHHh
Confidence 99999999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=248.44 Aligned_cols=212 Identities=19% Similarity=0.213 Sum_probs=165.0
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
.|+||++++++|+++..+|+|||-+.||+|...+++ ...+++.++..+.++|+.||+|||.+||.||||||+|
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~-------~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPEN 206 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK-------RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPEN 206 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHH-------hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccc
Confidence 599999999999999999999999999999999984 4579999999999999999999999999999999999
Q ss_pred eeeecCC---ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 85 CMVGKNY---TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 85 ILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
||-.+.. -+|||||.+........ . ++ ........+.+|..
T Consensus 207 iLC~~pn~vsPvKiCDfDLgSg~k~~~-----~----------------------------~s---pastP~L~tPvGSA 250 (463)
T KOG0607|consen 207 ILCESPNKVSPVKICDFDLGSGIKLNN-----D----------------------------CS---PASTPELLTPVGSA 250 (463)
T ss_pred eeecCCCCcCceeeeccccccccccCC-----C----------------------------CC---CCCCccccCcccch
Confidence 9997654 47999998843311110 0 00 00111235677889
Q ss_pred cccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh---------------HHHHHhhhhhhhcCCcc
Q psy5690 162 RWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN---------------EQVIENCSHWYQNNSKQ 221 (434)
Q Consensus 162 ~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~~ 221 (434)
.|||||+.. ...|+.++|.|||||++|-|+ .|.+||.+.-. ..+++.|.+.. ..
T Consensus 251 EfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImL--sGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk----Ye 324 (463)
T KOG0607|consen 251 EFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIML--SGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK----YE 324 (463)
T ss_pred hhcchhHHhhhccccccccccccHHHHHHHHHHHH--hCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC----Cc
Confidence 999999875 245799999999999999999 89999976421 23333333221 11
Q ss_pred cCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcccC
Q psy5690 222 QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNLG 265 (434)
Q Consensus 222 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~~ 265 (434)
........++.+.++++...+..|+.+|.++.++ |+|++.....
T Consensus 325 FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 325 FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 1112245688999999999999999999999999 7899876544
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=258.07 Aligned_cols=211 Identities=21% Similarity=0.298 Sum_probs=166.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++.+..++..|+++||+++++|.+++.+ ...+++..+..++.|+++||+|||++|++||||+
T Consensus 48 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~ 120 (265)
T cd05579 48 SQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN-------VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120 (265)
T ss_pred HhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCC
Confidence 568899999999999999999999999999999999973 2368999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||++.......... ............++.
T Consensus 121 ~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~ 165 (265)
T cd05579 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQIN-----------------------------------LNDDEKEDKRIVGTP 165 (265)
T ss_pred HHHeEEcCCCCEEEEecccchhcccCcccc-----------------------------------cccccccccCcccCc
Confidence 999999999999999999865421110000 000001122344667
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||.......+.++|+||||+++|+++ +|..||......+....+.. .....+.....+..+.+++.+|
T Consensus 166 ~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFL--VGIPPFHGETPEEIFQNILN------GKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred cccCHHHhcCCCCCcchhhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHhc------CCcCCCccccCCHHHHHHHHHH
Confidence 899999999888999999999999999999 89999988877766654432 1111111222488999999999
Q ss_pred ccCCCCCCCCH---HHH--HHHHHhc
Q psy5690 242 WKTNETDRPRF---SEI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~---~el--~~~L~~~ 262 (434)
|+.+|++||++ .++ ++||++.
T Consensus 238 l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 238 LVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred hcCCHhhcCCCccHHHHhcCccccCC
Confidence 99999999999 665 5666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=258.95 Aligned_cols=210 Identities=11% Similarity=0.108 Sum_probs=156.1
Q ss_pred CCCCCCCeeeEEEEEecCC----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 2 CSLKDPNLVRVIGVCSTED----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
+.++|+|++++++++.... ..++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+++|+|
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH 149 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR-------IKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHh-------hccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4578999999999875543 34788888844 77777752 234578889999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+|||++.++.++|+|||+|+......... ..........
T Consensus 150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~------------------------------------~~~~~~~~~~ 193 (294)
T PHA02882 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI------------------------------------EYSKEQKDLH 193 (294)
T ss_pred CCCCHHHEEEcCCCcEEEEEcCCceeeccCCccc------------------------------------cccccccccc
Confidence 9999999999999999999999987642211000 0000011234
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhh-hhhhcCCcccCCCCCCccHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCS-HWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
.||+.|+|||++.+..++.++|||||||++|||+ +|..||..... ........ .+........ .....+++++.
T Consensus 194 ~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~--~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 269 (294)
T PHA02882 194 RGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA--GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK--IKIKNANKFIY 269 (294)
T ss_pred CCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCccccchHHHHHhHHHHHHHhhhhh--hccCCCCHHHH
Confidence 6889999999999999999999999999999999 89999987743 22221111 1111111111 11345678999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHH
Q psy5690 236 DLMLECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el~~~L 259 (434)
+++..||..+|++||+++++.+.|
T Consensus 270 ~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 270 DFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHhCCCCCCCCHHHHHHhh
Confidence 999999999999999999998765
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=265.81 Aligned_cols=207 Identities=17% Similarity=0.239 Sum_probs=182.9
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
-+.+.|.||++|..|.++..+|+.||-|-||.|...++ ..+.+....+..++..+++|++|||++|||+||||
T Consensus 475 ~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLr-------dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLK 547 (732)
T KOG0614|consen 475 MECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILR-------DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLK 547 (732)
T ss_pred HhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhh-------hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCC
Confidence 34578999999999999999999999999999999998 55678899999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|++++.+|.+||.|||+|+.+.... ...+.+||+
T Consensus 548 PENllLd~~Gy~KLVDFGFAKki~~g~--------------------------------------------KTwTFcGTp 583 (732)
T KOG0614|consen 548 PENLLLDNRGYLKLVDFGFAKKIGSGR--------------------------------------------KTWTFCGTP 583 (732)
T ss_pred hhheeeccCCceEEeehhhHHHhccCC--------------------------------------------ceeeecCCc
Confidence 999999999999999999998743322 236789999
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|.|||++.+...+.++|.||||+++|||+ +|.+||.+.++...+..+...+. ....|..++....+||++.
T Consensus 584 EYVAPEIILnKGHD~avDyWaLGIli~ELL--~G~pPFs~~dpmktYn~ILkGid------~i~~Pr~I~k~a~~Lik~L 655 (732)
T KOG0614|consen 584 EYVAPEIILNKGHDRAVDYWALGILIYELL--TGSPPFSGVDPMKTYNLILKGID------KIEFPRRITKTATDLIKKL 655 (732)
T ss_pred ccccchhhhccCcchhhHHHHHHHHHHHHH--cCCCCCCCCchHHHHHHHHhhhh------hhhcccccchhHHHHHHHH
Confidence 999999999999999999999999999999 89999999999988887765443 3445677788999999999
Q ss_pred ccCCCCCCCC-----HHHH--HHHHHhcccCCC
Q psy5690 242 WKTNETDRPR-----FSEI--HLFLQRKNLGAR 267 (434)
Q Consensus 242 l~~dP~~Rps-----~~el--~~~L~~~~~~~~ 267 (434)
...+|.+|.. +.+| |.||...++...
T Consensus 656 Cr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 656 CRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred HhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 9999999985 7778 999999876543
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=254.36 Aligned_cols=202 Identities=26% Similarity=0.397 Sum_probs=159.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|+||+++++++...+..++|+||+++++|.+++. ....+++..+..++.|++.||+|||+.|++|+||
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl 125 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLE-------HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHh-------hcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 357899999999999999999999999999999999997 3345788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.+||+|||++......... . ........++
T Consensus 126 ~~~nil~~~~~~~kl~d~g~~~~~~~~~~~-------------------------------------~--~~~~~~~~~~ 166 (264)
T cd06626 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTT-------------------------------------M--GEEVQSLAGT 166 (264)
T ss_pred CHHHEEECCCCCEEEcccccccccCCCCCc-------------------------------------c--cccccCCcCC
Confidence 999999999999999999987653221100 0 0001224567
Q ss_pred ccccchhhhhcCC---CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 161 IRWMAWESLLLGK---NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 161 ~~y~aPE~~~~~~---~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..|+|||.+.+.. ++.++||||||+++|+++ +|..||....... ....+. .......+....+++.+.+
T Consensus 167 ~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~--~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA--TGKRPWSELDNEFQIMFHVG-----AGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred cCccChhhccCCCCCCCCcccchHHHHHHHHHHH--hCCCCccCCcchHHHHHHHh-----cCCCCCCCcccccCHHHHH
Confidence 7899999998766 789999999999999999 8999997654322 211111 1112222223345889999
Q ss_pred HHHHhccCCCCCCCCHHHH
Q psy5690 237 LMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el 255 (434)
++.+||+.+|.+||++.++
T Consensus 240 li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 240 FLDRCLESDPKKRPTASEL 258 (264)
T ss_pred HHHHHccCCcccCCCHHHH
Confidence 9999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=269.63 Aligned_cols=202 Identities=20% Similarity=0.251 Sum_probs=160.7
Q ss_pred CCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCee
Q psy5690 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCM 86 (434)
Q Consensus 7 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIL 86 (434)
-|+|+++++|...+++|||+|.+.. +|+++++.. ....++...++.++.||+.||.+||+.||||+||||||||
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL~~-NLYellK~n-----~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENIL 321 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELLST-NLYELLKNN-----KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENIL 321 (586)
T ss_pred eeEEEeeeccccccceeeeehhhhh-hHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhhee
Confidence 4899999999999999999999965 999999854 3456999999999999999999999999999999999999
Q ss_pred eecC--CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 87 VGKN--YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 87 l~~~--~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
|.+. ..+|++|||.|+......+ ....+.-|.
T Consensus 322 L~~~~r~~vKVIDFGSSc~~~q~vy----------------------------------------------tYiQSRfYR 355 (586)
T KOG0667|consen 322 LKDPKRSRIKVIDFGSSCFESQRVY----------------------------------------------TYIQSRFYR 355 (586)
T ss_pred eccCCcCceeEEecccccccCCcce----------------------------------------------eeeeccccc
Confidence 9754 3799999999876333221 223345699
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhh------------------c-C-------
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQ------------------N-N------- 218 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~------------------~-~------- 218 (434)
|||++.+.+|+.+.||||||||+.||+ +|.+.|.+.+..+.+..+.+.+. . .
T Consensus 356 APEVILGlpY~~~IDmWSLGCIlAEL~--tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~ 433 (586)
T KOG0667|consen 356 APEVILGLPYDTAIDMWSLGCILAELF--TGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCV 433 (586)
T ss_pred cchhhccCCCCCccceeehhhhHHhHh--cCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeee
Confidence 999999999999999999999999999 88898998887766655442211 1 0
Q ss_pred --C------------------cccCCC-C--------CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 --S------------------KQQYLP-R--------PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 --~------------------~~~~~~-~--------~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
. .....| . ...-...+.+++++||.+||.+|+|+.+. |+|+...
T Consensus 434 ~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 434 ETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred eecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 0 000011 0 01223468999999999999999999998 8999854
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=254.05 Aligned_cols=198 Identities=19% Similarity=0.347 Sum_probs=160.6
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
.|||++++++++..++..++||||+++++|.++++ . ..+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~n 131 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK-------A-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAAN 131 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH-------c-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHH
Confidence 59999999999999999999999999999999986 2 268899999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
|+++.++.++|+|||++....... .......|+..|+
T Consensus 132 i~i~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~~~y~ 168 (277)
T cd06917 132 ILVTNTGNVKLCDFGVAALLNQNS-------------------------------------------SKRSTFVGTPYWM 168 (277)
T ss_pred EEEcCCCCEEEccCCceeecCCCc-------------------------------------------cccccccCCccee
Confidence 999999999999999865421111 0112335677899
Q ss_pred chhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCC-ccHHHHHHHHHHhc
Q psy5690 165 AWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA-TCQKEIFDLMLECW 242 (434)
Q Consensus 165 aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl 242 (434)
|||.+.++ .++.++|+|||||++|+|+ +|..||...........+.. ......+. .++.++.+++.+||
T Consensus 169 aPE~~~~~~~~~~~~Dv~slG~~l~~ll--~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l 239 (277)
T cd06917 169 APEVITEGKYYDTKADIWSLGITIYEMA--TGNPPYSDVDAFRAMMLIPK-------SKPPRLEDNGYSKLLREFVAACL 239 (277)
T ss_pred CHHHhccCCccccchhHHHHHHHHHHHH--hCCCCCCCCChhhhhhcccc-------CCCCCCCcccCCHHHHHHHHHHc
Confidence 99998754 4688999999999999999 89999987665444322211 11111122 36789999999999
Q ss_pred cCCCCCCCCHHHH--HHHHHhc
Q psy5690 243 KTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 243 ~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.||++||++.++ ++|+++.
T Consensus 240 ~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 240 DEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred CCCcccCcCHHHHhhChHhhcc
Confidence 9999999999999 7888764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=256.74 Aligned_cols=205 Identities=23% Similarity=0.340 Sum_probs=160.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDl 80 (434)
+.++||||+++++++..++..+++|||++ |+|.+++.... .....+++..++.++.||+.||+|||++ +++||||
T Consensus 55 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dl 130 (283)
T cd06617 55 RSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVY---DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDV 130 (283)
T ss_pred HHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhc---cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCC
Confidence 45789999999999999999999999996 69998886432 1335789999999999999999999997 9999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++..... .......++
T Consensus 131 kp~nil~~~~~~~kl~dfg~~~~~~~~--------------------------------------------~~~~~~~~~ 166 (283)
T cd06617 131 KPSNVLINRNGQVKLCDFGISGYLVDS--------------------------------------------VAKTIDAGC 166 (283)
T ss_pred CHHHEEECCCCCEEEeecccccccccc--------------------------------------------cccccccCC
Confidence 999999999999999999986542110 011223466
Q ss_pred ccccchhhhhc----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhhhhhhcCCcccCCCC-CCccHHHH
Q psy5690 161 IRWMAWESLLL----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQYLPR-PATCQKEI 234 (434)
Q Consensus 161 ~~y~aPE~~~~----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 234 (434)
..|+|||.+.+ ..++.++|+|||||++|+|+ +|..||..... .+....+. ....... ...+++++
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l 237 (283)
T cd06617 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELA--TGRFPYDSWKTPFQQLKQVV-------EEPSPQLPAEKFSPEF 237 (283)
T ss_pred ccccChhhcCCcccccccCccccchhhHHHHHHHH--hCCCCCCccccCHHHHHHHH-------hcCCCCCCccccCHHH
Confidence 78999998865 44688999999999999999 89999975432 12221111 1111111 23578899
Q ss_pred HHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 235 FDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+++.+||..+|++||+++++ |+|+++..
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 999999999999999999999 78998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=254.13 Aligned_cols=199 Identities=21% Similarity=0.348 Sum_probs=161.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|+||+++++.+..++..++|+||+++++|.+++... ....+++..+..++.|+++||.|||+.+++|+||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl 127 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-----RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDI 127 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Confidence 35789999999999999999999999999999999999732 2235789999999999999999999999999999
Q ss_pred CCCCeeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 81 AARNCMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 81 kp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
||+||++++++ .+||+|||.+....... .......|
T Consensus 128 ~~~nil~~~~~~~~~l~d~~~~~~~~~~~-------------------------------------------~~~~~~~~ 164 (257)
T cd08225 128 KSQNIFLSKNGMVAKLGDFGIARQLNDSM-------------------------------------------ELAYTCVG 164 (257)
T ss_pred CHHHEEEcCCCCeEEecccccchhccCCc-------------------------------------------ccccccCC
Confidence 99999998875 46999999865421110 00112346
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+..|+|||++.+..++.++|+||||+++||++ +|..||...+..+....+. .....+....++.++.+++.
T Consensus 165 ~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELC--TLKHPFEGNNLHQLVLKIC-------QGYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred CccccCHHHHcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCccHHHHHHHHh-------cccCCCCCCCCCHHHHHHHH
Confidence 77899999998888999999999999999999 8899998776555443322 11222334567789999999
Q ss_pred HhccCCCCCCCCHHHHH
Q psy5690 240 ECWKTNETDRPRFSEIH 256 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~ 256 (434)
+||..+|++||++.|++
T Consensus 236 ~~l~~~p~~Rpt~~~ll 252 (257)
T cd08225 236 QLFKVSPRDRPSITSIL 252 (257)
T ss_pred HHhccChhhCcCHHHHh
Confidence 99999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=257.27 Aligned_cols=209 Identities=21% Similarity=0.334 Sum_probs=158.1
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCC
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRDL 80 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDl 80 (434)
++ +||||+++++++..++..+++|||+.. ++.++..... ......+++..+..++.|++.||+|||+. +++||||
T Consensus 58 ~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dl 134 (288)
T cd06616 58 RSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVY--EVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDV 134 (288)
T ss_pred HhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCC
Confidence 45 499999999999999999999999864 6665543110 01235789999999999999999999975 9999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++...... ......++
T Consensus 135 kp~Nil~~~~~~~kl~dfg~~~~~~~~~--------------------------------------------~~~~~~~~ 170 (288)
T cd06616 135 KPSNILLDRNGNIKLCDFGISGQLVDSI--------------------------------------------AKTRDAGC 170 (288)
T ss_pred CHHHEEEccCCcEEEeecchhHHhccCC--------------------------------------------ccccccCc
Confidence 9999999999999999999875421110 11223467
Q ss_pred ccccchhhhhcC---CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLLLG---KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~~---~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||.+.+. .++.++|||||||++|+|+ +|..||..... ..+.+...............+..++.++.+|
T Consensus 171 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~--~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 246 (288)
T cd06616 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA--TGKFPYPKWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNF 246 (288)
T ss_pred cCccCHHHhccccccCCcchhhhhHHHHHHHHHH--hCCCCchhcch--HHHHHhhhcCCCCCcCCCcCCCccCHHHHHH
Confidence 789999999876 6899999999999999999 89999976542 2222221111111111111223578899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+||+.||++||++++| ++|+++.
T Consensus 247 i~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 247 INLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred HHHHccCChhhCcCHHHHhcChhhhch
Confidence 999999999999999999 7899764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=256.94 Aligned_cols=194 Identities=23% Similarity=0.298 Sum_probs=161.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+++..++|+||+.+++|.+++. ....+++..+..++.||++||.|||++|++|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl 126 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS-------QKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDI 126 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHH-------hcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 367899999999999999999999999999999999997 3357889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||++....... ......++
T Consensus 127 ~~~nil~~~~~~~~l~d~~~~~~~~~~~--------------------------------------------~~~~~~~~ 162 (258)
T cd05578 127 KPDNILLDEQGHVHITDFNIATKVTPDT--------------------------------------------LTTSTSGT 162 (258)
T ss_pred CHHHeEEcCCCCEEEeecccccccCCCc--------------------------------------------cccccCCC
Confidence 9999999999999999999865421110 11223466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh---HHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN---EQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||.+.+..++.++|+||||+++|+|+ +|..||..... ....... .......+..++.++.++
T Consensus 163 ~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECL--RGKRPYRGHSRTIRDQIRAKQ--------ETADVLYPATWSTEAIDA 232 (258)
T ss_pred hhhcCHHHHcccCCCCcccchhhHHHHHHHH--hCCCCCCCCCccHHHHHHHHh--------ccccccCcccCcHHHHHH
Confidence 7899999999888999999999999999999 89999987764 2222111 113334456778999999
Q ss_pred HHHhccCCCCCCCCH--HHH
Q psy5690 238 MLECWKTNETDRPRF--SEI 255 (434)
Q Consensus 238 i~~cl~~dP~~Rps~--~el 255 (434)
+.+||+.||.+||++ +|+
T Consensus 233 i~~~l~~~p~~R~~~~~~~l 252 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDL 252 (258)
T ss_pred HHHHccCChhHcCCccHHHH
Confidence 999999999999999 766
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=258.60 Aligned_cols=200 Identities=23% Similarity=0.362 Sum_probs=160.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++.++||||++++++|.+++..++|+||+. |+|.+++... ...+++..+..++.|++.||.|||+.|++||||
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~------~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl 141 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH------KKPLQEVEIAAICHGALQGLAYLHSHERIHRDI 141 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHc------ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Confidence 357899999999999999999999999997 5888877532 246899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||++++++.++|+|||++..... .....++
T Consensus 142 ~p~nIl~~~~~~~kL~dfg~~~~~~~-----------------------------------------------~~~~~~~ 174 (307)
T cd06607 142 KAGNILLTEPGTVKLADFGSASLVSP-----------------------------------------------ANSFVGT 174 (307)
T ss_pred CcccEEECCCCCEEEeecCcceecCC-----------------------------------------------CCCccCC
Confidence 99999999999999999998643110 1123456
Q ss_pred ccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||++. ...++.++||||||+++|||+ +|..||...........+.. .......+..++.++.++
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~--tg~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA--ERKPPLFNMNAMSALYHIAQ------NDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred ccccCceeeeccCCCCCCcccchHHHHHHHHHHH--cCCCCCCCccHHHHHHHHhc------CCCCCCCchhhCHHHHHH
Confidence 7799999874 356788999999999999999 89999987765554332211 111111133567899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+||+.||++||++.+| |+|+.+.
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcChhhccc
Confidence 999999999999999999 7787753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=258.00 Aligned_cols=207 Identities=17% Similarity=0.212 Sum_probs=160.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++..++..++|+||+ +++|.+++... ...+++..++.++.||++||+|||++|++|+|||
T Consensus 54 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 126 (286)
T cd07832 54 QACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE------ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLK 126 (286)
T ss_pred HhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcC
Confidence 5788999999999999999999999999 99999998632 2568999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||++....... ........++.
T Consensus 127 p~ni~~~~~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~~ 164 (286)
T cd07832 127 PANLLISADGVLKIADFGLARLFSEEE------------------------------------------PRLYSHQVATR 164 (286)
T ss_pred HHHEEEcCCCcEEEeeeeecccccCCC------------------------------------------CCccccccCcc
Confidence 999999999999999999865421110 00112345778
Q ss_pred cccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC--------------c---ccC
Q psy5690 162 RWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS--------------K---QQY 223 (434)
Q Consensus 162 ~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~---~~~ 223 (434)
.|+|||.+.+. .++.++||||+||++|||+ +|..+|...........+........ . ...
T Consensus 165 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~--tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd07832 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELL--NGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPES 242 (286)
T ss_pred cccCceeeeccccCCchhHHHHHHHHHHHHH--cCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCC
Confidence 89999998754 4589999999999999999 78888877665444333222111000 0 000
Q ss_pred -----CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHH
Q psy5690 224 -----LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFL 259 (434)
Q Consensus 224 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L 259 (434)
.......+.++.+++.+||+.||++||+++++ |+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 243 KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred CcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 00113456889999999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=261.82 Aligned_cols=208 Identities=18% Similarity=0.216 Sum_probs=159.1
Q ss_pred CCCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++||||+++++++... ...|+||||+. ++|.+.+. . .+++..+..++.|++.||+|||++|
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~--~l~~~~~~~~~~ql~~aL~~LH~~g 138 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ-------M--DLDHERMSYLLYQMLCGIKHLHSAG 138 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHh-------h--cCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3578999999999998644 35799999996 58988885 1 2888999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 139 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--------------------------------------------~~ 174 (353)
T cd07850 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--------------------------------------------MM 174 (353)
T ss_pred eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC--------------------------------------------CC
Confidence 9999999999999999999999999975421110 01
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhh-------------------h
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHW-------------------Y 215 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~-------------------~ 215 (434)
....++..|+|||.+.+..++.++|||||||++|+|+ +|..||...+.......+... .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (353)
T cd07850 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI--RGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV 252 (353)
T ss_pred CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH--HCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHh
Confidence 2234677899999999999999999999999999999 889999876543332222110 0
Q ss_pred hcCCccc------------C----CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 216 QNNSKQQ------------Y----LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 216 ~~~~~~~------------~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
....... . ...+...++++.+++.+||+.||++||++.|+ |+||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0000000 0 00012346778999999999999999999999 899986433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=253.59 Aligned_cols=182 Identities=20% Similarity=0.204 Sum_probs=149.2
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
..||||+++++++.+.+..++||||+++|+|.+++.+ ...+++..+..++.|+++||+|||++|++||||||+
T Consensus 42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~ 114 (237)
T cd05576 42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK-------FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPN 114 (237)
T ss_pred cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-------hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 4699999999999999999999999999999999973 235899999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
||+++.++.++++|||.+...... .....++..|
T Consensus 115 Nil~~~~~~~~l~df~~~~~~~~~----------------------------------------------~~~~~~~~~y 148 (237)
T cd05576 115 NILLDDRGHIQLTYFSRWSEVEDS----------------------------------------------CDGEAVENMY 148 (237)
T ss_pred HEEEcCCCCEEEecccchhccccc----------------------------------------------cccCCcCccc
Confidence 999999999999999975431110 0122334569
Q ss_pred cchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhcc
Q psy5690 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWK 243 (434)
Q Consensus 164 ~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 243 (434)
+|||.+....++.++|+||+|+++|||+ +|..|+........ .......+..+++.+++++.+||+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~--~g~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~l~ 214 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELL--TGKTLVECHPSGIN------------THTTLNIPEWVSEEARSLLQQLLQ 214 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHH--HCcchhhcCchhcc------------cccccCCcccCCHHHHHHHHHHcc
Confidence 9999998888899999999999999999 77877654321100 011123355678899999999999
Q ss_pred CCCCCCCCH
Q psy5690 244 TNETDRPRF 252 (434)
Q Consensus 244 ~dP~~Rps~ 252 (434)
.||++||++
T Consensus 215 ~dp~~R~~~ 223 (237)
T cd05576 215 FNPTERLGA 223 (237)
T ss_pred CCHHHhcCC
Confidence 999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=256.54 Aligned_cols=204 Identities=17% Similarity=0.264 Sum_probs=153.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+.+ +|.+++... ...+++..+..++.|+++||.|||++|++||||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl 129 (291)
T cd07844 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDC------GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDL 129 (291)
T ss_pred HhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccC
Confidence 4678999999999999999999999999975 999998632 246889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .......++
T Consensus 130 ~p~nil~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 166 (291)
T cd07844 130 KPQNLLISERGELKLADFGLARAKSVPS-------------------------------------------KTYSNEVVT 166 (291)
T ss_pred CHHHEEEcCCCCEEECccccccccCCCC-------------------------------------------ccccccccc
Confidence 9999999999999999999865411100 001122346
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC-hHHHHHhhhhhhhcC-----------------Ccc
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELT-NEQVIENCSHWYQNN-----------------SKQ 221 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~-~~~~~~~~~~~~~~~-----------------~~~ 221 (434)
..|+|||++.+ ..++.++||||+||++|+|+ +|..||.... ..+....+....... ...
T Consensus 167 ~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd07844 167 LWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA--TGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP 244 (291)
T ss_pred cccCCcHHhhcCcccCcHHHHHHHHHHHHHHH--hCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccccc
Confidence 77999999875 45789999999999999999 8899997654 222221111100000 000
Q ss_pred cCC-----CCCCccH--HHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 222 QYL-----PRPATCQ--KEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 222 ~~~-----~~~~~~~--~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
... ......+ .++.+++.+||+.+|++||++.|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred ccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 000 0001233 7888999999999999999999983
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=256.78 Aligned_cols=212 Identities=22% Similarity=0.285 Sum_probs=163.9
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++|+||+++++++... +..++||||+.+ +|.+++... ...+++..+..++.|++.||+|||+.|++||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~ 132 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM------PTPFSESQVKCLMLQLLRGLQYLHENFIIHR 132 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 3578999999999998755 568999999964 899988632 2568999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.+||+|||+++...... .......
T Consensus 133 dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-------------------------------------------~~~~~~~ 169 (309)
T cd07845 133 DLKVSNLLLTDKGCLKIADFGLARTYGLPA-------------------------------------------KPMTPKV 169 (309)
T ss_pred CCCHHHEEECCCCCEEECccceeeecCCcc-------------------------------------------CCCCccc
Confidence 999999999999999999999876521110 0011223
Q ss_pred CCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCccc-------------CC
Q psy5690 159 LPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ-------------YL 224 (434)
Q Consensus 159 gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------~~ 224 (434)
++..|+|||.+.+ ..++.++|||||||++|||+ +|..||...+..+....+........... ..
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~--~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (309)
T cd07845 170 VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL--AHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTL 247 (309)
T ss_pred ccccccChhhhcCCCCcCchHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccc
Confidence 4567999999875 45789999999999999999 89999988877666554443221100000 00
Q ss_pred C---------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 225 P---------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 225 ~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
+ .....++++.++|.+||+.||++|||++++ |+|+++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 248 PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 0 012247889999999999999999999999 899986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=258.49 Aligned_cols=205 Identities=19% Similarity=0.256 Sum_probs=157.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+. ++|.+++... ....+++..+..++.|++.||+|||++|++||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l 126 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS-----PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 467899999999999999999999999996 6899998632 2356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.+||+|||+++...... .......++
T Consensus 127 ~p~nill~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 163 (284)
T cd07860 127 KPQNLLINTEGAIKLADFGLARAFGVPV-------------------------------------------RTYTHEVVT 163 (284)
T ss_pred CHHHEEECCCCCEEEeeccchhhcccCc-------------------------------------------ccccccccc
Confidence 9999999999999999999865421110 001222356
Q ss_pred ccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC--------------------
Q psy5690 161 IRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS-------------------- 219 (434)
Q Consensus 161 ~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------- 219 (434)
..|+|||.+.+.. ++.++|||||||++|||+ +|..||...+.......+........
T Consensus 164 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd07860 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV--TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKW 241 (284)
T ss_pred ccccCCeEEecCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccc
Confidence 7799999887654 588999999999999999 88999987665443322221110000
Q ss_pred -cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 220 -KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 220 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
..........+++++++++.+||+.||++||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 242 ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred cccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 0000011234668899999999999999999999993
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=256.71 Aligned_cols=205 Identities=16% Similarity=0.192 Sum_probs=158.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++..++..++||||++++.+..+.. ....+++..+..++.||+.||.|||++|++|+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl 126 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA-------SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDI 126 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 357899999999999999999999999999877776664 3345899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||++++++.+||+|||++........ .......++
T Consensus 127 ~~~ni~~~~~~~~kl~d~g~~~~~~~~~~------------------------------------------~~~~~~~~~ 164 (288)
T cd07833 127 KPENILVSESGVLKLCDFGFARALRARPA------------------------------------------SPLTDYVAT 164 (288)
T ss_pred CHHHeEECCCCCEEEEeeecccccCCCcc------------------------------------------ccccCcccc
Confidence 99999999999999999998655221110 011223456
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC-------------cccCC--
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS-------------KQQYL-- 224 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------~~~~~-- 224 (434)
..|+|||++.+. .++.++||||||+++|+|+ +|..||......+............. .....
T Consensus 165 ~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07833 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELL--DGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242 (288)
T ss_pred cCCcCCchhcCCCCcCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCC
Confidence 779999999888 7899999999999999999 88999987655443322211110000 00000
Q ss_pred ---------CCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 225 ---------PRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 225 ---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
..+..+++++.+++.+||..+|++||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred CCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 11233578899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=256.48 Aligned_cols=203 Identities=22% Similarity=0.255 Sum_probs=157.2
Q ss_pred CCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
++++||||+++++++..+ +..++||||+.+ +|.+++... ...+++..+..++.||+.||+|||++|++|+|
T Consensus 59 ~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~d 131 (293)
T cd07843 59 LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETM------KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD 131 (293)
T ss_pred HhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 578999999999999877 889999999974 999998732 23689999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||+++.++.++|+|||+++...... .......+
T Consensus 132 l~p~nili~~~~~~~l~d~g~~~~~~~~~-------------------------------------------~~~~~~~~ 168 (293)
T cd07843 132 LKTSNLLLNNRGILKICDFGLAREYGSPL-------------------------------------------KPYTQLVV 168 (293)
T ss_pred CCHHHEEECCCCcEEEeecCceeeccCCc-------------------------------------------cccccccc
Confidence 99999999999999999999876522110 00122345
Q ss_pred CccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC--------------C-----
Q psy5690 160 PIRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN--------------S----- 219 (434)
Q Consensus 160 t~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~----- 219 (434)
+..|+|||.+.+.. ++.++||||||+++|+|+ +|..||......+....+....... .
T Consensus 169 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~--~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (293)
T cd07843 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL--TKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246 (293)
T ss_pred cccccCchhhcCCccccchhhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccc
Confidence 67799999987654 588999999999999999 8899998776655444332211000 0
Q ss_pred ----cccCCCCCCc-cHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 220 ----KQQYLPRPAT-CQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 220 ----~~~~~~~~~~-~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
.......+.. +++.+.+++.+||+.||++|||+.|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred cccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 0000111222 578899999999999999999999993
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=258.78 Aligned_cols=204 Identities=19% Similarity=0.242 Sum_probs=157.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++..++..++|+||+++++|..+.. ....+++..+..++.||+.||+|||+.|++|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l 126 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK-------YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDI 126 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 357899999999999999999999999999999988775 3345899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||++++++.++|+|||++....... .......++
T Consensus 127 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 163 (286)
T cd07846 127 KPENILVSQSGVVKLCDFGFARTLAAPG-------------------------------------------EVYTDYVAT 163 (286)
T ss_pred CHHHEEECCCCcEEEEeeeeeeeccCCc-------------------------------------------cccCcccce
Confidence 9999999999999999999865421110 011223456
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC-----------------c--
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS-----------------K-- 220 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------~-- 220 (434)
..|+|||++.+. .++.++||||||+++|||+ +|..||......+....+........ .
T Consensus 164 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd07846 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEML--TGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241 (286)
T ss_pred eeccCcHHhccccccCchHhHHHHHHHHHHHH--cCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccccc
Confidence 789999998753 4688999999999999999 88899976655443322221111000 0
Q ss_pred ----ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 221 ----QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 221 ----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
.........++..+.+++.+||+.+|++||++.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 281 (286)
T cd07846 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281 (286)
T ss_pred ccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence 000001235678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=259.26 Aligned_cols=224 Identities=17% Similarity=0.205 Sum_probs=167.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+. |+|.+++. ....+++..+..++.|++.||+|||++|++||||
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-------~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl 145 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVD-------RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDL 145 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 357899999999999999999999999996 59999996 3456899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++............... ............++
T Consensus 146 ~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~ 196 (335)
T PTZ00024 146 SPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE-----------------------------TMQRREEMTSKVVT 196 (335)
T ss_pred cHHHeEECCCCCEEECCccceeecccccccccccccc-----------------------------cccccccccccccc
Confidence 9999999999999999999976643222110000000 00000111223457
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc------------------
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ------------------ 221 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------ 221 (434)
..|+|||.+.+. .++.++|||||||++|||+ +|..||...+..+....+..........
T Consensus 197 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~--tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (335)
T PTZ00024 197 LWYRAPELLMGAEKYHFAVDMWSVGCIFAELL--TGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRK 274 (335)
T ss_pred cCCCCChhcccCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCC
Confidence 789999998764 4688999999999999999 7899998877665544433221111000
Q ss_pred --cCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 222 --QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 222 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
........+++++.+++.+||+.||++||+++|+ |+|++...
T Consensus 275 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 275 PKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred cccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 0000123456789999999999999999999999 88998653
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=252.23 Aligned_cols=202 Identities=24% Similarity=0.341 Sum_probs=175.9
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+-|.+++++.+|+.-+++|+||||+.||+|--.++ .-+.+.+..+..++.+|+-||-|||++|||.||||.+|
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ-------Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDN 480 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 480 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHH-------HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccc
Confidence 35788999999999999999999999999999998 44578899999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.+|++||+|||+++..... .....+.+||+.|+
T Consensus 481 vmLd~eGHiKi~DFGmcKEni~~-------------------------------------------~~TTkTFCGTPdYi 517 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKENIFD-------------------------------------------GVTTKTFCGTPDYI 517 (683)
T ss_pred eEeccCCceEeeecccccccccC-------------------------------------------CcceeeecCCCccc
Confidence 99999999999999997652111 11335679999999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 244 (434)
|||++...+|+..+|.||+||+||||+ .|+.||.+.+.+++++.+.+ .....|..+|.+..++.+..|..
T Consensus 518 APEIi~YqPYgksvDWWa~GVLLyEml--aGQpPFdGeDE~elF~aI~e--------hnvsyPKslSkEAv~ickg~ltK 587 (683)
T KOG0696|consen 518 APEIIAYQPYGKSVDWWAFGVLLYEML--AGQPPFDGEDEDELFQAIME--------HNVSYPKSLSKEAVAICKGLLTK 587 (683)
T ss_pred ccceEEecccccchhHHHHHHHHHHHH--cCCCCCCCCCHHHHHHHHHH--------ccCcCcccccHHHHHHHHHHhhc
Confidence 999999999999999999999999999 99999999999999988764 23445788899999999999999
Q ss_pred CCCCCCCH-----HHH--HHHHHhcccCC
Q psy5690 245 NETDRPRF-----SEI--HLFLQRKNLGA 266 (434)
Q Consensus 245 dP~~Rps~-----~el--~~~L~~~~~~~ 266 (434)
.|.+|... .+| |+|++...+..
T Consensus 588 ~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 588 HPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred CCccccCCCCccccchhhCcchhhccHHH
Confidence 99999743 345 88888876543
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=263.16 Aligned_cols=248 Identities=17% Similarity=0.242 Sum_probs=181.9
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
.-+.+.||+||-.|.+.+.+|+||||++||++-.+|- ..+.|.+..++.++.++.+|+++.|..|+|||||||
T Consensus 685 EADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI-------rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKP 757 (1034)
T KOG0608|consen 685 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-------RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKP 757 (1034)
T ss_pred hcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH-------HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCc
Confidence 4467899999999999999999999999999999997 446899999999999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCccccccc---ccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYE---SDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
+|||||.+|++||.|||+|.-+.. +.++......+...-....+.......++.... ...........-..+|
T Consensus 758 DNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~----ra~~~h~r~~ahslvg 833 (1034)
T KOG0608|consen 758 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLER----RAMRQHQRILAHSLVG 833 (1034)
T ss_pred cceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHH----HHHhhhhhhhhhhhcC
Confidence 999999999999999999877654 233332222211100000000000000000000 0001111122345679
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|..|+|||++....|+..+|.||.||+||||+ .|+.||......+...++.+| ......+....++++..++|.
T Consensus 834 t~nyiapevl~r~g~~q~cdwws~gvil~em~--~g~~pf~~~tp~~tq~kv~nw----~~~l~~~~~~~ls~e~~~li~ 907 (1034)
T KOG0608|consen 834 TPNYIAPEVLARTGYTQLCDWWSVGVILYEML--VGQPPFLADTPGETQYKVINW----RNFLHIPYQGNLSKEALDLIQ 907 (1034)
T ss_pred CCcccChHHhcccCccccchhhHhhHHHHHHh--hCCCCccCCCCCcceeeeeeh----hhccccccccccCHHHHHHHH
Confidence 99999999999999999999999999999999 899999988877766655543 333445556788999999997
Q ss_pred HhccCCCCCCC---CHHHH--HHHHHhcccCCCc
Q psy5690 240 ECWKTNETDRP---RFSEI--HLFLQRKNLGARA 268 (434)
Q Consensus 240 ~cl~~dP~~Rp---s~~el--~~~L~~~~~~~~~ 268 (434)
++.. ++++|. .+++| |+||+.+......
T Consensus 908 kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslR 940 (1034)
T KOG0608|consen 908 KLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLR 940 (1034)
T ss_pred HHhc-ChhhhhcccchhhhhcCccccccchHhhh
Confidence 7553 577887 46678 9999987665433
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-32 Score=248.95 Aligned_cols=200 Identities=26% Similarity=0.378 Sum_probs=163.3
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
+++++||||+++++.+... +..++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~ 125 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125 (260)
T ss_pred HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 3578999999999999888 889999999999999999973 3378999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||+|+||+++.++.++|+|||.+........ ........
T Consensus 126 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----------------------------------------~~~~~~~~ 164 (260)
T cd06606 126 DIKGANILVDSDGVVKLADFGCAKRLGDIET-----------------------------------------GEGTGSVR 164 (260)
T ss_pred CCCHHHEEEcCCCCEEEcccccEEecccccc-----------------------------------------cccccCCC
Confidence 9999999999999999999998655322110 00112345
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
++..|+|||.+.....+.++||||||+++|+|+ +|..||...... .....+ .........+...+..+.++
T Consensus 165 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA--TGKPPWSELGNPMAALYKI------GSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred CCccccCHhhhcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCchHHHHHhc------cccCCCcCCCcccCHHHHHH
Confidence 667899999999888999999999999999999 889999877622 221111 11223344456678999999
Q ss_pred HHHhccCCCCCCCCHHHHH
Q psy5690 238 MLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~ 256 (434)
+.+||+.||++||++.+++
T Consensus 237 i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 237 LRKCLRRDPKKRPTADELL 255 (260)
T ss_pred HHHhCcCChhhCCCHHHHh
Confidence 9999999999999999993
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=252.29 Aligned_cols=199 Identities=24% Similarity=0.318 Sum_probs=161.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+.+..++|+||+++++|.+++.... .....+++..++.++.|++.||.|||++|++|+|||
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~ 133 (260)
T cd08222 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELK---HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLK 133 (260)
T ss_pred HhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHh---hcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Confidence 57899999999999999999999999999999999987432 134578999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++. +.++|+|||+++...... .......++.
T Consensus 134 ~~nili~~-~~~~l~d~g~~~~~~~~~-------------------------------------------~~~~~~~~~~ 169 (260)
T cd08222 134 AKNIFLKN-NLLKIGDFGVSRLLMGSC-------------------------------------------DLATTFTGTP 169 (260)
T ss_pred hhheEeec-CCEeecccCceeecCCCc-------------------------------------------ccccCCCCCc
Confidence 99999975 569999999865421110 0112234567
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||.+.+..++.++|+||||+++|+|+ +|..||......+....+. .......+..++.++.++|.+|
T Consensus 170 ~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~--~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~ 240 (260)
T cd08222 170 YYMSPEALKHQGYDSKSDIWSLGCILYEMC--CLAHAFEGQNFLSVVLRIV-------EGPTPSLPETYSRQLNSIMQSM 240 (260)
T ss_pred CccCHHHHccCCCCchhhHHHHHHHHHHHH--hCCCCCCCccHHHHHHHHH-------cCCCCCCcchhcHHHHHHHHHH
Confidence 899999998888899999999999999999 8899997665544443321 1223333557788999999999
Q ss_pred ccCCCCCCCCHHHHH
Q psy5690 242 WKTNETDRPRFSEIH 256 (434)
Q Consensus 242 l~~dP~~Rps~~el~ 256 (434)
|..||++||++.|++
T Consensus 241 l~~~p~~Rp~~~~il 255 (260)
T cd08222 241 LNKDPSLRPSAAEIL 255 (260)
T ss_pred hcCChhhCcCHHHHh
Confidence 999999999999993
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=254.08 Aligned_cols=199 Identities=22% Similarity=0.365 Sum_probs=159.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||++++++++.+++..++||||+. |+|.+++... ...+++..+..++.|++.||.|||++||+||||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL 151 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH------KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 151 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 357899999999999999999999999996 4888877532 345899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||++..... .....++
T Consensus 152 ~p~Nil~~~~~~~kl~dfg~~~~~~~-----------------------------------------------~~~~~~~ 184 (317)
T cd06635 152 KAGNILLTEPGQVKLADFGSASIASP-----------------------------------------------ANSFVGT 184 (317)
T ss_pred CcccEEECCCCCEEEecCCCccccCC-----------------------------------------------cccccCC
Confidence 99999999999999999998543110 1223466
Q ss_pred ccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||.+. .+.++.++|||||||++|||+ +|..||...........+.. ..........+++.+.++
T Consensus 185 ~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA--ERKPPLFNMNAMSALYHIAQ------NESPTLQSNEWSDYFRNF 256 (317)
T ss_pred ccccChhhhhcCCCCCCCccccHHHHHHHHHHHH--hCCCCCCCccHHHHHHHHHh------ccCCCCCCccccHHHHHH
Confidence 7899999984 456789999999999999999 88999987765554433321 111222244577899999
Q ss_pred HHHhccCCCCCCCCHHHHH--HHHHh
Q psy5690 238 MLECWKTNETDRPRFSEIH--LFLQR 261 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~--~~L~~ 261 (434)
+.+||+.+|.+||++.+++ .|+..
T Consensus 257 i~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 257 VDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHccCCcccCcCHHHHHhChhhhc
Confidence 9999999999999999994 55543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=251.35 Aligned_cols=203 Identities=23% Similarity=0.298 Sum_probs=158.2
Q ss_pred CCCCCCCeeeEEEEEecCCc-----eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCSTEDP-----ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++++||||+++++++...+. .+++|||+.+ +|.+++.... ...+++..+..++.|++.||.|||+.+++
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~~i~ 129 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCP-----KPGLPPETIKDLMRQLLRGVDFLHSHRIV 129 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHcc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 45689999999999988776 9999999974 8999887432 23589999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
|+||+|+||+++.++.+||+|||++....... ....
T Consensus 130 h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~--------------------------------------------~~~~ 165 (287)
T cd07838 130 HRDLKPQNILVTSDGQVKIADFGLARIYSFEM--------------------------------------------ALTS 165 (287)
T ss_pred eccCChhhEEEccCCCEEEeccCcceeccCCc--------------------------------------------cccc
Confidence 99999999999999999999999865421110 0112
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc--------------c
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ--------------Q 222 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~ 222 (434)
..++..|+|||.+.+..++.++|+|||||++|||+ +|..||......+....+.......... .
T Consensus 166 ~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T cd07838 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF--RRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPS 243 (287)
T ss_pred ccccccccChHHhccCCCCCcchhhhHHHHHHHHH--hCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhccc
Confidence 23567899999999999999999999999999999 7899998877666554443211110000 0
Q ss_pred C-----CCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 223 Y-----LPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 223 ~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
. .......++.+.+++.+||+.||++||++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 244 YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 0 000123457789999999999999999999993
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=247.44 Aligned_cols=197 Identities=25% Similarity=0.455 Sum_probs=163.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|||++++++++.+++..+++|||+++++|.+++. ....+++..+..++.|++.||.|||++|++||||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 125 (254)
T cd06627 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK-------KFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDI 125 (254)
T ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCC
Confidence 357899999999999999999999999999999999997 3357899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++....... .......++
T Consensus 126 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~-------------------------------------------~~~~~~~~~ 162 (254)
T cd06627 126 KAANILTTKDGVVKLADFGVATKLNDVS-------------------------------------------KDDASVVGT 162 (254)
T ss_pred CHHHEEECCCCCEEEeccccceecCCCc-------------------------------------------ccccccccc
Confidence 9999999999999999999875521111 001233466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++||||+|+++|+|+ +|..||............. .......+..+++.+.+++.+
T Consensus 163 ~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~--~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELL--TGNPPYYDLNPMAALFRIV-------QDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred hhhcCHhhhcCCCCCcchhHHHHHHHHHHHH--hCCCCCCCccHHHHHHHHh-------ccCCCCCCCCCCHHHHHHHHH
Confidence 7899999998888899999999999999999 8899998766544332221 122334456778999999999
Q ss_pred hccCCCCCCCCHHHHH
Q psy5690 241 CWKTNETDRPRFSEIH 256 (434)
Q Consensus 241 cl~~dP~~Rps~~el~ 256 (434)
||..+|++||++.+++
T Consensus 234 ~l~~~p~~R~~~~~~l 249 (254)
T cd06627 234 CFQKDPNLRPTAKQLL 249 (254)
T ss_pred HHhCChhhCcCHHHHh
Confidence 9999999999999983
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=261.04 Aligned_cols=215 Identities=20% Similarity=0.296 Sum_probs=161.6
Q ss_pred CCCCCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
|++++||||+++++++.. ....++||||+. |+|.+++. ....+++..+..++.||+.||.|||++||+
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 129 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIH-------SDQPLTEEHIRYFLYQLLRGLKYIHSANVI 129 (334)
T ss_pred HHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhc-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 467899999999998853 346899999995 69999986 345689999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+||+++.++.+||+|||+++....... ........
T Consensus 130 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---------------------------------------~~~~~~~~ 170 (334)
T cd07855 130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT---------------------------------------EHKYFMTE 170 (334)
T ss_pred cCCCCHHHEEEcCCCcEEecccccceeecccCc---------------------------------------CCCccccc
Confidence 999999999999999999999998754211100 00001123
Q ss_pred CCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhh--------------------hh
Q psy5690 157 ARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSH--------------------WY 215 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~--------------------~~ 215 (434)
..++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.+.+.......+.. ..
T Consensus 171 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~--~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~ 248 (334)
T cd07855 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML--GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYI 248 (334)
T ss_pred ccccccccChHHhcCCcccccccchHHHHHHHHHHH--cCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHH
Confidence 456788999999866 45789999999999999999 89999987654332221111 00
Q ss_pred hcCCcccCCC---CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 216 QNNSKQQYLP---RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 216 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
.........+ .....++++.+++.+||+.||++||+++++ |+|+++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 249 QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 0000000000 113457899999999999999999999998 899987543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=253.36 Aligned_cols=201 Identities=17% Similarity=0.215 Sum_probs=154.4
Q ss_pred CCC-CCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 2 CSL-KDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
+++ +|+||+++++++.++ +..++||||+. |+|.+++... ...+++..+..++.|++.||+|||+.|++||
T Consensus 52 ~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~ 124 (282)
T cd07831 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGR------KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR 124 (282)
T ss_pred hhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 345 499999999999887 88999999997 5888888632 2468999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++. +.+||+|||+++...... ......
T Consensus 125 dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--------------------------------------------~~~~~~ 159 (282)
T cd07831 125 DIKPENILIKD-DILKLADFGSCRGIYSKP--------------------------------------------PYTEYI 159 (282)
T ss_pred ccCHHHEEEcC-CCeEEEecccccccccCC--------------------------------------------CcCCCC
Confidence 99999999999 999999999875421110 001234
Q ss_pred CCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC----------cccCC---
Q psy5690 159 LPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS----------KQQYL--- 224 (434)
Q Consensus 159 gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~----------~~~~~--- 224 (434)
++..|+|||.+.. ..++.++|||||||++|||+ +|..||...+..+....+........ .....
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL--SLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCcccCChhHhhcCCCCCcchhHHHHHHHHHHHH--cCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 5678999998754 45688999999999999999 88999988766554433322111000 00000
Q ss_pred --------CCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 225 --------PRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 225 --------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
.....++.++.+++.+||+.||++||++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 277 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence 01124678999999999999999999999993
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=254.40 Aligned_cols=199 Identities=22% Similarity=0.351 Sum_probs=159.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+|++++++++..++..++||||+. |+|.+++.. ....+++..+..++.|++.||.|||+++++||||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl 141 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV------HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 357899999999999999999999999996 588887753 2345889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||++..... .....++
T Consensus 142 ~p~nil~~~~~~~kl~dfg~~~~~~~-----------------------------------------------~~~~~~~ 174 (308)
T cd06634 142 KAGNILLSEPGLVKLGDFGSASIMAP-----------------------------------------------ANXFVGT 174 (308)
T ss_pred CHHhEEECCCCcEEECCcccceeecC-----------------------------------------------cccccCC
Confidence 99999999999999999998643110 1223456
Q ss_pred ccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||.+. ...++.++|||||||++|+|+ +|..||......+....+.. ..........++..+.++
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA--ERKPPLFNMNAMSALYHIAQ------NESPALQSGHWSEYFRNF 246 (308)
T ss_pred ccccCHHHHhhcccCCCCcccchHHHHHHHHHHH--cCCCCCccccHHHHHHHHhh------cCCCCcCcccccHHHHHH
Confidence 7899999985 345788999999999999999 88999987665444332221 111111234677899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
|.+||+.+|++||+++++ ++|+..
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCccccc
Confidence 999999999999999999 566655
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=245.79 Aligned_cols=199 Identities=23% Similarity=0.424 Sum_probs=162.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|+||+++++++..++..++++||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl 124 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST------NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDI 124 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCC
Confidence 35788999999999999999999999999999999999732 257899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||++++++.++|+|||.+....... ......++
T Consensus 125 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~--------------------------------------------~~~~~~~~ 160 (253)
T cd05122 125 KAANILLTSDGEVKLIDFGLSAQLSDTK--------------------------------------------ARNTMVGT 160 (253)
T ss_pred CHHHEEEccCCeEEEeeccccccccccc--------------------------------------------cccceecC
Confidence 9999999999999999999865421110 01233466
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+....++.++|+||||+++|+|+ +|..||...+..+....... ......+....++..+.+++.+
T Consensus 161 ~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 161 PYWMAPEVINGKPYDYKADIWSLGITAIELA--EGKPPYSELPPMKALFKIAT-----NGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred CcccCHHHHcCCCCCccccHHHHHHHHHHHH--hCCCCCCCCchHHHHHHHHh-----cCCCCcCcccccCHHHHHHHHH
Confidence 7899999999888899999999999999999 88999987754444332211 1111222233347899999999
Q ss_pred hccCCCCCCCCHHHHH
Q psy5690 241 CWKTNETDRPRFSEIH 256 (434)
Q Consensus 241 cl~~dP~~Rps~~el~ 256 (434)
||+.||++|||+.+++
T Consensus 234 ~l~~~p~~R~t~~~~l 249 (253)
T cd05122 234 CLQKNPEKRPTAEQLL 249 (253)
T ss_pred HccCChhhCCCHHHHh
Confidence 9999999999999984
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=255.60 Aligned_cols=204 Identities=17% Similarity=0.238 Sum_probs=157.3
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++|||++++++++.+++..+++|||++ ++|.+++... ....+++..+..++.|+++||+|||+++++||||+
T Consensus 53 ~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~ 126 (283)
T cd07835 53 KELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS-----PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLK 126 (283)
T ss_pred HhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 56899999999999999999999999995 6999998732 12468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||+++...... .......++.
T Consensus 127 p~nil~~~~~~~~l~df~~~~~~~~~~-------------------------------------------~~~~~~~~~~ 163 (283)
T cd07835 127 PQNLLIDREGALKLADFGLARAFGVPV-------------------------------------------RTYTHEVVTL 163 (283)
T ss_pred HHHEEEcCCCcEEEeecccccccCCCc-------------------------------------------cccCcccccc
Confidence 999999999999999999865421100 0012223467
Q ss_pred cccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc---------------------CC
Q psy5690 162 RWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN---------------------NS 219 (434)
Q Consensus 162 ~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~---------------------~~ 219 (434)
.|+|||++.+. .++.++||||||+++|+|+ +|..||...+.......+...... ..
T Consensus 164 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd07835 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMV--NRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWA 241 (283)
T ss_pred CCCCCceeecCcccCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccccc
Confidence 89999988764 4688999999999999999 889999876654433222111000 00
Q ss_pred cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 220 KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 220 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
..........++.++.+++.+||+.||++||+++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 242 RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 0011111345668899999999999999999999993
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=269.60 Aligned_cols=208 Identities=35% Similarity=0.642 Sum_probs=180.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|.+|+|||+++++|+|.... +.||++|+++|+|.+|++.++ ..+..+..+.|..||++||.|||+++++||||
T Consensus 752 masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr------~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdL 824 (1177)
T KOG1025|consen 752 MASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR------DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDL 824 (1177)
T ss_pred HhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhh------ccccHHHHHHHHHHHHHHHHHHHhcchhhhhh
Confidence 67899999999999997765 889999999999999998543 57888999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
..+|||+.....+|+.|||+++....... .........+
T Consensus 825 aaRNVLVksP~hvkitdfgla~ll~~d~~-----------------------------------------ey~~~~gK~p 863 (1177)
T KOG1025|consen 825 AARNVLVKSPNHVKITDFGLAKLLAPDEK-----------------------------------------EYSAPGGKVP 863 (1177)
T ss_pred hhhheeecCCCeEEEEecchhhccCcccc-----------------------------------------cccccccccC
Confidence 99999999999999999999877432221 1122334456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||-|.+....|+.++|||||||++||++| .|..||.+.+.+++...+. .+.+++.|+.|+-+++.+|.+
T Consensus 864 ikwmale~i~~~~~thqSDVWsfGVtiWElmT-FGa~Py~gi~~~eI~dlle-------~geRLsqPpiCtiDVy~~mvk 935 (1177)
T KOG1025|consen 864 IKWMALESIRIRKYTHQSDVWSFGVTIWELMT-FGAKPYDGIPAEEIPDLLE-------KGERLSQPPICTIDVYMVMVK 935 (1177)
T ss_pred cHHHHHHHhhccCCCchhhhhhhhhhHHHHHh-cCCCccCCCCHHHhhHHHh-------ccccCCCCCCccHHHHHHHHH
Confidence 78999999999999999999999999999998 6999999999888765443 556688899999999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhccc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
||..|+..||+++++...|.+...
T Consensus 936 Cwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 936 CWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HhccCcccCccHHHHHHHHHHHhc
Confidence 999999999999999777766543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=251.00 Aligned_cols=211 Identities=18% Similarity=0.216 Sum_probs=159.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+++..++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++++||||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl 128 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS-----PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDL 128 (294)
T ss_pred HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC-----CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 357899999999999999999999999996 5888888632 2234678888999999999999999999999999
Q ss_pred CCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 81 AARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 81 kp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
+|+||+++. ++.+||+|||++....... .......+
T Consensus 129 ~p~nill~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~ 165 (294)
T PLN00009 129 KPQNLLIDRRTNALKLADFGLARAFGIPV-------------------------------------------RTFTHEVV 165 (294)
T ss_pred CcceEEEECCCCEEEEcccccccccCCCc-------------------------------------------cccccCce
Confidence 999999985 5578999999875421100 00122345
Q ss_pred CccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc---------------ccC
Q psy5690 160 PIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK---------------QQY 223 (434)
Q Consensus 160 t~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~~~ 223 (434)
+..|+|||.+.+. .++.++||||+||++|+|+ +|..||......+...++......... ...
T Consensus 166 ~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~--tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T PLN00009 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV--NQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPK 243 (294)
T ss_pred eecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhccc
Confidence 6789999998764 5688999999999999999 889999876655443332111100000 000
Q ss_pred -C-----CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 224 -L-----PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 224 -~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
. ......++++.+++.+||+.+|++||++.++ ++||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 244 WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred CCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0123467889999999999999999999999 7888875
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=247.60 Aligned_cols=199 Identities=21% Similarity=0.323 Sum_probs=165.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++|+||+++++++.++...++|+||+++++|.+++.... .....+++..++.++.|++.||+|||+.|++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l 129 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRK---KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDL 129 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCC
Confidence 367899999999999999999999999999999999987532 12356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.+||+|||++...... ......++
T Consensus 130 ~~~ni~~~~~~~~kl~d~g~~~~~~~~---------------------------------------------~~~~~~~~ 164 (256)
T cd08530 130 KSANILLVANDLVKIGDLGISKVLKKN---------------------------------------------MAKTQIGT 164 (256)
T ss_pred CcceEEEecCCcEEEeeccchhhhccC---------------------------------------------CcccccCC
Confidence 999999999999999999986542111 01123456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++|+||||+++|+|+ +|..||...+..+....+. .....+.+..++.++.+++.+
T Consensus 165 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~--~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA--TFAPPFEARSMQDLRYKVQ-------RGKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred ccccCHHHHCCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHh-------cCCCCCCchhhCHHHHHHHHH
Confidence 7799999999988999999999999999999 8999998887665544332 222333445678899999999
Q ss_pred hccCCCCCCCCHHHHH
Q psy5690 241 CWKTNETDRPRFSEIH 256 (434)
Q Consensus 241 cl~~dP~~Rps~~el~ 256 (434)
||+.+|++||++.+++
T Consensus 236 ~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 236 MLQVKPKLRPNCDKIL 251 (256)
T ss_pred HcCCCcccCCCHHHHh
Confidence 9999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=242.00 Aligned_cols=213 Identities=30% Similarity=0.565 Sum_probs=180.3
Q ss_pred CCCCCCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 2 CSLKDPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCN-SQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
..+.|||+.++.+++.+ ....++++.+..-|+|..+++.+++. ......++..+...++.|++.|++|||++||||.|
T Consensus 342 y~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkD 421 (563)
T KOG1024|consen 342 YGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKD 421 (563)
T ss_pred hcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccch
Confidence 45789999999999854 46788899999999999999865532 22345677888999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|..+|+++|+..++||+|-.++|.....++..-. .....
T Consensus 422 iAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLG-----------------------------------------DnEnR 460 (563)
T KOG1024|consen 422 IAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLG-----------------------------------------DNENR 460 (563)
T ss_pred hhhhcceehhheeEEeccchhccccCcccccccC-----------------------------------------CCCCC
Confidence 9999999999999999999998876555543211 22234
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+..||+||.+....|+.++|+|||||++|||+| .|+.||.+.+..++...++ .+.+...|-+||+++..+|.
T Consensus 461 PvkWMslEal~n~~yssasDvWsfGVllWELmt-lg~~PyaeIDPfEm~~ylk-------dGyRlaQP~NCPDeLf~vMa 532 (563)
T KOG1024|consen 461 PVKWMSLEALQNSHYSSASDVWSFGVLLWELMT-LGKLPYAEIDPFEMEHYLK-------DGYRLAQPFNCPDELFTVMA 532 (563)
T ss_pred cccccCHHHHhhhhhcchhhhHHHHHHHHHHHh-cCCCCccccCHHHHHHHHh-------ccceecCCCCCcHHHHHHHH
Confidence 577999999999999999999999999999998 6999999999998876554 45677789999999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
-||+.+|++||+++++..-|.+..
T Consensus 533 cCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 533 CCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHhcCcccCCCHHHHHHHHHHHH
Confidence 999999999999999977776643
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=254.82 Aligned_cols=207 Identities=20% Similarity=0.274 Sum_probs=153.8
Q ss_pred CCCCCCCCeeeEEEEEecCC--------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 1 MCSLKDPNLVRVIGVCSTED--------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
|++++||||+++++++...+ ..++||||+.+ +|.+++.. ....+++..++.++.||+.||+|||+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~------~~~~~~~~~~~~i~~qi~~al~~lH~ 137 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN------KNVKFTLSEIKKVMKMLLNGLYYIHR 137 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36789999999999987654 35999999964 89888862 23468999999999999999999999
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
+|++|+||||+||+++.++.+||+|||++......... ...
T Consensus 138 ~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---------------------------------------~~~ 178 (310)
T cd07865 138 NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS---------------------------------------KPN 178 (310)
T ss_pred CCeeccCCCHHHEEECCCCcEEECcCCCcccccCCccc---------------------------------------CCC
Confidence 99999999999999999999999999997653221100 000
Q ss_pred cCCCCCCCccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCccc---------
Q psy5690 153 SDTKARLPIRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ--------- 222 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 222 (434)
......++..|+|||.+.+.. ++.++||||||+++|||+ +|..||...........+...........
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~--t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (310)
T cd07865 179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW--TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLEL 256 (310)
T ss_pred CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhh
Confidence 112334677899999987653 688999999999999999 78999987765544333222111000000
Q ss_pred ----CCC-----------CCCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 223 ----YLP-----------RPATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 223 ----~~~-----------~~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
..+ .+...+..+.++|.+||..||++||+++|+
T Consensus 257 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~ 304 (310)
T cd07865 257 FKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304 (310)
T ss_pred hhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 000 011134677899999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=247.29 Aligned_cols=200 Identities=22% Similarity=0.321 Sum_probs=166.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++|||++++++.+..++..++|+||+++++|.+++.... .....+++..+..++.|++.||.|||++|++|+||+
T Consensus 54 ~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~ 130 (258)
T cd08215 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK---KEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK 130 (258)
T ss_pred HhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhh---ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCC
Confidence 56889999999999999999999999999999999997432 123678999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||.+....... .......++.
T Consensus 131 ~~nil~~~~~~~~l~d~~~~~~~~~~~-------------------------------------------~~~~~~~~~~ 167 (258)
T cd08215 131 PQNIFLTSNGLVKLGDFGISKVLSSTV-------------------------------------------DLAKTVVGTP 167 (258)
T ss_pred hHHeEEcCCCcEEECCccceeecccCc-------------------------------------------ceecceeeee
Confidence 999999999999999999865421110 0112234667
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||.+.+..++.++|+||+|+++|+|+ +|..||......+...... .....+.+..++.++.+++.+|
T Consensus 168 ~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~--~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELC--TLKHPFEGENLLELALKIL-------KGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred cccChhHhccCCCCccccHHHHHHHHHHHH--cCCCCCCCCcHHHHHHHHh-------cCCCCCCCCCCCHHHHHHHHHH
Confidence 899999999888999999999999999999 8999998877655544332 1223344557889999999999
Q ss_pred ccCCCCCCCCHHHHH
Q psy5690 242 WKTNETDRPRFSEIH 256 (434)
Q Consensus 242 l~~dP~~Rps~~el~ 256 (434)
|..+|++||++.+++
T Consensus 239 l~~~p~~Rp~~~~ll 253 (258)
T cd08215 239 LQKDPEERPSIAQIL 253 (258)
T ss_pred cCCChhhCcCHHHHh
Confidence 999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=259.42 Aligned_cols=209 Identities=19% Similarity=0.248 Sum_probs=160.2
Q ss_pred CCCCCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
+.++|+||+++++++... ...++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+++++
T Consensus 59 ~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~ 130 (337)
T cd07858 59 RHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR-------SSQTLSDDHCQYFLYQLLRGLKYIHSANVL 130 (337)
T ss_pred HhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 568999999999988654 34899999995 69999986 345799999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+||+++.++.+||+|||+++...... .....
T Consensus 131 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-------------------------------------------~~~~~ 167 (337)
T cd07858 131 HRDLKPSNLLLNANCDLKICDFGLARTTSEKG-------------------------------------------DFMTE 167 (337)
T ss_pred cCCCCHHHEEEcCCCCEEECcCccccccCCCc-------------------------------------------ccccc
Confidence 99999999999999999999999875421110 00122
Q ss_pred CCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc------------------
Q psy5690 157 ARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN------------------ 217 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~------------------ 217 (434)
..++..|+|||.+.. ..++.++|||||||++|+|+ +|..||.+.+.......+......
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (337)
T cd07858 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL--GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYI 245 (337)
T ss_pred cccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH--cCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHH
Confidence 345678999999875 46889999999999999999 899999776543322222111000
Q ss_pred --CCcccC---CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 218 --NSKQQY---LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 218 --~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
...... ......+++++.+++.+||+.||++||+++++ |+|++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 246 RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000 01123577889999999999999999999999 88998753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=252.96 Aligned_cols=210 Identities=20% Similarity=0.228 Sum_probs=157.1
Q ss_pred CCC-CCCCeeeEEEEEecCCc-----eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDP-----ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
+++ +||||+++++++...+. .++||||+++ +|.+++...... ....+++..++.++.||++||.|||++|+
T Consensus 55 ~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 131 (295)
T cd07837 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKHGV 131 (295)
T ss_pred HHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 345 46999999999977665 8999999985 899988643211 13468999999999999999999999999
Q ss_pred cccCCCCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 76 VHRDLAARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 76 iHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
+||||||+||+++. ++.+||+|||+++...... ...
T Consensus 132 ~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~ 168 (295)
T cd07837 132 MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-------------------------------------------KSY 168 (295)
T ss_pred eecCCChHHEEEecCCCeEEEeecccceecCCCc-------------------------------------------ccc
Confidence 99999999999998 8899999999865421100 001
Q ss_pred CCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc------------
Q psy5690 155 TKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ------------ 221 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 221 (434)
....+++.|+|||++.+ ..++.++||||||+++|+|+ +|..||...+..+....+..........
T Consensus 169 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T cd07837 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH 246 (295)
T ss_pred CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHH--cCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchh
Confidence 12235677999998865 45689999999999999999 8899998776555443322211100000
Q ss_pred --------cCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHH
Q psy5690 222 --------QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFL 259 (434)
Q Consensus 222 --------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L 259 (434)
........+++++.++|.+||..||.+||+++|+ |+|+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 247 EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 0000013467889999999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=254.03 Aligned_cols=207 Identities=20% Similarity=0.255 Sum_probs=161.9
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++ +|+||+++++++..++..++|+||+++|+|.+++. ....+++..+..++.|++.||.|||+.|++||||
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl 131 (290)
T cd05613 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS-------QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDI 131 (290)
T ss_pred HhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 355 68999999999999999999999999999999997 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........++
T Consensus 132 ~p~nil~~~~~~~kl~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 169 (290)
T cd05613 132 KLENILLDSNGHVVLTDFGLSKEFHEDE------------------------------------------VERAYSFCGT 169 (290)
T ss_pred CHHHeEECCCCCEEEeeCccceeccccc------------------------------------------ccccccccCC
Confidence 9999999999999999999865421110 0011223467
Q ss_pred ccccchhhhhcC--CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 161 IRWMAWESLLLG--KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 161 ~~y~aPE~~~~~--~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
..|+|||.+... .++.++||||||+++|+|+ +|..||...........+.... .....+.+..+++.+.+++
T Consensus 170 ~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll--~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ll 243 (290)
T cd05613 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL--TGASPFTVDGEKNSQAEISRRI----LKSEPPYPQEMSALAKDII 243 (290)
T ss_pred cccCChhhccCCCCCCCccccHHHHHHHHHHHh--cCCCCCCcCCccccHHHHHHHh----hccCCCCCccCCHHHHHHH
Confidence 789999998753 4678999999999999999 8999997543222212111111 1112334566789999999
Q ss_pred HHhccCCCCCCC-----CHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRP-----RFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rp-----s~~el--~~~L~~~~ 263 (434)
.+||+.||++|| +++++ |+|+++.+
T Consensus 244 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 244 QRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999999999997 77888 67887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=253.37 Aligned_cols=206 Identities=19% Similarity=0.254 Sum_probs=158.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+.+..++||||+++ +|.+++.... ....+++..+..++.|++.||+|||++|++||||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl 126 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG----VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDL 126 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC----CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 3578999999999999999999999999975 8999887433 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||++++++.++|+|||++....... .......++
T Consensus 127 ~p~ni~~~~~~~~~l~d~g~~~~~~~~~-------------------------------------------~~~~~~~~~ 163 (284)
T cd07836 127 KPQNLLINKRGELKLADFGLARAFGIPV-------------------------------------------NTFSNEVVT 163 (284)
T ss_pred CHHHEEECCCCcEEEeecchhhhhcCCc-------------------------------------------ccccccccc
Confidence 9999999999999999999865421100 011223456
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC----------c--ccCC---
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS----------K--QQYL--- 224 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~----------~--~~~~--- 224 (434)
..|++||++.+. .++.++|||||||++|+|+ +|..||.+.+..+....+........ . ....
T Consensus 164 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd07836 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI--TGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRY 241 (284)
T ss_pred ccccChHHhcCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCC
Confidence 789999998764 4688999999999999999 88999987766554443322110000 0 0000
Q ss_pred ------CCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 225 ------PRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 225 ------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
.....++..+.+++.+||+.||.+||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 242 PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 00123567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=246.35 Aligned_cols=200 Identities=22% Similarity=0.251 Sum_probs=160.2
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++|+||+++++++.+. +..++++||+++++|.+++. ....+++..+..++.|++.||.|||++|++|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-------~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~ 130 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK-------AYGALTENVTRRYTRQILQGVSYLHSNMIVHR 130 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 3578999999999998664 45889999999999999997 33458899999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.++|+|||+++...... ..........
T Consensus 131 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~----------------------------------------~~~~~~~~~~ 170 (264)
T cd06653 131 DIKGANILRDSAGNVKLGDFGASKRIQTIC----------------------------------------MSGTGIKSVT 170 (264)
T ss_pred CCCHHHEEEcCCCCEEECcccccccccccc----------------------------------------ccCccccccC
Confidence 999999999999999999999976521100 0000112334
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
++..|+|||.+.+..++.++|+|||||++|+++ +|..||..........++. ........+..+++++.+++
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~------~~~~~~~~p~~~~~~~~~~i 242 (264)
T cd06653 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEML--TEKPPWAEYEAMAAIFKIA------TQPTKPMLPDGVSDACRDFL 242 (264)
T ss_pred CcccccCHhhhcCCCCCccccHHHHHHHHHHHH--hCCCCCCccCHHHHHHHHH------cCCCCCCCCcccCHHHHHHH
Confidence 678899999999888899999999999999999 8999998765554433221 12223344677889999999
Q ss_pred HHhccCCCCCCCCHHHHH
Q psy5690 239 LECWKTNETDRPRFSEIH 256 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~ 256 (434)
.+||. +|..||++.+++
T Consensus 243 ~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 243 KQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred HHHhc-CcccCccHHHHh
Confidence 99999 579999999884
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=253.47 Aligned_cols=200 Identities=22% Similarity=0.364 Sum_probs=160.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++|||++++++++.+++..++||||+. |+|.+++.. ....+++..+..++.||+.||.|||++|++|+||
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~------~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl 147 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV------HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 357899999999999999999999999996 588888763 2346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.+||+|||++.... ......++
T Consensus 148 ~p~nili~~~~~~kL~dfg~~~~~~-----------------------------------------------~~~~~~~~ 180 (313)
T cd06633 148 KAGNILLTEPGQVKLADFGSASKSS-----------------------------------------------PANSFVGT 180 (313)
T ss_pred ChhhEEECCCCCEEEeecCCCcccC-----------------------------------------------CCCCcccc
Confidence 9999999999999999999853210 01233566
Q ss_pred ccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||++. ...++.++|||||||++|+|+ +|..||.............. ..........++..+.++
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA--ERKPPLFNMNAMSALYHIAQ------NDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred ccccChhhccccCCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHh------cCCCCCCccccCHHHHHH
Confidence 7899999985 356788999999999999999 88999988765554433221 011111123466789999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+||+.+|.+||++.++ ++|++..
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999 7787753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=255.91 Aligned_cols=210 Identities=21% Similarity=0.228 Sum_probs=154.9
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
+++++||||+++++++.+. +..++||||+++ +|.+++..... .....+++..++.++.|++.||+|||+++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~ 132 (316)
T cd07842 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQ--AKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHR 132 (316)
T ss_pred HHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhcc--CCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeC
Confidence 3578999999999999888 789999999975 78877754321 122468999999999999999999999999999
Q ss_pred CCCCCCeeeec----CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 79 DLAARNCMVGK----NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 79 Dlkp~NILl~~----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
||||+||+++. ++.+||+|||+++...... ......
T Consensus 133 dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~----------------------------------------~~~~~~ 172 (316)
T cd07842 133 DLKPANILVMGEGPERGVVKIGDLGLARLFNAPL----------------------------------------KPLADL 172 (316)
T ss_pred CCCHHHEEEcCCCCccceEEECCCccccccCCCc----------------------------------------cccccc
Confidence 99999999999 8999999999876521111 001112
Q ss_pred CCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH---------HHHhhhhhh---------
Q psy5690 155 TKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ---------VIENCSHWY--------- 215 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~---------~~~~~~~~~--------- 215 (434)
....++..|+|||++.+. .++.++|||||||++|+|+ +|..||....... ....+...+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 250 (316)
T cd07842 173 DPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL--TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWP 250 (316)
T ss_pred CCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH--hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHH
Confidence 334567889999988764 5789999999999999999 8899997654322 011100000
Q ss_pred ---------hcCCcccCCCCC-----------CccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 216 ---------QNNSKQQYLPRP-----------ATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 216 ---------~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
...........+ ...+.++.+++.+||+.||++|||+.|+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 251 DIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 000000000001 1456789999999999999999999999
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=257.07 Aligned_cols=212 Identities=21% Similarity=0.275 Sum_probs=159.4
Q ss_pred CCC-CCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 2 CSL-KDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
+++ +||||++++++|... ...++||||+. ++|.+++. .. .+++..+..++.||+.||+|||++||+||
T Consensus 61 ~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-------~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~ 131 (337)
T cd07852 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIR-------AN-ILEDVHKRYIMYQLLKALKYIHSGNVIHR 131 (337)
T ss_pred HHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHh-------cC-CCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 467 999999999998654 35899999997 59999986 22 67888999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.+||+|||++......... ..........
T Consensus 132 dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~--------------------------------------~~~~~~~~~~ 173 (337)
T cd07852 132 DLKPSNILLNSDCRVKLADFGLARSLSELEEN--------------------------------------PENPVLTDYV 173 (337)
T ss_pred CCCHHHEEEcCCCcEEEeeccchhcccccccc--------------------------------------ccCcchhccc
Confidence 99999999999999999999987653211100 0000112335
Q ss_pred CCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc--------------------
Q psy5690 159 LPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN-------------------- 217 (434)
Q Consensus 159 gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~-------------------- 217 (434)
++..|+|||.+.+ ..++.++||||||+++|+|+ +|+.||......+....+......
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~--tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (337)
T cd07852 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML--LGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDS 251 (337)
T ss_pred ccccccCceeeeccccccccchHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhh
Confidence 6788999998865 45688999999999999999 889999776554433322111100
Q ss_pred ---CCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 218 ---NSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 218 ---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
............++.++.+++.+||+.||++|||+.++ ++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 252 LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred cccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00000111123367899999999999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=247.58 Aligned_cols=193 Identities=23% Similarity=0.289 Sum_probs=162.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++.+..++..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.+++|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~-------~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l 119 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS-------KEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Confidence 357899999999999999999999999999999999997 3346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++|+|||.+....... .......++
T Consensus 120 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------------------------------------------~~~~~~~~~ 156 (250)
T cd05123 120 KPENILLDADGHIKLTDFGLAKELSSEG-------------------------------------------SRTNTFCGT 156 (250)
T ss_pred CcceEEEcCCCcEEEeecCcceecccCC-------------------------------------------CcccCCcCC
Confidence 9999999999999999999865421110 011334567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||...+...+.++|+||||+++|+++ +|..||......+....+.. ...+.+...+..+.+++.+
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~--~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~~i~~ 226 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEML--TGKPPFYAEDRKEIYEKILK--------DPLRFPEFLSPEARDLISG 226 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHhc--------CCCCCCCCCCHHHHHHHHH
Confidence 7899999998888899999999999999999 89999987776555444321 2334566678999999999
Q ss_pred hccCCCCCCCCHH
Q psy5690 241 CWKTNETDRPRFS 253 (434)
Q Consensus 241 cl~~dP~~Rps~~ 253 (434)
||..||++||++.
T Consensus 227 ~l~~~p~~R~~~~ 239 (250)
T cd05123 227 LLQKDPTKRLGSG 239 (250)
T ss_pred HhcCCHhhCCCcc
Confidence 9999999999993
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=258.30 Aligned_cols=212 Identities=21% Similarity=0.273 Sum_probs=158.4
Q ss_pred CCCCCCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|++++||||+++++++... ...++|+||+.+ +|.+++. ...+++..+..++.|+++||+|||++||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~~i 127 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK--------TQHLSNDHIQYFLYQILRGLKYIHSANV 127 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3578999999999987554 358999999964 8988885 2468999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+||+++.++.+||+|||+++...... .......
T Consensus 128 vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~----------------------------------------~~~~~~~ 167 (336)
T cd07849 128 LHRDLKPSNLLLNTNCDLKICDFGLARIADPEH----------------------------------------DHTGFLT 167 (336)
T ss_pred eccCCCHHHEEECCCCCEEECcccceeeccccc----------------------------------------cccCCcC
Confidence 999999999999999999999999875421110 0000112
Q ss_pred CCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhh------------------
Q psy5690 156 KARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQ------------------ 216 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~------------------ 216 (434)
...++..|+|||.+.+ ..++.++||||+||++|+|+ +|+.||.+.........+.....
T Consensus 168 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~--~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (336)
T cd07849 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML--SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNY 245 (336)
T ss_pred CcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhH
Confidence 3456788999998765 46789999999999999999 88999976554332221111000
Q ss_pred --cCCcccCCC---CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 217 --NNSKQQYLP---RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 217 --~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
........+ .....++++.+++.+||+.||++||++.|+ |+|++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 246 IKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000000 012356789999999999999999999999 88998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=252.56 Aligned_cols=214 Identities=18% Similarity=0.272 Sum_probs=166.8
Q ss_pred CCCC-CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSLK-DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++++ ||||+++++++..++..++||||+++++|.+++. ....+++..+..++.|++.||.|||+.|++|+||
T Consensus 56 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl 128 (280)
T cd05581 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-------KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDL 128 (280)
T ss_pred HhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 4566 9999999999999999999999999999999997 3347999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||+++.++.++++|||++................. .................++
T Consensus 129 ~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~ 185 (280)
T cd05581 129 KPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT-----------------------NIDSQIEKNRRRFASFVGT 185 (280)
T ss_pred CHHHeEECCCCCEEecCCccccccCCccccccCCCCCc-----------------------cccccccccccccccccCC
Confidence 99999999999999999999766433221100000000 0000001111122334567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||......++.++|+||||+++|+++ +|..||...........+. ......+..+++.+.+++.+
T Consensus 186 ~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~ 255 (280)
T cd05581 186 AEYVSPELLNEKPAGKSSDLWALGCIIYQML--TGKPPFRGSNEYLTFQKIL--------KLEYSFPPNFPPDAKDLIEK 255 (280)
T ss_pred ccccCHHHhCCCCCChhhhHHHHHHHHHHHH--hCCCCCCCccHHHHHHHHH--------hcCCCCCCccCHHHHHHHHH
Confidence 8899999999888999999999999999999 8999999887655544332 12233456678999999999
Q ss_pred hccCCCCCCCCH----HHH
Q psy5690 241 CWKTNETDRPRF----SEI 255 (434)
Q Consensus 241 cl~~dP~~Rps~----~el 255 (434)
||+.||++||++ +++
T Consensus 256 ~l~~~p~~R~~~~~~~~~l 274 (280)
T cd05581 256 LLVLDPQDRLGVNEGYDEL 274 (280)
T ss_pred HhcCCHhhCCCcccCHHHH
Confidence 999999999999 777
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=258.32 Aligned_cols=214 Identities=20% Similarity=0.252 Sum_probs=166.7
Q ss_pred CCCCCCCCeeeEEEEEecCC-----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED-----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|++++||||+++++++...+ ..|+||||+. ++|.+++. ....+++..+..++.||+.||+|||++||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~-------~~~~l~~~~~~~i~~~l~~~l~~LH~~gi 124 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIK-------SPQPLTDDHIQYFLYQILRGLKYLHSANV 124 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 35789999999999997775 7899999997 48999986 33479999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+||+++.++.++|+|||++........ ......
T Consensus 125 ~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~----------------------------------------~~~~~~ 164 (330)
T cd07834 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDED----------------------------------------EKGFLT 164 (330)
T ss_pred ecCCCCHHHEEEcCCCCEEEcccCceEeeccccc----------------------------------------cccccc
Confidence 9999999999999999999999998765222110 000112
Q ss_pred CCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc--------------
Q psy5690 156 KARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK-------------- 220 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 220 (434)
...++..|+|||.+.+. .++.++|+||||+++|+|+ +|..||.+.+..+....+.........
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 242 (330)
T cd07834 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL--TRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNY 242 (330)
T ss_pred ccccccCcCCceeeecccCCCcchhHHHHHHHHHHHH--cCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhH
Confidence 33467789999999887 7899999999999999999 899999887766554443322111000
Q ss_pred ------c---cCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 221 ------Q---QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 221 ------~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
. .........+.++.+++.+||+.+|++||+++++ |+||++...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 243 LKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0 0000123367889999999999999999999999 789987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=253.23 Aligned_cols=204 Identities=16% Similarity=0.213 Sum_probs=158.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++..++..++|+||+++ +|.+++..+ ...+++..+..++.|++.||.|||+++|+|+||
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl 124 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR------QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhh------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCc
Confidence 3568999999999999999999999999975 899888732 257899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||.+....... .......++
T Consensus 125 ~p~nili~~~~~~~l~df~~~~~~~~~~-------------------------------------------~~~~~~~~~ 161 (283)
T cd05118 125 KPENLLINTEGVLKLADFGLARSFGSPV-------------------------------------------RPYTHYVVT 161 (283)
T ss_pred CHHHEEECCCCcEEEeeeeeeEecCCCc-------------------------------------------ccccCccCc
Confidence 9999999999999999999865421111 011123456
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc-------------------
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK------------------- 220 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------- 220 (434)
..|+|||.+.+. .++.++|+||||+++|+|+ +|+.||...+..+....+.........
T Consensus 162 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~--tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELL--SRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred ccccCcHHHhcCCCCCchhHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 779999999876 7899999999999999999 789999877665443332211110000
Q ss_pred ccC---CCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 221 QQY---LPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 221 ~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
... ......++.++.+++.+||+.||.+||++.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll 278 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence 000 011234678899999999999999999999993
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=251.78 Aligned_cols=204 Identities=18% Similarity=0.211 Sum_probs=158.9
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++ +||||+++++.+..++..++||||+.+|+|.+++. ....+++..+..++.|+++||.|||+.+++||||
T Consensus 59 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl 131 (288)
T cd05583 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-------QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDI 131 (288)
T ss_pred HhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHh-------hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 356 69999999999999999999999999999999986 3346889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++...... ........++
T Consensus 132 ~p~nil~~~~~~~~l~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 169 (288)
T cd05583 132 KLENILLDSEGHVVLTDFGLSKEFLAEE------------------------------------------EERAYSFCGT 169 (288)
T ss_pred CHHHeEECCCCCEEEEECcccccccccc------------------------------------------ccccccccCC
Confidence 9999999999999999999865421110 0011223467
Q ss_pred ccccchhhhhcCC--CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 161 IRWMAWESLLLGK--NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 161 ~~y~aPE~~~~~~--~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
..|+|||.+.+.. .+.++||||||+++|||+ +|..||...........+.+... ....+.+..++..+.+++
T Consensus 170 ~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~--tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li 243 (288)
T cd05583 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL--TGASPFTVDGEQNSQSEISRRIL----KSKPPFPKTMSAEARDFI 243 (288)
T ss_pred ccccCHHHhcCCCCCCcchhhhHHHHHHHHHHH--hCCCCcccCcccchHHHHHHHHH----ccCCCCCcccCHHHHHHH
Confidence 7899999987665 688999999999999999 88999965432211111111111 112344566788999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHH
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~ 260 (434)
.+||+.||++|||+.++...|+
T Consensus 244 ~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 244 QKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHhcCCHhhccCcchHHHHhc
Confidence 9999999999999877754443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=250.69 Aligned_cols=203 Identities=17% Similarity=0.261 Sum_probs=150.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|+||+++++++..++..++|+||+. ++|.+++.. ....+++..+..++.|++.||.|||++||+|+||
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl 129 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ------HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 357899999999999999999999999996 688777752 2245778889999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.++|+|||+++...... .......++
T Consensus 130 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 166 (291)
T cd07870 130 KPQNLLISYLGELKLADFGLARAKSIPS-------------------------------------------QTYSSEVVT 166 (291)
T ss_pred ChHHEEEcCCCcEEEeccccccccCCCC-------------------------------------------CCCCCcccc
Confidence 9999999999999999999875421100 001223456
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhh--------------cCCcc---
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQ--------------NNSKQ--- 221 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~--------------~~~~~--- 221 (434)
..|+|||.+.+. .++.++|||||||++|+|+ +|..||...... +....+..... .....
T Consensus 167 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~--~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd07870 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEML--QGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL 244 (291)
T ss_pred ccccCCceeecCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhcc
Confidence 789999998754 5788999999999999999 889999765432 11111100000 00000
Q ss_pred cCCC-------CCCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 222 QYLP-------RPATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 222 ~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
...+ ..-..+.++.+++.+|++.||++|||++|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~ 285 (291)
T cd07870 245 PCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285 (291)
T ss_pred ccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence 0000 001125688999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=251.34 Aligned_cols=205 Identities=17% Similarity=0.214 Sum_probs=156.2
Q ss_pred CCCCCCCCeeeEEEEEecCC----------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5690 1 MCSLKDPNLVRVIGVCSTED----------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYL 70 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~----------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yL 70 (434)
+++++||||+++++++.+.. ..++|+||+++ ++.+++.. ....+++..+..++.|++.||+||
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~------~~~~~~~~~~~~i~~qi~~aL~~L 132 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES------GLVHFSEDHIKSFMKQLLEGLNYC 132 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 35789999999999987654 79999999976 78787762 234689999999999999999999
Q ss_pred hhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 71 ESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 71 H~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
|+.||+|+||||+||+++.++.+||+|||++........
T Consensus 133 H~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~----------------------------------------- 171 (302)
T cd07864 133 HKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES----------------------------------------- 171 (302)
T ss_pred HhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-----------------------------------------
Confidence 999999999999999999999999999998654211100
Q ss_pred cccCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCccc-------
Q psy5690 151 YLSDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ------- 222 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------- 222 (434)
.......++..|+|||.+.+. .++.++|||||||++|||+ +|+.||......+....+...........
T Consensus 172 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (302)
T cd07864 172 -RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF--TKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKL 248 (302)
T ss_pred -cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCChhhccccccc
Confidence 001122345679999988654 4688999999999999999 88999987766555444333211100000
Q ss_pred ---------------CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 223 ---------------YLPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 223 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
.......++..+.+++.+||+.||.+||++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 297 (302)
T cd07864 249 PYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297 (302)
T ss_pred ccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0011234678999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=255.21 Aligned_cols=208 Identities=17% Similarity=0.236 Sum_probs=160.2
Q ss_pred CCCCCCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++||||+++++++..+. ..++||||+ +++|.+++. ...+++..+..++.|++.||+|||+.|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~g 138 (343)
T cd07880 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK--------HEKLSEDRIQFLVYQMLKGLKYIHAAG 138 (343)
T ss_pred HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46789999999999987654 358999999 779998885 236899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+||+++.++.++|+|||++..... ..
T Consensus 139 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~----------------------------------------------~~ 172 (343)
T cd07880 139 IIHRDLKPGNLAVNEDCELKILDFGLARQTDS----------------------------------------------EM 172 (343)
T ss_pred eecCCCCHHHEEEcCCCCEEEeeccccccccc----------------------------------------------Cc
Confidence 99999999999999999999999998654111 01
Q ss_pred CCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc----------------
Q psy5690 155 TKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN---------------- 217 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 217 (434)
....++..|+|||.+.+ ..++.++|+|||||++|+++ +|..||...........+......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07880 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML--TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250 (343)
T ss_pred cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence 22345678999999876 45789999999999999999 889999876654333222110000
Q ss_pred ----C---CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcccC
Q psy5690 218 ----N---SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNLG 265 (434)
Q Consensus 218 ----~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~~ 265 (434)
. ...........+++++.+++.+|++.||++||++.++ |+|++.....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 0 0000001123567789999999999999999999999 7999886443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=248.47 Aligned_cols=201 Identities=22% Similarity=0.368 Sum_probs=157.3
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDLAA 82 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp 82 (434)
.+||||+++++++.++...++||||+. ++|.+++... ...+++..+..++.|++.||+|||+ .||+||||+|
T Consensus 71 ~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p 143 (296)
T cd06618 71 HDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRI------QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKP 143 (296)
T ss_pred cCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcH
Confidence 359999999999999999999999985 5888887632 2478999999999999999999997 5999999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+||+++.++.+||+|||++....... ......++..
T Consensus 144 ~nill~~~~~~kL~dfg~~~~~~~~~--------------------------------------------~~~~~~~~~~ 179 (296)
T cd06618 144 SNILLDASGNVKLCDFGISGRLVDSK--------------------------------------------AKTRSAGCAA 179 (296)
T ss_pred HHEEEcCCCCEEECccccchhccCCC--------------------------------------------cccCCCCCcc
Confidence 99999999999999999865421100 0112245678
Q ss_pred ccchhhhhcCC----CCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 163 WMAWESLLLGK----NTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 163 y~aPE~~~~~~----~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
|+|||.+.+.. ++.++||||||+++|+|+ +|..||...... +....+. .. .....+....++.++.++
T Consensus 180 y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~--~g~~p~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~~~~l~~l 252 (296)
T cd06618 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELA--TGQFPYKNCKTEFEVLTKIL---QE--EPPSLPPNEGFSPDFCSF 252 (296)
T ss_pred ccCHhhcCCCCCccccccchhHHHHHHHHHHHH--hCCCCCCcchhHHHHHHHHh---cC--CCCCCCCCCCCCHHHHHH
Confidence 99999987554 788999999999999999 899999764332 2222211 11 111222233578899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+||+.||++||+++++ ++|++..
T Consensus 253 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 253 VDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHccCChhhCCCHHHHhcChhhhcc
Confidence 999999999999999999 7888764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=254.97 Aligned_cols=205 Identities=18% Similarity=0.252 Sum_probs=156.7
Q ss_pred CCCCCCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++||||+++++++.... ..++|+||+.. +|.++.. ..+++..+..++.|++.||+|||++|
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~ 137 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG---------HPLSEDKVQYLVYQMLCGLKYIHSAG 137 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35789999999999986543 46999999964 7877653 35889999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
++||||||+||+++.++.+||+|||+++.... ..
T Consensus 138 i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~----------------------------------------------~~ 171 (342)
T cd07879 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADA----------------------------------------------EM 171 (342)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC----------------------------------------------CC
Confidence 99999999999999999999999998654110 01
Q ss_pred CCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhh-----------------
Q psy5690 155 TKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQ----------------- 216 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~----------------- 216 (434)
....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||...+.......+.....
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML--TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 22345677999999876 45789999999999999999 89999987765443332221100
Q ss_pred ---cCCc---ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 217 ---NNSK---QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 217 ---~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.... ..........++++.+++.+||+.||++||+++++ |+||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 00000012456789999999999999999999999 79998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=251.27 Aligned_cols=211 Identities=19% Similarity=0.206 Sum_probs=158.0
Q ss_pred CC-CCCCeeeEEEEEecC----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 3 SL-KDPNLVRVIGVCSTE----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
++ +||||+++++.+... ...++++||+. ++|.+++. ....+++..+..++.||+.||+|||++|++|
T Consensus 57 ~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~-------~~~~~~~~~~~~~~~qi~~aL~~LH~~givH 128 (332)
T cd07857 57 HFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIR-------SGQPLTDAHFQSFIYQILCGLKYIHSANVLH 128 (332)
T ss_pred HhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 45 599999999976432 45789999985 69999986 4457899999999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+||+++.++.+||+|||+++....... .........
T Consensus 129 ~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------~~~~~~~~~ 169 (332)
T cd07857 129 RDLKPGNLLVNADCELKICDFGLARGFSENPG---------------------------------------ENAGFMTEY 169 (332)
T ss_pred CCCCHHHeEEcCCCCEEeCcCCCceecccccc---------------------------------------cccccccCc
Confidence 99999999999999999999999765321110 000011234
Q ss_pred CCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhh--------------------
Q psy5690 158 RLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQ-------------------- 216 (434)
Q Consensus 158 ~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~-------------------- 216 (434)
.++..|+|||.+.+ ..++.++||||+||++|+++ +|..||...+.......+.....
T Consensus 170 ~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (332)
T cd07857 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL--GRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR 247 (332)
T ss_pred ccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHH--hCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHH
Confidence 67888999998876 46789999999999999999 88999987654433322211100
Q ss_pred cCCccc---CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 217 NNSKQQ---YLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 217 ~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
...... ........+..+.+++.+||+.||++||+++++ ++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 248 SLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000000 001122356889999999999999999999999 8899764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=249.19 Aligned_cols=203 Identities=18% Similarity=0.232 Sum_probs=155.6
Q ss_pred CCCC-CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSLK-DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++++ ||||+++++++.+++..++||||+ +|+|.+++... ....+++..+..++.|++.||.|||++|++|+||
T Consensus 52 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl 125 (283)
T cd07830 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR-----KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDL 125 (283)
T ss_pred HhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc-----ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 4567 999999999999999999999999 78999998732 1246899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|+||++++++.++|+|||++....... ......++
T Consensus 126 ~~~ni~i~~~~~~~l~d~~~~~~~~~~~--------------------------------------------~~~~~~~~ 161 (283)
T cd07830 126 KPENLLVSGPEVVKIADFGLAREIRSRP--------------------------------------------PYTDYVST 161 (283)
T ss_pred ChhhEEEcCCCCEEEeecccceeccCCC--------------------------------------------CcCCCCCc
Confidence 9999999999999999999865421110 01223456
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC--------------ccc---
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS--------------KQQ--- 222 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~~--- 222 (434)
..|+|||++.. ..++.++|+||||+++|||+ +|..||......+....+........ ...
T Consensus 162 ~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07830 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELY--TLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239 (283)
T ss_pred ccccCceeeecCcCcCCccchhhHHHHHHHHH--hCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc
Confidence 78999998854 45789999999999999999 78899977665444332221111000 000
Q ss_pred -----CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 223 -----YLPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 223 -----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
........+.++.+++.+||+.||++||+++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 278 (283)
T cd07830 240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278 (283)
T ss_pred cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 0000112257899999999999999999999983
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.52 Aligned_cols=96 Identities=22% Similarity=0.340 Sum_probs=89.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++...+..|+||||+.+|+|.+++.. ...+++..++.++.||+.||+|||+++|+|||||
T Consensus 59 ~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~-------~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLK 131 (669)
T cd05610 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI-------YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131 (669)
T ss_pred HhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCcc
Confidence 467999999999999999999999999999999999973 3468889999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCccccc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSH 104 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~ 104 (434)
|+|||++.++.+||+|||+++..
T Consensus 132 P~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 132 PDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred HHHEEEcCCCCEEEEeCCCCccc
Confidence 99999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=247.36 Aligned_cols=204 Identities=19% Similarity=0.290 Sum_probs=157.1
Q ss_pred CCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
++++|||++++++++... +..++|+||+++ +|.+++.. ....+++..++.++.||+.||+|||++|++|+|
T Consensus 53 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~d 125 (287)
T cd07840 53 QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS------PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRD 125 (287)
T ss_pred HhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhc------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 568999999999999887 889999999975 99998862 224789999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||++++++.++|+|||++........ .......+
T Consensus 126 l~p~nil~~~~~~~~l~d~g~~~~~~~~~~------------------------------------------~~~~~~~~ 163 (287)
T cd07840 126 IKGSNILINNDGVLKLADFGLARPYTKRNS------------------------------------------ADYTNRVI 163 (287)
T ss_pred CcHHHeEEcCCCCEEEccccceeeccCCCc------------------------------------------cccccccc
Confidence 999999999999999999998754221110 01122345
Q ss_pred Cccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCccc---------------C
Q psy5690 160 PIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ---------------Y 223 (434)
Q Consensus 160 t~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------~ 223 (434)
+..|+|||.+.+ ..++.++||||||+++|||+ +|..||...........+........... .
T Consensus 164 ~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~--t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (287)
T cd07840 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELF--LGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPK 241 (287)
T ss_pred ccccCCceeeEccccCChHHHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcccc
Confidence 677999998765 45789999999999999999 88999988776555444332111100000 0
Q ss_pred CC--------CCCccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 224 LP--------RPATCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 224 ~~--------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
.. ....+++++.+++.+||..+|.+||++.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 282 (287)
T cd07840 242 KPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282 (287)
T ss_pred ccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00 0111378899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=257.06 Aligned_cols=206 Identities=18% Similarity=0.242 Sum_probs=160.3
Q ss_pred CCCCCCCCeeeEEEEEecCCc------eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDP------ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
+++++||||+++++++..++. .++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+.|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~--------~~~l~~~~~~~~~~ql~~aL~~LH~~g 138 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK--------CQKLSDDHIQFLVYQILRGLKYIHSAG 138 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 357899999999998866554 89999999 669999986 246899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+||+++.++.++|+|||++...... .
T Consensus 139 i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----------------------------------------------~ 172 (343)
T cd07851 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----------------------------------------------M 172 (343)
T ss_pred eecCCCCHHHeEECCCCCEEEcccccccccccc----------------------------------------------c
Confidence 999999999999999999999999986542110 1
Q ss_pred CCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc----------------
Q psy5690 155 TKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN---------------- 217 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 217 (434)
....++..|+|||.+.+ ..++.++|||||||++|+++ +|..||......+....+......
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell--tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07851 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL--TGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARN 250 (343)
T ss_pred cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHH
Confidence 22345677999999875 36789999999999999999 889999877665444333221100
Q ss_pred ----CCcccC---CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 218 ----NSKQQY---LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 218 ----~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
...... ......+++++.+++.+||+.||++|||+.+| |+|+++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 251 YIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 000000 00112357889999999999999999999999 78998754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=247.34 Aligned_cols=205 Identities=21% Similarity=0.300 Sum_probs=159.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++|+||+++++++.+.+..++|+||++ ++|.+++.+.. ..+++..+..++.|++.||+|||++||+||||+
T Consensus 53 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~ 125 (282)
T cd07829 53 KELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLK 125 (282)
T ss_pred HhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 56789999999999999999999999997 59999997321 468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||++++++.++|+|||+++...... .......++.
T Consensus 126 ~~ni~~~~~~~~~l~d~g~~~~~~~~~-------------------------------------------~~~~~~~~~~ 162 (282)
T cd07829 126 PQNILINRDGVLKLADFGLARAFGIPL-------------------------------------------RTYTHEVVTL 162 (282)
T ss_pred hheEEEcCCCCEEEecCCcccccCCCc-------------------------------------------cccCccccCc
Confidence 999999999999999999865421110 0111223456
Q ss_pred cccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC----------------c----
Q psy5690 162 RWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS----------------K---- 220 (434)
Q Consensus 162 ~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~---- 220 (434)
.|+|||.+.+. .++.++|||||||++||++ +|..||......+....+........ .
T Consensus 163 ~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd07829 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMI--TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFP 240 (282)
T ss_pred CcCChHHhcCCcCCCccccHHHHHHHHHHHH--hCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccC
Confidence 79999999876 7899999999999999999 78999988765554433322110000 0
Q ss_pred -ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHH
Q psy5690 221 -QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLF 258 (434)
Q Consensus 221 -~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~ 258 (434)
..........+..+.+++.+||+.||++||+++++ |+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 241 PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 00000112346789999999999999999999998 444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=251.73 Aligned_cols=205 Identities=18% Similarity=0.253 Sum_probs=156.8
Q ss_pred CCCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
+++++||||+++++++... ...+++++++ +++|.++++ ...+++..+..++.|++.||+|||++|
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~ 140 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--------CQKLTDDHVQFLIYQILRGLKYIHSAD 140 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3578999999999998543 3478888887 779998885 235899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+||+++.++.+||+|||+++.... ..
T Consensus 141 ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~----------------------------------------------~~ 174 (345)
T cd07877 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDD----------------------------------------------EM 174 (345)
T ss_pred eeecCCChHHEEEcCCCCEEEecccccccccc----------------------------------------------cc
Confidence 99999999999999999999999998654110 01
Q ss_pred CCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc----------------
Q psy5690 155 TKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN---------------- 217 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 217 (434)
....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||...........+......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T cd07877 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL--TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252 (345)
T ss_pred cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence 22345678999999876 46788999999999999999 889999776554433322111000
Q ss_pred ----CCc---ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 218 ----NSK---QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 218 ----~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
... ..........++++.++|.+||+.||.+||++.++ |+|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000 00000112357789999999999999999999999 8899874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=238.72 Aligned_cols=217 Identities=19% Similarity=0.265 Sum_probs=162.8
Q ss_pred CCCCCCCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
++.|+||||+.+..+|.. +..+++++||++. +|.+.++-++.. ....++...+..|+.||+.|+.|||++=|+|||
T Consensus 81 ~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~--~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRD 157 (438)
T KOG0666|consen 81 LRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRAS--KAKQLPRSMVKSILWQILDGVHYLHSNWVLHRD 157 (438)
T ss_pred HHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccc--hhccCCHHHHHHHHHHHHhhhHHHhhhheeecc
Confidence 367899999999999977 7889999999988 999999866533 336899999999999999999999999999999
Q ss_pred CCCCCeeeecC----CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 80 LAARNCMVGKN----YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 80 lkp~NILl~~~----~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
|||.|||+..+ |.+||+|||++|.+..+-.. .....
T Consensus 158 LKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkp----------------------------------------l~s~d 197 (438)
T KOG0666|consen 158 LKPANILVMGDGPERGRVKIADLGLARLFNNPLKP----------------------------------------LASLD 197 (438)
T ss_pred CCcceEEEeccCCccCeeEeecccHHHHhhccccc----------------------------------------cccCC
Confidence 99999999877 89999999999885443311 11234
Q ss_pred CCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH---------HHHHhhhhhhhcCCc-----
Q psy5690 156 KARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE---------QVIENCSHWYQNNSK----- 220 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~---------~~~~~~~~~~~~~~~----- 220 (434)
..+.|+.|.|||.+.+. .|+.+.||||.||++.||+ +-.+-|.+.... +...+|.+.+.....
T Consensus 198 ~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL--tl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~ 275 (438)
T KOG0666|consen 198 PVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL--TLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPD 275 (438)
T ss_pred ceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH--ccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchh
Confidence 56678999999999975 5799999999999999999 666666543211 111111111100000
Q ss_pred ----------------ccCCC--------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 221 ----------------QQYLP--------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 221 ----------------~~~~~--------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
..... ....-++...+|+.++|++||.+|.|+++. |.+|.+.
T Consensus 276 lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 276 LKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred hhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 00000 001123457899999999999999999998 6777764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=249.94 Aligned_cols=205 Identities=20% Similarity=0.275 Sum_probs=156.8
Q ss_pred CCCCCCCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++||||++++++|.. ++..++++||+ +++|.++++ ...+++..+..++.|+++||+|||++|++|||
T Consensus 63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~--------~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~d 133 (328)
T cd07856 63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT--------SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133 (328)
T ss_pred HHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 357899999999999865 56789999999 569998885 23578888999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|+|+||+++.++.++|+|||.+..... ......+
T Consensus 134 l~p~Nili~~~~~~~l~dfg~~~~~~~----------------------------------------------~~~~~~~ 167 (328)
T cd07856 134 LKPSNILINENCDLKICDFGLARIQDP----------------------------------------------QMTGYVS 167 (328)
T ss_pred CCHHHEeECCCCCEEeCccccccccCC----------------------------------------------CcCCCcc
Confidence 999999999999999999998643110 0112345
Q ss_pred Cccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhh--------------------hcC
Q psy5690 160 PIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWY--------------------QNN 218 (434)
Q Consensus 160 t~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~--------------------~~~ 218 (434)
+..|+|||.+.+ ..++.++|||||||++|+|+ +|..||...........+.... ...
T Consensus 168 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~--tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd07856 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML--EGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245 (328)
T ss_pred cccccCceeeeccCCcCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence 677999998766 56799999999999999999 8899997765433222111100 000
Q ss_pred CcccCCC---CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 SKQQYLP---RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 ~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
......+ ....+++++.++|.+||+.+|++||+++++ ++|++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0000111 113467899999999999999999999999 7888754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=252.11 Aligned_cols=211 Identities=20% Similarity=0.256 Sum_probs=155.4
Q ss_pred CCCCCCCCeeeEEEEEecC--------------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--------------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~g 66 (434)
|++++||||+++++++... ...++||||++ ++|.+++. ...+++..++.++.||++|
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--------~~~l~~~~~~~~~~qi~~a 126 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE--------QGPLSEEHARLFMYQLLRG 126 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH--------cCCCCHHHHHHHHHHHHHH
Confidence 4578999999999877544 35789999997 59998885 2358899999999999999
Q ss_pred HHHhhhCCccccCCCCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccc
Q psy5690 67 MKYLESRDIVHRDLAARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSH 145 (434)
Q Consensus 67 L~yLH~~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 145 (434)
|+|||++|++||||||+||+++. ++.+||+|||.++.......
T Consensus 127 L~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~------------------------------------ 170 (342)
T cd07854 127 LKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS------------------------------------ 170 (342)
T ss_pred HHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccc------------------------------------
Confidence 99999999999999999999974 55789999998754211100
Q ss_pred cCCcccccCCCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhh----------
Q psy5690 146 YESDYYLSDTKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHW---------- 214 (434)
Q Consensus 146 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~---------- 214 (434)
.........++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||......+....+...
T Consensus 171 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07854 171 ----HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML--TGKPLFAGAHELEQMQLILESVPVVREEDRN 244 (342)
T ss_pred ----cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 0000112345678999998765 55788999999999999999 899999876554433222110
Q ss_pred ---------hhcCCcccCC---CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 215 ---------YQNNSKQQYL---PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 215 ---------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.......... ......+.++.+++.+||+.||++||+++|+ |+||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 245 ELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0000000000 0123467889999999999999999999999 7999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=282.46 Aligned_cols=202 Identities=25% Similarity=0.348 Sum_probs=154.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh---hCCccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE---SRDIVH 77 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH---~~~iiH 77 (434)
|++++|||||+++|+|.+++..++||||+++|+|.++++ .+++..+..++.|+++||+||| +.+|+|
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 806 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence 467899999999999999999999999999999999996 3789999999999999999999 669999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+||+++.++..++. ||..... ......
T Consensus 807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~-----------------------------------------------~~~~~~ 838 (968)
T PLN00113 807 GNLSPEKIIIDGKDEPHLR-LSLPGLL-----------------------------------------------CTDTKC 838 (968)
T ss_pred CCCCHHhEEECCCCceEEE-ecccccc-----------------------------------------------ccCCCc
Confidence 9999999999988877765 5542210 001223
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh--HHHHHhhhhhhhcC--------CcccCCCCC
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN--EQVIENCSHWYQNN--------SKQQYLPRP 227 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~--~~~~~~~~~~~~~~--------~~~~~~~~~ 227 (434)
.++..|+|||++.+..++.++|||||||++|||+ +|+.||..... ....+......... ......+.+
T Consensus 839 ~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELL--TGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred cccccccCcccccCCCCCcccchhhHHHHHHHHH--hCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 5678899999999999999999999999999999 88999854321 11111111000000 000011112
Q ss_pred CccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 228 ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 228 ~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.....++.+++.+||+.||++||+++|+.+.|++.
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 23345678899999999999999999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=247.95 Aligned_cols=214 Identities=18% Similarity=0.212 Sum_probs=155.3
Q ss_pred CCCCCCCCeeeEEEEEecCC--------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 1 MCSLKDPNLVRVIGVCSTED--------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
|++++||||+++++++.+.. .+++|+||+.+ +|...+.. ....+++..+..++.|+++||+|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~------~~~~~~~~~~~~i~~~l~~al~~lH~ 133 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN------PSVKLTESQIKCYMLQLLEGINYLHE 133 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhc------cccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 35789999999999875433 46999999965 78777752 23469999999999999999999999
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
+|++|+||||+||+++.++.++|+|||+++........... .......
T Consensus 134 ~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~--------------------------------~~~~~~~ 181 (311)
T cd07866 134 NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG--------------------------------GGGGGTR 181 (311)
T ss_pred CCeecCCCCHHHEEECCCCCEEECcCccchhccCCCccccc--------------------------------CCccccc
Confidence 99999999999999999999999999997653221110000 0000011
Q ss_pred cCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc-----------
Q psy5690 153 SDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK----------- 220 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 220 (434)
......++..|+|||.+.+. .++.++|||||||++|||+ +|..||.+.+.....+.+.........
T Consensus 182 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T cd07866 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF--TRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPG 259 (311)
T ss_pred ccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhccc
Confidence 11334567889999988754 5789999999999999999 889999877765544433221110000
Q ss_pred ----ccCCCC-------CCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 221 ----QQYLPR-------PATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 221 ----~~~~~~-------~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
...... ....++.+.+++.+||+.||++|||+.|+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 260 CEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred ccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 000000 12344678999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=234.47 Aligned_cols=213 Identities=19% Similarity=0.266 Sum_probs=170.6
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
-+||.+|-++.+|..+..+++|.||++||+|--+++ ....++++.+..+..+|+.||.|||++|||.||||.+
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmq-------rqrklpeeharfys~ei~lal~flh~rgiiyrdlkld 380 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-------RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLD 380 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehh-------hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeecccc
Confidence 379999999999999999999999999999999887 4568999999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
|||+|..|++||.|+|+++.--.+. -...+.+||++|
T Consensus 381 nvlldaeghikltdygmcke~l~~g-------------------------------------------d~tstfcgtpny 417 (593)
T KOG0695|consen 381 NVLLDAEGHIKLTDYGMCKEGLGPG-------------------------------------------DTTSTFCGTPNY 417 (593)
T ss_pred ceEEccCCceeecccchhhcCCCCC-------------------------------------------cccccccCCCcc
Confidence 9999999999999999976521111 123567999999
Q ss_pred cchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhcc
Q psy5690 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWK 243 (434)
Q Consensus 164 ~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 243 (434)
.|||++.+..|+..+|.|+|||+++||+ .|+.||+-...+.--++-..++...........|...+-....+++.-|+
T Consensus 418 iapeilrgeeygfsvdwwalgvlmfemm--agrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgfln 495 (593)
T KOG0695|consen 418 IAPEILRGEEYGFSVDWWALGVLMFEMM--AGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLN 495 (593)
T ss_pred cchhhhcccccCceehHHHHHHHHHHHH--cCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhc
Confidence 9999999999999999999999999999 99999963211110011111111111222334467778888899999999
Q ss_pred CCCCCCC------CHHHH--HHHHHhcccCCCc
Q psy5690 244 TNETDRP------RFSEI--HLFLQRKNLGARA 268 (434)
Q Consensus 244 ~dP~~Rp------s~~el--~~~L~~~~~~~~~ 268 (434)
+||++|. .+.++ |+|++...++...
T Consensus 496 kdp~erlgc~~~~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 496 KDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred CCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence 9999995 35677 8999887665543
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=249.30 Aligned_cols=205 Identities=20% Similarity=0.241 Sum_probs=169.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|.+++||.||.+.-.|+..+.+++|||-+.| ++.+.+- ..+.+++++.....++.||+.||.|||.++|+|+||
T Consensus 617 Lq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMIL-----SsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDL 690 (888)
T KOG4236|consen 617 LQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMIL-----SSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDL 690 (888)
T ss_pred HHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHH-----HhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccC
Confidence 4679999999999999999999999999955 6666654 236678999999999999999999999999999999
Q ss_pred CCCCeeeecC---CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVGKN---YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||+.+. .++||||||+||.+++..+ ..+.
T Consensus 691 KPENVLLas~~~FPQvKlCDFGfARiIgEksF--------------------------------------------RrsV 726 (888)
T KOG4236|consen 691 KPENVLLASASPFPQVKLCDFGFARIIGEKSF--------------------------------------------RRSV 726 (888)
T ss_pred CchheeeccCCCCCceeeccccceeecchhhh--------------------------------------------hhhh
Confidence 9999999653 4799999999988655432 2567
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|+|||++....|...-|+||.||++|--+ .|..||....+- .+++. +......+....+++++..+|
T Consensus 727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL--SGTFPFNEdEdI--ndQIQ----NAaFMyPp~PW~eis~~Aidl 798 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL--SGTFPFNEDEDI--NDQIQ----NAAFMYPPNPWSEISPEAIDL 798 (888)
T ss_pred cCCccccCHHHHhhccccccccceeeeEEEEEEe--cccccCCCccch--hHHhh----ccccccCCCchhhcCHHHHHH
Confidence 8999999999999999999999999999999988 889999875432 22222 222222333356788999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
|...|+..-.+|.|.+.- |.||++.+
T Consensus 799 In~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHHHHHHHhcchHhhccchhhhcch
Confidence 999999999999999987 89998764
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=235.24 Aligned_cols=210 Identities=21% Similarity=0.324 Sum_probs=162.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrD 79 (434)
|++=+.||||++||.+..++..|+.||++.- ||+.+.+.-. ...+..+++..+-+|....+.||+||-+ .+|||||
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy--~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRD 193 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVY--SVQKSRIPENILGHITVATVDALDYLKEELKIIHRD 193 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHH--HHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhcc
Confidence 3455789999999999999999999999965 8776654211 1245679999999999999999999986 4899999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
+||+|||++..|.+||||||++....++ ...+...|
T Consensus 194 vKPSNILldr~G~vKLCDFGIcGqLv~S--------------------------------------------iAkT~daG 229 (361)
T KOG1006|consen 194 VKPSNILLDRHGDVKLCDFGICGQLVDS--------------------------------------------IAKTVDAG 229 (361)
T ss_pred CChhheEEecCCCEeeecccchHhHHHH--------------------------------------------HHhhhccC
Confidence 9999999999999999999996542221 12244456
Q ss_pred Cccccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCC---CccHHHH
Q psy5690 160 PIRWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRP---ATCQKEI 234 (434)
Q Consensus 160 t~~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l 234 (434)
-..|||||-+.. ..|+.+||+||||+++||+. +|..||..++. .++++...... .......+ -.++..+
T Consensus 230 CrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvA--tG~fPyr~w~s--vfeql~~Vv~g--dpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 230 CRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVA--TGNFPYRKWDS--VFEQLCQVVIG--DPPILLFDKECVHYSFSM 303 (361)
T ss_pred CccccChhccCCccCCcchhhhhhhhcceEeeee--cCCCCcchHHH--HHHHHHHHHcC--CCCeecCcccccccCHHH
Confidence 677999999873 45899999999999999999 99999998765 44444332221 11222222 3477899
Q ss_pred HHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 235 FDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
..++.-|+.+|-.+||...++ ++|.....
T Consensus 304 ~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 999999999999999999999 55665543
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=223.91 Aligned_cols=213 Identities=22% Similarity=0.317 Sum_probs=166.0
Q ss_pred CCCCCCCeeeEEEEEec--------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 2 CSLKDPNLVRVIGVCST--------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
..|+|+|++.++++|.. ...+|+|+.+|+. +|.-++. ....+++..++.+++.+++.||.|+|..
T Consensus 71 ~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLs------n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~ 143 (376)
T KOG0669|consen 71 QLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLS------NRKVRFSLSEIKKVMKGLMNGLYYIHRN 143 (376)
T ss_pred HHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhc------CccccccHHHHHHHHHHHHHHHHHHHHh
Confidence 46899999999999843 2348999999987 9999985 2446899999999999999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
.|+|||+|++|+|++.+|.+||+|||+++.+..+.... ...
T Consensus 144 kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~---------------------------------------kpr 184 (376)
T KOG0669|consen 144 KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVV---------------------------------------KPR 184 (376)
T ss_pred hHHhhcccHhhEEEcCCceEEeeccccccceecccccC---------------------------------------CCC
Confidence 99999999999999999999999999988754332110 001
Q ss_pred CCCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccC---------
Q psy5690 154 DTKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY--------- 223 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------- 223 (434)
-+....|..|.+||.+.+ ..|+++.|||+.||++.||+ ++.+-+.+..+.+....+............
T Consensus 185 ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw--trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~ 262 (376)
T KOG0669|consen 185 YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW--TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLY 262 (376)
T ss_pred cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH--ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHH
Confidence 245567899999999986 57899999999999999999 888888888777666555432221111000
Q ss_pred -----CCC-------------CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 224 -----LPR-------------PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 224 -----~~~-------------~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.|. |-.-.++..+|+.+++..||.+|++++++ |.||.+.
T Consensus 263 ~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 263 QSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred HhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 000 11123478899999999999999999999 8888764
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=238.67 Aligned_cols=207 Identities=23% Similarity=0.353 Sum_probs=160.7
Q ss_pred CCCCCCCeeeEEEEE-ecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC--Ccccc
Q psy5690 2 CSLKDPNLVRVIGVC-STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR--DIVHR 78 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--~iiHr 78 (434)
+.|+||-||++|++| .+.+.+|-|+|||+|.+|+-|++ ....+++.++..|+.||+.||.||.+. .|||-
T Consensus 522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK-------QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHY 594 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK-------QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHY 594 (775)
T ss_pred hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHH-------hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeee
Confidence 468999999999999 45678999999999999999998 556899999999999999999999976 69999
Q ss_pred CCCCCCeeee---cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 79 DLAARNCMVG---KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 79 Dlkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
||||.|||+- ..|.+||.|||+++.+.+..+...+. .....
T Consensus 595 DLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdG------------------------------------meLTS 638 (775)
T KOG1151|consen 595 DLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDG------------------------------------MELTS 638 (775)
T ss_pred ccCCccEEEecCcccceeEeeecchhhhccCCccCcccc------------------------------------eeeec
Confidence 9999999994 35789999999998765443221110 01124
Q ss_pred CCCCCccccchhhhhcC----CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 156 KARLPIRWMAWESLLLG----KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~----~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
...||..|++||++.-+ +.+.|+||||+||++|+++ .|+.||......+.+-.-.. +.+. .....|.-+-++
T Consensus 639 QgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl--YGrKPFGhnqsQQdILqeNT-IlkA-tEVqFP~KPvVs 714 (775)
T KOG1151|consen 639 QGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL--YGRKPFGHNQSQQDILQENT-ILKA-TEVQFPPKPVVS 714 (775)
T ss_pred ccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh--ccCCCCCCchhHHHHHhhhc-hhcc-eeccCCCCCccC
Confidence 46789999999998754 3588999999999999999 99999987544332211111 1111 111223334578
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el 255 (434)
.+..++|++||++.-++|....++
T Consensus 715 seAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 715 SEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred HHHHHHHHHHHHhhhhhhhhHHHH
Confidence 899999999999999999888877
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=272.78 Aligned_cols=220 Identities=15% Similarity=0.128 Sum_probs=157.8
Q ss_pred CCCCC-CCeeeEEEEE-------ecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 2 CSLKD-PNLVRVIGVC-------STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 2 ~~L~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
+.++| +||++++|+| ...+.++.++||+ +++|.+++.. ....+++..++.++.||++||+|||++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~------~~~~~~~~~~~~i~~qi~~al~~lH~~ 99 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN------PDRSVDAFECFHVFRQIVEIVNAAHSQ 99 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc------ccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 56788 7999999988 3334677888987 5699999962 235699999999999999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccC------
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYE------ 147 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~------ 147 (434)
||+||||||+|||++..+.+|++|||++....... ...+++.|||.......
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~----------------------~~~~ki~DfG~a~~~~~~~~~~~ 157 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDE----------------------DATTKSREIGSSRREEILSERRI 157 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccc----------------------cCcccccccccccccccccccch
Confidence 99999999999999998999999999875422111 11344555554432110
Q ss_pred --------CcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC
Q psy5690 148 --------SDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS 219 (434)
Q Consensus 148 --------~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~ 219 (434)
...........||+.|||||++.+..++.++|||||||++|||+ ++..|+.... .....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl--~~~~~~~~~~--~~~~~~~~~----- 228 (793)
T PLN00181 158 EKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELF--CPVSSREEKS--RTMSSLRHR----- 228 (793)
T ss_pred hhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHh--hCCCchhhHH--HHHHHHHHh-----
Confidence 00001112246788999999999999999999999999999999 7777765322 111111110
Q ss_pred cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 220 KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 220 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
..++......+...+++.+||+.||.+||++.|+ |+|+.+
T Consensus 229 --~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 229 --VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred --hcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 0111111123456789999999999999999999 788854
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=252.87 Aligned_cols=202 Identities=19% Similarity=0.357 Sum_probs=168.8
Q ss_pred CCCCCeeeEEEEEe-----cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 4 LKDPNLVRVIGVCS-----TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 4 L~HpnIv~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
-+|||++.++|+|. .++.+|+|||||.+||.-++++.- .+..+.|..+..|++.++.||.+||...++||
T Consensus 73 ~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~-----~g~rl~E~~IaYI~re~lrgl~HLH~nkviHR 147 (953)
T KOG0587|consen 73 SHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNT-----KGNRLKEEWIAYILREILRGLAHLHNNKVIHR 147 (953)
T ss_pred cCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhh-----cccchhhHHHHHHHHHHHHHHHHHhhcceeee
Confidence 37999999999984 347799999999999999999843 36789999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|-.|||++.++.+||+|||.+... ........+..
T Consensus 148 DikG~NiLLT~e~~VKLvDFGvSaQl-------------------------------------------dsT~grRnT~i 184 (953)
T KOG0587|consen 148 DIKGQNVLLTENAEVKLVDFGVSAQL-------------------------------------------DSTVGRRNTFI 184 (953)
T ss_pred cccCceEEEeccCcEEEeeeeeeeee-------------------------------------------ecccccccCcC
Confidence 99999999999999999999986431 11222346778
Q ss_pred CCccccchhhhhcC-----CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 159 LPIRWMAWESLLLG-----KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 159 gt~~y~aPE~~~~~-----~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
||+.|||||++.+. .|+..+|+||||++..||. .|.+|+.++-....+-.+ ..........+..++++
T Consensus 185 GtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEla--dG~PPl~DmHPmraLF~I-----pRNPPPkLkrp~kWs~~ 257 (953)
T KOG0587|consen 185 GTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMA--EGAPPLCDMHPMRALFLI-----PRNPPPKLKRPKKWSKK 257 (953)
T ss_pred CCcccccceeeecccCCCCCcccccchhhccceeehhc--CCCCCccCcchhhhhccC-----CCCCCccccchhhHHHH
Confidence 99999999999864 3578999999999999999 999999888766554221 12233344447789999
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHHHH
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLFLQ 260 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~L~ 260 (434)
+.++|..||.+|.++||+..++ |+|+.
T Consensus 258 FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 258 FNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred HHHHHHHHHhhccccCcchhhhccCCccc
Confidence 9999999999999999999999 77776
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=233.46 Aligned_cols=219 Identities=18% Similarity=0.179 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeee
Q psy5690 9 LVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVG 88 (434)
Q Consensus 9 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~ 88 (434)
+|++.++|.-.++.|||+|.+ |-|+.+++... ...+++...+..++.|++++++|||+.+++|.||||+|||+.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N-----~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfv 226 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN-----NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFV 226 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccC-----CccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEe
Confidence 688899999999999999999 56999999733 456799999999999999999999999999999999999995
Q ss_pred cCCceEEccCCcc-cccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchh
Q psy5690 89 KNYTIKISDHAMY-CSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWE 167 (434)
Q Consensus 89 ~~~~~kL~DFGla-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 167 (434)
++...+.-+-+.. +. ...-.+..+++.|||......+. ....+.|..|.|||
T Consensus 227 ss~~~~~~~~k~~~~~----------------------~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPE 279 (415)
T KOG0671|consen 227 SSEYFKTYNPKKKVCF----------------------IRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPE 279 (415)
T ss_pred ccceEEEeccCCccce----------------------eccCCCcceEEEecCCcceeccC-----cceeeeccccCCch
Confidence 4433332222210 00 00011122333333332212221 14456788999999
Q ss_pred hhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHH---HHhhhh--------------hhhcC--------Ccc-
Q psy5690 168 SLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQV---IENCSH--------------WYQNN--------SKQ- 221 (434)
Q Consensus 168 ~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~---~~~~~~--------------~~~~~--------~~~- 221 (434)
++.+-+++.++||||+||||+|++ +|...|...++.+. .+.+.. ++... ..+
T Consensus 280 ViLgLGwS~pCDvWSiGCIL~Ely--tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~ 357 (415)
T KOG0671|consen 280 VILGLGWSQPCDVWSIGCILVELY--TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGK 357 (415)
T ss_pred heeccCcCCccCceeeeeEEEEee--ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcccccccc
Confidence 999999999999999999999999 88998887765552 222210 00000 000
Q ss_pred --c--CCCC--------CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 222 --Q--YLPR--------PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 222 --~--~~~~--------~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
. ..+. .+....++.+|+.+||.+||.+|+|+.|+ |+||+..
T Consensus 358 ~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 358 SKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred chhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 0 0000 11122468899999999999999999999 8999864
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=254.05 Aligned_cols=203 Identities=23% Similarity=0.295 Sum_probs=154.0
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+|||||++|+.-.++...||..|.|.. +|.++++..+ . +.........+.++.|+++||++||+.+||||||||+|
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~-~--d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQN 636 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSG-L--DVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQN 636 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccc-c--chhhcccccHHHHHHHHHHHHHHHHhcccccccCCCce
Confidence 699999999999999999999999965 9999998531 0 11111114567889999999999999999999999999
Q ss_pred eeeec---C--CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 85 CMVGK---N--YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 85 ILl~~---~--~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+. + ..++|+|||+++....... ......+..|
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~s----------------------------------------S~~r~s~~sG 676 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKS----------------------------------------SFSRLSGGSG 676 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcc----------------------------------------hhhcccCCCC
Confidence 99976 3 4689999999887433221 1112356678
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|-+|+|||++....-+.++||+|+||++|+.++| |..||.+....+. +|.. ............++ +..+||.
T Consensus 677 t~GW~APE~L~~~~~~~avDiFslGCvfyYvltg-G~HpFGd~~~R~~--NIl~---~~~~L~~L~~~~d~--eA~dLI~ 748 (903)
T KOG1027|consen 677 TSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTG-GSHPFGDSLERQA--NILT---GNYTLVHLEPLPDC--EAKDLIS 748 (903)
T ss_pred cccccCHHHHhccccCcccchhhcCceEEEEecC-CccCCCchHHhhh--hhhc---CccceeeeccCchH--HHHHHHH
Confidence 9999999999998888899999999999999963 7999987654432 1211 11111111111222 8999999
Q ss_pred HhccCCCCCCCCHHHH--HHHH
Q psy5690 240 ECWKTNETDRPRFSEI--HLFL 259 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L 259 (434)
+|++.||..||++.+| |++|
T Consensus 749 ~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 749 RMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred HhcCCCcccCCCHHHHhCCCcc
Confidence 9999999999999999 6655
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=247.78 Aligned_cols=205 Identities=20% Similarity=0.294 Sum_probs=154.3
Q ss_pred CCCCCCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++|+|+|||+++|+-++.. ...+|||||.||||..++++. .....+++.+.+.++.+++.||.|||++|
T Consensus 65 lkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P----EN~~GLpE~e~l~lL~d~~~al~~LrEn~ 140 (732)
T KOG4250|consen 65 LKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP----ENAYGLPESEFLDLLSDLVSALRHLRENG 140 (732)
T ss_pred HHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCc----ccccCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 57899999999999965443 468999999999999999843 25568999999999999999999999999
Q ss_pred ccccCCCCCCeeee--cCC--ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 75 IVHRDLAARNCMVG--KNY--TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 75 iiHrDlkp~NILl~--~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
|+||||||.||++- .+| .-||+|||.||...+..
T Consensus 141 IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s------------------------------------------ 178 (732)
T KOG4250|consen 141 IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS------------------------------------------ 178 (732)
T ss_pred ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC------------------------------------------
Confidence 99999999999984 234 46999999998743332
Q ss_pred cccCCCCCCCccccchhhhh-cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH----HHHhhhhh--------hhc
Q psy5690 151 YLSDTKARLPIRWMAWESLL-LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ----VIENCSHW--------YQN 217 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~----~~~~~~~~--------~~~ 217 (434)
...+..||..|.+||.+. .+.|+..+|.|||||++|++. ||..||....... ....+... .+.
T Consensus 179 --~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ca--TG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~ 254 (732)
T KOG4250|consen 179 --LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECA--TGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE 254 (732)
T ss_pred --eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHh--ccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence 236678999999999999 488899999999999999999 8999997644332 22111100 000
Q ss_pred C-----CcccCCCCCCccHH----HHHHHHHHhccCCCCCCC--CHHHH
Q psy5690 218 N-----SKQQYLPRPATCQK----EIFDLMLECWKTNETDRP--RFSEI 255 (434)
Q Consensus 218 ~-----~~~~~~~~~~~~~~----~l~~li~~cl~~dP~~Rp--s~~el 255 (434)
. ......|.+...+. .+-..+..+|..+|.+|. .+.+.
T Consensus 255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~ 303 (732)
T KOG4250|consen 255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRF 303 (732)
T ss_pred ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchH
Confidence 0 01122333444443 355677788899999998 54444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=228.34 Aligned_cols=198 Identities=28% Similarity=0.362 Sum_probs=159.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++|+||+++++++......++++||+++++|.+++... ..+++..+..++.+++.|+.|||+.+++|+||+
T Consensus 42 ~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~ 114 (244)
T smart00220 42 KKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR-------GRLSEDEARFYARQILSALEYLHSNGIIHRDLK 114 (244)
T ss_pred HhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcC
Confidence 5679999999999999999999999999999999999732 238899999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.++|+|||.+....... ......++.
T Consensus 115 ~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------------------------------------~~~~~~~~~ 150 (244)
T smart00220 115 PENILLDEDGHVKLADFGLARQLDPGG--------------------------------------------LLTTFVGTP 150 (244)
T ss_pred HHHeEECCCCcEEEccccceeeecccc--------------------------------------------ccccccCCc
Confidence 999999999999999999865421110 112344567
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCC-CChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAE-LTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|++||.+....++.++||||||+++|+++ +|..||.. .......+.... . ..........++.++.+++.+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~--~~~~p~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELL--TGKPPFPGDDQLLELFKKIGK----P-KPPFPPPEWKISPEAKDLIRK 223 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHhc----c-CCCCccccccCCHHHHHHHHH
Confidence 799999999888899999999999999999 88999987 333333332221 0 111111111177899999999
Q ss_pred hccCCCCCCCCHHHHHH
Q psy5690 241 CWKTNETDRPRFSEIHL 257 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~ 257 (434)
||..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999953
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=235.88 Aligned_cols=205 Identities=24% Similarity=0.342 Sum_probs=154.3
Q ss_pred CCCCCCeeeEEEEEecCC----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-----
Q psy5690 3 SLKDPNLVRVIGVCSTED----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR----- 73 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----- 73 (434)
.|+|+||++|+++-.... .+++|+||.+.|+|.+||+. ..++|....+++..+++||+|||+.
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~--------ntisw~~~cria~SmarGLa~LHee~p~~d 331 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA--------NTISWNSLCRIAESMARGLAHLHEELPRGD 331 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh--------ccccHHHHHHHHHHHHHHHHHhcccCCcCC
Confidence 589999999999976555 79999999999999999963 4699999999999999999999963
Q ss_pred ----CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCc
Q psy5690 74 ----DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESD 149 (434)
Q Consensus 74 ----~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 149 (434)
.|+|||||..|||+..|+.+.|+|||+|..+....
T Consensus 332 ~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~----------------------------------------- 370 (534)
T KOG3653|consen 332 HHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGK----------------------------------------- 370 (534)
T ss_pred CCCCccccccccccceEEccCCcEEeeccceeEEecCCC-----------------------------------------
Confidence 59999999999999999999999999987643111
Q ss_pred ccccCCCCCCCccccchhhhhcCCC------CCcCChHHHHHHHHHHHhhcCC----------CCCCC-----CChHHHH
Q psy5690 150 YYLSDTKARLPIRWMAWESLLLGKN------TTKSDVWSFAVTLWEILIHCNQ----------RPYAE-----LTNEQVI 208 (434)
Q Consensus 150 ~~~~~~~~~gt~~y~aPE~~~~~~~------s~~sDIwSlGvil~ellt~~g~----------~pf~~-----~~~~~~~ 208 (434)
.....-..+||.+|||||++.+..- =.+.||||+|.++|||++++.. .||.. ...+++.
T Consensus 371 ~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq 450 (534)
T KOG3653|consen 371 PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQ 450 (534)
T ss_pred CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHH
Confidence 0011234789999999999986432 2468999999999999975432 12321 1112222
Q ss_pred HhhhhhhhcCCcccCCCCCC-----ccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 209 ENCSHWYQNNSKQQYLPRPA-----TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+.+ ...++..+. ....-+.+.+..||..||+.|.|+.=+-+.+.+.
T Consensus 451 ~~VV~------kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 451 ELVVR------KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred HHHHh------hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 22211 112222222 2235688999999999999999999998888774
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=208.74 Aligned_cols=210 Identities=19% Similarity=0.308 Sum_probs=165.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.|+|.|||+++++...+..+-+|+|||.. +|..|... .++.+..+.+..++.|+++||.|+|++++.|||+
T Consensus 55 lkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfds------lng~~d~~~~rsfmlqllrgl~fchshnvlhrdl 127 (292)
T KOG0662|consen 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS------LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDL 127 (292)
T ss_pred HHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHh------cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccC
Confidence 4678999999999999999999999999965 99999974 4467899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|+|++.+|..|++|||+++.++-+. + .-.....|
T Consensus 128 kpqnllin~ngelkladfglarafgipv------------r-------------------------------cysaevvt 164 (292)
T KOG0662|consen 128 KPQNLLINRNGELKLADFGLARAFGIPV------------R-------------------------------CYSAEVVT 164 (292)
T ss_pred CcceEEeccCCcEEecccchhhhcCCce------------E-------------------------------eeeceeee
Confidence 9999999999999999999988743322 0 01223457
Q ss_pred ccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccC---------CC---CC
Q psy5690 161 IRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY---------LP---RP 227 (434)
Q Consensus 161 ~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~---~~ 227 (434)
..|.+|.++.+.+ |+...|+||.||++.|+.. .|++.|.+.+..+...++-..+........ .+ .+
T Consensus 165 lwyrppdvlfgakly~tsidmwsagcifaelan-agrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~yp 243 (292)
T KOG0662|consen 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN-AGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYP 243 (292)
T ss_pred eeccCcceeeeeehhccchHhhhcchHHHHHhh-cCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcc
Confidence 8899999998865 6889999999999999985 688888888877766655432221111111 01 11
Q ss_pred ---------CccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 228 ---------ATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 228 ---------~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+.....-++++.+.+.-+|.+|.++++. |+++.+
T Consensus 244 attswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 244 ATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 1222346799999999999999999988 555544
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=226.03 Aligned_cols=204 Identities=17% Similarity=0.238 Sum_probs=157.0
Q ss_pred CCCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|..++|+||++++.+|.-. ...|+||||+.. +|.+.+. ..+....+..++.|++.|++|||+.|
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~---------~elDH~tis~i~yq~~~~ik~lhs~~ 138 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL---------MELDHETISYILYQMLCGIKHLHSAG 138 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH---------HhcchHHHHHHHHHHHHHHHHHHhcc
Confidence 4568999999999999543 358999999965 9999886 35777889999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+||++..+..+||.|||+|+..... +..
T Consensus 139 IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--------------------------------------------~~m 174 (369)
T KOG0665|consen 139 IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--------------------------------------------FMM 174 (369)
T ss_pred eeecccCcccceecchhheeeccchhhcccCcc--------------------------------------------ccc
Confidence 999999999999999999999999998652111 233
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhh-------------------hh
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSH-------------------WY 215 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~-------------------~~ 215 (434)
+....|.-|.|||++.+..+...+||||+||++.||+ +|..-|.+...-+...++.+ +.
T Consensus 175 tpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli--~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELI--LGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred CchhheeeccCchheeccCCcccchhhhhhhHHHHHh--hceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 5566778899999999999999999999999999999 77777776543322211111 00
Q ss_pred hcCC---------------cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHH
Q psy5690 216 QNNS---------------KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQ 260 (434)
Q Consensus 216 ~~~~---------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~ 260 (434)
.... .......+..-...+++++.+||..||++|.|++++ |++++
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0000 000001111223568899999999999999999999 88887
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=206.59 Aligned_cols=161 Identities=22% Similarity=0.279 Sum_probs=130.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrD 79 (434)
|+....|.+|.+||.+...+..|+.||.+.. ||+.+-++- ...+..+++..+-+|+..++.||.|||++ .++|||
T Consensus 99 ~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v---~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRD 174 (282)
T KOG0984|consen 99 MRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKV---LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRD 174 (282)
T ss_pred ccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHH---HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhcc
Confidence 4567899999999999999999999999976 888876532 12567899999999999999999999987 899999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
+||+|||++.+|++|+||||++....++-. .+-..|
T Consensus 175 vKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--------------------------------------------kt~daG 210 (282)
T KOG0984|consen 175 VKPSNILINYDGQVKICDFGISGYLVDSIA--------------------------------------------KTMDAG 210 (282)
T ss_pred CCcceEEEccCCcEEEcccccceeehhhhH--------------------------------------------HHHhcC
Confidence 999999999999999999999655322211 122334
Q ss_pred Cccccchhhhhc----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC-hHHHHHhh
Q psy5690 160 PIRWMAWESLLL----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELT-NEQVIENC 211 (434)
Q Consensus 160 t~~y~aPE~~~~----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~-~~~~~~~~ 211 (434)
-..|||||.+.. ..|+.++||||||+++.||. +++.||.... ..+...++
T Consensus 211 CkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA--~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 211 CKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA--ILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred CCccCChhhcCcccCcccceeehhhhhhhhhhhhhh--hccccccccCCHHHHHHHH
Confidence 456999998863 47899999999999999999 8899998764 33444433
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=222.32 Aligned_cols=209 Identities=25% Similarity=0.378 Sum_probs=156.9
Q ss_pred CCCCCCeeeEEEEEecCC----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-----
Q psy5690 3 SLKDPNLVRVIGVCSTED----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR----- 73 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----- 73 (434)
-|+|+||+.|++.-..++ .+|+|++|.+.|||.|||.+ ..++....++++..++.||++||..
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--------~tv~~~~ml~LalS~AsGLaHLH~eI~GTq 332 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--------NTVTTEGMLKLALSIASGLAHLHMEIVGTQ 332 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCC
Confidence 379999999999875443 48999999999999999962 5688999999999999999999942
Q ss_pred ---CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 74 ---DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 74 ---~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
.|.|||||..|||+..++.+.|+|+|+|-...... ...
T Consensus 333 gKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t---------------------------------------~~i 373 (513)
T KOG2052|consen 333 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDT---------------------------------------DTI 373 (513)
T ss_pred CCchhhccccccccEEEccCCcEEEeeceeeEEecccC---------------------------------------Ccc
Confidence 59999999999999999999999999986532221 112
Q ss_pred cccCCCCCCCccccchhhhhcCCC------CCcCChHHHHHHHHHHHhhc--------CCCCCCCCCh----HHHHHhhh
Q psy5690 151 YLSDTKARLPIRWMAWESLLLGKN------TTKSDVWSFAVTLWEILIHC--------NQRPYAELTN----EQVIENCS 212 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~~~------s~~sDIwSlGvil~ellt~~--------g~~pf~~~~~----~~~~~~~~ 212 (434)
....+..+||.+|||||++...-. -..+||||||.++||+..++ -+.||.+... .+....+
T Consensus 374 di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkV- 452 (513)
T KOG2052|consen 374 DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKV- 452 (513)
T ss_pred cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcc-
Confidence 234467899999999999975421 34689999999999998432 2467765422 2222221
Q ss_pred hhhhcCCcccCCCCCCc-----cHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 213 HWYQNNSKQQYLPRPAT-----CQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 213 ~~~~~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
... +..++..|.. +-..+..+|+.||..+|..|.|+-.|.+.|.+..
T Consensus 453 --VCv--~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 453 --VCV--QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred --eee--cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 111 1222222222 2245778999999999999999999988887753
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=247.58 Aligned_cols=191 Identities=20% Similarity=0.260 Sum_probs=136.2
Q ss_pred CceEEEEecCCCCCHHHHHhhccCCCCCCCCC-CHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccC
Q psy5690 20 DPISTIQEYCEFGDLSTFLQIHNCNSQENPAI-SYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDH 98 (434)
Q Consensus 20 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l-~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DF 98 (434)
..+||-||||+.-.|.+++++.. .. ....++++++||++||.|+|++|||||||||.||+++.++.+||+||
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~-------~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDF 741 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNH-------FNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDF 741 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcc-------cchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeeccc
Confidence 34789999999978888886332 22 46789999999999999999999999999999999999999999999
Q ss_pred CcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCC---CC
Q psy5690 99 AMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK---NT 175 (434)
Q Consensus 99 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s 175 (434)
|+|+........... ..+ +. ...........++..||.-|+|||++.+.. |+
T Consensus 742 GLAt~~~~~~~~~d~-------------~~~--------~~----~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 742 GLATDLKENLESIDQ-------------DLS--------FS----TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ccchhhhhhhhhHhh-------------ccC--------cc----ccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 998763211000000 000 00 011112222457789999999999998755 89
Q ss_pred CcCChHHHHHHHHHHHhhcCCCCCCCC-ChHHHHHhhhhhhhcCCcccCCCCC----CccHHHHHHHHHHhccCCCCCCC
Q psy5690 176 TKSDVWSFAVTLWEILIHCNQRPYAEL-TNEQVIENCSHWYQNNSKQQYLPRP----ATCQKEIFDLMLECWKTNETDRP 250 (434)
Q Consensus 176 ~~sDIwSlGvil~ellt~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rp 250 (434)
.|+|+||||++++||+ .||... .......+++ . ...|.+ ..--+.-..+|..|++.||.+||
T Consensus 797 ~KiDmYSLGIVlFEM~-----yPF~TsMERa~iL~~LR-------~-g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEML-----YPFGTSMERASILTNLR-------K-GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred chhhhHHHHHHHHHHh-----ccCCchHHHHHHHHhcc-------c-CCCCCCcccccccchHHHHHHHHHhcCCCccCC
Confidence 9999999999999999 356432 2233333332 1 112222 22224567899999999999999
Q ss_pred CHHHH
Q psy5690 251 RFSEI 255 (434)
Q Consensus 251 s~~el 255 (434)
||.|+
T Consensus 864 tA~eL 868 (1351)
T KOG1035|consen 864 TATEL 868 (1351)
T ss_pred CHHHH
Confidence 99998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=243.69 Aligned_cols=203 Identities=15% Similarity=0.134 Sum_probs=133.8
Q ss_pred ecCCceEEEEecCCCCCHHHHHhhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 17 STEDPISTIQEYCEFGDLSTFLQIHNCNS-------------QENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 17 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~-------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
..++..++|+||+.+|+|.+++....... ..........+..++.||+.||+|||+++|+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 34567999999999999999997432100 00111223456789999999999999999999999999
Q ss_pred Ceeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 84 NCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 84 NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
|||++. ++.+||+|||+++...... ........+++.
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~------------------------------------------~~~~~~~~~t~~ 322 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGI------------------------------------------NYIPKEFLLDPR 322 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccc------------------------------------------ccCCcccccCCC
Confidence 999986 5789999999976421110 011133456788
Q ss_pred ccchhhhhcC----------------------CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhh-------h
Q psy5690 163 WMAWESLLLG----------------------KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCS-------H 213 (434)
Q Consensus 163 y~aPE~~~~~----------------------~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~-------~ 213 (434)
|+|||.+... .++.++|||||||++|||+ ++..++.... ......+. .
T Consensus 323 Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~--~~~~~~~~~~-~~~~~~l~~~~~~~~~ 399 (566)
T PLN03225 323 YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA--FPNLRSDSNL-IQFNRQLKRNDYDLVA 399 (566)
T ss_pred ccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHH--hCcCCCchHH-HHHHHHHHhcCCcHHH
Confidence 9999976432 2345679999999999999 6555543211 11111111 0
Q ss_pred hhhcCCcccC------CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 214 WYQNNSKQQY------LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 214 ~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
|......... ...........++|+.+||+.||++|||++|+ |+||++...
T Consensus 400 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 400 WRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 1000000000 00011123456699999999999999999999 899987543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=205.95 Aligned_cols=164 Identities=16% Similarity=0.177 Sum_probs=123.3
Q ss_pred CCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccc
Q psy5690 32 GDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYL 111 (434)
Q Consensus 32 gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 111 (434)
|+|.++++.+ +..+++..++.++.||+.||+|||+++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~----- 61 (176)
T smart00750 1 VSLADILEVR------GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP----- 61 (176)
T ss_pred CcHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----
Confidence 7999999732 346999999999999999999999998 999999999999999 998654111
Q ss_pred cccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHH
Q psy5690 112 SDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEIL 191 (434)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ell 191 (434)
....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 62 -------------------------------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 98 (176)
T smart00750 62 -------------------------------------------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL 98 (176)
T ss_pred -------------------------------------------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHH
Confidence 1124678899999999999999999999999999999
Q ss_pred hhcCCCCCCCCChH-HHHHhhhhhhhcCCcccCCCCCCccHH--HHHHHHHHhccCCCCCCCCHHHHHHHHH
Q psy5690 192 IHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRPATCQK--EIFDLMLECWKTNETDRPRFSEIHLFLQ 260 (434)
Q Consensus 192 t~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~~li~~cl~~dP~~Rps~~el~~~L~ 260 (434)
+|..||...... .....+........ ......+...+. ++.+++.+||+.||++||++.|++..+.
T Consensus 99 --tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 99 --DYELPYNEERELSAILEILLNGMPADD-PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred --hCCCCccccchhcHHHHHHHHHhccCC-ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 899999765432 22222221111110 001111233444 6999999999999999999999955443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=230.81 Aligned_cols=209 Identities=15% Similarity=0.165 Sum_probs=144.4
Q ss_pred CeeeEEEEEec--------CCceEEEEecCCCCCHHHHHhhccCCC-----------------CCCCCCCHHHHHHHHHH
Q psy5690 8 NLVRVIGVCST--------EDPISTIQEYCEFGDLSTFLQIHNCNS-----------------QENPAISYGCLIFMATQ 62 (434)
Q Consensus 8 nIv~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~q 62 (434)
++++++++|.. .+..++|+||+++|+|.++++...... .....+++..+..++.|
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 34778887753 356899999999999999997432110 01223567789999999
Q ss_pred HHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCcccc
Q psy5690 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMY 142 (434)
Q Consensus 63 i~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 142 (434)
++.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 318 l~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~---------------------------------- 363 (507)
T PLN03224 318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI---------------------------------- 363 (507)
T ss_pred HHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC----------------------------------
Confidence 9999999999999999999999999999999999999875421100
Q ss_pred ccccCCcccccCCCCCCCccccchhhhhcCCC----------------------CCcCChHHHHHHHHHHHhhcCCC-CC
Q psy5690 143 CSHYESDYYLSDTKARLPIRWMAWESLLLGKN----------------------TTKSDVWSFAVTLWEILIHCNQR-PY 199 (434)
Q Consensus 143 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----------------------s~~sDIwSlGvil~ellt~~g~~-pf 199 (434)
........+++.|+|||.+..... ..+.||||+||++|+|+ ++.. ||
T Consensus 364 --------~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~--~~~l~p~ 433 (507)
T PLN03224 364 --------NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMC--VPELRPV 433 (507)
T ss_pred --------ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHH--hCCCCCc
Confidence 001112234678999998864321 23479999999999999 6554 66
Q ss_pred CCCChHHHH-H----hhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCC---CCCCCHHHH--HHHHH
Q psy5690 200 AELTNEQVI-E----NCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNE---TDRPRFSEI--HLFLQ 260 (434)
Q Consensus 200 ~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~Rps~~el--~~~L~ 260 (434)
......... . ....|..........+.....++..++|+.+||..+| .+|+|++|+ |+||.
T Consensus 434 ~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 434 ANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred cchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 543211110 0 0111111111222233345678899999999999866 689999999 88874
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-28 Score=211.91 Aligned_cols=206 Identities=20% Similarity=0.278 Sum_probs=155.7
Q ss_pred CCCCCCCeeeEEEEEecCC-----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCSTED-----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
..++|.|++..+++..-.. .+|+++|.+.. +|...+- ....++.+.++-+++||++||+|||+.+|.
T Consensus 107 cfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIV-------SPQ~Ls~DHvKVFlYQILRGLKYLHsA~IL 178 (449)
T KOG0664|consen 107 SSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIV-------SPQALTPDHVKVFVYQILRGLKYLHTANIL 178 (449)
T ss_pred HhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheec-------cCCCCCcchhhhhHHHHHhhhHHHhhcchh
Confidence 4578999999999875443 47889999965 9999886 567889999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||.|+|++.+-.+||||||+++.....+ ....+.
T Consensus 179 HRDIKPGNLLVNSNCvLKICDFGLARvee~d~------------------------------------------~~hMTq 216 (449)
T KOG0664|consen 179 HRDIKPGNLLVNSNCILKICDFGLARTWDQRD------------------------------------------RLNMTH 216 (449)
T ss_pred hccCCCccEEeccCceEEecccccccccchhh------------------------------------------hhhhHH
Confidence 99999999999999999999999988632221 111123
Q ss_pred CCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc-----------------C
Q psy5690 157 ARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN-----------------N 218 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~-----------------~ 218 (434)
...|..|.|||++.+. .|+.+.||||.||++.|++ ..+..|...+..+..+.+.+.+.. .
T Consensus 217 EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELL--gRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 217 EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELL--QRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHH--hhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 3445679999999874 6899999999999999999 778888877665554443322110 0
Q ss_pred CcccCCC---------CCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy5690 219 SKQQYLP---------RPATCQKEIFDLMLECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 219 ~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 259 (434)
......| .+.....+..+++.+++..||.+|.+.++.++..
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0111111 1223345677888999999999999999885443
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-27 Score=225.78 Aligned_cols=200 Identities=19% Similarity=0.292 Sum_probs=163.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.-+|||||.++|.+...+..|++||||.+|+|++.-+ ....+++.++...+++.++||+|||+.|-+||||
T Consensus 66 ~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~-------~TgplselqiayvcRetl~gl~ylhs~gk~hRdi 138 (829)
T KOG0576|consen 66 LRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDI 138 (829)
T ss_pred eecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee-------ecccchhHHHHHHHhhhhccchhhhcCCcccccc
Confidence 356789999999999999999999999999999999876 6678999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|-.|||+++.|.+|++|||.+-.+ ...........||
T Consensus 139 KGanilltd~gDvklaDfgvsaqi-------------------------------------------tati~KrksfiGt 175 (829)
T KOG0576|consen 139 KGANILLTDEGDVKLADFGVSAQI-------------------------------------------TATIAKRKSFIGT 175 (829)
T ss_pred cccceeecccCceeecccCchhhh-------------------------------------------hhhhhhhhcccCC
Confidence 999999999999999999985331 1111233667899
Q ss_pred ccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+.|||||+.. .+.|..++|||++|++..|+- .-+.|-...-..+...-.. ....+.........+++.+.+|
T Consensus 176 pywmapEvaaverkggynqlcdiwa~gitAiel~--eLqpplfdlhpmr~l~LmT---kS~~qpp~lkDk~kws~~fh~f 250 (829)
T KOG0576|consen 176 PYWMAPEVAAVERKGGYNQLCDIWALGITAIELG--ELQPPLFDLHPMRALFLMT---KSGFQPPTLKDKTKWSEFFHNF 250 (829)
T ss_pred ccccchhHHHHHhcccccccccccccccchhhhh--hcCCcccccchHHHHHHhh---ccCCCCCcccCCccchHHHHHH
Confidence 9999999875 567899999999999999998 5566655544443322111 1122333444567889999999
Q ss_pred HHHhccCCCCCCCCHHHH
Q psy5690 238 MLECWKTNETDRPRFSEI 255 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el 255 (434)
++.|+..+|++||+++.+
T Consensus 251 vK~altknpKkRptaekl 268 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKL 268 (829)
T ss_pred HHHHhcCCCccCCChhhh
Confidence 999999999999999876
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-27 Score=219.79 Aligned_cols=203 Identities=17% Similarity=0.198 Sum_probs=158.4
Q ss_pred CCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCee
Q psy5690 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCM 86 (434)
Q Consensus 7 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NIL 86 (434)
-|+++|+..|...+++|||+|.+.- +|.++|++.+ .+..+....+..++.|+.-||..|-..||+|.||||+|||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG----~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiL 568 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYG----RNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNIL 568 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhC----cccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceE
Confidence 3678888899999999999999954 9999999876 6677888999999999999999999999999999999999
Q ss_pred eecC-CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccc
Q psy5690 87 VGKN-YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 165 (434)
Q Consensus 87 l~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~a 165 (434)
++.. ..+||||||.|....+... +......-|.|
T Consensus 569 VNE~k~iLKLCDfGSA~~~~enei---------------------------------------------tPYLVSRFYRa 603 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENEI---------------------------------------------TPYLVSRFYRA 603 (752)
T ss_pred eccCcceeeeccCccccccccccc---------------------------------------------cHHHHHHhccC
Confidence 9875 5679999998765433321 11122245999
Q ss_pred hhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC-------------------------C-
Q psy5690 166 WESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN-------------------------S- 219 (434)
Q Consensus 166 PE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------------~- 219 (434)
||++.+-.|++..|+||.||+||||. +|+.-|.+..+.+++...+...... .
T Consensus 604 PEIiLG~~yd~~iD~WSvgctLYElY--tGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D 681 (752)
T KOG0670|consen 604 PEIILGLPYDYPIDTWSVGCTLYELY--TGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVD 681 (752)
T ss_pred cceeecCcccCCccceeeceeeEEee--ccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEecc
Confidence 99999999999999999999999999 8999999988777654333111000 0
Q ss_pred -------------------------c-ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 220 -------------------------K-QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 220 -------------------------~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
. +..+......-.++.+|+.+||..||++|.+..+. |+|++.
T Consensus 682 ~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 682 KVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred ccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 0 00000011223568999999999999999999998 777753
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=219.87 Aligned_cols=143 Identities=22% Similarity=0.284 Sum_probs=126.0
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCC-CCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCE-FGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~-~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.|+||++++++|++++.+|++||-.. |-+|.+++. -+..+++.++..|+.|++.|+++||+.||||||||-+
T Consensus 627 sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE-------~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikde 699 (772)
T KOG1152|consen 627 SHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE-------FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDE 699 (772)
T ss_pred CccchhhhhheeecCCeeEEEecCCCCCcchhhhhh-------ccCccchHHHHHHHHHHHhccccccccCceecccccc
Confidence 39999999999999999999999874 669999997 5568999999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
||.++.+|-+||+|||.+..... ..-...+||..|
T Consensus 700 nvivd~~g~~klidfgsaa~~ks---------------------------------------------gpfd~f~gtv~~ 734 (772)
T KOG1152|consen 700 NVIVDSNGFVKLIDFGSAAYTKS---------------------------------------------GPFDVFVGTVDY 734 (772)
T ss_pred cEEEecCCeEEEeeccchhhhcC---------------------------------------------CCcceeeeeccc
Confidence 99999999999999997533110 011346799999
Q ss_pred cchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCC
Q psy5690 164 MAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAE 201 (434)
Q Consensus 164 ~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~ 201 (434)
.|||++.+.+| +..-|||++|+++|.++ ....||.+
T Consensus 735 aapevl~g~~y~gk~qdiwalgillytiv--ykenpyyn 771 (772)
T KOG1152|consen 735 AAPEVLGGEKYLGKPQDIWALGILLYTIV--YKENPYYN 771 (772)
T ss_pred cchhhhCCCccCCCcchhhhhhheeeEEE--eccCCCcC
Confidence 99999999988 78899999999999999 78888864
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=196.33 Aligned_cols=201 Identities=17% Similarity=0.254 Sum_probs=148.3
Q ss_pred CCCCeeeEEEE-EecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 5 KDPNLVRVIGV-CSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 5 ~HpnIv~l~~~-~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.|.||+.-|++ |+..+.+.+++||++.|+|..-+. ...+.+....+++.|+++|+.|+|++++||||||.+
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~--------~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~e 150 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE--------AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAE 150 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC--------cccccHHHHHHHHHHHHHHHHHhhccchhhcccccc
Confidence 48899987764 677788999999999999998874 356888889999999999999999999999999999
Q ss_pred Ceeeec--CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 84 NCMVGK--NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 84 NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|||+-+ ...+||||||..+..+... ....-+.
T Consensus 151 NiLif~~df~rvKlcDFG~t~k~g~tV----------------------------------------------~~~~~~~ 184 (378)
T KOG1345|consen 151 NILIFDADFYRVKLCDFGLTRKVGTTV----------------------------------------------KYLEYVN 184 (378)
T ss_pred eEEEecCCccEEEeeecccccccCcee----------------------------------------------hhhhhhc
Confidence 999943 4589999999865422111 1112234
Q ss_pred cccchhhhhcC---C--CCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 162 RWMAWESLLLG---K--NTTKSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 162 ~y~aPE~~~~~---~--~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
.|.+||.+... . ..+.+|||.||+++|.++ +|..||..... +.-+.++..|..... ...+..-..+++.+.
T Consensus 185 ~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl--tG~~PWQka~~~d~~Y~~~~~w~~rk~-~~~P~~F~~fs~~a~ 261 (378)
T KOG1345|consen 185 NYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL--TGKFPWQKASIMDKPYWEWEQWLKRKN-PALPKKFNPFSEKAL 261 (378)
T ss_pred ccCCcHHHhhccccceEecccccchheeeeeeeee--cCCCcchhhhccCchHHHHHHHhcccC-ccCchhhcccCHHHH
Confidence 58899987642 2 367899999999999999 89999974332 223333333332222 222333456788999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 236 DLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.+.++-|..++++|-...++.++.+..
T Consensus 262 r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 262 RLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred HHHHHhcCCcccccchhHHHHHHHHHH
Confidence 999999999999997666665544443
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=190.21 Aligned_cols=204 Identities=16% Similarity=0.248 Sum_probs=149.9
Q ss_pred CCC-CCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 3 SLK-DPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 3 ~L~-HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
.|. ||||++++++..+. ....+|+||+.+-+...+.. .++.-.+..++.|+++||.|+|++||+|||
T Consensus 88 nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----------tl~d~dIryY~~elLkALdyCHS~GImHRD 157 (338)
T KOG0668|consen 88 NLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----------TLTDYDIRYYIYELLKALDYCHSMGIMHRD 157 (338)
T ss_pred hccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----------hhchhhHHHHHHHHHHHHhHHHhcCccccc
Confidence 454 99999999998665 45789999999988877664 577788999999999999999999999999
Q ss_pred CCCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 80 LAARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 80 lkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
+||.|+++|. .-.++|+|+|+|..+.....+ +...
T Consensus 158 VKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY--------------------------------------------nVRV 193 (338)
T KOG0668|consen 158 VKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--------------------------------------------NVRV 193 (338)
T ss_pred CCcceeeechhhceeeeeecchHhhcCCCcee--------------------------------------------eeee
Confidence 9999999986 457899999998764332211 1112
Q ss_pred CCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCC-CCChHHHHHhhhhhh---------hcCC--------
Q psy5690 159 LPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYA-ELTNEQVIENCSHWY---------QNNS-------- 219 (434)
Q Consensus 159 gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~-~~~~~~~~~~~~~~~---------~~~~-------- 219 (434)
.+..|-.||.+.. ..|+..-|+|||||++..|+ ..+.||. +.++.+....+...+ .+..
T Consensus 194 ASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~mi--FrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~ 271 (338)
T KOG0668|consen 194 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI--FRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFE 271 (338)
T ss_pred ehhhcCCchheeechhccccHHHHHHHHHHHHHH--hccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHh
Confidence 2344778998875 45788999999999999999 5566664 444433332222110 0000
Q ss_pred ----ccc--------CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 220 ----KQQ--------YLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 220 ----~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
... ........++++.+++.+.|.+|-.+|+|+.|. |++|...
T Consensus 272 ~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 272 DILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred hHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 000 001122346899999999999999999999999 8888754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=189.74 Aligned_cols=168 Identities=30% Similarity=0.444 Sum_probs=143.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++.++|++|+++++++......++++|++.+++|.+++.... ..+++..+..++.++++++++||+.|++|+||
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl 118 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE------GKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 356889999999999999899999999999999999997321 46889999999999999999999999999999
Q ss_pred CCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 81 AARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 81 kp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
+|.||+++. ++.++|+|||.+........ ......+
T Consensus 119 ~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------------------------------------------~~~~~~~ 155 (215)
T cd00180 119 KPENILLDSDNGKVKLADFGLSKLLTSDKS-------------------------------------------LLKTIVG 155 (215)
T ss_pred CHhhEEEeCCCCcEEEecCCceEEccCCcc-------------------------------------------hhhcccC
Confidence 999999999 89999999998654221110 0122334
Q ss_pred CccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
...|++||.+... ..+.+.|+|++|++++++ ..+.+++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------~~~~~~l 194 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------PELKDLI 194 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------HHHHHHH
Confidence 5679999999887 788999999999999998 5788999
Q ss_pred HHhccCCCCCCCCHHHHHHH
Q psy5690 239 LECWKTNETDRPRFSEIHLF 258 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~ 258 (434)
.+|++.||++||+++++...
T Consensus 195 ~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 195 RKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHhhCCcccCcCHHHHhhC
Confidence 99999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=199.74 Aligned_cols=246 Identities=15% Similarity=0.197 Sum_probs=161.6
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
-+.||+++.+++..++..++|+||++..+..++.. .++...+..++..++.||.++|.+|||||||||+|
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~----------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsN 162 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR----------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSN 162 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHh----------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccc
Confidence 36799999999999999999999999999999886 57788999999999999999999999999999999
Q ss_pred eeeec-CCceEEccCCcccccccccccccccccccchhhh-hhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 85 CMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM-ANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 85 ILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+|.+. .+.-.|.|||+|-................+.... +......+.........++................||++
T Consensus 163 FL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~G 242 (418)
T KOG1167|consen 163 FLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPG 242 (418)
T ss_pred cccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCC
Confidence 99986 4567899999987422211111111100000000 111111111112222222222112222233455689999
Q ss_pred ccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhh------------h------hhh------
Q psy5690 163 WMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCS------------H------WYQ------ 216 (434)
Q Consensus 163 y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~------------~------~~~------ 216 (434)
|.|||++..- ..+.++||||.||++..++ ++..||.....+ .....+. . .++
T Consensus 243 fRaPEvL~k~~~QttaiDiws~GVI~Lsll--s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~ 320 (418)
T KOG1167|consen 243 FRAPEVLFRCPRQTTAIDIWSAGVILLSLL--SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPT 320 (418)
T ss_pred CCchHHHhhccCcCCccceeeccceeehhh--ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccc
Confidence 9999999854 4588999999999999999 889998653321 1110000 0 000
Q ss_pred ---------cC--------Cc--ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 217 ---------NN--------SK--QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 217 ---------~~--------~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.. .. .......+..+..+.+++.+|++.||.+|.|+++. |+|+...
T Consensus 321 ~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 321 IPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 00 00 00001112334578999999999999999999998 7888743
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=220.64 Aligned_cols=213 Identities=20% Similarity=0.214 Sum_probs=163.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++|+|||++..+..+.+.....-+||||++ +|..++. ....+...++..++.|++.|++|+|+.||.|||+|
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~-------~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK 447 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVM-------SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLK 447 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHh-------cccccchhhhhHHHHHHHHHHHHHHhcCceeccCc
Confidence 468999998888877766666666999999 9999997 33578889999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
++|++++.+|.+||+|||.+..+.... ........+.+|.-
T Consensus 448 ~enll~~~~g~lki~Dfg~~~vf~~~~---------------------------------------e~~~~~~~g~~gS~ 488 (601)
T KOG0590|consen 448 LENLLVTENGILKIIDFGAASVFRYPW---------------------------------------EKNIHESSGIVGSD 488 (601)
T ss_pred cccEEEecCCceEEeecCcceeeccCc---------------------------------------chhhhhhcCcccCC
Confidence 999999999999999999865422111 00012234567778
Q ss_pred cccchhhhhcCCCC-CcCChHHHHHHHHHHHhhcCCCCCCCCChHHHH-HhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNT-TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVI-ENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 162 ~y~aPE~~~~~~~s-~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
.|+|||++.+..|. ...||||.|+++..|. +|+.||......+.. .......+.............++.+.+.+|.
T Consensus 489 pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~--~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~ 566 (601)
T KOG0590|consen 489 PYLAPEVLTGKEYDPRAVDVWSCGIIYICMI--LGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIY 566 (601)
T ss_pred cCcCcccccccccCcchhhhhhccceEEEEe--cCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHH
Confidence 89999999999985 5689999999999999 889999765544321 1111111111112222224567788999999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+||+.||.+|.++++| -+|++...
T Consensus 567 ~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 567 RMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred HHccCChhheecHHHHhhChHhhhcc
Confidence 9999999999999999 57998753
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.8e-23 Score=179.47 Aligned_cols=199 Identities=25% Similarity=0.454 Sum_probs=162.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--cccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD--IVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHr 78 (434)
|+-+.||||+.++|.|....++.++..|++.|+|+..+++. .+-..+..++.+++.++++|++|||+.. |.--
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~-----t~vvvd~sqav~faldiargmaflhslep~ipr~ 315 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ-----TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRF 315 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC-----ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhh
Confidence 35578999999999999999999999999999999999832 4456778899999999999999999863 4445
Q ss_pred CCCCCCeeeecCCceEEc--cCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 79 DLAARNCMVGKNYTIKIS--DHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
-|....+++|++...+|+ |--+ .....+
T Consensus 316 ~lns~hvmidedltarismad~kf--------------------------------------------------sfqe~g 345 (448)
T KOG0195|consen 316 YLNSKHVMIDEDLTARISMADTKF--------------------------------------------------SFQEVG 345 (448)
T ss_pred hcccceEEecchhhhheeccccee--------------------------------------------------eeeccc
Confidence 688999999998877764 3111 011122
Q ss_pred CCCCccccchhhhhcCCC---CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 157 ARLPIRWMAWESLLLGKN---TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~---s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
..-.+.||+||.++..+- -.++|+|||++++||+. +...||.+.+..+.-.++. ..+.+...|+..+..
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~--trevpfadlspmecgmkia------leglrv~ippgis~h 417 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELN--TREVPFADLSPMECGMKIA------LEGLRVHIPPGISRH 417 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhh--ccccccccCCchhhhhhhh------hccccccCCCCccHH
Confidence 333467999999987654 35799999999999999 8899999999888765443 356677788999999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+..||.-|+..||.+||.++.|.+.|++.
T Consensus 418 m~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 99999999999999999999999999875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=182.44 Aligned_cols=149 Identities=30% Similarity=0.430 Sum_probs=126.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCC-CCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPA-ISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~-l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++++|+|++++++++......++++||+++++|.+++... .. +++..+..++.+++.++.+||+++++|+|+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di 124 (225)
T smart00221 52 KKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKK-------GGKLSEEEARFYLRQILEALEYLHSLGIVHRDL 124 (225)
T ss_pred HhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhc-------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 4678999999999999999999999999999999999732 23 789999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|.||+++.++.++|+|||.+....... ........++
T Consensus 125 ~~~ni~v~~~~~~~l~d~g~~~~~~~~~------------------------------------------~~~~~~~~~~ 162 (225)
T smart00221 125 KPENILLGMDGLVKLADFGLARFIHRDL------------------------------------------AALLKTVKGT 162 (225)
T ss_pred CHHHEEEcCCCCEEEeeCceeeEecCcc------------------------------------------cccccceecc
Confidence 9999999999999999999866532211 0011223455
Q ss_pred ccccchhhh-hcCCCCCcCChHHHHHHHHHHHhhcCCCCCCC
Q psy5690 161 IRWMAWESL-LLGKNTTKSDVWSFAVTLWEILIHCNQRPYAE 201 (434)
Q Consensus 161 ~~y~aPE~~-~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~ 201 (434)
..|++||.+ ....++.++|+|+||+++++|+ +|+.||..
T Consensus 163 ~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~--~g~~pf~~ 202 (225)
T smart00221 163 PFYLAPEVLLGGKGYGEAVDIWSLGVILYELL--WGPEPFSG 202 (225)
T ss_pred CCcCCHhHhcCCCCCCchhhHHHHHHHHHHHH--HCCCCccc
Confidence 679999998 6667788999999999999999 89999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=191.39 Aligned_cols=79 Identities=16% Similarity=0.350 Sum_probs=68.5
Q ss_pred CCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccC
Q psy5690 5 KDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRD 79 (434)
Q Consensus 5 ~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrD 79 (434)
.-.+||+|++.|.. +.++|+|+|++ |-+|..+|.+. ....++...+++|++||+.||.|||.+ ||||.|
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-----~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTD 213 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-----NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTD 213 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-----CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccC
Confidence 34579999999954 45799999999 66999999854 446799999999999999999999975 999999
Q ss_pred CCCCCeeeec
Q psy5690 80 LAARNCMVGK 89 (434)
Q Consensus 80 lkp~NILl~~ 89 (434)
|||+|||+..
T Consensus 214 lKPENvLl~~ 223 (590)
T KOG1290|consen 214 LKPENVLLCS 223 (590)
T ss_pred CCcceeeeec
Confidence 9999999953
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=195.08 Aligned_cols=213 Identities=25% Similarity=0.401 Sum_probs=161.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc-cccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI-VHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i-iHrD 79 (434)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++++|+.||.|||...| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~------~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN------EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc------cccCccHHHHHHHHHHHHHHHHHHhcCcceeeee
Confidence 7899999999999999999999999999999999999972 45678888889999999999999998876 9999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
++..|++++..+.+||+|||+...... ............
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~-----------------------------------------~~~~~~~~~~~~ 113 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEE-----------------------------------------TAEPEAHHPIRK 113 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccc-----------------------------------------cccccccchhHH
Confidence 999999999999999999998543211 000000111112
Q ss_pred CccccchhhhhcCC-------CCCcCChHHHHHHHHHHHhhcCCCCCCCCCh----HHHHHhhhhhhhcCCcccCCCCC-
Q psy5690 160 PIRWMAWESLLLGK-------NTTKSDVWSFAVTLWEILIHCNQRPYAELTN----EQVIENCSHWYQNNSKQQYLPRP- 227 (434)
Q Consensus 160 t~~y~aPE~~~~~~-------~s~~sDIwSlGvil~ellt~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~- 227 (434)
..-|.|||.+.... .+.+.||||||++++|++ ....||..... .+....+.. ......++...
T Consensus 114 ~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~--~r~~~~~~~~~~~~~~eii~~~~~---~~~~~~rP~i~~ 188 (484)
T KOG1023|consen 114 ALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL--FRSGPFDLRNLVEDPDEIILRVKK---GGSNPFRPSIEL 188 (484)
T ss_pred HHhccCHHHhcccccccccccccccCCeehHHHHHHHHH--hccCccccccccCChHHHHHHHHh---cCCCCcCcchhh
Confidence 34599999997642 367899999999999999 67888876332 233333322 01111122111
Q ss_pred -CccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcccC
Q psy5690 228 -ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNLG 265 (434)
Q Consensus 228 -~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~~~ 265 (434)
....+++..++.+||..+|.+||+++++-..++.....
T Consensus 189 ~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 189 LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 14556899999999999999999999997777665544
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=180.32 Aligned_cols=197 Identities=17% Similarity=0.225 Sum_probs=144.5
Q ss_pred CCCCeeeEEEEEec---------------------------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHH
Q psy5690 5 KDPNLVRVIGVCST---------------------------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLI 57 (434)
Q Consensus 5 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~ 57 (434)
+|||||++.++|.+ +..+|+||.-++. +|..|+.. ...+.....
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~--------~~~s~r~~~ 344 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT--------RHRSYRTGR 344 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc--------CCCchHHHH
Confidence 79999999998854 1247999999876 99999952 346667788
Q ss_pred HHHHHHHHHHHHhhhCCccccCCCCCCeeee--cCC--ceEEccCCcccccccccccccccccccchhhhhhcccCcccc
Q psy5690 58 FMATQIASGMKYLESRDIVHRDLAARNCMVG--KNY--TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYT 133 (434)
Q Consensus 58 ~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~--~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (434)
-++.|+++|+.|||.+||.|||+|.+|||+. +|+ .+.++|||.+-.. + ..|
T Consensus 345 ~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd-~--------------------~hG---- 399 (598)
T KOG4158|consen 345 VILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLAD-D--------------------NHG---- 399 (598)
T ss_pred HHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeec-c--------------------ccc----
Confidence 8999999999999999999999999999984 343 4688999975321 0 000
Q ss_pred eeecCccccccccCCcccccCCCCCCCccccchhhhhcCC------CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHH
Q psy5690 134 IKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK------NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQV 207 (434)
Q Consensus 134 ~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~ 207 (434)
..-++..-.-...|...-||||+....+ .-.|+|.|+.|.+.||++ +...||.......+
T Consensus 400 ------------lqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIf--g~~NPFY~rGem~L 465 (598)
T KOG4158|consen 400 ------------LQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIF--GRSNPFYKRGEMLL 465 (598)
T ss_pred ------------cccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHh--ccCCcccccchhee
Confidence 0011111123345666789999987432 135899999999999999 78899987433222
Q ss_pred HHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 208 IENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
.. ....+...++.++.+++.+++++...|+.||++|++..-.
T Consensus 466 ~~------r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 466 DT------RTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred ch------hhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 11 1122445667788999999999999999999999986543
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-21 Score=185.98 Aligned_cols=191 Identities=23% Similarity=0.279 Sum_probs=161.5
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||.+|+++-.++.+...+++++|..||+|...+. ....+.+.....+...++-|++++|+.+|+|||+|++|
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~-------~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~en 127 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLS-------KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLEN 127 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccc-------cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccc
Confidence 38999999999999999999999999999998886 55678888899999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
|+++.+|++++.|||+++..-+ .+..+||..||
T Consensus 128 illd~~Ghi~~tdfglske~v~-----------------------------------------------~~~~cgt~eym 160 (612)
T KOG0603|consen 128 VLLLLEGHIKLTDFGLSKEAVK-----------------------------------------------EKIACGTYEYR 160 (612)
T ss_pred eeecccCccccCCchhhhHhHh-----------------------------------------------hhhcccchhhh
Confidence 9999999999999999765211 12238899999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 244 (434)
|||++. .....+|.||||++.+||+ +|..||.. +....| .......|...+..+++++..++..
T Consensus 161 ApEI~~--gh~~a~D~ws~gvl~fell--tg~~pf~~----~~~~~I--------l~~~~~~p~~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 161 APEIIN--GHLSAADWWSFGVLAFELL--TGTLPFGG----DTMKRI--------LKAELEMPRELSAEARSLFRQLFKR 224 (612)
T ss_pred hhHhhh--ccCCcccchhhhhhHHHHh--hCCCCCch----HHHHHH--------hhhccCCchhhhHHHHHHHHHHHhh
Confidence 999998 5577899999999999999 88999988 333332 2234566888899999999999999
Q ss_pred CCCCCCCH-----HHH--HHHHHhcccC
Q psy5690 245 NETDRPRF-----SEI--HLFLQRKNLG 265 (434)
Q Consensus 245 dP~~Rps~-----~el--~~~L~~~~~~ 265 (434)
+|.+|.-. .|+ |++++..++.
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred CHHHHhccCcchhHHHhccchheeeeHh
Confidence 99999744 444 7788777665
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=192.88 Aligned_cols=203 Identities=17% Similarity=0.221 Sum_probs=143.6
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
.++|||++.+.-+-..+...|+|-+|..+ +|+|.+. ...-+..-+.+.|+.|++.||..+|..||+|||||.
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlS-------TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKs 148 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLS-------TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKS 148 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhc-------cchHHHHHHHHHHHHHHHHHHHHHHHcCcccccccc
Confidence 46899999998888888889999999977 9999996 556678888999999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+|||++.-..+.|+||.-.+...-+. +.. ... .++-++..+. ..
T Consensus 149 ENILiTSWNW~~LtDFAsFKPtYLPe----DNP------------------------------adf-~fFFDTSrRR-tC 192 (1431)
T KOG1240|consen 149 ENILITSWNWLYLTDFASFKPTYLPE----DNP------------------------------ADF-TFFFDTSRRR-TC 192 (1431)
T ss_pred ceEEEeeechhhhhcccccCCccCCC----CCc------------------------------ccc-eEEEecCCce-ee
Confidence 99999998889999998754422111 110 001 1112222222 35
Q ss_pred ccchhhhhcCC-----------CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 163 WMAWESLLLGK-----------NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 163 y~aPE~~~~~~-----------~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
|.|||-+.... .+++.||||+||++.||++ .|.++|.-. ++...-.. - .......+. .--+
T Consensus 193 YiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~-Eg~PlF~LS---QL~aYr~~-~-~~~~e~~Le--~Ied 264 (1431)
T KOG1240|consen 193 YIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL-EGRPLFTLS---QLLAYRSG-N-ADDPEQLLE--KIED 264 (1431)
T ss_pred ecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh-cCCCcccHH---HHHhHhcc-C-ccCHHHHHH--hCcC
Confidence 99999886421 4678999999999999995 467777421 11100000 0 000000000 0112
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHH
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHL 257 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~ 257 (434)
..++.++..|++.||++|.++++.++
T Consensus 265 ~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 265 VSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred ccHHHHHHHHHccCchhccCHHHHHH
Confidence 47899999999999999999999853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.5e-19 Score=167.41 Aligned_cols=209 Identities=23% Similarity=0.312 Sum_probs=155.7
Q ss_pred CCCCCC-CeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSLKDP-NLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L~Hp-nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+.+.|+ +++++++.+...+..++++|++.++++.+++...... ..+.......++.|++.++.|+|+.+++|||+
T Consensus 52 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~ 127 (384)
T COG0515 52 ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSKGIIHRDI 127 (384)
T ss_pred HHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 457777 7999999997777789999999999999777622100 37889999999999999999999999999999
Q ss_pred CCCCeeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 81 AARNCMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 81 kp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
||+||+++..+ .++++|||.++......... ..........+
T Consensus 128 kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~ 170 (384)
T COG0515 128 KPENILLDRDGRVVKLIDFGLAKLLPDPGSTS-------------------------------------SIPALPSTSVG 170 (384)
T ss_pred CHHHeeecCCCCeEEEeccCcceecCCCCccc-------------------------------------ccccccccccc
Confidence 99999999988 79999999976322111000 00012355678
Q ss_pred Cccccchhhhhc---CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh----HHHHHhhhhhhhcCCcccCCCCCC----
Q psy5690 160 PIRWMAWESLLL---GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN----EQVIENCSHWYQNNSKQQYLPRPA---- 228 (434)
Q Consensus 160 t~~y~aPE~~~~---~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~---- 228 (434)
+..|+|||.+.+ ..++...|+||+|+++++++ .|..||..... .+....+...... ........
T Consensus 171 t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~--~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 245 (384)
T COG0515 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL--TGLPPFEGEKNSSATSQTLKIILELPTP---SLASPLSPSNPE 245 (384)
T ss_pred ccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHH--hCCCCCCCCCccccHHHHHHHHHhcCCc---ccccccCccccc
Confidence 899999999987 57789999999999999999 88989877663 3333322211100 01111111
Q ss_pred ccHHHHHHHHHHhccCCCCCCCCHHHHH
Q psy5690 229 TCQKEIFDLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 229 ~~~~~l~~li~~cl~~dP~~Rps~~el~ 256 (434)
.....+.+++.+|+..+|..|.+..+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~r~~~~~~~ 273 (384)
T COG0515 246 LISKAASDLLKKLLAKDPKNRLSSSSDL 273 (384)
T ss_pred hhhHHHHHHHHHHHhcCchhcCCHHHHh
Confidence 1235789999999999999999888773
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-18 Score=165.51 Aligned_cols=213 Identities=15% Similarity=0.106 Sum_probs=158.4
Q ss_pred CCeeeEEEEE-ecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCe
Q psy5690 7 PNLVRVIGVC-STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNC 85 (434)
Q Consensus 7 pnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 85 (434)
+++.++++.+ ..+...++||+.+ |.+|.++.... ....++..++..++.|++.+|++||+.|++||||||+|+
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~-----~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~ 153 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRN-----PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENF 153 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhC-----CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHe
Confidence 5888999998 5778899999999 77999988632 246899999999999999999999999999999999999
Q ss_pred eeecC-----CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 86 MVGKN-----YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 86 Ll~~~-----~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+++.. ..+.|.|||+++......... ..............||
T Consensus 154 ~~g~~~~~~~~~~~llDfGlar~~~~~~~~~---------------------------------~~~~~~r~~~~~~rGT 200 (322)
T KOG1164|consen 154 VVGQSSRSEVRTLYLLDFGLARRFKYVGDSG---------------------------------GNLRPPRPQKGLFRGT 200 (322)
T ss_pred eecCCCCcccceEEEEecCCCccccccCCCC---------------------------------cccccCCCCccCCCCc
Confidence 99865 468999999988321111000 0000000112345699
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+++.+..+...+.+.|+||++.++.|++ .|..||....................... .....+.++..+...
T Consensus 201 ~ry~S~~~H~~~e~~r~DDles~~Y~l~el~--~g~LPW~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 275 (322)
T KOG1164|consen 201 LRYASINVHLGIEQGRRDDLESLFYMLLELL--KGSLPWEALEMTDLKSKFEKDPRKLLTDR---FGDLKPEEFAKILEY 275 (322)
T ss_pred cccccHHHhCCCccCCchhhhhHHHHHHHHh--cCCCCCccccccchHHHHHHHhhhhcccc---ccCCChHHHHHHHHH
Confidence 9999999999999999999999999999999 88899977664333322221111111110 234456788888888
Q ss_pred hccCCCCCCCCHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+-..+..++|....+...+++..
T Consensus 276 ~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 276 IDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred hhccCCcCCCCHHHHHHHHHHHH
Confidence 88899999999999988876653
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=161.26 Aligned_cols=211 Identities=12% Similarity=0.160 Sum_probs=168.0
Q ss_pred CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCe
Q psy5690 6 DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNC 85 (434)
Q Consensus 6 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 85 (434)
.++|.+.|-+..++-+-.+|+|++ |.||.+++.- .+..|+.+.+..++.|++.-++|+|++.+|.|||||+|.
T Consensus 83 ~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~------CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNF 155 (449)
T KOG1165|consen 83 TEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL------CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNF 155 (449)
T ss_pred CCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH------hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccce
Confidence 478888888888888899999999 7899999974 447899999999999999999999999999999999999
Q ss_pred eeecC-----CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 86 MVGKN-----YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 86 Ll~~~-----~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||... ..+.++|||+|+.+.++.. ...-.|....+..||
T Consensus 156 LIGrp~~k~~n~IhiiDFGmAK~YrDp~T------------------------------------kqHIPYrE~KSLsGT 199 (449)
T KOG1165|consen 156 LIGRPGTKDANVIHIIDFGMAKEYRDPKT------------------------------------KQHIPYREHKSLSGT 199 (449)
T ss_pred eecCCCCCCCceEEEEeccchhhhcCccc------------------------------------cccCccccccccccc
Confidence 99753 3578999999998665542 223335566778899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.+||+-....+.+.+.+.|.-|||-++...+ .|..||.+.......++...................+|.++..-+.-
T Consensus 200 ARYMSINTHlGrEQSRRDDLEaLGHvFmYFL--RGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~y 277 (449)
T KOG1165|consen 200 ARYMSINTHLGREQSRRDDLEALGHVFMYFL--RGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRY 277 (449)
T ss_pred eeeeEeeccccchhhhhhhHHHhhhhhhhhc--cCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHH
Confidence 9999999999999999999999999999999 89999998765544443333222222223333356788899888888
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
.-..+-.+-|+.+-+...|.+
T Consensus 278 vR~L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 278 VRRLDFFETPDYDYLRKLFDD 298 (449)
T ss_pred HHhcCcccCCCHHHHHHHHHH
Confidence 888888899998887555543
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-20 Score=175.94 Aligned_cols=180 Identities=19% Similarity=0.287 Sum_probs=131.4
Q ss_pred ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCc
Q psy5690 21 PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100 (434)
Q Consensus 21 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGl 100 (434)
.++|.|++|..++|.+++.++. .....++.....++.|++.|++| ++.+|+|+||.||.+..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~----~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR----TGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC----cccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhh
Confidence 4889999999999999997443 44567778889999999999999 9999999999999999999999999998
Q ss_pred ccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCCh
Q psy5690 101 YCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180 (434)
Q Consensus 101 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDI 180 (434)
........ ...+.....+...||..||+||.+.+..|+.++||
T Consensus 403 ~ts~~~~~-------------------------------------~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdI 445 (516)
T KOG1033|consen 403 VTSQDKDE-------------------------------------TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDI 445 (516)
T ss_pred eeecccCC-------------------------------------cccchhhhhhhcccccccCCHHHHhhhhhhhhcch
Confidence 54321110 11122234467789999999999999999999999
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 181 wSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
||||++++|+++. -...+.... ....+ ..+..++....--++-..|+.+++...|.+||++.+.
T Consensus 446 yaLGlil~EL~~~-f~T~~er~~---t~~d~-------r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 446 YALGLILAELLIQ-FSTQFERIA---TLTDI-------RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hhHHHHHHHHHHH-hccHHHHHH---hhhhh-------hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 9999999999941 112221111 11111 1222221111112455689999999999999966655
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.6e-19 Score=151.38 Aligned_cols=208 Identities=12% Similarity=0.150 Sum_probs=162.7
Q ss_pred CeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeee
Q psy5690 8 NLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMV 87 (434)
Q Consensus 8 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl 87 (434)
.|..+..+..+.+.-.+||+.+ |.||.+++.- ....++..+++.++-|++.-++|+|.++++||||||+|.|.
T Consensus 72 GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf------C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLM 144 (341)
T KOG1163|consen 72 GIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF------CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLM 144 (341)
T ss_pred CCchhhhhccccccceeeeecc-CccHHHHHHH------HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceee
Confidence 3455666677788889999999 8899999873 34679999999999999999999999999999999999998
Q ss_pred ec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 88 GK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 88 ~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
.- ...+.++|||+|+.+.+.. ....-.+..+....||.+|.
T Consensus 145 Glgrh~~kl~LIDFGLaKky~d~~------------------------------------t~~HIpyre~r~ltGTaRYA 188 (341)
T KOG1163|consen 145 GLGRHCNKLYLIDFGLAKKYRDIR------------------------------------TRQHIPYREDRNLTGTARYA 188 (341)
T ss_pred ccccccceEEEEeccchhhhcccc------------------------------------ccccCccccCCccceeeeeh
Confidence 64 3568999999998854433 12233355667788999999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 244 (434)
+-....+...+.+.|+-|+|.++..+. .|..||.+.......++.....+.............+|.++...+.-|-..
T Consensus 189 SinAh~g~eqSRRDDmeSvgYvLmYfn--rG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L 266 (341)
T KOG1163|consen 189 SINAHLGIEQSRRDDMESVGYVLMYFN--RGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGL 266 (341)
T ss_pred hhhhhhhhhhhhhhhhhhhcceeeeee--cCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhc
Confidence 988877777889999999999998888 899999998765544443333333333333333567889999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q psy5690 245 NETDRPRFSEIHLFLQ 260 (434)
Q Consensus 245 dP~~Rps~~el~~~L~ 260 (434)
--++-|+..-+.+.|.
T Consensus 267 ~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 267 GFEEKPDYMYLRQLFR 282 (341)
T ss_pred CCCCCCcHHHHHHHHH
Confidence 8999998887755554
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-18 Score=177.55 Aligned_cols=168 Identities=21% Similarity=0.204 Sum_probs=129.5
Q ss_pred HHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCcccc
Q psy5690 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMY 142 (434)
Q Consensus 63 i~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 142 (434)
++.+++|||+.||+|||+||+|.+++.-|++|+.|||+++....+... ... .|
T Consensus 152 mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at---nl~-----------eg------------- 204 (1205)
T KOG0606|consen 152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT---NLK-----------EG------------- 204 (1205)
T ss_pred hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc---hhh-----------hc-------------
Confidence 378999999999999999999999999999999999997763222210 000 00
Q ss_pred ccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCccc
Q psy5690 143 CSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ 222 (434)
Q Consensus 143 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 222 (434)
.+........+...+||+.|.|||++....|+..+|+|++|+++||.+ -|..||.+...++++..+......+
T Consensus 205 -~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFL--VgcvpffGdtpeelfg~visd~i~w---- 277 (1205)
T KOG0606|consen 205 -HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL--VGCVPFFGDTPEELFGQVISDDIEW---- 277 (1205)
T ss_pred -chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHh--eeeeeccCCCHHHHHhhhhhhhccc----
Confidence 011123334557779999999999999999999999999999999999 8999999999999887765433222
Q ss_pred CCCCCCccHHHHHHHHHHhccCCCCCCC---CHHHH--HHHHHhcccC
Q psy5690 223 YLPRPATCQKEIFDLMLECWKTNETDRP---RFSEI--HLFLQRKNLG 265 (434)
Q Consensus 223 ~~~~~~~~~~~l~~li~~cl~~dP~~Rp---s~~el--~~~L~~~~~~ 265 (434)
++.....++++++++.+.|+.+|..|- .+-+| |.+++...+.
T Consensus 278 -pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 278 -PEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred -cccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 222445678999999999999999997 34444 7777776555
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-18 Score=159.24 Aligned_cols=167 Identities=16% Similarity=0.254 Sum_probs=107.7
Q ss_pred eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcc
Q psy5690 22 ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMY 101 (434)
Q Consensus 22 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla 101 (434)
.+++|+-+. +||.+++..-.........+.......+..|+++.+++||++|++|+||+|+|++++.+|.++|+||+..
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~ 192 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL 192 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence 467888884 5999887532111112223344455667799999999999999999999999999999999999999875
Q ss_pred cccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcC--------C
Q psy5690 102 CSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLG--------K 173 (434)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~ 173 (434)
...+... . . ...+..|.+||..... .
T Consensus 193 ~r~g~~~-------------------------------------------~--~-~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 193 VRAGTRY-------------------------------------------R--C-SEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp EETTEEE-------------------------------------------E--G-GGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred eecCcee-------------------------------------------e--c-cCCCcccCChhhhhhhcccCcccce
Confidence 4421110 0 0 1223568999987553 4
Q ss_pred CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCC
Q psy5690 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDR 249 (434)
Q Consensus 174 ~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 249 (434)
++.+.|.|+||+++|.|+ |+..||........... .... ....++.++.||..+|++||.+|
T Consensus 227 ~t~~~DaW~LG~~ly~lW--C~~lPf~~~~~~~~~~~-----------~f~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLW--CGRLPFGLSSPEADPEW-----------DFSR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp E-HHHHHHHHHHHHHHHH--HSS-STCCCGGGSTSGG-----------GGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred eeeccCHHHHHHHHHHHH--HccCCCCCCCccccccc-----------cchh-cCCcCHHHHHHHHHHccCCcccC
Confidence 588999999999999999 99999987644322210 1111 23778999999999999999988
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-17 Score=158.48 Aligned_cols=86 Identities=13% Similarity=0.159 Sum_probs=70.8
Q ss_pred CCCCCCCCeee-EEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVR-VIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~-l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++|+|++. ++++ +..++||||++|++|.. +. ... ...++.|+++||.|||++||+|||
T Consensus 75 L~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~-------~~~------~~~~~~~i~~aL~~lH~~gIiHrD 136 (365)
T PRK09188 75 LKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-AR-------PHG------DPAWFRSAHRALRDLHRAGITHND 136 (365)
T ss_pred HHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hC-------ccc------hHHHHHHHHHHHHHHHHCCCeeCC
Confidence 46789999985 5442 46899999999999963 21 111 146789999999999999999999
Q ss_pred C-CCCCeeeecCCceEEccCCccccc
Q psy5690 80 L-AARNCMVGKNYTIKISDHAMYCSH 104 (434)
Q Consensus 80 l-kp~NILl~~~~~~kL~DFGla~~~ 104 (434)
| ||+|||++.++.+||+|||+|+..
T Consensus 137 L~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 137 LAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CCCcceEEEcCCCCEEEEECccceec
Confidence 9 999999999999999999998764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.9e-17 Score=143.50 Aligned_cols=86 Identities=20% Similarity=0.190 Sum_probs=71.6
Q ss_pred CCCCCCCeeeEEEEEecC--------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 2 CSLKDPNLVRVIGVCSTE--------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
.++.|++|..+.+++... +..++||||++|.+|.++.. +++ ....+++.+|..+|+.
T Consensus 90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~~----~~~~~i~~~l~~lH~~ 154 (232)
T PRK10359 90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----------ISE----DVKAKIKASIESLHQH 154 (232)
T ss_pred HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----------ccH----HHHHHHHHHHHHHHHc
Confidence 467899999999886543 35899999999999988742 222 2456999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
|++|||+||+||+++.++ ++|+|||..+.
T Consensus 155 gi~H~Dikp~Nili~~~g-i~liDfg~~~~ 183 (232)
T PRK10359 155 GMVSGDPHKGNFIVSKNG-LRIIDLSGKRC 183 (232)
T ss_pred CCccCCCChHHEEEeCCC-EEEEECCCccc
Confidence 999999999999999988 99999997543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.9e-16 Score=135.04 Aligned_cols=151 Identities=11% Similarity=0.047 Sum_probs=101.0
Q ss_pred CCCCC-CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLK-DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++|+ |+++++++++ +..+++|||+.|.+|.+... . ....++.|++.+|+++|++||+|||
T Consensus 55 L~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~-------~-------~~~~~~~qi~~~L~~lH~~GIvHrD 116 (218)
T PRK12274 55 LRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP-------R-------GDLAYFRAARRLLQQLHRCGVAHND 116 (218)
T ss_pred HHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh-------h-------hhHHHHHHHHHHHHHHHHCcCccCC
Confidence 35674 5889999987 45799999999999875442 1 1135778999999999999999999
Q ss_pred C-CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 80 L-AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 80 l-kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
| ||+|||++.++.++|+|||++.......... .....-.++.. ......
T Consensus 117 L~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~-r~L~~rDl~~l-----------------------------lk~~~~ 166 (218)
T PRK12274 117 LAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM-RLLAREDLRHL-----------------------------LKHKRM 166 (218)
T ss_pred CCCcceEEEcCCCCEEEEECCCceecCCcchHH-HHHHHHHHHHH-----------------------------HHHHHh
Confidence 9 7999999999999999999987533221100 00000000000 000112
Q ss_pred CCccccchhhhhcC-CCC-CcCChHHHHHHHHHHHhhcCCCCCCC
Q psy5690 159 LPIRWMAWESLLLG-KNT-TKSDVWSFAVTLWEILIHCNQRPYAE 201 (434)
Q Consensus 159 gt~~y~aPE~~~~~-~~s-~~sDIwSlGvil~ellt~~g~~pf~~ 201 (434)
.++.|+.|+.-.-. ..+ ...+.++.|+-+|.++ |+..+..+
T Consensus 167 y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~--~~~~~~~~ 209 (218)
T PRK12274 167 YCPAALTPVERRVLKRTSWIRELWFATGKPVYRFV--TRRVLHWE 209 (218)
T ss_pred cCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHH--hccCCccc
Confidence 34567778755432 223 4668889999999999 66666544
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.1e-16 Score=135.19 Aligned_cols=75 Identities=17% Similarity=0.137 Sum_probs=64.5
Q ss_pred eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCccccCCCCCCeeeecCCceEEccCCc
Q psy5690 22 ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYL-ESRDIVHRDLAARNCMVGKNYTIKISDHAM 100 (434)
Q Consensus 22 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~iiHrDlkp~NILl~~~~~~kL~DFGl 100 (434)
.++||||++++++..... ....++...+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++|+|||+
T Consensus 92 ~~iVmE~i~g~~l~~~~~-------~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~ 163 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRL-------KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQ 163 (190)
T ss_pred CEEEEEEeCCCCCcchhh-------hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccc
Confidence 489999999887765533 234688899999999999999999 799999999999999998 57899999999
Q ss_pred cccc
Q psy5690 101 YCSH 104 (434)
Q Consensus 101 a~~~ 104 (434)
|...
T Consensus 164 a~~~ 167 (190)
T cd05147 164 SVEH 167 (190)
T ss_pred cccC
Confidence 8653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=2e-16 Score=161.11 Aligned_cols=206 Identities=20% Similarity=0.238 Sum_probs=159.2
Q ss_pred CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCC
Q psy5690 6 DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE-SRDIVHRDLAARN 84 (434)
Q Consensus 6 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~N 84 (434)
|+|++++++...+.+..++++||..||++.+.+.. ......+...+..++.|+..|+.|+| +.++.|+|+||+|
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~-----~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n 154 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH-----PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSN 154 (601)
T ss_pred cccccccCCccCCCcccccccCccccccccccccc-----CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCcc
Confidence 99999999999999999999999999999988730 12225667778889999999999999 9999999999999
Q ss_pred eeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC-Ccc
Q psy5690 85 CMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL-PIR 162 (434)
Q Consensus 85 ILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g-t~~ 162 (434)
.+++.++ ..+++|||+|..+... ..........+| ++.
T Consensus 155 ~~l~~s~~~l~~~df~~At~~~~~----------------------------------------~g~~~~~~~~~g~s~~ 194 (601)
T KOG0590|consen 155 SLLDESGSALKIADFGLATAYRNK----------------------------------------NGAERSLKDRCGSSPP 194 (601)
T ss_pred chhccCCCcccCCCchhhcccccc----------------------------------------CCcceeeecccCCCCC
Confidence 9999999 9999999997653220 011112233455 888
Q ss_pred ccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 163 WMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 163 y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
|+|||...+.. .....|+||.|+++..++ +|..||......... ...|... ............+....+++.++
T Consensus 195 y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~--~g~~p~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~l~k~ 269 (601)
T KOG0590|consen 195 YGAPEHLSGKAYRGPSVDVWSLGIVLSAML--TGELPWDFPSRKDGR--YSSWKSN-KGRFTQLPWNSISDQAHDLLHKI 269 (601)
T ss_pred CCCcccccchhhcCCCcccccccccccccc--cCCCCcccccccccc--ceeeccc-ccccccCccccCChhhhhccccc
Confidence 99999998854 478899999999999999 899999776544321 1111111 11112333567788899999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHh
Q psy5690 242 WKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~ 261 (434)
+..+|..|.+.+++ ..|+..
T Consensus 270 l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 270 LKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccCCchhccccccccccccccc
Confidence 99999999999998 667766
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.9e-15 Score=132.01 Aligned_cols=94 Identities=13% Similarity=0.016 Sum_probs=72.6
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDLA 81 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlk 81 (434)
++.|+++.....+... ..++||||++|+++..... ....++...+..++.|++.++.++|+ +||+|||||
T Consensus 75 ~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l-------~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlk 145 (190)
T cd05145 75 RLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRL-------KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLS 145 (190)
T ss_pred HHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhh-------hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 4566666443333322 2489999999886544322 22356788899999999999999999 999999999
Q ss_pred CCCeeeecCCceEEccCCccccccc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYE 106 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~ 106 (434)
|+||+++ ++.++|+|||+++....
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceecCC
Confidence 9999998 88999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.6e-15 Score=130.72 Aligned_cols=87 Identities=16% Similarity=0.175 Sum_probs=69.7
Q ss_pred CCCCeeeEEEEEecCC---c-eEEEEec--CCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhhCCccc
Q psy5690 5 KDPNLVRVIGVCSTED---P-ISTIQEY--CEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGM-KYLESRDIVH 77 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~---~-~~lV~E~--~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL-~yLH~~~iiH 77 (434)
+||||++++|+++++. . +.+|+|| +.+|+|.+++++ ..+++. ..++.|++.++ +|||+++|+|
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~--------~~~~e~--~~~~~~~L~~l~~yLh~~~Ivh 128 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ--------CRYEED--VAQLRQLLKKLKRYLLDNRIVT 128 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc--------ccccHh--HHHHHHHHHHHHHHHHHCCEee
Confidence 7899999999998863 3 3378999 557999999962 235544 35678888888 9999999999
Q ss_pred cCCCCCCeeeec----CCceEEccCCcc
Q psy5690 78 RDLAARNCMVGK----NYTIKISDHAMY 101 (434)
Q Consensus 78 rDlkp~NILl~~----~~~~kL~DFGla 101 (434)
|||||+|||++. ++.++|+||+-+
T Consensus 129 rDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 129 MELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999999999974 347999995443
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.6e-14 Score=145.60 Aligned_cols=189 Identities=13% Similarity=0.108 Sum_probs=131.8
Q ss_pred eeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeee
Q psy5690 9 LVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVG 88 (434)
Q Consensus 9 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~ 88 (434)
|..+...+.-.+..++|+||.+.|+|.+++. ..+.+++..++.++.|++.-++.||..+||||||||+|.||.
T Consensus 756 ~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-------~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~ 828 (974)
T KOG1166|consen 756 IMHISSAHVFQNASVLVSEYSPYGTLLDLIN-------TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLR 828 (974)
T ss_pred hHHHHHHHccCCcceeeeeccccccHHHhhc-------cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEee
Confidence 3344444455677889999999999999997 667899999999999999999999999999999999999994
Q ss_pred c-------CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 89 K-------NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 89 ~-------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
. ...++|+|||.+-.+..- .....-....+|-
T Consensus 829 ~~~~~~~~~~~l~lIDfG~siDm~lf-----------------------------------------p~~~~F~~~~~td 867 (974)
T KOG1166|consen 829 REICADSDSKGLYLIDFGRSIDMKLF-----------------------------------------PDGTKFKAVWHTD 867 (974)
T ss_pred cccCCCCcccceEEEecccceeeeEc-----------------------------------------CCCcEEeeeeccc
Confidence 2 335899999975431100 0001123445667
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHH-HHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK-EIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~ 240 (434)
.+-++|+..+..+++..|-|.++.+++.|+.| +. .+ .... .........+..+.. -+.++...
T Consensus 868 ~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG--~y----------~q-~~~g---~~~~~~~~~~Ry~~~~~W~~~F~~ 931 (974)
T KOG1166|consen 868 LFDCIEMREGRPWTYQIDYFGLAATVHVMLFG--KY----------ME-VKNG---SSWMVKTNFPRYWKRDMWNKFFDL 931 (974)
T ss_pred cchhHHHhcCCCCchhhhhHHHHHHHHHHHHH--HH----------HH-hcCC---cceeccccchhhhhHHHHHHHHHH
Confidence 78999999999999999999999999999954 21 11 1000 000000001222223 35578888
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
+|..|-..=|...++...|++
T Consensus 932 lLN~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 932 LLNPDCDTLPNLQELRTELEE 952 (974)
T ss_pred HhCcCcccchhHHHHHHHHHH
Confidence 888666666677777555544
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=1e-13 Score=142.37 Aligned_cols=246 Identities=19% Similarity=0.171 Sum_probs=171.9
Q ss_pred CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCe
Q psy5690 6 DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNC 85 (434)
Q Consensus 6 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 85 (434)
||-++...-.+....+.+++++|+.+|+|...++..+ ..+..-+...+..+..+++|||...+.|+|++|.|+
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-------~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-------CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSL 935 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-------CcccccccchhHHHHhhhhccccchhhcccccccch
Confidence 4555555444556788999999999999999998433 445555666778899999999999999999999999
Q ss_pred eeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccc
Q psy5690 86 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 165 (434)
Q Consensus 86 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~a 165 (434)
+...+++.++.|||.........-..... - ....+..+ .............+.........+|+.|.+
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~s---g------~~~~~~~~---~~~~~~~~~~l~~~~~~~~~~~~~t~~~la 1003 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLS---G------PSSSGTPR---RLSRSERRPQLSADEARRKHAVVGTPDYLA 1003 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcc---c------ccccCccc---cccccccccccccchhhccccccCCCcccC
Confidence 99999999999999544322110000000 0 00000000 000000001111112233455678999999
Q ss_pred hhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCC
Q psy5690 166 WESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTN 245 (434)
Q Consensus 166 PE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 245 (434)
||...+......+|+|++|++++|.+ +|..||......+.++++... ....+.-+...+.+.++++.+.+..+
T Consensus 1004 Pe~~lg~~hgs~ad~~~~g~~l~e~l--~g~pp~na~tpq~~f~ni~~~-----~~~~p~g~~~~s~~aq~~~~~ll~~~ 1076 (1205)
T KOG0606|consen 1004 PEILLGRRHGSAADWWSSGVCLFEVL--TGIPPFNAETPQQIFENILNR-----DIPWPEGPEEGSYEAQDLINRLLTEE 1076 (1205)
T ss_pred CcccccccCCCcchhhhhhhhhhhhh--cCCCCCCCcchhhhhhccccC-----CCCCCCCccccChhhhhhhhhhhccC
Confidence 99999999999999999999999999 999999999999988776532 22223335567789999999999999
Q ss_pred CCCCCCHH---HH--HHHHHhcccCCCcccccccccc
Q psy5690 246 ETDRPRFS---EI--HLFLQRKNLGARASKITPVMKR 277 (434)
Q Consensus 246 P~~Rps~~---el--~~~L~~~~~~~~~~~~~~~~~~ 277 (434)
|.+|..+. ++ |++++...++........++++
T Consensus 1077 ~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~ 1113 (1205)
T KOG0606|consen 1077 PTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQ 1113 (1205)
T ss_pred chhccCcccccccccCCccCCCCccccccccCccCCC
Confidence 99999776 55 8899888777655554444443
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.1e-13 Score=129.03 Aligned_cols=139 Identities=26% Similarity=0.334 Sum_probs=98.5
Q ss_pred ccccceeEEeecCCCCcCCCCCCCCCCCCCCCCCCCCCceEEEEccCCccceeEEEEEEecceeeeeeeeEeeeccc---
Q psy5690 281 HVFSTVKIFFSMDGSSFQSNMSPIKESPNPEFFPKNRTAFNVVVGLKNRVSRFIKVQLYFKARWILLSEVTFDSITS--- 357 (434)
Q Consensus 281 ~~~~~~~~~~~~~~ss~~s~~~~~~~s~~~~~~~~~~~~~~vt~~l~~r~~~~i~~~~~~~~~~~~~~e~~f~~~~~--- 357 (434)
.++......++..+..+... +...+.+....++.+|.+.+|++||.+++++++|-|+++||++|||+|+|.-+
T Consensus 290 ri~~~~~~~f~~~gk~~~~~----~~~~~~~~~~~n~~~R~vrvPl~nR~ar~~k~~~~F~~dWlf~sEv~F~S~~an~~ 365 (807)
T KOG1094|consen 290 RIFGGVEVRFSGPGKAFEGE----PMRFNLGGDLGNPRARAVRVPLHNRVARFLKIRFLFAGDWLFFSEVSFISDAANNS 365 (807)
T ss_pred ccccceeEEEccCcccCCCc----eeeccCccccCCCccceEEeeccchhhheeEEEEEcCCceEEEEEEEEeechhhhc
Confidence 34445555565554444432 22233334467788899999999999999999999999999999999999311
Q ss_pred ------cCCCccc-----------chhhhHHHHHHHHHHHHHHHHHHHhhhHHHHHhhcccccccCCCCCcccccceeee
Q psy5690 358 ------QSPDTVT-----------YVGVIAGMFAMILLVLGCTVLFLVRRGRKKVALLHKHSALMNGSAPGVTMNMKELQ 420 (434)
Q Consensus 358 ------~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (434)
.-|.++. -.++|++++++++++++|++++||| |||.+.+++++..-..+..-+|+.+.+..
T Consensus 366 ~~~~~~~~P~s~~~~~v~~~~~~~t~~~~~~f~~if~iva~ii~~~L~R--~rr~~~ka~s~~~n~k~~v~lti~gnt~~ 443 (807)
T KOG1094|consen 366 LLALGGTFPESRGYQPVLKVDGSPTAILIIIFVAIFLIVALIIALMLWR--WRRLLSKASSRVLNEKLTVHLTVPGNTIL 443 (807)
T ss_pred chhhcCCCCCccccceeEEEcCCCceehHHHHHHHHHHHHHHHHHHHHH--HHHHHhhhccCCcccceeEEEeccCCcee
Confidence 1111111 1358889999999999999999998 77766555443333466668999998888
Q ss_pred eeecc
Q psy5690 421 MHMTT 425 (434)
Q Consensus 421 ~~~~~ 425 (434)
.|+..
T Consensus 444 ~hv~p 448 (807)
T KOG1094|consen 444 IHVRP 448 (807)
T ss_pred eccCC
Confidence 88754
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.6e-14 Score=128.34 Aligned_cols=198 Identities=21% Similarity=0.199 Sum_probs=134.9
Q ss_pred CCCCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC--Cc
Q psy5690 3 SLKDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR--DI 75 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--~i 75 (434)
++.|.|||+++.|+.+. ....+++||+..|+|.++|++-+ .....+......+|+.||+.||.|||+. -|
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~---~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK---KNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH---HhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 45799999999998543 45889999999999999998643 2345688888899999999999999986 59
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+|+++..+.|++..+|-+|+.--..... . ............
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~-----h----------------------------------~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDST-----H----------------------------------PSVNSTREAEKS 240 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcccc-----c----------------------------------hhhhhhhHhhhh
Confidence 9999999999999888888753111000 0 000000001112
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCC-CCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQR-PYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
...+-++|.+||.-.....+.++|||+||+...||. .+.. |-.+.+..+..+.+........ ...-
T Consensus 241 ~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema--ilEiq~tnseS~~~~ee~ia~~i~~le-----------n~lq 307 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA--ILEIQSTNSESKVEVEENIANVIIGLE-----------NGLQ 307 (458)
T ss_pred ccccCCccccCCcCcccccccchhhhhhhHHHHHHH--HheeccCCCcceeehhhhhhhheeecc-----------Cccc
Confidence 223446788999776667788999999999999998 3332 2222222222222222111111 1223
Q ss_pred HHHHHHhccCCCCCCCCHHHH
Q psy5690 235 FDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el 255 (434)
++++.+|++-+|..||++.++
T Consensus 308 r~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 308 RGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred cCcCcccccCCCCCCcchhhh
Confidence 468899999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.41 E-value=3e-13 Score=121.31 Aligned_cols=89 Identities=16% Similarity=0.157 Sum_probs=77.2
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
.++|++|+....++.+.+..+++|||++|++|.+++... .. ....++.+++.+|.++|+.|++|||++|
T Consensus 55 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p 123 (211)
T PRK14879 55 RARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN----------GM-EELELSREIGRLVGKLHSAGIIHGDLTT 123 (211)
T ss_pred HHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCc
Confidence 456788877777777778899999999999999998621 11 7788999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~ 103 (434)
+||+++ ++.++++|||.++.
T Consensus 124 ~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 124 SNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred ccEEEE-CCCEEEEECCcccC
Confidence 999999 78899999998765
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.4e-13 Score=136.31 Aligned_cols=87 Identities=16% Similarity=0.177 Sum_probs=77.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|++++....++.+++..++||||+++++|.+++. ....++.|++.+|.+||+.|++|||+
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~giiHrDl 454 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKAGIVHGDL 454 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhCCCccCCC
Confidence 356789999988888877788899999999999999884 24678999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccc
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~ 103 (434)
||+|||+ +++.++|+|||+++.
T Consensus 455 kp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 455 TTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ChHHEEE-ECCcEEEEeCccccc
Confidence 9999999 678899999999865
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=7.7e-13 Score=120.55 Aligned_cols=90 Identities=20% Similarity=0.151 Sum_probs=70.5
Q ss_pred CCCCCCCe--eeEEEEEecCCc----eEEEEecCCC-CCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 2 CSLKDPNL--VRVIGVCSTEDP----ISTIQEYCEF-GDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 2 ~~L~HpnI--v~l~~~~~~~~~----~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
.+|+|++| ++.+++...+.. .++|||+++| .+|.+++.. ..++.. .+.||+.+|.+||++|
T Consensus 95 ~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--------~~l~~~----~~~~i~~~l~~lH~~G 162 (239)
T PRK01723 95 AQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--------APLSEE----QWQAIGQLIARFHDAG 162 (239)
T ss_pred HHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--------CCCCHH----HHHHHHHHHHHHHHCC
Confidence 34667664 677777543322 3599999997 699998852 234443 3678999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
|+||||||+|||++.++.++|+|||.++.
T Consensus 163 I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 163 VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999988999999998766
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.2e-13 Score=117.72 Aligned_cols=86 Identities=17% Similarity=0.160 Sum_probs=70.7
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
.++|+++.....++...+..++||||++|++|.+++... .. .++.|++.+|.+||+.|++|||++|
T Consensus 53 ~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~-------~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~ 118 (199)
T TIGR03724 53 RARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEG-------ND-------ELLREIGRLVGKLHKAGIVHGDLTT 118 (199)
T ss_pred HHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhc-------HH-------HHHHHHHHHHHHHHHCCeecCCCCc
Confidence 456666554444555667789999999999999988521 11 7899999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~ 103 (434)
+||+++ ++.++++|||+++.
T Consensus 119 ~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 119 SNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ceEEEE-CCcEEEEECCCCcC
Confidence 999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.4e-12 Score=117.11 Aligned_cols=78 Identities=17% Similarity=0.080 Sum_probs=65.3
Q ss_pred ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-ccccCCCCCCeeeecCCceEEccCC
Q psy5690 21 PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD-IVHRDLAARNCMVGKNYTIKISDHA 99 (434)
Q Consensus 21 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-iiHrDlkp~NILl~~~~~~kL~DFG 99 (434)
..++||||++|++|..... .........+..++.|++.++.+||++| ++||||||+||+++ ++.++|+|||
T Consensus 122 ~~~lV~E~~~g~~L~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg 193 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRL-------KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVS 193 (237)
T ss_pred CceEEEEEecCCccccccc-------ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEECh
Confidence 4589999999988876543 2234556677899999999999999999 99999999999999 8899999999
Q ss_pred ccccccc
Q psy5690 100 MYCSHYE 106 (434)
Q Consensus 100 la~~~~~ 106 (434)
.+.....
T Consensus 194 ~a~~~~~ 200 (237)
T smart00090 194 QSVELDH 200 (237)
T ss_pred hhhccCC
Confidence 9875433
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.6e-12 Score=123.04 Aligned_cols=91 Identities=16% Similarity=0.298 Sum_probs=80.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE-SRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~iiHrD 79 (434)
|+.|+||||+++++.++.++..|+|+|-+. .|..++++ +....+...+.||+.||.||| +.+++|++
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgN 130 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----------LGKEEVCLGLFQILAALSFLNDDCNLVHGN 130 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----------hHHHHHHHHHHHHHHHHHHHhccCCeeecc
Confidence 578999999999999999999999999984 78888872 335677788999999999998 56899999
Q ss_pred CCCCCeeeecCCceEEccCCcccc
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~ 103 (434)
|.-+.|+++..|..||++|.+++.
T Consensus 131 v~~~SVfVn~~GeWkLggle~v~~ 154 (690)
T KOG1243|consen 131 VCKDSVFVNESGEWKLGGLELVSK 154 (690)
T ss_pred EeeeeEEEcCCCcEEEeeeEEEec
Confidence 999999999999999999988654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.5e-12 Score=112.53 Aligned_cols=73 Identities=19% Similarity=0.121 Sum_probs=62.5
Q ss_pred CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCC
Q psy5690 20 DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHA 99 (434)
Q Consensus 20 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFG 99 (434)
+..++||||++|++|..... . .....++.+++.++.++|+.|++||||||+||+++.++.++|+|||
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~-------~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg 170 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRV-------L------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWP 170 (198)
T ss_pred CCceEEEEEeCCcchhhccc-------c------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECC
Confidence 45689999999999876542 0 3456788999999999999999999999999999999999999999
Q ss_pred cccccc
Q psy5690 100 MYCSHY 105 (434)
Q Consensus 100 la~~~~ 105 (434)
.+....
T Consensus 171 ~~~~~~ 176 (198)
T cd05144 171 QMVSTD 176 (198)
T ss_pred ccccCC
Confidence 986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.2e-11 Score=119.32 Aligned_cols=202 Identities=16% Similarity=0.136 Sum_probs=146.4
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHhhhCCccccCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIAS----GMKYLESRDIVHRDL 80 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~----gL~yLH~~~iiHrDl 80 (434)
.|+|.++.+..++.++..++-+|+|. .+|.++... ....++...++..+.+... ||.++|..+++|-|+
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~ 248 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHT------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDL 248 (524)
T ss_pred ccccccccCcccccCCcceeeecccc-chhHHhhhc------ccccCCchhhhhHHhhhhhcccccccccCCCccccccc
Confidence 58999999999999999999999995 699998873 2344788888999999999 999999999999999
Q ss_pred CCCCeeeecC-CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 81 AARNCMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 81 kp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
||+||+...+ ...+++|||+...+....... .+.......+
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~--------------------------------------~~~~~~r~~~ 290 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSS--------------------------------------VFKVSKRPEG 290 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCcccc--------------------------------------ceeeeecCCC
Confidence 9999999999 789999999976644433211 0111122245
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
...|++||... +-++...|||++|.++.+.. ++........... |.+..............+.++...+.
T Consensus 291 ~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~--l~~~~~~~g~~~~-------W~~~r~~~ip~e~~~~~s~~l~~~~~ 360 (524)
T KOG0601|consen 291 DCIYAAKELLN-GLATFASDIFSLGEVILEAI--LGSHLPSVGKNSS-------WSQLRQGYIPLEFCEGGSSSLRSVTS 360 (524)
T ss_pred CceEeChhhhc-cccchHhhhcchhhhhHhhH--hhcccccCCCCCC-------ccccccccCchhhhcCcchhhhhHHH
Confidence 56799999875 44688999999999999988 5544433221110 11111111122223344567777999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHh
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
.|++.+|..|+++..+ +.++..
T Consensus 361 ~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 361 QMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred HhcCcchhhhhHHHHHhccccccc
Confidence 9999999999999888 445543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.3e-10 Score=97.74 Aligned_cols=83 Identities=19% Similarity=0.109 Sum_probs=71.4
Q ss_pred CCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---CccccCCCCC
Q psy5690 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR---DIVHRDLAAR 83 (434)
Q Consensus 7 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlkp~ 83 (434)
.+++++++++..++..+++|||++++++..+ +......++.+++++++++|.. +++|+|++|+
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~ 118 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPG 118 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcc
Confidence 5888999998888899999999988766432 4455667889999999999985 6999999999
Q ss_pred CeeeecCCceEEccCCcccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~ 103 (434)
||+++..+.+++.|||.++.
T Consensus 119 Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 119 NILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eEEEECCcEEEEEecccccC
Confidence 99999989999999998765
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.9e-10 Score=99.00 Aligned_cols=75 Identities=19% Similarity=0.083 Sum_probs=59.6
Q ss_pred ceEEEEecCCCCCHHH-HHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCCeeeecCCceEEccC
Q psy5690 21 PISTIQEYCEFGDLST-FLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDLAARNCMVGKNYTIKISDH 98 (434)
Q Consensus 21 ~~~lV~E~~~~gsL~~-~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~~kL~DF 98 (434)
..++||||++++++.. .+... ... ..+..++.+++.++.++|. .||+||||||+||+++ ++.++++||
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~--------~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDf 158 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDV--------RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDV 158 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhh--------hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEEC
Confidence 4689999999854432 12100 011 5678899999999999999 9999999999999999 899999999
Q ss_pred Ccccccc
Q psy5690 99 AMYCSHY 105 (434)
Q Consensus 99 Gla~~~~ 105 (434)
|.+....
T Consensus 159 g~a~~~~ 165 (187)
T cd05119 159 PQAVEID 165 (187)
T ss_pred ccccccc
Confidence 9986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.5e-10 Score=109.12 Aligned_cols=185 Identities=17% Similarity=0.142 Sum_probs=134.1
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
.|.|++.++..+...+..++=-|||+++++..... ....+.+...+.+..|++.++.++|+..++|+|+||+|
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~-------~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psn 396 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV-------TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSN 396 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhH-------HHHhcCcchhhhhHHHHHhccccccchhhhcccccccc
Confidence 58888888888877788889999999999887764 44567888899999999999999999999999999999
Q ss_pred eeeecC-CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 85 CMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 85 ILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
|++..+ +..++.|||....... ........-++
T Consensus 397 i~i~~~~~~~~~~~~~~~t~~~~----------------------------------------------~~~~~~~~~r~ 430 (524)
T KOG0601|consen 397 ILISNDGFFSKLGDFGCWTRLAF----------------------------------------------SSGVFHHIDRL 430 (524)
T ss_pred eeeccchhhhhccccccccccce----------------------------------------------ecccccccccc
Confidence 999876 7788999987532100 00111111223
Q ss_pred c--chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 164 M--AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 164 ~--aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
+ +++......+..+.|++|||..+.+.. ++. ++......-. . ......+.......++..+.+.+
T Consensus 431 ~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~--~~~-~ls~~~~~~~---------~-i~~~~~p~~~~~~~~~q~~~kv~ 497 (524)
T KOG0601|consen 431 YPIAEILLEDYPHLSKADIFSLGLSVDEAI--TGS-PLSESGVQSL---------T-IRSGDTPNLPGLKLQLQVLLKVM 497 (524)
T ss_pred cccchhhccccccccccccccccccccccc--cCc-ccCcccccce---------e-eecccccCCCchHHhhhhhhhhh
Confidence 3 555555677889999999999999998 432 3322211100 0 11122333444558888999999
Q ss_pred ccCCCCCCCCHHHH
Q psy5690 242 WKTNETDRPRFSEI 255 (434)
Q Consensus 242 l~~dP~~Rps~~el 255 (434)
...++..||.+.++
T Consensus 498 ~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 498 INPDRKRRPSAVEL 511 (524)
T ss_pred cCCccccchhhhhh
Confidence 99999999999888
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.8e-09 Score=93.08 Aligned_cols=83 Identities=16% Similarity=0.121 Sum_probs=62.9
Q ss_pred CeeeEEEEEecCCceEEEEecCCCCCHHH-HHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hhCCccccCCCCCCe
Q psy5690 8 NLVRVIGVCSTEDPISTIQEYCEFGDLST-FLQIHNCNSQENPAISYGCLIFMATQIASGMKYL-ESRDIVHRDLAARNC 85 (434)
Q Consensus 8 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yL-H~~~iiHrDlkp~NI 85 (434)
++.+.+++ ...++||||+.++.+.. .++ ...++......+..|++.+|..| |+.|+|||||++.||
T Consensus 89 ~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--------d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 89 PCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--------DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred CCCeEEEe----cCCEEEEEEcCCCCccchhhh--------ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 44555554 56789999997654422 222 12345566778889999999999 899999999999999
Q ss_pred eeecCCceEEccCCcccc
Q psy5690 86 MVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 86 Ll~~~~~~kL~DFGla~~ 103 (434)
+++ ++.+.|+|||.+..
T Consensus 157 L~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EEE-CCcEEEEECCCcee
Confidence 996 57899999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=6e-08 Score=91.51 Aligned_cols=196 Identities=15% Similarity=0.179 Sum_probs=126.7
Q ss_pred eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcc
Q psy5690 22 ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMY 101 (434)
Q Consensus 22 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla 101 (434)
..+.|..+.+..=-..+.+...+...-....|+.++..++.++.+.+.||++|.+-||+.++|+|+++++.+.|.|-...
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 56777777654222222111111123356789999999999999999999999999999999999999999999884321
Q ss_pred cccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhh-----cCCCCC
Q psy5690 102 CSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL-----LGKNTT 176 (434)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ 176 (434)
-. + ..........|...|.+||.-. +..-+.
T Consensus 165 qi-------------------------------~-------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~ 200 (637)
T COG4248 165 QI-------------------------------N-------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTA 200 (637)
T ss_pred ee-------------------------------c-------------cCCceEecccCccccCCHHHhccccccccCCCc
Confidence 00 0 0001112345667899999765 233477
Q ss_pred cCChHHHHHHHHHHHhhcCCCCCCCCChH-----HHHHhhhhh---hhcCCcccCCCCC-----CccHHHHHHHHHHhcc
Q psy5690 177 KSDVWSFAVTLWEILIHCNQRPYAELTNE-----QVIENCSHW---YQNNSKQQYLPRP-----ATCQKEIFDLMLECWK 243 (434)
Q Consensus 177 ~sDIwSlGvil~ellt~~g~~pf~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~ 243 (434)
..|-|.||+++++++. .|+.||.+.... .....|..+ +.........+.| .-+++++..+..+|+.
T Consensus 201 ~hD~FGLavLiF~lL~-ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~ 279 (637)
T COG4248 201 NHDNFGLAVLIFHLLF-GGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFT 279 (637)
T ss_pred cccchhHHHHHHHHHh-cCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhc
Confidence 8999999999999996 369999874321 111122211 1112222222223 3356889999999996
Q ss_pred CC--CCCCCCHHHHHHHHHhc
Q psy5690 244 TN--ETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 244 ~d--P~~Rps~~el~~~L~~~ 262 (434)
.. +.-||+++.-...|...
T Consensus 280 ~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 280 ESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred ccCCCCCCCCHHHHHHHHHHH
Confidence 53 56899998876555443
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.1e-09 Score=109.04 Aligned_cols=161 Identities=17% Similarity=0.181 Sum_probs=106.9
Q ss_pred HHHHHHHHHHHHHHhhhC-CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccce
Q psy5690 56 LIFMATQIASGMKYLESR-DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTI 134 (434)
Q Consensus 56 ~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (434)
...=+.+++.|+.|+|.+ ++||++|.|++|.++..+.+||+.|+++....++..+. .
T Consensus 101 ~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p----------------------~ 158 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYP----------------------F 158 (700)
T ss_pred hhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccc----------------------c
Confidence 333455677999999965 89999999999999999999999999865433221100 0
Q ss_pred eecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhh
Q psy5690 135 KISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHW 214 (434)
Q Consensus 135 ~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~ 214 (434)
..-|+.+. .-......|.|||++.....+.++|++|+||++|.+.. .|+.-+.......... ...
T Consensus 159 ~~yd~~lp------------~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~-~gk~i~~a~~~~~~~~-~~~- 223 (700)
T KOG2137|consen 159 SEYDPPLP------------LLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYN-GGKSIIAANGGLLSYS-FSR- 223 (700)
T ss_pred ccCCCCCC------------hhhccCcccccchhhccccccccccceeeeeEEEEEec-CCcchhhccCCcchhh-hhh-
Confidence 00000000 00112356999999999888999999999999998873 3444444332222211 110
Q ss_pred hhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH
Q psy5690 215 YQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI 255 (434)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 255 (434)
.............++.++++=+.+++..++..||++.++
T Consensus 224 --~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 224 --NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred --cccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 011111222246788999999999999999999988777
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.4e-08 Score=93.12 Aligned_cols=181 Identities=13% Similarity=0.125 Sum_probs=126.1
Q ss_pred CCCCCCCeeeEEEEEec----CCceEEEEecCCC-CCHHHHHhhccCC--------CCCCCCCCHHHHHHHHHHHHHHHH
Q psy5690 2 CSLKDPNLVRVIGVCST----EDPISTIQEYCEF-GDLSTFLQIHNCN--------SQENPAISYGCLIFMATQIASGMK 68 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~l~~~~~~--------~~~~~~l~~~~~~~i~~qi~~gL~ 68 (434)
+++.|+|||++.++|.. +..+++|++|+++ ++|.++--..... ...+...++..+|.++.|+..||.
T Consensus 328 kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~ 407 (655)
T KOG3741|consen 328 KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALY 407 (655)
T ss_pred HHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHH
Confidence 57899999999999863 3568999999885 5777765322211 223556888999999999999999
Q ss_pred HhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCC
Q psy5690 69 YLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYES 148 (434)
Q Consensus 69 yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 148 (434)
++|+.|+..+-|.+.+||++.+.+++|...|+........
T Consensus 408 sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---------------------------------------- 447 (655)
T KOG3741|consen 408 SIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP---------------------------------------- 447 (655)
T ss_pred HHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC----------------------------------------
Confidence 9999999999999999999988888888777633211100
Q ss_pred cccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHH-HHhhhhhhhcCCcccCCCCC
Q psy5690 149 DYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQV-IENCSHWYQNNSKQQYLPRP 227 (434)
Q Consensus 149 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 227 (434)
. |-+.+ -.+-|.=.||.++..|.+++ ...+......+. .+.+ -
T Consensus 448 ---------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~-~ns~~~d~~~~s~~~~I---------------~ 491 (655)
T KOG3741|consen 448 ---------------T--EPLES---QQQNDLRDLGLLLLALATGT-ENSNRTDSTQSSHLTRI---------------T 491 (655)
T ss_pred ---------------C--cchhH---HhhhhHHHHHHHHHHHhhcc-cccccccchHHHHHHHh---------------h
Confidence 0 11111 23568899999999999432 122222222222 2222 3
Q ss_pred CccHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q psy5690 228 ATCQKEIFDLMLECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 228 ~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 259 (434)
..++.++++++.-....++.+ -++.++++.+
T Consensus 492 ~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 492 TTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred hhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 456788899999888888886 5677775544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.4e-09 Score=103.12 Aligned_cols=79 Identities=18% Similarity=0.103 Sum_probs=61.9
Q ss_pred CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHhhhCCccccCCCCCCeeeecCCceEEcc
Q psy5690 19 EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIAS-GMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97 (434)
Q Consensus 19 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~-gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~D 97 (434)
.+..++||||++|++|.++..... ... ....++.+++. .+..+|..|++|+|+||.||+++.++.++++|
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~------~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liD 300 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDE------AGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALD 300 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHh------cCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEe
Confidence 355799999999999998875211 111 23456666666 47889999999999999999999999999999
Q ss_pred CCccccccc
Q psy5690 98 HAMYCSHYE 106 (434)
Q Consensus 98 FGla~~~~~ 106 (434)
||++.....
T Consensus 301 fG~~~~l~~ 309 (437)
T TIGR01982 301 FGIVGRLSE 309 (437)
T ss_pred CCCeeECCH
Confidence 999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.4e-08 Score=84.56 Aligned_cols=72 Identities=21% Similarity=0.127 Sum_probs=60.1
Q ss_pred ecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEc
Q psy5690 17 STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKIS 96 (434)
Q Consensus 17 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~ 96 (434)
.+.+...|+|||++|-.|.+++.. . ...++..+-.-+.-||..||+|+||.++||++...+ +.++
T Consensus 69 vD~~~~~I~me~I~G~~lkd~l~~-------~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~I 133 (204)
T COG3642 69 VDPDNGLIVMEYIEGELLKDALEE-------A-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFI 133 (204)
T ss_pred EcCCCCEEEEEEeCChhHHHHHHh-------c-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEE
Confidence 356778899999999999989862 1 245677777888899999999999999999997654 9999
Q ss_pred cCCcccc
Q psy5690 97 DHAMYCS 103 (434)
Q Consensus 97 DFGla~~ 103 (434)
|||++..
T Consensus 134 DfGLg~~ 140 (204)
T COG3642 134 DFGLGEF 140 (204)
T ss_pred ECCcccc
Confidence 9999765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.9e-08 Score=90.10 Aligned_cols=78 Identities=12% Similarity=0.048 Sum_probs=64.4
Q ss_pred ceEEEEecCCCC-CHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeec-------CCc
Q psy5690 21 PISTIQEYCEFG-DLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGK-------NYT 92 (434)
Q Consensus 21 ~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~-------~~~ 92 (434)
..++|||++++- +|.+++.... ....+......++.+++..+.-||+.||+|+|+++.|||++. ++.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-----~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-----TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCce
Confidence 578999999875 8999985321 234456677889999999999999999999999999999975 467
Q ss_pred eEEccCCcccc
Q psy5690 93 IKISDHAMYCS 103 (434)
Q Consensus 93 ~kL~DFGla~~ 103 (434)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998643
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.69 E-value=7.4e-08 Score=81.26 Aligned_cols=82 Identities=17% Similarity=0.153 Sum_probs=62.8
Q ss_pred EecCCceEEEEecCCC-CCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCC---
Q psy5690 16 CSTEDPISTIQEYCEF-GDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNY--- 91 (434)
Q Consensus 16 ~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~--- 91 (434)
+.+...-+++|||++| .++.+++...- ...........++.+|-+.+.-||..+||||||..+||++..++
T Consensus 79 ~~D~~~~~i~ME~~~g~~~vk~~i~~~~-----~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~ 153 (229)
T KOG3087|consen 79 FIDTYGGQIYMEFIDGASTVKDFILSTM-----EDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQI 153 (229)
T ss_pred EEecCCCeEEEEeccchhHHHHHHHHHc-----cCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcC
Confidence 4456677899999976 48888887442 12222233367889999999999999999999999999997654
Q ss_pred ceEEccCCccc
Q psy5690 92 TIKISDHAMYC 102 (434)
Q Consensus 92 ~~kL~DFGla~ 102 (434)
.+.++|||++.
T Consensus 154 ~~~lIdfgls~ 164 (229)
T KOG3087|consen 154 TPILIDFGLSS 164 (229)
T ss_pred ceEEEeecchh
Confidence 35899999853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.2e-07 Score=84.50 Aligned_cols=88 Identities=17% Similarity=0.061 Sum_probs=70.8
Q ss_pred eeeEEEEEecC----CceEEEEecCCCC-CHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 9 LVRVIGVCSTE----DPISTIQEYCEFG-DLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 9 Iv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
+++.+++.+.. ...++|+|++++. +|.+++... ...+......++.+++..+.-||+.||+|+|+++.
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-------~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~ 147 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-------EQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPS 147 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-------cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcc
Confidence 34555665442 2358999999874 899999732 22566677889999999999999999999999999
Q ss_pred CeeeecCC---ceEEccCCcccc
Q psy5690 84 NCMVGKNY---TIKISDHAMYCS 103 (434)
Q Consensus 84 NILl~~~~---~~kL~DFGla~~ 103 (434)
|||++.++ .+.++||+.++.
T Consensus 148 NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 148 NILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cEEEeCCCCceeEEEEcchhcee
Confidence 99999887 899999997665
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.7e-08 Score=82.85 Aligned_cols=77 Identities=19% Similarity=0.071 Sum_probs=58.6
Q ss_pred eeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc-----cccCCCCC
Q psy5690 9 LVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI-----VHRDLAAR 83 (434)
Q Consensus 9 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i-----iHrDlkp~ 83 (434)
+.+++++. ....++||||++|.++.+.- . ....++.+++++|..||+.++ +|+|++|.
T Consensus 55 ~P~~~~~~--~~~~~lv~e~i~G~~l~~~~------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~ 117 (170)
T cd05151 55 GPKLYYFD--PETGVLITEFIEGSELLTED------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPG 117 (170)
T ss_pred CCceEEEe--CCCCeEEEEecCCCcccccc------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcC
Confidence 34555554 33458999999998775420 0 112456899999999999885 99999999
Q ss_pred CeeeecCCceEEccCCcccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~ 103 (434)
||+++ ++.++++|||.+..
T Consensus 118 Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 118 NFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cEEEE-CCeEEEEecccccC
Confidence 99998 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.8e-07 Score=81.50 Aligned_cols=82 Identities=18% Similarity=0.124 Sum_probs=55.2
Q ss_pred CeeeEEEEEecCCceEEEEecCC--CCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH-hhhCCccccCCCCCC
Q psy5690 8 NLVRVIGVCSTEDPISTIQEYCE--FGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKY-LESRDIVHRDLAARN 84 (434)
Q Consensus 8 nIv~l~~~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~y-LH~~~iiHrDlkp~N 84 (434)
++.+.+++. ..++||||++ |..+..+.. ..++......++.+++..+.. +|..||+||||.+.|
T Consensus 71 ~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~---------~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~N 137 (188)
T PF01163_consen 71 PVPKPYDYN----RNVIVMEYIGEDGVPLPRLKD---------VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYN 137 (188)
T ss_dssp SS--EEEEE----TTEEEEE--EETTEEGGCHHH---------CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTS
T ss_pred cCCcEEEEe----CCEEEEEecCCCccchhhHHh---------ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhh
Confidence 455666552 5679999998 655655443 122245567788888886665 579999999999999
Q ss_pred eeeecCCceEEccCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~ 103 (434)
|+++++ .+.++|||.+..
T Consensus 138 Ilv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 138 ILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp EEEETT-CEEE--GTTEEE
T ss_pred EEeecc-eEEEEecCccee
Confidence 999877 899999998655
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.5e-07 Score=93.23 Aligned_cols=80 Identities=13% Similarity=0.029 Sum_probs=55.0
Q ss_pred CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCC----ceE
Q psy5690 19 EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNY----TIK 94 (434)
Q Consensus 19 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~----~~k 94 (434)
....++||||++|+.+.++-.-.. .......+....+..++.|+ +..|++|+|+||.||+++.++ .++
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~ 304 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRA-AGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYI 304 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHh-cCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEE
Confidence 356789999999999987532100 00011123333444444444 458999999999999999888 999
Q ss_pred EccCCccccccc
Q psy5690 95 ISDHAMYCSHYE 106 (434)
Q Consensus 95 L~DFGla~~~~~ 106 (434)
+.|||++.....
T Consensus 305 llDFGivg~l~~ 316 (537)
T PRK04750 305 ALDFGIVGSLNK 316 (537)
T ss_pred EEecceEEECCH
Confidence 999999876544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.5e-06 Score=74.25 Aligned_cols=67 Identities=25% Similarity=0.255 Sum_probs=53.0
Q ss_pred CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCC
Q psy5690 20 DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHA 99 (434)
Q Consensus 20 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFG 99 (434)
...+++|||++|..|.+... +++ .+...+.+++.-||+.|+.|+|.+|.|+++++++ ++++||+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eEEEEEEEEecCeecccchh-----------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 34678999999988876542 222 2446677889999999999999999999998554 9999998
Q ss_pred ccc
Q psy5690 100 MYC 102 (434)
Q Consensus 100 la~ 102 (434)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.16 E-value=3.9e-06 Score=75.45 Aligned_cols=89 Identities=18% Similarity=0.183 Sum_probs=62.7
Q ss_pred CCeeeEEEEEecC---CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-----------
Q psy5690 7 PNLVRVIGVCSTE---DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES----------- 72 (434)
Q Consensus 7 pnIv~l~~~~~~~---~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~----------- 72 (434)
.++.+++.+.... +..++||||++|+++.+.+. ...++......++.+++++|..||+
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~ 128 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL--------RPELSPEERRALARALADTLAALHSVDPAAVGLGDL 128 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC--------CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCccc
Confidence 3467777776553 36789999999988766442 0234555555566666666666652
Q ss_pred ---------------------------------------------CCccccCCCCCCeeeec--CCceEEccCCcccc
Q psy5690 73 ---------------------------------------------RDIVHRDLAARNCMVGK--NYTIKISDHAMYCS 103 (434)
Q Consensus 73 ---------------------------------------------~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~ 103 (434)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 129 GRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred CCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999988 56689999998654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.9e-05 Score=68.23 Aligned_cols=78 Identities=14% Similarity=-0.007 Sum_probs=63.8
Q ss_pred ceEEEEecCCC-CCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCc--eEEcc
Q psy5690 21 PISTIQEYCEF-GDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYT--IKISD 97 (434)
Q Consensus 21 ~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~--~kL~D 97 (434)
..+||+|-+.| -||.+++... .....+......++.+++..+.-||+.|+.|+|+.+.||+++.++. ++++|
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~-----~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQH-----AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcC-----CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEE
Confidence 37899997753 5899988622 1235577778899999999999999999999999999999986666 89999
Q ss_pred CCcccc
Q psy5690 98 HAMYCS 103 (434)
Q Consensus 98 FGla~~ 103 (434)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 987554
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.6e-05 Score=69.48 Aligned_cols=92 Identities=16% Similarity=0.150 Sum_probs=70.4
Q ss_pred CCCC-CCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh---CCcccc
Q psy5690 3 SLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES---RDIVHR 78 (434)
Q Consensus 3 ~L~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---~~iiHr 78 (434)
.+++ +++++++|+| ..++|+||...+++...-. ....-...+|..+.+|+.++++.+++|+. ..+.-.
T Consensus 15 ~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~----~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lc 86 (188)
T PF12260_consen 15 LLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYR----PLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLC 86 (188)
T ss_pred HcCCCCCCCCeeeEC----CCEEEEEeecCcccccccc----ccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence 3444 5999999999 2367899998776542100 00011247899999999999999999997 347779
Q ss_pred CCCCCCeeeecCCceEEccCCccc
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYC 102 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~ 102 (434)
|++++|+-+++++.+|++|...+-
T Consensus 87 Dv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 87 DVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred ecchHHeEEeCCCcEEEEechhcc
Confidence 999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.89 E-value=3.3e-05 Score=82.02 Aligned_cols=189 Identities=19% Similarity=0.233 Sum_probs=122.9
Q ss_pred CCCCCCCeeeEEEEEecCCc----eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 2 CSLKDPNLVRVIGVCSTEDP----ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
.++.|+|++.+++|-...-. ..+..|+|..-++...++ .-..++....+.+..++.+||.|+|+....|
T Consensus 237 ~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-------~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 237 SKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-------SVGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-------hccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 46789999999999755432 335568898888988887 5567889999999999999999999986555
Q ss_pred cCCCCC---CeeeecCCceEEc--cCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 78 RDLAAR---NCMVGKNYTIKIS--DHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 78 rDlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
.-+..+ +--.+..+...+. ||+.++.......
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~------------------------------------------- 346 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK------------------------------------------- 346 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCccc-------------------------------------------
Confidence 544443 2223344445544 6665443222111
Q ss_pred cCCCCCCCccccchhhhhcCCCC--CcCChHHHHHHHHHHHhhcCCCCCC-CCChHHHHHhhhhhhhcCCcccCCCCCCc
Q psy5690 153 SDTKARLPIRWMAWESLLLGKNT--TKSDVWSFAVTLWEILIHCNQRPYA-ELTNEQVIENCSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~~s--~~sDIwSlGvil~ellt~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (434)
......+..|.++|......+. ...|+|.+|.....+. .+..+-. ........ +..
T Consensus 347 -~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~--~~~~i~~~~~~~~~~l------------------~~~ 405 (1351)
T KOG1035|consen 347 -SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS--QGEDISEKSAVPVSLL------------------DVL 405 (1351)
T ss_pred -chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh--hcCcccccccchhhhh------------------ccc
Confidence 0111223346777777665554 3479999999999988 4432211 11111110 122
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
......+...+|+..++++|+++.++ |.+++.
T Consensus 406 ~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 406 STSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred cchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 22367889999999999999999999 566654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=5.4e-05 Score=68.37 Aligned_cols=70 Identities=21% Similarity=0.202 Sum_probs=54.6
Q ss_pred CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCC
Q psy5690 20 DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHA 99 (434)
Q Consensus 20 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFG 99 (434)
+...+||||++|-.|... ++.......++..|++-+.-+-..|+||+|+.+-||+++++|.+.++||-
T Consensus 180 nRHaVvMe~ieG~eL~~~------------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 180 NRHAVVMEYIEGVELYRL------------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred ccceeeeehcccceeecc------------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCc
Confidence 568999999998655442 12344555666677776666668999999999999999999999999996
Q ss_pred cc
Q psy5690 100 MY 101 (434)
Q Consensus 100 la 101 (434)
-+
T Consensus 248 Q~ 249 (304)
T COG0478 248 QA 249 (304)
T ss_pred cc
Confidence 53
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.67 E-value=8.4e-06 Score=81.19 Aligned_cols=144 Identities=19% Similarity=0.128 Sum_probs=103.2
Q ss_pred CCCCCCCC-eeeEEEEEecCCceEEEEecCCCC-CHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPN-LVRVIGVCSTEDPISTIQEYCEFG-DLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~Hpn-Iv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|.+++||| .+..++-++.++..+++++++.+| +-...+. .....+..-+...+.+.-.+++++||+.-=+|+
T Consensus 287 LdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~------~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~ 360 (829)
T KOG0576|consen 287 LDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT------VSEIALEQYQFAYPLRKETRPLAELHSSYKVHR 360 (829)
T ss_pred HHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC------hhhHhhhhhhhhhhhhhhcccccccccccccCc
Confidence 34689999 788888888888999999999887 2221111 112233344455667777889999998877899
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
| ||+... +..+..||+....+ ...+......
T Consensus 361 d----~~l~s~-~~~~~~~~~v~~~L--------------------------------------------~~~~~~~t~~ 391 (829)
T KOG0576|consen 361 D----NILGSE-EEVKLLDFAVPPQL--------------------------------------------TRTMKPRTAI 391 (829)
T ss_pred c----cccccc-cccccccccCCccc--------------------------------------------CcccccccCC
Confidence 8 777654 67888998874321 1111345667
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCC
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAE 201 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~ 201 (434)
+|..|+|||+...+.+..+.|.|++|+-..++. -|..|-..
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a--p~~pPr~~ 432 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA--PGLPPRSS 432 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcC--CCCCCCCC
Confidence 888999999999999999999999998777776 55555443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0019 Score=58.29 Aligned_cols=29 Identities=14% Similarity=0.077 Sum_probs=25.6
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++|+|+.|.||++++++ +.++||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 478999999999999888 99999998654
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.00087 Score=65.81 Aligned_cols=78 Identities=24% Similarity=0.322 Sum_probs=49.9
Q ss_pred CcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCC----CCCCccHHHHHHHHHHhccCCCCCCCC
Q psy5690 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYL----PRPATCQKEIFDLMLECWKTNETDRPR 251 (434)
Q Consensus 176 ~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps 251 (434)
+|+||||+|.++.|+. -|..-+......+..+.+..++......... ...-.++..+..+..+|+-..|..||.
T Consensus 110 pKsdVwsl~~i~~el~--L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l 187 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELY--LGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL 187 (725)
T ss_pred cchhhhhHHHHHHHHH--HhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc
Confidence 4999999999999998 6666665555555444444333222111111 112245567788899999999999986
Q ss_pred HHHH
Q psy5690 252 FSEI 255 (434)
Q Consensus 252 ~~el 255 (434)
..+.
T Consensus 188 ~~~~ 191 (725)
T KOG1093|consen 188 PMEL 191 (725)
T ss_pred hhHH
Confidence 6655
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0037 Score=57.14 Aligned_cols=29 Identities=17% Similarity=0.085 Sum_probs=25.9
Q ss_pred CccccCCCCCCeeeecCCceEEccCCccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYC 102 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~ 102 (434)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 58999999999999987778899999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0027 Score=56.99 Aligned_cols=75 Identities=15% Similarity=0.057 Sum_probs=55.5
Q ss_pred ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCCeeeecCCceEEccCC
Q psy5690 21 PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDLAARNCMVGKNYTIKISDHA 99 (434)
Q Consensus 21 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~~kL~DFG 99 (434)
...+||||+... - ..++......+...++..+..++++.+.-|-. .++||+||..-|||+. ++.+.++|+|
T Consensus 140 ~nVLvMEfIg~~-g------~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~ 211 (268)
T COG1718 140 NNVLVMEFIGDD-G------LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVS 211 (268)
T ss_pred CCeEEEEeccCC-C------CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECc
Confidence 457999999542 1 01111122333444688888999999988877 8999999999999998 8899999999
Q ss_pred cccc
Q psy5690 100 MYCS 103 (434)
Q Consensus 100 la~~ 103 (434)
-|..
T Consensus 212 QaV~ 215 (268)
T COG1718 212 QAVT 215 (268)
T ss_pred cccc
Confidence 7654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0026 Score=64.10 Aligned_cols=79 Identities=14% Similarity=0.112 Sum_probs=56.5
Q ss_pred CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHH-HHHhhhCCccccCCCCCCeeeecCCceEEcc
Q psy5690 19 EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG-MKYLESRDIVHRDLAARNCMVGKNYTIKISD 97 (434)
Q Consensus 19 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~g-L~yLH~~~iiHrDlkp~NILl~~~~~~kL~D 97 (434)
.+.-.++|||++|-.+.+...-. ...++. ..++..++++ +..+-..|+.|.|.+|.||+++.+|.+.+.|
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~------~~g~d~---k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lD 308 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALK------SAGIDR---KELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLD 308 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHH------hcCCCH---HHHHHHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEc
Confidence 46678999999999888884311 123332 2333333333 3444458999999999999999999999999
Q ss_pred CCccccccc
Q psy5690 98 HAMYCSHYE 106 (434)
Q Consensus 98 FGla~~~~~ 106 (434)
||+.....+
T Consensus 309 fGi~g~l~~ 317 (517)
T COG0661 309 FGIVGRLDP 317 (517)
T ss_pred CcceecCCH
Confidence 999776544
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00012 Score=79.84 Aligned_cols=151 Identities=13% Similarity=-0.028 Sum_probs=103.7
Q ss_pred CCCCCCCeeeEEEEEe--cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-----C
Q psy5690 2 CSLKDPNLVRVIGVCS--TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-----D 74 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-----~ 74 (434)
+...|++++..+.-.. +....+.+++|+.+|.+.+.+-+.- .+...+...-+.....+.+.+..-+|+. -
T Consensus 1284 ~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~---ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T 1360 (2724)
T KOG1826|consen 1284 REAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGL---EESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNT 1360 (2724)
T ss_pred hhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcc---ccCCcchhchHHHHHHHHHhccchhhhcccCCcc
Confidence 3457777776655442 2345789999999999999986322 1222233333333333436667776654 2
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
.+|+++|+-|.++..+.++|+.++|+.+...... ...
T Consensus 1361 ~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-------------------------------------------sf~ 1397 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-------------------------------------------SFF 1397 (2724)
T ss_pred chhhhhhhhccceecCCcccccccccccccCchH-------------------------------------------hhh
Confidence 7899999999999999999999999966210000 011
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCC
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYA 200 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~ 200 (434)
....+++-|+.|++...-.++.++|+|..|+-+|+.. .|..+|.
T Consensus 1398 Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs--~~n~~fi 1441 (2724)
T KOG1826|consen 1398 GLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS--DGNAYFI 1441 (2724)
T ss_pred hhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh--cccHHHH
Confidence 2334556799999999999998999999999999987 6655553
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.015 Score=51.25 Aligned_cols=83 Identities=20% Similarity=0.252 Sum_probs=60.6
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCC------CCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEF------GDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
...+.+|.+++|+.+++--..+|+|.+.. -+|.++++. ..++. ... ..+-+=.+||-+.+|+
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--------~~~~~-~~~---~~L~~f~~~l~~~~Iv 140 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--------GGLTE-ELR---QALDEFKRYLLDHHIV 140 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--------CCccH-HHH---HHHHHHHHHHHHcCCe
Confidence 34688999999999999889999998643 368888852 23444 333 3333445677889999
Q ss_pred ccCCCCCCeeeecCC----ceEEcc
Q psy5690 77 HRDLAARNCMVGKNY----TIKISD 97 (434)
Q Consensus 77 HrDlkp~NILl~~~~----~~kL~D 97 (434)
.+|++|.||++.... .+.|+|
T Consensus 141 ~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 141 IRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ecCCCcccEEEEecCCCceEEEEEe
Confidence 999999999996432 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.009 Score=64.63 Aligned_cols=30 Identities=27% Similarity=0.271 Sum_probs=24.0
Q ss_pred CccccCCCCCCeeeecC-C-ceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKN-Y-TIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~-~-~~kL~DFGla~~ 103 (434)
.+||+|+++.||+++.+ + ..-|.||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 49999999999999753 3 357899988654
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.012 Score=59.30 Aligned_cols=78 Identities=17% Similarity=0.206 Sum_probs=52.9
Q ss_pred CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHH-HHHhhhCCccccCCCCCCeeeec----CCce
Q psy5690 19 EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG-MKYLESRDIVHRDLAARNCMVGK----NYTI 93 (434)
Q Consensus 19 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~g-L~yLH~~~iiHrDlkp~NILl~~----~~~~ 93 (434)
...-.++|||++|..+.+.-.- ....++... ++..+.++ ++-+-..|++|+|=+|.||+++. ++.+
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i------~~~gi~~~~---i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~i 344 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAI------DKRGISPHD---ILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEI 344 (538)
T ss_pred CcceEEEEEecCCccCCCHHHH------HHcCCCHHH---HHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccE
Confidence 3467899999999876655321 122344443 33344333 23334578999999999999984 6689
Q ss_pred EEccCCcccccc
Q psy5690 94 KISDHAMYCSHY 105 (434)
Q Consensus 94 kL~DFGla~~~~ 105 (434)
.+-|||+.....
T Consensus 345 vllDhGl~~~is 356 (538)
T KOG1235|consen 345 VLLDHGLYAVIS 356 (538)
T ss_pred EEEccccccccc
Confidence 999999976643
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.0077 Score=56.17 Aligned_cols=69 Identities=14% Similarity=0.132 Sum_probs=52.1
Q ss_pred CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccC
Q psy5690 19 EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDH 98 (434)
Q Consensus 19 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DF 98 (434)
.+..|+|||++.|-.|.+.-+ ... +..+...+..-+.-|-.+|+||+|..--||++++++.++++||
T Consensus 180 ~~RH~Vvmelv~g~Pl~~v~~----------v~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDF 246 (465)
T KOG2268|consen 180 HNRHCVVMELVDGYPLRQVRH----------VED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDF 246 (465)
T ss_pred ccceeeHHHhhcccceeeeee----------cCC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeec
Confidence 357899999999887766432 112 2234444555566677899999999999999999999999999
Q ss_pred Cc
Q psy5690 99 AM 100 (434)
Q Consensus 99 Gl 100 (434)
--
T Consensus 247 PQ 248 (465)
T KOG2268|consen 247 PQ 248 (465)
T ss_pred hH
Confidence 64
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.069 Score=50.77 Aligned_cols=71 Identities=14% Similarity=0.016 Sum_probs=54.6
Q ss_pred CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCCCCCCeeeecCCceEEccC
Q psy5690 20 DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRDLAARNCMVGKNYTIKISDH 98 (434)
Q Consensus 20 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlkp~NILl~~~~~~kL~DF 98 (434)
...|++|++. |+++... ....+.++..++.+.+.-++-+..+ ..-|||+.-.|||++ .|++.|+||
T Consensus 299 ~y~yl~~kdh-gt~is~i-----------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-----------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred eEEEEEEecC-Cceeeee-----------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEe
Confidence 3467777776 5555432 2456778888888887777666654 688999999999999 999999999
Q ss_pred Ccccc
Q psy5690 99 AMYCS 103 (434)
Q Consensus 99 Gla~~ 103 (434)
-++|.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99885
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.063 Score=50.92 Aligned_cols=31 Identities=23% Similarity=0.449 Sum_probs=27.3
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++||+|+++.||+++.++...++||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5899999999999999888778999998643
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.72 E-value=0.12 Score=49.31 Aligned_cols=31 Identities=23% Similarity=0.392 Sum_probs=26.6
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++||+|+++.||+++.+...-++||+.++.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999998766568999998654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.12 Score=49.04 Aligned_cols=30 Identities=20% Similarity=0.308 Sum_probs=25.7
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.+++|+|+.+.||+++. +.+.++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997543
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.081 Score=48.03 Aligned_cols=31 Identities=23% Similarity=0.169 Sum_probs=25.9
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.+++|+|+.+.||+++.+...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998776667999997643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=93.37 E-value=0.1 Score=47.25 Aligned_cols=30 Identities=20% Similarity=0.227 Sum_probs=26.4
Q ss_pred CccccCCCCCCeeeec-CCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGK-NYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~-~~~~kL~DFGla~~ 103 (434)
+++|+|+.+.|||++. ++.+.++||..|..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 5899999999999998 57899999987654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.35 E-value=0.11 Score=48.86 Aligned_cols=31 Identities=23% Similarity=0.420 Sum_probs=27.2
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.+++|+|+.|.||++++++.+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887778999998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=92.73 E-value=0.086 Score=47.29 Aligned_cols=31 Identities=26% Similarity=0.223 Sum_probs=21.4
Q ss_pred CCccccCCCCCCeeee-cCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVG-KNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~ 103 (434)
..++|+|+.|.||+++ .++.+-|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 3599999999999999 566668999998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=92.44 E-value=0.18 Score=47.69 Aligned_cols=30 Identities=17% Similarity=0.171 Sum_probs=26.4
Q ss_pred CccccCCCCCCeeeecC----CceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKN----YTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~----~~~kL~DFGla~~ 103 (434)
.++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 58999999999999875 7899999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=92.30 E-value=0.41 Score=42.04 Aligned_cols=74 Identities=20% Similarity=0.201 Sum_probs=51.7
Q ss_pred CCCCCCCe--eeEEEEEecC------------------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q psy5690 2 CSLKDPNL--VRVIGVCSTE------------------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMAT 61 (434)
Q Consensus 2 ~~L~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~ 61 (434)
+.+.+.++ |+++||..-. ....||-||.+... .+. ..-+.
T Consensus 112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~----~~~~~ 171 (207)
T PF13095_consen 112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQ----IRDIP 171 (207)
T ss_pred HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccc----hhHHH
Confidence 44566677 8999987322 11457777775532 112 22356
Q ss_pred HHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCc
Q psy5690 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100 (434)
Q Consensus 62 qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGl 100 (434)
+|.+-+..+|..||+-+|+++.|.. .-||+|||.
T Consensus 172 ~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~ 205 (207)
T PF13095_consen 172 QMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSS 205 (207)
T ss_pred HHHHHHHHHHHCCeeeccCcccccc-----CCEEEeccc
Confidence 7788889999999999999999986 358999985
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.07 E-value=0.12 Score=44.92 Aligned_cols=28 Identities=18% Similarity=0.191 Sum_probs=24.6
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.+|+|+.|.|+++++++ ++++||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998777 88999998654
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.55 E-value=0.28 Score=45.44 Aligned_cols=48 Identities=13% Similarity=0.077 Sum_probs=36.0
Q ss_pred HHHHHHHHHHHHHHhhhC--CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 56 LIFMATQIASGMKYLESR--DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 56 ~~~i~~qi~~gL~yLH~~--~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
..+.+..+-.++.-.+.. -++|+|+.|+|++.++.+.++|+||..|..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 333444555555555544 589999999999999999999999987654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.47 E-value=0.24 Score=47.26 Aligned_cols=29 Identities=21% Similarity=0.221 Sum_probs=26.1
Q ss_pred ccccCCCCCCeeeecCCc-eEEccCCcccc
Q psy5690 75 IVHRDLAARNCMVGKNYT-IKISDHAMYCS 103 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~-~kL~DFGla~~ 103 (434)
+||+|+.|.||+++.+.. +.+.|||-++.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999998874 89999998765
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=90.57 E-value=0.28 Score=46.53 Aligned_cols=30 Identities=10% Similarity=0.023 Sum_probs=27.4
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
++||+|+.+.|+|++.++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999998999999988655
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=90.34 E-value=0.18 Score=46.34 Aligned_cols=29 Identities=24% Similarity=0.242 Sum_probs=25.3
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++|+|+.|.||++++++ +.++||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999877 78999987654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=90.17 E-value=0.24 Score=43.96 Aligned_cols=37 Identities=22% Similarity=0.227 Sum_probs=31.8
Q ss_pred HHHHHHhhh--CCccccCCCCCCeeeecCCceEEccCCc
Q psy5690 64 ASGMKYLES--RDIVHRDLAARNCMVGKNYTIKISDHAM 100 (434)
Q Consensus 64 ~~gL~yLH~--~~iiHrDlkp~NILl~~~~~~kL~DFGl 100 (434)
+++|.-.|+ .+.+|||..|+||+-|+.|.+||.|-+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 466777884 3799999999999999999999999664
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=89.53 E-value=0.44 Score=46.01 Aligned_cols=30 Identities=27% Similarity=0.313 Sum_probs=25.8
Q ss_pred CccccCCCCCCeeeec-CCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGK-NYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~-~~~~kL~DFGla~~ 103 (434)
.++|+|+++.|||+++ ++.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999986 46799999988653
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=89.36 E-value=0.18 Score=44.85 Aligned_cols=30 Identities=23% Similarity=0.313 Sum_probs=21.3
Q ss_pred CccccCCCCCCeee-ecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMV-GKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl-~~~~~~kL~DFGla~~ 103 (434)
-++|+|+.+.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999988654
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=89.10 E-value=0.4 Score=45.41 Aligned_cols=48 Identities=21% Similarity=0.304 Sum_probs=32.5
Q ss_pred HHHHHHHHHHHHHHHH--hh----hCCccccCCCCCCeeeecC------------------CceEEccCCcccc
Q psy5690 54 GCLIFMATQIASGMKY--LE----SRDIVHRDLAARNCMVGKN------------------YTIKISDHAMYCS 103 (434)
Q Consensus 54 ~~~~~i~~qi~~gL~y--LH----~~~iiHrDlkp~NILl~~~------------------~~~kL~DFGla~~ 103 (434)
+-++.+..||+ |-| .- ..+.+|-||||+|||+-++ -.++|.||.+++.
T Consensus 275 ~YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 275 EYVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 34566777775 444 22 2368999999999998432 2357778888655
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=89.06 E-value=0.66 Score=40.77 Aligned_cols=31 Identities=23% Similarity=0.216 Sum_probs=25.9
Q ss_pred CCccccCCCCCCeeeecCC-----ceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNY-----TIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~-----~~kL~DFGla~~ 103 (434)
..++|||+.+.||++..++ .+.+.||..++.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4689999999999997543 589999998765
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=86.49 E-value=0.48 Score=44.19 Aligned_cols=30 Identities=17% Similarity=0.206 Sum_probs=24.8
Q ss_pred CccccCCCCCCeeeecCCc-eEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYT-IKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~-~kL~DFGla~~ 103 (434)
.++|+|+++.||++++++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987554 56999998654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=86.38 E-value=0.73 Score=44.10 Aligned_cols=29 Identities=14% Similarity=-0.059 Sum_probs=24.4
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++||+|+.+.|||++ + .+.++||+-++.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4689999999999995 4 578999998654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=85.82 E-value=0.99 Score=50.12 Aligned_cols=31 Identities=19% Similarity=0.287 Sum_probs=25.9
Q ss_pred CCccccCCCCCCeeeecCC--ceE-EccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNY--TIK-ISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~--~~k-L~DFGla~~ 103 (434)
+++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998775 454 999998654
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=85.59 E-value=1.1 Score=35.78 Aligned_cols=27 Identities=33% Similarity=0.561 Sum_probs=13.9
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHhhhHHH
Q psy5690 367 GVIAGMFAMILLVLGCTVLFLVRRGRKK 394 (434)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (434)
.||+|++++|+..+++ +.++.||++||
T Consensus 68 ~Ii~gv~aGvIg~Ill-i~y~irR~~Kk 94 (122)
T PF01102_consen 68 GIIFGVMAGVIGIILL-ISYCIRRLRKK 94 (122)
T ss_dssp HHHHHHHHHHHHHHHH-HHHHHHHHS--
T ss_pred ehhHHHHHHHHHHHHH-HHHHHHHHhcc
Confidence 5667777777655443 33334555444
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=83.51 E-value=1.3 Score=49.11 Aligned_cols=32 Identities=16% Similarity=0.172 Sum_probs=25.6
Q ss_pred hCCccccCCCCCCeeeecCC--c---eEEccCCcccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNY--T---IKISDHAMYCS 103 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~--~---~kL~DFGla~~ 103 (434)
..++||+|+.+.||+++.+. . .-|+|||.+..
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 35899999999999998652 3 37899998654
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=83.23 E-value=1.9 Score=41.37 Aligned_cols=29 Identities=21% Similarity=0.237 Sum_probs=25.1
Q ss_pred ccccCCCCCCeeeec-CCceEEccCCcccc
Q psy5690 75 IVHRDLAARNCMVGK-NYTIKISDHAMYCS 103 (434)
Q Consensus 75 iiHrDlkp~NILl~~-~~~~kL~DFGla~~ 103 (434)
.+|.|+.+.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 47899999998643
|
|
| >COG1862 YajC Preprotein translocase subunit YajC [Intracellular trafficking and secretion] | Back alignment and domain information |
|---|
Probab=83.16 E-value=1 Score=34.29 Aligned_cols=41 Identities=20% Similarity=0.407 Sum_probs=28.2
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhHHHHHhhcccccccCCCCCccc
Q psy5690 370 AGMFAMILLVLGCTVLFLVRRGRKKVALLHKHSALMNGSAPGVT 413 (434)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (434)
+..++.+++++++|..+.+|+.++|.- .+...+++|..|-.
T Consensus 9 ~~~ll~~vl~~~ifyFli~RPQrKr~K---~~~~ml~sL~kGD~ 49 (97)
T COG1862 9 LVLLLPLVLIFAIFYFLIIRPQRKRMK---EHQELLNSLKKGDE 49 (97)
T ss_pred HHHHHHHHHHHHHHHHhhcCHHHHHHH---HHHHHHHhccCCCE
Confidence 445566666667777778888877744 36677788887643
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.10 E-value=2 Score=40.61 Aligned_cols=38 Identities=21% Similarity=0.201 Sum_probs=26.0
Q ss_pred HHHHHHHHHHHHHHHHhh----hCCccccCCCCCCeeeecCC
Q psy5690 54 GCLIFMATQIASGMKYLE----SRDIVHRDLAARNCMVGKNY 91 (434)
Q Consensus 54 ~~~~~i~~qi~~gL~yLH----~~~iiHrDlkp~NILl~~~~ 91 (434)
+-++.+..||+.-.-..- ..+.+|-||||+|||+-++.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 456677888864432332 23689999999999995543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=81.60 E-value=2.4 Score=38.10 Aligned_cols=29 Identities=28% Similarity=0.353 Sum_probs=24.8
Q ss_pred CCeeeEEEEEecCCceEEEEecCCCCCHH
Q psy5690 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLS 35 (434)
Q Consensus 7 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 35 (434)
-.|.+++.+..+.++.|+|+||++-|.+.
T Consensus 71 i~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 71 ITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 45778888888999999999999987766
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=81.08 E-value=1.1 Score=42.44 Aligned_cols=30 Identities=17% Similarity=0.213 Sum_probs=27.0
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++|||+++.|++++..+-+-+.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 489999999999999988899999998654
|
|
| >PF02009 Rifin_STEVOR: Rifin/stevor family; InterPro: IPR002858 Malaria is still a major cause of mortality in many areas of the world | Back alignment and domain information |
|---|
Probab=80.92 E-value=1.9 Score=40.39 Aligned_cols=39 Identities=26% Similarity=0.462 Sum_probs=0.0
Q ss_pred cchhhhHHHHHHHHHHHHHHHHHHHhhhHHHHHhhcccc
Q psy5690 364 TYVGVIAGMFAMILLVLGCTVLFLVRRGRKKVALLHKHS 402 (434)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (434)
.+-+|++.++++++.+|..+++.|..|+|||.-...|.+
T Consensus 254 ~~t~I~aSiiaIliIVLIMvIIYLILRYRRKKKmkKKlQ 292 (299)
T PF02009_consen 254 LTTAIIASIIAILIIVLIMVIIYLILRYRRKKKMKKKLQ 292 (299)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhHHHH
|
Plasmodium falciparum causes the most severe human form of the disease and is responsible for most fatalities. Severe cases of malaria can occur when the parasite invades and then proliferates within red blood cell erythrocytes. The parasite produces many variant antigenic proteins, encoded by multigene families, which are present on the surface of the infected erythrocyte and play important roles in virulence. A crucial survival mechanism for the malaria parasite is its ability to evade the immune response by switching these variant surface antigens. The high virulence of P. falciparum relative to other malarial parasites is in large part due to the fact that in this organism many of these surface antigens mediate the binding of infected erythrocytes to the vascular endothelium (cytoadherence) and non-infected erythrocytes (rosetting). This can lead to the accumulation of infected cells in the vasculature of a variety of organs, blocking the blood flow and reducing the oxygen supply. Clinical symptoms of severe infection can include fever, progressive anaemia, multi-organ dysfunction and coma. For more information see []. Several multicopy gene families have been described in Plasmodium falciparum, including the stevor family of subtelomeric open reading frames and the rif interspersed repetitive elements. Both families contain three predicted transmembrane segments. It has been proposed that stevor and rif are members of a larger superfamily that code for variant surface antigens []. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 434 | ||||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-38 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-38 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-38 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-38 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-38 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-38 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-38 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-38 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-38 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-38 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-38 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-38 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-38 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-38 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-38 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-38 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-37 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-37 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-37 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-37 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-37 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-37 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-37 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-36 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-36 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-35 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-35 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-35 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-35 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-35 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-35 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-35 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-35 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-35 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-35 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-35 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-35 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-34 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-34 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-34 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-33 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-33 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-33 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-33 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-32 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-32 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-32 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-32 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-32 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-32 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-32 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-32 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-32 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-32 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-32 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-32 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-32 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-31 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-31 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-31 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-31 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-31 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-31 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-30 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-30 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-30 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-30 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-30 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-30 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-30 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-30 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-30 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-30 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-30 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-30 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-30 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-30 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-29 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-29 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-29 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-29 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-29 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-29 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-29 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-29 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-29 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-29 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-29 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-29 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-29 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-29 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-29 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-29 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-29 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-29 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-29 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-28 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-28 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-28 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-28 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-28 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-28 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-28 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-27 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-27 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-27 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-27 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-27 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-27 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-27 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-27 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-27 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-27 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-27 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-27 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-27 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-27 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-27 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-26 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-26 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-26 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-26 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-26 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-26 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-26 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-26 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-26 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-26 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-26 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-26 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-26 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-26 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-26 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-26 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-26 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-26 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-26 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-26 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-26 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-25 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-25 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-25 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-25 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-25 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-25 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-25 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-25 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-25 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-25 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-25 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-25 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-25 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-25 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-25 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-25 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-25 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-25 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-25 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-25 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-25 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-25 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-25 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-25 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-25 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-25 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-25 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-25 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-25 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-25 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-25 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-25 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-25 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-25 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-24 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-24 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-24 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-24 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-24 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-24 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-24 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-24 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-24 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-24 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-24 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-24 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-24 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-24 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-24 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-24 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-24 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-24 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-24 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-24 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-24 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-24 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-24 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-24 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-24 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-24 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-24 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-24 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-24 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-24 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-24 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-24 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-24 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-23 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-23 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-23 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-23 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-23 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-23 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-23 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-23 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-23 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-23 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-23 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-23 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-23 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-23 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-23 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-23 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-23 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-23 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-23 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-23 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-23 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-23 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-23 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-23 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-23 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-23 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-22 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-22 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-22 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-22 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-22 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-22 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-22 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-22 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-22 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-22 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-22 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-22 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-22 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-22 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-22 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-22 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-22 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-22 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-22 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-22 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-22 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-21 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-21 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-21 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-21 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-21 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-21 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-21 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-21 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-21 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-20 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-20 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-20 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-20 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-19 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-19 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-17 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-17 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-17 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-17 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-04 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-04 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-04 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-04 |
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 3e-88
Identities = 85/269 (31%), Positives = 122/269 (45%), Gaps = 57/269 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH--------NCNSQENPAIS 52
+ L+ ++VR GVC+ P+ + EY GDL+ FL+ H +
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 53 YGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLS 112
G L+ +A+Q+A+GM YL VHRDLA RNC+VG+ +KI D M
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM------------ 204
Query: 113 DTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLG 172
+R I Y +DYY + LPIRWM ES+L
Sbjct: 205 ---SR-----------------DI---------YSTDYYRVGGRTMLPIRWMPPESILYR 235
Query: 173 KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232
K TT+SDVWSF V LWEI + Q P+ +L+N + I+ + + L RP C
Sbjct: 236 KFTTESDVWSFGVVLWEIFTYGKQ-PWYQLSNTEAIDCITQGRE-------LERPRACPP 287
Query: 233 EIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++ +M CW+ R ++H LQ
Sbjct: 288 EVYAIMRGCWQREPQQRHSIKDVHARLQA 316
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 7e-88
Identities = 91/270 (33%), Positives = 127/270 (47%), Gaps = 58/270 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH---------NCNSQENPAI 51
+ +L+ ++V+ GVC DP+ + EY + GDL+ FL+ H Q +
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 52 SYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYL 111
++ +A+QIASGM YL S+ VHRDLA RNC+VG N +KI D M
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM----------- 179
Query: 112 SDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL 171
+R + Y +DYY LPIRWM ES++
Sbjct: 180 ----SR-----------------DV---------YSTDYYRVGGHTMLPIRWMPPESIMY 209
Query: 172 GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231
K TT+SDVWSF V LWEI + Q P+ +L+N +VIE + L RP C
Sbjct: 210 RKFTTESDVWSFGVILWEIFTYGKQ-PWFQLSNTEVIECITQGR-------VLERPRVCP 261
Query: 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
KE++D+ML CW+ R EI+ L
Sbjct: 262 KEVYDVMLGCWQREPQQRLNIKEIYKILHA 291
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 2e-87
Identities = 89/278 (32%), Positives = 127/278 (45%), Gaps = 66/278 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH-----------------NC 43
M +PN+V+++GVC+ P+ + EY +GDL+ FL+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 44 NSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103
+S P +S + +A Q+A+GM YL R VHRDLA RNC+VG+N +KI+D +
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL--- 220
Query: 104 HYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163
+R I Y +DYY +D +PIRW
Sbjct: 221 ------------SR-----------------NI---------YSADYYKADGNDAIPIRW 242
Query: 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY 223
M ES+ + TT+SDVW++ V LWEI + Q PY + +E+VI
Sbjct: 243 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-PYYGMAHEEVIYYVRD-------GNI 294
Query: 224 LPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
L P C E+++LM CW DRP F IH LQR
Sbjct: 295 LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 8e-87
Identities = 82/269 (30%), Positives = 124/269 (46%), Gaps = 58/269 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH---------NCNSQENPAI 51
L+ PN+V ++GV + + P+S I YC GDL FL + + + A+
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 52 SYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYL 111
+ + QIA+GM+YL S +VH+DLA RN +V +KISD +
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL----------- 174
Query: 112 SDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL 171
R ++ Y +DYY + LPIRWMA E+++
Sbjct: 175 ----FR-----------------EV---------YAADYYKLLGNSLLPIRWMAPEAIMY 204
Query: 172 GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231
GK + SD+WS+ V LWE+ + Q PY +N+ V+E + LP P C
Sbjct: 205 GKFSIDSDIWSYGVVLWEVFSYGLQ-PYCGYSNQDVVEMIRNRQ-------VLPCPDDCP 256
Query: 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQ 260
++ LM+ECW + RPRF +IH L+
Sbjct: 257 AWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 4e-85
Identities = 94/264 (35%), Positives = 119/264 (45%), Gaps = 52/264 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENP---AISYGCLI 57
M ++VR++GV S P I E GDL ++L+ NP S +I
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
MA +IA GM YL + VHRDLAARNCMV +++T+KI D M R
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM---------------TR 186
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
I YE+DYY K LP+RWM+ ESL G TT
Sbjct: 187 -----------------DI---------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTY 220
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SDVWSF V LWEI Q PY L+NEQV+ L +P C +F+L
Sbjct: 221 SDVWSFGVVLWEIATLAEQ-PYQGLSNEQVLRFVMEGG-------LLDKPDNCPDMLFEL 272
Query: 238 MLECWKTNETDRPRFSEIHLFLQR 261
M CW+ N RP F EI ++
Sbjct: 273 MRMCWQYNPKMRPSFLEIISSIKE 296
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 2e-81
Identities = 73/264 (27%), Positives = 111/264 (42%), Gaps = 52/264 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ N+VR IGV P + E GDL +FL+ + +++ L+ +A
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
IA G +YLE +HRD+AARNC++ G KI D M AR
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM---------------AR 191
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
I Y + YY A LP++WM E+ + G T+K
Sbjct: 192 -----------------DI---------YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 225
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
+D WSF V LWEI PY +N++V+E + + + P C ++ +
Sbjct: 226 TDTWSFGVLLWEIFSLGYM-PYPSKSNQEVLEFVTSGGR-------MDPPKNCPGPVYRI 277
Query: 238 MLECWKTNETDRPRFSEIHLFLQR 261
M +CW+ DRP F+ I ++
Sbjct: 278 MTQCWQHQPEDRPNFAIILERIEY 301
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 5e-81
Identities = 73/264 (27%), Positives = 111/264 (42%), Gaps = 52/264 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ N+VR IGV P + E GDL +FL+ + +++ L+ +A
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
IA G +YLE +HRD+AARNC++ G KI D M AR
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM---------------AR 232
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
I Y + YY A LP++WM E+ + G T+K
Sbjct: 233 -----------------DI---------YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK 266
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
+D WSF V LWEI PY +N++V+E + + + P C ++ +
Sbjct: 267 TDTWSFGVLLWEIFSLGYM-PYPSKSNQEVLEFVTSGGR-------MDPPKNCPGPVYRI 318
Query: 238 MLECWKTNETDRPRFSEIHLFLQR 261
M +CW+ DRP F+ I ++
Sbjct: 319 MTQCWQHQPEDRPNFAIILERIEY 342
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 2e-79
Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 59/271 (21%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH---------NCNSQENPA 50
M + N++ ++G C+ + P+ I EY G+L +L+ + N
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY 110
+++ L+ Q+A GM+YL S+ +HRDLAARN +V +N +KI+D +
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL---------- 203
Query: 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL 170
AR I DYY T RLP++WMA E+L
Sbjct: 204 -----AR-----------------DI---------NNIDYYKKTTNGRLPVKWMAPEALF 232
Query: 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230
T +SDVWSF V +WEI PY + E++ + + + +PA C
Sbjct: 233 DRVYTHQSDVWSFGVLMWEIFTLGGS-PYPGIPVEELFKLLKEGH-------RMDKPANC 284
Query: 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++ +M +CW + RP F ++ L R
Sbjct: 285 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 3e-79
Identities = 74/271 (27%), Positives = 118/271 (43%), Gaps = 59/271 (21%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH---------NCNSQENPA 50
M + N++ ++G C+ + P+ I EY G+L +L+ + N
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY 110
+++ L+ Q+A GM+YL S+ +HRDLAARN +V +N +KI+D +
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL---------- 249
Query: 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL 170
AR I DYY T RLP++WMA E+L
Sbjct: 250 -----AR-----------------DI---------NNIDYYKKTTNGRLPVKWMAPEALF 278
Query: 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230
T +SDVWSF V +WEI PY + E++ + + + +PA C
Sbjct: 279 DRVYTHQSDVWSFGVLMWEIFTLGGS-PYPGIPVEELFKLLKEGH-------RMDKPANC 330
Query: 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++ +M +CW + RP F ++ L R
Sbjct: 331 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 2e-78
Identities = 81/278 (29%), Positives = 128/278 (46%), Gaps = 66/278 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH-----------------NC 43
+ + P+++++ G CS + P+ I EY ++G L FL+ +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 44 NSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103
+ + A++ G LI A QI+ GM+YL +VHRDLAARN +V + +KISD +
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL--- 196
Query: 104 HYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163
+R + YE D Y+ ++ R+P++W
Sbjct: 197 ------------SR-----------------DV---------YEEDSYVKRSQGRIPVKW 218
Query: 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY 223
MA ESL TT+SDVWSF V LWEI+ PY + E++ +
Sbjct: 219 MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN-PYPGIPPERLFNLLKTGH-------R 270
Query: 224 LPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
+ RP C +E++ LML+CWK RP F++I L++
Sbjct: 271 MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-78
Identities = 78/266 (29%), Positives = 123/266 (46%), Gaps = 55/266 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST-----IQEYCEFGDLSTFLQIHNCNSQENPAISYGC 55
M PN++R++GVC I + ++GDL T+L + I
Sbjct: 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH-IPLQT 148
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 115
L+ IA GM+YL +R+ +HRDLAARNCM+ + T+ ++D +
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL--------------- 193
Query: 116 ARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
++ KI Y DYY A++P++W+A ESL T
Sbjct: 194 SK-----------------KI---------YSGDYYRQGRIAKMPVKWIAIESLADRVYT 227
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
+KSDVW+F VT+WEI PY + N ++ + H + L +P C E++
Sbjct: 228 SKSDVWAFGVTMWEIATRGMT-PYPGVQNHEMYDYLLHGH-------RLKQPEDCLDELY 279
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQR 261
++M CW+T+ DRP FS + L L++
Sbjct: 280 EIMYSCWRTDPLDRPTFSVLRLQLEK 305
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 1e-77
Identities = 73/267 (27%), Positives = 114/267 (42%), Gaps = 56/267 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST------IQEYCEFGDLSTFLQIHNCNSQENPAISYG 54
M P++ +++GV I + + GDL FL +
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN-LPLQ 137
Query: 55 CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDT 114
L+ IA GM+YL SR+ +HRDLAARNCM+ ++ T+ ++D +
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL-------------- 183
Query: 115 KARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN 174
+R KI Y DYY ++LP++W+A ESL
Sbjct: 184 -SR-----------------KI---------YSGDYYRQGCASKLPVKWLALESLADNLY 216
Query: 175 TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234
T SDVW+F VT+WEI+ PYA + N ++ L +P C +E+
Sbjct: 217 TVHSDVWAFGVTMWEIMTRGQT-PYAGIENAEIYNYLIGGN-------RLKQPPECMEEV 268
Query: 235 FDLMLECWKTNETDRPRFSEIHLFLQR 261
+DLM +CW + RP F+ + + L+
Sbjct: 269 YDLMYQCWSADPKQRPSFTCLRMELEN 295
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 7e-77
Identities = 76/271 (28%), Positives = 119/271 (43%), Gaps = 59/271 (21%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH---------NCNSQENPA 50
M + N++ ++G C+ + P+ I EY G+L +LQ N +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY 110
+S L+ A Q+A GM+YL S+ +HRDLAARN +V ++ +KI+D +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---------- 237
Query: 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL 170
AR I + DYY T RLP++WMA E+L
Sbjct: 238 -----AR-----------------DI---------HHIDYYKKTTNGRLPVKWMAPEALF 266
Query: 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230
T +SDVWSF V LWEI PY + E++ + + + +P+ C
Sbjct: 267 DRIYTHQSDVWSFGVLLWEIFTLGGS-PYPGVPVEELFKLLKEGH-------RMDKPSNC 318
Query: 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++ +M +CW + RP F ++ L R
Sbjct: 319 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 8e-77
Identities = 87/261 (33%), Positives = 131/261 (50%), Gaps = 55/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +K PNLV+++GVC+ E P I E+ +G+L +L+ +S L++MA
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-----ECNRQEVSAVVLLYMA 117
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
TQI+S M+YLE ++ +HRDLAARNC+VG+N+ +K++D + +RL
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL---------------SRL-- 160
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
D Y + A+ PI+W A ESL K + KSDV
Sbjct: 161 -------------------------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F V LWEI + PY + QV E Y+ + RP C +++++LM
Sbjct: 196 WAFGVLLWEIATY-GMSPYPGIDLSQVYELLEKDYR-------MERPEGCPEKVYELMRA 247
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ N +DRP F+EIH +
Sbjct: 248 CWQWNPSDRPSFAEIHQAFET 268
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 3e-76
Identities = 80/271 (29%), Positives = 117/271 (43%), Gaps = 62/271 (22%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH---------NCNSQENPA 50
+C L PN++ ++G C + EY G+L FL+ +
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY 110
+S L+ A +A GM YL + +HRDLAARN +VG+NY KI+D +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL---------- 188
Query: 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL 170
+R + Y+ T RLP+RWMA ESL
Sbjct: 189 -----SR-----------------------------GQEVYVKKTMGRLPVRWMAIESLN 214
Query: 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230
TT SDVWS+ V LWEI + PY +T ++ E Y+ L +P C
Sbjct: 215 YSVYTTNSDVWSYGVLLWEI-VSLGGTPYCGMTCAELYEKLPQGYR-------LEKPLNC 266
Query: 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++DLM +CW+ +RP F++I + L R
Sbjct: 267 DDEVYDLMRQCWREKPYERPSFAQILVSLNR 297
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 8e-76
Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M S+ +P++ R++G+C + I + FG L +++ + I L+
Sbjct: 71 MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR------EHKDNIGSQYLLNWC 123
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM YLE R +VHRDLAARN +V +KI +D+ L+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI-----------TDFGLA-------- 164
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ + + ++PI+WMA ES+L T +SDV
Sbjct: 165 KLL----------------------GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 202
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VT+WE++ +PY + ++ + LP+P C +++ +M +
Sbjct: 203 WSYGVTVWELMTFG-SKPYDGIPASEISSILEKGER-------LPQPPICTIDVYMIMRK 254
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW + RP+F E+ + +
Sbjct: 255 CWMIDADSRPKFRELIIEFSK 275
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 6e-75
Identities = 76/261 (29%), Positives = 119/261 (45%), Gaps = 57/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +L P++V++IG+ E+P I E +G+L +L+ + ++ L+ +
Sbjct: 67 MKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNK------NSLKVLTLVLYS 119
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QI M YLES + VHRD+A RN +V +K+ D + +R
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL---------------SRYI- 163
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ DYY + + RLPI+WM+ ES+ + TT SDV
Sbjct: 164 -------------------------EDEDYYKA-SVTRLPIKWMSPESINFRRFTTASDV 197
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W FAV +WEIL ++P+ L N+ VI + LP+P C ++ LM
Sbjct: 198 WMFAVCMWEILSFG-KQPFFWLENKDVIGVLEKGDR-------LPKPDLCPPVLYTLMTR 249
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW + +DRPRF+E+ L
Sbjct: 250 CWDYDPSDRPRFTELVCSLSD 270
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 7e-75
Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 62/274 (22%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH-----------NCNSQEN 48
+ L + N+V ++G C+ P I EYC +GDL FL+ +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 49 PAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESD 108
A+ L+ + Q+A GM +L S++ +HRDLAARN ++ KI D +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL-------- 191
Query: 109 YYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWES 168
AR I Y+ ARLP++WMA ES
Sbjct: 192 -------AR-----------------DI---------KNDSNYVVKGNARLPVKWMAPES 218
Query: 169 LLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAEL-TNEQVIENCSHWYQNNSKQQYLPRP 227
+ T +SDVWS+ + LWE+ + PY + + + + + + P
Sbjct: 219 IFNCVYTFESDVWSYGIFLWELFSLGSS-PYPGMPVDSKFYKMIKEGF-------RMLSP 270
Query: 228 ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++D+M CW + RP F +I +++
Sbjct: 271 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 1e-74
Identities = 77/263 (29%), Positives = 112/263 (42%), Gaps = 57/263 (21%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH-------NCNSQENPAISYGCLIFM 59
N+V ++G C+ P+ I EYC +GDL FL+ + N S L+
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
++Q+A GM +L S++ +HRD+AARN ++ + KI D + AR
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---------------AR-- 212
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
I Y+ ARLP++WMA ES+ T +SD
Sbjct: 213 ---------------DI---------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSD 248
Query: 180 VWSFAVTLWEILIHCNQRPY-AELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
VWS+ + LWEI PY L N + + YQ + +PA K I+ +M
Sbjct: 249 VWSYGILLWEI-FSLGLNPYPGILVNSKFYKLVKDGYQ-------MAQPAFAPKNIYSIM 300
Query: 239 LECWKTNETDRPRFSEIHLFLQR 261
CW T RP F +I FLQ
Sbjct: 301 QACWALEPTHRPTFQQICSFLQE 323
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-74
Identities = 78/262 (29%), Positives = 116/262 (44%), Gaps = 54/262 (20%)
Query: 1 MCSLKDPNLVRVIGVCS-TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
M PN++ ++G+C +E + Y + GDL F++ E + LI
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDLIGF 133
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
Q+A GMKYL S+ VHRDLAARNCM+ + +T+K++D + Y+ +YY K
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK---- 189
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
T A+LP++WMA ESL K TTKSD
Sbjct: 190 -----------------------------------TGAKLPVKWMALESLQTQKFTTKSD 214
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF V LWE++ PY ++ + L +P C ++++ML
Sbjct: 215 VWSFGVLLWELMTR-GAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDPLYEVML 266
Query: 240 ECWKTNETDRPRFSEIHLFLQR 261
+CW RP FSE+ +
Sbjct: 267 KCWHPKAEMRPSFSELVSRISA 288
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-74
Identities = 68/261 (26%), Positives = 107/261 (40%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +L LV++ GVC+ + PI I EY G L +L+ L+ M
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMC 126
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ M+YLES+ +HRDLAARNC+V +K+SD + +R
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL---------------SRY-- 169
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
D Y S ++ P+RW E L+ K ++KSD+
Sbjct: 170 -------------------------VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F V +WEI + PY TN + E+ + + L RP ++++ +M
Sbjct: 205 WAFGVLMWEIYSLG-KMPYERFTNSETAEHIAQGLR-------LYRPHLASEKVYTIMYS 256
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW +RP F + +
Sbjct: 257 CWHEKADERPTFKILLSNILD 277
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-74
Identities = 71/277 (25%), Positives = 109/277 (39%), Gaps = 69/277 (24%)
Query: 1 MCSLKDPNLVRVIGVC--STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ SL+ N+V+ GVC + + I EY +G L +LQ H I + L+
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQ 149
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
+QI GM+YL ++ +HRDLA RN +V +KI D + ++
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL---------------TKV 194
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
+ +YY PI W A ESL K + S
Sbjct: 195 -------------------------LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVAS 229
Query: 179 DVWSFAVTLWEILIHCNQR--------------PYAELTNEQVIENCSHWYQNNSKQQYL 224
DVWSF V L+E+ + + ++ +IE + + L
Sbjct: 230 DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR-------L 282
Query: 225 PRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
PRP C EI+ +M ECW N RP F ++ L + +
Sbjct: 283 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 2e-74
Identities = 80/261 (30%), Positives = 123/261 (47%), Gaps = 57/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M P++V++IGV TE+P+ I E C G+L +FLQ+ ++ LI A
Sbjct: 70 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK------YSLDLASLILYA 122
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+++ + YLES+ VHRD+AARN +V N +K+ D + +R
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---------------SRYM- 166
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+S YY + +K +LPI+WMA ES+ + T+ SDV
Sbjct: 167 -------------------------EDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDV 200
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W F V +WEIL+H +P+ + N VI + LP P C ++ LM +
Sbjct: 201 WMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGE-------RLPMPPNCPPTLYSLMTK 252
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW + + RPRF+E+ L
Sbjct: 253 CWAYDPSRRPRFTELKAQLST 273
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 2e-74
Identities = 74/266 (27%), Positives = 112/266 (42%), Gaps = 60/266 (22%)
Query: 7 PNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIH---------NCNSQENPAISYGCL 56
N+V ++G C+ P+ I E+C+FG+LST+L+ ++ L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
I + Q+A GM++L SR +HRDLAARN ++ + +KI D + A
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL---------------A 195
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
R I Y+ Y+ ARLP++WMA E++ T
Sbjct: 196 R-----------------DI---------YKDPDYVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 177 KSDVWSFAVTLWEILIHCNQRPYAELT-NEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
+SDVWSF V LWEI PY + +E+ + P E++
Sbjct: 230 QSDVWSFGVLLWEIFSLGAS-PYPGVKIDEEFCRRLKEGT-------RMRAPDYTTPEMY 281
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQR 261
ML+CW + RP FSE+ L
Sbjct: 282 QTMLDCWHGEPSQRPTFSELVEHLGN 307
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 3e-74
Identities = 67/276 (24%), Positives = 106/276 (38%), Gaps = 70/276 (25%)
Query: 1 MCSLKDPNLVRVIGVCS--TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ +L ++++ G C + + EY G L +L H+ + L+
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ--------LLL 138
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
A QI GM YL ++ +HRDLAARN ++ + +KI D + A+
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL---------------AKA 183
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
+ + +YY P+ W A E L K S
Sbjct: 184 -----------------VPE--------GHEYYRVREDGDSPVFWYAPECLKEYKFYYAS 218
Query: 179 DVWSFAVTLWEILIHCNQR-------------PYAELTNEQVIENCSHWYQNNSKQQYLP 225
DVWSF VTL+E+L HC+ ++T ++ E + LP
Sbjct: 219 DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER-------LP 271
Query: 226 RPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
RP C E++ LM CW+T + RP F + L+
Sbjct: 272 RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 3e-74
Identities = 73/264 (27%), Positives = 114/264 (43%), Gaps = 58/264 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIS-TIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
M L PN++ +IG+ + + + Y GDL F++ + LI
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR------SPQRNPTVKDLISF 129
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
Q+A GM+YL + VHRDLAARNCM+ +++T+K++D + AR
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGL---------------ARD- 173
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS--DTKARLPIRWMAWESLLLGKNTTK 177
I + +YY ARLP++W A ESL + TTK
Sbjct: 174 ----------------I---------LDREYYSVQQHRHARLPVKWTALESLQTYRFTTK 208
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SDVWSF V LWE+L PY + + + LP+P C ++ +
Sbjct: 209 SDVWSFGVLLWELLTRGAP-PYRHIDPFDLTHFLAQGR-------RLPQPEYCPDSLYQV 260
Query: 238 MLECWKTNETDRPRFSEIHLFLQR 261
M +CW+ + RP F + +++
Sbjct: 261 MQQCWEADPAVRPTFRVLVGEVEQ 284
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 3e-74
Identities = 66/276 (23%), Positives = 106/276 (38%), Gaps = 68/276 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ +L N+V+ G+C+ + + I I E+ G L +L + I+ +
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK------NKINLKQQLK 130
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
A QI GM YL SR VHRDLAARN +V + +KI D + +
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL---------------TKA 175
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
+ +YY P+ W A E L+ K S
Sbjct: 176 -------------------------IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIAS 210
Query: 179 DVWSFAVTLWEILIHCNQR-------------PYAELTNEQVIENCSHWYQNNSKQQYLP 225
DVWSF VTL E+L +C+ + ++T +++ + LP
Sbjct: 211 DVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR-------LP 263
Query: 226 RPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
P C E++ LM +CW+ ++R F + +
Sbjct: 264 CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 3e-74
Identities = 81/261 (31%), Positives = 115/261 (44%), Gaps = 55/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ PN+VR+IGVC+ + PI + E + GD TFL+ E + L+ M
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR------TEGARLRVKTLLQMV 219
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
A+GM+YLES+ +HRDLAARNC+V + +KISD M +R
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM---------------SRE-- 262
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ Y S ++P++W A E+L G+ +++SDV
Sbjct: 263 ------------------------EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + LWE PY L+N+Q E LP P C +F LM +
Sbjct: 299 WSFGILLWETFSLG-ASPYPNLSNQQTREFVEKGG-------RLPCPELCPDAVFRLMEQ 350
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW RP FS I+ LQ
Sbjct: 351 CWAYEPGQRPSFSTIYQELQS 371
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 4e-74
Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 69/277 (24%)
Query: 1 MCSLKDPNLVRVIGVC--STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ SL+ N+V+ GVC + + I EY +G L +LQ H I + L+
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQ 118
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
+QI GM+YL ++ +HRDLA RN +V +KI D + ++
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL---------------TKV 163
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
+ + +++ PI W A ESL K + S
Sbjct: 164 -----------------LPQ--------DKEFFKVKEPGESPIFWYAPESLTESKFSVAS 198
Query: 179 DVWSFAVTLWEILIHCNQR--------------PYAELTNEQVIENCSHWYQNNSKQQYL 224
DVWSF V L+E+ + + ++ +IE + + L
Sbjct: 199 DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR-------L 251
Query: 225 PRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
PRP C EI+ +M ECW N RP F ++ L + +
Sbjct: 252 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 4e-74
Identities = 71/260 (27%), Positives = 106/260 (40%), Gaps = 56/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P LV+ GVCS E PI + EY G L +L+ + L+ M
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR------SHGKGLEPSQLLEMC 110
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ GM +LES +HRDLAARNC+V ++ +K+SD M R
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGM---------------TRY-- 153
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
D Y+S + P++W A E K ++KSDV
Sbjct: 154 -------------------------VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F + +WE+ + PY TN +V+ S ++ L RP I+ +M
Sbjct: 189 WAFGILMWEVFSL-GKMPYDLYTNSEVVLKVSQGHR-------LYRPHLASDTIYQIMYS 240
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CW RP F ++ ++
Sbjct: 241 CWHELPEKRPTFQQLLSSIE 260
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 4e-74
Identities = 75/261 (28%), Positives = 113/261 (43%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P LV++ GVC + PI + E+ E G LS +L+ + + L+ M
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR------TQRGLFAAETLLGMC 110
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ GM YLE ++HRDLAARNC+VG+N IK+SD M R
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM---------------TRF-- 153
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
D Y S T + P++W + E + ++KSDV
Sbjct: 154 -------------------------VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 188
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V +WE+ + PY +N +V+E+ S ++ L +P ++ +M
Sbjct: 189 WSFGVLMWEVFSE-GKIPYENRSNSEVVEDISTGFR-------LYKPRLASTHVYQIMNH 240
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ DRP FS + L
Sbjct: 241 CWRERPEDRPAFSRLLRQLAE 261
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 1e-73
Identities = 79/261 (30%), Positives = 116/261 (44%), Gaps = 54/261 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M PN++R+ GV + + EY E G L TFL+ H+ + L+ M
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD------GQFTIMQLVGML 157
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ +GM+YL VHRDLAARN +V N K+SD + +R+
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL---------------SRV-- 200
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ D + D + T ++PIRW A E++ ++ SDV
Sbjct: 201 ---------------LED--------DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDV 237
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V +WE+L + +RPY +TN VI + Y+ LP P C + LML+
Sbjct: 238 WSFGVVMWEVLAYG-ERPYWNMTNRDVISSVEEGYR-------LPAPMGCPHALHQLMLD 289
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW + RPRFS+I L
Sbjct: 290 CWHKDRAQRPRFSQIVSVLDA 310
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-73
Identities = 70/261 (26%), Positives = 114/261 (43%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ SL ++VR++G+C + + +Y G L ++ H A+ L+
Sbjct: 69 IGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHR------GALGPQLLLNWG 121
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM YLE +VHR+LAARN ++ ++++D + A L
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV---------------ADLL- 165
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
D L ++A+ PI+WMA ES+ GK T +SDV
Sbjct: 166 -------------------------PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDV 200
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VT+WE++ PYA L +V + + L +P C +++ +M++
Sbjct: 201 WSYGVTVWELMTFG-AEPYAGLRLAEVPDLLEKGER-------LAQPQICTIDVYMVMVK 252
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW +E RP F E+ R
Sbjct: 253 CWMIDENIRPTFKELANEFTR 273
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 3e-73
Identities = 72/261 (27%), Positives = 118/261 (45%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +P +VR+IG+C + + E E G L+ +LQ +N + +I +
Sbjct: 72 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ-------QNRHVKDKNIIELV 123
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q++ GMKYLE + VHRDLAARN ++ + KISD + ++
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL---------------SKA-- 166
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ + +YY + T + P++W A E + K ++KSDV
Sbjct: 167 ---------------LRA--------DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 203
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V +WE + Q+PY + +V + + PA C +E++DLM
Sbjct: 204 WSFGVLMWEAFSYG-QKPYRGMKGSEVTAMLEKGER-------MGCPAGCPREMYDLMNL 255
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW + +RP F+ + L L+
Sbjct: 256 CWTYDVENRPGFAAVELRLRN 276
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 3e-73
Identities = 74/262 (28%), Positives = 115/262 (43%), Gaps = 54/262 (20%)
Query: 1 MCSLKDPNLVRVIGVCS-TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
M PN++ ++G+C +E + Y + GDL F++ E + LI
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR------NETHNPTVKDLIGF 197
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
Q+A GMK+L S+ VHRDLAARNCM+ + +T+K++D + Y+ ++
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD--------- 248
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
+ T A+LP++WMA ESL K TTKSD
Sbjct: 249 ------------------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSD 278
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF V LWE++ PY ++ + L +P C ++++ML
Sbjct: 279 VWSFGVLLWELMTR-GAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDPLYEVML 330
Query: 240 ECWKTNETDRPRFSEIHLFLQR 261
+CW RP FSE+ +
Sbjct: 331 KCWHPKAEMRPSFSELVSRISA 352
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 6e-73
Identities = 74/272 (27%), Positives = 111/272 (40%), Gaps = 66/272 (24%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIH----------------NCNSQENPA 50
N+V ++G C+ PI I EYC +GDL +L+ ++
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY 110
+++ L+ A Q+A GM++LE + VHRDLAARN +V +KI D +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL---------- 218
Query: 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL 170
AR I Y+ ARLP++WMA ESL
Sbjct: 219 -----AR-----------------DI---------MSDSNYVVRGNARLPVKWMAPESLF 247
Query: 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAEL-TNEQVIENCSHWYQNNSKQQYLPRPAT 229
G T KSDVWS+ + LWEI PY + + + + + + +P
Sbjct: 248 EGIYTIKSDVWSYGILLWEIFSLGVN-PYPGIPVDANFYKLIQNGF-------KMDQPFY 299
Query: 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
+EI+ +M CW + RP F + FL
Sbjct: 300 ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 8e-73
Identities = 78/261 (29%), Positives = 123/261 (47%), Gaps = 54/261 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M N++R+ GV S P+ I EY E G L FL+ + S L+ M
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD------GEFSVLQLVGML 153
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
IA+GMKYL + + VHRDLAARN +V N K+SD + +R+
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGL---------------SRV-- 196
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ D + + + + ++PIRW A E++ K T+ SDV
Sbjct: 197 ---------------LED--------DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 233
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + +WE+ + +RPY EL+N +V++ + ++ LP P C I+ LM++
Sbjct: 234 WSFGIVMWEV-MTYGERPYWELSNHEVMKAINDGFR-------LPTPMDCPSAIYQLMMQ 285
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ RP+F++I L +
Sbjct: 286 CWQQERARRPKFADIVSILDK 306
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-72
Identities = 65/262 (24%), Positives = 108/262 (41%), Gaps = 60/262 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDP-ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
M L+ NLV+++GV E + + EY G L +L+ S+ + CL+
Sbjct: 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKF 122
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
+ + M+YLE + VHRDLAARN +V ++ K+SD + +
Sbjct: 123 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL---------------TK-- 165
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
+ + +LP++W A E+L K +TKSD
Sbjct: 166 -----------------------------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 196
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF + LWEI + PY + + V+ Y+ + P C ++++M
Sbjct: 197 VWSFGILLWEI-YSFGRVPYPRIPLKDVVPRVEKGYK-------MDAPDGCPPAVYEVMK 248
Query: 240 ECWKTNETDRPRFSEIHLFLQR 261
CW + RP F ++ L+
Sbjct: 249 NCWHLDAAMRPSFLQLREQLEH 270
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-72
Identities = 73/270 (27%), Positives = 106/270 (39%), Gaps = 56/270 (20%)
Query: 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ +L +V+ GV + + EY G L FLQ H + L+
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR------ARLDASRLLL 131
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
++QI GM+YL SR VHRDLAARN +V +KI+D + A+L
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL---------------AKL 176
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
+ DYY+ + PI W A ESL + +S
Sbjct: 177 -------------------------LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQS 211
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS------KQQY-LPRPATCQ 231
DVWSF V L+E+ +C + + + C S ++ LP P C
Sbjct: 212 DVWSFGVVLYELFTYC-DKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACP 270
Query: 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E+ +LM CW + DRP FS + L
Sbjct: 271 AEVHELMKLCWAPSPQDRPSFSALGPQLDM 300
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-72
Identities = 69/261 (26%), Positives = 114/261 (43%), Gaps = 55/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +P +VR+IGVC + + + E G L FL + I + +
Sbjct: 64 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV------GKREEIPVSNVAELL 116
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q++ GMKYLE ++ VHRDLAARN ++ + KI SD+ LS
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI-----------SDFGLS-------- 157
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ + + YY + + + P++W A E + K +++SDV
Sbjct: 158 KALGA---------------------DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 196
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VT+WE L + Q+PY ++ +V+ + + P C E++ LM +
Sbjct: 197 WSYGVTMWEALSYG-QKPYKKMKGPEVMAFIEQGKR-------MECPPECPPELYALMSD 248
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW DRP F + ++
Sbjct: 249 CWIYKWEDRPDFLTVEQRMRA 269
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-72
Identities = 83/261 (31%), Positives = 119/261 (45%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ LVR+ V T++PI I EY E G L FL+ + ++ L+ MA
Sbjct: 62 MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLK-----TPSGIKLTINKLLDMA 115
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM ++E R+ +HRDL A N +V + KI+D + ARL
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL---------------ARL-- 158
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E++ G T KSDV
Sbjct: 159 -------------------------IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L EI+ H + PY +TN +VI+N Y+ + RP C +E++ LM
Sbjct: 194 WSFGILLTEIVTH-GRIPYPGMTNPEVIQNLERGYR-------MVRPDNCPEELYQLMRL 245
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CWK DRP F + L+
Sbjct: 246 CWKERPEDRPTFDYLRSVLED 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-72
Identities = 77/261 (29%), Positives = 122/261 (46%), Gaps = 54/261 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M PN++R+ GV + P+ + EY E G L +FL+ H+ + L+ M
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------AQFTVIQLVGML 153
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
IASGMKYL VHRDLAARN ++ N K+SD + R+
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL---------------GRV-- 196
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ D + + + ++PIRW + E++ K T+ SDV
Sbjct: 197 ---------------LED--------DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDV 233
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ + LWE+ + +RPY E++N+ VI+ Y+ LP P C ++ LML+
Sbjct: 234 WSYGIVLWEV-MSYGERPYWEMSNQDVIKAVDEGYR-------LPPPMDCPAALYQLMLD 285
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ + +RP+F +I L +
Sbjct: 286 CWQKDRNNRPKFEQIVSILDK 306
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-72
Identities = 66/261 (25%), Positives = 115/261 (44%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M S+ +P++ R++G+C + I + FG L +++ + I L+
Sbjct: 71 MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR------EHKDNIGSQYLLNWC 123
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM YLE R +VHRDLAARN +V +KI +D+ L+
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI-----------TDFGLA-------- 164
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ + + ++PI+WMA ES+L T +SDV
Sbjct: 165 KLL----------------------GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV 202
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VT+WE++ +PY + ++ + LP+P C +++ +M++
Sbjct: 203 WSYGVTVWELMTFG-SKPYDGIPASEISSILEKGER-------LPQPPICTIDVYMIMVK 254
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW + RP+F E+ + +
Sbjct: 255 CWMIDADSRPKFRELIIEFSK 275
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 5e-72
Identities = 75/262 (28%), Positives = 108/262 (41%), Gaps = 56/262 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M SL NL+R+ GV P+ + E G L L+ H G L A
Sbjct: 75 MHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYA 127
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+A GM YLES+ +HRDLAARN ++ +KI D + R
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL---------------MRA-- 170
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ +D D+Y+ ++P W A ESL + SD
Sbjct: 171 -------------LPQND----------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 207
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY-LPRPATCQKEIFDLML 239
W F VTLWE+ + Q P+ L Q++ K+ LPRP C ++I+++M+
Sbjct: 208 WMFGVTLWEMFTYG-QEPWIGLNGSQILHKI-------DKEGERLPRPEDCPQDIYNVMV 259
Query: 240 ECWKTNETDRPRFSEIHLFLQR 261
+CW DRP F + FL
Sbjct: 260 QCWAHKPEDRPTFVALRDFLLE 281
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 6e-71
Identities = 85/261 (32%), Positives = 129/261 (49%), Gaps = 55/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +K PNLV+++GVC+ E P I E+ +G+L +L+ +S L++MA
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-----ECNRQEVSAVVLLYMA 324
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
TQI+S M+YLE ++ +HR+LAARNC+VG+N+ +K++D + +R
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL---------------SR--- 366
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
D Y + A+ PI+W A ESL K + KSDV
Sbjct: 367 ------------------------LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F V LWEI PY + QV E Y+ + RP C +++++LM
Sbjct: 403 WAFGVLLWEI-ATYGMSPYPGIDLSQVYELLEKDYR-------MERPEGCPEKVYELMRA 454
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ N +DRP F+EIH +
Sbjct: 455 CWQWNPSDRPSFAEIHQAFET 475
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 4e-70
Identities = 66/262 (25%), Positives = 108/262 (41%), Gaps = 60/262 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDP-ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
M L+ NLV+++GV E + + EY G L +L+ S+ + CL+
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKF 294
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
+ + M+YLE + VHRDLAARN +V ++ K+SD + +
Sbjct: 295 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL---------------TK-- 337
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
+ + +LP++W A E+L K +TKSD
Sbjct: 338 -----------------------------EASSTQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF + LWEI + PY + + V+ Y+ + P C ++D+M
Sbjct: 369 VWSFGILLWEI-YSFGRVPYPRIPLKDVVPRVEKGYK-------MDAPDGCPPAVYDVMK 420
Query: 240 ECWKTNETDRPRFSEIHLFLQR 261
CW + RP F ++ L+
Sbjct: 421 NCWHLDAATRPTFLQLREQLEH 442
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 8e-70
Identities = 77/261 (29%), Positives = 116/261 (44%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +L+ LV++ V T++PI I E+ G L FL+ S E LI +
Sbjct: 237 MKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLK-----SDEGSKQPLPKLIDFS 290
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM ++E R+ +HRDL A N +V + KI+D + AR
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL---------------AR--- 332
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E++ G T KSDV
Sbjct: 333 ------------------------VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L EI+ + + PY ++N +VI Y+ +PRP C +E++++M+
Sbjct: 369 WSFGILLMEIVTYG-RIPYPGMSNPEVIRALERGYR-------MPRPENCPEELYNIMMR 420
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CWK +RP F I L
Sbjct: 421 CWKNRPEERPTFEYIQSVLDD 441
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-69
Identities = 60/262 (22%), Positives = 99/262 (37%), Gaps = 56/262 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +LV GVC D +QE+ +FG L T+L+ + I+ + +A
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK------KNKNCINILWKLEVA 119
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+A+ M +LE ++H ++ A+N ++ + K
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRK-------------------------- 153
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSD 179
G IK+SD + + D + I W+ E + KN +D
Sbjct: 154 -------TGNPPFIKLSDPGISITVLPKDIL------QERIPWVPPECIENPKNLNLATD 200
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
WSF TLWEI +P + L +++ ++ +Q LP P E+ +L+
Sbjct: 201 KWSFGTTLWEICSG-GDKPLSALDSQRKLQFYEDRHQ-------LPAPKAA--ELANLIN 250
Query: 240 ECWKTNETDRPRFSEIHLFLQR 261
C RP F I L
Sbjct: 251 NCMDYEPDHRPSFRAIIRDLNS 272
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 6e-69
Identities = 83/261 (31%), Positives = 126/261 (48%), Gaps = 57/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M P++V++IGV TE+P+ I E C G+L +FLQ+ ++ LI A
Sbjct: 445 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK------FSLDLASLILYA 497
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+++ + YLES+ VHRD+AARN +V N +K+ D+ LS
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL-----------GDFGLS-------- 538
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
R+M +S YY + +K +LPI+WMA ES+ + T+ SDV
Sbjct: 539 RYM----------------------EDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDV 575
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W F V +WEIL+H +P+ + N VI + LP P C ++ LM +
Sbjct: 576 WMFGVCMWEILMH-GVKPFQGVKNNDVIGRIENGE-------RLPMPPNCPPTLYSLMTK 627
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW + + RPRF+E+ L
Sbjct: 628 CWAYDPSRRPRFTELKAQLST 648
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-67
Identities = 77/261 (29%), Positives = 115/261 (44%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ LV++ V +E+PI + EY G L FL+ + L+ MA
Sbjct: 233 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-----TGKYLRLPQLVDMA 286
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIASGM Y+E + VHRDL A N +VG+N K++D + AR
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL---------------AR--- 328
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E+ L G+ T KSDV
Sbjct: 329 ------------------------LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L E+ + PY + N +V++ Y+ +P P C + + DLM +
Sbjct: 365 WSFGILLTELTTKG-RVPYPGMVNREVLDQVERGYR-------MPCPPECPESLHDLMCQ 416
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ +RP F + FL+
Sbjct: 417 CWRKEPEERPTFEYLQAFLED 437
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-67
Identities = 77/261 (29%), Positives = 116/261 (44%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ LV++ V +E+PI + EY G L FL+ + + L+ MA
Sbjct: 316 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLK-----GETGKYLRLPQLVDMA 369
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIASGM Y+E + VHRDL A N +VG+N K++D + AR
Sbjct: 370 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL---------------AR--- 411
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E+ L G+ T KSDV
Sbjct: 412 ------------------------LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L E+ + PY + N +V++ Y+ +P P C + + DLM +
Sbjct: 448 WSFGILLTELTTKG-RVPYPGMVNREVLDQVERGYR-------MPCPPECPESLHDLMCQ 499
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ +RP F + FL+
Sbjct: 500 CWRKEPEERPTFEYLQAFLED 520
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 3e-67
Identities = 68/261 (26%), Positives = 114/261 (43%), Gaps = 55/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +P +VR+IGVC + + + E G L FL + I + +
Sbjct: 390 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV------GKREEIPVSNVAELL 442
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q++ GMKYLE ++ VHR+LAARN ++ + KI SD+ LS
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKI-----------SDFGLS-------- 483
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ + + YY + + + P++W A E + K +++SDV
Sbjct: 484 KALGA---------------------DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 522
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VT+WE L + Q+PY ++ +V+ + + P C E++ LM +
Sbjct: 523 WSYGVTMWEALSYG-QKPYKKMKGPEVMAFIEQGKR-------MECPPECPPELYALMSD 574
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW DRP F + ++
Sbjct: 575 CWIYKWEDRPDFLTVEQRMRA 595
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-54
Identities = 58/261 (22%), Positives = 96/261 (36%), Gaps = 44/261 (16%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ PN+++ IGV + ++ I EY + G L ++ + + + A
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK------SMDSQYPWSQRVSFA 114
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTK-ARLP 119
IASGM YL S +I+HRDL + NC+V +N + ++D + + + + P
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
R +VG WMA E + K D
Sbjct: 175 DRKKRYTVVGN------------------------------PYWMAPEMINGRSYDEKVD 204
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
V+SF + L EI+ N P N + P C F + +
Sbjct: 205 VFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-------RYCPPNCPPSFFPITV 257
Query: 240 ECWKTNETDRPRFSEIHLFLQ 260
C + RP F ++ +L+
Sbjct: 258 RCCDLDPEKRPSFVKLEHWLE 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-53
Identities = 59/265 (22%), Positives = 102/265 (38%), Gaps = 57/265 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + N++ +G T ++ + ++CE L L LI +A
Sbjct: 74 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLH------ASETKFEMKKLIDIA 126
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q A GM YL ++ I+HRDL + N + ++ T+KI D + A
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL---------------ATEKS 171
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN---TTK 177
RW S + + I WMA E + + + + +
Sbjct: 172 RW-----------------------SGSHQF---EQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236
SDV++F + L+E++ Q PY+ + N +Q+IE + + C K +
Sbjct: 206 SDVYAFGIVLYELM--TGQLPYSNINNRDQIIEMVGR---GSLSPDLSKVRSNCPKRMKR 260
Query: 237 LMLECWKTNETDRPRFSEIHLFLQR 261
LM EC K +RP F I ++
Sbjct: 261 LMAECLKKKRDERPSFPRILAEIEE 285
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 177 bits (449), Expect = 9e-52
Identities = 64/245 (26%), Positives = 95/245 (38%), Gaps = 50/245 (20%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77
T S + E LS + ++ LI + Q+A GM++L SR +H
Sbjct: 157 TSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 216
Query: 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKIS 137
RDLAARN ++ + +KI D + AR
Sbjct: 217 RDLAARNILLSEKNVVKICDFGL---------------AR-------------------- 241
Query: 138 DHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQR 197
Y+ Y+ ARLP++WMA E++ T +SDVWSF V LWEI
Sbjct: 242 ------DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI-FSLGAS 294
Query: 198 PYAELT-NEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIH 256
PY + +E+ + + P E++ ML+CW + RP FSE+
Sbjct: 295 PYPGVKIDEEFCRRLKEGTR-------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 347
Query: 257 LFLQR 261
L
Sbjct: 348 EHLGN 352
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-51
Identities = 64/263 (24%), Positives = 95/263 (36%), Gaps = 56/263 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
LK PN++ + GVC E + + E+ G L+ L I L+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--------GKRIPPDILVNWA 111
Query: 61 TQIASGMKYLESR---DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
QIA GM YL I+HRDL + N ++ +
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS-------------------- 151
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
N +KI+D + + + A WMA E + +
Sbjct: 152 -------------NKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKG 194
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SDVWS+ V LWE+L + P+ + V Y + LP P+TC + L
Sbjct: 195 SDVWSYGVLLWELL--TGEVPFRGIDGLAVA------YGVAMNKLALPIPSTCPEPFAKL 246
Query: 238 MLECWKTNETDRPRFSEIHLFLQ 260
M +CW + RP F+ I L
Sbjct: 247 MEDCWNPDPHSRPSFTNILDQLT 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-46
Identities = 45/267 (16%), Positives = 93/267 (34%), Gaps = 56/267 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ N+V +G C + ++ I C+ L + ++ + +A
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK------IVLDVNKTRQIA 136
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP- 119
+I GM YL ++ I+H+DL ++N + I+D ++ + K R+
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 120 --IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP--IRWMAWESLLLGKN- 174
+ +A P IR ++ ++
Sbjct: 196 GWLCHLA-----------------------------------PEIIRQLSPDTEEDKLPF 220
Query: 175 TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234
+ SDV++ +E+ + P+ E +I K KEI
Sbjct: 221 SKHSDVFALGTIWYELH--AREWPFKTQPAEAIIWQM----GTGMKP--NLSQIGMGKEI 272
Query: 235 FDLMLECWKTNETDRPRFSEIHLFLQR 261
D++L CW + +RP F+++ L++
Sbjct: 273 SDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-46
Identities = 68/263 (25%), Positives = 102/263 (38%), Gaps = 57/263 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ PN+V +G + +S + EY G L L Q + + MA
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ----LDERRRLSMA 143
Query: 61 TQIASGMKYLESRD--IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
+A GM YL +R+ IVHR+L + N +V K YT+K+ D + +RL
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL---------------SRL 188
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS 178
++ +LS A WMA E L + KS
Sbjct: 189 ----------------------------KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
DV+SF V LWE+ Q+P+ L QV+ K + L P ++ ++
Sbjct: 221 DVYSFGVILWELA--TLQQPWGNLNPAQVV------AAVGFKCKRLEIPRNLNPQVAAII 272
Query: 239 LECWKTNETDRPRFSEIHLFLQR 261
CW RP F+ I L+
Sbjct: 273 EGCWTNEPWKRPSFATIMDLLRP 295
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-43
Identities = 49/266 (18%), Positives = 89/266 (33%), Gaps = 64/266 (24%)
Query: 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ PN++ V+G C + + I + +G L L N + +
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-----EGTNFVVDQSQAVK 115
Query: 59 MATQIASGMKYLESRD--IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
A +A GM +L + + I L +R+ M+ ++ T +IS + S
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGR 168
Query: 117 RLPIRWMA-NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT 175
W+A + K N
Sbjct: 169 MYAPAWVAPEALQKKPEDT---------------------------------------NR 189
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
+D+WSFAV LWE++ + P+A+L+N ++ + + P +
Sbjct: 190 RSADMWSFAVLLWELV--TREVPFADLSNMEIG------MKVALEGLRPTIPPGISPHVS 241
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQR 261
LM C + RP+F I L++
Sbjct: 242 KLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 52/266 (19%), Positives = 95/266 (35%), Gaps = 61/266 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +L PN+V++ G+ +P + E+ GDL L + I + + +
Sbjct: 77 MSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRL--LDKAHP----IKWSVKLRLM 128
Query: 61 TQIASGMKYLESRD--IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
IA G++Y+++++ IVHRDL + N +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE-------------------------- 162
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN---T 175
K++D + S + +WMA E + + T
Sbjct: 163 ----------NAPVCAKVADFGLSQQSVHSV-----SGLLGNFQWMAPE-TIGAEEESYT 206
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
K+D +SFA+ L+ IL + P+ E + ++ + P C +
Sbjct: 207 EKADTYSFAMILYTIL--TGEGPFDEYSYGKI----KFINMIREEGLRPTIPEDCPPRLR 260
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQR 261
+++ CW + RP FS I L
Sbjct: 261 NVIELCWSGDPKKRPHFSYIVKELSE 286
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-38
Identities = 61/301 (20%), Positives = 99/301 (32%), Gaps = 68/301 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + PN+V++ G C +P+ + EY E G L L ++ P + +
Sbjct: 55 LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLH----GAEPLPYYTAAHAMSWC 108
Query: 61 TQIASGMKYLESRD---IVHRDLAARNCMVGKNYT-IKISDHAMYCSHYESDYYLSDTKA 116
Q + G+ YL S ++HRDL N ++ T +KI D+ +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC-----------DFGTA---- 153
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
+ M + WMA E +
Sbjct: 154 ----CDIQTHMTNNKGSA---------------------------AWMAPEVFEGSNYSE 182
Query: 177 KSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
K DV+S+ + LWE++ ++P+ E+ I H P K I
Sbjct: 183 KCDVFSWGIILWEVI--TRRKPFDEIGGPAFRIMWAVH------NGTRPPLIKNLPKPIE 234
Query: 236 DLMLECWKTNETDRPRFSEIHLFLQ---RKNLGARASKITPVMKRLPLHVFSTVKIFFSM 292
LM CW + + RP EI + R GA P LP V+ +
Sbjct: 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDF 294
Query: 293 D 293
Sbjct: 295 A 295
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 53/287 (18%), Positives = 97/287 (33%), Gaps = 69/287 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST----IQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
++ N++ I T I +Y E G L +L+ + + +
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK--------STTLDAKSM 136
Query: 57 IFMATQIASGMKYLESRD--------IVHRDLAARNCMVGKNYTIKISD--HAMYCSHYE 106
+ +A SG+ +L + I HRDL ++N +V KN T I+D A+
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 107 SDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAW 166
++ + R+M ++ D ++ +H++S
Sbjct: 197 NEVDIPPNTRVGTKRYMPP---------EVLDESLNRNHFQSY----------------- 230
Query: 167 ESLLLGKNTTKSDVWSFAVTLWEILIHCN--------QRPYAELTNEQV-IENCSHWYQN 217
+D++SF + LWE+ C Q PY +L E+
Sbjct: 231 ---------IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCI 281
Query: 218 NSKQQYLPR---PATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
+ P C +++ LM ECW N R + L +
Sbjct: 282 KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 60/291 (20%), Positives = 97/291 (33%), Gaps = 77/291 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST----IQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
L+ N++ I + ++ T + +Y E G L +L ++ +
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--------RYTVTVEGM 141
Query: 57 IFMATQIASGMKYLESR--------DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESD 108
I +A ASG+ +L I HRDL ++N +V KN T I+D + H
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH---- 197
Query: 109 YYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWES 168
A I N VG TK R+MA E
Sbjct: 198 -----DSATDTIDIAPNHRVG-------------------------TK-----RYMAPEV 222
Query: 169 LLLGKN------TTKSDVWSFAVTLWEILIHCN--------QRPYAELTNEQV-IENCSH 213
L N ++D+++ + WEI C+ Q PY +L +E
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282
Query: 214 WYQNNSKQQYLP---RPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
+ +P + + + +M ECW N R I L +
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 54/287 (18%), Positives = 94/287 (32%), Gaps = 69/287 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST----IQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
L+ N++ I T ST I Y E G L +LQ +
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--------LTTLDTVSC 107
Query: 57 IFMATQIASGMKYLESRD--------IVHRDLAARNCMVGKNYTIKISD--HAMYCSHYE 106
+ + IASG+ +L I HRDL ++N +V KN I+D A+ S
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 107 SDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAW 166
+ + + R+MA ++ D + ++S
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVL---------DETIQVDCFDSY----------------- 201
Query: 167 ESLLLGKNTTKSDVWSFAVTLWEILIHCN--------QRPYAELTNEQV-IENCSHWYQN 217
+ D+W+F + LWE+ + P+ ++ E+
Sbjct: 202 ---------KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCV 252
Query: 218 NSKQQYLP---RPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
+ ++ +P + LM ECW N + R I L +
Sbjct: 253 DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 50/294 (17%), Positives = 91/294 (30%), Gaps = 85/294 (28%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST----IQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
+ +K N+++ IG + I + E G LS FL+ +S+ L
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--------ANVVSWNEL 123
Query: 57 IFMATQIASGMKYLESRD----------IVHRDLAARNCMVGKNYTIKISDHAMYCSHYE 106
+A +A G+ YL I HRD+ ++N ++ N T I+D
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG------- 176
Query: 107 SDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAW 166
L+ + VG T+ R+MA
Sbjct: 177 ----LALKFEAGKSAGDTHGQVG-------------------------TR-----RYMAP 202
Query: 167 ESLLLGKNTT-----KSDVWSFAVTLWEILIHCN---------QRPYAEL-----TNEQV 207
E L N + D+++ + LWE+ C P+ E + E +
Sbjct: 203 EVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM 262
Query: 208 IEN-CSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQ 260
E + + + + + + ECW + R + +
Sbjct: 263 QEVVVHKKKRPVLRDYWQKHAGMAM--LCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 48/304 (15%), Positives = 86/304 (28%), Gaps = 92/304 (30%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQ-----EYCEFGDLSTFLQIHNCNSQENPAISYGC 55
+ ++ N+ R I ++ EY G L +L +H +
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--------TSDWVS 112
Query: 56 LIFMATQIASGMKYLES---------RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYE 106
+A + G+ YL + I HRDL +RN +V + T ISD +
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 107 SDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAW 166
+ + I VG T R+MA
Sbjct: 173 NRLVRPGEEDNAAIS-----EVG-------------------------TI-----RYMAP 197
Query: 167 ESL-------LLGKNTTKSDVWSFAVTLWEILIHCN-----------QRPYAEL-----T 203
E L + D+++ + WEI + C Q + T
Sbjct: 198 EVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPT 257
Query: 204 NEQVIENCSHWYQNNSKQQYLPRPATCQ------KEIFDLMLECWKTNETDRPRFSEIHL 257
E + S ++Q P + + + + + +CW + R
Sbjct: 258 FEDMQVLVSR------EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 258 FLQR 261
+
Sbjct: 312 RMAE 315
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-17
Identities = 51/271 (18%), Positives = 94/271 (34%), Gaps = 69/271 (25%)
Query: 1 MCSLKDPNLVRVIG----VCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
+ L+ PN+VR + I + E G L T+L+ +
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI--KVLRS--- 133
Query: 57 IFMATQIASGMKYLESRD--IVHRDLAARNCMV-GKNYTIKISDHAMYCSHYESDYYLSD 113
QI G+++L +R I+HRDL N + G ++KI D +
Sbjct: 134 --WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL------------- 178
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
A L A ++G + +MA E + K
Sbjct: 179 --ATLKRASFAKAVIG--------------TPE----------------FMAPE-MYEEK 205
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233
DV++F + + E+ ++ PY+E N I + + S + E
Sbjct: 206 YDESVDVYAFGMCMLEMA--TSEYPYSECQNAAQI-----YRRVTSGVKPASFDKVAIPE 258
Query: 234 IFDLMLECWKTNETDRPRFSEI--HLFLQRK 262
+ +++ C + N+ +R ++ H F Q +
Sbjct: 259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 50/266 (18%), Positives = 100/266 (37%), Gaps = 63/266 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
+ ++K PN+V+ + + +YCE GDL + QE+ + +
Sbjct: 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------ 130
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
QI +K++ R I+HRD+ ++N + K+ T+++ D + L+ T
Sbjct: 131 FVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGD--FGIAR-----VLNSTVE--- 180
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKS 178
+A +G + YYLS P E + K KS
Sbjct: 181 ---LARACIG------------------TPYYLS------P------E-ICENKPYNNKS 206
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
D+W+ L+E+ + + + + ++ + P ++ L+
Sbjct: 207 DIWALGCVLYELC--TLKHAFEAGSMKNLVLKI-------ISGSFPPVSLHYSYDLRSLV 257
Query: 239 LECWKTNETDRPRFSEI--HLFLQRK 262
+ +K N DRP + I F+ ++
Sbjct: 258 SQLFKRNPRDRPSVNSILEKGFIAKR 283
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 9e-16
Identities = 45/284 (15%), Positives = 93/284 (32%), Gaps = 70/284 (24%)
Query: 3 SLKDPNLVRVIGVCSTEDPIST-----------IQ-EYCEFGDLSTFLQIHNCNSQENPA 50
L+ P +VR ++ IQ + C +L + ++ + E
Sbjct: 59 KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDW--MNGRCTIEERE 116
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD----HAMYCSHYE 106
S IF QIA +++L S+ ++HRDL N + +K+ D AM +
Sbjct: 117 RSVCLHIF--LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM-----D 169
Query: 107 SDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAW 166
D +P VG + Y+S P
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVG------------------TKLYMS------P------ 199
Query: 167 ESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLP 225
E + G + + K D++S + L+E+L ++ + + + ++ P
Sbjct: 200 E-QIHGNSYSHKVDIFSLGLILFELL----YPFSTQMERVRTLTDV-------RNLKFPP 247
Query: 226 RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNLGAR 267
+ ++ + + +RP I + + + +
Sbjct: 248 LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 42/272 (15%), Positives = 78/272 (28%), Gaps = 55/272 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
L P +V + G ++ E E G L ++ C E+ A+ Y
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYY------L 156
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLP 119
Q G++YL +R I+H D+ A N ++ + + D + D
Sbjct: 157 GQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGH-ALCLQPDGLGKSLLTG-- 213
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
+ + G MA E ++ K D
Sbjct: 214 -----DYIPGTET------------------------------HMAPEVVMGKPCDAKVD 238
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
+WS + +L C P+ + + + P +C +
Sbjct: 239 IWSSCCMMLHMLNGC--HPWTQYFRGPLC-----LKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 240 ECWKTNETDRPRFSEI--HLFLQRKNLGARAS 269
E + R E+ + + +G S
Sbjct: 292 EGLRKEPVHRASAMELRRKVGKALQEVGGLKS 323
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 44/264 (16%), Positives = 94/264 (35%), Gaps = 58/264 (21%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
L PN+++ ++ ++ + E + GDLS ++ ++ I + Q
Sbjct: 88 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHF---KKQKRLIPERTVWKYFVQ 144
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 122
+ S ++++ SR ++HRD+ N + +K+ D + + S
Sbjct: 145 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGD--LGLGR-----FFSSKTT------ 191
Query: 123 MANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWS 182
A+ +VG Y +M+ E + KSD+WS
Sbjct: 192 AAHSLVGTPY------------------------------YMSPERIHENGYNFKSDIWS 221
Query: 183 FAVTLWEILIHCNQRP--YAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ-KEIFDLML 239
L+E+ + Y + N + + + Y P P+ +E+ L+
Sbjct: 222 LGCLLYEM---AALQSPFYGDKMNLYSL------CKKIEQCDYPPLPSDHYSEELRQLVN 272
Query: 240 ECWKTNETDRPRFSEIHLFLQRKN 263
C + RP + ++ +R +
Sbjct: 273 MCINPDPEKRPDVTYVYDVAKRMH 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 39/259 (15%), Positives = 68/259 (26%), Gaps = 69/259 (26%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
P VR+ + E C L + + E Y
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGY------LRDTLLA 169
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISD--HAMYCSHYESDYYLSDTKARLPIRWMA 124
+ +L S+ +VH D+ N +G K+ D L
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL----------------VELGTAGAG 213
Query: 125 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184
G +MA E LL G T +DV+S
Sbjct: 214 EVQEGDPR------------------------------YMAPE-LLQGSYGTAADVFSLG 242
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
+T+ E+ CN Q + Q ++ A E+ +++ +
Sbjct: 243 LTILEVA--CNMELPHGGEGWQQL------RQGYLPPEF---TAGLSSELRSVLVMMLEP 291
Query: 245 NETDRPRFSEI--HLFLQR 261
+ R + L++
Sbjct: 292 DPKLRATAEALLALPVLRQ 310
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 45/275 (16%), Positives = 92/275 (33%), Gaps = 68/275 (24%)
Query: 1 MCSLKDPNL--VRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ L+ + +R+ T+ I + E DL+++L+ SY
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSID-PWERKSY----- 160
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
+ + + IVH DL N ++ +K+ D + ++ DT +
Sbjct: 161 -WKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGI------ANQMQPDTTSV- 211
Query: 119 PIRWMANCMVGKNYTIKISDHAMYCSHYESDYY-----LSDTKARLPIRWMAWESLLLGK 173
+ + VG + Y + D + K
Sbjct: 212 ----VKDSQVG------------------AVNYMPPEAIKDMSSSRENGKSKS------K 243
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNE----QVIENCSHWYQNNSKQQYLPRPAT 229
+ KSDVWS L+ + + P+ ++ N+ I + +H P
Sbjct: 244 ISPKSDVWSLGCILYYMT--YGKTPFQQIINQISKLHAIIDPNHEI---------EFPDI 292
Query: 230 CQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262
+K++ D++ C K + R E+ H ++Q +
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327
|
| >4ag4_A Epithelial discoidin domain-containing receptor 1; immune system-transferase complex; HET: NAG; 2.80A {Homo sapiens} Length = 351 | Back alignment and structure |
|---|
Score = 72.1 bits (176), Expect = 4e-14
Identities = 25/116 (21%), Positives = 41/116 (35%), Gaps = 17/116 (14%)
Query: 244 TNETDRPR-FSEIHLFLQRKNLGARASKITPVMKRLPLHVFSTVKIFFSMDGSSFQSNMS 302
E DR R F + + M L + V+ F +
Sbjct: 246 EFEFDRLRAFQAMQVHCNN-------------MHTLGARLPGGVECRFRRGPAMAWEG-E 291
Query: 303 PIKESPNPEFFPKNRTAFNVVVGLKNRVSRFIKVQLYFKARWILLSEVTFDSITSQ 358
P++ + A V V L RV+RF++ + F W+L SE++F S +
Sbjct: 292 PMRHNLGGNLGDPR--ARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDAAA 345
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 47/275 (17%), Positives = 94/275 (34%), Gaps = 68/275 (24%)
Query: 1 MCSLKDPNL--VRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ L+ + +R+ T+ I + E DL+++L+ SY
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSID-PWERKSY----- 113
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
+ + + IVH DL N ++ +K+ D + ++ DT +
Sbjct: 114 -WKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGI------ANQMQPDTTSV- 164
Query: 119 PIRWMANCMVGK-NY----TIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
+ + VG NY IK + +S
Sbjct: 165 ----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI----------------------- 197
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNE----QVIENCSHWYQNNSKQQYLPRPAT 229
+ KSDVWS L+ + + P+ ++ N+ I + +H + P
Sbjct: 198 -SPKSDVWSLGCILYYMT--YGKTPFQQIINQISKLHAIIDPNH---------EIEFPDI 245
Query: 230 CQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262
+K++ D++ C K + R E+ H ++Q +
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 53/270 (19%), Positives = 87/270 (32%), Gaps = 65/270 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHN--CNSQENPAISYGCLIF 58
LK N+V+ +G S I E G LS L+ E Y
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY----- 127
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKAR 117
QI G+KYL IVHRD+ N ++ + +KIS D+ S K
Sbjct: 128 -TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS-----------DFGTS--KRL 173
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN--T 175
I G +MA E + G
Sbjct: 174 AGINPCTETFTGTLQ------------------------------YMAPEIIDKGPRGYG 203
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRPATCQKEI 234
+D+WS T+ E+ + P+ EL + ++ + + P + E
Sbjct: 204 KAADIWSLGCTIIEMAT--GKPPFYELGEPQAAM------FKVGMFKVHPEIPESMSAEA 255
Query: 235 FDLMLECWKTNETDRPRFSEI--HLFLQRK 262
+L+C++ + R +++ FL+
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLKVS 285
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 47/275 (17%), Positives = 94/275 (34%), Gaps = 68/275 (24%)
Query: 1 MCSLKDPNL--VRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ L+ + +R+ T+ I + E DL+++L+ SY
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSID-PWERKSY----- 132
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
+ + + IVH DL N ++ +K+ D + ++ DT +
Sbjct: 133 -WKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGI------ANQMQPDTTSV- 183
Query: 119 PIRWMANCMVG-KNY----TIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
+ + VG NY IK + +S
Sbjct: 184 ----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI----------------------- 216
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNE----QVIENCSHWYQNNSKQQYLPRPAT 229
+ KSDVWS L+ + + P+ ++ N+ I + +H + P
Sbjct: 217 -SPKSDVWSLGCILYYMT--YGKTPFQQIINQISKLHAIIDPNH---------EIEFPDI 264
Query: 230 CQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262
+K++ D++ C K + R E+ H ++Q +
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 39/261 (14%), Positives = 79/261 (30%), Gaps = 52/261 (19%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
++VR + +D + EYC G L+ + + + L + Q+ G
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENY---RIMSYFKEAELKDLLLQVGRG 127
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
++Y+ S +VH D+ N + + + + S+
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN------------------ 169
Query: 127 MVGKNYTIKISD--HAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK--NTTKSDVWS 182
KI D H S + R++A E +L + K+D+++
Sbjct: 170 ----KVMFKIGDLGHVTRISS-------PQVEEGDS-RFLANE-VLQENYTHLPKADIFA 216
Query: 183 FAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECW 242
A+T+ P + + + P +E +L+
Sbjct: 217 LALTVVCA---AGAEPLP---------RNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMI 264
Query: 243 KTNETDRPRFSEI--HLFLQR 261
+ RP + H L
Sbjct: 265 HPDPERRPSAMALVKHSVLLS 285
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 8e-13
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
C LK P+++ + + + + E C G+++ +L+ EN A +
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF----MH- 119
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI +GM YL S I+HRDL N ++ +N IKI+D
Sbjct: 120 -QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIAD 155
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 9e-13
Identities = 49/271 (18%), Positives = 95/271 (35%), Gaps = 66/271 (24%)
Query: 1 MCSLKDPNLVRVIG--VCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ LK PN+VR + T + + EYCE GDL++ + ++E + ++
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG---TKERQYLDEEFVLR 115
Query: 59 MATQIASGMKYLESR-----DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSD 113
+ TQ+ +K R ++HRDL N + +K+ D + L+
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD--FGLAR-----ILNH 168
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
+ A VG + YY+S P E +
Sbjct: 169 DTS------FAKTFVG------------------TPYYMS------P------E-QMNRM 191
Query: 174 N-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232
+ KSD+WS L+E+ P+ + +++ + ++ P
Sbjct: 192 SYNEKSDIWSLGCLLYELC--ALMPPFTAFSQKELAGKI-------REGKFRRIPYRYSD 242
Query: 233 EIFDLMLECWKTNETDRPRFSEI--HLFLQR 261
E+ +++ + RP EI + +
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 39/239 (16%), Positives = 74/239 (30%), Gaps = 67/239 (28%)
Query: 27 EYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCM 86
E+C+ G L +++ + + QI G+ Y+ S+ +++RDL N
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALE-----LFEQITKGVDYIHSKKLINRDLKPSNIF 154
Query: 87 VGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHY 146
+ +KI D+ L L G T+
Sbjct: 155 LVDTKQVKIG-----------DFGLV---TSLKNDGKRTRSKG---TL------------ 185
Query: 147 ESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNE 205
Y+S P E + ++ + D+++ + L E+L E +
Sbjct: 186 ---RYMS------P------E-QISSQDYGKEVDLYALGLILAELL--HVCDTAFETSKF 227
Query: 206 QVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262
+ + K+ L+ + DRP SEI L + +K
Sbjct: 228 F------------TDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 36/266 (13%), Positives = 81/266 (30%), Gaps = 59/266 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST----IQEYCEFGDLSTFLQIHNCNSQ---ENPAISY 53
PN++R++ C E + + + G L ++ E+ +
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW- 138
Query: 54 GCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSD 113
+ I G++ + ++ HRDL N ++G + D S
Sbjct: 139 ---LL--LGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD------------LGSM 181
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS----DTKARLPIRWMAWESL 169
+A + + + ++ A C + Y + ++ I
Sbjct: 182 NQACIHVEGSRQALTLQD------WAAQRC----TISYRAPELFSVQSHCVI-------- 223
Query: 170 LLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229
++DVWS L+ ++ + PY + V + Q +P+
Sbjct: 224 -----DERTDVWSLGCVLYAMM--FGEGPY-----DMVFQKGDSVALAVQNQLSIPQSPR 271
Query: 230 CQKEIFDLMLECWKTNETDRPRFSEI 255
++ L+ + RP +
Sbjct: 272 HSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 20/99 (20%), Positives = 42/99 (42%), Gaps = 2/99 (2%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHN-CNSQENPAISYGCLIFM 59
+ +K+ + G+ + D + I EY E + F + + I + +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 60 ATQIASGMKYL-ESRDIVHRDLAARNCMVGKNYTIKISD 97
+ + Y+ ++I HRD+ N ++ KN +K+SD
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSD 195
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 25/97 (25%), Positives = 45/97 (46%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
L+ PN++R+ G + I EY G + LQ + E +Y
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFD-EQRTATY------I 115
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
T++A+ + Y S+ ++HRD+ N ++G +KI+D
Sbjct: 116 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 152
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 24/97 (24%), Positives = 37/97 (38%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
SL ++V G D + + E C L + + E A Y
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARYY------L 147
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI G +YL ++HRDL N + ++ +KI D
Sbjct: 148 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD 184
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 5e-11
Identities = 23/97 (23%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
L+ PN++R+ I + E+ G+L LQ H E + ++
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATF------M 120
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
++A + Y R ++HRD+ N ++G +KI+D
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIAD 157
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 7e-11
Identities = 24/97 (24%), Positives = 37/97 (38%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
SL ++V G D + + E C L + + E A Y
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT-EPEARYY------L 121
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI G +YL ++HRDL N + ++ +KI D
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD 158
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 26/242 (10%), Positives = 67/242 (27%), Gaps = 49/242 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ ++ ++ + E +G L I+ + + G +I A
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL--LNAINLYKNTPEKVMPQGLVISFA 178
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
++ ++ + +I+H D+ N ++G + + +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED---------------------- 216
Query: 121 RWMANCMVGKNYTIKISD--HAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTK 177
+ + + D ++ + + K E +L K +
Sbjct: 217 --------DLSAGLALIDLGQSIDMKLFPKGTIFT-AKCETSGF-QCVE-MLSNKPWNYQ 265
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
D + A T++ +L +V ++ E F +
Sbjct: 266 IDYFGVAATVYCML--FGTYM-------KVKNEGGECKPEGLFRRLPHLD--MWNEFFHV 314
Query: 238 ML 239
ML
Sbjct: 315 ML 316
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 42/240 (17%), Positives = 86/240 (35%), Gaps = 51/240 (21%)
Query: 25 IQ-EYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83
IQ + C +L + ++ S E+ IF+ QIA +++L S+ ++HRDL
Sbjct: 138 IQMQLCRKENLKDW--MNRRCSLEDREHGVCLHIFI--QIAEAVEFLHSKGLMHRDLKPS 193
Query: 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYC 143
N + +K+ D + + + D +P VG T
Sbjct: 194 NIFFTMDDVVKVGDFGLVTA-MDQDEEEQTVLTPMPAYATHTGQVG---TK--------- 240
Query: 144 SHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAEL 202
Y M+ E + G N + K D++S + L+E+L + E
Sbjct: 241 ------LY------------MSPE-QIHGNNYSHKVDIFSLGLILFELLYSFS--TQMER 279
Query: 203 TNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQ 260
++I + ++ + ++ + + T+RP ++I + +
Sbjct: 280 V--RIITDV-------RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 28/110 (25%), Positives = 40/110 (36%), Gaps = 19/110 (17%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST------------IQ-EYCEFGDLSTFLQIHNCNSQE 47
+ SL +VR IQ EYCE G L + N N Q
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 48 NPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ QI + Y+ S+ I+HRDL N + ++ +KI D
Sbjct: 116 DEYWRL------FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L PN+V++ V TE + I EY G++ +L H +E A F
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEA----RSKF-- 120
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI S ++Y + IVHRDL A N ++ + IKI+D
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIAD 157
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 26/113 (23%), Positives = 51/113 (45%), Gaps = 9/113 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQE-YCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
+ ++ N+++V+ + + + E + DL F+ H E A IF
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLA----SYIFR 137
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLS 112
Q+ S + YL +DI+HRD+ N ++ +++TIK+ D ++ E
Sbjct: 138 --QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS-AAYLERGKLFY 187
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 7 PNLVRVIGV--CSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIA 64
PN+V+++ V ED + + E G + E+ A Y F +
Sbjct: 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLKPLSEDQARFY----FQ--DLI 147
Query: 65 SGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
G++YL + I+HRD+ N +VG++ IKI+D
Sbjct: 148 KGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIAD 180
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 23/105 (21%), Positives = 39/105 (37%), Gaps = 14/105 (13%)
Query: 1 MCSLKDPNLVRVIGV--CSTEDPISTIQEYCEFGDLSTFLQIH--NCNSQENPAISYGCL 56
+ L N+V++ + +T I E+C G L T L+ E+ +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV--- 117
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVG----KNYTIKISD 97
+ GM +L IVHR++ N M K++D
Sbjct: 118 ---LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 30/108 (27%), Positives = 44/108 (40%), Gaps = 17/108 (15%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST------IQEYCEFGDLSTFLQIH--NCNSQENPAIS 52
M L PN+V V ++ EYCE GDL +L C +E P
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI-- 123
Query: 53 YGCLIFMATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
++ I+S ++YL I+HRDL N ++ + KI D
Sbjct: 124 ---RTLLS-DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 23/105 (21%), Positives = 39/105 (37%), Gaps = 14/105 (13%)
Query: 1 MCSLKDPNLVRVIGV--CSTEDPISTIQEYCEFGDLSTFLQIH--NCNSQENPAISYGCL 56
+ L N+V++ + +T I E+C G L T L+ E+ +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV--- 117
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVG----KNYTIKISD 97
+ GM +L IVHR++ N M K++D
Sbjct: 118 ---LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 4e-09
Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 2/95 (2%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
LK N+VR+ V TE+ ++ + E+ + DL ++ + F Q
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW-Q 116
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ G+ + I+HRDL +N ++ K +K+ D
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGD 151
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + P+++++ V ST + EY G+L ++ + +E A F
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRL----FQ- 118
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI S + Y +VHRDL N ++ + KI+D
Sbjct: 119 -QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIAD 154
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 9e-09
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
L N+V+ G + EYC G+L + + E A + F
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF----F-- 111
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ +G+ YL I HRD+ N ++ + +KISD
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISD 148
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 25/97 (25%), Positives = 40/97 (41%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
L N+V+ G + EYC G+L + + E A + F
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRF----F-- 111
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ +G+ YL I HRD+ N ++ + +KISD
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISD 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 6/95 (6%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
L PN+V+++ V TE+ + + E+ DL F + P +F Q
Sbjct: 58 ELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKF--MDASALTGIPLPLIKSYLF---Q 111
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ G+ + S ++HRDL +N ++ IK++D
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLAD 146
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 8/99 (8%)
Query: 1 MCSLKDPNLVRVIGVCSTEDP--ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ L+ N+++++ V E+ + + EYC G + A Y F
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY----F 115
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G++YL S+ IVH+D+ N ++ T+KIS
Sbjct: 116 --CQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISA 152
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 37/189 (19%), Positives = 64/189 (33%), Gaps = 49/189 (25%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M P++V+ G + + EYC G +S +++ N E I+
Sbjct: 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE-DEIATILQ---- 132
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
G++YL +HRD+ A N ++ K++D L+DT A+
Sbjct: 133 -STLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG-VAGQ------LTDTMAK--- 181
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
N ++G + WMA E + +D+
Sbjct: 182 ---RNTVIGTPF------------------------------WMAPEVIQEIGYNCVADI 208
Query: 181 WSFAVTLWE 189
WS +T E
Sbjct: 209 WSLGITAIE 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 51/300 (17%), Positives = 95/300 (31%), Gaps = 93/300 (31%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ P +V G ++ IS E+ + G L L+ I L ++
Sbjct: 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVS 137
Query: 61 TQIASGMKYL-ESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
+ G+ YL E I+HRD+ N +V IK+ D + L D+
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-------QLIDS----- 185
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
MAN VG T++ +M+ E L + +SD
Sbjct: 186 ---MANSFVG-------------------------TRS-----YMSPERLQGTHYSVQSD 212
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ-------- 231
+WS ++L E+ + + P +++ + ++ + +
Sbjct: 213 IWSMGLSLVEMAV--GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 232 ----KEIFDLMLE------------------------CWKTNETDRPRFSEI--HLFLQR 261
IF+L+ C N +R ++ H F++R
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 42/213 (19%), Positives = 81/213 (38%), Gaps = 57/213 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L PN++++ + + E + G+L + ++ + A+ +
Sbjct: 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-------II 142
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
Q+ SG+ YL +IVHRDL N ++ K+ IKI D + + +E+ + +
Sbjct: 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL-SAVFENQKKMKE---- 197
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
+G + YY +A E +L K K
Sbjct: 198 ---------RLG------------------TAYY------------IAPE-VLRKKYDEK 217
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIEN 210
DVWS V L+ +L P+ T+++++
Sbjct: 218 CDVWSIGVILFILL--AGYPPFGGQTDQEILRK 248
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 43/213 (20%), Positives = 74/213 (34%), Gaps = 57/213 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L PN++++ + + E G+L + S E A
Sbjct: 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAARI------I 132
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
Q+ SG+ Y+ IVHRDL N ++ K+ I+I D + +H+E+ + D
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL-STHFEASKKMKD---- 187
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
+G + YY +A E +L G K
Sbjct: 188 ---------KIG------------------TAYY------------IAPE-VLHGTYDEK 207
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIEN 210
DVWS V L+ +L P+ +++
Sbjct: 208 CDVWSTGVILYILL--SGCPPFNGANEYDILKK 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 36/189 (19%), Positives = 71/189 (37%), Gaps = 51/189 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M K+PN+V + D + + EY G L+ + + + A+ CL
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---- 126
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+++L S ++HRD+ + N ++G + ++K++D +C+ ++ +++
Sbjct: 127 ----QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG-FCAQ------ITPEQSK--- 172
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ MVG Y WMA E + K D+
Sbjct: 173 ---RSTMVGTPY------------------------------WMAPEVVTRKAYGPKVDI 199
Query: 181 WSFAVTLWE 189
WS + E
Sbjct: 200 WSLGIMAIE 208
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 28/108 (25%), Positives = 43/108 (39%), Gaps = 14/108 (12%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
S PN++R +T+ + E C +L ++ N + + I + Q
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 63 IASGMKYLESRDIVHRDL-------------AARNCMVGKNYTIKISD 97
IASG+ +L S I+HRDL A +N I ISD
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 53/215 (24%), Positives = 83/215 (38%), Gaps = 59/215 (27%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
+ SL PN++++ V + + E+ E G+L F QI N + E A +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--FEQIINRHKFDECDAANIMK---- 153
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKA 116
QI SG+ YL +IVHRD+ N ++ IKI D + S + DY L D
Sbjct: 154 --QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL-SSFFSKDYKLRD--- 207
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
+G + YY +A E +L K
Sbjct: 208 ----------RLG------------------TAYY------------IAPE-VLKKKYNE 226
Query: 177 KSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENC 211
K DVWS V ++ +L C P+ ++ +I+
Sbjct: 227 KCDVWSCGVIMYILL--CGYPPFGGQNDQDIIKKV 259
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 9e-08
Identities = 24/95 (25%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
LK N+V++ V T+ + + E+ + DL L + + A S+ Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF------LLQ 108
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ +G+ Y R ++HRDL +N ++ + +KI+D
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIAD 143
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + P+++++ V ST I + EY G+L ++ N E + F
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRL----FQ- 123
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI SG+ Y +VHRDL N ++ + KI+D
Sbjct: 124 -QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIAD 159
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 20/99 (20%), Positives = 38/99 (38%), Gaps = 9/99 (9%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCE-FGDLSTFLQIHNCNSQENPAISYGCLIFM 59
S ++R++ D I E E DL F+ E A S+ F
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ-EELARSF----F- 155
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV-GKNYTIKISD 97
Q+ +++ + ++HRD+ N ++ +K+ D
Sbjct: 156 -WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 40/265 (15%), Positives = 68/265 (25%), Gaps = 59/265 (22%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
PN++R E C L +++ + I+ Q SG
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITL------LQQTTSG 130
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
+ +L S +IVHRDL N + +S A I+
Sbjct: 131 LAHLHSLNIVHRDLKPHNIL------------------------ISMPNAHGKIK----- 161
Query: 127 MVGKNYTIKISDH--AMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN---TTKSDVW 181
ISD + + W+A E L T D++
Sbjct: 162 -------AMISDFGLCKKLAVGRHSFSRRSGVPGTEG-WIAPEMLSEDCKENPTYTVDIF 213
Query: 182 SFAVTLWEILIHCN-QRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
S + ++ P+ + Q L +L+ +
Sbjct: 214 SAGCVFYYVI--SEGSHPFGKSLQRQANI-----LLGACSLDCLHPEKHEDVIARELIEK 266
Query: 241 CWKTNETDRPRFSEI--HLFLQRKN 263
+ RP + H F
Sbjct: 267 MIAMDPQKRPSAKHVLKHPFFWSLE 291
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 7/94 (7%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
LK PNLV ++ V + + + EYC+ + L + Q
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHELD--RYQRGVPEHL---VKSITW-QT 111
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ + + +HRD+ N ++ K+ IK+ D
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSVIKLCD 145
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 17/183 (9%), Positives = 36/183 (19%), Gaps = 53/183 (28%)
Query: 27 EYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCM 86
DL + L + Q+ L+S+ +VH N
Sbjct: 168 PAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF 226
Query: 87 VGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHY 146
+ + + + D +
Sbjct: 227 IMPDGRLMLGDVSA--LWKVGTR--------------GPASSV----------------- 253
Query: 147 ESDYYLSDTKARLPIRWMAWESLLLGKN---TTKSDVWSFAVTLWEILIHCNQRPYAELT 203
Y L T + W ++++ + C P+ +T
Sbjct: 254 -PVTYAP-------------REFLNASTATFTHALNAWQLGLSIYRVW--CLFLPFGLVT 297
Query: 204 NEQ 206
Sbjct: 298 PGI 300
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 25/218 (11%), Positives = 66/218 (30%), Gaps = 47/218 (21%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEF----GDLSTFLQIHNCNSQENPAISYGCLIFM 59
+KDP ++I V E + + + + +L TF ++ +S + ++ + + +
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
Q+ + L +VH L + ++ + + ++ + +S
Sbjct: 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH--LVRDGASAVSPIG---- 270
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
+ ++ + T D
Sbjct: 271 ------------------------RGFAPPETTAERMLP-------FGQHHPTLMTFAFD 299
Query: 180 VWSFAVTLWEILIHCNQRPY----AELTNEQVIENCSH 213
W+ + ++ I C P A +E + +C +
Sbjct: 300 TWTLGLAIYWIW--CADLPNTDDAALGGSEWIFRSCKN 335
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 26/95 (27%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
LK N+VR+ V ++ ++ + E+C+ DL + +CN +P I +F Q
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEI-VKSFLF---Q 109
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ G+ + SR+++HRDL +N ++ +N +K+++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLAN 144
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 23/95 (24%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
L PN+V +I V +E ++ + E+ E DL L + Q++ ++ Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKI-----YLY-Q 127
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ G+ + I+HRDL +N ++ + +K++D
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLAD 162
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 18/99 (18%), Positives = 33/99 (33%), Gaps = 11/99 (11%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQ----EYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+L P +V V E P + EY + L + ++ I
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-------TEGPMTPKRAIE 120
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ + + I+HRD+ N M+ +K+ D
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 159
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 19/93 (20%), Positives = 40/93 (43%), Gaps = 9/93 (9%)
Query: 7 PNLVRVIGVCSTEDPISTIQEY-CEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIAS 65
P ++R++ T++ + E DL ++ E P+ F Q+ +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG-EGPS----RCFF--GQVVA 150
Query: 66 GMKYLESRDIVHRDLAARNCMV-GKNYTIKISD 97
+++ SR +VHRD+ N ++ + K+ D
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 24/97 (24%), Positives = 48/97 (49%), Gaps = 11/97 (11%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLI--FMA 60
LK N+V + + TE ++ + EY + DL +L +C + N + F+
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMH-----NVKLFLF 107
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G+ Y + ++HRDL +N ++ + +K++D
Sbjct: 108 -QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLAD 143
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 25/106 (23%), Positives = 45/106 (42%), Gaps = 15/106 (14%)
Query: 3 SLKDPNLVRVIGVC--STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYG-----C 55
LK PN++ + V + + + +Y E DL ++ H + +
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNY----TIKISD 97
L++ QI G+ YL + ++HRDL N +V +KI+D
Sbjct: 133 LLY---QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 24/99 (24%), Positives = 39/99 (39%), Gaps = 8/99 (8%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P L+ + + + I E+ G+L + + E I+Y
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY------M 155
Query: 61 TQIASGMKYLESRDIVHRDLAARN--CMVGKNYTIKISD 97
Q G+K++ IVH D+ N C K ++KI D
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 194
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 29/132 (21%), Positives = 43/132 (32%), Gaps = 35/132 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L PN+ R+ V E I + E C G L L + +S A+
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 61 T---------------------------------QIASGMKYLESRDIVHRDLAARNCMV 87
QI S + YL ++ I HRD+ N +
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 88 G--KNYTIKISD 97
K++ IK+ D
Sbjct: 202 STNKSFEIKLVD 213
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 8/99 (8%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ P LV + ++ + I E+ G+L + + E+ A+ Y
Sbjct: 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY------M 261
Query: 61 TQIASGMKYLESRDIVHRDLAARN--CMVGKNYTIKISD 97
Q+ G+ ++ + VH DL N ++ +K+ D
Sbjct: 262 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 300
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 30/189 (15%), Positives = 66/189 (34%), Gaps = 51/189 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M + N+V + + + + E+ + G L+ + N ++ + L
Sbjct: 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---- 151
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ YL ++ ++HRD+ + + ++ + +K+SD +C+ +S +
Sbjct: 152 ----QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFG-FCAQ------ISKDVPK--- 197
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+VG Y WMA E + T+ D+
Sbjct: 198 ---RKSLVGTPY------------------------------WMAPEVISRSLYATEVDI 224
Query: 181 WSFAVTLWE 189
WS + + E
Sbjct: 225 WSLGIMVIE 233
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 22/94 (23%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQI 63
L+ NLV ++ VC + + E+ + + L++ Y +F QI
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKY---LF---QI 133
Query: 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+G+ + S +I+HRD+ N +V ++ +K+ D
Sbjct: 134 INGIGFCHSHNIIHRDIKPENILVSQSGVVKLCD 167
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 26/102 (25%), Positives = 40/102 (39%), Gaps = 13/102 (12%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
+ + PN++ + V + I E G+L F + S E A S+
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESLSEEEATSF------ 120
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV----GKNYTIKISD 97
QI G+ YL ++ I H DL N M+ IK+ D
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQ 62
L N+V +I V +D + EY E LS +++ + +S I Q
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-------SHGPLSVDTAINFTNQ 119
Query: 63 IASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
I G+K+ IVHRD+ +N ++ N T+KI D
Sbjct: 120 ILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFD 154
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 20/100 (20%), Positives = 43/100 (43%), Gaps = 17/100 (17%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYG-----CLI 57
L PN++ ++ + IS + ++ E DL + ++ ++ +
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--------KDNSLVLTPSHIKAYM 118
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
G++YL I+HRDL N ++ +N +K++D
Sbjct: 119 L---MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLAD 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 25/97 (25%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L+ P+++++ V +T I + EY G+L ++ + E+ + F
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYI-VEKKRMTEDEGRRF----FQ- 115
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI ++Y IVHRDL N ++ N +KI+D
Sbjct: 116 -QIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIAD 151
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 18/99 (18%), Positives = 39/99 (39%), Gaps = 8/99 (8%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + N++ + + + + I E+ D+ + E +SY
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY------V 108
Query: 61 TQIASGMKYLESRDIVHRDLAARN--CMVGKNYTIKISD 97
Q+ +++L S +I H D+ N ++ TIKI +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIE 147
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 13/102 (12%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
+ ++ PN++ + + + + I E G+L F + S E+ A +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGEL--FDFLAEKESLTEDEATQF------ 113
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV----GKNYTIKISD 97
QI G+ YL S+ I H DL N M+ N IK+ D
Sbjct: 114 LKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLID 155
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 28/205 (13%), Positives = 60/205 (29%), Gaps = 47/205 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
PN+V ++ + + + +G + H + AI+Y
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ---- 135
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP- 119
+ + Y+ VHR + A + ++ + + +S S + R
Sbjct: 136 -GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS-------MISHGQRQRV 187
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN--TTK 177
+ V W++ E L K
Sbjct: 188 VHDFPKYSVKVLP------------------------------WLSPEVLQQNLQGYDAK 217
Query: 178 SDVWSFAVTLWEILIHCNQRPYAEL 202
SD++S +T E L + + P+ ++
Sbjct: 218 SDIYSVGITACE-LANGHV-PFKDM 240
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 31/99 (31%), Positives = 45/99 (45%), Gaps = 9/99 (9%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
SL+ PN+VR V T ++ I EY G+L + S E+ A + F
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS-EDEARFF----FQ- 123
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYT--IKISD 97
Q+ SG+ Y S I HRDL N ++ + +KI D
Sbjct: 124 -QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 36/194 (18%), Positives = 68/194 (35%), Gaps = 54/194 (27%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + P +V+++G + + + E+C G + + + E P I C
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVVCR---- 124
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ + +L S+ I+HRDL A N ++ I+++D + T +
Sbjct: 125 -QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFG-VSAK------NLKTLQK--- 173
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT----- 175
+ +G Y WMA E ++
Sbjct: 174 ---RDSFIGTPY------------------------------WMAPEVVMCETMKDTPYD 200
Query: 176 TKSDVWSFAVTLWE 189
K+D+WS +TL E
Sbjct: 201 YKADIWSLGITLIE 214
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 25/102 (24%), Positives = 39/102 (38%), Gaps = 13/102 (12%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
+ + N++ + V + I E G+L F + S E A S+
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESLSEEEATSF------ 120
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV----GKNYTIKISD 97
QI G+ YL ++ I H DL N M+ IK+ D
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 27/102 (26%), Positives = 41/102 (40%), Gaps = 13/102 (12%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
+ ++ PN++ + V + + I E G+L F + S E A +
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESLTEEEATEF------ 119
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV----GKNYTIKISD 97
QI +G+ YL S I H DL N M+ IKI D
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 24/105 (22%), Positives = 44/105 (41%), Gaps = 16/105 (15%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQ-----ENPAISYGC 55
+ SL PN++++ V + + E CE G+L +I + ++ E
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL--LERIVSAQARGKALSEGYVAEL-- 129
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
Q+ + + Y S+ +VH+DL N + + IKI D
Sbjct: 130 ----MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQI--HNCNSQENPAISYGCLIF 58
M L NL+++ +++ I + EY + G+L F +I + N E I +
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL--FDRIIDESYNLTELDTILF----- 192
Query: 59 MATQIASGMKYLESRDIVHRDLAARN--CMVGKNYTIKISD 97
QI G++++ I+H DL N C+ IKI D
Sbjct: 193 -MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIID 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 15/98 (15%), Positives = 42/98 (42%), Gaps = 4/98 (4%)
Query: 4 LKDPNLVRVIGVCSTEDPISTIQEYCEF----GDLSTFLQIHNCNSQENPAISYGCLIFM 59
+KDP ++I V E + + + + +L TF ++ +S + ++ + + +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ + L +VH L + ++ + + ++
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 40/202 (19%), Positives = 71/202 (35%), Gaps = 53/202 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ P + + G + + I EY G L+ + I+
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILR---- 126
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+I G+ YL S +HRD+ A N ++ ++ +K++D L+DT+ +
Sbjct: 127 -EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG-VAGQ------LTDTQIK--- 175
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
N VG + WMA E + +K+D+
Sbjct: 176 ---RNTFVGTPF------------------------------WMAPEVIKQSAYDSKADI 202
Query: 181 WSFAVTLWEILIHCNQRPYAEL 202
WS +T E L + P++EL
Sbjct: 203 WSLGITAIE-LAR-GEPPHSEL 222
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 23/108 (21%), Positives = 47/108 (43%), Gaps = 25/108 (23%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQ--------EYCEFGDLSTFLQIHNCNSQENPAISYG 54
LK N+V +I +C T+ ++CE DL+ L N + +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--------SNVLVKFT 122
Query: 55 -----CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
++ + +G+ Y+ I+HRD+ A N ++ ++ +K++D
Sbjct: 123 LSEIKRVMQ---MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 23/101 (22%), Positives = 41/101 (40%), Gaps = 12/101 (11%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
M SL PN++R+ I + E C G+L F ++ + +E+ A
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL--FERVVHKRVFRESDAARI------ 111
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
+ S + Y ++ HRDL N + + +K+ D
Sbjct: 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLID 152
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 12/101 (11%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
+ L PN++++ + + E G+L F +I E+ A
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARI------ 126
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
Q+ SG+ Y+ +IVHRDL N ++ K+ IKI D
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIID 167
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 18/96 (18%), Positives = 36/96 (37%), Gaps = 17/96 (17%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL-----IFMAT 61
PN++++ T + + + G+L F + L +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYL----------TEKVTLSEKETRKIMR 131
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ + L +IVHRDL N ++ + IK++D
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 21/105 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLI--- 57
+ L P ++++ ED + E E G+L F ++ + L
Sbjct: 194 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL--FDKV----------VGNKRLKEAT 240
Query: 58 --FMATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
Q+ ++YL I+HRDL N ++ ++ IKI+D
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 11/96 (11%)
Query: 7 PNLVRVIGVCSTEDPISTIQ-----EYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMAT 61
PN+VR++ VC+T I+ E+ + DL T+L PA + L+
Sbjct: 74 PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMR--- 127
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q G+ +L + IVHRDL N +V T+K++D
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 38/195 (19%), Positives = 69/195 (35%), Gaps = 59/195 (30%)
Query: 7 PNLVRVIG------VCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
N+ G +D + + E+C G ++ ++ N+ + I+Y C
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR---- 136
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+I G+ +L ++HRD+ +N ++ +N +K+ D + L T R
Sbjct: 137 -EILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQ------LDRTVGR--- 185
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNT----- 175
N +G Y WMA E + +N
Sbjct: 186 ---RNTFIGTPY------------------------------WMAPEVIACDENPDATYD 212
Query: 176 TKSDVWSFAVTLWEI 190
KSD+WS +T E+
Sbjct: 213 FKSDLWSLGITAIEM 227
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 26/105 (24%), Positives = 41/105 (39%), Gaps = 20/105 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL---- 56
+ L PN++++ + T IS + E G+L F +I + G
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL--FDRI----------VEKGYYSERD 149
Query: 57 -IFMATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
QI + YL IVHRDL N + + +KI+D
Sbjct: 150 AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIAD 194
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 18/103 (17%), Positives = 40/103 (38%), Gaps = 18/103 (17%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL--- 56
+ + P+++ +I + + + + G+L F + L
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL--FDYL----------TEKVALSEK 200
Query: 57 --IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ + + +L + +IVHRDL N ++ N I++SD
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 25/101 (24%), Positives = 38/101 (37%), Gaps = 12/101 (11%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
L+ PN+VR+ E + + G+L F I E A
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASH------C 110
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
QI + Y S IVHR+L N ++ K +K++D
Sbjct: 111 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 45/290 (15%), Positives = 82/290 (28%), Gaps = 66/290 (22%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQ--------EYCEFGDLSTFLQIHNCNSQENPAI 51
M L PN+V+ S S E C+ + ++ + +
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 52 SYGCLIFMATQIASGMKYLESRD--IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDY 109
IF Q ++++ + I+HRDL N ++ TIK+ D + S
Sbjct: 139 ---LKIF--YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD---FGS------ 184
Query: 110 YLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS----DTKARLPIRWMA 165
A + + + + + Y + D + PI
Sbjct: 185 ------ATTISHYPDYSWSAQRRALVEEEITRNT----TPMYRTPEIIDLYSNFPI---- 230
Query: 166 WESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLP 225
K D+W+ L+ + Q P+ E + I N Y +P
Sbjct: 231 ---------GEKQDIWALGCILYLLC--FRQHPF-EDGAKLRIVNGK--YS-------IP 269
Query: 226 RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNLGARASKITP 273
T L+ + N +R +E+ L
Sbjct: 270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 19/103 (18%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYG---CLIFM 59
L+ N++ + V + I EY E DL ++ +NP +S ++
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD-------KNPDVSMRVIKSFLY- 139
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYT-----IKISD 97
Q+ +G+ + SR +HRDL +N ++ + +KI D
Sbjct: 140 --QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 12/101 (11%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
+ L PN++++ + + E G+L F +I E+ A
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARI------ 126
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
Q+ SG+ Y+ +IVHRDL N ++ K+ IKI D
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIID 167
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 18/104 (17%), Positives = 41/104 (39%), Gaps = 14/104 (13%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISY----GCL 56
LK P++V ++ S++ + + E+ + DL +I + + Y
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--CFEI---VKRADAGFVYSEAVASH 134
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
QI ++Y +I+HRD+ ++ + +K+
Sbjct: 135 YMR--QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGG 176
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 7e-06
Identities = 23/80 (28%), Positives = 42/80 (52%), Gaps = 3/80 (3%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77
T+ + + GD+ I+N + ++NP IF QI SG+++L R+I++
Sbjct: 256 TKTDLCLVMTIMNGGDI--RYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312
Query: 78 RDLAARNCMVGKNYTIKISD 97
RDL N ++ + ++ISD
Sbjct: 313 RDLKPENVLLDDDGNVRISD 332
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 25/101 (24%), Positives = 38/101 (37%), Gaps = 12/101 (11%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
L+ PN+VR+ E + + G+L F I E A
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASH------C 133
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
QI + Y S IVHR+L N ++ K +K++D
Sbjct: 134 IQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 8e-06
Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 11/96 (11%)
Query: 7 PNLVRVIGVCSTEDPISTIQ-----EYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMAT 61
PN+VR+ VC+ + E+ + DL+T+L P + ++F
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMF--- 127
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G+ +L S +VHRDL +N +V + IK++D
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 163
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 9e-06
Identities = 24/105 (22%), Positives = 41/105 (39%), Gaps = 20/105 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL---- 56
+ +K N+V + + + + + G+L F +I + G
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL--FDRI----------LERGVYTEKD 107
Query: 57 -IFMATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
+ Q+ S +KYL IVHRDL N + +N I I+D
Sbjct: 108 ASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITD 152
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 36/204 (17%), Positives = 73/204 (35%), Gaps = 42/204 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQ-IHNCNSQENPAISYGCLIFM 59
M PN+V +D + + + G + ++ I ++ + + +
Sbjct: 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
++ G++YL +HRD+ A N ++G++ +++I+D + + ++ K R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG-VSAFLATGGDITRNKVR-- 183
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKS 178
VG WMA E + + K+
Sbjct: 184 -----KTFVGTPC------------------------------WMAPEVMEQVRGYDFKA 208
Query: 179 DVWSFAVTLWEILIHCNQRPYAEL 202
D+WSF +T E L PY +
Sbjct: 209 DIWSFGITAIE-LAT-GAAPYHKY 230
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L+ PN ++ G E + EYC G S L++H QE I+
Sbjct: 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE-VEIAAVTH---- 161
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
G+ YL S +++HRD+ A N ++ + +K+ D
Sbjct: 162 -GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGD 197
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 23/83 (27%), Positives = 37/83 (44%), Gaps = 11/83 (13%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNSQ---ENPAISYGCLIFMATQIASGMKYLESRD 74
T+D + + GDL I++ E A+ Y A +I G++ L
Sbjct: 255 TKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFY------AAEICCGLEDLHRER 306
Query: 75 IVHRDLAARNCMVGKNYTIKISD 97
IV+RDL N ++ + I+ISD
Sbjct: 307 IVYRDLKPENILLDDHGHIRISD 329
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 25/101 (24%), Positives = 44/101 (43%), Gaps = 13/101 (12%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFM 59
+ L P ++++ ED + E E G+L F ++ +E L F
Sbjct: 69 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL--FDKVVGNKRLKEATC----KLYF- 120
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
Q+ ++YL I+HRDL N ++ ++ IKI+D
Sbjct: 121 -YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 160
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 22/97 (22%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P V++ ++ + Y + G+L +++ + C F
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYT 136
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+I S ++YL + I+HRDL N ++ ++ I+I+D
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 45/266 (16%), Positives = 79/266 (29%), Gaps = 71/266 (26%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
P +V+ G T + E ++ I L M I
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP-------IPERILGKMTVAIVKA 136
Query: 67 MKYLES-RDIVHRDLAARNCMVGKNYTIKISD---HAMYCSHYESDYYLSDTKARLPIRW 122
+ YL+ ++HRD+ N ++ + IK+ D L D KA+
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG----------RLVDDKAK----- 181
Query: 123 MANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWE-----SLLLGKNTTK 177
+ G +MA E +
Sbjct: 182 --DRSAGCAA------------------------------YMAPERIDPPDPTKPDYDIR 209
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
+DVWS ++L E+ Q PY E + Q LP +
Sbjct: 210 ADVWSLGISLVELAT--GQFPYKNCKT--DFEVLTKVLQEEPPL--LPGHMGFSGDFQSF 263
Query: 238 MLECWKTNETDRPRFSEI--HLFLQR 261
+ +C + RP+++++ H F++R
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 26/97 (26%), Positives = 38/97 (39%), Gaps = 14/97 (14%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQ---ENPAISYGCLIFMATQI 63
P ++ + V I I EY G++ F ++ EN I QI
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEI--FSLCLPELAEMVSENDVIRL------IKQI 140
Query: 64 ASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
G+ YL +IVH DL +N ++ IKI D
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 20/105 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL---- 56
LK PN+VR+ S E I + G+L F I ++
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL--FEDI----------VAREYYSEAD 111
Query: 57 -IFMATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
QI + + +VHR+L N ++ K +K++D
Sbjct: 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLAD 156
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 8e-05
Identities = 25/91 (27%), Positives = 43/91 (47%), Gaps = 4/91 (4%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
NLV ++G S D + + Y G L L + P +S+ +A A+G
Sbjct: 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGT--PPLSWHMRCKIAQGAANG 145
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ +L +HRD+ + N ++ + +T KISD
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISD 176
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 17/98 (17%), Positives = 35/98 (35%), Gaps = 13/98 (13%)
Query: 3 SLKDPNLVRV--IGVCSTEDPISTI-QEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
L++P++V + G D + DL+ L+ ++ + +
Sbjct: 90 RLQEPHVVPIHDFGE---IDGQLYVDMRLINGVDLAAMLR-------RQGPLAPPRAVAI 139
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI S + + HRD+ N +V + + D
Sbjct: 140 VRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVD 177
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 17/98 (17%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENP-------AISYGCLIFM 59
P+LV +IG C + + I +Y E G+L L + + I G
Sbjct: 95 PHLVSLIGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIG----- 147
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
A G+ YL +R I+HRD+ + N ++ +N+ KI+D
Sbjct: 148 ---AARGLHYLHTRAIIHRDVKSINILLDENFVPKITD 182
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 10/36 (27%), Positives = 21/36 (58%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ G ++ I+HRDL NC++ ++ ++K+ D
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCD 172
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 17/36 (47%), Positives = 23/36 (63%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI G+KY+ S DI+HRDL N V ++ +KI D
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 175
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 22/103 (21%), Positives = 37/103 (35%), Gaps = 21/103 (20%)
Query: 3 SLKDPNLVRVIGVCSTEDPISTIQ-----EYCEFGDLSTFLQIHNCNSQENP---AISYG 54
+ P++V++ D EY L Q+ P AI+Y
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYL 188
Query: 55 CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+I + YL S +V+ DL N M+ + +K+ D
Sbjct: 189 L------EILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 16/36 (44%), Positives = 23/36 (63%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G+K+L S I+HRDL N +V + T+KI D
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 24/114 (21%), Positives = 43/114 (37%), Gaps = 31/114 (27%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPIST------IQEYCEFGDLSTFLQIHNCNSQENPAISY 53
P++VR++ V E+ + + E + G+L F +I
Sbjct: 64 HWRASQCPHIVRIVDVY--ENLYAGRKCLLIVMECLDGGEL--FSRI----------QDR 109
Query: 54 GCLIF-------MATQIASGMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
G F + I ++YL S +I HRD+ N + N +K++D
Sbjct: 110 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 21/102 (20%), Positives = 41/102 (40%), Gaps = 13/102 (12%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIS-----TIQEYCEFGDLSTFLQIHNCNSQENPAISYGC 55
+ L ++V+V+ + +D + E + D I
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKL--FRTPVYLTELHIKT-- 160
Query: 56 LIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
+ + G+KY+ S I+HRDL NC+V ++ ++K+ D
Sbjct: 161 --LLY-NLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD 199
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 21/81 (25%), Positives = 38/81 (46%), Gaps = 9/81 (11%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFMATQIASGMKYLESRDIV 76
T D +S I + GDL + E Y A +I G++++ +R +V
Sbjct: 263 TPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFY------AAEIILGLEHMHNRFVV 314
Query: 77 HRDLAARNCMVGKNYTIKISD 97
+RDL N ++ ++ ++ISD
Sbjct: 315 YRDLKPANILLDEHGHVRISD 335
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 14/36 (38%), Positives = 22/36 (61%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
QI G+KY+ S +++HRDL N ++ +KI D
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 21/141 (14%), Positives = 47/141 (33%), Gaps = 4/141 (2%)
Query: 55 CLIFMATQIASGMKYLESR-DIVHRDLAARNCMVG-KNYTIKISDHAMYCSHYESDYYLS 112
C+ + Q+ G+ YL ++ I+H D+ N ++ I+ S
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 113 DTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL--PIRWMAWESLL 170
+ N +V + + + ++ ++ + E L+
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLI 266
Query: 171 LGKNTTKSDVWSFAVTLWEIL 191
T +D+WS A +E+
Sbjct: 267 GSGYNTPADIWSTACMAFELA 287
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 13/36 (36%), Positives = 22/36 (61%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G++Y+ + I+HRDL N V ++ +KI D
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILD 171
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 3e-04
Identities = 23/101 (22%), Positives = 39/101 (38%), Gaps = 20/101 (19%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENP-------AISYGCLIFM 59
NL+R+ G C T + Y G +++ L + P I+ G
Sbjct: 87 RNLLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALG----- 139
Query: 60 ATQIASGMKYL--ESR-DIVHRDLAARNCMVGKNYTIKISD 97
A G+ YL I+HRD+ A N ++ + + + D
Sbjct: 140 ---SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 12/95 (12%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFMATQIAS 65
PN+V++ V + + E G+L F +I E A + ++ S
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGEL--FERIKKKKHFSETEASY------IMRKLVS 117
Query: 66 GMKYLESRDIVHRDLAARNCMV---GKNYTIKISD 97
+ ++ +VHRDL N + N IKI D
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIID 152
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 16/36 (44%), Positives = 23/36 (63%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G+K+L S I+HRDL N +V + T+KI D
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILD 170
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 11/36 (30%), Positives = 19/36 (52%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q +K L +++HRDL N ++ N +K+ D
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD 155
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 20/104 (19%), Positives = 42/104 (40%), Gaps = 11/104 (10%)
Query: 1 MCSLKDPNLVRVIGV------CSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYG 54
M L N+VR+ E ++ + +Y + + ++ Q P I
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVK 159
Query: 55 CLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKN-YTIKISD 97
++ Q+ + Y+ S I HRD+ +N ++ + +K+ D
Sbjct: 160 LYMY---QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 200
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 13/36 (36%), Positives = 17/36 (47%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
I G+ L +VHRDL N ++ N I I D
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 15/36 (41%), Positives = 22/36 (61%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ G+KY+ S +VHRDL N V ++ +KI D
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILD 169
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 22/96 (22%), Positives = 40/96 (41%), Gaps = 13/96 (13%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFMATQIAS 65
PN++ + V + + E + G+L +I E A + + I
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGEL--LDKILRQKFFSEREASA------VLFTITK 127
Query: 66 GMKYLESRDIVHRDLAARNCMV----GKNYTIKISD 97
++YL ++ +VHRDL N + G +I+I D
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICD 163
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 9/84 (10%)
Query: 18 TEDPISTIQEYCEFGDLSTFLQIHNCNS-QENPAISYGCLIFMATQIASGMKYLESRDIV 76
T D + + EY GDL I +E A+ Y A +IA G+ +L+S+ I+
Sbjct: 413 TMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFY------AAEIAIGLFFLQSKGII 464
Query: 77 HRDLAARNCMVGKNYTIKISDHAM 100
+RDL N M+ IKI+D M
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGM 488
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 11/36 (30%), Positives = 21/36 (58%)
Query: 62 QIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD 97
Q+ +KYL S ++HRD+ N ++ +K++D
Sbjct: 117 QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVAD 152
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 434 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.68 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.42 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.12 | |
| 4ag4_A | 351 | Epithelial discoidin domain-containing receptor 1; | 98.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.68 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.46 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.44 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.57 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.04 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.99 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.79 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.22 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 92.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.26 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.23 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 88.94 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 87.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 87.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 87.1 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.22 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 84.23 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 83.63 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 83.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 82.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 81.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.52 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=383.25 Aligned_cols=213 Identities=41% Similarity=0.770 Sum_probs=182.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccC------CCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNC------NSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++|+|||||+++|+|.+++..++|||||++|+|.+++++++. .......+++.++..++.||++||+|||+++
T Consensus 69 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ 148 (299)
T 4asz_A 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH 148 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5789999999999999999999999999999999999975431 1123457999999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 149 iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~-----------------------------------------~~~~~ 187 (299)
T 4asz_A 149 FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-----------------------------------------YYRVG 187 (299)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----------------------------------------CEEET
T ss_pred cccCccCHhhEEECCCCcEEECCcccceecCCCC-----------------------------------------ceeec
Confidence 9999999999999999999999999987532211 11122
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
....||+.|||||++.+..|+.++|||||||++|||+ + |+.||.+.+..+....+.. +..++.|..++++
T Consensus 188 ~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell--t~G~~Pf~~~~~~~~~~~i~~-------~~~~~~p~~~~~~ 258 (299)
T 4asz_A 188 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF--TYGKQPWYQLSNNEVIECITQ-------GRVLQRPRTCPQE 258 (299)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTTCCTTTTSCHHHHHHHHHH-------TCCCCCCTTCCHH
T ss_pred CceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHc-------CCCCCCCccchHH
Confidence 3446889999999999999999999999999999999 6 8999999988887766643 2345667889999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+.+||.+||+.||++|||++||+++|++..
T Consensus 259 ~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 259 VYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=382.53 Aligned_cols=209 Identities=17% Similarity=0.281 Sum_probs=180.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||+++++|++++.+|+|||||+||+|.+++++. ..+++..+..++.||+.||+|||++||+||||
T Consensus 86 l~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDl 158 (311)
T 4aw0_A 86 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 158 (311)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 57899999999999999999999999999999999999843 47999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... ......+.+||
T Consensus 159 KPeNILl~~~g~vKl~DFGla~~~~~~~-----------------------------------------~~~~~~~~~GT 197 (311)
T 4aw0_A 159 KPENILLNEDMHIQITDFGTAKVLSPES-----------------------------------------KQARANSFVGT 197 (311)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTT-----------------------------------------TCCCBCCCCSC
T ss_pred CHHHeEEcCCCCEEEEEcCCceecCCCC-----------------------------------------CcccccCcccC
Confidence 9999999999999999999987632111 01122456899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.+..|+.++||||+||++|||+ +|..||.+.+..+...++... ....+..+++++++||.+
T Consensus 198 p~YmAPEvl~~~~y~~~~DiWSlGvilyeml--~G~~PF~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLV--AGLPPFRAGNEGLIFAKIIKL--------EYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp GGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHT--------CCCCCTTCCHHHHHHHHH
T ss_pred cccCCHHHHcCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHcC--------CCCCCcccCHHHHHHHHH
Confidence 9999999999999999999999999999999 899999999888887776531 234467789999999999
Q ss_pred hccCCCCCCCCHHHH--------HHHHHhcccCCC
Q psy5690 241 CWKTNETDRPRFSEI--------HLFLQRKNLGAR 267 (434)
Q Consensus 241 cl~~dP~~Rps~~el--------~~~L~~~~~~~~ 267 (434)
||+.||++|||++|+ |+||+..++...
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 999999999999985 567776655443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=380.20 Aligned_cols=213 Identities=38% Similarity=0.738 Sum_probs=176.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN--------SQENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
|++|+|||||+++|+|.+++..|+|||||++|+|.+++++++.. ......+++.++..|+.||++||+|||+
T Consensus 97 l~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 176 (329)
T 4aoj_A 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG 176 (329)
T ss_dssp HTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 57899999999999999999999999999999999999865321 1123569999999999999999999999
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
++||||||||+|||++.++.+||+|||+|+...... ...
T Consensus 177 ~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~-----------------------------------------~~~ 215 (329)
T 4aoj_A 177 LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-----------------------------------------YYR 215 (329)
T ss_dssp TTCCCSCCCGGGEEEETTTEEEECCCC-----------------------------------------------------
T ss_pred CCeecccccHhhEEECCCCcEEEcccccceeccCCC-----------------------------------------cce
Confidence 999999999999999999999999999987532211 111
Q ss_pred cCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 153 SDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
......||+.|||||++.+..++.++|||||||++|||+ + |+.||.+.+..+....+.. +.+++.|..++
T Consensus 216 ~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ell--t~G~~Pf~~~~~~~~~~~i~~-------g~~~~~p~~~~ 286 (329)
T 4aoj_A 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF--TYGKQPWYQLSNTEAIDCITQ-------GRELERPRACP 286 (329)
T ss_dssp ----CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH--TTSCCTTCSSCHHHHHHHHHH-------TCCCCCCTTCC
T ss_pred ecCcccccccccChhhhcCCCCCccccccchHHHHHHHH--cCCCCCCCCCCHHHHHHHHHc-------CCCCCCccccc
Confidence 224567899999999999999999999999999999999 6 8999999988887766543 23456678899
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+++.+||.+||+.||++|||++||+++|+...
T Consensus 287 ~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 287 PEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 99999999999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=378.15 Aligned_cols=212 Identities=39% Similarity=0.748 Sum_probs=182.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
|++|+|||||+++|+|.+++..++|||||++|||.++|..++... .....+++..+..++.||++||+|||
T Consensus 83 l~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 162 (308)
T 4gt4_A 83 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 162 (308)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999999999999999999999999999997543211 11346899999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
+++||||||||+|||+++++.+||+|||+|+...... ..
T Consensus 163 ~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~-----------------------------------------~~ 201 (308)
T 4gt4_A 163 SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD-----------------------------------------YY 201 (308)
T ss_dssp HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGG-----------------------------------------CB
T ss_pred hCCCCCCCccccceEECCCCCEEECCcccceeccCCC-----------------------------------------ce
Confidence 9999999999999999999999999999987532211 11
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (434)
.......||+.|||||++.++.|+.++|||||||++|||+ + |..||.+.+..+....+. .+...+.|..+
T Consensus 202 ~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~--t~g~~Pf~~~~~~~~~~~i~-------~~~~~~~p~~~ 272 (308)
T 4gt4_A 202 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF--SYGLQPYCGYSNQDVVEMIR-------NRQVLPCPDDC 272 (308)
T ss_dssp CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTTCCTTTTCCHHHHHHHHH-------TTCCCCCCTTC
T ss_pred eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHH--hCCCCCCCCCCHHHHHHHHH-------cCCCCCCcccc
Confidence 2234567899999999999999999999999999999999 5 899999998888776654 23455668889
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++++.+||.+||+.||++|||+.||++.|+..
T Consensus 273 ~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 273 PAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred hHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=373.43 Aligned_cols=204 Identities=22% Similarity=0.295 Sum_probs=178.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||++++++++++.+|+|||||+||+|.+++++. ..+++..+..++.||+.||+|||++||+||||
T Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 152 (304)
T 3ubd_A 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSLGIIYRDL 152 (304)
T ss_dssp CCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 67899999999999999999999999999999999999843 47999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... ....+.+||
T Consensus 153 Kp~NILl~~~g~vKl~DFGla~~~~~~~-------------------------------------------~~~~~~~GT 189 (304)
T 3ubd_A 153 KPENILLDEEGHIKLTDFGLSKESIDHE-------------------------------------------KKAYSFCGT 189 (304)
T ss_dssp CGGGEEECTTSCEEEESSEEEEC------------------------------------------------CCCCSCCCC
T ss_pred CHHHeEEcCCCCEEecccccceeccCCC-------------------------------------------ccccccccC
Confidence 9999999999999999999986521111 112456899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.+..|+.++|||||||++|||+ +|..||.+.+..+....+.. ...+.|..+++++.+||.+
T Consensus 190 ~~YmAPE~~~~~~y~~~~DiwSlGvilyeml--tG~~PF~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEML--TGTLPFQGKDRKETMTMILK--------AKLGMPQFLSPEAQSLLRM 259 (304)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------CCCCCCTTSCHHHHHHHHH
T ss_pred cccCCHHHhccCCCCCCCcccchHHHHHHHH--hCCCCCCCcCHHHHHHHHHc--------CCCCCCCcCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999999988888776643 1234567789999999999
Q ss_pred hccCCCCCCCC-----HHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRPR-----FSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rps-----~~el--~~~L~~~~~ 264 (434)
||+.||++||| ++|+ |+||+..++
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 99999999998 4688 889987654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=379.68 Aligned_cols=204 Identities=15% Similarity=0.232 Sum_probs=177.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||+++++|.+++.+|||||||+||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||
T Consensus 125 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 196 (346)
T 4fih_A 125 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 196 (346)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Confidence 4578999999999999999999999999999999999963 35899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... ......+||
T Consensus 197 Kp~NILl~~~g~vKl~DFGla~~~~~~~-------------------------------------------~~~~~~~GT 233 (346)
T 4fih_A 197 KSDSILLTHDGRVKLSDFGFCAQVSKEV-------------------------------------------PRRKSLVGT 233 (346)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSSS-------------------------------------------CCBCCCCSC
T ss_pred CHHHEEECCCCCEEEecCcCceecCCCC-------------------------------------------CcccccccC
Confidence 9999999999999999999987532211 112456899
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.+..|+.++|||||||++|||+ +|..||.+.+..+....+... .....+.+..+++++.+||.+
T Consensus 234 p~YmAPEvl~~~~y~~~~DiWSlGvilyeml--~G~~PF~~~~~~~~~~~i~~~-----~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 234 PYWMAPELISRLPYGPEVDIWSLGIMVIEMV--DGEPPYFNEPPLKAMKMIRDN-----LPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHHS-----SCCCCSCGGGSCHHHHHHHHH
T ss_pred cCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCcCHHHHHHHHHcC-----CCCCCCccccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 899999998888777665431 122333456788999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||++|||++|+ |+||++.
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999 8999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=368.58 Aligned_cols=210 Identities=23% Similarity=0.400 Sum_probs=168.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|++.+ +.+++|||||++|+|.+++.. ....+++..+..|+.||+.||+|||+++||||||
T Consensus 86 l~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~------~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDl 158 (307)
T 3omv_A 86 LRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV------QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158 (307)
T ss_dssp HTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT------SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred HHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCcc
Confidence 578999999999999854 578999999999999999973 3357999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||+++++.+||+|||+|+...... .........||
T Consensus 159 Kp~NILl~~~~~~Ki~DFGla~~~~~~~-----------------------------------------~~~~~~~~~GT 197 (307)
T 3omv_A 159 KSNNIFLHEGLTVKIGDFGLATVKSRWS-----------------------------------------GSQQVEQPTGS 197 (307)
T ss_dssp CSSSEEEETTEEEEECCCSSCBC-----------------------------------------------------CCCC
T ss_pred CHHHEEECCCCcEEEeeccCceecccCC-----------------------------------------cceeecccccC
Confidence 9999999999999999999987522111 01122456799
Q ss_pred ccccchhhhhc---CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLLL---GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~---~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+.|||||++.+ +.|+.++|||||||++|||+ +|+.||.+.+.......... ...........+..+++++.+|
T Consensus 198 ~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ell--tg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~l~~l 273 (307)
T 3omv_A 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM--TGELPYSHINNRDQIIFMVG--RGYASPDLSKLYKNCPKAMKRL 273 (307)
T ss_dssp TTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHH--HSSCTTTTCCCHHHHHHHHH--TTCCCCCSTTSCTTSCHHHHHH
T ss_pred CCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHH--HCCCCCCCCChHHHHHHHHh--cCCCCCCcccccccchHHHHHH
Confidence 99999999974 45899999999999999999 89999988766544433221 1111222233456789999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
|.+||+.||++|||+.||+..|+..
T Consensus 274 i~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 274 VADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp HHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999998877654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=381.39 Aligned_cols=205 Identities=19% Similarity=0.308 Sum_probs=178.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||++++++++++.+|+|||||+||+|.+++... ....+++..++.|+.||+.||+|||++||+||||
T Consensus 77 l~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~-----~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 151 (350)
T 4b9d_A 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-----KGVLFQEDQILDWFVQICLALKHVHDRKILHRDI 151 (350)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTC
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccC
Confidence 45789999999999999999999999999999999999743 3346789999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... ......+||
T Consensus 152 Kp~NILl~~~g~vKl~DFGla~~~~~~~-------------------------------------------~~~~~~~GT 188 (350)
T 4b9d_A 152 KSQNIFLTKDGTVQLGDFGIARVLNSTV-------------------------------------------ELARACIGT 188 (350)
T ss_dssp CGGGEEECTTCCEEECSTTEESCCCHHH-------------------------------------------HHHHHHHSC
T ss_pred CHHHEEECCCCCEEEcccccceeecCCc-------------------------------------------ccccccCCC
Confidence 9999999999999999999987632211 011234688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.+..|+.++|||||||++|||+ +|..||.+.+..+...++.. ....+.+..+++++.+||.+
T Consensus 189 ~~YmAPE~l~~~~y~~~~DiwSlGvilyeml--tG~~PF~~~~~~~~~~~i~~-------~~~~~~~~~~s~~~~~li~~ 259 (350)
T 4b9d_A 189 PYYLSPEICENKPYNNKSDIWALGCVLYELC--TLKHAFEAGSMKNLVLKIIS-------GSFPPVSLHYSYDLRSLVSQ 259 (350)
T ss_dssp CTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHH-------TCCCCCCTTSCHHHHHHHHH
T ss_pred ccccCHHHHCCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCcCHHHHHHHHHc-------CCCCCCCccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999999988887766643 22345567889999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||++|||++|+ |+||++.
T Consensus 260 ~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 260 LFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HccCChhHCcCHHHHhcCHHhhcC
Confidence 999999999999999 7899864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=375.55 Aligned_cols=210 Identities=16% Similarity=0.224 Sum_probs=173.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||+++++|.+++.+|||||||+||+|.+++++. ..+++..+..++.||+.||+|||++|||||||
T Consensus 104 l~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 176 (336)
T 4g3f_A 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176 (336)
T ss_dssp TTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Confidence 67899999999999999999999999999999999999843 46999999999999999999999999999999
Q ss_pred CCCCeeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 81 AARNCMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 81 kp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
||+|||++.++ .+||+|||+|+....... ..........+|
T Consensus 177 Kp~NILl~~~g~~vKl~DFGla~~~~~~~~--------------------------------------~~~~~~~~~~~G 218 (336)
T 4g3f_A 177 KADNVLLSSDGSRAALCDFGHALCLQPDGL--------------------------------------GKSLLTGDYIPG 218 (336)
T ss_dssp CGGGEEECTTSCCEEECCCTTCEEC--------------------------------------------------CCCCC
T ss_pred CHHHEEEeCCCCEEEEeeCCCCeEccCCCc--------------------------------------ccceecCCcccc
Confidence 99999999987 699999999876422210 000112234579
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|+.|||||++.+..|+.++|||||||++|||+ +|..||.+.+..+....+... .......+..+++++.++|.
T Consensus 219 T~~YmAPE~~~~~~y~~~~DiwSlGvilyeml--tG~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~s~~~~~li~ 291 (336)
T 4g3f_A 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHML--NGCHPWTQYFRGPLCLKIASE-----PPPIREIPPSCAPLTAQAIQ 291 (336)
T ss_dssp CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCSSTTTCCSCCHHHHHHS-----CCGGGGSCTTSCHHHHHHHH
T ss_pred CccccCHHHHCCCCCCcHHHHHHHHHHHHHHH--HCcCCCCCCCHHHHHHHHHcC-----CCCchhcCccCCHHHHHHHH
Confidence 99999999999999999999999999999999 899999887766555544321 11122346678999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++|||+.|+++.+.+.
T Consensus 292 ~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 292 EGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHHHHHH
Confidence 99999999999999997777654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=361.94 Aligned_cols=199 Identities=21% Similarity=0.296 Sum_probs=167.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++.+|+||||| +|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~-------~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDi 138 (275)
T 3hyh_A 67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ-------RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 138 (275)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH-------SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Confidence 35789999999999999999999999999 6799999973 357999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... ...+.+||
T Consensus 139 KP~NILl~~~~~vkl~DFGla~~~~~~~--------------------------------------------~~~~~~GT 174 (275)
T 3hyh_A 139 KPENLLLDEHLNVKIADFGLSNIMTDGN--------------------------------------------FLKTSCGS 174 (275)
T ss_dssp CTTTEEECTTCCEEECCSSCC-----------------------------------------------------------
T ss_pred ChHHeEECCCCCEEEeecCCCeecCCCC--------------------------------------------ccCCeeEC
Confidence 9999999999999999999986521110 12346799
Q ss_pred ccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|||||++.+..+ +.++||||+||++|||+ +|..||.+.+..+....+.. ...+.+..+++++++|+.
T Consensus 175 ~~Y~APE~~~~~~y~~~~~DiwSlGvily~ll--tg~~PF~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 175 PNYAAPEVISGKLYAGPEVDVWSCGVILYVML--CRRLPFDDESIPVLFKNISN--------GVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------TCCCCCTTSCHHHHHHHH
T ss_pred cccCChhhhcCCCCCCChhhhHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHH
Confidence 99999999998876 58999999999999999 89999999888877766643 123446678999999999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHh
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+||+.||++|||++|+ |+||+.
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHccCChhHCcCHHHHHcCccccc
Confidence 9999999999999999 889975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=381.34 Aligned_cols=204 Identities=15% Similarity=0.232 Sum_probs=177.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||+++++|.+++.+|||||||+||+|.++++. ..+++..+..++.||+.||+|||++|||||||
T Consensus 202 l~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDi 273 (423)
T 4fie_A 202 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 273 (423)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 4678999999999999999999999999999999999962 35899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.+|.+||+|||+|+...... ......+||
T Consensus 274 Kp~NILl~~~g~vKl~DFGla~~~~~~~-------------------------------------------~~~~~~~GT 310 (423)
T 4fie_A 274 KSDSILLTHDGRVKLSDFGFCAQVSKEV-------------------------------------------PRRKSLVGT 310 (423)
T ss_dssp STTTEEECTTCCEEECCCTTCEECCSSC-------------------------------------------CCBCCCEEC
T ss_pred CHHHEEEcCCCCEEEecCccceECCCCC-------------------------------------------ccccccccC
Confidence 9999999999999999999987532211 112456799
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.+..|+.++|||||||++|||+ +|..||.+.+..+....+... .....+.+..+++++++||.+
T Consensus 311 p~YmAPEvl~~~~y~~~~DiWSlGvilyeml--~G~~PF~~~~~~~~~~~i~~~-----~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 311 PYWMAPELISRLPYGPEVDIWSLGIMVIEMV--DGEPPYFNEPPLKAMKMIRDN-----LPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp TTTCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHHS-----CCCCCSCTTSSCHHHHHHHHH
T ss_pred cCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCcCHHHHHHHHHcC-----CCCCCcccccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 899999998888877665431 122334456789999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||++|||++|+ |+||++.
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCC
Confidence 999999999999999 8899874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=364.89 Aligned_cols=200 Identities=24% Similarity=0.361 Sum_probs=163.8
Q ss_pred CCCCCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--
Q psy5690 1 MCSLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD-- 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-- 74 (434)
|++|+|||||+++++|++ ++.+|+|||||+||+|.+++++. ..+++..+..++.||+.||+|||++|
T Consensus 79 l~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH~~~~~ 151 (290)
T 3fpq_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRTPP 151 (290)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 468999999999999865 34589999999999999999843 47999999999999999999999998
Q ss_pred ccccCCCCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 75 IVHRDLAARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 75 iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|+||||||+|||++. ++.+||+|||+|+..... .
T Consensus 152 IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~---------------------------------------------~ 186 (290)
T 3fpq_A 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---------------------------------------------F 186 (290)
T ss_dssp CCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT---------------------------------------------S
T ss_pred EEecccChhheeEECCCCCEEEEeCcCCEeCCCC---------------------------------------------c
Confidence 999999999999985 789999999998641110 1
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
....+||+.|||||++.+ .|+.++|||||||++|||+ +|..||.+.... .....+.. .......+..+++
T Consensus 187 ~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyell--tg~~Pf~~~~~~~~~~~~i~~------~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 187 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA--TSEYPYSECQNAAQIYRRVTS------GVKPASFDKVAIP 257 (290)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH--HSSCTTTTCSSHHHHHHHHTT------TCCCGGGGGCCCH
T ss_pred cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHH--HCCCCCCCCCcHHHHHHHHHc------CCCCCCCCccCCH
Confidence 134579999999998865 6999999999999999999 899999876544 33333321 1111122455678
Q ss_pred HHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
++.+||.+||+.||++|||++|+ |+||++
T Consensus 258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999 789875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=367.53 Aligned_cols=212 Identities=33% Similarity=0.636 Sum_probs=173.1
Q ss_pred CCCC-CCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5690 2 CSLK-DPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYL 70 (434)
Q Consensus 2 ~~L~-HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yL 70 (434)
++++ |||||+++|+|.+ ++.+++|||||++|+|.++|++.+.. ......+++..+..++.||++||+||
T Consensus 122 ~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL 201 (353)
T 4ase_A 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 201 (353)
T ss_dssp HHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred HHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence 3454 5999999999966 46799999999999999999864321 11235689999999999999999999
Q ss_pred hhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 71 ESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 71 H~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
|+++||||||||+|||++.++.+||+|||+|+...... .
T Consensus 202 H~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~-----------------------------------------~ 240 (353)
T 4ase_A 202 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----------------------------------------D 240 (353)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT-----------------------------------------T
T ss_pred hhCCeecCccCccceeeCCCCCEEECcchhhhhcccCC-----------------------------------------C
Confidence 99999999999999999999999999999987632211 1
Q ss_pred cccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHH-HhhhhhhhcCCcccCCCCCCc
Q psy5690 151 YLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVI-ENCSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 229 (434)
+.......||+.|||||++.+..|+.++|||||||++|||+| .|..||.+....+.. ..+. .+.+++.|..
T Consensus 241 ~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t-~G~~Pf~~~~~~~~~~~~i~-------~g~~~~~p~~ 312 (353)
T 4ase_A 241 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDEEFCRRLK-------EGTRMRAPDY 312 (353)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT-TSCCSSTTCCCSHHHHHHHH-------HTCCCCCCTT
T ss_pred ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHh-CCCCCCCCCCHHHHHHHHHH-------cCCCCCCCcc
Confidence 122244568899999999999999999999999999999993 289999887654433 3222 2345566788
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+++++.++|.+||+.||++|||+.||++.|++.
T Consensus 313 ~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 313 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 999999999999999999999999998887764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=350.62 Aligned_cols=216 Identities=15% Similarity=0.257 Sum_probs=154.8
Q ss_pred CCCCCCCCeeeEEEEEecCC------------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCSTED------------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMK 68 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~------------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~ 68 (434)
|++|+|||||+++++|.+.+ .+|+|||||++|+|.+++..+. ......+..++.++.||++||+
T Consensus 57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~al~ 132 (299)
T 4g31_A 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC----TIEERERSVCLHIFLQIAEAVE 132 (299)
T ss_dssp HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC----SGGGSCHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC----CCChhHHHHHHHHHHHHHHHHH
Confidence 57899999999999997654 3799999999999999998432 2233456678999999999999
Q ss_pred HhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCC
Q psy5690 69 YLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYES 148 (434)
Q Consensus 69 yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 148 (434)
|||++||+||||||+|||++.++.+||+|||+|+........... ....
T Consensus 133 ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~-------------------------------~~~~ 181 (299)
T 4g31_A 133 FLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV-------------------------------LTPM 181 (299)
T ss_dssp HHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-----------------------------------------------
T ss_pred HHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCcccccc-------------------------------cccc
Confidence 999999999999999999999999999999998774332210000 0000
Q ss_pred cccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhhcCCcccCCCCC
Q psy5690 149 DYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRP 227 (434)
Q Consensus 149 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 227 (434)
......++.+||+.|||||++.+..|+.++|||||||++|||+ + ||...... .....+. ....++..
T Consensus 182 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell--~---Pf~~~~~~~~~~~~~~-------~~~~p~~~ 249 (299)
T 4g31_A 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--Y---PFSTQMERVRTLTDVR-------NLKFPPLF 249 (299)
T ss_dssp ----------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH--S---CCSSHHHHHHHHHHHH-------TTCCCHHH
T ss_pred ccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHc--c---CCCCccHHHHHHHHHh-------cCCCCCCC
Confidence 1111234568999999999999999999999999999999999 5 77643221 1111111 11122222
Q ss_pred CccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 228 ATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 228 ~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
...++++.+|+.+||+.||++|||+.|+ |+||++.+
T Consensus 250 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 250 TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 3445678899999999999999999999 67887653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=342.76 Aligned_cols=208 Identities=23% Similarity=0.326 Sum_probs=157.5
Q ss_pred CCCCCCCCeeeEEEEEecCC----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---
Q psy5690 1 MCSLKDPNLVRVIGVCSTED----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR--- 73 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--- 73 (434)
+++++|||||+++|+|.+++ .+|+|||||++|+|.++++. ..+++..+.+++.|++.||+|||++
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gl~ylH~~~~~ 122 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 46789999999999997654 47999999999999999973 3589999999999999999999987
Q ss_pred -----CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCC
Q psy5690 74 -----DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYES 148 (434)
Q Consensus 74 -----~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 148 (434)
+|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 123 ~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~---------------------------------------~ 163 (303)
T 3hmm_A 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT---------------------------------------D 163 (303)
T ss_dssp TTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT---------------------------------------T
T ss_pred ccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC---------------------------------------C
Confidence 99999999999999999999999999987532211 0
Q ss_pred cccccCCCCCCCccccchhhhhcC------CCCCcCChHHHHHHHHHHHhhcCCCCCC----------CCC-----hHHH
Q psy5690 149 DYYLSDTKARLPIRWMAWESLLLG------KNTTKSDVWSFAVTLWEILIHCNQRPYA----------ELT-----NEQV 207 (434)
Q Consensus 149 ~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDIwSlGvil~ellt~~g~~pf~----------~~~-----~~~~ 207 (434)
..........||+.|||||++.+. .++.++|||||||++|||+ +|..||. ... ..+.
T Consensus 164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~--tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH--HTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH--HCCCCCCccccccccchhcccccchHHHH
Confidence 011122346799999999999764 3577999999999999999 6655443 221 1122
Q ss_pred HHhhhhhhhcCCcccCCCCC-----CccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 208 IENCSHWYQNNSKQQYLPRP-----ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
...+. ....+++.| ..+++.+.+|+.+||+.||++|||+.||.+.|++..
T Consensus 242 ~~~~~------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 242 RKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHT------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHh------cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 21111 111222222 234568999999999999999999999999888753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=367.95 Aligned_cols=203 Identities=20% Similarity=0.253 Sum_probs=173.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++|||||+++++|.+++.+|+|||||+||+|.+++.+. ..+++..+..++.||+.||+|||++||||||||
T Consensus 247 ~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK 319 (689)
T 3v5w_A 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319 (689)
T ss_dssp SSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred hhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 5789999999999999999999999999999999999843 479999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.+|++||+|||+|+..... ...+.+||+
T Consensus 320 PeNILld~~G~vKL~DFGlA~~~~~~---------------------------------------------~~~t~~GTp 354 (689)
T 3v5w_A 320 PANILLDEHGHVRISDLGLACDFSKK---------------------------------------------KPHASVGTH 354 (689)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSC---------------------------------------------CCCSCCSCG
T ss_pred hHHeEEeCCCCEEecccceeeecCCC---------------------------------------------CCCCccCCc
Confidence 99999999999999999998652111 124568999
Q ss_pred cccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH---HHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 162 RWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE---QVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 162 ~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.|||||++.. ..|+.++|||||||++|||+ +|..||.+.+.. +....+. ......+..+++++++|
T Consensus 355 ~YmAPEvl~~~~~y~~~vDiWSLGvilYEmL--tG~~PF~~~~~~~~~~i~~~i~--------~~~~~~p~~~S~~a~dL 424 (689)
T 3v5w_A 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLL--RGHSPFRQHKTKDKHEIDRMTL--------TMAVELPDSFSPELRSL 424 (689)
T ss_dssp GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH--HSSCTTCGGGCCCHHHHHHHHH--------HCCCCCCTTSCHHHHHH
T ss_pred CccCHHHHhCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHhhc--------CCCCCCCccCCHHHHHH
Confidence 9999999975 57999999999999999999 899999764332 2222221 12334567889999999
Q ss_pred HHHhccCCCCCCCC-----HHHH--HHHHHhcccCC
Q psy5690 238 MLECWKTNETDRPR-----FSEI--HLFLQRKNLGA 266 (434)
Q Consensus 238 i~~cl~~dP~~Rps-----~~el--~~~L~~~~~~~ 266 (434)
|.+||+.||++|++ ++|| |+||+..++..
T Consensus 425 I~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp HHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred HHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 99999999999997 7899 99999876643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=346.92 Aligned_cols=213 Identities=18% Similarity=0.257 Sum_probs=170.7
Q ss_pred CCCCCCCCeeeEEEEEec------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCST------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++|+|||||++++++.. .+.+|+|||||+ |+|.+++. ....+++..+..++.||+.||+|||++|
T Consensus 107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~-------~~~~l~~~~~~~~~~qil~al~ylH~~~ 178 (398)
T 4b99_A 107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIH-------SSQPLTLEHVRYFLYQLLRGLKYMHSAQ 178 (398)
T ss_dssp HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHT-------SSSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 457899999999999754 367899999995 68999997 4567999999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
||||||||+|||++.++.+||+|||+|+....... ......
T Consensus 179 iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~---------------------------------------~~~~~~ 219 (398)
T 4b99_A 179 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA---------------------------------------EHQYFM 219 (398)
T ss_dssp CBCCCCCGGGEEECTTCCEEECCCTTCBCC----------------------------------------------CCCC
T ss_pred CcCCCcCccccccCCCCCEEEeecceeeecccCcc---------------------------------------cccccc
Confidence 99999999999999999999999999876322110 001123
Q ss_pred CCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc------------
Q psy5690 155 TKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ------------ 221 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 221 (434)
...+||+.|||||++.+. .++.++||||+||++|||+ +|..||.+.+..+....+..........
T Consensus 220 ~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell--~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~ 297 (398)
T 4b99_A 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML--ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRA 297 (398)
T ss_dssp CSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH--HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHH
T ss_pred ccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH--HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh
Confidence 457899999999998875 4699999999999999999 8999999988877776654322111000
Q ss_pred ------cCCCC-----CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 222 ------QYLPR-----PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 222 ------~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
...+. ...+++++.+||.+||+.||++|||++|+ |+||++.
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 298 YIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp HHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 00000 13467899999999999999999999999 8999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=341.00 Aligned_cols=232 Identities=16% Similarity=0.172 Sum_probs=163.2
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+|||||+++++|.+++.+|+|||||++|+|.+++. .+++.++..++.||+.||+|||++||+||||||+|
T Consensus 78 ~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeN 147 (361)
T 4f9c_A 78 GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSN 147 (361)
T ss_dssp SBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHH
Confidence 69999999999999999999999999999999985 48999999999999999999999999999999999
Q ss_pred eeeecC-CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 85 CMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 85 ILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
||++.+ +.+||+|||+|+.................. .... ... .+ .............+||+.|
T Consensus 148 iLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~----~~~~--------~~~--~~-~~~~~~~~~~~~~~GT~~Y 212 (361)
T 4f9c_A 148 FLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ----QERC--------SQN--KC-SICLSRRQQVAPRAGTPGF 212 (361)
T ss_dssp EEEETTTTEEEECCCTTCEECTTCSCGGGGGC-----------------------------------------CCCCGGG
T ss_pred eEEeCCCCeEEECcCCCCcccCCcccccccccccccc----cccc--------ccc--cc-cccccccccccccccCccc
Confidence 999876 799999999998754433211100000000 0000 000 00 0000011122456899999
Q ss_pred cchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhhhhhh-------------------------
Q psy5690 164 MAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQ------------------------- 216 (434)
Q Consensus 164 ~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~~~~~------------------------- 216 (434)
+|||++.+. .|+.++||||+||++|||+ +|+.||..... .+....+.....
T Consensus 213 ~APE~l~~~~~y~~~~DiWSlG~il~ell--~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~ 290 (361)
T 4f9c_A 213 RAPEVLTKCPNQTTAIDMWSAGVIFLSLL--SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQD 290 (361)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHH--HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCC
T ss_pred cCHHHHcCCCCCCCccchhhhHHHHHHHH--HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchh
Confidence 999999875 5899999999999999999 89999965443 222222211000
Q ss_pred ---------c------------CCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 217 ---------N------------NSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 217 ---------~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
. .......+....+++++.+|+.+||+.||++|+|++|+ |+||++.+
T Consensus 291 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 291 LRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred hhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0 00000111234577899999999999999999999999 89998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=359.18 Aligned_cols=210 Identities=17% Similarity=0.191 Sum_probs=177.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||+++++|.+++.+|+|||||+||+|.+++.. ....+++..+..++.||+.||+|||++||+||||
T Consensus 208 l~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~------~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDl 281 (573)
T 3uto_A 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD------EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDL 281 (573)
T ss_dssp HHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC------TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccC
Confidence 4578999999999999999999999999999999999962 3357999999999999999999999999999999
Q ss_pred CCCCeeeecC--CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 81 AARNCMVGKN--YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 81 kp~NILl~~~--~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||+|||++.+ +.+||+|||+|+...... .....+
T Consensus 282 Kp~Nill~~~~~~~vKl~DFG~a~~~~~~~--------------------------------------------~~~~~~ 317 (573)
T 3uto_A 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQ--------------------------------------------SVKVTT 317 (573)
T ss_dssp CGGGEEESSSSCCCEEECCCSSCEECCTTS--------------------------------------------EEEEEC
T ss_pred ChhhccccCCCCCCEEEeeccceeEccCCC--------------------------------------------ceeeeE
Confidence 9999999854 899999999987632211 113346
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|||||++.+..|+.++|||||||++|||+ +|..||.+.+..+....+.... .....+....+++++++||
T Consensus 318 GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml--~G~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL--SGLSPFGGENDDETLRNVKSCD----WNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp SSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH--HSCCSSCCSSHHHHHHHHHTTC----CCCCSGGGTTSCHHHHHHH
T ss_pred ECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCcCHHHHHHHHHhCC----CCCCcccccCCCHHHHHHH
Confidence 899999999999999999999999999999999 8999999999888877664321 1111222356889999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhcccCC
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKNLGA 266 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~~~~ 266 (434)
.+||+.||++|||++|+ |+||+......
T Consensus 392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 392 RKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred HHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 99999999999999999 77998765443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=314.24 Aligned_cols=200 Identities=23% Similarity=0.278 Sum_probs=173.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+|||||
T Consensus 69 ~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlk 141 (328)
T 3fe3_A 69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141 (328)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCC
Confidence 5689999999999999999999999999999999999743 468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ......||+
T Consensus 142 p~NIll~~~~~~kl~DFG~a~~~~~~~--------------------------------------------~~~~~~gt~ 177 (328)
T 3fe3_A 142 AENLLLDADMNIKIADFGFSNEFTVGG--------------------------------------------KLDAFCGAP 177 (328)
T ss_dssp GGGEEECTTSCEEECSTTCCGGGSSSC--------------------------------------------GGGTTSSSG
T ss_pred HHHEEEcCCCCEEEeeccCceecCCCC--------------------------------------------ccccccCCc
Confidence 999999999999999999975421110 123456889
Q ss_pred cccchhhhhcCCCC-CcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNT-TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s-~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..+. .++|||||||++|+|+ +|..||.+.+..+....+... ....+..+++++.+++.+
T Consensus 178 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~~li~~ 247 (328)
T 3fe3_A 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLV--SGSLPFDGQNLKELRERVLRG--------KYRIPFYMSTDCENLLKR 247 (328)
T ss_dssp GGCCHHHHHTCCCCSHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHC--------CCCCCTTSCHHHHHHHHH
T ss_pred ceeCcccccCCCcCCchhhhhhhHHHHHHHH--hCCCCCCCCCHHHHHHHHHhC--------CCCCCCCCCHHHHHHHHH
Confidence 99999999988874 7999999999999999 899999998887776655431 223456688999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||.+|||++|+ |+|++..
T Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HCCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999 8898764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=315.37 Aligned_cols=203 Identities=24% Similarity=0.318 Sum_probs=175.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+.+..++||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+|||||
T Consensus 60 ~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 132 (337)
T 1o6l_A 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132 (337)
T ss_dssp HSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred HhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCC
Confidence 5789999999999999999999999999999999999733 468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .......||+
T Consensus 133 p~NIll~~~g~vkL~DFG~a~~~~~~~-------------------------------------------~~~~~~~gt~ 169 (337)
T 1o6l_A 133 LENLMLDKDGHIKITDFGLCKEGISDG-------------------------------------------ATMKTFCGTP 169 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCBCSCCTT-------------------------------------------CCBCCCEECG
T ss_pred HHHEEECCCCCEEEeeccchhhcccCC-------------------------------------------CcccccccCh
Confidence 999999999999999999976421100 0123456889
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.. .....+..+++++.++|.+|
T Consensus 170 ~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMM--CGRLPFYNQDHERLFELILM--------EEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp GGCCGGGGSSSCBCTTHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------CCCCCCTTSCHHHHHHHHHH
T ss_pred hhCChhhhcCCCCCchhhcccchhHHHHHh--cCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999998887777665532 12334567889999999999
Q ss_pred ccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 242 WKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 242 l~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
|+.||++|| +++|+ |+|++..++
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 999999999 89999 889987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=310.84 Aligned_cols=203 Identities=19% Similarity=0.320 Sum_probs=172.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++..++..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||++||+|||||
T Consensus 72 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlk 143 (297)
T 3fxz_A 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143 (297)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred hcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Confidence 468999999999999999999999999999999999963 258999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .......||+
T Consensus 144 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~ 180 (297)
T 3fxz_A 144 SDNILLGMDGSVKLTDFGFCAQITPEQ-------------------------------------------SKRSTMVGTP 180 (297)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTT-------------------------------------------CCBCCCCSCG
T ss_pred HHHEEECCCCCEEEeeCCCceecCCcc-------------------------------------------cccCCccCCc
Confidence 999999999999999999875422111 1123456889
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||...........+... .......+..+++.+.+++.+|
T Consensus 181 ~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~ 253 (297)
T 3fxz_A 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMI--EGEPPYLNENPLRALYLIATN-----GTPELQNPEKLSAIFRDFLNRC 253 (297)
T ss_dssp GGCCHHHHHCSCBCTHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHHH-----CSCCCSCGGGSCHHHHHHHHHH
T ss_pred CccChhhhcCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhC-----CCCCCCCccccCHHHHHHHHHH
Confidence 999999999999999999999999999999 899999988776655433221 1223334567889999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHhc
Q psy5690 242 WKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~~ 262 (434)
|+.||++|||++|+ |+|++..
T Consensus 254 l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 254 LEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccCChhHCcCHHHHhhChhhccc
Confidence 99999999999999 7888764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=317.47 Aligned_cols=211 Identities=33% Similarity=0.651 Sum_probs=175.9
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLE 71 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH 71 (434)
+++ +||||++++++|.+++..|+||||+++|+|.+++...+.. ......+++..++.++.||+.||+|||
T Consensus 141 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 220 (370)
T 2psq_A 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 220 (370)
T ss_dssp HHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 356 8999999999999999999999999999999999865321 012346899999999999999999999
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 221 ~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-----------------------------------------~~ 259 (370)
T 2psq_A 221 SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----------------------------------------YY 259 (370)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCC-----------------------------------------TT
T ss_pred hCCeeccccchhhEEECCCCCEEEccccCCcccCccc-----------------------------------------ce
Confidence 9999999999999999999999999999976532211 11
Q ss_pred ccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc
Q psy5690 152 LSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (434)
.......+|+.|+|||++.+..++.++|||||||++|||+ + |..||.+....+....+.. ....+.+..+
T Consensus 260 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ell--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~ 330 (370)
T 2psq_A 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF--TLGGSPYPGIPVEELFKLLKE-------GHRMDKPANC 330 (370)
T ss_dssp CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH--TTSCCSSTTCCGGGHHHHHHT-------TCCCCCCTTS
T ss_pred ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHH--cCCCCCCCCCCHHHHHHHHhc-------CCCCCCCCCC
Confidence 1223445678899999999999999999999999999999 6 8999998877766654432 2234456788
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++++.++|.+||+.||++||++.|+++.|++.
T Consensus 331 ~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 331 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999999988874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=309.77 Aligned_cols=208 Identities=31% Similarity=0.498 Sum_probs=169.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD--IVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHrD 79 (434)
++++||||+++++++.+++..++||||+++|+|.+++...+ ....+++..++.++.||+.||+|||++| |+|||
T Consensus 89 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~D 164 (309)
T 3p86_A 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG----AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164 (309)
T ss_dssp HHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT----HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTT
T ss_pred HhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCC
Confidence 56899999999999999999999999999999999997321 1124899999999999999999999999 99999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++..... ........|
T Consensus 165 ikp~NIll~~~~~~kL~Dfg~a~~~~~~-------------------------------------------~~~~~~~~g 201 (309)
T 3p86_A 165 LKSPNLLVDKKYTVKVCDFGLSRLKAST-------------------------------------------FLSSKSAAG 201 (309)
T ss_dssp CCGGGEEECTTCCEEECCCC------------------------------------------------------------
T ss_pred CChhhEEEeCCCcEEECCCCCCcccccc-------------------------------------------ccccccCCC
Confidence 9999999999999999999997542111 011234568
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+.. .......+..+++++.+++.
T Consensus 202 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell--tg~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~ 273 (309)
T 3p86_A 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELA--TLQQPWGNLNPAQVVAAVGF------KCKRLEIPRNLNPQVAAIIE 273 (309)
T ss_dssp CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHH--HCCCTTTTSCHHHHHHHHHH------SCCCCCCCTTSCHHHHHHHH
T ss_pred CccccChhhhcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHh------cCCCCCCCccCCHHHHHHHH
Confidence 88999999999999999999999999999999 88999999887776654421 22334456788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
+||+.||++|||++++++.|+....
T Consensus 274 ~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 274 GCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999987643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=311.59 Aligned_cols=200 Identities=22% Similarity=0.321 Sum_probs=174.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+|||||
T Consensus 61 ~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 133 (318)
T 1fot_A 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133 (318)
T ss_dssp HSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-------TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred hhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 568999999999999999999999999999999999973 3468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++.... ......||+
T Consensus 134 p~NIll~~~g~~kL~Dfg~a~~~~~----------------------------------------------~~~~~~gt~ 167 (318)
T 1fot_A 134 PENILLDKNGHIKITDFGFAKYVPD----------------------------------------------VTYTLCGTP 167 (318)
T ss_dssp GGGEEECTTSCEEECCCSSCEECSS----------------------------------------------CBCCCCSCT
T ss_pred hheEEEcCCCCEEEeecCcceecCC----------------------------------------------ccccccCCc
Confidence 9999999999999999999764211 113456889
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+... ....+..+++++.+++.+|
T Consensus 168 ~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~i~~~--------~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEML--AGYTPFYDSNTMKTYEKILNA--------ELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp TTCCHHHHTTCCBCTTHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHHC--------CCCCCTTSCHHHHHHHHHH
T ss_pred cccCHhHhcCCCCCcccchhhhHHHHHHHH--hCCCCCCCCCHHHHHHHHHhC--------CCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 899999988877776655431 2334567889999999999
Q ss_pred ccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 242 WKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 242 l~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
|+.||++|| +++|+ |+|+++..+
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~hp~f~~~~~ 267 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 267 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred hccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence 999999999 89999 899987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=318.77 Aligned_cols=206 Identities=39% Similarity=0.688 Sum_probs=174.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.++++..+ ..+++..+..++.||+.||+|||++||+||||
T Consensus 166 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDl 239 (377)
T 3cbl_A 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239 (377)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcCCccc
Confidence 468999999999999999999999999999999999997432 35899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++....... ........+|
T Consensus 240 kp~Nil~~~~~~~kl~DfG~s~~~~~~~~-----------------------------------------~~~~~~~~~~ 278 (377)
T 3cbl_A 240 AARNCLVTEKNVLKISDFGMSREEADGVY-----------------------------------------AASGGLRQVP 278 (377)
T ss_dssp SGGGEEECTTCCEEECCGGGCEECTTSEE-----------------------------------------ECCSSCCEEE
T ss_pred CHHHEEEcCCCcEEECcCCCceecCCCce-----------------------------------------eecCCCCCCC
Confidence 99999999999999999999765221110 0011223356
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+..++.++|||||||++|||+ + |..||......+....+. .....+.+..+++++.++|.
T Consensus 279 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~--t~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 279 VKWTAPEALNYGRYSSESDVWSFGILLWETF--SLGASPYPNLSNQQTREFVE-------KGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp GGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH--TTSCCSSTTSCHHHHHHHHH-------TTCCCCCCTTCCHHHHHHHH
T ss_pred cCcCCHhHhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHH-------cCCCCCCCCCCCHHHHHHHH
Confidence 7899999999999999999999999999999 6 899999988777665443 22345567788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++|||+++|++.|++.
T Consensus 350 ~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCchhCcCHHHHHHHHHHH
Confidence 99999999999999999988875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=310.06 Aligned_cols=208 Identities=36% Similarity=0.647 Sum_probs=175.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.++++. ....+++..++.++.||+.||+|||++||+||||
T Consensus 104 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 177 (325)
T 3kul_A 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT------HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDL 177 (325)
T ss_dssp HTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT------TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCC
Confidence 4678999999999999999999999999999999999973 2356999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ..........+|
T Consensus 178 kp~NIll~~~~~~kl~Dfg~a~~~~~~~----------------------------------------~~~~~~~~~~~t 217 (325)
T 3kul_A 178 AARNVLVDSNLVCKVSDFGLSRVLEDDP----------------------------------------DAAYTTTGGKIP 217 (325)
T ss_dssp SGGGEEECTTCCEEECCCSSCEECC--------------------------------------------CCEECC---CC
T ss_pred CcceEEECCCCCEEECCCCcccccccCc----------------------------------------cceeeccCCCCc
Confidence 9999999999999999999986532211 001112334567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ....+.+..+++++.+++.
T Consensus 218 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~ 288 (325)
T 3kul_A 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVL--AYGERPYWNMTNRDVISSVEE-------GYRLPAPMGCPHALHQLML 288 (325)
T ss_dssp GGGSCHHHHHHCEECHHHHHHHHHHHHHHHH--TTSCCTTTTSCHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHH
T ss_pred ccccCHhHhcCCCCCcHHHHHHHHHHHHHHH--cCCCCCcccCCHHHHHHHHHc-------CCCCCCCCCcCHHHHHHHH
Confidence 7899999999999999999999999999999 6 9999999888877765542 2344556788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+||+.||++||++.+|++.|++..
T Consensus 289 ~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 289 DCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=316.19 Aligned_cols=205 Identities=19% Similarity=0.219 Sum_probs=173.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 69 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDl 141 (361)
T 2yab_A 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA-------QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDL 141 (361)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT-------TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 468899999999999999999999999999999999997 4457999999999999999999999999999999
Q ss_pred CCCCeeeecCC----ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 81 AARNCMVGKNY----TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 81 kp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||+|||++.++ .+||+|||+++...... ....
T Consensus 142 kp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~--------------------------------------------~~~~ 177 (361)
T 2yab_A 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--------------------------------------------EFKN 177 (361)
T ss_dssp SGGGEEESCTTSSSCCEEECCCSSCEECCTTC--------------------------------------------CCCC
T ss_pred CHHHEEEeCCCCCccCEEEEecCCceEcCCCC--------------------------------------------cccc
Confidence 99999998776 79999999976521110 1134
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..||+.|+|||++.+..++.++|||||||++|+|+ +|..||.+.+..+....+..... ......+..+++++.+
T Consensus 178 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll--~g~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~s~~~~~ 251 (361)
T 2yab_A 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL--SGASPFLGDTKQETLANITAVSY----DFDEEFFSQTSELAKD 251 (361)
T ss_dssp CCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSCCSSCCSSHHHHHHHHHTTCC----CCCHHHHTTSCHHHHH
T ss_pred CCCCccEECchHHcCCCCCccccHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhcCC----CCCchhccCCCHHHHH
Confidence 56889999999999999999999999999999999 89999999888877766543211 0011112457789999
Q ss_pred HHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 237 LMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||.+||..||++|||++|+ |+||+..
T Consensus 252 li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 252 FIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred HHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 9999999999999999999 7888743
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=316.09 Aligned_cols=201 Identities=20% Similarity=0.282 Sum_probs=171.6
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+++..|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 154 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN 154 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHH
Confidence 7999999999999999999999999999999999743 469999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.++.+||+|||+++..... .......+||+.|+
T Consensus 155 ILl~~~g~ikL~DFG~a~~~~~~-------------------------------------------~~~~~~~~gt~~y~ 191 (353)
T 3txo_A 155 VLLDHEGHCKLADFGMCKEGICN-------------------------------------------GVTTATFCGTPDYI 191 (353)
T ss_dssp EEECTTSCEEECCCTTCBCSCC----------------------------------------------------CCGGGC
T ss_pred EEECCCCCEEEccccceeecccC-------------------------------------------CccccccCCCcCeE
Confidence 99999999999999997641111 01123457899999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 244 (434)
|||++.+..++.++|||||||++|||+ +|..||...+..+....+.. .....+..+++++.+++.+||+.
T Consensus 192 aPE~~~~~~~~~~~DiwslG~il~ell--~G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~li~~lL~~ 261 (353)
T 3txo_A 192 APEILQEMLYGPAVDWWAMGVLLYEML--CGHAPFEAENEDDLFEAILN--------DEVVYPTWLHEDATGILKSFMTK 261 (353)
T ss_dssp CHHHHHHHHCTTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ChhhcCCCCcCCccCCCcchHHHHHHH--hCCCCCCCCCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHHHhhh
Confidence 999999999999999999999999999 89999999988887776643 12334566889999999999999
Q ss_pred CCCCCCCH------HHH--HHHHHhcccC
Q psy5690 245 NETDRPRF------SEI--HLFLQRKNLG 265 (434)
Q Consensus 245 dP~~Rps~------~el--~~~L~~~~~~ 265 (434)
||++||++ +|+ |+||+..++.
T Consensus 262 dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 262 NPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp SGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred CHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 99999998 788 8899876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.78 Aligned_cols=201 Identities=19% Similarity=0.234 Sum_probs=175.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||
T Consensus 95 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 167 (350)
T 1rdq_E 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Confidence 46789999999999999999999999999999999999843 46899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++.... ......||
T Consensus 168 kp~NIll~~~g~~kL~DFg~a~~~~~----------------------------------------------~~~~~~gt 201 (350)
T 1rdq_E 168 KPENLLIDQQGYIQVTDFGFAKRVKG----------------------------------------------RTWTLCGT 201 (350)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSS----------------------------------------------CBCCCEEC
T ss_pred ccceEEECCCCCEEEcccccceeccC----------------------------------------------CcccccCC
Confidence 99999999999999999999764211 01234678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+... ....+..+++++.++|.+
T Consensus 202 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~Pf~~~~~~~~~~~i~~~--------~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMA--AGYPPFFADQPIQIYEKIVSG--------KVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHC--------CCCCCTTCCHHHHHHHHH
T ss_pred ccccCHHHhcCCCCCCcCCEecccHhHhHHh--hCCCCCCCCCHHHHHHHHHcC--------CCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999 899999998887777665431 233456788999999999
Q ss_pred hccCCCCCCCC-----HHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRPR-----FSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rps-----~~el--~~~L~~~~~ 264 (434)
||+.||++||+ ++|| |+|++..++
T Consensus 272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 99999999998 8999 889987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=318.36 Aligned_cols=212 Identities=33% Similarity=0.589 Sum_probs=177.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++...+........+++..++.++.||+.||+|||++||+|||||
T Consensus 129 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 208 (367)
T 3l9p_A 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208 (367)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 46799999999999999999999999999999999998765444445679999999999999999999999999999999
Q ss_pred CCCeeeecCC---ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGKNY---TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||++.++ .+||+|||+++...... .........
T Consensus 209 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~-----------------------------------------~~~~~~~~~ 247 (367)
T 3l9p_A 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----------------------------------------YYRKGGCAM 247 (367)
T ss_dssp GGGEEESCSSTTCCEEECCCHHHHHHHHHS-----------------------------------------SCTTCCGGG
T ss_pred hhhEEEecCCCCceEEECCCcccccccccc-----------------------------------------ccccCCCcC
Confidence 9999998554 59999999976421111 011123345
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+|+.|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ......+..+++++.++
T Consensus 248 ~t~~y~aPE~~~~~~~~~~~DvwslG~il~ell--t~g~~pf~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~l 318 (367)
T 3l9p_A 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--SLGYMPYPSKSNQEVLEFVTS-------GGRMDPPKNCPGPVYRI 318 (367)
T ss_dssp SCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCSSTTCCHHHHHHHHHT-------TCCCCCCTTCCHHHHHH
T ss_pred CcccEECHHHhcCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCccCCHHHHHH
Confidence 678899999999999999999999999999999 6 8999999888777665542 22344466788999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+.+||+.||++||++++|++.|+...
T Consensus 319 i~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 319 MTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 99999999999999999988887653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=314.19 Aligned_cols=204 Identities=23% Similarity=0.267 Sum_probs=174.8
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++||||+++++++.+.+..|+||||++||+|.+++.+. ..+++..++.++.||+.||+|||++||+|||||
T Consensus 94 ~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 166 (373)
T 2r5t_A 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 166 (373)
T ss_dssp CCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 5789999999999999999999999999999999999743 468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ......+||+
T Consensus 167 p~NIll~~~g~ikL~DFG~a~~~~~~~-------------------------------------------~~~~~~~gt~ 203 (373)
T 2r5t_A 167 PENILLDSQGHIVLTDFGLCKENIEHN-------------------------------------------STTSTFCGTP 203 (373)
T ss_dssp GGGEEECTTSCEEECCCCBCGGGBCCC-------------------------------------------CCCCSBSCCC
T ss_pred HHHEEECCCCCEEEeeCccccccccCC-------------------------------------------CccccccCCc
Confidence 999999999999999999976411100 1124457899
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+... ....+..+++++.+++.+|
T Consensus 204 ~y~aPE~~~~~~~~~~~DiwslG~il~ell--~G~~Pf~~~~~~~~~~~i~~~--------~~~~~~~~~~~~~~li~~l 273 (373)
T 2r5t_A 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEML--YGLPPFYSRNTAEMYDNILNK--------PLQLKPNITNSARHLLEGL 273 (373)
T ss_dssp CCCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCTTCCSBHHHHHHHHHHS--------CCCCCSSSCHHHHHHHHHH
T ss_pred cccCHHHhCCCCCCchhhhHHHHHHHHHHH--cCCCCCCCCCHHHHHHHHHhc--------ccCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 899999998888777665431 2233567889999999999
Q ss_pred ccCCCCCCCCH----HHH--HHHHHhcccC
Q psy5690 242 WKTNETDRPRF----SEI--HLFLQRKNLG 265 (434)
Q Consensus 242 l~~dP~~Rps~----~el--~~~L~~~~~~ 265 (434)
|+.||++||++ +++ |+|++..++.
T Consensus 274 L~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 274 LQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp TCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred cccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 99999999987 466 7888776543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.66 Aligned_cols=202 Identities=26% Similarity=0.339 Sum_probs=174.5
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
++||||+++++++.+++..|+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 147 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChh
Confidence 48999999999999999999999999999999999743 46899999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
|||++.++.+||+|||+++...... .......||+.|
T Consensus 148 NIll~~~g~vkL~DFG~a~~~~~~~-------------------------------------------~~~~~~~gt~~y 184 (345)
T 1xjd_A 148 NILLDKDGHIKIADFGMCKENMLGD-------------------------------------------AKTNTFCGTPDY 184 (345)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT-------------------------------------------CCBCCCCSCGGG
T ss_pred hEEECCCCCEEEeEChhhhhcccCC-------------------------------------------CcccCCCCCccc
Confidence 9999999999999999976421100 012456789999
Q ss_pred cchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhcc
Q psy5690 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWK 243 (434)
Q Consensus 164 ~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 243 (434)
+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+... ....+..+++++.+++.+||+
T Consensus 185 ~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~Pf~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~~li~~lL~ 254 (345)
T 1xjd_A 185 IAPEILLGQKYNHSVDWWSFGVLLYEML--IGQSPFHGQDEEELFHSIRMD--------NPFYPRWLEKEAKDLLVKLFV 254 (345)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHC--------CCCCCTTSCHHHHHHHHHHSC
T ss_pred CChhhhcCCCCCChhhhHHHHHHHHHHh--cCCCCCCCCCHHHHHHHHHhC--------CCCCCcccCHHHHHHHHHHhc
Confidence 9999999999999999999999999999 899999998887777665431 223456788999999999999
Q ss_pred CCCCCCCCHH-HH--HHHHHhcccC
Q psy5690 244 TNETDRPRFS-EI--HLFLQRKNLG 265 (434)
Q Consensus 244 ~dP~~Rps~~-el--~~~L~~~~~~ 265 (434)
.||++||++. ++ |+|++..++.
T Consensus 255 ~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 255 REPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp SSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred CCHhHcCCChHHHHcCccccCCCHH
Confidence 9999999997 88 8999876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=311.28 Aligned_cols=202 Identities=23% Similarity=0.319 Sum_probs=174.0
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
.+ +||||+++++++.+.+..|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 76 ~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlk 148 (353)
T 2i0e_A 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 148 (353)
T ss_dssp CTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred hcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCC
Confidence 44 8999999999999999999999999999999999743 468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ......+||+
T Consensus 149 p~NIll~~~g~vkL~DFG~a~~~~~~~-------------------------------------------~~~~~~~gt~ 185 (353)
T 2i0e_A 149 LDNVMLDSEGHIKIADFGMCKENIWDG-------------------------------------------VTTKTFCGTP 185 (353)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCTT-------------------------------------------CCBCCCCSCG
T ss_pred HHHEEEcCCCcEEEEeCCcccccccCC-------------------------------------------cccccccCCc
Confidence 999999999999999999976421100 0124457899
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+..+.+.. .....+..+++++.+++.+|
T Consensus 186 ~y~aPE~~~~~~~~~~~DiwslG~il~ell--~G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~l 255 (353)
T 2i0e_A 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEML--AGQAPFEGEDEDELFQSIME--------HNVAYPKSMSKEAVAICKGL 255 (353)
T ss_dssp GGCCHHHHTTCCBSTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------CCCCCCTTSCHHHHHHHHHH
T ss_pred cccChhhhcCCCcCCcccccchHHHHHHHH--cCCCCCCCCCHHHHHHHHHh--------CCCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999999888877766643 12334567889999999999
Q ss_pred ccCCCCCCCC-----HHHH--HHHHHhccc
Q psy5690 242 WKTNETDRPR-----FSEI--HLFLQRKNL 264 (434)
Q Consensus 242 l~~dP~~Rps-----~~el--~~~L~~~~~ 264 (434)
|+.||++||+ ++++ |+|++..++
T Consensus 256 L~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 256 MTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp TCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred hhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 9999999995 5888 889887654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=320.96 Aligned_cols=220 Identities=15% Similarity=0.211 Sum_probs=181.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||++++++|.+++..|+||||+++|+|.+++.+ ....+++..+..++.||+.||+|||++||+|||||
T Consensus 129 ~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~------~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLK 202 (437)
T 4aw2_A 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK------FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIK 202 (437)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH------ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccC
Confidence 357999999999999999999999999999999999973 23579999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ........||+
T Consensus 203 p~NILl~~~g~vkL~DFGla~~~~~~~------------------------------------------~~~~~~~~GT~ 240 (437)
T 4aw2_A 203 PDNILMDMNGHIRLADFGSCLKLMEDG------------------------------------------TVQSSVAVGTP 240 (437)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTS------------------------------------------CEECCSCCSCG
T ss_pred HHHeeEcCCCCEEEcchhhhhhcccCC------------------------------------------CcccccccCCc
Confidence 999999999999999999976522111 11123457899
Q ss_pred cccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 162 RWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 162 ~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
.|+|||++. ...++.++|||||||++|||+ +|..||.+.+..+....+...... ...+.....+++++.+
T Consensus 241 ~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell--tG~~Pf~~~~~~~~~~~i~~~~~~---~~~p~~~~~~s~~~~d 315 (437)
T 4aw2_A 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML--YGETPFYAESLVETYGKIMNHKER---FQFPTQVTDVSENAKD 315 (437)
T ss_dssp GGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHTHHHH---CCCCSSCCCSCHHHHH
T ss_pred CeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH--hCCCCCCCCChhHHHHhhhhcccc---ccCCcccccCCHHHHH
Confidence 999999997 456899999999999999999 899999999888877766532211 1122223458899999
Q ss_pred HHHHhccCCCCC--CCCHHHH--HHHHHhcccCCCccccccc
Q psy5690 237 LMLECWKTNETD--RPRFSEI--HLFLQRKNLGARASKITPV 274 (434)
Q Consensus 237 li~~cl~~dP~~--Rps~~el--~~~L~~~~~~~~~~~~~~~ 274 (434)
||.+||..+|++ |++++|+ |+||+..++.......+|.
T Consensus 316 Li~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~ 357 (437)
T 4aw2_A 316 LIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPY 357 (437)
T ss_dssp HHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSC
T ss_pred HHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCC
Confidence 999999988888 9999999 8999998776654444443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=311.75 Aligned_cols=204 Identities=18% Similarity=0.188 Sum_probs=171.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlk 155 (362)
T 2bdw_A 83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV-------AREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155 (362)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT-------TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred HhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCc
Confidence 46899999999999999999999999999999999997 44578999999999999999999999999999999
Q ss_pred CCCeeeecC---CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGKN---YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||++.+ +.+||+|||+++...... ......
T Consensus 156 p~NIll~~~~~~~~~kl~DfG~a~~~~~~~--------------------------------------------~~~~~~ 191 (362)
T 2bdw_A 156 PENLLLASKAKGAAVKLADFGLAIEVNDSE--------------------------------------------AWHGFA 191 (362)
T ss_dssp GGGEEESCSSTTCCEEECCCTTCBCCTTCC--------------------------------------------SCCCSC
T ss_pred hHHEEEecCCCCCCEEEeecCcceEecCCc--------------------------------------------ccccCC
Confidence 999999765 459999999976522110 113456
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|+|||++.+..++.++|||||||++|+|+ +|..||.+.+..+....+.... .....+....+++++.+++
T Consensus 192 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll--~g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~li 265 (362)
T 2bdw_A 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL--VGYPPFWDEDQHRLYAQIKAGA----YDYPSPEWDTVTPEAKSLI 265 (362)
T ss_dssp SCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHTC----CCCCTTGGGGSCHHHHHHH
T ss_pred CCccccCHHHHccCCCCchhhHHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHhCC----CCCCcccccCCCHHHHHHH
Confidence 889999999999999999999999999999999 8999999988777766554321 1111122346789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||++||+++|+ |+|+...
T Consensus 266 ~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 266 DSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999 8999754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=319.91 Aligned_cols=205 Identities=19% Similarity=0.178 Sum_probs=173.3
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++|||||++|+|.+++.. ...+++..+..++.||+.||+|||++||+|||||
T Consensus 65 ~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-------~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlK 137 (444)
T 3soa_A 65 RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-------REYYSEADASHCIQQILEAVLHCHQMGVVHRNLK 137 (444)
T ss_dssp HHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH-------CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred HhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 568999999999999999999999999999999999973 3569999999999999999999999999999999
Q ss_pred CCCeeee---cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVG---KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||++ .++.+||+|||+++...... .......
T Consensus 138 p~NIll~~~~~~~~vkL~DFG~a~~~~~~~-------------------------------------------~~~~~~~ 174 (444)
T 3soa_A 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQ-------------------------------------------QAWFGFA 174 (444)
T ss_dssp STTEEESBSSTTCCEEECCCSSCBCCCTTC-------------------------------------------CBCCCSC
T ss_pred HHHEEEeccCCCCcEEEccCceeEEecCCC-------------------------------------------ceeeccc
Confidence 9999998 45789999999976522111 1123457
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|+|||++.+..++.++|||||||++|+|+ +|..||.+.+..+....+.... .....+....+++++.+|+
T Consensus 175 gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell--~G~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li 248 (444)
T 3soa_A 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILL--VGYPPFWDEDQHRLYQQIKAGA----YDFPSPEWDTVTPEAKDLI 248 (444)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHTC----CCCCTTTTTTSCHHHHHHH
T ss_pred CCcccCCHHHhcCCCCCCccccHHHHHHHHHHH--hCCCCCCCccHHHHHHHHHhCC----CCCCccccccCCHHHHHHH
Confidence 899999999999999999999999999999999 8999999988887776654321 1112223356789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||++|||+.|+ |+|++..
T Consensus 249 ~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 249 NKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHcCCChhHCCCHHHHhcCccccCC
Confidence 99999999999999999 7788654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.23 Aligned_cols=208 Identities=18% Similarity=0.256 Sum_probs=176.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+.++|||||+++++|.+++..|+|||||+||+|.++++. ..+++..+..++.||+.||+|||++||+|||||
T Consensus 124 ~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLK 195 (410)
T 3v8s_A 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195 (410)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence 457999999999999999999999999999999999963 258999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .......+||+
T Consensus 196 p~NILl~~~g~ikL~DFG~a~~~~~~~------------------------------------------~~~~~~~~gt~ 233 (410)
T 3v8s_A 196 PDNMLLDKSGHLKLADFGTCMKMNKEG------------------------------------------MVRCDTAVGTP 233 (410)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTS------------------------------------------EEECCSCCSCG
T ss_pred HHHeeECCCCCEEEeccceeEeeccCC------------------------------------------cccccCCcCCc
Confidence 999999999999999999976532111 11124567899
Q ss_pred cccchhhhhcCC----CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 162 RWMAWESLLLGK----NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 162 ~y~aPE~~~~~~----~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.|+|||++.+.. ++.++|||||||++|||+ +|..||.+.+..+....+..... ....+....+++++++|
T Consensus 234 ~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell--~G~~Pf~~~~~~~~~~~i~~~~~----~~~~p~~~~~s~~~~~l 307 (410)
T 3v8s_A 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML--VGDTPFYADSLVGTYSKIMNHKN----SLTFPDDNDISKEAKNL 307 (410)
T ss_dssp GGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHTHHH----HCCCCTTCCCCHHHHHH
T ss_pred cccCHHHhhccCCCcCCCCcceEecchHHHHHHH--hCCCCCCCCChhhHHHHHHhccc----cccCCCcccccHHHHHH
Confidence 999999998765 789999999999999999 89999999988887776654221 11233345688999999
Q ss_pred HHHhccCCCCC--CCCHHHH--HHHHHhcccC
Q psy5690 238 MLECWKTNETD--RPRFSEI--HLFLQRKNLG 265 (434)
Q Consensus 238 i~~cl~~dP~~--Rps~~el--~~~L~~~~~~ 265 (434)
|.+||+.+|.+ ||+++|| |+|++..++.
T Consensus 308 i~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 308 ICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp HHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred HHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 99999999988 9999999 8999987554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=296.84 Aligned_cols=205 Identities=36% Similarity=0.684 Sum_probs=175.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~di 132 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh------cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCc
Confidence 3578999999999999999999999999999999999973 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ........+|
T Consensus 133 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 170 (269)
T 4hcu_A 133 AARNCLVGENQVIKVSDFGMTRFVLDDQ------------------------------------------YTSSTGTKFP 170 (269)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHH------------------------------------------HHSTTSTTCC
T ss_pred chheEEEcCCCCEEeccccccccccccc------------------------------------------cccccCcccc
Confidence 9999999999999999999976522211 1122344567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||.+.+..++.++||||||+++|+|+ + |..||......+....+.. ......+..+++++.+++.
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 171 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVF--SEGKIPYENRSNSEVVEDIST-------GFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCTTTTCCHHHHHHHHHT-------TCCCCCCTTSCHHHHHHHH
T ss_pred cccCCHHHhcCCCCCchhhhHHHHHHHHHHh--cCCCCCCCCCCHHHHHHHHhc-------CccCCCCCcCCHHHHHHHH
Confidence 7899999999999999999999999999999 6 8999999888877665543 1233445667899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++||++.++++.|++.
T Consensus 242 ~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHHHHHH
Confidence 99999999999999999998875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=311.34 Aligned_cols=208 Identities=35% Similarity=0.669 Sum_probs=166.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.++++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 100 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 173 (373)
T 2qol_A 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK------HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDL 173 (373)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCC
Confidence 4688999999999999999999999999999999999973 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++....... .........+|
T Consensus 174 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~----------------------------------------~~~~~~~~~~~ 213 (373)
T 2qol_A 174 AARNILINSNLVCKVSDFGLGRVLEDDPE----------------------------------------AAYTTRGGKIP 213 (373)
T ss_dssp CGGGEEECTTCCEEECCC--------------------------------------------------------------
T ss_pred CcceEEEcCCCCEEECcCccccccccCCc----------------------------------------cceeccCCCcC
Confidence 99999999999999999999765322110 00011223456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ....+.+..++.++.+++.
T Consensus 214 ~~y~aPE~~~~~~~~~~~Dv~SlG~il~ell--t~g~~P~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~ 284 (373)
T 2qol_A 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVM--SYGERPYWEMSNQDVIKAVDE-------GYRLPPPMDCPAALYQLML 284 (373)
T ss_dssp CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTC-CTTTTCCHHHHHHHHHT-------TEECCCCTTCBHHHHHHHH
T ss_pred CCccChhhhccCCcCchhcHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCccccHHHHHHHH
Confidence 7899999999999999999999999999999 5 8999998887776655432 2234446678899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+||+.||++||++++|++.|++..
T Consensus 285 ~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 285 DCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhCcChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999888753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=308.50 Aligned_cols=213 Identities=40% Similarity=0.794 Sum_probs=176.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC-----------------CCCCCCCHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-----------------QENPAISYGCLIFMATQI 63 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~qi 63 (434)
|++++||||+++++++.+++..++||||+++|+|.+++....... .....+++..++.++.||
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 357899999999999999999999999999999999998542110 012578999999999999
Q ss_pred HHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccc
Q psy5690 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYC 143 (434)
Q Consensus 64 ~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 143 (434)
++||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 184 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~----------------------------------- 228 (343)
T 1luf_A 184 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD----------------------------------- 228 (343)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----------------------------------
T ss_pred HHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCc-----------------------------------
Confidence 999999999999999999999999999999999999976532111
Q ss_pred cccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCccc
Q psy5690 144 SHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQ 222 (434)
Q Consensus 144 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 222 (434)
.........+|+.|+|||++.+..++.++|||||||++|||+ + |..||.+....+....+.. ..
T Consensus 229 ------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~--t~g~~p~~~~~~~~~~~~~~~-------~~ 293 (343)
T 1luf_A 229 ------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF--SYGLQPYYGMAHEEVIYYVRD-------GN 293 (343)
T ss_dssp ------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTTCCTTTTSCHHHHHHHHHT-------TC
T ss_pred ------cccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH--hcCCCcCCCCChHHHHHHHhC-------CC
Confidence 011123445678899999999999999999999999999999 7 8999999887776655432 22
Q ss_pred CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 223 YLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 223 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
....+..+++++.+++.+||+.||++||++.++++.|++..
T Consensus 294 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 294 ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 33456778899999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=316.98 Aligned_cols=219 Identities=16% Similarity=0.196 Sum_probs=178.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||++++++|.+++..|+||||+++|+|.+++.+.+ ..+++..++.++.||+.||+|||++||+|||||
T Consensus 116 ~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLK 189 (412)
T 2vd5_A 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG------ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIK 189 (412)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccC
Confidence 35789999999999999999999999999999999997432 468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++++||+|||+++...... .......+||+
T Consensus 190 p~NILld~~g~vkL~DFGla~~~~~~~------------------------------------------~~~~~~~~Gt~ 227 (412)
T 2vd5_A 190 PDNILLDRCGHIRLADFGSCLKLRADG------------------------------------------TVRSLVAVGTP 227 (412)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTS------------------------------------------CEECSSCCSCG
T ss_pred HHHeeecCCCCEEEeechhheeccCCC------------------------------------------ccccceecccc
Confidence 999999999999999999976522111 01123457899
Q ss_pred cccchhhhh-------cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 162 RWMAWESLL-------LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 162 ~y~aPE~~~-------~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
.|+|||++. ...++.++|||||||++|||+ +|..||...+..+....+....... ..+..+..+++++
T Consensus 228 ~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell--tG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~~s~~~ 302 (412)
T 2vd5_A 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF--YGQTPFYADSTAETYGKIVHYKEHL---SLPLVDEGVPEEA 302 (412)
T ss_dssp GGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHTHHHHC---CCC----CCCHHH
T ss_pred CcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH--hCCCCCCCCCHHHHHHHHHhcccCc---CCCccccCCCHHH
Confidence 999999998 356899999999999999999 8999999988888777665432111 1122235688999
Q ss_pred HHHHHHhccCCCCCC---CCHHHH--HHHHHhcccCCCccccccc
Q psy5690 235 FDLMLECWKTNETDR---PRFSEI--HLFLQRKNLGARASKITPV 274 (434)
Q Consensus 235 ~~li~~cl~~dP~~R---ps~~el--~~~L~~~~~~~~~~~~~~~ 274 (434)
++||.+||. +|++| |+++|+ |+||+..++.......+|.
T Consensus 303 ~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~ 346 (412)
T 2vd5_A 303 RDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPF 346 (412)
T ss_dssp HHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSC
T ss_pred HHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCC
Confidence 999999999 99998 589999 8999998776655444443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=303.96 Aligned_cols=212 Identities=38% Similarity=0.726 Sum_probs=175.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC-----------------CCCCCCCHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-----------------QENPAISYGCLIFMATQI 63 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~qi 63 (434)
|++++||||+++++++.+++..++||||+++|+|.+++....... .....+++..++.++.||
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 467899999999999999999999999999999999998543210 012358999999999999
Q ss_pred HHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccc
Q psy5690 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYC 143 (434)
Q Consensus 64 ~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 143 (434)
+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 160 ~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~----------------------------------- 204 (314)
T 2ivs_A 160 SQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED----------------------------------- 204 (314)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTS-----------------------------------
T ss_pred HHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccc-----------------------------------
Confidence 999999999999999999999999999999999999976532211
Q ss_pred cccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCccc
Q psy5690 144 SHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQ 222 (434)
Q Consensus 144 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 222 (434)
.........+|+.|+|||++.+..++.++|||||||++|||+ + |..||.+....+....+.. ..
T Consensus 205 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~--t~g~~p~~~~~~~~~~~~~~~-------~~ 269 (314)
T 2ivs_A 205 ------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV--TLGGNPYPGIPPERLFNLLKT-------GH 269 (314)
T ss_dssp ------CEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH--TTSCCSSTTCCGGGHHHHHHT-------TC
T ss_pred ------cceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHhhc-------CC
Confidence 111223445678899999999999999999999999999999 7 8999998877666554432 22
Q ss_pred CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 223 YLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 223 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
....+..+++++.+++.+||+.||++||+++|+.+.|++.
T Consensus 270 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 270 RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3445667889999999999999999999999999988875
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=310.31 Aligned_cols=207 Identities=18% Similarity=0.175 Sum_probs=172.3
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+.+..++|||||++|+|.+++.. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 56 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~------~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlk 129 (321)
T 1tki_A 56 NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT------SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129 (321)
T ss_dssp HHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence 468999999999999999999999999999999999962 23468999999999999999999999999999999
Q ss_pred CCCeeeec--CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 82 ARNCMVGK--NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 82 p~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|+|||++. ++.+||+|||+++...... ......|
T Consensus 130 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~~g 165 (321)
T 1tki_A 130 PENIIYQTRRSSTIKIIEFGQARQLKPGD--------------------------------------------NFRLLFT 165 (321)
T ss_dssp GGGEEESSSSCCCEEECCCTTCEECCTTC--------------------------------------------EEEEEES
T ss_pred HHHEEEccCCCCCEEEEECCCCeECCCCC--------------------------------------------ccccccC
Confidence 99999987 7899999999976532111 0122356
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|+.|+|||++.+..++.++|||||||++|+|+ +|..||......+....+..... .........+++++.+++.
T Consensus 166 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~s~~~~~li~ 239 (321)
T 1tki_A 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLL--SGINPFLAETNQQIIENIMNAEY----TFDEEAFKEISIEAMDFVD 239 (321)
T ss_dssp CGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHHTCC----CCCHHHHTTSCHHHHHHHH
T ss_pred ChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH--hCCCCCcCCCHHHHHHHHHcCCC----CCChhhhccCCHHHHHHHH
Confidence 78899999999888899999999999999999 89999999888777766543111 0000112357889999999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
+||+.||++|||+.|+ |+|+++...
T Consensus 240 ~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 240 RLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHcCCChhHCcCHHHHhcChhhccCcc
Confidence 9999999999999999 899987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.21 Aligned_cols=204 Identities=16% Similarity=0.263 Sum_probs=172.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|.+++. ...+++..+..++.|++.||+|||++||+||||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 167 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--------QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDI 167 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH--------hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 467899999999999999999999999999999999985 236899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .......||
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt 204 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKDV-------------------------------------------PKRKSLVGT 204 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSSS-------------------------------------------CCBCCCCSC
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccCc-------------------------------------------cccccccCC
Confidence 9999999999999999999975521110 012345688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+... ..........+++++.+++.+
T Consensus 205 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~--~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMV--DGEPPYFSDSPVQAMKRLRDS-----PPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHHS-----SCCCCTTGGGSCHHHHHHHHH
T ss_pred ccccCHhhhcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHhcC-----CCCCcCccccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 899999988777665544321 111222344678899999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||++|||++|+ |+|+.+.
T Consensus 278 ~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 278 MLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HccCChhhCcCHHHHhcChhhccC
Confidence 999999999999999 6788764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=318.62 Aligned_cols=204 Identities=24% Similarity=0.306 Sum_probs=175.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrD 79 (434)
|++++||||++++++|.+++..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ +||+|||
T Consensus 202 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrD 274 (446)
T 4ejn_A 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274 (446)
T ss_dssp CCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCC
T ss_pred HHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECC
Confidence 5788999999999999999999999999999999999973 3468999999999999999999998 9999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++...... .......|
T Consensus 275 lkp~NIll~~~~~~kl~DFG~a~~~~~~~-------------------------------------------~~~~~~~g 311 (446)
T 4ejn_A 275 LKLENLMLDKDGHIKITDFGLCKEGIKDG-------------------------------------------ATMKTFCG 311 (446)
T ss_dssp CCGGGEEECSSSCEEECCCCCCCTTCC------------------------------------------------CCSSS
T ss_pred CCHHHEEECCCCCEEEccCCCceeccCCC-------------------------------------------cccccccC
Confidence 99999999999999999999976421110 11234678
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.. .....+..+++++.+||.
T Consensus 312 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM--CGRLPFYNQDHEKLFELILM--------EEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------CCCCCCTTSCHHHHHHHH
T ss_pred CccccCHhhcCCCCCCCccchhhhHHHHHHHh--hCCCCCCCCCHHHHHHHHHh--------CCCCCCccCCHHHHHHHH
Confidence 99999999999999999999999999999999 89999999888777665532 123345678899999999
Q ss_pred HhccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 240 ECWKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 240 ~cl~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
+||+.||++|| +++|+ |+||+..++
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 99999999999 99999 889987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=300.60 Aligned_cols=209 Identities=20% Similarity=0.271 Sum_probs=168.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dl 137 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAHDMRIVHRDI 137 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 46789999999999999999999999999999999999743 46899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ........||
T Consensus 138 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~gt 175 (294)
T 4eqm_A 138 KPQNILIDSNKTLKIFDFGIAKALSETS------------------------------------------LTQTNHVLGT 175 (294)
T ss_dssp CGGGEEECTTSCEEECCCSSSTTC-------------------------------------------------------C
T ss_pred CHHHEEECCCCCEEEEeCCCcccccccc------------------------------------------ccccCccccC
Confidence 9999999999999999999976532111 0112334678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|+|+ +|..||.+....+....... .............+++.+.+++.+
T Consensus 176 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll--~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~ 250 (294)
T 4eqm_A 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEML--VGEPPFNGETAVSIAIKHIQ---DSVPNVTTDVRKDIPQSLSNVILR 250 (294)
T ss_dssp CSSCCHHHHHTCCCCTTHHHHHHHHHHHHHH--HSSCSSCSSCHHHHHHHHHS---SCCCCHHHHSCTTSCHHHHHHHHH
T ss_pred ccccCHhHhcCCCCCchHhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHhh---ccCCCcchhcccCCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999998876655433211 111111112245678999999999
Q ss_pred hccCCCCCCC-CHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRP-RFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rp-s~~el~~~L~~~~ 263 (434)
||+.||++|| +++++...|++..
T Consensus 251 ~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 251 ATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HhcCCHhHccccHHHHHHHHHHHH
Confidence 9999999999 8999988888753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=312.62 Aligned_cols=202 Identities=19% Similarity=0.286 Sum_probs=168.7
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.+|||||++++++.+++..++||||+++|+|..++.+. ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 110 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~ 182 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 182 (396)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred CCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHH
Confidence 38999999999999999999999999999999999843 46999999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
|||++.++.+||+|||+++...... ......+||+.|
T Consensus 183 NILl~~~g~ikL~DFGla~~~~~~~-------------------------------------------~~~~~~~gt~~Y 219 (396)
T 4dc2_A 183 NVLLDSEGHIKLTDYGMCKEGLRPG-------------------------------------------DTTSTFCGTPNY 219 (396)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT-------------------------------------------CCBCCCCBCGGG
T ss_pred HEEECCCCCEEEeecceeeecccCC-------------------------------------------CccccccCCccc
Confidence 9999999999999999976411100 112456789999
Q ss_pred cchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh---------HHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN---------EQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 164 ~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
+|||++.+..++.++|||||||++|||+ +|..||..... ....+.+. ......+..+++++
T Consensus 220 ~aPE~l~~~~~~~~~DiwslGvllyell--~G~~Pf~~~~~~~~~~~~~~~~~~~~i~--------~~~~~~p~~~s~~~ 289 (396)
T 4dc2_A 220 IAPEILRGEDYGFSVDWWALGVLMFEMM--AGRSPFDIVGSSDNPDQNTEDYLFQVIL--------EKQIRIPRSLSVKA 289 (396)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSSTTTTC------CCHHHHHHHHH--------HCCCCCCTTSCHHH
T ss_pred CCchhhcCCCCChHHHHHHHHHHHHHHH--hCCCCCcccccccccchhhHHHHHHHHh--------ccccCCCCcCCHHH
Confidence 9999999999999999999999999999 89999964321 11222221 12334567789999
Q ss_pred HHHHHHhccCCCCCCCCH------HHH--HHHHHhcccC
Q psy5690 235 FDLMLECWKTNETDRPRF------SEI--HLFLQRKNLG 265 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~------~el--~~~L~~~~~~ 265 (434)
.+||.+||+.||++||++ +|| |+||+..++.
T Consensus 290 ~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp HHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred HHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 999999999999999985 677 8899876543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=307.51 Aligned_cols=203 Identities=22% Similarity=0.304 Sum_probs=171.3
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+|||||
T Consensus 76 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlk 148 (327)
T 3a62_A 76 EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLHQKGIIYRDLK 148 (327)
T ss_dssp HHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCC
Confidence 4689999999999999999999999999999999999743 468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .......||+
T Consensus 149 p~Nill~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~ 185 (327)
T 3a62_A 149 PENIMLNHQGHVKLTDFGLCKESIHDG-------------------------------------------TVTHTFCGTI 185 (327)
T ss_dssp TTTEEECTTSCEEECCCSCC-----------------------------------------------------CTTSSCC
T ss_pred HHHeEECCCCcEEEEeCCcccccccCC-------------------------------------------ccccccCCCc
Confidence 999999999999999999975421100 0113456889
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+... ....+..+++++.+++.+|
T Consensus 186 ~y~aPE~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~i~~~--------~~~~p~~~~~~~~~li~~~ 255 (327)
T 3a62_A 186 EYMAPEILMRSGHNRAVDWWSLGALMYDML--TGAPPFTGENRKKTIDKILKC--------KLNLPPYLTQEARDLLKKL 255 (327)
T ss_dssp TTSCHHHHTTSCCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHT--------CCCCCTTSCHHHHHHHHHH
T ss_pred CccCHhhCcCCCCCCcccchhHHHHHHHHH--HCCCCCCCCCHHHHHHHHHhC--------CCCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999999 899999998877776655431 2234567889999999999
Q ss_pred ccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 242 WKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 242 l~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
|+.||++|| +++|+ |+||+..++
T Consensus 256 L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 256 LKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp SCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred HhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 999999999 78888 789876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=305.00 Aligned_cols=205 Identities=33% Similarity=0.620 Sum_probs=170.3
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++. ++..++||||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+|||||
T Consensus 70 ~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dik 142 (325)
T 3kex_A 70 GSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQH------RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142 (325)
T ss_dssp HTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSS------GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred hcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHc------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 4689999999999986 56799999999999999999732 2468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .........+|.
T Consensus 143 p~Nil~~~~~~~kl~Dfg~a~~~~~~~-----------------------------------------~~~~~~~~~~~~ 181 (325)
T 3kex_A 143 ARNVLLKSPSQVQVADFGVADLLPPDD-----------------------------------------KQLLYSEAKTPI 181 (325)
T ss_dssp STTEEESSSSCEEECSCSGGGGSCCCT-----------------------------------------TCCC-----CCT
T ss_pred hheEEECCCCeEEECCCCcccccCccc-----------------------------------------ccccccCCCCcc
Confidence 999999999999999999986532211 001123345677
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..++.++|||||||++|+|+ + |..||.+....+....+.. ......+..++.++.+++.+
T Consensus 182 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~ 252 (325)
T 3kex_A 182 KWMALESIHFGKYTHQSDVWSYGVTVWELM--TFGAEPYAGLRLAEVPDLLEK-------GERLAQPQICTIDVYMVMVK 252 (325)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCTTTTSCTTHHHHHHHT-------TCBCCCCTTBCTTTTHHHHH
T ss_pred cccChHHhccCCCChhhHhHHhHHHHHHHH--hCCCCCccccCHHHHHHHHHc-------CCCCCCCCcCcHHHHHHHHH
Confidence 899999999999999999999999999999 7 9999998877666554432 22344466678899999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
||+.||++||++.++++.|++..
T Consensus 253 ~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 253 CWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HcCCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999998763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=309.65 Aligned_cols=200 Identities=19% Similarity=0.258 Sum_probs=168.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++.+++..++||||+ +|+|.+++... ..+++..+..++.||+.||+|||++||+||||
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dl 134 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCC
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence 46789999999999999999999999999 68999999733 46999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ......||
T Consensus 135 kp~NIll~~~~~~kl~DFG~s~~~~~~~--------------------------------------------~~~~~~gt 170 (336)
T 3h4j_B 135 KPENLLLDDNLNVKIADFGLSNIMTDGN--------------------------------------------FLKTSCGS 170 (336)
T ss_dssp STTTEEECTTCCEEECCSSCTBTTTTSB--------------------------------------------TTCCCTTS
T ss_pred chhhEEEcCCCCEEEEEeccceeccCCc--------------------------------------------ccccccCC
Confidence 9999999999999999999976421111 12345688
Q ss_pred ccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+..+ +.++|||||||++|+|+ +|..||.+....+.... ........+..+++++.+++.
T Consensus 171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~Pf~~~~~~~~~~~--------i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVML--VGRLPFDDEFIPNLFKK--------VNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp TTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHH--HSSCSSBCSSSTTCBCC--------CCSSCCCCCTTSCHHHHHHHH
T ss_pred cCcCCHHHHcCCCCCCCccchhHHHHHHHHHH--hCCCCCCCccHHHHHHH--------HHcCCCCCcccCCHHHHHHHH
Confidence 99999999988776 78999999999999999 89999987654433221 122233446678899999999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+||+.||.+|||++|+ |+||+..
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999999999999 8999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.98 Aligned_cols=205 Identities=20% Similarity=0.250 Sum_probs=168.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 60 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlk 132 (323)
T 3tki_A 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-------PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132 (323)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB-------TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 46899999999999999999999999999999999986 44579999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .........||+
T Consensus 133 p~NIll~~~~~~kl~Dfg~a~~~~~~~-----------------------------------------~~~~~~~~~gt~ 171 (323)
T 3tki_A 133 PENLLLDERDNLKISDFGLATVFRYNN-----------------------------------------RERLLNKMCGTL 171 (323)
T ss_dssp GGGEEECTTCCEEECCCTTCEECEETT-----------------------------------------EECCBCSCCSCG
T ss_pred hHHEEEeCCCCEEEEEeeccceeccCC-----------------------------------------cccccCCCccCc
Confidence 999999999999999999976522111 011123457889
Q ss_pred cccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 162 ~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
.|+|||++.+..+ +.++|||||||++|+|+ +|..||....... ...... ......+....+++++.+|+.
T Consensus 172 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~ 243 (323)
T 3tki_A 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAML--AGELPWDQPSDSCQEYSDWK------EKKTYLNPWKKIDSAPLALLH 243 (323)
T ss_dssp GGSCHHHHHCSSBCHHHHHHHHHHHHHHHHH--HSSCSCSSSCTTSHHHHHHH------TTCTTSTTGGGSCHHHHHHHH
T ss_pred CccCcHHhccCCCCCCcccHHHHHHHHHHHH--hCCCCCCCCchHHHHHHHHh------cccccCCccccCCHHHHHHHH
Confidence 9999999988776 77899999999999999 8999998765432 221111 111222234567899999999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+||+.||++|||++|+ |+|+++.
T Consensus 244 ~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 244 KILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHccCChhhCcCHHHHhhChhhccc
Confidence 9999999999999999 7888764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.44 Aligned_cols=206 Identities=34% Similarity=0.630 Sum_probs=175.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++. ++..++||||+++|+|.++++... ...+++..+..++.||+.||+|||++||+||||
T Consensus 237 l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDl 310 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310 (454)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred HhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 57899999999999986 667999999999999999997321 235788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... +.......+|
T Consensus 311 kp~Nill~~~~~~kl~DFG~a~~~~~~~------------------------------------------~~~~~~~~~~ 348 (454)
T 1qcf_A 311 RAANILVSASLVCKIADFGLARVIEDNE------------------------------------------YTAREGAKFP 348 (454)
T ss_dssp SGGGEEECTTCCEEECSTTGGGGBCCHH------------------------------------------HHTTCSSSSC
T ss_pred CHHHEEECCCCcEEEeeCCCceEcCCCc------------------------------------------eeccCCCccc
Confidence 9999999999999999999986532211 1112334567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++....++.++|||||||++|||+ + |..||.+....+....+.. ....+.+..+++++.++|.
T Consensus 349 ~~y~aPE~~~~~~~~~~~DvwslG~~l~el~--t~g~~P~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~ 419 (454)
T 1qcf_A 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIV--TYGRIPYPGMSNPEVIRALER-------GYRMPRPENCPEELYNIMM 419 (454)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCSSTTCCHHHHHHHHHH-------TCCCCCCTTSCHHHHHHHH
T ss_pred ccccCHHHhccCCCCcHHHHHhHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHH
Confidence 8899999999999999999999999999999 6 8999999888777665542 2345557788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+||+.||++|||+++|...|++..
T Consensus 420 ~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 420 RCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHccCChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999853
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=297.37 Aligned_cols=201 Identities=22% Similarity=0.350 Sum_probs=172.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dl 135 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSKRVIHRDI 135 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCC
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCEecccC
Confidence 46789999999999999999999999999999999999743 46899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||++...... ......|+
T Consensus 136 kp~Nili~~~~~~~l~Dfg~~~~~~~~---------------------------------------------~~~~~~~~ 170 (279)
T 3fdn_A 136 KPENLLLGSAGELKIADFGWSVHAPSS---------------------------------------------RRTDLCGT 170 (279)
T ss_dssp CGGGEEECTTSCEEECSCCEESCC-----------------------------------------------------CCC
T ss_pred ChHhEEEcCCCCEEEEeccccccCCcc---------------------------------------------cccccCCC
Confidence 999999999999999999986431111 11234578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||.+.+..++.++||||||+++|+|+ +|..||......+....+.. .....+..+++++.+++.+
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL--VGKPPFEANTYQETYKRISR--------VEFTFPDFVTEGARDLISR 240 (279)
T ss_dssp CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHH--------TCCCCCTTSCHHHHHHHHH
T ss_pred CCccCHhHhccCCCCccchhHhHHHHHHHHH--HCCCCCCCCcHHHHHHHHHh--------CCCCCCCcCCHHHHHHHHH
Confidence 8899999999999999999999999999999 89999998887776655432 1233456688999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||+.||++||+++|+ |+|++...
T Consensus 241 ~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 241 LLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp HCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred HhccChhhCCCHHHHhhCccccCCc
Confidence 999999999999999 89998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=294.90 Aligned_cols=205 Identities=34% Similarity=0.655 Sum_probs=174.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++...+ ..+++..++.++.|++.||+|||++||+|||||
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik 131 (268)
T 3sxs_A 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131 (268)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCS
T ss_pred HhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcC
Confidence 46899999999999999999999999999999999997432 358999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... ........+|.
T Consensus 132 p~Nil~~~~~~~~l~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~~ 169 (268)
T 3sxs_A 132 ARNCLVDRDLCVKVSDFGMTRYVLDDQ------------------------------------------YVSSVGTKFPV 169 (268)
T ss_dssp GGGEEECTTCCEEECCTTCEEECCTTC------------------------------------------EEECCSCCCCG
T ss_pred cceEEECCCCCEEEccCccceecchhh------------------------------------------hhcccCCCcCc
Confidence 999999999999999999976532211 11123445677
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||.+.+..++.++||||||+++|+|+ + |..||......+....+.. ......+..+++++.+++.+
T Consensus 170 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~ 240 (268)
T 3sxs_A 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVF--SLGKMPYDLYTNSEVVLKVSQ-------GHRLYRPHLASDTIYQIMYS 240 (268)
T ss_dssp GGCCHHHHHHSEEETTHHHHHHHHHHHHHH--TTTCCTTTTSCHHHHHHHHHT-------TCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCHHHHhccCCchhhhhHHHHHHHHHHH--cCCCCCccccChHHHHHHHHc-------CCCCCCCCcChHHHHHHHHH
Confidence 899999999989999999999999999999 7 8999998887776655432 22334456678999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
||+.||++|||+.|+++.|++..
T Consensus 241 ~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 241 CWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TTCSSGGGSCCHHHHHHHHGGGC
T ss_pred HcCCChhhCcCHHHHHHHHHHhh
Confidence 99999999999999999998763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=309.08 Aligned_cols=211 Identities=34% Similarity=0.646 Sum_probs=177.1
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
++ +||||+++++++.+++..++||||+++|+|.+++...... ......+++..++.++.||+.||+|||+
T Consensus 130 ~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 209 (382)
T 3tt0_A 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209 (382)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 35 8999999999999999999999999999999999865421 1123469999999999999999999999
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
+||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 210 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----------------------------------------~~~ 248 (382)
T 3tt0_A 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----------------------------------------YYK 248 (382)
T ss_dssp TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCC-----------------------------------------TTC
T ss_pred CCEecCCCCcceEEEcCCCcEEEcccCccccccccc-----------------------------------------ccc
Confidence 999999999999999999999999999976532211 111
Q ss_pred cCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 153 SDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
......+|+.|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ......+..++
T Consensus 249 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ell--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 319 (382)
T 3tt0_A 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF--TLGGSPYPGVPVEELFKLLKE-------GHRMDKPSNCT 319 (382)
T ss_dssp CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH--TTSCCSSTTCCHHHHHHHHHT-------TCCCCCCSSCC
T ss_pred cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCccCC
Confidence 223445678899999999999999999999999999999 6 8999999887777655432 22344567788
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+++.+++.+||+.||++|||++||++.|++..
T Consensus 320 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 320 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=308.12 Aligned_cols=204 Identities=20% Similarity=0.217 Sum_probs=170.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 69 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlk 141 (326)
T 2y0a_A 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA-------EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLK 141 (326)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT-------TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH-------hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCC
Confidence 46899999999999999999999999999999999997 44579999999999999999999999999999999
Q ss_pred CCCeeeecCC----ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 82 ARNCMVGKNY----TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 82 p~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|+|||++.++ .+||+|||+++...... .....
T Consensus 142 p~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~ 177 (326)
T 2y0a_A 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--------------------------------------------EFKNI 177 (326)
T ss_dssp GGGEEESCSSSSSCCEEECCCTTCEECCTTS--------------------------------------------CCCCC
T ss_pred HHHEEEecCCCCCCCEEEEECCCCeECCCCC--------------------------------------------ccccc
Confidence 9999998877 79999999976521110 11335
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|+|||++.+..++.++|||||||++|+|+ +|..||.+....+....+.... ..........+++.+.++
T Consensus 178 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l 251 (326)
T 2y0a_A 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL--SGASPFLGDTKQETLANVSAVN----YEFEDEYFSNTSALAKDF 251 (326)
T ss_dssp CSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSCCSSCCSSHHHHHHHHHHTC----CCCCHHHHTTSCHHHHHH
T ss_pred cCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHH--HCcCCCCCCCHHHHHHHHHhcC----CCcCccccccCCHHHHHH
Confidence 6889999999999999999999999999999999 8999999888777665543211 011111124567899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+||+.||++|||++|+ |+||+..
T Consensus 252 i~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 252 IRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HHHHccCChhhCCCHHHHhcCCCccCC
Confidence 999999999999999999 6788654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=301.14 Aligned_cols=202 Identities=24% Similarity=0.345 Sum_probs=166.5
Q ss_pred CCCCCCCCeeeEEEEEec--CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++.+ ++..++||||+++|+|.+++ ....+++..+..++.||+.||+|||++||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--------TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--------CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 357899999999999986 56799999999999998764 33469999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+|||++.++.+||+|||+++...... .......
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~ 198 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSD-------------------------------------------ALLSNTV 198 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSS-------------------------------------------CEECCCC
T ss_pred CCCHHHEEECCCCCEEEecCCCcccccccc-------------------------------------------ccccCCc
Confidence 999999999999999999999976532111 0113346
Q ss_pred CCccccchhhhhcCC---CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 159 LPIRWMAWESLLLGK---NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 159 gt~~y~aPE~~~~~~---~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
||+.|+|||++.+.. ++.++|||||||++|+|+ +|..||...........+.. .....+....+++++.
T Consensus 199 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~--~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~ 270 (298)
T 2zv2_A 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV--FGQCPFMDERIMCLHSKIKS------QALEFPDQPDIAEDLK 270 (298)
T ss_dssp SCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH------CCCCCCSSSCCCHHHH
T ss_pred CCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH--HCCCCCCCccHHHHHHHHhc------ccCCCCCccccCHHHH
Confidence 889999999998765 377899999999999999 89999998877665544432 1122233456889999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+++.+||+.||++||+++|+ |+|+++
T Consensus 271 ~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 271 DLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 99999999999999999999 888863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=312.53 Aligned_cols=204 Identities=21% Similarity=0.323 Sum_probs=170.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++++|.+.+..++||||+.||+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDl 141 (384)
T 4fr4_A 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ-------QNVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141 (384)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH-------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 357899999999999999999999999999999999998 4457999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++..... .......||
T Consensus 142 kp~NIll~~~g~vkL~DFG~a~~~~~~--------------------------------------------~~~~~~~gt 177 (384)
T 4fr4_A 142 KPDNILLDEHGHVHITDFNIAAMLPRE--------------------------------------------TQITTMAGT 177 (384)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTT--------------------------------------------CCBCCCCSC
T ss_pred cHHHeEECCCCCEEEeccceeeeccCC--------------------------------------------CceeccCCC
Confidence 999999999999999999997652111 012446789
Q ss_pred ccccchhhhhc---CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh---HHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 161 IRWMAWESLLL---GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN---EQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 161 ~~y~aPE~~~~---~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
+.|+|||++.. ..++.++|||||||++|||+ +|..||..... .+....+. ......+..+++++
T Consensus 178 ~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ell--tG~~Pf~~~~~~~~~~~~~~~~--------~~~~~~p~~~s~~~ 247 (384)
T 4fr4_A 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL--RGRRPYHIRSSTSSKEIVHTFE--------TTVVTYPSAWSQEM 247 (384)
T ss_dssp GGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHH--HSSCSSCCCTTSCHHHHHHHHH--------HCCCCCCTTSCHHH
T ss_pred ccccCCeeeccCCCCCCCccceeechHHHHHHHH--hCCCCCCCCCCccHHHHHHHHh--------hcccCCCCcCCHHH
Confidence 99999999974 45899999999999999999 89999975433 22222221 12334467788999
Q ss_pred HHHHHHhccCCCCCCCC-HHHH--HHHHHhcccC
Q psy5690 235 FDLMLECWKTNETDRPR-FSEI--HLFLQRKNLG 265 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps-~~el--~~~L~~~~~~ 265 (434)
.+||.+||+.||++||+ ++++ |+|++..++.
T Consensus 248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 99999999999999998 8888 7899876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=308.14 Aligned_cols=200 Identities=19% Similarity=0.293 Sum_probs=166.9
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+++..|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 140 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 140 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHH
Confidence 8999999999999999999999999999999999743 468999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.++.+||+|||+++...... .......||+.|+
T Consensus 141 Ill~~~g~~kL~DFG~a~~~~~~~-------------------------------------------~~~~~~~gt~~y~ 177 (345)
T 3a8x_A 141 VLLDSEGHIKLTDYGMCKEGLRPG-------------------------------------------DTTSTFCGTPNYI 177 (345)
T ss_dssp EEECTTSCEEECCGGGCBCSCCTT-------------------------------------------CCBCCCCSCGGGC
T ss_pred EEECCCCCEEEEeccccccccCCC-------------------------------------------CcccccCCCcccc
Confidence 999999999999999976421100 0123457899999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC---------hHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT---------NEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
|||++.+..++.++|||||||++|||+ +|..||.... .......+. ......+..+++++.
T Consensus 178 aPE~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~i~--------~~~~~~p~~~s~~~~ 247 (345)
T 3a8x_A 178 APEILRGEDYGFSVDWWALGVLMFEMM--AGRSPFDIVGSSDNPDQNTEDYLFQVIL--------EKQIRIPRSLSVKAA 247 (345)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCTTTTTTC-------CHHHHHHHHH--------HCCCCCCTTSCHHHH
T ss_pred CccccCCCCCChHHhHHHHHHHHHHHH--hCCCCcCCcccccccccccHHHHHHHHH--------cCCCCCCCCCCHHHH
Confidence 999999999999999999999999999 8999997532 122222221 122334667889999
Q ss_pred HHHHHhccCCCCCCCCH------HHH--HHHHHhccc
Q psy5690 236 DLMLECWKTNETDRPRF------SEI--HLFLQRKNL 264 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~------~el--~~~L~~~~~ 264 (434)
+++.+||+.||++||++ +|+ |+|++...+
T Consensus 248 ~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp HHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred HHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 99999999999999985 677 899987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=297.91 Aligned_cols=205 Identities=38% Similarity=0.742 Sum_probs=163.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++ .++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||
T Consensus 70 l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 142 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR------KYSLDLASLILYAYQLSTALAYLESKRFVHRDI 142 (281)
T ss_dssp HHTCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHT------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 3578999999999998 456789999999999999999742 246899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........+|
T Consensus 143 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 180 (281)
T 1mp8_A 143 AARNVLVSSNDCVKLGDFGLSRYMEDST------------------------------------------YYKASKGKLP 180 (281)
T ss_dssp SGGGEEEEETTEEEECC-------------------------------------------------------------CC
T ss_pred cHHHEEECCCCCEEECccccccccCccc------------------------------------------ccccccCCCc
Confidence 9999999999999999999976532211 0111233456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||++ +|..||......+....+.. ....+.+..+++++.+++.+
T Consensus 181 ~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~-~g~~pf~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~~ 252 (281)
T 1mp8_A 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILM-HGVKPFQGVKNNDVIGRIEN-------GERLPMPPNCPPTLYSLMTK 252 (281)
T ss_dssp GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT-TSCCTTTTCCGGGHHHHHHT-------TCCCCCCTTCCHHHHHHHHH
T ss_pred ccccChhhcccCCCCCccCchHHHHHHHHHHh-cCCCCCCcCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHHH
Confidence 78999999999999999999999999999993 28999998877666554432 22344567889999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++||++.|+.+.|++.
T Consensus 253 ~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 253 CWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred HccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999888775
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=316.24 Aligned_cols=201 Identities=19% Similarity=0.315 Sum_probs=173.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++||||+++++++.+.+..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDL 142 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC-------KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142 (476)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT-------SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccc
Confidence 467899999999999999999999999999999999997 4457999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ......||
T Consensus 143 kp~NIll~~~~~vkL~DFG~a~~~~~~~--------------------------------------------~~~~~~gt 178 (476)
T 2y94_A 143 KPENVLLDAHMNAKIADFGLSNMMSDGE--------------------------------------------FLRTSCGS 178 (476)
T ss_dssp SGGGEEECTTCCEEECCCSSCEECCTTC--------------------------------------------CBCCCCSC
T ss_pred cHHHEEEecCCCeEEEeccchhhccccc--------------------------------------------cccccCCC
Confidence 9999999999999999999976521110 11345688
Q ss_pred ccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+..+ +.++|||||||++|+|+ +|..||.+.........+... ....+..+++++.+|+.
T Consensus 179 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell--tG~~Pf~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALL--CGTLPFDDDHVPTLFKKICDG--------IFYTPQYLNPSVISLLK 248 (476)
T ss_dssp STTCCHHHHTTCCBCSHHHHHHHHHHHHHHHH--HSSCSSCCSSSHHHHHHHHTT--------CCCCCTTCCHHHHHHHH
T ss_pred cCeEChhhccCCCCCCCcceehhhHHHHHHHh--hCCCCCCCCCHHHHHHHHhcC--------CcCCCccCCHHHHHHHH
Confidence 99999999998776 68999999999999999 899999988877776655421 22335667899999999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+||+.||++|||++|+ |+|+++.
T Consensus 249 ~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999 8899864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=313.00 Aligned_cols=220 Identities=15% Similarity=0.238 Sum_probs=167.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++|||||++++++.+++..++||||+++|+|.+++... ....+++..+..++.||+.||+|||++||+|||||
T Consensus 81 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk 155 (389)
T 3gni_B 81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH-----FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVK 155 (389)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT-----CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh-----cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 5689999999999999999999999999999999999743 23468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||.+......... ............||.
T Consensus 156 p~NIll~~~~~~kl~dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~~gt~ 199 (389)
T 3gni_B 156 ASHILISVDGKVYLSGLRSNLSMISHGQR------------------------------------QRVVHDFPKYSVKVL 199 (389)
T ss_dssp GGGEEECTTCCEEECCGGGCEECEETTEE------------------------------------CSCBCCCCTTCTTTG
T ss_pred HHHEEEcCCCCEEEcccccceeecccccc------------------------------------ccccccccccccccc
Confidence 99999999999999999986542211100 000001123346888
Q ss_pred cccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc----------------------
Q psy5690 162 RWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN---------------------- 217 (434)
Q Consensus 162 ~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~---------------------- 217 (434)
.|+|||++.+ ..++.++|||||||++|||+ +|..||.+.+..+...........
T Consensus 200 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (389)
T 3gni_B 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELA--NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVA 277 (389)
T ss_dssp GGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH--HSSCTTTTCCSTTHHHHC----------------------------
T ss_pred cccCHHHHhccCCCCCcHhHHHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccc
Confidence 9999999987 57899999999999999999 899999876554443222110000
Q ss_pred ----------------CCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 218 ----------------NSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 218 ----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
.......+.+..+++++.+||.+||+.||++|||++|+ |+||++...
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 278 NSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp ----------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred ccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 00000112345577899999999999999999999999 899987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=316.25 Aligned_cols=203 Identities=32% Similarity=0.626 Sum_probs=171.8
Q ss_pred CCCCCCCCeeeEEEEEecCC-ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++||||+++++++.+.+ ..++||||+++|+|.++++..+ ...+++..+..++.||+.||+|||++||+|||
T Consensus 240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrD 314 (450)
T 1k9a_A 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314 (450)
T ss_dssp HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHC-----TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 46789999999999987665 7999999999999999998542 23478999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++..... .....+
T Consensus 315 lkp~Nill~~~~~~kl~DfG~a~~~~~~----------------------------------------------~~~~~~ 348 (450)
T 1k9a_A 315 LAARNVLVSEDNVAKVSDFGLTKEASST----------------------------------------------QDTGKL 348 (450)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECC----------------------------------------------------CC
T ss_pred CCHhhEEECCCCCEEEeeCCCccccccc----------------------------------------------ccCCCC
Confidence 9999999999999999999997641110 112245
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
+..|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. +...+.+..+++++.++|
T Consensus 349 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~--t~g~~P~~~~~~~~~~~~i~~-------~~~~~~p~~~~~~l~~li 419 (450)
T 1k9a_A 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIY--SFGRVPYPRIPLKDVVPRVEK-------GYKMDAPDGCPPAVYDVM 419 (450)
T ss_dssp CTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHH--TTTCCSSTTSCTTTHHHHHHT-------TCCCCCCTTCCHHHHHHH
T ss_pred CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCCcCCHHHHHHH
Confidence 67899999999999999999999999999999 6 8999998877666654432 234556778999999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+||+.||++|||+.++...|++..
T Consensus 420 ~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 420 KNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999888753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.91 Aligned_cols=207 Identities=40% Similarity=0.747 Sum_probs=176.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++++|.+++..++||||+++|+|.++++.. ....+++..++.++.||+.||+|||++||+||||
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 344 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-----NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-----CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc-----CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 35689999999999999999999999999999999999743 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... +.......+|
T Consensus 345 kp~NIll~~~~~~kl~DFG~a~~~~~~~------------------------------------------~~~~~~~~~~ 382 (495)
T 1opk_A 345 AARNCLVGENHLVKVADFGLSRLMTGDT------------------------------------------YTAHAGAKFP 382 (495)
T ss_dssp SGGGEEECGGGCEEECCTTCEECCTTCC------------------------------------------EECCTTCCCC
T ss_pred ChhhEEECCCCcEEEeecccceeccCCc------------------------------------------eeecCCCcCC
Confidence 9999999999999999999986532111 1122344567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+..++.++|||||||++|||+ + |..||.+....+..+.+. .....+.+..+++++.+||.
T Consensus 383 ~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~--t~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~ 453 (495)
T 1opk_A 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIA--TYGMSPYPGIDLSQVYELLE-------KDYRMERPEGCPEKVYELMR 453 (495)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHH--TTSCCSSTTCCGGGHHHHHH-------TTCCCCCCTTCCHHHHHHHH
T ss_pred cceeCHhHHhcCCCCcHHhHHhHHHHHHHHH--hCCCCCCCCCCHHHHHHHHH-------cCCCCCCCCCCCHHHHHHHH
Confidence 8899999999999999999999999999999 6 899999887766655443 22344557788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+||+.||++|||+.+|++.|+...
T Consensus 454 ~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 454 ACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHcCcChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.31 Aligned_cols=205 Identities=33% Similarity=0.659 Sum_probs=170.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||++++++|.++ ..++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+|||||
T Consensus 72 ~~l~h~~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dik 144 (327)
T 3poz_A 72 ASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144 (327)
T ss_dssp HHCCBTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHS------TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhCCCCCEeEEEEEEecC-CeEEEEEecCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCC
Confidence 468999999999999875 488999999999999999743 3568999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .........+|.
T Consensus 145 p~NIll~~~~~~kl~Dfg~a~~~~~~~-----------------------------------------~~~~~~~~~~t~ 183 (327)
T 3poz_A 145 ARNVLVKTPQHVKITDFGLAKLLGAEE-----------------------------------------KEYHAEGGKVPI 183 (327)
T ss_dssp GGGEEEEETTEEEECCTTHHHHHTTTC-----------------------------------------C-------CCCG
T ss_pred hheEEECCCCCEEEccCcceeEccCCc-----------------------------------------ccccccCCCccc
Confidence 999999999999999999986532211 011123345678
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..++.++|||||||++|||+ + |..||......+....+. .....+.+..++.++.+++.+
T Consensus 184 ~y~aPE~~~~~~~~~~~Di~slG~il~ell--t~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~ 254 (327)
T 3poz_A 184 KWMALESILHRIYTHQSDVWSYGVTVWELM--TFGSKPYDGIPASEISSILE-------KGERLPQPPICTIDVYMIMVK 254 (327)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCTTTTCCGGGHHHHHH-------TTCCCCCCTTBCHHHHHHHHH
T ss_pred cccChHHhccCCCCchhhhhhhHHHHHHHH--hcCCCCccCCCHHHHHHHHH-------cCCCCCCCccCCHHHHHHHHH
Confidence 899999999999999999999999999999 7 899999887766654443 223344567788999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
||+.||++||++.|++..|++..
T Consensus 255 ~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 255 CWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HcCCChhhCCCHHHHHHHHHHHH
Confidence 99999999999999998887753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=308.54 Aligned_cols=209 Identities=18% Similarity=0.229 Sum_probs=168.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++|||||++|+|.+++.... .....+++..+..++.||+.||+|||++||+|||||
T Consensus 81 ~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlk 157 (351)
T 3c0i_A 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA---DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVK 157 (351)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhc---ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence 46899999999999999999999999999999998886432 123468999999999999999999999999999999
Q ss_pred CCCeeeecCCc---eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGKNYT---IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||++.++. +||+|||+++...... .......
T Consensus 158 p~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~-------------------------------------------~~~~~~~ 194 (351)
T 3c0i_A 158 PHCVLLASKENSAPVKLGGFGVAIQLGESG-------------------------------------------LVAGGRV 194 (351)
T ss_dssp GGGEEECSSSTTCCEEECCCTTCEECCTTS-------------------------------------------CBCCCCC
T ss_pred hHHeEEecCCCCCcEEEecCcceeEecCCC-------------------------------------------eeecCCc
Confidence 99999987654 9999999976532111 0123456
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|+|||++.+..++.++|||||||++|+|+ +|..||.+.. .+....+... ...........+++++.+++
T Consensus 195 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~-~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li 267 (351)
T 3c0i_A 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILL--SGCLPFYGTK-ERLFEGIIKG----KYKMNPRQWSHISESAKDLV 267 (351)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSSCSSH-HHHHHHHHHT----CCCCCHHHHTTSCHHHHHHH
T ss_pred CCcCccCHHHHcCCCCCchHhhHHHHHHHHHHH--HCCCCCCCcH-HHHHHHHHcC----CCCCCccccccCCHHHHHHH
Confidence 889999999999999999999999999999999 8999998754 3333333211 00001111245788999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+||+.||++|||+.|+ |+|++...
T Consensus 268 ~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 268 RRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred HHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 99999999999999999 78998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=297.38 Aligned_cols=210 Identities=17% Similarity=0.255 Sum_probs=165.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 126 (288)
T 1ob3_A 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV------CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126 (288)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 4678999999999999999999999999975 99999973 2356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .......+|
T Consensus 127 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~t 163 (288)
T 1ob3_A 127 KPQNLLINREGELKIADFGLARAFGIPV-------------------------------------------RKYTHEIVT 163 (288)
T ss_dssp CGGGEEECTTSCEEECCTTHHHHHCC----------------------------------------------------CC
T ss_pred CHHHEEEcCCCCEEEeECccccccCccc-------------------------------------------ccccccccc
Confidence 9999999999999999999975421110 011234568
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc------------------
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ------------------ 221 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------ 221 (434)
+.|+|||++.+. .++.++|||||||++|||+ +|..||.+....+....+..........
T Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T 1ob3_A 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV--NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241 (288)
T ss_dssp CTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred ccccCchheeCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccc
Confidence 899999999764 5899999999999999999 8899999888766655443321110000
Q ss_pred ---cCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 222 ---QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 222 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
........+++++.+++.+||+.||++|||++|+ |+||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0001124578899999999999999999999999 7888753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.86 Aligned_cols=210 Identities=18% Similarity=0.263 Sum_probs=167.3
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 74 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dik 146 (311)
T 3niz_A 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE------NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLK 146 (311)
T ss_dssp HHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT------CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence 468999999999999999999999999975 88888863 33468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .......+|+
T Consensus 147 p~NIl~~~~~~~kl~Dfg~a~~~~~~~-------------------------------------------~~~~~~~~t~ 183 (311)
T 3niz_A 147 PQNLLINSDGALKLADFGLARAFGIPV-------------------------------------------RSYTHEVVTL 183 (311)
T ss_dssp GGGEEECTTCCEEECCCTTCEETTSCC-------------------------------------------C---CCCCCC
T ss_pred hHhEEECCCCCEEEccCcCceecCCCc-------------------------------------------ccccCCcccC
Confidence 999999999999999999976522110 0113346788
Q ss_pred cccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc-------------------
Q psy5690 162 RWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ------------------- 221 (434)
Q Consensus 162 ~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------- 221 (434)
.|+|||++.+ ..++.++|||||||++|+|+ +|..||.+....+....+..........
T Consensus 184 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (311)
T 3niz_A 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI--TGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVF 261 (311)
T ss_dssp TTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH--HSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCC
T ss_pred CcCCHHHhcCCCCCCchHHhHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccc
Confidence 9999999986 56899999999999999999 8899998877665555443322111000
Q ss_pred ---cCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 222 ---QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 222 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
........+++++.+|+.+||+.||++|||++|+ |+||++.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 262 EKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 0000123467899999999999999999999999 78998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=294.87 Aligned_cols=205 Identities=32% Similarity=0.633 Sum_probs=174.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di 146 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCG------GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCC
Confidence 35789999999999999999999999999999999999732 346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ........+|
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 184 (283)
T 3gen_A 147 AARNCLVNDQGVVKVSDFGLSRYVLDDE------------------------------------------YTSSVGSKFP 184 (283)
T ss_dssp SGGGEEECTTSCEEECSTTGGGGBCCHH------------------------------------------HHSTTSTTSC
T ss_pred ccceEEEcCCCCEEEccccccccccccc------------------------------------------cccccCCccC
Confidence 9999999999999999999976532111 1122334567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+..++.++||||||+++|+|+ + |..||......+....+.. ......+..+++.+.+++.
T Consensus 185 ~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY--SLGKMPYERFTNSETAEHIAQ-------GLRLYRPHLASEKVYTIMY 255 (283)
T ss_dssp GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH--TTTCCTTTTSCHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHH
T ss_pred cccCCHHHhccCCCCchhhHHHHHHHHHHHH--hCCCCCccccChhHHHHHHhc-------ccCCCCCCcCCHHHHHHHH
Confidence 8899999999999999999999999999999 7 9999999888777665542 2233445667899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++|||+++++..|++.
T Consensus 256 ~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 256 SCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHccCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999888764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=303.90 Aligned_cols=221 Identities=23% Similarity=0.352 Sum_probs=168.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.++++.. ...+++..+..++.|++.||+|||++||+||||
T Consensus 61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dl 134 (310)
T 3s95_A 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM------DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134 (310)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHC------CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 46889999999999999999999999999999999999742 356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++............. ..............||
T Consensus 135 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~gt 185 (310)
T 3s95_A 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR-----------------------------SLKKPDRKKRYTVVGN 185 (310)
T ss_dssp STTSEEECTTSCEEECCCTTCEECC-------------------------------------------------CCCCSC
T ss_pred CcCeEEECCCCCEEEeecccceecccccccccccc-----------------------------cccccccccccccCCC
Confidence 99999999999999999999876433221100000 0000011112356789
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||............. .........+..+++++.+++.+
T Consensus 186 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~--~g~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~ 258 (310)
T 3s95_A 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEII--GRVNADPDYLPRTMDFGLN-----VRGFLDRYCPPNCPPSFFPITVR 258 (310)
T ss_dssp GGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HTCCSSTTTSCBCTTSSBC-----HHHHHHHTCCTTCCTTHHHHHHH
T ss_pred cceeCHHHhcCCCCCcHHHHHHHHHHHHHHh--cCCCCCcchhhhHHHHhhh-----hhccccccCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999 7788876543211100000 00000111245677899999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
||+.||++|||++++.++|++..
T Consensus 259 ~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 259 CCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=299.76 Aligned_cols=216 Identities=17% Similarity=0.278 Sum_probs=172.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||++ |+|.+++...... .....+++..+..++.||+.||+|||++||+||||
T Consensus 57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl 134 (317)
T 2pmi_A 57 MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVG-NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL 134 (317)
T ss_dssp HTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSS-SCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhcccc-ccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 468999999999999999999999999998 5999999754311 12346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......+|
T Consensus 135 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~t 171 (317)
T 2pmi_A 135 KPQNLLINKRGQLKLGDFGLARAFGIPV-------------------------------------------NTFSSEVVT 171 (317)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTSCC-------------------------------------------CCCCCCCSC
T ss_pred ChHHeEEcCCCCEEECcCccceecCCCc-------------------------------------------ccCCCCccc
Confidence 9999999999999999999976521110 011334678
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc----------------c-
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ----------------Q- 222 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------~- 222 (434)
+.|+|||++.+. .++.++|||||||++|||+ +|..||.+....+....+.......... .
T Consensus 172 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (317)
T 2pmi_A 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI--TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQR 249 (317)
T ss_dssp CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCC
T ss_pred ccccCchHhhCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccc
Confidence 899999999864 6899999999999999999 8999999988777665543321110000 0
Q ss_pred ---------CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 223 ---------YLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 223 ---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.......+++++.+|+.+||+.||++|||++|+ |+||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 250 PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 001123567899999999999999999999999 88998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=309.99 Aligned_cols=207 Identities=18% Similarity=0.224 Sum_probs=172.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||
T Consensus 102 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDl 175 (387)
T 1kob_A 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA------EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175 (387)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC------TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence 4689999999999999999999999999999999999862 2346899999999999999999999999999999
Q ss_pred CCCCeeeec--CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 81 AARNCMVGK--NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 81 kp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||+|||++. ++.+||+|||+++...... ......
T Consensus 176 kp~NIll~~~~~~~vkL~DFG~a~~~~~~~--------------------------------------------~~~~~~ 211 (387)
T 1kob_A 176 KPENIMCETKKASSVKIIDFGLATKLNPDE--------------------------------------------IVKVTT 211 (387)
T ss_dssp CGGGEEESSTTCCCEEECCCTTCEECCTTS--------------------------------------------CEEEEC
T ss_pred chHHeEEecCCCCceEEEecccceecCCCc--------------------------------------------ceeeec
Confidence 999999974 5779999999976522111 012235
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+... ...........+++++.++|
T Consensus 212 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell--tg~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li 285 (387)
T 1kob_A 212 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL--SGLSPFAGEDDLETLQNVKRC----DWEFDEDAFSSVSPEAKDFI 285 (387)
T ss_dssp SSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH--HSCCSSCCSSHHHHHHHHHHC----CCCCCSSTTTTSCHHHHHHH
T ss_pred cCCCccCchhccCCCCCCcccEeeHhHHHHHHH--hCCCCCCCCCHHHHHHHHHhC----CCCCCccccccCCHHHHHHH
Confidence 788999999999999999999999999999999 899999998877766655431 11112223456789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+||+.||++|||++|+ |+|++...
T Consensus 286 ~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 286 KNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999999999999 78887643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=300.89 Aligned_cols=212 Identities=33% Similarity=0.676 Sum_probs=167.4
Q ss_pred CCCCCCCCeeeEEEEEecCCce------EEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPI------STIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~------~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++||||+++++++...+.. ++||||+++|+|.+++...... .....+++..++.++.||+.||+|||++|
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 157 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLPLQTLVRFMVDIACGMEYLSSRN 157 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcc-ccccccCHHHHHHHHHHHHHHHHHHHcCC
Confidence 4678999999999999877655 9999999999999999754311 12236899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 158 ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~-----------------------------------------~~~~~ 196 (323)
T 3qup_A 158 FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-----------------------------------------YYRQG 196 (323)
T ss_dssp CCCSCCSGGGEEECTTSCEEECCCCC------------------------------------------------------
T ss_pred cccCCCCcceEEEcCCCCEEEeeccccccccccc-----------------------------------------ccccc
Confidence 9999999999999999999999999976532211 01112
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
....+++.|+|||.+.+..++.++|||||||++|||+ + |..||.+....+....+.. ......+..++++
T Consensus 197 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 267 (323)
T 3qup_A 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM--TRGQTPYAGIENAEIYNYLIG-------GNRLKQPPECMEE 267 (323)
T ss_dssp ----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCTTTTCCGGGHHHHHHT-------TCCCCCCTTCCHH
T ss_pred ccccCcccccCchhhcCCCCCCccchhhHHHHHHHHH--hCCCCCccccChHHHHHHHhc-------CCCCCCCCccCHH
Confidence 3344677899999999999999999999999999999 6 8999998887766654432 2234456678899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+.+++.+||+.||++|||+.++.+.|++.-
T Consensus 268 l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 268 VYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=293.26 Aligned_cols=205 Identities=18% Similarity=0.192 Sum_probs=172.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+|||||
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik 132 (284)
T 3kk8_A 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-------REFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132 (284)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCC
Confidence 468999999999999999999999999999999999873 3468999999999999999999999999999999
Q ss_pred CCCeeeecCCc---eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGKNYT---IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+||+++.++. +||+|||++....... ......
T Consensus 133 p~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------~~~~~~ 168 (284)
T 3kk8_A 133 PENLLLASKAKGAAVKLADFGLAIEVNDSE--------------------------------------------AWHGFA 168 (284)
T ss_dssp GGGEEESSSSTTCCEEECCCTTCEECCSSC--------------------------------------------BCCCSC
T ss_pred HHHEEEecCCCCCcEEEeeceeeEEcccCc--------------------------------------------cccCCC
Confidence 99999986655 9999999975421111 113356
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|+|||++.+..++.++||||||+++|+|+ +|..||......+....+... ......+....+++++.+++
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~--~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li 242 (284)
T 3kk8_A 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL--VGYPPFWDEDQHRLYAQIKAG----AYDYPSPEWDTVTPEAKSLI 242 (284)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHT----CCCCCTTTTTTSCHHHHHHH
T ss_pred CCcCCcCchhhcCCCCCcccchHHHHHHHHHHH--HCCCCCCCCchhHHHHHHHhc----cccCCchhhcccCHHHHHHH
Confidence 788999999999999999999999999999999 899999998877776655431 11122233456789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+||+.||++|||++|+ |+||++..
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 243 DSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHcccChhhCCCHHHHhcCccccCCh
Confidence 99999999999999999 89998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.02 Aligned_cols=206 Identities=35% Similarity=0.631 Sum_probs=171.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+ +..++||||+++|+|.++++.. ....+++..+..++.||+.||+|||++||+||||
T Consensus 233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDl 306 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-----TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306 (452)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-----HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 356899999999999866 7799999999999999999743 1245899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........+|
T Consensus 307 kp~Nill~~~~~~kl~DfG~a~~~~~~~------------------------------------------~~~~~~~~~~ 344 (452)
T 1fmk_A 307 RAANILVGENLVCKVADFGLARLIEDNE------------------------------------------YTARQGAKFP 344 (452)
T ss_dssp SGGGEEECGGGCEEECCCCTTC--------------------------------------------------------CC
T ss_pred ChhhEEECCCCCEEECCCccceecCCCc------------------------------------------eecccCCccc
Confidence 9999999999999999999976532111 1111234567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+..++.++|||||||++|||+ + |..||.+....+....+.. ....+.+..+++++.++|.
T Consensus 345 ~~y~aPE~~~~~~~~~~sDvwslG~~l~el~--t~g~~P~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~ 415 (452)
T 1fmk_A 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELT--TKGRVPYPGMVNREVLDQVER-------GYRMPCPPECPESLHDLMC 415 (452)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTTCCSSTTCCHHHHHHHHHT-------TCCCCCCTTSCHHHHHHHH
T ss_pred ccccCHhHHhcCCCCccccHHhHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHH
Confidence 8899999999999999999999999999999 6 8999999888777665532 2345557788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+||+.||++|||+++|...|++..
T Consensus 416 ~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 416 QCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HHccCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999853
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=301.93 Aligned_cols=206 Identities=33% Similarity=0.656 Sum_probs=168.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..+ ..++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 71 l~~l~hp~iv~~~~~~~~~-~~~~v~~~~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 143 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREH------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 143 (327)
T ss_dssp HTTCCBTTBCCCCEEEESS-SEEEEECCCSSCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCeeEEEEEEecC-CceEEEEecCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCC
Confidence 4678999999999999875 488999999999999999743 356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .........+|
T Consensus 144 kp~NIl~~~~~~~kL~DfG~a~~~~~~~-----------------------------------------~~~~~~~~~~t 182 (327)
T 3lzb_A 144 AARNVLVKTPQHVKITDFGLAKLLGAEE-----------------------------------------KEYHAEGGKVP 182 (327)
T ss_dssp CGGGEEEEETTEEEECCTTC---------------------------------------------------------CCC
T ss_pred CHHHEEEcCCCCEEEccCcceeEccCcc-----------------------------------------ccccccCCCcc
Confidence 9999999999999999999986532211 00111234567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+..++.++|||||||++|||+ + |..||......+....+. .....+.+..+++++.+++.
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell--~~g~~p~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~ 253 (327)
T 3lzb_A 183 IKWMALESILHRIYTHQSDVWSYGVTVWELM--TFGSKPYDGIPASEISSILE-------KGERLPQPPICTIDVYMIMR 253 (327)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCTTTTCCGGGHHHHHH-------TTCCCCCCTTBCHHHHHHHH
T ss_pred ccccCHHHHcCCCCChHHHHHHHHHHHHHHH--HCCCCCCCCCCHHHHHHHHH-------cCCCCCCCccCCHHHHHHHH
Confidence 7899999999999999999999999999999 7 999999887776655443 22344556778899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+||+.||++||++.|+++.|++..
T Consensus 254 ~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 254 KCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=308.36 Aligned_cols=206 Identities=18% Similarity=0.193 Sum_probs=172.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||
T Consensus 140 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 213 (373)
T 2x4f_A 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE------SYNLTELDTILFMKQICEGIRHMHQMYILHLDL 213 (373)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHT------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Confidence 46899999999999999999999999999999999998632 246899999999999999999999999999999
Q ss_pred CCCCeee--ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 81 AARNCMV--GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 81 kp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||+|||+ +.++.+||+|||+++...... ......
T Consensus 214 kp~NIll~~~~~~~~kl~DFG~a~~~~~~~--------------------------------------------~~~~~~ 249 (373)
T 2x4f_A 214 KPENILCVNRDAKQIKIIDFGLARRYKPRE--------------------------------------------KLKVNF 249 (373)
T ss_dssp CGGGEEEEETTTTEEEECCCSSCEECCTTC--------------------------------------------BCCCCC
T ss_pred CHHHEEEecCCCCcEEEEeCCCceecCCcc--------------------------------------------cccccc
Confidence 9999999 456789999999976532111 112345
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.... ..........+++++.+|+
T Consensus 250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell--tg~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~li 323 (373)
T 2x4f_A 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL--SGLSPFLGDNDAETLNNILACR----WDLEDEEFQDISEEAKEFI 323 (373)
T ss_dssp SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHHTC----CCSCSGGGTTSCHHHHHHH
T ss_pred CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhcc----CCCChhhhccCCHHHHHHH
Confidence 889999999999989999999999999999999 8999999988777666554311 1111112346789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||.+||+++|+ |+||++.
T Consensus 324 ~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 324 SKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999 7899865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=294.10 Aligned_cols=200 Identities=18% Similarity=0.281 Sum_probs=172.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+|||||
T Consensus 69 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 141 (284)
T 2vgo_A 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHERKVIHRDIK 141 (284)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred hcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 5789999999999999999999999999999999999743 468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||++...... ......|+.
T Consensus 142 p~Nil~~~~~~~kl~Dfg~~~~~~~~---------------------------------------------~~~~~~~~~ 176 (284)
T 2vgo_A 142 PENLLMGYKGELKIADFGWSVHAPSL---------------------------------------------RRRTMCGTL 176 (284)
T ss_dssp GGGEEECTTCCEEECCCTTCEECSSS---------------------------------------------CBCCCCSCG
T ss_pred HHHEEEcCCCCEEEecccccccCccc---------------------------------------------ccccccCCC
Confidence 99999999999999999986441110 112346788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++||||||+++|+|+ +|..||......+....+.. .....+..+++++.+++.+|
T Consensus 177 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~ 246 (284)
T 2vgo_A 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFL--VGMPPFDSPSHTETHRRIVN--------VDLKFPPFLSDGSKDLISKL 246 (284)
T ss_dssp GGCCHHHHTTCCBCTTHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHT--------TCCCCCTTSCHHHHHHHHHH
T ss_pred CcCCHHHhccCCCCcccchhhHHHHHHHHH--HCCCCCCCCCHhHHHHHHhc--------cccCCCCcCCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999998877766554432 12234567889999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 242 WKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~~~ 263 (434)
|+.||.+||+++++ |+|++...
T Consensus 247 l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 247 LRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp SCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred hhcCHhhCCCHHHHhhCHHHHhhc
Confidence 99999999999999 78998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=299.51 Aligned_cols=213 Identities=17% Similarity=0.282 Sum_probs=169.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||++ |+|.+++... ...+++..+..++.||+.||+|||++||+||||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Di 126 (324)
T 3mtl_A 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC------GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDL 126 (324)
T ss_dssp HSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSC
T ss_pred HHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCc
Confidence 467899999999999999999999999997 5999998743 346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......+|
T Consensus 127 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~-------------------------------------------~~~~~~~~t 163 (324)
T 3mtl_A 127 KPQNLLINERGELKLADFGLARAKSIPT-------------------------------------------KTYDNEVVT 163 (324)
T ss_dssp CGGGEEECTTCCEEECSSSEEECC-------------------------------------------------------C
T ss_pred CHHHEEECCCCCEEEccCcccccccCCc-------------------------------------------cccccccCc
Confidence 9999999999999999999976421111 011234568
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccC----------------
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY---------------- 223 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------------- 223 (434)
..|+|||++.+ ..++.++|||||||++|+|+ +|..||.+.+..+....+............
T Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (324)
T 3mtl_A 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA--TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPK 241 (324)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCC
T ss_pred ccccChhhhcCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccccc
Confidence 89999999986 56799999999999999999 889999998877766555432221111000
Q ss_pred ------CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcccC
Q psy5690 224 ------LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNLG 265 (434)
Q Consensus 224 ------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~~ 265 (434)
......+++++.+|+.+||+.||++|||++|+ |+||.+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 01123467899999999999999999999999 8999987543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=296.01 Aligned_cols=210 Identities=18% Similarity=0.283 Sum_probs=164.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~di 127 (292)
T 3o0g_A 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS------CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127 (292)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 4688999999999999999999999999976 66666653 3357999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......+|
T Consensus 128 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~t 164 (292)
T 3o0g_A 128 KPQNLLINRNGELKLANFGLARAFGIPV-------------------------------------------RCYSAEVVT 164 (292)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCSCC-------------------------------------------SCCCSCCSC
T ss_pred CHHHEEEcCCCCEEEeecccceecCCcc-------------------------------------------ccccCCccc
Confidence 9999999999999999999976521110 112345678
Q ss_pred ccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCC-CCCCChHHHHHhhhhhhhcCCc------------------
Q psy5690 161 IRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRP-YAELTNEQVIENCSHWYQNNSK------------------ 220 (434)
Q Consensus 161 ~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~p-f~~~~~~~~~~~~~~~~~~~~~------------------ 220 (434)
..|+|||++.+.. ++.++|||||||++|||+ +|..| |......+....+.........
T Consensus 165 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~--~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T 3o0g_A 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA--NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp GGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT--TTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cCCcChHHHcCCCCcCchHHHHHHHHHHHHHH--HcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccc
Confidence 8999999998766 799999999999999999 66666 5555555554444322111000
Q ss_pred ---ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 221 ---QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 221 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.........+++++.+|+.+||+.||++|||++|+ |+||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 00111223578899999999999999999999999 7888764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.67 Aligned_cols=209 Identities=33% Similarity=0.637 Sum_probs=167.9
Q ss_pred CCCCeeeEEEEEecCC-ceEEEEecCCCCCHHHHHhhccCCC--------------------------------------
Q psy5690 5 KDPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNS-------------------------------------- 45 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~-------------------------------------- 45 (434)
+||||+++++++.+.+ ..++|||||++|+|.++++......
T Consensus 84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (359)
T 3vhe_A 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA 163 (359)
T ss_dssp CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence 7999999999998765 4999999999999999998543100
Q ss_pred ---------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCccccc
Q psy5690 46 ---------------------QENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSH 104 (434)
Q Consensus 46 ---------------------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~ 104 (434)
.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 00122899999999999999999999999999999999999999999999999997653
Q ss_pred ccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHH
Q psy5690 105 YESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFA 184 (434)
Q Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlG 184 (434)
.... .........+|..|+|||++.+..++.++||||||
T Consensus 244 ~~~~-----------------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 282 (359)
T 3vhe_A 244 YKDP-----------------------------------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 282 (359)
T ss_dssp TSCT-----------------------------------------TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred cccc-----------------------------------------cchhccccCCCceeEChhhhcCCCCCchhhhhhHH
Confidence 2111 11122345677889999999999999999999999
Q ss_pred HHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 185 VTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 185 vil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
|++|||+ + |..||.+....+....... .......+..+++++.+++.+||+.||++|||++|+++.|++.
T Consensus 283 ~il~ell--t~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 283 VLLWEIF--SLGASPYPGVKIDEEFCRRLK------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp HHHHHHT--TTSCCSSTTCCCSHHHHHHHH------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHH--hcCCCCCCccchhHHHHHHHH------cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 9999999 7 8999988765443322211 2223444667889999999999999999999999999988864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=288.79 Aligned_cols=201 Identities=25% Similarity=0.438 Sum_probs=169.8
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--cc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD--IV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--ii 76 (434)
|++++||||+++++++.+. +..++||||+++|+|.+++... ....+++..++.++.||+.||+|||++| |+
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~ 135 (271)
T 3kmu_A 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-----TNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135 (271)
T ss_dssp GCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC-----SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCT
T ss_pred HHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc-----ccCCCCHHHHHHHHHHHHHHHHHHhcCCCcee
Confidence 4688999999999999877 7889999999999999999732 2236899999999999999999999999 99
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+||+++.++.++|+|||++... ....
T Consensus 136 H~dikp~Nil~~~~~~~~l~~~~~~~~~------------------------------------------------~~~~ 167 (271)
T 3kmu_A 136 RHALNSRSVMIDEDMTARISMADVKFSF------------------------------------------------QSPG 167 (271)
T ss_dssp TCCCSGGGEEECTTSCEEEEGGGSCCTT------------------------------------------------SCTT
T ss_pred cCCCccceEEEcCCcceeEEeccceeee------------------------------------------------cccC
Confidence 9999999999999999999988874320 1123
Q ss_pred CCCCccccchhhhhcCCCCC---cCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTT---KSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~---~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
..+|+.|+|||++.+..++. ++|||||||++|||+ +|..||......+....+.. .......+..++++
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV--TREVPFADLSNMEIGMKVAL------EGLRPTIPPGISPH 239 (271)
T ss_dssp CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHH--HCSCTTTTSCHHHHHHHHHH------SCCCCCCCTTCCHH
T ss_pred ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHH--hCCCCccccChHHHHHHHHh------cCCCCCCCCCCCHH
Confidence 45678899999998766544 799999999999999 89999998887766544322 22334456778999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+++.+||+.||++|||++++++.|++.
T Consensus 240 ~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 240 VSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 99999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=322.76 Aligned_cols=206 Identities=33% Similarity=0.618 Sum_probs=171.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++++|.. +..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||
T Consensus 390 l~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDl 462 (613)
T 2ozo_A 390 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462 (613)
T ss_dssp HTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcC
Confidence 468999999999999976 569999999999999999963 2356999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ..........+|
T Consensus 463 kp~NILl~~~~~vkL~DFGla~~~~~~~----------------------------------------~~~~~~~~~~~~ 502 (613)
T 2ozo_A 463 AARNVLLVNRHYAKISDFGLSKALGADD----------------------------------------SYYTARSAGKWP 502 (613)
T ss_dssp SGGGEEEEETTEEEECCCSTTTTCC------------------------------------------------------C
T ss_pred CHHHEEEcCCCcEEEeeccCcccccCCC----------------------------------------ceeeeccCCCCc
Confidence 9999999999999999999986532211 001111233456
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. +...+.+..+++++.++|.
T Consensus 503 ~~y~APE~~~~~~~~~~sDvwSlGv~l~ell--t~G~~Pf~~~~~~~~~~~i~~-------~~~~~~p~~~~~~l~~li~ 573 (613)
T 2ozo_A 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEAL--SYGQKPYKKMKGPEVMAFIEQ-------GKRMECPPECPPELYALMS 573 (613)
T ss_dssp CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCTTTTCCSHHHHHHHHT-------TCCCCCCTTCCHHHHHHHH
T ss_pred cceeCHhhhcCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCCCCHHHHHHHHHc-------CCCCCCCCcCCHHHHHHHH
Confidence 7899999999999999999999999999999 6 9999999888777665542 2345567789999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++||++++|++.|+..
T Consensus 574 ~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 574 DCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999888875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=304.65 Aligned_cols=212 Identities=34% Similarity=0.630 Sum_probs=171.3
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC----------------CCCCCCCHHHHHHHHHHHHH
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS----------------QENPAISYGCLIFMATQIAS 65 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~qi~~ 65 (434)
++ +||||+++++++..++..++||||+++|+|.+++....... .....+++..++.++.||+.
T Consensus 104 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 183 (344)
T 1rjb_A 104 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183 (344)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred hhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHH
Confidence 45 89999999999999999999999999999999998543210 01134899999999999999
Q ss_pred HHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccc
Q psy5690 66 GMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSH 145 (434)
Q Consensus 66 gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 145 (434)
||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 184 aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~------------------------------------- 226 (344)
T 1rjb_A 184 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS------------------------------------- 226 (344)
T ss_dssp HHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------------------
T ss_pred HHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCc-------------------------------------
Confidence 9999999999999999999999999999999999976532111
Q ss_pred cCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCC
Q psy5690 146 YESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYL 224 (434)
Q Consensus 146 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (434)
.........+|+.|+|||++.+..++.++|||||||++|+|+ + |..||.+............ .....
T Consensus 227 ----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~--t~g~~p~~~~~~~~~~~~~~~------~~~~~ 294 (344)
T 1rjb_A 227 ----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF--SLGVNPYPGIPVDANFYKLIQ------NGFKM 294 (344)
T ss_dssp ----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT--TTSCCSSTTCCCSHHHHHHHH------TTCCC
T ss_pred ----cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH--cCCCCCcccCCcHHHHHHHHh------cCCCC
Confidence 001123344677899999999999999999999999999999 6 8999988765544332221 12234
Q ss_pred CCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 225 PRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 225 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+.+..+++++.+++.+||+.||.+|||+.++++.|+...
T Consensus 295 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 295 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 446678899999999999999999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.42 Aligned_cols=206 Identities=25% Similarity=0.313 Sum_probs=158.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+|||||
T Consensus 71 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlk 143 (361)
T 3uc3_A 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143 (361)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCC
T ss_pred HhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 4689999999999999999999999999999999999733 469999999999999999999999999999999
Q ss_pred CCCeeeecCCc--eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 82 ARNCMVGKNYT--IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 82 p~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|+|||++.++. +||+|||+++..... .......|
T Consensus 144 p~Nill~~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------~~~~~~~g 179 (361)
T 3uc3_A 144 LENTLLDGSPAPRLKICDFGYSKSSVLH--------------------------------------------SQPKSTVG 179 (361)
T ss_dssp GGGEEECSSSSCCEEECCCCCC----------------------------------------------------------
T ss_pred HHHEEEcCCCCceEEEeecCcccccccc--------------------------------------------CCCCCCcC
Confidence 99999987765 999999987531110 01133468
Q ss_pred CccccchhhhhcCCCCCc-CChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTK-SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~-sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
|+.|+|||++.+..++.+ +|||||||++|+|+ +|..||................. ......+....+++++.+||
T Consensus 180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML--VGAYPFEDPEEPRDYRKTIQRIL--SVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHH--HSSCSCC----CCCHHHHHHHHH--TTCCCCCTTSCCCHHHHHHH
T ss_pred CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHH--hCCCCCCCCccHHHHHHHHHHHh--cCCCCCCCcCCCCHHHHHHH
Confidence 899999999998887655 89999999999999 89999987544222111111010 11222333446789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||++|||+.|+ |+||.+.
T Consensus 256 ~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 256 SRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHccCChhHCcCHHHHHhCcchhcC
Confidence 99999999999999999 8999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=297.30 Aligned_cols=207 Identities=21% Similarity=0.309 Sum_probs=165.7
Q ss_pred CCCCCeeeEEEEEecCC-----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 4 LKDPNLVRVIGVCSTED-----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
++||||+++++++.... ..++||||+. |+|.+++... ....+++..+..++.||+.||+|||++||+||
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~ 144 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA-----PPPGLPAETIKDLMRQFLRGLDFLHANCIVHR 144 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC-----CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 46999999999997765 4899999997 5999999733 22349999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+|||++.++.+||+|||+++...... ......
T Consensus 145 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~~ 180 (308)
T 3g33_A 145 DLKPENILVTSGGTVKLADFGLARIYSYQM--------------------------------------------ALTPVV 180 (308)
T ss_dssp CCCTTTEEECTTSCEEECSCSCTTTSTTCC--------------------------------------------CSGGGG
T ss_pred CCCHHHEEEcCCCCEEEeeCccccccCCCc--------------------------------------------ccCCcc
Confidence 999999999999999999999976421110 113346
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCC--------------
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYL-------------- 224 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 224 (434)
||+.|+|||++.+..++.++|||||||++|||+ +|..||.+....+....+.............
T Consensus 181 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (308)
T 3g33_A 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRG 258 (308)
T ss_dssp CCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTT--TSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCC
T ss_pred ccccccCchHHcCCCCCchHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCC
Confidence 788999999999999999999999999999999 8999999988877766554322111100000
Q ss_pred -----CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 225 -----PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 225 -----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.....+++++.+|+.+||+.||++|||+.|+ |+||++.
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 259 PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred CCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0123567899999999999999999999999 7888764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=305.20 Aligned_cols=209 Identities=36% Similarity=0.682 Sum_probs=164.0
Q ss_pred CCCCCCCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++||||+++++++.. ++..++||||+++|+|.++++. ....+++..+..++.||+.||+|||++||+|||
T Consensus 144 l~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 217 (373)
T 3c1x_A 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRD 217 (373)
T ss_dssp STTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh------cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCc
Confidence 578999999999999754 5678999999999999999973 334688999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++....... ..........+
T Consensus 218 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~---------------------------------------~~~~~~~~~~~ 258 (373)
T 3c1x_A 218 LAARNCMLDEKFTVKVADFGLARDMYDKEF---------------------------------------DSVHNKTGAKL 258 (373)
T ss_dssp CCGGGEEECTTCCEEECCC------------------------------------------------------------C
T ss_pred cchheEEECCCCCEEEeecccccccccccc---------------------------------------ccccccCCCCC
Confidence 999999999999999999999865322110 00011233456
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
|+.|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ......+..+++++.+++
T Consensus 259 ~~~y~aPE~~~~~~~~~~~DvwSlG~il~ell--t~~~~p~~~~~~~~~~~~~~~-------~~~~~~p~~~~~~l~~li 329 (373)
T 3c1x_A 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELM--TRGAPPYPDVNTFDITVYLLQ-------GRRLLQPEYCPDPLYEVM 329 (373)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCSCTTSCSSCHHHHHHT-------TCCCCCCTTCCHHHHHHH
T ss_pred cccccChHHhcCCCCCcHHHHHHHHHHHHHHH--hCcCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHH
Confidence 78899999999999999999999999999999 5 7888887765554443321 223444667889999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+||+.||++||+++|+++.|++..
T Consensus 330 ~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 330 LKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.93 Aligned_cols=205 Identities=21% Similarity=0.272 Sum_probs=159.9
Q ss_pred CCCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 3 SLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
..+||||++++++|.. ++.+|+|||||++|+|.+++... ....+++..+..++.||+.||+|||++||+||
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 185 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-----GDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 3589999999999875 56789999999999999999732 23469999999999999999999999999999
Q ss_pred CCCCCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 79 DLAARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 79 Dlkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
||||+|||++. ++.+||+|||+++..... ....
T Consensus 186 Dlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--------------------------------------------~~~~ 221 (400)
T 1nxk_A 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSH--------------------------------------------NSLT 221 (400)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCTTCEECC--------------------------------------------------
T ss_pred CcCcceEEEecCCCCccEEEEecccccccCCC--------------------------------------------Cccc
Confidence 99999999987 788999999997642110 0113
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH----HHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ----VIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
...||+.|+|||++.+..++.++|||||||++|||+ +|..||....... ....+.. .......+....++
T Consensus 222 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~s 295 (400)
T 1nxk_A 222 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL--CGYPPFYSNHGLAISPGMKTRIRM----GQYEFPNPEWSEVS 295 (400)
T ss_dssp -----CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHH--HSSCSCCCCTTCSSCCSHHHHHHH----TCCCCCTTTTTTSC
T ss_pred cCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHH--hCCCCCCCCccccccHHHHHHHHc----CcccCCCcccccCC
Confidence 456788999999999999999999999999999999 8999997654322 1111111 11111122235688
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+++.+||.+||+.||++|||++|+ |+|+.+.
T Consensus 296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 999999999999999999999999 8899864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=294.92 Aligned_cols=204 Identities=35% Similarity=0.652 Sum_probs=170.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++ ..+..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+|||||
T Consensus 73 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dik 144 (291)
T 1xbb_A 73 QQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ-------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLA 144 (291)
T ss_dssp HTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH-------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh-------CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCC
Confidence 578999999999999 56788999999999999999973 3468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... ..........++.
T Consensus 145 p~Nil~~~~~~~kl~Dfg~~~~~~~~~----------------------------------------~~~~~~~~~~~~~ 184 (291)
T 1xbb_A 145 ARNVLLVTQHYAKISDFGLSKALRADE----------------------------------------NYYKAQTHGKWPV 184 (291)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCTTC----------------------------------------SEEEC----CCCG
T ss_pred cceEEEeCCCcEEEccCCcceeeccCC----------------------------------------CcccccccCCCCc
Confidence 999999999999999999976532211 0011122344678
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..++.++||||||+++|+|+ + |..||......+....+.. ......+..+++++.+++.+
T Consensus 185 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~ 255 (291)
T 1xbb_A 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAF--SYGQKPYRGMKGSEVTAMLEK-------GERMGCPAGCPREMYDLMNL 255 (291)
T ss_dssp GGCCHHHHHHCEEEHHHHHHHHHHHHHHHH--TTTCCSSTTCCHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHHH
T ss_pred eeeChHHhccCCCChhhhHHHHHHHHHHHH--hcCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHHH
Confidence 899999999988999999999999999999 7 9999999887776654432 22344567789999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++||++.++.+.|++.
T Consensus 256 ~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 256 CWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999888775
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=299.41 Aligned_cols=208 Identities=37% Similarity=0.648 Sum_probs=170.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+.+..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 173 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK------DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 173 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHT------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 35789999999999999999999999999999999999742 356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++....... .........+|
T Consensus 174 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----------------------------------------~~~~~~~~~~~ 213 (333)
T 1mqb_A 174 AARNILVNSNLVCKVSDFGLSRVLEDDPE----------------------------------------ATYTTSGGKIP 213 (333)
T ss_dssp CGGGEEECTTCCEEECCCCC---------------------------------------------------------CCC
T ss_pred ChheEEECCCCcEEECCCCcchhhccccc----------------------------------------cccccCCCCcc
Confidence 99999999999999999999765322110 00111233457
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ....+.+..+++++.+++.
T Consensus 214 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell--t~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~ 284 (333)
T 1mqb_A 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVM--TYGERPYWELSNHEVMKAIND-------GFRLPTPMDCPSAIYQLMM 284 (333)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH--TTSCCTTTTCCHHHHHHHHHT-------TCCCCCCTTCBHHHHHHHH
T ss_pred ccccCchhcccCCCCchhhhHHHHHHHHHHH--cCCCCCcccCCHHHHHHHHHC-------CCcCCCcccCCHHHHHHHH
Confidence 7899999999999999999999999999999 6 8999998887776655432 2234456678899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+||+.||++||++.++.+.|++..
T Consensus 285 ~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 285 QCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999888753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=289.98 Aligned_cols=204 Identities=35% Similarity=0.684 Sum_probs=173.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++|++|||||
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 131 (267)
T 3t9t_A 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131 (267)
T ss_dssp HTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred HhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhC------cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCc
Confidence 5789999999999999999999999999999999999743 2468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... ........++.
T Consensus 132 p~Nili~~~~~~kl~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~~ 169 (267)
T 3t9t_A 132 ARNCLVGENQVIKVSDFGMTRFVLDDQ------------------------------------------YTSSTGTKFPV 169 (267)
T ss_dssp GGGEEECGGGCEEECCTTGGGGBCCHH------------------------------------------HHSTTSTTCCG
T ss_pred hheEEECCCCCEEEccccccccccccc------------------------------------------ccccccccccc
Confidence 999999999999999999976522111 11123345677
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..++.++||||||+++|+|+ + |..||......+....+.. ......+..+++++.+++.+
T Consensus 170 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~~g~~p~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~~ 240 (267)
T 3t9t_A 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVF--SEGKIPYENRSNSEVVEDIST-------GFRLYKPRLASTHVYQIMNH 240 (267)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCTTTTCCHHHHHHHHHT-------TCCCCCCTTSCHHHHHHHHH
T ss_pred cccChhhhcCCCccchhchhhhHHHHHHHh--ccCCCCCCCCCHHHHHHHHhc-------CCcCCCCccCcHHHHHHHHH
Confidence 899999999999999999999999999999 6 8999998887776665542 12233456678999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++||+++++++.|++.
T Consensus 241 ~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 241 CWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred HccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999998875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=307.32 Aligned_cols=205 Identities=18% Similarity=0.235 Sum_probs=147.6
Q ss_pred CCC-CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 3 SLK-DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 3 ~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++. ||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 61 ~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 133 (325)
T 3kn6_A 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK-------KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133 (325)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-------HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCC
Confidence 354 9999999999999999999999999999999998 34579999999999999999999999999999999
Q ss_pred CCCeeeecCC---ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGKNY---TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||++.++ .+||+|||+++...... .......
T Consensus 134 p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-------------------------------------------~~~~~~~ 170 (325)
T 3kn6_A 134 PENLLFTDENDNLEIKIIDFGFARLKPPDN-------------------------------------------QPLKTPC 170 (325)
T ss_dssp GGGEEEEC----CEEEECCCTTCEECCC----------------------------------------------------
T ss_pred HHHEEEecCCCcccEEEeccccceecCCCC-------------------------------------------CcccccC
Confidence 9999998765 89999999976421111 0113445
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-------HHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-------EQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
||+.|+|||++.+..++.++|||||||++|+|+ +|..||..... .+....+.. .......+....++
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTML--SGQVPFQSHDRSLTCTSAVEIMKKIKK----GDFSFEGEAWKNVS 244 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHH--HSSCTTC-------CCCHHHHHHHHTT----TCCCCCSHHHHTSC
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHH--hCCCCCCCCccccccccHHHHHHHHHc----CCCCCCcccccCCC
Confidence 788999999999999999999999999999999 89999986543 223332221 00100111113578
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+++.+|+.+||+.||++|||++|+ |+|+++..
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 899999999999999999999999 89998653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=298.69 Aligned_cols=212 Identities=42% Similarity=0.682 Sum_probs=175.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---SQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
|++++||||+++++++.+++..++||||+++|+|.+++...+.. ......+++..++.++.||+.||+|||++||+|
T Consensus 82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 161 (322)
T 1p4o_A 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 161 (322)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 46789999999999999999999999999999999999753210 011245789999999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+||+++.++.+||+|||+++...... ........
T Consensus 162 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~ 200 (322)
T 1p4o_A 162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----------------------------------------YYRKGGKG 200 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCTTCCCGGGGGG-----------------------------------------CEEGGGSS
T ss_pred CCCccceEEEcCCCeEEECcCcccccccccc-----------------------------------------ccccccCC
Confidence 9999999999999999999999976532211 01112334
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
.+|+.|+|||++.+..++.++|||||||++|+|+ + |..||......+....+.. ....+.+..+++++.+
T Consensus 201 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~ 271 (322)
T 1p4o_A 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA--TLAEQPYQGLSNEQVLRFVME-------GGLLDKPDNCPDMLFE 271 (322)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--HTSCCTTTTSCHHHHHHHHHT-------TCCCCCCTTCCHHHHH
T ss_pred CCCCCccChhhhccCCCCchhhHHHHHHHHHHHH--hcCCCccccCCHHHHHHHHHc-------CCcCCCCCCCCHHHHH
Confidence 5678899999999999999999999999999999 6 8999998887776654432 2233446678899999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 237 LMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++.+||+.||++|||+.|+++.|++.
T Consensus 272 li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 272 LMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 99999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=309.10 Aligned_cols=216 Identities=13% Similarity=0.115 Sum_probs=166.2
Q ss_pred CCCCCCCeeeEEEEEecC----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 2 CSLKDPNLVRVIGVCSTE----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
+.++||||+++++++... ...++||||+ +|+|.+++... ...+++..++.++.||+.||+|||++||+|
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~------~~~l~~~~~~~i~~qi~~~l~~lH~~~iiH 175 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN------AKRFSRKTVLQLSLRILDILEYIHEHEYVH 175 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEE
Confidence 578999999999999765 4589999999 99999999742 256999999999999999999999999999
Q ss_pred cCCCCCCeeee--cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 78 RDLAARNCMVG--KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 78 rDlkp~NILl~--~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
|||||+|||++ .++.+||+|||+++........ .........
T Consensus 176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~------------------------------------~~~~~~~~~ 219 (364)
T 3op5_A 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH------------------------------------KAYAADPKR 219 (364)
T ss_dssp CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCC------------------------------------CCSSCCSSC
T ss_pred ecCCHHHEEEecCCCCeEEEEECCcceecccCCcc------------------------------------cccccCccc
Confidence 99999999999 8899999999998764322110 000011123
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHH-hhhhhhhcCCccc--CCCCCCccHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIE-NCSHWYQNNSKQQ--YLPRPATCQK 232 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~ 232 (434)
...||+.|+|||++.+..++.++|||||||++|||+ +|..||.+........ ............. .......+++
T Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~--~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (364)
T 3op5_A 220 CHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL--TGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPG 297 (364)
T ss_dssp CCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCH
T ss_pred ccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH--hCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHH
Confidence 456899999999999999999999999999999999 8999998643322211 1110000000000 0001246688
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++.+++..||+.||++||++++|.+.|++.
T Consensus 298 ~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 298 EIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 999999999999999999999999988875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=291.70 Aligned_cols=199 Identities=32% Similarity=0.549 Sum_probs=163.8
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC---cccc
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD---IVHR 78 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---iiHr 78 (434)
++++||||+++++++.+++..++||||+++|+|.+++. ...+++..++.++.|++.||+|||++| |+||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~ 132 (271)
T 3dtc_A 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132 (271)
T ss_dssp HHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCS
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeec
Confidence 45899999999999999999999999999999999985 246899999999999999999999999 8999
Q ss_pred CCCCCCeeeec--------CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 79 DLAARNCMVGK--------NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 79 Dlkp~NILl~~--------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
||||+||+++. ++.+||+|||+++.....
T Consensus 133 dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------------------------------------------- 169 (271)
T 3dtc_A 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT------------------------------------------- 169 (271)
T ss_dssp CCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------------------------------------------
T ss_pred CCchHHEEEecccccccccCcceEEccCCcccccccc-------------------------------------------
Confidence 99999999986 678999999997542111
Q ss_pred cccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc
Q psy5690 151 YLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (434)
......||+.|+|||.+.+..++.++||||||+++|+|+ +|..||...........+.. .....+.+..+
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~ 239 (271)
T 3dtc_A 170 --TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL--TGEVPFRGIDGLAVAYGVAM------NKLALPIPSTC 239 (271)
T ss_dssp --------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHH--HCCCTTTTSCHHHHHHHHHT------SCCCCCCCTTC
T ss_pred --cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHhhhc------CCCCCCCCccc
Confidence 112345788999999999999999999999999999999 89999998877665543321 22334456778
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
++++.+++.+||+.||++|||+.|+++.|++
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 8999999999999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=301.40 Aligned_cols=203 Identities=18% Similarity=0.207 Sum_probs=165.6
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+++..|+|||||++|+|.+++. ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~-------~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~N 146 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-------RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSN 146 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-------TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH-------HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHH
Confidence 79999999999999999999999999999999997 44579999999999999999999999999999999999
Q ss_pred eeeecC----CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 85 CMVGKN----YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 85 ILl~~~----~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+.++ +.+||+|||+++...... .......||
T Consensus 147 Il~~~~~~~~~~~kl~Dfg~a~~~~~~~-------------------------------------------~~~~~~~gt 183 (342)
T 2qr7_A 147 ILYVDESGNPESIRICDFGFAKQLRAEN-------------------------------------------GLLMTPCYT 183 (342)
T ss_dssp EEESSSSCSGGGEEECCCTTCEECBCTT-------------------------------------------CCBCCSSCC
T ss_pred EEEecCCCCcCeEEEEECCCcccCcCCC-------------------------------------------CceeccCCC
Confidence 998543 359999999976521110 011345678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCC---ChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAEL---TNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||... ...+....+... ........+..+++++.+|
T Consensus 184 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~Pf~~~~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~l 257 (342)
T 2qr7_A 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTML--TGYTPFANGPDDTPEEILARIGSG----KFSLSGGYWNSVSDTAKDL 257 (342)
T ss_dssp SSCCCHHHHHHHHHHHHHHHHHHHHHHHHHH--HSSCSSCSSTTSCHHHHHHHHHHC----CCCCCSTTTTTSCHHHHHH
T ss_pred ccccCHHHhcCCCCCCccCeeeHhHHHHHHh--cCCCCCCCCCcCCHHHHHHHHccC----CcccCccccccCCHHHHHH
Confidence 9999999999888899999999999999999 899999863 333444433321 1111122245688999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+.+||+.||++||+++|+ |+|+.+..
T Consensus 258 i~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 258 VSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred HHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 999999999999999999 89997643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=304.32 Aligned_cols=205 Identities=20% Similarity=0.203 Sum_probs=163.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 103 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik 175 (349)
T 2w4o_A 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV-------EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175 (349)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT-------TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 46899999999999999999999999999999999997 44568999999999999999999999999999999
Q ss_pred CCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||++. ++.+||+|||+++...... ......
T Consensus 176 p~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~~ 211 (349)
T 2w4o_A 176 PENLLYATPAPDAPLKIADFGLSKIVEHQV--------------------------------------------LMKTVC 211 (349)
T ss_dssp GGGEEESSSSTTCCEEECCCC-----------------------------------------------------------
T ss_pred cccEEEecCCCCCCEEEccCccccccCccc--------------------------------------------cccccc
Confidence 99999975 8899999999976421110 113346
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
||+.|+|||++.+..++.++|||||||++|||+ +|..||......+ ....+.. .......+....++.++.++
T Consensus 212 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~~~~l 285 (349)
T 2w4o_A 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILL--CGFEPFYDERGDQFMFRRILN----CEYYFISPWWDEVSLNAKDL 285 (349)
T ss_dssp -CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCTTCCTTCHHHHHHHHHT----TCCCCCTTTTTTSCHHHHHH
T ss_pred CCCCccCHHHhcCCCCCcccchHHHHHHHHHHH--hCCCCCCCCcccHHHHHHHHh----CCCccCCchhhhCCHHHHHH
Confidence 788999999999999999999999999999999 8899998766554 3333321 11111223345678999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+.+||+.||++|||+.|+ |+||+...
T Consensus 286 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 286 VRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999 67887643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=298.07 Aligned_cols=211 Identities=31% Similarity=0.614 Sum_probs=171.0
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN-----------SQENPAISYGCLIFMATQIASGMKYL 70 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~~~l~~~~~~~i~~qi~~gL~yL 70 (434)
++ +||||+++++++.+++..++||||+++|+|.+++...+.. ......+++..++.++.||+.||+||
T Consensus 82 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 161 (313)
T 1t46_A 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (313)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred hcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 45 8999999999999999999999999999999999854321 01123589999999999999999999
Q ss_pred hhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 71 ESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 71 H~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
|++||+||||||+||+++.++.+||+|||+++...... .
T Consensus 162 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~ 200 (313)
T 1t46_A 162 ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----------------------------------------N 200 (313)
T ss_dssp HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCT-----------------------------------------T
T ss_pred HHCCeecCCCccceEEEcCCCCEEEccccccccccccc-----------------------------------------c
Confidence 99999999999999999999999999999976532211 0
Q ss_pred cccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCc
Q psy5690 151 YLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (434)
........+|+.|+|||++.+..++.++|||||||++|+|+ + |..||.............. .......+..
T Consensus 201 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell--t~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~ 272 (313)
T 1t46_A 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF--SLGSSPYPGMPVDSKFYKMIK------EGFRMLSPEH 272 (313)
T ss_dssp SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTTCCSSTTCCSSHHHHHHHH------HTCCCCCCTT
T ss_pred ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHH--hCCCCCCCcccchhHHHHHhc------cCCCCCCccc
Confidence 11123345678899999999999999999999999999999 6 8999988765443332221 1122334567
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+++++.+++.+||+.||++|||++|+++.|++.
T Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 889999999999999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.97 Aligned_cols=204 Identities=16% Similarity=0.206 Sum_probs=169.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl 132 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-------KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDL 132 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCC
Confidence 3578999999999999999999999999999999999973 346899999999999999999999999999999
Q ss_pred CCCCeee---ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+||++ +.++.+||+|||++....... .....
T Consensus 133 kp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~--------------------------------------------~~~~~ 168 (277)
T 3f3z_A 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGK--------------------------------------------MMRTK 168 (277)
T ss_dssp SGGGEEESSSSTTCCEEECCCTTCEECCTTS--------------------------------------------CBCCC
T ss_pred CHHHEEEecCCCCCcEEEEecccceeccCcc--------------------------------------------chhcc
Confidence 9999999 778899999999875421111 11334
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.+|+.|+|||++.+. ++.++||||||+++|+|+ +|..||......+....+..... .........+++++.++
T Consensus 169 ~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l 241 (277)
T 3f3z_A 169 VGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLL--CGYPPFSAPTDSEVMLKIREGTF----TFPEKDWLNVSPQAESL 241 (277)
T ss_dssp CSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHCCC----CCCHHHHTTSCHHHHHH
T ss_pred CCCCCccChHHhccc-CCchhhehhHHHHHHHHH--HCCCCCCCCCHHHHHHHHHhCCC----CCCchhhhcCCHHHHHH
Confidence 678899999998654 899999999999999999 89999999887776665543110 00000012567899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+||+.||++||++.++ |+|+++.
T Consensus 242 i~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 242 IRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999 8999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=300.74 Aligned_cols=210 Identities=20% Similarity=0.300 Sum_probs=161.8
Q ss_pred CCCCCCCCeeeEEEEEecCCc----eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDP----ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR--- 73 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--- 73 (434)
|++++||||+++++++..+.. .++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~ 143 (322)
T 3soc_A 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYLHEDIPG 143 (322)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHTCCEEE
T ss_pred HhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhhccc
Confidence 578999999999999987543 6999999999999999963 2489999999999999999999999
Q ss_pred -------CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCcccccccc
Q psy5690 74 -------DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHY 146 (434)
Q Consensus 74 -------~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 146 (434)
||+||||||+|||++.++.+||+|||+++......
T Consensus 144 l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~-------------------------------------- 185 (322)
T 3soc_A 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK-------------------------------------- 185 (322)
T ss_dssp ETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTS--------------------------------------
T ss_pred cccccCCCEEeCCCChHhEEECCCCeEEEccCCccccccccc--------------------------------------
Confidence 99999999999999999999999999976532211
Q ss_pred CCcccccCCCCCCCccccchhhhhcC-----CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH------------HHH
Q psy5690 147 ESDYYLSDTKARLPIRWMAWESLLLG-----KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ------------VIE 209 (434)
Q Consensus 147 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~------------~~~ 209 (434)
.........||+.|+|||++.+. .++.++|||||||++|||+ +|..||.+..... ...
T Consensus 186 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~--tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 186 ---SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA--SRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ---CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH--TTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred ---CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH--hCCCCCCCCcchhccchhhhhccCCchh
Confidence 01112345688999999999873 4466889999999999999 8899987542210 000
Q ss_pred hhhhhhhcCCcccCCCC-----CCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 210 NCSHWYQNNSKQQYLPR-----PATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 210 ~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+...... ....+.. ...+++++.+++.+||+.||++|||++|+++.|++..
T Consensus 261 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 261 DMQEVVVH--KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHHTT--SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhhc--ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000001 1111111 2234567999999999999999999999999988753
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=299.07 Aligned_cols=216 Identities=24% Similarity=0.369 Sum_probs=168.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++.... .....+++..++.++.|++.||+|||++||+||||
T Consensus 89 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 165 (321)
T 2qkw_B 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD---LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDV 165 (321)
T ss_dssp GGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSC---CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccC---CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCC
Confidence 467899999999999999999999999999999999986332 12346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .........||
T Consensus 166 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~gt 204 (321)
T 2qkw_B 166 KSINILLDENFVPKITDFGISKKGTELD-----------------------------------------QTHLSTVVKGT 204 (321)
T ss_dssp CSTTEEECTTCCEEECCCTTCEECSSSS-----------------------------------------CCCCBCCCEEE
T ss_pred CHHHEEECCCCCEEEeeccccccccccc-----------------------------------------ccccccccCCC
Confidence 9999999999999999999976421110 00111334578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHH---Hhhhhhhh------cCCcccCCCCCCccH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVI---ENCSHWYQ------NNSKQQYLPRPATCQ 231 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~---~~~~~~~~------~~~~~~~~~~~~~~~ 231 (434)
..|+|||++.+..++.++|||||||++|||+ +|..||......+.. ........ ..........+..++
T Consensus 205 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (321)
T 2qkw_B 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL--CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESL 282 (321)
T ss_dssp TTTCCHHHHHHCBCCTHHHHHHHHHHHHHHH--HCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHH
T ss_pred ccccCHHHhcCCCCCcccchHhHHHHHHHHH--hCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHH
Confidence 8999999999999999999999999999999 889999765432211 10000000 001111222345677
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.++.+++.+||+.||++|||++|+++.|+..
T Consensus 283 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 283 RKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 8899999999999999999999999988875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=297.21 Aligned_cols=213 Identities=15% Similarity=0.140 Sum_probs=168.4
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++ +|+|++++++++.++...++||||+ +|+|.+++... ...+++..+..++.||+.||+|||++||+|||||
T Consensus 61 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlk 133 (298)
T 1csn_A 61 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 133 (298)
T ss_dssp HTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred HHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 35 7999999999999999999999999 99999999743 2458999999999999999999999999999999
Q ss_pred CCCeeeecCCc-----eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 82 ARNCMVGKNYT-----IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 82 p~NILl~~~~~-----~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
|+||+++.++. +||+|||+++....... .....+.....
T Consensus 134 p~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------~~~~~~~~~~~ 177 (298)
T 1csn_A 134 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT------------------------------------KQHIPYREKKN 177 (298)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTT------------------------------------CCBCCCCCCCC
T ss_pred HHHEEeccCCCCCCCeEEEEECccccccccccc------------------------------------cccccccCccC
Confidence 99999987766 99999999875332210 00011122345
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC---hHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT---NEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
..||+.|+|||++.+..++.++|||||||++|||+ +|..||.... ..+....+..... ..........++++
T Consensus 178 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 252 (298)
T 1csn_A 178 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL--RGSLPWQGLKAATNKQKYERIGEKKQ---STPLRELCAGFPEE 252 (298)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCTTSSCCSCCHHHHHHHHHHHHH---HSCHHHHTTTSCHH
T ss_pred CCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH--cCCCCcchhhccccHHHHHHHHhhcc---CccHHHHHhhCcHH
Confidence 67899999999999999999999999999999999 8999998753 2333332221111 01111113467899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+.+++.+||+.||++||++++|.+.|++..
T Consensus 253 l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 253 FYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 999999999999999999999999888753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.41 Aligned_cols=205 Identities=33% Similarity=0.617 Sum_probs=172.3
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++ ..+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||++||+|||||
T Consensus 65 ~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 137 (287)
T 1u59_A 65 HQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLA 137 (287)
T ss_dssp HHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh------CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCc
Confidence 468999999999999 55679999999999999999962 33569999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... ..........+|+
T Consensus 138 p~Nili~~~~~~kl~Dfg~~~~~~~~~----------------------------------------~~~~~~~~~~~~~ 177 (287)
T 1u59_A 138 ARNVLLVNRHYAKISDFGLSKALGADD----------------------------------------SYYTARSAGKWPL 177 (287)
T ss_dssp GGGEEEEETTEEEECCCTTCEECTTCS----------------------------------------CEECCCCSSCCCG
T ss_pred hheEEEcCCCCEEECcccceeeeccCc----------------------------------------ceeeccccccccc
Confidence 999999999999999999976532211 0011123345678
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ....+.+..+++++.+++.+
T Consensus 178 ~y~aPE~~~~~~~~~~~Di~slG~il~ell--t~g~~p~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~~ 248 (287)
T 1u59_A 178 KWYAPECINFRKFSSRSDVWSYGVTMWEAL--SYGQKPYKKMKGPEVMAFIEQ-------GKRMECPPECPPELYALMSD 248 (287)
T ss_dssp GGCCHHHHHHCEECHHHHHHHHHHHHHHHH--TTSCCTTTTCCTHHHHHHHHT-------TCCCCCCTTCCHHHHHHHHH
T ss_pred cccCHHHhccCCCCchhhHHHHHHHHHHHH--cCCCCCcccCCHHHHHHHHhc-------CCcCCCCCCcCHHHHHHHHH
Confidence 899999999888999999999999999999 7 9999998887776654432 22344567889999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++||++.++++.|++.
T Consensus 249 ~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 249 CWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp TTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999998888775
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=295.03 Aligned_cols=215 Identities=32% Similarity=0.542 Sum_probs=166.2
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++... ...++||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 138 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KERIDHIKLLQYTSQICKGMEYLGTKRYIHR 138 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC------GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc------ccccCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 3578999999999998543 5689999999999999999743 2358999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+|||++.++.+||+|||+++...... ..........
T Consensus 139 Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----------------------------------------~~~~~~~~~~ 178 (295)
T 3ugc_A 139 DLATRNILVENENRVKIGDFGLTKVLPQDK----------------------------------------EFFKVKEPGE 178 (295)
T ss_dssp CCSGGGEEEEETTEEEECCCCSCC-----------------------------------------------------CTT
T ss_pred CCCHhhEEEcCCCeEEEccCcccccccCCc----------------------------------------ceeeeccCCC
Confidence 999999999999999999999976532211 0011123345
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHh---------hhhhhhcCCcccCCCCCCc
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIEN---------CSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~ 229 (434)
++..|+|||.+.+..++.++|||||||++|||+ +|..||........... ..............+.+..
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~--~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (295)
T 3ugc_A 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG 256 (295)
T ss_dssp CGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--HTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTT
T ss_pred CccceeCcHHhcCCCCChHHHHHHHHHHHHHHH--hcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcC
Confidence 677899999999999999999999999999999 78888765432211000 0000111122334556778
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+++++.+++.+||+.||++|||+.|+++.|++..
T Consensus 257 ~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 257 CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 8999999999999999999999999999988753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=302.73 Aligned_cols=212 Identities=14% Similarity=0.186 Sum_probs=167.3
Q ss_pred CCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++| +||||+++++++.+++..++||||+ +|+|.+++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 59 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDl 131 (330)
T 2izr_A 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC------DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDV 131 (330)
T ss_dssp HHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 345 8999999999999999999999999 89999999743 357999999999999999999999999999999
Q ss_pred CCCCeeeecCCc-----eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 81 AARNCMVGKNYT-----IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 81 kp~NILl~~~~~-----~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
||+|||++.++. +||+|||+++........ ....+....
T Consensus 132 kp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~------------------------------------~~~~~~~~~ 175 (330)
T 2izr_A 132 KPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK------------------------------------KHIPYREHK 175 (330)
T ss_dssp CGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC------------------------------------CBCCCCCCC
T ss_pred CHHHeeeccCCCCCCceEEEEEcccceeeecCCCC------------------------------------ccccccccC
Confidence 999999998887 999999998753222100 001111234
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH---HHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ---VIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
...||+.|+|||++.+..++.++|||||||++|||+ +|..||.+....+ ....+....... ........++
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell--~g~~Pf~~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~p- 249 (330)
T 2izr_A 176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL--RGSLPWQGLKADTLKERYQKIGDTKRAT---PIEVLCENFP- 249 (330)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCTTTTCCCSSHHHHHHHHHHHHHHS---CHHHHTTTCH-
T ss_pred CcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHh--cCCCCccccccccHHHHHHHHHhhhccC---CHHHHhccCh-
Confidence 567899999999999999999999999999999999 8999998754333 222222111000 0000122355
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++.+++.+||+.||.+||++++|.+.|++.
T Consensus 250 ~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 250 EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 999999999999999999999999888765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=299.29 Aligned_cols=210 Identities=33% Similarity=0.659 Sum_probs=173.4
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------QENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
++ +||||+++++++.+++..++||||+++|+|.+++....... .....+++..++.++.||+.||+|||+
T Consensus 96 ~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 175 (334)
T 2pvf_A 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175 (334)
T ss_dssp HHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 45 89999999999999999999999999999999998543110 012358999999999999999999999
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
+||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 176 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-----------------------------------------~~~ 214 (334)
T 2pvf_A 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----------------------------------------YYK 214 (334)
T ss_dssp TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTS-----------------------------------------SEE
T ss_pred CCeeCCCCccceEEEcCCCCEEEccccccccccccc-----------------------------------------ccc
Confidence 999999999999999999999999999976532211 111
Q ss_pred cCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 153 SDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
......+|+.|+|||++.+..++.++|||||||++|||+ + |..||.+....+....+.. ......+..++
T Consensus 215 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 285 (334)
T 2pvf_A 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF--TLGGSPYPGIPVEELFKLLKE-------GHRMDKPANCT 285 (334)
T ss_dssp CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH--TTSCCSSTTCCHHHHHHHHHH-------TCCCCCCTTCC
T ss_pred ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHH--hCCCCCcCcCCHHHHHHHHhc-------CCCCCCCccCC
Confidence 223345678899999999988999999999999999999 6 8999998887776655432 12334466788
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+++.+++.+||+.||++||++.|+++.|++.
T Consensus 286 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999999888875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=323.96 Aligned_cols=205 Identities=35% Similarity=0.663 Sum_probs=170.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.. +..++||||+++|+|.++++ ....+++..+..++.||+.||+|||++||+||||
T Consensus 424 l~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDL 495 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ-------QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495 (635)
T ss_dssp HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH-------HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh-------hCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCC
Confidence 356899999999999964 56899999999999999997 3357899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ..........+|
T Consensus 496 kp~NILl~~~~~~kL~DFGla~~~~~~~----------------------------------------~~~~~~~~~~~t 535 (635)
T 4fl3_A 496 AARNVLLVTQHYAKISDFGLSKALRADE----------------------------------------NYYKAQTHGKWP 535 (635)
T ss_dssp SGGGEEEEETTEEEECCTTHHHHTTC-----------------------------------------------------C
T ss_pred ChHhEEEeCCCCEEEEEcCCccccccCc----------------------------------------cccccccCCCCc
Confidence 9999999999999999999986532211 011122334567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+..++.++|||||||++|||+ + |..||.+....+....+.. ....+.+..+++++.++|.
T Consensus 536 ~~y~APE~~~~~~~~~~sDvwSlGv~l~ell--t~G~~Pf~~~~~~~~~~~i~~-------~~~~~~p~~~~~~l~~li~ 606 (635)
T 4fl3_A 536 VKWYAPECINYYKFSSKSDVWSFGVLMWEAF--SYGQKPYRGMKGSEVTAMLEK-------GERMGCPAGCPREMYDLMN 606 (635)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTTCCSSTTCCHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHH
T ss_pred eeeeChhhhcCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHH
Confidence 8899999999999999999999999999999 7 9999999988877665542 2345557788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++||++++|.+.|++.
T Consensus 607 ~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 607 LCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHH
Confidence 99999999999999999888764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=295.89 Aligned_cols=211 Identities=37% Similarity=0.714 Sum_probs=173.7
Q ss_pred CCCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5690 1 MCSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYL 70 (434)
Q Consensus 1 l~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yL 70 (434)
|+++ +||||+++++++.+++..++||||+++|+|.+++...+.. ......+++..++.++.||+.||+||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3567 8999999999999999999999999999999999743200 01234789999999999999999999
Q ss_pred hhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 71 ESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 71 H~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
|++||+||||||+||+++.++.+||+|||+++....
T Consensus 159 H~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~-------------------------------------------- 194 (327)
T 1fvr_A 159 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------------------------------------------- 194 (327)
T ss_dssp HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCE--------------------------------------------
T ss_pred HhCCccCCCCccceEEEcCCCeEEEcccCcCccccc--------------------------------------------
Confidence 999999999999999999999999999998753110
Q ss_pred cccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCc
Q psy5690 151 YLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (434)
........++..|+|||++.+..++.++|||||||++|||+ + |..||......+....+.. ......+..
T Consensus 195 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell--t~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~~ 265 (327)
T 1fvr_A 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV--SLGGTPYCGMTCAELYEKLPQ-------GYRLEKPLN 265 (327)
T ss_dssp ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH--TTSCCTTTTCCHHHHHHHGGG-------TCCCCCCTT
T ss_pred cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHH--cCCCCCCCCCcHHHHHHHhhc-------CCCCCCCCC
Confidence 01112334567899999999988999999999999999999 7 9999999887777655432 223344667
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
+++++.+++.+||+.||++||+++|+++.|++...
T Consensus 266 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 266 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 88999999999999999999999999988887543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=293.54 Aligned_cols=205 Identities=40% Similarity=0.752 Sum_probs=173.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++... ....+++..++.++.|++.||+|||++||+|||||
T Consensus 64 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dik 138 (288)
T 3kfa_A 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-----NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138 (288)
T ss_dssp HHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC-----CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCS
T ss_pred HhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc-----ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence 4689999999999999999999999999999999999743 23568999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... ........+|+
T Consensus 139 p~Nil~~~~~~~~l~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~~ 176 (288)
T 3kfa_A 139 ARNCLVGENHLVKVADFGLSRLMTGDT------------------------------------------YTAHAGAKFPI 176 (288)
T ss_dssp GGGEEECGGGCEEECCCCGGGTSCSSS------------------------------------------SEEETTEEECG
T ss_pred cceEEEcCCCCEEEccCccceeccCCc------------------------------------------cccccCCcccc
Confidence 999999999999999999976532111 01112334567
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||.+.+..++.++||||||+++|+|+ + |..||......+....+.. ......+..+++++.+++.+
T Consensus 177 ~y~aPE~~~~~~~~~~~Di~slG~il~~ll--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~ 247 (288)
T 3kfa_A 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIA--TYGMSPYPGIDLSQVYELLEK-------DYRMERPEGCPEKVYELMRA 247 (288)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCSSTTCCGGGHHHHHHT-------TCCCCCCTTCCHHHHHHHHH
T ss_pred CcCChhhhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHhc-------cCCCCCCCCCCHHHHHHHHH
Confidence 899999999999999999999999999999 7 8999988877666554432 22344567788999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++|||++++++.|++.
T Consensus 248 ~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 248 CWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999888765
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=298.14 Aligned_cols=208 Identities=16% Similarity=0.212 Sum_probs=161.0
Q ss_pred CCCCCCCCeeeEEEEEecCCce----EEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPI----STIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
|++++||||+++++++...+.. |+||||+++|+|.++++.. ..+++..++.++.|++.||+|||++||+
T Consensus 66 l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~iv 138 (311)
T 3ork_A 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNGII 138 (311)
T ss_dssp CCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 5788999999999999766544 9999999999999999733 4689999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+|||++.++.+||+|||+++....... .......
T Consensus 139 H~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----------------------------------------~~~~~~~ 178 (311)
T 3ork_A 139 HRDVKPANIMISATNAVKVMDFGIARAIADSGN----------------------------------------SVTQTAA 178 (311)
T ss_dssp CCCCCGGGEEEETTSCEEECCCSCC-------------------------------------------------------
T ss_pred cCCCCHHHEEEcCCCCEEEeeccCccccccccc----------------------------------------ccccccc
Confidence 999999999999999999999999765322110 0011233
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..||+.|+|||++.+..++.++|||||||++|||+ +|..||.+....+........ ...........+++++.+
T Consensus 179 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll--~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~ 252 (311)
T 3ork_A 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL--TGEPPFTGDSPVSVAYQHVRE----DPIPPSARHEGLSADLDA 252 (311)
T ss_dssp ---CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHC----CCCCHHHHSTTCCHHHHH
T ss_pred cCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHhcC----CCCCcccccCCCCHHHHH
Confidence 46789999999999999999999999999999999 899999988876655433211 011111113457889999
Q ss_pred HHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 237 LMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
++.+||+.||++||++.++ ++|++.
T Consensus 253 li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 253 VVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 9999999999999976655 566654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=298.38 Aligned_cols=211 Identities=33% Similarity=0.598 Sum_probs=173.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++............+++..++.++.||+.||.|||++||+|||||
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlk 167 (327)
T 2yfx_A 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167 (327)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred hhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCC
Confidence 46799999999999999999999999999999999998665433344568999999999999999999999999999999
Q ss_pred CCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||++. +..+||+|||+++...... .........
T Consensus 168 p~NIli~~~~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~ 206 (327)
T 2yfx_A 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----------------------------------------YYRKGGCAM 206 (327)
T ss_dssp GGGEEESCSSTTCCEEECCCHHHHHHHC-----------------------------------------------CCGGG
T ss_pred HhHEEEecCCCcceEEECcccccccccccc-----------------------------------------ccccCCCcC
Confidence 99999984 4469999999875421111 001122345
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+|+.|+|||++.+..++.++|||||||++|+|+ + |..||......+....+.. ......+..+++.+.++
T Consensus 207 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~l 277 (327)
T 2yfx_A 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--SLGYMPYPSKSNQEVLEFVTS-------GGRMDPPKNCPGPVYRI 277 (327)
T ss_dssp SCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCSSTTCCHHHHHHHHHT-------TCCCCCCTTCCHHHHHH
T ss_pred CCcceeCHhHhcCCCCCchhhHHHHHHHHHHHH--cCCCCCCCCcCHHHHHHHHhc-------CCCCCCCCCCCHHHHHH
Confidence 678899999999999999999999999999999 6 8999998877766654432 22334456788999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+||+.||++||++.++++.|+..
T Consensus 278 i~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 278 MTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999998888764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=315.04 Aligned_cols=206 Identities=20% Similarity=0.244 Sum_probs=173.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+.+..++|||||.+|+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 80 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dl 152 (484)
T 3nyv_A 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-------SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDL 152 (484)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-------TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 468999999999999999999999999999999999997 4457999999999999999999999999999999
Q ss_pred CCCCeee---ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||+ +.++.+||+|||+++...... .....
T Consensus 153 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~ 188 (484)
T 3nyv_A 153 KPENLLLESKSKDANIRIIDFGLSTHFEASK--------------------------------------------KMKDK 188 (484)
T ss_dssp CGGGEEESSSSTTCCEEECCTTHHHHBCCCC--------------------------------------------SHHHH
T ss_pred CHHHEEEecCCCCCcEEEEeeeeeEEccccc--------------------------------------------ccccC
Confidence 9999999 567899999999976522111 01223
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|+|||++.+ .++.++|||||||++|+|+ +|..||.+.+..+....+... ......+....+++++.+|
T Consensus 189 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~l 261 (484)
T 3nyv_A 189 IGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL--SGCPPFNGANEYDILKKVEKG----KYTFELPQWKKVSESAKDL 261 (484)
T ss_dssp TTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHC----CCCCCSGGGGGSCHHHHHH
T ss_pred CCCccccCceeecC-CCCCcceeHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHcC----CCCCCCcccccCCHHHHHH
Confidence 57889999999876 6899999999999999999 899999998888777665431 1111223345678999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
+.+||+.||++|||++|+ |+|++....
T Consensus 262 i~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 262 IRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 999999999999999999 899987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.05 Aligned_cols=206 Identities=22% Similarity=0.354 Sum_probs=164.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+.+..++||||+++|+|.+++.... .....+++..++.++.||+.||+|||++||+||||
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~di 150 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQ---ARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL 150 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhh---hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCC
Confidence 357899999999999999999999999999999999986432 12356999999999999999999999999999999
Q ss_pred CCCCeee---ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+||++ +.++.+||+|||+++...... .....
T Consensus 151 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~ 186 (285)
T 3is5_A 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDE--------------------------------------------HSTNA 186 (285)
T ss_dssp SGGGEEESSSSTTCCEEECCCCCCCC------------------------------------------------------
T ss_pred CHHHEEEecCCCCCCEEEEeeecceecCCcc--------------------------------------------cCcCc
Confidence 9999999 456789999999975421110 11334
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.+|..|+|||++. ..++.++|||||||++|||+ +|..||.+....+........ ..........+++++.++
T Consensus 187 ~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll--~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l 258 (285)
T 3is5_A 187 AGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL--TGCLPFTGTSLEEVQQKATYK-----EPNYAVECRPLTPQAVDL 258 (285)
T ss_dssp CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHC-----CCCCCC--CCCCHHHHHH
T ss_pred ccccCcCChHHhc-cCCCcccCeehHHHHHHHHH--hCCCCCCCCCHHHHHhhhccC-----CcccccccCcCCHHHHHH
Confidence 5788999999885 56889999999999999999 899999988877665543321 111122233467899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+.+||+.||++|||++|+ |+||++
T Consensus 259 i~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 259 LKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999999999999 678765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=302.02 Aligned_cols=211 Identities=34% Similarity=0.638 Sum_probs=170.1
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS-------QENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~-------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
++ +||||+++++++.+++..++||||+++|+|.+++....... .....+++..++.++.||+.||+|||++|
T Consensus 105 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 184 (333)
T 2i1m_A 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184 (333)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 45 89999999999999999999999999999999997542100 01346899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 185 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~~~~~ 223 (333)
T 2i1m_A 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-----------------------------------------NYIVK 223 (333)
T ss_dssp EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCT-----------------------------------------TSEEC
T ss_pred cccCCcccceEEECCCCeEEECcccccccccccc-----------------------------------------ceeec
Confidence 9999999999999999999999999976522111 01112
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
....+|+.|+|||++.+..++.++|||||||++|||+ + |..||.+............ .......+..++++
T Consensus 224 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~--t~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 295 (333)
T 2i1m_A 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF--SLGLNPYPGILVNSKFYKLVK------DGYQMAQPAFAPKN 295 (333)
T ss_dssp SSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHT--TTSCCSSTTCCSSHHHHHHHH------HTCCCCCCTTCCHH
T ss_pred CCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHH--cCCCCCCcccchhHHHHHHHh------cCCCCCCCCCCCHH
Confidence 3345677899999999999999999999999999999 6 8899987665444332221 11223345667899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+++.+||+.||.+|||+.|++++|++.
T Consensus 296 l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 296 IYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=291.99 Aligned_cols=209 Identities=37% Similarity=0.698 Sum_probs=169.7
Q ss_pred CCCCCCCCeeeEEEEEe-cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCS-TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++||||+++++++. .++..++||||+++|+|.++++. ....+++..++.++.|++.||+|||++||+|||
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~------~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 153 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRD 153 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 35789999999999964 55678999999999999999973 335689999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||+++.++.+||+|||+++........ .........+
T Consensus 154 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------------~~~~~~~~~~ 194 (298)
T 3f66_A 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYY---------------------------------------SVHNKTGAKL 194 (298)
T ss_dssp CSGGGEEECTTCCEEECSCGGGCCCSCGGGC---------------------------------------BC-----CCB
T ss_pred CchheEEECCCCCEEECcccccccccccchh---------------------------------------ccccccCCCC
Confidence 9999999999999999999998653222110 0111234567
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
|+.|+|||.+.+..++.++|||||||++|+|+ + +.+||......+....+.. ......+..+++++.+++
T Consensus 195 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li 265 (298)
T 3f66_A 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELM--TRGAPPYPDVNTFDITVYLLQ-------GRRLLQPEYCPDPLYEVM 265 (298)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCSSTTSCTTTHHHHHHT-------TCCCCCCTTCCHHHHHHH
T ss_pred CccccChHHhcCCCCChHHHHHHHHHHHHHHH--hCCCCCCccCCHHHHHHHHhc-------CCCCCCCccCCHHHHHHH
Confidence 78899999999999999999999999999999 6 6777877666555443321 223344567889999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+||+.||++||++.|+++.|++..
T Consensus 266 ~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 266 LKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=302.72 Aligned_cols=216 Identities=13% Similarity=0.136 Sum_probs=166.2
Q ss_pred CCCCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 2 CSLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
+.++||||+++++++.. ++..++||||+ +|+|.+++.. ...+++..++.++.||+.||+|||++||+|
T Consensus 103 ~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 174 (345)
T 2v62_A 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ-------NGTFKKSTVLQLGIRMLDVLEYIHENEYVH 174 (345)
T ss_dssp HTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG-------GGBCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 46799999999999987 67899999999 9999999973 237999999999999999999999999999
Q ss_pred cCCCCCCeeeecCC--ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 78 RDLAARNCMVGKNY--TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 78 rDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
|||||+|||++.++ .+||+|||+++........ .........
T Consensus 175 ~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~------------------------------------~~~~~~~~~ 218 (345)
T 2v62_A 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH------------------------------------KQYQENPRK 218 (345)
T ss_dssp SCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCC------------------------------------CCCCCCGGG
T ss_pred CCcCHHHEEEccCCCCcEEEEeCCCceeccccccc------------------------------------ccchhcccc
Confidence 99999999999877 9999999998764322100 000001123
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhhhhhhcCCccc--CCCCCCccHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQ--YLPRPATCQK 232 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (434)
...||..|+|||++.+..++.++|||||||++|||+ +|..||..... .................. .......+++
T Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (345)
T 2v62_A 219 GHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL--CGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCC 296 (345)
T ss_dssp CSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH--HSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCH
T ss_pred ccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH--hCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHH
Confidence 457889999999999999999999999999999999 89999965322 111111111110000000 0001226788
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
++.+++.+||+.||++||++++|.+.|++..
T Consensus 297 ~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 297 EIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 9999999999999999999999999998854
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=324.95 Aligned_cols=201 Identities=23% Similarity=0.332 Sum_probs=175.6
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+.+.+|+||||+++|+|.++++.. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~N 472 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDN 472 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTT
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhh
Confidence 7999999999999999999999999999999999843 469999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.++.+||+|||+++...... .......||+.|+
T Consensus 473 ILl~~~g~ikL~DFGla~~~~~~~-------------------------------------------~~~~~~~GT~~Y~ 509 (674)
T 3pfq_A 473 VMLDSEGHIKIADFGMCKENIWDG-------------------------------------------VTTKTFCGTPDYI 509 (674)
T ss_dssp EEECSSSCEEECCCTTCEECCCTT-------------------------------------------CCBCCCCSCSSSC
T ss_pred EEEcCCCcEEEeecceeeccccCC-------------------------------------------cccccccCCCccc
Confidence 999999999999999976421110 1124567899999
Q ss_pred chhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC
Q psy5690 165 AWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244 (434)
Q Consensus 165 aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 244 (434)
|||++.+..++.++|||||||++|||+ +|..||.+.+..+..+.+.. .....+..+++++.+||.+||+.
T Consensus 510 APE~l~~~~~~~~~DvwSlGvilyell--tG~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~lL~~ 579 (674)
T 3pfq_A 510 APEIIAYQPYGKSVDWWAFGVLLYEML--AGQAPFEGEDEDELFQSIME--------HNVAYPKSMSKEAVAICKGLMTK 579 (674)
T ss_dssp CHHHHTCCCBSTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHS--------SCCCCCTTSCHHHHHHHHHHSCS
T ss_pred CHhhhcCCCCCccceEechHHHHHHHH--cCCCCCCCCCHHHHHHHHHh--------CCCCCCccCCHHHHHHHHHHccC
Confidence 999999999999999999999999999 89999999988888776643 22344667899999999999999
Q ss_pred CCCCCCCH-----HHH--HHHHHhcccC
Q psy5690 245 NETDRPRF-----SEI--HLFLQRKNLG 265 (434)
Q Consensus 245 dP~~Rps~-----~el--~~~L~~~~~~ 265 (434)
||++||++ +|| |+||+..++.
T Consensus 580 dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 580 HPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp SSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred CHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 99999987 888 8999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=290.23 Aligned_cols=211 Identities=25% Similarity=0.409 Sum_probs=160.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++ ..+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+||||
T Consensus 74 l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dl 146 (289)
T 3og7_A 74 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA------SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146 (289)
T ss_dssp HTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT------C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Confidence 4689999999999965 55678999999999999999962 3356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .........||
T Consensus 147 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~gt 185 (289)
T 3og7_A 147 KSNNIFLHEDNTVKIGDFGLATEKSRWS-----------------------------------------GSHQFEQLSGS 185 (289)
T ss_dssp CGGGEEEETTTEEEECCCC-----------------------------------------------------------CC
T ss_pred ccceEEECCCCCEEEccceecccccccc-----------------------------------------ccccccccCCC
Confidence 9999999999999999999975421100 00111334578
Q ss_pred ccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
..|+|||++. +..++.++|||||||++|+|+ +|..||......+........ .............+++++.++
T Consensus 186 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~--~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~l 261 (289)
T 3og7_A 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM--TGQLPYSNINNRDQIIEMVGR--GSLSPDLSKVRSNCPKRMKRL 261 (289)
T ss_dssp CTTCCHHHHC----CCSCHHHHHHHHHHHHHHHH--HSSCTTSSCCCHHHHHHHHHH--TSCCCCTTSSCTTSCHHHHHH
T ss_pred ccccCchhhcccCCCCCCcccchHHHHHHHHHHH--HCCCCccccchHHHHHHHhcc--cccCcchhhccccCCHHHHHH
Confidence 8999999997 566788999999999999999 899999886655443322211 111111222345788999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+.+||+.||++|||++++++.|++..
T Consensus 262 i~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 262 MAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHh
Confidence 99999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=298.09 Aligned_cols=199 Identities=22% Similarity=0.359 Sum_probs=167.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+. |+|.+++... ...+++..+..++.|++.||+|||++||+|||||
T Consensus 109 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 181 (348)
T 1u5q_A 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 181 (348)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCS
T ss_pred HhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence 46899999999999999999999999997 6898888633 2468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++.... .....||+
T Consensus 182 p~NIll~~~~~~kL~DfG~a~~~~~-----------------------------------------------~~~~~gt~ 214 (348)
T 1u5q_A 182 AGNILLSEPGLVKLGDFGSASIMAP-----------------------------------------------ANSFVGTP 214 (348)
T ss_dssp GGGEEEETTTEEEECCCTTCBSSSS-----------------------------------------------BCCCCSCG
T ss_pred HHHEEECCCCCEEEeeccCceecCC-----------------------------------------------CCcccCCc
Confidence 9999999999999999998754210 12346788
Q ss_pred cccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 162 RWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 162 ~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
.|+|||++. ...++.++|||||||++|||+ +|..||...+.......+.. .......+..+++.+.+++
T Consensus 215 ~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELA--ERKPPLFNMNAMSALYHIAQ------NESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp GGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHH------SCCCCCCCTTSCHHHHHHH
T ss_pred ceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHh------cCCCCCCCCCCCHHHHHHH
Confidence 999999985 567899999999999999999 89999988877665544322 1112222456789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||++|||++++ |+|+.+.
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHcccChhhCcCHHHHhhChhhhcc
Confidence 99999999999999999 8898764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=317.83 Aligned_cols=206 Identities=35% Similarity=0.632 Sum_probs=174.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+||||+++++++.+ +..++||||+++|+|.++++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 316 l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 389 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389 (535)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 357899999999999866 77999999999999999997431 235899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... +.......++
T Consensus 390 kp~NIll~~~~~~kl~DFG~a~~~~~~~------------------------------------------~~~~~~~~~~ 427 (535)
T 2h8h_A 390 RAANILVGENLVCKVADFGLARLIEDNE------------------------------------------YTARQGAKFP 427 (535)
T ss_dssp SGGGEEECGGGCEEECCTTSTTTCCCHH------------------------------------------HHTTCSTTSC
T ss_pred CHhhEEEcCCCcEEEcccccceecCCCc------------------------------------------eecccCCcCc
Confidence 9999999999999999999976532111 1112334567
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+..++.++|||||||++|||+ + |..||.+....+....+.. ....+.+..+++++.+||.
T Consensus 428 ~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~--t~g~~P~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~ 498 (535)
T 2h8h_A 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELT--TKGRVPYPGMVNREVLDQVER-------GYRMPCPPECPESLHDLMC 498 (535)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHT--TTTCCSSTTCCHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHH
T ss_pred ccccCHHHhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHH
Confidence 8899999999999999999999999999999 6 8999999888777665532 2344556788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+||+.||++|||+++|+..|++..
T Consensus 499 ~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 499 QCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHcCCChhHCcCHHHHHHHHHHHh
Confidence 999999999999999999999853
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=312.56 Aligned_cols=204 Identities=20% Similarity=0.269 Sum_probs=170.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++++|.+.+..++|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||
T Consensus 90 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dl 162 (494)
T 3lij_A 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDL 162 (494)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 46899999999999999999999999999999999998733 46899999999999999999999999999999
Q ss_pred CCCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||++. ++.+||+|||+++...... .....
T Consensus 163 kp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~--------------------------------------------~~~~~ 198 (494)
T 3lij_A 163 KPENLLLESKEKDALIKIVDFGLSAVFENQK--------------------------------------------KMKER 198 (494)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCEECBTTB--------------------------------------------CBCCC
T ss_pred ChhhEEEeCCCCCCcEEEEECCCCeECCCCc--------------------------------------------ccccc
Confidence 999999976 4459999999976521110 12345
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|+|||++. ..++.++||||+||++|+|+ +|..||.+....+....+.... .....+....+++++.++
T Consensus 199 ~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~l 271 (494)
T 3lij_A 199 LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL--AGYPPFGGQTDQEILRKVEKGK----YTFDSPEWKNVSEGAKDL 271 (494)
T ss_dssp CSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHTC----CCCCSGGGTTSCHHHHHH
T ss_pred CCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhCC----CCCCchhcccCCHHHHHH
Confidence 6889999999886 56899999999999999999 8999999998887776654321 111122234678999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+||+.||.+|||+.|+ |+||++.
T Consensus 272 i~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 272 IKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999999 8999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=290.34 Aligned_cols=211 Identities=33% Similarity=0.632 Sum_probs=171.4
Q ss_pred CCCCCCCCeeeEEEEEecCCce-EEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPI-STIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~-~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++||||+++++++.+.+.. ++||||+.+|+|.+++.. ....+++..+..++.|++.||+|||++||+|||
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d 149 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS------PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRD 149 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc------cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 3578999999999999776655 999999999999999973 245689999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||+++.++.+||+|||+++........ .........+
T Consensus 150 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~ 190 (298)
T 3pls_A 150 LAARNCMLDESFTVKVADFGLARDILDREYY---------------------------------------SVQQHRHARL 190 (298)
T ss_dssp CSGGGEEECTTCCEEECCTTSSCTTTTGGGG---------------------------------------CSCCSSCTTC
T ss_pred CCcceEEEcCCCcEEeCcCCCcccccCCccc---------------------------------------ccccCcCCCC
Confidence 9999999999999999999998653221110 0112234567
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|..|+|||.+.+..++.++|||||||++|+|+++ +.+||......+....+. .....+.+..+++++.+++.
T Consensus 191 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~ 262 (298)
T 3pls_A 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR-GAPPYRHIDPFDLTHFLA-------QGRRLPQPEYCPDSLYQVMQ 262 (298)
T ss_dssp GGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHT-SCCTTTTSCGGGHHHHHH-------TTCCCCCCTTCCHHHHHHHH
T ss_pred CccccChhhhccCCCChhhchhhHHHHHHHHhhC-CCCCCccCCHHHHHHHhh-------cCCCCCCCccchHHHHHHHH
Confidence 8899999999999999999999999999999932 566666666655544332 22234456678899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
+||+.||.+|||++++++.|++...
T Consensus 263 ~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 263 QCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999999999999999999987643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=289.67 Aligned_cols=203 Identities=35% Similarity=0.663 Sum_probs=167.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+ +..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+|||||
T Consensus 68 ~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 140 (281)
T 3cc6_A 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERN------KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIA 140 (281)
T ss_dssp HHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHH------TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred HhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhc------cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCc
Confidence 45789999999999865 4678999999999999999743 2458999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... ........+|.
T Consensus 141 p~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~~ 178 (281)
T 3cc6_A 141 VRNILVASPECVKLGDFGLSRYIEDED------------------------------------------YYKASVTRLPI 178 (281)
T ss_dssp GGGEEEEETTEEEECCCCGGGCC---------------------------------------------------CCCCCG
T ss_pred cceEEECCCCcEEeCccCCCccccccc------------------------------------------ccccccCCCCc
Confidence 999999999999999999976532111 01123345678
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..++.++|||||||++|+|+ + |..||......+....+.. ....+.+..+++.+.+++.+
T Consensus 179 ~y~aPE~~~~~~~~~~~Di~slG~il~~ll--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~ 249 (281)
T 3cc6_A 179 KWMSPESINFRRFTTASDVWMFAVCMWEIL--SFGKQPFFWLENKDVIGVLEK-------GDRLPKPDLCPPVLYTLMTR 249 (281)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTTCCTTTTSCGGGHHHHHHH-------TCCCCCCTTCCHHHHHHHHH
T ss_pred ceeCchhhccCCCCchhccHHHHHHHHHHH--hCCCCCcccCChHHHHHHHhc-------CCCCCCCCCCCHHHHHHHHH
Confidence 899999999999999999999999999999 7 8999987776655544332 22344566788999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++||++.|++..|++.
T Consensus 250 ~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 250 CWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred HccCCchhCcCHHHHHHHHHHH
Confidence 9999999999999999888764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=299.00 Aligned_cols=204 Identities=18% Similarity=0.200 Sum_probs=170.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+|||||
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dik 142 (321)
T 2a2a_A 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA-------QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLK 142 (321)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-------TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 46899999999999999999999999999999999997 44578999999999999999999999999999999
Q ss_pred CCCeeeecCC----ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 82 ARNCMVGKNY----TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 82 p~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|+||+++.++ .+||+|||+++...... .....
T Consensus 143 p~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------~~~~~ 178 (321)
T 2a2a_A 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--------------------------------------------EFKNI 178 (321)
T ss_dssp GGGEEESCTTSSSCCEEECCCTTCEECCTTC--------------------------------------------CCCCC
T ss_pred hHHEEEecCCCCcCCEEEccCccceecCccc--------------------------------------------ccccc
Confidence 9999999887 79999999975421110 11334
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|+|||++.+..++.++|||||||++|+|+ +|..||.+....+....+..... .........+++.+.++
T Consensus 179 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~~~~~l 252 (321)
T 2a2a_A 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL--SGASPFLGDTKQETLANITSVSY----DFDEEFFSHTSELAKDF 252 (321)
T ss_dssp CSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSCCSSCCSSHHHHHHHHHTTCC----CCCHHHHTTCCHHHHHH
T ss_pred CCCCCccCcccccCCCCCCccccHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHhccc----ccChhhhcccCHHHHHH
Confidence 5788999999999999999999999999999999 89999998887777665542110 00111124567899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+||+.||++|||++|+ |+|++..
T Consensus 253 i~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 253 IRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp HHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred HHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999999999999999 6788643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=301.00 Aligned_cols=217 Identities=22% Similarity=0.253 Sum_probs=168.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC---------------------------------CCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS---------------------------------QEN 48 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~---------------------------------~~~ 48 (434)
++++||||+++++++.+++..++||||+++|+|.+++....... ...
T Consensus 83 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (345)
T 3hko_A 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLD 162 (345)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECC
T ss_pred HhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 46899999999999999999999999999999999985321100 002
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCC--ceEEccCCcccccccccccccccccccchhhhhhc
Q psy5690 49 PAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNY--TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126 (434)
Q Consensus 49 ~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (434)
..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 163 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~------------------ 224 (345)
T 3hko_A 163 FVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN------------------ 224 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTT------------------
T ss_pred ccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccC------------------
Confidence 2346778899999999999999999999999999999998766 89999999976532111
Q ss_pred ccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh
Q psy5690 127 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN 204 (434)
Q Consensus 127 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~ 204 (434)
...........||+.|+|||++.+ ..++.++|||||||++|||+ +|..||.+...
T Consensus 225 ---------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~ 281 (345)
T 3hko_A 225 ---------------------NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL--MGAVPFPGVND 281 (345)
T ss_dssp ---------------------CC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHH--HSSCSSCCSSH
T ss_pred ---------------------ccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCCCh
Confidence 011112244568899999999975 67899999999999999999 89999999888
Q ss_pred HHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 205 EQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+....+.... .....+....+++++.+++.+||+.||++||++.|+ |+||++..
T Consensus 282 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 282 ADTISQVLNKK----LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHCC----CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHhcc----cccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 77665543211 111112233578999999999999999999999999 88998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=296.06 Aligned_cols=201 Identities=19% Similarity=0.278 Sum_probs=172.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+|||||
T Consensus 96 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 168 (335)
T 2owb_A 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-------RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168 (335)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCC
Confidence 578999999999999999999999999999999999873 3468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... .......||.
T Consensus 169 p~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~gt~ 205 (335)
T 2owb_A 169 LGNLFLNEDLEVKIGDFGLATKVEYDG-------------------------------------------ERKKVLCGTP 205 (335)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTT-------------------------------------------CCBCCCCSCC
T ss_pred chhEEEcCCCCEEEeeccCceecccCc-------------------------------------------ccccccCCCc
Confidence 999999999999999999976521110 0113346788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|+|+ +|..||......+....+.. .....+..+++++.+++.+|
T Consensus 206 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~ 275 (335)
T 2owb_A 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLL--VGKPPFETSCLKETYLRIKK--------NEYSIPKHINPVAASLIQKM 275 (335)
T ss_dssp SSCCHHHHHTSCBCTHHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHH--------TCCCCCTTSCHHHHHHHHHH
T ss_pred cccCHHHhccCCCCchhhHHHHHHHHHHHH--HCcCCCCCCCHHHHHHHHhc--------CCCCCCccCCHHHHHHHHHH
Confidence 999999999999999999999999999999 89999998877666544432 12233567789999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHhc
Q psy5690 242 WKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~~ 262 (434)
|+.||++||+++|+ |+||...
T Consensus 276 l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 276 LQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ccCChhHCcCHHHHhcCccccCC
Confidence 99999999999999 7899874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=291.76 Aligned_cols=203 Identities=23% Similarity=0.369 Sum_probs=147.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++++||||+++++++.+++..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++||+||||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 138 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN------RVKPFSENEARHFMHQIITGMLYLHSHGILHRDL 138 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT------CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSC
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 3678999999999999999999999999999999999973 2356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||++....... .......||
T Consensus 139 ~p~Nili~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 175 (278)
T 3cok_A 139 TLSNLLLTRNMNIKIADFGLATQLKMPH-------------------------------------------EKHYTLCGT 175 (278)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECC-------------------------------------------------------
T ss_pred CHHHEEEcCCCCEEEEeecceeeccCCC-------------------------------------------CcceeccCC
Confidence 9999999999999999999875421110 011234577
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||.+.+..++.++||||||+++|+|+ +|..||......+....+. ......+..++.++.+++.+
T Consensus 176 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~ 245 (278)
T 3cok_A 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLL--IGRPPFDTDTVKNTLNKVV--------LADYEMPSFLSIEAKDLIHQ 245 (278)
T ss_dssp ----------------CTHHHHHHHHHHHHH--HSSCSSCCCSCC-----CC--------SSCCCCCTTSCHHHHHHHHH
T ss_pred CCcCCcchhcCCCCCchhhHHHHHHHHHHHH--hCCCCCCChhHHHHHHHHh--------hcccCCccccCHHHHHHHHH
Confidence 8899999999988999999999999999999 8899998766544433221 11223456688999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||++||+++++ |+|+++.
T Consensus 246 ~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 246 LLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999 6788754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=293.94 Aligned_cols=211 Identities=36% Similarity=0.714 Sum_probs=167.4
Q ss_pred CCCCCCCCeeeEEEEEecCC-----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED-----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|++++||||+++++++.+.+ ..++||||+++|+|.+++..... ......+++..++.++.||+.||.|||++||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 168 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL-ETGPKHIPLQTLLKFMVDIALGMEYLSNRNF 168 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTB-TTSCCCCCHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhh-hcCCccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 35789999999999997755 35999999999999999954321 1134579999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+||+++.++.+||+|||+++...... ......
T Consensus 169 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~~~~~~ 207 (313)
T 3brb_A 169 LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-----------------------------------------YYRQGR 207 (313)
T ss_dssp CCCCCSGGGEEECTTSCEEECSCSCC------------------------------------------------------
T ss_pred ccCCCCcceEEEcCCCcEEEeecCcceeccccc-----------------------------------------ccCccc
Confidence 999999999999999999999999976532111 011123
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
...+++.|+|||.+.+..++.++|||||||++|+|+ + |..||......+....+.. ......+..+++++
T Consensus 208 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l 278 (313)
T 3brb_A 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA--TRGMTPYPGVQNHEMYDYLLH-------GHRLKQPEDCLDEL 278 (313)
T ss_dssp ---CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHH--TTSCCSSTTCCGGGHHHHHHT-------TCCCCCBTTCCHHH
T ss_pred ccCCCccccCchhhcCCCccchhhhHHHHHHHHHHH--hcCCCCCccCCHHHHHHHHHc-------CCCCCCCccccHHH
Confidence 345677899999999999999999999999999999 6 8899988877666554432 22344466788999
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 235 FDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.+++.+||+.||++||++.++...|++.
T Consensus 279 ~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 279 YEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999988875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=290.50 Aligned_cols=201 Identities=19% Similarity=0.278 Sum_probs=172.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+|||||
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~ 142 (294)
T 2rku_A 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-------RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142 (294)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 578999999999999999999999999999999999873 3468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... .......||.
T Consensus 143 p~Nil~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~~ 179 (294)
T 2rku_A 143 LGNLFLNEDLEVKIGDFGLATKVEYDG-------------------------------------------ERKKVLCGTP 179 (294)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSTT-------------------------------------------CCBCCCCSCC
T ss_pred hHhEEEcCCCCEEEEeccCceecccCc-------------------------------------------cccccccCCC
Confidence 999999999999999999975421110 0113346788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++||||||+++|+|+ +|..||......+....+.. .....+..+++++.+++.+|
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~ 249 (294)
T 2rku_A 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLL--VGKPPFETSCLKETYLRIKK--------NEYSIPKHINPVAASLIQKM 249 (294)
T ss_dssp SSCCHHHHTTSCBCTHHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHT--------TCCCCCTTSCHHHHHHHHHH
T ss_pred CcCCcchhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHhh--------ccCCCccccCHHHHHHHHHH
Confidence 999999999988999999999999999999 89999998877666554432 12234567789999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHhc
Q psy5690 242 WKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~~ 262 (434)
|+.||++||+++|+ |+|+.+.
T Consensus 250 l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 250 LQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp TCSSGGGSCCGGGGGGSHHHHTS
T ss_pred cccChhhCcCHHHHhhChheecC
Confidence 99999999999999 7899864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.65 Aligned_cols=195 Identities=20% Similarity=0.369 Sum_probs=164.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCC-CHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFG-DLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++||||+++++++.+++..++||||+.+| +|.+++. ....+++..+..++.||+.||+|||++||+|||
T Consensus 83 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~D 155 (335)
T 3dls_A 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID-------RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRD 155 (335)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHH-------TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEec
Confidence 46789999999999999999999999999777 9999997 445799999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++...... ......|
T Consensus 156 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~--------------------------------------------~~~~~~g 191 (335)
T 3dls_A 156 IKDENIVIAEDFTIKLIDFGSAAYLERGK--------------------------------------------LFYTFCG 191 (335)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTC--------------------------------------------CBCEECS
T ss_pred cCHHHEEEcCCCcEEEeecccceECCCCC--------------------------------------------ceeccCC
Confidence 99999999999999999999976521111 1123457
Q ss_pred CccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
|+.|+|||++.+..+ +.++|||||||++|+|+ +|..||...... .......+..+++++.+++
T Consensus 192 t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~--------------~~~~~~~~~~~~~~l~~li 255 (335)
T 3dls_A 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV--FEENPFCELEET--------------VEAAIHPPYLVSKELMSLV 255 (335)
T ss_dssp CGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHH--HSSCSCSSGGGG--------------TTTCCCCSSCCCHHHHHHH
T ss_pred CccccChhhhcCCCCCCCcccchhHHHHHHHHH--hCCCchhhHHHH--------------HhhccCCCcccCHHHHHHH
Confidence 899999999998877 78999999999999999 899999763221 1112233556889999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||++|||++++ |+|+++.
T Consensus 256 ~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 256 SGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHccCChhhCcCHHHHhcCccccCC
Confidence 99999999999999999 6788653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=293.73 Aligned_cols=213 Identities=22% Similarity=0.339 Sum_probs=168.4
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++||+|||||
T Consensus 85 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlk 160 (307)
T 2nru_A 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD----GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIK 160 (307)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG----GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 46899999999999999999999999999999999997443 34568999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... .........||.
T Consensus 161 p~Nili~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~g~~ 199 (307)
T 2nru_A 161 SANILLDEAFTAKISDFGLARASEKFA-----------------------------------------QTVMTSRIVGTT 199 (307)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSCS-----------------------------------------SCEECSSCCSCG
T ss_pred HHHEEEcCCCcEEEeeccccccccccc-----------------------------------------ccccccccCCCc
Confidence 999999999999999999976522110 001123456889
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc-------CCcccCCCCCCccHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN-------NSKQQYLPRPATCQKEI 234 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l 234 (434)
.|+|||.+.+ .++.++|||||||++|+|+ +|..||......+....+...... .........+..+++.+
T Consensus 200 ~y~aPE~~~~-~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (307)
T 2nru_A 200 AYMAPEALRG-EITPKSDIYSFGVVLLEII--TGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAM 276 (307)
T ss_dssp GGCCHHHHTT-EECTHHHHHHHHHHHHHHH--HCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHH
T ss_pred CcCChHHhcC-CCCccchhHHHHHHHHHHH--HCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHH
Confidence 9999998865 5789999999999999999 889999875543222111111000 01112223345677889
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 235 FDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.+++.+||+.||++||+++++.+.|++.
T Consensus 277 ~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 277 YSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 9999999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=298.39 Aligned_cols=210 Identities=20% Similarity=0.290 Sum_probs=163.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||++ |+|.+++.. ...+++..+..++.||+.||+|||++||+||||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dl 158 (329)
T 3gbz_A 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDK-------NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDL 158 (329)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH-------CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCC
Confidence 467899999999999999999999999997 499999973 346899999999999999999999999999999
Q ss_pred CCCCeeee-----cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 81 AARNCMVG-----KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 81 kp~NILl~-----~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
||+|||++ .++.+||+|||+++...... ....
T Consensus 159 kp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~-------------------------------------------~~~~ 195 (329)
T 3gbz_A 159 KPQNLLLSVSDASETPVLKIGDFGLARAFGIPI-------------------------------------------RQFT 195 (329)
T ss_dssp CGGGEEEEC-----CCEEEECCTTHHHHHC--------------------------------------------------
T ss_pred CHHHEEEecCCCCccceEEECcCCCccccCCcc-------------------------------------------cccC
Confidence 99999994 45569999999976521110 0113
Q ss_pred CCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccC-----------
Q psy5690 156 KARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY----------- 223 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------- 223 (434)
...+|..|+|||++.+. .++.++|||||||++|||+ +|..||......+....+............
T Consensus 196 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (329)
T 3gbz_A 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML--MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ 273 (329)
T ss_dssp ----CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred CCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH--HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh
Confidence 34568889999999875 4799999999999999999 899999988877666554432111100000
Q ss_pred -CC----------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 224 -LP----------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 224 -~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+ .+..+++++.+|+.+||+.||++|||++|+ |+||++.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 274 SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 00 011267899999999999999999999999 78998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=319.16 Aligned_cols=204 Identities=19% Similarity=0.246 Sum_probs=171.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++|||||++++++.+++..|+||||++||+|.+++... ....+++..+..++.||+.||+|||++||+|||||
T Consensus 239 ~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~-----~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLK 313 (576)
T 2acx_A 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-----GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLK 313 (576)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS-----SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCc
Confidence 4689999999999999999999999999999999999732 23458999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ......||+
T Consensus 314 PeNILld~~g~vKL~DFGla~~~~~~~--------------------------------------------~~~~~~GT~ 349 (576)
T 2acx_A 314 PENILLDDHGHIRISDLGLAVHVPEGQ--------------------------------------------TIKGRVGTV 349 (576)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTC--------------------------------------------CEECCCSCG
T ss_pred hheEEEeCCCCeEEEecccceecccCc--------------------------------------------cccccCCCc
Confidence 999999999999999999976521110 112347899
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh----HHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN----EQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||..... .+....+.. .....+..+++++.+|
T Consensus 350 ~Y~APEvl~~~~~~~~~DiwSLGvilyeLl--tG~~PF~~~~~~~~~~~i~~~i~~--------~~~~~p~~~s~~~~dL 419 (576)
T 2acx_A 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMI--AGQSPFQQRKKKIKREEVERLVKE--------VPEEYSERFSPQARSL 419 (576)
T ss_dssp GGCCHHHHTTCEESSHHHHHHHHHHHHHHH--HSSCSSSCSSSCCCHHHHHHHHHH--------CCCCCCTTSCHHHHHH
T ss_pred cccCHHHHcCCCCCccchHHHHHHHHHHHH--hCCCCCcccccchhHHHHHHHhhc--------ccccCCccCCHHHHHH
Confidence 999999999989999999999999999999 89999987642 233332221 1223356788999999
Q ss_pred HHHhccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 238 MLECWKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 238 i~~cl~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
|.+||+.||++|| +++|+ |+||++.++
T Consensus 420 I~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 420 CSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp HHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred HHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 9999999999999 78999 899988654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=311.97 Aligned_cols=206 Identities=21% Similarity=0.270 Sum_probs=171.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+.+..++|||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||
T Consensus 75 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dl 147 (486)
T 3mwu_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147 (486)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccC
Confidence 35689999999999999999999999999999999999733 46899999999999999999999999999999
Q ss_pred CCCCeeee---cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVG---KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||++ .++.+||+|||+++...... .....
T Consensus 148 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~ 183 (486)
T 3mwu_A 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNT--------------------------------------------KMKDR 183 (486)
T ss_dssp SGGGEEESSSSTTCCEEECSCSCTTTBCCC------------------------------------------------CC
T ss_pred chHHEEEecCCCCCCEEEEECCcCeECCCCC--------------------------------------------ccCCC
Confidence 99999995 45679999999976421110 11344
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|+|||++.+ .++.++|||||||++|+|+ +|..||.+.+..+....+.... .....+....+++++.++
T Consensus 184 ~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 184 IGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL--SGTPPFYGKNEYDILKRVETGK----YAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp TTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHTC----CCSCSGGGGGSCHHHHHH
T ss_pred cCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhCC----CCCCCcccCCCCHHHHHH
Confidence 68899999999875 5899999999999999999 8999999988877776654321 111223345678999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
|.+||+.||++|||+.++ |+|+++...
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 999999999999999999 899987643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=291.82 Aligned_cols=208 Identities=25% Similarity=0.368 Sum_probs=160.1
Q ss_pred CCCCCCeeeEEEEEecC----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-------
Q psy5690 3 SLKDPNLVRVIGVCSTE----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE------- 71 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH------- 71 (434)
+++||||+++++++... +..++||||+++|+|.++++ ...+++..++.++.|++.||+|||
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ 129 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT--------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTT
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh--------hcccCHHHHHHHHHHHHHHHHHHHHhhhhcc
Confidence 48999999999997543 45899999999999999995 246999999999999999999999
Q ss_pred -hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 72 -SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 72 -~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 130 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------~~ 170 (301)
T 3q4u_A 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN---------------------------------------QL 170 (301)
T ss_dssp CBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT---------------------------------------EE
T ss_pred CCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccc---------------------------------------cc
Confidence 99999999999999999999999999999765322110 00
Q ss_pred cccCCCCCCCccccchhhhhcC------CCCCcCChHHHHHHHHHHHhhcC----------CCCCCCCCh----HHHHHh
Q psy5690 151 YLSDTKARLPIRWMAWESLLLG------KNTTKSDVWSFAVTLWEILIHCN----------QRPYAELTN----EQVIEN 210 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDIwSlGvil~ellt~~g----------~~pf~~~~~----~~~~~~ 210 (434)
........||+.|+|||++.+. .++.++|||||||++|||+ +| ..||..... ......
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~--tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 248 (301)
T 3q4u_A 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248 (301)
T ss_dssp ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH--TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH--hhhcCccccccccccccccCCCCcchhhhhH
Confidence 1112345789999999999876 3457899999999999999 77 788865322 111111
Q ss_pred hhhhhhcCCcccCCC---CCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 211 CSHWYQNNSKQQYLP---RPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 211 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
. ..........+ ....+++++.+++.+||+.||++|||++||++.|++.
T Consensus 249 ~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 249 V---VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp H---HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred H---HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 11111111111 1234678899999999999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=300.00 Aligned_cols=204 Identities=18% Similarity=0.207 Sum_probs=162.7
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
.++||||+++++++...+..++||||+ +|+|.+++... ....+++..+..++.||+.||+|||++||+||||||
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 165 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-----NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKP 165 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCc
Confidence 456999999999999999999999999 88999999743 234589999999999999999999999999999999
Q ss_pred CCeeeec-------------------------CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeec
Q psy5690 83 RNCMVGK-------------------------NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKIS 137 (434)
Q Consensus 83 ~NILl~~-------------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (434)
+|||++. ++.+||+|||+++....
T Consensus 166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------------------------------- 214 (360)
T 3llt_A 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------------------------------- 214 (360)
T ss_dssp GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-------------------------------
T ss_pred ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-------------------------------
Confidence 9999975 78899999999754111
Q ss_pred CccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc
Q psy5690 138 DHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN 217 (434)
Q Consensus 138 d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~ 217 (434)
......||+.|+|||++.+..++.++|||||||++|+|+ +|..||......+....+......
T Consensus 215 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~ 277 (360)
T 3llt_A 215 ---------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY--TGSLLFRTHEHMEHLAMMESIIQP 277 (360)
T ss_dssp ---------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHTCC
T ss_pred ---------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH--HCCCCCCCCcHHHHHHHHHHhcCC
Confidence 113456788999999999999999999999999999999 899999988776655444322110
Q ss_pred CC--------------------cccCCCC------------------CCccHHHHHHHHHHhccCCCCCCCCHHHH--HH
Q psy5690 218 NS--------------------KQQYLPR------------------PATCQKEIFDLMLECWKTNETDRPRFSEI--HL 257 (434)
Q Consensus 218 ~~--------------------~~~~~~~------------------~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~ 257 (434)
.. .....+. ....++.+.+|+.+||+.||++|||++|+ |+
T Consensus 278 ~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 278 IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 00 0000000 01123678899999999999999999999 66
Q ss_pred HHH
Q psy5690 258 FLQ 260 (434)
Q Consensus 258 ~L~ 260 (434)
||+
T Consensus 358 ~f~ 360 (360)
T 3llt_A 358 FLE 360 (360)
T ss_dssp GGC
T ss_pred ccC
Confidence 763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=287.38 Aligned_cols=199 Identities=26% Similarity=0.441 Sum_probs=163.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--cccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD--IVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~--iiHr 78 (434)
|++++||||+++++++.+.. ++||||+++|+|.+++.. ....+++..++.++.|++.||+|||++| |+||
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~ 148 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD------KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHR 148 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC------TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCS
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc------ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecC
Confidence 46789999999999986554 799999999999999863 3357999999999999999999999999 9999
Q ss_pred CCCCCCeeeecCCc-----eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 79 DLAARNCMVGKNYT-----IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 79 Dlkp~NILl~~~~~-----~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
||||+||+++.++. +||+|||+++.... .
T Consensus 149 dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----------------------------------------------~ 182 (287)
T 4f0f_A 149 DLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----------------------------------------------S 182 (287)
T ss_dssp CCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS----------------------------------------------C
T ss_pred CCCcceEEEeccCCCCceeEEeCCCCccccccc----------------------------------------------c
Confidence 99999999988776 99999998753111 1
Q ss_pred CCCCCCCccccchhhhh--cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHH--HHhhhhhhhcCCcccCCCCCCc
Q psy5690 154 DTKARLPIRWMAWESLL--LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQV--IENCSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~--~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 229 (434)
.....||+.|+|||++. ...++.++|||||||++|||+ +|..||........ ...+. ........+..
T Consensus 183 ~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~--~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~ 254 (287)
T 4f0f_A 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL--TGEGPFDEYSYGKIKFINMIR------EEGLRPTIPED 254 (287)
T ss_dssp EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH--HSSCTTTTCCCCHHHHHHHHH------HSCCCCCCCTT
T ss_pred ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH--cCCCCCccccccHHHHHHHHh------ccCCCCCCCcc
Confidence 12346788999999984 455688999999999999999 89999987654433 22111 12233445677
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+++++.+++.+||+.||++|||++|+++.|++
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 255 CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 88999999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.69 Aligned_cols=198 Identities=27% Similarity=0.441 Sum_probs=163.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 139 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN------KNCINILWKLEVAKQLAAAMHFLEENTLIHGNV 139 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHT------GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCc
Confidence 35789999999999999999999999999999999999743 234899999999999999999999999999999
Q ss_pred CCCCeeeecCCc--------eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 81 AARNCMVGKNYT--------IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 81 kp~NILl~~~~~--------~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
||+|||++.++. +||+|||+++.....
T Consensus 140 kp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------- 174 (289)
T 4fvq_A 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------------------------------------------- 174 (289)
T ss_dssp CGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---------------------------------------------
T ss_pred CcceEEEecCCcccccccceeeeccCcccccccCc---------------------------------------------
Confidence 999999998887 999999986542111
Q ss_pred cCCCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCcc
Q psy5690 153 SDTKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (434)
....+|..|+|||++.+ ..++.++|||||||++|||+ + +..||............. .....+...
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--~g~~~~~~~~~~~~~~~~~~---------~~~~~~~~~ 241 (289)
T 4fvq_A 175 --DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC--SGGDKPLSALDSQRKLQFYE---------DRHQLPAPK 241 (289)
T ss_dssp --HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHH--TTTCCTTTTSCHHHHHHHHH---------TTCCCCCCS
T ss_pred --cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHH--cCCCCCccccchHHHHHHhh---------ccCCCCCCC
Confidence 11234567999999987 67899999999999999999 6 556666655544433221 122234455
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++++.+++.+||+.||++|||++|+++.|++.
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 77899999999999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=300.44 Aligned_cols=210 Identities=20% Similarity=0.283 Sum_probs=168.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrD 79 (434)
|++++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++ ||+|||
T Consensus 85 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~d 157 (360)
T 3eqc_A 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 157 (360)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSC
T ss_pred HHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 46789999999999999999999999999999999999743 4689999999999999999999996 999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++..... ......|
T Consensus 158 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~---------------------------------------------~~~~~~g 192 (360)
T 3eqc_A 158 VKPSNILVNSRGEIKLCDFGVSGQLIDS---------------------------------------------MANSFVG 192 (360)
T ss_dssp CSGGGEEECTTCCEEECCCCCCHHHHHH---------------------------------------------C----CC
T ss_pred ccHHHEEECCCCCEEEEECCCCcccccc---------------------------------------------cccCCCC
Confidence 9999999999999999999986542110 1123467
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhh-------------------------
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHW------------------------- 214 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~------------------------- 214 (434)
|+.|+|||++.+..++.++|||||||++|+|+ +|..||......+....+...
T Consensus 193 t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (360)
T 3eqc_A 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA--VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270 (360)
T ss_dssp CCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHH--HTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred CCCeECHHHHcCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence 88999999999999999999999999999999 899999887655443221100
Q ss_pred ----------hhcC-CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 215 ----------YQNN-SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 215 ----------~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
.... ...........+++++.+|+.+||+.||++|||++|+ |+||++...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp ---CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 0000 0001111123468899999999999999999999999 899988643
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=289.76 Aligned_cols=207 Identities=35% Similarity=0.643 Sum_probs=171.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++ .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+|||||
T Consensus 76 ~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dik 148 (291)
T 1u46_A 76 HSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 148 (291)
T ss_dssp HHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCc
Confidence 4679999999999997754 899999999999999997432 458999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... ..........+|.
T Consensus 149 p~Nili~~~~~~kl~Dfg~~~~~~~~~----------------------------------------~~~~~~~~~~~~~ 188 (291)
T 1u46_A 149 ARNLLLATRDLVKIGDFGLMRALPQND----------------------------------------DHYVMQEHRKVPF 188 (291)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCC-C----------------------------------------CEEEC-----CCG
T ss_pred hheEEEcCCCCEEEccccccccccccc----------------------------------------cchhhhccCCCCc
Confidence 999999999999999999976532211 0011123345677
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..++.++||||||+++|+|+ + |..||......+....+.. .....+.+..+++++.+++.+
T Consensus 189 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~ 260 (291)
T 1u46_A 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMF--TYGQEPWIGLNGSQILHKIDK------EGERLPRPEDCPQDIYNVMVQ 260 (291)
T ss_dssp GGCCHHHHHHCEEEHHHHHHHHHHHHHHHH--TTSCCTTTTCCHHHHHHHHHT------SCCCCCCCTTCCHHHHHHHHH
T ss_pred eeeCchhhcCCCCCchhhHHHHHHHHHHHH--hCCCCCcccCCHHHHHHHHHc------cCCCCCCCcCcCHHHHHHHHH
Confidence 899999999988999999999999999999 7 8999999887776655432 222344566788999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
||+.||++||++.+++++|++..
T Consensus 261 ~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 261 CWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HccCCcccCcCHHHHHHHHHHhC
Confidence 99999999999999999998764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.71 Aligned_cols=207 Identities=19% Similarity=0.277 Sum_probs=171.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+.+..|+||||++||+|.+++.... .....+++..++.++.||+.||+|||++||+|||||
T Consensus 240 ~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~---~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLK 316 (543)
T 3c4z_A 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD---EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK 316 (543)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSS---TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhh---cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Confidence 46899999999999999999999999999999999997432 124579999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .......||+
T Consensus 317 P~NILl~~~g~vkL~DFGla~~~~~~~-------------------------------------------~~~~~~~GT~ 353 (543)
T 3c4z_A 317 PENVLLDDDGNVRISDLGLAVELKAGQ-------------------------------------------TKTKGYAGTP 353 (543)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCTTC-------------------------------------------CCBCCCCSCT
T ss_pred hHHEEEeCCCCEEEeecceeeeccCCC-------------------------------------------cccccccCCc
Confidence 999999999999999999976521110 0113357899
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC----hHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT----NEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||.... ..+....+.. .....+..+++++.++
T Consensus 354 ~Y~APE~l~~~~~~~~~DiwSlGvilyell--tG~~PF~~~~~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~l 423 (543)
T 3c4z_A 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMI--AARGPFRARGEKVENKELKQRVLE--------QAVTYPDKFSPASKDF 423 (543)
T ss_dssp TTSCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSSCCTTCCCCHHHHHHHHHH--------CCCCCCTTSCHHHHHH
T ss_pred cccChhhhcCCCCChHHhcCcchHHHHHHH--hCCCCCCCCccchhHHHHHHHHhh--------cccCCCcccCHHHHHH
Confidence 999999999999999999999999999999 8999998753 2333333321 1233456788999999
Q ss_pred HHHhccCCCCCCCCH-----HHH--HHHHHhccc
Q psy5690 238 MLECWKTNETDRPRF-----SEI--HLFLQRKNL 264 (434)
Q Consensus 238 i~~cl~~dP~~Rps~-----~el--~~~L~~~~~ 264 (434)
+.+||+.||++||++ ++| |+||+..++
T Consensus 424 i~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 424 CEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp HHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred HHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 999999999999964 777 889987654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=292.06 Aligned_cols=207 Identities=14% Similarity=0.146 Sum_probs=162.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl 160 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAHAAGATHRDV 160 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCC
Confidence 46789999999999999999999999999999999999743 46899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ........++
T Consensus 161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~ 198 (309)
T 2h34_A 161 KPENILVSADDFAYLVDFGIASATTDEK------------------------------------------LTQLGNTVGT 198 (309)
T ss_dssp CGGGEEECTTSCEEECSCCC----------------------------------------------------------CC
T ss_pred ChHHEEEcCCCCEEEecCccCccccccc------------------------------------------cccccccCCC
Confidence 9999999999999999999875421111 0111334578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++||||||+++|+|+ +|..||...........+.. ........+..+++++.+++.+
T Consensus 199 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~ 271 (309)
T 2h34_A 199 LYYMAPERFSESHATYRADIYALTCVLYECL--TGSPPYQGDQLSVMGAHINQ-----AIPRPSTVRPGIPVAFDAVIAR 271 (309)
T ss_dssp GGGCCGGGTCC----CCCHHHHHHHHHHHHH--HSSCSSCSCHHHHHHHHHHS-----CCCCGGGTSTTCCTHHHHHHHH
T ss_pred cCccCHHHHcCCCCCchHhHHHHHHHHHHHH--HCCCCCCCchHHHHHHHhcc-----CCCCccccCCCCCHHHHHHHHH
Confidence 8999999999999999999999999999999 89999988765544332221 1111122345678899999999
Q ss_pred hccCCCCCCC-CHHHHHHHHHhcc
Q psy5690 241 CWKTNETDRP-RFSEIHLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rp-s~~el~~~L~~~~ 263 (434)
||+.||++|| +++++...|++.-
T Consensus 272 ~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 272 GMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred hccCCHHHHHHhHHHHHHHHHHHH
Confidence 9999999999 9999998888753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=294.96 Aligned_cols=210 Identities=16% Similarity=0.220 Sum_probs=166.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++++|.+++. ....+++..+..++.|++.||+|||++||+|||||
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlk 129 (311)
T 4agu_A 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR-------YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVK 129 (311)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-------TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh-------hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 46899999999999999999999999999999999987 44568999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... .......+|.
T Consensus 130 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~~~ 166 (311)
T 4agu_A 130 PENILITKHSVIKLCDFGFARLLTGPS-------------------------------------------DYYDDEVATR 166 (311)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC-------------------------------------------------------G
T ss_pred hhhEEEcCCCCEEEeeCCCchhccCcc-------------------------------------------cccCCCcCCc
Confidence 999999999999999999976522111 0112346788
Q ss_pred cccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC-------------CcccCCCC-
Q psy5690 162 RWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN-------------SKQQYLPR- 226 (434)
Q Consensus 162 ~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~- 226 (434)
.|+|||++.+ ..++.++|||||||++|+|+ +|..||.+....+....+....... ......+.
T Consensus 167 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T 4agu_A 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELL--SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDP 244 (311)
T ss_dssp GGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCC
T ss_pred cccChHHHhcCCCCCcchhhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCc
Confidence 8999999986 56799999999999999999 8899999887766554433211100 00011111
Q ss_pred ---------CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 227 ---------PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 227 ---------~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
...+++++.+++.+||+.||++|||++|+ |+|+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 245 EDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp SSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 13567889999999999999999999999 88998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=288.37 Aligned_cols=200 Identities=19% Similarity=0.301 Sum_probs=164.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.||+.||+|||++|++|||||
T Consensus 66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 138 (276)
T 2h6d_A 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138 (276)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCC
T ss_pred hcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 5789999999999999999999999999999999999743 468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||++....... ......+++
T Consensus 139 p~Nil~~~~~~~~l~dfg~~~~~~~~~--------------------------------------------~~~~~~~~~ 174 (276)
T 2h6d_A 139 PENVLLDAHMNAKIADFGLSNMMSDGE--------------------------------------------FLRTSCGSP 174 (276)
T ss_dssp GGGEEECTTSCEEECCCCGGGCCCC-------------------------------------------------------
T ss_pred hhhEEECCCCCEEEeecccccccCCCc--------------------------------------------ceecccCCc
Confidence 999999999999999999875521110 112345778
Q ss_pred cccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||.+.+..+ +.++||||||+++|+|+ +|..||......+....+.. .....+..+++++.+++.+
T Consensus 175 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~ 244 (276)
T 2h6d_A 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALL--CGTLPFDDEHVPTLFKKIRG--------GVFYIPEYLNRSVATLLMH 244 (276)
T ss_dssp --CCTGGGTTSCCCHHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------CCCCCCTTSCHHHHHHHHH
T ss_pred cccCHHHHcCCCCCCccchHHHHHHHHHHHH--hCCCCCCCCcHHHHHHHhhc--------CcccCchhcCHHHHHHHHH
Confidence 8999999988765 68999999999999999 88999998877766655432 1223356678999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||++|||++|+ |+||++.
T Consensus 245 ~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 245 MLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999 7899864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=293.34 Aligned_cols=216 Identities=21% Similarity=0.332 Sum_probs=168.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---Cccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR---DIVH 77 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~---~iiH 77 (434)
|++++||||+++++++.+++..++||||+++|+|.+++.... .....+++..+..++.|++.||+|||++ ||+|
T Consensus 81 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH 157 (326)
T 3uim_A 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP---ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIH 157 (326)
T ss_dssp GGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCS---TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEEC
T ss_pred HHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Confidence 467899999999999999999999999999999999998443 2334699999999999999999999999 9999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+|||++.++.+||+|||+++...... .......
T Consensus 158 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~ 195 (326)
T 3uim_A 158 RDVKAANILLDEEFEAVVGDFGLAKLMDYKD------------------------------------------THVTTAV 195 (326)
T ss_dssp CCCSGGGEEECTTCCEEECCCSSCEECCSSS------------------------------------------SCEECCC
T ss_pred CCCchhhEEECCCCCEEeccCccccccCccc------------------------------------------ccccccc
Confidence 9999999999999999999999976532111 0112334
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC-----hHHHHHhhhhhhhcC------CcccCCCC
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT-----NEQVIENCSHWYQNN------SKQQYLPR 226 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~-----~~~~~~~~~~~~~~~------~~~~~~~~ 226 (434)
.||+.|+|||++.+..++.++|||||||++|+|+ +|..||.... .......+....... ........
T Consensus 196 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 3uim_A 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI--TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNY 273 (326)
T ss_dssp CSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHH--HCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSC
T ss_pred cCCcCccCHHHhccCCCCccccchhHHHHHHHHH--hCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcccc
Confidence 5889999999999999999999999999999999 8999995211 111111111100000 01111122
Q ss_pred CCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 227 PATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 227 ~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+...++++.+++.+||+.||++|||+.||++.|++..
T Consensus 274 ~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 274 KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 3455688999999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=291.58 Aligned_cols=211 Identities=30% Similarity=0.507 Sum_probs=167.8
Q ss_pred CCCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++.+. +..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 150 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN------KNKINLKQQLKYAVQICKGMDYLGSRQYVHR 150 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHH------TTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc------cccCCHHHHHHHHHHHHHHHHHhhcCCcccC
Confidence 3578999999999999876 6689999999999999999643 2468999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.+||+|||+++...... ..........
T Consensus 151 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----------------------------------------~~~~~~~~~~ 190 (302)
T 4e5w_A 151 DLAARNVLVESEHQVKIGDFGLTKAIETDK----------------------------------------EYYTVKDDRD 190 (302)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTC----------------------------------------CEEECCCCTT
T ss_pred CCchheEEEcCCCCEEECcccccccccCCC----------------------------------------cceeccCCCC
Confidence 999999999999999999999976532211 1111224456
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-----------HHHHhhhhhhhcCCcccCCCCC
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-----------QVIENCSHWYQNNSKQQYLPRP 227 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 227 (434)
+|..|+|||++.+..++.++|||||||++|+|+ +|..|+...... .....+. .........+.+
T Consensus 191 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 265 (302)
T 4e5w_A 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELL--TYCDSDSSPMALFLKMIGPTHGQMTVTRLV---NTLKEGKRLPCP 265 (302)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH--TTTCGGGSHHHHHHHHHCSCCGGGHHHHHH---HHHHTTCCCCCC
T ss_pred CCccccCCeeecCCCCCcchhHHHHHHHHHHHH--HccCCCcchhhHHhhccCCcccccCHHHHH---HHHhccCCCCCC
Confidence 788899999999999999999999999999999 787776432111 0011111 111223345556
Q ss_pred CccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 228 ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 228 ~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
..+++++.+++.+||+.||++|||+.++++.|++.
T Consensus 266 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 266 PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 78899999999999999999999999999998864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=287.36 Aligned_cols=206 Identities=20% Similarity=0.278 Sum_probs=167.2
Q ss_pred CCCCCCCCeeeEEEEE--ecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVC--STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~--~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++ .+.+..++||||+++| |.+++... ....+++..+..++.||+.||+|||++||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~ 133 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV-----PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHK 133 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHS-----TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhC-----cccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 4688999999999998 4456899999999876 88877643 34578999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.+||+|||+++...... .........
T Consensus 134 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~-----------------------------------------~~~~~~~~~ 172 (305)
T 2wtk_C 134 DIKPGNLLLTTGGTLKISALGVAEALHPFA-----------------------------------------ADDTCRTSQ 172 (305)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTC-----------------------------------------SSCEECCCC
T ss_pred CCCcccEEEcCCCcEEeeccccccccCccc-----------------------------------------cccccccCC
Confidence 999999999999999999999976522110 000113345
Q ss_pred CCccccchhhhhcCCC--CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKN--TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~--s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
||..|+|||++.+... +.++|||||||++|||+ +|..||......+....+.. .....+..+++++.+
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~i~~--------~~~~~~~~~~~~l~~ 242 (305)
T 2wtk_C 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNIT--TGLYPFEGDNIYKLFENIGK--------GSYAIPGDCGPPLSD 242 (305)
T ss_dssp SCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHH--------CCCCCCSSSCHHHHH
T ss_pred CCCCCcChhhccCcccCCcchhhHHHHHHHHHHHH--hCCCCCCCchHHHHHHHHhc--------CCCCCCCccCHHHHH
Confidence 7889999999986543 77999999999999999 89999998887776655532 123345678899999
Q ss_pred HHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 237 LMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
++.+||+.||++||+++|+ |+|+++..
T Consensus 243 li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999 78998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=309.78 Aligned_cols=200 Identities=11% Similarity=0.064 Sum_probs=157.6
Q ss_pred CCCCCCCCeeeEE-------EEEecCCc-----------------eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHH
Q psy5690 1 MCSLKDPNLVRVI-------GVCSTEDP-----------------ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56 (434)
Q Consensus 1 l~~L~HpnIv~l~-------~~~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~ 56 (434)
|++++|||||+++ +++.+++. .++||||+ +|+|.+++...+........+++..+
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~ 208 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR 208 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence 4678999999998 77766543 89999999 67999999865422222334556888
Q ss_pred HHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceee
Q psy5690 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKI 136 (434)
Q Consensus 57 ~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (434)
+.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 209 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------------------------------ 258 (377)
T 3byv_A 209 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------------------------------ 258 (377)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC------------------------------
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC------------------------------
Confidence 89999999999999999999999999999999999999999999764111
Q ss_pred cCccccccccCCcccccCCCCCCCccccchhhhhcC-----------CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH
Q psy5690 137 SDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLG-----------KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE 205 (434)
Q Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~ 205 (434)
......| +.|+|||++.+. .++.++|||||||++|||+ +|..||......
T Consensus 259 ----------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell--tg~~Pf~~~~~~ 319 (377)
T 3byv_A 259 ----------------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW--CADLPITKDAAL 319 (377)
T ss_dssp ----------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH--HSSCCC------
T ss_pred ----------------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH--HCCCCCcccccc
Confidence 0123345 789999999987 8999999999999999999 899999765543
Q ss_pred HHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 206 QVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.....+ ......+++++.++|.+||+.||++||++.|+ |+||++.
T Consensus 320 ~~~~~~------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 320 GGSEWI------------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp CCSGGG------------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred cchhhh------------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 322211 11235678999999999999999999999999 7899875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=287.97 Aligned_cols=203 Identities=31% Similarity=0.618 Sum_probs=165.9
Q ss_pred CCCCCCCCeeeEEEEEecC-CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE-DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++||||+++++++.+. +..++||||+++|+|.+++...+ ...+++..+..++.|++.||+|||++|++|||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 142 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence 4688999999999997554 57999999999999999997432 12378899999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||+++.++.+||+|||+++..... .....+
T Consensus 143 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~----------------------------------------------~~~~~~ 176 (278)
T 1byg_A 143 LAARNVLVSEDNVAKVSDFGLTKEASST----------------------------------------------QDTGKL 176 (278)
T ss_dssp CSGGGEEECTTSCEEECCCCC----------------------------------------------------------C
T ss_pred CCcceEEEeCCCcEEEeecccccccccc----------------------------------------------ccCCCc
Confidence 9999999999999999999986542110 112345
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
+..|+|||++.+..++.++||||||+++|+|+ + |..||......+....+.. ......+..+++++.+++
T Consensus 177 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li 247 (278)
T 1byg_A 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIY--SFGRVPYPRIPLKDVVPRVEK-------GYKMDAPDGCPPAVYEVM 247 (278)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCSCTTSCGGGHHHHHTT-------TCCCCCCTTCCHHHHHHH
T ss_pred cccccCHHHhCCCCCCchhcHHHHHHHHHHHH--hCCCCCCCCCCHHHHHHHHhc-------CCCCCCcccCCHHHHHHH
Confidence 67899999999999999999999999999999 6 8999988877666554432 223445677889999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+||+.||++||++.|+.+.|++..
T Consensus 248 ~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 248 KNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCChhhCCCHHHHHHHHHHHH
Confidence 9999999999999999999888753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=288.01 Aligned_cols=204 Identities=37% Similarity=0.634 Sum_probs=170.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++. ++..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++||+|||||
T Consensus 63 ~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dik 136 (279)
T 1qpc_A 63 KQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-----SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136 (279)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH-----HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 4689999999999986 45689999999999999999632 11268999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... ........++.
T Consensus 137 p~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~~ 174 (279)
T 1qpc_A 137 AANILVSDTLSCKIADFGLARLIEDNE------------------------------------------YTAREGAKFPI 174 (279)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSC------------------------------------------EECCTTCCCCT
T ss_pred HhhEEEcCCCCEEECCCcccccccCcc------------------------------------------cccccCCCCcc
Confidence 999999999999999999976532211 11123345677
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..++.++||||||+++|||+ + |..||.+....+....+.. ......+..+++++.+++.+
T Consensus 175 ~y~aPE~~~~~~~~~~~Di~slG~il~el~--~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~ 245 (279)
T 1qpc_A 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLER-------GYRMVRPDNCPEELYQLMRL 245 (279)
T ss_dssp TTSCHHHHHHCEECHHHHHHHHHHHHHHHH--TTTCCSSTTCCHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHHH
T ss_pred CccChhhhccCCCCchhhhHHHHHHHHHHH--hCCCCCCcccCHHHHHHHHhc-------ccCCCCcccccHHHHHHHHH
Confidence 899999999888999999999999999999 6 8999998887776655432 12334456788999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++|||++++.+.|++.
T Consensus 246 ~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 246 CWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccChhhCCCHHHHHHHHHHH
Confidence 9999999999999999888875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=292.44 Aligned_cols=203 Identities=20% Similarity=0.248 Sum_probs=171.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+|||||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dik 133 (304)
T 2jam_A 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133 (304)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCC
T ss_pred HhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 4689999999999999999999999999999999999733 468999999999999999999999999999999
Q ss_pred CCCeee---ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+||++ +.++.+||+|||+++..... ......
T Consensus 134 p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---------------------------------------------~~~~~~ 168 (304)
T 2jam_A 134 PENLLYLTPEENSKIMITDFGLSKMEQNG---------------------------------------------IMSTAC 168 (304)
T ss_dssp GGGCEESSSSTTCCEEBCSCSTTCCCCCB---------------------------------------------TTHHHH
T ss_pred HHHEEEecCCCCCCEEEccCCcceecCCC---------------------------------------------cccccc
Confidence 999999 77889999999986541110 011234
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|+|||++.+..++.++|||||||++|+|+ +|..||......+....+.... .....+....+++++.+++
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~li 242 (304)
T 2jam_A 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL--CGYPPFYEETESKLFEKIKEGY----YEFESPFWDDISESAKDFI 242 (304)
T ss_dssp SCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHHCC----CCCCTTTTTTSCHHHHHHH
T ss_pred CCCCccChHHhccCCCCchhhHHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHcCC----CCCCccccccCCHHHHHHH
Confidence 678899999999999999999999999999999 8999999888777666554321 1112233456789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||++||+++|+ |+|++..
T Consensus 243 ~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 243 CHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHcCCChhHCcCHHHHhcCccccCC
Confidence 99999999999999999 7899864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=294.03 Aligned_cols=195 Identities=17% Similarity=0.134 Sum_probs=156.5
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.+||||++++++|.+++..++||||+ +|+|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 186 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG------ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHH
Confidence 48999999999999999999999999 679999987542 46999999999999999999999999999999999
Q ss_pred CeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccc
Q psy5690 84 NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163 (434)
Q Consensus 84 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y 163 (434)
|||++.++.+||+|||+++...... ......||+.|
T Consensus 187 NIll~~~~~~kl~DFG~a~~~~~~~--------------------------------------------~~~~~~gt~~y 222 (311)
T 3p1a_A 187 NIFLGPRGRCKLGDFGLLVELGTAG--------------------------------------------AGEVQEGDPRY 222 (311)
T ss_dssp GEEECGGGCEEECCCTTCEECC--------------------------------------------------CCCCCGGG
T ss_pred HEEECCCCCEEEccceeeeecccCC--------------------------------------------CCcccCCCccc
Confidence 9999999999999999975421111 11334588999
Q ss_pred cchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhcc
Q psy5690 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWK 243 (434)
Q Consensus 164 ~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 243 (434)
+|||++.+ .++.++|||||||++|||+ +|..|+........ +.. .......+..+++++.+++.+||+
T Consensus 223 ~aPE~~~~-~~~~~~DiwslG~il~el~--~g~~~~~~~~~~~~---~~~------~~~~~~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 223 MAPELLQG-SYGTAADVFSLGLTILEVA--CNMELPHGGEGWQQ---LRQ------GYLPPEFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp CCGGGGGT-CCSTHHHHHHHHHHHHHHH--HTCCCCSSHHHHHH---HTT------TCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred cCHhHhcC-CCCchhhHHHHHHHHHHHH--hCCCCCCCccHHHH---Hhc------cCCCcccccCCCHHHHHHHHHHcC
Confidence 99999876 7899999999999999999 67665554322221 111 001111234578999999999999
Q ss_pred CCCCCCCCHHHH--HHHHHh
Q psy5690 244 TNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 244 ~dP~~Rps~~el--~~~L~~ 261 (434)
.||++|||++|+ |+||++
T Consensus 291 ~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 291 PDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp SSTTTSCCHHHHHTSGGGSC
T ss_pred CChhhCcCHHHHHhCccccC
Confidence 999999999999 778764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.40 Aligned_cols=206 Identities=21% Similarity=0.270 Sum_probs=172.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||
T Consensus 100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dl 172 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLHKHNIVHRDI 172 (504)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 35789999999999999999999999999999999999743 46999999999999999999999999999999
Q ss_pred CCCCeeeecCC---ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVGKNY---TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||++.++ .+||+|||+++...... .....
T Consensus 173 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~ 208 (504)
T 3q5i_A 173 KPENILLENKNSLLNIKIVDFGLSSFFSKDY--------------------------------------------KLRDR 208 (504)
T ss_dssp SGGGEEESSTTCCSSEEECCCTTCEECCTTS--------------------------------------------CBCCC
T ss_pred cHHHEEEecCCCCccEEEEECCCCEEcCCCC--------------------------------------------ccccc
Confidence 99999998775 69999999976521110 11345
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|+|||++. +.++.++||||+||++|+|+ +|..||.+.+..+....+.... .....+....+++++.+|
T Consensus 209 ~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~l 281 (504)
T 3q5i_A 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL--CGYPPFGGQNDQDIIKKVEKGK----YYFDFNDWKNISDEAKEL 281 (504)
T ss_dssp CSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHCC----CCCCHHHHTTSCHHHHHH
T ss_pred cCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHcCC----CCCCccccCCCCHHHHHH
Confidence 6889999999987 56899999999999999999 8999999998887776654311 000111124678999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
+.+||+.||.+|||++|+ |+|+++...
T Consensus 282 i~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 282 IKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred HHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 999999999999999999 899987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=294.79 Aligned_cols=205 Identities=21% Similarity=0.250 Sum_probs=170.0
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+++..++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~N 161 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE-----LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQN 161 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC-----C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh-----cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHH
Confidence 5799999999999999999999999999999998521 34579999999999999999999999999999999999
Q ss_pred eeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 85 CMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 85 ILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
||++. ++.+||+|||+++...... ......||+
T Consensus 162 Il~~~~~~~~~~kL~Dfg~a~~~~~~~--------------------------------------------~~~~~~gt~ 197 (327)
T 3lm5_A 162 ILLSSIYPLGDIKIVDFGMSRKIGHAC--------------------------------------------ELREIMGTP 197 (327)
T ss_dssp EEESCBTTBCCEEECCGGGCEEC-----------------------------------------------------CCCG
T ss_pred EEEecCCCCCcEEEeeCccccccCCcc--------------------------------------------ccccccCCc
Confidence 99987 7899999999976521110 112346788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|+|+ +|..||......+....+... ......+....+++.+.+++.+|
T Consensus 198 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~~~~~li~~~ 271 (327)
T 3lm5_A 198 EYLAPEILNYDPITTATDMWNIGIIAYMLL--THTSPFVGEDNQETYLNISQV----NVDYSEETFSSVSQLATDFIQSL 271 (327)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHT----CCCCCTTTTTTSCHHHHHHHHHH
T ss_pred CccCCeeecCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCchHHHHHHHhc----ccccCchhhcccCHHHHHHHHHH
Confidence 999999999999999999999999999999 899999998877766554332 12223333457889999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 242 WKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
|+.||++|||++++ |+|+++.+.
T Consensus 272 L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 272 LVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp SCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred cCCChhhCcCHHHHhCCHhhccccc
Confidence 99999999999999 889987644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=292.20 Aligned_cols=201 Identities=26% Similarity=0.476 Sum_probs=160.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh---CCcccc
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES---RDIVHR 78 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---~~iiHr 78 (434)
++++||||+++++++. +..++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ +||+||
T Consensus 56 ~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~ 129 (307)
T 2eva_A 56 SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAE----PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129 (307)
T ss_dssp HHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSS----SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCC
T ss_pred hcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccC----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence 4689999999999886 45899999999999999997332 22347889999999999999999999 899999
Q ss_pred CCCCCCeeeecCCc-eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 79 DLAARNCMVGKNYT-IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 79 Dlkp~NILl~~~~~-~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||||+||+++.++. +||+|||+++.... .....
T Consensus 130 dlkp~NIll~~~~~~~kl~Dfg~~~~~~~----------------------------------------------~~~~~ 163 (307)
T 2eva_A 130 DLKPPNLLLVAGGTVLKICDFGTACDIQT----------------------------------------------HMTNN 163 (307)
T ss_dssp CCSGGGEEEETTTTEEEECCCCC---------------------------------------------------------
T ss_pred CCChhHEEEeCCCCEEEEccccccccccc----------------------------------------------ccccC
Confidence 99999999998886 79999998754211 01223
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH--HHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ--VIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
.||..|+|||++.+..++.++|||||||++|||+ +|..||....... ...... .....+.+..+++.+.
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~--~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~ 234 (307)
T 2eva_A 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI--TRRKPFDEIGGPAFRIMWAVH-------NGTRPPLIKNLPKPIE 234 (307)
T ss_dssp -CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHH--HTCCTTTTTCSSHHHHHHHHH-------TTCCCCCBTTCCHHHH
T ss_pred CCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHH--HCCCCchhhCccHHHHHHHHh-------cCCCCCcccccCHHHH
Confidence 5788999999999999999999999999999999 8899998654322 211111 2223444567889999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 236 DLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+++.+||+.||++|||++++++.|++..
T Consensus 235 ~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 235 SLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=289.95 Aligned_cols=205 Identities=18% Similarity=0.225 Sum_probs=168.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.||+.||+|||++|++|||||
T Consensus 63 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 135 (283)
T 3bhy_A 63 REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-------KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLK 135 (283)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence 468899999999999999999999999999999999973 3468999999999999999999999999999999
Q ss_pred CCCeeeecCC----ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 82 ARNCMVGKNY----TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 82 p~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|+||+++.++ .+||+|||+++...... .....
T Consensus 136 p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~--------------------------------------------~~~~~ 171 (283)
T 3bhy_A 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--------------------------------------------EFKNI 171 (283)
T ss_dssp GGGEEESCSSSSSCCEEECCCTTCEECC----------------------------------------------------
T ss_pred hHHEEEecCCCCCCceEEEecccceeccCCC--------------------------------------------ccccc
Confidence 9999998877 79999999875421110 11234
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.+++.|+|||++.+..++.++||||||+++|+|+ +|..||......+....+.... ..........+++.+.++
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l 245 (283)
T 3bhy_A 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL--SGASPFLGETKQETLTNISAVN----YDFDEEYFSNTSELAKDF 245 (283)
T ss_dssp CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHTTC----CCCCHHHHTTCCHHHHHH
T ss_pred CCCcCccCcceecCCCCCcchhhhhHHHHHHHHH--HCCCCCCCcchHHHHHHhHhcc----cCCcchhcccCCHHHHHH
Confidence 5788899999999999999999999999999999 8899999888776665543211 111111124567899999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+.+||+.||++||++.|+ |+|++...
T Consensus 246 i~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 246 IRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 999999999999999999 78998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=302.02 Aligned_cols=214 Identities=15% Similarity=0.165 Sum_probs=164.7
Q ss_pred CCCCCCCCeeeEEEEEecCCc------eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDP------ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|+.++||||++++++|...+. .++||||+++ ++.+.+.... .....+++..+..++.||+.||+|||++|
T Consensus 86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 161 (394)
T 4e7w_A 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYA---KLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161 (394)
T ss_dssp HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHH---HTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 457899999999999965443 8899999987 4444443211 13457999999999999999999999999
Q ss_pred ccccCCCCCCeeee-cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 75 IVHRDLAARNCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 75 iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|+||||||+|||++ .++.+||+|||+++...... .
T Consensus 162 ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~--------------------------------------------~ 197 (394)
T 4e7w_A 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--------------------------------------------P 197 (394)
T ss_dssp EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--------------------------------------------C
T ss_pred ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC--------------------------------------------C
Confidence 99999999999999 79999999999976521111 1
Q ss_pred CCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC--------------
Q psy5690 154 DTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN-------------- 218 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 218 (434)
.....+|+.|+|||++.+. .++.++|||||||++|||+ +|..||.+.+..+....+.......
T Consensus 198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 275 (394)
T 4e7w_A 198 NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM--QGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275 (394)
T ss_dssp CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSS
T ss_pred CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 1345678899999999765 5899999999999999999 8999999988766555443221100
Q ss_pred -CcccCC------CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 219 -SKQQYL------PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 219 -~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
...... ..+..+++++.+|+.+||+.||++|||+.|+ |+||++...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 000000 0123477899999999999999999999999 899987644
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.35 Aligned_cols=206 Identities=19% Similarity=0.334 Sum_probs=172.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|.+++... ...+++..+..++.||+.||.|||++|++||||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl 151 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR------NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDI 151 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCc
Confidence 35789999999999999999999999999999999999632 356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .......|+
T Consensus 152 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 188 (314)
T 3com_A 152 KAGNILLNTEGHAKLADFGVAGQLTDTM-------------------------------------------AKRNTVIGT 188 (314)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECBTTB-------------------------------------------SCBCCCCSC
T ss_pred CHHHEEECCCCCEEEeecccchhhhhhc-------------------------------------------cccCccCCC
Confidence 9999999999999999999975421110 011334678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
..|+|||++.+..++.++||||||+++|+|+ +|..||...........+.. ........+..+++++.+++.+
T Consensus 189 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~ 261 (314)
T 3com_A 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMA--EGKPPYADIHPMRAIFMIPT-----NPPPTFRKPELWSDNFTDFVKQ 261 (314)
T ss_dssp GGGCCHHHHSSSCBCTTHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHH-----SCCCCCSSGGGSCHHHHHHHHH
T ss_pred CCccChhhcCCCCCCccccHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHhc-----CCCcccCCcccCCHHHHHHHHH
Confidence 8999999999999999999999999999999 88999988776554433221 1112223355678999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||++||+++++ |+|++..
T Consensus 262 ~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 262 CLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999 8999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=292.47 Aligned_cols=211 Identities=15% Similarity=0.193 Sum_probs=163.5
Q ss_pred CCCCCCCeeeEEEEEecCC--ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTED--PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
++++||||+++++++...+ ..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++||+|||
T Consensus 62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~D 137 (319)
T 4euu_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS----NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137 (319)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGG----GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence 4689999999999997765 7899999999999999998543 233499999999999999999999999999999
Q ss_pred CCCCCeee----ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 80 LAARNCMV----GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 80 lkp~NILl----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
|||+|||+ +.++.+||+|||+++...... ...
T Consensus 138 lkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~--------------------------------------------~~~ 173 (319)
T 4euu_A 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--------------------------------------------QFV 173 (319)
T ss_dssp CSGGGEEEEECTTSCEEEEECCCTTCEECCTTC--------------------------------------------CBC
T ss_pred CCHHHEEEeccCCCCceEEEccCCCceecCCCC--------------------------------------------cee
Confidence 99999999 777889999999976522111 112
Q ss_pred CCCCCccccchhhhh--------cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh----HHHHHhhhhhhhc------
Q psy5690 156 KARLPIRWMAWESLL--------LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN----EQVIENCSHWYQN------ 217 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~--------~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~----~~~~~~~~~~~~~------ 217 (434)
...||..|+|||++. +..++.++|||||||++|||+ +|..||..... .+....+....-.
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 251 (319)
T 4euu_A 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA--TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251 (319)
T ss_dssp CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH--HSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEE
T ss_pred ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCccchhHHHHHHHhcCCCcccchhh
Confidence 346889999999987 467899999999999999999 89999975432 2222222211000
Q ss_pred -----------CCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 218 -----------NSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 218 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
............+++.+.+++.+||+.||++|||++|+++...+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp ECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 000011122345678899999999999999999999998877654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=294.69 Aligned_cols=209 Identities=17% Similarity=0.231 Sum_probs=168.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+.+..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++||+|||||
T Consensus 67 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 139 (346)
T 1ua2_A 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 139 (346)
T ss_dssp HHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred hhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh------cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCC
Confidence 468999999999999999999999999976 89999863 23468899999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... .......+|+
T Consensus 140 p~Nil~~~~~~~kl~Dfg~a~~~~~~~-------------------------------------------~~~~~~~~t~ 176 (346)
T 1ua2_A 140 PNNLLLDENGVLKLADFGLAKSFGSPN-------------------------------------------RAYTHQVVTR 176 (346)
T ss_dssp GGGEEECTTCCEEECCCGGGSTTTSCC-------------------------------------------CCCCCSCCCC
T ss_pred HHHEEEcCCCCEEEEecccceeccCCc-------------------------------------------ccCCcccccc
Confidence 999999999999999999976522111 1123456788
Q ss_pred cccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCccc---------------CCC
Q psy5690 162 RWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQ---------------YLP 225 (434)
Q Consensus 162 ~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------~~~ 225 (434)
.|+|||++.+. .++.++|||||||++|||+ +|..||.+....+....+........... ...
T Consensus 177 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (346)
T 1ua2_A 177 WYRAPELLFGARMYGVGVDMWAVGCILAELL--LRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 254 (346)
T ss_dssp TTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCC
T ss_pred cccCchHhhCCCCCCchhhhHhHHHHHHHHH--HCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCC
Confidence 99999999764 5789999999999999999 78999998887766655443221110000 000
Q ss_pred C-----CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 226 R-----PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 226 ~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
. ...+++++.+|+.+||+.||++|||++|+ |+|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 255 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 0 14567899999999999999999999999 7888764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=288.50 Aligned_cols=202 Identities=20% Similarity=0.327 Sum_probs=171.7
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++. ...+++..+..++.|++.||.|||++||+|||||
T Consensus 75 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 146 (303)
T 3a7i_A 75 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--------PGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146 (303)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT--------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 46799999999999999999999999999999999995 2468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... .......|+.
T Consensus 147 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~~~ 183 (303)
T 3a7i_A 147 AANVLLSEHGEVKLADFGVAGQLTDTQ-------------------------------------------IKRNTFVGTP 183 (303)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTTB-------------------------------------------CCBCCCCSCG
T ss_pred hheEEECCCCCEEEeecccceecCccc-------------------------------------------cccCccCCCc
Confidence 999999999999999999975522111 0123456788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++||||||+++|+|+ +|..||......+....+.. ......+..++..+.+++.+|
T Consensus 184 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~ 254 (303)
T 3a7i_A 184 FWMAPEVIKQSAYDSKADIWSLGITAIELA--RGEPPHSELHPMKVLFLIPK-------NNPPTLEGNYSKPLKEFVEAC 254 (303)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHH-------SCCCCCCSSCCHHHHHHHHHH
T ss_pred CccCHHHHhcCCCCchhhhHHHHHHHHHHc--cCCCCCCCcCHHHHHHHhhc-------CCCCCCccccCHHHHHHHHHH
Confidence 999999999999999999999999999999 88999998877665544322 122334567889999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 242 WKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~~~ 263 (434)
|+.||++|||++|+ |+|+.+..
T Consensus 255 l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 255 LNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp CCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred cCCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999 78887653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.68 Aligned_cols=205 Identities=20% Similarity=0.250 Sum_probs=166.8
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++|++|||||
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 132 (276)
T 2yex_A 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-------PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIK 132 (276)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB-------TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh-------hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 56899999999999999999999999999999999986 44579999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||++....... .........|+.
T Consensus 133 p~Nil~~~~~~~kl~dfg~~~~~~~~~-----------------------------------------~~~~~~~~~~~~ 171 (276)
T 2yex_A 133 PENLLLDERDNLKISDFGLATVFRYNN-----------------------------------------RERLLNKMCGTL 171 (276)
T ss_dssp GGGEEECTTCCEEECCCTTCEECEETT-----------------------------------------EECCBCCCCSCG
T ss_pred hHHEEEccCCCEEEeeCCCccccCCCc-----------------------------------------chhcccCCcccc
Confidence 999999999999999999975421110 001123456788
Q ss_pred cccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 162 ~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
.|+|||.+.+..+ +.++||||||+++|+|+ +|..||....... ....+.. .....+....+++++.+++.
T Consensus 172 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~ 243 (276)
T 2yex_A 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAML--AGELPWDQPSDSCQEYSDWKE------KKTYLNPWKKIDSAPLALLH 243 (276)
T ss_dssp GGCCGGGGTCSSBCHHHHHHHHHHHHHHHHH--HSSCCCSCSCTTSHHHHHHHT------TCTTSTTGGGSCHHHHHHHH
T ss_pred CccChHHHhcCCCCCCcchHHHHHHHHHHHH--hCCCCCCCCchHHHHHHHhhh------cccccCchhhcCHHHHHHHH
Confidence 9999999987765 77899999999999999 8999998765432 2222111 11122224567899999999
Q ss_pred HhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+||+.||++|||++|+ |+|+++.
T Consensus 244 ~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 244 KILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHCCCCchhCCCHHHHhcCccccCh
Confidence 9999999999999999 7788764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=295.87 Aligned_cols=209 Identities=20% Similarity=0.280 Sum_probs=166.0
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..++||||+++++|.+++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 79 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk 151 (331)
T 4aaa_A 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL-------FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIK 151 (331)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred hhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh-------hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcC
Confidence 46899999999999999999999999999999998876 44569999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||+++...... .......+|.
T Consensus 152 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~t~ 188 (331)
T 4aaa_A 152 PENILVSQSGVVKLCDFGFARTLAAPG-------------------------------------------EVYDDEVATR 188 (331)
T ss_dssp GGGEEECTTSCEEECCCTTC-------------------------------------------------------CCCCC
T ss_pred hheEEEcCCCcEEEEeCCCceeecCCc-------------------------------------------cccCCCcCCc
Confidence 999999999999999999975422111 0112345788
Q ss_pred cccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC-------------CcccCCC--
Q psy5690 162 RWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN-------------SKQQYLP-- 225 (434)
Q Consensus 162 ~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~~-- 225 (434)
.|+|||++.+. .++.++|||||||++|+|+ +|..||......+....+....... ......+
T Consensus 189 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (331)
T 4aaa_A 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMF--MGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEI 266 (331)
T ss_dssp TTCCHHHHTTCTTCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCC
T ss_pred cccCcccccCCCCcchHHHHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccc
Confidence 89999999875 6899999999999999999 8899999887766554433211100 0000000
Q ss_pred --------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 226 --------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 226 --------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
....+++++.+|+.+||+.||++|||++|+ |+||+..
T Consensus 267 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 267 KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp SSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 013567899999999999999999999999 8999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=293.53 Aligned_cols=208 Identities=34% Similarity=0.649 Sum_probs=166.2
Q ss_pred CCCCeeeEEEEEecCC-ceEEEEecCCCCCHHHHHhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 5 KDPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNS---------QENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
+||||+++++++...+ ..++||||+++|+|.+++....... .....+++..++.++.||+.||+|||++|
T Consensus 89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 168 (316)
T 2xir_A 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168 (316)
T ss_dssp CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 6999999999997654 5999999999999999998543110 00223889999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----------------------------------------~~~~~ 207 (316)
T 2xir_A 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----------------------------------------DYVRK 207 (316)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT-----------------------------------------TSEEE
T ss_pred cccccCccceEEECCCCCEEECCCccccccccCc-----------------------------------------cceec
Confidence 9999999999999999999999999976532111 01111
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHH-HhhhhhhhcCCcccCCCCCCccHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVI-ENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
....+|+.|+|||++.+..++.++|||||||++|+|+ + |..||......+.. ..+. .......+..+++
T Consensus 208 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--t~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 278 (316)
T 2xir_A 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF--SLGASPYPGVKIDEEFCRRLK-------EGTRMRAPDYTTP 278 (316)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCSSTTCCCSHHHHHHHH-------HTCCCCCCTTCCH
T ss_pred cCCCcceeecCchhhccccccchhHHHHHHHHHHHHH--hCCCCCCcccchhHHHHHHhc-------cCccCCCCCCCCH
Confidence 2345678899999999999999999999999999999 6 89999876644332 2221 1223344566889
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
++.+++.+||+.||++|||+.|+++.|++.
T Consensus 279 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 279 EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999999888764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=303.17 Aligned_cols=227 Identities=21% Similarity=0.278 Sum_probs=166.1
Q ss_pred CCC-CCCeeeEEEEEecCC--ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 3 SLK-DPNLVRVIGVCSTED--PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 3 ~L~-HpnIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
++. ||||+++++++..++ ..|+||||++ |+|.++++. ..+++..+..++.||+.||+|||++||+|||
T Consensus 64 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrD 134 (388)
T 3oz6_A 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA--------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRD 134 (388)
T ss_dssp HTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH--------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred hccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCC
Confidence 455 999999999997544 6899999997 599999963 3688999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+++................ . .. ...............|
T Consensus 135 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~----------~--------~~----~~~~~~~~~~~~~~~g 192 (388)
T 3oz6_A 135 MKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI----------N--------EN----TENFDDDQPILTDYVA 192 (388)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCC----------C---------------------------CCC
T ss_pred CCHHHeEEcCCCCEEecCCcccccccccccccccccccc----------c--------cc----ccccccccccccCCcc
Confidence 999999999999999999999876433221100000000 0 00 0000001112345678
Q ss_pred Cccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc------------------
Q psy5690 160 PIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK------------------ 220 (434)
Q Consensus 160 t~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------ 220 (434)
|+.|+|||++.+ ..++.++|||||||++|||+ +|..||.+.+..+....+.........
T Consensus 193 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~ 270 (388)
T 3oz6_A 193 TRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL--CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESL 270 (388)
T ss_dssp GGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHH
T ss_pred cCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC
Confidence 999999999986 67899999999999999999 899999988877666554322111000
Q ss_pred --------ccC-------------CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 221 --------QQY-------------LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 221 --------~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
... ......+++++.+|+.+||+.||++|||++|+ |+||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 271 KEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred cccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 000 00123567899999999999999999999999 8898764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=295.86 Aligned_cols=216 Identities=33% Similarity=0.480 Sum_probs=170.9
Q ss_pred CCCCCCCCeeeEEEEEe--cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCS--TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++. +.+..++||||+++|+|.+++...+ ..+++..++.++.|++.||+|||++||+||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~ 151 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLGSRRCVHR 151 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 35789999999999986 4456899999999999999997432 358999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+|||++.++.+||+|||+++...... ..........
T Consensus 152 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~----------------------------------------~~~~~~~~~~ 191 (327)
T 3lxl_A 152 DLAARNILVESEAHVKIADFGLAKLLPLDK----------------------------------------DYYVVREPGQ 191 (327)
T ss_dssp CCSGGGEEEEETTEEEECCGGGCEECCTTC----------------------------------------SEEECSSCCC
T ss_pred CCChhhEEECCCCCEEEcccccceecccCC----------------------------------------ccceeeccCC
Confidence 999999999999999999999976532111 1111223456
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHh--------hhhhhhcCCcccCCCCCCcc
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIEN--------CSHWYQNNSKQQYLPRPATC 230 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 230 (434)
+|..|+|||++.+..++.++|||||||++|+|+ +|..||........... ..............+.+..+
T Consensus 192 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (327)
T 3lxl_A 192 SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF--TYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPAC 269 (327)
T ss_dssp SCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH--TTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTC
T ss_pred ccccccCHHHhccCCCChHHhHHHHHHHHHHHH--hCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcc
Confidence 788899999999999999999999999999999 88999876443211100 00011111233345557788
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
++++.+++.+||+.||++|||++|+++.|+....
T Consensus 270 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 270 PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999999998644
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=289.64 Aligned_cols=211 Identities=19% Similarity=0.282 Sum_probs=166.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++.+++..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl 156 (319)
T 2y4i_B 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD------AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156 (319)
T ss_dssp GTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS------SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 4688999999999999999999999999999999999962 2346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++ ++.+||+|||+++....... ...........|+
T Consensus 157 kp~NIl~~-~~~~~l~Dfg~~~~~~~~~~--------------------------------------~~~~~~~~~~~g~ 197 (319)
T 2y4i_B 157 KSKNVFYD-NGKVVITDFGLFSISGVLQA--------------------------------------GRREDKLRIQNGW 197 (319)
T ss_dssp CSTTEEEC---CCEECCCSCCC------------------------------------------------CCSCBCCSGG
T ss_pred ChhhEEEe-CCCEEEeecCCccccccccc--------------------------------------cccccccccCCCc
Confidence 99999998 68999999998765221110 0001112334578
Q ss_pred ccccchhhhhc---------CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccH
Q psy5690 161 IRWMAWESLLL---------GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 161 ~~y~aPE~~~~---------~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
..|+|||++.+ ..++.++|||||||++|||+ +|..||...........+... .........++
T Consensus 198 ~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~--~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 269 (319)
T 2y4i_B 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH--AREWPFKTQPAEAIIWQMGTG------MKPNLSQIGMG 269 (319)
T ss_dssp GGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH--HSSCSSSSCCHHHHHHHHHTT------CCCCCCCSSCC
T ss_pred ccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHhccC------CCCCCCcCCCC
Confidence 89999999975 34688999999999999999 889999988877766544321 11111233577
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
+++.+++.+||+.||++|||++++++.|++...
T Consensus 270 ~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 270 KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 899999999999999999999999999998643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=295.77 Aligned_cols=202 Identities=19% Similarity=0.303 Sum_probs=158.7
Q ss_pred CCCC--CCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 3 SLKD--PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 3 ~L~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
+++| |||+++++++.+++..++||| +.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||
T Consensus 63 ~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDi 134 (343)
T 3dbq_A 63 KLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK-------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDL 134 (343)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH-------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred hhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 4555 999999999999999999999 457899999983 357899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++ ++.+||+|||+++...... .........||
T Consensus 135 kp~NIll~-~~~~kl~DFG~a~~~~~~~-----------------------------------------~~~~~~~~~gt 172 (343)
T 3dbq_A 135 KPANFLIV-DGMLKLIDFGIANQMQPDT-----------------------------------------TSVVKDSQVGT 172 (343)
T ss_dssp CGGGEEEE-TTEEEECCCSSSCCC-----------------------------------------------------CCC
T ss_pred CcceEEEE-CCcEEEeecccccccCccc-----------------------------------------ccccCCCCcCC
Confidence 99999997 6789999999976532111 01112345688
Q ss_pred ccccchhhhhc-----------CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhhcCCcccCCCCCC
Q psy5690 161 IRWMAWESLLL-----------GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRPA 228 (434)
Q Consensus 161 ~~y~aPE~~~~-----------~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 228 (434)
+.|+|||++.+ ..++.++|||||||++|||+ +|..||...... .....+. ........+.
T Consensus 173 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~ 244 (343)
T 3dbq_A 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT--YGKTPFQQIINQISKLHAII------DPNHEIEFPD 244 (343)
T ss_dssp CSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHH--HSSCTTTTCCSHHHHHHHHH------CTTSCCCCCC
T ss_pred cCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHH--hCCCcchhhhhHHHHHHHHh------cCCcccCCcc
Confidence 99999999975 67789999999999999999 899999875433 2222111 1222334456
Q ss_pred ccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 229 TCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 229 ~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
..++++.+++.+||+.||++|||+.|+ |+|++..
T Consensus 245 ~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 677899999999999999999999999 8999853
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=288.08 Aligned_cols=200 Identities=23% Similarity=0.353 Sum_probs=160.7
Q ss_pred CCCCCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--
Q psy5690 1 MCSLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD-- 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-- 74 (434)
|++++||||+++++++.. +...++||||+++|+|.+++... ..+++..++.++.||+.||.|||++|
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~~~ 151 (290)
T 1t4h_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRTPP 151 (290)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 468899999999999865 35589999999999999999743 46899999999999999999999999
Q ss_pred ccccCCCCCCeeee-cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 75 IVHRDLAARNCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 75 iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|+||||||+||+++ .++.+||+|||+++..... .
T Consensus 152 i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~---------------------------------------------~ 186 (290)
T 1t4h_A 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---------------------------------------------F 186 (290)
T ss_dssp CCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---------------------------------------------S
T ss_pred EEECCCCHHHEEEECCCCCEEEeeCCCccccccc---------------------------------------------c
Confidence 99999999999997 7889999999987531111 1
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHH-HHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQV-IENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
.....||+.|+|||++. +.++.++|||||||++|+|+ +|..||........ ...+.. .......+...++
T Consensus 187 ~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~--~g~~pf~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 187 AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMA--TSEYPYSECQNAAQIYRRVTS------GVKPASFDKVAIP 257 (290)
T ss_dssp BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHH--HSSCTTTTCSSHHHHHHHHTT------TCCCGGGGGCCCH
T ss_pred cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHH--hCCCCCCCcCcHHHHHHHHhc------cCCccccCCCCCH
Confidence 12345788899999886 45899999999999999999 88999987554433 322221 1111122345668
Q ss_pred HHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
++.+++.+||+.||++|||++|+ |+||++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 99999999999999999999999 678765
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=300.00 Aligned_cols=199 Identities=18% Similarity=0.260 Sum_probs=165.0
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++...+..++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 158 ~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~N 230 (365)
T 2y7j_A 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE-------KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPEN 230 (365)
T ss_dssp TCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 799999999999999999999999999999999973 3468999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
|+++.++.+||+|||+++...... ......||+.|+
T Consensus 231 Il~~~~~~ikl~DfG~~~~~~~~~--------------------------------------------~~~~~~gt~~y~ 266 (365)
T 2y7j_A 231 ILLDDNMQIRLSDFGFSCHLEPGE--------------------------------------------KLRELCGTPGYL 266 (365)
T ss_dssp EEECTTCCEEECCCTTCEECCTTC--------------------------------------------CBCCCCSCGGGC
T ss_pred EEECCCCCEEEEecCcccccCCCc--------------------------------------------ccccCCCCCCcc
Confidence 999999999999999875422110 113456889999
Q ss_pred chhhhhcC------CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 165 AWESLLLG------KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 165 aPE~~~~~------~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
|||++.+. .++.++|||||||++|+|+ +|..||...........+.... .....+....+++++.+++
T Consensus 267 aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell--~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~~~~li 340 (365)
T 2y7j_A 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLL--AGSPPFWHRRQILMLRMIMEGQ----YQFSSPEWDDRSSTVKDLI 340 (365)
T ss_dssp CHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHTC----CCCCHHHHSSSCHHHHHHH
T ss_pred ChhhccccccccCcCCCchhhHHhHHHHHHHHH--HCCCCCCCCCHHHHHHHHHhCC----CCCCCcccccCCHHHHHHH
Confidence 99998743 5788999999999999999 8999999887766655443211 1111111245678899999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHH
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQ 260 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~ 260 (434)
.+||+.||++||+++|+ |+||+
T Consensus 341 ~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 341 SRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HHHcCCChhHCcCHHHHhcCcccC
Confidence 99999999999999999 66765
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=295.45 Aligned_cols=208 Identities=17% Similarity=0.199 Sum_probs=157.7
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~ 140 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHH
Confidence 57999999999999999999999999999999999743 46899999999999999999999999999999999
Q ss_pred CeeeecCCc---eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 84 NCMVGKNYT---IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 84 NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|||++.++. +||+|||+++........ ............||
T Consensus 141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~~gt 184 (316)
T 2ac3_A 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDC------------------------------------SPISTPELLTPCGS 184 (316)
T ss_dssp GEEESCSSSSCSEEECCTTCCC-------------------------------------------------------CCS
T ss_pred HEEEccCCCcCceEEEEccCccccccCCcc------------------------------------ccccccccccccCC
Confidence 999988766 999999997653211100 00000111334688
Q ss_pred ccccchhhhhc-----CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh---------------HHHHHhhhhhhhcCCc
Q psy5690 161 IRWMAWESLLL-----GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN---------------EQVIENCSHWYQNNSK 220 (434)
Q Consensus 161 ~~y~aPE~~~~-----~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~---------------~~~~~~~~~~~~~~~~ 220 (434)
..|+|||++.+ ..++.++|||||||++|||+ +|..||..... ......+...
T Consensus 185 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------ 256 (316)
T 2ac3_A 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL--SGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG------ 256 (316)
T ss_dssp GGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH--HSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHC------
T ss_pred cCccChHHhhcccccccCCCcccccHhHHHHHHHHH--HCCCCCcccccccccccccccchhHHHHHHHHHhcc------
Confidence 99999999975 45789999999999999999 88999977542 1222222110
Q ss_pred ccCCC--CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 221 QQYLP--RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 221 ~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
....+ ....+++++.+|+.+||+.||++|||++|+ |+||++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 00111 013567899999999999999999999999 6788764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=296.88 Aligned_cols=194 Identities=16% Similarity=0.236 Sum_probs=141.2
Q ss_pred eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcc
Q psy5690 22 ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMY 101 (434)
Q Consensus 22 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla 101 (434)
.++|||||++|+|.+++.... .....++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 211 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRC----SLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCC----SGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEecCCCCHHHHHhccc----CccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcc
Confidence 799999999999999998543 2334566778999999999999999999999999999999999999999999998
Q ss_pred cccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChH
Q psy5690 102 CSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVW 181 (434)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIw 181 (434)
+........... ..............||+.|+|||++.+..++.++|||
T Consensus 212 ~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 260 (332)
T 3qd2_B 212 TAMDQDEEEQTV-------------------------------LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260 (332)
T ss_dssp EECSCC---------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHH
T ss_pred cccccchhhccc-------------------------------cccccccccccccCCCcCccChHHhcCCCCcchhhHH
Confidence 764332210000 0000111223456789999999999999999999999
Q ss_pred HHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHH
Q psy5690 182 SFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFL 259 (434)
Q Consensus 182 SlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L 259 (434)
||||++|||+ +|..|+... ........ ...........++++.+++.+||+.||++||+++|+ |+||
T Consensus 261 slG~il~el~--~~~~~~~~~--~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f 329 (332)
T 3qd2_B 261 SLGLILFELL--YSFSTQMER--VRIITDVR-------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329 (332)
T ss_dssp HHHHHHHHHH--SCCCCHHHH--HHHHHHHH-------TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred HHHHHHHHHH--HcCCChhHH--HHHHHHhh-------ccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhh
Confidence 9999999999 766554221 11111111 111111123455788999999999999999999999 5566
Q ss_pred Hh
Q psy5690 260 QR 261 (434)
Q Consensus 260 ~~ 261 (434)
++
T Consensus 330 ~~ 331 (332)
T 3qd2_B 330 EN 331 (332)
T ss_dssp CC
T ss_pred hc
Confidence 53
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=288.50 Aligned_cols=196 Identities=18% Similarity=0.230 Sum_probs=157.0
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++.+++..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N 145 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYR---IMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHH
Confidence 899999999999999999999999999999999975421 12568999999999999999999999999999999999
Q ss_pred eeeecC-------------------CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccc
Q psy5690 85 CMVGKN-------------------YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSH 145 (434)
Q Consensus 85 ILl~~~-------------------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 145 (434)
|+++.+ ..+||+|||.++....
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--------------------------------------- 186 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--------------------------------------- 186 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTC---------------------------------------
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCC---------------------------------------
Confidence 999844 4789999998654211
Q ss_pred cCCcccccCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCC
Q psy5690 146 YESDYYLSDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYL 224 (434)
Q Consensus 146 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (434)
.....||..|+|||++.+. .++.++|||||||++|+|+ +|..++......... . .....
T Consensus 187 --------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~~~~~~~~~~~~~~~---~-------~~~~~ 246 (289)
T 1x8b_A 187 --------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA--GAEPLPRNGDQWHEI---R-------QGRLP 246 (289)
T ss_dssp --------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT--TCCCCCSSSHHHHHH---H-------TTCCC
T ss_pred --------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh--cCCCCCcchhHHHHH---H-------cCCCC
Confidence 1223478899999999876 5568999999999999999 777766544322221 1 12233
Q ss_pred CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 225 PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 225 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
..+..+++++.+++.+||+.||++|||+.|+ |+||++.
T Consensus 247 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 247 RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 4466788999999999999999999999999 7787753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=307.98 Aligned_cols=205 Identities=18% Similarity=0.224 Sum_probs=158.9
Q ss_pred CCCCCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 2 CSLKDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
+.++||||+++++++...+ ..|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||++||
T Consensus 116 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~---------~~l~~~~~~~~~~qil~aL~~lH~~~i 185 (464)
T 3ttj_A 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAGI 185 (464)
T ss_dssp HHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4689999999999996553 46999999976 6777775 248999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+||+|||+++..... ....
T Consensus 186 iHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--------------------------------------------~~~~ 221 (464)
T 3ttj_A 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--------------------------------------------FMMT 221 (464)
T ss_dssp CCCCCCGGGEEECTTSCEEECCCCCC-----C--------------------------------------------CCC-
T ss_pred ccCCCChHhEEEeCCCCEEEEEEEeeeecCCC--------------------------------------------cccC
Confidence 99999999999999999999999997652111 0123
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC-----------------
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN----------------- 218 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 218 (434)
...||+.|+|||++.+..++.++|||||||++|||+ +|+.||.+.+..+....+.......
T Consensus 222 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell--~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~ 299 (464)
T 3ttj_A 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299 (464)
T ss_dssp ---CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHT
T ss_pred CCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhh
Confidence 457889999999999999999999999999999999 8999999888766555443221100
Q ss_pred --CcccCCCC----CC-----------ccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 --SKQQYLPR----PA-----------TCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 --~~~~~~~~----~~-----------~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
........ +. ..++++.+|+.+||+.||++|||++|+ |+||+..
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00000000 00 116789999999999999999999999 8899753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=298.08 Aligned_cols=200 Identities=21% Similarity=0.275 Sum_probs=163.5
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++..++..++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 117 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N 189 (355)
T 1vzo_A 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 189 (355)
T ss_dssp TCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 6999999999999999999999999999999999743 468999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
||++.++.+||+|||+++...... ........||+.|+
T Consensus 190 Ill~~~~~~kl~DfG~a~~~~~~~------------------------------------------~~~~~~~~gt~~y~ 227 (355)
T 1vzo_A 190 ILLDSNGHVVLTDFGLSKEFVADE------------------------------------------TERAYDFCGTIEYM 227 (355)
T ss_dssp EEECTTSCEEESCSSEEEECCGGG------------------------------------------GGGGCGGGSCCTTC
T ss_pred EEECCCCcEEEeeCCCCeecccCC------------------------------------------CCcccCcccCcCcc
Confidence 999999999999999976532111 00112346789999
Q ss_pred chhhhhcC--CCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh----HHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 165 AWESLLLG--KNTTKSDVWSFAVTLWEILIHCNQRPYAELTN----EQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 165 aPE~~~~~--~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
|||++.+. .++.++|||||||++|||+ +|..||..... ......+. ....+.+..+++.+.+|+
T Consensus 228 aPE~~~~~~~~~~~~~DvwslG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li 297 (355)
T 1vzo_A 228 APDIVRGGDSGHDKAVDWWSLGVLMYELL--TGASPFTVDGEKNSQAEISRRIL--------KSEPPYPQEMSALAKDLI 297 (355)
T ss_dssp CHHHHTTCC---CTHHHHHHHHHHHHHHH--HSSCTTSCTTSCCCHHHHHHHHH--------HCCCCCCTTSCHHHHHHH
T ss_pred ChhhhcCCCCCCCchhhHHHHHHHHHHHH--HCCCCCccCCccchHHHHHHHHh--------ccCCCCCcccCHHHHHHH
Confidence 99999863 4689999999999999999 88999975432 22222211 123344667889999999
Q ss_pred HHhccCCCCCCC-----CHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRP-----RFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rp-----s~~el--~~~L~~~~ 263 (434)
.+||+.||++|| +++|+ |+|+++.+
T Consensus 298 ~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp HHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 999999999999 99999 78887754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=289.09 Aligned_cols=207 Identities=24% Similarity=0.309 Sum_probs=165.8
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+.+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++||+|||||
T Consensus 74 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~ 149 (295)
T 2clq_A 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW----GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149 (295)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT----CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc----cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCC
Confidence 57899999999999999999999999999999999997542 23456788999999999999999999999999999
Q ss_pred CCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 82 ARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 82 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
|+||+++. ++.+||+|||+++...... .......|+
T Consensus 150 p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 186 (295)
T 2clq_A 150 GDNVLINTYSGVLKISDFGTSKRLAGIN-------------------------------------------PCTETFTGT 186 (295)
T ss_dssp GGGEEEETTTCCEEECCTTTCEESCC------------------------------------------------CCCCCC
T ss_pred hhhEEEECCCCCEEEeecccccccCCCC-------------------------------------------CcccccCCC
Confidence 99999998 8999999999876421110 011334678
Q ss_pred ccccchhhhhcCC--CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 161 IRWMAWESLLLGK--NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 161 ~~y~aPE~~~~~~--~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
..|+|||++.+.. ++.++||||||+++|+|+ +|..||.............. ........+..+++++.+++
T Consensus 187 ~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA--TGKPPFYELGEPQAAMFKVG-----MFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp GGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHH--HTSCTTGGGSSHHHHHHHHH-----HHCCCCCCCTTSCHHHHHHH
T ss_pred ccccChhhhcCCCCCCCcHHHHHHHHHHHHHHH--HCCCCccCCCchhHHHHhhc-----cccccccccccCCHHHHHHH
Confidence 8999999998654 789999999999999999 88999976544332111100 01122344667889999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||++||+++++ |+|++..
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHccCChhhCCCHHHHhcChhhhhc
Confidence 99999999999999999 6788754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=285.74 Aligned_cols=206 Identities=20% Similarity=0.292 Sum_probs=157.8
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDl 80 (434)
+.++||||+++++++.+++..++||||++ |+|.+++.... .....+++..++.++.|++.||+|||++ ||+||||
T Consensus 61 ~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl 136 (290)
T 3fme_A 61 RTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVI---DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDV 136 (290)
T ss_dssp TTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCC
T ss_pred HhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCC
Confidence 57899999999999999999999999997 59888876421 1345799999999999999999999998 9999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ......||
T Consensus 137 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------~~~~~~~t 172 (290)
T 3fme_A 137 KPSNVLINALGQVKMCDFGISGYLVDDV--------------------------------------------AKDIDAGC 172 (290)
T ss_dssp SGGGCEECTTCCEEBCCC-----------------------------------------------------------CCC
T ss_pred CHHHEEECCCCCEEEeecCCcccccccc--------------------------------------------cccccCCC
Confidence 9999999999999999999976521110 11233578
Q ss_pred ccccchhhh----hcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 161 IRWMAWESL----LLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 161 ~~y~aPE~~----~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
+.|+|||++ .+..++.++|||||||++|+|+ +|..||..... ......... ..........+++++.
T Consensus 173 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 244 (290)
T 3fme_A 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELA--ILRFPYDSWGTPFQQLKQVVE------EPSPQLPADKFSAEFV 244 (290)
T ss_dssp CCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH--HTSCSSCCCSCHHHHHHHHHH------SCCCCCCTTTSCHHHH
T ss_pred ccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH--HCCCCccccCchHHHHHHHhc------cCCCCcccccCCHHHH
Confidence 889999996 4567899999999999999999 88999986433 222222111 1111222356789999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+++.+||+.||++|||++|+ |+|++...
T Consensus 245 ~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 245 DFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 99999999999999999999 88998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=305.68 Aligned_cols=237 Identities=17% Similarity=0.240 Sum_probs=158.5
Q ss_pred CCCCCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++++|||||++++++... +.+|+||||+ +|+|.+++. ....+++..+..++.||+.||+|||++||+
T Consensus 107 ~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-------~~~~l~~~~~~~~~~qi~~aL~~LH~~~ii 178 (458)
T 3rp9_A 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR-------TPVYLTELHIKTLLYNLLVGVKYVHSAGIL 178 (458)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHH-------SSCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcc-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcC
Confidence 468999999999999433 5699999998 569999997 446799999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+|||++.++.+||+|||+++............ +... ........++. ...........
T Consensus 179 HrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~----~~~~-------~~~~~~~~~~~-----~~~~~~~~~~~ 242 (458)
T 3rp9_A 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL----PISP-------REDDMNLVTFP-----HTKNLKRQLTG 242 (458)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCC----C-------------------------------------
T ss_pred CCCCChhhEEECCCCCEeecccccchhccCcccccccc----ccCc-------ccccccccccc-----ccccccccccC
Confidence 99999999999999999999999998754322110000 0000 00000000000 00001112345
Q ss_pred CCCCccccchhhhh-cCCCCCcCChHHHHHHHHHHHhhc-----------CCCCCCCCCh--------------------
Q psy5690 157 ARLPIRWMAWESLL-LGKNTTKSDVWSFAVTLWEILIHC-----------NQRPYAELTN-------------------- 204 (434)
Q Consensus 157 ~~gt~~y~aPE~~~-~~~~s~~sDIwSlGvil~ellt~~-----------g~~pf~~~~~-------------------- 204 (434)
..||+.|+|||++. +..++.++|||||||++|||+ + |.++|.+...
T Consensus 243 ~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell--tg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~ 320 (458)
T 3rp9_A 243 HVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL--NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGN 320 (458)
T ss_dssp --CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH--TTSTTTCSSGGGCCCSCC--------------------CHHH
T ss_pred CcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH--HhccccccccccccccCCCCccccccccccccccccccccCC
Confidence 67899999999874 567899999999999999999 5 5666655431
Q ss_pred HHHHHhhhhhh--------------------hc---CCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHH
Q psy5690 205 EQVIENCSHWY--------------------QN---NSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFL 259 (434)
Q Consensus 205 ~~~~~~~~~~~--------------------~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L 259 (434)
.+....+.... .. ............+++++.+||.+||+.||++|||++|+ |+||
T Consensus 321 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 321 RDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 11111111000 00 00001111124557899999999999999999999999 8999
Q ss_pred Hhccc
Q psy5690 260 QRKNL 264 (434)
Q Consensus 260 ~~~~~ 264 (434)
++...
T Consensus 401 ~~~~~ 405 (458)
T 3rp9_A 401 KEVRI 405 (458)
T ss_dssp TTTCC
T ss_pred hhcCC
Confidence 88643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=288.21 Aligned_cols=222 Identities=18% Similarity=0.267 Sum_probs=165.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN-SQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++||||+++++++..++..++||||+++|+|.+++...... ......+++..++.++.||+.||+|||++||+|||
T Consensus 67 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 146 (303)
T 2vwi_A 67 MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRD 146 (303)
T ss_dssp CCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 56889999999999999999999999999999999999742211 11245689999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||+++.++.+||+|||+++........ ..........|
T Consensus 147 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--------------------------------------~~~~~~~~~~~ 188 (303)
T 2vwi_A 147 VKAGNILLGEDGSVQIADFGVSAFLATGGDI--------------------------------------TRNKVRKTFVG 188 (303)
T ss_dssp CSGGGEEECTTCCEEECCCHHHHHCC-----------------------------------------------------C
T ss_pred CChhhEEEcCCCCEEEEeccchheeccCCCc--------------------------------------cchhhhcccCC
Confidence 9999999999999999999987553211100 00011233467
Q ss_pred Cccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC--CcccCCCCCCccHHHHHH
Q psy5690 160 PIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN--SKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 160 t~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ 236 (434)
|+.|+|||++.+ ..++.++|||||||++|+|+ +|..||......+............ ...........+++++.+
T Consensus 189 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (303)
T 2vwi_A 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELA--TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRK 266 (303)
T ss_dssp CCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH--HSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHH
T ss_pred CccccCHHHhccccCCCchhhHHHHHHHHHHHH--hCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHH
Confidence 889999999976 56899999999999999999 8999998876655433221100000 000111223567889999
Q ss_pred HHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 237 LMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
++.+||+.||++||+++|+ |+||++.
T Consensus 267 li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 267 MISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred HHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 9999999999999999999 6788764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=297.20 Aligned_cols=205 Identities=16% Similarity=0.258 Sum_probs=166.3
Q ss_pred CCCCCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 2 CSLKDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
++++||||+++++++..++ ..|+||||+ +++|.++++. ..+++..+..++.||+.||+|||++||
T Consensus 79 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~i 149 (367)
T 1cm8_A 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAAGI 149 (367)
T ss_dssp HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4689999999999997653 469999999 7899999963 358999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+||+|||+++.... ...
T Consensus 150 vH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~----------------------------------------------~~~ 183 (367)
T 1cm8_A 150 IHRDLKPGNLAVNEDCELKILDFGLARQADS----------------------------------------------EMT 183 (367)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCS----------------------------------------------SCC
T ss_pred cccCcCHHHEEEcCCCCEEEEeeeccccccc----------------------------------------------ccC
Confidence 9999999999999999999999999764211 113
Q ss_pred CCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc-----------------
Q psy5690 156 KARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN----------------- 217 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~----------------- 217 (434)
...+|..|+|||++.+ ..++.++||||+||++|||+ +|..||.+.+..+....+......
T Consensus 184 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 261 (367)
T 1cm8_A 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI--TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261 (367)
T ss_dssp SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHH
T ss_pred cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHH
Confidence 4567889999999987 67899999999999999999 899999988776655444321110
Q ss_pred ------CCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 218 ------NSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 218 ------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
............+++++.+|+.+||+.||++|||++|+ |+||++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 262 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00011111234568899999999999999999999999 78998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=294.23 Aligned_cols=212 Identities=30% Similarity=0.530 Sum_probs=167.8
Q ss_pred CCCCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
++++||||+++++++.+. ...++||||+++|+|.+++.. ..+++..++.++.||+.||+|||++||+|||
T Consensus 88 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~D 159 (318)
T 3lxp_A 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRD 159 (318)
T ss_dssp HHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh--------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 468999999999999874 568999999999999999963 2489999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+||+++.++.+||+|||+++...... ..........+
T Consensus 160 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~----------------------------------------~~~~~~~~~~~ 199 (318)
T 3lxp_A 160 LAARNVLLDNDRLVKIGDFGLAKAVPEGH----------------------------------------EYYRVREDGDS 199 (318)
T ss_dssp CSGGGEEECTTCCEEECCGGGCEECCTTC----------------------------------------SEEEC---CCC
T ss_pred CchheEEEcCCCCEEECCccccccccccc----------------------------------------cccccccCCCC
Confidence 99999999999999999999976532211 11112234457
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHH--------hhhhhhhcCCcccCCCCCCccH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIE--------NCSHWYQNNSKQQYLPRPATCQ 231 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 231 (434)
|..|+|||++.+..++.++|||||||++|+|+ +|..||.......... ...............+.+..++
T Consensus 200 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (318)
T 3lxp_A 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELL--THCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCP 277 (318)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH--TTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCC
T ss_pred CceeeChHHhcCCCCCcHHHHHHHHHHHHHHH--hCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCcccc
Confidence 78899999999999999999999999999999 8899987643221100 0000011112233455577889
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+++.+++.+||+.||++|||++|++++|++..
T Consensus 278 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 278 AEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 99999999999999999999999999988753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=288.27 Aligned_cols=208 Identities=24% Similarity=0.343 Sum_probs=161.3
Q ss_pred CCCCCCeeeEEEEEecC----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-----
Q psy5690 3 SLKDPNLVRVIGVCSTE----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR----- 73 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~----- 73 (434)
.++||||+++++++... +..++||||+++|+|.++++. ..+++..++.++.|++.||+|||++
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ 158 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTT
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence 46999999999999877 679999999999999999963 2589999999999999999999998
Q ss_pred ---CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 74 ---DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 74 ---~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 159 ~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------~~ 199 (337)
T 3mdy_A 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN---------------------------------------EV 199 (337)
T ss_dssp CBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------------------------------------------
T ss_pred cCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccc---------------------------------------cc
Confidence 999999999999999999999999999765322110 00
Q ss_pred cccCCCCCCCccccchhhhhcCCCCCc------CChHHHHHHHHHHHhhcC----------CCCCCCCCh----HHHHHh
Q psy5690 151 YLSDTKARLPIRWMAWESLLLGKNTTK------SDVWSFAVTLWEILIHCN----------QRPYAELTN----EQVIEN 210 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~~~s~~------sDIwSlGvil~ellt~~g----------~~pf~~~~~----~~~~~~ 210 (434)
........||+.|+|||++.+..++.+ +|||||||++|||+ +| ..||..... ......
T Consensus 200 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~--tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 277 (337)
T 3mdy_A 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA--RRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277 (337)
T ss_dssp ---CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH--TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH--hccCcccccccccccHhhhcCCCCchhhhHH
Confidence 111234578899999999988777665 99999999999999 77 677755321 111111
Q ss_pred hhhhhhcCCcccCCCC-----CCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 211 CSHWYQNNSKQQYLPR-----PATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 211 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
.. .. ....... ...+++++.+++.+||+.||++|||+.|+++.|++...
T Consensus 278 ~~---~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 278 IV---CI--KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp HH---TT--SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH---hh--hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 11 11 1111112 23678889999999999999999999999999987643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=289.06 Aligned_cols=206 Identities=20% Similarity=0.350 Sum_probs=167.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++..++..++||||+++|+|.+++... ...+++..+..++.||+.||.|||++|++|||||
T Consensus 71 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 144 (302)
T 2j7t_A 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL------DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144 (302)
T ss_dssp HHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred hcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence 4679999999999999999999999999999999998743 2468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+||+++.++.+||+|||++...... ........||.
T Consensus 145 p~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------~~~~~~~~~~~ 181 (302)
T 2j7t_A 145 AGNVLMTLEGDIRLADFGVSAKNLKT-------------------------------------------LQKRDSFIGTP 181 (302)
T ss_dssp GGGEEECTTSCEEECCCHHHHHHHHH-------------------------------------------HHC-----CCG
T ss_pred HHHEEECCCCCEEEEECCCCcccccc-------------------------------------------ccccccccCCh
Confidence 99999999999999999986431100 00112345788
Q ss_pred cccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 162 RWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 162 ~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
.|+|||++. ...++.++|||||||++|+|+ +|..||...........+... .......+..++.++.+
T Consensus 182 ~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~ 254 (302)
T 2j7t_A 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA--QIEPPHHELNPMRVLLKIAKS-----DPPTLLTPSKWSVEFRD 254 (302)
T ss_dssp GGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHHS-----CCCCCSSGGGSCHHHHH
T ss_pred hhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHh--cCCCCCccCCHHHHHHHHhcc-----CCcccCCccccCHHHHH
Confidence 899999984 567899999999999999999 899999988776655443321 11222335677899999
Q ss_pred HHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 237 LMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
++.+||+.||++|||++++ |+|++...
T Consensus 255 li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 255 FLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 9999999999999999999 78887643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=297.44 Aligned_cols=205 Identities=18% Similarity=0.226 Sum_probs=156.8
Q ss_pred CCCCCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 2 CSLKDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
++++||||+++++++...+ ..++||||+++ +|.+++. ..+++..+..++.||+.||+|||++||
T Consensus 79 ~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~~i 148 (371)
T 2xrw_A 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAGI 148 (371)
T ss_dssp HHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh---------hccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4689999999999997665 68999999975 8988886 248899999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+||+|||+++...... ...
T Consensus 149 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~ 184 (371)
T 2xrw_A 149 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--------------------------------------------MMT 184 (371)
T ss_dssp CCSCCCGGGEEECTTSCEEECCCCC-------------------------------------------------------
T ss_pred ecccCCHHHEEEcCCCCEEEEEeeccccccccc--------------------------------------------ccC
Confidence 999999999999999999999999976421110 113
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC-----------------
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN----------------- 218 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 218 (434)
...||+.|+|||++.+..++.++|||||||++|+|+ +|..||.+.+..+....+.......
T Consensus 185 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 262 (371)
T 2xrw_A 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI--KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVE 262 (371)
T ss_dssp -----CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHH
T ss_pred CceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHh
Confidence 356788999999999999999999999999999999 8999999887766554443211000
Q ss_pred --Cc-----------ccCCCC----CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 --SK-----------QQYLPR----PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 --~~-----------~~~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.. ....+. ....++++.+|+.+||+.||++|||++|+ |+||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 263 NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp SSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 00 000000 01126789999999999999999999999 8999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=294.53 Aligned_cols=199 Identities=19% Similarity=0.297 Sum_probs=158.2
Q ss_pred CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCe
Q psy5690 6 DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNC 85 (434)
Q Consensus 6 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 85 (434)
||||+++++++..++..++||| +.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NI 186 (390)
T 2zmd_A 115 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK-------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186 (390)
T ss_dssp CTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH-------CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGE
T ss_pred CCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHE
Confidence 6999999999999999999999 568899999983 34688999999999999999999999999999999999
Q ss_pred eeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccc
Q psy5690 86 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 165 (434)
Q Consensus 86 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~a 165 (434)
|++ ++.+||+|||+++...... .........||+.|+|
T Consensus 187 ll~-~~~~kl~DFG~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~a 224 (390)
T 2zmd_A 187 LIV-DGMLKLIDFGIANQMQPDT-----------------------------------------TSVVKDSQVGAVNYMP 224 (390)
T ss_dssp EES-SSCEEECCCSSSCCC--------------------------------------------------CCSCCCGGGCC
T ss_pred EEE-CCeEEEEecCccccccCCC-----------------------------------------ccccCCCCCcCCCccC
Confidence 995 6889999999976532111 0011234568999999
Q ss_pred hhhhhc-----------CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 166 WESLLL-----------GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 166 PE~~~~-----------~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
||++.+ ..++.++|||||||++|||+ +|..||...... .....+. ......+.+...+++
T Consensus 225 PE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell--~G~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 296 (390)
T 2zmd_A 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT--YGKTPFQQIINQISKLHAII------DPNHEIEFPDIPEKD 296 (390)
T ss_dssp HHHHHCC------------CCHHHHHHHHHHHHHHHH--HSSCTTTTCCCHHHHHHHHH------CTTSCCCCCCCSCHH
T ss_pred hHHhhhccccccccccccCCCChhhHHHHHHHHHHHH--HCCCcchhhhHHHHHHHHHh------CccccCCCCccchHH
Confidence 999975 36789999999999999999 899999875432 2222221 112233345556789
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+|+.+||+.||++||++.|+ |+|++..
T Consensus 297 ~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 9999999999999999999999 8999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=286.95 Aligned_cols=202 Identities=18% Similarity=0.214 Sum_probs=168.1
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
+||||+++++++..++..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|
T Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 154 (298)
T 1phk_A 82 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-------KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 154 (298)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence 499999999999999999999999999999999973 3468999999999999999999999999999999999
Q ss_pred eeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcccc
Q psy5690 85 CMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 164 (434)
Q Consensus 85 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~ 164 (434)
|+++.++.+||+|||+++...... ......++..|+
T Consensus 155 il~~~~~~~kl~dfg~~~~~~~~~--------------------------------------------~~~~~~~~~~y~ 190 (298)
T 1phk_A 155 ILLDDDMNIKLTDFGFSCQLDPGE--------------------------------------------KLREVCGTPSYL 190 (298)
T ss_dssp EEECTTCCEEECCCTTCEECCTTC--------------------------------------------CBCCCCSCGGGC
T ss_pred EEEcCCCcEEEecccchhhcCCCc--------------------------------------------ccccccCCcccc
Confidence 999999999999999875421110 113345788999
Q ss_pred chhhhh------cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 165 AWESLL------LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 165 aPE~~~------~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
|||++. ...++.++||||||+++|+|+ +|..||......+....+... ......+....+++++.+++
T Consensus 191 aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li 264 (298)
T 1phk_A 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL--AGSPPFWHRKQMLMLRMIMSG----NYQFGSPEWDDYSDTVKDLV 264 (298)
T ss_dssp CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHT----CCCCCTTTGGGSCHHHHHHH
T ss_pred CHHHhccccccccccCCcccccHhHHHHHHHHH--HCCCCCcCccHHHHHHHHhcC----CcccCcccccccCHHHHHHH
Confidence 999986 456789999999999999999 889999988877665544321 11112222356789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+||+.||++||+++|+ |+||++..
T Consensus 265 ~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 265 SRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred HHHccCCcccCCCHHHHHhChHhhhcc
Confidence 99999999999999999 78887653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.80 Aligned_cols=204 Identities=37% Similarity=0.736 Sum_probs=169.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++. ++..++||||+++|+|.++++.. ...+++..++.++.|++.||+|||++||+|||||
T Consensus 446 ~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDik 518 (656)
T 2j0j_A 446 RQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518 (656)
T ss_dssp HHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHT------TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence 4689999999999984 56789999999999999999742 2468999999999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+|||+++...... ........+|+
T Consensus 519 p~NILl~~~~~vkL~DFG~a~~~~~~~------------------------------------------~~~~~~~~~t~ 556 (656)
T 2j0j_A 519 ARNVLVSSNDCVKLGDFGLSRYMEDST------------------------------------------YYKASKGKLPI 556 (656)
T ss_dssp GGGEEEEETTEEEECCCCCCCSCCC----------------------------------------------------CCG
T ss_pred hHhEEEeCCCCEEEEecCCCeecCCCc------------------------------------------ceeccCCCCCc
Confidence 999999999999999999976532211 01112345677
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
.|+|||++.+..++.++|||||||++|||++ .|..||.+....+....+.. ....+.+..+++++.+++.+|
T Consensus 557 ~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-~g~~Pf~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~~~ 628 (656)
T 2j0j_A 557 KWMAPESINFRRFTSASDVWMFGVCMWEILM-HGVKPFQGVKNNDVIGRIEN-------GERLPMPPNCPPTLYSLMTKC 628 (656)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT-TSCCTTTTCCHHHHHHHHHH-------TCCCCCCTTCCHHHHHHHHHH
T ss_pred ceeCHHHhcCCCCCchhhHHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHc-------CCCCCCCccccHHHHHHHHHH
Confidence 8999999999999999999999999999993 28999999888777655532 233455678899999999999
Q ss_pred ccCCCCCCCCHHHHHHHHHhc
Q psy5690 242 WKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~~el~~~L~~~ 262 (434)
|+.||++||++.++++.|++.
T Consensus 629 l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 629 WAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp TCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCChhHCcCHHHHHHHHHHH
Confidence 999999999999999888764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=296.33 Aligned_cols=212 Identities=19% Similarity=0.224 Sum_probs=166.7
Q ss_pred CCCCCCCCeeeEEEEEecC--------------------------------------CceEEEEecCCCCCHHHHHhhcc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE--------------------------------------DPISTIQEYCEFGDLSTFLQIHN 42 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~--------------------------------------~~~~lV~E~~~~gsL~~~l~~~~ 42 (434)
|+.++||||++++++|... ...++||||++ |+|.+.+....
T Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 132 (383)
T 3eb0_A 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI 132 (383)
T ss_dssp HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHH
T ss_pred HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH
Confidence 4689999999999998443 34889999997 58888776422
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeee-cCCceEEccCCcccccccccccccccccccchh
Q psy5690 43 CNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 121 (434)
Q Consensus 43 ~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 121 (434)
.....+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++......
T Consensus 133 ---~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~------------- 196 (383)
T 3eb0_A 133 ---RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE------------- 196 (383)
T ss_dssp ---HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-------------
T ss_pred ---hcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-------------
Confidence 1346799999999999999999999999999999999999998 68899999999976521111
Q ss_pred hhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCC
Q psy5690 122 WMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYA 200 (434)
Q Consensus 122 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~ 200 (434)
......+|..|+|||++.+. .++.++||||+||++|||+ +|..||.
T Consensus 197 -------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~ 243 (383)
T 3eb0_A 197 -------------------------------PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI--LGKPLFS 243 (383)
T ss_dssp -------------------------------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH--HSSCSSC
T ss_pred -------------------------------CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH--hCCCCCC
Confidence 11334567889999998875 4899999999999999999 8999999
Q ss_pred CCChHHHHHhhhhhhhcCC---------------------cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HH
Q psy5690 201 ELTNEQVIENCSHWYQNNS---------------------KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HL 257 (434)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~ 257 (434)
+....+....+........ .......+..+++++.+|+.+||+.||++|||+.|+ |+
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 9887766555432211100 000001244578899999999999999999999999 78
Q ss_pred HHHhc
Q psy5690 258 FLQRK 262 (434)
Q Consensus 258 ~L~~~ 262 (434)
||++.
T Consensus 324 ~f~~~ 328 (383)
T 3eb0_A 324 FFDHL 328 (383)
T ss_dssp GGHHH
T ss_pred HHHHH
Confidence 99875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=292.86 Aligned_cols=209 Identities=19% Similarity=0.269 Sum_probs=144.3
Q ss_pred CCCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 3 SLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
.++||||+++++++.. +...++||||+++|+|.+++... ....+++..++.++.||+.||+|||++||+||
T Consensus 78 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~ 152 (336)
T 3fhr_A 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER-----GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR 152 (336)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC------CCCCBHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 4689999999999976 44589999999999999999843 23469999999999999999999999999999
Q ss_pred CCCCCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 79 DLAARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 79 Dlkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
||||+|||++. ++.+||+|||+++..... ...
T Consensus 153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---------------------------------------------~~~ 187 (336)
T 3fhr_A 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---------------------------------------------ALQ 187 (336)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEEC---------------------------------------------------
T ss_pred CCCHHHEEEEecCCCceEEEeccccceecccc---------------------------------------------ccc
Confidence 99999999976 455999999997542111 112
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
...+|+.|+|||++.+..++.++|||||||++|+|+ +|..||.........................+....+++++.
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (336)
T 3fhr_A 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL--CGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK 265 (336)
T ss_dssp ----------------CHHHHHHHHHHHHHHHHHHH--HSSCCC---------------------CCCTTTSTTCCHHHH
T ss_pred cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHH--HCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHH
Confidence 345688899999998888899999999999999999 899999876654433222211111112222233357889999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+++.+||+.||++|||++|+ |+||++..
T Consensus 266 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 266 QLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred HHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 99999999999999999999 78998753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=292.10 Aligned_cols=216 Identities=19% Similarity=0.235 Sum_probs=155.9
Q ss_pred CCCCCCCeeeEEEEEec-----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC---
Q psy5690 2 CSLKDPNLVRVIGVCST-----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR--- 73 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~--- 73 (434)
+.++||||+++++.+.. ....++||||+++|+|.+++... ..++..+..++.||+.||+|||++
T Consensus 62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~~~ 133 (336)
T 3g2f_A 62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLHTELPR 133 (336)
T ss_dssp TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCC
T ss_pred HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc--------ccchhHHHHHHHHHHHHHHHHHhhhcc
Confidence 46899999999986632 23578999999999999999633 358899999999999999999999
Q ss_pred ------CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccC
Q psy5690 74 ------DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYE 147 (434)
Q Consensus 74 ------~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 147 (434)
||+||||||+|||++.++.+||+|||+++......... .
T Consensus 134 ~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~-----------------------------------~ 178 (336)
T 3g2f_A 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR-----------------------------------P 178 (336)
T ss_dssp GGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-------------------------------------
T ss_pred ccccccceeecccccceEEEcCCCcEEEeeccceeecccccccC-----------------------------------c
Confidence 99999999999999999999999999987643322100 0
Q ss_pred CcccccCCCCCCCccccchhhhhc-------CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-H--------------
Q psy5690 148 SDYYLSDTKARLPIRWMAWESLLL-------GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-E-------------- 205 (434)
Q Consensus 148 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~-------------- 205 (434)
...........||+.|+|||++.+ ..++.++|||||||++|||+ +|..||..... .
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell--~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3g2f_A 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF--MRCTDLFPGESVPEYQMAFQTEVGNHP 256 (336)
T ss_dssp -------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH--TTBGGGSTTSCCCCCCCTTHHHHCSSC
T ss_pred cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH--hcCCcCCCccchhHHHHhhhcccCCCc
Confidence 001112234578999999999987 34567899999999999999 77665533211 0
Q ss_pred --HHHHh-hhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 206 --QVIEN-CSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 206 --~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.... +..................+++++.++|.+||+.||++|||++|+++.|++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 257 TFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 00000 0000000000011111233667899999999999999999999999988875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=283.83 Aligned_cols=209 Identities=22% Similarity=0.320 Sum_probs=168.7
Q ss_pred CCCCCCeeeEEEEEe-----cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 3 SLKDPNLVRVIGVCS-----TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
+++||||+++++++. .....++||||+. |+|.+++... ....+++..+..++.||+.||+|||++||+|
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H 143 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV-----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVH 143 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS-----CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 358999999999997 5567999999997 6999999743 2345899999999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+||+++.++.+||+|||+++..... ......
T Consensus 144 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~~ 179 (326)
T 1blx_A 144 RDLKPQNILVTSSGQIKLADFGLARIYSFQ--------------------------------------------MALTSV 179 (326)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCGG--------------------------------------------GGGCCC
T ss_pred ccCCHHHeEEcCCCCEEEecCcccccccCC--------------------------------------------CCcccc
Confidence 999999999999999999999997542111 012345
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC------------------
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS------------------ 219 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------ 219 (434)
.+|..|+|||++.+..++.++|||||||++|+|+ +|..||.+....+....+........
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 1blx_A 180 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 257 (326)
T ss_dssp CCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCC
T ss_pred ccccceeCHHHHhcCCCCcchhHHHHHHHHHHHH--cCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhccc
Confidence 6788999999999999999999999999999999 89999998887766555433211100
Q ss_pred -cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 220 -KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 220 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
..........+++++.+++.+||+.||++||++.|+ |+||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 258 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 000111234678899999999999999999999999 68998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=290.66 Aligned_cols=213 Identities=17% Similarity=0.235 Sum_probs=165.5
Q ss_pred CCCCCCCeeeEEEEEec--------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 2 CSLKDPNLVRVIGVCST--------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
++++||||+++++++.. ++..++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||++
T Consensus 71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~ 143 (351)
T 3mi9_A 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN------VLVKFTLSEIKRVMQMLLNGLYYIHRN 143 (351)
T ss_dssp HHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC------TTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46899999999999976 3468999999975 88888762 335699999999999999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 144 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------~~~~~ 184 (351)
T 3mi9_A 144 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN---------------------------------------SQPNR 184 (351)
T ss_dssp TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSS---------------------------------------SSCCC
T ss_pred CeeCCCCCHHHEEEcCCCCEEEccchhccccccccc---------------------------------------ccccc
Confidence 999999999999999999999999999765321110 00112
Q ss_pred CCCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCC------
Q psy5690 154 DTKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPR------ 226 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 226 (434)
.....||+.|+|||++.+ ..++.++|||||||++|||+ +|..||.+.........+...............
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 262 (351)
T 3mi9_A 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW--TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELY 262 (351)
T ss_dssp CCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGG
T ss_pred cCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhh
Confidence 244567899999999976 45799999999999999999 889999998877766555432221111100000
Q ss_pred ---------CC---------ccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 227 ---------PA---------TCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 227 ---------~~---------~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.. ..++++.+|+.+||+.||++|||++|+ |+||+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 263 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp TSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred cccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 00 025679999999999999999999999 8899764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.32 Aligned_cols=217 Identities=11% Similarity=0.104 Sum_probs=164.8
Q ss_pred CCCCCCeee---------------EEEEEec-CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q psy5690 3 SLKDPNLVR---------------VIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66 (434)
Q Consensus 3 ~L~HpnIv~---------------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~g 66 (434)
+++||||++ +++++.. ++..++||||+ +|+|.+++... ....+++..++.++.||+.|
T Consensus 98 ~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~l~~~~~~~i~~qi~~~ 171 (352)
T 2jii_A 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-----PKHVLSERSVLQVACRLLDA 171 (352)
T ss_dssp HHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-----GGGCCCHHHHHHHHHHHHHH
T ss_pred HhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-----CcCCCCHHHHHHHHHHHHHH
Confidence 456777666 7888866 67899999999 99999999843 12579999999999999999
Q ss_pred HHHhhhCCccccCCCCCCeeeecCC--ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCcccccc
Q psy5690 67 MKYLESRDIVHRDLAARNCMVGKNY--TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCS 144 (434)
Q Consensus 67 L~yLH~~~iiHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 144 (434)
|+|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 172 L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~---------------------------------- 217 (352)
T 2jii_A 172 LEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH---------------------------------- 217 (352)
T ss_dssp HHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCC----------------------------------
T ss_pred HHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcc----------------------------------
Confidence 9999999999999999999999988 8999999998764322110
Q ss_pred ccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC--hHHHHHhhhhhhhcCCcc-
Q psy5690 145 HYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT--NEQVIENCSHWYQNNSKQ- 221 (434)
Q Consensus 145 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~- 221 (434)
............||+.|+|||++.+..++.++|||||||++|||+ +|..||.... ..........+.......
T Consensus 218 --~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (352)
T 2jii_A 218 --VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL--YGFLPWTNCLPNTEDIMKQKQKFVDKPGPFV 293 (352)
T ss_dssp --CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSCCTTGGGTTCHHHHHHHHHHHHHSCCCEE
T ss_pred --ccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH--hCCCCcccCCcCHHHHHHHHHhccCChhhhh
Confidence 000001123457889999999999999999999999999999999 8999998764 222222222111111000
Q ss_pred cCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 222 QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 222 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
........+++++.+++.+||+.||++||+++++.+.|++..
T Consensus 294 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 294 GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 001112356899999999999999999999999999888753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=287.75 Aligned_cols=202 Identities=17% Similarity=0.335 Sum_probs=160.5
Q ss_pred CCCCeeeEEEEEec------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 5 KDPNLVRVIGVCST------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 5 ~HpnIv~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
+||||+++++++.. .+..++||||+++|+|.+++... ....+++..+..++.||+.||+|||++||+||
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 153 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-----KGNTLKEEWIAYICREILRGLSHLHQHKVIHR 153 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS-----GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc-----ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 79999999999976 46789999999999999999743 22468999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.+||+|||++....... .......
T Consensus 154 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~ 190 (326)
T 2x7f_A 154 DIKGQNVLLTENAEVKLVDFGVSAQLDRTV-------------------------------------------GRRNTFI 190 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCTTTC--------------------------------------------------------
T ss_pred CCcHHHEEEcCCCCEEEeeCcCceecCcCc-------------------------------------------ccccccc
Confidence 999999999999999999999875421110 0112345
Q ss_pred CCccccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 159 LPIRWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 159 gt~~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
||..|+|||++. ...++.++|||||||++|+|+ +|..||...........+.. ..........+++.
T Consensus 191 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 262 (326)
T 2x7f_A 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA--EGAPPLCDMHPMRALFLIPR------NPAPRLKSKKWSKK 262 (326)
T ss_dssp CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHH------SCCCCCSCSCSCHH
T ss_pred CCccccChhhhccccccCcCCCccchHHHHHHHHHHHH--hCCCCCCCCcHHHHHHHhhc------CccccCCccccCHH
Confidence 788999999997 566889999999999999999 88999988776655443321 11111224567899
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+++.+||+.||++||+++++ |+|+++.
T Consensus 263 l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 263 FQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 9999999999999999999999 7899864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=289.50 Aligned_cols=213 Identities=17% Similarity=0.193 Sum_probs=165.5
Q ss_pred CCCCCCCeeeEEEEEecCCc-------eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--h
Q psy5690 2 CSLKDPNLVRVIGVCSTEDP-------ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE--S 72 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~-------~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--~ 72 (434)
++++||||+++++++...+. .++||||+++ +|.+.+.... .....+++..+..++.|++.||.||| +
T Consensus 74 ~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 149 (360)
T 3e3p_A 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYY---RRQVAPPPILIKVFLFQLIRSIGCLHLPS 149 (360)
T ss_dssp HHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHTSTT
T ss_pred HhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 34689999999999966443 8899999976 6655544221 14467899999999999999999999 9
Q ss_pred CCccccCCCCCCeeeec-CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 73 RDIVHRDLAARNCMVGK-NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
+||+||||||+|||++. ++.+||+|||+++......
T Consensus 150 ~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~------------------------------------------- 186 (360)
T 3e3p_A 150 VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE------------------------------------------- 186 (360)
T ss_dssp TCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-------------------------------------------
T ss_pred CCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-------------------------------------------
Confidence 99999999999999997 8999999999976532111
Q ss_pred ccCCCCCCCccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC-----------
Q psy5690 152 LSDTKARLPIRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS----------- 219 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 219 (434)
......||..|+|||++.+.. ++.++|||||||++|||+ +|..||.+.+.......+........
T Consensus 187 -~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3e3p_A 187 -PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM--LGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSH 263 (360)
T ss_dssp -CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC
T ss_pred -CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHH--hCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccch
Confidence 113446788999999997654 799999999999999999 88999999887766655443211000
Q ss_pred -------------cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 220 -------------KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 220 -------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
...........++++.+|+.+||+.||++|||+.|+ |+||++...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 264 TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred hhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 000111223467899999999999999999999999 899998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=298.53 Aligned_cols=206 Identities=17% Similarity=0.178 Sum_probs=165.0
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
..+|+||+++++++...+..++||||+. |+|.+++... ....+++..+..++.||+.||+|||++||+||||||
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp 228 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN-----KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSG
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 3589999999999999999999999996 6999999743 234589999999999999999999999999999999
Q ss_pred CCeeeecCCc--eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 83 RNCMVGKNYT--IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 83 ~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
+|||++.++. +||+|||+++.... ......||
T Consensus 229 ~NILl~~~~~~~vkL~DFG~a~~~~~----------------------------------------------~~~~~~gt 262 (429)
T 3kvw_A 229 ENILLKQQGRSGIKVIDFGSSCYEHQ----------------------------------------------RVYTYIQS 262 (429)
T ss_dssp GGEEESSTTSCCEEECCCTTCEETTC----------------------------------------------CCCSSCSC
T ss_pred HHeEEccCCCcceEEeecccceecCC----------------------------------------------cccccCCC
Confidence 9999999887 99999999754111 11345678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc---------------c----
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK---------------Q---- 221 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~---- 221 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+......... .
T Consensus 263 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell--tG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 340 (429)
T 3kvw_A 263 RFYRAPEVILGARYGMPIDMWSLGCILAELL--TGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPR 340 (429)
T ss_dssp GGGCCHHHHHTBCCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBT
T ss_pred CCccChHHHhCCCCCchHHHHhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcc
Confidence 8999999999999999999999999999999 889999988876665544322110000 0
Q ss_pred ------------------------cCCC--------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 222 ------------------------QYLP--------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 222 ------------------------~~~~--------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
...+ .....++++.+||.+||+.||++|||++|+ |+||++.
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 341 YCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred cccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence 0000 012236789999999999999999999999 7899874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.56 Aligned_cols=232 Identities=14% Similarity=0.210 Sum_probs=158.4
Q ss_pred CCCCCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++++||||+++++++... +..|+||||+. |+|.++++ ....+++..+..++.||+.||+|||++||+
T Consensus 80 ~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-------~~~~l~~~~~~~i~~qil~aL~~LH~~giv 151 (432)
T 3n9x_A 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK-------TPIFLTEEHIKTILYNLLLGENFIHESGII 151 (432)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH-------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 568999999999999766 56999999996 59999997 445799999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+|||++.++.+||+|||+++............... .... ..............
T Consensus 152 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~--------------------~~~~-~~~~~~~~~~~~~~ 210 (432)
T 3n9x_A 152 HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE--------------------ENEE-PGPHNKNLKKQLTS 210 (432)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEEC----------------------------------------------------
T ss_pred CCCCCHHHeEECCCCCEEEccCCCccccccccccccccccc--------------------cccc-ccccccchhccccC
Confidence 99999999999999999999999987643322100000000 0000 00000000112355
Q ss_pred CCCCccccchhhh-hcCCCCCcCChHHHHHHHHHHHhhc-----------CCCCCCCCCh-----------------HHH
Q psy5690 157 ARLPIRWMAWESL-LLGKNTTKSDVWSFAVTLWEILIHC-----------NQRPYAELTN-----------------EQV 207 (434)
Q Consensus 157 ~~gt~~y~aPE~~-~~~~~s~~sDIwSlGvil~ellt~~-----------g~~pf~~~~~-----------------~~~ 207 (434)
..||+.|+|||++ ....++.++|||||||++|||+ + |.++|.+.+. .+.
T Consensus 211 ~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell--~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~q 288 (432)
T 3n9x_A 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL--NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQ 288 (432)
T ss_dssp CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH--TTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHH
T ss_pred CCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH--hcccccccccccccccCCCccccccCcccccccccccchHHH
Confidence 6789999999986 4566899999999999999999 5 3444433220 011
Q ss_pred HHhhhh--------------------hhhcCCcccCCC---CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 208 IENCSH--------------------WYQNNSKQQYLP---RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 208 ~~~~~~--------------------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
...+.. +..........+ ....+++++.+|+.+||+.||++|||++|+ |+||++.
T Consensus 289 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 289 LNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV 368 (432)
T ss_dssp HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTT
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhc
Confidence 111100 000000000000 013578899999999999999999999999 8999886
Q ss_pred cc
Q psy5690 263 NL 264 (434)
Q Consensus 263 ~~ 264 (434)
..
T Consensus 369 ~~ 370 (432)
T 3n9x_A 369 RK 370 (432)
T ss_dssp CC
T ss_pred cC
Confidence 44
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=305.60 Aligned_cols=203 Identities=20% Similarity=0.236 Sum_probs=155.3
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.. +..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++||+|||||
T Consensus 195 ~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlk 266 (419)
T 3i6u_A 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVV-------GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 266 (419)
T ss_dssp HHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTS-------SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 56899999999999854 55899999999999999886 44679999999999999999999999999999999
Q ss_pred CCCeeeecCC---ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGKNY---TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||++.++ .+||+|||+++...... ......
T Consensus 267 p~NIll~~~~~~~~~kl~DFG~a~~~~~~~--------------------------------------------~~~~~~ 302 (419)
T 3i6u_A 267 PENVLLSSQEEDCLIKITDFGHSKILGETS--------------------------------------------LMRTLC 302 (419)
T ss_dssp GGGEEESSSSSSCCEEECCSSTTTSCC-----------------------------------------------------
T ss_pred hHhEEEecCCCcceEEEeecccceecCCCc--------------------------------------------cccccC
Confidence 9999997544 59999999976532111 113456
Q ss_pred CCccccchhhhhc---CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 159 LPIRWMAWESLLL---GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 159 gt~~y~aPE~~~~---~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
||+.|+|||++.+ ..++.++|||||||++|+|+ +|..||....... ....+.. ............+++++
T Consensus 303 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll--tg~~pf~~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~~ 376 (419)
T 3i6u_A 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL--SGYPPFSEHRTQVSLKDQITS----GKYNFIPEVWAEVSEKA 376 (419)
T ss_dssp --CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH--HSSCSSCCCSSSCCHHHHHHT----TCCCCCHHHHTTSCHHH
T ss_pred CCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH--HCCCCCCCCcchHHHHHHHhc----CCCCCCchhhcccCHHH
Confidence 7899999999863 56788999999999999999 8999997654322 2222211 00111111124578899
Q ss_pred HHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 235 FDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+++.+||+.||++||+++|+ |+|+++.
T Consensus 377 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 377 LDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred HHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 999999999999999999999 7888754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=285.31 Aligned_cols=203 Identities=21% Similarity=0.310 Sum_probs=165.1
Q ss_pred CCCCCCCeeeEEEEEe--cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----
Q psy5690 2 CSLKDPNLVRVIGVCS--TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD----- 74 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~----- 74 (434)
++++||||+++++++. .++..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++|
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ 136 (279)
T 2w5a_A 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136 (279)
T ss_dssp HHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHHC-----
T ss_pred HhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCe
Confidence 4689999999999884 45779999999999999999975431 2345899999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 137 ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~-------------------------------------------~~ 173 (279)
T 2w5a_A 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-------------------------------------------FA 173 (279)
T ss_dssp -CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH-------------------------------------------HH
T ss_pred eEEeccchhhEEEcCCCCEEEecCchheeeccccc-------------------------------------------cc
Confidence 99999999999999999999999998765221100 00
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
....++..|+|||++.+..++.++||||||+++|+|+ +|..||......+....+.. ......+..+++++
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~p~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l 244 (279)
T 2w5a_A 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC--ALMPPFTAFSQKELAGKIRE-------GKFRRIPYRYSDEL 244 (279)
T ss_dssp HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH-------TCCCCCCTTSCHHH
T ss_pred cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHH--HCCCCCcccCHHHHHHHHhh-------cccccCCcccCHHH
Confidence 1234677899999999999999999999999999999 88999998887766655432 12234456788999
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHH
Q psy5690 235 FDLMLECWKTNETDRPRFSEIHLFL 259 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el~~~L 259 (434)
.+++.+||+.||++||+++|+++.+
T Consensus 245 ~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 245 NEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHHHHHHcCCCcccCCCHHHHHhCh
Confidence 9999999999999999999996544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=283.07 Aligned_cols=209 Identities=17% Similarity=0.253 Sum_probs=160.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||+++++++..++..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||++|++||||
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl 162 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK---KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDI 162 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhc---ccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCC
Confidence 357899999999999999999999999999999999997432 12456899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... .......++
T Consensus 163 ~p~NIl~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------~~~~~~~~~ 199 (310)
T 2wqm_A 163 KPANVFITATGVVKLGDLGLGRFFSSKT-------------------------------------------TAAHSLVGT 199 (310)
T ss_dssp CGGGEEECTTSCEEECCC-------------------------------------------------------------C
T ss_pred cHHHEEEcCCCCEEEEeccceeeecCCC-------------------------------------------ccccccCCC
Confidence 9999999999999999999875421110 011234577
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh--HHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN--EQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
..|+|||++.+..++.++||||||+++|+|+ +|..||.+... ......+.. ..........+++++.+++
T Consensus 200 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~--~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li 271 (310)
T 2wqm_A 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMA--ALQSPFYGDKMNLYSLCKKIEQ------CDYPPLPSDHYSEELRQLV 271 (310)
T ss_dssp CSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCTTC---CCHHHHHHHHHT------TCSCCCCTTTSCHHHHHHH
T ss_pred eeEeChHHhCCCCCCchhhHHHHHHHHHHHH--hCCCCCcccchhHHHHHHHhhc------ccCCCCcccccCHHHHHHH
Confidence 8899999999999999999999999999999 88999976432 222222211 1111112356789999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+||+.||++||+++++++.|++..
T Consensus 272 ~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 272 NMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCChhhCCCHHHHHHHHHHHH
Confidence 9999999999999999999998753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.05 Aligned_cols=204 Identities=18% Similarity=0.247 Sum_probs=153.8
Q ss_pred CCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 2 CSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
++++||||+++++++... ...++|+||+ +++|.++++ ...+++..+..++.||+.||+|||++||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~gi 153 (367)
T 2fst_X 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--------CQKLTDDHVQFLIYQILRGLKYIHSADI 153 (367)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 468999999999999654 5689999999 689999985 2469999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+||+|||+++.... ...
T Consensus 154 vH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~----------------------------------------------~~~ 187 (367)
T 2fst_X 154 IHRDLKPSNLAVNEDCELKILDFGLARHTAD----------------------------------------------EMT 187 (367)
T ss_dssp CCCCCCGGGEEECTTCCEEECC----------------------------------------------------------
T ss_pred eeCCCCHhhEEECCCCCEEEeeccccccccc----------------------------------------------cCC
Confidence 9999999999999999999999999764211 013
Q ss_pred CCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC----------------
Q psy5690 156 KARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN---------------- 218 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 218 (434)
...+|..|+|||++.+ ..++.++|||||||++|||+ +|..||.+.+..+....+.......
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 265 (367)
T 2fst_X 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL--TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265 (367)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHH
T ss_pred CcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence 3467888999999987 67899999999999999999 8999999888766555443321110
Q ss_pred ----CcccCC---CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 ----SKQQYL---PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 ----~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
...... ......++++.+|+.+||+.||++|||++|+ |+||++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 266 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318 (367)
T ss_dssp HHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence 000000 0013457889999999999999999999999 8899865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=281.44 Aligned_cols=199 Identities=20% Similarity=0.270 Sum_probs=162.3
Q ss_pred CCCCCCCeeeEEEEEec----------------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHH
Q psy5690 2 CSLKDPNLVRVIGVCST----------------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIAS 65 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~----------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~ 65 (434)
++++||||+++++++.. ....++||||+++|+|.+++... ....+++..++.++.||+.
T Consensus 59 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~i~~qi~~ 133 (284)
T 2a19_B 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-----RGEKLDKVLALELFEQITK 133 (284)
T ss_dssp HHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG-----GGSCCCHHHHHHHHHHHHH
T ss_pred HhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc-----cCCCCCHHHHHHHHHHHHH
Confidence 46899999999999854 34589999999999999999743 2346899999999999999
Q ss_pred HHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccc
Q psy5690 66 GMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSH 145 (434)
Q Consensus 66 gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 145 (434)
||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 134 ~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------------------------------------- 176 (284)
T 2a19_B 134 GVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG------------------------------------- 176 (284)
T ss_dssp HHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS-------------------------------------
T ss_pred HHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc-------------------------------------
Confidence 9999999999999999999999999999999999875521110
Q ss_pred cCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCC
Q psy5690 146 YESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLP 225 (434)
Q Consensus 146 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (434)
......+++.|+|||++.+..++.++||||||+++|+|+ +|..|+... ......+.. ..
T Consensus 177 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~~~~~~~~~--~~~~~~~~~----------~~ 235 (284)
T 2a19_B 177 -------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL--HVCDTAFET--SKFFTDLRD----------GI 235 (284)
T ss_dssp -------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH--SCCSSHHHH--HHHHHHHHT----------TC
T ss_pred -------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH--hcCCcchhH--HHHHHHhhc----------cc
Confidence 113345788999999999999999999999999999999 788776432 112211111 11
Q ss_pred CCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 226 RPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 226 ~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+..+++++.+++.+||+.||++||++.|+++.|....
T Consensus 236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 24567789999999999999999999999988887754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=283.47 Aligned_cols=213 Identities=16% Similarity=0.183 Sum_probs=162.6
Q ss_pred CCCCCCeeeEEEEE-ecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 3 SLKDPNLVRVIGVC-STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 3 ~L~HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
+++|++++..++.+ ..++..++||||+ +|+|.+++... ...+++..+..++.||+.||+|||++||+|||||
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 132 (296)
T 4hgt_A 60 MMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVK 132 (296)
T ss_dssp HHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 46677766655554 6777889999999 89999999732 3469999999999999999999999999999999
Q ss_pred CCCeee---ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||+ +.++.+||+|||+++........ ....+.......
T Consensus 133 p~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~------------------------------------~~~~~~~~~~~~ 176 (296)
T 4hgt_A 133 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH------------------------------------QHIPYRENKNLT 176 (296)
T ss_dssp GGGEEECCGGGTTCEEECCCTTCEECBCTTTC------------------------------------CBCCCCCSCCCC
T ss_pred HHHeeeeccCCCCeEEEecCccceeccCcccC------------------------------------ccCCCCcccccC
Confidence 999999 78899999999998663222100 000112234567
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH---HHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE---QVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
||..|+|||++.+..++.++|||||||++|+|+ +|..||...... +....+.... ...........+++++.
T Consensus 177 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~ 251 (296)
T 4hgt_A 177 GTARYASINTHLGIEQSRRDDLESLGYVLMYFN--LGSLPWQGLKAATKRQKYERISEKK---MSTPIEVLCKGYPSEFA 251 (296)
T ss_dssp SCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCTTSSCCCSSSSSHHHHHHHHH---HHSCHHHHTTTSCHHHH
T ss_pred CCccccchHHhcCCCCCchhHHHHHHHHHHHHh--cCCCCCcccchhhhhhhhhhhhccc---ccchhhhhhccCCHHHH
Confidence 899999999999999999999999999999999 899999875432 1111111100 00001111245678999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 236 DLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+++.+||+.||++||+++++.+.|++..
T Consensus 252 ~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 252 TYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 9999999999999999999999988753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=281.62 Aligned_cols=204 Identities=21% Similarity=0.267 Sum_probs=167.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+.+..++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++|||||
T Consensus 76 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~ 148 (287)
T 2wei_A 76 KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148 (287)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 5789999999999999999999999999999999998733 468999999999999999999999999999999
Q ss_pred CCCeeeecC---CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGKN---YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+||+++.+ +.+||+|||+++...... ......
T Consensus 149 p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~--------------------------------------------~~~~~~ 184 (287)
T 2wei_A 149 PENILLESKEKDCDIKIIDFGLSTCFQQNT--------------------------------------------KMKDRI 184 (287)
T ss_dssp GGGEEESCSSTTCCEEECSTTGGGTBCCCS--------------------------------------------SCSCHH
T ss_pred hhhEEEecCCCcccEEEeccCcceeecCCC--------------------------------------------cccccc
Confidence 999999754 469999999875421110 012234
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
++..|+|||.+.+ .++.++||||||+++|+|+ +|..||.+....+....+... ......+....+++++.+++
T Consensus 185 ~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~--~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li 257 (287)
T 2wei_A 185 GTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL--SGTPPFYGKNEYDILKRVETG----KYAFDLPQWRTISDDAKDLI 257 (287)
T ss_dssp HHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHC----CCCCCSGGGTTSCHHHHHHH
T ss_pred CcccccChHHhcC-CCCCchhhHhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHcC----CCCCCchhhhhcCHHHHHHH
Confidence 6778999999875 4899999999999999999 889999998877766554321 11111222356789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+||+.||++|||++|+ |+|+++..
T Consensus 258 ~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 258 RKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHcccChhhCcCHHHHhcCHHHhccc
Confidence 99999999999999999 67998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=297.46 Aligned_cols=203 Identities=11% Similarity=0.104 Sum_probs=147.5
Q ss_pred CCCCeeeEE-------EEEecCC-----------------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHH----
Q psy5690 5 KDPNLVRVI-------GVCSTED-----------------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL---- 56 (434)
Q Consensus 5 ~HpnIv~l~-------~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~---- 56 (434)
+||||++++ +++..++ ..|+||||++ |+|.+++...+ ..+.+..+
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~ 194 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD------FVYVFRGDEGIL 194 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH------HSCCCCHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc------cccchhhhhhhh
Confidence 799988755 5554433 3799999998 89999998543 23344455
Q ss_pred --HHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccce
Q psy5690 57 --IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTI 134 (434)
Q Consensus 57 --~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (434)
..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 195 vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-------------------------- 248 (371)
T 3q60_A 195 ALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-------------------------- 248 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE--------------------------
T ss_pred hHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc--------------------------
Confidence 6777999999999999999999999999999999999999999976521110
Q ss_pred eecCccccccccCCcccccCCCCCCCccccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhh
Q psy5690 135 KISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCS 212 (434)
Q Consensus 135 ~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~ 212 (434)
....+|+.|+|||++.+ ..++.++|||||||++|||+ +|..||......... ...
T Consensus 249 --------------------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell--tg~~Pf~~~~~~~~~-~~~ 305 (371)
T 3q60_A 249 --------------------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW--CLFLPFGLVTPGIKG-SWK 305 (371)
T ss_dssp --------------------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH--HSSCSTTBCCTTCTT-CCC
T ss_pred --------------------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH--hCCCCCCCcCccccc-chh
Confidence 12334588999999987 67899999999999999999 899999876432111 000
Q ss_pred hh--hhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 213 HW--YQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 213 ~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.. ..........+....+++++.+||.+||+.||++|||++++ |+||++..
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 306 RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 00 00111222233345788999999999999999999999999 89998764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=282.58 Aligned_cols=206 Identities=17% Similarity=0.184 Sum_probs=165.5
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
..|++++++++++..++..++||||+ +|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+
T Consensus 74 ~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 147 (339)
T 1z57_A 74 NSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN-----GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPE 147 (339)
T ss_dssp TCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc-----CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHH
Confidence 35677999999999999999999999 88999999743 2246889999999999999999999999999999999
Q ss_pred Ceeeec-------------------CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCcccccc
Q psy5690 84 NCMVGK-------------------NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCS 144 (434)
Q Consensus 84 NILl~~-------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 144 (434)
|||++. ++.+||+|||+++....
T Consensus 148 Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-------------------------------------- 189 (339)
T 1z57_A 148 NILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-------------------------------------- 189 (339)
T ss_dssp GEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--------------------------------------
T ss_pred HEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--------------------------------------
Confidence 999987 66799999998754111
Q ss_pred ccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC------
Q psy5690 145 HYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN------ 218 (434)
Q Consensus 145 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~------ 218 (434)
......||..|+|||++.+..++.++|||||||++|||+ +|..||...+..+....+.......
T Consensus 190 --------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~ 259 (339)
T 1z57_A 190 --------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY--LGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259 (339)
T ss_dssp --------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHH--HSSCSCCCSCHHHHHHHHHHHHCSCCHHHHH
T ss_pred --------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Confidence 113346788999999999999999999999999999999 8899999887765544332211100
Q ss_pred ------------------------------CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 219 ------------------------------SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 219 ------------------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
............++++.+|+.+||+.||++|||++|+ |+||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred hccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 0001112234557889999999999999999999999 79998753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=287.25 Aligned_cols=211 Identities=33% Similarity=0.573 Sum_probs=166.3
Q ss_pred CCCCCCCCeeeEEEEEecCC--ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED--PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
|++++||||+++++++...+ ..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 169 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH------KERIDHIKLLQYTSQICKGMEYLGTKRYIHR 169 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS------TTSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence 35789999999999986654 789999999999999999743 2468999999999999999999999999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.+||+|||+++...... ..........
T Consensus 170 dikp~NIli~~~~~~kL~Dfg~~~~~~~~~----------------------------------------~~~~~~~~~~ 209 (326)
T 2w1i_A 170 DLATRNILVENENRVKIGDFGLTKVLPQDK----------------------------------------EYYKVKEPGE 209 (326)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCSSC----------------------------------------SEEECSSCCS
T ss_pred CCCcceEEEcCCCcEEEecCcchhhccccc----------------------------------------cccccccCCC
Confidence 999999999999999999999976532211 0011123345
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH------------HHHhhhhhhhcCCcccCCCC
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ------------VIENCSHWYQNNSKQQYLPR 226 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~------------~~~~~~~~~~~~~~~~~~~~ 226 (434)
++..|+|||.+.+..++.++|||||||++|||+ +|..||......- ....+.... ......+.
T Consensus 210 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~--tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 284 (326)
T 2w1i_A 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL---KNNGRLPR 284 (326)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH--HTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH---HTTCCCCC
T ss_pred CceeEECchhhcCCCCCchhhHHHHHHHHHHHH--hcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh---hcCCCCCC
Confidence 677899999999988999999999999999999 7888876432110 000111111 12233455
Q ss_pred CCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 227 PATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 227 ~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+..+++++.+++.+||+.||++||++.|+++.|++.
T Consensus 285 ~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 285 PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 678899999999999999999999999999988875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=296.40 Aligned_cols=213 Identities=17% Similarity=0.178 Sum_probs=163.4
Q ss_pred CCCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++|||||+++++|... ..+++||||+++ +|.+.+.... .....+++..++.++.||+.||+|||++|
T Consensus 101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 176 (420)
T 1j1b_A 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176 (420)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4578999999999998542 236799999976 7777665321 13467999999999999999999999999
Q ss_pred ccccCCCCCCeeeecC-CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 75 IVHRDLAARNCMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 75 iiHrDlkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|+||||||+|||++.+ +.+||+|||+++...... .
T Consensus 177 ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~--------------------------------------------~ 212 (420)
T 1j1b_A 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--------------------------------------------P 212 (420)
T ss_dssp EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC--------------------------------------------C
T ss_pred ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC--------------------------------------------C
Confidence 9999999999999965 578999999976521110 1
Q ss_pred CCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc---------CC--cc
Q psy5690 154 DTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN---------NS--KQ 221 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~---------~~--~~ 221 (434)
.....+|+.|+|||++.+. .++.++|||||||++|||+ +|+.||.+.+..+....+...... .. ..
T Consensus 213 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell--~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~ 290 (420)
T 1j1b_A 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL--LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290 (420)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 1334678899999999765 7899999999999999999 899999988766555444321100 00 00
Q ss_pred cCCC----------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 222 QYLP----------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 222 ~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
...+ .+..+++++.+|+.+||+.||++||++.|+ |+||++..
T Consensus 291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000 123567899999999999999999999999 88998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=291.24 Aligned_cols=216 Identities=18% Similarity=0.238 Sum_probs=167.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCcccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN-SQENPAISYGCLIFMATQIASGMKYLES-RDIVHR 78 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHr 78 (434)
|++++||||+++++++.+++..++||||+++|+|.+++...... ......+++..++.++.||+.||+|||+ +||+||
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 46789999999999999999999999999999999983211000 1125679999999999999999999999 999999
Q ss_pred CCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 79 DLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 79 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||||+||+++.++.+||+|||+++..... ......
T Consensus 177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---------------------------------------------~~~~~~ 211 (348)
T 2pml_X 177 DVKPSNILMDKNGRVKLSDFGESEYMVDK---------------------------------------------KIKGSR 211 (348)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECBTT---------------------------------------------EECSSC
T ss_pred CCChHhEEEcCCCcEEEeccccccccccc---------------------------------------------cccCCC
Confidence 99999999999999999999987542111 113456
Q ss_pred CCccccchhhhhcC-CCCC-cCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhhhhhhcCCcc-----------cCC
Q psy5690 159 LPIRWMAWESLLLG-KNTT-KSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQ-----------QYL 224 (434)
Q Consensus 159 gt~~y~aPE~~~~~-~~s~-~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~-----------~~~ 224 (434)
++..|+|||++.+. .++. ++|||||||++|||+ +|..||..... .+....+.......... ...
T Consensus 212 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 289 (348)
T 2pml_X 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF--YNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKST 289 (348)
T ss_dssp SCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH--HSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC----
T ss_pred CCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccc
Confidence 78899999999887 5655 999999999999999 88999988766 55554443211000000 000
Q ss_pred CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 225 PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 225 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.....+++++.+++.+||+.||.+||+++|+ |+||++..
T Consensus 290 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 290 CSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp ----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 0015678999999999999999999999999 77887643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=281.80 Aligned_cols=214 Identities=16% Similarity=0.178 Sum_probs=162.7
Q ss_pred CCCCCCCeeeEEEEE-ecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSLKDPNLVRVIGVC-STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++++|++++..++++ ..++..++||||+ +|+|.+++... ...+++..++.++.||+.||+|||++||+||||
T Consensus 59 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 131 (296)
T 3uzp_A 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDV 131 (296)
T ss_dssp HHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCC
Confidence 346777766555554 6677889999999 89999999732 346999999999999999999999999999999
Q ss_pred CCCCeee---ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||+ +.++.+||+|||+++........ ....+......
T Consensus 132 kp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------~~~~~~~~~~~ 175 (296)
T 3uzp_A 132 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH------------------------------------QHIPYRENKNL 175 (296)
T ss_dssp CGGGEEECCGGGTTCEEECCCTTCEECBCTTTC------------------------------------CBCCCCCSCCC
T ss_pred CHHHeEEecCCCCCeEEEeeCCCcccccccccc------------------------------------ccccccccccc
Confidence 9999999 47889999999997653222110 00011123456
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH---HHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE---QVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
.||..|+|||++.+..++.++|||||||++|||+ +|..||...... +....+..... ..........+++++
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l 250 (296)
T 3uzp_A 176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFN--LGSLPWQGLKAATKRQKYERISEKKM---STPIEVLCKGYPSEF 250 (296)
T ss_dssp CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCTTSSCCCSSSSSHHHHHHHHHH---HSCHHHHTTTSCHHH
T ss_pred ccccccCChhhhcCCCCCcchhhHHHHHHHHHHH--hCCCCCCCcCchhhhhhhhhhccccc---CCchHHHHhhCCHHH
Confidence 7889999999999999999999999999999999 899999864321 22222211100 000011125678999
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 235 FDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+++.+||+.||++||+++++.+.|++..
T Consensus 251 ~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 251 ATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 99999999999999999999999998763
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=291.83 Aligned_cols=203 Identities=17% Similarity=0.237 Sum_probs=162.2
Q ss_pred CCCCCCCeeeEEEEEecCCce------EEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPI------STIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~------~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
++++||||+++++++...+.. ++||||+. |+|.+++. ..+++..+..++.||+.||+|||++||
T Consensus 96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~i 165 (371)
T 4exu_A 96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG---------MEFSEEKIQYLVYQMLKGLKYIHSAGV 165 (371)
T ss_dssp HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999877655 99999997 58988874 348999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+||+|||+++.... ...
T Consensus 166 vH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----------------------------------------------~~~ 199 (371)
T 4exu_A 166 VHRDLKPGNLAVNEDCELKILDFGLARHADA----------------------------------------------EMT 199 (371)
T ss_dssp CCSCCCGGGEEECTTCCEEECSTTCC------------------------------------------------------
T ss_pred cCCCcCHHHeEECCCCCEEEEecCccccccc----------------------------------------------CcC
Confidence 9999999999999999999999999754211 113
Q ss_pred CCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC----------------
Q psy5690 156 KARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN---------------- 218 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 218 (434)
...+|+.|+|||++.+ ..++.++|||||||++|+|+ +|..||.+.+..+....+.......
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 277 (371)
T 4exu_A 200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML--TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 277 (371)
T ss_dssp CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh
Confidence 3456888999999987 67899999999999999999 8999999888766655443211100
Q ss_pred ----Cccc---CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 ----SKQQ---YLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 ----~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.... .......+++++.+|+.+||+.||++|||++|+ |+||+..
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 0000 001123567899999999999999999999999 8899764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=288.50 Aligned_cols=201 Identities=10% Similarity=0.071 Sum_probs=159.9
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
..|+||+++++++..++..++|||||++|+|.+++...+. .....+++..++.++.||+.||+|||++||+||||||+
T Consensus 124 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~ 201 (365)
T 3e7e_A 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKN--TPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201 (365)
T ss_dssp GGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHT--STTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGG
T ss_pred hhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhc--ccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHH
Confidence 4499999999999999999999999999999999975431 13457999999999999999999999999999999999
Q ss_pred Ceeeec-----------CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 84 NCMVGK-----------NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 84 NILl~~-----------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
|||++. ++.+||+|||+++...... ...
T Consensus 202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----------------------------------------~~~ 240 (365)
T 3e7e_A 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP-----------------------------------------KGT 240 (365)
T ss_dssp GEEECGGGTCC------CTTEEECCCTTCEEGGGSC-----------------------------------------TTE
T ss_pred HEEecccccCccccccccCCEEEeeCchhhhhhccC-----------------------------------------CCc
Confidence 999998 8999999999986421100 001
Q ss_pred cCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 153 SDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
......||..|+|||++.+..++.++|||||||++|||+ +|..||........ .. ..... ....++
T Consensus 241 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell--tg~~pf~~~~~~~~--------~~--~~~~~--~~~~~~ 306 (365)
T 3e7e_A 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML--FGTYMKVKNEGGEC--------KP--EGLFR--RLPHLD 306 (365)
T ss_dssp EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH--HSSCCCEEEETTEE--------EE--CSCCT--TCSSHH
T ss_pred eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH--hCCCccccCCCCce--------ee--chhcc--ccCcHH
Confidence 124457899999999999999999999999999999999 88999865432110 00 00001 113468
Q ss_pred HHHHHHHHhccCCCCCCC-CHHHHHHHHHh
Q psy5690 233 EIFDLMLECWKTNETDRP-RFSEIHLFLQR 261 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rp-s~~el~~~L~~ 261 (434)
.+.+++..|++.+|.+|+ +++++...|++
T Consensus 307 ~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 307 MWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp HHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 899999999999999996 67777555544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=290.47 Aligned_cols=203 Identities=21% Similarity=0.252 Sum_probs=159.1
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++..++ .++||||+++|+|.+++. ....+++..+..++.||+.||+|||++||+|||||
T Consensus 70 ~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 141 (322)
T 2ycf_A 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV-------GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 141 (322)
T ss_dssp HHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHS-------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 4689999999999987654 899999999999999996 44579999999999999999999999999999999
Q ss_pred CCCeeeecCCc---eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMVGKNYT---IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||++.++. +||+|||+++...... ......
T Consensus 142 p~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------~~~~~~ 177 (322)
T 2ycf_A 142 PENVLLSSQEEDCLIKITDFGHSKILGETS--------------------------------------------LMRTLC 177 (322)
T ss_dssp GGGEEESSSSSSCCEEECCCTTCEECCCCH--------------------------------------------HHHHHH
T ss_pred HHHEEEecCCCCCeEEEccCccceeccccc--------------------------------------------cccccc
Confidence 99999987654 9999999976532111 001234
Q ss_pred CCccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH-HHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 159 LPIRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE-QVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 159 gt~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
||..|+|||++. ...++.++|||||||++|+|+ +|..||...... .....+.. ............+++++
T Consensus 178 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 251 (322)
T 2ycf_A 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL--SGYPPFSEHRTQVSLKDQITS----GKYNFIPEVWAEVSEKA 251 (322)
T ss_dssp SCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH--HSSCSSCSTTCSSCHHHHHHH----TCCCCCHHHHTTSCHHH
T ss_pred CCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH--hCCCCCcccchHHHHHHHHHh----CccccCchhhhhcCHHH
Confidence 678899999985 466789999999999999999 889999765432 12222211 00011111124567899
Q ss_pred HHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 235 FDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+++.+||+.||++||+++++ |+||+..
T Consensus 252 ~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 252 LDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred HHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 999999999999999999999 6787654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=290.96 Aligned_cols=210 Identities=19% Similarity=0.252 Sum_probs=165.1
Q ss_pred CCCCCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++++||||+++++++... ...++||||+. |+|.++++. ..+++..+..++.||+.||+|||++||+
T Consensus 80 ~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~iv 150 (364)
T 3qyz_A 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSANVL 150 (364)
T ss_dssp HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 468999999999999655 36899999997 599999963 3589999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+|||++.++.+||+|||+++....... .......
T Consensus 151 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~----------------------------------------~~~~~~~ 190 (364)
T 3qyz_A 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHD----------------------------------------HTGFLTE 190 (364)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCGGGC----------------------------------------BCCTTCC
T ss_pred cCCCChHhEEECCCCCEEEEeCcceEecCCCCC----------------------------------------ccccccc
Confidence 999999999999999999999999765322110 0011234
Q ss_pred CCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC----------------
Q psy5690 157 ARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS---------------- 219 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 219 (434)
..||+.|+|||++.+ ..++.++|||||||++|+|+ +|..||.+....+....+........
T Consensus 191 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 268 (364)
T 3qyz_A 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML--SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268 (364)
T ss_dssp CCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHH--HSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHH
T ss_pred cccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHH--HCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHH
Confidence 578899999998765 45899999999999999999 88999988776665544432111100
Q ss_pred ----cccCC---CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 220 ----KQQYL---PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 220 ----~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
..... .....+++++.+|+.+||+.||++|||++|+ |+||++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00000 0124567899999999999999999999999 8899875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=284.66 Aligned_cols=205 Identities=15% Similarity=0.196 Sum_probs=159.6
Q ss_pred CCC-CCCeeeEEEEEec--CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 3 SLK-DPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 3 ~L~-HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
+++ ||||+++++++.+ ....++||||+.+++|.++++ .+++..+..++.||+.||+|||++||+|||
T Consensus 86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 155 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCHSMGIMHRD 155 (330)
T ss_dssp HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----------GCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 454 9999999999987 667899999999999999985 488999999999999999999999999999
Q ss_pred CCCCCeeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 80 LAARNCMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 80 lkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|||+|||++.++ .+||+|||+++...... ......
T Consensus 156 ikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------------------------------------------~~~~~~ 191 (330)
T 3nsz_A 156 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--------------------------------------------EYNVRV 191 (330)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCTTC--------------------------------------------CCCSCC
T ss_pred CCHHHEEEcCCCCEEEEEeCCCceEcCCCC--------------------------------------------cccccc
Confidence 999999999776 89999999976421111 113346
Q ss_pred CCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC-hHHHHHhhhhh---------hhcC---------
Q psy5690 159 LPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELT-NEQVIENCSHW---------YQNN--------- 218 (434)
Q Consensus 159 gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~-~~~~~~~~~~~---------~~~~--------- 218 (434)
++..|+|||++.+ ..++.++|||||||++|+|+ +|..||.... ..+....+... ....
T Consensus 192 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (330)
T 3nsz_A 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI--FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 269 (330)
T ss_dssp SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH--HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHH
T ss_pred ccccccChhhhcCCCcCCchhhHHHHHHHHHHHH--hCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchh
Confidence 7788999999987 66899999999999999999 8899985433 22222111110 0000
Q ss_pred -----------CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 219 -----------SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 219 -----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
........+..+++++.+||.+||+.||++|||++|+ |+||+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 270 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0000111123478999999999999999999999999 78998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=295.10 Aligned_cols=220 Identities=17% Similarity=0.257 Sum_probs=155.0
Q ss_pred CCCCCCCCeeeEEEEEec--CCceEEEEecCCCCCHHHHHhhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCN--SQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~--~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
|++|+||||+++++++.. +...++||||+. |+|.+++...... ......+++..++.++.||+.||+|||++||+
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv 150 (405)
T 3rgf_A 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 150 (405)
T ss_dssp HHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 356899999999999954 678999999996 5898888643211 11223589999999999999999999999999
Q ss_pred ccCCCCCCeee----ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 77 HRDLAARNCMV----GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 77 HrDlkp~NILl----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
||||||+|||+ +.++.+||+|||+++...... ....
T Consensus 151 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~----------------------------------------~~~~ 190 (405)
T 3rgf_A 151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL----------------------------------------KPLA 190 (405)
T ss_dssp CCCCCGGGEEECCSSTTTTCEEECCTTCCC--------------------------------------------------
T ss_pred CCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCC----------------------------------------cccc
Confidence 99999999999 677899999999986532211 0001
Q ss_pred cCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH---------HHHHhhhhhhhcCCc--
Q psy5690 153 SDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE---------QVIENCSHWYQNNSK-- 220 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~---------~~~~~~~~~~~~~~~-- 220 (434)
......||+.|+|||++.+. .++.++|||||||++|||+ +|..||.+.... +....+.........
T Consensus 191 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~ 268 (405)
T 3rgf_A 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL--TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 268 (405)
T ss_dssp ------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHH--HSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTT
T ss_pred cCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHH--hCCCCCCCccccccccccchHHHHHHHHHhhCCCChhh
Confidence 12345788999999999874 5899999999999999999 899999765432 222222111100000
Q ss_pred -------------------ccCC---------CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 221 -------------------QQYL---------PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 221 -------------------~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.... ......++++.+||.+||+.||++|||++|+ |+||.+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 269 WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp CGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred cchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 0000 0011225688999999999999999999999 89998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=282.52 Aligned_cols=212 Identities=18% Similarity=0.228 Sum_probs=163.1
Q ss_pred CCCCCCCCeeeEEEEEe--------------cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCS--------------TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~--------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~g 66 (434)
|++++||||+++++++. +.+..++||||++ |+|.+++. ...+++..++.++.|++.|
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--------~~~~~~~~~~~~~~qi~~~ 132 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--------QGPLLEEHARLFMYQLLRG 132 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT--------TCCCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh--------cCCccHHHHHHHHHHHHHH
Confidence 35789999999999984 3467899999997 59999995 2468999999999999999
Q ss_pred HHHhhhCCccccCCCCCCeeee-cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccc
Q psy5690 67 MKYLESRDIVHRDLAARNCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSH 145 (434)
Q Consensus 67 L~yLH~~~iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 145 (434)
|+|||++||+||||||+||+++ .++.+||+|||+++.......
T Consensus 133 l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------ 176 (320)
T 2i6l_A 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS------------------------------------ 176 (320)
T ss_dssp HHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC-----------------------------------------
T ss_pred HHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcc------------------------------------
Confidence 9999999999999999999997 567999999999765321100
Q ss_pred cCCcccccCCCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC------
Q psy5690 146 YESDYYLSDTKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN------ 218 (434)
Q Consensus 146 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~------ 218 (434)
.........+|..|+|||.+.+ ..++.++|||||||++|||+ +|..||.+....+....+.......
T Consensus 177 ----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (320)
T 2i6l_A 177 ----HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML--TGKTLFAGAHELEQMQLILESIPVVHEEDRQ 250 (320)
T ss_dssp -------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHH
T ss_pred ----cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCchhhhh
Confidence 0001123346788999999876 67899999999999999999 8999999887766554433211000
Q ss_pred -------------CcccC---CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 219 -------------SKQQY---LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 219 -------------~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
..... ......+++++.+++.+||+.||++|||++|+ |+||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 251 ELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred hhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 00000 00124578899999999999999999999999 89998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=290.80 Aligned_cols=208 Identities=17% Similarity=0.209 Sum_probs=159.9
Q ss_pred CCCCCCCeeeEEEEEec-----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCST-----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++++||||+++++++.. ....++||||+. |+|.+++.. ....+++..+..++.||+.||+|||++||+
T Consensus 84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 156 (362)
T 3pg1_A 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD------QRIVISPQHIQYFMYHILLGLHVLHEAGVV 156 (362)
T ss_dssp HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC------TTSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh------cccCCCHHHHHHHHHHHHHHHHHHHHCcCE
Confidence 46899999999999844 235899999997 589998872 335689999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+|||++.++.+||+|||+++..... .....
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~ 192 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDTAD--------------------------------------------ANKTH 192 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC--------------------------------------------------------
T ss_pred ecCCChHHEEEcCCCCEEEEecCcccccccc--------------------------------------------cccce
Confidence 9999999999999999999999997541111 01133
Q ss_pred CCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC-----------------
Q psy5690 157 ARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN----------------- 218 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 218 (434)
..+|..|+|||++.+ ..++.++|||||||++|+|+ +|..||.+....+....+.......
T Consensus 193 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 270 (362)
T 3pg1_A 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF--NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL 270 (362)
T ss_dssp ---CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHT
T ss_pred ecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHH
Confidence 467788999999987 67899999999999999999 8999999887766655443211100
Q ss_pred ---Ccc----cCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 ---SKQ----QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 ---~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
... ........+++.+.+|+.+||+.||++|||++|+ |+||++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp TTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 000 0001123557889999999999999999999999 8899875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.43 Aligned_cols=218 Identities=18% Similarity=0.204 Sum_probs=165.0
Q ss_pred CCCCCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 2 CSLKDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
++++||||+++++++..+ ...++||||+. |+|.+++.. ..+++..+..++.|++.||+|||++||+
T Consensus 64 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~iv 134 (353)
T 2b9h_A 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST--------QMLSDDHIQYFIYQTLRAVKVLHGSNVI 134 (353)
T ss_dssp HHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 468999999999998654 67899999997 599999963 3589999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+|||++.++.+||+|||+++.......... ...........
T Consensus 135 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~---------------------------------~~~~~~~~~~~ 181 (353)
T 2b9h_A 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS---------------------------------EPTGQQSGMVE 181 (353)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECC-------------------------------------------------CC
T ss_pred cCCCCHHHeEEcCCCcEEEEeccccccccccccccc---------------------------------Cccccccchhh
Confidence 999999999999999999999999876432211000 00000011234
Q ss_pred CCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc---------------
Q psy5690 157 ARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK--------------- 220 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 220 (434)
..||..|+|||++.+ ..++.++|||||||++|+|+ +|..||.+.+..+....+.........
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (353)
T 2b9h_A 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF--LRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREY 259 (353)
T ss_dssp CCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHH
T ss_pred ccccccccCCeeeccCCCccchhhHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHH
Confidence 578899999998875 67899999999999999999 899999988766554433221110000
Q ss_pred ----ccCC-----CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 221 ----QQYL-----PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 221 ----~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.... .....+++++.+++.+||+.||++|||++|+ |+||+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 260 IKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0000 0123578899999999999999999999999 78998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=286.10 Aligned_cols=203 Identities=17% Similarity=0.242 Sum_probs=161.6
Q ss_pred CCCCCCCeeeEEEEEecCCc------eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 2 CSLKDPNLVRVIGVCSTEDP------ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
++++||||+++++++...+. .++||||+. |+|.+++. ..+++..+..++.||+.||+|||++||
T Consensus 78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~i 147 (353)
T 3coi_A 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG---------LKFSEEKIQYLVYQMLKGLKYIHSAGV 147 (353)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT---------SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 46899999999999987654 499999997 58888764 248999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+||+++.++.+||+|||+++.... ...
T Consensus 148 vH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~----------------------------------------------~~~ 181 (353)
T 3coi_A 148 VHRDLKPGNLAVNEDCELKILDFGLARHADA----------------------------------------------EMT 181 (353)
T ss_dssp CCSSCCGGGEEECTTCCEEECSTTCTTC----------------------------------------------------
T ss_pred ccCCCCHHHEeECCCCcEEEeecccccCCCC----------------------------------------------Ccc
Confidence 9999999999999999999999998754111 012
Q ss_pred CCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhh------------------
Q psy5690 156 KARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQ------------------ 216 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~------------------ 216 (434)
...+|..|+|||++.+ ..++.++|||||||++|+|+ +|..||.+.+..+....+.....
T Consensus 182 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 259 (353)
T 3coi_A 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML--TGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY 259 (353)
T ss_dssp --CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHH--HSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHH
T ss_pred ccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHH
Confidence 3456888999999987 67899999999999999999 89999998876655544332110
Q ss_pred --cCC---cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 217 --NNS---KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 217 --~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
... ..........+++++.+++.+||+.||++|||++|+ |+||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 260 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000 111122234678999999999999999999999999 7898764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=281.38 Aligned_cols=216 Identities=15% Similarity=0.259 Sum_probs=163.8
Q ss_pred CCCCCCCeeeEEEEEe----cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 2 CSLKDPNLVRVIGVCS----TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
++++||||+++++++. ..+..++||||+++|+|.+++.... .....+++..++.++.||+.||+|||++||+|
T Consensus 81 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 157 (317)
T 2buj_A 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK---DKGNFLTEDQILWLLLGICRGLEAIHAKGYAH 157 (317)
T ss_dssp HTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 5789999999999996 3357899999999999999997542 13457999999999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+||+++.++.+||+|||+++........... ..........
T Consensus 158 ~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~ 203 (317)
T 2buj_A 158 RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ----------------------------------ALTLQDWAAQ 203 (317)
T ss_dssp CCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHH----------------------------------HHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEecCcchhcccccccccc----------------------------------cccccccccc
Confidence 999999999999999999999987652211100000 0000000123
Q ss_pred CCCccccchhhhhcCC---CCCcCChHHHHHHHHHHHhhcCCCCCCCCCh--HHHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 158 RLPIRWMAWESLLLGK---NTTKSDVWSFAVTLWEILIHCNQRPYAELTN--EQVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~---~s~~sDIwSlGvil~ellt~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
.||..|+|||++.+.. ++.++|||||||++|+|+ +|..||..... ......+. .....+.+..+++
T Consensus 204 ~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~--~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 274 (317)
T 2buj_A 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM--FGEGPYDMVFQKGDSVALAVQ-------NQLSIPQSPRHSS 274 (317)
T ss_dssp HSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH--HSSCTTHHHHHTTSCHHHHHH-------CC--CCCCTTSCH
T ss_pred cCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH--hCCCChhhhhcccchhhHHhh-------ccCCCCccccCCH
Confidence 4578899999987654 688999999999999999 88999854211 01111111 1223344567789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
++.+++.+||+.||++||+++++++.|++..
T Consensus 275 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred HHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 9999999999999999999999999998864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=294.82 Aligned_cols=211 Identities=15% Similarity=0.197 Sum_probs=162.1
Q ss_pred CCCCCCCeeeEEEEEecCC--ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 2 CSLKDPNLVRVIGVCSTED--PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
++++||||+++++++...+ ..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++||+|||
T Consensus 62 ~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 137 (396)
T 4eut_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS----NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137 (396)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG----GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh----cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECC
Confidence 4689999999999998765 6899999999999999997432 223499999999999999999999999999999
Q ss_pred CCCCCeee----ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 80 LAARNCMV----GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 80 lkp~NILl----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
|||+|||+ +.++.+||+|||+++...... ...
T Consensus 138 lkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~--------------------------------------------~~~ 173 (396)
T 4eut_A 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--------------------------------------------QFV 173 (396)
T ss_dssp CCGGGEEEEECTTSCEEEEECCGGGCEECCCGG--------------------------------------------GSS
T ss_pred cCHHHEEEeecCCCceeEEEecCCCceEccCCC--------------------------------------------ccc
Confidence 99999999 777789999999976522111 113
Q ss_pred CCCCCccccchhhhhc--------CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC----hHHHHHhhhhhhhc------
Q psy5690 156 KARLPIRWMAWESLLL--------GKNTTKSDVWSFAVTLWEILIHCNQRPYAELT----NEQVIENCSHWYQN------ 217 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~--------~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~----~~~~~~~~~~~~~~------ 217 (434)
...||..|+|||++.+ ..++.++|||||||++|||+ +|..||.... ..+....+......
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~--tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 251 (396)
T 4eut_A 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA--TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251 (396)
T ss_dssp CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHH--HSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEE
T ss_pred cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHH--HCCCCCCCCCcccchHHHHHHHhcCCCcccchhh
Confidence 3568899999999875 45678999999999999999 8999997532 22333222211000
Q ss_pred --C---------CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 218 --N---------SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 218 --~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
. ...........+++.+.+++.+||+.||++||+++|+.+.+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp ECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred eeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 0 00001112245678899999999999999999999998777664
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=282.28 Aligned_cols=211 Identities=19% Similarity=0.276 Sum_probs=147.9
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDl 80 (434)
+.++||||+++++++.+++..++||||+++ +|.+++..... .....+++..+..++.|++.||.|||++ ||+||||
T Consensus 76 ~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl 152 (327)
T 3aln_A 76 RSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYS--VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI 152 (327)
T ss_dssp SSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHH--TTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCC
T ss_pred HcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHh--hhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCC
Confidence 568999999999999999999999999975 88888763211 1245789999999999999999999999 9999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ......||
T Consensus 153 kp~NIll~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------~~~~~~gt 188 (327)
T 3aln_A 153 KPSNILLDRSGNIKLCDFGISGQLVDSI--------------------------------------------AKTRDAGC 188 (327)
T ss_dssp CGGGEEEETTTEEEECCCSSSCC---------------------------------------------------------
T ss_pred CHHHEEEcCCCCEEEccCCCceeccccc--------------------------------------------ccccCCCC
Confidence 9999999999999999999976521110 11223578
Q ss_pred ccccchhhh----hcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 161 IRWMAWESL----LLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 161 ~~y~aPE~~----~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..|+|||++ .+..++.++|||||||++|+|+ +|..||........ .+..................+++++.+
T Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~ 264 (327)
T 3aln_A 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA--TGRFPYPKWNSVFD--QLTQVVKGDPPQLSNSEEREFSPSFIN 264 (327)
T ss_dssp -----------------CCSHHHHHHHHHHHHHHH--HSCCCSSCC---------CCCCCSCCCCCCCCSSCCCCHHHHH
T ss_pred ccccCceeeccccCcCCCCchhhHHHHHHHHHHHH--HCCCCCCCcchHHH--HHHHHhcCCCCCCCCcccccCCHHHHH
Confidence 889999998 4567899999999999999999 88999987543211 111111111111111123467899999
Q ss_pred HHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 237 LMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
++.+||+.||++||++.++ |+|+.+..
T Consensus 265 li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 265 FVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 9999999999999999999 88998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=295.22 Aligned_cols=215 Identities=13% Similarity=0.169 Sum_probs=164.6
Q ss_pred CCCC-CCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 3 SLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 3 ~L~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
.|+| ++|..+..++..++..++||||+ +|+|.+++... ...+++..++.++.||+.||+|||++||+|||||
T Consensus 58 ~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIK 130 (483)
T 3sv0_A 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130 (483)
T ss_dssp HTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 4555 66667777778888899999999 89999999742 3569999999999999999999999999999999
Q ss_pred CCCeee---ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 82 ARNCMV---GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 82 p~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
|+|||+ +.++.+||+|||+++....... .....+.......
T Consensus 131 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~------------------------------------~~~~~~~~~~~~~ 174 (483)
T 3sv0_A 131 PDNFLMGLGRRANQVYIIDFGLAKKYRDTST------------------------------------HQHIPYRENKNLT 174 (483)
T ss_dssp GGGEEECCGGGTTCEEECCCTTCEECBCTTT------------------------------------CCBCCCCCCCCCC
T ss_pred cceEEEecCCCCCeEEEEeCCcceeccCCcc------------------------------------ccccccccccccC
Confidence 999999 5889999999999876332210 0001122234567
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||..|+|||++.+..++.++|||||||++|||+ +|..||.+.......+.+..................+++++.+++
T Consensus 175 gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ell--tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li 252 (483)
T 3sv0_A 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYF 252 (483)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHH
T ss_pred CCccccCHHHhcCCCCChHHHHHHHHHHHHHHH--hCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHH
Confidence 899999999999999999999999999999999 899999875542222111111111001111111245678999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.+||+.||++||++++|.+.|++.
T Consensus 253 ~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 253 HYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHHHHHH
Confidence 999999999999999998887764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=281.78 Aligned_cols=206 Identities=24% Similarity=0.358 Sum_probs=161.5
Q ss_pred CCCCCCeeeEEEEEecCC----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-------
Q psy5690 3 SLKDPNLVRVIGVCSTED----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE------- 71 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH------- 71 (434)
.++||||+++++++...+ ..++||||+++|+|.+++.+ ..+++..++.++.|++.||+|||
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ 163 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--------cCccHHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 479999999999998776 79999999999999999963 25899999999999999999999
Q ss_pred -hCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 72 -SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 72 -~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 164 ~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---------------------------------------~~ 204 (342)
T 1b6c_B 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD---------------------------------------TI 204 (342)
T ss_dssp CBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTT---------------------------------------EE
T ss_pred ccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccc---------------------------------------cc
Confidence 89999999999999999999999999999765322110 00
Q ss_pred cccCCCCCCCccccchhhhhcCC------CCCcCChHHHHHHHHHHHhhcC----------CCCCCCCCh-----HHHHH
Q psy5690 151 YLSDTKARLPIRWMAWESLLLGK------NTTKSDVWSFAVTLWEILIHCN----------QRPYAELTN-----EQVIE 209 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDIwSlGvil~ellt~~g----------~~pf~~~~~-----~~~~~ 209 (434)
........||..|+|||++.+.. ++.++|||||||++|||+ +| ..||..... .....
T Consensus 205 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~--tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 282 (342)
T 1b6c_B 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282 (342)
T ss_dssp EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH--TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH--hccCcCCcccccccCccccCcCcccHHHHHH
Confidence 01224456889999999998763 236899999999999999 66 788876432 22222
Q ss_pred hhhhhhhcCCcccCCCCC-----CccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 210 NCSHWYQNNSKQQYLPRP-----ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
.+.. .......+ ..+++.+.+++.+||+.||++|||+.+|++.|++..
T Consensus 283 ~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 283 VVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp HHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 2211 11111112 345678999999999999999999999999998764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=292.99 Aligned_cols=205 Identities=19% Similarity=0.212 Sum_probs=153.8
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++ +|||||++++++.+++..|+|||||. |+|.+++... .....+..+..++.||+.||+|||++||+|||||
T Consensus 73 ~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK 145 (432)
T 3p23_A 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK------DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLK 145 (432)
T ss_dssp HSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS------SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred hccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc------CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCC
Confidence 45 79999999999999999999999996 5999999733 2345555678999999999999999999999999
Q ss_pred CCCeeeec-----CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 82 ARNCMVGK-----NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 82 p~NILl~~-----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
|+|||++. ...+||+|||+++...... ........
T Consensus 146 p~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~----------------------------------------~~~~~~~~ 185 (432)
T 3p23_A 146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGR----------------------------------------HSFSRRSG 185 (432)
T ss_dssp TTSEEECCCBTTTBCCEEECCTTEEECC----------------------------------------------------
T ss_pred HHHEEEecCCCCCceeEEEecccceeeccCCC----------------------------------------cceeeccc
Confidence 99999953 2357899999986532211 00111234
Q ss_pred CCCCccccchhhhh---cCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 157 ARLPIRWMAWESLL---LGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 157 ~~gt~~y~aPE~~~---~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
..||+.|+|||++. ...++.++|||||||++|||+ + |..||............. .............+.
T Consensus 186 ~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell--t~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 258 (432)
T 3p23_A 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI--SEGSHPFGKSLQRQANILLG-----ACSLDCLHPEKHEDV 258 (432)
T ss_dssp CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH--TTSCBTTBSTTTHHHHHHTT-----CCCCTTSCTTCHHHH
T ss_pred cCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH--cCCCCCcchhhHHHHHHHhc-----cCCccccCccccccH
Confidence 56899999999998 456788999999999999999 6 899997665544432211 111112222345567
Q ss_pred HHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
.+.+|+.+||+.||++|||++|+ |+||..
T Consensus 259 ~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 259 IARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 79999999999999999999999 677754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=277.27 Aligned_cols=204 Identities=20% Similarity=0.326 Sum_probs=156.5
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRDL 80 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrDl 80 (434)
+.++||||+++++++.+++..++||||+ ++.+..+.... ...+++..+..++.|++.||.|||++ ||+||||
T Consensus 79 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl 151 (318)
T 2dyl_A 79 KSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRM------QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV 151 (318)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred HhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCC
Confidence 4679999999999999999999999999 55666665432 34689999999999999999999995 9999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+++...... ......+|
T Consensus 152 kp~Nil~~~~~~~kl~dfg~~~~~~~~~--------------------------------------------~~~~~~~~ 187 (318)
T 2dyl_A 152 KPSNILLDERGQIKLCDFGISGRLVDDK--------------------------------------------AKDRSAGC 187 (318)
T ss_dssp CGGGEEECTTSCEEECCCTTC----------------------------------------------------------C
T ss_pred CHHHEEECCCCCEEEEECCCchhccCCc--------------------------------------------cccccCCC
Confidence 9999999999999999999875421110 11234578
Q ss_pred ccccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC-hHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 161 IRWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT-NEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 161 ~~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
..|+|||++. ...++.++|||||||++|+|+ +|..||.... ..+....+.. ......+....+++++
T Consensus 188 ~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l 260 (318)
T 2dyl_A 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA--TGQFPYKNCKTDFEVLTKVLQ-----EEPPLLPGHMGFSGDF 260 (318)
T ss_dssp CTTCCHHHHC--------CCTHHHHHHHHHHHHHHH--HSSCTTTTCCSHHHHHHHHHH-----SCCCCCCSSSCCCHHH
T ss_pred ccccChhhcccccccccCCccccchhhHHHHHHHHH--hCCCCCCCCCccHHHHHHHhc-----cCCCCCCccCCCCHHH
Confidence 8899999994 456789999999999999999 7899998743 3333333221 1112223334678999
Q ss_pred HHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 235 FDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+++.+||+.||.+||+++++ |+|+++..
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 261 QSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 999999999999999999999 88998753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=284.69 Aligned_cols=214 Identities=18% Similarity=0.266 Sum_probs=145.9
Q ss_pred CC-CCCCeeeEEEEEe--------cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 3 SL-KDPNLVRVIGVCS--------TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~--------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
++ +||||+++++++. .....++||||+. |+|.+++.... ....+++..++.++.||+.||+|||++
T Consensus 81 ~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~ 155 (337)
T 3ll6_A 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME----SRGPLSCDTVLKIFYQTCRAVQHMHRQ 155 (337)
T ss_dssp HHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH----TTCSCCHHHHHHHHHHHHHHHHHHHTS
T ss_pred HhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34 4999999999994 3344899999996 69999987533 345699999999999999999999999
Q ss_pred C--ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccc
Q psy5690 74 D--IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYY 151 (434)
Q Consensus 74 ~--iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 151 (434)
| |+||||||+|||++.++.+||+|||+++............ ......
T Consensus 156 ~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~-------------------------------~~~~~~ 204 (337)
T 3ll6_A 156 KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA-------------------------------QRRALV 204 (337)
T ss_dssp SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------------------
T ss_pred CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccc-------------------------------cccccc
Confidence 9 9999999999999999999999999987643321100000 000000
Q ss_pred ccCCCCCCCccccchhhh---hcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCC
Q psy5690 152 LSDTKARLPIRWMAWESL---LLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA 228 (434)
Q Consensus 152 ~~~~~~~gt~~y~aPE~~---~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (434)
.......+|+.|+|||++ .+..++.++|||||||++|+|+ +|..||.......... .....+...
T Consensus 205 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~--~g~~p~~~~~~~~~~~----------~~~~~~~~~ 272 (337)
T 3ll6_A 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC--FRQHPFEDGAKLRIVN----------GKYSIPPHD 272 (337)
T ss_dssp -------------------CCTTSCSSHHHHHHHHHHHHHHHH--HSSCCC----------------------CCCCTTC
T ss_pred hhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH--hCCCCCcchhHHHhhc----------CcccCCccc
Confidence 112345678899999998 5667789999999999999999 8899997655443322 112223345
Q ss_pred ccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 229 TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 229 ~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
.+++.+.+++.+||+.||++||+++|+++.|+....
T Consensus 273 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 273 TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 566789999999999999999999999998887644
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=292.41 Aligned_cols=213 Identities=21% Similarity=0.238 Sum_probs=151.0
Q ss_pred CCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.+|||||++++++.+++..++|||||. |+|.+++.............++..++.++.||+.||+|||++||+||||||+
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 389999999999999999999999995 6999999854321111112244567889999999999999999999999999
Q ss_pred CeeeecC-------------CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 84 NCMVGKN-------------YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 84 NILl~~~-------------~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
|||++.+ +.+||+|||+++....... ..
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~---------------------------------------~~ 185 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS---------------------------------------SF 185 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------------------------------------
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCc---------------------------------------cc
Confidence 9999754 4899999999865322110 00
Q ss_pred cccCCCCCCCccccchhhhhc-------CCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCccc
Q psy5690 151 YLSDTKARLPIRWMAWESLLL-------GKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQ 222 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 222 (434)
........||+.|+|||++.+ ..++.++|||||||++|||+ + |..||......+. .+....... ...
T Consensus 186 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ell--t~g~~Pf~~~~~~~~--~i~~~~~~~-~~~ 260 (434)
T 2rio_A 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL--SKGKHPFGDKYSRES--NIIRGIFSL-DEM 260 (434)
T ss_dssp ---------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHH--TTSCCTTCSTTTHHH--HHHHTCCCC-CCC
T ss_pred eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHH--hCCCCCCCCchhhHH--HHhcCCCCc-ccc
Confidence 001234568899999999976 56799999999999999999 6 8999976554332 111111000 111
Q ss_pred CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 223 YLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 223 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
.......+++++.+++.+||+.||++|||+.|+ |+|+..
T Consensus 261 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 261 KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 111133567899999999999999999999999 677743
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=276.76 Aligned_cols=217 Identities=19% Similarity=0.193 Sum_probs=155.3
Q ss_pred CCCCCCCCeeeEEEEEec-------------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCST-------------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGM 67 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL 67 (434)
|++++||||+++++++.+ .+..++||||+++|+|.+++... ...+++..++.++.|++.||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l 129 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE------NLNQQRDEYWRLFRQILEAL 129 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS------CGGGCHHHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc------ccccchHHHHHHHHHHHHHH
Confidence 467899999999999865 35689999999999999999742 24678899999999999999
Q ss_pred HHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccC
Q psy5690 68 KYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYE 147 (434)
Q Consensus 68 ~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 147 (434)
+|||++||+||||||+||+++.++.+||+|||+++.............. ..
T Consensus 130 ~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~-----------------------------~~ 180 (303)
T 1zy4_A 130 SYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ-----------------------------NL 180 (303)
T ss_dssp HHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-----------------------------------------
T ss_pred HHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccc-----------------------------cc
Confidence 9999999999999999999999999999999998764322110000000 00
Q ss_pred CcccccCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh-HHHHHhhhhhhhcCCcccCCC
Q psy5690 148 SDYYLSDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQYLP 225 (434)
Q Consensus 148 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 225 (434)
...........||..|+|||++.+. .++.++|||||||++|+|+ + ||..... .+....+. .........
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~---p~~~~~~~~~~~~~~~----~~~~~~~~~ 251 (303)
T 1zy4_A 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--Y---PFSTGMERVNILKKLR----SVSIEFPPD 251 (303)
T ss_dssp -------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH--S---CCSSHHHHHHHHHHHH----STTCCCCTT
T ss_pred cccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH--h---ccCCchhHHHHHHhcc----ccccccCcc
Confidence 0001112345678899999999865 6899999999999999999 6 5543322 22222221 111122223
Q ss_pred CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 226 RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 226 ~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
.+...++.+.+++.+||+.||++|||++++ |+|++.
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 252 FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred ccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 345667889999999999999999999999 567754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=278.31 Aligned_cols=205 Identities=18% Similarity=0.193 Sum_probs=162.6
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARN 84 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~N 84 (434)
.|.+++.+++++...+..++||||+ +|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-----~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~N 153 (355)
T 2eu9_A 80 NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKEN-----NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPEN 153 (355)
T ss_dssp SCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-----TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGG
T ss_pred CceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 3455999999999999999999999 66787777633 22468999999999999999999999999999999999
Q ss_pred eee-------------------ecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccc
Q psy5690 85 CMV-------------------GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSH 145 (434)
Q Consensus 85 ILl-------------------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 145 (434)
||+ +.++.+||+|||+++....
T Consensus 154 Ill~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--------------------------------------- 194 (355)
T 2eu9_A 154 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--------------------------------------- 194 (355)
T ss_dssp EEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS---------------------------------------
T ss_pred EEEecccccccccccccccccccCCCcEEEeecCccccccc---------------------------------------
Confidence 999 6678999999998754111
Q ss_pred cCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC------
Q psy5690 146 YESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS------ 219 (434)
Q Consensus 146 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~------ 219 (434)
......||+.|+|||++.+..++.++|||||||++|||+ +|..||......+....+........
T Consensus 195 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 265 (355)
T 2eu9_A 195 -------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY--RGFTLFQTHENREHLVMMEKILGPIPSHMIHR 265 (355)
T ss_dssp -------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred -------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhh
Confidence 113456789999999999999999999999999999999 89999998877665443332111000
Q ss_pred ------------------------------cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 220 ------------------------------KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 220 ------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
...........++++.+|+.+||+.||++|||++|+ |+||++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 266 TRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp CSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred ccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 000111123446789999999999999999999999 79998753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=275.18 Aligned_cols=199 Identities=19% Similarity=0.294 Sum_probs=156.1
Q ss_pred CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCe
Q psy5690 6 DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNC 85 (434)
Q Consensus 6 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NI 85 (434)
||||+++++++.+++..++||| +.+|+|.+++.. ...+++..+..++.|+++||+|||++||+||||||+||
T Consensus 87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 158 (313)
T 3cek_A 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK-------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 158 (313)
T ss_dssp CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH-------CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence 6999999999999999999999 557899999983 34789999999999999999999999999999999999
Q ss_pred eeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccc
Q psy5690 86 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMA 165 (434)
Q Consensus 86 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~a 165 (434)
+++ ++.+||+|||+++...... .........||..|+|
T Consensus 159 l~~-~~~~kL~Dfg~~~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~a 196 (313)
T 3cek_A 159 LIV-DGMLKLIDFGIANQMQPDT-----------------------------------------TSVVKDSQVGTVNYMP 196 (313)
T ss_dssp EEE-TTEEEECCCSSSCC-------------------------------------------------------CCGGGCC
T ss_pred EEE-CCeEEEeeccccccccCcc-----------------------------------------ccccccCCCCCCCcCC
Confidence 996 4899999999976532111 0011133467889999
Q ss_pred hhhhhc-----------CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 166 WESLLL-----------GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 166 PE~~~~-----------~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
||++.+ ..++.++|||||||++|||+ +|..||....... ....+. ........+..++++
T Consensus 197 PE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~--~g~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 268 (313)
T 3cek_A 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT--YGKTPFQQIINQISKLHAII------DPNHEIEFPDIPEKD 268 (313)
T ss_dssp HHHHTTCC----------CCCHHHHHHHHHHHHHHHH--HSSCTTTTCCSHHHHHHHHH------CTTSCCCCCCCSCHH
T ss_pred HHHHhhcccccccccccccCCchHHHHHHHHHHHHHH--hCCCchhhHHHHHHHHHHHH------hcccccCCcccchHH
Confidence 999976 46788999999999999999 8899998764332 222111 122233445566789
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
+.+++.+||+.||++||+++|+ |+|++..
T Consensus 269 l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 269 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 9999999999999999999999 7899864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=282.63 Aligned_cols=203 Identities=17% Similarity=0.155 Sum_probs=159.7
Q ss_pred CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--hCCccccCCCCC
Q psy5690 6 DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE--SRDIVHRDLAAR 83 (434)
Q Consensus 6 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlkp~ 83 (434)
|++|+++++++..++..++||||+. |+|.+++... ....+++..+..++.|++.||.||| +.||+||||||+
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~ 188 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT-----NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT-----TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGG
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc-----CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcc
Confidence 4469999999999999999999996 5999999743 2245899999999999999999999 479999999999
Q ss_pred Ceeee--cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 84 NCMVG--KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 84 NILl~--~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|||++ .++.+||+|||+++.... ......||+
T Consensus 189 NIll~~~~~~~~kL~DFG~a~~~~~----------------------------------------------~~~~~~~t~ 222 (382)
T 2vx3_A 189 NILLCNPKRSAIKIVDFGSSCQLGQ----------------------------------------------RIYQYIQSR 222 (382)
T ss_dssp GEEESSTTSCCEEECCCTTCEETTC----------------------------------------------CCCSSCSCG
T ss_pred cEEEecCCCCcEEEEeccCceeccc----------------------------------------------ccccccCCc
Confidence 99995 477899999999765211 113456788
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCC------------------cc--
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS------------------KQ-- 221 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------~~-- 221 (434)
.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+........ ..
T Consensus 223 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell--tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (382)
T 2vx3_A 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMH--TGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTW 300 (382)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCE
T ss_pred cccChHHHcCCCCCcHHHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccccc
Confidence 899999999999999999999999999999 89999998887766555443211000 00
Q ss_pred -----------cCCCC-------------------------CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 222 -----------QYLPR-------------------------PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 222 -----------~~~~~-------------------------~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
...+. .....+++.+||.+||+.||++|||++|+ |+||++.
T Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 301 NLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp EECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred ccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 00000 00112578999999999999999999999 7898764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=287.19 Aligned_cols=202 Identities=17% Similarity=0.244 Sum_probs=154.1
Q ss_pred CCCCeeeEEEEEe----cCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccC
Q psy5690 5 KDPNLVRVIGVCS----TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRD 79 (434)
Q Consensus 5 ~HpnIv~l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrD 79 (434)
+|+||+++++++. .+...++||||+ +|+|.+++... ....+++..++.++.||+.||+|||++ ||+|||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrD 172 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS-----NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTD 172 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT-----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCC
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc-----ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 4889999999997 556799999999 55777776532 235689999999999999999999998 999999
Q ss_pred CCCCCeeeecCC-------------------------------------------------ceEEccCCccccccccccc
Q psy5690 80 LAARNCMVGKNY-------------------------------------------------TIKISDHAMYCSHYESDYY 110 (434)
Q Consensus 80 lkp~NILl~~~~-------------------------------------------------~~kL~DFGla~~~~~~~~~ 110 (434)
|||+|||++.++ .+||+|||+++....
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---- 248 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---- 248 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----
Confidence 999999998775 688888888654211
Q ss_pred ccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHH
Q psy5690 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEI 190 (434)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~el 190 (434)
......||..|+|||++.+..++.++|||||||++|||
T Consensus 249 ------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 286 (397)
T 1wak_A 249 ------------------------------------------HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFEL 286 (397)
T ss_dssp ------------------------------------------CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHH
Confidence 11344678999999999999999999999999999999
Q ss_pred HhhcCCCCCCCCCh------HHHHHhhhhhhhc------------------CCcc----------------cCCCCCCcc
Q psy5690 191 LIHCNQRPYAELTN------EQVIENCSHWYQN------------------NSKQ----------------QYLPRPATC 230 (434)
Q Consensus 191 lt~~g~~pf~~~~~------~~~~~~~~~~~~~------------------~~~~----------------~~~~~~~~~ 230 (434)
+ +|..||..... ......+...... .... .....+...
T Consensus 287 l--tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (397)
T 1wak_A 287 A--TGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE 364 (397)
T ss_dssp H--HSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHH
T ss_pred h--hCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhh
Confidence 9 89999976542 1111111110000 0000 001123455
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHH--HHHHH
Q psy5690 231 QKEIFDLMLECWKTNETDRPRFSEI--HLFLQ 260 (434)
Q Consensus 231 ~~~l~~li~~cl~~dP~~Rps~~el--~~~L~ 260 (434)
++++.+||.+||+.||++|||++|+ |+||+
T Consensus 365 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 365 AAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 6789999999999999999999999 67775
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=278.61 Aligned_cols=191 Identities=19% Similarity=0.310 Sum_probs=154.9
Q ss_pred CCCCCeeeEEEEEecCCceEEEEec-CCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 4 LKDPNLVRVIGVCSTEDPISTIQEY-CEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
++||||+++++++...+..++|+|| +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||
T Consensus 95 ~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 167 (312)
T 2iwi_A 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKD 167 (312)
T ss_dssp CCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSG
T ss_pred CCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh
Confidence 3899999999999999999999999 7899999999743 4689999999999999999999999999999999
Q ss_pred CCeeee-cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 83 RNCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 83 ~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
+||+++ .++.+||+|||+++..... ......|+.
T Consensus 168 ~Nil~~~~~~~~kl~dfg~~~~~~~~---------------------------------------------~~~~~~~~~ 202 (312)
T 2iwi_A 168 ENILIDLRRGCAKLIDFGSGALLHDE---------------------------------------------PYTDFDGTR 202 (312)
T ss_dssp GGEEEETTTTEEEECCCSSCEECCSS---------------------------------------------CBCCCCSCT
T ss_pred hhEEEeCCCCeEEEEEcchhhhcccC---------------------------------------------cccccCCcc
Confidence 999999 7899999999997652211 112345788
Q ss_pred cccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 162 ~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
.|+|||++.+..+ +.++|||||||++|+|+ +|..||.... +... .....+..+++++.+++.+
T Consensus 203 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~--~~~~------------~~~~~~~~~~~~~~~li~~ 266 (312)
T 2iwi_A 203 VYSPPEWISRHQYHALPATVWSLGILLYDMV--CGDIPFERDQ--EILE------------AELHFPAHVSPDCCALIRR 266 (312)
T ss_dssp TTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH--HSSCSCCSHH--HHHH------------TCCCCCTTSCHHHHHHHHH
T ss_pred cccCceeeecCCCCCccchHHHHHHHHHHHH--HCCCCCCChH--HHhh------------hccCCcccCCHHHHHHHHH
Confidence 8999999987776 45899999999999999 8899997532 1111 1123356778999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||++||+++|+ |+|++..
T Consensus 267 ~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 267 CLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp HTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred HccCChhhCcCHHHHhcChhhcCc
Confidence 999999999999999 5687764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=278.95 Aligned_cols=190 Identities=19% Similarity=0.261 Sum_probs=159.0
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCC-CCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEF-GDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.||||+++++++..++..++|+|++.+ ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 178 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 178 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHH
Confidence 479999999999999999999999976 899999974 346899999999999999999999999999999999
Q ss_pred Ceeee-cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 84 NCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 84 NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
|||++ .++.+||+|||+++..... ......||..
T Consensus 179 NIll~~~~~~~kL~Dfg~~~~~~~~---------------------------------------------~~~~~~gt~~ 213 (320)
T 3a99_A 179 NILIDLNRGELKLIDFGSGALLKDT---------------------------------------------VYTDFDGTRV 213 (320)
T ss_dssp GEEEETTTTEEEECCCTTCEECCSS---------------------------------------------CBCCCCSCGG
T ss_pred HEEEeCCCCCEEEeeCccccccccc---------------------------------------------cccCCCCCcc
Confidence 99999 7889999999997652111 1123457889
Q ss_pred ccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 163 WMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 163 y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
|+|||++.+..+ +.++|||||||++|||+ +|..||.... +... .....+..+++++.+++.+|
T Consensus 214 y~aPE~~~~~~~~~~~~Di~slG~il~el~--~g~~pf~~~~--~~~~------------~~~~~~~~~~~~~~~li~~~ 277 (320)
T 3a99_A 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV--CGDIPFEHDE--EIIR------------GQVFFRQRVSSECQHLIRWC 277 (320)
T ss_dssp GSCHHHHHHSCBCHHHHHHHHHHHHHHHHH--HSSCSCCSHH--HHHH------------CCCCCSSCCCHHHHHHHHHH
T ss_pred CCChHHhccCCCCCccchHHhHHHHHHHHH--HCCCCCCChh--hhhc------------ccccccccCCHHHHHHHHHH
Confidence 999999987776 68899999999999999 8899997542 1111 11223456789999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHhc
Q psy5690 242 WKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~~ 262 (434)
|+.||++||+++|+ |+|+++.
T Consensus 278 l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 278 LALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp TCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ccCChhhCcCHHHHhcCHhhcCc
Confidence 99999999999999 6788764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=282.24 Aligned_cols=204 Identities=18% Similarity=0.231 Sum_probs=156.4
Q ss_pred CCCCeeeEEEEEecCC----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccC
Q psy5690 5 KDPNLVRVIGVCSTED----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRD 79 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrD 79 (434)
.||||+++++++...+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ ||+|||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~D 157 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY-----EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTD 157 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT-----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSC
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh-----hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecC
Confidence 4899999999997654 789999999 88999999743 234589999999999999999999998 999999
Q ss_pred CCCCCeeeec------CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 80 LAARNCMVGK------NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 80 lkp~NILl~~------~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|||+|||++. .+.+||+|||+++.... .
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~----------------------------------------------~ 191 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDE----------------------------------------------H 191 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTB----------------------------------------------C
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCC----------------------------------------------C
Confidence 9999999954 34799999999754211 1
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCCh------HHHHHhhhhhhhcC---------
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTN------EQVIENCSHWYQNN--------- 218 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~------~~~~~~~~~~~~~~--------- 218 (434)
.....||+.|+|||++.+..++.++|||||||++|||+ +|..||..... .+....+.......
T Consensus 192 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 269 (373)
T 1q8y_A 192 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI--TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269 (373)
T ss_dssp CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH--HSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHH--hCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccc
Confidence 13346788999999999999999999999999999999 89999986542 11111111100000
Q ss_pred ---------------C----------cccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 ---------------S----------KQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 ---------------~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
. .......+..+++++.+||.+||+.||++|||++|+ |+||++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 270 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp THHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred hhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence 0 000112345667899999999999999999999999 7899864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=271.46 Aligned_cols=185 Identities=21% Similarity=0.322 Sum_probs=146.7
Q ss_pred CCCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 3 SLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
.++||||+++++++.. ++..++||||+++|+|.+++... ....+++..++.++.|++.||+|||++||+||
T Consensus 67 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 141 (299)
T 3m2w_A 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-----GDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141 (299)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC-----TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred hccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 4589999999999976 67799999999999999999843 23469999999999999999999999999999
Q ss_pred CCCCCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 79 DLAARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 79 Dlkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
||||+||+++. ++.+||+|||+++..
T Consensus 142 dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~--------------------------------------------------- 170 (299)
T 3m2w_A 142 DVKPENLLYTSKRPNAILKLTDFGFAKET--------------------------------------------------- 170 (299)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCTTCEEC---------------------------------------------------
T ss_pred CCCHHHEEEecCCCCCcEEEecccccccc---------------------------------------------------
Confidence 99999999998 788999999986431
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCC----CccH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRP----ATCQ 231 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 231 (434)
.+..++.++|||||||++|||+ +|..||................ .......+ ..++
T Consensus 171 --------------~~~~~~~~~DiwslG~il~el~--tg~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 230 (299)
T 3m2w_A 171 --------------TGEKYDKSCDMWSLGVIMYILL--CGYPPFYSNHGLAISPGMKTRI----RMGQYEFPNPEWSEVS 230 (299)
T ss_dssp --------------TTCGGGGHHHHHHHHHHHHHHH--HSSCSCCC-------CCSCCSS----CTTCCSSCHHHHTTSC
T ss_pred --------------ccccCCchhhHHHHHHHHHHHH--HCCCCCCCCcchhhhHHHHHHH----hhccccCCchhcccCC
Confidence 0123567899999999999999 8999998766544432221111 11111112 4678
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 232 KEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 232 ~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
+++.+++.+||+.||++|||++|+ |+|+++..
T Consensus 231 ~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 999999999999999999999999 88998754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=291.03 Aligned_cols=212 Identities=20% Similarity=0.197 Sum_probs=160.6
Q ss_pred CCCCCCCeeeEEEEEec------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 2 CSLKDPNLVRVIGVCST------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
++++||||+++++++.. ++..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++||
T Consensus 67 ~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~----~~~~lse~~i~~I~~QLl~aL~yLHs~gI 142 (676)
T 3qa8_A 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE----NCCGLKEGPIRTLLSDISSALRYLHENRI 142 (676)
T ss_dssp HHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS----CTTCCCSSHHHHHHHHHHHHHHHHHHTTB
T ss_pred HhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc----cCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999999865 677899999999999999998432 33468999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCc---eEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 76 VHRDLAARNCMVGKNYT---IKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
+||||||+||+++.++. +||+|||+++......
T Consensus 143 VHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-------------------------------------------- 178 (676)
T 3qa8_A 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-------------------------------------------- 178 (676)
T ss_dssp CCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC--------------------------------------------
T ss_pred ccCCCCHHHeEeecCCCceeEEEccccccccccccc--------------------------------------------
Confidence 99999999999997664 8999999976521111
Q ss_pred cCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHH---------hhhhhh---hcCCc
Q psy5690 153 SDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIE---------NCSHWY---QNNSK 220 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~---------~~~~~~---~~~~~ 220 (434)
......||..|+|||++.+..++.++|||||||++|+|+ +|..||.......... ...... .....
T Consensus 179 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLl--tG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~ 256 (676)
T 3qa8_A 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI--TGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKF 256 (676)
T ss_dssp CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHH--SSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCC
T ss_pred ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHH--HCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccccc
Confidence 113356788999999999999999999999999999999 8999997654322110 000000 00000
Q ss_pred ccC----CCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 221 QQY----LPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 221 ~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
... ......+++.+.+++.+||+.||++|||++++ |+|++...
T Consensus 257 ~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 257 SSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp CSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred ccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 011 11234578999999999999999999999998 67776543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=266.36 Aligned_cols=178 Identities=14% Similarity=0.120 Sum_probs=143.9
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++++++.+++..|+||||++|++|.++++ . .....++..++.|++.||+|||++||+|||||
T Consensus 86 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-------~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dik 156 (286)
T 3uqc_A 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-------T--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDH 156 (286)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT-------T--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred hcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh-------c--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 57899999999999999999999999999999999995 1 13556788999999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++.++.+||+++|
T Consensus 157 p~NIll~~~g~~kl~~~~-------------------------------------------------------------- 174 (286)
T 3uqc_A 157 PSRVRVSIDGDVVLAYPA-------------------------------------------------------------- 174 (286)
T ss_dssp GGGEEEETTSCEEECSCC--------------------------------------------------------------
T ss_pred cccEEEcCCCCEEEEecc--------------------------------------------------------------
Confidence 999999999999998655
Q ss_pred cccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccC--CCCCCccHHHHHHHHH
Q psy5690 162 RWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY--LPRPATCQKEIFDLML 239 (434)
Q Consensus 162 ~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~ 239 (434)
|++| ++.++|||||||++|||+ +|..||.+.+..+...... ........ ......+++++.+++.
T Consensus 175 -~~~~-------~~~~~Di~slG~il~ell--tg~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (286)
T 3uqc_A 175 -TMPD-------ANPQDDIRGIGASLYALL--VNRWPLPEAGVRSGLAPAE---RDTAGQPIEPADIDRDIPFQISAVAA 241 (286)
T ss_dssp -CCTT-------CCHHHHHHHHHHHHHHHH--HSEECSCCCSBCCCSEECC---BCTTSCBCCHHHHCTTSCHHHHHHHH
T ss_pred -ccCC-------CCchhHHHHHHHHHHHHH--HCCCCCCcCCcchhhHHHH---HHhccCCCChhhcccCCCHHHHHHHH
Confidence 3332 578999999999999999 8999998765433211000 00000000 0113567899999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhccc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKNL 264 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~~ 264 (434)
+||+.||++| |+.|+++.|++...
T Consensus 242 ~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 242 RSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HHcccCCccC-CHHHHHHHHHHHhc
Confidence 9999999999 99999999988654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-32 Score=283.88 Aligned_cols=185 Identities=16% Similarity=0.118 Sum_probs=145.2
Q ss_pred CCCCCCCCeeeEEEEEecCCc-----eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDP-----ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|++++||||+++++++...+. .|+||||++|++|.+++. ..+++..++.++.||+.||+|||++||
T Consensus 133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~gi 203 (681)
T 2pzi_A 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSYLHSIGL 203 (681)
T ss_dssp GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467899999999999987766 799999999999998875 268999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.+ .+||+|||+++.... ..
T Consensus 204 iHrDlkp~NIll~~~-~~kl~DFG~a~~~~~-----------------------------------------------~~ 235 (681)
T 2pzi_A 204 VYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----------------------------------------------FG 235 (681)
T ss_dssp ECCCCSGGGEEECSS-CEEECCCTTCEETTC-----------------------------------------------CS
T ss_pred eecccChHHeEEeCC-cEEEEecccchhccc-----------------------------------------------CC
Confidence 999999999999875 899999999754211 13
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
...||+.|+|||++.+.. +.++|||||||++|+|+ +|..||.+...... .........++.+.
T Consensus 236 ~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~--~g~~~~~~~~~~~~--------------~~~~~~~~~~~~l~ 298 (681)
T 2pzi_A 236 YLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALT--LDLPTRNGRYVDGL--------------PEDDPVLKTYDSYG 298 (681)
T ss_dssp CCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHH--SCCCEETTEECSSC--------------CTTCHHHHHCHHHH
T ss_pred ccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHH--hCCCCCcccccccc--------------cccccccccCHHHH
Confidence 346889999999997764 88999999999999999 88888764211100 00000112347899
Q ss_pred HHHHHhccCCCCCCCC-HHHHHHHH
Q psy5690 236 DLMLECWKTNETDRPR-FSEIHLFL 259 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps-~~el~~~L 259 (434)
++|.+||+.||++||+ ++++...|
T Consensus 299 ~li~~~l~~dP~~R~~~~~~l~~~l 323 (681)
T 2pzi_A 299 RLLRRAIDPDPRQRFTTAEEMSAQL 323 (681)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHhhhccCChhhCCCHHHHHHHHH
Confidence 9999999999999995 55564433
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=270.09 Aligned_cols=181 Identities=12% Similarity=0.061 Sum_probs=142.1
Q ss_pred ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCc
Q psy5690 21 PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAM 100 (434)
Q Consensus 21 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGl 100 (434)
..+++|+++ +|+|.++++...........+++..++.++.||++||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~ 257 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence 467788876 6799999853221112345688889999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhh----------h
Q psy5690 101 YCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESL----------L 170 (434)
Q Consensus 101 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~ 170 (434)
++..... .....| +.|+|||++ .
T Consensus 258 a~~~~~~----------------------------------------------~~~~~g-~~y~aPE~~~~~~~~~~~~~ 290 (413)
T 3dzo_A 258 LVRDGAS----------------------------------------------AVSPIG-RGFAPPETTAERMLPFGQHH 290 (413)
T ss_dssp CEETTEE----------------------------------------------ECCCCC-TTTCCHHHHHHHTSTTGGGC
T ss_pred eeecCCc----------------------------------------------cccCCC-CceeCchhhhcccccccccc
Confidence 7652111 123455 789999999 4
Q ss_pred cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccCCCCCCC
Q psy5690 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRP 250 (434)
Q Consensus 171 ~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 250 (434)
...++.++|||||||++|||+ +|+.||......+....+ ......+++++.+||.+||+.||++||
T Consensus 291 ~~~~~~~~DvwSlGvil~ell--tg~~Pf~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 291 PTLMTFAFDTWTLGLAIYWIW--CADLPNTDDAALGGSEWI------------FRSCKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp CEEECHHHHHHHHHHHHHHHH--HSSCCCCTTGGGSCSGGG------------GSSCCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred CcCCCchhhHHHHHHHHHHHH--HCCCCCCCcchhhhHHHH------------HhhcccCCHHHHHHHHHHccCChhhCc
Confidence 445788999999999999999 899999876544332211 111235678999999999999999999
Q ss_pred CHHHH--HHHHHhcc
Q psy5690 251 RFSEI--HLFLQRKN 263 (434)
Q Consensus 251 s~~el--~~~L~~~~ 263 (434)
++.++ ++|+++..
T Consensus 357 t~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 357 LPLQAMETPEYEQLR 371 (413)
T ss_dssp CHHHHTTSHHHHHHH
T ss_pred CHHHHHhCHHHHHHH
Confidence 99999 78887653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=261.29 Aligned_cols=173 Identities=12% Similarity=0.064 Sum_probs=129.7
Q ss_pred CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCCeeeecCC------
Q psy5690 19 EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE-SRDIVHRDLAARNCMVGKNY------ 91 (434)
Q Consensus 19 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NILl~~~~------ 91 (434)
++..|+|||||++|++.+.+. ...+++..++.++.||+.||+||| ++||+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~--------~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~ 205 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMR--------TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHY 205 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGT--------TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEE
T ss_pred cCeEEEEEEecCCCccHHHHH--------hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceee
Confidence 678999999999997766663 145899999999999999999999 99999999999999999887
Q ss_pred --------------ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 92 --------------TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 92 --------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
.+||+|||+|+.... ...
T Consensus 206 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------------------------------------------~~~ 237 (336)
T 2vuw_A 206 TLNGKSSTIPSCGLQVSIIDYTLSRLERD------------------------------------------------GIV 237 (336)
T ss_dssp EETTEEEEEECTTEEEEECCCTTCBEEET------------------------------------------------TEE
T ss_pred eccCccccccCCCceEEEeeccccEecCC------------------------------------------------CcE
Confidence 899999999765211 123
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHH-HHHHHhhcCCCCCCCCCh-HHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVT-LWEILIHCNQRPYAELTN-EQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvi-l~ellt~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
.||+.|+|||++.+.. +.++||||+|++ .++++ .|..||..... ......+.... ........+.+..+++++.
T Consensus 238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~--~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRW--GEYHPYSNVLWLHYLTDKMLKQM-TFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCT--TSCCTHHHHHHHHHHHHHHHHTC-CCSSCCCSHHHHHHHHHHH
T ss_pred EEeecccChhhhcCCC-ccceehhhhhCCCCcccc--cccCCCcchhhhhHHHHhhhhhh-ccCcccchhhhhhcCHHHH
Confidence 5778899999998766 889999998777 67777 78888854221 11111111000 0111111112345789999
Q ss_pred HHHHHhccCCCCCCCCHHHHH
Q psy5690 236 DLMLECWKTNETDRPRFSEIH 256 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el~ 256 (434)
+||.+||++| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999987 888886
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-30 Score=260.75 Aligned_cols=137 Identities=13% Similarity=0.023 Sum_probs=100.6
Q ss_pred CCCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|+++ +|+||+++++++++++..||||||++||+|.++++ ....++.. +|+.||+.||+|+|++||||||
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~-------~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRD 364 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA-------AGEEIDRE---KILGSLLRSLAALEKQGFWHDD 364 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH-------TTCCCCHH---HHHHHHHHHHHHHHHTTCEESC
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH-------hCCCCCHH---HHHHHHHHHHHHHHHCCceecc
Confidence 3456 79999999999999999999999999999999998 33456554 5889999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.+|.+||+|||+|+...... ....+.+|
T Consensus 365 IKPeNILL~~dg~vKL~DFGlAr~~~~~~-------------------------------------------~~~~t~vG 401 (569)
T 4azs_A 365 VRPWNVMVDARQHARLIDFGSIVTTPQDC-------------------------------------------SWPTNLVQ 401 (569)
T ss_dssp CCGGGEEECTTSCEEECCCTTEESCC----------------------------------------------CCSHHHHH
T ss_pred CchHhEEECCCCCEEEeecccCeeCCCCC-------------------------------------------ccccCcee
Confidence 99999999999999999999987532211 01133568
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEIL 191 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ell 191 (434)
|+.|||||++.+ .+..++|+||+|++++++.
T Consensus 402 Tp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~ 432 (569)
T 4azs_A 402 SFFVFVNELFAE-NKSWNGFWRSAPVHPFNLP 432 (569)
T ss_dssp HHHHHHHHHC------------------CCCC
T ss_pred chhhccHHHhCC-CCCCcccccccccchhhhc
Confidence 899999999875 4577899999999988776
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-23 Score=212.24 Aligned_cols=143 Identities=15% Similarity=0.076 Sum_probs=112.6
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
++++||||+++..++...+..|+||||+++|+|.++++ . +..++.|+++||+|||++||+|||||
T Consensus 394 ~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~-------~--------~~~i~~qi~~aL~~LH~~gIiHrDiK 458 (540)
T 3en9_A 394 ALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIE-------D--------NLDIAYKIGEIVGKLHKNDVIHNDLT 458 (540)
T ss_dssp HHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHST-------T--------CTHHHHHHHHHHHHHHHTTEECTTCC
T ss_pred HhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHH-------H--------HHHHHHHHHHHHHHHHHCcCccCCCC
Confidence 46799999966666667788899999999999999986 1 56899999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 161 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~ 161 (434)
|+|||++. .+||+|||+++......... ...+.......||+
T Consensus 459 p~NILl~~--~~kL~DFGla~~~~~~~~~~------------------------------------~~~~~~~~~~~GT~ 500 (540)
T 3en9_A 459 TSNFIFDK--DLYIIDFGLGKISNLDEDKA------------------------------------VDLIVFKKAVLSTH 500 (540)
T ss_dssp TTSEEESS--SEEECCCTTCEECCCHHHHH------------------------------------HHHHHHHHHHHHHC
T ss_pred HHHEEECC--eEEEEECccCEECCCccccc------------------------------------cchhhhhhhhcCCC
Confidence 99999998 99999999987643321100 00000112345788
Q ss_pred cccchhhhhc--CCCCCcCChHHHHHHHHHHHhhcCCCCC
Q psy5690 162 RWMAWESLLL--GKNTTKSDVWSFAVTLWEILIHCNQRPY 199 (434)
Q Consensus 162 ~y~aPE~~~~--~~~s~~sDIwSlGvil~ellt~~g~~pf 199 (434)
.|||||++.. ..|+..+|+|+..+-..+-+ .++.+|
T Consensus 501 ~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v--~~r~rY 538 (540)
T 3en9_A 501 HEKFDEIWERFLEGYKSVYDRWEIILELMKDV--ERRARY 538 (540)
T ss_dssp GGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH--HTCSCC
T ss_pred CcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH--Hhcccc
Confidence 8999999987 66788899999998888877 445444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=7.6e-18 Score=156.78 Aligned_cols=78 Identities=21% Similarity=0.152 Sum_probs=65.6
Q ss_pred eeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeec
Q psy5690 10 VRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGK 89 (434)
Q Consensus 10 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~ 89 (434)
+++.+++.. +..++||||++||+|.+ +. . .....++.|++.||.|||++||+||||||+|||++
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------V------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------C------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cc-------h------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-
Confidence 566665533 56799999999999988 42 1 23457999999999999999999999999999999
Q ss_pred CCceEEccCCcccc
Q psy5690 90 NYTIKISDHAMYCS 103 (434)
Q Consensus 90 ~~~~kL~DFGla~~ 103 (434)
++.+||+|||+++.
T Consensus 228 ~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 228 EEGIWIIDFPQSVE 241 (282)
T ss_dssp TTEEEECCCTTCEE
T ss_pred CCcEEEEECCCCeE
Confidence 99999999999653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.42 E-value=4.6e-14 Score=129.46 Aligned_cols=73 Identities=15% Similarity=0.083 Sum_probs=61.1
Q ss_pred CceEEEEecCCC-C----CHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCCeeeecCCce
Q psy5690 20 DPISTIQEYCEF-G----DLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLE-SRDIVHRDLAARNCMVGKNYTI 93 (434)
Q Consensus 20 ~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlkp~NILl~~~~~~ 93 (434)
+..++||||+.+ | +|.++.. ..++..+..++.|++.||.||| +.||+||||||+|||++. .+
T Consensus 141 ~~~~lVmE~~g~~g~~~~~L~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~ 208 (258)
T 1zth_A 141 MKNVLLMEFIGEDELPAPTLVELGR----------ELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KV 208 (258)
T ss_dssp ETTEEEEECCEETTEECCBHHHHGG----------GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SE
T ss_pred CCCEEEEEecCCCCCccccHHHHhh----------ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cE
Confidence 367899999942 4 6776653 1235577899999999999999 999999999999999988 89
Q ss_pred EEccCCccccc
Q psy5690 94 KISDHAMYCSH 104 (434)
Q Consensus 94 kL~DFGla~~~ 104 (434)
+|+|||+|...
T Consensus 209 ~liDFG~a~~~ 219 (258)
T 1zth_A 209 YFIDMGQAVTL 219 (258)
T ss_dssp EECCCTTCEET
T ss_pred EEEECcccccC
Confidence 99999998764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.12 E-value=6.4e-12 Score=120.37 Aligned_cols=70 Identities=10% Similarity=0.059 Sum_probs=57.5
Q ss_pred ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCCeeeecCC---------
Q psy5690 21 PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNY--------- 91 (434)
Q Consensus 21 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~NILl~~~~--------- 91 (434)
..++||||++|++|.++.. ...+..++.||+.+|.+||++|||||||||.|||+++++
T Consensus 185 ~~~LVME~i~G~~L~~l~~-------------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~ 251 (397)
T 4gyi_A 185 RHTIVMSLVDALPMRQVSS-------------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSIT 251 (397)
T ss_dssp TTEEEEECCSCEEGGGCCC-------------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEE
T ss_pred CceEEEEecCCccHhhhcc-------------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccc
Confidence 3479999999988865431 123467889999999999999999999999999998776
Q ss_pred -ceEEccCCcccc
Q psy5690 92 -TIKISDHAMYCS 103 (434)
Q Consensus 92 -~~kL~DFGla~~ 103 (434)
.+.|+||+-+..
T Consensus 252 ~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 252 LTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEECCCTTCEE
T ss_pred cceEEEEeCCccc
Confidence 389999997543
|
| >4ag4_A Epithelial discoidin domain-containing receptor 1; immune system-transferase complex; HET: NAG; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.80 E-value=6.8e-09 Score=97.32 Aligned_cols=77 Identities=25% Similarity=0.415 Sum_probs=57.9
Q ss_pred cCCcccccceeEEeecCC-CCcCCCCCCCCCCCCCCCCCCCCCceEEEEccCCccceeEEEEEEecceeeeeeeeEeeec
Q psy5690 277 RLPLHVFSTVKIFFSMDG-SSFQSNMSPIKESPNPEFFPKNRTAFNVVVGLKNRVSRFIKVQLYFKARWILLSEVTFDSI 355 (434)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~-ss~~s~~~~~~~s~~~~~~~~~~~~~~vt~~l~~r~~~~i~~~~~~~~~~~~~~e~~f~~~ 355 (434)
...+++++...+.|+.+. ..+.. .++.-.+.++ ..++++|+|++++++|.+++++|+|+|+++|||+|||+|+|.
T Consensus 267 ~~~v~~f~~~~~~Fs~~~~~~~~~--~p~~~~~~~d--~~~~~ar~v~i~l~~r~~~~vk~~~~f~~~Wll~SEi~F~s~ 342 (351)
T 4ag4_A 267 TLGARLPGGVECRFRRGPAMAWEG--EPMRHNLGGN--LGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISD 342 (351)
T ss_dssp GGTBCCCSEEEEEEECSSSSSCSS--SCEEEECSSC--CSCCSCEEEEEEEEEEEEEEEEEEEECSSSEEEEEEEEEEEE
T ss_pred cccceeeeEEEEEEECCCCccccC--CceEeecCCC--cCCCccceEEEeCCCcceeEEEEEEEcCCceEEEEEEEEccC
Confidence 445567778888888774 33322 2333333322 455779999999999999999999999999999999999997
Q ss_pred cc
Q psy5690 356 TS 357 (434)
Q Consensus 356 ~~ 357 (434)
-.
T Consensus 343 ~~ 344 (351)
T 4ag4_A 343 AA 344 (351)
T ss_dssp EC
T ss_pred ch
Confidence 53
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=2.2e-08 Score=91.49 Aligned_cols=85 Identities=12% Similarity=-0.030 Sum_probs=69.5
Q ss_pred CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-------------
Q psy5690 6 DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES------------- 72 (434)
Q Consensus 6 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~------------- 72 (434)
|..+.++++++.+.+..|+||||++|.+|.+.+. +......++.+++++|..||+
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~ 136 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLD 136 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccC------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHH
Confidence 5678899999988889999999999999987631 112334788899999999998
Q ss_pred ----------------------------------------------CCccccCCCCCCeeeecCCceEEccCCccc
Q psy5690 73 ----------------------------------------------RDIVHRDLAARNCMVGKNYTIKISDHAMYC 102 (434)
Q Consensus 73 ----------------------------------------------~~iiHrDlkp~NILl~~~~~~kL~DFGla~ 102 (434)
..++|+|+++.||+++++..+.|+||+.+.
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 137 SRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876566799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.46 E-value=2e-07 Score=84.69 Aligned_cols=80 Identities=18% Similarity=0.096 Sum_probs=61.1
Q ss_pred eeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--------------
Q psy5690 9 LVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD-------------- 74 (434)
Q Consensus 9 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-------------- 74 (434)
+.++++++..++..++||||++|.+|. .. . . ....++.++++.|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~-------~---~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~ 141 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SS-------H---L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRI 141 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TS-------C---C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cC-------c---C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 567899888888899999999998884 21 0 1 12245667777777777543
Q ss_pred --------------------------------------------ccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 75 --------------------------------------------IVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 75 --------------------------------------------iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
++|+|++|.||++++++.+.|+|||.+..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 142 ERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.44 E-value=2.2e-07 Score=88.99 Aligned_cols=89 Identities=17% Similarity=0.181 Sum_probs=71.1
Q ss_pred CCCeeeEEEEEecC---CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh----------
Q psy5690 6 DPNLVRVIGVCSTE---DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES---------- 72 (434)
Q Consensus 6 HpnIv~l~~~~~~~---~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---------- 72 (434)
+..++++++++.+. +..++||||++|..+.+. ....++......++.++++.|..||+
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~---------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~ 167 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ---------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGD 167 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT---------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTT
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC---------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccc
Confidence 45688899998776 458999999999777431 11346778888899999999999996
Q ss_pred ------------------------------------------------CCccccCCCCCCeeeecCCc--eEEccCCccc
Q psy5690 73 ------------------------------------------------RDIVHRDLAARNCMVGKNYT--IKISDHAMYC 102 (434)
Q Consensus 73 ------------------------------------------------~~iiHrDlkp~NILl~~~~~--~kL~DFGla~ 102 (434)
..++|||+++.||+++.++. +.|+||+.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 168 YGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp SSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred cCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999987653 6899999875
Q ss_pred c
Q psy5690 103 S 103 (434)
Q Consensus 103 ~ 103 (434)
.
T Consensus 248 ~ 248 (359)
T 3dxp_A 248 L 248 (359)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.14 E-value=9e-07 Score=82.63 Aligned_cols=86 Identities=14% Similarity=0.036 Sum_probs=61.2
Q ss_pred eeeEEEEEecCC---ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-------------
Q psy5690 9 LVRVIGVCSTED---PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES------------- 72 (434)
Q Consensus 9 Iv~l~~~~~~~~---~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~------------- 72 (434)
+.+.++....++ ..|+|||+++|.+|.+... ..++..+...++.|++..|..||+
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~ 145 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLD 145 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCC
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCcccc---------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhh
Confidence 445555543333 3588999999988875432 135666666777777777777774
Q ss_pred ---------------------------------------------CCccccCCCCCCeeeec--CCceEEccCCcccc
Q psy5690 73 ---------------------------------------------RDIVHRDLAARNCMVGK--NYTIKISDHAMYCS 103 (434)
Q Consensus 73 ---------------------------------------------~~iiHrDlkp~NILl~~--~~~~kL~DFGla~~ 103 (434)
..++|+|+++.||+++. ...+.++||+.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 146 FREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 23799999999999998 45678999998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00018 Score=62.43 Aligned_cols=140 Identities=11% Similarity=0.024 Sum_probs=90.9
Q ss_pred CHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCCeeeecCCceEEccCCcccccccccccc
Q psy5690 33 DLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYL 111 (434)
Q Consensus 33 sL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 111 (434)
||.+.|+.++ .+++++++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~~~------~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEILRLYN------QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHcC------CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 7999998544 689999999999999999877621 1111233456889999999888764 1100
Q ss_pred cccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHH
Q psy5690 112 SDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEIL 191 (434)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ell 191 (434)
.....+.|||... ...+.+.=|||||+++|.-+
T Consensus 98 ----------------------------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 98 ----------------------------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp -------------------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHh
Confidence 0012356777653 23356777999999999988
Q ss_pred hhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhccC-------------------------CC
Q psy5690 192 IHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT-------------------------NE 246 (434)
Q Consensus 192 t~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~-------------------------dP 246 (434)
--..| ...+..+++.+..||..|..- .+
T Consensus 131 --DygL~-------------------------e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~ 183 (229)
T 2yle_A 131 --DYGLK-------------------------ENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKI 183 (229)
T ss_dssp --TTTCC-------------------------TTEEECCCHHHHHHHHHHTTCCC--------------------CCSCC
T ss_pred --hcCCC-------------------------cccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccc
Confidence 21111 112456778888999888755 24
Q ss_pred CCCCCHHHHHHHHHhc
Q psy5690 247 TDRPRFSEIHLFLQRK 262 (434)
Q Consensus 247 ~~Rps~~el~~~L~~~ 262 (434)
..|.++++|++.-...
T Consensus 184 ~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 184 SAIRSYRDVMKLCAAH 199 (229)
T ss_dssp CCCCSHHHHHHHHHTT
T ss_pred cCcCCHHHHHHHHHhh
Confidence 6788999998776653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=8.5e-05 Score=67.67 Aligned_cols=84 Identities=14% Similarity=0.003 Sum_probs=59.0
Q ss_pred eeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh----------------
Q psy5690 9 LVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES---------------- 72 (434)
Q Consensus 9 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---------------- 72 (434)
|.++++++.+++..++|||+++|.++.+..... ......+..+++..|.-||+
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~ 150 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRL 150 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCC-----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccch
Confidence 678889999899999999999998877655311 11122333444444444442
Q ss_pred ------------------------------------------CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 ------------------------------------------RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ------------------------------------------~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 151 AQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1278999999999999877778999998653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00021 Score=66.55 Aligned_cols=30 Identities=17% Similarity=0.223 Sum_probs=24.6
Q ss_pred CccccCCCCCCeeeec---CCc-eEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGK---NYT-IKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~---~~~-~kL~DFGla~~ 103 (434)
.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 4699999999999987 355 58999997654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00057 Score=64.87 Aligned_cols=32 Identities=13% Similarity=0.114 Sum_probs=26.4
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
...++|+|+++.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 34689999999999999644578999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.01 Score=55.43 Aligned_cols=31 Identities=23% Similarity=0.357 Sum_probs=27.6
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888899999998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.71 E-value=0.02 Score=53.46 Aligned_cols=32 Identities=22% Similarity=0.152 Sum_probs=27.0
Q ss_pred hCCccccCCCCCCeeeecC----CceEEccCCcccc
Q psy5690 72 SRDIVHRDLAARNCMVGKN----YTIKISDHAMYCS 103 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~----~~~kL~DFGla~~ 103 (434)
...++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999874 6789999998654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.79 E-value=0.053 Score=49.78 Aligned_cols=29 Identities=17% Similarity=0.102 Sum_probs=24.6
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5667789999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.22 E-value=0.034 Score=53.90 Aligned_cols=32 Identities=19% Similarity=0.347 Sum_probs=27.8
Q ss_pred hhCCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 71 ESRDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 71 H~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
+...++|||+++.|||++.++ ++++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 466899999999999998776 99999998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=92.77 E-value=0.17 Score=46.82 Aligned_cols=26 Identities=27% Similarity=0.432 Sum_probs=23.1
Q ss_pred CCccccCCCCCCeeeecCCceEEccCC
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHA 99 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFG 99 (434)
..++|+|+.+.|++++.++ +.+.|++
T Consensus 207 ~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 207 PSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred ceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3699999999999999887 8899985
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.26 E-value=0.055 Score=50.10 Aligned_cols=31 Identities=19% Similarity=0.297 Sum_probs=26.3
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.+++|+|+++.|||++.+..+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999998776668999997654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.59 E-value=0.15 Score=47.28 Aligned_cols=29 Identities=17% Similarity=-0.029 Sum_probs=24.9
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4689999999999998 4 889999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.23 E-value=0.24 Score=46.25 Aligned_cols=31 Identities=29% Similarity=0.310 Sum_probs=27.1
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987654
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.94 E-value=1.1 Score=28.89 Aligned_cols=19 Identities=21% Similarity=0.291 Sum_probs=11.0
Q ss_pred hhhHHHHHHHHHHHHHHHH
Q psy5690 367 GVIAGMFAMILLVLGCTVL 385 (434)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~ 385 (434)
+|++++++.++++.+++++
T Consensus 11 iIi~svl~GLLLL~Lii~~ 29 (54)
T 2l8s_A 11 VILLSAFAGLLLLMLLILA 29 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHH
Confidence 5666666666655554444
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.43 E-value=1.8 Score=37.41 Aligned_cols=82 Identities=13% Similarity=0.020 Sum_probs=58.6
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHH-HhhhCCccccCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMK-YLESRDIVHRDLAAR 83 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~-yLH~~~iiHrDlkp~ 83 (434)
.||+. -..+-.+++.+.+.++.-+++.=...++ .++....++++.+|+.-.. +++ .-+|--|+|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----------~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----------KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----------TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----------hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCc
Confidence 46776 3344466777777777654433333443 4778888999988887666 443 4567778999
Q ss_pred CeeeecCCceEEccCCc
Q psy5690 84 NCMVGKNYTIKISDHAM 100 (434)
Q Consensus 84 NILl~~~~~~kL~DFGl 100 (434)
||+++.++.+++.-.|+
T Consensus 114 NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGV 130 (219)
T ss_dssp GEEECTTCCEEESCCEE
T ss_pred eEEEeCCCcEEEEEcCC
Confidence 99999999999999887
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=87.28 E-value=0.47 Score=45.22 Aligned_cols=31 Identities=16% Similarity=0.306 Sum_probs=25.9
Q ss_pred hCCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 72 SRDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 72 ~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
...++|||+.+.||+++.+ .++++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 4579999999999999765 489999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=87.28 E-value=0.51 Score=46.10 Aligned_cols=15 Identities=27% Similarity=0.313 Sum_probs=14.1
Q ss_pred CccccCCCCCCeeee
Q psy5690 74 DIVHRDLAARNCMVG 88 (434)
Q Consensus 74 ~iiHrDlkp~NILl~ 88 (434)
.++|+|+.+.|||++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=87.10 E-value=0.37 Score=45.46 Aligned_cols=29 Identities=17% Similarity=0.236 Sum_probs=24.1
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++|+|+++.|||++.+. +.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999997654 89999987653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.22 E-value=0.93 Score=39.06 Aligned_cols=82 Identities=6% Similarity=0.027 Sum_probs=59.5
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCC-CCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCE-FGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~-~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.||+.+.. .+-++++.+.+.++.-+ +-++.. + ...+....++++.+|+.-..+++. -+|--|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----------k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----------KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----------GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----------HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecc
Confidence 57888866 56666676666666544 223333 2 257788889999999887755543 467778999
Q ss_pred CeeeecCCceEEccCCc
Q psy5690 84 NCMVGKNYTIKISDHAM 100 (434)
Q Consensus 84 NILl~~~~~~kL~DFGl 100 (434)
||+++.++.+++.--|+
T Consensus 109 NL~f~~~~~p~i~~RGi 125 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGL 125 (215)
T ss_dssp GEEECTTSCEEESCCEE
T ss_pred eEEEcCCCCEEEEEccC
Confidence 99999999999999886
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=84.23 E-value=0.35 Score=46.88 Aligned_cols=30 Identities=20% Similarity=0.253 Sum_probs=24.7
Q ss_pred CccccCCCCCCeeeecC----------------------------CceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKN----------------------------YTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~----------------------------~~~kL~DFGla~~ 103 (434)
.++|+|+.+.|||++.+ +.+.++||..+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 48999999999999875 6789999987654
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=83.63 E-value=0.92 Score=27.99 Aligned_cols=7 Identities=29% Similarity=0.572 Sum_probs=2.7
Q ss_pred HHHHHhh
Q psy5690 384 VLFLVRR 390 (434)
Q Consensus 384 ~~~~~~~ 390 (434)
+++++||
T Consensus 32 ~~~~RRR 38 (44)
T 2jwa_A 32 GILIKRR 38 (44)
T ss_dssp HHHHHHH
T ss_pred Hhheehh
Confidence 3333433
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.53 E-value=2 Score=30.47 Aligned_cols=29 Identities=21% Similarity=0.401 Sum_probs=14.8
Q ss_pred hhhHHHHHHHHHHHHHHHHHHH--------hhhHHHHH
Q psy5690 367 GVIAGMFAMILLVLGCTVLFLV--------RRGRKKVA 396 (434)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 396 (434)
+|++|+++. +++++++++++| ||-++||-
T Consensus 12 ~Iv~gvi~g-illiGllllliwk~~~~i~DrrE~~kFE 48 (79)
T 2knc_B 12 VVLLSVMGA-ILLIGLAALLIWKLLITIHDRKEFAKFE 48 (79)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 444444443 344454555555 56666665
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=81.48 E-value=0.63 Score=44.21 Aligned_cols=30 Identities=13% Similarity=0.193 Sum_probs=26.2
Q ss_pred CccccCCCCCCeeeecC----CceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKN----YTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~----~~~kL~DFGla~~ 103 (434)
.++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 58999999999999876 6899999998653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 434 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-38 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-37 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-37 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-35 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-34 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-33 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-32 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-31 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-29 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-29 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-28 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-27 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-26 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-25 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-25 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-25 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-25 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-18 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-18 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-17 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-16 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-16 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-15 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-15 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-15 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-14 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-14 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-09 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-09 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-08 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-40
Identities = 55/266 (20%), Positives = 96/266 (36%), Gaps = 51/266 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + N++ +G T ++ + ++CE L L I + I A
Sbjct: 58 LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI------A 110
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q A GM YL ++ I+HRDL + N + ++ T+KI D + + I
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
WMA + + Y + +SDV
Sbjct: 171 LWMAPE---------------VIRMQDKNPY-----------------------SFQSDV 192
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
++F + L+E++ Q PY+ + N I + + C K + LM E
Sbjct: 193 YAFGIVLYELM--TGQLPYSNINNRDQIIF--MVGRGYLSPDLSKVRSNCPKAMKRLMAE 248
Query: 241 CWKTNETDRPRFSEI--HLFLQRKNL 264
C K +RP F +I + L ++L
Sbjct: 249 CLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-38
Identities = 80/260 (30%), Positives = 116/260 (44%), Gaps = 56/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ LVR+ V T++PI I EY E G L FL+ + ++ L+ MA
Sbjct: 62 MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPS-----GIKLTINKLLDMA 115
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM ++E R+ +HRDL A N +V + KI+D +
Sbjct: 116 AQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL-------------------- 155
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E++ G T KSDV
Sbjct: 156 ----------------------ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L EI+ H + PY +TN +VI+N Y+ + RP C +E++ LM
Sbjct: 194 WSFGILLTEIVTHG-RIPYPGMTNPEVIQNLERGYR-------MVRPDNCPEELYQLMRL 245
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CWK DRP F + L+
Sbjct: 246 CWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 9e-38
Identities = 72/261 (27%), Positives = 108/261 (41%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P LV++ GVC + PI + E+ E G LS +L+ L+ M
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE------TLLGMC 107
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ GM YLE ++HRDLAARNC+VG+N IK+SD M + Y
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT---------- 157
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ P++W + E + ++KSDV
Sbjct: 158 --SSTGTKF------------------------------PVKWASPEVFSFSRYSSKSDV 185
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V +WE+ + PY +N +V+E+ S ++ L +P ++ +M
Sbjct: 186 WSFGVLMWEVFSEG-KIPYENRSNSEVVEDISTGFR-------LYKPRLASTHVYQIMNH 237
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CWK DRP FS + L
Sbjct: 238 CWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-37
Identities = 67/259 (25%), Positives = 107/259 (41%), Gaps = 58/259 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +L LV++ GVC+ + PI I EY G L +L+ Q L+ M
Sbjct: 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ------QLLEMC 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ M+YLES+ +HRDLAARNC+V +K+SD + + +Y S
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-------- 158
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
++ P+RW E L+ K ++KSD+
Sbjct: 159 ----------------------------------VGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F V +WEI + PY TN + E+ + L RP ++++ +M
Sbjct: 185 WAFGVLMWEIY-SLGKMPYERFTNSETAEHIAQGL-------RLYRPHLASEKVYTIMYS 236
Query: 241 CWKTNETDRPRFSEI--HL 257
CW +RP F + ++
Sbjct: 237 CWHEKADERPTFKILLSNI 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 7e-37
Identities = 86/261 (32%), Positives = 129/261 (49%), Gaps = 55/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M +K PNLV+++GVC+ E P I E+ +G+L +L+ N +S L++MA
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMA 121
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
TQI+S M+YLE ++ +HRDLAARNC+VG+N+ +K++D +
Sbjct: 122 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-------------------- 161
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
D Y + A+ PI+W A ESL K + KSDV
Sbjct: 162 ----------------------SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+F V LWEI + PY + QV E Y+ + RP C +++++LM
Sbjct: 200 WAFGVLLWEIATYGMS-PYPGIDLSQVYELLEKDYR-------MERPEGCPEKVYELMRA 251
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ N +DRP F+EIH +
Sbjct: 252 CWQWNPSDRPSFAEIHQAFET 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 8e-37
Identities = 65/262 (24%), Positives = 106/262 (40%), Gaps = 60/262 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
M L+ NLV+++GV E + + EY G L +L+ S+ + CL+
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-----SRGRSVLGGDCLLKF 108
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
+ + M+YLE + VHRDLAARN +V ++ K+SD + +
Sbjct: 109 SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----------- 157
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
+LP++W A E+L K +TKSD
Sbjct: 158 -----------------------------------DTGKLPVKWTAPEALREKKFSTKSD 182
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF + LWEI + PY + + V+ Y+ + P C ++++M
Sbjct: 183 VWSFGILLWEIY-SFGRVPYPRIPLKDVVPRVEKGYK-------MDAPDGCPPAVYEVMK 234
Query: 240 ECWKTNETDRPRFSEIHLFLQR 261
CW + RP F ++ L+
Sbjct: 235 NCWHLDAAMRPSFLQLREQLEH 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 2e-36
Identities = 86/278 (30%), Positives = 125/278 (44%), Gaps = 66/278 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHN-----------------C 43
M +PN+V+++GVC+ P+ + EY +GDL+ FL+ +
Sbjct: 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129
Query: 44 NSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103
+S P +S + +A Q+A+GM YL R VHRDLA RNC+VG+N +KI+D + +
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 104 HYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRW 163
Y +DYY +D +PIRWM
Sbjct: 190 IYSADYYKADGNDAIPIRWMP--------------------------------------- 210
Query: 164 MAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQY 223
ES+ + TT+SDVW++ V LWEI +PY + +E+VI
Sbjct: 211 --PESIFYNRYTTESDVWAYGVVLWEIF-SYGLQPYYGMAHEEVIYYV-------RDGNI 260
Query: 224 LPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
L P C E+++LM CW DRP F IH LQR
Sbjct: 261 LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-36
Identities = 74/260 (28%), Positives = 117/260 (45%), Gaps = 56/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +P +VR+IG+C E + + E E G L+ +LQ +N + +I +
Sbjct: 62 MQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ-------QNRHVKDKNIIELV 113
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q++ GMKYLE + VHRDLAARN ++ + KISD + + +
Sbjct: 114 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE------------ 161
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+YY + T + P++W A E + K ++KSDV
Sbjct: 162 ----------------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 193
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V +WE Q+PY + +V K + + PA C +E++DLM
Sbjct: 194 WSFGVLMWEAF-SYGQKPYRGMKGSEVTAMLE-------KGERMGCPAGCPREMYDLMNL 245
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CW + +RP F+ + L L+
Sbjct: 246 CWTYDVENRPGFAAVELRLR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-36
Identities = 79/271 (29%), Positives = 115/271 (42%), Gaps = 62/271 (22%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHN---------CNSQENPA 50
+C L PN++ ++G C + EY G+L FL+ +
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY 110
+S L+ A +A GM YL + +HRDLAARN +VG+NY KI+D +
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ------ 177
Query: 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL 170
+ Y+ T RLP+RWMA ESL
Sbjct: 178 --------------------------------------EVYVKKTMGRLPVRWMAIESLN 199
Query: 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230
TT SDVWS+ V LWEI+ PY +T ++ E Y+ L +P C
Sbjct: 200 YSVYTTNSDVWSYGVLLWEIV-SLGGTPYCGMTCAELYEKLPQGYR-------LEKPLNC 251
Query: 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++DLM +CW+ +RP F++I + L R
Sbjct: 252 DDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-35
Identities = 74/270 (27%), Positives = 109/270 (40%), Gaps = 64/270 (23%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPA---------------- 50
N+V ++G C+ PI I EYC +GDL +L+ E+
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY 110
+++ L+ A Q+A GM++LE + VHRDLAARN +V +KI D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD------------- 207
Query: 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL 170
+A + Y+ ARLP++WMA ESL
Sbjct: 208 ----------FGLARDI------------------MSDSNYVVRGNARLPVKWMAPESLF 239
Query: 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230
G T KSDVWS+ + LWEI PY + + Y+ + +P
Sbjct: 240 EGIYTIKSDVWSYGILLWEIF-SLGVNPYPGIPVDANF------YKLIQNGFKMDQPFYA 292
Query: 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQ 260
+EI+ +M CW + RP F + FL
Sbjct: 293 TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 6e-35
Identities = 75/260 (28%), Positives = 113/260 (43%), Gaps = 56/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ LV++ V +E+PI + EY G L FL+ P + + MA
Sbjct: 66 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMA 119
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIASGM Y+E + VHRDL A N +VG+N K++D +
Sbjct: 120 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL-------------------- 159
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
E + Y + A+ PI+W A E+ L G+ T KSDV
Sbjct: 160 ----------------------ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + L E+ + PY + N +V++ Y+ +P P C + + DLM +
Sbjct: 198 WSFGILLTELTTKG-RVPYPGMVNREVLDQVERGYR-------MPCPPECPESLHDLMCQ 249
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CW+ +RP F + FL+
Sbjct: 250 CWRKEPEERPTFEYLQAFLE 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 9e-35
Identities = 91/265 (34%), Positives = 121/265 (45%), Gaps = 52/265 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAI---SYGCLI 57
M ++VR++GV S P I E GDL ++L+ NP + S +I
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
MA +IA GM YL + VHRDLAAR
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAAR---------------------------------- 162
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
NCMV +++T+KI D M YE+DYY K LP+RWM+ ESL G TT
Sbjct: 163 -------NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY 215
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SDVWSF V LWEI ++PY L+NEQV+ + L +P C +F+L
Sbjct: 216 SDVWSFGVVLWEIA-TLAEQPYQGLSNEQVLRFV-------MEGGLLDKPDNCPDMLFEL 267
Query: 238 MLECWKTNETDRPRFSEIHLFLQRK 262
M CW+ N RP F EI ++ +
Sbjct: 268 MRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 1e-34
Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 55/260 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L +P +VR+IGVC + + + E G L FL + I + +
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV------GKREEIPVSNVAELL 115
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q++ GMKYLE ++ VHRDLAARN ++ + KISD + + D Y +
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR------ 169
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ + P++W A E + K +++SDV
Sbjct: 170 ----------------------------------SAGKWPLKWYAPECINFRKFSSRSDV 195
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VT+WE L Q+PY ++ +V+ + + + P C E++ LM +
Sbjct: 196 WSYGVTMWEAL-SYGQKPYKKMKGPEVMAFIE-------QGKRMECPPECPPELYALMSD 247
Query: 241 CWKTNETDRPRFSEIHLFLQ 260
CW DRP F + ++
Sbjct: 248 CWIYKWEDRPDFLTVEQRMR 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 4e-34
Identities = 73/261 (27%), Positives = 111/261 (42%), Gaps = 52/261 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M PN++ + GV + P+ I E+ E G L +FL+ ++ + M
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV------GML 134
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
IA+GMKYL + VHRDLAARN +V N K+SD +
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL-------------------- 174
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
Y S ++PIRW A E++ K T+ SDV
Sbjct: 175 ------------------SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDV 216
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ + +WE++ +RPY ++TN+ VI + LP P C + LML+
Sbjct: 217 WSYGIVMWEVM-SYGERPYWDMTNQDVINAI-------EQDYRLPPPMDCPSALHQLMLD 268
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ + RP+F +I L +
Sbjct: 269 CWQKDRNHRPKFGQIVNTLDK 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-34
Identities = 61/273 (22%), Positives = 105/273 (38%), Gaps = 60/273 (21%)
Query: 1 MCSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN-----------SQEN 48
+ L + N+V ++G C+ P I EYC +GDL FL+ + +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 49 PAISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESD 108
A+ L+ + Q+A GM +L S++ +HRDLAARN ++ KI D +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 109 YYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWES 168
Y+ ARLP++WMA +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFN-------------------------------------- 221
Query: 169 LLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPA 228
T +SDVWS+ + LWE+ + + + + ++ + P
Sbjct: 222 ---CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-------MLSPE 271
Query: 229 TCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++D+M CW + RP F +I +++
Sbjct: 272 HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-33
Identities = 69/264 (26%), Positives = 111/264 (42%), Gaps = 58/264 (21%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQE---------NPAISYGCLI 57
N++ ++G C+ + P+ I EY G+L +LQ E +S L+
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 58 FMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 117
A Q+A GM+YL S+ +HRDLAARN +V ++ +KI+D + + DYY
Sbjct: 139 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY------- 191
Query: 118 LPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
P++WMA E+L T +
Sbjct: 192 ----KKTTNGRL------------------------------PVKWMAPEALFDRIYTHQ 217
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
SDVWSF V LWEI PY + E++ ++ + + +P+ C E++ +
Sbjct: 218 SDVWSFGVLLWEIF-TLGGSPYPGVPVEEL-------FKLLKEGHRMDKPSNCTNELYMM 269
Query: 238 MLECWKTNETDRPRFSEIHLFLQR 261
M +CW + RP F ++ L R
Sbjct: 270 MRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-33
Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 56/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M S+ +P++ R++G+C + I + FG L +++ H N +++
Sbjct: 65 MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------C 117
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QIA GM YLE R +VHRDLAARN +V +KI+D + + ++PI
Sbjct: 118 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+WMA ES+L T +SDV
Sbjct: 178 KWMA-----------------------------------------LESILHRIYTHQSDV 196
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS+ VT+WE++ +PY + ++ K + LP+P C +++ +M++
Sbjct: 197 WSYGVTVWELM-TFGSKPYDGIPASEISSIL-------EKGERLPQPPICTIDVYMIMVK 248
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW + RP+F E+ + +
Sbjct: 249 CWMIDADSRPKFRELIIEFSK 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-33
Identities = 74/262 (28%), Positives = 114/262 (43%), Gaps = 54/262 (20%)
Query: 1 MCSLKDPNLVRVIGVCS-TEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
M PN++ ++G+C +E + Y + GDL F++ N I +
Sbjct: 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF------ 135
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
Q+A GMK+L S+ VHRDLAARNCM+ + +T+K++D + Y+ ++ K
Sbjct: 136 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---- 191
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
T A+LP++WMA ESL K TTKSD
Sbjct: 192 -----------------------------------TGAKLPVKWMALESLQTQKFTTKSD 216
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWSF V LWE++ PY ++ + L +P C ++++ML
Sbjct: 217 VWSFGVLLWELM-TRGAPPYPDVNTFDITVYLLQGR-------RLLQPEYCPDPLYEVML 268
Query: 240 ECWKTNETDRPRFSEIHLFLQR 261
+CW RP FSE+ +
Sbjct: 269 KCWHPKAEMRPSFSELVSRISA 290
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 4e-33
Identities = 48/268 (17%), Positives = 95/268 (35%), Gaps = 63/268 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ S PN+V+++ E+ + + E+C G + + + ++ + +
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML------ELERPLTESQIQVVC 116
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q + YL I+HRDL A N + + IK++D + + +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--------- 167
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-----T 175
+ +G WMA E ++ +
Sbjct: 168 ----DSFIG------------------------------TPYWMAPEVVMCETSKDRPYD 193
Query: 176 TKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
K+DVWS +TL E+ + P+ EL +V+ + S+ L +P+
Sbjct: 194 YKADVWSLGITLIEMA--EIEPPHHELNPMRVLLKIA-----KSEPPTLAQPSRWSSNFK 246
Query: 236 DLMLECWKTNETDRPRFSEI--HLFLQR 261
D + +C + N R S++ H F+
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 5e-33
Identities = 78/261 (29%), Positives = 119/261 (45%), Gaps = 57/261 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M P++V++IGV TE+P+ I E C G+L +FLQ+ + I Y A
Sbjct: 62 MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY------A 114
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+++ + YLES+ VHRD+AARN +V N +K+ D + +S YY +
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-------- 166
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+K +LPI+WMA ES+ + T+ SDV
Sbjct: 167 ----------------------------------SKGKLPIKWMAPESINFRRFTSASDV 192
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W F V +WEIL+ +P+ + N VI + LP P C ++ LM +
Sbjct: 193 WMFGVCMWEILM-HGVKPFQGVKNNDVIGRI-------ENGERLPMPPNCPPTLYSLMTK 244
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW + + RPRF+E+ L
Sbjct: 245 CWAYDPSRRPRFTELKAQLST 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 5e-33
Identities = 71/261 (27%), Positives = 103/261 (39%), Gaps = 54/261 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M SL NL+R+ GV P+ + E G L + + G L A
Sbjct: 65 MHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSL------LDRLRKHQGHFLLGTLSRYA 117
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+A GM YLES+ +HRDLAARN ++ +KI D +
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGL-------------------- 157
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
M D+Y+ ++P W A ESL + SD
Sbjct: 158 --------------------MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDT 197
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W F VTLWE+ Q P+ L Q++ + + LPRP C ++I+++M++
Sbjct: 198 WMFGVTLWEMF-TYGQEPWIGLNGSQILHKIDK------EGERLPRPEDCPQDIYNVMVQ 250
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW DRP F + FL
Sbjct: 251 CWAHKPEDRPTFVALRDFLLE 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 73/261 (27%), Positives = 119/261 (45%), Gaps = 54/261 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M N++R+ GV S P+ I EY E G + +++ S L+ M
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGA------LDKFLREKDGEFSVLQLVGML 116
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
IA+GMKYL + + VHRDLAARN +V N K+SD + +
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-------------- 162
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ + + + ++PIRW A E++ K T+ SDV
Sbjct: 163 --------------------------DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 196
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + +WE++ + +RPY EL+N +V++ + ++ LP P C I+ LM++
Sbjct: 197 WSFGIVMWEVMTYG-ERPYWELSNHEVMKAINDGFR-------LPTPMDCPSAIYQLMMQ 248
Query: 241 CWKTNETDRPRFSEIHLFLQR 261
CW+ RP+F++I L +
Sbjct: 249 CWQQERARRPKFADIVSILDK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-31
Identities = 46/279 (16%), Positives = 89/279 (31%), Gaps = 63/279 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M K+PN+V + D + + EY G L+ + + + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ--------IAAVC 122
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+ +++L S ++HRD+ + N ++G + ++K++D S
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-------- 174
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
MVG WMA E + K D+
Sbjct: 175 -----TMVG------------------------------TPYWMAPEVVTRKAYGPKVDI 199
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS + E++ + PY + + + + L P D +
Sbjct: 200 WSLGIMAIEMI--EGEPPYLNENPLRALYLIA-----TNGTPELQNPEKLSAIFRDFLNR 252
Query: 241 CWKTNETDRPRFSEI--HLFLQRKNLGARASKITPVMKR 277
C + R E+ H FL+ S +TP++
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAK---PLSSLTPLIAA 288
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (288), Expect = 1e-29
Identities = 44/268 (16%), Positives = 79/268 (29%), Gaps = 67/268 (25%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L+ PN ++ G E + EYC + + +
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-------IAAVT 121
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
G+ YL S +++HRD+ A N ++ + +K+ D +
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------------- 168
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLL---GKNTTK 177
N VG WMA E +L G+ K
Sbjct: 169 ----NSFVG------------------------------TPYWMAPEVILAMDEGQYDGK 194
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
DVWS +T E+ + P + + Y + + + +
Sbjct: 195 VDVWSLGITCIELA--ERKPPLFNMNAMSAL------YHIAQNESPALQSGHWSEYFRNF 246
Query: 238 MLECWKTNETDRPRFSEI--HLFLQRKN 263
+ C + DRP + H F+ R+
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 6e-29
Identities = 69/271 (25%), Positives = 110/271 (40%), Gaps = 58/271 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTED-PISTIQEYCEFGDLSTFLQIHNCNSQENPA--------- 50
+ N+V ++G C+ P+ I E+C+FG+LST+L+
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 51 ISYGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYY 110
++ LI + Q+A GM++L SR +HRDLAARN ++ + +KI D + Y+ Y
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 111 LSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL 170
+ ARLP++WMA +
Sbjct: 191 VRKGDARLPLKWMAPET-----------------------------------------IF 209
Query: 171 LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATC 230
T +SDVWSF V LWEI PY + ++ + + + + P
Sbjct: 210 DRVYTIQSDVWSFGVLLWEIF-SLGASPYPGVKIDE------EFCRRLKEGTRMRAPDYT 262
Query: 231 QKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
E++ ML+CW + RP FSE+ L
Sbjct: 263 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 113 bits (284), Expect = 9e-29
Identities = 45/319 (14%), Positives = 99/319 (31%), Gaps = 63/319 (19%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L+ P LV + ++ + I E+ G+L + E+ +S +
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA------DEHNKMSEDEAVEYM 130
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ G+ ++ + VH DL N M
Sbjct: 131 RQVCKGLCHMHENNYVHLDLKPENIMFTTK------------------------------ 160
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
++ +K+ D + +H + + T + A E +D+
Sbjct: 161 ---------RSNELKLIDFGL-TAHLDPKQSVKVTTGTA--EFAAPEVAEGKPVGYYTDM 208
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS V + +L P+ +++ + N ++ + ++ D + +
Sbjct: 209 WSVGVLSYILL--SGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFIRK 262
Query: 241 CWKTNETDRPRFSEI--HLFLQRKNLGARASKITPVMKRLPLHVFSTVKIFFSMDGSSFQ 298
+ R + H +L N R S+I P ++ ++ ++
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI-------PSSRYTKIRDSIKTKYDAWP 315
Query: 299 SNMSPIKESPNPEFFPKNR 317
+ P+ N K+R
Sbjct: 316 EPLPPLGRISNYSSLRKHR 334
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-28
Identities = 44/268 (16%), Positives = 87/268 (32%), Gaps = 64/268 (23%)
Query: 1 MCSLKDPNLVRVIGVC--STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIF 58
+ LK PN+VR T + + EYCE GDL++ + ++E + ++
Sbjct: 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG---TKERQYLDEEFVLR 113
Query: 59 MATQIASGMKYLESRD-----IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSD 113
+ TQ+ +K R ++HRDL N + +K+ D +
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL------------- 160
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
D + P +M+ E +
Sbjct: 161 -----------------------------ARILNHDTSFAKAFVGTP-YYMSPEQMNRMS 190
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233
KSD+WS L+E + P+ + +++ + ++ P E
Sbjct: 191 YNEKSDIWSLGCLLYE--LCALMPPFTAFSQKEL-------AGKIREGKFRRIPYRYSDE 241
Query: 234 IFDLMLECWKTNETDRPRFSEI--HLFL 259
+ +++ + RP EI + +
Sbjct: 242 LNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 2e-28
Identities = 44/265 (16%), Positives = 86/265 (32%), Gaps = 64/265 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
L+ PN++R+ G + I EY G + LQ + ++
Sbjct: 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR-------TATYI 112
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
T++A+ + Y S+ ++HRD+ N ++G +KI+D S
Sbjct: 113 TELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---------- 162
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ G + ++ E + + K D+
Sbjct: 163 -----TLCG------------------------------TLDYLPPEMIEGRMHDEKVDL 187
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS V +E L + P+ T ++ + + P + DL+
Sbjct: 188 WSLGVLCYEFL--VGKPPFEANTYQETYKRI--------SRVEFTFPDFVTEGARDLISR 237
Query: 241 CWKTNETDRPRFSEI--HLFLQRKN 263
K N + RP E+ H ++ +
Sbjct: 238 LLKHNPSQRPMLREVLEHPWITANS 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-28
Identities = 50/285 (17%), Positives = 90/285 (31%), Gaps = 65/285 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST----IQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
L+ N++ I + ++ T + +Y E G L +L + + ++
Sbjct: 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTA 110
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
+A + I HRDL ++N +V KN T I+D + H + +
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA-- 168
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL------ 170
N VG R+MA E L
Sbjct: 169 -------PNHRVG------------------------------TKRYMAPEVLDDSINMK 191
Query: 171 LGKNTTKSDVWSFAVTLWEILIHC--------NQRPYAELTNEQVIENCSHWYQNNSKQQ 222
++ ++D+++ + WEI C Q PY +L + + +Q+
Sbjct: 192 HFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQK 249
Query: 223 YLPR------PATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261
P + + +M ECW N R I L +
Sbjct: 250 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 1e-27
Identities = 45/264 (17%), Positives = 82/264 (31%), Gaps = 58/264 (21%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
L N+V+ G + EYC G+L ++ + +
Sbjct: 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-------PDIGMPEPDAQRFF 109
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ +G+ YL I HRD+ N ++ + +KISD + ++ K
Sbjct: 110 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK----- 164
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK-NTTKSD 179
M G + ++A E L + + D
Sbjct: 165 ------MCG------------------------------TLPYVAPELLKRREFHAEPVD 188
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
VWS + L +L EL +Q ++C + K+ YL L+
Sbjct: 189 VWSCGIVLTAML-------AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 240 ECWKTNETDRPRFSEI--HLFLQR 261
+ N + R +I + +
Sbjct: 242 KILVENPSARITIPDIKKDRWYNK 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 108 bits (272), Expect = 4e-27
Identities = 45/319 (14%), Positives = 96/319 (30%), Gaps = 64/319 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P L+ + + + I E+ G+L + E+ +S +I
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA------AEDYKMSEAEVINYM 133
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q G+K++ IVH D+ N M
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETK------------------------------ 163
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
K ++KI D + + T + A E + +D+
Sbjct: 164 ---------KASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDM 211
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+ V + +L P+A + + ++N + + ++ E D +
Sbjct: 212 WAIGVLGYVLL--SGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFIKN 265
Query: 241 CWKTNETDRPRFSEI--HLFLQRKNLGARASKITPVMKRLPLHVFSTVKIFFSMDGSSFQ 298
+ R + H +L+ + + + R+P ++ ++ + +
Sbjct: 266 LLQKEPRKRLTVHDALEHPWLKGDH--------SNLTSRIPSSRYNKIRQKIKEKYADWP 317
Query: 299 SNMSPIKESPNPEFFPKNR 317
+ I N K+R
Sbjct: 318 APQPAIGRIANFSSLRKHR 336
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 3e-26
Identities = 44/279 (15%), Positives = 86/279 (30%), Gaps = 57/279 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + N++ + + + + I E+ D+ + E +SY
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY------V 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ +++L S +I H D+ N +
Sbjct: 109 HQVCEALQFLHSHNIGHFDIRPENIIYQTR------------------------------ 138
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
++ TIKI + D + A + A E +T +D+
Sbjct: 139 ---------RSSTIKIIEFGQARQLKPGDNFRLLFTAP---EYYAPEVHQHDVVSTATDM 186
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS ++ +L P+ TN+Q+IEN N E D +
Sbjct: 187 WSLGTLVYVLL--SGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 241 CWKTNETDRPRFSEI--HLFLQRKNLGARASKITPVMKR 277
R SE H +L+ + + ++K+ +K
Sbjct: 241 LLVKERKSRMTASEALQHPWLK-QKIERVSTKVIRTLKH 278
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 4e-26
Identities = 52/269 (19%), Positives = 94/269 (34%), Gaps = 69/269 (25%)
Query: 1 MCSLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
+ L+ PN+VR + + I + E G L T+L+ + L
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-------RFKVMKIKVL 114
Query: 57 IFMATQIASGMKYLESRD--IVHRDLAARNCMV-GKNYTIKISDHAMYCSHYESDYYLSD 113
QI G+++L +R I+HRDL N + G ++KI D +
Sbjct: 115 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL------------- 161
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
A L A ++G +MA E + K
Sbjct: 162 --ATLKRASFAKAVIG------------------------------TPEFMAPE-MYEEK 188
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233
DV++F + + E+ ++ PY+E N I + + S + E
Sbjct: 189 YDESVDVYAFGMCMLEMA--TSEYPYSECQNAAQI-----YRRVTSGVKPASFDKVAIPE 241
Query: 234 IFDLMLECWKTNETDRPRFSEI--HLFLQ 260
+ +++ C + N+ +R ++ H F Q
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 103 bits (257), Expect = 1e-25
Identities = 37/257 (14%), Positives = 74/257 (28%), Gaps = 53/257 (20%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
PN++++ T + + + G+L +L E +S + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-------EKVTLSEKETRKIMRALLEV 122
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
+ L +IVHRDL N ++ + IK++D C + + ++A
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYLA-- 177
Query: 127 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVT 186
P + + D+WS V
Sbjct: 178 ---------------------------------PEIIECSMNDNHPGYGKEVDMWSTGVI 204
Query: 187 LWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNE 246
++ +L P+ ++ + + Q P + DL+
Sbjct: 205 MYTLL--AGSPPFWHRKQMLMLRM----IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 258
Query: 247 TDRPRFSEI--HLFLQR 261
R E H F Q+
Sbjct: 259 QKRYTAEEALAHPFFQQ 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 4e-25
Identities = 39/263 (14%), Positives = 86/263 (32%), Gaps = 58/263 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
M L P V++ ++ + Y + G+L +++ + C F
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYT 114
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+I S ++YL + I+HRDL N ++ ++ I+I +D+ + +
Sbjct: 115 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQI-----------TDFGTAKVLSPESK 163
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ AN VG ++++ E L SD+
Sbjct: 164 QARANSFVG------------------------------TAQYVSPELLTEKSACKSSDL 193
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+ +++++ P+ + + + P + DL+ +
Sbjct: 194 WALGCIIYQLV--AGLPPFRAGNEYLIFQKI--------IKLEYDFPEKFFPKARDLVEK 243
Query: 241 CWKTNETDRPRFSEIHLFLQRKN 263
+ T R E+ + K
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 101 bits (253), Expect = 5e-25
Identities = 31/261 (11%), Positives = 70/261 (26%), Gaps = 43/261 (16%)
Query: 1 MCSLKDPNLVRVIGVCSTE-DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
++ + I C E D + E + + + S ++ +
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLE-------DLFNFCSRKFSLKTVLLL 108
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
A Q+ S ++Y+ S++ +HRD+ N ++G K + + Y +
Sbjct: 109 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLG---KKGNLVYIIDFGLAKKYRDARTHQHI 165
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
+ G R+ + + L + + + D
Sbjct: 166 PYRENKNLTG------------------------------TARYASINTHLGIEQSRRDD 195
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
+ S L P+ L + + E +
Sbjct: 196 LESLGYVLMYFN--LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN 253
Query: 240 ECWKTNETDRPRFSEIHLFLQ 260
C D+P +S + +
Sbjct: 254 FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 6e-25
Identities = 50/302 (16%), Positives = 91/302 (30%), Gaps = 93/302 (30%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ P +V G ++ IS E+ + G L L ++ I L ++
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-------KKAGRIPEQILGKVS 110
Query: 61 TQIASGMKYLESR-DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
+ G+ YL + I+HRD+ N +V IK+ D + +
Sbjct: 111 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV---------------SGQL 155
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
I MAN VG +M+ E L + +SD
Sbjct: 156 IDSMANSFVG------------------------------TRSYMSPERLQGTHYSVQSD 185
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQV---------------IENCSHWYQNNSKQQYL 224
+WS ++L E+ + P +++ + S
Sbjct: 186 IWSMGLSLVEMA--VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 225 PRPATCQKEIF---------------------DLMLECWKTNETDRPRFSEI--HLFLQR 261
RP E+ D + +C N +R ++ H F++R
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303
Query: 262 KN 263
+
Sbjct: 304 SD 305
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 9e-25
Identities = 52/250 (20%), Positives = 85/250 (34%), Gaps = 60/250 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + P L + T++ + + EY GDL +Q F A
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-------SCHKFDLSRATFYA 109
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+I G+++L S+ IV+RDL N ++ K+ IKI+D M + D
Sbjct: 110 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----------- 158
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
N G ++A E LL K D
Sbjct: 159 --KTNTFCG------------------------------TPDYIAPEILLGQKYNHSVDW 186
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF V L+E+L Q P+ E++ + + P +KE DL+++
Sbjct: 187 WSFGVLLYEML--IGQSPFHGQDEEELFHSI--------RMDNPFYPRWLEKEAKDLLVK 236
Query: 241 CWKTNETDRP 250
+ R
Sbjct: 237 LFVREPEKRL 246
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 99.3 bits (247), Expect = 5e-24
Identities = 43/294 (14%), Positives = 86/294 (29%), Gaps = 65/294 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ +K PN+V + + + + I + G+L + ++ + +
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD-------ASRLI 113
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ +KYL IVHRDL N +
Sbjct: 114 FQVLDAVKYLHDLGIVHRDLKPENLL---------------------------------- 139
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ ++ I ISD + + A ++A E L + D
Sbjct: 140 ----YYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDC 192
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS V + +L C P+ + + ++ E + P D +
Sbjct: 193 WSIGVIAYILL--CGYPPFYDENDAKLFEQ----ILKAEYEFDSPYWDDISDSAKDFIRH 246
Query: 241 CWKTNETDRPRFSEI--HLFLQRKNLGARASKITPVMKRLPLHVFSTVKIFFSM 292
+ + R + H ++ T + K + V +K F+
Sbjct: 247 LMEKDPEKRFTCEQALQHPWIA---------GDTALDKNIHQSVSEQIKKNFAK 291
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 7e-24
Identities = 48/318 (15%), Positives = 101/318 (31%), Gaps = 59/318 (18%)
Query: 4 LKDPNLVRVIGVC----STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFM 59
+ P++VR++ V + + + E + G+L + +Q + + A + +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ-----DRGDQAFTEREASEI 116
Query: 60 ATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
I ++YL S +I HRD+ N +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSK----------------------------- 147
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSD 179
N +K++D + + ++A E L K D
Sbjct: 148 ---------RPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCD 195
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
+WS V ++ + C P+ + + + P + +E+ L+
Sbjct: 196 MWSLGVIMYI--LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 253
Query: 240 ECWKTNETDRPRFSEI--HLFLQRKNLGARASKITPVMKRLPLHVFSTVK-----IFFSM 292
KT T R +E H ++ + + T + + + VK +M
Sbjct: 254 NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATM 313
Query: 293 DGSSFQSNMSPIKESPNP 310
Q + I+++ NP
Sbjct: 314 RVDYEQIKIKKIEDASNP 331
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 96.0 bits (238), Expect = 4e-23
Identities = 36/254 (14%), Positives = 76/254 (29%), Gaps = 57/254 (22%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST----IQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
+L P +V V E P + EY + L + + +
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR-------A 113
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
I + + + I+HRD+ N M+ +K+ D + + +S ++ T A
Sbjct: 114 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
++G ++++ E
Sbjct: 174 ----------VIG------------------------------TAQYLSPEQARGDSVDA 193
Query: 177 KSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236
+SDV+S L+E+L + P+ + V + R ++
Sbjct: 194 RSDVYSLGCVLYEVL--TGEPPFTGDSPVSVAYQ----HVREDPIPPSARHEGLSADLDA 247
Query: 237 LMLECWKTNETDRP 250
++L+ N +R
Sbjct: 248 VVLKALAKNPENRY 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.7 bits (227), Expect = 5e-21
Identities = 42/251 (16%), Positives = 85/251 (33%), Gaps = 60/251 (23%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + P +V + T D +S I + GDL L H S+ + + F A
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD-------MRFYA 113
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+I G++++ +R +V+RDL N ++ ++ ++ISD + C + + S
Sbjct: 114 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG------ 167
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN-TTKSD 179
+MA E L G + +D
Sbjct: 168 ---------------------------------------THGYMAPEVLQKGVAYDSSAD 188
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239
+S L+++L P+ + + H + + P + E+ L+
Sbjct: 189 WFSLGCMLFKLL--RGHSPFRQHKTKDK-----HEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 240 ECWKTNETDRP 250
+ + R
Sbjct: 242 GLLQRDVNRRL 252
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 90.5 bits (224), Expect = 8e-21
Identities = 44/250 (17%), Positives = 80/250 (32%), Gaps = 63/250 (25%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + P ++R+ G I I +Y E G+L + L+ F A
Sbjct: 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-------VAKFYA 110
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
++ ++YL S+DI++RDL N ++ KN IKI+D + Y L
Sbjct: 111 AEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG------- 163
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
++A E + D
Sbjct: 164 ---------------------------------------TPDYIAPEVVSTKPYNKSIDW 184
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WSF + ++E+L P+ + + E L P +++ DL+
Sbjct: 185 WSFGILIYEML--AGYTPFYDSNTMKTYEKI--------LNAELRFPPFFNEDVKDLLSR 234
Query: 241 CWKTNETDRP 250
+ + R
Sbjct: 235 LITRDLSQRL 244
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 2e-20
Identities = 41/265 (15%), Positives = 79/265 (29%), Gaps = 55/265 (20%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ ++ PN++ + V + + I E G+L F E +++
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF-------LAEKESLTEEEATEFL 119
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QI +G+ YL S I H DL N M+ K
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK-------------------------- 153
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
IKI D + + + ++A E + ++D+
Sbjct: 154 -----------PRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADM 199
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
WS V + +L P+ T ++ + N S + D +
Sbjct: 200 WSIGVITYILL--SGASPFLGDTKQETLANVSAVNYEFED----EYFSNTSALAKDFIRR 253
Query: 241 CWKTNETDRPRFSEI--HLFLQRKN 263
+ R + H +++ K+
Sbjct: 254 LLVKDPKKRMTIQDSLQHPWIKPKD 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 83.3 bits (205), Expect = 1e-18
Identities = 26/256 (10%), Positives = 65/256 (25%), Gaps = 42/256 (16%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
+ V + + S + + A Q+ +
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVK-------TVAMAAKQMLAR 113
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
++ + + +V+RD+ N ++G+ S + Y+ D
Sbjct: 114 VQSIHEKSLVYRDIKPDNFLIGRP-----------NSKNANMIYVVD------------- 149
Query: 127 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVT 186
+ + Y R+M+ + L + + + D+ +
Sbjct: 150 -------FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202
Query: 187 LWEILI-HCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKTN 245
L + TN+Q E Q+ ++ +E + M
Sbjct: 203 FMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG---FPEEFYKYMHYARNLA 259
Query: 246 ETDRPRFSEIHLFLQR 261
P + + +
Sbjct: 260 FDATPDYDYLQGLFSK 275
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 6e-18
Identities = 46/250 (18%), Positives = 81/250 (32%), Gaps = 60/250 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + + P L + T D + + EY G+L L ++E F
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------RARFYG 111
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
+I S ++YL SRD+V+RD+ N M+ K+ IKI+D + +
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--------- 162
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
G ++A E L D
Sbjct: 163 ----KTFCG------------------------------TPEYLAPEVLEDNDYGRAVDW 188
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W V ++E++ C + P+ +E++ E + + P T E L+
Sbjct: 189 WGLGVVMYEMM--CGRLPFYNQDHERLFELI--------LMEEIRFPRTLSPEAKSLLAG 238
Query: 241 CWKTNETDRP 250
K + R
Sbjct: 239 LLKKDPKQRL 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.5 bits (198), Expect = 1e-17
Identities = 39/264 (14%), Positives = 75/264 (28%), Gaps = 71/264 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
S ++R++ D I E E QE A S+
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF------F 116
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLP 119
Q+ +++ + ++HRD+ N ++ N +K+ D ++ Y
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---------- 166
Query: 120 IRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKS- 178
G + E + + +S
Sbjct: 167 -----TDFDGTRV------------------------------YSPPEWIRYHRYHGRSA 191
Query: 179 DVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238
VWS + L++++ C P+ + + + E L+
Sbjct: 192 AVWSLGILLYDMV--CGDIPF--------------EHDEEIIRGQVFFRQRVSSECQHLI 235
Query: 239 LECWKTNETDRPRFSEI--HLFLQ 260
C +DRP F EI H ++Q
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 9e-17
Identities = 42/277 (15%), Positives = 77/277 (27%), Gaps = 65/277 (23%)
Query: 7 PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASG 66
P LV + TE + I +Y G+L T L ++ + +I
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-------EVQIYVGEIVLA 141
Query: 67 MKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANC 126
+++L I++RD+ N ++ N + ++D ++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDF-----------------------GLSKE 178
Query: 127 MVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN--TTKSDVWSFA 184
V +MA + + G + D WS
Sbjct: 179 FVADETERAYDFCGTI-------------------EYMAPDIVRGGDSGHDKAVDWWSLG 219
Query: 185 VTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECWKT 244
V ++E+L P+ + + P P DL+
Sbjct: 220 VLMYELL--TGASPFTVDGEKNSQAE----ISRRILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 245 NETDRPRFSEI-------HLFLQRKNLGA-RASKITP 273
+ R HLF Q+ N A K+
Sbjct: 274 DPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 1e-16
Identities = 45/281 (16%), Positives = 84/281 (29%), Gaps = 68/281 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ + + PN+VR+ VC+ + F + L + E P + + M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-PGVPTETIKDMM 122
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ G+ +L S +VHRDL +N +V + IK++D + +
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-------------- 168
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+ +V + + A E LL T D+
Sbjct: 169 QMALTSVVV------------------------------TLWYRAPEVLLQSSYATPVDL 198
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIEN-------------------CSHWYQNNSKQ 221
WS E+ + + ++ + + + S Q
Sbjct: 199 WSVGCIFAEMF--RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 256
Query: 222 QYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQ 260
+ DL+L+C N R H + Q
Sbjct: 257 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.6 bits (190), Expect = 1e-16
Identities = 41/284 (14%), Positives = 84/284 (29%), Gaps = 75/284 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L PN+V+++ V TE+ + + E+ DL F+ P I
Sbjct: 55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLI-----KSYL 108
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ G+ + S ++HRDL +N ++ IK++D + +
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---------- 158
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK-NTTKSD 179
T + + + A E LL K +T D
Sbjct: 159 ---------------------------------YTHEVVTLWYRAPEILLGCKYYSTAVD 185
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIE---------------------NCSHWYQNN 218
+WS E++ + + + + + +
Sbjct: 186 IWSLGCIFAEMV--TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 219 SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQ 260
++Q + ++ L+ + + R H F Q
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 73.0 bits (178), Expect = 5e-15
Identities = 38/262 (14%), Positives = 76/262 (29%), Gaps = 32/262 (12%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ LK N+V++ V T+ + + E+ +
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV-------TAKSFL 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ +G+ Y R ++HRDL +N ++ + +KI+D + + + L
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
R M K Y+ I ++ C E ++ G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAE---------------------MVNGTPLFPGV- 204
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
S A L I N + + + + DL+ +
Sbjct: 205 -SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
Query: 241 CWKTNETDRPRFSEI--HLFLQ 260
K + R + H + +
Sbjct: 264 MLKLDPNQRITAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.4 bits (179), Expect = 5e-15
Identities = 36/276 (13%), Positives = 87/276 (31%), Gaps = 45/276 (16%)
Query: 1 MCSLKDPNLVRVIGVCSTEDP--------ISTIQEYCEFGDLSTFLQIHNCNSQENPAIS 52
+ LK N+V +I +C T+ I + ++CE + +
Sbjct: 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE---- 118
Query: 53 YGCLIFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDH--AMYCSHYESDYY 110
+ + + +G+ Y+ I+HRD+ A N ++ ++ +K++D A S ++
Sbjct: 119 ---IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 175
Query: 111 LSDTKARLPIRWMANCMV--GKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWES 168
T + + + ++ ++Y I C E
Sbjct: 176 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE--------------------- 214
Query: 169 LLLGKN--TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPR 226
+ ++ A+ + ++ + + N ++ E K + +
Sbjct: 215 MWTRSPIMQGNTEQHQLAL-ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 273
Query: 227 PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQ 260
DL+ + + R + H F
Sbjct: 274 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.0 bits (178), Expect = 5e-15
Identities = 37/293 (12%), Positives = 80/293 (27%), Gaps = 73/293 (24%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L PN++ ++ + IS + ++ E ++ ++ + +Y
Sbjct: 54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAY------M 106
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
G++YL I+HRDL N ++ +N +K++D + S
Sbjct: 107 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------------- 153
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKN--TTKS 178
V RW LL G
Sbjct: 154 NRAYTHQVV-------------------------------TRWYRAPELLFGARMYGVGV 182
Query: 179 DVWSFAVTLWEIL------------------IHCNQRPYAELTNEQVIENCSHWYQNNSK 220
D+W+ L E+L P E + +++
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 221 QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKNLGARASKI 271
+ ++ DL+ + N R ++ + + ++
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (178), Expect = 8e-15
Identities = 40/290 (13%), Positives = 66/290 (22%), Gaps = 79/290 (27%)
Query: 1 MCSLKDPNLVRVIGVCSTEDP------ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYG 54
M L N+VR+ + ++ + +Y S+ +
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY----SRAKQTLPVI 122
Query: 55 CLIFMATQIASGMKYLESRDIVHRDL-AARNCMVGKNYTIKISDHAMYCSHYESDYYLSD 113
+ Q+ + Y+ S I HRD+ + +K+ D
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---------- 172
Query: 114 TKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGK 173
+ S+ S YY
Sbjct: 173 ----------------------LVRGEPNVSYICSRYY-----------RAPELIFGATD 199
Query: 174 NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIEN---------------CSHWYQNN 218
T+ DVWS L E+L Q + + + + Y
Sbjct: 200 YTSSIDVWSAGCVLAELL--LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 219 SKQQYLPRPAT------CQKEIFDLMLECWKTNETDRPRFSEI--HLFLQ 260
Q P T E L + T R E H F
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 70.2 bits (171), Expect = 7e-14
Identities = 38/250 (15%), Positives = 75/250 (30%), Gaps = 63/250 (25%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ ++ P LV++ + + EY G++ + L+ S F A
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-------RIGRFSEPHARFYA 147
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QI +YL S D+++RDL N ++ + I+++D + L
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG------- 200
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
+A E +L D
Sbjct: 201 ---------------------------------------TPEALAPEIILSKGYNKAVDW 221
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
W+ V ++E+ P+ Q+ E + P+ ++ DL+
Sbjct: 222 WALGVLIYEMA--AGYPPFFADQPIQIYEKIVSG--------KVRFPSHFSSDLKDLLRN 271
Query: 241 CWKTNETDRP 250
+ + T R
Sbjct: 272 LLQVDLTKRF 281
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.6 bits (169), Expect = 8e-14
Identities = 39/262 (14%), Positives = 78/262 (29%), Gaps = 31/262 (11%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ LK N+VR+ V ++ ++ + E+C+ F + E +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE-------IVKSFL 107
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ G+ + SR+++HRDL +N ++ +N +K+++ + + S L
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
R K Y+ I + C E L
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAE----------------------LANAGRPLFPG 205
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240
L I + + + + + + + DL+
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
Query: 241 CWKTNETDRPRFSEI--HLFLQ 260
K N R E H +
Sbjct: 266 LLKCNPVQRISAEEALQHPYFS 287
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 3e-13
Identities = 43/291 (14%), Positives = 84/291 (28%), Gaps = 80/291 (27%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPIST----IQEYCEFGDLSTFLQIHNCNSQENPAISYGCL 56
+ + N++ + + + + DL L+ + +S +
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--------LSNDHI 111
Query: 57 IFMATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 116
+ QI G+KY+ S +++HRDL N ++ +KI D + +
Sbjct: 112 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 117 RLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTT 176
+ RW + A E +L K T
Sbjct: 172 YVATRW----------------------------------------YRAPEIMLNSKGYT 191
Query: 177 KS-DVWSFAVTLWEILIHCNQRPYAELTNEQVIE-----------------------NCS 212
KS D+WS L E+L N+ + + N
Sbjct: 192 KSIDIWSVGCILAEML--SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 213 HWYQNNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261
+ +K + + DL+ + N R + H +L++
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.0 bits (147), Expect = 8e-11
Identities = 34/286 (11%), Positives = 86/286 (30%), Gaps = 77/286 (26%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ ++ N++ ++ V + ++ + ++ F+ ++ + + F+
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP---FMGTDLGKLMKHEKLGEDRIQFLV 127
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
Q+ G++Y+ + I+HRDL N V ++ +KI D + + S+ +
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL------ARQADSEMTGYVVT 181
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLL-LGKNTTKSD 179
RW + A E +L + T D
Sbjct: 182 RW----------------------------------------YRAPEVILNWMRYTQTVD 201
Query: 180 VWSFAVTLWEILIHCNQRPYAELTNEQVIE-----------------------NCSHWYQ 216
+WS + E++ + + + ++ N
Sbjct: 202 IWSVGCIMAEMI--TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259
Query: 217 NNSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQ 260
K+ + +L+ + + R E H + +
Sbjct: 260 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (136), Expect = 2e-09
Identities = 37/265 (13%), Positives = 84/265 (31%), Gaps = 24/265 (9%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDL--STFLQIHNCNSQENPAISYGCLIF 58
M + N++ ++ V + + + Q+ +L + Q+
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----- 124
Query: 59 MATQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 118
Q+ G+K+L S I+HRDL N +V + T+KI D + + S T +
Sbjct: 125 -LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVV 180
Query: 119 PIRWMA-NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
+ A ++G Y + ++ C E + ++ + N
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH------KILFPGRDYIDQW---NKVI 231
Query: 178 SDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237
+ + + + R Y E + + ++ + DL
Sbjct: 232 EQLGTPCPEFMKK-LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290
Query: 238 MLECWKTNETDRPRFSEI--HLFLQ 260
+ + + R + H ++
Sbjct: 291 LSKMLVIDPAKRISVDDALQHPYIN 315
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.5 bits (130), Expect = 8e-09
Identities = 38/266 (14%), Positives = 89/266 (33%), Gaps = 35/266 (13%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ +K N++ ++ V + + + L + Q+ ++ + F+
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLI 127
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPI 120
QI G+KY+ S DI+HRDL N V ++ +KI D + +
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----GYVATRW 183
Query: 121 RWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDV 180
M+ + + D ++ + + +L G +
Sbjct: 184 YRAPEIMLNWMHYNQTVD--IWSVGC------------IMAELLTGRTLFPGTD------ 223
Query: 181 WSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNS---KQQYLPRPATCQKEIFDL 237
+ ++++ P AEL + E+ ++ Q+ + K + DL
Sbjct: 224 ---HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
Query: 238 MLECWKTNETDRPRFSEI--HLFLQR 261
+ + + R ++ H + +
Sbjct: 281 LEKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 54.1 bits (129), Expect = 1e-08
Identities = 34/260 (13%), Positives = 76/260 (29%), Gaps = 32/260 (12%)
Query: 7 PNLVRVIGVC--STEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIA 64
PN++ + + + + E+ D Q ++ + F +I
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----------TLTDYDIRFYMYEIL 139
Query: 65 SGMKYLESRDIVHRDLAARNCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWM 123
+ Y S I+HRD+ N M+ ++ +++ D + ++ Y + +
Sbjct: 140 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKG 197
Query: 124 ANCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWS 182
+V + Y + ++ C + + P G + V
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIF------RKEPFFH--------GHDNYDQLVRI 243
Query: 183 FAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECW 242
V E L + EL H + + + E D + +
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 243 KTNETDRPRFSEI--HLFLQ 260
+ + R E H +
Sbjct: 304 RYDHQSRLTAREAMEHPYFY 323
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 28/267 (10%), Positives = 70/267 (26%), Gaps = 15/267 (5%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
S+ ++++++ + + P L + + Y I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK- 132
Query: 61 TQIASGMKYLE-SRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 119
Q+ G+ Y+ I+H D+ N ++ + + + +Y +
Sbjct: 133 -QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 120 IRWMA--NCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMAWESLLLGKNTTK 177
R ++G + + C +E S +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITG------DFLFEPDEGHSYTKDDDHIA 245
Query: 178 SDVWSFAVTLWEILIHCNQRP--YAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235
+ +L + + + I W + + KEI
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 236 DLMLECWKTNETDRPRFSEI--HLFLQ 260
D + + + R + H +L+
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 43.6 bits (102), Expect = 1e-05
Identities = 15/113 (13%), Positives = 34/113 (30%), Gaps = 13/113 (11%)
Query: 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMA 60
+ L ++ G+ + + + + +++ + + +
Sbjct: 60 SARNEFRALQKLQGLA--------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLD- 110
Query: 61 TQIASGMKYLESRDIVHRDLAARNCMVGKNYTIKISD--HAMYCSHYESDYYL 111
I + R IVH DL+ N +V I I D ++ L
Sbjct: 111 -MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREIL 161
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 434 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.64 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.56 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.01 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.95 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 91.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 90.09 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=357.94 Aligned_cols=200 Identities=23% Similarity=0.349 Sum_probs=175.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..|+|||||++|+|.+++.+. ..+++..+..++.||++||+|||++||+||||
T Consensus 60 l~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDi 132 (263)
T d2j4za1 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSKRVIHRDI 132 (263)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeee
Confidence 45789999999999999999999999999999999999843 46999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+..... ......||
T Consensus 133 Kp~Nill~~~~~~kl~DFG~a~~~~~~---------------------------------------------~~~~~~Gt 167 (263)
T d2j4za1 133 KPENLLLGSAGELKIADFGWSVHAPSS---------------------------------------------RRTTLCGT 167 (263)
T ss_dssp CGGGEEECTTSCEEECCCCSCSCCCCC---------------------------------------------CCEETTEE
T ss_pred ccccceecCCCCEeecccceeeecCCC---------------------------------------------cccccCCC
Confidence 999999999999999999997642111 11234688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|+.||.+.+..+....+.. .....+..+++++.+|+.+
T Consensus 168 ~~Y~APE~~~~~~~~~~~DiwSlGvilyell--~G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~ 237 (263)
T d2j4za1 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL--VGKPPFEANTYQETYKRISR--------VEFTFPDFVTEGARDLISR 237 (263)
T ss_dssp GGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHT--------TCCCCCTTSCHHHHHHHHH
T ss_pred CcccCHHHHcCCCCCchhhhhhHhHHHHHHh--cCCCCCCCCCHHHHHHHHHc--------CCCCCCccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999999888777766542 1234466789999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHhc
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
||+.||++|||++|+ |+||++.
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999 7899864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=362.04 Aligned_cols=209 Identities=17% Similarity=0.279 Sum_probs=175.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..|+|||||+||+|.+++.. ...+++..+..++.|++.||+|||++||+||||
T Consensus 62 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~-------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDi 134 (288)
T d1uu3a_ 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDL 134 (288)
T ss_dssp HHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc-------cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcC
Confidence 3578999999999999999999999999999999999984 347999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... .........||
T Consensus 135 Kp~NIll~~~~~vkl~DFG~a~~~~~~~-----------------------------------------~~~~~~~~~GT 173 (288)
T d1uu3a_ 135 KPENILLNEDMHIQITDFGTAKVLSPES-----------------------------------------KQARANSFVGT 173 (288)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECC---------------------------------------------------CCCC
T ss_pred CccccccCCCceEEecccccceecccCC-----------------------------------------cccccccccCC
Confidence 9999999999999999999987532111 01112345789
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+...++.. .....+..+++++.+||.+
T Consensus 174 ~~Y~APE~~~~~~~~~~~DiwSlGvilyell--~g~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLV--AGLPPFRAGNEYLIFQKIIK--------LEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp GGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHT--------TCCCCCTTCCHHHHHHHHT
T ss_pred ccccCceeeccCCCCcccceehhhHHHHHHh--hCCCCCCCcCHHHHHHHHHc--------CCCCCCccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999999888877766543 1233466789999999999
Q ss_pred hccCCCCCCCCHHHH--------HHHHHhcccCCC
Q psy5690 241 CWKTNETDRPRFSEI--------HLFLQRKNLGAR 267 (434)
Q Consensus 241 cl~~dP~~Rps~~el--------~~~L~~~~~~~~ 267 (434)
||+.||++|||++|+ |+||+..++...
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 999999999999986 456665544433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-47 Score=355.21 Aligned_cols=210 Identities=35% Similarity=0.653 Sum_probs=169.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|+|.+++..++|||||++|+|.+++.. ....+++.++..++.||++||+|||++||+||||
T Consensus 81 l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~------~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDl 154 (299)
T d1jpaa_ 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ------NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDL 154 (299)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCcc
Confidence 5789999999999999999999999999999999999873 3356999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++....... ...........||
T Consensus 155 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~--------------------------------------~~~~~~~~~~~~t 196 (299)
T d1jpaa_ 155 AARNILVNSNLVCKVSDFGLSRFLEDDTS--------------------------------------DPTYTSALGGKIP 196 (299)
T ss_dssp CGGGEEECTTCCEEECCC-------------------------------------------------------------C
T ss_pred ccceEEECCCCcEEECCcccceEccCCCC--------------------------------------cceeeecccccCC
Confidence 99999999999999999999876332210 0001112334578
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.++.++.++|||||||++|||++ .|..||.+....+....+.. ....+.+..+++++.+|+.+
T Consensus 197 ~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t-~g~~Pf~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~~ 268 (299)
T d1jpaa_ 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS-YGERPYWDMTNQDVINAIEQ-------DYRLPPPMDCPSALHQLMLD 268 (299)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT-TSCCTTTTCCHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHHH
T ss_pred ccccCHHHHhcCCCCcccccccchHHHHHHHh-CCCCCCCCCCHHHHHHHHHc-------CCCCCCCccchHHHHHHHHH
Confidence 99999999999999999999999999999993 28999999888877665542 33455677899999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++|||++||++.|++.
T Consensus 269 cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 269 CWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999998888764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=356.34 Aligned_cols=206 Identities=19% Similarity=0.246 Sum_probs=170.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..|+|||||++|+|.++++ ....+++..+..++.||++||+|||++||+||||
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~-------~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDi 129 (271)
T d1nvra_ 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-------PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 129 (271)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB-------TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcc
Confidence 467999999999999999999999999999999999996 4467999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... .........||
T Consensus 130 Kp~NILl~~~~~~KL~DFG~a~~~~~~~-----------------------------------------~~~~~~~~~GT 168 (271)
T d1nvra_ 130 KPENLLLDERDNLKISDFGLATVFRYNN-----------------------------------------RERLLNKMCGT 168 (271)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECEETT-----------------------------------------EECCBCCCCSC
T ss_pred cHHHEEECCCCCEEEccchhheeeccCC-----------------------------------------ccccccceeeC
Confidence 9999999999999999999987532211 01122456799
Q ss_pred ccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHH-HHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQV-IENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 161 ~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
+.|||||++.+..+ +.++||||+||++|||+ +|..||........ ..... ...........+++++.+|+
T Consensus 169 ~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml--~G~~pf~~~~~~~~~~~~~~------~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAML--AGELPWDQPSDSCQEYSDWK------EKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp GGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHH--HSSCSCSSSSTTSHHHHHHH------TTCTTSTTGGGSCHHHHHHH
T ss_pred cCccCHhHhcCCCCCCCceeeeHhHHHHHHHH--hCCCCCCCCChHHHHHHHHh------cCCCCCCccccCCHHHHHHH
Confidence 99999999998876 67899999999999999 89999977654322 22111 11222233456789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||++|||++|+ |+|+++.
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 99999999999999999 7898753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=355.29 Aligned_cols=203 Identities=20% Similarity=0.327 Sum_probs=174.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..|+|||||+||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||
T Consensus 71 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDi 142 (293)
T d1yhwa1 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142 (293)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Confidence 3578999999999999999999999999999999998862 35899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... .......||
T Consensus 143 Kp~NILl~~~~~vkl~DFG~a~~~~~~~-------------------------------------------~~~~~~~gt 179 (293)
T d1yhwa1 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ-------------------------------------------SKRSTMVGT 179 (293)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSTT-------------------------------------------CCBCCCCSC
T ss_pred cHHHeEECCCCcEeeccchhheeecccc-------------------------------------------ccccccccC
Confidence 9999999999999999999986532111 112445789
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+... .....+.+..+++++++||.+
T Consensus 180 ~~Y~aPE~~~~~~~~~~~DiwSlGvilyeml--tG~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI--EGEPPYLNENPLRALYLIATN-----GTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp GGGCCHHHHSSSCBCTHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHHH-----CSCCCSSGGGSCHHHHHHHHH
T ss_pred CCccChhhhcCCCCCchhceehHhHHHHHHh--hCCCCCCCCCHHHHHHHHHhC-----CCCCCCCcccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 899999988876665444321 122334456789999999999
Q ss_pred hccCCCCCCCCHHHH--HHHHHh
Q psy5690 241 CWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el--~~~L~~ 261 (434)
||+.||++|||++|+ |+||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 999999999999999 789974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-47 Score=349.13 Aligned_cols=210 Identities=25% Similarity=0.407 Sum_probs=167.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|++. ++..++|||||++|+|.+++.. ....+++..+..++.||++||+|||++||+||||
T Consensus 58 l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~------~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDl 130 (276)
T d1uwha_ 58 LRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHI------IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130 (276)
T ss_dssp HTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHT------SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHhcCCEecccc
Confidence 57899999999999875 4578999999999999999973 3356999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... .........||
T Consensus 131 Kp~NiLl~~~~~~Kl~DFGla~~~~~~~-----------------------------------------~~~~~~~~~gt 169 (276)
T d1uwha_ 131 KSNNIFLHEDLTVKIGDFGLATVKSRWS-----------------------------------------GSHQFEQLSGS 169 (276)
T ss_dssp CGGGEEEETTSSEEECCCCCSCC-----------------------------------------------------CCCC
T ss_pred CHHHEEEcCCCCEEEccccceeeccccC-----------------------------------------CcccccccccC
Confidence 9999999999999999999986532111 01122445789
Q ss_pred ccccchhhhhc---CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLLL---GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~---~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+.|||||++.+ ..++.++|||||||++|||+ +|+.||.+.+.......... ...........+..+++++.+|
T Consensus 170 ~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~--tg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~l~~l 245 (276)
T d1uwha_ 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM--TGQLPYSNINNRDQIIFMVG--RGYLSPDLSKVRSNCPKAMKRL 245 (276)
T ss_dssp GGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHH--HSSCTTTTCCCHHHHHHHHH--HTSCCCCGGGSCTTCCHHHHHH
T ss_pred cccCCHHHHhcccCCCCCchhhhhhhHHHHHHHH--HCCCCCCCCChHHHHHHHHh--cCCCCCcchhccccchHHHHHH
Confidence 99999999974 35789999999999999999 89999998766544332221 1111112223356788999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
|.+||+.||++|||++||++.|+..
T Consensus 246 i~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 246 MAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999998888764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=350.23 Aligned_cols=205 Identities=36% Similarity=0.667 Sum_probs=172.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|+|.+ +..++|||||++|+|.++++ ....+++..+..++.||+.||+|||++||+||||
T Consensus 62 l~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~-------~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDl 133 (277)
T d1xbba_ 62 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ-------QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133 (277)
T ss_dssp HHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH-------HCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHh-------hccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCC
Confidence 468999999999999965 46789999999999999997 3457999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ..........||
T Consensus 134 Kp~Nill~~~~~~kl~DFGla~~~~~~~----------------------------------------~~~~~~~~~~gt 173 (277)
T d1xbba_ 134 AARNVLLVTQHYAKISDFGLSKALRADE----------------------------------------NYYKAQTHGKWP 173 (277)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECCTTC----------------------------------------SEEEC----CCC
T ss_pred cchhhcccccCcccccchhhhhhccccc----------------------------------------cccccccccCCC
Confidence 9999999999999999999987532211 111122345688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||++ .|..||.+.+..+....+. .+.+++.+..+++++.+||.+
T Consensus 174 ~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt-~g~~Pf~~~~~~~~~~~i~-------~~~~~~~p~~~~~~~~~li~~ 245 (277)
T d1xbba_ 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFS-YGQKPYRGMKGSEVTAMLE-------KGERMGCPAGCPREMYDLMNL 245 (277)
T ss_dssp GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-TTCCSSTTCCHHHHHHHHH-------TTCCCCCCTTCCHHHHHHHHH
T ss_pred ceecCchhhcCCCCCchhhhccchhhhhHHhh-CCCCCCCCCCHHHHHHHHH-------cCCCCCCCcccCHHHHHHHHH
Confidence 99999999999999999999999999999993 2899999988877766553 234556678899999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||+.||++|||+++|...|+.
T Consensus 246 cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 246 CWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp HTCSSTTTSCCHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHhhC
Confidence 999999999999999777665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=349.14 Aligned_cols=207 Identities=33% Similarity=0.616 Sum_probs=175.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|++.+ +..|+|||||++|+|.+++.. ....+++..+..++.||++||+|||++||+||||
T Consensus 63 l~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~------~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDl 135 (285)
T d1u59a_ 63 MHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135 (285)
T ss_dssp HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcC
Confidence 357899999999999865 568999999999999999862 3357999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ..........||
T Consensus 136 Kp~Nill~~~~~~Kl~DFGla~~~~~~~----------------------------------------~~~~~~~~~~gt 175 (285)
T d1u59a_ 136 AARNVLLVNRHYAKISDFGLSKALGADD----------------------------------------SYYTARSAGKWP 175 (285)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECTTCS----------------------------------------CEECCCCSSCCC
T ss_pred chhheeeccCCceeeccchhhhcccccc----------------------------------------cccccccccccC
Confidence 9999999999999999999987632211 111122345688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.++.++.++|||||||++|||++ .|..||.+.+..+....+. .+.+++.|..+++++.+||.+
T Consensus 176 ~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt-~G~~Pf~~~~~~~~~~~i~-------~~~~~~~p~~~~~~l~~li~~ 247 (285)
T d1u59a_ 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALS-YGQKPYKKMKGPEVMAFIE-------QGKRMECPPECPPELYALMSD 247 (285)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT-TSCCTTTTCCTHHHHHHHH-------TTCCCCCCTTCCHHHHHHHHH
T ss_pred ccccChHHHhCCCCCccchhhcchHHHHHHHh-CCCCCCCCCCHHHHHHHHH-------cCCCCCCCCcCCHHHHHHHHH
Confidence 99999999999999999999999999999993 2899999988877766554 233456678899999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++|||+.+|++.|+..
T Consensus 248 cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 248 CWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999998888764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=352.94 Aligned_cols=205 Identities=22% Similarity=0.349 Sum_probs=172.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..++|||||++|+|.+++.+. ...+++..+..++.||+.||+|||++||+||||
T Consensus 63 l~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~------~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDi 136 (288)
T d2jfla1 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL------ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 136 (288)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeec
Confidence 35789999999999999999999999999999999998643 246999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... .......||
T Consensus 137 Kp~NIll~~~~~~Kl~DFG~a~~~~~~~-------------------------------------------~~~~~~~Gt 173 (288)
T d2jfla1 137 KAGNILFTLDGDIKLADFGVSAKNTRTI-------------------------------------------QRRDSFIGT 173 (288)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECHHHH-------------------------------------------HHHTCCCSC
T ss_pred ChhheeECCCCCEEEEechhhhccCCCc-------------------------------------------ccccccccc
Confidence 9999999999999999999976421110 012345789
Q ss_pred ccccchhhhh-----cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 161 IRWMAWESLL-----LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 161 ~~y~aPE~~~-----~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
+.|+|||++. ...|+.++|||||||++|||+ +|..||.+.+..+....+... .......+..+++++.
T Consensus 174 ~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyeml--tg~~Pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA--EIEPPHHELNPMRVLLKIAKS-----EPPTLAQPSRWSSNFK 246 (288)
T ss_dssp CTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHH--HSSCTTTTSCGGGHHHHHHHS-----CCCCCSSGGGSCHHHH
T ss_pred cccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHh--hCCCCCCCCCHHHHHHHHHcC-----CCCCCCccccCCHHHH
Confidence 9999999984 455789999999999999999 899999988877766555421 1223344567899999
Q ss_pred HHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 236 DLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+||.+||+.||++|||++|+ |+||+.
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999999999999999 778864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=345.22 Aligned_cols=206 Identities=36% Similarity=0.674 Sum_probs=168.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|+|.+++..++|||||++|+|.+++.. ....+++..+..++.||+.||+|||+++|+||||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~------~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDl 127 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTC
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc------cccCCCHHHHHHHHHHHHHHHHhhhccceeeccc
Confidence 3578999999999999999999999999999999999873 3356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........||
T Consensus 128 Kp~Nill~~~~~~Kl~DFGla~~~~~~~------------------------------------------~~~~~~~~gt 165 (263)
T d1sm2a_ 128 AARNCLVGENQVIKVSDFGMTRFVLDDQ------------------------------------------YTSSTGTKFP 165 (263)
T ss_dssp SGGGEEECGGGCEEECSCC------------------------------------------------------------C
T ss_pred chhheeecCCCCeEecccchheeccCCC------------------------------------------ceeecceecC
Confidence 9999999999999999999986532211 1112345678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||++ .|.+||...+..+..+.+.. ......|..+++++.+++.+
T Consensus 166 ~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t-~~~~~~~~~~~~~~~~~i~~-------~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS-EGKIPYENRSNSEVVEDIST-------GFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp TTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHT-TSCCTTCSCCHHHHHHHHHH-------TCCCCCCTTSCHHHHHHHHH
T ss_pred cccCChHHhcCCCCCchhhhcchHHHHHHHHH-CCCCCCCCCCHHHHHHHHHh-------cCCCCCccccCHHHHHHHHH
Confidence 89999999999999999999999999999994 26777777777777665543 23445567889999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++|||++||++.|++.
T Consensus 238 cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=350.78 Aligned_cols=203 Identities=20% Similarity=0.335 Sum_probs=162.6
Q ss_pred CCCCCCCCeeeEEEEEec--CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC----
Q psy5690 1 MCSLKDPNLVRVIGVCST--EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD---- 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~---- 74 (434)
|++++|||||++++++.+ ++.+|+|||||++|+|.+++.+.. .....+++..++.++.||+.||+|||++|
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~---~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~ 133 (269)
T d2java1 57 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGT---KERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 133 (269)
T ss_dssp TTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHH---HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---
T ss_pred HHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhcc---ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 678999999999999865 466899999999999999996432 13457999999999999999999999876
Q ss_pred -ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 75 -IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 75 -iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 134 ~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-------------------------------------------~~ 170 (269)
T d2java1 134 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------------------------------------------SF 170 (269)
T ss_dssp ------CCGGGEEECTTSCEEECCHHHHHHC-------------------------------------------------
T ss_pred CEEeCcCchhhcCcCCCCcEEEeeccceeecccCC-------------------------------------------Cc
Confidence 9999999999999999999999999986532111 01
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
.....||+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.. ....+.+..++++
T Consensus 171 ~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~--tg~~Pf~~~~~~~~~~~i~~-------~~~~~~~~~~s~~ 241 (269)
T d2java1 171 AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC--ALMPPFTAFSQKELAGKIRE-------GKFRRIPYRYSDE 241 (269)
T ss_dssp -----CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHH-------TCCCCCCTTSCHH
T ss_pred cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHh--hCCCCCCCCCHHHHHHHHHc-------CCCCCCCcccCHH
Confidence 23457889999999999999999999999999999999 89999999888877766543 2223446678999
Q ss_pred HHHHHHHhccCCCCCCCCHHHH--HHH
Q psy5690 234 IFDLMLECWKTNETDRPRFSEI--HLF 258 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el--~~~ 258 (434)
+.+|+.+||+.||++|||++|+ |+|
T Consensus 242 l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 242 LNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 9999999999999999999999 444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=357.16 Aligned_cols=210 Identities=34% Similarity=0.638 Sum_probs=173.1
Q ss_pred CC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCC----------------CCCCCCCHHHHHHHHHHHHH
Q psy5690 3 SL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNS----------------QENPAISYGCLIFMATQIAS 65 (434)
Q Consensus 3 ~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~qi~~ 65 (434)
++ +|||||+++|+|.+.+..++|||||++|+|.++++.++... .....+++..++.++.||++
T Consensus 96 ~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 175 (325)
T d1rjba_ 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAK 175 (325)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHH
T ss_pred HhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHH
Confidence 45 89999999999999999999999999999999997543211 11245899999999999999
Q ss_pred HHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccc
Q psy5690 66 GMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSH 145 (434)
Q Consensus 66 gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 145 (434)
||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 176 gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~------------------------------------- 218 (325)
T d1rjba_ 176 GMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS------------------------------------- 218 (325)
T ss_dssp HHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT-------------------------------------
T ss_pred HHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCC-------------------------------------
Confidence 9999999999999999999999999999999999987532211
Q ss_pred cCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCC
Q psy5690 146 YESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYL 224 (434)
Q Consensus 146 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (434)
.........||+.|||||++.++.++.++|||||||++|||+ + |..||.+.+..+....+.. ....+
T Consensus 219 ----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml--t~g~~Pf~~~~~~~~~~~~~~------~~~~~ 286 (325)
T d1rjba_ 219 ----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF--SLGVNPYPGIPVDANFYKLIQ------NGFKM 286 (325)
T ss_dssp ----TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT--TTSCCSSTTCCCSHHHHHHHH------TTCCC
T ss_pred ----ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH--hCCCCCCCCCCHHHHHHHHHh------cCCCC
Confidence 011123455789999999999999999999999999999999 5 8999988766555443322 23345
Q ss_pred CCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q psy5690 225 PRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 225 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+.+..+++++.+||.+||+.||++|||++||++.|..
T Consensus 287 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 6677899999999999999999999999999998863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=352.22 Aligned_cols=204 Identities=19% Similarity=0.225 Sum_probs=166.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++.+|+|||||+||+|.+++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 61 l~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~-------~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDi 133 (307)
T d1a06a_ 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV-------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 133 (307)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-------TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh-------cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEe
Confidence 467899999999999999999999999999999999997 4457999999999999999999999999999999
Q ss_pred CCCCeeee---cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVG---KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~---~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||+. .++.+||+|||+|+...... .....
T Consensus 134 Kp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~--------------------------------------------~~~~~ 169 (307)
T d1a06a_ 134 KPENLLYYSLDEDSKIMISDFGLSKMEDPGS--------------------------------------------VLSTA 169 (307)
T ss_dssp CGGGEEESSSSTTCCEEECCC-----------------------------------------------------------
T ss_pred cccceeecccCCCceEEEeccceeEEccCCC--------------------------------------------eeeee
Confidence 99999995 47899999999976522111 11345
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|||||++.+..++.++|||||||++|||+ +|..||.+....+....+... ......+.+..+++++.+|
T Consensus 170 ~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell--~g~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~l 243 (307)
T d1a06a_ 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL--CGYPPFYDENDAKLFEQILKA----EYEFDSPYWDDISDSAKDF 243 (307)
T ss_dssp ---CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHTT----CCCCCTTTTTTSCHHHHHH
T ss_pred eeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH--hCCCCCCCCCHHHHHHHHhcc----CCCCCCccccCCCHHHHHH
Confidence 6899999999999999999999999999999999 899999998887776655431 1222333456788999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
+.+||+.||++|||++|+ |+||+.
T Consensus 244 i~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 244 IRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 999999999999999999 678875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-46 Score=347.62 Aligned_cols=207 Identities=41% Similarity=0.746 Sum_probs=173.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|+|.+++..++|||||++|+|.+++... ....+++..+..++.||++||+|||++||+||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~-----~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 141 (287)
T d1opja_ 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-----NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 141 (287)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-----CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhc-----cccchHHHHHHHHHHHHHHHHHHHHHCCcccCcc
Confidence 45789999999999999999999999999999999999743 3457899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... ........|+
T Consensus 142 Kp~NILl~~~~~~Kl~DFG~a~~~~~~~------------------------------------------~~~~~~~~g~ 179 (287)
T d1opja_ 142 AARNCLVGENHLVKVADFGLSRLMTGDT------------------------------------------YTAHAGAKFP 179 (287)
T ss_dssp SGGGEEECGGGCEEECCCCCTTTCCSSS------------------------------------------SEEETTEEEC
T ss_pred ccCeEEECCCCcEEEccccceeecCCCC------------------------------------------ceeecccccc
Confidence 9999999999999999999987532211 1112334577
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCC-CCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQR-PYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.+..++.++|||||||++|||+ ++.. ||...+..+..+.+. ....++.+..+++++.+|+.
T Consensus 180 ~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell--~~~~p~~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIA--TYGMSPYPGIDLSQVYELLE-------KDYRMERPEGCPEKVYELMR 250 (287)
T ss_dssp GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH--TTSCCSSTTCCHHHHHHHHH-------TTCCCCCCTTCCHHHHHHHH
T ss_pred ccccChHHHcCCCCCchhhhhhHHHHHHHHH--hCCCCCCCcchHHHHHHHHh-------cCCCCCCCccchHHHHHHHH
Confidence 8899999999999999999999999999999 6544 555555555544332 23345667789999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+||+.||++|||++||+++|+...
T Consensus 251 ~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 251 ACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHH
Confidence 999999999999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-46 Score=349.88 Aligned_cols=200 Identities=20% Similarity=0.308 Sum_probs=171.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..|+|||||.+|+|..++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 69 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~-------~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDi 141 (309)
T d1u5ra_ 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV-------HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-------HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH-------hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCC
Confidence 578999999999999999999999999999999987776 3357999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+... ......||
T Consensus 142 Kp~NILl~~~~~~Kl~DFG~a~~~~-----------------------------------------------~~~~~~GT 174 (309)
T d1u5ra_ 142 KAGNILLSEPGLVKLGDFGSASIMA-----------------------------------------------PANSFVGT 174 (309)
T ss_dssp SGGGEEEETTTEEEECCCTTCBSSS-----------------------------------------------SBCCCCSC
T ss_pred CcceEEECCCCCEEEeecccccccC-----------------------------------------------CCCccccC
Confidence 9999999999999999999975411 11345689
Q ss_pred ccccchhhhhc---CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 161 IRWMAWESLLL---GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 161 ~~y~aPE~~~~---~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
+.|||||++.+ +.|+.++|||||||++|||+ +|..||.+....+....+.. .......+..+++++.+|
T Consensus 175 ~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~--~g~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA--ERKPPLFNMNAMSALYHIAQ------NESPALQSGHWSEYFRNF 246 (309)
T ss_dssp GGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHH--HSSCTTTTSCHHHHHHHHHH------SCCCCCSCTTSCHHHHHH
T ss_pred ccccCHHHHhccCCCCcCchhhhhhHHHHHHHHH--HCCCCCCCCCHHHHHHHHHh------CCCCCCCCCCCCHHHHHH
Confidence 99999999964 45899999999999999999 89999998887766654432 111222345688999999
Q ss_pred HHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
|.+||+.||++|||++|+ |+|+.+.
T Consensus 247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999 8899764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=344.18 Aligned_cols=199 Identities=23% Similarity=0.359 Sum_probs=162.2
Q ss_pred CCCCCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC--
Q psy5690 1 MCSLKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD-- 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~-- 74 (434)
|++++|||||+++++|++ ++.+|+|||||++|+|.+++.+. ..+++..+..++.||++||+|||+++
T Consensus 62 l~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH~~~~~ 134 (270)
T d1t4ha_ 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRTPP 134 (270)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 578999999999999865 34589999999999999999743 47899999999999999999999998
Q ss_pred ccccCCCCCCeeee-cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 75 IVHRDLAARNCMVG-KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 75 iiHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|+||||||+|||++ +++.+||+|||+|+..... .
T Consensus 135 IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~---------------------------------------------~ 169 (270)
T d1t4ha_ 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---------------------------------------------F 169 (270)
T ss_dssp CCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---------------------------------------------S
T ss_pred EEeCCcChhhceeeCCCCCEEEeecCcceeccCC---------------------------------------------c
Confidence 99999999999996 4789999999997641110 1
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhhhcCCcccCCCCCCccHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWYQNNSKQQYLPRPATCQK 232 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (434)
.....||+.|||||++.+ .++.++|||||||++|||+ +|+.||.+..... ....+.. .......+..+++
T Consensus 170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~--~g~~Pf~~~~~~~~~~~~i~~------~~~~~~~~~~~~~ 240 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA--TSEYPYSECQNAAQIYRRVTS------GVKPASFDKVAIP 240 (270)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH--HSSCTTTTCSSHHHHHHHHTT------TCCCGGGGGCCCH
T ss_pred cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHH--HCCCCCCCcccHHHHHHHHHc------CCCCcccCccCCH
Confidence 134568999999998865 5999999999999999999 8999998765443 3333322 1111122445778
Q ss_pred HHHHHHHHhccCCCCCCCCHHHH--HHHHH
Q psy5690 233 EIFDLMLECWKTNETDRPRFSEI--HLFLQ 260 (434)
Q Consensus 233 ~l~~li~~cl~~dP~~Rps~~el--~~~L~ 260 (434)
++.+||.+||+.||++|||++|+ |+||+
T Consensus 241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999999 66764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=353.75 Aligned_cols=209 Identities=20% Similarity=0.285 Sum_probs=167.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhC-CccccC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESR-DIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~-~iiHrD 79 (434)
|++++|||||+++++|.+++.+|+|||||+||+|.+++.+. ..+++..+..++.||+.||+|||++ ||+|||
T Consensus 58 l~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRD 130 (322)
T d1s9ja_ 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 130 (322)
T ss_dssp GGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSC
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccc
Confidence 57899999999999999999999999999999999999743 4699999999999999999999974 999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+||+|||+|+..... ......|
T Consensus 131 iKP~NILl~~~~~vkl~DFGla~~~~~~---------------------------------------------~~~~~~G 165 (322)
T d1s9ja_ 131 VKPSNILVNSRGEIKLCDFGVSGQLIDS---------------------------------------------MANSFVG 165 (322)
T ss_dssp CSGGGEEECTTCCEEECCCCCCHHHHHH---------------------------------------------TC---CC
T ss_pred cCHHHeeECCCCCEEEeeCCCccccCCC---------------------------------------------ccccccC
Confidence 9999999999999999999998652111 1134578
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhh-----------------------
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQ----------------------- 216 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~----------------------- 216 (434)
|+.|+|||++.+..|+.++||||+||++|||+ +|+.||.+.+..+..........
T Consensus 166 T~~Y~APEvl~~~~y~~~~DiWSlGvil~ell--~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T d1s9ja_ 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA--VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243 (322)
T ss_dssp SSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH--HSSCCSSCCCTTHHHHHC----------------------------
T ss_pred CccccCchHHcCCCCCcHHHHHHHHHHHHHHH--HCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccc
Confidence 99999999999999999999999999999999 89999987654332111000000
Q ss_pred ------------cCCcccCCCC-CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 217 ------------NNSKQQYLPR-PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 217 ------------~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.......... ...++.++.+|+.+||+.||++|||++|+ |+||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp --CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0000000111 12467899999999999999999999999 89998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=333.98 Aligned_cols=205 Identities=32% Similarity=0.629 Sum_probs=177.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|+|.+++..++||||+++|+|.+++.. ....+++..+..++.|+++||+|||++||+||||
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~------~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dl 126 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE------MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 126 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS------GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCC
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc------cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccc
Confidence 3578999999999999999999999999999999999863 3356889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........+|
T Consensus 127 k~~Nill~~~~~~kl~DfG~a~~~~~~~------------------------------------------~~~~~~~~~t 164 (258)
T d1k2pa_ 127 AARNCLVNDQGVVKVSDFGLSRYVLDDE------------------------------------------YTSSVGSKFP 164 (258)
T ss_dssp SGGGEEECTTCCEEECCCSSCCBCSSSS------------------------------------------CCCCCCSCCC
T ss_pred cceeEEEcCCCcEEECcchhheeccCCC------------------------------------------ceeecccCCC
Confidence 9999999999999999999986532211 1122345788
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||.+.+..++.++|||||||++|||++ .|+.||...+..+....+.. ..+.+.|..+++++.+||.+
T Consensus 165 ~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t-~g~~Pf~~~~~~~~~~~i~~-------~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS-LGKMPYERFTNSETAEHIAQ-------GLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT-TSCCTTTTSCHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHHH
T ss_pred CCcCCcHHhcCCCCCcceeecccchhhHhHHh-cCCCCCCCCCHHHHHHHHHh-------CCCCCCcccccHHHHHHHHH
Confidence 99999999999999999999999999999993 27999999998887766543 33455677889999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHh
Q psy5690 241 CWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~ 261 (434)
||+.||++|||++||+..|.+
T Consensus 237 cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCSSGGGSCCHHHHHHHHHC
T ss_pred HccCCHhHCcCHHHHHHHhhC
Confidence 999999999999999887754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-45 Score=345.03 Aligned_cols=201 Identities=21% Similarity=0.335 Sum_probs=176.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..|+|||||+||+|..++. ....+++..+..++.||+.||+|||++||+||||
T Consensus 58 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDi 130 (316)
T d1fota_ 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-------KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDL 130 (316)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH-------HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred HHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc-------ccccccccHHHHHHHHHHHhhhhhccCcEEcccc
Confidence 467899999999999999999999999999999999998 4457889999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+.... ......||
T Consensus 131 Kp~NILl~~~g~vkL~DFG~a~~~~~----------------------------------------------~~~~~~Gt 164 (316)
T d1fota_ 131 KPENILLDKNGHIKITDFGFAKYVPD----------------------------------------------VTYTLCGT 164 (316)
T ss_dssp CGGGEEECTTSCEEECCCSSCEECSS----------------------------------------------CBCCCCSC
T ss_pred CchheeEcCCCCEEEecCccceEecc----------------------------------------------ccccccCc
Confidence 99999999999999999999765211 11346789
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.. .....+..+++++.+++.+
T Consensus 165 ~~Y~APE~l~~~~y~~~~DiwSlGvilyeml--tG~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~ 234 (316)
T d1fota_ 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEML--AGYTPFYDSNTMKTYEKILN--------AELRFPPFFNEDVKDLLSR 234 (316)
T ss_dssp TTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHH--------CCCCCCTTSCHHHHHHHHH
T ss_pred ccccCHHHHcCCCCCchhhccccchhHHHHH--hCCCCCCCcCHHHHHHHHHc--------CCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999999988887766543 1234466788999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
||+.||.+|+ |++|+ |+||++.++
T Consensus 235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~ 265 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred HhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence 9999999996 89999 889987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=348.23 Aligned_cols=203 Identities=24% Similarity=0.324 Sum_probs=177.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++.+|+|||||+||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||
T Consensus 59 l~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~-------~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDl 131 (337)
T d1o6la_ 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc-------ccCCcHHHHHHHHHHHhhhhhhhhhcCcccccc
Confidence 4678999999999999999999999999999999999984 357899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.+|.+||+|||+|+...... ......+||
T Consensus 132 KP~NILl~~~g~vkl~DFG~a~~~~~~~-------------------------------------------~~~~~~~GT 168 (337)
T d1o6la_ 132 KLENLMLDKDGHIKITDFGLCKEGISDG-------------------------------------------ATMKTFCGT 168 (337)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCSCCTT-------------------------------------------CCBCCCEEC
T ss_pred CHHHeEecCCCCEEEeecccccccccCC-------------------------------------------cccccceeC
Confidence 9999999999999999999986522111 112446789
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..|+.++|||||||++|||+ +|..||.+.+..+....+.. .....|..+++++.+||.+
T Consensus 169 ~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml--~G~~pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM--CGRLPFYNQDHERLFELILM--------EEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp GGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------CCCCCCTTSCHHHHHHHHH
T ss_pred HHHhhhhhccCCCCChhhcccchhhHHHHHH--HCCCCCCCcCHHHHHHHHhc--------CCCCCCccCCHHHHHHHHh
Confidence 9999999999999999999999999999999 89999999988877765542 2344567889999999999
Q ss_pred hccCCCCCCCC-----HHHH--HHHHHhcc
Q psy5690 241 CWKTNETDRPR-----FSEI--HLFLQRKN 263 (434)
Q Consensus 241 cl~~dP~~Rps-----~~el--~~~L~~~~ 263 (434)
||+.||++|++ ++|+ |+||++.+
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred hccCCchhhcccccccHHHHHcCcccccCC
Confidence 99999999995 8888 88997754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=340.43 Aligned_cols=204 Identities=37% Similarity=0.644 Sum_probs=170.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|++.+ +..++|||||++|+|.+++... ....+++..+..++.||++||+|||+++|+||||
T Consensus 62 l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~-----~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDi 135 (272)
T d1qpca_ 62 MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-----SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135 (272)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH-----HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCcc
Confidence 357899999999998854 5689999999999999988632 2235899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... ........||
T Consensus 136 Kp~NIll~~~~~~Kl~DFGla~~~~~~~------------------------------------------~~~~~~~~gt 173 (272)
T d1qpca_ 136 RAANILVSDTLSCKIADFGLARLIEDNE------------------------------------------YTAREGAKFP 173 (272)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSSC------------------------------------------EECCTTCCCC
T ss_pred chhheeeecccceeeccccceEEccCCc------------------------------------------cccccccCCc
Confidence 9999999999999999999987532211 1122445688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.++.++.++|||||||++|||+ + |.+||......+....+.. ....+.+..+++++.+|+.
T Consensus 174 ~~y~APE~~~~~~~~~~sDvwS~Gvvl~ell--t~~~~~~~~~~~~~~~~~i~~-------~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIV--THGRIPYPGMTNPEVIQNLER-------GYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp TTTSCHHHHHHCEECHHHHHHHHHHHHHHHH--TTTCCSSTTCCHHHHHHHHHT-------TCCCCCCTTCCHHHHHHHH
T ss_pred ccccChHHHhCCCCCchhhhhhhHHHHHHHH--hCCCCCCCCCCHHHHHHHHHh-------cCCCCCcccChHHHHHHHH
Confidence 8999999999999999999999999999999 5 5666677776666655532 3345567789999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHh
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQR 261 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~ 261 (434)
+||+.||++|||++||++.|++
T Consensus 245 ~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 245 LCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhh
Confidence 9999999999999999887775
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=338.34 Aligned_cols=207 Identities=37% Similarity=0.665 Sum_probs=169.2
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|++.+.+..++|||||.+|++.+++.. ....+++..+..++.||+.||+|||+++|+||||
T Consensus 63 l~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~------~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDl 136 (283)
T d1mqba_ 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE------KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 136 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc------ccccccHHHHHHHHHHHHHhhhhccccccccCcc
Confidence 4678999999999999999999999999999999998863 3357999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ..........||
T Consensus 137 Kp~NILl~~~~~~Kl~DFGla~~~~~~~----------------------------------------~~~~~~~~~~gt 176 (283)
T d1mqba_ 137 AARNILVNSNLVCKVSDFGLSRVLEDDP----------------------------------------EATYTTSGGKIP 176 (283)
T ss_dssp CGGGEEECTTCCEEECCCCC---------------------------------------------------------CCC
T ss_pred ccceEEECCCCeEEEcccchhhcccCCC----------------------------------------ccceEeccCCCC
Confidence 9999999999999999999987632211 001122345678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.++.++.++|||||||++|||+ + |.+|+...+..+....+. .+.+.+.+..+++++.+|+.
T Consensus 177 ~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~--t~~~~~~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~l~~li~ 247 (283)
T d1mqba_ 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVM--TYGERPYWELSNHEVMKAIN-------DGFRLPTPMDCPSAIYQLMM 247 (283)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHH--TTSCCTTTTCCHHHHHHHHH-------TTCCCCCCTTCBHHHHHHHH
T ss_pred ccccCHHHHccCCCCCcccccccHHHHHHHH--hCCCCccccCCHHHHHHHHh-------ccCCCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999999999 5 455666666666655543 23455667789999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++|||+.||++.|++.
T Consensus 248 ~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 248 QCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHCcCCHhHCcCHHHHHHHHHHH
Confidence 99999999999999999988764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-45 Score=351.27 Aligned_cols=208 Identities=17% Similarity=0.195 Sum_probs=174.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||++++++.+++..|+|||||+||+|.+++.+ ....+++..+..++.||+.||+|||++||+||||
T Consensus 77 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~------~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDi 150 (350)
T d1koaa2 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD------EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDL 150 (350)
T ss_dssp HHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC------TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeee
Confidence 3578999999999999999999999999999999999952 3356999999999999999999999999999999
Q ss_pred CCCCeeeec--CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 81 AARNCMVGK--NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 81 kp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||+|||++. ++.+||+|||+++...... ......
T Consensus 151 Kp~NIll~~~~~~~vkL~DFG~a~~~~~~~--------------------------------------------~~~~~~ 186 (350)
T d1koaa2 151 KPENIMFTTKRSNELKLIDFGLTAHLDPKQ--------------------------------------------SVKVTT 186 (350)
T ss_dssp CGGGEEESSTTSCCEEECCCTTCEECCTTS--------------------------------------------CEEEEC
T ss_pred chhHeeeccCCCCeEEEeecchheeccccc--------------------------------------------ccceec
Confidence 999999964 5789999999986532211 113356
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|||||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.... ..........+++++++||
T Consensus 187 gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell--~G~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL--SGLSPFGGENDDETLRNVKSCD----WNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp SCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHTC----CCSCCGGGGGCCHHHHHHH
T ss_pred CcccccCHHHHcCCCCChhHhhhhhhHHHHHHH--hCCCCCCCCCHHHHHHHHHhCC----CCCCcccccCCCHHHHHHH
Confidence 789999999999999999999999999999999 8999999988888777664321 1111222356789999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhccc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKNL 264 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~~ 264 (434)
.+||+.||++|||++|+ |+||+..+.
T Consensus 261 ~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 261 RKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 99999999999999999 778986544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-45 Score=349.63 Aligned_cols=207 Identities=18% Similarity=0.229 Sum_probs=175.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||+++++|.+++.+|+|||||+||+|.+++.. ....+++.+++.++.||+.||+|||++||+||||
T Consensus 80 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~------~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDi 153 (352)
T d1koba_ 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA------EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 153 (352)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC------TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 5789999999999999999999999999999999998762 3356999999999999999999999999999999
Q ss_pred CCCCeeee--cCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 81 AARNCMVG--KNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 81 kp~NILl~--~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||+|||++ .++.+||+|||+|+...... ......
T Consensus 154 Kp~NILl~~~~~~~vkL~DFGla~~~~~~~--------------------------------------------~~~~~~ 189 (352)
T d1koba_ 154 KPENIMCETKKASSVKIIDFGLATKLNPDE--------------------------------------------IVKVTT 189 (352)
T ss_dssp CGGGEEESSTTCCCEEECCCTTCEECCTTS--------------------------------------------CEEEEC
T ss_pred ccccccccccCCCeEEEeecccceecCCCC--------------------------------------------ceeecc
Confidence 99999997 57899999999986532211 113346
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
||+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+... ...........+++++.+||
T Consensus 190 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell--tG~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 190 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL--SGLSPFAGEDDLETLQNVKRC----DWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp SSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH--HSCCSSCCSSHHHHHHHHHHC----CCCCCSSTTTTSCHHHHHHH
T ss_pred CcccccCHHHHcCCCCCCccchHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhC----CCCCCcccccCCCHHHHHHH
Confidence 788999999999999999999999999999999 899999998888777665431 11112223457889999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.+||+.||++|||++|+ |+||+...
T Consensus 264 ~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 264 KNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999999999 77997653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=344.55 Aligned_cols=206 Identities=19% Similarity=0.213 Sum_probs=172.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++|+|||||+++++|.+++..|+|||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDi 139 (293)
T d1jksa_ 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDL 139 (293)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhhhcceeeccc
Confidence 35689999999999999999999999999999999999743 47999999999999999999999999999999
Q ss_pred CCCCeeeecCC----ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 81 AARNCMVGKNY----TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 81 kp~NILl~~~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||+|||++.++ .+|++|||+++...... ....
T Consensus 140 Kp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~--------------------------------------------~~~~ 175 (293)
T d1jksa_ 140 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--------------------------------------------EFKN 175 (293)
T ss_dssp SGGGEEESCSSSSSCCEEECCCTTCEECTTSC--------------------------------------------BCSC
T ss_pred ccceEEEecCCCcccceEecchhhhhhcCCCc--------------------------------------------cccc
Confidence 99999998776 59999999976532111 1234
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..||+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.... .....+.+..+++++.+
T Consensus 176 ~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell--~g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~ 249 (293)
T d1jksa_ 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL--SGASPFLGDTKQETLANVSAVN----YEFEDEYFSNTSALAKD 249 (293)
T ss_dssp CCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHTTC----CCCCHHHHTTSCHHHHH
T ss_pred cCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH--cCCCCCCCCCHHHHHHHHHhcC----CCCCchhcCCCCHHHHH
Confidence 56788999999999999999999999999999999 8999999988888776654311 11111123467889999
Q ss_pred HHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 237 LMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||.+||+.||++|||++|+ |+||+..+
T Consensus 250 li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 250 FIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999 77887643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=335.97 Aligned_cols=205 Identities=37% Similarity=0.740 Sum_probs=166.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|++. ++..++|||||++|+|.+++.. ....+++..++.++.||++||+|||++||+||||
T Consensus 62 l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~------~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDl 134 (273)
T d1mp8a_ 62 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV------RKYSLDLASLILYAYQLSTALAYLESKRFVHRDI 134 (273)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH------TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc------cCCCCCHHHHHHHHHHHHHHhhhhcccCeecccc
Confidence 46799999999999995 5679999999999999998863 3356899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+||+++.++.+||+|||+|+...... ........||
T Consensus 135 Kp~NIll~~~~~~Kl~DfG~a~~~~~~~------------------------------------------~~~~~~~~gt 172 (273)
T d1mp8a_ 135 AARNVLVSSNDCVKLGDFGLSRYMEDST------------------------------------------YYKASKGKLP 172 (273)
T ss_dssp SGGGEEEEETTEEEECC-------------------------------------------------------------CC
T ss_pred chhheeecCCCcEEEccchhheeccCCc------------------------------------------ceeccceecC
Confidence 9999999999999999999986532111 1122345678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.+..++.++|||||||++|||++ .|..||...+..+....+.. +...+.+..+++++.+||.+
T Consensus 173 ~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt-~g~~P~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~~~~li~~ 244 (273)
T d1mp8a_ 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILM-HGVKPFQGVKNNDVIGRIEN-------GERLPMPPNCPPTLYSLMTK 244 (273)
T ss_dssp GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT-TSCCTTTTCCGGGHHHHHHT-------TCCCCCCTTCCHHHHHHHHH
T ss_pred cccchhhHhccCCCCCccccccchHHHHHHHh-cCCCCCCCCCHHHHHHHHHc-------CCCCCCCCCCCHHHHHHHHH
Confidence 89999999999999999999999999999993 38999999888777765542 33456678899999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++|||++||++.|++.
T Consensus 245 cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 245 CWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999998888764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-44 Score=344.49 Aligned_cols=201 Identities=19% Similarity=0.239 Sum_probs=176.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+.+..++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++|||||||
T Consensus 95 l~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDI 167 (350)
T d1rdqe_ 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHcCCCcEeecccccccccccccccccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcC
Confidence 57899999999999999999999999999999999999743 46999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+.... ......||
T Consensus 168 KP~NILl~~~g~ikL~DFG~a~~~~~----------------------------------------------~~~~~~Gt 201 (350)
T d1rdqe_ 168 KPENLLIDQQGYIQVTDFGFAKRVKG----------------------------------------------RTWTLCGT 201 (350)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSS----------------------------------------------CBCCCEEC
T ss_pred CHHHcccCCCCCEEeeeceeeeeccc----------------------------------------------ccccccCc
Confidence 99999999999999999999865211 11345688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|||||++.+..++.++|||||||++|||+ +|..||.+.+.......+.. .....+..+++++.++|.+
T Consensus 202 ~~Y~APE~~~~~~~~~~~DiwSlGvilyeml--tG~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMA--AGYPPFFADQPIQIYEKIVS--------GKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------CCCCCCTTCCHHHHHHHHH
T ss_pred cccCCHHHHcCCCCCccccccchhHHHHHHH--hCCCCCCCcCHHHHHHHHhc--------CCCCCCccCCHHHHHHHHH
Confidence 9999999999999999999999999999999 89999999888777766543 1234466789999999999
Q ss_pred hccCCCCCCC-----CHHHH--HHHHHhccc
Q psy5690 241 CWKTNETDRP-----RFSEI--HLFLQRKNL 264 (434)
Q Consensus 241 cl~~dP~~Rp-----s~~el--~~~L~~~~~ 264 (434)
||+.||++|+ +++|+ |+||+..++
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 9999999995 89999 889987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.6e-45 Score=348.64 Aligned_cols=205 Identities=20% Similarity=0.240 Sum_probs=171.5
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|+.++|||||++++++.+++.+|+|||||+||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~-------~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDl 133 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-------HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 133 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh-------cccccHHHHHHHHHHHHHHHHHHHHCCccceee
Confidence 3578999999999999999999999999999999999984 346899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+..... ......||
T Consensus 134 KP~NILl~~~g~iKl~DFGla~~~~~~---------------------------------------------~~~~~~GT 168 (364)
T d1omwa3 134 KPANILLDEHGHVRISDLGLACDFSKK---------------------------------------------KPHASVGT 168 (364)
T ss_dssp SGGGEEECSSSCEEECCCTTCEECSSS---------------------------------------------CCCSCCSC
T ss_pred ccceeEEcCCCcEEEeeeceeeecCCC---------------------------------------------cccccccc
Confidence 999999999999999999998652211 12345789
Q ss_pred ccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++.. ..++.++|||||||++|||+ +|..||.+....+...... .........+..+++++.+||.
T Consensus 169 ~~y~APE~~~~~~~~~~~~DiwSlGvilyeml--tG~~Pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~s~~~~~li~ 241 (364)
T d1omwa3 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL--RGHSPFRQHKTKDKHEIDR-----MTLTMAVELPDSFSPELRSLLE 241 (364)
T ss_dssp GGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH--HSSCSSCSSCSSCHHHHHH-----HSSSCCCCCCSSSCHHHHHHHH
T ss_pred cccchhHHhhcCCCCCcccchhHHHHHHHHHH--hCCCCCCCCCHHHHHHHHH-----hcccCCCCCCCCCCHHHHHHHH
Confidence 99999999975 56899999999999999999 8999998765433222111 1122334456788999999999
Q ss_pred HhccCCCCCCCC-----HHHH--HHHHHhccc
Q psy5690 240 ECWKTNETDRPR-----FSEI--HLFLQRKNL 264 (434)
Q Consensus 240 ~cl~~dP~~Rps-----~~el--~~~L~~~~~ 264 (434)
+||+.||++||| ++|+ |+||+..++
T Consensus 242 ~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 999999999998 7898 899987653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=333.08 Aligned_cols=207 Identities=36% Similarity=0.661 Sum_probs=174.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|+|.+ +..++|||||++|+|.+++..+. ..+++..+..++.||+.||+|||++||+||||
T Consensus 65 l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDi 137 (273)
T d1u46a_ 65 MHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 137 (273)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhccc------CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeee
Confidence 357899999999999965 57889999999999999887432 46999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ..........+|
T Consensus 138 kp~NIll~~~~~vkl~DfGl~~~~~~~~----------------------------------------~~~~~~~~~~~~ 177 (273)
T d1u46a_ 138 AARNLLLATRDLVKIGDFGLMRALPQND----------------------------------------DHYVMQEHRKVP 177 (273)
T ss_dssp CGGGEEEEETTEEEECCCTTCEECCC-C----------------------------------------CEEEC-----CC
T ss_pred cHHHhccccccceeeccchhhhhcccCC----------------------------------------CcceecCccccC
Confidence 9999999999999999999987632221 111122345677
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
..|+|||++.+..++.++|||||||++|||+ + |..||.+.+..+....+.. ....++.+..+++++.+|+.
T Consensus 178 ~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml--t~G~~Pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~l~~li~ 249 (273)
T d1u46a_ 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMF--TYGQEPWIGLNGSQILHKIDK------EGERLPRPEDCPQDIYNVMV 249 (273)
T ss_dssp GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH--TTSCCTTTTCCHHHHHHHHHT------SCCCCCCCTTCCHHHHHHHH
T ss_pred cccCCHHHHhCCCCCcchhhhhhHHHHHHHH--hCCCCCCCCcCHHHHHHHHHh------CCCCCCCcccccHHHHHHHH
Confidence 8899999999999999999999999999999 5 8999999988887766542 23445667788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++|||++||+++|++.
T Consensus 250 ~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 250 QCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=340.10 Aligned_cols=201 Identities=26% Similarity=0.355 Sum_probs=175.8
Q ss_pred CCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q psy5690 3 SLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAA 82 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp 82 (434)
.++|||||++++++.+++..|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp 131 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKL 131 (320)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcc
Confidence 579999999999999999999999999999999999843 4689999999999999999999999999999999
Q ss_pred CCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 83 RNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 83 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
+|||++.++.+||+|||+++...... .......||+.
T Consensus 132 ~NiL~~~~~~~kl~DFG~a~~~~~~~-------------------------------------------~~~~~~~gt~~ 168 (320)
T d1xjda_ 132 DNILLDKDGHIKIADFGMCKENMLGD-------------------------------------------AKTNTFCGTPD 168 (320)
T ss_dssp GGEEECTTSCEEECCCTTCBCCCCTT-------------------------------------------CCBCCCCSCGG
T ss_pred cceeecCCCceeccccchhhhccccc-------------------------------------------ccccccCCCCC
Confidence 99999999999999999986521111 11244578999
Q ss_pred ccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHhc
Q psy5690 163 WMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLECW 242 (434)
Q Consensus 163 y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 242 (434)
|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+.. ..+..+..+++++.+||.+||
T Consensus 169 y~aPE~~~~~~~~~~~DiwSlGvilyeml--tG~~PF~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~dli~~~L 238 (320)
T d1xjda_ 169 YIAPEILLGQKYNHSVDWWSFGVLLYEML--IGQSPFHGQDEEELFHSIRM--------DNPFYPRWLEKEAKDLLVKLF 238 (320)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHH--------CCCCCCTTSCHHHHHHHHHHS
T ss_pred cCCHHHHcCCCCCchhhhhhhhHHHHHHH--hCCCCCCCCCHHHHHHHHHc--------CCCCCCccCCHHHHHHHHHhc
Confidence 99999999999999999999999999999 89999999988887766542 223456678999999999999
Q ss_pred cCCCCCCCCHH-HH--HHHHHhcc
Q psy5690 243 KTNETDRPRFS-EI--HLFLQRKN 263 (434)
Q Consensus 243 ~~dP~~Rps~~-el--~~~L~~~~ 263 (434)
+.||++||++. |+ |+||++.+
T Consensus 239 ~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 239 VREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp CSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ccCCCCCcCHHHHHHhCchhccCC
Confidence 99999999995 77 88998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-44 Score=335.15 Aligned_cols=212 Identities=41% Similarity=0.799 Sum_probs=176.9
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC-----------------CCCCCCCCHHHHHHHHHHH
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN-----------------SQENPAISYGCLIFMATQI 63 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~qi 63 (434)
|++++||||++++++|.+.+..++||||+++|+|.+++...... ......+++..+..++.||
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 46789999999999999999999999999999999999754311 1123458999999999999
Q ss_pred HHHHHHhhhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccc
Q psy5690 64 ASGMKYLESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYC 143 (434)
Q Consensus 64 ~~gL~yLH~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 143 (434)
+.||+|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 150 ~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~----------------------------------- 194 (301)
T d1lufa_ 150 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD----------------------------------- 194 (301)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG-----------------------------------
T ss_pred HHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCc-----------------------------------
Confidence 999999999999999999999999999999999999986532211
Q ss_pred cccCCcccccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcC-CCCCCCCChHHHHHhhhhhhhcCCccc
Q psy5690 144 SHYESDYYLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCN-QRPYAELTNEQVIENCSHWYQNNSKQQ 222 (434)
Q Consensus 144 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 222 (434)
.........+|+.|+|||.+.+..++.++|||||||++|||+ ++ ..||.+.+..+....+.. +.
T Consensus 195 ------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell--~~~~~p~~~~~~~e~~~~v~~-------~~ 259 (301)
T d1lufa_ 195 ------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF--SYGLQPYYGMAHEEVIYYVRD-------GN 259 (301)
T ss_dssp ------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTTCCTTTTSCHHHHHHHHHT-------TC
T ss_pred ------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHH--ccCCCCCCCCCHHHHHHHHHc-------CC
Confidence 111224456788999999999999999999999999999999 55 578998888887766542 33
Q ss_pred CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 223 YLPRPATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 223 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.++.+..+++++.+|+.+||+.||++|||+.||+++|++.
T Consensus 260 ~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 260 ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 4556778999999999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-44 Score=333.41 Aligned_cols=203 Identities=18% Similarity=0.222 Sum_probs=171.7
Q ss_pred CCCC-CCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSLK-DPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++++ |||||++++++.+++..|+|||||++|+|.++++.. ..+++..+..++.||++||+|||++||+||||
T Consensus 64 ~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDl 136 (277)
T d1phka_ 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKLNIVHRDL 136 (277)
T ss_dssp HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCccccc
Confidence 3455 999999999999999999999999999999999743 47999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ......||
T Consensus 137 kp~Nill~~~~~~kl~DFG~a~~~~~~~--------------------------------------------~~~~~~gt 172 (277)
T d1phka_ 137 KPENILLDDDMNIKLTDFGFSCQLDPGE--------------------------------------------KLREVCGT 172 (277)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTC--------------------------------------------CBCCCCSC
T ss_pred ccceEEEcCCCCeEEccchheeEccCCC--------------------------------------------ceeeeecc
Confidence 9999999999999999999976532111 12345688
Q ss_pred ccccchhhhhc------CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHH
Q psy5690 161 IRWMAWESLLL------GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEI 234 (434)
Q Consensus 161 ~~y~aPE~~~~------~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (434)
..|+|||.+.+ ..++.++||||+||++|||+ +|..||.+.+.......+... ......+....+|+++
T Consensus 173 ~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml--~g~~Pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~ 246 (277)
T d1phka_ 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL--AGSPPFWHRKQMLMLRMIMSG----NYQFGSPEWDDYSDTV 246 (277)
T ss_dssp GGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHT----CCCCCTTTGGGSCHHH
T ss_pred CCCCCHHHhhccccccCCCCCchheEcccchhhhhhc--cCCCCCCCCCHHHHHHHHHhC----CCCCCCcccccCCHHH
Confidence 99999999964 34688999999999999999 899999999887776655431 1122233345789999
Q ss_pred HHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 235 FDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 235 ~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
++|+.+||+.||++|||++|+ |+||++
T Consensus 247 ~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 247 KDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 999999999999999999999 788875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=332.33 Aligned_cols=205 Identities=36% Similarity=0.645 Sum_probs=167.6
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|+|. ++..++|||||++|+|..++... ....+++.++..++.||+.||+|||++||+||||
T Consensus 66 l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~Dl 139 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE-----TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 139 (285)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHH-----HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhc-----ccccchHHHHHHHHHHHHHHHHHHhhhheecccc
Confidence 35789999999999985 45689999999999999998643 2346999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........||
T Consensus 140 Kp~NIll~~~~~~kl~DfGla~~~~~~~------------------------------------------~~~~~~~~gt 177 (285)
T d1fmka3 140 RAANILVGENLVCKVADFGLARLIEDNE------------------------------------------YTARQGAKFP 177 (285)
T ss_dssp SGGGEEECGGGCEEECCCCTTC--------------------------------------------------------CC
T ss_pred cceEEEECCCCcEEEcccchhhhccCCC------------------------------------------ceeecccccc
Confidence 9999999999999999999986532211 1122345688
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
+.|+|||++..+.++.++|||||||++|||+ + |.+|+......+....+.. ....+.+..+++++.+++.
T Consensus 178 ~~y~aPE~~~~~~~~~ksDI~S~Giil~el~--t~~~p~~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELT--TKGRVPYPGMVNREVLDQVER-------GYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTTCCSSTTCCHHHHHHHHHT-------TCCCCCCTTSCHHHHHHHH
T ss_pred ccccChHHHhCCCCCcHHhhhcchHHHHHHH--hCCCCCCCCCCHHHHHHHHHh-------cCCCCCCcccCHHHHHHHH
Confidence 9999999999999999999999999999999 5 4556666666666655432 2345567889999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++||++++|+++|++.
T Consensus 249 ~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 249 QCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHTT
T ss_pred HHcccCHhHCcCHHHHHHHHhhh
Confidence 99999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=329.42 Aligned_cols=203 Identities=31% Similarity=0.612 Sum_probs=168.8
Q ss_pred CCCCCCCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++|||||+++|+|.+ .+.+++||||+++|+|.+++.+.+ ...+++..++.++.||+.||.|||+++|+|||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~d 128 (262)
T d1byga_ 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128 (262)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHhhccccccCceeccc
Confidence 478999999999999854 467899999999999999997432 23589999999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||++.++.+|++|||+++.... ......+
T Consensus 129 lkp~Nil~~~~~~~kl~dfg~s~~~~~----------------------------------------------~~~~~~~ 162 (262)
T d1byga_ 129 LAARNVLVSEDNVAKVSDFGLTKEASS----------------------------------------------TQDTGKL 162 (262)
T ss_dssp CSGGGEEECTTSCEEECCCCC----------------------------------------------------------C
T ss_pred cchHhheecCCCCEeecccccceecCC----------------------------------------------CCccccc
Confidence 999999999999999999999764211 1123356
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLML 239 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 239 (434)
|..|+|||++.+..++.++|||||||++|||++ .|..||...+..+....+. .+.+++.+..+++++.+|+.
T Consensus 163 ~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t-~~~~p~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS-FGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT-TSCCSCTTSCGGGHHHHHT-------TTCCCCCCTTCCHHHHHHHH
T ss_pred cccCCChHHHhCCCCChHHHHHhHHHHHHHHHH-CCCCCCCCCCHHHHHHHHH-------cCCCCCCCccCCHHHHHHHH
Confidence 778999999999999999999999999999993 2788998888777766653 23455667788999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHhc
Q psy5690 240 ECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 240 ~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||+.||++|||+.+|++.|++.
T Consensus 235 ~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHHHHHH
Confidence 99999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=329.02 Aligned_cols=209 Identities=34% Similarity=0.652 Sum_probs=177.0
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
+|||||+++++|.+++..++|||||++|+|.+++..+... ......+++..++.++.||+.||+|||+++|
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i 156 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 156 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence 7999999999999999999999999999999999755321 1234568999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+||+|||+++...... ......
T Consensus 157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~-----------------------------------------~~~~~~ 195 (299)
T d1fgka_ 157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----------------------------------------YYKKTT 195 (299)
T ss_dssp CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCC-----------------------------------------TTCCCT
T ss_pred EeeeecccceeecCCCCeEeccchhhccccccc-----------------------------------------cccccc
Confidence 999999999999999999999999976532211 111224
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHH
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIF 235 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (434)
...+|+.|+|||.+.++.|+.++|||||||++|||++ .|..||.+.+..+....+. .+..++.+..+++++.
T Consensus 196 ~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~-~g~~p~~~~~~~~~~~~i~-------~~~~~~~p~~~~~~l~ 267 (299)
T d1fgka_ 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-LGGSPYPGVPVEELFKLLK-------EGHRMDKPSNCTNELY 267 (299)
T ss_dssp TSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT-TSCCSSTTCCHHHHHHHHH-------TTCCCCCCSSCCHHHH
T ss_pred cCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhcc-CCCCCCCCCCHHHHHHHHH-------cCCCCCCCccchHHHH
Confidence 4567889999999999999999999999999999993 2789999888877765543 2344566778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 236 DLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 236 ~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+||.+||+.||++|||+.||++.|++.
T Consensus 268 ~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 268 MMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-44 Score=335.98 Aligned_cols=206 Identities=32% Similarity=0.648 Sum_probs=170.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||+++|+|.++ ..++++||+.+|+|.+++.. ....+++..++.++.||+.||+|||++||+||||
T Consensus 65 l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDl 137 (317)
T d1xkka_ 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 137 (317)
T ss_dssp HHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH------TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccc------cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcc
Confidence 3578999999999999764 67888999999999998874 3457899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .........||
T Consensus 138 Kp~NIll~~~~~~kl~DFGla~~~~~~~-----------------------------------------~~~~~~~~~gt 176 (317)
T d1xkka_ 138 AARNVLVKTPQHVKITDFGLAKLLGAEE-----------------------------------------KEYHAEGGKVP 176 (317)
T ss_dssp CGGGEEEEETTEEEECCCSHHHHTTTTC-----------------------------------------C--------CC
T ss_pred hhhcceeCCCCCeEeeccccceeccccc-----------------------------------------ccccccccccC
Confidence 9999999999999999999987632211 11112334678
Q ss_pred ccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHH
Q psy5690 161 IRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLE 240 (434)
Q Consensus 161 ~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 240 (434)
+.|+|||++.++.++.++|||||||++|||+| .|..||.+.+..+....+.. +.+++.+..+++++.+|+.+
T Consensus 177 ~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t-~g~~p~~~~~~~~~~~~i~~-------~~~~~~p~~~~~~~~~li~~ 248 (317)
T d1xkka_ 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMT-FGSKPYDGIPASEISSILEK-------GERLPQPPICTIDVYMIMVK 248 (317)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT-TSCCTTTTSCGGGHHHHHHH-------TCCCCCCTTBCHHHHHHHHH
T ss_pred ccccChHHHhcCCCChhhhhhhHHHHHHHHHH-CCCCCCCCCCHHHHHHHHHc-------CCCCCCCcccCHHHHHHHHH
Confidence 99999999999999999999999999999994 28999998887776654432 34456678899999999999
Q ss_pred hccCCCCCCCCHHHHHHHHHhc
Q psy5690 241 CWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 241 cl~~dP~~Rps~~el~~~L~~~ 262 (434)
||+.||++|||+.||+..|++.
T Consensus 249 cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 249 CWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCChhhCcCHHHHHHHHHHH
Confidence 9999999999999998777654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=333.67 Aligned_cols=210 Identities=15% Similarity=0.200 Sum_probs=169.7
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..|+|||||.+|++..+.. ....+++..+..++.||+.||+|||++||+||||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~-------~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDi 126 (299)
T d1ua2a_ 54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD-------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDL 126 (299)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTT-------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhh-------cccCCCHHHHHHHHHHHHHHHHHhhccceecccC
Confidence 356899999999999999999999999999877766654 4567999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... .......||
T Consensus 127 Kp~NIli~~~~~~KL~DFG~a~~~~~~~-------------------------------------------~~~~~~~gt 163 (299)
T d1ua2a_ 127 KPNNLLLDENGVLKLADFGLAKSFGSPN-------------------------------------------RAYTHQVVT 163 (299)
T ss_dssp CGGGEEECTTCCEEECCCGGGSTTTSCC-------------------------------------------CCCCCSCCC
T ss_pred CcceEEecCCCccccccCccccccCCCc-------------------------------------------ccccceecC
Confidence 9999999999999999999976522211 112345688
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc---------------cCC
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ---------------QYL 224 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------------~~~ 224 (434)
+.|+|||++.+. .++.++|||||||++|||+ +|..||.+.+..+....+.+........ ...
T Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~--~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELL--LRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp CTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred hhhccHHHHccCCCCChhhhhhhcchHHHHHH--hCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 999999998755 5799999999999999999 8899999988877766554322111000 000
Q ss_pred CC-----CCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 225 PR-----PATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 225 ~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.. ....++++.+|+.+||+.||++|||++|+ |+||++.
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 00 13467899999999999999999999999 7899764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=341.69 Aligned_cols=209 Identities=21% Similarity=0.274 Sum_probs=164.5
Q ss_pred CCCCCeeeEEEEEec----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 4 LKDPNLVRVIGVCST----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 4 L~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
++|||||+++++|++ +..+|+|||||+||+|.+++.++ ....+++.++..++.||+.||+|||++||+|||
T Consensus 62 ~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~-----~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRD 136 (335)
T d2ozaa1 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-----GDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 136 (335)
T ss_dssp TTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC-----SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred cCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc-----CCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccc
Confidence 589999999999875 46689999999999999999732 235799999999999999999999999999999
Q ss_pred CCCCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 80 LAARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 80 lkp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
|||+|||++. ++.+||+|||+|+...... ....
T Consensus 137 iKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~--------------------------------------------~~~~ 172 (335)
T d2ozaa1 137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHN--------------------------------------------SLTT 172 (335)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEECCCCC--------------------------------------------CCCC
T ss_pred ccccccccccccccccccccccceeeeccCCC--------------------------------------------cccc
Confidence 9999999975 5679999999986532111 1244
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..||+.|+|||++.+..|+.++|||||||++|+|+ +|..||.+.+..+....+.............+....+++++.+
T Consensus 173 ~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll--tg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 250 (335)
T d2ozaa1 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL--CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250 (335)
T ss_dssp CSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT--TSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHH
T ss_pred ccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHh--hCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHH
Confidence 57899999999999999999999999999999999 8999998776554443322211111111111112357889999
Q ss_pred HHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 237 LMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 237 li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
||.+||+.||++|||+.|+ |+|+.+..
T Consensus 251 li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 251 LIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 9999999999999999999 78997643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=330.14 Aligned_cols=210 Identities=37% Similarity=0.710 Sum_probs=176.1
Q ss_pred CCCC-CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccC---------CCCCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5690 1 MCSL-KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNC---------NSQENPAISYGCLIFMATQIASGMKYL 70 (434)
Q Consensus 1 l~~L-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~~~~~l~~~~~~~i~~qi~~gL~yL 70 (434)
|+++ +|||||+++|+|.+++..++||||+++|+|.++++.... .......+++..+..++.||+.||.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 4567 799999999999999999999999999999999974310 012346799999999999999999999
Q ss_pred hhCCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcc
Q psy5690 71 ESRDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDY 150 (434)
Q Consensus 71 H~~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 150 (434)
|+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 144 H~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~------------------------------------------- 180 (309)
T d1fvra_ 144 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------------------------------------------- 180 (309)
T ss_dssp HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-------------------------------------------
T ss_pred hcCCccccccccceEEEcCCCceEEcccccccccccc-------------------------------------------
Confidence 9999999999999999999999999999997652111
Q ss_pred cccCCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhc-CCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCc
Q psy5690 151 YLSDTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHC-NQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPAT 229 (434)
Q Consensus 151 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (434)
.......||..|+|||.+.++.++.++|||||||++|||+ + +..||.+.+..+....+.. +.+++.+..
T Consensus 181 -~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell--~~~~~p~~~~~~~~~~~~i~~-------~~~~~~~~~ 250 (309)
T d1fvra_ 181 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV--SLGGTPYCGMTCAELYEKLPQ-------GYRLEKPLN 250 (309)
T ss_dssp -CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH--TTSCCTTTTCCHHHHHHHGGG-------TCCCCCCTT
T ss_pred -ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHH--hcCCCCCCCCCHHHHHHHHHh-------cCCCCCCcc
Confidence 1123446788999999999999999999999999999999 5 4568988888887766543 234566778
Q ss_pred cHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 230 CQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 230 ~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
+++++.+||.+||+.||++|||++||++.|++..
T Consensus 251 ~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 251 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 9999999999999999999999999998888753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=329.35 Aligned_cols=211 Identities=33% Similarity=0.623 Sum_probs=163.8
Q ss_pred CCCCCeeeEEEEEecC-CceEEEEecCCCCCHHHHHhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 4 LKDPNLVRVIGVCSTE-DPISTIQEYCEFGDLSTFLQIHNCN---------SQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
.+|+|||++++++..+ +..++|||||++|+|.++++..+.. ......+++..+..++.||++||+|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3799999999998654 5689999999999999999754321 01234589999999999999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 154 ~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~-----------------------------------------~~~~ 192 (299)
T d1ywna1 154 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----------------------------------------DYVR 192 (299)
T ss_dssp TCCCSCCCGGGEEECGGGCEEECC------CCSCT-----------------------------------------TSCC
T ss_pred CCcCCcCCccceeECCCCcEEEccCcchhhccccc-----------------------------------------cccc
Confidence 99999999999999999999999999986532211 1112
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
.....||+.|+|||++.+..++.++|||||||++|||++ .+..||......+...... ..+..++.+..++++
T Consensus 193 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt-~~~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 265 (299)
T d1ywna1 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-LGASPYPGVKIDEEFCRRL------KEGTRMRAPDYTTPE 265 (299)
T ss_dssp TTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT-TSCCSSTTCCCSHHHHHHH------HHTCCCCCCTTCCHH
T ss_pred cCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHh-CCCCCCCCCCHHHHHHHHH------hcCCCCCCCccCCHH
Confidence 245678999999999999999999999999999999993 1467887766544332221 123345567788999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.++|.+||+.||++|||++||++.|++.
T Consensus 266 l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 266 MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999888764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=335.73 Aligned_cols=206 Identities=18% Similarity=0.188 Sum_probs=172.0
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++++++.+|+|||||+||+|.+++.. ....+++.++..++.||+.||+|||++||+||||
T Consensus 55 l~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~------~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDl 128 (321)
T d1tkia_ 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT------SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccc
Confidence 3568999999999999999999999999999999999972 2246999999999999999999999999999999
Q ss_pred CCCCeeeecC--CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCC
Q psy5690 81 AARNCMVGKN--YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKAR 158 (434)
Q Consensus 81 kp~NILl~~~--~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~ 158 (434)
||+|||++.+ ..+||+|||+++...... ......
T Consensus 129 Kp~NIll~~~~~~~ikl~DFG~~~~~~~~~--------------------------------------------~~~~~~ 164 (321)
T d1tkia_ 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD--------------------------------------------NFRLLF 164 (321)
T ss_dssp CGGGEEESSSSCCCEEECCCTTCEECCTTC--------------------------------------------EEEEEE
T ss_pred cccceeecCCCceEEEEcccchhhccccCC--------------------------------------------cccccc
Confidence 9999999854 589999999976532111 112345
Q ss_pred CCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 159 LPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 159 gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
+|+.|+|||.+.+..++.++||||+||++|+|+ +|..||.+.+..+....+..... .........+++++.+|+
T Consensus 165 ~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll--~G~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL--SGINPFLAETNQQIIENIMNAEY----TFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp SCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH--HSSCTTCCSSHHHHHHHHHHTCC----CCCHHHHTTSCHHHHHHH
T ss_pred cccccccchhccCCCCCchhhcccHHHHHHHHH--hCCCCCCCCCHHHHHHHHHhCCC----CCChhhccCCCHHHHHHH
Confidence 678899999999999999999999999999999 89999999988887776643210 001111235788999999
Q ss_pred HHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.+||+.||++|||++|+ |+||++.
T Consensus 239 ~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999 7899864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-43 Score=323.34 Aligned_cols=208 Identities=17% Similarity=0.232 Sum_probs=163.4
Q ss_pred CCCCCCCCeeeEEEEEecCCc----eEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDP----ISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
|++++|||||++++++...+. .|+|||||+||+|.+++... ..+++.++..++.||+.||+|||++||+
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~ii 133 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNGII 133 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 457899999999999976543 89999999999999999743 4799999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+|||++.++..+++|||.++...... ........
T Consensus 134 HrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~----------------------------------------~~~~~~~~ 173 (277)
T d1o6ya_ 134 HRDVKPANIMISATNAVKVMDFGIARAIADSG----------------------------------------NSVTQTAA 173 (277)
T ss_dssp CCCCSGGGEEEETTSCEEECCCTTCEECC---------------------------------------------------
T ss_pred CccccCcccccCccccceeehhhhhhhhcccc----------------------------------------cccccccc
Confidence 99999999999999999999999865421111 11112345
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFD 236 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (434)
..||+.|+|||++.+..++.++|||||||++|||+ +|..||.+.+..+....+... ...........+|+++.+
T Consensus 174 ~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyell--tG~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~l~~ 247 (277)
T d1o6ya_ 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL--TGEPPFTGDSPVSVAYQHVRE----DPIPPSARHEGLSADLDA 247 (277)
T ss_dssp -----TTCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHC----CCCCGGGTSSSCCHHHHH
T ss_pred ccCcccccCHHHHcCCCCCcceecccchHHHHHHH--hCCCCCCCcCHHHHHHHHHhc----CCCCCchhccCCCHHHHH
Confidence 67899999999999999999999999999999999 899999988877765544321 111111234578899999
Q ss_pred HHHHhccCCCCCCC-CHHHHHHHHHh
Q psy5690 237 LMLECWKTNETDRP-RFSEIHLFLQR 261 (434)
Q Consensus 237 li~~cl~~dP~~Rp-s~~el~~~L~~ 261 (434)
+|.+||+.||++|| |++++...|.+
T Consensus 248 li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 248 VVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999 89999555544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=323.54 Aligned_cols=213 Identities=42% Similarity=0.676 Sum_probs=179.3
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN---SQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~---~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
|++++|||||+++|+|..++..++|||||++|+|.+++...... ......+++..+..++.|+++||.|||+++|+|
T Consensus 77 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivH 156 (308)
T d1p4oa_ 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 156 (308)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 46899999999999999999999999999999999998743211 112345788999999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+|||++.++++||+|||+++...... ........
T Consensus 157 rDlk~~NiLld~~~~~Kl~DFGla~~~~~~~-----------------------------------------~~~~~~~~ 195 (308)
T d1p4oa_ 157 RDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----------------------------------------YYRKGGKG 195 (308)
T ss_dssp SCCSGGGEEECTTCCEEECCTTCCCGGGGGG-----------------------------------------CEEGGGSS
T ss_pred ceEcCCceeecCCceEEEeecccceeccCCc-----------------------------------------ceeeccce
Confidence 9999999999999999999999987532221 11122345
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.+|+.|+|||.+.+..++.++|||||||++|||+++ +..||.+.+..+....+.. +..++.+..+++++.++
T Consensus 196 ~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~-~~~p~~~~~~~~~~~~i~~-------~~~~~~p~~~~~~l~~l 267 (308)
T d1p4oa_ 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL-AEQPYQGLSNEQVLRFVME-------GGLLDKPDNCPDMLFEL 267 (308)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT-SCCTTTTSCHHHHHHHHHT-------TCCCCCCTTCCHHHHHH
T ss_pred ecccccCCHHHHccCCCCcccccccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHh-------CCCCCCcccchHHHHHH
Confidence 678999999999999999999999999999999942 4689999888887766542 33456677899999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
|.+||+.||++|||+++|++.|++.
T Consensus 268 i~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 268 MRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=323.71 Aligned_cols=210 Identities=30% Similarity=0.608 Sum_probs=172.9
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCN-----------SQENPAISYGCLIFMATQIASGMKYLESR 73 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~~~l~~~~~~~i~~qi~~gL~yLH~~ 73 (434)
+|||||+++|+|.+++..++|||||++|+|.+++++.... ......+++..+..++.||+.||+|||++
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 6999999999999999999999999999999999865421 11234689999999999999999999999
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|++||||||+||+++.++.+|++|||+++...... ....
T Consensus 165 ~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~-----------------------------------------~~~~ 203 (311)
T d1t46a_ 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS-----------------------------------------NYVV 203 (311)
T ss_dssp TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCT-----------------------------------------TSEE
T ss_pred CeeecccccccccccccCcccccccchheeccCCC-----------------------------------------cceE
Confidence 99999999999999999999999999987532211 1122
Q ss_pred CCCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 154 DTKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
.....||+.|+|||++.+..++.++|||||||++|||++ .|.+||...+..+....+.. .+..+..+..++++
T Consensus 204 ~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt-~g~p~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~ 276 (311)
T d1t46a_ 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-LGSSPYPGMPVDSKFYKMIK------EGFRMLSPEHAPAE 276 (311)
T ss_dssp CSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT-TTCCSSTTCCSSHHHHHHHH------HTCCCCCCTTSCHH
T ss_pred eeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHh-CCCCCCCCCCHHHHHHHHHh------cCCCCCCcccccHH
Confidence 345678899999999999999999999999999999993 26777777666555443322 22344556778899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+||.+||+.||++|||++||++.|++.
T Consensus 277 l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 277 MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 99999999999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=323.03 Aligned_cols=208 Identities=36% Similarity=0.653 Sum_probs=168.4
Q ss_pred CCCCCCCCeeeEEEEEec-CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q psy5690 1 MCSLKDPNLVRVIGVCST-EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRD 79 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrD 79 (434)
|++++|||||+++|++.+ ++..++|||||++|+|.+++.. .....++..+..++.|++.||.|||+.+|+|||
T Consensus 82 l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~------~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrD 155 (311)
T d1r0pa_ 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRD 155 (311)
T ss_dssp HHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc------ccccchHHHHHHHHHHHHHhhhhhcccCcccCC
Confidence 468999999999999865 5679999999999999999873 335677889999999999999999999999999
Q ss_pred CCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCC
Q psy5690 80 LAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARL 159 (434)
Q Consensus 80 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~g 159 (434)
|||+|||+++++.+||+|||+++....... ..........|
T Consensus 156 LK~~NILl~~~~~~kL~DFG~~~~~~~~~~---------------------------------------~~~~~~~~~~g 196 (311)
T d1r0pa_ 156 LAARNCMLDEKFTVKVADFGLARDMYDKEF---------------------------------------DSVHNKTGAKL 196 (311)
T ss_dssp CSGGGEEECTTCCEEECSSGGGCCTTTTTC---------------------------------------CCTTCTTCSSC
T ss_pred ccHHhEeECCCCCEEEecccchhhcccccc---------------------------------------ccceecccccc
Confidence 999999999999999999999876332211 01112234578
Q ss_pred CccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCC-hHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 160 PIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELT-NEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 160 t~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
|..|+|||.+..+.++.++||||||+++|||+ +|..||.... ..+....+. .+.++..+..+++++.+||
T Consensus 197 t~~y~aPE~~~~~~~~~ksDI~SfGivl~El~--t~~~p~~~~~~~~~~~~~i~-------~g~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELM--TRGAPPYPDVNTFDITVYLL-------QGRRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH--TTSCCSCC------CHHHHH-------TTCCCCCCTTCCHHHHHHH
T ss_pred cccccChHHHhcCCCCChhHhhhhHHHHHHHH--HCCCCCCCCCCHHHHHHHHH-------cCCCCCCcccCcHHHHHHH
Confidence 89999999999999999999999999999999 6666665433 333333222 2234556778899999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 239 LECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 239 ~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
.+||+.||++||++.||++.|++.
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHH
Confidence 999999999999999999999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-42 Score=319.58 Aligned_cols=212 Identities=18% Similarity=0.249 Sum_probs=167.8
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..|+||||+.+ ++.+++... ....+++..+..++.||+.||+|||++|||||||
T Consensus 55 l~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~-----~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDi 128 (298)
T d1gz8a_ 55 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDAS-----ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128 (298)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHT-----TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhcCCEEcccc
Confidence 5789999999999999999999999999976 555555422 3456999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+|+...... .......||
T Consensus 129 KpeNIl~~~~~~~kl~DFG~a~~~~~~~-------------------------------------------~~~~~~~gt 165 (298)
T d1gz8a_ 129 KPQNLLINTEGAIKLADFGLARAFGVPV-------------------------------------------RTYTHEVVT 165 (298)
T ss_dssp CGGGEEECTTSCEEECSTTHHHHHCCCS-------------------------------------------BCTTCCBCC
T ss_pred CchheeecccCcceeccCCcceeccCCc-------------------------------------------ccceeeccc
Confidence 9999999999999999999986532111 112345688
Q ss_pred ccccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcc------------cCC---
Q psy5690 161 IRWMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQ------------QYL--- 224 (434)
Q Consensus 161 ~~y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------~~~--- 224 (434)
+.|+|||.+....+ +.++||||+||++|+|+ +|+.||.+.+..+....+.......... ...
T Consensus 166 ~~y~apE~~~~~~~~~~~~DiwSlGvily~m~--~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T d1gz8a_ 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV--TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243 (298)
T ss_dssp CTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCC
T ss_pred ceeeehhhhccccCCCccccccccchhhhHHh--hCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccc
Confidence 99999999887664 88999999999999999 8999999887766554433211110000 000
Q ss_pred ------CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 225 ------PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 225 ------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
.....+++++.+|+.+||+.||++|||++|+ |+||++..
T Consensus 244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 0012467889999999999999999999999 78998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=320.82 Aligned_cols=190 Identities=19% Similarity=0.262 Sum_probs=159.2
Q ss_pred CCCCeeeEEEEEecCCceEEEEecCCC-CCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q psy5690 5 KDPNLVRVIGVCSTEDPISTIQEYCEF-GDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLAAR 83 (434)
Q Consensus 5 ~HpnIv~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlkp~ 83 (434)
.|||||++++++.+++..++||||+.+ +++.+++.. ...+++..++.++.||++||+|||++||+||||||+
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-------~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~ 139 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 139 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCccc
Confidence 399999999999999999999999976 688888873 357999999999999999999999999999999999
Q ss_pred CeeeecC-CceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCCcc
Q psy5690 84 NCMVGKN-YTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIR 162 (434)
Q Consensus 84 NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt~~ 162 (434)
|||++.+ +.+||+|||+|+..... ......||+.
T Consensus 140 NIll~~~~~~vkl~DFG~a~~~~~~---------------------------------------------~~~~~~GT~~ 174 (273)
T d1xwsa_ 140 NILIDLNRGELKLIDFGSGALLKDT---------------------------------------------VYTDFDGTRV 174 (273)
T ss_dssp GEEEETTTTEEEECCCTTCEECCSS---------------------------------------------CBCCCCSCGG
T ss_pred ceEEecCCCeEEECccccceecccc---------------------------------------------cccccccCCC
Confidence 9999854 79999999997642111 1134578999
Q ss_pred ccchhhhhcCCC-CCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHHHHh
Q psy5690 163 WMAWESLLLGKN-TTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLMLEC 241 (434)
Q Consensus 163 y~aPE~~~~~~~-s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 241 (434)
|+|||++.+..+ +.++||||+||++|||+ +|..||.... +... .....+..+++++.+|+.+|
T Consensus 175 y~aPE~~~~~~~~~~~~DiwSlGvilyell--~g~~Pf~~~~--~i~~------------~~~~~~~~~s~~~~~li~~~ 238 (273)
T d1xwsa_ 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMV--CGDIPFEHDE--EIIR------------GQVFFRQRVSSECQHLIRWC 238 (273)
T ss_dssp GSCHHHHHHSCBCHHHHHHHHHHHHHHHHH--HSSCSCCSHH--HHHH------------CCCCCSSCCCHHHHHHHHHH
T ss_pred cCCHHHHcCCCCCCcccccccceeeehhHh--hCCCCCCCch--HHhh------------cccCCCCCCCHHHHHHHHHH
Confidence 999999987765 67799999999999999 8999997632 2211 11233567889999999999
Q ss_pred ccCCCCCCCCHHHH--HHHHHhc
Q psy5690 242 WKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 242 l~~dP~~Rps~~el--~~~L~~~ 262 (434)
|+.||++|||++|+ |+||++.
T Consensus 239 L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 239 LALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp TCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999 7798763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=320.10 Aligned_cols=208 Identities=21% Similarity=0.279 Sum_probs=168.2
Q ss_pred CCCCCCeeeEEEEEec-----CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q psy5690 3 SLKDPNLVRVIGVCST-----EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVH 77 (434)
Q Consensus 3 ~L~HpnIv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiH 77 (434)
.++||||++++++|.. ....+++|||+.+|++..... .....+++..++.++.|++.||+|||++||+|
T Consensus 66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivH 139 (305)
T d1blxa_ 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK------VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVH 139 (305)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH------SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence 3589999999999853 346899999998877765554 14467899999999999999999999999999
Q ss_pred cCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 78 RDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 78 rDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
|||||+|||++.++.+||+|||+++..... ......
T Consensus 140 rDiKp~NILi~~~~~~kl~dfg~~~~~~~~--------------------------------------------~~~~~~ 175 (305)
T d1blxa_ 140 RDLKPQNILVTSSGQIKLADFGLARIYSFQ--------------------------------------------MALTSV 175 (305)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCGG--------------------------------------------GGGCCC
T ss_pred cCCCccEEEEcCCCCeeecchhhhhhhccc--------------------------------------------ccCCCc
Confidence 999999999999999999999986542111 122456
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC-------------------
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN------------------- 218 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 218 (434)
.||+.|+|||++.+..|+.++||||+||++|||+ +|..||.+.+..+....+.......
T Consensus 176 ~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (305)
T d1blxa_ 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 253 (305)
T ss_dssp CCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCC
T ss_pred ccChhhcCcchhcCCCCChhehhhchHHHHHHHH--HCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccc
Confidence 7899999999999999999999999999999999 8999999988777665544321110
Q ss_pred CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 219 SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 219 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
...........+++++.+|+.+||+.||++|||++|+ |+||++.
T Consensus 254 ~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 254 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0011112245678899999999999999999999999 8899875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.3e-41 Score=313.36 Aligned_cols=209 Identities=16% Similarity=0.201 Sum_probs=166.1
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++|||||++++++.+++..++++||+.++.+..+.+ ....+++..+..++.||+.||+|||++||+||||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDi 126 (286)
T d1ob3a_ 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV-------CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126 (286)
T ss_dssp GGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHT-------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHh-------hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCC
Confidence 578999999999999999999999999998877776665 4567999999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+|++|||.+.....+. .......++
T Consensus 127 Kp~NIll~~~~~~kl~DfG~a~~~~~~~-------------------------------------------~~~~~~~~~ 163 (286)
T d1ob3a_ 127 KPQNLLINREGELKIADFGLARAFGIPV-------------------------------------------RKYTHEIVT 163 (286)
T ss_dssp CGGGEEECTTSCEEECCTTHHHHHCC----------------------------------------------------CC
T ss_pred CCceeeEcCCCCEEecccccceecccCc-------------------------------------------cccceeccc
Confidence 9999999999999999999976532211 011334577
Q ss_pred ccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcC---------------------
Q psy5690 161 IRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNN--------------------- 218 (434)
Q Consensus 161 ~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------- 218 (434)
+.|+|||.+.+. .++.++|||||||++|||+ +|+.||.+.+..+...++.......
T Consensus 164 ~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~--~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T d1ob3a_ 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV--NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241 (286)
T ss_dssp CTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred chhhhHHHHhCCCCCCcceeehhcCcHHHHHH--HCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccc
Confidence 889999999765 4589999999999999999 8999999887766655443211100
Q ss_pred CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 219 SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 219 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
...........+++++.+|+.+||+.||++|||++|+ |+||++
T Consensus 242 ~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0000111234577899999999999999999999999 688864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-41 Score=313.23 Aligned_cols=212 Identities=22% Similarity=0.291 Sum_probs=157.4
Q ss_pred CCCCCCCCeeeEEEEEecCC----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh----
Q psy5690 1 MCSLKDPNLVRVIGVCSTED----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES---- 72 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~---- 72 (434)
+++++|||||+++|+|.+++ .+|+|||||++|+|.+++++ ..+++..++.++.|++.||+|||+
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------~~l~~~~~~~~~~~ia~gl~~lH~~~~~ 122 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 46789999999999997654 58999999999999999973 258999999999999999999996
Q ss_pred ----CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCC
Q psy5690 73 ----RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYES 148 (434)
Q Consensus 73 ----~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 148 (434)
+||+||||||+|||++.++.+||+|||+++.......
T Consensus 123 ~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~--------------------------------------- 163 (303)
T d1vjya_ 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD--------------------------------------- 163 (303)
T ss_dssp TTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT---------------------------------------
T ss_pred hccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc---------------------------------------
Confidence 5999999999999999999999999999775322110
Q ss_pred cccccCCCCCCCccccchhhhhcCC------CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-----------HHHhh
Q psy5690 149 DYYLSDTKARLPIRWMAWESLLLGK------NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-----------VIENC 211 (434)
Q Consensus 149 ~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-----------~~~~~ 211 (434)
..........||+.|+|||++.+.. ++.++|||||||++|||+ +|..||......+ ....+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~--tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA--RRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH--HTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh--hCCCCCCcccccccchhhcccccchHHHH
Confidence 0111223467899999999987653 467899999999999999 6766653221100 00001
Q ss_pred hhhhhcCCcccCCCCC-----CccHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhcc
Q psy5690 212 SHWYQNNSKQQYLPRP-----ATCQKEIFDLMLECWKTNETDRPRFSEIHLFLQRKN 263 (434)
Q Consensus 212 ~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~~~ 263 (434)
..... ....+++.+ ......+.+|+.+||+.||++|||+.||++.|++..
T Consensus 242 ~~~~~--~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 242 RKVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHT--TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHh--ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11011 111122222 224467999999999999999999999999888753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=312.35 Aligned_cols=212 Identities=17% Similarity=0.134 Sum_probs=162.4
Q ss_pred CCCCCCCCeeeEEEEEecC------CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTE------DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++|||||+++++|... ..+++|||||++|.+..+..... ....+++..++.++.||+.||+|||++|
T Consensus 67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~~ 142 (350)
T d1q5ka_ 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSFG 142 (350)
T ss_dssp HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhh----ccCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 3578999999999998543 34789999998754333332111 4567999999999999999999999999
Q ss_pred ccccCCCCCCeeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCccccc
Q psy5690 75 IVHRDLAARNCMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLS 153 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 153 (434)
|+||||||+|||++.++ .+||+|||+++...... .
T Consensus 143 IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~--------------------------------------------~ 178 (350)
T d1q5ka_ 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--------------------------------------------P 178 (350)
T ss_dssp EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS--------------------------------------------C
T ss_pred CcccCCCcceEEEecCCCceeEecccchhhccCCc--------------------------------------------c
Confidence 99999999999999775 89999999976532111 1
Q ss_pred CCCCCCCccccchhhhhc-CCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc---------------
Q psy5690 154 DTKARLPIRWMAWESLLL-GKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN--------------- 217 (434)
Q Consensus 154 ~~~~~gt~~y~aPE~~~~-~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~--------------- 217 (434)
.....||..|+|||.+.+ ..++.++||||+||++|||+ +|..||...+..+....+......
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~--~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 256 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL--LGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH--HTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehh--hCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence 134568889999998875 46899999999999999999 899999988776655444321100
Q ss_pred CCccc------CCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 218 NSKQQ------YLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 218 ~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
..... .......+++++.+|+.+||+.||++|||+.|+ |+||++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00000 001123567899999999999999999999999 7899875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=312.08 Aligned_cols=206 Identities=16% Similarity=0.261 Sum_probs=165.5
Q ss_pred CCCCCCCCeeeEEEEEecCC------ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTED------PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRD 74 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ 74 (434)
|++++|||||+++++|...+ .+|+||||| +++|..+++. ..+++..++.++.||+.||+|||++|
T Consensus 71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~ 141 (346)
T d1cm8a_ 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAAG 141 (346)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 45789999999999997654 479999999 6688887752 36999999999999999999999999
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
|+||||||+|||++.++.+|++|||+|+.... ..
T Consensus 142 IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~----------------------------------------------~~ 175 (346)
T d1cm8a_ 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADS----------------------------------------------EM 175 (346)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEECCS----------------------------------------------SC
T ss_pred CcccccCcchhhcccccccccccccceeccCC----------------------------------------------cc
Confidence 99999999999999999999999999765211 11
Q ss_pred CCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc----------------
Q psy5690 155 TKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN---------------- 217 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 217 (434)
+...||+.|+|||++.+. .++.++||||+||++|||+ +|..||.+.+.......+......
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (346)
T d1cm8a_ 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI--TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253 (346)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHH--HCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence 345688899999999865 4689999999999999999 899999988766554433221100
Q ss_pred -------CCcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 218 -------NSKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 218 -------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
............+++++.+||.+||..||++|||++|+ |+||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 01111112234567899999999999999999999999 78998753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=310.95 Aligned_cols=207 Identities=21% Similarity=0.262 Sum_probs=167.5
Q ss_pred CCCCC-CCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++++| |||+++++++.+.+..+++|||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||
T Consensus 83 ~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDi 155 (322)
T d1vzoa_ 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 155 (322)
T ss_dssp HHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhhcCCEEeccC
Confidence 45656 89999999999999999999999999999999843 46788999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||+++...... ........|+
T Consensus 156 Kp~Nill~~~~~vkL~DFG~a~~~~~~~------------------------------------------~~~~~~~~g~ 193 (322)
T d1vzoa_ 156 KLENILLDSNGHVVLTDFGLSKEFVADE------------------------------------------TERAYDFCGT 193 (322)
T ss_dssp CGGGEEECTTSCEEESCSSEEEECCGGG------------------------------------------GGGGCGGGSC
T ss_pred CccceeecCCCCEEEeeccchhhhcccc------------------------------------------cccccccccc
Confidence 9999999999999999999986532211 0112334677
Q ss_pred ccccchhhhhcC--CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHHH
Q psy5690 161 IRWMAWESLLLG--KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDLM 238 (434)
Q Consensus 161 ~~y~aPE~~~~~--~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (434)
+.|+|||.+.+. .++.++|||||||++|||+ +|..||......+....+.... .....+.+..+++++.+|+
T Consensus 194 ~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyell--tG~~PF~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li 267 (322)
T d1vzoa_ 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL--TGASPFTVDGEKNSQAEISRRI----LKSEPPYPQEMSALAKDLI 267 (322)
T ss_dssp CTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH--HSSCTTSCTTSCCCHHHHHHHH----HHCCCCCCTTSCHHHHHHH
T ss_pred cccchhHHhhcCCcCCCchhhhHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHHhc----ccCCCCCcccCCHHHHHHH
Confidence 889999999765 3588999999999999999 8999998765544333332211 1223445667899999999
Q ss_pred HHhccCCCCCCC-----CHHHH--HHHHHhcc
Q psy5690 239 LECWKTNETDRP-----RFSEI--HLFLQRKN 263 (434)
Q Consensus 239 ~~cl~~dP~~Rp-----s~~el--~~~L~~~~ 263 (434)
.+||++||++|| +++|+ |+||++.+
T Consensus 268 ~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 268 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 999999999999 48899 78998754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=304.08 Aligned_cols=213 Identities=16% Similarity=0.215 Sum_probs=164.1
Q ss_pred CCCCCCCCeeeEEEEEec--------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5690 1 MCSLKDPNLVRVIGVCST--------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES 72 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~ 72 (434)
|++++||||+++++++.. ++..|+|||||.++.+..+.. ....+++..++.++.||+.||+|||+
T Consensus 63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~-------~~~~~~~~~~~~i~~qil~~l~~lH~ 135 (318)
T d3blha1 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEIKRVMQMLLNGLYYIHR 135 (318)
T ss_dssp HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC-------TTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh-------cccccccHHHHHHHHHHHHHHHHhcc
Confidence 457899999999999855 346899999998876655443 44678999999999999999999999
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYL 152 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 152 (434)
+||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 136 ~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~---------------------------------------~~~~ 176 (318)
T d3blha1 136 NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN---------------------------------------SQPN 176 (318)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC--------------------------------------------CC
T ss_pred CCEEecCcCchheeecCCCcEEeeecceeeecccccc---------------------------------------cccc
Confidence 9999999999999999999999999999865322111 0111
Q ss_pred cCCCCCCCccccchhhhhcC-CCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCC------
Q psy5690 153 SDTKARLPIRWMAWESLLLG-KNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLP------ 225 (434)
Q Consensus 153 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 225 (434)
......||+.|+|||++.+. .++.++||||+||++|||+ +|+.||.+....+....+..............
T Consensus 177 ~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 254 (318)
T d3blha1 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW--TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254 (318)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC--
T ss_pred cccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh--hCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhh
Confidence 22345789999999999865 6899999999999999999 89999998887776665544332211110000
Q ss_pred ---------CC---------CccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 226 ---------RP---------ATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 226 ---------~~---------~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
.. ...++++.+||.+||+.||++|||++|+ |+||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp -----CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 00 0124678899999999999999999999 889874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-39 Score=299.44 Aligned_cols=216 Identities=13% Similarity=0.157 Sum_probs=160.5
Q ss_pred CCCCCCC-eeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 2 CSLKDPN-LVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 2 ~~L~Hpn-Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
++++|+| |+.+.+++.+++..++||||+ +|+|.+.+.. ....+++..+..++.|++.||+|||++||+||||
T Consensus 57 ~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDi 129 (299)
T d1ckia_ 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF------CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDV 129 (299)
T ss_dssp HHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh------ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccC
Confidence 4566665 555566667888899999999 5577777653 3457999999999999999999999999999999
Q ss_pred CCCCeeeec---CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 81 AARNCMVGK---NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 81 kp~NILl~~---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||+|||++. +..+||+|||+|+....... ............
T Consensus 130 Kp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~------------------------------------~~~~~~~~~~~~ 173 (299)
T d1ckia_ 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDART------------------------------------HQHIPYRENKNL 173 (299)
T ss_dssp CGGGEEECCGGGTTCEEECCCSSCEECBCTTT------------------------------------CCBCCCCBCCSC
T ss_pred CHhhccccccCCCceeeeeccCcceecccccc------------------------------------ccceeccccCCc
Confidence 999999753 55799999999876433221 011112233556
Q ss_pred CCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCcccCCCCCCccHHHHHHH
Q psy5690 158 RLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSKQQYLPRPATCQKEIFDL 237 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 237 (434)
.||+.|+|||++.+..++.++|||||||++|||+ +|..||...........+..................+|+++.++
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~--tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~l 251 (299)
T d1ckia_ 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFN--LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATY 251 (299)
T ss_dssp CCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH--HSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHH
T ss_pred CCCccccCHHHHhCCCCCChhhEEecCHHHHHHH--hCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHH
Confidence 7999999999999999999999999999999999 89999988765544333222111111111111235678999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 238 MLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 238 i~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+||+.||++||+++++.+.|++.
T Consensus 252 i~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 252 LNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999998888764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=296.21 Aligned_cols=209 Identities=18% Similarity=0.243 Sum_probs=166.4
Q ss_pred CCCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q psy5690 1 MCSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDL 80 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 80 (434)
|++++||||++++++|.+.+..++|+|++.+++|..++. ....+++..+..++.|++.||+|||++||+||||
T Consensus 55 l~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~-------~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDi 127 (292)
T d1unla_ 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-------CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127 (292)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH-------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhcCcCCEEeeccccccccceeEEeeeccccccccccc-------cccccchhHHHHHHHHHHHHHHHhhcCCEeeecc
Confidence 478999999999999999999999999999999988887 4567899999999999999999999999999999
Q ss_pred CCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCCCCC
Q psy5690 81 AARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLP 160 (434)
Q Consensus 81 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~gt 160 (434)
||+|||++.++.+||+|||.++...... .......++
T Consensus 128 KP~NIli~~~~~~kl~DFG~a~~~~~~~-------------------------------------------~~~~~~~~~ 164 (292)
T d1unla_ 128 KPQNLLINRNGELKLANFGLARAFGIPV-------------------------------------------RCYSAEVVT 164 (292)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSCC-------------------------------------------SCCCSCCSC
T ss_pred cCcccccccCCceeeeecchhhcccCCC-------------------------------------------ccceeeccc
Confidence 9999999999999999999986532211 011233456
Q ss_pred ccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCC-CCChHHHHHhhhhhhhcC--------------------
Q psy5690 161 IRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYA-ELTNEQVIENCSHWYQNN-------------------- 218 (434)
Q Consensus 161 ~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~-~~~~~~~~~~~~~~~~~~-------------------- 218 (434)
..|+|||.+.... ++.++||||+||++|||+ +|..||. +.+..+....+.......
T Consensus 165 ~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T d1unla_ 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA--NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp GGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT--TTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cchhhhhHhccCCCCCchhhccccchHHHHHh--hCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccc
Confidence 7799999988765 589999999999999999 7888754 444444444332211100
Q ss_pred -CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHh
Q psy5690 219 -SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQR 261 (434)
Q Consensus 219 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~ 261 (434)
...........+++++.+|+.+||+.||++|||++|+ |+||++
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 0111112234667899999999999999999999999 789975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-39 Score=306.69 Aligned_cols=212 Identities=18% Similarity=0.218 Sum_probs=162.2
Q ss_pred CCCCCCCCeeeEEEEEecCC----ceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q psy5690 1 MCSLKDPNLVRVIGVCSTED----PISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIV 76 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~ii 76 (434)
|++|+||||+++++++.... ..+++++|+.+|+|.++++. ..+++..++.++.||+.||+|||++||+
T Consensus 60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~--------~~l~~~~i~~i~~qil~al~yLH~~~ii 131 (345)
T d1pmea_ 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSANVL 131 (345)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 45789999999999996653 23455566779999999963 2589999999999999999999999999
Q ss_pred ccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 77 HRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 77 HrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
||||||+|||++.++.+||+|||+++...... ........
T Consensus 132 HRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~----------------------------------------~~~~~~~~ 171 (345)
T d1pmea_ 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDH----------------------------------------DHTGFLTE 171 (345)
T ss_dssp CCCCCGGGEEECTTCCEEECCCTTCEECCGGG----------------------------------------CBCCTTCC
T ss_pred CCCCCcceEEECCCCCEEEcccCceeeccCCC----------------------------------------ccceeecc
Confidence 99999999999999999999999976532211 00112245
Q ss_pred CCCCccccchhhhh-cCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc------------------
Q psy5690 157 ARLPIRWMAWESLL-LGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN------------------ 217 (434)
Q Consensus 157 ~~gt~~y~aPE~~~-~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~------------------ 217 (434)
..||+.|+|||++. +..++.++||||+||++|||+ +|..||.+.+..+...........
T Consensus 172 ~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T d1pmea_ 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML--SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249 (345)
T ss_dssp CCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHH
T ss_pred ccccceechHHHhhcCCCCCchhhhhccCceehHHh--hCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccc
Confidence 67889999999985 456789999999999999999 889999887765444332211100
Q ss_pred --CCcccCC---CCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 218 --NSKQQYL---PRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 218 --~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
....... .....+++++.+|+.+||+.||++|||++|+ |+||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred ccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 0000000 0123567889999999999999999999999 7888754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.9e-39 Score=298.61 Aligned_cols=212 Identities=14% Similarity=0.142 Sum_probs=165.8
Q ss_pred CCCC-CCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 3 SLKD-PNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 3 ~L~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
.|+| +|++.+++++.+++..++||||+ +|+|.++++.. ...+++..+..++.|++.||+|||++||+|||||
T Consensus 56 ~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~------~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiK 128 (293)
T d1csna_ 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIK 128 (293)
T ss_dssp HTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred HhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhh------ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence 4554 89999999999999999999999 68999998743 3468999999999999999999999999999999
Q ss_pred CCCeeeec-----CCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCC
Q psy5690 82 ARNCMVGK-----NYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTK 156 (434)
Q Consensus 82 p~NILl~~-----~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 156 (434)
|+|||++. ++.+||+|||+|+........ ..........
T Consensus 129 p~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~------------------------------------~~~~~~~~~~ 172 (293)
T d1csna_ 129 PDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK------------------------------------QHIPYREKKN 172 (293)
T ss_dssp GGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC------------------------------------CBCCCCCCCC
T ss_pred ccceeecCcccccCCceEEcccceeEEcccCccc------------------------------------cceeecccCc
Confidence 99999974 578999999998774332210 0011112345
Q ss_pred CCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChH---HHHHhhhhhhhcCCcccCCCCCCccHHH
Q psy5690 157 ARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNE---QVIENCSHWYQNNSKQQYLPRPATCQKE 233 (434)
Q Consensus 157 ~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (434)
..||+.|||||++.+..++.++|||||||++|||+ +|..||.+.... +....+...... .........+|++
T Consensus 173 ~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell--tg~~Pf~~~~~~~~~~~~~~i~~~~~~---~~~~~l~~~~p~~ 247 (293)
T d1csna_ 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL--RGSLPWQGLKAATNKQKYERIGEKKQS---TPLRELCAGFPEE 247 (293)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH--HSSCTTSSCCSCCHHHHHHHHHHHHHH---SCHHHHTTTSCHH
T ss_pred eEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHH--hCCCcCCCccchhHHHHHHHHHhccCC---CChHHhcCCCCHH
Confidence 67999999999999999999999999999999999 899999765433 222222211111 1111113457789
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHhc
Q psy5690 234 IFDLMLECWKTNETDRPRFSEIHLFLQRK 262 (434)
Q Consensus 234 l~~li~~cl~~dP~~Rps~~el~~~L~~~ 262 (434)
+.+++..|+..+|++||+++.+.+.|++.
T Consensus 248 l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 248 FYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 99999999999999999999998877764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-38 Score=300.44 Aligned_cols=206 Identities=14% Similarity=0.176 Sum_probs=158.2
Q ss_pred CCC-CCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q psy5690 2 CSL-KDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHR 78 (434)
Q Consensus 2 ~~L-~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHr 78 (434)
+++ +||||++++++|... ...++|||||.+|+|.++. ..+++..+..++.||+.||+|||++||+||
T Consensus 84 ~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~gIvHr 153 (328)
T d3bqca1 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSMGIMHR 153 (328)
T ss_dssp HHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhcccccc
Confidence 345 499999999999744 5699999999999997654 368999999999999999999999999999
Q ss_pred CCCCCCeeeecCC-ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCCCC
Q psy5690 79 DLAARNCMVGKNY-TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDTKA 157 (434)
Q Consensus 79 Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 157 (434)
||||+|||++.++ .+||+|||+|+...... .....
T Consensus 154 DiKp~NILi~~~~~~vkl~DFG~a~~~~~~~--------------------------------------------~~~~~ 189 (328)
T d3bqca1 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--------------------------------------------EYNVR 189 (328)
T ss_dssp CCSGGGEEEETTTTEEEECCGGGCEECCTTC--------------------------------------------CCCSC
T ss_pred cccccceEEcCCCCeeeecccccceeccCCC--------------------------------------------ccccc
Confidence 9999999998755 68999999976522111 12345
Q ss_pred CCCccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH-HHHhhhhhh---------hc---------
Q psy5690 158 RLPIRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ-VIENCSHWY---------QN--------- 217 (434)
Q Consensus 158 ~gt~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~-~~~~~~~~~---------~~--------- 217 (434)
.+|..|+|||.+.+.. ++.++||||+||++|||+ +|..||....... ....+.... ..
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~--~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 267 (328)
T d3bqca1 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI--FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267 (328)
T ss_dssp CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH--HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred ccCccccCcccccCCCCCCcccchhhhhhhhHHhc--cCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence 6788999999988754 799999999999999999 8899997654322 111111000 00
Q ss_pred --C---------CcccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 218 --N---------SKQQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 218 --~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
. ...........+++++.+||.+||+.||++|||++|+ |+||+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0 0001111234567899999999999999999999999 78998754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-38 Score=302.23 Aligned_cols=207 Identities=18% Similarity=0.221 Sum_probs=161.1
Q ss_pred CCCCCCCCeeeEEEEEecC-----CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 1 MCSLKDPNLVRVIGVCSTE-----DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 1 l~~L~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
|++++|||||++++++... ...++++||+.+|+|.+++. ...+++..++.++.||+.||+|||++||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~--------~~~l~e~~~~~i~~qil~aL~~LH~~gi 142 (348)
T d2gfsa1 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--------CQKLTDDHVQFLIYQILRGLKYIHSADI 142 (348)
T ss_dssp HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc--------cccccHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3578999999999999643 33466677788999999995 2369999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+|++|||++..... ...
T Consensus 143 iHrDiKp~NILi~~~~~~kl~dfg~a~~~~~----------------------------------------------~~~ 176 (348)
T d2gfsa1 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDD----------------------------------------------EMT 176 (348)
T ss_dssp CCCCCCGGGEEECTTCCEEECCC----CCTG----------------------------------------------GGS
T ss_pred cccccCCccccccccccccccccchhcccCc----------------------------------------------ccc
Confidence 9999999999999999999999998654211 123
Q ss_pred CCCCCccccchhhhhcCC-CCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhcCCc--------------
Q psy5690 156 KARLPIRWMAWESLLLGK-NTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQNNSK-------------- 220 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~-~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 220 (434)
...|+..|+|||.+.+.. ++.++|||||||++|+|+ +|..||.+.+.......+.........
T Consensus 177 ~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll--~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (348)
T d2gfsa1 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL--TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254 (348)
T ss_dssp SSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHH--HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred cccccccccCchhhcCCccCCcccchhhhhHHHHHHH--hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence 456788899999987754 589999999999999999 899999988776665554332111100
Q ss_pred ---ccCCC------CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhcc
Q psy5690 221 ---QQYLP------RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRKN 263 (434)
Q Consensus 221 ---~~~~~------~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~~ 263 (434)
....+ ....+++++.+||.+||+.||++|||++|+ |+||++..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00000 023567899999999999999999999999 78998753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=302.80 Aligned_cols=205 Identities=18% Similarity=0.225 Sum_probs=155.7
Q ss_pred CCCCCCCeeeEEEEEec------CCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5690 2 CSLKDPNLVRVIGVCST------EDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDI 75 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~i 75 (434)
++++|||||+++++|.. ....|+|||||.+ ++.+.+. ..+++..++.++.||+.||+|||++||
T Consensus 71 ~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~---------~~~~~~~i~~~~~qil~gl~~LH~~gi 140 (355)
T d2b1pa1 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAGI 140 (355)
T ss_dssp HHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh---------cCCCHHHHHHHHHHHHHHHHHhhhccc
Confidence 56899999999999954 3678999999976 5555553 358999999999999999999999999
Q ss_pred cccCCCCCCeeeecCCceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccCC
Q psy5690 76 VHRDLAARNCMVGKNYTIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSDT 155 (434)
Q Consensus 76 iHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 155 (434)
+||||||+|||++.++.+|++|||+++..... ....
T Consensus 141 iHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~--------------------------------------------~~~~ 176 (355)
T d2b1pa1 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--------------------------------------------FMMT 176 (355)
T ss_dssp CCSCCCGGGEEECTTCCEEECCCCC-------------------------------------------------------
T ss_pred ccccCCccccccccccceeeechhhhhccccc--------------------------------------------cccc
Confidence 99999999999999999999999986542111 1223
Q ss_pred CCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHHHHHhhhhhhhc------------------
Q psy5690 156 KARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQVIENCSHWYQN------------------ 217 (434)
Q Consensus 156 ~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~~~~~~~~~~~~------------------ 217 (434)
...+|+.|+|||++.+..++.++||||+||++|||+ +|..||.+.+.......+......
T Consensus 177 ~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell--~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 254 (355)
T d2b1pa1 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254 (355)
T ss_dssp ----CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH--HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHH
T ss_pred cccccccccChhhhcCCCCCCCcccccccchHHHHh--hCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhh
Confidence 456788999999999999999999999999999999 889999887766554443221110
Q ss_pred -CCccc-----------CCC----CCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 218 -NSKQQ-----------YLP----RPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 218 -~~~~~-----------~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
..... ..+ .....++++.+|+.+||+.||++|||++|+ |+||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp TSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred cCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 00000 000 012346789999999999999999999999 8999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=2.9e-32 Score=261.94 Aligned_cols=207 Identities=17% Similarity=0.244 Sum_probs=149.3
Q ss_pred CCCCCeeeEEEEEecC--CceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCC
Q psy5690 4 LKDPNLVRVIGVCSTE--DPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLES-RDIVHRDL 80 (434)
Q Consensus 4 L~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~-~~iiHrDl 80 (434)
+.|+||+++++++... ...+++++++..+.......... ....+++..+..++.||+.||+|||+ +||+||||
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDl 152 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY----EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDI 152 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHT----TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCC
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccc----cccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccC
Confidence 3589999999998654 45667777766554443333222 45678999999999999999999997 89999999
Q ss_pred CCCCeeeecCC------ceEEccCCcccccccccccccccccccchhhhhhcccCcccceeecCccccccccCCcccccC
Q psy5690 81 AARNCMVGKNY------TIKISDHAMYCSHYESDYYLSDTKARLPIRWMANCMVGKNYTIKISDHAMYCSHYESDYYLSD 154 (434)
Q Consensus 81 kp~NILl~~~~------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 154 (434)
||+|||++.++ .++++|||.++.... ..
T Consensus 153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~----------------------------------------------~~ 186 (362)
T d1q8ya_ 153 KPENVLMEIVDSPENLIQIKIADLGNACWYDE----------------------------------------------HY 186 (362)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTB----------------------------------------------CC
T ss_pred ChhHeeeeccCcccccceeeEeeccccccccc----------------------------------------------cc
Confidence 99999998765 389999998654211 12
Q ss_pred CCCCCCccccchhhhhcCCCCCcCChHHHHHHHHHHHhhcCCCCCCCCChHH------HHHhhhhh--------------
Q psy5690 155 TKARLPIRWMAWESLLLGKNTTKSDVWSFAVTLWEILIHCNQRPYAELTNEQ------VIENCSHW-------------- 214 (434)
Q Consensus 155 ~~~~gt~~y~aPE~~~~~~~s~~sDIwSlGvil~ellt~~g~~pf~~~~~~~------~~~~~~~~-------------- 214 (434)
....||+.|+|||++.+..++.++||||+||++++|+ +|+.||....... ........
T Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~--~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~ 264 (362)
T d1q8ya_ 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI--TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY 264 (362)
T ss_dssp CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH--HSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred ccccccccccChhhccccCCCccccccchHHHHHHHH--HCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccc
Confidence 3456889999999999999999999999999999999 8899997543211 11000000
Q ss_pred ----hhcC------Cc----------ccCCCCCCccHHHHHHHHHHhccCCCCCCCCHHHH--HHHHHhc
Q psy5690 215 ----YQNN------SK----------QQYLPRPATCQKEIFDLMLECWKTNETDRPRFSEI--HLFLQRK 262 (434)
Q Consensus 215 ----~~~~------~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el--~~~L~~~ 262 (434)
.... .. ..........++++.+|+.+||+.||.+|||++|+ |+||++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 265 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred cccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 0000 00 00111234567889999999999999999999999 7899853
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.64 E-value=2.8e-17 Score=141.86 Aligned_cols=83 Identities=19% Similarity=0.146 Sum_probs=68.2
Q ss_pred CCCCCCCeeeEEEEEecCCceEEEEecCCCCCHHHHHhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q psy5690 2 CSLKDPNLVRVIGVCSTEDPISTIQEYCEFGDLSTFLQIHNCNSQENPAISYGCLIFMATQIASGMKYLESRDIVHRDLA 81 (434)
Q Consensus 2 ~~L~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~gL~yLH~~~iiHrDlk 81 (434)
.++.|.+++..+++. ..+++|||++++.+. .++...+..++.|++.||+|||++||+|||||
T Consensus 69 ~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~--------------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiK 130 (191)
T d1zara2 69 QKLQGLAVPKVYAWE----GNAVLMELIDAKELY--------------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLS 130 (191)
T ss_dssp HHTTTSSSCCEEEEE----TTEEEEECCCCEEGG--------------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHccCCCcceEEEec----CCEEEEEeecccccc--------------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCC
Confidence 357889999888763 347999999875542 24455667899999999999999999999999
Q ss_pred CCCeeeecCCceEEccCCcccc
Q psy5690 82 ARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 82 p~NILl~~~~~~kL~DFGla~~ 103 (434)
|+|||++++ .++|+|||.|+.
T Consensus 131 P~NILv~~~-~~~liDFG~a~~ 151 (191)
T d1zara2 131 QYNVLVSEE-GIWIIDFPQSVE 151 (191)
T ss_dssp TTSEEEETT-EEEECCCTTCEE
T ss_pred hhheeeeCC-CEEEEECCCccc
Confidence 999999865 589999998765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.35 E-value=0.00017 Score=63.03 Aligned_cols=29 Identities=21% Similarity=0.150 Sum_probs=25.1
Q ss_pred ccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 75 IVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 75 iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
++|+|+.|.||++++++.+-|+||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCCceEEEeechhccc
Confidence 78999999999998776667999998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.56 E-value=0.0018 Score=55.90 Aligned_cols=30 Identities=20% Similarity=0.107 Sum_probs=25.7
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999998876678999998654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.01 E-value=0.013 Score=53.99 Aligned_cols=29 Identities=17% Similarity=0.280 Sum_probs=24.7
Q ss_pred CccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 74 DIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 74 ~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++|||+.+.|||+++++ ++++||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999998764 89999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.95 E-value=0.015 Score=51.75 Aligned_cols=31 Identities=19% Similarity=0.297 Sum_probs=27.6
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.|+||+|+.++||+++.+...-+.||+.++.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999998765
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=91.66 E-value=0.086 Score=48.20 Aligned_cols=29 Identities=21% Similarity=0.290 Sum_probs=22.6
Q ss_pred ccccCCCCCCeeeec----------------------------CCceEEccCCcccc
Q psy5690 75 IVHRDLAARNCMVGK----------------------------NYTIKISDHAMYCS 103 (434)
Q Consensus 75 iiHrDlkp~NILl~~----------------------------~~~~kL~DFGla~~ 103 (434)
++|+|+.+.||++.. ++.++++||..|..
T Consensus 220 ~CHnDL~~~NiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lID~EYa~~ 276 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 276 (395)
T ss_dssp EECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEecCCCcccEeeccccccccccccccccccccccccccccCCCCcEEEEeecccCC
Confidence 689999999999843 46789999987643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=90.09 E-value=0.15 Score=45.20 Aligned_cols=29 Identities=17% Similarity=-0.082 Sum_probs=23.6
Q ss_pred CCccccCCCCCCeeeecCCceEEccCCcccc
Q psy5690 73 RDIVHRDLAARNCMVGKNYTIKISDHAMYCS 103 (434)
Q Consensus 73 ~~iiHrDlkp~NILl~~~~~~kL~DFGla~~ 103 (434)
.++||+|+.+.|||+++ + ..++||+-++.
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999964 3 45899998764
|